,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
11091,GO:0043209,0,1,9,45,myelin sheath,CC,PLLP;TUBB4A;MAG;PLP1;ERMN;MYO1D;CNTN2;MBP;GJC2
3673,GO:0007272,2.03946549741701e-14,1,15,134,ensheathment of neurons,BP,CLDN11;BCAS1;SOX10;PLLP;FA2H;MAG;PLP1;MYRF;GAL3ST1;NKX6-2;KLK6;MAL;UGT8;CNTN2;MBP
4020,GO:0008366,2.03946549741701e-14,1,15,134,axon ensheathment,BP,CLDN11;BCAS1;SOX10;PLLP;FA2H;MAG;PLP1;MYRF;GAL3ST1;NKX6-2;KLK6;MAL;UGT8;CNTN2;MBP
10754,GO:0042552,3.38719896544423e-13,1,14,132,myelination,BP,BCAS1;SOX10;PLLP;FA2H;MAG;PLP1;MYRF;GAL3ST1;NKX6-2;KLK6;MAL;UGT8;CNTN2;MBP
6995,GO:0022010,4.73523547343154e-11,1,7,21,central nervous system myelination,BP,SOX10;FA2H;MAG;PLP1;MYRF;NKX6-2;CNTN2
8279,GO:0032291,4.73523547343154e-11,1,7,21,axon ensheathment in central nervous system,BP,SOX10;FA2H;MAG;PLP1;MYRF;NKX6-2;CNTN2
3675,GO:0007275,1.03983702262728e-09,0.999999999725379,61,4743,multicellular organism development,BP,CRLF1;ANLN;CLDN11;STMN4;NGFR;EYA2;BCAS1;ERBB3;FGFR3;CDH19;DCX;LRP2;TF;CAPN3;SOX10;PLLP;FA2H;MAG;BVES;PPL;TRIM67;GJB6;LDB3;PLP1;MYRF;GAL3ST1;RPS4Y1;HAPLN2;PDGFRA;GPNMB;RAPGEF5;ENPP2;MOG;PCSK6;EGFR;NKX6-2;ANK3;GJA1;FZD7;ACAN;SLC45A3;ADAMTS4;EDIL3;CTHRC1;GREM1;KLK6;MOBP;GJB1;SGCD;KNDC1;MAL;DMRT2;UGT8;MYO1D;BOK;CNTN2;GLDN;APOD;MYT1;MBP;GJC2
6687,GO:0019911,1.49759187432628e-09,0.999999999993346,5,10,structural constituent of myelin sheath,MF,PLLP;PLP1;MOBP;MAL;MBP
13088,GO:0048731,1.86465600572078e-09,0.999999999478294,57,4260,system development,BP,CRLF1;ANLN;CLDN11;STMN4;NGFR;BCAS1;ERBB3;FGFR3;DCX;LRP2;TF;CAPN3;SOX10;PLLP;FA2H;MAG;BVES;PPL;TRIM67;GJB6;LDB3;PLP1;MYRF;GAL3ST1;HAPLN2;PDGFRA;GPNMB;RAPGEF5;ENPP2;MOG;PCSK6;EGFR;NKX6-2;ANK3;GJA1;FZD7;ACAN;SLC45A3;ADAMTS4;CTHRC1;GREM1;KLK6;MOBP;GJB1;SGCD;KNDC1;MAL;DMRT2;UGT8;MYO1D;BOK;CNTN2;GLDN;APOD;MYT1;MBP;GJC2
3715,GO:0007399,2.46583311548783e-09,0.999999999367978,40,2236,nervous system development,BP,CLDN11;STMN4;NGFR;BCAS1;ERBB3;DCX;LRP2;SOX10;PLLP;FA2H;MAG;TRIM67;PLP1;MYRF;GAL3ST1;HAPLN2;RAPGEF5;MOG;EGFR;NKX6-2;ANK3;GJA1;FZD7;ACAN;SLC45A3;CTHRC1;KLK6;MOBP;GJB1;KNDC1;MAL;UGT8;MYO1D;BOK;CNTN2;GLDN;APOD;MYT1;MBP;GJC2
13142,GO:0048856,2.72200821100999e-09,0.999999999231829,63,5145,anatomical structure development,BP,CRLF1;ANLN;CLDN11;STMN4;NGFR;EYA2;BCAS1;ERBB3;FGFR3;CDH19;DCX;LRP2;TF;CAPN3;SOX10;PLLP;FA2H;MAG;BVES;PPL;TRIM67;GJB6;LDB3;PLP1;MYRF;GAL3ST1;RPS4Y1;HAPLN2;PDGFRA;CPM;GPNMB;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;NKX6-2;ANK3;GJA1;FZD7;ACAN;SLC45A3;ADAMTS4;EDIL3;CTHRC1;GREM1;KLK6;MOBP;GJB1;SGCD;KNDC1;MAL;DMRT2;UGT8;MYO1D;BOK;CNTN2;GLDN;APOD;MYT1;MBP;GJC2
5087,GO:0014003,1.0614090967693e-08,0.999999999712618,7,44,oligodendrocyte development,BP,SOX10;FA2H;MAG;PLP1;MYRF;NKX6-2;CNTN2
13079,GO:0048709,1.62039356647748e-08,0.99999999914619,9,100,oligodendrocyte differentiation,BP,SOX10;FA2H;MAG;PLP1;MYRF;NKX6-2;SLC45A3;BOK;CNTN2
3726,GO:0007417,2.43427669043023e-08,0.999999994935475,24,965,central nervous system development,BP,NGFR;DCX;LRP2;SOX10;FA2H;MAG;PLP1;MYRF;HAPLN2;MOG;EGFR;NKX6-2;ACAN;SLC45A3;KLK6;KNDC1;MAL;UGT8;MYO1D;BOK;CNTN2;APOD;MBP;GJC2
8443,GO:0032502,2.44112235870824e-08,0.999999992503178,64,5572,developmental process,BP,CRLF1;BAIAP3;ANLN;CLDN11;STMN4;NGFR;EYA2;BCAS1;ERBB3;FGFR3;CDH19;DCX;LRP2;TF;CAPN3;SOX10;PLLP;FA2H;MAG;BVES;PPL;TRIM67;GJB6;LDB3;PLP1;MYRF;GAL3ST1;RPS4Y1;HAPLN2;PDGFRA;CPM;GPNMB;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;NKX6-2;ANK3;GJA1;FZD7;ACAN;SLC45A3;ADAMTS4;EDIL3;CTHRC1;GREM1;KLK6;MOBP;GJB1;SGCD;KNDC1;MAL;DMRT2;UGT8;MYO1D;BOK;CNTN2;GLDN;APOD;MYT1;MBP;GJC2
11530,GO:0044304,3.50971088748569e-08,0.99999999843238,8,66,main axon,CC,TUBB4A;MAG;ERMN;ANK3;MYO1D;CNTN2;MBP;GJC2
10529,GO:0042063,4.24198251559178e-08,0.999999995246656,13,282,gliogenesis,BP,ERBB3;LRP2;SOX10;FA2H;MAG;PLP1;MYRF;EGFR;NKX6-2;SLC45A3;BOK;CNTN2;GJC2
4620,GO:0010001,1.82936830705375e-07,0.99999998143424,11,217,glial cell differentiation,BP,ERBB3;SOX10;FA2H;MAG;PLP1;MYRF;EGFR;NKX6-2;SLC45A3;BOK;CNTN2
2462,GO:0005198,3.80515670859226e-07,0.999999934161078,16,580,structural molecule activity,MF,CLDN11;CAPN3;PLLP;TUBB4A;BVES;PPL;PLP1;RPS4Y1;ANK3;ACAN;EDIL3;CTHRC1;MOBP;MAL;MBP;COL28A1
16474,GO:0071944,6.77017176370135e-07,0.999999762775117,53,4460,cell periphery,CC,CRLF1;BAIAP3;ANLN;CLDN11;NGFR;ERBB3;FGFR3;CDH19;LRP2;NKAIN1;FOLH1;TF;CAPN3;MLC1;MAG;BVES;PLCL1;ATP10B;PPL;GJB6;PLP1;GAL3ST1;PDGFRA;CPM;GPNMB;ERMN;ENPP2;MOG;PCSK6;EGFR;ANK3;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SLC45A3;SLC5A11;MOBP;GJB1;SGCD;MAL;UGT8;MYO1D;GPR62;CNTN2;ANKS1B;GLDN;NKAIN2;DAPK1;MBP;GJC2;TMEM88B
6878,GO:0021782,7.7027904799048e-07,0.999999945393989,8,113,glial cell development,BP,SOX10;FA2H;MAG;PLP1;MYRF;EGFR;NKX6-2;CNTN2
2483,GO:0005243,8.40405084023081e-07,0.999999991064571,4,14,gap junction channel activity,MF,GJB6;GJA1;GJB1;GJC2
2821,GO:0005922,8.40405084023081e-07,0.999999991064571,4,14,connexin complex,CC,GJB6;GJA1;GJB1;GJC2
18205,GO:0099612,8.79908496240447e-07,0.999999991598658,4,10,protein localization to axon,BP,ANK3;MAL;UGT8;CNTN2
8902,GO:0033269,1.23500399291056e-06,0.999999997942236,3,4,internode region of axon,CC,TUBB4A;ERMN;MBP
8442,GO:0032501,2.64179127496843e-06,0.999999029310262,64,6269,multicellular organismal process,BP,CRLF1;ANLN;CLDN11;STMN4;NGFR;EYA2;BCAS1;ERBB3;FGFR3;CDH19;DCX;LRP2;TF;CAPN3;SOX10;PLLP;FA2H;MAG;BVES;PLCL1;PPL;TRIM67;GJB6;LDB3;PLP1;MYRF;GAL3ST1;RPS4Y1;HAPLN2;PDGFRA;GPNMB;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;NKX6-2;ANK3;GJA1;PIEZO2;FZD7;ACAN;SLC45A3;ADAMTS4;EDIL3;CTHRC1;GREM1;KLK6;MOBP;GJB1;SGCD;KNDC1;MAL;DMRT2;UGT8;MYO1D;BOK;CNTN2;GLDN;APOD;MYT1;MBP;GJC2
20039,GO:1903763,2.71335647628961e-06,0.999999991330067,3,5,gap junction channel activity involved in cell communication by electrical coupling,MF,GJB6;GJA1;GJC2
3320,GO:0006682,3.77171750928214e-06,0.999999983982633,3,6,galactosylceramide biosynthetic process,BP,FA2H;GAL3ST1;UGT8
6506,GO:0019375,3.77171750928214e-06,0.999999983982633,3,6,galactolipid biosynthetic process,BP,FA2H;GAL3ST1;UGT8
12943,GO:0048468,5.32914744392929e-06,0.999998251427552,31,1970,cell development,BP,STMN4;NGFR;DCX;LRP2;CAPN3;SOX10;FA2H;MAG;BVES;TRIM67;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;EGFR;NKX6-2;ANK3;GJA1;FZD7;ACAN;SLC45A3;CTHRC1;KLK6;SGCD;KNDC1;UGT8;CNTN2;GLDN;APOD;GJC2
7044,GO:0022829,5.70680648607166e-06,0.99999989198494,4,22,wide pore channel activity,MF,GJB6;GJA1;GJB1;GJC2
2799,GO:0005886,6.2737425737936e-06,0.999997599589095,50,4367,plasma membrane,CC,CRLF1;BAIAP3;CLDN11;NGFR;ERBB3;FGFR3;CDH19;LRP2;NKAIN1;FOLH1;TF;CAPN3;MLC1;MAG;BVES;PLCL1;ATP10B;PPL;GJB6;PLP1;GAL3ST1;PDGFRA;CPM;GPNMB;ENPP2;MOG;PCSK6;EGFR;ANK3;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SLC45A3;SLC5A11;GJB1;SGCD;MAL;UGT8;MYO1D;GPR62;CNTN2;ANKS1B;GLDN;NKAIN2;DAPK1;MBP;GJC2;TMEM88B
5096,GO:0014013,8.52847096760868e-06,0.999999318274616,7,113,regulation of gliogenesis,BP,LRP2;SOX10;MAG;NKX6-2;SLC45A3;CNTN2;GJC2
2820,GO:0005921,9.72292673747092e-06,0.999999787792532,4,23,gap junction,CC,GJB6;GJA1;GJB1;GJC2
12361,GO:0046476,1.0725207076626e-05,0.999999923510719,3,8,glycosylceramide biosynthetic process,BP,FA2H;GAL3ST1;UGT8
6993,GO:0022008,1.58222928398835e-05,0.999994918868332,26,1553,neurogenesis,BP,STMN4;NGFR;ERBB3;DCX;LRP2;SOX10;FA2H;MAG;TRIM67;PLP1;MYRF;EGFR;NKX6-2;ANK3;GJA1;FZD7;SLC45A3;CTHRC1;KLK6;KNDC1;UGT8;BOK;CNTN2;GLDN;APOD;GJC2
13152,GO:0048869,1.60425295324133e-05,0.999993732194569,44,3702,cellular developmental process,BP,ANLN;STMN4;NGFR;EYA2;ERBB3;FGFR3;DCX;LRP2;TF;CAPN3;SOX10;FA2H;MAG;BVES;PPL;TRIM67;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;GPNMB;ENPP2;PCSK6;EGFR;NKX6-2;ANK3;GJA1;FZD7;ACAN;SLC45A3;CTHRC1;GREM1;KLK6;SGCD;KNDC1;MAL;UGT8;BOK;CNTN2;GLDN;APOD;MYT1;GJC2
3319,GO:0006681,1.61602354504701e-05,0.999999861323276,3,9,galactosylceramide metabolic process,BP,FA2H;GAL3ST1;UGT8
6505,GO:0019374,1.61602354504701e-05,0.999999861323276,3,9,galactolipid metabolic process,BP,FA2H;GAL3ST1;UGT8
4613,GO:0009986,1.95062229223379e-05,0.999995350515545,16,730,cell surface,CC,CRLF1;NGFR;FGFR3;LRP2;FOLH1;TF;PDGFRA;CPM;MOG;PCSK6;EGFR;ANK3;GREM1;CNTN2;GLDN;MBP
7177,GO:0030154,2.57306296406291e-05,0.999989763713596,43,3636,cell differentiation,BP,ANLN;STMN4;NGFR;EYA2;ERBB3;FGFR3;DCX;LRP2;TF;CAPN3;SOX10;FA2H;MAG;BVES;PPL;TRIM67;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;GPNMB;PCSK6;EGFR;NKX6-2;ANK3;GJA1;FZD7;ACAN;SLC45A3;CTHRC1;GREM1;KLK6;SGCD;KNDC1;MAL;UGT8;BOK;CNTN2;GLDN;APOD;MYT1;GJC2
6644,GO:0019838,2.7225606184185e-05,0.999997380841284,7,124,growth factor binding,MF,NGFR;ERBB3;FGFR3;LRP2;PDGFRA;PCSK6;EGFR
3589,GO:0007155,3.79907068027803e-05,0.999988182975072,22,1261,cell adhesion,BP,CLDN11;ERBB3;CDH19;MAG;BVES;HAPLN2;PDGFRA;GPNMB;MOG;EGFR;ANK3;CNTNAP4;FZD7;ACAN;EDIL3;GREM1;SUSD5;CNTN2;GLDN;APOD;MBP;COL28A1
7028,GO:0022610,4.0863555591987e-05,0.999987223398061,22,1267,biological adhesion,BP,CLDN11;ERBB3;CDH19;MAG;BVES;HAPLN2;PDGFRA;GPNMB;MOG;EGFR;ANK3;CNTNAP4;FZD7;ACAN;EDIL3;GREM1;SUSD5;CNTN2;GLDN;APOD;MBP;COL28A1
5759,GO:0016264,5.62849717949656e-05,0.99999919913153,3,12,gap junction assembly,BP,GJB6;GJA1;GJB1
4817,GO:0010644,6.40549620794638e-05,0.9999976566273,4,30,cell communication by electrical coupling,BP,GJB6;ANK3;GJA1;GJC2
7702,GO:0031224,7.12002677411805e-05,0.999969909571747,45,4199,intrinsic component of membrane,CC,CLDN11;NGFR;ERBB3;FGFR3;CDH19;LRP2;NKAIN1;FOLH1;MLC1;PLLP;FA2H;MAG;BVES;ATP10B;GJB6;PLP1;MYRF;GAL3ST1;PDGFRA;CPM;GPNMB;MOG;EGFR;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SLC45A3;SLC5A11;TMEM144;GJB1;SGCD;MAL;SUSD5;UGT8;BOK;TMEM125;TMEM151A;GPR62;CNTN2;GLDN;NKAIN2;GJC2;TMEM88B
11094,GO:0043218,7.57640079578513e-05,0.999998768324883,3,14,compact myelin,CC,PLLP;MAG;MBP
2815,GO:0005911,7.70051572124438e-05,0.999983608343304,12,449,cell-cell junction,CC,CLDN11;NGFR;CDH19;MLC1;BVES;PPL;GJB6;LDB3;ANK3;GJA1;GJB1;GJC2
5098,GO:0014015,8.05382108199968e-05,0.999994757350481,5,70,positive regulation of gliogenesis,BP,LRP2;SOX10;MAG;NKX6-2;GJC2
13092,GO:0048738,8.99504962382969e-05,0.999987393562276,8,197,cardiac muscle tissue development,BP,ERBB3;LRP2;BVES;PDGFRA;GJA1;FZD7;GREM1;SGCD
8903,GO:0033270,9.85747986026764e-05,0.999998303284546,3,12,paranode region of axon,CC,MAG;ERMN;GJC2
11802,GO:0045178,0.000118401762233774,0.999991651453962,5,66,basal part of cell,CC,CLDN11;ERBB3;TF;EGFR;ANK3
4579,GO:0009888,0.000145944759234093,0.999946769173934,25,1738,tissue development,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;CAPN3;SOX10;FA2H;BVES;PPL;HAPLN2;PDGFRA;GPNMB;PCSK6;EGFR;GJA1;FZD7;ACAN;CTHRC1;GREM1;KLK6;SGCD;DMRT2;APOD
3315,GO:0006677,0.000158962761752646,0.999996537439634,3,18,glycosylceramide metabolic process,BP,FA2H;GAL3ST1;UGT8
5635,GO:0016021,0.000169969241406255,0.999925423138518,43,4061,integral component of membrane,CC,CLDN11;NGFR;ERBB3;FGFR3;CDH19;LRP2;NKAIN1;FOLH1;MLC1;PLLP;FA2H;MAG;BVES;ATP10B;GJB6;PLP1;MYRF;GAL3ST1;PDGFRA;GPNMB;MOG;EGFR;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SLC45A3;SLC5A11;TMEM144;GJB1;SGCD;MAL;SUSD5;UGT8;BOK;TMEM125;TMEM151A;GPR62;GLDN;NKAIN2;GJC2;TMEM88B
3729,GO:0007422,0.000170305287288043,0.999986947389835,5,74,peripheral nervous system development,BP,ERBB3;SOX10;FA2H;HAPLN2;UGT8
12531,GO:0046849,0.000216420933680313,0.999982444163045,5,84,bone remodeling,BP,TF;EGFR;GJA1;CTHRC1;GREM1
15653,GO:0070447,0.00022161776693641,0.999999369380932,2,3,positive regulation of oligodendrocyte progenitor proliferation,BP,LRP2;GJC2
7943,GO:0031641,0.000227298321030218,0.999988071428995,4,44,regulation of myelination,BP,SOX10;MAG;MYRF;NKX6-2
7945,GO:0031643,0.000243406525705419,0.999993867070921,3,18,positive regulation of myelination,BP,SOX10;MAG;MYRF
21065,GO:1905867,0.000268771083412008,0.999998617217824,2,5,epididymis development,BP,GJA1;GJB1
8274,GO:0032286,0.000283504471938046,0.999998709624797,2,4,central nervous system myelin maintenance,BP,FA2H;MYRF
3545,GO:0007043,0.000298588583599806,0.999965308112906,6,132,cell-cell junction assembly,BP,CLDN11;CDH19;GJB6;GJA1;GJB1;UGT8
9552,GO:0035051,0.000330618693495929,0.999960873725244,6,128,cardiocyte differentiation,BP,BVES;PDGFRA;EGFR;FZD7;GREM1;SGCD
2602,GO:0005540,0.00033170188989113,0.999990581539199,3,20,hyaluronic acid binding,MF,HAPLN2;ACAN;SUSD5
13071,GO:0048699,0.000377052149053211,0.999860982996397,22,1455,generation of neurons,BP,STMN4;NGFR;DCX;LRP2;SOX10;MAG;TRIM67;PLP1;EGFR;NKX6-2;ANK3;GJA1;FZD7;SLC45A3;CTHRC1;KLK6;KNDC1;UGT8;CNTN2;GLDN;APOD;GJC2
7349,GO:0030424,0.000386561750526963,0.999895401072837,13,612,axon,CC,CLDN11;STMN4;NGFR;LRP2;TUBB4A;MAG;ERMN;ANK3;MYO1D;CNTN2;GLDN;MBP;GJC2
7106,GO:0030030,0.00041568720362983,0.999845569019344,22,1465,cell projection organization,BP,ANLN;STMN4;NGFR;DCX;LRP2;TUBB4A;MAG;TRIM67;PLP1;ERMN;ENPP2;EGFR;ANK3;GJA1;CTHRC1;KLK6;KNDC1;UGT8;CNTN2;GLDN;DNAH17;APOD
13108,GO:0048771,0.000462429343002374,0.999941487928555,6,148,tissue remodeling,BP,TF;GPNMB;EGFR;GJA1;CTHRC1;GREM1
4595,GO:0009925,0.000497704468676374,0.999967617794907,4,50,basal plasma membrane,CC,ERBB3;TF;EGFR;ANK3
3326,GO:0006688,0.000515667775669285,0.999982557503567,3,25,glycosphingolipid biosynthetic process,BP,FA2H;GAL3ST1;UGT8
885,GO:0002175,0.000523003897055257,0.999996234596629,2,5,protein localization to paranode region of axon,BP,MAL;UGT8
10596,GO:0042246,0.000531133371946457,0.999964461773629,4,63,tissue regeneration,BP,CAPN3;FZD7;KLK6;APOD
12940,GO:0048406,0.000558365392406138,0.999995844783256,2,5,nerve growth factor binding,MF,NGFR;PCSK6
13638,GO:0051247,0.000609373157420975,0.999771500210039,21,1511,positive regulation of protein metabolic process,BP,CRLF1;NGFR;ERBB3;FGFR3;LRP2;TF;CAPN3;TRIM67;PDGFRA;GPNMB;ENPP2;EGFR;ST18;GJA1;FZD7;GREM1;KNDC1;BOK;CNTN2;DAPK1;MBP
5148,GO:0014706,0.000652144440900372,0.999861226504559,9,343,striated muscle tissue development,BP,EYA2;ERBB3;LRP2;BVES;PDGFRA;GJA1;FZD7;GREM1;SGCD
18440,GO:0120036,0.000778630373447324,0.999702189232754,21,1426,plasma membrane bounded cell projection organization,BP,ANLN;STMN4;NGFR;DCX;LRP2;TUBB4A;MAG;TRIM67;PLP1;ENPP2;EGFR;ANK3;GJA1;CTHRC1;KLK6;KNDC1;UGT8;CNTN2;GLDN;DNAH17;APOD
7652,GO:0031099,0.000779923192882986,0.999890590240513,6,174,regeneration,BP,CAPN3;MAG;EGFR;FZD7;KLK6;APOD
15476,GO:0070161,0.000805697140826329,0.999751822976597,14,776,anchoring junction,CC,CLDN11;NGFR;FGFR3;CDH19;MLC1;BVES;PPL;GJB6;LDB3;EGFR;ANK3;GJA1;GJB1;GJC2
4529,GO:0009653,0.000808331981870806,0.999644604188063,30,2472,anatomical structure morphogenesis,BP,NGFR;EYA2;FGFR3;CDH19;LRP2;CAPN3;SOX10;MAG;BVES;GJB6;LDB3;PDGFRA;CPM;GPNMB;ERMN;ENPP2;EGFR;ANK3;GJA1;FZD7;ACAN;CTHRC1;GREM1;SGCD;KNDC1;DMRT2;UGT8;CNTN2;APOD;MBP
8262,GO:0032270,0.000813880801120491,0.999694415944906,20,1437,positive regulation of cellular protein metabolic process,BP,CRLF1;NGFR;ERBB3;FGFR3;LRP2;TF;CAPN3;TRIM67;PDGFRA;GPNMB;ENPP2;EGFR;ST18;FZD7;GREM1;KNDC1;BOK;CNTN2;DAPK1;MBP
11997,GO:0045685,0.000881585411228813,0.999932232482813,4,68,regulation of glial cell differentiation,BP,MAG;NKX6-2;SLC45A3;CNTN2
14651,GO:0060537,0.000944523260933321,0.999788022855906,9,361,muscle tissue development,BP,EYA2;ERBB3;LRP2;BVES;PDGFRA;GJA1;FZD7;GREM1;SGCD
9140,GO:0034103,0.000949376277842928,0.999925590525399,4,67,regulation of tissue remodeling,BP,TF;GPNMB;EGFR;GREM1
14190,GO:0055007,0.000951201468213699,0.999892422809563,5,102,cardiac muscle cell differentiation,BP,BVES;PDGFRA;FZD7;GREM1;SGCD
5795,GO:0016328,0.000987367737661852,0.99992197530595,4,63,lateral plasma membrane,CC,ERBB3;BVES;ANK3;GJB1
11773,GO:0045121,0.0011565801941616,0.999760085933947,8,309,membrane raft,CC,MLC1;PLLP;MAG;BVES;EGFR;GJA1;MAL;MYO1D
13035,GO:0048646,0.00115852957902285,0.999599087924047,16,998,anatomical structure formation involved in morphogenesis,BP,NGFR;EYA2;LRP2;CAPN3;LDB3;PDGFRA;GPNMB;ENPP2;GJA1;FZD7;CTHRC1;GREM1;KNDC1;DMRT2;UGT8;APOD
17923,GO:0098857,0.00118837439777529,0.999752429133294,8,310,membrane microdomain,CC,MLC1;PLLP;MAG;BVES;EGFR;GJA1;MAL;MYO1D
12965,GO:0048513,0.00119473920430669,0.999441206239911,34,3112,animal organ development,BP,CRLF1;ANLN;NGFR;ERBB3;FGFR3;DCX;LRP2;TF;CAPN3;SOX10;FA2H;BVES;PPL;GJB6;LDB3;PLP1;PDGFRA;GPNMB;PCSK6;EGFR;NKX6-2;GJA1;FZD7;ACAN;CTHRC1;GREM1;SGCD;KNDC1;MYO1D;BOK;CNTN2;APOD;MBP;GJC2
12090,GO:0045862,0.00121674621192706,0.999745358828961,8,334,positive regulation of proteolysis,BP,NGFR;CAPN3;TRIM67;ST18;BOK;CNTN2;DAPK1;MBP
2162,GO:0004714,0.00122523195137187,0.99989748799895,4,61,transmembrane receptor protein tyrosine kinase activity,MF,ERBB3;FGFR3;PDGFRA;EGFR
11106,GO:0043235,0.00123038996804992,0.99971306789406,9,372,receptor complex,CC,CRLF1;ERBB3;FGFR3;LRP2;TF;PEX5L;PDGFRA;EGFR;GPR62
5304,GO:0015144,0.00125405440232127,0.999940914922601,3,34,carbohydrate transmembrane transporter activity,MF,SLC45A3;SLC5A11;TMEM144
4722,GO:0010470,0.00125468784510554,0.99994110862308,3,32,regulation of gastrulation,BP,GJA1;FZD7;MBP
13043,GO:0048666,0.00135175362534078,0.999509661476973,17,1073,neuron development,BP,STMN4;NGFR;DCX;LRP2;MAG;TRIM67;PLP1;EGFR;ANK3;GJA1;CTHRC1;KLK6;KNDC1;UGT8;CNTN2;GLDN;APOD
3747,GO:0007507,0.00136448685101458,0.999621186225632,11,529,heart development,BP,ERBB3;LRP2;BVES;LDB3;PDGFRA;EGFR;GJA1;FZD7;ACAN;GREM1;SGCD
4709,GO:0010454,0.00142091366749144,0.999978331102136,2,11,negative regulation of cell fate commitment,BP,NKX6-2;FZD7
9834,GO:0035633,0.00146658091285793,0.999927159798854,3,33,maintenance of blood-brain barrier,BP,GJB6;GJA1;MBP
17778,GO:0098589,0.00148187616545121,0.999680212874359,8,321,membrane region,CC,MLC1;PLLP;MAG;BVES;EGFR;GJA1;MAL;MYO1D
16059,GO:0071260,0.00149920672552344,0.999866362395144,4,77,cellular response to mechanical stimulus,BP,MAG;EGFR;GJA1;PIEZO2
2601,GO:0005539,0.00152929303473949,0.999755073693107,6,190,glycosaminoglycan binding,MF,HAPLN2;GPNMB;PCSK6;ACAN;SUSD5;SPOCK3
1861,GO:0004180,0.00153057514112608,0.999922295697624,3,37,carboxypeptidase activity,MF,FOLH1;CPM;CNDP1
15650,GO:0070444,0.00154510742374402,0.999977007040172,2,8,oligodendrocyte progenitor proliferation,BP,LRP2;GJC2
15651,GO:0070445,0.00154510742374402,0.999977007040172,2,8,regulation of oligodendrocyte progenitor proliferation,BP,LRP2;GJC2
13078,GO:0048708,0.00160850793733633,0.999853903056021,4,76,astrocyte differentiation,BP,MAG;PLP1;EGFR;CNTN2
8238,GO:0032228,0.00164529463622522,0.999914928700665,3,33,regulation of synaptic transmission, GABAergic,BP,BAIAP3;PLCL1;CNTNAP4
13586,GO:0051146,0.00169037483491969,0.99967298608004,7,250,striated muscle cell differentiation,BP,CAPN3;BVES;LDB3;PDGFRA;FZD7;GREM1;SGCD
5793,GO:0016324,0.00170950824224419,0.99962262824471,8,320,apical plasma membrane,CC,ERBB3;LRP2;TF;MLC1;GJB6;EGFR;GJA1;MAL
14925,GO:0061024,0.0017211771713887,0.999449543205344,13,778,membrane organization,BP,EYA2;LRP2;TF;FA2H;ATP10B;MYRF;EGFR;ANK3;MAL;BOK;CNTN2;GLDN;MBP
7200,GO:0030182,0.00176674767999675,0.999306501140009,19,1314,neuron differentiation,BP,STMN4;NGFR;DCX;LRP2;MAG;TRIM67;PLP1;EGFR;NKX6-2;ANK3;GJA1;FZD7;CTHRC1;KLK6;KNDC1;UGT8;CNTN2;GLDN;APOD
10555,GO:0042127,0.00180027872946139,0.999291830761051,19,1452,regulation of cell population proliferation,BP,CRLF1;NGFR;ERBB3;FGFR3;LRP2;SOX10;FA2H;GJB6;PDGFRA;GPNMB;EGFR;ST18;GJA1;FZD7;CTHRC1;GREM1;BOK;APOD;GJC2
3968,GO:0008284,0.00190296997988275,0.99938416581642,13,815,positive regulation of cell population proliferation,BP,CRLF1;NGFR;ERBB3;FGFR3;LRP2;SOX10;PDGFRA;EGFR;GJA1;FZD7;CTHRC1;GREM1;GJC2
14400,GO:0060191,0.00198977295347458,0.999807855872718,4,84,regulation of lipase activity,BP,FGFR3;PDGFRA;PCSK6;EGFR
11035,GO:0043121,0.00204401729140078,0.999963923382074,2,9,neurotrophin binding,MF,NGFR;PCSK6
11828,GO:0045216,0.00212878312687696,0.999636076545919,6,188,cell-cell junction organization,BP,CLDN11;CDH19;GJB6;GJA1;GJB1;UGT8
14205,GO:0055024,0.00216453952505747,0.999786481743875,4,79,regulation of cardiac muscle tissue development,BP,ERBB3;GJA1;FZD7;GREM1
17483,GO:0097191,0.00235451792348725,0.999588482823514,6,215,extrinsic apoptotic signaling pathway,BP,EYA2;ERBB3;FGFR3;MAL;BOK;DAPK1
7123,GO:0030054,0.0024216372070804,0.99892688274417,24,1935,cell junction,CC,BAIAP3;CLDN11;NGFR;BCAS1;FGFR3;CDH19;MLC1;BVES;PPL;GJB6;LDB3;PLP1;PDGFRA;EGFR;ANK3;GJA1;CNTNAP4;ACAN;LGI3;GJB1;CNTN2;ANKS1B;MBP;GJC2
10970,GO:0043005,0.00243798187960792,0.999037517696267,18,1264,neuron projection,CC,CLDN11;STMN4;NGFR;DCX;LRP2;TUBB4A;MAG;ERMN;ANK3;LGI3;KNDC1;MYO1D;CNTN2;ANKS1B;GLDN;APOD;MBP;GJC2
7688,GO:0031175,0.00272802458019578,0.999003706697681,15,947,neuron projection development,BP,STMN4;NGFR;LRP2;MAG;TRIM67;PLP1;EGFR;ANK3;GJA1;CTHRC1;KLK6;KNDC1;UGT8;CNTN2;APOD
5041,GO:0010950,0.00293836398539122,0.99956612947691,5,160,positive regulation of endopeptidase activity,BP,NGFR;ST18;BOK;DAPK1;MBP
13319,GO:0050730,0.00294145950105588,0.999462230137274,6,221,regulation of peptidyl-tyrosine phosphorylation,BP,CRLF1;ERBB3;FGFR3;ENPP2;EGFR;GREM1
8752,GO:0032989,0.00303025291582063,0.99896506665766,13,756,cellular component morphogenesis,BP,NGFR;LRP2;CAPN3;MAG;LDB3;PDGFRA;ENPP2;EGFR;ANK3;GJA1;KNDC1;UGT8;CNTN2
3750,GO:0007517,0.00304011027840174,0.999262702708274,8,356,muscle organ development,BP,ERBB3;LRP2;CAPN3;BVES;GJA1;FZD7;GREM1;SGCD
6433,GO:0019199,0.00310671165496723,0.999661488051936,4,78,transmembrane receptor protein kinase activity,MF,ERBB3;FGFR3;PDGFRA;EGFR
21468,GO:2000026,0.00315097636543576,0.998593784959406,23,1889,regulation of multicellular organismal development,BP,NGFR;ERBB3;LRP2;CAPN3;SOX10;MAG;TRIM67;MYRF;GPNMB;ENPP2;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;CTHRC1;GREM1;KLK6;KNDC1;DMRT2;CNTN2;MBP;GJC2
13971,GO:0051897,0.00316339490364932,0.999525370763054,5,150,positive regulation of protein kinase B signaling,BP,ERBB3;FGFR3;LRP2;PDGFRA;EGFR
2587,GO:0005516,0.00317052140588865,0.999412868723698,6,189,calmodulin binding,MF,NGFR;EGFR;PHKG1;MYO1D;DAPK1;MBP
17885,GO:0098797,0.00327268911800461,0.99904521572806,10,538,plasma membrane protein complex,CC,ERBB3;CDH19;TF;GJB6;EGFR;GJA1;KCNJ6;GJB1;SGCD;GJC2
5050,GO:0010960,0.00328375150313384,0.999923235543903,2,11,magnesium ion homeostasis,BP,EGFR;ANK3
17852,GO:0098737,0.00328618134268604,1,1,1,protein insertion into plasma membrane,BP,MAL
18425,GO:0120003,0.00328618134268604,1,1,1,hinge region between urothelial plaques of apical plasma membrane,CC,MAL
12532,GO:0046850,0.00330195991877622,0.999778020813154,3,45,regulation of bone remodeling,BP,TF;EGFR;GREM1
13355,GO:0050793,0.00334296662831248,0.99841996583668,27,2379,regulation of developmental process,BP,NGFR;ERBB3;FGFR3;LRP2;CAPN3;SOX10;MAG;BVES;TRIM67;MYRF;PDGFRA;GPNMB;ERMN;ENPP2;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;CTHRC1;GREM1;KLK6;KNDC1;DMRT2;CNTN2;MBP;GJC2
10961,GO:0042995,0.00334633141703318,0.998455936651608,25,2092,cell projection,CC,ANLN;CLDN11;STMN4;NGFR;DCX;LRP2;MLC1;TUBB4A;MAG;BVES;LDB3;PDGFRA;ERMN;ANK3;CNTNAP4;LGI3;KNDC1;MYO1D;CNTN2;ANKS1B;GLDN;DNAH17;APOD;MBP;GJC2
9333,GO:0034443,0.00344267922190564,1,1,1,negative regulation of lipoprotein oxidation,BP,APOD
14686,GO:0060588,0.00344267922190564,1,1,1,negative regulation of lipoprotein lipid oxidation,BP,APOD
13637,GO:0051246,0.00345249080064996,0.998363866258015,27,2473,regulation of protein metabolic process,BP,CRLF1;NGFR;ERBB3;FGFR3;LRP2;TF;CAPN3;PLCL1;TRIM67;PDGFRA;GPNMB;ENPP2;EGFR;ST18;CNDP1;GJA1;FZD7;GREM1;KNDC1;BOK;CNTN2;APOD;SPOCK3;DAPK1;MBP;GJC2;COL28A1
16721,GO:0072359,0.00348028035720745,0.998694640106968,15,993,circulatory system development,BP,NGFR;ERBB3;LRP2;BVES;LDB3;PDGFRA;GPNMB;ENPP2;EGFR;GJA1;FZD7;ACAN;GREM1;SGCD;APOD
6040,GO:0016805,0.00350924439610151,0.999911347017447,2,15,dipeptidase activity,MF,FOLH1;CNDP1
13153,GO:0048870,0.00353740290209426,0.998517944844004,19,1462,cell motility,BP,ANLN;ERBB3;DCX;TF;SOX10;MAG;BVES;PDGFRA;GPNMB;ENPP2;EGFR;GJA1;TMSB15A;CTHRC1;GREM1;CNTN2;DNAH17;APOD;SPOCK3
13873,GO:0051674,0.00353740290209426,0.998517944844004,19,1462,localization of cell,BP,ANLN;ERBB3;DCX;TF;SOX10;MAG;BVES;PDGFRA;GPNMB;ENPP2;EGFR;GJA1;TMSB15A;CTHRC1;GREM1;CNTN2;DNAH17;APOD;SPOCK3
13609,GO:0051179,0.00358569759773549,0.998085179036202,52,5892,localization,BP,BAIAP3;ANLN;NGFR;EYA2;ERBB3;DCX;LRP2;NKAIN1;TF;CAPN3;SOX10;MLC1;PLLP;TUBB4A;MAG;BVES;PEX5L;ATP10B;TRIM67;GJB6;RPS4Y1;PDGFRA;GPNMB;ENPP2;PCSK6;EGFR;ANK3;GJA1;PIEZO2;KCNJ6;SNX22;TMSB15A;SLC45A3;SLC5A11;TMEM144;CTHRC1;GREM1;LGI3;GJB1;SGCD;MAL;UGT8;MYO1D;BOK;CNTN2;ANKS1B;DNAH17;NKAIN2;APOD;SPOCK3;DAPK1;GJC2
12819,GO:0048146,0.0036180403278023,0.999748257273715,3,47,positive regulation of fibroblast proliferation,BP,NGFR;PDGFRA;EGFR
4822,GO:0010649,0.003652850638558,0.999907488561426,2,13,regulation of cell communication by electrical coupling,BP,ANK3;GJA1
11792,GO:0045161,0.00366980277548416,0.999907907837297,2,12,neuronal ion channel clustering,BP,CNTN2;GLDN
14186,GO:0055002,0.00370419707540231,0.999423693910987,5,146,striated muscle cell development,BP,CAPN3;BVES;LDB3;PDGFRA;SGCD
12986,GO:0048546,0.00383457745719197,0.999728140065819,3,45,digestive tract morphogenesis,BP,SOX10;PDGFRA;EGFR
18434,GO:0120025,0.00383892436790582,0.998232090782187,24,1998,plasma membrane bounded cell projection,CC,ANLN;CLDN11;STMN4;NGFR;DCX;LRP2;MLC1;TUBB4A;MAG;BVES;LDB3;PDGFRA;ERMN;ANK3;LGI3;KNDC1;MYO1D;CNTN2;ANKS1B;GLDN;DNAH17;APOD;MBP;GJC2
14660,GO:0060548,0.0038489339096736,0.99864623853722,13,889,negative regulation of cell death,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;MAG;GPNMB;EGFR;GREM1;BOK;DAPK1
4820,GO:0010647,0.00393865009237485,0.998297834882503,20,1651,positive regulation of cell communication,BP,CRLF1;BAIAP3;NGFR;ERBB3;FGFR3;LRP2;TF;PDGFRA;GPNMB;EGFR;ST18;ANK3;GJA1;FZD7;GREM1;KLK6;MAL;BOK;GPR62;CNTN2
13320,GO:0050731,0.00398870237368452,0.999367380793781,5,163,positive regulation of peptidyl-tyrosine phosphorylation,BP,CRLF1;ERBB3;FGFR3;ENPP2;GREM1
327,GO:0000902,0.00402427322901869,0.998466449937756,15,979,cell morphogenesis,BP,NGFR;CDH19;LRP2;MAG;BVES;ERMN;ENPP2;EGFR;ANK3;GJA1;FZD7;GREM1;KNDC1;UGT8;CNTN2
13995,GO:0051932,0.00408498105710791,0.999703783978416,3,45,synaptic transmission, GABAergic,BP,BAIAP3;PLCL1;CNTNAP4
4510,GO:0009611,0.00415384395683562,0.998746074942424,10,563,response to wounding,BP,ERBB3;PLLP;MAG;PPL;PDGFRA;EGFR;GJA1;FZD7;KLK6;APOD
7083,GO:0023056,0.00416300314414203,0.998191498198937,20,1659,positive regulation of signaling,BP,CRLF1;BAIAP3;NGFR;ERBB3;FGFR3;LRP2;TF;BVES;PDGFRA;GPNMB;EGFR;ST18;GJA1;FZD7;GREM1;KLK6;MAL;BOK;GPR62;CNTN2
20773,GO:1905207,0.00429169036461631,0.999682367727982,3,48,regulation of cardiocyte differentiation,BP,EGFR;FZD7;GREM1
11009,GO:0043066,0.00432920465732462,0.998524302454853,12,797,negative regulation of apoptotic process,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;MAG;EGFR;GREM1;BOK;DAPK1
21550,GO:2000179,0.00450979339877086,0.999660567331515,3,47,positive regulation of neural precursor cell proliferation,BP,LRP2;SOX10;GJC2
5043,GO:0010952,0.00460333769759953,0.999243793726529,5,179,positive regulation of peptidase activity,BP,NGFR;ST18;BOK;DAPK1;MBP
14092,GO:0052548,0.00490299576462603,0.998847258672742,7,349,regulation of endopeptidase activity,BP,NGFR;ST18;BOK;SPOCK3;DAPK1;MBP;COL28A1
11012,GO:0043069,0.00501116765661673,0.998259476083292,12,811,negative regulation of programmed cell death,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;MAG;EGFR;GREM1;BOK;DAPK1
7283,GO:0030296,0.00505555437446161,0.999845948369838,2,15,protein tyrosine kinase activator activity,MF,ERBB3;GREM1
2554,GO:0005402,0.00514778905099451,0.99984053256205,2,16,carbohydrate:cation symporter activity,MF,SLC45A3;SLC5A11
11801,GO:0045177,0.00530919551087466,0.998586668211422,8,383,apical part of cell,CC,ERBB3;LRP2;TF;MLC1;GJB6;EGFR;GJA1;MAL
13634,GO:0051239,0.00542401764772754,0.997258728004902,30,2873,regulation of multicellular organismal process,BP,NGFR;ERBB3;LRP2;TF;CAPN3;SOX10;FA2H;MAG;BVES;PLCL1;TRIM67;MYRF;PDGFRA;GPNMB;ENPP2;MOG;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;CTHRC1;GREM1;KLK6;KNDC1;DMRT2;CNTN2;APOD;MBP;GJC2
14185,GO:0055001,0.00544804759670343,0.999070281972146,5,160,muscle cell development,BP,CAPN3;BVES;LDB3;PDGFRA;SGCD
21607,GO:2000287,0.00551773122169858,1,1,1,positive regulation of myotome development,BP,DMRT2
21609,GO:2000290,0.00551773122169858,1,1,1,regulation of myotome development,BP,DMRT2
5792,GO:0016323,0.00557248916135575,0.998838823410176,6,227,basolateral plasma membrane,CC,ERBB3;TF;MLC1;EGFR;ANK3;MYO1D
5634,GO:0016020,0.00564525847058188,0.996926019585678,62,7600,membrane,CC,CRLF1;BAIAP3;CLDN11;NGFR;ERBB3;FGFR3;CDH19;LRP2;NKAIN1;FOLH1;TF;CAPN3;SOX10;MLC1;PLLP;FA2H;MAG;BVES;PEX5L;PLCL1;ATP10B;PPL;GJB6;PLP1;MYRF;GAL3ST1;RPS4Y1;PDGFRA;CPM;GPNMB;ENPP2;MOG;PCSK6;EGFR;ANK3;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SNX22;SLC45A3;SLC5A11;TMEM144;GJB1;SGCD;MAL;SUSD5;UGT8;MYO1D;BOK;TMEM125;TMEM151A;GPR62;CNTN2;ANKS1B;GLDN;NKAIN2;DAPK1;MBP;GJC2;TMEM88B
10480,GO:0040011,0.00567712486514525,0.997460228651724,20,1638,locomotion,BP,ANLN;NGFR;ERBB3;DCX;TF;SOX10;MAG;BVES;PDGFRA;GPNMB;ENPP2;EGFR;GJA1;TMSB15A;CTHRC1;GREM1;CNTN2;DNAH17;APOD;SPOCK3
7184,GO:0030162,0.00568607977534622,0.998202793633432,10,632,regulation of proteolysis,BP,NGFR;CAPN3;TRIM67;ST18;BOK;CNTN2;SPOCK3;DAPK1;MBP;COL28A1
17600,GO:0097435,0.00578684299490248,0.998054703495775,11,656,supramolecular fiber organization,BP,STMN4;TF;CAPN3;TUBB4A;LDB3;PDGFRA;ERMN;ACAN;TMSB15A;GREM1;MYO1D
4742,GO:0010518,0.00587507187571112,0.999510154220971,3,57,positive regulation of phospholipase activity,BP,FGFR3;PDGFRA;EGFR
4608,GO:0009967,0.00591640384079027,0.997448811899765,18,1479,positive regulation of signal transduction,BP,CRLF1;NGFR;ERBB3;FGFR3;LRP2;TF;PDGFRA;GPNMB;EGFR;ST18;GJA1;FZD7;GREM1;KLK6;MAL;BOK;GPR62;CNTN2
17611,GO:0097453,0.00594082968096466,1,1,1,mesaxon,CC,MAG
21126,GO:1990015,0.00594082968096466,1,1,1,ensheathing process,CC,MAG
9648,GO:0035295,0.00594920812526603,0.99770860332928,14,961,tube development,BP,CRLF1;NGFR;LRP2;SOX10;PDGFRA;GPNMB;ENPP2;EGFR;GJA1;CTHRC1;GREM1;GJB1;SGCD;APOD
12045,GO:0045780,0.00597001702036256,0.999799131926678,2,17,positive regulation of bone resorption,BP,TF;EGFR
12534,GO:0046852,0.00597001702036256,0.999799131926678,2,17,positive regulation of bone remodeling,BP,TF;EGFR
733,GO:0001949,0.00598583836369724,1,1,1,sebaceous gland cell differentiation,BP,FA2H
16913,GO:0080132,0.00598583836369724,1,1,1,fatty acid alpha-hydroxylase activity,MF,FA2H
5026,GO:0010927,0.00601041102172425,0.999206506218056,4,100,cellular component assembly involved in morphogenesis,BP,CAPN3;LDB3;PDGFRA;UGT8
11692,GO:0044853,0.00603367064522751,0.999202022272132,4,103,plasma membrane raft,CC,MLC1;BVES;MAL;MYO1D
11093,GO:0043217,0.00611217214090479,0.999793130770547,2,16,myelin maintenance,BP,FA2H;MYRF
8901,GO:0033268,0.0062113621586827,0.999789527972044,2,15,node of Ranvier,CC,ANK3;CNTN2
3523,GO:0007010,0.00626465302941446,0.997346893583893,17,1262,cytoskeleton organization,BP,ANLN;STMN4;DCX;TF;CAPN3;TUBB4A;PPL;LDB3;PDGFRA;ERMN;ANK3;GJA1;TMSB15A;UGT8;MYO1D;CNTN2;DNAH17
17629,GO:0097489,0.00631080249151129,1,1,1,multivesicular body, internal vesicle lumen,CC,EGFR
20403,GO:1904492,0.00639946968381502,1,1,1,Ac-Asp-Glu binding,MF,FOLH1
20404,GO:1904493,0.00639946968381502,1,1,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,FOLH1
5860,GO:0016485,0.00641343026779825,0.998859488028293,5,187,protein processing,BP,MYRF;CPM;PCSK6;KLK6;CNTN2
14210,GO:0055037,0.00641497964518136,0.998860530676904,5,172,recycling endosome,CC,BAIAP3;TF;MLC1;FZD7;BOK
4420,GO:0009247,0.00647917510325017,0.999438543426554,3,63,glycolipid biosynthetic process,BP,FA2H;GAL3ST1;UGT8
5896,GO:0016540,0.00649438571572265,0.999768397492804,2,20,protein autoprocessing,BP,MYRF;KLK6
3939,GO:0008235,0.00651288912459427,0.999436088136833,3,58,metalloexopeptidase activity,MF,FOLH1;CPM;CNDP1
12503,GO:0046777,0.00651992607698409,0.998596139403016,6,229,protein autophosphorylation,BP,FGFR3;PDGFRA;GPNMB;EGFR;GREM1;DAPK1
14424,GO:0060231,0.0067953665738717,0.999751924235366,2,20,mesenchymal to epithelial transition,BP,FZD7;GREM1
6262,GO:0018108,0.00686173635786964,0.99828379828863,7,329,peptidyl-tyrosine phosphorylation,BP,CRLF1;ERBB3;FGFR3;PDGFRA;ENPP2;EGFR;GREM1
12383,GO:0046513,0.00689912905365489,0.999388746102056,3,62,ceramide biosynthetic process,BP,FA2H;GAL3ST1;UGT8
1926,GO:0004367,0.00692822898746355,1,1,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,GPD1
12759,GO:0047952,0.00692822898746355,1,1,1,glycerol-3-phosphate dehydrogenase [NAD(P)+] activity,MF,GPD1
11139,GO:0043280,0.00692851074962963,0.999043136609087,4,125,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,NGFR;ST18;BOK;DAPK1
10985,GO:0043025,0.00693861150285854,0.997894672491544,9,499,neuronal cell body,CC,NGFR;TUBB4A;ERMN;KNDC1;MYO1D;CNTN2;APOD;MBP;GJC2
1655,GO:0003851,0.00696658521070501,1,1,1,2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity,MF,UGT8
12661,GO:0047263,0.00696658521070501,1,1,1,N-acylsphingosine galactosyltransferase activity,MF,UGT8
8260,GO:0032268,0.00697199647368789,0.996576252380767,25,2347,regulation of cellular protein metabolic process,BP,CRLF1;NGFR;ERBB3;FGFR3;LRP2;TF;CAPN3;PLCL1;TRIM67;PDGFRA;GPNMB;ENPP2;EGFR;ST18;CNDP1;FZD7;GREM1;KNDC1;BOK;CNTN2;SPOCK3;DAPK1;MBP;GJC2;COL28A1
14957,GO:0061061,0.00702015155624438,0.997712537742524,10,593,muscle structure development,BP,ERBB3;LRP2;CAPN3;BVES;LDB3;PDGFRA;GJA1;FZD7;GREM1;SGCD
14091,GO:0052547,0.00709600360656481,0.998211961534818,7,374,regulation of peptidase activity,BP,NGFR;ST18;BOK;SPOCK3;DAPK1;MBP;COL28A1
3325,GO:0006687,0.00714771966019664,0.999358561718596,3,62,glycosphingolipid metabolic process,BP,FA2H;GAL3ST1;UGT8
6297,GO:0018212,0.0071557573744243,0.998195963155411,7,332,peptidyl-tyrosine modification,BP,CRLF1;ERBB3;FGFR3;PDGFRA;ENPP2;EGFR;GREM1
4818,GO:0010645,0.00723082118536771,1,1,1,regulation of cell communication by chemical coupling,BP,GJA1
4824,GO:0010652,0.00723082118536771,1,1,1,positive regulation of cell communication by chemical coupling,BP,GJA1
21031,GO:1905772,0.00723082118536771,1,1,1,positive regulation of mesodermal cell differentiation,BP,GJA1
21089,GO:1905904,0.00723082118536771,1,1,1,positive regulation of mesoderm formation,BP,GJA1
10825,GO:0042692,0.00723773367771153,0.998171649172624,7,327,muscle cell differentiation,BP,CAPN3;BVES;LDB3;PDGFRA;FZD7;GREM1;SGCD
14248,GO:0055103,0.00732589054121138,1,1,1,ligase regulator activity,MF,CAPN3
21152,GO:1990092,0.00732589054121138,1,1,1,calcium-dependent self proteolysis,BP,CAPN3
18831,GO:1900383,0.00733858126952683,1,1,1,regulation of synaptic plasticity by receptor localization to synapse,BP,ANKS1B
566,GO:0001715,0.00751391254521484,1,1,1,ectodermal cell fate specification,BP,FZD7
10820,GO:0042665,0.00751391254521484,1,1,1,regulation of ectodermal cell fate specification,BP,FZD7
10821,GO:0042666,0.00751391254521484,1,1,1,negative regulation of ectodermal cell fate specification,BP,FZD7
21684,GO:2000383,0.00751391254521484,1,1,1,regulation of ectoderm development,BP,FZD7
21685,GO:2000384,0.00751391254521484,1,1,1,negative regulation of ectoderm development,BP,FZD7
9743,GO:0035498,0.00752612371055885,1,1,1,carnosine metabolic process,BP,CARNS1
9744,GO:0035499,0.00752612371055885,1,1,1,carnosine biosynthetic process,BP,CARNS1
12729,GO:0047730,0.00752612371055885,1,1,1,carnosine synthase activity,MF,CARNS1
18249,GO:0102102,0.00752612371055885,1,1,1,homocarnosine synthase activity,MF,CARNS1
18752,GO:1900158,0.00755146553727138,1,1,1,negative regulation of bone mineralization involved in bone maturation,BP,GREM1
19307,GO:1902178,0.00758923596708626,1,1,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,FGFR3
7024,GO:0022603,0.0075924009195306,0.996988965982488,14,1004,regulation of anatomical structure morphogenesis,BP,NGFR;MAG;BVES;GPNMB;ERMN;ENPP2;GJA1;FZD7;CTHRC1;GREM1;KNDC1;DMRT2;CNTN2;MBP
14896,GO:0060977,0.00763289032071331,0.999710195769372,2,16,coronary vasculature morphogenesis,BP,LRP2;SGCD
20876,GO:1905413,0.00766740349148527,1,1,1,regulation of dense core granule exocytosis,BP,BAIAP3
334,GO:0000921,0.00776033790351842,1,1,1,septin ring assembly,BP,ANLN
6848,GO:0021700,0.00779003326729394,0.998256715039937,6,254,developmental maturation,BP,BAIAP3;FGFR3;SOX10;GREM1;CNTN2;GLDN
13384,GO:0050839,0.00786079949084116,0.997567202644589,9,500,cell adhesion molecule binding,MF,ANLN;CDH19;PPL;GPNMB;EGFR;ANK3;EDIL3;CNTN2;GLDN
3174,GO:0006508,0.00789288435117804,0.996493488337562,18,1537,proteolysis,BP,NGFR;FOLH1;CAPN3;TRIM67;MYRF;CPM;PCSK6;ST18;CNDP1;ACAN;ADAMTS4;KLK6;BOK;CNTN2;SPOCK3;DAPK1;MBP;COL28A1
3473,GO:0006928,0.00805201013225896,0.996150223973979,22,1898,movement of cell or subcellular component,BP,ANLN;NGFR;ERBB3;DCX;TF;SOX10;MAG;BVES;PDGFRA;GPNMB;ENPP2;EGFR;GJA1;TMSB15A;CTHRC1;GREM1;SGCD;MYO1D;CNTN2;DNAH17;APOD;SPOCK3
14402,GO:0060193,0.00808914761687066,0.999239321386187,3,66,positive regulation of lipase activity,BP,FGFR3;PDGFRA;EGFR
8447,GO:0032507,0.00809449790803177,0.999239706709528,3,63,maintenance of protein location in cell,BP,ANK3;GJA1;TMSB15A
5049,GO:0010959,0.00809783557600305,0.997908995084495,7,356,regulation of metal ion transport,BP,NKAIN1;TF;CAPN3;ANK3;GJA1;NKAIN2;GJC2
7909,GO:0031579,0.00831250681164199,0.999659563338404,2,23,membrane raft organization,BP,FA2H;MAL
20774,GO:1905208,0.00836707809253249,0.999659793843108,2,20,negative regulation of cardiocyte differentiation,BP,EGFR;FZD7
9251,GO:0034329,0.0084993563010441,0.997547804043147,8,392,cell junction assembly,BP,CLDN11;CDH19;GJB6;GJA1;GREM1;GJB1;UGT8;APOD
12027,GO:0045745,0.00850758387707736,0.999646326047994,2,24,positive regulation of G protein-coupled receptor signaling pathway,BP,KLK6;CNTN2
10335,GO:0038034,0.008675067378249,0.999162142702889,3,69,signal transduction in absence of ligand,BP,EYA2;ERBB3;BOK
17484,GO:0097192,0.008675067378249,0.999162142702889,3,69,extrinsic apoptotic signaling pathway in absence of ligand,BP,EYA2;ERBB3;BOK
2366,GO:0005018,0.00874173972157273,1,1,1,platelet-derived growth factor alpha-receptor activity,MF,PDGFRA
4741,GO:0010517,0.00875670938030125,0.999152837265017,3,65,regulation of phospholipase activity,BP,FGFR3;PDGFRA;EGFR
18941,GO:1901215,0.00875691547884547,0.998320671236881,5,194,negative regulation of neuron death,BP,CRLF1;ERBB3;MAG;GPNMB;BOK
17401,GO:0097058,0.00883781369090715,0.999980587017741,1,2,CRLF-CLCF1 complex,CC,CRLF1
2723,GO:0005769,0.00884191670894908,0.997679305535015,7,342,early endosome,CC,TF;MLC1;GPNMB;EGFR;GJA1;MYO1D;BOK
12168,GO:0045995,0.00907885004395981,0.998647204541429,4,115,regulation of embryonic development,BP,GJA1;FZD7;DMRT2;MBP
1632,GO:0003779,0.00912912504766698,0.99733252980721,8,405,actin binding,MF,ANLN;GJB6;LDB3;ERMN;EGFR;TMSB15A;MOBP;MYO1D
15475,GO:0070160,0.00913397537769498,0.998636379002605,4,116,tight junction,CC,CLDN11;BVES;ANK3;GJA1
16024,GO:0071206,0.00932907386869641,1,1,1,establishment of protein localization to juxtaparanode region of axon,BP,CNTN2
10271,GO:0036477,0.00948090154972097,0.996420029139462,12,810,somatodendritic compartment,CC,NGFR;LRP2;TUBB4A;ERMN;ANK3;KNDC1;MYO1D;CNTN2;ANKS1B;APOD;MBP;GJC2
15932,GO:0070977,0.00958168252465206,0.999585792584401,2,18,bone maturation,BP,FGFR3;GREM1
7948,GO:0031646,0.00960570108476268,0.99904019095151,3,62,positive regulation of nervous system process,BP,SOX10;MAG;MYRF
13562,GO:0051119,0.00977185535594089,0.999564716366225,2,23,sugar transmembrane transporter activity,MF,SLC45A3;SLC5A11
20507,GO:1904700,0.00978649459310088,0.999976184128861,1,2,granulosa cell apoptotic process,BP,BOK
20513,GO:1904708,0.00978649459310088,0.999976184128861,1,2,regulation of granulosa cell apoptotic process,BP,BOK
5081,GO:0012501,0.0103975959487326,0.995061896281748,20,1831,programmed cell death,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;CAPN3;SOX10;MAG;PPL;GJB6;PCSK6;EGFR;ST18;GJA1;SLC5A11;GREM1;MAL;BOK;DAPK1
4511,GO:0009612,0.0104085350156027,0.99791758447937,5,198,response to mechanical stimulus,BP,MAG;PPL;EGFR;GJA1;PIEZO2
18872,GO:1900827,0.0105414666641519,1,1,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,ANK3
7246,GO:0030239,0.0105441549233067,0.99890931876727,3,63,myofibril assembly,BP,CAPN3;LDB3;PDGFRA
14577,GO:0060429,0.0106432971801417,0.995600931580312,14,1063,epithelium development,BP,CRLF1;NGFR;LRP2;SOX10;FA2H;PPL;HAPLN2;PCSK6;EGFR;GJA1;FZD7;CTHRC1;GREM1;DMRT2
3934,GO:0008219,0.010672418527391,0.994834879142483,21,1961,cell death,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;CAPN3;SOX10;MAG;PPL;GJB6;GPNMB;PCSK6;EGFR;ST18;GJA1;SLC5A11;GREM1;MAL;BOK;DAPK1
21504,GO:2000098,0.0106804917999112,0.99997162131371,1,2,negative regulation of smooth muscle cell-matrix adhesion,BP,APOD
9046,GO:0033688,0.0107038221732667,0.999500034748144,2,23,regulation of osteoblast proliferation,BP,CTHRC1;GREM1
1862,GO:0004181,0.0107536865376202,0.999493678635702,2,25,metallocarboxypeptidase activity,MF,FOLH1;CPM
9329,GO:0034439,0.010840077238801,0.999970764546697,1,2,lipoprotein lipid oxidation,BP,APOD
9332,GO:0034442,0.010840077238801,0.999970764546697,1,2,regulation of lipoprotein oxidation,BP,APOD
10572,GO:0042160,0.010840077238801,0.999970764546697,1,2,lipoprotein modification,BP,APOD
10573,GO:0042161,0.010840077238801,0.999970764546697,1,2,lipoprotein oxidation,BP,APOD
14685,GO:0060587,0.010840077238801,0.999970764546697,1,2,regulation of lipoprotein lipid oxidation,BP,APOD
5723,GO:0016202,0.0108459813760042,0.998295781181393,4,125,regulation of striated muscle tissue development,BP,ERBB3;GJA1;FZD7;GREM1
3967,GO:0008283,0.0108738479777869,0.994903731606839,19,1698,cell population proliferation,BP,CRLF1;NGFR;ERBB3;FGFR3;LRP2;SOX10;FA2H;GJB6;PDGFRA;GPNMB;EGFR;ST18;GJA1;FZD7;CTHRC1;GREM1;BOK;APOD;GJC2
3854,GO:0008092,0.0109504178229397,0.995613458505564,13,908,cytoskeletal protein binding,MF,ANLN;STMN4;DCX;CAPN3;GJB6;LDB3;ERMN;EGFR;ANK3;GJA1;TMSB15A;MOBP;MYO1D
5150,GO:0014717,0.0110214231810813,0.999969775401136,1,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,CAPN3
5151,GO:0014718,0.0110214231810813,0.999969775401136,1,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,CAPN3
22050,GO:2001056,0.0112041065047704,0.998219180558014,4,141,positive regulation of cysteine-type endopeptidase activity,BP,NGFR;ST18;BOK;DAPK1
13970,GO:0051896,0.0112115320212399,0.997714972443291,5,203,regulation of protein kinase B signaling,BP,ERBB3;FGFR3;LRP2;PDGFRA;EGFR
4708,GO:0010453,0.0112592778163767,0.999454461867513,2,27,regulation of cell fate commitment,BP,NKX6-2;FZD7
10971,GO:0043006,0.0113298248517079,0.999968055226843,1,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,EGFR
13024,GO:0048634,0.0116282228465324,0.998134645262723,4,128,regulation of muscle organ development,BP,ERBB3;GJA1;FZD7;GREM1
18749,GO:1900154,0.0117260775577961,0.999965774750263,1,2,regulation of bone trabecula formation,BP,GREM1
18750,GO:1900155,0.0117260775577961,0.999965774750263,1,2,negative regulation of bone trabecula formation,BP,GREM1
19185,GO:1901861,0.0118959241387968,0.998078980923013,4,128,regulation of muscle tissue development,BP,ERBB3;GJA1;FZD7;GREM1
10386,GO:0038131,0.0120045328443734,0.999964124888189,1,2,neuregulin receptor activity,MF,ERBB3
16346,GO:0071695,0.012103932413424,0.99748599278153,5,204,anatomical structure maturation,BP,FGFR3;SOX10;GREM1;CNTN2;GLDN
9142,GO:0034105,0.0124316467470237,0.999367097284527,2,26,positive regulation of tissue remodeling,BP,TF;EGFR
4819,GO:0010646,0.0125132571544448,0.99318366173076,31,3188,regulation of cell communication,BP,CRLF1;BAIAP3;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;PEX5L;PLCL1;TRIM67;PDGFRA;GPNMB;PCSK6;EGFR;ST18;ANK3;GJA1;CNTNAP4;FZD7;CTHRC1;GREM1;KLK6;MAL;BOK;GPR62;CNTN2;APOD;DAPK1
13080,GO:0048710,0.0127170889790569,0.999344830627871,2,26,regulation of astrocyte differentiation,BP,MAG;CNTN2
12108,GO:0045907,0.012796580713613,0.999337094597721,2,27,positive regulation of vasoconstriction,BP,EGFR;GJA1
17788,GO:0098609,0.0128891955247178,0.995147090265311,11,747,cell-cell adhesion,BP,CLDN11;CDH19;MAG;BVES;PDGFRA;GPNMB;EGFR;ANK3;CNTN2;GLDN;MBP
2359,GO:0005006,0.0129379028683544,0.999958309491097,1,2,epidermal growth factor-activated receptor activity,MF,EGFR
12818,GO:0048145,0.0129431208208113,0.998548769504196,3,76,regulation of fibroblast proliferation,BP,NGFR;PDGFRA;EGFR
2722,GO:0005768,0.0129680886610734,0.994888526671204,12,888,endosome,CC,BAIAP3;NGFR;LRP2;TF;MLC1;GPNMB;EGFR;GJA1;FZD7;MYO1D;BOK;GPR62
7657,GO:0031106,0.0131222514877629,0.999957108920447,1,2,septin ring organization,BP,ANLN
10806,GO:0042634,0.0132131994978758,0.999305495781394,2,26,regulation of hair cycle,BP,NGFR;FA2H
2734,GO:0005783,0.0132847414871433,0.994185352439335,15,1255,endoplasmic reticulum,CC,FGFR3;LRP2;TF;MLC1;FA2H;ATP10B;PCSK6;ANK3;KLK6;SGCD;MAL;MYO1D;BOK;APOD;COL28A1
13010,GO:0048598,0.0133483304187938,0.995496018114654,9,554,embryonic morphogenesis,BP,EYA2;LRP2;GJB6;PDGFRA;GJA1;FZD7;CTHRC1;GREM1;MBP
14385,GO:0060168,0.0133492460045869,0.999955607047262,1,2,positive regulation of adenosine receptor signaling pathway,BP,CNTN2
18751,GO:1900157,0.0133551451172604,0.999955567669825,1,2,regulation of bone mineralization involved in bone maturation,BP,GREM1
10731,GO:0042488,0.0133607319901869,0.99995553036043,1,2,positive regulation of odontogenesis of dentin-containing tooth,BP,NGFR
20496,GO:1904685,0.0133660890177009,0.999955494571148,1,2,positive regulation of metalloendopeptidase activity,BP,MBP
11282,GO:0043524,0.013388449313846,0.9977587352818,4,139,negative regulation of neuron apoptotic process,BP,CRLF1;ERBB3;MAG;BOK
12817,GO:0048144,0.013484385783724,0.99846452343491,3,77,fibroblast proliferation,BP,NGFR;PDGFRA;EGFR
16707,GO:0072337,0.0135879998630204,0.999275251907484,2,26,modified amino acid transport,BP,LRP2;GJA1
15647,GO:0070435,0.0136425930691251,0.999953627616337,1,2,Shc-EGFR complex,CC,EGFR
13117,GO:0048799,0.0136717824355451,0.999276527933637,2,22,animal organ maturation,BP,FGFR3;GREM1
15350,GO:0062023,0.0137745740220468,0.996058545078119,7,381,collagen-containing extracellular matrix,CC,PCSK6;ACAN;ADAMTS4;EDIL3;CTHRC1;GREM1;COL28A1
8089,GO:0031954,0.0138391778533241,0.99925654208614,2,25,positive regulation of protein autophosphorylation,BP,GPNMB;GREM1
11525,GO:0044297,0.0138554828311108,0.995295395898391,9,566,cell body,CC,NGFR;TUBB4A;ERMN;KNDC1;MYO1D;CNTN2;APOD;MBP;GJC2
436,GO:0001501,0.0138596182467522,0.995636358377586,8,469,skeletal system development,BP,FGFR3;HAPLN2;PDGFRA;GJA1;ACAN;ADAMTS4;GREM1;DMRT2
3307,GO:0006665,0.0139674655032195,0.997630966938926,4,145,sphingolipid metabolic process,BP,FA2H;GAL3ST1;ENPP2;UGT8
3937,GO:0008233,0.0139823868291709,0.995589014849933,8,498,peptidase activity,MF,FOLH1;CAPN3;MYRF;CPM;PCSK6;CNDP1;ADAMTS4;KLK6
4816,GO:0010643,0.0142883653226936,0.999949116869145,1,2,cell communication by chemical coupling,BP,GJA1
11504,GO:0044255,0.0143931166379339,0.994243387990592,12,936,cellular lipid metabolic process,BP,FGFR3;LRP2;FA2H;PLP1;GAL3ST1;PDGFRA;ENPP2;EGFR;SLC45A3;GPD1;UGT8;APOD
12254,GO:0046168,0.0143977324123824,0.999948332055662,1,2,glycerol-3-phosphate catabolic process,BP,GPD1
10674,GO:0042383,0.0144671076993625,0.997524390326187,4,132,sarcolemma,CC,CAPN3;BVES;ANK3;SGCD
12683,GO:0047391,0.0144902928030941,0.999947663118967,1,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,ENPP2
15577,GO:0070315,0.0145473234962622,0.999947248798363,1,2,G1 to G0 transition involved in cell differentiation,BP,CAPN3
8382,GO:0032431,0.0146205942367986,0.999929010797183,1,3,activation of phospholipase A2 activity,BP,EGFR
2385,GO:0005052,0.0146978381148413,0.999946147425749,1,2,peroxisome matrix targeting signal-1 binding,MF,PEX5L
14488,GO:0060322,0.0147070661530249,0.994355405031662,11,743,head development,BP,LRP2;PLP1;PDGFRA;EGFR;KNDC1;MYO1D;BOK;CNTN2;APOD;MBP;GJC2
10481,GO:0040012,0.014758903849301,0.994078083009815,12,880,regulation of locomotion,BP,ERBB3;TF;BVES;PDGFRA;GPNMB;ENPP2;EGFR;GJA1;TMSB15A;GREM1;APOD;SPOCK3
8693,GO:0032902,0.0148709663526849,0.999944866401862,1,2,nerve growth factor production,BP,PCSK6
14196,GO:0055013,0.014881620108226,0.998248094078125,3,68,cardiac muscle cell development,BP,BVES;PDGFRA;SGCD
20239,GO:1904170,0.0149508212882816,0.999944270419863,1,2,regulation of bleb assembly,BP,ANLN
20240,GO:1904172,0.0149508212882816,0.999944270419863,1,2,positive regulation of bleb assembly,BP,ANLN
9045,GO:0033687,0.0149828751705532,0.999155169421764,2,28,osteoblast proliferation,BP,CTHRC1;GREM1
7081,GO:0023051,0.0149905380956289,0.991709334291366,31,3228,regulation of signaling,BP,CRLF1;BAIAP3;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;BVES;PEX5L;PLCL1;TRIM67;PDGFRA;GPNMB;PCSK6;EGFR;ST18;GJA1;CNTNAP4;FZD7;CTHRC1;GREM1;KLK6;MAL;BOK;GPR62;CNTN2;APOD;DAPK1
10389,GO:0038143,0.0150399973499016,0.999943601055612,1,2,ERBB3:ERBB2 complex,CC,ERBB3
2612,GO:0005576,0.0150917574972558,0.991704033096042,30,3370,extracellular region,CC,CRLF1;NGFR;BCAS1;ERBB3;FGFR3;LRP2;FOLH1;TF;TUBB4A;PPL;HAPLN2;CPM;ERMN;ENPP2;PCSK6;EGFR;CNDP1;ACAN;ADAMTS4;EDIL3;CTHRC1;GREM1;GPD1;KLK6;LGI3;MYO1D;GLDN;APOD;SPOCK3;COL28A1
17197,GO:0090291,0.015121595111135,0.99994298504683,1,2,negative regulation of osteoclast proliferation,BP,GREM1
14228,GO:0055077,0.0151341050949506,0.999942890306687,1,2,gap junction hemi-channel activity,MF,GJA1
1927,GO:0004368,0.0152367482918406,0.999942109979967,1,2,glycerol-3-phosphate dehydrogenase (quinone) activity,MF,GPD1
2952,GO:0006127,0.0152367482918406,0.999942109979967,1,2,glycerophosphate shuttle,BP,GPD1
6104,GO:0016901,0.0152367482918406,0.999942109979967,1,2,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,GPD1
19454,GO:1902533,0.0152771165860829,0.993839330649295,12,926,positive regulation of intracellular signal transduction,BP,ERBB3;FGFR3;LRP2;TF;PDGFRA;GPNMB;EGFR;GJA1;FZD7;GREM1;BOK;GPR62
4559,GO:0009790,0.0154276776573491,0.993534179906662,13,979,embryo development,BP,EYA2;LRP2;SOX10;GJB6;PDGFRA;PCSK6;EGFR;GJA1;FZD7;CTHRC1;GREM1;DMRT2;MBP
2140,GO:0004683,0.015531797603022,0.999107497443846,2,28,calmodulin-dependent protein kinase activity,MF,PHKG1;DAPK1
14811,GO:0060795,0.0155396509613156,0.999101996759186,2,31,cell fate commitment involved in formation of primary germ layer,BP,EYA2;FZD7
5564,GO:0015868,0.0155701239289875,0.99909930860041,2,31,purine ribonucleotide transport,BP,GJA1;GJB1
17184,GO:0090277,0.0155731047977235,0.998125089935522,3,85,positive regulation of peptide hormone secretion,BP,BAIAP3;EGFR;GJA1
695,GO:0001894,0.0156243285278192,0.996538702769189,5,223,tissue homeostasis,BP,TF;GJB6;EGFR;GJA1;MBP
6947,GO:0021912,0.0156250293667493,0.999918884852277,1,3,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,NKX6-2
14211,GO:0055038,0.0157733516171906,0.998094569822966,3,80,recycling endosome membrane,CC,BAIAP3;FZD7;BOK
13002,GO:0048584,0.015784391336747,0.992054662564291,21,2035,positive regulation of response to stimulus,BP,CRLF1;BAIAP3;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;PDGFRA;GPNMB;MOG;EGFR;ST18;GJA1;FZD7;GREM1;KLK6;MAL;BOK;GPR62;CNTN2
14873,GO:0060931,0.015791616277544,0.999937799276703,1,2,sinoatrial node cell development,BP,BVES
9523,GO:0034986,0.0158064303824766,0.999937682049133,1,2,iron chaperone activity,MF,TF
7763,GO:0031315,0.0158140642586051,0.999937621597001,1,2,extrinsic component of mitochondrial outer membrane,CC,SOX10
16987,GO:0086075,0.0164855414233192,0.999932188586993,1,2,gap junction channel activity involved in cardiac conduction electrical coupling,MF,GJA1
22117,GO:2001235,0.0165091891296643,0.99705243018412,4,166,positive regulation of apoptotic signaling pathway,BP,NGFR;ST18;MAL;BOK
2402,GO:0005102,0.0165492477097363,0.992558930545997,15,1316,signaling receptor binding,MF,CRLF1;ERBB3;TF;MAG;PLCL1;PDGFRA;GPNMB;MOG;EGFR;FZD7;EDIL3;CTHRC1;GREM1;BOK;ANKS1B
8994,GO:0033590,0.0165868681443223,0.999908551027432,1,3,response to cobalamin,BP,EGFR
12942,GO:0048408,0.0167575100974934,0.999906652496753,1,3,epidermal growth factor binding,MF,EGFR
5561,GO:0015865,0.0167829926342901,0.998988481513866,2,32,purine nucleotide transport,BP,GJA1;GJB1
21503,GO:2000097,0.0168342955568908,0.999905791784044,1,3,regulation of smooth muscle cell-matrix adhesion,BP,APOD
12913,GO:0048333,0.0169097155034418,0.998980083900838,2,30,mesodermal cell differentiation,BP,EYA2;GJA1
16672,GO:0072275,0.0169240550020634,0.999928517021623,1,2,metanephric glomerulus morphogenesis,BP,PDGFRA
16673,GO:0072276,0.0169240550020634,0.999928517021623,1,2,metanephric glomerulus vasculature morphogenesis,BP,PDGFRA
16674,GO:0072277,0.0169240550020634,0.999928517021623,1,2,metanephric glomerular capillary formation,BP,PDGFRA
13733,GO:0051402,0.0170313287942154,0.996143544175317,5,228,neuron apoptotic process,BP,CRLF1;NGFR;ERBB3;MAG;BOK
2161,GO:0004713,0.0171628714786207,0.996910224645697,4,133,protein tyrosine kinase activity,MF,ERBB3;FGFR3;PDGFRA;EGFR
14384,GO:0060167,0.0172316831604628,0.999901273727154,1,3,regulation of adenosine receptor signaling pathway,BP,CNTN2
19521,GO:1902722,0.0172755946354499,0.9999007679368,1,3,positive regulation of prolactin secretion,BP,EGFR
3497,GO:0006970,0.0173579671605656,0.997826316699281,3,81,response to osmotic stress,BP,CAPN3;MLC1;EGFR
20954,GO:1905576,0.0173876641214456,0.999899471170338,1,3,ganglioside GT1b binding,MF,MAG
17854,GO:0098742,0.0174709217927055,0.996024273607323,5,201,cell-cell adhesion via plasma-membrane adhesion molecules,BP,CLDN11;CDH19;MAG;CNTN2;MBP
6207,GO:0017147,0.0174961157119687,0.998925575680961,2,30,Wnt-protein binding,MF,FZD7;CTHRC1
11212,GO:0043403,0.0175437509551425,0.99891457130739,2,34,skeletal muscle tissue regeneration,BP,CAPN3;FZD7
13837,GO:0051604,0.017573650311986,0.995985585383798,5,249,protein maturation,BP,MYRF;CPM;PCSK6;KLK6;CNTN2
11259,GO:0043491,0.0175791295747799,0.995987827323031,5,227,protein kinase B signaling,BP,ERBB3;FGFR3;LRP2;PDGFRA;EGFR
11088,GO:0043204,0.0176966807202647,0.996778657277028,4,151,perikaryon,CC,NGFR;KNDC1;MYO1D;GJC2
3942,GO:0008238,0.0177354201547186,0.997758111654969,3,86,exopeptidase activity,MF,FOLH1;CPM;CNDP1
3317,GO:0006679,0.0178908203388744,0.999893544517305,1,3,glucosylceramide biosynthetic process,BP,FA2H
2615,GO:0005581,0.0179042705767795,0.997733790520107,3,78,collagen trimer,CC,CTHRC1;GLDN;COL28A1
4823,GO:0010650,0.0181146652637873,0.999918055638286,1,2,positive regulation of cell communication by electrical coupling,BP,ANK3
14189,GO:0055006,0.0182120259768414,0.997683900464368,3,73,cardiac cell development,BP,BVES;PDGFRA;SGCD
2463,GO:0005200,0.0183104255123681,0.997658221343326,3,85,structural constituent of cytoskeleton,MF,TUBB4A;PPL;ANK3
5234,GO:0014901,0.0183282072975064,0.999888253501793,1,3,satellite cell activation involved in skeletal muscle regeneration,BP,CAPN3
3314,GO:0006672,0.0184269978934947,0.997635377295379,3,89,ceramide metabolic process,BP,FA2H;GAL3ST1;UGT8
17195,GO:0090289,0.0184417046214958,0.999886859394252,1,3,regulation of osteoclast proliferation,BP,GREM1
7597,GO:0031012,0.0189257708804335,0.993693179197102,8,502,extracellular matrix,CC,HAPLN2;PCSK6;ACAN;ADAMTS4;EDIL3;CTHRC1;GREM1;COL28A1
791,GO:0002028,0.0189584022947673,0.997543538601246,3,85,regulation of sodium ion transport,BP,NKAIN1;ANK3;NKAIN2
13523,GO:0051049,0.0190774242967354,0.990673411496048,18,1631,regulation of transport,BP,BAIAP3;ERBB3;NKAIN1;TF;CAPN3;MLC1;BVES;EGFR;ANK3;GJA1;KCNJ6;GREM1;LGI3;BOK;NKAIN2;APOD;DAPK1;GJC2
1436,GO:0003163,0.0192038731409434,0.999877271703542,1,3,sinoatrial node development,BP,BVES
14866,GO:0060921,0.0192038731409434,0.999877271703542,1,3,sinoatrial node cell differentiation,BP,BVES
3840,GO:0008065,0.0192117994146094,0.999877169928725,1,3,establishment of blood-nerve barrier,BP,HAPLN2
7186,GO:0030165,0.0192391601571192,0.997497541390038,3,79,PDZ domain binding,MF,GJA1;FZD7;TMEM88B
21548,GO:2000177,0.0195371613253829,0.997442578177339,3,81,regulation of neural precursor cell proliferation,BP,LRP2;SOX10;GJC2
2405,GO:0005109,0.0195922424081424,0.998715015281448,2,34,frizzled binding,MF,FZD7;CTHRC1
20111,GO:1903899,0.0198623588547394,0.99986867151289,1,3,positive regulation of PERK-mediated unfolded protein response,BP,BOK
10364,GO:0038098,0.019964962874338,0.999867304985242,1,3,sequestering of BMP from receptor via BMP binding,BP,GREM1
9611,GO:0035239,0.0199950257584209,0.991966314057879,11,782,tube morphogenesis,BP,NGFR;LRP2;SOX10;PDGFRA;GPNMB;ENPP2;EGFR;CTHRC1;GREM1;SGCD;APOD
8676,GO:0032879,0.020003145565172,0.989184646044112,25,2496,regulation of localization,BP,BAIAP3;NGFR;ERBB3;NKAIN1;TF;CAPN3;MLC1;BVES;TRIM67;PDGFRA;GPNMB;ENPP2;EGFR;ANK3;GJA1;KCNJ6;TMSB15A;GREM1;LGI3;BOK;NKAIN2;APOD;SPOCK3;DAPK1;GJC2
18441,GO:0120039,0.0200218196234583,0.992337320065583,10,650,plasma membrane bounded cell projection morphogenesis,BP,NGFR;LRP2;MAG;ENPP2;EGFR;ANK3;GJA1;KNDC1;UGT8;CNTN2
15611,GO:0070374,0.0200936316043924,0.996194671055453,4,170,positive regulation of ERK1 and ERK2 cascade,BP,FGFR3;PDGFRA;GPNMB;EGFR
6948,GO:0021913,0.0201037363937882,0.99984871222778,1,4,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,NKX6-2
10384,GO:0038128,0.0201196126421686,0.998667563777427,2,31,ERBB2 signaling pathway,BP,ERBB3;EGFR
4619,GO:0009996,0.0201267349203376,0.999848364396352,1,4,negative regulation of cell fate specification,BP,FZD7
14017,GO:0051960,0.020150379100095,0.991552805697709,12,878,regulation of nervous system development,BP,NGFR;LRP2;SOX10;MAG;TRIM67;MYRF;NKX6-2;SLC45A3;KLK6;KNDC1;CNTN2;GJC2
10488,GO:0040019,0.020289458758312,0.99865031860742,2,31,positive regulation of embryonic development,BP,GJA1;DMRT2
9252,GO:0034330,0.0203660505958763,0.992184352510955,10,650,cell junction organization,BP,CLDN11;CDH19;GJB6;ANK3;GJA1;GREM1;GJB1;UGT8;CNTN2;APOD
13334,GO:0050767,0.0203718092470906,0.991792162015228,11,777,regulation of neurogenesis,BP,NGFR;LRP2;SOX10;MAG;TRIM67;NKX6-2;SLC45A3;KLK6;KNDC1;CNTN2;GJC2
560,GO:0001708,0.0205126378912644,0.997258961738616,3,90,cell fate specification,BP,EYA2;NKX6-2;FZD7
13144,GO:0048858,0.0206016488436771,0.99207914472138,10,654,cell projection morphogenesis,BP,NGFR;LRP2;MAG;ENPP2;EGFR;ANK3;GJA1;KNDC1;UGT8;CNTN2
557,GO:0001705,0.0207261524021433,0.999856944152102,1,3,ectoderm formation,BP,FZD7
564,GO:0001712,0.0207261524021433,0.999856944152102,1,3,ectodermal cell fate commitment,BP,FZD7
2365,GO:0005017,0.0207391545353046,0.99985676376047,1,3,platelet-derived growth factor-activated receptor activity,MF,PDGFRA
4887,GO:0010750,0.0208477344000819,0.999855252842967,1,3,positive regulation of nitric oxide mediated signal transduction,BP,EGFR
16827,GO:0072658,0.0208978447540811,0.99989078530579,1,2,maintenance of protein location in membrane,BP,ANK3
16829,GO:0072660,0.0208978447540811,0.99989078530579,1,2,maintenance of protein location in plasma membrane,BP,ANK3
13548,GO:0051094,0.0209370388599634,0.990307824020732,15,1271,positive regulation of developmental process,BP,NGFR;ERBB3;LRP2;CAPN3;SOX10;MAG;TRIM67;MYRF;ENPP2;NKX6-2;GJA1;CTHRC1;GREM1;DMRT2;GJC2
3428,GO:0006862,0.0209948074040205,0.998568109701772,2,36,nucleotide transport,BP,GJA1;GJB1
7377,GO:0030510,0.0211205774348928,0.997151445377524,3,83,regulation of BMP signaling pathway,BP,LRP2;PCSK6;GREM1
2945,GO:0006116,0.0211396596772776,0.999851150939686,1,3,NADH oxidation,BP,GPD1
20836,GO:1905332,0.0211824354060607,0.998554049674825,2,33,positive regulation of morphogenesis of an epithelium,BP,GJA1;GREM1
17482,GO:0097190,0.0213271275319108,0.992730508273561,8,560,apoptotic signaling pathway,BP,NGFR;EYA2;ERBB3;FGFR3;ST18;MAL;BOK;DAPK1
13636,GO:0051241,0.0213282471016745,0.990658959001074,13,1081,negative regulation of multicellular organismal process,BP,NGFR;SOX10;MAG;PLCL1;PDGFRA;GPNMB;EGFR;NKX6-2;GJA1;FZD7;GREM1;CNTN2;APOD
11306,GO:0043552,0.0214858565376169,0.998522228440835,2,33,positive regulation of phosphatidylinositol 3-kinase activity,BP,FGFR3;PDGFRA
575,GO:0001733,0.0216563617534693,0.99982432524002,1,4,galactosylceramide sulfotransferase activity,MF,GAL3ST1
13306,GO:0050694,0.0216563617534693,0.99982432524002,1,4,galactose 3-O-sulfotransferase activity,MF,GAL3ST1
14207,GO:0055026,0.0217600576382614,0.998491213410291,2,34,negative regulation of cardiac muscle tissue development,BP,GJA1;FZD7
4607,GO:0009966,0.0219052305579188,0.987834153274896,27,2802,regulation of signal transduction,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;PEX5L;TRIM67;PDGFRA;GPNMB;PCSK6;EGFR;ST18;GJA1;FZD7;CTHRC1;GREM1;KLK6;MAL;BOK;GPR62;CNTN2;APOD;DAPK1
10647,GO:0042327,0.0220886263134144,0.990614530098948,12,952,positive regulation of phosphorylation,BP,CRLF1;ERBB3;FGFR3;TF;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;GREM1;GPD1;KNDC1
8998,GO:0033594,0.0221007749259939,0.999817006399045,1,4,response to hydroxyisoflavone,BP,EGFR
595,GO:0001766,0.0222011720608599,0.999815332124834,1,4,membrane raft polarization,BP,MAL
4099,GO:0008489,0.0223097244987094,0.999834129049483,1,3,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,UGT8
15948,GO:0070997,0.022440494133788,0.993662889875456,6,333,neuron death,BP,CRLF1;NGFR;ERBB3;MAG;GPNMB;BOK
4455,GO:0009331,0.0226443901160951,0.999829089197398,1,3,glycerol-3-phosphate dehydrogenase complex,CC,GPD1
20834,GO:1905330,0.0229962287701615,0.995463642419255,4,172,regulation of morphogenesis of an epithelium,BP,GJA1;FZD7;CTHRC1;GREM1
11130,GO:0043269,0.0230696691188088,0.991457513463048,9,632,regulation of ion transport,BP,NKAIN1;TF;CAPN3;ANK3;GJA1;KCNJ6;NKAIN2;DAPK1;GJC2
11808,GO:0045185,0.0231518292347546,0.996760206962253,3,92,maintenance of protein location,BP,ANK3;GJA1;TMSB15A
9414,GO:0034634,0.0232304828597666,0.999820079376614,1,3,glutathione transmembrane transporter activity,MF,GJA1
10932,GO:0042937,0.0232304828597666,0.999820079376614,1,3,tripeptide transmembrane transporter activity,MF,GJA1
5097,GO:0014014,0.0233839668111103,0.998307481728706,2,38,negative regulation of gliogenesis,BP,SOX10;NKX6-2
21219,GO:1990349,0.0234008158931465,0.999794730481271,1,4,gap junction-mediated intercellular transport,BP,GJB6
21907,GO:2000725,0.0234103144032545,0.99831032865713,2,35,regulation of cardiac muscle cell differentiation,BP,FZD7;GREM1
21278,GO:1990502,0.0234252245173576,0.999817033903079,1,3,dense core granule maturation,BP,BAIAP3
13463,GO:0050954,0.0234260862375812,0.995357563690719,4,159,sensory perception of mechanical stimulus,BP,LRP2;GJB6;PIEZO2;MBP
8753,GO:0032990,0.0235350170342016,0.990754317760757,10,672,cell part morphogenesis,BP,NGFR;LRP2;MAG;ENPP2;EGFR;ANK3;GJA1;KNDC1;UGT8;CNTN2
16144,GO:0071393,0.0235544370781262,0.999814998951084,1,3,cellular response to progesterone stimulus,BP,SOX10
7173,GO:0030148,0.0235996125771497,0.996672079757266,3,94,sphingolipid biosynthetic process,BP,FA2H;GAL3ST1;UGT8
6863,GO:0021762,0.0237108984354206,0.998269336323451,2,39,substantia nigra development,BP,PLP1;MBP
1501,GO:0003257,0.0238229868996258,0.999810733201668,1,3,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,GREM1
8818,GO:0033106,0.0239974635853134,0.999769773447294,1,5,cis-Golgi network membrane,CC,BOK
723,GO:0001937,0.0240195174176836,0.998240375584405,2,36,negative regulation of endothelial cell proliferation,BP,NGFR;GJA1
10355,GO:0038086,0.0242550964648736,0.999803766216809,1,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,PDGFRA
10357,GO:0038091,0.0242550964648736,0.999803766216809,1,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,PDGFRA
17142,GO:0090218,0.0244117302406615,0.998196146375586,2,36,positive regulation of lipid kinase activity,BP,FGFR3;PDGFRA
13086,GO:0048729,0.0244689652627701,0.99084818321941,9,612,tissue morphogenesis,BP,NGFR;EYA2;LRP2;SOX10;EGFR;GJA1;FZD7;CTHRC1;GREM1
16635,GO:0072210,0.0245649769097583,0.998180942796122,2,35,metanephric nephron development,BP,PDGFRA;GREM1
778,GO:0002009,0.0245704016456978,0.991405525008559,8,518,morphogenesis of an epithelium,BP,NGFR;LRP2;SOX10;EGFR;GJA1;FZD7;CTHRC1;GREM1
9805,GO:0035594,0.0246528678023784,0.999772054920974,1,4,ganglioside binding,MF,MAG
3728,GO:0007420,0.0247607191621704,0.990190380061049,10,701,brain development,BP,LRP2;PLP1;EGFR;KNDC1;MYO1D;BOK;CNTN2;APOD;MBP;GJC2
18870,GO:1900825,0.0248953312978242,0.999767524994705,1,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,ANK3
17628,GO:0097487,0.0251341964213581,0.999763018244294,1,4,multivesicular body, internal vesicle,CC,EGFR
21363,GO:1990769,0.025221385739541,0.999761362318292,1,4,proximal neuron projection,CC,GJC2
8211,GO:0032185,0.0252604931200961,0.999760617685835,1,4,septin cytoskeleton organization,BP,ANLN
3306,GO:0006664,0.0252873244504342,0.996333118518061,3,103,glycolipid metabolic process,BP,FA2H;GAL3ST1;UGT8
14019,GO:0051962,0.0253318503483509,0.991089413974186,8,508,positive regulation of nervous system development,BP,NGFR;LRP2;SOX10;MAG;TRIM67;MYRF;NKX6-2;GJC2
8402,GO:0032455,0.0254608383243425,0.999756784578928,1,4,nerve growth factor processing,BP,PCSK6
4584,GO:0009893,0.0255720725409913,0.985181709366297,31,3394,positive regulation of metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;BVES;TRIM67;PLP1;MYRF;PDGFRA;GPNMB;ENPP2;EGFR;ST18;ANK3;GJA1;FZD7;SLC45A3;GREM1;GPD1;KNDC1;DMRT2;BOK;CNTN2;DAPK1;MBP;GJC2
11794,GO:0045163,0.025597720336481,0.999781305951748,1,3,clustering of voltage-gated potassium channels,BP,CNTN2
3468,GO:0006915,0.0256588723875057,0.987020865453331,18,1743,apoptotic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;CAPN3;SOX10;MAG;GJB6;EGFR;ST18;GJA1;SLC5A11;GREM1;MAL;BOK;DAPK1
9818,GO:0035609,0.0257229906453541,0.999751722455849,1,4,C-terminal protein deglutamylation,BP,FOLH1
1187,GO:0002686,0.0257333727591611,0.998032580861618,2,42,negative regulation of leukocyte migration,BP,GREM1;APOD
11404,GO:0043932,0.0257617849459774,0.999734483343128,1,5,ossification involved in bone remodeling,BP,CTHRC1
21532,GO:2000145,0.0257824760486625,0.98922931272411,11,843,regulation of cell motility,BP,ERBB3;TF;PDGFRA;GPNMB;ENPP2;EGFR;GJA1;TMSB15A;GREM1;APOD;SPOCK3
21880,GO:2000672,0.0258365329371217,0.999749513609952,1,4,negative regulation of motor neuron apoptotic process,BP,CRLF1
19899,GO:1903509,0.025902770466898,0.996208702892019,3,104,liposaccharide metabolic process,BP,FA2H;GAL3ST1;UGT8
4107,GO:0008506,0.0259777476796573,0.999746752624476,1,4,sucrose:proton symporter activity,MF,SLC45A3
4115,GO:0008515,0.0259777476796573,0.999746752624476,1,4,sucrose transmembrane transporter activity,MF,SLC45A3
4530,GO:0009669,0.0259777476796573,0.999746752624476,1,4,sucrose:cation symporter activity,MF,SLC45A3
5311,GO:0015154,0.0259777476796573,0.999746752624476,1,4,disaccharide transmembrane transporter activity,MF,SLC45A3
5312,GO:0015157,0.0259777476796573,0.999746752624476,1,4,oligosaccharide transmembrane transporter activity,MF,SLC45A3
5501,GO:0015766,0.0259777476796573,0.999746752624476,1,4,disaccharide transport,BP,SLC45A3
5502,GO:0015770,0.0259777476796573,0.999746752624476,1,4,sucrose transport,BP,SLC45A3
5503,GO:0015772,0.0259777476796573,0.999746752624476,1,4,oligosaccharide transport,BP,SLC45A3
11775,GO:0045124,0.026069036700664,0.998000598134054,2,38,regulation of bone resorption,BP,TF;EGFR
2464,GO:0005201,0.0264874000499224,0.994556000351023,4,149,extracellular matrix structural constituent,MF,ACAN;EDIL3;CTHRC1;COL28A1
10951,GO:0042981,0.0265280120570153,0.987341104168581,15,1375,regulation of apoptotic process,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;MAG;EGFR;ST18;GJA1;GREM1;MAL;BOK;DAPK1
7816,GO:0031406,0.0265642230687796,0.994519648520956,4,187,carboxylic acid binding,MF,MAG;HAPLN2;ACAN;SUSD5
3596,GO:0007162,0.0268473019526443,0.993164140580264,5,254,negative regulation of cell adhesion,BP,ERBB3;GPNMB;FZD7;APOD;MBP
5903,GO:0016560,0.0268533740657189,0.999729290919574,1,4,protein import into peroxisome matrix, docking,BP,PEX5L
16307,GO:0071638,0.0268742458029884,0.999710924455347,1,5,negative regulation of monocyte chemotactic protein-1 production,BP,APOD
5428,GO:0015467,0.0268807675832277,0.999728735140529,1,4,G-protein activated inward rectifier potassium channel activity,MF,KCNJ6
7082,GO:0023052,0.0269208211334333,0.983544752313253,45,5417,signaling,BP,CRLF1;BAIAP3;NGFR;EYA2;ERBB3;FGFR3;DCX;LRP2;TF;CAPN3;SOX10;MAG;BVES;PEX5L;PLCL1;TRIM67;GJB6;PLP1;PDGFRA;GPNMB;RAPGEF5;MOG;PCSK6;EGFR;ST18;ANK3;GJA1;CNTNAP4;FZD7;CTHRC1;GREM1;KLK6;GJB1;SGCD;KNDC1;MAL;SUSD5;BOK;GPR62;CNTN2;ANKS1B;APOD;DAPK1;MBP;GJC2
1408,GO:0003104,0.0269995027223037,0.999726319492743,1,4,positive regulation of glomerular filtration,BP,GJA1
5196,GO:0014834,0.0270743449450482,0.999724791273346,1,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,FZD7
4785,GO:0010604,0.0271223137750125,0.984398804916389,29,3138,positive regulation of macromolecule metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;BVES;TRIM67;PLP1;MYRF;PDGFRA;GPNMB;ENPP2;EGFR;ST18;ANK3;GJA1;FZD7;GREM1;KNDC1;DMRT2;BOK;CNTN2;DAPK1;MBP;GJC2
3941,GO:0008237,0.0272229239027935,0.994349181231752,4,167,metallopeptidase activity,MF,FOLH1;CPM;CNDP1;ADAMTS4
11999,GO:0045687,0.0272558764836349,0.99785120481036,2,42,positive regulation of glial cell differentiation,BP,MAG;NKX6-2
2757,GO:0005826,0.0273762378816855,0.999718583151559,1,4,actomyosin contractile ring,CC,ANLN
15608,GO:0070371,0.027413912389055,0.992978742016335,5,267,ERK1 and ERK2 cascade,BP,FGFR3;TF;PDGFRA;GPNMB;EGFR
7678,GO:0031133,0.0274984091006483,0.999716050911402,1,4,regulation of axon diameter,BP,CNTN2
13325,GO:0050748,0.0275663227420651,0.999695757219474,1,5,negative regulation of lipoprotein metabolic process,BP,APOD
17892,GO:0098805,0.0276076678416284,0.986172433463147,17,1589,whole membrane,CC,BAIAP3;LRP2;TF;SOX10;MLC1;PLLP;MAG;BVES;PEX5L;GPNMB;EGFR;GJA1;FZD7;MAL;MYO1D;BOK;GPR62
16923,GO:0080184,0.0276573690363125,0.999693732698339,1,5,response to phenylpropanoid,BP,EGFR
16761,GO:0072507,0.0277267476498338,0.990859109026661,7,457,divalent inorganic cation homeostasis,BP,CAPN3;PDGFRA;EGFR;ANK3;GJA1;SGCD;BOK
5036,GO:0010941,0.0279174296202395,0.98628005833502,16,1511,regulation of cell death,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;MAG;GPNMB;EGFR;ST18;GJA1;GREM1;MAL;BOK;DAPK1
8381,GO:0032430,0.0279500530421876,0.999687178521217,1,5,positive regulation of phospholipase A2 activity,BP,EGFR
14955,GO:0061055,0.0279963708346202,0.999705610931043,1,4,myotome development,BP,DMRT2
21700,GO:2000405,0.0281870677683135,0.999681819526661,1,5,negative regulation of T cell migration,BP,APOD
15048,GO:0061302,0.0282990977956488,0.999679270458519,1,5,smooth muscle cell-matrix adhesion,BP,APOD
10631,GO:0042303,0.0283451637889977,0.9957114414669,3,97,molting cycle,BP,NGFR;FA2H;EGFR
10805,GO:0042633,0.0283451637889977,0.9957114414669,3,97,hair cycle,BP,NGFR;FA2H;EGFR
16052,GO:0071248,0.0284106524412551,0.994020768513659,4,177,cellular response to metal ion,BP,TF;CAPN3;EGFR;ANK3
14869,GO:0060926,0.0284997544331526,0.999694863366855,1,4,cardiac pacemaker cell development,BP,BVES
18663,GO:1900019,0.0286075282690415,0.999692536974898,1,4,regulation of protein kinase C activity,BP,EGFR
18664,GO:1900020,0.0286075282690415,0.999692536974898,1,4,positive regulation of protein kinase C activity,BP,EGFR
5086,GO:0014002,0.0287985072853831,0.997665825173785,2,40,astrocyte development,BP,PLP1;EGFR
720,GO:0001934,0.0288322893807788,0.987742854606008,11,883,positive regulation of protein phosphorylation,BP,CRLF1;ERBB3;FGFR3;TF;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;GREM1;KNDC1
3704,GO:0007354,0.0288504817023875,0.999666574608083,1,5,zygotic determination of anterior/posterior axis, embryo,BP,PCSK6
8689,GO:0032898,0.0289964311193993,0.999684067792566,1,4,neurotrophin production,BP,PCSK6
5631,GO:0016015,0.0290657809278123,0.999647563962521,1,6,morphogen activity,MF,GREM1
11327,GO:0043588,0.0291053806704755,0.992430959142915,5,257,skin development,BP,NGFR;FA2H;PPL;PCSK6;EGFR
21787,GO:2000543,0.0294302764095787,0.999652955557016,1,5,positive regulation of gastrulation,BP,GJA1
11010,GO:0043067,0.0295074447480028,0.985723349546468,15,1393,regulation of programmed cell death,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;MAG;EGFR;ST18;GJA1;GREM1;MAL;BOK;DAPK1
3668,GO:0007267,0.0297215313451495,0.984979946644052,17,1587,cell-cell signaling,BP,BAIAP3;FGFR3;SOX10;PLCL1;GJB6;PLP1;GPNMB;EGFR;GJA1;CNTNAP4;FZD7;CTHRC1;GREM1;GJB1;CNTN2;MBP;GJC2
17564,GO:0097360,0.0297869674002256,0.999666492974292,1,4,chorionic trophoblast cell proliferation,BP,BOK
19013,GO:1901382,0.0297869674002256,0.999666492974292,1,4,regulation of chorionic trophoblast cell proliferation,BP,BOK
21683,GO:2000382,0.029842948467877,0.999643094012264,1,5,positive regulation of mesoderm development,BP,GJA1
17289,GO:0090521,0.0300034298953356,0.999661596655095,1,4,glomerular visceral epithelial cell migration,BP,ANLN
3707,GO:0007369,0.0300352176102142,0.993574016719263,4,168,gastrulation,BP,EYA2;GJA1;FZD7;MBP
18948,GO:1901228,0.0300627778571736,0.999660247908237,1,4,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,GREM1
13939,GO:0051799,0.0300972244242046,0.999659463826353,1,4,negative regulation of hair follicle development,BP,NGFR
19954,GO:1903588,0.0301463126262043,0.999635755368595,1,5,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,NGFR
4729,GO:0010496,0.0302592627529504,0.999633003688299,1,5,intercellular transport,BP,GJB6
11223,GO:0043415,0.0302820242795194,0.999632447904867,1,5,positive regulation of skeletal muscle tissue regeneration,BP,CAPN3
9211,GO:0034219,0.0303382503633137,0.99528782997611,3,98,carbohydrate transmembrane transport,BP,SLC45A3;SLC5A11;TMEM144
5856,GO:0016477,0.0303512247835471,0.985263215274215,15,1323,cell migration,BP,ANLN;DCX;SOX10;MAG;BVES;PDGFRA;GPNMB;ENPP2;EGFR;GJA1;TMSB15A;CTHRC1;GREM1;CNTN2;APOD
13635,GO:0051240,0.0304286215483629,0.984578489677953,17,1586,positive regulation of multicellular organismal process,BP,NGFR;ERBB3;LRP2;TF;SOX10;MAG;TRIM67;MYRF;ENPP2;EGFR;NKX6-2;GJA1;CTHRC1;GREM1;DMRT2;MBP;GJC2
20478,GO:1904646,0.0304380307451851,0.99746353806066,2,38,cellular response to amyloid-beta,BP,NGFR;GJA1
815,GO:0002062,0.030439011487142,0.995267051904354,3,97,chondrocyte differentiation,BP,FGFR3;ACAN;GREM1
11068,GO:0043177,0.030460338102481,0.993442492648122,4,198,organic acid binding,MF,MAG;HAPLN2;ACAN;SUSD5
4710,GO:0010455,0.0304997223534356,0.999611708447372,1,6,positive regulation of cell fate commitment,BP,NKX6-2
5646,GO:0016043,0.0306828681966424,0.980996283884384,47,5635,cellular component organization,BP,BAIAP3;ANLN;CLDN11;STMN4;NGFR;EYA2;CDH19;DCX;LRP2;TF;CAPN3;FA2H;TUBB4A;MAG;PEX5L;ATP10B;PPL;TRIM67;GJB6;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;ERMN;ENPP2;EGFR;ANK3;GJA1;ACAN;TMSB15A;ADAMTS4;CTHRC1;GREM1;KLK6;GJB1;KNDC1;MAL;UGT8;MYO1D;BOK;CNTN2;GLDN;DNAH17;APOD;MBP;COL28A1
15271,GO:0061792,0.0307950227082863,0.999643383196971,1,4,secretory granule maturation,BP,BAIAP3
9492,GO:0034756,0.0308746667747283,0.999602043042357,1,6,regulation of iron ion transport,BP,TF
18700,GO:1900086,0.0311412989718841,0.999635263756641,1,4,positive regulation of peptidyl-tyrosine autophosphorylation,BP,GREM1
3290,GO:0006643,0.0312414242085743,0.993224626919175,4,190,membrane lipid metabolic process,BP,FA2H;GAL3ST1;ENPP2;UGT8
11929,GO:0045595,0.0313700415046765,0.98375411646674,18,1685,regulation of cell differentiation,BP,NGFR;LRP2;CAPN3;SOX10;MAG;TRIM67;PDGFRA;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;CTHRC1;GREM1;KLK6;KNDC1;CNTN2;GJC2
129,GO:0000268,0.0313749343044447,0.999605260308569,1,5,peroxisome targeting sequence binding,MF,PEX5L
16054,GO:0071253,0.0316806319857319,0.999597479794947,1,5,connexin binding,MF,GJA1
14865,GO:0060920,0.0318683991806792,0.99959266266803,1,5,cardiac pacemaker cell differentiation,BP,BVES
10744,GO:0042531,0.0319233994786944,0.997248497639694,2,48,positive regulation of tyrosine phosphorylation of STAT protein,BP,CRLF1;FGFR3
15126,GO:0061502,0.0320184628601687,0.999614281502003,1,4,early endosome to recycling endosome transport,BP,MYO1D
21970,GO:2000821,0.0320720455325201,0.999587405344381,1,5,regulation of grooming behavior,BP,CNTNAP4
17015,GO:0090027,0.0322732043741412,0.999582178701199,1,5,negative regulation of monocyte chemotaxis,BP,GREM1
1499,GO:0003254,0.032303020847707,0.99721028591281,2,42,regulation of membrane depolarization,BP,ANK3;BOK
11039,GO:0043125,0.0323113027317474,0.999581185049433,1,5,ErbB-3 class receptor binding,MF,ERBB3
5110,GO:0014037,0.0324248684535132,0.997204503927631,2,38,Schwann cell differentiation,BP,ERBB3;FA2H
7448,GO:0030665,0.0325313686597923,0.994799225323525,3,110,clathrin-coated vesicle membrane,CC,LRP2;TF;EGFR
4763,GO:0010562,0.0325984041582423,0.985332196639521,12,1010,positive regulation of phosphorus metabolic process,BP,CRLF1;ERBB3;FGFR3;TF;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;GREM1;GPD1;KNDC1
12134,GO:0045937,0.0325984041582423,0.985332196639521,12,1010,positive regulation of phosphate metabolic process,BP,CRLF1;ERBB3;FGFR3;TF;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;GREM1;GPD1;KNDC1
8269,GO:0032277,0.0327127657275715,0.999552918390695,1,6,negative regulation of gonadotropin secretion,BP,GJA1
13154,GO:0048871,0.0329658299440036,0.988733506093272,7,459,multicellular organismal homeostasis,BP,TF;FA2H;PLCL1;GJB6;EGFR;GJA1;MBP
4622,GO:0010008,0.032973114314042,0.98872905786822,7,469,endosome membrane,CC,BAIAP3;TF;GPNMB;EGFR;FZD7;BOK;GPR62
11827,GO:0045214,0.0330372728382179,0.997112133335738,2,42,sarcomere organization,BP,CAPN3;LDB3
12778,GO:0048015,0.0330630899881418,0.992711628755375,4,171,phosphatidylinositol-mediated signaling,BP,ERBB3;PLCL1;PDGFRA;EGFR
14311,GO:0060054,0.0330717999973746,0.99954298480228,1,6,positive regulation of epithelial cell proliferation involved in wound healing,BP,FZD7
7910,GO:0031580,0.0331409246883225,0.999541059596223,1,6,membrane raft distribution,BP,MAL
21879,GO:2000671,0.0331473370083389,0.999559079080405,1,5,regulation of motor neuron apoptotic process,BP,CRLF1
13695,GO:0051336,0.0332707438390249,0.984491194837607,13,1136,regulation of hydrolase activity,BP,NGFR;FGFR3;BVES;PDGFRA;PCSK6;EGFR;ST18;MYO1D;BOK;SPOCK3;DAPK1;MBP;COL28A1
18922,GO:1901164,0.0332774145103223,0.999537246147308,1,6,negative regulation of trophoblast cell migration,BP,GJA1
4970,GO:0010863,0.0333528893980377,0.997064883048219,2,44,positive regulation of phospholipase C activity,BP,PDGFRA;EGFR
9506,GO:0034775,0.0333824587484255,0.999580471528753,1,4,glutathione transmembrane transport,BP,GJA1
9721,GO:0035443,0.0333824587484255,0.999580471528753,1,4,tripeptide transmembrane transport,BP,GJA1
14827,GO:0060828,0.0334087326281484,0.990986878401531,5,273,regulation of canonical Wnt signaling pathway,BP,SOX10;EGFR;FZD7;CTHRC1;GREM1
17957,GO:0098902,0.0334270954023152,0.999551553155939,1,5,regulation of membrane depolarization during action potential,BP,ANK3
10352,GO:0038083,0.0335223205582399,0.997051826872934,2,40,peptidyl-tyrosine autophosphorylation,BP,EGFR;GREM1
11140,GO:0043281,0.0336094275982247,0.992540009282772,4,201,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,NGFR;ST18;BOK;DAPK1
14218,GO:0055065,0.033813048240618,0.987425827126939,8,584,metal ion homeostasis,BP,TF;CAPN3;PDGFRA;EGFR;ANK3;GJA1;SGCD;BOK
7272,GO:0030282,0.0338460207942962,0.994509025020404,3,106,bone mineralization,BP,FGFR3;GPNMB;GREM1
20754,GO:1905167,0.0338570440007875,0.999615958238164,1,3,positive regulation of lysosomal protein catabolic process,BP,LRP2
11224,GO:0043416,0.0341000470453446,0.999513923545038,1,6,regulation of skeletal muscle tissue regeneration,BP,CAPN3
12966,GO:0048514,0.0346915856923952,0.987039433486796,8,548,blood vessel morphogenesis,BP,NGFR;LRP2;PDGFRA;GPNMB;ENPP2;GREM1;SGCD;APOD
5890,GO:0016530,0.0347502627330575,0.999495077777411,1,6,metallochaperone activity,MF,TF
5629,GO:0016012,0.0348230693283199,0.999492944933301,1,6,sarcoglycan complex,CC,SGCD
3522,GO:0007009,0.0349913868344191,0.994253426566882,3,102,plasma membrane organization,BP,FA2H;MYRF;ANK3
10354,GO:0038085,0.0350340059703678,0.999507073402443,1,5,vascular endothelial growth factor binding,MF,PDGFRA
21029,GO:1905770,0.03516369625979,0.999482905825581,1,6,regulation of mesodermal cell differentiation,BP,GJA1
21087,GO:1905902,0.03516369625979,0.999482905825581,1,6,regulation of mesoderm formation,BP,GJA1
20385,GO:1904447,0.035195651262749,0.999502480907658,1,5,folate import across plasma membrane,BP,LRP2
21864,GO:2000648,0.0352455911387327,0.99680705021329,2,43,positive regulation of stem cell proliferation,BP,SOX10;GJA1
2143,GO:0004689,0.0354992128452923,0.999493798044782,1,5,phosphorylase kinase activity,MF,PHKG1
2841,GO:0005964,0.0354992128452923,0.999493798044782,1,5,phosphorylase kinase complex,CC,PHKG1
12780,GO:0048017,0.0355020678358752,0.991996778037427,4,175,inositol lipid-mediated signaling,BP,ERBB3;PLCL1;PDGFRA;EGFR
7105,GO:0030029,0.0356866702749529,0.984977006057474,10,741,actin filament-based process,BP,ANLN;TF;CAPN3;LDB3;PDGFRA;ERMN;GJA1;TMSB15A;SGCD;MYO1D
12555,GO:0046887,0.0358744002635797,0.994038670756997,3,116,positive regulation of hormone secretion,BP,BAIAP3;EGFR;GJA1
13118,GO:0048806,0.036164372562467,0.99667792941998,2,43,genitalia development,BP,LRP2;PDGFRA
13029,GO:0048640,0.0361953785693576,0.993975176912696,3,104,negative regulation of developmental growth,BP,FGFR3;MAG;GJA1
18002,GO:0098966,0.0362857749960399,0.999503702781481,1,4,perisynaptic extracellular matrix,CC,ACAN
18157,GO:0099535,0.0362857749960399,0.999503702781481,1,4,synapse-associated extracellular matrix,CC,ACAN
14206,GO:0055025,0.0363191934781425,0.996658714993992,2,42,positive regulation of cardiac muscle tissue development,BP,ERBB3;GREM1
19832,GO:1903367,0.0365419265033519,0.999425473844714,1,7,positive regulation of fear response,BP,GJA1
22019,GO:2000987,0.0365419265033519,0.999425473844714,1,7,positive regulation of behavioral fear response,BP,GJA1
18813,GO:1900274,0.0367554819474704,0.996586295914853,2,46,regulation of phospholipase C activity,BP,PDGFRA;EGFR
879,GO:0002158,0.0368275416060745,0.999432432829393,1,6,osteoclast proliferation,BP,GREM1
5095,GO:0014012,0.037001424988134,0.999427020397453,1,6,peripheral nervous system axon regeneration,BP,APOD
14729,GO:0060676,0.0370705023655978,0.999424863004942,1,6,ureteric bud formation,BP,GREM1
2360,GO:0005007,0.0371242543111259,0.9994460194544,1,5,fibroblast growth factor-activated receptor activity,MF,FGFR3
18035,GO:0099025,0.0371955445086519,0.999443873328488,1,5,anchored component of postsynaptic membrane,CC,CNTN2
10808,GO:0042636,0.0373018594146952,0.999440664989023,1,5,negative regulation of hair cycle,BP,NGFR
9915,GO:0035749,0.0373567652175321,0.999415878714684,1,6,myelin sheath adaxonal region,CC,MAG
3401,GO:0006812,0.037414717876339,0.982810587717757,12,1031,cation transport,BP,LRP2;NKAIN1;TF;CAPN3;ANK3;GJA1;PIEZO2;KCNJ6;SLC5A11;NKAIN2;DAPK1;GJC2
18698,GO:1900084,0.037491567238153,0.999434916761212,1,5,regulation of peptidyl-tyrosine autophosphorylation,BP,GREM1
13336,GO:0050769,0.0374988432593428,0.986833092750308,7,450,positive regulation of neurogenesis,BP,NGFR;LRP2;SOX10;MAG;TRIM67;NKX6-2;GJC2
9939,GO:0035790,0.0377403366945358,0.99942733370836,1,5,platelet-derived growth factor receptor-alpha signaling pathway,BP,PDGFRA
15656,GO:0070459,0.0377846160210107,0.999385431700773,1,7,prolactin secretion,BP,EGFR
20025,GO:1903727,0.0379616825863009,0.996407331259957,2,48,positive regulation of phospholipid metabolic process,BP,FGFR3;PDGFRA
6627,GO:0019800,0.0379770122953719,0.999396169866779,1,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,SPOCK3
11408,GO:0043949,0.0380429666714803,0.996400230042385,2,46,regulation of cAMP-mediated signaling,BP,PEX5L;GPR62
3918,GO:0008199,0.0381126160693983,0.999374634449523,1,7,ferric iron binding,MF,TF
9415,GO:0034635,0.0381227829923755,0.999415575745462,1,5,glutathione transport,BP,GJA1
10934,GO:0042939,0.0381227829923755,0.999415575745462,1,5,tripeptide transport,BP,GJA1
2641,GO:0005615,0.0381402273593253,0.978415532451937,23,2632,extracellular space,CC,CRLF1;BCAS1;ERBB3;LRP2;FOLH1;TF;TUBB4A;PPL;CPM;ERMN;ENPP2;PCSK6;EGFR;ADAMTS4;EDIL3;CTHRC1;GREM1;GPD1;KLK6;MYO1D;GLDN;APOD;COL28A1
17556,GO:0097345,0.0382126954559848,0.996360241637904,2,53,mitochondrial outer membrane permeabilization,BP,EYA2;BOK
13335,GO:0050768,0.0383667910494431,0.989263795492784,5,268,negative regulation of neurogenesis,BP,NGFR;SOX10;MAG;NKX6-2;CNTN2
21786,GO:2000542,0.0384098870361348,0.999382218167694,1,6,negative regulation of gastrulation,BP,FZD7
9860,GO:0035673,0.0384279793124875,0.999406105672738,1,5,oligopeptide transmembrane transporter activity,MF,GJA1
6145,GO:0017034,0.0385173155667058,0.999403318987113,1,5,Rap guanyl-nucleotide exchange factor activity,MF,RAPGEF5
2725,GO:0005771,0.0385981852560541,0.996301595748584,2,54,multivesicular body,CC,EGFR;GJA1
2033,GO:0004528,0.0386302830869299,0.999375052553957,1,6,phosphodiesterase I activity,MF,ENPP2
13159,GO:0048878,0.0386436437135073,0.982157277544997,12,1052,chemical homeostasis,BP,BAIAP3;NGFR;TF;CAPN3;FA2H;GJB6;PDGFRA;EGFR;ANK3;GJA1;SGCD;BOK
5152,GO:0014719,0.0391203128219758,0.999358970086611,1,6,skeletal muscle satellite cell activation,BP,CAPN3
15729,GO:0070573,0.039503825413966,0.999327776477538,1,7,metallodipeptidase activity,MF,CNDP1
5913,GO:0016576,0.0395224381915608,0.99934561751864,1,6,histone dephosphorylation,BP,EYA2
15469,GO:0070141,0.0396204687210039,0.999342341214976,1,6,response to UV-A,BP,EGFR
13869,GO:0051665,0.0397050533089088,0.999320856497793,1,7,membrane raft localization,BP,MAL
4588,GO:0009897,0.0398023492924295,0.988742250858177,5,299,external side of plasma membrane,CC,CRLF1;LRP2;TF;PDGFRA;MOG
7785,GO:0031344,0.0399895055864291,0.983676144048357,9,650,regulation of cell projection organization,BP,ANLN;NGFR;MAG;TRIM67;ERMN;ENPP2;KLK6;KNDC1;CNTN2
10387,GO:0038132,0.0399924662675785,0.999356345506518,1,5,neuregulin binding,MF,ERBB3
7655,GO:0031103,0.0403861898105628,0.996052522226932,2,46,axon regeneration,BP,MAG;APOD
17521,GO:0097264,0.0405059213757789,0.99931237150803,1,6,self proteolysis,BP,CAPN3
5176,GO:0014807,0.0405456839482112,0.999311009750171,1,6,regulation of somitogenesis,BP,DMRT2
3209,GO:0006548,0.040595991099743,0.999289785619065,1,7,histidine catabolic process,BP,CARNS1
14138,GO:0052805,0.040595991099743,0.999289785619065,1,7,imidazole-containing compound catabolic process,BP,CARNS1
13976,GO:0051902,0.0407926727557477,0.999282831316764,1,7,negative regulation of mitochondrial depolarization,BP,BOK
19288,GO:1902110,0.0409390900201561,0.995947930348403,2,55,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,EYA2;BOK
4176,GO:0008635,0.0410907767759635,0.999272225257194,1,7,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,BOK
12873,GO:0048260,0.0411682667543819,0.995931162370027,2,47,positive regulation of receptor-mediated endocytosis,BP,TF;GREM1
11281,GO:0043523,0.0411837793411703,0.990260347691354,4,199,regulation of neuron apoptotic process,BP,CRLF1;ERBB3;MAG;BOK
13413,GO:0050877,0.0413578720989536,0.981380523038024,11,920,nervous system process,BP,LRP2;SOX10;MAG;GJB6;MYRF;EGFR;NKX6-2;ANK3;PIEZO2;CNTN2;MBP
16557,GO:0072103,0.0415604097842446,0.999304432358817,1,5,glomerulus vasculature morphogenesis,BP,PDGFRA
16558,GO:0072104,0.0415604097842446,0.999304432358817,1,5,glomerular capillary formation,BP,PDGFRA
13605,GO:0051173,0.0415740280782332,0.975608796354901,26,2840,positive regulation of nitrogen compound metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;TRIM67;MYRF;PDGFRA;GPNMB;ENPP2;EGFR;ST18;GJA1;FZD7;GREM1;GPD1;KNDC1;DMRT2;BOK;CNTN2;DAPK1;MBP
10333,GO:0038031,0.0416900793603017,0.999271230331869,1,6,non-canonical Wnt signaling pathway via JNK cascade,BP,FZD7
7381,GO:0030514,0.0417130098549811,0.995850529024849,2,46,negative regulation of BMP signaling pathway,BP,LRP2;GREM1
2826,GO:0005930,0.0418521262841478,0.992627694471298,3,104,axoneme,CC,DCX;TUBB4A;DNAH17
6914,GO:0021853,0.0419066606850387,0.9992635741566,1,6,cerebral cortex GABAergic interneuron migration,BP,CNTN2
20646,GO:1904936,0.0419066606850387,0.9992635741566,1,6,interneuron migration,BP,CNTN2
17911,GO:0098838,0.0420738753473975,0.999257635264096,1,6,folate transmembrane transport,BP,LRP2
10753,GO:0042551,0.0421625001523662,0.995781272289567,2,46,neuron maturation,BP,CNTN2;GLDN
16047,GO:0071241,0.0422114782697373,0.989938409297404,4,201,cellular response to inorganic substance,BP,TF;CAPN3;EGFR;ANK3
20709,GO:1905050,0.042219220653695,0.999215549700555,1,8,positive regulation of metallopeptidase activity,BP,MBP
12082,GO:0045843,0.0424695225043225,0.995722940623386,2,50,negative regulation of striated muscle tissue development,BP,GJA1;FZD7
8087,GO:0031952,0.0424870291335103,0.995734012720934,2,45,regulation of protein autophosphorylation,BP,GPNMB;GREM1
13121,GO:0048812,0.0424997776587898,0.982459439680863,9,636,neuron projection morphogenesis,BP,NGFR;LRP2;MAG;EGFR;ANK3;GJA1;KNDC1;UGT8;CNTN2
5137,GO:0014066,0.0425216364320367,0.992454958299871,3,111,regulation of phosphatidylinositol 3-kinase signaling,BP,ERBB3;PDGFRA;EGFR
3279,GO:0006629,0.0425234826052986,0.979455138499129,13,1221,lipid metabolic process,BP,FGFR3;LRP2;FA2H;PLCL1;PLP1;GAL3ST1;PDGFRA;ENPP2;EGFR;SLC45A3;GPD1;UGT8;APOD
5494,GO:0015748,0.0426208156876469,0.992424301396357,3,117,organophosphate ester transport,BP,ATP10B;GJA1;GJB1
5628,GO:0016011,0.0427751361245024,0.999210810959844,1,7,dystroglycan complex,CC,SGCD
3588,GO:0007154,0.0428703249200361,0.972807479592775,44,5427,cell communication,BP,CRLF1;BAIAP3;NGFR;EYA2;ERBB3;FGFR3;DCX;LRP2;TF;CAPN3;SOX10;MAG;PEX5L;PLCL1;TRIM67;GJB6;PLP1;PDGFRA;GPNMB;RAPGEF5;MOG;PCSK6;EGFR;ST18;ANK3;GJA1;CNTNAP4;FZD7;CTHRC1;GREM1;KLK6;GJB1;SGCD;KNDC1;MAL;SUSD5;BOK;GPR62;CNTN2;ANKS1B;APOD;DAPK1;MBP;GJC2
17374,GO:0097014,0.0428722615398209,0.992375103856883,3,105,ciliary plasm,CC,DCX;TUBB4A;DNAH17
330,GO:0000912,0.0429180583429435,0.999227282274673,1,6,assembly of actomyosin apparatus involved in cytokinesis,BP,ANLN
331,GO:0000915,0.0429180583429435,0.999227282274673,1,6,actomyosin contractile ring assembly,BP,ANLN
2584,GO:0005509,0.0429249669069745,0.983280796381572,8,563,calcium ion binding,MF,BAIAP3;CDH19;LRP2;CAPN3;TUBB4A;ENPP2;EDIL3;SPOCK3
12323,GO:0046394,0.0429787088956757,0.987585786088772,5,315,carboxylic acid biosynthetic process,BP,FOLH1;FA2H;PLP1;SLC45A3;CARNS1
2822,GO:0005923,0.042981601790807,0.992342181858632,3,110,bicellular tight junction,CC,CLDN11;BVES;ANK3
19654,GO:1903011,0.0431892511928313,0.999217400082883,1,6,negative regulation of bone development,BP,GREM1
10728,GO:0042482,0.0432078836029156,0.999194623804595,1,7,positive regulation of odontogenesis,BP,NGFR
1347,GO:0002931,0.0434186739535189,0.995574373627526,2,50,response to ischemia,BP,BVES;GJA1
20477,GO:1904645,0.0434576321585375,0.99557642988763,2,47,response to amyloid-beta,BP,NGFR;GJA1
5654,GO:0016053,0.0435113417947003,0.987389843381142,5,316,organic acid biosynthetic process,BP,FOLH1;FA2H;PLP1;SLC45A3;CARNS1
18165,GO:0099544,0.0435157750074707,0.999236820102885,1,5,perisynaptic space,CC,ACAN
13614,GO:0051205,0.043532901297061,0.995536783746801,2,59,protein insertion into membrane,BP,EGFR;MAL
17739,GO:0097755,0.0435606346575983,0.995544712434419,2,53,positive regulation of blood vessel diameter,BP,EGFR;GJA1
19514,GO:1902686,0.0437524801146585,0.995505794171904,2,57,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,EYA2;BOK
4800,GO:0010624,0.0438304209666959,0.999193781873368,1,6,regulation of Schwann cell proliferation,BP,SOX10
4801,GO:0010626,0.0438304209666959,0.999193781873368,1,6,negative regulation of Schwann cell proliferation,BP,SOX10
10959,GO:0042989,0.0440758763661318,0.999120305356662,1,10,sequestering of actin monomers,BP,TMSB15A
20330,GO:1904352,0.0440776846747312,0.999216799828802,1,5,positive regulation of protein catabolic process in the vacuole,BP,LRP2
556,GO:0001704,0.0440947929070003,0.992062279501338,3,112,formation of primary germ layer,BP,EYA2;GJA1;FZD7
13861,GO:0051651,0.0441824355747827,0.989317733106076,4,197,maintenance of location in cell,BP,CAPN3;ANK3;GJA1;TMSB15A
13025,GO:0048635,0.0442387509771962,0.99544194707796,2,51,negative regulation of muscle organ development,BP,GJA1;FZD7
7087,GO:0030001,0.0443046899937286,0.980641297590912,10,814,metal ion transport,BP,LRP2;NKAIN1;TF;CAPN3;ANK3;GJA1;KCNJ6;SLC5A11;NKAIN2;GJC2
5515,GO:0015798,0.0443151508031675,0.999208259790245,1,5,myo-inositol transport,BP,SLC5A11
14457,GO:0060284,0.0443348921910061,0.979816797291401,11,884,regulation of cell development,BP,NGFR;LRP2;SOX10;MAG;TRIM67;NKX6-2;SLC45A3;KLK6;KNDC1;CNTN2;GJC2
20244,GO:1904180,0.0443384561598901,0.999134104311336,1,8,negative regulation of membrane depolarization,BP,BOK
10743,GO:0042509,0.0445088428768385,0.995385161468205,2,57,regulation of tyrosine phosphorylation of STAT protein,BP,CRLF1;FGFR3
21334,GO:1990712,0.0445836848556552,0.999142050148381,1,7,HFE-transferrin receptor complex,CC,TF
18940,GO:1901214,0.0447659194836129,0.986932521809946,5,296,regulation of neuron death,BP,CRLF1;ERBB3;MAG;GPNMB;BOK
2536,GO:0005351,0.0448771720734496,0.999130616139122,1,7,carbohydrate:proton symporter activity,MF,SLC45A3
12876,GO:0048263,0.0450349978595099,0.999106441495974,1,8,determination of dorsal identity,BP,GREM1
4136,GO:0008544,0.0450680603290309,0.986821035664527,5,294,epidermis development,BP,NGFR;FA2H;PPL;PCSK6;EGFR
6937,GO:0021894,0.0451523209768032,0.999119826596788,1,7,cerebral cortex GABAergic interneuron development,BP,CNTN2
16600,GO:0072172,0.045194173480644,0.999100057775991,1,8,mesonephric tubule formation,BP,GREM1
7210,GO:0030198,0.0452979088055362,0.984937000784729,6,361,extracellular matrix organization,BP,HAPLN2;PDGFRA;ACAN;ADAMTS4;GREM1;COL28A1
16023,GO:0071205,0.0453562874682354,0.999170260229321,1,5,protein localization to juxtaparanode region of axon,BP,CNTN2
9638,GO:0035272,0.0454085719682384,0.995259751333755,2,49,exocrine system development,BP,SOX10;EGFR
13090,GO:0048733,0.045477129603998,0.999131484897074,1,6,sebaceous gland development,BP,FA2H
9146,GO:0034112,0.0456648859828816,0.999099546484388,1,7,positive regulation of homotypic cell-cell adhesion,BP,ANK3
3969,GO:0008285,0.0456920807153754,0.981972629014845,8,625,negative regulation of cell population proliferation,BP,NGFR;SOX10;GJB6;GPNMB;ST18;GJA1;GREM1;APOD
19286,GO:1902108,0.045817912956479,0.995171546525857,2,58,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,EYA2;BOK
11696,GO:0044857,0.0458369900285198,0.999074042370402,1,8,plasma membrane raft organization,BP,FA2H
11006,GO:0043062,0.0458488376829778,0.984709331098977,6,362,extracellular structure organization,BP,HAPLN2;PDGFRA;ACAN;ADAMTS4;GREM1;COL28A1
16334,GO:0071676,0.0459533699379973,0.999088028900754,1,7,negative regulation of mononuclear cell migration,BP,GREM1
15011,GO:0061156,0.0463345421323366,0.999098112898907,1,6,pulmonary artery morphogenesis,BP,LRP2
17792,GO:0098632,0.0463428146519501,0.995102411683499,2,51,cell-cell adhesion mediator activity,MF,CNTN2;GLDN
7767,GO:0031325,0.0464044800111216,0.97225731225004,27,3000,positive regulation of cellular metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;BVES;TRIM67;MYRF;PDGFRA;GPNMB;ENPP2;EGFR;ST18;FZD7;SLC45A3;GREM1;GPD1;KNDC1;DMRT2;BOK;CNTN2;DAPK1;MBP
9942,GO:0035794,0.0464590645789234,0.995064583364028,2,59,positive regulation of mitochondrial membrane permeability,BP,EYA2;BOK
1500,GO:0003256,0.046533527108991,0.999090276407754,1,6,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,GREM1
13657,GO:0051270,0.0466683356119186,0.978572549045165,11,920,regulation of cellular component movement,BP,ERBB3;TF;PDGFRA;GPNMB;ENPP2;EGFR;GJA1;TMSB15A;GREM1;APOD;SPOCK3
9817,GO:0035608,0.0467672610073661,0.999055132792257,1,7,protein deglutamylation,BP,FOLH1
21518,GO:2000116,0.0467712401747379,0.988472320161846,4,222,regulation of cysteine-type endopeptidase activity,BP,NGFR;ST18;BOK;DAPK1
20494,GO:1904683,0.046791262136978,0.999080074854211,1,6,regulation of metalloendopeptidase activity,BP,MBP
7606,GO:0031032,0.04689350529228,0.988451449222558,4,188,actomyosin structure organization,BP,ANLN;CAPN3;LDB3;PDGFRA
19186,GO:1901862,0.0470645927099917,0.994978554909211,2,53,negative regulation of muscle tissue development,BP,GJA1;FZD7
2555,GO:0005412,0.0471521811290132,0.999039368143695,1,7,glucose:sodium symporter activity,MF,SLC5A11
21013,GO:1905710,0.0472334351584418,0.994934698297235,2,60,positive regulation of membrane permeability,BP,EYA2;BOK
11910,GO:0045545,0.0476109461616422,0.99902040553293,1,7,syndecan binding,MF,GPNMB
14895,GO:0060976,0.0477409784004033,0.994891222252149,2,45,coronary vasculature development,BP,LRP2;SGCD
6457,GO:0019229,0.0478453749043113,0.994851742477724,2,52,regulation of vasoconstriction,BP,EGFR;GJA1
13524,GO:0051050,0.0479538026037148,0.978754790399467,10,843,positive regulation of transport,BP,BAIAP3;TF;CAPN3;MLC1;EGFR;ANK3;GJA1;GREM1;BOK;GJC2
11686,GO:0044837,0.048044651058095,0.99900230506545,1,7,actomyosin contractile ring organization,BP,ANLN
21917,GO:2000739,0.0480698659717258,0.999028608212731,1,6,regulation of mesenchymal stem cell differentiation,BP,PDGFRA
11305,GO:0043551,0.0481426073903653,0.994804970815633,2,51,regulation of phosphatidylinositol 3-kinase activity,BP,FGFR3;PDGFRA
7284,GO:0030297,0.0481558915285681,0.998997635283674,1,7,transmembrane receptor protein tyrosine kinase activator activity,MF,GREM1
3663,GO:0007260,0.0481785948158462,0.994779096215104,2,59,tyrosine phosphorylation of STAT protein,BP,CRLF1;FGFR3
3316,GO:0006678,0.0482090279369839,0.998974775269048,1,8,glucosylceramide metabolic process,BP,FA2H
16408,GO:0071840,0.0482555330968242,0.968960667287315,47,5809,cellular component organization or biogenesis,BP,BAIAP3;ANLN;CLDN11;STMN4;NGFR;EYA2;CDH19;DCX;LRP2;TF;CAPN3;FA2H;TUBB4A;MAG;PEX5L;ATP10B;PPL;TRIM67;GJB6;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;ERMN;ENPP2;EGFR;ANK3;GJA1;ACAN;TMSB15A;ADAMTS4;CTHRC1;GREM1;KLK6;GJB1;KNDC1;MAL;UGT8;MYO1D;BOK;CNTN2;GLDN;DNAH17;APOD;MBP;COL28A1
13012,GO:0048608,0.0482705185401962,0.983692568188796,6,394,reproductive structure development,BP,LRP2;PDGFRA;EGFR;GJA1;GJB1;BOK
19830,GO:1903365,0.0482893162355502,0.998955238091651,1,9,regulation of fear response,BP,GJA1
21971,GO:2000822,0.0482893162355502,0.998955238091651,1,9,regulation of behavioral fear response,BP,GJA1
6834,GO:0021684,0.048360731034537,0.998989007218173,1,7,cerebellar granular layer formation,BP,KNDC1
6851,GO:0021707,0.048360731034537,0.998989007218173,1,7,cerebellar granule cell differentiation,BP,KNDC1
4148,GO:0008584,0.0484249575110348,0.990945283891009,3,120,male gonad development,BP,LRP2;PDGFRA;BOK
16653,GO:0072239,0.0485140593456071,0.998982524195168,1,7,metanephric glomerulus vasculature development,BP,PDGFRA
18888,GO:1901029,0.0486571964235748,0.998939107866848,1,9,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
10332,GO:0038030,0.0488996828496455,0.998966125899071,1,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,FZD7
15576,GO:0070314,0.0489710652731681,0.998963075764998,1,7,G1 to G0 transition,BP,CAPN3
16179,GO:0071447,0.0489941541701162,0.998940784018645,1,8,cellular response to hydroperoxide,BP,DAPK1
17608,GO:0097450,0.0489994522575302,0.998961861530834,1,7,astrocyte end-foot,CC,MLC1
7002,GO:0022029,0.0492876390218355,0.994615455844311,2,50,telencephalon cell migration,BP,EGFR;CNTN2
16129,GO:0071374,0.0493122288081785,0.998948434753337,1,7,cellular response to parathyroid hormone stimulus,BP,GJA1
8525,GO:0032642,0.0493571337230989,0.994580057272945,2,59,regulation of chemokine production,BP,APOD;MBP
8638,GO:0032808,0.0495212721968001,0.998939411952203,1,7,lacrimal gland development,BP,SOX10
7250,GO:0030246,0.049526271364505,0.987565483247837,4,228,carbohydrate binding,MF,MAG;ENPP2;ACAN;CNTN2
16029,GO:0071214,0.0495678437788019,0.985121162462764,5,305,cellular response to abiotic stimulus,BP,CAPN3;MAG;EGFR;GJA1;PIEZO2
18323,GO:0104004,0.0495678437788019,0.985121162462764,5,305,cellular response to environmental stimulus,BP,CAPN3;MAG;EGFR;GJA1;PIEZO2
12402,GO:0046546,0.049577276255527,0.990641956496363,3,121,development of primary male sexual characteristics,BP,LRP2;PDGFRA;BOK
13143,GO:0048857,0.049730142828832,0.9945236005898,2,56,neural nucleus development,BP,PLP1;MBP
7243,GO:0030235,0.0500076036450117,0.998918268623448,1,7,nitric-oxide synthase regulator activity,MF,EGFR
4923,GO:0010810,0.0500098414454086,0.987422283008429,4,197,regulation of cell-substrate adhesion,BP,FZD7;EDIL3;GREM1;APOD
21650,GO:2000343,0.0500600755933691,0.998876440522865,1,9,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,MBP
15115,GO:0061458,0.0501670270170311,0.9828925641778,6,398,reproductive system development,BP,LRP2;PDGFRA;EGFR;GJA1;GJB1;BOK
4837,GO:0010668,0.0502411123362088,0.998908041158894,1,7,ectodermal cell differentiation,BP,FZD7
7709,GO:0031232,0.0504031419756135,0.998878365674595,1,8,extrinsic component of external side of plasma membrane,CC,TF
12073,GO:0045834,0.0504544983413292,0.990401387348062,3,129,positive regulation of lipid metabolic process,BP,FGFR3;PDGFRA;SLC45A3
14977,GO:0061098,0.0505091462561303,0.994398253338496,2,53,positive regulation of protein tyrosine kinase activity,BP,ERBB3;GREM1
21693,GO:2000394,0.0505117762876396,0.998896124895254,1,7,positive regulation of lamellipodium morphogenesis,BP,ENPP2
7654,GO:0031102,0.0505818335387692,0.994385758613588,2,53,neuron projection regeneration,BP,MAG;APOD
7025,GO:0022604,0.0510114674432813,0.980856275441597,7,470,regulation of cell morphogenesis,BP,NGFR;MAG;BVES;ERMN;ENPP2;KNDC1;CNTN2
5146,GO:0014704,0.0510779394379845,0.99430944908129,2,50,intercalated disc,CC,ANK3;GJA1
14433,GO:0060249,0.0511192590782553,0.982486544213238,6,405,anatomical structure homeostasis,BP,TF;CAPN3;GJB6;EGFR;GJA1;MBP
17393,GO:0097049,0.0511476954360645,0.998844645726979,1,8,motor neuron apoptotic process,BP,CRLF1
12354,GO:0046467,0.051206372073778,0.990197989098651,3,132,membrane lipid biosynthetic process,BP,FA2H;GAL3ST1;UGT8
13037,GO:0048660,0.0515698121723417,0.990103645828674,3,129,regulation of smooth muscle cell proliferation,BP,EGFR;GJA1;APOD
657,GO:0001838,0.0516114631285332,0.990101237015939,3,121,embryonic epithelial tube formation,BP,LRP2;CTHRC1;GREM1
14018,GO:0051961,0.0517642976949674,0.984281871069844,5,291,negative regulation of nervous system development,BP,NGFR;SOX10;MAG;NKX6-2;CNTN2
12875,GO:0048262,0.0518259070974449,0.998794952170064,1,9,determination of dorsal/ventral asymmetry,BP,GREM1
5093,GO:0014010,0.0518474722694073,0.998836352836981,1,7,Schwann cell proliferation,BP,SOX10
7554,GO:0030913,0.0518570127604703,0.998835920116517,1,7,paranodal junction assembly,BP,UGT8
19339,GO:1902237,0.051908193184703,0.998776215667636,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,BOK
12779,GO:0048016,0.0519640190920847,0.994149266292629,2,52,inositol phosphate-mediated signaling,BP,ERBB3;GPR62
3281,GO:0006633,0.0520727916068141,0.98995622371038,3,142,fatty acid biosynthetic process,BP,FA2H;PLP1;SLC45A3
12995,GO:0048565,0.0522299386462877,0.98993386675015,3,122,digestive tract development,BP,SOX10;PDGFRA;EGFR
5576,GO:0015884,0.0523412490612413,0.998789527668072,1,8,folic acid transport,BP,LRP2
17779,GO:0098590,0.05251948373824,0.973820102696663,13,1133,plasma membrane region,CC,ERBB3;LRP2;TF;MLC1;BVES;GJB6;EGFR;ANK3;GJA1;CNTNAP4;MAL;MYO1D;CNTN2
13036,GO:0048659,0.0525582958459687,0.989836453900381,3,130,smooth muscle cell proliferation,BP,EGFR;GJA1;APOD
13076,GO:0048705,0.0526001346675694,0.986546368613367,4,210,skeletal system morphogenesis,BP,FGFR3;PDGFRA;ACAN;GREM1
18939,GO:1901213,0.0526296093075371,0.998800605416644,1,7,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,GREM1
18543,GO:0140104,0.0530283170988635,0.998722279974704,1,10,molecular carrier activity,MF,TF
13495,GO:0051015,0.0530695634597764,0.986400239065898,4,191,actin filament binding,MF,GJB6;ERMN;EGFR;MYO1D
3208,GO:0006547,0.0532795941977124,0.998725683266676,1,9,histidine metabolic process,BP,CARNS1
2369,GO:0005021,0.0533498930107757,0.998767196414023,1,7,vascular endothelial growth factor-activated receptor activity,MF,PDGFRA
11890,GO:0045453,0.0535985531366416,0.993844001032945,2,58,bone resorption,BP,TF;EGFR
9149,GO:0034115,0.0537715905861885,0.998701791793453,1,9,negative regulation of heterotypic cell-cell adhesion,BP,MBP
15738,GO:0070587,0.0537715905861885,0.998701791793453,1,9,regulation of cell-cell adhesion involved in gastrulation,BP,MBP
18726,GO:1900122,0.0539407096244269,0.998693527005741,1,9,positive regulation of receptor binding,BP,PLCL1
11090,GO:0043208,0.0541050745749942,0.998705673021147,1,8,glycosphingolipid binding,MF,MAG
14324,GO:0060070,0.0543254194827086,0.983275203496661,5,312,canonical Wnt signaling pathway,BP,SOX10;EGFR;FZD7;CTHRC1;GREM1
21359,GO:1990763,0.0546727750761537,0.998657442320092,1,9,arrestin family protein binding,MF,GPR62
6930,GO:0021885,0.0548755138737411,0.99362974902661,2,53,forebrain cell migration,BP,EGFR;CNTN2
15106,GO:0061438,0.054956252138786,0.998690998969522,1,7,renal system vasculature morphogenesis,BP,PDGFRA
15107,GO:0061439,0.054956252138786,0.998690998969522,1,7,kidney vasculature morphogenesis,BP,PDGFRA
17568,GO:0097367,0.0549688559090862,0.968652275411457,20,2013,carbohydrate derivative binding,MF,ERBB3;FGFR3;TUBB4A;MAG;BVES;CDK18;ATP10B;HAPLN2;PDGFRA;GPNMB;PCSK6;EGFR;ACAN;PHKG1;CARNS1;SUSD5;MYO1D;DNAH17;SPOCK3;DAPK1
15550,GO:0070268,0.0550953796637774,0.993562776801884,2,63,cornification,BP,PPL;PCSK6
2915,GO:0006072,0.0552307991754754,0.998677742180639,1,7,glycerol-3-phosphate metabolic process,BP,GPD1
11793,GO:0045162,0.0552465848064246,0.998676977879471,1,7,clustering of voltage-gated sodium channels,BP,GLDN
9147,GO:0034113,0.0555995059914366,0.993483782992653,2,58,heterotypic cell-cell adhesion,BP,GLDN;MBP
3400,GO:0006811,0.0560706477745045,0.970405488189118,15,1473,ion transport,BP,LRP2;NKAIN1;TF;CAPN3;MLC1;PLLP;ATP10B;ANK3;GJA1;PIEZO2;KCNJ6;SLC5A11;NKAIN2;DAPK1;GJC2
12332,GO:0046427,0.0562469235985202,0.993350430938937,2,64,positive regulation of receptor signaling pathway via JAK-STAT,BP,CRLF1;FGFR3
9831,GO:0035630,0.056284955527275,0.998598072475357,1,8,bone mineralization involved in bone maturation,BP,GREM1
2416,GO:0005127,0.0565074635828668,0.998586842289876,1,8,ciliary neurotrophic factor receptor binding,MF,CRLF1
20062,GO:1903800,0.0565749173148671,0.998543666678983,1,10,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR
7211,GO:0030199,0.056597513402582,0.993320220738901,2,52,collagen fibril organization,BP,ACAN;GREM1
11060,GO:0043168,0.0567391394315492,0.966148823202599,24,2551,anion binding,MF,BAIAP3;ERBB3;FGFR3;FOLH1;TUBB4A;MAG;BVES;PLCL1;CDK18;ATP10B;HAPLN2;PDGFRA;GPNMB;PCSK6;EGFR;FZD7;SNX22;ACAN;PHKG1;CARNS1;SUSD5;MYO1D;DNAH17;DAPK1
8498,GO:0032602,0.0569872540186526,0.993209522774782,2,66,chemokine production,BP,APOD;MBP
4179,GO:0008643,0.0570571115542603,0.988598672394479,3,130,carbohydrate transport,BP,SLC45A3;SLC5A11;TMEM144
21270,GO:1990459,0.0570667899969954,0.998535928691397,1,9,transferrin receptor binding,MF,TF
8380,GO:0032429,0.0571539975837258,0.998531400695152,1,9,regulation of phospholipase A2 activity,BP,EGFR
13732,GO:0051400,0.0571749891590778,0.998512264994673,1,10,BH domain binding,MF,BOK
20208,GO:1904064,0.0571802777869012,0.988559697258607,3,134,positive regulation of cation transmembrane transport,BP,CAPN3;ANK3;GJC2
4886,GO:0010749,0.0572631681169376,0.998548359144908,1,8,regulation of nitric oxide mediated signal transduction,BP,EGFR
13357,GO:0050795,0.0573226056081884,0.993162013471265,2,60,regulation of behavior,BP,GJA1;CNTNAP4
9561,GO:0035082,0.0575405384457889,0.993133182191156,2,56,axoneme assembly,BP,DCX;DNAH17
20109,GO:1903897,0.0575915918376091,0.998508571974364,1,9,regulation of PERK-mediated unfolded protein response,BP,BOK
9778,GO:0035556,0.0582560328737355,0.965450048860201,23,2507,intracellular signal transduction,BP,NGFR;ERBB3;FGFR3;DCX;LRP2;TF;CAPN3;PEX5L;PLCL1;TRIM67;PDGFRA;GPNMB;RAPGEF5;EGFR;GJA1;FZD7;GREM1;SGCD;KNDC1;BOK;GPR62;DAPK1;MBP
16073,GO:0071286,0.0584646042962973,0.998516449744173,1,7,cellular response to magnesium ion,BP,ANK3
9859,GO:0035672,0.0585633363214838,0.998480912071296,1,8,oligopeptide transmembrane transport,BP,GJA1
16603,GO:0072175,0.0587461241812474,0.988124241869918,3,129,epithelial tube formation,BP,LRP2;CTHRC1;GREM1
12021,GO:0045739,0.0587629290263275,0.99289903342045,2,58,positive regulation of DNA repair,BP,EYA2;EGFR
16754,GO:0072497,0.0589670941846249,0.998459647938227,1,8,mesenchymal stem cell differentiation,BP,PDGFRA
20624,GO:1904894,0.0589880488646423,0.99283563097165,2,66,positive regulation of receptor signaling pathway via STAT,BP,CRLF1;FGFR3
8268,GO:0032276,0.0590949549328713,0.998409491620781,1,10,regulation of gonadotropin secretion,BP,GJA1
13547,GO:0051093,0.0591096387481036,0.97282734650186,10,859,negative regulation of developmental process,BP,NGFR;FGFR3;SOX10;MAG;EGFR;NKX6-2;GJA1;FZD7;GREM1;CNTN2
11858,GO:0045296,0.0591823049385942,0.981344743186285,5,308,cadherin binding,MF,ANLN;CDH19;PPL;EGFR;ANK3
11930,GO:0045596,0.0592200989829259,0.975381166856614,8,631,negative regulation of cell differentiation,BP,NGFR;SOX10;MAG;EGFR;NKX6-2;FZD7;GREM1;CNTN2
7297,GO:0030315,0.0594574934698408,0.992781235456889,2,54,T-tubule,CC,CAPN3;ANK3
5367,GO:0015267,0.0597951884422474,0.978715357391299,6,404,channel activity,MF,GJB6;GJA1;PIEZO2;KCNJ6;GJB1;GJC2
7040,GO:0022803,0.0597951884422474,0.978715357391299,6,404,passive transmembrane transporter activity,MF,GJB6;GJA1;PIEZO2;KCNJ6;GJB1;GJC2
19350,GO:1902260,0.0598748663280816,0.998366740889733,1,10,negative regulation of delayed rectifier potassium channel activity,BP,ANK3
15737,GO:0070586,0.0600344493477908,0.998357921870205,1,10,cell-cell adhesion involved in gastrulation,BP,MBP
4861,GO:0010721,0.0600624439739542,0.980990728571182,5,305,negative regulation of cell development,BP,NGFR;SOX10;MAG;NKX6-2;CNTN2
7099,GO:0030018,0.0601814009815742,0.98772481423289,3,122,Z disc,CC,CAPN3;LDB3;ANK3
7812,GO:0031402,0.060426178845098,0.998381542795074,1,8,sodium ion binding,MF,CAPN3
18867,GO:1900750,0.0604794215583405,0.998291289519464,1,13,oligopeptide binding,MF,FOLH1
474,GO:0001553,0.0608266789313321,0.998334209254371,1,9,luteinization,BP,PDGFRA
2796,GO:0005883,0.0609757926827429,0.998351608891613,1,8,neurofilament,CC,CLDN11
8888,GO:0033234,0.0611573767229656,0.998295178290614,1,10,negative regulation of protein sumoylation,BP,CAPN3
543,GO:0001678,0.0611895656927614,0.987418534431787,3,135,cellular glucose homeostasis,BP,BAIAP3;NGFR;GJB6
11304,GO:0043550,0.061239360762566,0.992425304044962,2,59,regulation of lipid kinase activity,BP,FGFR3;PDGFRA
8155,GO:0032059,0.0612490255977268,0.998310717616621,1,9,bleb,CC,ANLN
15999,GO:0071107,0.0614108012733658,0.998301674760474,1,9,response to parathyroid hormone,BP,GJA1
3600,GO:0007166,0.0616156395570894,0.962894519286327,24,2692,cell surface receptor signaling pathway,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;SOX10;PLP1;PDGFRA;MOG;PCSK6;EGFR;ST18;FZD7;CTHRC1;GREM1;MAL;SUSD5;BOK;CNTN2;ANKS1B;APOD;DAPK1
11332,GO:0043603,0.0616238288480462,0.971447081378803,10,982,cellular amide metabolic process,BP,FOLH1;FA2H;GAL3ST1;RPS4Y1;CPM;PCSK6;EGFR;CARNS1;UGT8;DAPK1
14259,GO:0055123,0.0616487938709663,0.987290750186615,3,131,digestive system development,BP,SOX10;PDGFRA;EGFR
6901,GO:0021826,0.0616645139039411,0.998287443067735,1,9,substrate-independent telencephalic tangential migration,BP,CNTN2
6904,GO:0021830,0.0616645139039411,0.998287443067735,1,9,interneuron migration from the subpallium to the cortex,BP,CNTN2
6909,GO:0021843,0.0616645139039411,0.998287443067735,1,9,substrate-independent telencephalic tangential interneuron migration,BP,CNTN2
19912,GO:1903524,0.0617506362631336,0.992312409288046,2,64,positive regulation of blood circulation,BP,EGFR;GJA1
14230,GO:0055080,0.0618530407625205,0.974051174785703,8,661,cation homeostasis,BP,TF;CAPN3;PDGFRA;EGFR;ANK3;GJA1;SGCD;BOK
17791,GO:0098631,0.0620618264418928,0.992263402197631,2,60,cell adhesion mediator activity,MF,CNTN2;GLDN
12125,GO:0045926,0.0621958408662501,0.983190533066149,4,231,negative regulation of growth,BP,FGFR3;MAG;GJA1;GREM1
5314,GO:0015166,0.0622649748886344,0.998232110985285,1,10,polyol transmembrane transporter activity,MF,SLC5A11
6833,GO:0021683,0.0623089177350964,0.998251022564361,1,9,cerebellar granular layer morphogenesis,BP,KNDC1
12771,GO:0048008,0.0624506711619259,0.992208237891118,2,54,platelet-derived growth factor receptor signaling pathway,BP,PDGFRA;APOD
13005,GO:0048589,0.0626894797916188,0.973637879748817,8,603,developmental growth,BP,FGFR3;CAPN3;SOX10;MAG;GJA1;FZD7;KLK6;APOD
3601,GO:0007167,0.062881221569689,0.969649862295423,11,965,enzyme linked receptor protein signaling pathway,BP,NGFR;ERBB3;FGFR3;LRP2;TF;PDGFRA;PCSK6;EGFR;GREM1;ANKS1B;APOD
11073,GO:0043184,0.0630098361110605,0.998210962103064,1,9,vascular endothelial growth factor receptor 2 binding,MF,GREM1
11145,GO:0043296,0.0630594260083213,0.986884724753777,3,128,apical junction complex,CC,CLDN11;BVES;ANK3
8275,GO:0032287,0.0630599664758926,0.998235542805371,1,8,peripheral nervous system myelin maintenance,BP,FA2H
14323,GO:0060068,0.0631029832886882,0.998205603353354,1,9,vagina development,BP,LRP2
12563,GO:0046902,0.0633529688611101,0.991987131008369,2,69,regulation of mitochondrial membrane permeability,BP,EYA2;BOK
12812,GO:0048103,0.0635583184732935,0.998179289743315,1,9,somatic stem cell division,BP,FZD7
12032,GO:0045760,0.0636105935900089,0.998176256225225,1,9,positive regulation of action potential,BP,ANK3
7038,GO:0022626,0.0636181357831862,0.991881089158969,2,103,cytosolic ribosome,CC,RPS4Y1;APOD
21469,GO:2000027,0.0636500855988586,0.98266340518177,4,237,regulation of animal organ morphogenesis,BP,NGFR;FZD7;CTHRC1;GREM1
7946,GO:0031644,0.0638613148311359,0.986643314727958,3,133,regulation of nervous system process,BP,SOX10;MAG;MYRF
16556,GO:0072102,0.0641173227883106,0.998175111221964,1,8,glomerulus morphogenesis,BP,PDGFRA
755,GO:0001973,0.0642477676745222,0.998097634786179,1,11,G protein-coupled adenosine receptor signaling pathway,BP,CNTN2
9800,GO:0035588,0.0642477676745222,0.998097634786179,1,11,G protein-coupled purinergic receptor signaling pathway,BP,CNTN2
7700,GO:0031214,0.0643138533980447,0.986503989157764,3,138,biomineral tissue development,BP,FGFR3;GPNMB;GREM1
18417,GO:0110148,0.0643138533980447,0.986503989157764,3,138,biomineralization,BP,FGFR3;GPNMB;GREM1
14945,GO:0061045,0.0647562105558242,0.991719507698756,2,65,negative regulation of wound healing,BP,PDGFRA;GJA1
15835,GO:0070830,0.0647684362308753,0.991719860267162,2,64,bicellular tight junction assembly,BP,CLDN11;GJA1
14102,GO:0052646,0.0649984324806126,0.998094773138015,1,9,alditol phosphate metabolic process,BP,GPD1
4930,GO:0010817,0.0650389323924824,0.976348862862614,6,448,regulation of hormone levels,BP,BAIAP3;PDGFRA;PCSK6;EGFR;GJA1;KLK6
22144,GO:2001269,0.0650849158530744,0.99804710774757,1,11,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,ST18
12972,GO:0048522,0.06528635069598,0.957324059976649,40,4959,positive regulation of cellular process,BP,CRLF1;BAIAP3;ANLN;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;MLC1;MAG;BVES;TRIM67;MYRF;PDGFRA;GPNMB;ENPP2;EGFR;ST18;NKX6-2;ANK3;GJA1;FZD7;SLC45A3;EDIL3;CTHRC1;GREM1;GPD1;KLK6;KNDC1;MAL;DMRT2;BOK;GPR62;CNTN2;DAPK1;MBP;GJC2
17870,GO:0098771,0.0653433672887522,0.972273402909129,8,669,inorganic ion homeostasis,BP,TF;CAPN3;PDGFRA;EGFR;ANK3;GJA1;SGCD;BOK
1362,GO:0003002,0.0654050334241253,0.97878889161246,5,331,regionalization,BP,LRP2;PCSK6;NKX6-2;GREM1;DMRT2
2376,GO:0005035,0.0655402927804127,0.998003175940383,1,12,death receptor activity,MF,NGFR
1401,GO:0003093,0.0656958311855202,0.998029300670675,1,10,regulation of glomerular filtration,BP,GJA1
4925,GO:0010812,0.0658363016478946,0.991529108882485,2,57,negative regulation of cell-substrate adhesion,BP,FZD7;APOD
20245,GO:1904181,0.0659247469311346,0.997995736401229,1,11,positive regulation of membrane depolarization,BP,ANK3
4860,GO:0010720,0.0659325381499841,0.973793199384051,7,517,positive regulation of cell development,BP,NGFR;LRP2;SOX10;MAG;TRIM67;NKX6-2;GJC2
12083,GO:0045844,0.0659895673529186,0.991487892723974,2,60,positive regulation of striated muscle tissue development,BP,ERBB3;GREM1
13026,GO:0048636,0.0659895673529186,0.991487892723974,2,60,positive regulation of muscle organ development,BP,ERBB3;GREM1
20374,GO:1904427,0.0660324124304501,0.991461193775756,2,66,positive regulation of calcium ion transmembrane transport,BP,CAPN3;GJC2
20071,GO:1903817,0.0660386924053743,0.997988713815388,1,11,negative regulation of voltage-gated potassium channel activity,BP,ANK3
9868,GO:0035690,0.0664439747167595,0.991372781706361,2,68,cellular response to drug,BP,SOX10;EGFR
3403,GO:0006814,0.0666223811066975,0.981593350599684,4,218,sodium ion transport,BP,NKAIN1;ANK3;SLC5A11;NKAIN2
9047,GO:0033689,0.0666591024140313,0.99799486986057,1,9,negative regulation of osteoblast proliferation,BP,GREM1
2458,GO:0005178,0.0667029708064206,0.985800835369833,3,133,integrin binding,MF,GPNMB;EGFR;EDIL3
6739,GO:0021521,0.0667133729330576,0.99794687436492,1,11,ventral spinal cord interneuron specification,BP,NKX6-2
14673,GO:0060573,0.0667133729330576,0.99794687436492,1,11,cell fate specification involved in pattern specification,BP,NKX6-2
6935,GO:0021892,0.06685785508874,0.997937857046259,1,11,cerebral cortex GABAergic interneuron differentiation,BP,CNTN2
14549,GO:0060394,0.067181695161781,0.997917572126434,1,11,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,GREM1
8130,GO:0032024,0.0674921457708381,0.991162499913419,2,67,positive regulation of insulin secretion,BP,BAIAP3;GJA1
9998,GO:0035904,0.0675265393483656,0.991195707502191,2,55,aorta development,BP,NGFR;LRP2
18495,GO:0120192,0.0675714411165743,0.991149104781048,2,66,tight junction assembly,BP,CLDN11;GJA1
10828,GO:0042698,0.0676244580321685,0.991141161008177,2,65,ovulation cycle,BP,PDGFRA;EGFR
10001,GO:0035907,0.06792548261402,0.997891438787048,1,10,dorsal aorta development,BP,NGFR
9048,GO:0033690,0.0679619408334889,0.997868280058714,1,11,positive regulation of osteoblast proliferation,BP,CTHRC1
19187,GO:1901863,0.0683673485054183,0.991001687417106,2,61,positive regulation of muscle tissue development,BP,ERBB3;GREM1
3745,GO:0007501,0.0684278002930098,0.997820947269124,1,12,mesodermal cell fate specification,BP,EYA2
559,GO:0001707,0.0684431024153258,0.990979581732968,2,63,mesoderm formation,BP,EYA2;GJA1
15114,GO:0061450,0.0684467801317219,0.99781972245187,1,12,trophoblast cell migration,BP,GJA1
18921,GO:1901163,0.0684467801317219,0.99781972245187,1,12,regulation of trophoblast cell migration,BP,GJA1
21476,GO:2000045,0.0685145370959517,0.98523899684028,3,146,regulation of G1/S transition of mitotic cell cycle,BP,GPNMB;EGFR;GJC2
1483,GO:0003223,0.0688350673564804,0.997892736609234,1,8,ventricular compact myocardium morphogenesis,BP,LRP2
10123,GO:0036122,0.0689446009841108,0.997787470659899,1,12,BMP binding,MF,GREM1
16069,GO:0071281,0.0689803306333297,0.997803052630744,1,11,cellular response to iron ion,BP,TF
16282,GO:0071605,0.0690147898710385,0.997767742481414,1,13,monocyte chemotactic protein-1 production,BP,APOD
16306,GO:0071637,0.0690147898710385,0.997767742481414,1,13,regulation of monocyte chemotactic protein-1 production,BP,APOD
11096,GO:0043220,0.0690878623327185,0.997796106361343,1,11,Schmidt-Lanterman incisure,CC,MAG
483,GO:0001568,0.0691102759852071,0.970339591061273,8,627,blood vessel development,BP,NGFR;LRP2;PDGFRA;GPNMB;ENPP2;GREM1;SGCD;APOD
8849,GO:0033162,0.0694178710468969,0.997741244712011,1,13,melanosome membrane,CC,GPNMB
11717,GO:0045009,0.0694178710468969,0.997741244712011,1,13,chitosome,CC,GPNMB
17364,GO:0090741,0.0694178710468969,0.997741244712011,1,13,pigment granule membrane,CC,GPNMB
3426,GO:0006857,0.069543633277659,0.997788388886084,1,10,oligopeptide transport,BP,GJA1
9795,GO:0035581,0.070050625851634,0.997755582045415,1,10,sequestering of extracellular ligand from receptor,BP,GREM1
1420,GO:0003139,0.0700586337265663,0.997732887284096,1,11,secondary heart field specification,BP,LRP2
15451,GO:0070106,0.0702074342523661,0.997723115853378,1,11,interleukin-27-mediated signaling pathway,BP,CRLF1
7828,GO:0031424,0.0702324326965204,0.990578296780849,2,74,keratinization,BP,PPL;PCSK6
6738,GO:0021520,0.0704416618949029,0.997689016685911,1,12,spinal cord motor neuron cell fate specification,BP,NKX6-2
8928,GO:0033327,0.0704773704608822,0.997705334585708,1,11,Leydig cell differentiation,BP,PDGFRA
1866,GO:0004198,0.0704983889885961,0.997703947069273,1,11,calcium-dependent cysteine-type endopeptidase activity,MF,CAPN3
4669,GO:0010232,0.0705811869232556,0.997679728700447,1,12,vascular transport,BP,GJA1
14901,GO:0060982,0.0706736987703248,0.997742518782041,1,9,coronary artery morphogenesis,BP,LRP2
508,GO:0001618,0.0707577259025819,0.990492870283126,2,65,virus receptor activity,MF,MOG;EGFR
18572,GO:0140272,0.0707577259025819,0.990492870283126,2,65,exogenous protein binding,MF,MOG;EGFR
15906,GO:0070938,0.0710658905483771,0.997689139231368,1,10,contractile ring,CC,ANLN
10730,GO:0042487,0.0712436033417854,0.99763537144207,1,12,regulation of odontogenesis of dentin-containing tooth,BP,NGFR
7965,GO:0031674,0.0713738047095847,0.984382297244776,3,133,I band,CC,CAPN3;LDB3;ANK3
5136,GO:0014065,0.0717336716164035,0.984265510438847,3,137,phosphatidylinositol 3-kinase signaling,BP,ERBB3;PDGFRA;EGFR
22063,GO:2001135,0.0718164462483006,0.997639379385536,1,10,regulation of endocytic recycling,BP,BVES
5157,GO:0014731,0.0719159117763052,0.997697062174904,1,8,spectrin-associated cytoskeleton,CC,ANK3
10652,GO:0042340,0.0719369962298156,0.997607954396849,1,11,keratan sulfate catabolic process,BP,ACAN
14137,GO:0052803,0.0721523886938242,0.997573814266223,1,12,imidazole-containing compound metabolic process,BP,CARNS1
8156,GO:0032060,0.072306095116781,0.997583000091088,1,11,bleb assembly,BP,ANLN
14536,GO:0060379,0.0725680389475745,0.99758900453978,1,10,cardiac muscle cell myoblast differentiation,BP,GREM1
9501,GO:0034767,0.0725977552529425,0.983984620968008,3,147,positive regulation of ion transmembrane transport,BP,CAPN3;ANK3;GJC2
12465,GO:0046661,0.0725992037967632,0.983989257126271,3,143,male sex differentiation,BP,LRP2;PDGFRA;BOK
8462,GO:0032536,0.0726589531682374,0.997559019320418,1,11,regulation of cell projection size,BP,CNTN2
3786,GO:0007605,0.0727154602476308,0.983957143547699,3,140,sensory perception of sound,BP,LRP2;GJB6;MBP
7376,GO:0030509,0.0728194449099074,0.983929015203777,3,137,BMP signaling pathway,BP,LRP2;PCSK6;GREM1
14509,GO:0060346,0.0728365721399306,0.997570873702676,1,10,bone trabecula formation,BP,GREM1
15609,GO:0070372,0.072920872843889,0.979219948659016,4,250,regulation of ERK1 and ERK2 cascade,BP,FGFR3;PDGFRA;GPNMB;EGFR
7728,GO:0031267,0.0730933711256128,0.972651456329265,6,394,small GTPase binding,MF,ANLN;NGFR;PEX5L;RAPGEF5;MOBP;KNDC1
21279,GO:1990504,0.0731381879892967,0.997579983551253,1,9,dense core granule exocytosis,BP,BAIAP3
12912,GO:0048332,0.0733749221130561,0.98993832465972,2,65,mesoderm morphogenesis,BP,EYA2;GJA1
16043,GO:0071230,0.073556069413992,0.989902877109382,2,64,cellular response to amino acid stimulus,BP,PDGFRA;EGFR
20752,GO:1905165,0.0736234445037999,0.997547295336094,1,9,regulation of lysosomal protein catabolic process,BP,LRP2
2819,GO:0005916,0.073634603563366,0.997516579772012,1,10,fascia adherens,CC,GJA1
13081,GO:0048711,0.0736851594791266,0.997468147951764,1,12,positive regulation of astrocyte differentiation,BP,MAG
40,GO:0000082,0.0737767013693063,0.978898475667237,4,244,G1/S transition of mitotic cell cycle,BP,CDK18;GPNMB;EGFR;GJC2
14234,GO:0055085,0.0738726351121557,0.960255072919051,14,1399,transmembrane transport,BP,LRP2;CAPN3;PEX5L;GJB6;ANK3;GJA1;PIEZO2;KCNJ6;SLC45A3;SLC5A11;TMEM144;GJB1;DAPK1;GJC2
759,GO:0001977,0.0739882219343239,0.997446981095697,1,12,renal system process involved in regulation of blood volume,BP,GJA1
16812,GO:0072584,0.0741753441298955,0.997433866621732,1,12,caveolin-mediated endocytosis,BP,MLC1
3145,GO:0006468,0.07419002787868,0.957802448881392,17,1764,protein phosphorylation,BP,CRLF1;ERBB3;FGFR3;TF;PLCL1;CDK18;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;PHKG1;GREM1;KNDC1;DAPK1;MBP;GJC2
13314,GO:0050714,0.0748042438280468,0.983288222250666,3,152,positive regulation of protein secretion,BP,BAIAP3;EGFR;GJA1
2724,GO:0005770,0.0748610401848645,0.97848091341183,4,249,late endosome,CC,BAIAP3;TF;EGFR;GJA1
718,GO:0001932,0.074947113792316,0.960513150900485,13,1283,regulation of protein phosphorylation,BP,CRLF1;ERBB3;FGFR3;TF;PLCL1;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;GREM1;KNDC1;GJC2
9417,GO:0034638,0.075011820683033,0.997356903853477,1,13,phosphatidylcholine catabolic process,BP,ENPP2
16546,GO:0072091,0.0750798468557159,0.989567396862226,2,66,regulation of stem cell proliferation,BP,SOX10;GJA1
13054,GO:0048678,0.0751011749931541,0.989544528029433,2,72,response to axon injury,BP,MAG;APOD
7178,GO:0030155,0.0751025931975621,0.967194227498069,8,660,regulation of cell adhesion,BP,ERBB3;GPNMB;ANK3;FZD7;EDIL3;GREM1;APOD;MBP
18708,GO:1900103,0.0752015366671609,0.997361331119013,1,12,positive regulation of endoplasmic reticulum unfolded protein response,BP,BOK
18496,GO:0120193,0.0753771000574755,0.989493215698285,2,69,tight junction organization,BP,CLDN11;GJA1
16800,GO:0072567,0.0756851443465444,0.997308547851337,1,13,chemokine (C-X-C motif) ligand 2 production,BP,MBP
21648,GO:2000341,0.0756851443465444,0.997308547851337,1,13,regulation of chemokine (C-X-C motif) ligand 2 production,BP,MBP
8062,GO:0031901,0.0756979753430653,0.983013649308239,3,146,early endosome membrane,CC,GPNMB;EGFR;BOK
17366,GO:0097001,0.0757200473984815,0.997306028925104,1,13,ceramide binding,MF,MAG
11492,GO:0044224,0.0757777025895473,0.997367716436147,1,10,juxtaparanode region of axon,CC,CNTN2
10476,GO:0040007,0.0760033854827002,0.963426939890449,10,883,growth,BP,FGFR3;CAPN3;SOX10;MAG;EGFR;GJA1;FZD7;GREM1;KLK6;APOD
12944,GO:0048469,0.076489564414059,0.982752403022885,3,154,cell maturation,BP,SOX10;CNTN2;GLDN
19953,GO:1903587,0.076591750059067,0.997261404889871,1,12,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,NGFR
13967,GO:0051893,0.0770140044904201,0.989158992443973,2,62,regulation of focal adhesion assembly,BP,GREM1;APOD
17066,GO:0090109,0.0770140044904201,0.989158992443973,2,62,regulation of cell-substrate junction assembly,BP,GREM1;APOD
22115,GO:2001233,0.0773001393219133,0.973695227032824,5,376,regulation of apoptotic signaling pathway,BP,NGFR;EYA2;ST18;MAL;BOK
15769,GO:0070664,0.077342205165045,0.989036736329402,2,78,negative regulation of leukocyte proliferation,BP,GPNMB;GREM1
3764,GO:0007548,0.0775348254820932,0.977456682085566,4,240,sex differentiation,BP,LRP2;PDGFRA;DMRT2;BOK
1545,GO:0003337,0.0775785953830452,0.997170146420351,1,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GREM1
1434,GO:0003161,0.0776857436193055,0.997181425447196,1,12,cardiac conduction system development,BP,BVES
16199,GO:0071472,0.0778932186798075,0.997166123628506,1,12,cellular response to salt stress,BP,CAPN3
21691,GO:2000392,0.0779400931291829,0.99718553056609,1,11,regulation of lamellipodium morphogenesis,BP,ENPP2
919,GO:0002244,0.0780111902011064,0.982255812166521,3,163,hematopoietic progenitor cell differentiation,BP,ANLN;BVES;PDGFRA
21697,GO:2000402,0.0780332074377451,0.997136384552611,1,13,negative regulation of lymphocyte migration,BP,APOD
18723,GO:1900119,0.0781453575128887,0.997096924110787,1,15,positive regulation of execution phase of apoptosis,BP,BOK
13630,GO:0051234,0.0782794733928727,0.948317344920443,37,4644,establishment of localization,BP,BAIAP3;NGFR;EYA2;ERBB3;LRP2;NKAIN1;TF;CAPN3;MLC1;PLLP;BVES;PEX5L;ATP10B;GJB6;RPS4Y1;ENPP2;PCSK6;EGFR;ANK3;GJA1;PIEZO2;KCNJ6;SNX22;SLC45A3;SLC5A11;TMEM144;GREM1;LGI3;GJB1;MAL;MYO1D;BOK;CNTN2;NKAIN2;APOD;DAPK1;GJC2
16645,GO:0072224,0.0783024337419238,0.997158901361184,1,11,metanephric glomerulus development,BP,PDGFRA
9589,GO:0035148,0.078532374165823,0.982110817406526,3,145,tube formation,BP,LRP2;CTHRC1;GREM1
17194,GO:0090288,0.0786196440206759,0.982084169583166,3,144,negative regulation of cellular response to growth factor stimulus,BP,NGFR;LRP2;GREM1
8550,GO:0032682,0.0786908753955688,0.997070280990416,1,14,negative regulation of chemokine production,BP,APOD
17456,GO:0097154,0.0787075904829781,0.997085921373174,1,13,GABAergic neuron differentiation,BP,CNTN2
5512,GO:0015791,0.0787656234116914,0.99710131439595,1,12,polyol transport,BP,SLC5A11
12951,GO:0048484,0.0788140799043602,0.997077911393465,1,13,enteric nervous system development,BP,SOX10
18719,GO:1900115,0.0788773496085247,0.997092959929655,1,12,extracellular regulation of signal transduction,BP,GREM1
18720,GO:1900116,0.0788773496085247,0.997092959929655,1,12,extracellular negative regulation of signal transduction,BP,GREM1
12077,GO:0045838,0.0794848096272431,0.997027199641991,1,13,positive regulation of membrane potential,BP,ANK3
135,GO:0000281,0.0795054662965927,0.988576421490795,2,70,mitotic cytokinesis,BP,ANLN;ANK3
10637,GO:0042310,0.0797659709020525,0.988517800891268,2,70,vasoconstriction,BP,EGFR;GJA1
8266,GO:0032274,0.0798640026641963,0.996998331069728,1,13,gonadotropin secretion,BP,GJA1
15074,GO:0061351,0.0800806102959077,0.981615250148592,3,142,neural precursor cell proliferation,BP,LRP2;SOX10;GJC2
14994,GO:0061134,0.080559055129999,0.98142231198662,3,172,peptidase regulator activity,MF,MAL;SPOCK3;COL28A1
5901,GO:0016558,0.0806615023996986,0.99693714676874,1,13,protein import into peroxisome matrix,BP,PEX5L
11146,GO:0043297,0.0807213294939995,0.988295470833692,2,72,apical junction assembly,BP,CLDN11;GJA1
5889,GO:0016529,0.0807751660332097,0.988307338608542,2,65,sarcoplasmic reticulum,CC,ANK3;SGCD
10635,GO:0042308,0.0807912391276572,0.996927133146783,1,13,negative regulation of protein import into nucleus,BP,APOD
20453,GO:1904590,0.0807912391276572,0.996927133146783,1,13,negative regulation of protein import,BP,APOD
5796,GO:0016331,0.080895526561859,0.981344470767158,3,146,morphogenesis of embryonic epithelium,BP,LRP2;CTHRC1;GREM1
18423,GO:0110165,0.0809269735033555,0.98468098769008,97,14761,cellular anatomical entity,CC,CRLF1;BAIAP3;ANLN;CLDN11;STMN4;PLEKHH1;NGFR;EYA2;BCAS1;ERBB3;FGFR3;CDH19;DCX;LRP2;NKAIN1;FOLH1;TF;CAPN3;SOX10;MLC1;PLLP;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;CDK18;ATP10B;PPL;TRIM67;GJB6;LDB3;PLP1;MYRF;GAL3ST1;RPS4Y1;HAPLN2;PDGFRA;CPM;GPNMB;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SNX22;ACAN;TMSB15A;SLC45A3;ADAMTS4;SLC5A11;TMEM144;EDIL3;PHKG1;CTHRC1;GREM1;GPD1;KLK6;MOBP;LGI3;GJB1;SGCD;KNDC1;MAL;CARNS1;DMRT2;SUSD5;UGT8;MYO1D;BOK;TMEM125;TMEM151A;GPR62;CNTN2;ANKS1B;GLDN;DNAH17;NKAIN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;TMEM88B;COL28A1
4815,GO:0010642,0.0809295219656796,0.996937300536063,1,12,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,APOD
18947,GO:1901224,0.0810067453190461,0.988218819516557,2,76,positive regulation of NIK/NF-kappaB signaling,BP,EGFR;GREM1
17303,GO:0090559,0.0812837856502343,0.988150214849188,2,78,regulation of membrane permeability,BP,EYA2;BOK
7145,GO:0030111,0.0813706708691073,0.971911812005443,5,348,regulation of Wnt signaling pathway,BP,SOX10;EGFR;FZD7;CTHRC1;GREM1
6454,GO:0019226,0.081710101530117,0.988083633904359,2,68,transmission of nerve impulse,BP,MAG;ANK3
3739,GO:0007494,0.0817404188091965,0.996853358632488,1,13,midgut development,BP,EGFR
1363,GO:0003006,0.0817472264527244,0.961750156376251,9,811,developmental process involved in reproduction,BP,CLDN11;LRP2;GAL3ST1;PDGFRA;EGFR;GJA1;GJB1;DMRT2;BOK
7664,GO:0031115,0.0818522842243456,0.996844604478755,1,13,negative regulation of microtubule polymerization,BP,TUBB4A
12533,GO:0046851,0.0822322328941442,0.99679632325876,1,14,negative regulation of bone remodeling,BP,GREM1
6336,GO:0018410,0.0822375881316176,0.996814356054001,1,13,C-terminal protein amino acid modification,BP,FOLH1
2453,GO:0005172,0.0824473882736715,0.996797823007362,1,13,vascular endothelial growth factor receptor binding,MF,GREM1
7371,GO:0030502,0.0827305523881901,0.99677543857775,1,13,negative regulation of bone mineralization,BP,GREM1
3456,GO:0006898,0.0827697728956863,0.975395914740602,4,248,receptor-mediated endocytosis,BP,LRP2;TF;GREM1;CNTN2
18089,GO:0099144,0.0828417031534053,0.996788488354334,1,12,anchored component of synaptic membrane,CC,CNTN2
10814,GO:0042659,0.083010601054437,0.996753221281386,1,13,regulation of cell fate specification,BP,FZD7
13323,GO:0050746,0.0830704987719172,0.99672962615258,1,14,regulation of lipoprotein metabolic process,BP,APOD
8264,GO:0032272,0.0830842184566528,0.987757859808296,2,71,negative regulation of protein polymerization,BP,TUBB4A;TMSB15A
3599,GO:0007165,0.0832253208129695,0.944434936998257,39,4951,signal transduction,BP,CRLF1;BAIAP3;NGFR;EYA2;ERBB3;FGFR3;DCX;LRP2;TF;CAPN3;SOX10;PEX5L;PLCL1;TRIM67;PLP1;PDGFRA;GPNMB;RAPGEF5;MOG;PCSK6;EGFR;ST18;ANK3;GJA1;FZD7;CTHRC1;GREM1;KLK6;SGCD;KNDC1;MAL;SUSD5;BOK;GPR62;CNTN2;ANKS1B;APOD;DAPK1;MBP
18439,GO:0120035,0.0832552006492729,0.962833313756208,8,641,regulation of plasma membrane bounded cell projection organization,BP,ANLN;NGFR;MAG;TRIM67;ENPP2;KLK6;KNDC1;CNTN2
19552,GO:1902806,0.0833916882812262,0.980509038056586,3,158,regulation of cell cycle G1/S phase transition,BP,GPNMB;EGFR;GJC2
20328,GO:1904350,0.0834275874182821,0.996768374200824,1,11,regulation of protein catabolic process in the vacuole,BP,LRP2
16042,GO:0071229,0.0836107801580712,0.987643016748096,2,69,cellular response to acid chemical,BP,PDGFRA;EGFR
3603,GO:0007169,0.0838440010868973,0.962507887669452,8,668,transmembrane receptor protein tyrosine kinase signaling pathway,BP,NGFR;ERBB3;FGFR3;PDGFRA;EGFR;GREM1;ANKS1B;APOD
18644,GO:0150116,0.083852681650915,0.987602148904668,2,65,regulation of cell-substrate junction organization,BP,GREM1;APOD
6831,GO:0021681,0.084009755161514,0.996673312942365,1,13,cerebellar granular layer development,BP,KNDC1
729,GO:0001944,0.0842850205105083,0.962270789272752,8,657,vasculature development,BP,NGFR;LRP2;PDGFRA;GPNMB;ENPP2;GREM1;SGCD;APOD
2044,GO:0004551,0.0847640040998977,0.996560864075406,1,16,nucleotide diphosphatase activity,MF,ENPP2
17418,GO:0097090,0.0849616119941273,0.996646432920941,1,11,presynaptic membrane organization,BP,CNTN2
9718,GO:0035437,0.0851755406895519,0.996559008452722,1,14,maintenance of protein localization in endoplasmic reticulum,BP,GJA1
10528,GO:0042060,0.0854303156638902,0.966715615152908,6,455,wound healing,BP,ERBB3;PPL;PDGFRA;EGFR;GJA1;FZD7
7112,GO:0030036,0.085619435713522,0.961545830461582,8,650,actin cytoskeleton organization,BP,ANLN;TF;CAPN3;LDB3;PDGFRA;ERMN;TMSB15A;MYO1D
13093,GO:0048739,0.0856568273591215,0.996623577275949,1,10,cardiac muscle fiber development,BP,SGCD
712,GO:0001921,0.085749393164183,0.996531788535952,1,13,positive regulation of receptor recycling,BP,BVES
12941,GO:0048407,0.0857800964595348,0.996580415694528,1,11,platelet-derived growth factor binding,MF,PDGFRA
21533,GO:2000146,0.0858264151492035,0.974172198275454,4,250,negative regulation of cell motility,BP,GJA1;GREM1;APOD;SPOCK3
14930,GO:0061029,0.0860646952532544,0.996505811721527,1,13,eyelid development in camera-type eye,BP,EGFR
11069,GO:0043178,0.0861390310125999,0.987035016311679,2,74,alcohol binding,MF,PLCL1;APOD
10645,GO:0042325,0.0862447970200604,0.95247721325126,14,1436,regulation of phosphorylation,BP,CRLF1;ERBB3;FGFR3;TF;PLCL1;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;GREM1;GPD1;KNDC1;GJC2
3399,GO:0006810,0.0865251197355918,0.942460887915035,36,4536,transport,BP,BAIAP3;NGFR;EYA2;ERBB3;LRP2;NKAIN1;TF;CAPN3;MLC1;PLLP;BVES;PEX5L;ATP10B;GJB6;RPS4Y1;ENPP2;PCSK6;EGFR;ANK3;GJA1;PIEZO2;KCNJ6;SNX22;SLC45A3;SLC5A11;TMEM144;GREM1;LGI3;GJB1;MYO1D;BOK;CNTN2;NKAIN2;APOD;DAPK1;GJC2
11995,GO:0045683,0.0865954499431631,0.996441390178377,1,14,negative regulation of epidermis development,BP,NGFR
11521,GO:0044291,0.0866940240833303,0.98692511842379,2,68,cell-cell contact zone,CC,ANK3;GJA1
15873,GO:0070886,0.0868242806486919,0.996442820310839,1,13,positive regulation of calcineurin-NFAT signaling cascade,BP,ERBB3
18352,GO:0106058,0.0868242806486919,0.996442820310839,1,13,positive regulation of calcineurin-mediated signaling,BP,ERBB3
12694,GO:0047484,0.0868551802807543,0.996419654385471,1,14,regulation of response to osmotic stress,BP,MLC1
18661,GO:1900016,0.0868848141263099,0.996417170100319,1,14,negative regulation of cytokine production involved in inflammatory response,BP,APOD
12112,GO:0045913,0.0869861910785439,0.986855943788712,2,68,positive regulation of carbohydrate metabolic process,BP,SLC45A3;GPD1
11409,GO:0043950,0.087070246980252,0.996383675892639,1,15,positive regulation of cAMP-mediated signaling,BP,GPR62
16373,GO:0071772,0.0870793338981103,0.979291498639893,3,149,response to BMP,BP,LRP2;PCSK6;GREM1
16374,GO:0071773,0.0870793338981103,0.979291498639893,3,149,cellular response to BMP stimulus,BP,LRP2;PCSK6;GREM1
3571,GO:0007096,0.0871618846245878,0.996375932978363,1,15,regulation of exit from mitosis,BP,ANLN
7282,GO:0030295,0.0872405610858564,0.986767665068624,2,76,protein kinase activator activity,MF,ERBB3;GREM1
3469,GO:0006919,0.0872991002833486,0.986733718524591,2,83,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,NGFR;BOK
7917,GO:0031589,0.0873195093503086,0.969247074864737,5,330,cell-substrate adhesion,BP,BVES;FZD7;EDIL3;GREM1;APOD
11688,GO:0044843,0.0873405771728039,0.97355466554627,4,258,cell cycle G1/S phase transition,BP,CDK18;GPNMB;EGFR;GJC2
13338,GO:0050771,0.0877558864777705,0.986673044065634,2,68,negative regulation of axonogenesis,BP,NGFR;MAG
13486,GO:0051004,0.0878388146208738,0.996302508924962,1,16,regulation of lipoprotein lipase activity,BP,PCSK6
1190,GO:0002689,0.0879637891432566,0.996291803647041,1,16,negative regulation of leukocyte chemotaxis,BP,GREM1
3912,GO:0008191,0.088116928462187,0.996278663969679,1,16,metalloendopeptidase inhibitor activity,MF,SPOCK3
3702,GO:0007351,0.0882268832573767,0.996303726952816,1,14,tripartite regional subdivision,BP,PCSK6
4155,GO:0008595,0.0882268832573767,0.996303726952816,1,14,anterior/posterior axis specification, embryo,BP,PCSK6
17740,GO:0097756,0.0882391309581769,0.986535827588185,2,74,negative regulation of blood vessel diameter,BP,EGFR;GJA1
1114,GO:0002544,0.0882935525876948,0.996249252594968,1,17,chronic inflammatory response,BP,GJA1
2746,GO:0005796,0.0884791716768624,0.986471764281403,2,76,Golgi lumen,CC,PCSK6;ACAN
17054,GO:0090090,0.0885766732670873,0.978756724050335,3,170,negative regulation of canonical Wnt signaling pathway,BP,SOX10;CTHRC1;GREM1
7120,GO:0030048,0.0886225078576698,0.978784879935065,3,140,actin filament-based movement,BP,GJA1;SGCD;MYO1D
7834,GO:0031432,0.0890317087914304,0.996234818940282,1,14,titin binding,MF,CAPN3
562,GO:0001710,0.0893426001923354,0.996172632740137,1,16,mesodermal cell fate commitment,BP,EYA2
10149,GO:0036157,0.0894197229992474,0.996278783993353,1,11,outer dynein arm,CC,DNAH17
14658,GO:0060546,0.0894477233842073,0.996198942237108,1,14,negative regulation of necroptotic process,BP,BOK
15371,GO:0062099,0.0894477233842073,0.996198942237108,1,14,negative regulation of programmed necrotic cell death,BP,BOK
3604,GO:0007171,0.0900174330336714,0.996171645872027,1,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,GREM1
2279,GO:0004888,0.0901905596724335,0.959018044731666,8,734,transmembrane signaling receptor activity,MF,CRLF1;NGFR;ERBB3;FGFR3;PDGFRA;EGFR;FZD7;GPR62
18183,GO:0099568,0.0906477475600796,0.972226914102754,4,233,cytoplasmic region,CC,ANLN;DCX;TUBB4A;DNAH17
5437,GO:0015562,0.0906594402560413,0.996115879199997,1,13,efflux transmembrane transporter activity,MF,GJA1
14678,GO:0060579,0.0907424381368125,0.996066685186298,1,15,ventral spinal cord interneuron fate commitment,BP,NKX6-2
14680,GO:0060581,0.0907424381368125,0.996066685186298,1,15,cell fate commitment involved in pattern specification,BP,NKX6-2
14436,GO:0060253,0.0908235939163939,0.996079034166962,1,14,negative regulation of glial cell proliferation,BP,SOX10
18413,GO:0110110,0.0908368386518384,0.985898395935337,2,77,positive regulation of animal organ morphogenesis,BP,NGFR;GREM1
10708,GO:0042445,0.091011760867148,0.977915061177147,3,178,hormone metabolic process,BP,PDGFRA;PCSK6;KLK6
21681,GO:2000380,0.091134905265915,0.996014807517059,1,16,regulation of mesoderm development,BP,GJA1
8235,GO:0032225,0.0911457040945751,0.996013846601094,1,16,regulation of synaptic transmission, dopaminergic,BP,CNTNAP4
7545,GO:0030901,0.0912301760902477,0.985793010047673,2,80,midbrain development,BP,PLP1;MBP
11219,GO:0043410,0.0912843278560296,0.963812414076417,6,479,positive regulation of MAPK cascade,BP,FGFR3;TF;PDGFRA;GPNMB;EGFR;FZD7
7446,GO:0030662,0.0912852853332374,0.977830434685963,3,170,coated vesicle membrane,CC,LRP2;TF;EGFR
6684,GO:0019905,0.0913092974565582,0.9857932138189,2,74,syntaxin binding,MF,BAIAP3;DAPK1
13703,GO:0051345,0.0913319010591923,0.958394062830881,8,697,positive regulation of hydrolase activity,BP,NGFR;FGFR3;PDGFRA;EGFR;ST18;BOK;DAPK1;MBP
3803,GO:0007625,0.0914102697731433,0.995990267206769,1,16,grooming behavior,BP,CNTNAP4
2133,GO:0004672,0.0915169264368267,0.960769086786248,7,528,protein kinase activity,MF,ERBB3;FGFR3;CDK18;PDGFRA;EGFR;PHKG1;DAPK1
16931,GO:0086003,0.0915262494629713,0.985767544047924,2,67,cardiac muscle cell contraction,BP,GJA1;SGCD
19143,GO:1901701,0.0916079523976495,0.952764386836842,11,1080,cellular response to oxygen-containing compound,BP,BAIAP3;NGFR;SOX10;MLC1;GJB6;PDGFRA;EGFR;GJA1;FZD7;GPD1;DAPK1
2814,GO:0005905,0.0917492697931618,0.985704605699432,2,69,clathrin-coated pit,CC,LRP2;TF
454,GO:0001525,0.0920630529126193,0.963430273987712,6,460,angiogenesis,BP,NGFR;PDGFRA;GPNMB;ENPP2;GREM1;APOD
8144,GO:0032045,0.0923402771739151,0.995944619255632,1,14,guanyl-nucleotide exchange factor complex,CC,KNDC1
16929,GO:0086001,0.0923825753998762,0.9855577979198,2,67,cardiac muscle cell action potential,BP,ANK3;GJA1
22142,GO:2001267,0.0925091315511279,0.995875940998827,1,17,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,ST18
11931,GO:0045597,0.0925579559970135,0.953779366174679,10,927,positive regulation of cell differentiation,BP,NGFR;LRP2;SOX10;MAG;TRIM67;NKX6-2;GJA1;CTHRC1;GREM1;GJC2
1264,GO:0002793,0.0928537693271692,0.97728965129271,3,169,positive regulation of peptide secretion,BP,BAIAP3;EGFR;GJA1
19669,GO:1903035,0.0929458236505621,0.985374235578763,2,79,negative regulation of response to wounding,BP,PDGFRA;GJA1
6827,GO:0021675,0.0933511657813204,0.985290946080681,2,74,nerve development,BP,NGFR;ERBB3
9143,GO:0034109,0.0938946525143799,0.985148979060729,2,76,homotypic cell-cell adhesion,BP,PDGFRA;ANK3
2700,GO:0005741,0.094038515031025,0.97687618676939,3,170,mitochondrial outer membrane,CC,SOX10;GJA1;BOK
4170,GO:0008625,0.0941582037446206,0.985061001408253,2,83,extrinsic apoptotic signaling pathway via death domain receptors,BP,MAL;DAPK1
18966,GO:1901264,0.0943348513817245,0.98500842484546,2,86,carbohydrate derivative transport,BP,GJA1;GJB1
6556,GO:0019538,0.0944562241660116,0.936132528192032,39,5028,protein metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;FOLH1;TF;CAPN3;PLCL1;CDK18;TRIM67;MYRF;GAL3ST1;RPS4Y1;PDGFRA;CPM;GPNMB;ENPP2;PCSK6;EGFR;ST18;CNDP1;GJA1;FZD7;ACAN;ADAMTS4;PHKG1;GREM1;KLK6;KNDC1;BOK;CNTN2;APOD;SPOCK3;DAPK1;MBP;GJC2;COL28A1
8871,GO:0033194,0.0945319017609556,0.99570661040127,1,16,response to hydroperoxide,BP,DAPK1
16989,GO:0086080,0.095149406172541,0.995714177104112,1,13,protein binding involved in heterotypic cell-cell adhesion,MF,GLDN
8111,GO:0031994,0.0951868790347572,0.99571073828322,1,13,insulin-like growth factor I binding,MF,LRP2
14659,GO:0060547,0.0952092951852693,0.995643730025297,1,16,negative regulation of necrotic cell death,BP,BOK
15102,GO:0061430,0.0954153206514959,0.995689743643157,1,13,bone trabecula morphogenesis,BP,GREM1
12968,GO:0048518,0.0958441315014527,0.934729283185426,42,5420,positive regulation of biological process,BP,CRLF1;BAIAP3;ANLN;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;MLC1;MAG;BVES;TRIM67;PLP1;MYRF;PDGFRA;GPNMB;ENPP2;MOG;EGFR;ST18;NKX6-2;ANK3;GJA1;FZD7;SLC45A3;EDIL3;CTHRC1;GREM1;GPD1;KLK6;KNDC1;MAL;DMRT2;BOK;GPR62;CNTN2;DAPK1;MBP;GJC2
11887,GO:0045445,0.0958798550919195,0.984635489979665,2,81,myoblast differentiation,BP,CAPN3;GREM1
13561,GO:0051117,0.0960375673940706,0.984592596609125,2,82,ATPase binding,MF,NKAIN1;EGFR
14843,GO:0060850,0.0961682994311087,0.995553897880719,1,16,regulation of transcription involved in cell fate commitment,BP,NKX6-2
5800,GO:0016338,0.0963889860799489,0.995501060963331,1,18,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN11
20707,GO:1905048,0.096485282542444,0.995543260076003,1,15,regulation of metallopeptidase activity,BP,MBP
16539,GO:0072079,0.096691394255212,0.995487431814689,1,17,nephron tubule formation,BP,GREM1
16677,GO:0072283,0.0967487833037938,0.99551842991354,1,15,metanephric renal vesicle morphogenesis,BP,GREM1
17090,GO:0090150,0.0974397719951999,0.969338512889714,4,314,establishment of protein localization to membrane,BP,RPS4Y1;EGFR;ANK3;MAL
17193,GO:0090287,0.0974695417473994,0.969367412738849,4,255,regulation of cellular response to growth factor stimulus,BP,NGFR;LRP2;PCSK6;GREM1
14301,GO:0060044,0.0976672675420328,0.99543131977126,1,15,negative regulation of cardiac muscle cell proliferation,BP,GJA1
12990,GO:0048557,0.0978212344175268,0.995396830427027,1,16,embryonic digestive tract morphogenesis,BP,PDGFRA
7680,GO:0031143,0.0980195117499217,0.995397681613298,1,15,pseudopodium,CC,LDB3
11800,GO:0045176,0.0985625216291188,0.995368557565467,1,14,apical protein localization,BP,MAL
11392,GO:0043901,0.0987785640873509,0.995256768128754,1,19,negative regulation of multi-organism process,BP,GJA1
12010,GO:0045723,0.0997190233776372,0.9951787199686,1,18,positive regulation of fatty acid biosynthetic process,BP,SLC45A3
9729,GO:0035461,0.100044133898796,0.995201851241018,1,15,vitamin transmembrane transport,BP,LRP2
2811,GO:0005901,0.100059344709137,0.983590296901878,2,75,caveola,CC,MLC1;BVES
5677,GO:0016101,0.100096620104478,0.983537123214725,2,88,diterpenoid metabolic process,BP,LRP2;EGFR
14232,GO:0055082,0.100203726016302,0.953411842257503,8,735,cellular chemical homeostasis,BP,BAIAP3;NGFR;TF;CAPN3;GJB6;PDGFRA;GJA1;BOK
7811,GO:0031401,0.100224525799862,0.947473145559953,11,1088,positive regulation of protein modification process,BP,CRLF1;ERBB3;FGFR3;TF;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;GREM1;KNDC1
19259,GO:1902043,0.100352080087938,0.995171693909602,1,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,MAL
8716,GO:0032930,0.100360865454118,0.995115259630976,1,18,positive regulation of superoxide anion generation,BP,EGFR
17122,GO:0090190,0.100414839063639,0.995144668551883,1,16,positive regulation of branching involved in ureteric bud morphogenesis,BP,GREM1
10723,GO:0042475,0.10050449067203,0.983460151407009,2,79,odontogenesis of dentin-containing tooth,BP,NGFR;PDGFRA
6441,GO:0019209,0.100590826844461,0.983427454622632,2,82,kinase activator activity,MF,ERBB3;GREM1
438,GO:0001503,0.100597374970564,0.963047575547096,5,366,ossification,BP,FGFR3;GPNMB;EGFR;CTHRC1;GREM1
18137,GO:0099512,0.10071536403327,0.95085256586523,9,800,supramolecular fiber,CC,CLDN11;DCX;CAPN3;TUBB4A;PPL;GJB6;LDB3;ANK3;DNAH17
8171,GO:0032092,0.100967795168731,0.983336361325503,2,80,positive regulation of protein binding,BP,PLCL1;CTHRC1
13360,GO:0050801,0.101041307065414,0.952936886091068,8,733,ion homeostasis,BP,TF;CAPN3;PDGFRA;EGFR;ANK3;GJA1;SGCD;BOK
4548,GO:0009749,0.101204611430973,0.974333524256468,3,170,response to glucose,BP,BAIAP3;GJB6;GJA1
5888,GO:0016528,0.101453212594367,0.983232870209732,2,74,sarcoplasm,CC,ANK3;SGCD
5382,GO:0015295,0.101724781713303,0.995014653751704,1,16,solute:proton symporter activity,MF,SLC45A3
2443,GO:0005161,0.101866471445944,0.995046511381101,1,14,platelet-derived growth factor receptor binding,MF,PDGFRA
12037,GO:0045765,0.102078817149849,0.967393322087238,4,269,regulation of angiogenesis,BP,NGFR;GPNMB;ENPP2;GREM1
8489,GO:0032588,0.10233405142584,0.982962949251413,2,85,trans-Golgi network membrane,CC,BAIAP3;BOK
5877,GO:0016505,0.102479338863628,0.994902740405992,1,18,peptidase activator activity involved in apoptotic process,MF,MAL
1412,GO:0003128,0.102763217482069,0.994910317321791,1,16,heart field specification,BP,LRP2
17110,GO:0090177,0.102848085395604,0.99492363296366,1,15,establishment of planar polarity involved in neural tube closure,BP,CTHRC1
2795,GO:0005882,0.102997329855866,0.982795148204904,2,83,intermediate filament,CC,CLDN11;PPL
10042,GO:0035988,0.10304118630836,0.994882197852253,1,16,chondrocyte proliferation,BP,FGFR3
2744,GO:0005794,0.103160018349601,0.941523702136567,14,1454,Golgi apparatus,CC,BAIAP3;STMN4;FGFR3;LRP2;MYRF;GAL3ST1;PDGFRA;PCSK6;EGFR;ANK3;GJA1;KCNJ6;ACAN;BOK
13001,GO:0048583,0.103214437467776,0.931598273097896,30,3708,regulation of response to stimulus,BP,CRLF1;BAIAP3;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;MLC1;PEX5L;TRIM67;PDGFRA;GPNMB;MOG;PCSK6;EGFR;ST18;GJA1;FZD7;CTHRC1;GREM1;KLK6;MAL;BOK;GPR62;CNTN2;APOD;DAPK1
7292,GO:0030308,0.103355500252177,0.973546887332221,3,175,negative regulation of cell growth,BP,MAG;GJA1;GREM1
6451,GO:0019220,0.103617970060295,0.940117307352922,15,1608,regulation of phosphate metabolic process,BP,CRLF1;ERBB3;FGFR3;TF;PLCL1;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;GREM1;GPD1;KNDC1;MYO1D;GJC2
15195,GO:0061640,0.103720398027872,0.982604385877939,2,83,cytoskeleton-dependent cytokinesis,BP,ANLN;ANK3
728,GO:0001942,0.103796106583675,0.982594906965421,2,80,hair follicle development,BP,NGFR;EGFR
15781,GO:0070679,0.103901203556873,0.994872060508706,1,13,inositol 1,4,5 trisphosphate binding,MF,PLCL1
13606,GO:0051174,0.104035876378171,0.939838244323085,15,1609,regulation of phosphorus metabolic process,BP,CRLF1;ERBB3;FGFR3;TF;PLCL1;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;GREM1;GPD1;KNDC1;MYO1D;GJC2
13715,GO:0051371,0.104141003045241,0.994818258903794,1,14,muscle alpha-actinin binding,MF,LDB3
13525,GO:0051051,0.10430148229957,0.96125638595003,5,399,negative regulation of transport,BP,ERBB3;ANK3;GJA1;BOK;APOD
18138,GO:0099513,0.104326946987786,0.953845889622819,7,581,polymeric cytoskeletal fiber,CC,CLDN11;DCX;TUBB4A;PPL;GJB6;LDB3;DNAH17
19232,GO:1901990,0.104340830084409,0.961239907881044,5,394,regulation of mitotic cell cycle phase transition,BP,ANLN;TUBB4A;GPNMB;EGFR;GJC2
6733,GO:0021514,0.104767263130771,0.994685742813889,1,17,ventral spinal cord interneuron differentiation,BP,NKX6-2
4602,GO:0009953,0.104798321776521,0.982305397568913,2,87,dorsal/ventral pattern formation,BP,NKX6-2;GREM1
2095,GO:0004620,0.104884065696871,0.982295682095741,2,83,phospholipase activity,MF,PLCL1;ENPP2
7659,GO:0031110,0.105834933050269,0.982056529789921,2,79,regulation of microtubule polymerization or depolymerization,BP,STMN4;TUBB4A
18066,GO:0099081,0.105962178789632,0.947747919080874,9,807,supramolecular polymer,CC,CLDN11;DCX;CAPN3;TUBB4A;PPL;GJB6;LDB3;ANK3;DNAH17
20023,GO:1903725,0.105968837040663,0.982002573475579,2,84,regulation of phospholipid metabolic process,BP,FGFR3;PDGFRA
5042,GO:0010951,0.10667976971237,0.972303713111354,3,193,negative regulation of endopeptidase activity,BP,NGFR;SPOCK3;COL28A1
5441,GO:0015629,0.106894218063345,0.955841172972702,6,464,actin cytoskeleton,CC,ANLN;GJB6;LDB3;MOBP;MYO1D;DAPK1
7071,GO:0023019,0.106904942860957,0.994426984980107,1,19,signal transduction involved in regulation of gene expression,BP,PDGFRA
13038,GO:0048661,0.107054605347413,0.981710779839557,2,84,positive regulation of smooth muscle cell proliferation,BP,EGFR;GJA1
8714,GO:0032928,0.107108510640554,0.994390322341088,1,20,regulation of superoxide anion generation,BP,EGFR
12330,GO:0046425,0.10748277787098,0.981572730748253,2,91,regulation of receptor signaling pathway via JAK-STAT,BP,CRLF1;FGFR3
6692,GO:0019932,0.107511821443376,0.959706445350921,5,390,second-messenger-mediated signaling,BP,ERBB3;PEX5L;EGFR;SGCD;GPR62
14976,GO:0061097,0.107587705632735,0.981570377363528,2,83,regulation of protein tyrosine kinase activity,BP,ERBB3;GREM1
17082,GO:0090136,0.107865635644206,0.99440538034053,1,15,epithelial cell-cell adhesion,BP,BVES
4547,GO:0009746,0.108006163534862,0.971835640562336,3,175,response to hexose,BP,BAIAP3;GJB6;GJA1
20743,GO:1905146,0.10824479490107,0.994365150957684,1,15,lysosomal protein catabolic process,BP,LRP2
7514,GO:0030864,0.10842528198176,0.981366780986346,2,77,cortical actin cytoskeleton,CC,ANLN;MOBP
17872,GO:0098773,0.108547455899499,0.981313866310227,2,82,skin epidermis development,BP,NGFR;EGFR
7397,GO:0030540,0.10857225292121,0.994305885253492,1,16,female genitalia development,BP,LRP2
14892,GO:0060973,0.108637174830703,0.994277380886277,1,17,cell migration involved in heart development,BP,BVES
7010,GO:0022404,0.108671642594676,0.981280104168518,2,82,molting cycle process,BP,NGFR;EGFR
7011,GO:0022405,0.108671642594676,0.981280104168518,2,82,hair cycle process,BP,NGFR;EGFR
7932,GO:0031625,0.108752175348994,0.964480571199393,4,283,ubiquitin protein ligase binding,MF,NGFR;ERBB3;EGFR;BOK
10497,GO:0040037,0.108843088266331,0.994276842423816,1,16,negative regulation of fibroblast growth factor receptor signaling pathway,BP,NGFR
7101,GO:0030021,0.109192333465839,0.994239277669338,1,16,extracellular matrix structural constituent conferring compression resistance,MF,ACAN
9141,GO:0034104,0.109590679667999,0.994137424774724,1,19,negative regulation of tissue remodeling,BP,GREM1
5139,GO:0014068,0.109802176738807,0.980979400169411,2,80,positive regulation of phosphatidylinositol 3-kinase signaling,BP,ERBB3;PDGFRA
10658,GO:0042359,0.110054540374093,0.99410422030276,1,18,vitamin D metabolic process,BP,LRP2
19349,GO:1902259,0.110279303085174,0.994079602394193,1,18,regulation of delayed rectifier potassium channel activity,BP,ANK3
6596,GO:0019731,0.110439439155593,0.99394197762599,1,28,antibacterial humoral response,BP,TF
10150,GO:0036158,0.110485971011176,0.994099017522112,1,16,outer dynein arm assembly,BP,DNAH17
21867,GO:2000651,0.110612390455279,0.99408521634324,1,16,positive regulation of sodium ion transmembrane transporter activity,BP,ANK3
1393,GO:0003071,0.111010213824043,0.993981289579703,1,19,renal system process involved in regulation of systemic arterial blood pressure,BP,GJA1
6086,GO:0016881,0.111244292837355,0.993973300602163,1,18,acid-amino acid ligase activity,MF,CARNS1
7350,GO:0030425,0.111346045940017,0.94996260417815,7,579,dendrite,CC,NGFR;LRP2;ANK3;KNDC1;MYO1D;ANKS1B;APOD
4028,GO:0008381,0.111555903711981,0.993958957313128,1,17,mechanosensitive ion channel activity,MF,PIEZO2
13369,GO:0050811,0.111578290086791,0.993956480273072,1,17,GABA receptor binding,MF,PLCL1
535,GO:0001667,0.111585038466079,0.957721276127595,5,374,ameboidal-type cell migration,BP,ANLN;SOX10;ENPP2;GJA1;GREM1
10897,GO:0042813,0.112037111366504,0.993954502262603,1,15,Wnt-activated receptor activity,MF,FZD7
15741,GO:0070593,0.112087785590548,0.99392290372232,1,16,dendrite self-avoidance,BP,CNTN2
21908,GO:2000726,0.112182543511823,0.993889419768153,1,17,negative regulation of cardiac muscle cell differentiation,BP,FZD7
10290,GO:0036499,0.112367494840957,0.993813507707636,1,20,PERK-mediated unfolded protein response,BP,BOK
18597,GO:0140467,0.112367494840957,0.993813507707636,1,20,integrated stress response signaling,BP,BOK
21909,GO:2000727,0.112403122616402,0.993844341174137,1,18,positive regulation of cardiac muscle cell differentiation,BP,GREM1
17606,GO:0097447,0.112483603359287,0.949326055374722,7,581,dendritic tree,CC,NGFR;LRP2;ANK3;KNDC1;MYO1D;ANKS1B;APOD
17013,GO:0090025,0.112608220180237,0.993771417721099,1,21,regulation of monocyte chemotaxis,BP,GREM1
525,GO:0001656,0.11264553583623,0.980183439131118,2,83,metanephros development,BP,PDGFRA;GREM1
12293,GO:0046328,0.11314988073642,0.969909548904185,3,171,regulation of JNK cascade,BP,TF;EGFR;FZD7
13618,GO:0051216,0.113150842569444,0.969902816323254,3,175,cartilage development,BP,FGFR3;ACAN;GREM1
17121,GO:0090189,0.113607115282417,0.993690110904516,1,19,regulation of branching involved in ureteric bud morphogenesis,BP,GREM1
4756,GO:0010544,0.11375061814885,0.993692593644239,1,18,negative regulation of platelet activation,BP,PDGFRA
7744,GO:0031293,0.113815939491245,0.993685188479471,1,18,membrane protein intracellular domain proteolysis,BP,NGFR
9049,GO:0033691,0.113888588366727,0.993658119214405,1,19,sialic acid binding,MF,MAG
5044,GO:0010954,0.114180145077125,0.993624892365383,1,19,positive regulation of protein processing,BP,CNTN2
437,GO:0001502,0.114213057479856,0.993661240196916,1,17,cartilage condensation,BP,ACAN
14656,GO:0060544,0.114227209970112,0.993638460512798,1,18,regulation of necroptotic process,BP,BOK
15370,GO:0062098,0.114227209970112,0.993638460512798,1,18,regulation of programmed necrotic cell death,BP,BOK
13593,GO:0051153,0.114283425551748,0.979700757797389,2,90,regulation of striated muscle cell differentiation,BP,FZD7;GREM1
13937,GO:0051797,0.114549201349422,0.99358270335598,1,19,regulation of hair follicle development,BP,NGFR
2539,GO:0005355,0.114654621580879,0.993570625458664,1,19,glucose transmembrane transporter activity,MF,SLC5A11
5307,GO:0015149,0.114654621580879,0.993570625458664,1,19,hexose transmembrane transporter activity,MF,SLC5A11
20622,GO:1904892,0.114690919589953,0.979573403564965,2,94,regulation of receptor signaling pathway via STAT,BP,CRLF1;FGFR3
13528,GO:0051054,0.114716548236646,0.969300209916279,3,179,positive regulation of DNA metabolic process,BP,EYA2;EGFR;GREM1
3848,GO:0008081,0.114871386187101,0.979564736047966,2,82,phosphoric diester hydrolase activity,MF,PLCL1;ENPP2
10598,GO:0042249,0.1149780318204,0.993574142602157,1,17,establishment of planar polarity of embryonic epithelium,BP,CTHRC1
9240,GO:0034284,0.11501610191037,0.969184139879466,3,180,response to monosaccharide,BP,BAIAP3;GJB6;GJA1
3348,GO:0006721,0.115100711738282,0.979451839060193,2,96,terpenoid metabolic process,BP,LRP2;EGFR
16837,GO:0072673,0.115113955688524,0.993558601757119,1,17,lamellipodium morphogenesis,BP,ENPP2
3701,GO:0007350,0.115176779003679,0.993529884346502,1,18,blastoderm segmentation,BP,PCSK6
5381,GO:0015294,0.11560195748842,0.979354739614759,2,83,solute:cation symporter activity,MF,SLC45A3;SLC5A11
10525,GO:0042056,0.115785395371181,0.993379436181875,1,23,chemoattractant activity,MF,GPNMB
7165,GO:0030136,0.116110503222317,0.96876289350225,3,181,clathrin-coated vesicle,CC,LRP2;TF;EGFR
16537,GO:0072077,0.116668185042855,0.993357414107486,1,18,renal vesicle morphogenesis,BP,GREM1
12494,GO:0046716,0.116959918900525,0.993303541445896,1,19,muscle cell cellular homeostasis,BP,CAPN3
2812,GO:0005902,0.117050418365057,0.978939916047318,2,84,microvillus,CC,PDGFRA;MYO1D
4718,GO:0010466,0.117077228043533,0.968364474739133,3,200,negative regulation of peptidase activity,BP,NGFR;SPOCK3;COL28A1
15037,GO:0061213,0.117126257408199,0.993284050211249,1,19,positive regulation of mesonephros development,BP,GREM1
4621,GO:0010002,0.11726477707883,0.99331007473351,1,17,cardioblast differentiation,BP,GREM1
11029,GO:0043112,0.117545289623161,0.96820979638804,3,181,receptor metabolic process,BP,BVES;GREM1;CNTN2
7826,GO:0031420,0.117596172357059,0.993271344580681,1,17,alkali metal ion binding,MF,CAPN3
5627,GO:0016010,0.117875263974843,0.993195915989566,1,19,dystrophin-associated glycoprotein complex,CC,SGCD
17335,GO:0090665,0.117875263974843,0.993195915989566,1,19,glycoprotein complex,CC,SGCD
7454,GO:0030673,0.118294076782292,0.99324392863879,1,15,axolemma,CC,MYO1D
4286,GO:0009074,0.118866194293217,0.992989839628998,1,25,aromatic amino acid family catabolic process,BP,CARNS1
18881,GO:1901017,0.119262816166978,0.993031056720979,1,19,negative regulation of potassium ion transmembrane transporter activity,BP,ANK3
10486,GO:0040017,0.119425288380467,0.949162612716865,6,504,positive regulation of locomotion,BP,TF;BVES;PDGFRA;GPNMB;ENPP2;EGFR
9148,GO:0034114,0.119428040389363,0.992960485914271,1,22,regulation of heterotypic cell-cell adhesion,BP,MBP
10482,GO:0040013,0.120022366988389,0.959427795390564,4,280,negative regulation of locomotion,BP,GJA1;GREM1;APOD;SPOCK3
8299,GO:0032331,0.120078005279516,0.992933238305304,1,19,negative regulation of chondrocyte differentiation,BP,GREM1
1402,GO:0003094,0.120667517546102,0.992883193892353,1,18,glomerular filtration,BP,GJA1
16543,GO:0072087,0.120762876230757,0.992850505590775,1,19,renal vesicle development,BP,GREM1
13974,GO:0051900,0.120807733698309,0.992808759541966,1,21,regulation of mitochondrial depolarization,BP,BOK
8760,GO:0033002,0.120828383577017,0.966929226738686,3,183,muscle cell proliferation,BP,EGFR;GJA1;APOD
22027,GO:2001022,0.12085375388323,0.977819248901829,2,91,positive regulation of response to DNA damage stimulus,BP,EYA2;EGFR
16148,GO:0071397,0.121008905962656,0.992865686643849,1,17,cellular response to cholesterol,BP,MLC1
804,GO:0002043,0.121255794430899,0.99279064878434,1,19,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,NGFR
13973,GO:0051899,0.12175416285967,0.977592454361917,2,82,membrane depolarization,BP,ANK3;BOK
19452,GO:1902531,0.122175737248007,0.927538708600649,15,1643,regulation of intracellular signal transduction,BP,ERBB3;FGFR3;LRP2;TF;CAPN3;PEX5L;TRIM67;PDGFRA;GPNMB;EGFR;GJA1;FZD7;GREM1;BOK;GPR62
12798,GO:0048041,0.122491463230675,0.97738147390565,2,81,focal adhesion assembly,BP,GREM1;APOD
8132,GO:0032026,0.123207662108195,0.992597735835557,1,17,response to magnesium ion,BP,ANK3
19115,GO:1901655,0.123210128069184,0.977129903016669,2,91,cellular response to ketone,BP,SOX10;EGFR
17855,GO:0098743,0.123613349528865,0.992500745015411,1,19,cell aggregation,BP,ACAN
491,GO:0001578,0.123862518809656,0.976956948652465,2,86,microtubule bundle formation,BP,DCX;DNAH17
2097,GO:0004622,0.124622225316343,0.992319533260731,1,22,lysophospholipase activity,MF,ENPP2
12438,GO:0046625,0.12481732448508,0.99231162063627,1,21,sphingolipid binding,MF,MAG
3926,GO:0008210,0.124880585689615,0.992257583562956,1,24,estrogen metabolic process,BP,PDGFRA
13658,GO:0051271,0.125009171952038,0.95712780892023,4,283,negative regulation of cellular component movement,BP,GJA1;GREM1;APOD;SPOCK3
9644,GO:0035282,0.125130962404086,0.976565622968988,2,90,segmentation,BP,PCSK6;DMRT2
11581,GO:0044389,0.125175087324411,0.957035530287656,4,300,ubiquitin-like protein ligase binding,MF,NGFR;ERBB3;EGFR;BOK
6677,GO:0019898,0.125184336150321,0.957048370436902,4,281,extrinsic component of membrane,CC,CDH19;TF;SOX10;MAL
11464,GO:0044093,0.125195986210579,0.925456327336199,15,1652,positive regulation of molecular function,BP,NGFR;ERBB3;FGFR3;TF;CAPN3;PLCL1;PDGFRA;EGFR;ST18;ANK3;CTHRC1;GREM1;BOK;DAPK1;MBP
7396,GO:0030539,0.125270213464901,0.992254372818148,1,21,male genitalia development,BP,PDGFRA
2871,GO:0006006,0.125551921202877,0.965053079511963,3,189,glucose metabolic process,BP,SLC45A3;GPD1;APOD
12516,GO:0046823,0.12564829554212,0.992206410432972,1,21,negative regulation of nucleocytoplasmic transport,BP,APOD
10106,GO:0036094,0.12574175296738,0.920176008358502,20,2277,small molecule binding,MF,ERBB3;FGFR3;TUBB4A;MAG;BVES;PLCL1;CDK18;ATP10B;HAPLN2;PDGFRA;EGFR;ACAN;PHKG1;GPD1;CARNS1;SUSD5;MYO1D;DNAH17;APOD;DAPK1
13352,GO:0050789,0.125798766029433,0.913774603682757,69,9758,regulation of biological process,BP,CRLF1;BAIAP3;ANLN;STMN4;NGFR;EYA2;ERBB3;FGFR3;DCX;LRP2;NKAIN1;TF;CAPN3;SOX10;MLC1;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;CDK18;TRIM67;GJB6;PLP1;MYRF;RPS4Y1;PDGFRA;GPNMB;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;CNTNAP4;FZD7;KCNJ6;TMSB15A;SLC45A3;EDIL3;CTHRC1;GREM1;GPD1;KLK6;LGI3;SGCD;KNDC1;MAL;DMRT2;SUSD5;MYO1D;BOK;GPR62;CNTN2;ANKS1B;NKAIN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
13969,GO:0051895,0.125840531385614,0.992244357008699,1,18,negative regulation of focal adhesion assembly,BP,APOD
18646,GO:0150118,0.125840531385614,0.992244357008699,1,18,negative regulation of cell-substrate junction organization,BP,APOD
3714,GO:0007398,0.125947760150764,0.992207778870676,1,19,ectoderm development,BP,FZD7
5594,GO:0015919,0.126097098583275,0.992168064488649,1,20,peroxisomal membrane transport,BP,PEX5L
11078,GO:0043194,0.126168842271642,0.992257756278612,1,16,axon initial segment,CC,ANK3
11403,GO:0043931,0.126207267780271,0.992252923036689,1,16,ossification involved in bone maturation,BP,GREM1
19229,GO:1901987,0.126313443087556,0.950283180421283,5,418,regulation of cell cycle phase transition,BP,ANLN;TUBB4A;GPNMB;EGFR;GJC2
3541,GO:0007039,0.126507290469335,0.992136683052881,1,19,protein catabolic process in the vacuole,BP,LRP2
6153,GO:0017049,0.126508786040538,0.992115584507909,1,20,GTP-Rho binding,MF,ANLN
4821,GO:0010648,0.126687619192004,0.928804913610615,12,1281,negative regulation of cell communication,BP,NGFR;EYA2;ERBB3;LRP2;SOX10;TRIM67;EGFR;GJA1;CTHRC1;GREM1;BOK;APOD
10727,GO:0042481,0.126883293877385,0.992031367915002,1,22,regulation of odontogenesis,BP,NGFR
1633,GO:0003785,0.127086832091582,0.991974805176503,1,24,actin monomer binding,MF,TMSB15A
19804,GO:1903319,0.127225323682765,0.992004677419681,1,21,positive regulation of protein maturation,BP,CNTN2
17607,GO:0097449,0.127355476941814,0.992051812622923,1,18,astrocyte projection,CC,MLC1
17495,GO:0097205,0.127576064575931,0.991999938713166,1,19,renal filtration,BP,GJA1
12816,GO:0048143,0.127605376613349,0.991938167396656,1,22,astrocyte activation,BP,EGFR
5305,GO:0015145,0.127697036088706,0.991943810306271,1,21,monosaccharide transmembrane transporter activity,MF,SLC5A11
19653,GO:1903010,0.127815595984278,0.991947779428402,1,20,regulation of bone development,BP,GREM1
9411,GO:0034629,0.127876658479224,0.99193989313066,1,20,cellular protein-containing complex localization,BP,SGCD
13959,GO:0051882,0.128026844900206,0.991883504780528,1,22,mitochondrial depolarization,BP,BOK
7084,GO:0023057,0.12818185896963,0.927811778113024,12,1284,negative regulation of signaling,BP,NGFR;EYA2;ERBB3;LRP2;SOX10;TRIM67;EGFR;GJA1;CTHRC1;GREM1;BOK;APOD
4591,GO:0009913,0.128229625445474,0.963976665434266,3,191,epidermal cell differentiation,BP,FA2H;PPL;PCSK6
16715,GO:0072349,0.12851797574866,0.99187839933879,1,19,modified amino acid transmembrane transporter activity,MF,GJA1
16124,GO:0071363,0.128717320112757,0.940048395532868,7,624,cellular response to growth factor stimulus,BP,NGFR;FGFR3;LRP2;PDGFRA;PCSK6;EGFR;GREM1
17183,GO:0090276,0.128987176174974,0.963671054892103,3,191,regulation of peptide hormone secretion,BP,BAIAP3;EGFR;GJA1
11740,GO:0045056,0.128999100605236,0.991815945989558,1,19,transcytosis,BP,LRP2
7251,GO:0030247,0.129087786972061,0.991728707816511,1,23,polysaccharide binding,MF,ENPP2
11656,GO:0044772,0.129234014906269,0.943781182060751,6,541,mitotic cell cycle phase transition,BP,ANLN;TUBB4A;CDK18;GPNMB;EGFR;GJC2
8099,GO:0031968,0.129646783526687,0.963401184499191,3,193,organelle outer membrane,CC,SOX10;GJA1;BOK
12970,GO:0048520,0.129749901906527,0.991658013460068,1,22,positive regulation of behavior,BP,GJA1
15038,GO:0061217,0.130075925261495,0.99161498250852,1,22,regulation of mesonephros development,BP,GREM1
14325,GO:0060071,0.130086299801372,0.975026589001314,2,104,Wnt signaling pathway, planar cell polarity pathway,BP,FZD7;CTHRC1
3917,GO:0008198,0.130293064077996,0.991569613150283,1,23,ferrous iron binding,MF,TF
7481,GO:0030742,0.130313383656521,0.991566917347748,1,23,GTP-dependent protein binding,MF,RAPGEF5
18945,GO:1901222,0.131048251220481,0.974745202153865,2,100,regulation of NIK/NF-kappaB signaling,BP,EGFR;GREM1
148,GO:0000302,0.131104073332892,0.962785290901436,3,210,response to reactive oxygen species,BP,PDGFRA;EGFR;APOD
11998,GO:0045686,0.131152283402196,0.991455224930382,1,23,negative regulation of glial cell differentiation,BP,NKX6-2
13947,GO:0051861,0.131223016086211,0.99144577216104,1,23,glycolipid binding,MF,MAG
4578,GO:0009887,0.131749552830666,0.929491113985864,10,988,animal organ morphogenesis,BP,NGFR;FGFR3;LRP2;GJB6;PDGFRA;EGFR;FZD7;ACAN;CTHRC1;GREM1
12872,GO:0048259,0.131970005601486,0.974487339549192,2,93,regulation of receptor-mediated endocytosis,BP,TF;GREM1
662,GO:0001843,0.13202636143374,0.974486109408845,2,89,neural tube closure,BP,LRP2;CTHRC1
2885,GO:0006029,0.132078493254359,0.974474347918204,2,88,proteoglycan metabolic process,BP,ACAN;SPOCK3
15044,GO:0061298,0.132111700144038,0.991431171783199,1,18,retina vasculature development in camera-type eye,BP,PDGFRA
9498,GO:0034764,0.132248112607128,0.962352368282782,3,187,positive regulation of transmembrane transport,BP,CAPN3;ANK3;GJC2
17601,GO:0097440,0.132335553124256,0.991401356260094,1,18,apical dendrite,CC,MYO1D
15104,GO:0061436,0.132512350142082,0.991289718770292,1,22,establishment of skin barrier,BP,FA2H
3519,GO:0007006,0.132693589802928,0.974211728456535,2,109,mitochondrial membrane organization,BP,EYA2;BOK
2482,GO:0005242,0.132874315769341,0.991259804822088,1,21,inward rectifier potassium channel activity,MF,KCNJ6
14701,GO:0060606,0.133102865210912,0.974150356728181,2,90,tube closure,BP,LRP2;CTHRC1
6732,GO:0021513,0.13313017400068,0.991206204041542,1,22,spinal cord dorsal/ventral patterning,BP,NKX6-2
9620,GO:0035250,0.133354754499456,0.991158305222103,1,23,UDP-galactosyltransferase activity,MF,UGT8
6662,GO:0019867,0.133679394288129,0.96175290404433,3,195,outer membrane,CC,SOX10;GJA1;BOK
526,GO:0001657,0.134222631034004,0.973791413491317,2,93,ureteric bud development,BP,CRLF1;GREM1
2827,GO:0005938,0.134465177535779,0.952683860659701,4,273,cell cortex,CC,ANLN;ERMN;MOBP;MYO1D
2813,GO:0005903,0.134647385388826,0.973663365883878,2,92,brush border,CC,LRP2;MYO1D
16216,GO:0071496,0.134651897477343,0.952565448756314,4,302,cellular response to external stimulus,BP,MAG;EGFR;GJA1;PIEZO2
20060,GO:1903798,0.13469041557538,0.990993429988351,1,22,regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR
5649,GO:0016048,0.134725513109622,0.990988612853349,1,22,detection of temperature stimulus,BP,NGFR
6281,GO:0018193,0.134873730141705,0.925271955894368,11,1135,peptidyl-amino acid modification,BP,CRLF1;ERBB3;FGFR3;FOLH1;CAPN3;PLCL1;PDGFRA;ENPP2;EGFR;GREM1;SPOCK3
6200,GO:0017134,0.134954743270803,0.990976680645679,1,21,fibroblast growth factor binding,MF,FGFR3
17108,GO:0090175,0.134954981949284,0.973518263425543,2,106,regulation of establishment of planar polarity,BP,FZD7;CTHRC1
16703,GO:0072330,0.135146182321096,0.961123940372335,3,212,monocarboxylic acid biosynthetic process,BP,FA2H;PLP1;SLC45A3
19068,GO:1901564,0.135205773443016,0.904467518945268,43,5851,organonitrogen compound metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;FOLH1;TF;CAPN3;FA2H;PLCL1;CDK18;TRIM67;MYRF;GAL3ST1;RPS4Y1;PDGFRA;CPM;GPNMB;ENPP2;PCSK6;EGFR;ST18;CNDP1;GJA1;FZD7;ACAN;ADAMTS4;PHKG1;GREM1;GPD1;KLK6;KNDC1;CARNS1;UGT8;BOK;CNTN2;APOD;SPOCK3;DAPK1;MBP;GJC2;COL28A1
6749,GO:0021533,0.135355159014153,0.990943294913673,1,20,cell differentiation in hindbrain,BP,KNDC1
7199,GO:0030178,0.135807077953112,0.960861592415118,3,204,negative regulation of Wnt signaling pathway,BP,SOX10;CTHRC1;GREM1
5061,GO:0010975,0.135978876138491,0.940043142355424,6,486,regulation of neuron projection development,BP,NGFR;MAG;TRIM67;KLK6;KNDC1;CNTN2
19371,GO:1902307,0.136123776931171,0.990815501083543,1,21,positive regulation of sodium ion transmembrane transport,BP,ANK3
12058,GO:0045807,0.136157510109184,0.973179862714182,2,95,positive regulation of endocytosis,BP,TF;GREM1
4044,GO:0008406,0.136232730854936,0.960705345553657,3,191,gonad development,BP,LRP2;PDGFRA;BOK
14225,GO:0055074,0.13640154803337,0.945028173868592,5,421,calcium ion homeostasis,BP,CAPN3;PDGFRA;GJA1;SGCD;BOK
4609,GO:0009968,0.136513268638895,0.924182643474687,11,1168,negative regulation of signal transduction,BP,NGFR;EYA2;ERBB3;LRP2;SOX10;TRIM67;EGFR;CTHRC1;GREM1;BOK;APOD
4180,GO:0008645,0.136949047371551,0.972935207579926,2,94,hexose transmembrane transport,BP,SLC45A3;SLC5A11
5205,GO:0014850,0.137087805282825,0.990681455080718,1,21,response to muscle activity,BP,CAPN3
21525,GO:2000134,0.137181568153624,0.972839547125284,2,100,negative regulation of G1/S transition of mitotic cell cycle,BP,GPNMB;GJC2
3414,GO:0006835,0.137539202067698,0.972753342676102,2,93,dicarboxylic acid transport,BP,LRP2;GJA1
710,GO:0001919,0.137853950741323,0.990553781063536,1,22,regulation of receptor recycling,BP,BVES
6970,GO:0021953,0.137910064211964,0.960014742968215,3,187,central nervous system neuron differentiation,BP,NKX6-2;KNDC1;CNTN2
11333,GO:0043604,0.137986814841946,0.934570942703132,7,739,amide biosynthetic process,BP,FA2H;GAL3ST1;RPS4Y1;EGFR;CARNS1;UGT8;DAPK1
13631,GO:0051235,0.138064968911524,0.950930723440654,4,296,maintenance of location,BP,CAPN3;ANK3;GJA1;TMSB15A
9496,GO:0034762,0.138203931853596,0.938772253129985,6,519,regulation of transmembrane transport,BP,CAPN3;ANK3;GJA1;KCNJ6;DAPK1;GJC2
11542,GO:0044321,0.138333830140637,0.99048612543286,1,22,response to leptin,BP,LRP2
16591,GO:0072163,0.138498285367449,0.972446091984846,2,94,mesonephric epithelium development,BP,CRLF1;GREM1
16592,GO:0072164,0.138498285367449,0.972446091984846,2,94,mesonephric tubule development,BP,CRLF1;GREM1
12483,GO:0046697,0.13865093510261,0.990405152382693,1,24,decidualization,BP,GJA1
745,GO:0001963,0.138816365784558,0.990350995151707,1,26,synaptic transmission, dopaminergic,BP,CNTNAP4
8455,GO:0032526,0.138891742943013,0.972294881674905,2,101,response to retinoic acid,BP,GJA1;FZD7
15483,GO:0070168,0.139545633017834,0.990314146238732,1,22,negative regulation of biomineral tissue development,BP,GREM1
18419,GO:0110150,0.139545633017834,0.990314146238732,1,22,negative regulation of biomineralization,BP,GREM1
18996,GO:1901342,0.139637357864296,0.950163760860927,4,302,regulation of vasculature development,BP,NGFR;GPNMB;ENPP2;GREM1
10675,GO:0042391,0.139644680759954,0.943322297436202,5,402,regulation of membrane potential,BP,BVES;ANK3;GJA1;PIEZO2;BOK
4528,GO:0009651,0.13970102438002,0.990255299612266,1,24,response to salt stress,BP,CAPN3
16942,GO:0086014,0.139802040698448,0.990375561490358,1,18,atrial cardiac muscle cell action potential,BP,GJA1
16952,GO:0086026,0.139802040698448,0.990375561490358,1,18,atrial cardiac muscle cell to AV node cell signaling,BP,GJA1
16980,GO:0086066,0.139802040698448,0.990375561490358,1,18,atrial cardiac muscle cell to AV node cell communication,BP,GJA1
17884,GO:0098796,0.139896842206172,0.924200330265393,10,1064,membrane protein complex,CC,ERBB3;CDH19;TF;GJB6;EGFR;GJA1;KCNJ6;GJB1;SGCD;GJC2
14511,GO:0060348,0.14011108288461,0.959097080725026,3,185,bone development,BP,FGFR3;GJA1;GREM1
17063,GO:0090103,0.140259457430075,0.99019278898936,1,23,cochlea morphogenesis,BP,CTHRC1
4135,GO:0008543,0.140908119491178,0.97166246453038,2,98,fibroblast growth factor receptor signaling pathway,BP,NGFR;FGFR3
15927,GO:0070972,0.140968576173981,0.971534898546207,2,138,protein localization to endoplasmic reticulum,BP,RPS4Y1;GJA1
14835,GO:0060840,0.140982261176574,0.971686029164829,2,87,artery development,BP,NGFR;LRP2
21853,GO:2000637,0.141111662943951,0.990069960785467,1,23,positive regulation of gene silencing by miRNA,BP,EGFR
15895,GO:0070920,0.141217486076936,0.990054652201228,1,23,regulation of production of small RNA involved in gene silencing by RNA,BP,EGFR
4025,GO:0008378,0.141301496751001,0.990008042243864,1,25,galactosyltransferase activity,MF,UGT8
8887,GO:0033233,0.141886929073835,0.989939428549535,1,24,regulation of protein sumoylation,BP,CAPN3
21601,GO:2000278,0.141891401164805,0.971331836953215,2,102,regulation of DNA biosynthetic process,BP,GJA1;GREM1
19553,GO:1902807,0.141975244210063,0.971304829684789,2,102,negative regulation of cell cycle G1/S phase transition,BP,GPNMB;GJC2
5495,GO:0015749,0.141991141102612,0.971322402906004,2,96,monosaccharide transmembrane transport,BP,SLC45A3;SLC5A11
11325,GO:0043586,0.142150422665713,0.989938967208438,1,22,tongue development,BP,EGFR
18724,GO:1900120,0.142356802817965,0.98987083539959,1,24,regulation of receptor binding,BP,PLCL1
19011,GO:1901380,0.142499971489832,0.989868135341628,1,23,negative regulation of potassium ion transmembrane transport,BP,ANK3
11783,GO:0045137,0.142887606269357,0.957905510444062,3,196,development of primary sexual characteristics,BP,LRP2;PDGFRA;BOK
12064,GO:0045821,0.143065190703269,0.989851599321035,1,20,positive regulation of glycolytic process,BP,GPD1
643,GO:0001823,0.143088647520241,0.970964154164125,2,97,mesonephros development,BP,CRLF1;GREM1
13290,GO:0050678,0.143232521322933,0.948408450804759,4,304,regulation of epithelial cell proliferation,BP,NGFR;EGFR;GJA1;FZD7
4177,GO:0008637,0.143256244122125,0.970852252551051,2,114,apoptotic mitochondrial changes,BP,EYA2;BOK
7122,GO:0030050,0.143699679327009,0.989815806604083,1,18,vesicle transport along actin filament,BP,MYO1D
2852,GO:0005980,0.143713930386192,0.989732336631902,1,21,glycogen catabolic process,BP,PHKG1
18706,GO:1900101,0.143969308851313,0.989616431800161,1,25,regulation of endoplasmic reticulum unfolded protein response,BP,BOK
8983,GO:0033561,0.144221172236685,0.989596243629515,1,24,regulation of water loss via skin,BP,FA2H
13356,GO:0050794,0.144289845929095,0.898709852793939,66,9292,regulation of cellular process,BP,CRLF1;BAIAP3;ANLN;STMN4;NGFR;EYA2;ERBB3;FGFR3;DCX;LRP2;TF;CAPN3;SOX10;MLC1;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;CDK18;TRIM67;GJB6;PLP1;MYRF;PDGFRA;GPNMB;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;CNTNAP4;FZD7;KCNJ6;TMSB15A;SLC45A3;EDIL3;CTHRC1;GREM1;GPD1;KLK6;LGI3;SGCD;KNDC1;MAL;DMRT2;SUSD5;MYO1D;BOK;GPR62;CNTN2;ANKS1B;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
14671,GO:0060571,0.144567617054804,0.989527513487471,1,25,morphogenesis of an epithelial fold,BP,EGFR
16627,GO:0072202,0.144760899044801,0.989534858695834,1,23,cell differentiation involved in metanephros development,BP,GREM1
8883,GO:0033218,0.144800279282549,0.947614838018788,4,330,amide binding,MF,NGFR;FOLH1;MAG;PEX5L
8276,GO:0032288,0.144847153267516,0.989565142421965,1,21,myelin assembly,BP,UGT8
3855,GO:0008093,0.144868515124482,0.989561977010352,1,21,cytoskeletal anchor activity,MF,ANK3
10993,GO:0043034,0.144907522980754,0.989608451378855,1,19,costamere,CC,ANK3
3664,GO:0007263,0.145309202455354,0.989416745616875,1,25,nitric oxide mediated signal transduction,BP,EGFR
21962,GO:2000810,0.145509796143298,0.989423208615992,1,23,regulation of bicellular tight junction assembly,BP,GJA1
2158,GO:0004709,0.145605122080522,0.989452515560202,1,21,MAP kinase kinase kinase activity,MF,EGFR
15447,GO:0070102,0.145862185791646,0.989391318321013,1,22,interleukin-6-mediated signaling pathway,BP,ST18
5034,GO:0010939,0.146142933845072,0.989275183912545,1,26,regulation of necrotic cell death,BP,BOK
2590,GO:0005520,0.146366164128803,0.989294768065995,1,23,insulin-like growth factor binding,MF,LRP2
7306,GO:0030325,0.146615508685557,0.989257216490162,1,23,adrenal gland development,BP,PDGFRA
6592,GO:0019722,0.146635527847444,0.956296823395729,3,201,calcium-mediated signaling,BP,ERBB3;EGFR;SGCD
5101,GO:0014020,0.146640200164279,0.969810043564224,2,96,primary neural tube formation,BP,LRP2;CTHRC1
3347,GO:0006720,0.147055733817563,0.969609245600399,2,114,isoprenoid metabolic process,BP,LRP2;EGFR
1868,GO:0004252,0.147089089145896,0.969581162177146,2,120,serine-type endopeptidase activity,MF,PCSK6;KLK6
4813,GO:0010640,0.147158646912619,0.989196413903855,1,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,APOD
5777,GO:0016298,0.147197834167335,0.96959890899672,2,103,lipase activity,MF,PLCL1;ENPP2
6845,GO:0021697,0.147230553450146,0.989185548822709,1,22,cerebellar cortex formation,BP,KNDC1
14353,GO:0060122,0.147279841831631,0.989137333536439,1,24,inner ear receptor cell stereocilium organization,BP,CTHRC1
14507,GO:0060343,0.147664157323212,0.989078931190145,1,24,trabecula formation,BP,GREM1
13216,GO:0050321,0.147842421286512,0.989092861679941,1,22,tau-protein kinase activity,MF,PHKG1
3371,GO:0006760,0.147893336171643,0.989009257312365,1,26,folic acid-containing compound metabolic process,BP,FOLH1
14370,GO:0060148,0.148046221399546,0.989020706692896,1,24,positive regulation of posttranscriptional gene silencing,BP,EGFR
4712,GO:0010458,0.148046803969827,0.988985777665296,1,26,exit from mitosis,BP,ANLN
10197,GO:0036315,0.148144094741744,0.989070585182475,1,21,cellular response to sterol,BP,MLC1
4908,GO:0010771,0.148421251212279,0.969226793521243,2,95,negative regulation of cell morphogenesis involved in differentiation,BP,NGFR;MAG
16499,GO:0072012,0.148531410799885,0.988966357006785,1,23,glomerulus vasculature development,BP,PDGFRA
3713,GO:0007389,0.148610476696564,0.938485558756447,5,425,pattern specification process,BP,LRP2;PCSK6;NKX6-2;GREM1;DMRT2
3455,GO:0006897,0.148819487208433,0.932694770164766,6,531,endocytosis,BP,LRP2;TF;MLC1;ENPP2;GREM1;CNTN2
2466,GO:0005215,0.148837226774414,0.918330838701126,10,1034,transporter activity,MF,GJB6;GJA1;PIEZO2;KCNJ6;SLC45A3;SLC5A11;TMEM144;GJB1;APOD;GJC2
13992,GO:0051928,0.14888640254753,0.969022286118878,2,108,positive regulation of calcium ion transport,BP,CAPN3;GJC2
592,GO:0001763,0.148964317102184,0.955313724725959,3,189,morphogenesis of a branching structure,BP,SOX10;ERMN;GREM1
14938,GO:0061037,0.14905689356121,0.988847528915314,1,25,negative regulation of cartilage development,BP,GREM1
6730,GO:0021511,0.149514014189294,0.988795498177955,1,24,spinal cord patterning,BP,NKX6-2
14187,GO:0055003,0.149579642542031,0.988939632322673,1,18,cardiac myofibril assembly,BP,PDGFRA
6288,GO:0018200,0.149668585489589,0.988736033196887,1,26,peptidyl-glutamic acid modification,BP,FOLH1
7098,GO:0030017,0.150232748764678,0.9547542185754,3,194,sarcomere,CC,CAPN3;LDB3;ANK3
842,GO:0002092,0.150271489552381,0.988698622596045,1,23,positive regulation of receptor internalization,BP,GREM1
3858,GO:0008104,0.150528133382119,0.90110480105593,21,2541,protein localization,BP,BAIAP3;NGFR;LRP2;TF;CAPN3;MLC1;PEX5L;TRIM67;RPS4Y1;EGFR;ANK3;GJA1;SNX22;TMSB15A;SGCD;MAL;UGT8;MYO1D;CNTN2;ANKS1B;APOD
9336,GO:0034446,0.150650956640517,0.968467706635999,2,99,substrate adhesion-dependent cell spreading,BP,BVES;FZD7
2779,GO:0005858,0.150739433403552,0.988762285032726,1,18,axonemal dynein complex,CC,DNAH17
13337,GO:0050770,0.150750526721642,0.954554498925928,3,181,regulation of axonogenesis,BP,NGFR;MAG;CNTN2
5563,GO:0015867,0.150897394445203,0.988544828642705,1,26,ATP transport,BP,GJA1
15849,GO:0070848,0.150920364263832,0.926828869359312,7,651,response to growth factor,BP,NGFR;FGFR3;LRP2;PDGFRA;PCSK6;EGFR;GREM1
11819,GO:0045202,0.150977445100285,0.912377127604035,12,1258,synapse,CC,BAIAP3;NGFR;BCAS1;PLP1;EGFR;ANK3;CNTNAP4;ACAN;LGI3;CNTN2;ANKS1B;MBP
4423,GO:0009251,0.151179852367746,0.988579919484507,1,22,glucan catabolic process,BP,PHKG1
3662,GO:0007259,0.151756563541327,0.968055777393713,2,110,receptor signaling pathway via JAK-STAT,BP,CRLF1;FGFR3
4545,GO:0009743,0.152264476248294,0.953848823353409,3,205,response to carbohydrate,BP,BAIAP3;GJB6;GJA1
7930,GO:0031623,0.152478013966362,0.967826768543188,2,106,receptor internalization,BP,GREM1;CNTN2
5861,GO:0016486,0.152592006420529,0.988278345289031,1,26,peptide hormone processing,BP,PCSK6
18592,GO:0140448,0.152592006420529,0.988278345289031,1,26,signaling receptor ligand precursor processing,BP,PCSK6
14203,GO:0055022,0.153066007311468,0.988221100189282,1,25,negative regulation of cardiac muscle tissue growth,BP,GJA1
14992,GO:0061117,0.153066007311468,0.988221100189282,1,25,negative regulation of heart growth,BP,GJA1
807,GO:0002052,0.15348939286946,0.98819453342105,1,23,positive regulation of neuroblast proliferation,BP,SOX10
7628,GO:0031069,0.153684305437638,0.988122874205387,1,25,hair follicle morphogenesis,BP,NGFR
5784,GO:0016310,0.153779543698285,0.901533366161386,18,2136,phosphorylation,BP,CRLF1;ERBB3;FGFR3;TF;PLCL1;CDK18;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;PHKG1;GREM1;GPD1;KNDC1;DAPK1;MBP;GJC2
8065,GO:0031904,0.153841283022079,0.988047575351518,1,28,endosome lumen,CC,LRP2
11450,GO:0044057,0.153965763146386,0.929694327053909,6,544,regulation of system process,BP,SOX10;MAG;BVES;MYRF;EGFR;GJA1
16065,GO:0071276,0.154026357448159,0.987954317703591,1,33,cellular response to cadmium ion,BP,EGFR
3658,GO:0007254,0.154102498241996,0.953052358462284,3,199,JNK cascade,BP,TF;EGFR;FZD7
16940,GO:0086012,0.154135468151681,0.988140737065422,1,21,membrane depolarization during cardiac muscle cell action potential,BP,ANK3
518,GO:0001649,0.154271276086377,0.952971011559619,3,203,osteoblast differentiation,BP,GPNMB;CTHRC1;GREM1
739,GO:0001956,0.154312231162163,0.988063760443681,1,23,positive regulation of neurotransmitter secretion,BP,BAIAP3
12360,GO:0046475,0.154406136786016,0.98797262483003,1,27,glycerophospholipid catabolic process,BP,ENPP2
11084,GO:0043200,0.154538748187746,0.967132331592764,2,105,response to amino acid,BP,PDGFRA;EGFR
15377,GO:0062197,0.15456128264939,0.942744304936188,4,328,cellular response to chemical stress,BP,CAPN3;PDGFRA;EGFR;DAPK1
18721,GO:1900117,0.155244077221276,0.987821944117808,1,28,regulation of execution phase of apoptosis,BP,BOK
7406,GO:0030552,0.155782618245821,0.987828168046511,1,23,cAMP binding,MF,BVES
6138,GO:0017016,0.155874521045542,0.93453401980553,5,383,Ras GTPase binding,MF,ANLN;NGFR;RAPGEF5;MOBP;KNDC1
13772,GO:0051480,0.156026074350196,0.942006754951617,4,323,regulation of cytosolic calcium ion concentration,BP,CAPN3;PDGFRA;GJA1;BOK
12165,GO:0045992,0.15606638695368,0.987740395660799,1,25,negative regulation of embryonic development,BP,FZD7
11501,GO:0044247,0.156194583058328,0.987761722479693,1,23,cellular polysaccharide catabolic process,BP,PHKG1
15152,GO:0061564,0.156224264686918,0.928392399516434,6,502,axon development,BP,NGFR;MAG;PLP1;ANK3;CNTN2;APOD
19195,GO:1901888,0.156300292419927,0.952104816404419,3,187,regulation of cell junction assembly,BP,GJA1;GREM1;APOD
16978,GO:0086064,0.156711772276813,0.987678033255122,1,23,cell communication by electrical coupling involved in cardiac conduction,BP,GJA1
11654,GO:0044770,0.156823291149392,0.928004669975887,6,572,cell cycle phase transition,BP,ANLN;TUBB4A;CDK18;GPNMB;EGFR;GJC2
9802,GO:0035590,0.15702841744678,0.987502607238312,1,30,purinergic nucleotide receptor signaling pathway,BP,CNTN2
2611,GO:0005575,0.157336078014235,0.964231631764065,97,14892,cellular_component,CC,CRLF1;BAIAP3;ANLN;CLDN11;STMN4;PLEKHH1;NGFR;EYA2;BCAS1;ERBB3;FGFR3;CDH19;DCX;LRP2;NKAIN1;FOLH1;TF;CAPN3;SOX10;MLC1;PLLP;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;CDK18;ATP10B;PPL;TRIM67;GJB6;LDB3;PLP1;MYRF;GAL3ST1;RPS4Y1;HAPLN2;PDGFRA;CPM;GPNMB;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SNX22;ACAN;TMSB15A;SLC45A3;ADAMTS4;SLC5A11;TMEM144;EDIL3;PHKG1;CTHRC1;GREM1;GPD1;KLK6;MOBP;LGI3;GJB1;SGCD;KNDC1;MAL;CARNS1;DMRT2;SUSD5;UGT8;MYO1D;BOK;TMEM125;TMEM151A;GPR62;CNTN2;ANKS1B;GLDN;DNAH17;NKAIN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;TMEM88B;COL28A1
2147,GO:0004693,0.157408641218372,0.987469389158123,1,28,cyclin-dependent protein serine/threonine kinase activity,MF,CDK18
17618,GO:0097472,0.157408641218372,0.987469389158123,1,28,cyclin-dependent protein kinase activity,MF,CDK18
7060,GO:0022857,0.15818742349019,0.914988614855196,9,914,transmembrane transporter activity,MF,GJB6;GJA1;PIEZO2;KCNJ6;SLC45A3;SLC5A11;TMEM144;GJB1;GJC2
13526,GO:0051052,0.158192775227192,0.940912637206409,4,314,regulation of DNA metabolic process,BP,EYA2;EGFR;GJA1;GREM1
20206,GO:1904062,0.158593022228664,0.940702215452864,4,320,regulation of cation transmembrane transport,BP,CAPN3;ANK3;DAPK1;GJC2
4587,GO:0009896,0.158930425152211,0.932812189110204,5,417,positive regulation of catabolic process,BP,LRP2;TRIM67;GJA1;GPD1;DAPK1
6272,GO:0018146,0.159270978924749,0.98719632936532,1,26,keratan sulfate biosynthetic process,BP,ACAN
20492,GO:1904680,0.159690841825352,0.987108602320866,1,27,peptide transmembrane transporter activity,MF,GJA1
6938,GO:0021895,0.159979086021383,0.987098160656383,1,25,cerebral cortex neuron differentiation,BP,CNTN2
8181,GO:0032102,0.160075571017103,0.939930735088336,4,333,negative regulation of response to external stimulus,BP,PDGFRA;GJA1;GREM1;APOD
18140,GO:0099515,0.160117703847886,0.987202309630231,1,20,actin filament-based transport,BP,MYO1D
12464,GO:0046660,0.160334228460809,0.965132746596404,2,106,female sex differentiation,BP,LRP2;PDGFRA
7126,GO:0030057,0.160347152775503,0.987106422217063,1,22,desmosome,CC,PPL
15105,GO:0061437,0.160446423710772,0.987020285067063,1,25,renal system vasculature development,BP,PDGFRA
15108,GO:0061440,0.160446423710772,0.987020285067063,1,25,kidney vasculature development,BP,PDGFRA
8457,GO:0032528,0.160791124666861,0.986984057319943,1,24,microvillus organization,BP,GLDN
81,GO:0000165,0.160837951323555,0.916660904587468,8,820,MAPK cascade,BP,ERBB3;FGFR3;TF;PDGFRA;GPNMB;EGFR;FZD7;MBP
132,GO:0000272,0.161009506200947,0.986947553573805,1,24,polysaccharide catabolic process,BP,PHKG1
16670,GO:0072273,0.161031919869074,0.98692236801336,1,25,metanephric nephron morphogenesis,BP,GREM1
17711,GO:0097696,0.161120701610451,0.964828740540156,2,114,receptor signaling pathway via STAT,BP,CRLF1;FGFR3
8660,GO:0032838,0.161191834310916,0.949912480508016,3,191,plasma membrane bounded cell projection cytoplasm,CC,DCX;TUBB4A;DNAH17
17594,GO:0097421,0.161214163711882,0.986792066954307,1,31,liver regeneration,BP,EGFR
13571,GO:0051128,0.16161389474144,0.894648624792566,19,2212,regulation of cellular component organization,BP,ANLN;STMN4;NGFR;TF;TUBB4A;MAG;TRIM67;PDGFRA;ERMN;ENPP2;EGFR;GJA1;TMSB15A;GREM1;KLK6;KNDC1;BOK;CNTN2;APOD
4631,GO:0010038,0.161647864824444,0.939120558365,4,335,response to metal ion,BP,TF;CAPN3;EGFR;ANK3
19337,GO:1902235,0.161816668001566,0.986703975832157,1,30,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,BOK
13472,GO:0050974,0.162371792530391,0.986658082183661,1,27,detection of mechanical stimulus involved in sensory perception,BP,PIEZO2
9837,GO:0035637,0.162463174469757,0.949331213751686,3,195,multicellular organismal signaling,BP,MAG;ANK3;GJA1
10866,GO:0042759,0.162551860854123,0.986579021463014,1,30,long-chain fatty acid biosynthetic process,BP,PLP1
19679,GO:1903047,0.162783890823977,0.915410370323643,8,820,mitotic cell cycle process,BP,ANLN;TUBB4A;CDK18;GPNMB;EGFR;ANK3;GJA1;GJC2
16246,GO:0071549,0.163596362512238,0.986400426271983,1,30,cellular response to dexamethasone stimulus,BP,EGFR
3724,GO:0007413,0.163642412041882,0.986527227408317,1,23,axonal fasciculation,BP,CNTN2
18340,GO:0106030,0.163642412041882,0.986527227408317,1,23,neuron projection fasciculation,BP,CNTN2
7174,GO:0030149,0.164089246551025,0.986331050398036,1,29,sphingolipid catabolic process,BP,ENPP2
7039,GO:0022627,0.164250883175638,0.986146173922607,1,44,cytosolic small ribosomal subunit,CC,RPS4Y1
3639,GO:0007214,0.165004159295292,0.986247701776016,1,25,gamma-aminobutyric acid signaling pathway,BP,PLCL1
1858,GO:0004175,0.165258463589507,0.937249185433052,4,338,endopeptidase activity,MF,CAPN3;PCSK6;ADAMTS4;KLK6
17221,GO:0090322,0.165808341194539,0.98598967656633,1,32,regulation of superoxide metabolic process,BP,EGFR
7314,GO:0030334,0.16593332575384,0.913386081449281,8,792,regulation of cell migration,BP,PDGFRA;GPNMB;ENPP2;EGFR;GJA1;TMSB15A;GREM1;APOD
19994,GO:1903671,0.165936478524088,0.986065723366651,1,26,negative regulation of sprouting angiogenesis,BP,NGFR
10755,GO:0042554,0.166071006008027,0.985957579810355,1,31,superoxide anion generation,BP,EGFR
4284,GO:0009072,0.16642468438813,0.985845168026046,1,35,aromatic amino acid family metabolic process,BP,CARNS1
6016,GO:0016773,0.166524851635393,0.917205838789528,7,624,phosphotransferase activity, alcohol group as acceptor,MF,ERBB3;FGFR3;CDK18;PDGFRA;EGFR;PHKG1;DAPK1
660,GO:0001841,0.166694038626462,0.96289666867903,2,104,neural tube formation,BP,LRP2;CTHRC1
578,GO:0001736,0.166721520840006,0.962830034885508,2,119,establishment of planar polarity,BP,FZD7;CTHRC1
3598,GO:0007164,0.166721520840006,0.962830034885508,2,119,establishment of tissue polarity,BP,FZD7;CTHRC1
3669,GO:0007268,0.166884279890869,0.916964761482161,7,661,chemical synaptic transmission,BP,BAIAP3;PLCL1;PLP1;EGFR;CNTNAP4;CNTN2;MBP
17969,GO:0098916,0.166884279890869,0.916964761482161,7,661,anterograde trans-synaptic signaling,BP,BAIAP3;PLCL1;PLP1;EGFR;CNTNAP4;CNTN2;MBP
2648,GO:0005640,0.16704495076685,0.985894042816276,1,25,nuclear outer membrane,CC,BOK
17924,GO:0098858,0.167245669922574,0.947148987122089,3,198,actin-based cell projection,CC,PDGFRA;ERMN;MYO1D
6273,GO:0018149,0.167247531087037,0.985817580802905,1,27,peptide cross-linking,BP,SPOCK3
7069,GO:0023014,0.167999760582699,0.912035729646303,8,828,signal transduction by protein phosphorylation,BP,ERBB3;FGFR3;TF;PDGFRA;GPNMB;EGFR;FZD7;MBP
1583,GO:0003416,0.168137991153356,0.985661120353454,1,27,endochondral bone growth,BP,FGFR3
20775,GO:1905209,0.168308840001915,0.985630996186361,1,27,positive regulation of cardiocyte differentiation,BP,GREM1
1962,GO:0004435,0.16843902839248,0.985673153176735,1,24,phosphatidylinositol phospholipase C activity,MF,PLCL1
13087,GO:0048730,0.168470721096374,0.985583812106433,1,28,epidermis morphogenesis,BP,NGFR
13621,GO:0051222,0.168561144186733,0.935532756400843,4,330,positive regulation of protein transport,BP,BAIAP3;EGFR;ANK3;GJA1
741,GO:0001958,0.168690534892975,0.985563573606018,1,27,endochondral ossification,BP,FGFR3
10097,GO:0036075,0.168690534892975,0.985563573606018,1,27,replacement ossification,BP,FGFR3
15851,GO:0070851,0.168752791567346,0.962110608529068,2,116,growth factor receptor binding,MF,PDGFRA;GREM1
12544,GO:0046875,0.168809984406143,0.985542439431497,1,27,ephrin receptor binding,MF,ANKS1B
12019,GO:0045737,0.168965234290325,0.985478801561985,1,29,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,EGFR
18764,GO:1900181,0.16899361821713,0.98550991695224,1,27,negative regulation of protein localization to nucleus,BP,APOD
72,GO:0000149,0.169014071328316,0.962042815549697,2,109,SNARE binding,MF,BAIAP3;DAPK1
8966,GO:0033500,0.169341585496725,0.94614829783161,3,218,carbohydrate homeostasis,BP,BAIAP3;NGFR;GJB6
10784,GO:0042593,0.169341585496725,0.94614829783161,3,218,glucose homeostasis,BP,BAIAP3;NGFR;GJB6
12017,GO:0045732,0.169375227250308,0.946144944586801,3,211,positive regulation of protein catabolic process,BP,LRP2;TRIM67;GJA1
7300,GO:0030318,0.169435709547161,0.985497367580653,1,24,melanocyte differentiation,BP,SOX10
11988,GO:0045667,0.169626454834171,0.961813692518516,2,111,regulation of osteoblast differentiation,BP,CTHRC1;GREM1
10719,GO:0042471,0.169742038339922,0.961764206984328,2,113,ear morphogenesis,BP,GJB6;CTHRC1
13003,GO:0048585,0.169846218275146,0.897122645722457,13,1498,negative regulation of response to stimulus,BP,NGFR;EYA2;ERBB3;LRP2;SOX10;TRIM67;PDGFRA;EGFR;GJA1;CTHRC1;GREM1;BOK;APOD
3546,GO:0007044,0.169897942859523,0.961778175999689,2,97,cell-substrate junction assembly,BP,GREM1;APOD
9144,GO:0034110,0.17021122158434,0.98529328574391,1,27,regulation of homotypic cell-cell adhesion,BP,ANK3
4906,GO:0010769,0.170274229435551,0.934672309839905,4,295,regulation of cell morphogenesis involved in differentiation,BP,NGFR;MAG;KNDC1;CNTN2
110,GO:0000226,0.170288230367022,0.919991640641725,6,534,microtubule cytoskeleton organization,BP,STMN4;DCX;TUBB4A;GJA1;CNTN2;DNAH17
3888,GO:0008150,0.170418828133081,0.921750052934543,94,14293,biological_process,BP,CRLF1;BAIAP3;ANLN;CLDN11;STMN4;NGFR;EYA2;BCAS1;ERBB3;FGFR3;CDH19;DCX;LRP2;NKAIN1;FOLH1;TF;CAPN3;SOX10;MLC1;PLLP;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;CDK18;ATP10B;PPL;TRIM67;GJB6;LDB3;PLP1;MYRF;GAL3ST1;RPS4Y1;HAPLN2;PDGFRA;CPM;GPNMB;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SNX22;ACAN;TMSB15A;SLC45A3;ADAMTS4;SLC5A11;TMEM144;EDIL3;PHKG1;CTHRC1;GREM1;GPD1;KLK6;MOBP;LGI3;GJB1;SGCD;KNDC1;MAL;CARNS1;DMRT2;SUSD5;UGT8;MYO1D;BOK;TMEM125;GPR62;CNTN2;ANKS1B;GLDN;DNAH17;NKAIN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
6169,GO:0017075,0.170813191400922,0.985206157071716,1,26,syntaxin-1 binding,MF,DAPK1
8669,GO:0032872,0.17096085772914,0.945411590464873,3,211,regulation of stress-activated MAPK cascade,BP,TF;EGFR;FZD7
13786,GO:0051503,0.171189704805316,0.98506415869608,1,30,adenine nucleotide transport,BP,GJA1
13500,GO:0051020,0.171350991139888,0.919364014190181,6,508,GTPase binding,MF,ANLN;NGFR;PEX5L;RAPGEF5;MOBP;KNDC1
9931,GO:0035774,0.171459764586115,0.985015401844323,1,30,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,BAIAP3
2797,GO:0005884,0.171487289621621,0.961142280069005,2,110,actin filament,CC,GJB6;LDB3
1365,GO:0003008,0.171492558024091,0.894090283016641,14,1606,system process,BP,LRP2;SOX10;MAG;BVES;GJB6;MYRF;EGFR;NKX6-2;ANK3;GJA1;PIEZO2;SGCD;CNTN2;MBP
11647,GO:0044743,0.171597592748068,0.98494628111421,1,33,protein transmembrane import into intracellular organelle,BP,PEX5L
17889,GO:0098801,0.171603999133539,0.984989326815994,1,30,regulation of renal system process,BP,GJA1
19900,GO:1903510,0.171835683037464,0.961023553861217,2,108,mucopolysaccharide metabolic process,BP,ACAN;SPOCK3
458,GO:0001533,0.172374683635761,0.984884649234188,1,28,cornified envelope,CC,PPL
4802,GO:0010628,0.172453968222463,0.888845070800308,17,2037,positive regulation of gene expression,BP,NGFR;ERBB3;TF;CAPN3;SOX10;PLP1;MYRF;EGFR;ST18;ANK3;GJA1;FZD7;GREM1;DMRT2;CNTN2;MBP;GJC2
4144,GO:0008569,0.172493483759823,0.985156072293644,1,18,ATP-dependent microtubule motor activity, minus-end-directed,MF,DNAH17
2582,GO:0005506,0.172497575869038,0.960726268742736,2,123,iron ion binding,MF,TF;FA2H
13824,GO:0051590,0.172515503597359,0.984878612612987,1,27,positive regulation of neurotransmitter transport,BP,BAIAP3
15797,GO:0070723,0.172827553165756,0.984865863711049,1,25,response to cholesterol,BP,MLC1
17217,GO:0090314,0.172908765879058,0.984752346953338,1,30,positive regulation of protein targeting to membrane,BP,ANK3
13027,GO:0048638,0.173448678453276,0.932975108842893,4,312,regulation of developmental growth,BP,FGFR3;CAPN3;MAG;GJA1
13990,GO:0051924,0.173461112493727,0.944225619375542,3,224,regulation of calcium ion transport,BP,CAPN3;GJA1;GJC2
3742,GO:0007498,0.173668361992992,0.960328689828533,2,114,mesoderm development,BP,EYA2;GJA1
2778,GO:0005856,0.17417016962959,0.887566681093995,17,1955,cytoskeleton,CC,ANLN;CLDN11;PLEKHH1;DCX;TUBB4A;PPL;TRIM67;GJB6;LDB3;ERMN;ANK3;TMSB15A;MOBP;SGCD;MYO1D;DNAH17;DAPK1
7658,GO:0031109,0.174207865243333,0.960150396604974,2,109,microtubule polymerization or depolymerization,BP,STMN4;TUBB4A
10757,GO:0042558,0.174290218380678,0.984467922019541,1,32,pteridine-containing compound metabolic process,BP,FOLH1
18159,GO:0099537,0.174649134478078,0.912060683174487,7,669,trans-synaptic signaling,BP,BAIAP3;PLCL1;PLP1;EGFR;CNTNAP4;CNTN2;MBP
7513,GO:0030863,0.174691114593717,0.960004043411207,2,102,cortical cytoskeleton,CC,ANLN;MOBP
15557,GO:0070286,0.175206391994917,0.984408233339176,1,26,axonemal dynein complex assembly,BP,DNAH17
3028,GO:0006282,0.175212367794419,0.959767669761791,2,112,regulation of DNA repair,BP,EYA2;EGFR
14862,GO:0060914,0.175871399711757,0.984224493001462,1,29,heart formation,BP,LRP2
3805,GO:0007628,0.17608316860185,0.984224403954856,1,27,adult walking behavior,BP,CNTN2
15569,GO:0070302,0.176239735040808,0.942939987523116,3,214,regulation of stress-activated protein kinase signaling cascade,BP,TF;EGFR;FZD7
9037,GO:0033674,0.176466114570278,0.91622117385975,6,560,positive regulation of kinase activity,BP,ERBB3;FGFR3;TF;PDGFRA;EGFR;GREM1
2269,GO:0004866,0.176791457996364,0.959116397997459,2,131,endopeptidase inhibitor activity,MF,SPOCK3;COL28A1
18910,GO:1901099,0.176934093621597,0.983961721043241,1,33,negative regulation of signal transduction in absence of ligand,BP,EYA2
22122,GO:2001240,0.176934093621597,0.983961721043241,1,33,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,EYA2
8830,GO:0033135,0.177001223989519,0.959084986956351,2,117,regulation of peptidyl-serine phosphorylation,BP,PLCL1;EGFR
13042,GO:0048665,0.177715335575421,0.983829595268172,1,32,neuron fate specification,BP,NKX6-2
12353,GO:0046466,0.177718358042877,0.983829025900168,1,32,membrane lipid catabolic process,BP,ENPP2
3610,GO:0007178,0.177799492791852,0.930646479681024,4,320,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LRP2;TF;PCSK6;GREM1
802,GO:0002040,0.178154346021383,0.958678834520105,2,111,sprouting angiogenesis,BP,NGFR;GREM1
7506,GO:0030855,0.178183968273917,0.915162498401867,6,572,epithelial cell differentiation,BP,FA2H;PPL;HAPLN2;PCSK6;FZD7;GREM1
18643,GO:0150115,0.178204402268363,0.958711405820451,2,100,cell-substrate junction organization,BP,GREM1;APOD
8104,GO:0031982,0.178214668802618,0.876148079346004,26,3437,vesicle,CC,BAIAP3;NGFR;BCAS1;FGFR3;LRP2;FOLH1;TF;MLC1;TUBB4A;ATP10B;PPL;CPM;GPNMB;ERMN;EGFR;GJA1;FZD7;SNX22;EDIL3;GPD1;KLK6;LGI3;MYO1D;BOK;GPR62;APOD
3630,GO:0007202,0.17829949015433,0.983719353492451,1,32,activation of phospholipase C activity,BP,EGFR
1425,GO:0003148,0.178734045598046,0.983728689257957,1,27,outflow tract septum morphogenesis,BP,LRP2
9637,GO:0035270,0.178861922442441,0.958382723827573,2,119,endocrine system development,BP,PDGFRA;NKX6-2
2099,GO:0004629,0.178926506679947,0.983714987223769,1,26,phospholipase C activity,MF,PLCL1
2635,GO:0005604,0.179364164775419,0.95828835800632,2,98,basement membrane,CC,ACAN;COL28A1
12122,GO:0045923,0.179494678546449,0.983508633923885,1,31,positive regulation of fatty acid metabolic process,BP,SLC45A3
18889,GO:1901030,0.179523293745386,0.983457754585007,1,34,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
8936,GO:0033363,0.179769460324275,0.983491921461421,1,29,secretory granule organization,BP,BAIAP3
10496,GO:0040036,0.18018317159721,0.983432938821354,1,28,regulation of fibroblast growth factor receptor signaling pathway,BP,NGFR
12496,GO:0046718,0.180664055808321,0.957705109589286,2,119,viral entry into host cell,BP,MOG;EGFR
11128,GO:0043267,0.180882371064321,0.983260862041529,1,30,negative regulation of potassium ion transport,BP,ANK3
11767,GO:0045111,0.180943868564428,0.95761097801256,2,116,intermediate filament cytoskeleton,CC,CLDN11;PPL
7542,GO:0030898,0.181139865203926,0.983376483088795,1,23,actin-dependent ATPase activity,MF,MYO1D
16100,GO:0071333,0.181182314484144,0.957513178660675,2,118,cellular response to glucose stimulus,BP,BAIAP3;GJB6
13730,GO:0051393,0.181468483962953,0.9832319779703,1,26,alpha-actinin binding,MF,LDB3
11986,GO:0045665,0.181495483392206,0.940453127023548,3,211,negative regulation of neuron differentiation,BP,NGFR;MAG;CNTN2
12996,GO:0048566,0.182152379952994,0.982998732539829,1,31,embryonic digestive tract development,BP,PDGFRA
14505,GO:0060341,0.182339661502461,0.898818910389198,9,939,regulation of cellular localization,BP,BAIAP3;NGFR;CAPN3;MLC1;BVES;TRIM67;EGFR;ANK3;APOD
13292,GO:0050680,0.182870828543467,0.95688089427722,2,116,negative regulation of epithelial cell proliferation,BP,NGFR;GJA1
6481,GO:0019318,0.182876814598575,0.939764178001757,3,226,hexose metabolic process,BP,SLC45A3;GPD1;APOD
9499,GO:0034765,0.182892102883064,0.919092473662051,5,446,regulation of ion transmembrane transport,BP,CAPN3;ANK3;KCNJ6;DAPK1;GJC2
13363,GO:0050804,0.182931724536165,0.919081474090235,5,430,modulation of chemical synaptic transmission,BP,BAIAP3;PLCL1;EGFR;CNTNAP4;CNTN2
18763,GO:1900180,0.182961331526538,0.956842521195839,2,117,regulation of protein localization to nucleus,BP,NGFR;APOD
4498,GO:0009581,0.183200832016885,0.956751383796357,2,117,detection of external stimulus,BP,NGFR;PIEZO2
66,GO:0000132,0.183269491076469,0.982799808197789,1,30,establishment of mitotic spindle orientation,BP,GJA1
20913,GO:1905477,0.183274594624874,0.956711795957564,2,120,positive regulation of protein localization to membrane,BP,EGFR;ANK3
10892,GO:0042802,0.1833285504365,0.885411963441015,14,1711,identical protein binding,MF,CLDN11;ERBB3;FGFR3;SOX10;MLC1;MAG;PDGFRA;EGFR;GREM1;GPD1;BOK;GPR62;CNTN2;DAPK1
3478,GO:0006935,0.183333646318541,0.911981004102045,6,584,chemotaxis,BP,NGFR;PDGFRA;GPNMB;ENPP2;GREM1;CNTN2
816,GO:0002063,0.183377690709834,0.982818423590991,1,28,chondrocyte development,BP,ACAN
18109,GO:0099177,0.183474225223202,0.918762451241088,5,431,regulation of trans-synaptic signaling,BP,BAIAP3;PLCL1;EGFR;CNTNAP4;CNTN2
7097,GO:0030016,0.183690853050579,0.939397125426374,3,213,myofibril,CC,CAPN3;LDB3;ANK3
13077,GO:0048706,0.183769833735045,0.956515613168555,2,122,embryonic skeletal system development,BP,PDGFRA;DMRT2
8341,GO:0032386,0.184224921355198,0.927161000497372,4,334,regulation of intracellular transport,BP,MLC1;BVES;ANK3;APOD
6699,GO:0019955,0.18461132702663,0.956190358686411,2,123,cytokine binding,MF,CRLF1;GREM1
14434,GO:0060251,0.184711097106919,0.982518112709805,1,30,regulation of glial cell proliferation,BP,SOX10
10651,GO:0042339,0.184784524149573,0.982485510949062,1,31,keratan sulfate metabolic process,BP,ACAN
10649,GO:0042330,0.185380772202361,0.910709269976081,6,586,taxis,BP,NGFR;PDGFRA;GPNMB;ENPP2;GREM1;CNTN2
16098,GO:0071331,0.185582070310333,0.955829228044847,2,120,cellular response to hexose stimulus,BP,BAIAP3;GJB6
6996,GO:0022011,0.186196789818298,0.982288856308023,1,27,myelination in peripheral nervous system,BP,FA2H
8280,GO:0032292,0.186196789818298,0.982288856308023,1,27,peripheral nervous system axon ensheathment,BP,FA2H
10724,GO:0042476,0.186300828512993,0.9555645995166,2,117,odontogenesis,BP,NGFR;PDGFRA
18525,GO:0140058,0.186651502532599,0.982223604105266,1,26,neuron projection arborization,BP,LRP2
7345,GO:0030414,0.186752215858858,0.95532766442073,2,135,peptidase inhibitor activity,MF,SPOCK3;COL28A1
11520,GO:0044283,0.186899296789618,0.909740084876234,6,636,small molecule biosynthetic process,BP,FOLH1;FA2H;PLP1;SLC45A3;GPD1;CARNS1
19534,GO:1902745,0.186947901375291,0.982096062256418,1,29,positive regulation of lamellipodium organization,BP,ENPP2
3470,GO:0006921,0.187058416476531,0.981986210339541,1,34,cellular component disassembly involved in execution phase of apoptosis,BP,BOK
3940,GO:0008236,0.187419983370154,0.955063534619934,2,137,serine-type peptidase activity,MF,PCSK6;KLK6
8080,GO:0031941,0.187460438247498,0.981955337410478,1,31,filamentous actin,CC,LDB3
1431,GO:0003158,0.187568885215746,0.955083609583165,2,115,endothelium development,BP,HAPLN2;GJA1
8989,GO:0033572,0.187719463670398,0.981839234434477,1,35,transferrin transport,BP,TF
20652,GO:1904951,0.187780133017949,0.925205722418014,4,346,positive regulation of establishment of protein localization,BP,BAIAP3;EGFR;ANK3;GJA1
16096,GO:0071326,0.188258399736398,0.954792535338372,2,121,cellular response to monosaccharide stimulus,BP,BAIAP3;GJB6
12774,GO:0048011,0.188462754525247,0.98175455972722,1,31,neurotrophin TRK receptor signaling pathway,BP,NGFR
17331,GO:0090659,0.189396975543779,0.981605878131917,1,29,walking behavior,BP,CNTN2
4499,GO:0009582,0.189490859206696,0.954317451723735,2,120,detection of abiotic stimulus,BP,NGFR;PIEZO2
5456,GO:0015672,0.189709338202193,0.915052529405235,5,467,monovalent inorganic cation transport,BP,NKAIN1;ANK3;KCNJ6;SLC5A11;NKAIN2
722,GO:0001936,0.189723494000438,0.954230780229242,2,119,regulation of endothelial cell proliferation,BP,NGFR;GJA1
7375,GO:0030507,0.189950698968461,0.98153973182385,1,27,spectrin binding,MF,ANK3
4603,GO:0009954,0.189955047186408,0.981418480717556,1,33,proximal/distal pattern formation,BP,GREM1
18158,GO:0099536,0.189970837964163,0.902187395052543,7,688,synaptic signaling,BP,BAIAP3;PLCL1;PLP1;EGFR;CNTNAP4;CNTN2;MBP
6594,GO:0019725,0.190571225789275,0.897094658741345,8,871,cellular homeostasis,BP,BAIAP3;NGFR;TF;CAPN3;GJB6;PDGFRA;GJA1;BOK
683,GO:0001881,0.190739913873755,0.981293964594253,1,31,receptor recycling,BP,BVES
397,GO:0001101,0.191223109519508,0.953636817971081,2,121,response to acid chemical,BP,PDGFRA;EGFR
9649,GO:0035296,0.191498167595504,0.953510161279637,2,126,regulation of tube diameter,BP,EGFR;GJA1
17733,GO:0097746,0.191498167595504,0.953510161279637,2,126,regulation of blood vessel diameter,BP,EGFR;GJA1
2414,GO:0005125,0.191794556072993,0.953292511988527,2,162,cytokine activity,MF,CRLF1;GREM1
20188,GO:1904031,0.191993224190014,0.981002131835101,1,33,positive regulation of cyclin-dependent protein kinase activity,BP,EGFR
4632,GO:0010039,0.192293625614305,0.980957685795842,1,32,response to iron ion,BP,TF
15871,GO:0070884,0.192331931529373,0.980968273987262,1,31,regulation of calcineurin-NFAT signaling cascade,BP,ERBB3
8314,GO:0032355,0.192427667960894,0.95313768373105,2,128,response to estradiol,BP,EGFR;GJA1
17927,GO:0098868,0.19243989743617,0.980946076859807,1,31,bone growth,BP,FGFR3
14995,GO:0061135,0.192569097807816,0.95304624657515,2,139,endopeptidase regulator activity,MF,SPOCK3;COL28A1
9590,GO:0035150,0.192883153057071,0.952961777415155,2,127,regulation of tube size,BP,EGFR;GJA1
5801,GO:0016339,0.193240385685193,0.980822217115934,1,29,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,CDH19
15538,GO:0070252,0.193308456131348,0.952860021174078,2,111,actin-mediated cell contraction,BP,GJA1;SGCD
1546,GO:0003338,0.193402393564824,0.980747576724448,1,31,metanephros morphogenesis,BP,GREM1
41,GO:0000083,0.193602616343706,0.980653317407021,1,34,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,CDK18
16545,GO:0072089,0.194238203289242,0.952469967062073,2,116,stem cell proliferation,BP,SOX10;GJA1
15348,GO:0062013,0.194415384331318,0.952374924556109,2,122,positive regulation of small molecule metabolic process,BP,SLC45A3;GPD1
6740,GO:0021522,0.195031853131262,0.980355385673208,1,34,spinal cord motor neuron differentiation,BP,NKX6-2
6222,GO:0017171,0.195055566510697,0.95205886652711,2,140,serine hydrolase activity,MF,PCSK6;KLK6
12333,GO:0046434,0.195128207523837,0.95205548891314,2,132,organophosphate catabolic process,BP,ENPP2;GPD1
17061,GO:0090101,0.195180200973089,0.952092129383633,2,117,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LRP2;GREM1
11561,GO:0044344,0.19531401295129,0.952018272899115,2,122,cellular response to fibroblast growth factor stimulus,BP,NGFR;FGFR3
17216,GO:0090313,0.195474089804476,0.980262701253207,1,34,regulation of protein targeting to membrane,BP,ANK3
13353,GO:0050790,0.195520731115024,0.871363079744847,17,2100,regulation of catalytic activity,BP,NGFR;ERBB3;FGFR3;TF;CAPN3;BVES;PDGFRA;PCSK6;EGFR;ST18;GREM1;MYO1D;BOK;SPOCK3;DAPK1;MBP;COL28A1
784,GO:0002020,0.195655586325222,0.951882417685738,2,122,protease binding,MF,ADAMTS4;MBP
735,GO:0001952,0.195873432509409,0.951829828001087,2,114,regulation of cell-matrix adhesion,BP,GREM1;APOD
4437,GO:0009268,0.195939208850081,0.980133915545057,1,36,response to pH,BP,GJA1
17719,GO:0097718,0.196085670510708,0.980208802543591,1,30,disordered domain specific binding,MF,GJA1
7809,GO:0031399,0.196275528440435,0.87579868677907,14,1659,regulation of protein modification process,BP,CRLF1;ERBB3;FGFR3;TF;CAPN3;PLCL1;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;GREM1;KNDC1;GJC2
7132,GO:0030072,0.196574073329396,0.933055338017465,3,233,peptide hormone secretion,BP,BAIAP3;EGFR;GJA1
5876,GO:0016504,0.196778044297771,0.979942341599324,1,37,peptidase activator activity,MF,MAL
11142,GO:0043292,0.196810070189655,0.932956412495864,3,223,contractile fiber,CC,CAPN3;LDB3;ANK3
6844,GO:0021696,0.197069979661618,0.980001688478838,1,30,cerebellar cortex morphogenesis,BP,KNDC1
17956,GO:0098901,0.197283800538531,0.980027963343242,1,27,regulation of cardiac muscle cell action potential,BP,ANK3
21602,GO:2000279,0.197771114966856,0.979794753951242,1,33,negative regulation of DNA biosynthetic process,BP,GJA1
10196,GO:0036314,0.1983786327784,0.979746928969808,1,29,response to sterol,BP,MLC1
14030,GO:0051973,0.19849642442626,0.979606575420217,1,35,positive regulation of telomerase activity,BP,GREM1
14491,GO:0060325,0.198503508615939,0.979697966145066,1,30,face morphogenesis,BP,PDGFRA
18350,GO:0106056,0.198738762377127,0.979607136345355,1,32,regulation of calcineurin-mediated signaling,BP,ERBB3
14941,GO:0061041,0.199057188276721,0.950501177657206,2,127,regulation of wound healing,BP,PDGFRA;GJA1
15387,GO:0065007,0.199092644159477,0.857222418988703,71,10303,biological regulation,BP,CRLF1;BAIAP3;ANLN;STMN4;NGFR;EYA2;ERBB3;FGFR3;DCX;LRP2;NKAIN1;TF;CAPN3;SOX10;MLC1;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;CDK18;ATP10B;TRIM67;GJB6;PLP1;MYRF;RPS4Y1;PDGFRA;GPNMB;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;TMSB15A;SLC45A3;EDIL3;CTHRC1;GREM1;GPD1;KLK6;LGI3;SGCD;KNDC1;MAL;DMRT2;SUSD5;MYO1D;BOK;GPR62;CNTN2;ANKS1B;NKAIN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
7703,GO:0031225,0.199138820676814,0.950423898762778,2,140,anchored component of membrane,CC,CPM;CNTN2
12551,GO:0046883,0.199672749000737,0.931495438183697,3,239,regulation of hormone secretion,BP,BAIAP3;EGFR;GJA1
694,GO:0001893,0.199733850399218,0.979341260846461,1,35,maternal placenta development,BP,GJA1
13594,GO:0051154,0.199978653170605,0.979305187344725,1,34,negative regulation of striated muscle cell differentiation,BP,FZD7
14025,GO:0051968,0.199998135936119,0.979357360457249,1,31,positive regulation of synaptic transmission, glutamatergic,BP,EGFR
242,GO:0000578,0.200278895175783,0.979223810115397,1,35,embryonic axis specification,BP,PCSK6
9315,GO:0034405,0.200374282434195,0.979256456224337,1,32,response to fluid shear stress,BP,GJA1
18414,GO:0110111,0.200444475294536,0.979241333412792,1,32,negative regulation of animal organ morphogenesis,BP,GREM1
21083,GO:1905898,0.200528249715371,0.979154162772448,1,36,positive regulation of response to endoplasmic reticulum stress,BP,BOK
17760,GO:0098552,0.200679609579712,0.908442172615688,5,493,side of membrane,CC,CRLF1;LRP2;TF;PDGFRA;MOG
4573,GO:0009855,0.200936989657575,0.94975337508454,2,124,determination of bilateral symmetry,BP,PCSK6;GREM1
3354,GO:0006734,0.202391213561512,0.978733918899497,1,37,NADH metabolic process,BP,GPD1
4564,GO:0009799,0.202537150523699,0.949099149379491,2,125,specification of symmetry,BP,PCSK6;GREM1
5116,GO:0014044,0.203007463785637,0.978727573227394,1,30,Schwann cell development,BP,FA2H
5380,GO:0015293,0.203027964826386,0.948911296185694,2,122,symporter activity,MF,SLC45A3;SLC5A11
3963,GO:0008277,0.2034285160935,0.948716128559572,2,130,regulation of G protein-coupled receptor signaling pathway,BP,KLK6;CNTN2
19518,GO:1902692,0.20374632495825,0.978543933465729,1,31,regulation of neuroblast proliferation,BP,SOX10
3377,GO:0006775,0.203755636291194,0.978419786752288,1,38,fat-soluble vitamin metabolic process,BP,LRP2
4755,GO:0010543,0.204084808950908,0.978429322286272,1,33,regulation of platelet activation,BP,PDGFRA
16143,GO:0071392,0.204367932816476,0.978331162540607,1,35,cellular response to estradiol stimulus,BP,EGFR
17056,GO:0090092,0.204381618618072,0.929135345525542,3,229,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LRP2;PCSK6;GREM1
21699,GO:2000404,0.204606393777683,0.97821778023719,1,39,regulation of T cell migration,BP,APOD
16947,GO:0086019,0.20504102203081,0.978305319543765,1,29,cell-cell signaling involved in cardiac conduction,BP,GJA1
17116,GO:0090184,0.20504244307818,0.978181959324531,1,35,positive regulation of kidney development,BP,GREM1
4902,GO:0010765,0.205404236008124,0.978137860543617,1,33,positive regulation of sodium ion transport,BP,ANK3
21597,GO:2000273,0.205552699192939,0.978086292697522,1,34,positive regulation of signaling receptor activity,BP,GREM1
1116,GO:0002548,0.206297063858803,0.977759140887795,1,46,monocyte chemotaxis,BP,GREM1
71,GO:0000146,0.20665596074852,0.978031969517486,1,26,microfilament motor activity,MF,MYO1D
2741,GO:0005790,0.206772666079534,0.97785337431276,1,32,smooth endoplasmic reticulum,CC,MYO1D
10353,GO:0038084,0.206796170914609,0.977809215866214,1,34,vascular endothelial growth factor signaling pathway,BP,PDGFRA
15548,GO:0070266,0.207473200278264,0.977622756683975,1,36,necroptotic process,BP,BOK
16094,GO:0071322,0.207505104481021,0.947042085895202,2,129,cellular response to carbohydrate stimulus,BP,BAIAP3;GJB6
13286,GO:0050673,0.207518892201684,0.914123826616545,4,355,epithelial cell proliferation,BP,NGFR;EGFR;GJA1;FZD7
3590,GO:0007156,0.207987211249903,0.946962947023681,2,104,homophilic cell adhesion via plasma membrane adhesion molecules,BP,CDH19;CNTN2
13389,GO:0050850,0.208270555611917,0.977411790323087,1,38,positive regulation of calcium-mediated signaling,BP,ERBB3
12434,GO:0046621,0.208509288395369,0.97744357223481,1,33,negative regulation of organ growth,BP,GJA1
4642,GO:0010092,0.208616991845156,0.977381981734139,1,35,specification of animal organ identity,BP,LRP2
16375,GO:0071774,0.208748784556087,0.946533670991015,2,127,response to fibroblast growth factor,BP,NGFR;FGFR3
18701,GO:1900087,0.208927922891842,0.977294514682245,1,36,positive regulation of G1/S transition of mitotic cell cycle,BP,EGFR
19196,GO:1901889,0.20928707091497,0.97728834555696,1,32,negative regulation of cell junction assembly,BP,APOD
13835,GO:0051602,0.209295522156514,0.977194889024876,1,37,response to electrical stimulus,BP,GJB6
12954,GO:0048487,0.209887470706573,0.97706022007442,1,37,beta-tubulin binding,MF,GJB6
12028,GO:0045746,0.21036379147052,0.976951543753072,1,37,negative regulation of Notch signaling pathway,BP,EGFR
5443,GO:0015631,0.210589811373315,0.912380561068379,4,336,tubulin binding,MF,STMN4;DCX;GJB6;GJA1
16245,GO:0071548,0.210866804857593,0.976805990948215,1,39,response to dexamethasone,BP,EGFR
5779,GO:0016301,0.211108432821857,0.888170182286111,7,680,kinase activity,MF,ERBB3;FGFR3;CDK18;PDGFRA;EGFR;PHKG1;DAPK1
20512,GO:1904707,0.21155574406851,0.976731174167294,1,34,positive regulation of vascular associated smooth muscle cell proliferation,BP,GJA1
15113,GO:0061448,0.211679387509664,0.925379241024322,3,236,connective tissue development,BP,FGFR3;ACAN;GREM1
8573,GO:0032722,0.212015136688232,0.976541798563177,1,39,positive regulation of chemokine production,BP,MBP
13704,GO:0051346,0.212246418819129,0.911377852829183,4,377,negative regulation of hydrolase activity,BP,NGFR;MYO1D;SPOCK3;COL28A1
13663,GO:0051281,0.21236230552629,0.976476656717432,1,38,positive regulation of release of sequestered calcium ion into cytosol,BP,CAPN3
13610,GO:0051180,0.212402102892071,0.976483331629198,1,37,vitamin transport,BP,LRP2
7405,GO:0030551,0.212491050632824,0.97653597307479,1,33,cyclic nucleotide binding,MF,BVES
13674,GO:0051294,0.212512861865801,0.976492248989154,1,35,establishment of spindle orientation,BP,GJA1
17033,GO:0090066,0.213068793993514,0.900844546783877,5,472,regulation of anatomical structure size,BP,MAG;EGFR;GJA1;TMSB15A;CNTN2
5803,GO:0016342,0.213488154618384,0.976349749639537,1,31,catenin complex,CC,CDH19
13147,GO:0048863,0.213873525577831,0.924218422418065,3,248,stem cell differentiation,BP,SOX10;PDGFRA;GREM1
21585,GO:2000249,0.214073487173924,0.976064166174199,1,39,regulation of actin cytoskeleton reorganization,BP,PDGFRA
7316,GO:0030336,0.214199193616196,0.924067063138779,3,238,negative regulation of cell migration,BP,GJA1;GREM1;APOD
11588,GO:0044409,0.214530142499004,0.944089762247183,2,131,entry into host,BP,MOG;EGFR
13083,GO:0048713,0.214798754888213,0.975894621870153,1,39,regulation of oligodendrocyte differentiation,BP,SLC45A3
11204,GO:0043394,0.215133667505544,0.975922852158723,1,33,proteoglycan binding,MF,GPNMB
17580,GO:0097386,0.215185577861655,0.97591072202198,1,33,glial cell projection,CC,MLC1
17515,GO:0097242,0.215577240867023,0.975819092989275,1,33,amyloid-beta clearance,BP,LRP2
7775,GO:0031333,0.215623801510729,0.943633375932796,2,129,negative regulation of protein-containing complex assembly,BP,TUBB4A;TMSB15A
10475,GO:0040001,0.216235303239817,0.97562465079085,1,35,establishment of mitotic spindle localization,BP,GJA1
11708,GO:0044877,0.216337010991394,0.871347438850741,10,1116,protein-containing complex binding,MF,MLC1;GJB6;PDGFRA;GPNMB;ERMN;EGFR;ANK3;EDIL3;MYO1D;BOK
15389,GO:0065009,0.21639159617922,0.85001492318065,21,2700,regulation of molecular function,BP,NGFR;ERBB3;FGFR3;TF;CAPN3;BVES;PLCL1;PDGFRA;PCSK6;EGFR;ST18;ANK3;GJA1;CTHRC1;GREM1;MYO1D;BOK;SPOCK3;DAPK1;MBP;COL28A1
10477,GO:0040008,0.216657674477445,0.890702620469482,6,610,regulation of growth,BP,FGFR3;CAPN3;MAG;EGFR;GJA1;GREM1
11452,GO:0044060,0.21695027266835,0.975372910868867,1,40,regulation of endocrine process,BP,GJA1
8446,GO:0032506,0.217036361755713,0.975367431592538,1,39,cytokinetic process,BP,ANLN
22138,GO:2001258,0.217378333240452,0.975257091234123,1,41,negative regulation of cation channel activity,BP,ANK3
3732,GO:0007435,0.217444564287228,0.975339116695293,1,35,salivary gland morphogenesis,BP,EGFR
5010,GO:0010907,0.218309045982391,0.97517471354558,1,33,positive regulation of glucose metabolic process,BP,SLC45A3
13458,GO:0050931,0.218583295873053,0.975088441885926,1,34,pigment cell differentiation,BP,SOX10
10974,GO:0043009,0.218726324695714,0.88934774548177,6,601,chordate embryonic development,BP,LRP2;SOX10;PDGFRA;EGFR;CTHRC1;DMRT2
14305,GO:0060048,0.218899108858565,0.942241393728719,2,127,cardiac muscle contraction,BP,GJA1;SGCD
11795,GO:0045165,0.219143600779708,0.921464553815753,3,244,cell fate commitment,BP,EYA2;NKX6-2;FZD7
10326,GO:0038023,0.219395885717885,0.877262181146588,8,905,signaling receptor activity,MF,CRLF1;NGFR;ERBB3;FGFR3;PDGFRA;EGFR;FZD7;GPR62
14342,GO:0060089,0.219395885717885,0.877262181146588,8,905,molecular transducer activity,MF,CRLF1;NGFR;ERBB3;FGFR3;PDGFRA;EGFR;FZD7;GPR62
12295,GO:0046330,0.219525084861154,0.941963561748128,2,129,positive regulation of JNK cascade,BP,TF;FZD7
14489,GO:0060323,0.219538719496859,0.974840346668156,1,35,head morphogenesis,BP,PDGFRA
2862,GO:0005996,0.220250992552518,0.920865371089882,3,252,monosaccharide metabolic process,BP,SLC45A3;GPD1;APOD
2394,GO:0005088,0.220389118346895,0.941668320618206,2,113,Ras guanyl-nucleotide exchange factor activity,MF,RAPGEF5;KNDC1
10853,GO:0042743,0.220407350221617,0.974435823684349,1,49,hydrogen peroxide metabolic process,BP,EGFR
11131,GO:0043270,0.220436813840825,0.920767092128461,3,252,positive regulation of ion transport,BP,CAPN3;ANK3;GJC2
4161,GO:0008610,0.220731128267826,0.888004847481391,6,639,lipid biosynthetic process,BP,FA2H;PLP1;GAL3ST1;SLC45A3;GPD1;UGT8
10632,GO:0042304,0.221518207850648,0.974277207712479,1,40,regulation of fatty acid biosynthetic process,BP,SLC45A3
5082,GO:0012505,0.221765625699933,0.838612635553579,30,4056,endomembrane system,CC,BAIAP3;STMN4;NGFR;FGFR3;LRP2;TF;MLC1;FA2H;ATP10B;MYRF;GAL3ST1;PDGFRA;GPNMB;PCSK6;EGFR;ANK3;GJA1;FZD7;KCNJ6;ACAN;KLK6;LGI3;GJB1;SGCD;MAL;MYO1D;BOK;GPR62;APOD;COL28A1
7411,GO:0030574,0.222013172455418,0.974172537804593,1,39,collagen catabolic process,BP,KLK6
18887,GO:1901028,0.223030038340247,0.973852952458088,1,44,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
579,GO:0001738,0.223031908491255,0.940401354837323,2,140,morphogenesis of a polarized epithelium,BP,FZD7;CTHRC1
5656,GO:0016055,0.223108409042312,0.894537613778727,5,485,Wnt signaling pathway,BP,SOX10;EGFR;FZD7;CTHRC1;GREM1
19727,GO:1903169,0.223566167996193,0.940175827033497,2,138,regulation of calcium ion transmembrane transport,BP,CAPN3;GJC2
10413,GO:0038179,0.223697231603631,0.973795495696647,1,37,neurotrophin signaling pathway,BP,NGFR
19950,GO:1903580,0.22403987837297,0.973693820870099,1,38,positive regulation of ATP metabolic process,BP,GPD1
531,GO:0001662,0.224138915778756,0.973652732464084,1,39,behavioral fear response,BP,GJA1
6447,GO:0019216,0.224259350082766,0.9043452633696,4,369,regulation of lipid metabolic process,BP,FGFR3;PDGFRA;SLC45A3;APOD
721,GO:0001935,0.224309055834542,0.939866903356918,2,134,endothelial cell proliferation,BP,NGFR;GJA1
4466,GO:0009395,0.224796838864493,0.973459459481293,1,41,phospholipid catabolic process,BP,ENPP2
21624,GO:2000310,0.224912648771226,0.973556455074625,1,34,regulation of NMDA receptor activity,BP,DAPK1
18653,GO:0198738,0.22539973666563,0.893082999943464,5,487,cell-cell signaling by wnt,BP,SOX10;EGFR;FZD7;CTHRC1;GREM1
18372,GO:0106106,0.225434179639083,0.93937004021229,2,135,cold-induced thermogenesis,BP,PLCL1;GJA1
18480,GO:0120161,0.225434179639083,0.93937004021229,2,135,regulation of cold-induced thermogenesis,BP,PLCL1;GJA1
16333,GO:0071675,0.22567851854934,0.973199373279821,1,44,regulation of mononuclear cell migration,BP,GREM1
10783,GO:0042592,0.225975529820863,0.853198064502999,14,1727,homeostatic process,BP,BAIAP3;NGFR;TF;CAPN3;FA2H;PLCL1;GJB6;PDGFRA;EGFR;ANK3;GJA1;SGCD;BOK;MBP
12158,GO:0045981,0.226018255574108,0.973223465048358,1,37,positive regulation of nucleotide metabolic process,BP,GPD1
18850,GO:1900544,0.226018255574108,0.973223465048358,1,37,positive regulation of purine nucleotide metabolic process,BP,GPD1
7228,GO:0030216,0.22617855526083,0.93902368287468,2,140,keratinocyte differentiation,BP,PPL;PCSK6
3660,GO:0007257,0.226524664130142,0.973116808522164,1,36,activation of JUN kinase activity,BP,TF
10894,GO:0042805,0.226560375352817,0.973128084885328,1,35,actinin binding,MF,LDB3
17537,GO:0097300,0.226608113619206,0.973010077929784,1,41,programmed necrotic cell death,BP,BOK
17220,GO:0090317,0.226613965658591,0.973008619332359,1,41,negative regulation of intracellular protein transport,BP,APOD
3920,GO:0008201,0.226677920853413,0.938807585323479,2,139,heparin binding,MF,GPNMB;PCSK6
6194,GO:0017124,0.22676977016925,0.938817002945128,2,127,SH3 domain binding,MF,LRP2;GJA1
18537,GO:0140096,0.226789980299603,0.848680817743854,16,1923,catalytic activity, acting on a protein,MF,EYA2;ERBB3;FGFR3;FOLH1;CAPN3;CDK18;MYRF;PDGFRA;CPM;PCSK6;EGFR;CNDP1;ADAMTS4;PHKG1;KLK6;DAPK1
10616,GO:0042277,0.227151401855906,0.917162076911922,3,266,peptide binding,MF,NGFR;FOLH1;PEX5L
21534,GO:2000147,0.227189936889704,0.89194131054771,5,490,positive regulation of cell motility,BP,TF;PDGFRA;GPNMB;ENPP2;EGFR
16116,GO:0071354,0.227777171378347,0.97278546311558,1,37,cellular response to interleukin-6,BP,ST18
14351,GO:0060119,0.227951642934311,0.972741804311966,1,37,inner ear receptor cell development,BP,CTHRC1
12022,GO:0045740,0.22853983294423,0.972558548336043,1,39,positive regulation of DNA replication,BP,EGFR
10583,GO:0042176,0.228898368873503,0.901580256863144,4,369,regulation of protein catabolic process,BP,LRP2;TRIM67;EGFR;GJA1
10346,GO:0038061,0.229206148064024,0.937634021246104,2,155,NIK/NF-kappaB signaling,BP,EGFR;GREM1
8572,GO:0032720,0.229223477547169,0.972297620374063,1,45,negative regulation of tumor necrosis factor production,BP,GPNMB
6456,GO:0019228,0.229342424287515,0.972454439749532,1,34,neuronal action potential,BP,ANK3
14016,GO:0051959,0.2296757335995,0.972569611182749,1,27,dynein light intermediate chain binding,MF,DNAH17
13039,GO:0048662,0.230005209066064,0.972126443649632,1,43,negative regulation of smooth muscle cell proliferation,BP,APOD
16357,GO:0071709,0.230116456743782,0.972196901304516,1,37,membrane assembly,BP,ANK3
19095,GO:1901618,0.230257265792988,0.972092153528579,1,41,organic hydroxy compound transmembrane transporter activity,MF,SLC5A11
14902,GO:0060986,0.230523152600662,0.972009364110668,1,42,endocrine hormone secretion,BP,GJA1
736,GO:0001953,0.230853900639658,0.972050626341842,1,35,negative regulation of cell-matrix adhesion,BP,APOD
6648,GO:0019843,0.231054712275381,0.971708813070284,1,57,rRNA binding,MF,RPS4Y1
18660,GO:1900015,0.231059533481968,0.971904177464427,1,40,regulation of cytokine production involved in inflammatory response,BP,APOD
8785,GO:0033036,0.231282716367432,0.836937702432059,22,2853,macromolecule localization,BP,BAIAP3;NGFR;LRP2;TF;CAPN3;MLC1;PEX5L;ATP10B;TRIM67;RPS4Y1;EGFR;ANK3;GJA1;SNX22;TMSB15A;SGCD;MAL;UGT8;MYO1D;CNTN2;ANKS1B;APOD
19136,GO:1901682,0.231331319651274,0.971869701776768,1,38,sulfur compound transmembrane transporter activity,MF,GJA1
8481,GO:0032570,0.231384717166941,0.971789781483599,1,42,response to progesterone,BP,SOX10
11516,GO:0044275,0.231389086652521,0.971854982209915,1,38,cellular carbohydrate catabolic process,BP,PHKG1
905,GO:0002209,0.231868686552374,0.971697648656562,1,40,behavioral defense response,BP,GJA1
10967,GO:0043001,0.232128757562451,0.971666133728633,1,38,Golgi to plasma membrane protein transport,BP,ANK3
22121,GO:2001239,0.232180721373368,0.971557248101538,1,44,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,EYA2
6789,GO:0021587,0.232232214831336,0.971678644202845,1,36,cerebellum morphogenesis,BP,KNDC1
10679,GO:0042398,0.232553448585304,0.971448000580713,1,45,cellular modified amino acid biosynthetic process,BP,CARNS1
16822,GO:0072595,0.232951164508098,0.971403706771549,1,41,maintenance of protein localization in organelle,BP,GJA1
11901,GO:0045505,0.233030612559076,0.971687422261086,1,28,dynein intermediate chain binding,MF,DNAH17
10383,GO:0038127,0.2330318321079,0.936009881970949,2,132,ERBB signaling pathway,BP,ERBB3;EGFR
7760,GO:0031312,0.233317063238568,0.97130948802495,1,41,extrinsic component of organelle membrane,CC,SOX10
4302,GO:0009100,0.233494054596601,0.898815943635802,4,369,glycoprotein metabolic process,BP,GAL3ST1;PCSK6;ACAN;SPOCK3
11807,GO:0045184,0.233858628367319,0.844983670969903,15,1898,establishment of protein localization,BP,BAIAP3;NGFR;LRP2;TF;MLC1;PEX5L;RPS4Y1;EGFR;ANK3;GJA1;SNX22;MAL;MYO1D;CNTN2;APOD
7208,GO:0030195,0.233890823183644,0.971116459064204,1,44,negative regulation of blood coagulation,BP,PDGFRA
13892,GO:0051716,0.234064266746672,0.823762450745203,44,6196,cellular response to stimulus,BP,CRLF1;BAIAP3;NGFR;EYA2;ERBB3;FGFR3;DCX;LRP2;TF;CAPN3;SOX10;MLC1;MAG;PEX5L;PLCL1;TRIM67;GJB6;PLP1;PDGFRA;GPNMB;RAPGEF5;MOG;PCSK6;EGFR;ST18;ANK3;GJA1;PIEZO2;FZD7;CTHRC1;GREM1;GPD1;KLK6;SGCD;KNDC1;MAL;SUSD5;BOK;GPR62;CNTN2;ANKS1B;APOD;DAPK1;MBP
13483,GO:0050999,0.234449625014319,0.970985968370947,1,43,regulation of nitric-oxide synthase activity,BP,EGFR
10787,GO:0042596,0.23471181875234,0.970948777655369,1,41,fear response,BP,GJA1
7660,GO:0031111,0.235782840670741,0.970742551793496,1,37,negative regulation of microtubule polymerization or depolymerization,BP,TUBB4A
691,GO:0001890,0.236422584648005,0.93443806716282,2,142,placenta development,BP,EGFR;GJA1
19934,GO:1903556,0.236767900509006,0.970326304841102,1,47,negative regulation of tumor necrosis factor superfamily cytokine production,BP,GPNMB
442,GO:0001508,0.236796128788885,0.934328634682959,2,128,action potential,BP,ANK3;GJA1
13826,GO:0051592,0.236865232329385,0.934257129973459,2,137,response to calcium ion,BP,CAPN3;EGFR
3731,GO:0007431,0.237000971012182,0.970386100814179,1,39,salivary gland development,BP,EGFR
11989,GO:0045668,0.237115044015593,0.970321443026456,1,41,negative regulation of osteoblast differentiation,BP,GREM1
9402,GO:0034614,0.237592593313635,0.933869802301335,2,152,cellular response to reactive oxygen species,BP,PDGFRA;EGFR
4561,GO:0009792,0.237628840996838,0.876701557814521,6,618,embryo development ending in birth or egg hatching,BP,LRP2;SOX10;PDGFRA;EGFR;CTHRC1;DMRT2
5429,GO:0015485,0.237808813723262,0.970122746832793,1,42,cholesterol binding,MF,APOD
7216,GO:0030204,0.237870579626383,0.970176530828779,1,38,chondroitin sulfate metabolic process,BP,SPOCK3
8855,GO:0033173,0.238009344332184,0.970121121828821,1,39,calcineurin-NFAT signaling cascade,BP,ERBB3
7819,GO:0031410,0.238100162059558,0.838005292303755,17,2189,cytoplasmic vesicle,CC,BAIAP3;NGFR;FGFR3;LRP2;TF;MLC1;ATP10B;GPNMB;EGFR;GJA1;FZD7;SNX22;KLK6;LGI3;MYO1D;BOK;GPR62
18681,GO:1900047,0.238561204618303,0.969879441872321,1,45,negative regulation of hemostasis,BP,PDGFRA
7773,GO:0031331,0.238815501611268,0.895592454075615,4,362,positive regulation of cellular catabolic process,BP,LRP2;TRIM67;GPD1;DAPK1
6884,GO:0021795,0.239186221426077,0.969829295987437,1,38,cerebral cortex cell migration,BP,EGFR
2766,GO:0005840,0.239968215155868,0.932628703082944,2,216,ribosome,CC,RPS4Y1;APOD
2383,GO:0005048,0.240043993374421,0.969546894341628,1,41,signal sequence binding,MF,PEX5L
16533,GO:0072073,0.240790858264909,0.932485415229178,2,132,kidney epithelium development,BP,CRLF1;GREM1
17925,GO:0098862,0.240843572588847,0.932443346659692,2,136,cluster of actin-based cell projections,CC,LRP2;MYO1D
13587,GO:0051147,0.240866334116552,0.932404064641037,2,143,regulation of muscle cell differentiation,BP,FZD7;GREM1
17715,GO:0097708,0.240935978290915,0.835735897101361,17,2193,intracellular vesicle,CC,BAIAP3;NGFR;FGFR3;LRP2;TF;MLC1;ATP10B;GPNMB;EGFR;GJA1;FZD7;SNX22;KLK6;LGI3;MYO1D;BOK;GPR62
3437,GO:0006875,0.241056740225712,0.88296992551915,5,523,cellular metal ion homeostasis,BP,TF;CAPN3;PDGFRA;GJA1;BOK
3504,GO:0006979,0.241430477486765,0.893942210369505,4,407,response to oxidative stress,BP,PDGFRA;EGFR;APOD;DAPK1
7602,GO:0031018,0.242230012300902,0.968928765921152,1,43,endocrine pancreas development,BP,NKX6-2
7066,GO:0022898,0.242244822664447,0.908926371727431,3,253,regulation of transmembrane transporter activity,BP,ANK3;GJA1;DAPK1
22126,GO:2001244,0.24226859338452,0.968791237523967,1,53,positive regulation of intrinsic apoptotic signaling pathway,BP,BOK
4598,GO:0009948,0.242877509687258,0.968723953239339,1,45,anterior/posterior axis specification,BP,PCSK6
19587,GO:1902895,0.24318924519905,0.968720703200199,1,40,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,NGFR
17979,GO:0098927,0.243340316353689,0.968679866111763,1,40,vesicle-mediated transport between endosomal compartments,BP,MYO1D
15807,GO:0070741,0.243407331604531,0.968643896591218,1,41,response to interleukin-6,BP,ST18
11217,GO:0043408,0.243575953636019,0.872633477238135,6,644,regulation of MAPK cascade,BP,FGFR3;TF;PDGFRA;GPNMB;EGFR;FZD7
9784,GO:0035567,0.243869893667881,0.931001272603501,2,147,non-canonical Wnt signaling pathway,BP,FZD7;CTHRC1
16493,GO:0072006,0.24404977823392,0.930980870442832,2,132,nephron development,BP,PDGFRA;GREM1
19829,GO:1903364,0.24405146498174,0.930936541711118,2,142,positive regulation of cellular protein catabolic process,BP,LRP2;TRIM67
6785,GO:0021575,0.244250105743457,0.968452204480774,1,39,hindbrain morphogenesis,BP,KNDC1
13375,GO:0050819,0.245006378177314,0.968117186706417,1,47,negative regulation of coagulation,BP,PDGFRA
1106,GO:0002534,0.245033164141087,0.968168529516067,1,43,cytokine production involved in inflammatory response,BP,APOD
21583,GO:2000242,0.245081735058458,0.968096576022829,1,47,negative regulation of reproductive process,BP,GJA1
7516,GO:0030866,0.245328655015105,0.968178764331273,1,38,cortical actin cytoskeleton organization,BP,ANLN
3181,GO:0006518,0.245340954392093,0.871381931528406,6,728,peptide metabolic process,BP,RPS4Y1;CPM;PCSK6;EGFR;CARNS1;DAPK1
5606,GO:0015935,0.245699433636526,0.967719185058781,1,70,small ribosomal subunit,CC,RPS4Y1
3236,GO:0006575,0.24573483869157,0.930081735247548,2,162,cellular modified amino acid metabolic process,BP,FOLH1;CARNS1
12089,GO:0045861,0.245944245506138,0.906804906669755,3,283,negative regulation of proteolysis,BP,NGFR;SPOCK3;COL28A1
13522,GO:0051048,0.246130805969425,0.929916373131584,2,156,negative regulation of secretion,BP,ERBB3;GJA1
13659,GO:0051272,0.246480227949901,0.879426646548952,5,505,positive regulation of cellular component movement,BP,TF;PDGFRA;GPNMB;ENPP2;EGFR
6215,GO:0017158,0.246579854446062,0.967778769869111,1,41,regulation of calcium ion-dependent exocytosis,BP,BAIAP3
19554,GO:1902808,0.247204514055812,0.96755671671794,1,44,positive regulation of cell cycle G1/S phase transition,BP,EGFR
3987,GO:0008307,0.247729049047021,0.967480661548033,1,40,structural constituent of muscle,MF,CAPN3
19592,GO:1902904,0.248602935833825,0.928831664601641,2,137,negative regulation of supramolecular fiber organization,BP,TUBB4A;TMSB15A
6581,GO:0019674,0.249559506166823,0.966872864224797,1,46,NAD metabolic process,BP,GPD1
13734,GO:0051403,0.249804745556207,0.904670297100683,3,259,stress-activated MAPK cascade,BP,TF;EGFR;FZD7
478,GO:0001558,0.249899236321177,0.888728985126001,4,383,regulation of cell growth,BP,MAG;EGFR;GJA1;GREM1
21401,GO:1990845,0.249979702194921,0.92815314405823,2,144,adaptive thermogenesis,BP,PLCL1;GJA1
16197,GO:0071470,0.250231454706658,0.966748917449887,1,42,cellular response to osmotic stress,BP,CAPN3
22118,GO:2001236,0.250456863260935,0.927900433898345,2,151,regulation of extrinsic apoptotic signaling pathway,BP,EYA2;MAL
14708,GO:0060627,0.250503838212052,0.876765610957756,5,507,regulation of vesicle-mediated transport,BP,BAIAP3;TF;BVES;GREM1;LGI3
13705,GO:0051347,0.250674557613217,0.867751498403475,6,637,positive regulation of transferase activity,BP,ERBB3;FGFR3;TF;PDGFRA;EGFR;GREM1
6084,GO:0016879,0.250792407327056,0.966574662728837,1,43,ligase activity, forming carbon-nitrogen bonds,MF,CARNS1
5252,GO:0015026,0.250933647468338,0.966552246053517,1,42,coreceptor activity,MF,NGFR
13475,GO:0050982,0.251203196407462,0.966513673048822,1,40,detection of mechanical stimulus,BP,PIEZO2
3767,GO:0007566,0.251296995672243,0.966385689241753,1,46,embryo implantation,BP,GJA1
11761,GO:0045104,0.252077126017273,0.966267954118335,1,40,intermediate filament cytoskeleton organization,BP,PPL
9395,GO:0034599,0.252272175629647,0.90323461356705,3,278,cellular response to oxidative stress,BP,PDGFRA;EGFR;DAPK1
11462,GO:0044091,0.252537738774475,0.966100558728304,1,42,membrane biogenesis,BP,ANK3
3296,GO:0006654,0.252921154798927,0.966010437730136,1,41,phosphatidic acid biosynthetic process,BP,GPD1
17720,GO:0097720,0.252928274903216,0.965990081580072,1,42,calcineurin-mediated signaling,BP,ERBB3
14300,GO:0060043,0.252976403639481,0.965994801014475,1,41,regulation of cardiac muscle cell proliferation,BP,GJA1
12781,GO:0048018,0.253033548327922,0.902720906684497,3,334,receptor ligand activity,MF,CRLF1;GPNMB;GREM1
12950,GO:0048483,0.25307107680516,0.965949635203882,1,42,autonomic nervous system development,BP,SOX10
15383,GO:0065002,0.253549910288157,0.965705908234274,1,49,intracellular protein transmembrane transport,BP,PEX5L
13546,GO:0051092,0.253629977703685,0.926396687193891,2,150,positive regulation of NF-kappaB transcription factor activity,BP,CAPN3;GREM1
3266,GO:0006612,0.253724682505011,0.926228180765668,2,191,protein targeting to membrane,BP,RPS4Y1;ANK3
16938,GO:0086010,0.253747979735124,0.965908982144605,1,35,membrane depolarization during action potential,BP,ANK3
18482,GO:0120163,0.254384051366206,0.965541938575212,1,44,negative regulation of cold-induced thermogenesis,BP,PLCL1
328,GO:0000904,0.254419525355984,0.85800502010874,7,710,cell morphogenesis involved in differentiation,BP,NGFR;MAG;BVES;ANK3;FZD7;KNDC1;CNTN2
7023,GO:0022602,0.254539707986778,0.965514413297925,1,43,ovulation cycle process,BP,PDGFRA
329,GO:0000910,0.254809125949069,0.925857153339788,2,144,cytokinesis,BP,ANLN;ANK3
7704,GO:0031226,0.255207386404318,0.835563107125946,12,1458,intrinsic component of plasma membrane,CC,NGFR;ERBB3;FGFR3;FOLH1;MAG;GAL3ST1;PDGFRA;GPNMB;EGFR;GJA1;KCNJ6;CNTN2
14304,GO:0060047,0.255369438538166,0.901498224679705,3,260,heart contraction,BP,BVES;GJA1;SGCD
19532,GO:1902743,0.255374903556524,0.965293426955836,1,42,regulation of lamellipodium organization,BP,ENPP2
16125,GO:0071364,0.25543825865811,0.965293988083003,1,41,cellular response to epidermal growth factor stimulus,BP,EGFR
6205,GO:0017145,0.255819852078928,0.965184650245895,1,41,stem cell division,BP,FZD7
15547,GO:0070265,0.256076629995204,0.964982111002114,1,49,necrotic cell death,BP,BOK
7787,GO:0031346,0.256280989589961,0.884754277381997,4,361,positive regulation of cell projection organization,BP,ANLN;NGFR;TRIM67;ENPP2
11059,GO:0043167,0.256448847458592,0.805262274789161,41,5549,ion binding,MF,BAIAP3;EYA2;ERBB3;FGFR3;CDH19;LRP2;FOLH1;TF;CAPN3;FA2H;TUBB4A;MAG;BVES;PLCL1;CDK18;ATP10B;TRIM67;LDB3;HAPLN2;PDGFRA;CPM;GPNMB;ENPP2;PCSK6;EGFR;ST18;CNDP1;FZD7;SNX22;ACAN;ADAMTS4;EDIL3;PHKG1;CARNS1;DMRT2;SUSD5;MYO1D;DNAH17;SPOCK3;MYT1;DAPK1
3886,GO:0008146,0.256566234241399,0.96486909005714,1,47,sulfotransferase activity,MF,GAL3ST1
11016,GO:0043085,0.256813222759546,0.837494066656931,11,1326,positive regulation of catalytic activity,BP,NGFR;ERBB3;FGFR3;TF;PDGFRA;EGFR;ST18;GREM1;BOK;DAPK1;MBP
3291,GO:0006644,0.257377708013475,0.884020995540742,4,394,phospholipid metabolic process,BP,FGFR3;PDGFRA;ENPP2;GPD1
12801,GO:0048066,0.257384633042534,0.964697202937489,1,43,developmental pigmentation,BP,SOX10
13269,GO:0050654,0.257582964493981,0.964639835505904,1,43,chondroitin sulfate proteoglycan metabolic process,BP,SPOCK3
11760,GO:0045103,0.257653143989048,0.964656694353222,1,41,intermediate filament-based process,BP,PPL
12475,GO:0046686,0.257764437809596,0.96441037085414,1,56,response to cadmium ion,BP,EGFR
10527,GO:0042059,0.257854386099728,0.964527331042533,1,45,negative regulation of epidermal growth factor receptor signaling pathway,BP,EGFR
4721,GO:0010469,0.257865452579007,0.924375371009264,2,147,regulation of signaling receptor activity,BP,GREM1;DAPK1
11515,GO:0044273,0.258012234947987,0.964421964511672,1,49,sulfur compound catabolic process,BP,ACAN
5092,GO:0014009,0.258790140174731,0.964255386340819,1,45,glial cell proliferation,BP,SOX10
14029,GO:0051972,0.259040858527179,0.964151023752036,1,47,regulation of telomerase activity,BP,GREM1
10716,GO:0042461,0.259465323025452,0.96411118140593,1,42,photoreceptor cell development,BP,DCX
10919,GO:0042887,0.260013466435791,0.963882014737961,1,46,amide transmembrane transporter activity,MF,GJA1
6693,GO:0019933,0.26021652470248,0.923205006381485,2,155,cAMP-mediated signaling,BP,PEX5L;GPR62
8361,GO:0032409,0.260930769664264,0.898283357976471,3,264,regulation of transporter activity,BP,ANK3;GJA1;DAPK1
2380,GO:0005044,0.261364582745667,0.963536087110971,1,43,scavenger receptor activity,MF,ENPP2
7400,GO:0030546,0.26149735058178,0.897838977615168,3,339,signaling receptor activator activity,MF,CRLF1;GPNMB;GREM1
19142,GO:1901700,0.261692526665996,0.830471671530578,12,1515,response to oxygen-containing compound,BP,BAIAP3;NGFR;SOX10;MLC1;GJB6;PDGFRA;EGFR;GJA1;FZD7;GPD1;APOD;DAPK1
5119,GO:0014047,0.261882909544523,0.963383330824121,1,43,glutamate secretion,BP,GJA1
14619,GO:0060485,0.262071356341614,0.897622845035778,3,263,mesenchyme development,BP,ERBB3;SOX10;GREM1
11236,GO:0043436,0.262172759579136,0.846332674632638,8,1005,oxoacid metabolic process,BP,FOLH1;FA2H;PLP1;ACAN;SLC45A3;GPD1;CARNS1;SPOCK3
12358,GO:0046473,0.263076040351749,0.963030351414705,1,43,phosphatidic acid metabolic process,BP,GPD1
11865,GO:0045332,0.263418510833072,0.963010364788899,1,39,phospholipid translocation,BP,ATP10B
16927,GO:0085029,0.263453259835686,0.962937323900898,1,42,extracellular matrix assembly,BP,HAPLN2
4018,GO:0008360,0.263785546058942,0.921506134895329,2,144,regulation of cell shape,BP,BVES;ERMN
2850,GO:0005978,0.263797566654258,0.962854931210982,1,41,glycogen biosynthetic process,BP,PHKG1
4422,GO:0009250,0.263797566654258,0.962854931210982,1,41,glucan biosynthetic process,BP,PHKG1
6736,GO:0021517,0.263832194486617,0.96273771446503,1,47,ventral spinal cord development,BP,NKX6-2
7164,GO:0030135,0.263934889100578,0.896510136186639,3,277,coated vesicle,CC,LRP2;TF;EGFR
14054,GO:0052126,0.264306720863057,0.921216733285207,2,152,movement in host environment,BP,MOG;EGFR
7384,GO:0030517,0.26484926195544,0.962521432342967,1,42,negative regulation of axon extension,BP,MAG
655,GO:0001836,0.265542396270397,0.962096132887902,1,57,release of cytochrome c from mitochondria,BP,BOK
7544,GO:0030900,0.265877487282792,0.878637069135942,4,369,forebrain development,BP,LRP2;EGFR;MYO1D;CNTN2
18228,GO:0099738,0.265950824141976,0.962211698882981,1,41,cell cortex region,CC,ANLN
9965,GO:0035850,0.266448987966761,0.962022271789266,1,43,epithelial cell differentiation involved in kidney development,BP,GREM1
1630,GO:0003774,0.266492118965086,0.920276750216695,2,124,motor activity,MF,MYO1D;DNAH17
5063,GO:0010977,0.266972734089608,0.919935138352616,2,144,negative regulation of neuron projection development,BP,NGFR;MAG
7014,GO:0022408,0.267097841722433,0.91980509107389,2,161,negative regulation of cell-cell adhesion,BP,GPNMB;MBP
13668,GO:0051287,0.267316027394415,0.961593788782971,1,54,NAD binding,MF,GPD1
11982,GO:0045661,0.26854993383475,0.961270924086856,1,50,regulation of myoblast differentiation,BP,CAPN3
4748,GO:0010524,0.269418694778876,0.960991614241857,1,51,positive regulation of calcium ion transport into cytosol,BP,CAPN3
9602,GO:0035196,0.269576420841347,0.961036990771616,1,45,production of miRNAs involved in gene silencing by miRNA,BP,EGFR
22120,GO:2001238,0.269726264345172,0.960911484049929,1,50,positive regulation of extrinsic apoptotic signaling pathway,BP,MAL
7215,GO:0030203,0.269731528271527,0.91854656277634,2,148,glycosaminoglycan metabolic process,BP,ACAN;SPOCK3
19668,GO:1903034,0.26985069206296,0.918458343906876,2,155,regulation of response to wounding,BP,PDGFRA;GJA1
6761,GO:0021545,0.269876292096581,0.960927951956023,1,46,cranial nerve development,BP,ERBB3
16714,GO:0072348,0.269964587926967,0.960918281101057,1,45,sulfur compound transport,BP,GJA1
3507,GO:0006984,0.271174397293351,0.960496647983094,1,48,ER-nucleus signaling pathway,BP,BOK
3528,GO:0007019,0.271311625998127,0.960542281815815,1,43,microtubule depolymerization,BP,STMN4
13673,GO:0051293,0.271622082661135,0.960427486313295,1,44,establishment of spindle localization,BP,GJA1
19910,GO:1903522,0.271708693005772,0.891946296638992,3,270,regulation of blood circulation,BP,BVES;EGFR;GJA1
4804,GO:0010631,0.272044068178419,0.891757276792678,3,265,epithelial cell migration,BP,ANLN;ENPP2;GREM1
1464,GO:0003197,0.272077578774409,0.960268542086883,1,45,endocardial cushion development,BP,ERBB3
13780,GO:0051494,0.272109251407572,0.917365411383323,2,146,negative regulation of cytoskeleton organization,BP,TUBB4A;TMSB15A
7651,GO:0031098,0.272224810780817,0.891637791240797,3,271,stress-activated protein kinase signaling cascade,BP,TF;EGFR;FZD7
3436,GO:0006874,0.272378959303295,0.874388934843455,4,410,cellular calcium ion homeostasis,BP,CAPN3;PDGFRA;GJA1;BOK
13072,GO:0048701,0.272431767048405,0.960141366333975,1,46,embryonic cranial skeleton morphogenesis,BP,PDGFRA
19918,GO:1903532,0.272526925490372,0.891437319436903,3,282,positive regulation of secretion by cell,BP,BAIAP3;EGFR;GJA1
8298,GO:0032330,0.272549627000725,0.960122569566342,1,45,regulation of chondrocyte differentiation,BP,GREM1
13595,GO:0051155,0.272671813228365,0.959988925565928,1,51,positive regulation of striated muscle cell differentiation,BP,GREM1
16084,GO:0071310,0.272689855733117,0.80821163296925,18,2389,cellular response to organic substance,BP,CRLF1;BAIAP3;NGFR;FGFR3;LRP2;SOX10;MLC1;GJB6;PDGFRA;PCSK6;EGFR;ST18;GJA1;FZD7;GREM1;GPD1;BOK;DAPK1
1372,GO:0003015,0.272944136678027,0.891212011206974,3,270,heart process,BP,BVES;GJA1;SGCD
17078,GO:0090132,0.272961517545575,0.891209768756172,3,266,epithelium migration,BP,ANLN;ENPP2;GREM1
14298,GO:0060041,0.273510741590767,0.916683854477328,2,141,retina development in camera-type eye,BP,DCX;PDGFRA
8403,GO:0032456,0.274856011383968,0.959405050536774,1,45,endocytic recycling,BP,BVES
2918,GO:0006082,0.27508876083535,0.836664147243177,8,1019,organic acid metabolic process,BP,FOLH1;FA2H;PLP1;ACAN;SLC45A3;GPD1;CARNS1;SPOCK3
6843,GO:0021695,0.275234758423476,0.95928653672782,1,45,cerebellar cortex development,BP,KNDC1
12463,GO:0046658,0.27528387251834,0.959159433912754,1,52,anchored component of plasma membrane,CC,CNTN2
8601,GO:0032768,0.276081229181499,0.958908603972672,1,52,regulation of monooxygenase activity,BP,EGFR
6672,GO:0019887,0.276454296374069,0.915087322047475,2,167,protein kinase regulator activity,MF,ERBB3;GREM1
15850,GO:0070849,0.276606059128268,0.958855822885374,1,45,response to epidermal growth factor,BP,EGFR
21436,GO:1990939,0.276991392820787,0.959006458708496,1,34,ATP-dependent microtubule motor activity,MF,DNAH17
12127,GO:0045930,0.277204596371968,0.888613745254874,3,298,negative regulation of mitotic cell cycle,BP,GPNMB;EGFR;GJC2
17115,GO:0090183,0.277324753178094,0.958560313935168,1,49,regulation of kidney development,BP,GREM1
12547,GO:0046879,0.277935882334671,0.888202479772538,3,282,hormone secretion,BP,BAIAP3;EGFR;GJA1
7950,GO:0031648,0.27813511708256,0.958319609474716,1,48,protein destabilization,BP,CAPN3
18926,GO:1901185,0.278139436743972,0.958302031298703,1,49,negative regulation of ERBB signaling pathway,BP,EGFR
8671,GO:0032874,0.278433537511457,0.914132575715551,2,153,positive regulation of stress-activated MAPK cascade,BP,TF;FZD7
17853,GO:0098739,0.278970462139441,0.91388915002973,2,146,import across plasma membrane,BP,LRP2;KCNJ6
15317,GO:0061900,0.279016625746255,0.958007270932334,1,50,glial cell activation,BP,EGFR
18912,GO:1901136,0.279586460088052,0.913474673459152,2,171,carbohydrate derivative catabolic process,BP,ACAN;GPD1
17076,GO:0090130,0.279844804349652,0.887073776352447,3,271,tissue migration,BP,ANLN;ENPP2;GREM1
15897,GO:0070925,0.279892026981202,0.839376703709803,7,785,organelle assembly,BP,ANLN;DCX;CAPN3;TUBB4A;LDB3;PDGFRA;DNAH17
21297,GO:1990573,0.279944208710901,0.957778043226337,1,46,potassium ion import across plasma membrane,BP,KCNJ6
14193,GO:0055010,0.280718093181032,0.957549006060047,1,45,ventricular cardiac muscle tissue morphogenesis,BP,LRP2
642,GO:0001822,0.281316219808741,0.886203324190026,3,262,kidney development,BP,CRLF1;PDGFRA;GREM1
9205,GO:0034204,0.281457720669725,0.95737349333793,1,42,lipid translocation,BP,ATP10B
20077,GO:1903827,0.281474456590726,0.855693477936078,5,527,regulation of cellular protein localization,BP,NGFR;TRIM67;EGFR;ANK3;APOD
6595,GO:0019730,0.281540806932235,0.956917916860775,1,78,antimicrobial humoral response,BP,TF
2790,GO:0005875,0.282726108140824,0.911969029771463,2,144,microtubule associated complex,CC,DCX;DNAH17
7100,GO:0030020,0.283210766452462,0.956855463842679,1,40,extracellular matrix structural constituent conferring tensile strength,MF,COL28A1
133,GO:0000278,0.283305126446602,0.830458583238369,8,956,mitotic cell cycle,BP,ANLN;TUBB4A;CDK18;GPNMB;EGFR;ANK3;GJA1;GJC2
13553,GO:0051099,0.283311107218566,0.911584952857014,2,163,positive regulation of binding,BP,PLCL1;CTHRC1
15571,GO:0070304,0.283683164348376,0.911424366857567,2,155,positive regulation of stress-activated protein kinase signaling cascade,BP,TF;FZD7
15747,GO:0070613,0.283748571922819,0.956424324101616,1,54,regulation of protein processing,BP,CNTN2
2390,GO:0005080,0.284474580291576,0.956279714653575,1,48,protein kinase C binding,MF,LDB3
12556,GO:0046888,0.284577136172455,0.956140524842198,1,55,negative regulation of hormone secretion,BP,GJA1
21696,GO:2000401,0.284715389147805,0.956082350116354,1,56,regulation of lymphocyte migration,BP,APOD
20510,GO:1904705,0.284787807342532,0.95614421554855,1,50,regulation of vascular associated smooth muscle cell proliferation,BP,GJA1
21409,GO:1990874,0.284787807342532,0.95614421554855,1,50,vascular associated smooth muscle cell proliferation,BP,GJA1
12993,GO:0048562,0.285128068716939,0.883848983161495,3,280,embryonic organ morphogenesis,BP,GJB6;PDGFRA;CTHRC1
10594,GO:0042221,0.285171254841062,0.787212974777223,27,3796,response to chemical,BP,CRLF1;BAIAP3;NGFR;FGFR3;LRP2;TF;CAPN3;SOX10;MLC1;GJB6;PDGFRA;GPNMB;ENPP2;PCSK6;EGFR;ST18;ANK3;GJA1;FZD7;GREM1;GPD1;BOK;CNTN2;APOD;DAPK1;MBP;GJC2
15090,GO:0061383,0.285358209148842,0.95600880600719,1,47,trabecula morphogenesis,BP,GREM1
14490,GO:0060324,0.286068156932867,0.955794819513917,1,46,face development,BP,PDGFRA
5253,GO:0015030,0.286286103681306,0.955579723306664,1,55,Cajal body,CC,ANKS1B
8718,GO:0032934,0.286554271406542,0.955549005298777,1,51,sterol binding,MF,APOD
11985,GO:0045664,0.286780367759565,0.842112274909962,6,631,regulation of neuron differentiation,BP,NGFR;MAG;TRIM67;KLK6;KNDC1;CNTN2
15017,GO:0061178,0.286791093130213,0.955441020317972,1,53,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,BAIAP3
3631,GO:0007204,0.287248545663341,0.882533069805838,3,290,positive regulation of cytosolic calcium ion concentration,BP,CAPN3;PDGFRA;GJA1
17062,GO:0090102,0.288200099584533,0.955037908803583,1,49,cochlea development,BP,CTHRC1
13572,GO:0051129,0.288636962119092,0.840738148407944,6,662,negative regulation of cellular component organization,BP,NGFR;TUBB4A;MAG;TMSB15A;BOK;APOD
16389,GO:0071806,0.288756817047164,0.954735675176787,1,57,protein transmembrane transport,BP,PEX5L
8342,GO:0032387,0.288802930902554,0.954760329213954,1,54,negative regulation of intracellular transport,BP,APOD
13445,GO:0050918,0.28884758920613,0.95475981892703,1,53,positive chemotaxis,BP,GPNMB
16842,GO:0072678,0.288967716197588,0.954653006192358,1,58,T cell migration,BP,APOD
13420,GO:0050885,0.28919602733231,0.95476205919418,1,46,neuromuscular process controlling balance,BP,NKX6-2
5859,GO:0016482,0.289214351028175,0.908566436844457,2,149,cytosolic transport,BP,BAIAP3;MYO1D
14739,GO:0060688,0.289318847486698,0.954602896768912,1,53,regulation of morphogenesis of a branching structure,BP,GREM1
6734,GO:0021515,0.289412543240496,0.954571660924373,1,53,cell differentiation in spinal cord,BP,NKX6-2
3972,GO:0008289,0.289918715548769,0.83978748593404,6,685,lipid binding,MF,BAIAP3;MAG;FZD7;SNX22;MAL;APOD
7614,GO:0031050,0.290020293975373,0.954432533299288,1,49,dsRNA processing,BP,EGFR
15894,GO:0070918,0.290020293975373,0.954432533299288,1,49,production of small RNA involved in gene silencing by RNA,BP,EGFR
10557,GO:0042130,0.290498707309641,0.954141130940278,1,58,negative regulation of T cell proliferation,BP,GPNMB
7662,GO:0031113,0.290516934927733,0.95426656282019,1,49,regulation of microtubule polymerization,BP,TUBB4A
4592,GO:0009914,0.291526867473593,0.87989925647135,3,290,hormone transport,BP,BAIAP3;EGFR;GJA1
4656,GO:0010171,0.291894393800626,0.953822286942747,1,48,body morphogenesis,BP,PDGFRA
7886,GO:0031526,0.293635605589039,0.953199228009524,1,50,brush border membrane,CC,LRP2
7167,GO:0030139,0.29373264808704,0.878521402552892,3,296,endocytic vesicle,CC,LRP2;TF;EGFR
528,GO:0001659,0.293765873257854,0.906100681297264,2,163,temperature homeostasis,BP,PLCL1;GJA1
19802,GO:1903317,0.294319292533858,0.95287582113451,1,56,regulation of protein maturation,BP,CNTN2
10009,GO:0035924,0.294633822376092,0.952827315241331,1,52,cellular response to vascular endothelial growth factor stimulus,BP,PDGFRA
3525,GO:0007015,0.294975792252378,0.859439446951341,4,395,actin filament organization,BP,TF;ERMN;TMSB15A;MYO1D
4840,GO:0010676,0.295078302681451,0.952726254319235,1,49,positive regulation of cellular carbohydrate metabolic process,BP,SLC45A3
13862,GO:0051653,0.295319487913874,0.95266225818335,1,48,spindle localization,BP,GJA1
13588,GO:0051148,0.295506443674519,0.952514006711254,1,53,negative regulation of muscle cell differentiation,BP,FZD7
16138,GO:0071385,0.295528909847009,0.95247684476741,1,55,cellular response to glucocorticoid stimulus,BP,EGFR
9401,GO:0034613,0.295777112660708,0.797384973029158,14,1825,cellular protein localization,BP,NGFR;CAPN3;PEX5L;TRIM67;RPS4Y1;EGFR;ANK3;GJA1;TMSB15A;SGCD;MAL;UGT8;CNTN2;APOD
2880,GO:0006022,0.296507914678607,0.904650204994425,2,160,aminoglycan metabolic process,BP,ACAN;SPOCK3
3483,GO:0006941,0.296534307456008,0.904627757620621,2,162,striated muscle contraction,BP,GJA1;SGCD
13639,GO:0051248,0.296582265175146,0.820264008134955,8,971,negative regulation of protein metabolic process,BP,NGFR;CAPN3;EGFR;GREM1;APOD;SPOCK3;DAPK1;COL28A1
6683,GO:0019904,0.296823866903675,0.834727310025069,6,661,protein domain specific binding,MF,LRP2;GJA1;FZD7;MYO1D;BOK;TMEM88B
15413,GO:0070059,0.296983911917344,0.951949911902259,1,57,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,BOK
840,GO:0002090,0.297058114571658,0.951997583351514,1,52,regulation of receptor internalization,BP,GREM1
7399,GO:0030545,0.297774643518481,0.875900481392928,3,363,receptor regulator activity,MF,CRLF1;GPNMB;GREM1
2767,GO:0005844,0.298106425671453,0.951468173300247,1,65,polysome,CC,RPS4Y1
12963,GO:0048511,0.298889716813704,0.875319539285148,3,287,rhythmic process,BP,NGFR;PDGFRA;EGFR
6950,GO:0021915,0.299601677715226,0.90300970300749,2,155,neural tube development,BP,LRP2;CTHRC1
16490,GO:0072001,0.29962413118725,0.874892017302512,3,271,renal system development,BP,CRLF1;PDGFRA;GREM1
14349,GO:0060113,0.299658337787296,0.951132503745979,1,50,inner ear receptor cell differentiation,BP,CTHRC1
3730,GO:0007423,0.299807025747505,0.842747477374676,5,528,sensory organ development,BP,DCX;GJB6;PDGFRA;EGFR;CTHRC1
12945,GO:0048471,0.300003409348647,0.832366530447178,6,674,perinuclear region of cytoplasm,CC,TF;MLC1;LDB3;EGFR;MOBP;APOD
4936,GO:0010823,0.300044586209001,0.950903342317084,1,56,negative regulation of mitochondrion organization,BP,BOK
15874,GO:0070887,0.300063840229826,0.780714201226166,21,2911,cellular response to chemical stimulus,BP,CRLF1;BAIAP3;NGFR;FGFR3;LRP2;TF;CAPN3;SOX10;MLC1;GJB6;PDGFRA;PCSK6;EGFR;ST18;ANK3;GJA1;FZD7;GREM1;GPD1;BOK;DAPK1
13358,GO:0050796,0.300409223787777,0.90252672895174,2,166,regulation of insulin secretion,BP,BAIAP3;GJA1
4516,GO:0009628,0.300914815169584,0.811353633325665,9,1125,response to abiotic stimulus,BP,NGFR;CAPN3;MLC1;MAG;PPL;GJB6;EGFR;GJA1;PIEZO2
14295,GO:0060038,0.301137212235349,0.950617273482778,1,50,cardiac muscle cell proliferation,BP,GJA1
19257,GO:1902041,0.301284889572848,0.950456003862627,1,57,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,MAL
15799,GO:0070727,0.30143159032387,0.792705152009335,14,1834,cellular macromolecule localization,BP,NGFR;CAPN3;PEX5L;TRIM67;RPS4Y1;EGFR;ANK3;GJA1;TMSB15A;SGCD;MAL;UGT8;CNTN2;APOD
19585,GO:1902893,0.302032628860428,0.950286227204584,1,51,regulation of pri-miRNA transcription by RNA polymerase II,BP,NGFR
12998,GO:0048568,0.302090089303512,0.854578143478854,4,418,embryonic organ development,BP,GJB6;PDGFRA;EGFR;CTHRC1
96,GO:0000186,0.302399789499343,0.950193333860415,1,49,activation of MAPKK activity,BP,EGFR
1186,GO:0002685,0.302604992388792,0.901251840041659,2,190,regulation of leukocyte migration,BP,GREM1;APOD
17386,GO:0097035,0.302767279714456,0.950083394484618,1,48,regulation of membrane lipid distribution,BP,ATP10B
16092,GO:0071320,0.303067396870145,0.949958634871291,1,49,cellular response to cAMP,BP,GPD1
13089,GO:0048732,0.303481027064427,0.853633933060939,4,412,gland development,BP,SOX10;FA2H;PDGFRA;EGFR
803,GO:0002042,0.303627357742073,0.949707906766713,1,52,cell migration involved in sprouting angiogenesis,BP,GREM1
21865,GO:2000649,0.303695137022982,0.94965166284374,1,54,regulation of sodium ion transmembrane transporter activity,BP,ANK3
10893,GO:0042803,0.30420018212885,0.839551625277237,5,578,protein homodimerization activity,MF,MAG;PDGFRA;GREM1;GPD1;BOK
593,GO:0001764,0.304515102740415,0.900362252666153,2,151,neuron migration,BP,DCX;CNTN2
13405,GO:0050866,0.304645257938485,0.900161476215074,2,183,negative regulation of cell activation,BP,PDGFRA;GPNMB
3268,GO:0006614,0.304737949770194,0.948922842522418,1,94,SRP-dependent cotranslational protein targeting to membrane,BP,RPS4Y1
15331,GO:0061951,0.305229738871304,0.949123580471489,1,53,establishment of protein localization to plasma membrane,BP,ANK3
2415,GO:0005126,0.305304012106548,0.899760343497845,2,196,cytokine receptor binding,MF,CRLF1;GREM1
2731,GO:0005778,0.305771941181514,0.948855847667294,1,58,peroxisomal membrane,CC,PEX5L
8064,GO:0031903,0.305771941181514,0.948855847667294,1,58,microbody membrane,CC,PEX5L
14548,GO:0060393,0.306234986816466,0.948704434074162,1,57,regulation of pathway-restricted SMAD protein phosphorylation,BP,GREM1
16137,GO:0071384,0.306579359122931,0.948567318749158,1,58,cellular response to corticosteroid stimulus,BP,EGFR
6695,GO:0019935,0.306803206119139,0.899003039740298,2,176,cyclic-nucleotide-mediated signaling,BP,PEX5L;GPR62
1375,GO:0003018,0.306964119373029,0.89892954331325,2,172,vascular process in circulatory system,BP,EGFR;GJA1
12901,GO:0048306,0.30699435021631,0.948301265887502,1,68,calcium-dependent protein binding,MF,MYO1D
14513,GO:0060350,0.307118296233566,0.948449627520414,1,53,endochondral bone morphogenesis,BP,FGFR3
17955,GO:0098900,0.30757958478317,0.948355894110274,1,49,regulation of action potential,BP,ANK3
6676,GO:0019897,0.308055938364158,0.898365072936862,2,163,extrinsic component of plasma membrane,CC,CDH19;TF
3394,GO:0006801,0.308257332623005,0.947900859716885,1,63,superoxide metabolic process,BP,EGFR
13449,GO:0050922,0.308560675625424,0.947915143144003,1,54,negative regulation of chemotaxis,BP,GREM1
7276,GO:0030286,0.308620747194615,0.948022665058474,1,47,dynein complex,CC,DNAH17
2884,GO:0006027,0.309575442540136,0.947548742458987,1,54,glycosaminoglycan catabolic process,BP,ACAN
12413,GO:0046580,0.309706134366537,0.947571303105979,1,50,negative regulation of Ras protein signal transduction,BP,TRIM67
14918,GO:0061005,0.309803336566277,0.947499857881768,1,52,cell differentiation involved in kidney development,BP,GREM1
22137,GO:2001257,0.309863210944418,0.897350136449148,2,167,regulation of cation channel activity,BP,ANK3;DAPK1
16758,GO:0072503,0.310084180615411,0.849053639965054,4,440,cellular divalent inorganic cation homeostasis,BP,CAPN3;PDGFRA;GJA1;BOK
13958,GO:0051881,0.310236659528186,0.947161022699032,1,65,regulation of mitochondrial membrane potential,BP,BOK
13521,GO:0051047,0.310757671419527,0.86775287077971,3,305,positive regulation of secretion,BP,BAIAP3;EGFR;GJA1
12379,GO:0046503,0.311069454393868,0.946918590875029,1,60,glycerolipid catabolic process,BP,ENPP2
2270,GO:0004867,0.311093973945515,0.946860138851145,1,64,serine-type endopeptidase inhibitor activity,MF,COL28A1
527,GO:0001658,0.311808355352049,0.94673734772669,1,54,branching involved in ureteric bud morphogenesis,BP,GREM1
2800,GO:0005887,0.312111221952931,0.793471070778278,11,1385,integral component of plasma membrane,CC,NGFR;ERBB3;FGFR3;FOLH1;MAG;GAL3ST1;PDGFRA;GPNMB;EGFR;GJA1;KCNJ6
2749,GO:0005801,0.312234842387464,0.946549879966439,1,56,cis-Golgi network,CC,BOK
16443,GO:0071897,0.312892343463899,0.895635247891203,2,175,DNA biosynthetic process,BP,GJA1;GREM1
9633,GO:0035265,0.313066694603841,0.895595812049577,2,161,organ growth,BP,FGFR3;GJA1
12828,GO:0048168,0.313321054473773,0.946217983930889,1,52,regulation of neuronal synaptic plasticity,BP,CNTN2
18524,GO:0140056,0.31354382365862,0.895295206236437,2,169,organelle localization by membrane tethering,BP,TUBB4A;BVES
2816,GO:0005912,0.313712886535018,0.895258334563385,2,156,adherens junction,CC,CDH19;LDB3
9015,GO:0033619,0.314115405776506,0.945829634062116,1,58,membrane protein proteolysis,BP,NGFR
17440,GO:0097120,0.314130875441139,0.945885843049292,1,54,receptor localization to synapse,BP,ANKS1B
15179,GO:0061614,0.314195320737476,0.945879054111296,1,53,pri-miRNA transcription by RNA polymerase II,BP,NGFR
16930,GO:0086002,0.314240788674956,0.945937059533157,1,49,cardiac muscle cell action potential involved in contraction,BP,GJA1
3757,GO:0007528,0.314258710381394,0.945930466431111,1,49,neuromuscular junction development,BP,ANK3
3825,GO:0008038,0.31518601100583,0.94556877051642,1,50,neuron recognition,BP,CNTN2
11391,GO:0043900,0.315530763310017,0.945264957878684,1,61,regulation of multi-organism process,BP,GJA1
11343,GO:0043621,0.315725047429914,0.94531401603295,1,53,protein self-association,MF,CNTN2
8476,GO:0032559,0.315728346434491,0.786875701294143,12,1413,adenyl ribonucleotide binding,MF,ERBB3;FGFR3;BVES;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;DNAH17;DAPK1
3440,GO:0006879,0.315938801590801,0.945113477332004,1,61,cellular iron ion homeostasis,BP,TF
1486,GO:0003229,0.31659117496688,0.945010472924045,1,52,ventricular cardiac muscle tissue development,BP,LRP2
13365,GO:0050806,0.317374425619883,0.893158090489542,2,166,positive regulation of synaptic transmission,BP,BAIAP3;EGFR
18880,GO:1901016,0.317512224068132,0.9445995754632,1,56,regulation of potassium ion transmembrane transporter activity,BP,ANK3
15693,GO:0070527,0.318724214709702,0.944115306335986,1,58,platelet aggregation,BP,PDGFRA
10633,GO:0042306,0.31931524939786,0.943924077049166,1,56,regulation of protein import into nucleus,BP,APOD
16332,GO:0071674,0.319765325524831,0.943565393877273,1,71,mononuclear cell migration,BP,GREM1
4673,GO:0010256,0.320532319341079,0.841788095301243,4,415,endomembrane system organization,BP,BAIAP3;FA2H;MYRF;ANK3
6202,GO:0017137,0.321047544034047,0.891124676524465,2,156,Rab GTPase binding,MF,NGFR;MOBP
586,GO:0001755,0.321145631519705,0.943249970933254,1,55,neural crest cell migration,BP,SOX10
18546,GO:0140115,0.321321179291057,0.94315116438079,1,57,export across plasma membrane,BP,GJA1
696,GO:0001895,0.321430581021617,0.943065208852203,1,60,retina homeostasis,BP,TF
9930,GO:0035773,0.321461474487818,0.94305348788377,1,60,insulin secretion involved in cellular response to glucose stimulus,BP,BAIAP3
6024,GO:0016782,0.321521121973459,0.94296581278408,1,65,transferase activity, transferring sulfur-containing groups,MF,GAL3ST1
12973,GO:0048523,0.322015006798627,0.752211535890542,31,4362,negative regulation of cellular process,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;TUBB4A;MAG;TRIM67;GJB6;PDGFRA;GPNMB;EGFR;ST18;NKX6-2;ANK3;GJA1;FZD7;TMSB15A;CTHRC1;GREM1;MYO1D;BOK;CNTN2;APOD;SPOCK3;DAPK1;MBP;GJC2;COL28A1
21398,GO:1990841,0.322481463751849,0.942743076244761,1,55,promoter-specific chromatin binding,MF,SOX10
14544,GO:0060389,0.322853075085927,0.942524079593964,1,60,pathway-restricted SMAD protein phosphorylation,BP,GREM1
8204,GO:0032153,0.322884999871921,0.942572823358981,1,56,cell division site,CC,ANLN
13291,GO:0050679,0.322955642129453,0.889952601680168,2,175,positive regulation of epithelial cell proliferation,BP,EGFR;FZD7
5849,GO:0016459,0.32297100652883,0.942629712538425,1,51,myosin complex,CC,MYO1D
19697,GO:1903078,0.323371479598287,0.942387246872232,1,56,positive regulation of protein localization to plasma membrane,BP,EGFR
7408,GO:0030554,0.324035725131825,0.779969674527128,12,1425,adenyl nucleotide binding,MF,ERBB3;FGFR3;BVES;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;DNAH17;DAPK1
16215,GO:0071495,0.324038080410342,0.787925874093258,10,1237,cellular response to endogenous stimulus,BP,NGFR;FGFR3;LRP2;SOX10;PDGFRA;PCSK6;EGFR;GJA1;GREM1;GPD1
3267,GO:0006613,0.32423501633949,0.941662447227261,1,98,cotranslational protein targeting to membrane,BP,RPS4Y1
13040,GO:0048663,0.324286627949879,0.941948026903083,1,62,neuron fate commitment,BP,NKX6-2
7494,GO:0030837,0.324598925217393,0.941901284632917,1,57,negative regulation of actin filament polymerization,BP,TMSB15A
6294,GO:0018209,0.324816369106733,0.858632896369414,3,291,peptidyl-serine modification,BP,PLCL1;EGFR;SPOCK3
13311,GO:0050708,0.325445627159307,0.858185588995086,3,307,regulation of protein secretion,BP,BAIAP3;EGFR;GJA1
3276,GO:0006625,0.326287401014419,0.941103108716019,1,68,protein targeting to peroxisome,BP,PEX5L
16830,GO:0072662,0.326287401014419,0.941103108716019,1,68,protein localization to peroxisome,BP,PEX5L
16831,GO:0072663,0.326287401014419,0.941103108716019,1,68,establishment of protein localization to peroxisome,BP,PEX5L
1105,GO:0002532,0.326333863141584,0.941146084673535,1,63,production of molecular mediator involved in inflammatory response,BP,APOD
11990,GO:0045669,0.326962280647117,0.940974516715307,1,58,positive regulation of osteoblast differentiation,BP,CTHRC1
13622,GO:0051223,0.327859766618886,0.822214958104135,5,574,regulation of protein transport,BP,BAIAP3;EGFR;ANK3;GJA1;APOD
2883,GO:0006026,0.327944247276289,0.940578128925864,1,59,aminoglycan catabolic process,BP,ACAN
16979,GO:0086065,0.328547246789416,0.940445069442106,1,53,cell communication involved in cardiac conduction,BP,GJA1
12969,GO:0048519,0.328784838028704,0.744498915786382,34,4863,negative regulation of biological process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;CAPN3;SOX10;TUBB4A;MAG;PLCL1;TRIM67;GJB6;RPS4Y1;PDGFRA;GPNMB;EGFR;ST18;NKX6-2;ANK3;GJA1;FZD7;TMSB15A;CTHRC1;GREM1;MYO1D;BOK;CNTN2;APOD;SPOCK3;DAPK1;MBP;GJC2;COL28A1
13098,GO:0048747,0.329155085777263,0.940208320865666,1,53,muscle fiber development,BP,SGCD
3452,GO:0006893,0.329173994098989,0.940147197854099,1,56,Golgi to plasma membrane transport,BP,ANK3
16826,GO:0072657,0.330040331326915,0.82055730359838,5,613,protein localization to membrane,BP,CAPN3;RPS4Y1;EGFR;ANK3;MAL
3616,GO:0007186,0.330137226847104,0.809518120693242,6,774,G protein-coupled receptor signaling pathway,BP,BAIAP3;PLCL1;FZD7;KLK6;GPR62;CNTN2
20452,GO:1904589,0.330368095235964,0.939631492878461,1,59,regulation of protein import,BP,APOD
8202,GO:0032147,0.330536160338194,0.854816921967406,3,303,activation of protein kinase activity,BP,TF;EGFR;GREM1
6015,GO:0016772,0.330657824610086,0.800489988536553,7,808,transferase activity, transferring phosphorus-containing groups,MF,ERBB3;FGFR3;CDK18;PDGFRA;EGFR;PHKG1;DAPK1
19114,GO:1901654,0.330856202174839,0.885355375551979,2,185,response to ketone,BP,SOX10;EGFR
14363,GO:0060135,0.330911523981856,0.939374028462535,1,62,maternal process involved in female pregnancy,BP,GJA1
7089,GO:0030003,0.331457715036995,0.819509397688111,5,596,cellular cation homeostasis,BP,TF;CAPN3;PDGFRA;GJA1;BOK
7305,GO:0030324,0.331494152760416,0.885048010756412,2,169,lung development,BP,PDGFRA;EGFR
7786,GO:0031345,0.331608068406515,0.884968542970815,2,172,negative regulation of cell projection organization,BP,NGFR;MAG
10733,GO:0042490,0.332346006098218,0.938884843386819,1,57,mechanoreceptor differentiation,BP,CTHRC1
7515,GO:0030865,0.332558241319132,0.938768707932391,1,59,cortical cytoskeleton organization,BP,ANLN
12392,GO:0046530,0.332957016620031,0.938643190038323,1,57,photoreceptor cell differentiation,BP,DCX
18630,GO:0150076,0.333829605876057,0.938219811693973,1,62,neuroinflammatory response,BP,EGFR
10952,GO:0042982,0.334239081073784,0.938071324764727,1,61,amyloid precursor protein metabolic process,BP,KLK6
5653,GO:0016052,0.334470002996959,0.883264332930242,2,179,carbohydrate catabolic process,BP,PHKG1;GPD1
7012,GO:0022406,0.335005755684598,0.88295344416996,2,178,membrane docking,BP,TUBB4A;BVES
14202,GO:0055021,0.335237736963514,0.937703530391596,1,59,regulation of cardiac muscle tissue growth,BP,GJA1
3644,GO:0007219,0.336170315870103,0.882259564292818,2,180,Notch signaling pathway,BP,EGFR;SUSD5
20911,GO:1905475,0.336520730568944,0.882041085292416,2,183,regulation of protein localization to membrane,BP,EGFR;ANK3
14438,GO:0060255,0.337054165318344,0.735055379998823,39,5629,regulation of macromolecule metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;BVES;PLCL1;CDK18;TRIM67;PLP1;MYRF;RPS4Y1;PDGFRA;GPNMB;ENPP2;MOG;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;FZD7;GREM1;KNDC1;DMRT2;BOK;CNTN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
7269,GO:0030278,0.337335081316913,0.881567720382647,2,181,regulation of ossification,BP,CTHRC1;GREM1
18065,GO:0099080,0.337884828802537,0.781588458040852,9,1099,supramolecular complex,CC,CLDN11;DCX;CAPN3;TUBB4A;PPL;GJB6;LDB3;ANK3;DNAH17
6453,GO:0019222,0.339069992337085,0.732425417486108,42,6103,regulation of metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;BVES;PLCL1;CDK18;TRIM67;PLP1;MYRF;RPS4Y1;PDGFRA;GPNMB;ENPP2;MOG;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;FZD7;SLC45A3;GREM1;GPD1;KNDC1;DMRT2;MYO1D;BOK;CNTN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
11008,GO:0043065,0.339716916280186,0.813283123774418,5,602,positive regulation of apoptotic process,BP,NGFR;ST18;MAL;BOK;DAPK1
3280,GO:0006631,0.339847722938896,0.848487001154803,3,342,fatty acid metabolic process,BP,FA2H;PLP1;SLC45A3
13034,GO:0048645,0.339945771731862,0.935745240604305,1,63,animal organ formation,BP,LRP2
8658,GO:0032835,0.340101697135007,0.935794263710678,1,56,glomerulus development,BP,PDGFRA
13532,GO:0051058,0.340951608584115,0.935448289700481,1,56,negative regulation of small GTPase mediated signal transduction,BP,TRIM67
11081,GO:0043197,0.34113523309884,0.879361926603214,2,169,dendritic spine,CC,NGFR;ANKS1B
14728,GO:0060675,0.341170444483472,0.935291119245214,1,60,ureteric bud morphogenesis,BP,GREM1
7304,GO:0030323,0.342039630540033,0.878803928285504,2,173,respiratory tube development,BP,PDGFRA;EGFR
3699,GO:0007346,0.342246303298671,0.81136591463696,5,599,regulation of mitotic cell cycle,BP,ANLN;TUBB4A;GPNMB;EGFR;GJC2
13423,GO:0050891,0.34267788498867,0.934673746491588,1,60,multicellular organismal water homeostasis,BP,FA2H
7270,GO:0030279,0.34296482414257,0.934495821971356,1,64,negative regulation of ossification,BP,GREM1
6439,GO:0019207,0.343224241366203,0.878015564215027,2,193,kinase regulator activity,MF,ERBB3;GREM1
12884,GO:0048278,0.344118516498904,0.934006193179128,1,65,vesicle docking,BP,BVES
16599,GO:0072171,0.344233592980981,0.934017177189586,1,61,mesonephric tubule morphogenesis,BP,GREM1
8365,GO:0032413,0.344494239846735,0.933837267877839,1,66,negative regulation of ion transmembrane transporter activity,BP,ANK3
2135,GO:0004674,0.344847937940704,0.824348224907901,4,406,protein serine/threonine kinase activity,MF,CDK18;EGFR;PHKG1;DAPK1
13130,GO:0048839,0.344913339792776,0.877058854058122,2,178,inner ear development,BP,GJB6;CTHRC1
5405,GO:0015370,0.344939627832112,0.933741063422641,1,60,solute:sodium symporter activity,MF,SLC5A11
3435,GO:0006873,0.344972289268405,0.809284259449275,5,606,cellular ion homeostasis,BP,TF;CAPN3;PDGFRA;GJA1;BOK
11319,GO:0043574,0.345300744955456,0.933429262194129,1,72,peroxisomal transport,BP,PEX5L
14936,GO:0061035,0.345401278572466,0.933549747018768,1,60,regulation of cartilage development,BP,GREM1
7444,GO:0030659,0.345635061161751,0.79747865352468,6,725,cytoplasmic vesicle membrane,CC,LRP2;TF;ATP10B;GPNMB;EGFR;SNX22
7653,GO:0031100,0.346024626384222,0.933151322503159,1,70,animal organ regeneration,BP,EGFR
19369,GO:1902305,0.346140688853383,0.933196083026073,1,63,regulation of sodium ion transmembrane transport,BP,ANK3
6213,GO:0017156,0.34649964488338,0.933093275313931,1,60,calcium-ion regulated exocytosis,BP,BAIAP3
16352,GO:0071702,0.346723936778269,0.745108119802738,18,2510,organic substance transport,BP,BAIAP3;NGFR;LRP2;TF;MLC1;PEX5L;ATP10B;RPS4Y1;EGFR;ANK3;GJA1;SNX22;SLC45A3;SLC5A11;TMEM144;GJB1;MYO1D;APOD
8724,GO:0032945,0.346771187844764,0.932816607227533,1,72,negative regulation of mononuclear cell proliferation,BP,GPNMB
13285,GO:0050672,0.346771187844764,0.932816607227533,1,72,negative regulation of lymphocyte proliferation,BP,GPNMB
4574,GO:0009880,0.347011533493973,0.932833116032347,1,63,embryonic pattern specification,BP,PCSK6
16079,GO:0071300,0.347145935998194,0.932776995371649,1,63,cellular response to retinoic acid,BP,FZD7
11535,GO:0044309,0.347419369258246,0.875577389429496,2,171,neuron spine,CC,NGFR;ANKS1B
6146,GO:0017038,0.347668807547353,0.87537873852018,2,182,protein import,BP,PEX5L;APOD
3410,GO:0006826,0.347737881641004,0.93243554243435,1,70,iron ion transport,BP,TF
11011,GO:0043068,0.347935197313633,0.807017307363156,5,608,positive regulation of programmed cell death,BP,NGFR;ST18;MAL;BOK;DAPK1
14997,GO:0061138,0.347969625806838,0.875226150298917,2,175,morphogenesis of a branching epithelium,BP,SOX10;GREM1
5187,GO:0014823,0.348316103875276,0.932272499953163,1,64,response to activity,BP,CAPN3
4520,GO:0009636,0.348404223403235,0.874813209365185,2,217,response to toxic substance,BP,MBP;GJC2
6678,GO:0019899,0.348615855801232,0.747645873085885,16,2096,enzyme binding,MF,ANLN;NGFR;ERBB3;DCX;NKAIN1;MAG;PEX5L;LDB3;RAPGEF5;EGFR;ADAMTS4;PHKG1;MOBP;KNDC1;BOK;MBP
17890,GO:0098802,0.348650113387334,0.874796188873631,2,179,plasma membrane signaling receptor complex,CC,ERBB3;TF
686,GO:0001885,0.348946078631965,0.932053730724453,1,61,endothelial cell development,BP,HAPLN2
587,GO:0001756,0.349567899314276,0.931792147373358,1,61,somitogenesis,BP,DMRT2
3719,GO:0007405,0.349834410854854,0.93173066889773,1,58,neuroblast proliferation,BP,SOX10
8490,GO:0032589,0.349898772038287,0.931703552863715,1,58,neuron projection membrane,CC,MYO1D
21814,GO:2000573,0.350609729484967,0.931251029237433,1,68,positive regulation of DNA biosynthetic process,BP,GREM1
5652,GO:0016051,0.35098933986614,0.873328355548596,2,190,carbohydrate biosynthetic process,BP,PHKG1;GPD1
12356,GO:0046470,0.351380270295841,0.930863572922447,1,73,phosphatidylcholine metabolic process,BP,ENPP2
3160,GO:0006487,0.3526751049261,0.93033572292843,1,71,protein N-linked glycosylation,BP,GAL3ST1
11735,GO:0045047,0.355385327245754,0.928881356137668,1,107,protein targeting to ER,BP,RPS4Y1
14191,GO:0055008,0.355578735567253,0.929267667603574,1,59,cardiac muscle tissue morphogenesis,BP,LRP2
7068,GO:0022904,0.356009721613067,0.928664194107961,1,98,respiratory electron transport chain,BP,GPD1
2939,GO:0006109,0.35604337293686,0.870266403945675,2,180,regulation of carbohydrate metabolic process,BP,SLC45A3;GPD1
20342,GO:1904377,0.356061140273607,0.928993249141294,1,63,positive regulation of protein localization to cell periphery,BP,EGFR
13421,GO:0050886,0.35617256778833,0.928822084487905,1,72,endocrine process,BP,GJA1
7027,GO:0022607,0.357227652926703,0.734039063726855,19,2601,cellular component assembly,BP,ANLN;CLDN11;CDH19;DCX;CAPN3;TUBB4A;GJB6;LDB3;HAPLN2;PDGFRA;ANK3;GJA1;TMSB15A;GREM1;GJB1;UGT8;BOK;DNAH17;APOD
15768,GO:0070663,0.357800437214118,0.869049856128762,2,216,regulation of leukocyte proliferation,BP,GPNMB;GREM1
15508,GO:0070201,0.358530433886494,0.798850013283973,5,598,regulation of establishment of protein localization,BP,BAIAP3;EGFR;ANK3;GJA1;APOD
5650,GO:0016049,0.35890102430236,0.813901014373045,4,448,cell growth,BP,MAG;EGFR;GJA1;GREM1
22139,GO:2001259,0.359155935348405,0.927591643687996,1,67,positive regulation of cation channel activity,BP,ANK3
20619,GO:1904888,0.359373151669623,0.927556690026654,1,63,cranial skeletal system development,BP,PDGFRA
568,GO:0001725,0.359527326690169,0.927505593018766,1,62,stress fiber,CC,LDB3
17647,GO:0097517,0.359527326690169,0.927505593018766,1,62,contractile actin filament bundle,CC,LDB3
17051,GO:0090087,0.359661579136048,0.797967888724913,5,601,regulation of peptide transport,BP,BAIAP3;EGFR;ANK3;GJA1;APOD
20732,GO:1905114,0.359726164126936,0.79793024956629,5,586,cell surface receptor signaling pathway involved in cell-cell signaling,BP,SOX10;EGFR;FZD7;CTHRC1;GREM1
5268,GO:0015077,0.360446553904762,0.834297005856623,3,320,monovalent inorganic cation transmembrane transporter activity,MF,KCNJ6;SLC45A3;SLC5A11
13135,GO:0048844,0.360587643966317,0.927076160280234,1,60,artery morphogenesis,BP,LRP2
8709,GO:0032922,0.36130127462495,0.926745839052229,1,61,circadian regulation of gene expression,BP,NGFR
10760,GO:0042562,0.36146738990538,0.926500752196223,1,73,hormone binding,MF,EGFR
8677,GO:0032880,0.361571261303967,0.775620636828267,7,869,regulation of protein localization,BP,BAIAP3;NGFR;TRIM67;EGFR;ANK3;GJA1;APOD
18838,GO:1900449,0.362220564452042,0.926324585236741,1,62,regulation of glutamate receptor signaling pathway,BP,DAPK1
7369,GO:0030500,0.36236550102892,0.926197957672984,1,66,regulation of bone mineralization,BP,GREM1
13447,GO:0050920,0.362381887789262,0.866239545380323,2,202,regulation of chemotaxis,BP,PDGFRA;GREM1
6142,GO:0017022,0.363457940065806,0.925700503547593,1,67,myosin binding,MF,MOBP
19993,GO:1903670,0.363815863460435,0.925556502304662,1,66,regulation of sprouting angiogenesis,BP,NGFR
13884,GO:0051701,0.364055478107854,0.865218535384878,2,194,interaction with host,BP,MOG;EGFR
5209,GO:0014855,0.365013566452377,0.925055165506615,1,64,striated muscle cell proliferation,BP,GJA1
7141,GO:0030104,0.365049027823721,0.925008543412649,1,66,water homeostasis,BP,FA2H
11203,GO:0043393,0.365078816313827,0.864574481749932,2,194,regulation of protein binding,BP,PLCL1;CTHRC1
7765,GO:0031323,0.365336760289609,0.709794498031781,38,5500,regulation of cellular metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;BVES;PLCL1;CDK18;TRIM67;MYRF;PDGFRA;GPNMB;ENPP2;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;SLC45A3;GREM1;GPD1;KNDC1;DMRT2;MYO1D;BOK;CNTN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
7034,GO:0022617,0.365527176042303,0.924752434768488,1,69,extracellular matrix disassembly,BP,ADAMTS4
7351,GO:0030426,0.366235680324868,0.863925733543986,2,175,growth cone,CC,STMN4;NGFR
1262,GO:0002791,0.366247469315927,0.83017209808896,3,332,regulation of peptide secretion,BP,BAIAP3;EGFR;GJA1
524,GO:0001655,0.367073436705211,0.829637655731326,3,306,urogenital system development,BP,CRLF1;PDGFRA;GREM1
14569,GO:0060420,0.367610878778652,0.923862625289898,1,66,regulation of heart growth,BP,GJA1
16136,GO:0071383,0.367908906822001,0.862801509109772,2,190,cellular response to steroid hormone stimulus,BP,SOX10;EGFR
16705,GO:0072332,0.368243313355973,0.923469677826376,1,74,intrinsic apoptotic signaling pathway by p53 class mediator,BP,BOK
9254,GO:0034332,0.368451194403401,0.923566905562445,1,61,adherens junction organization,BP,CDH19
12557,GO:0046889,0.369160317407882,0.923080557774131,1,72,positive regulation of lipid biosynthetic process,BP,SLC45A3
21371,GO:1990778,0.369202982868424,0.828089657929946,3,320,protein localization to cell periphery,BP,EGFR;ANK3;MAL
10586,GO:0042180,0.36953669096378,0.861659433814216,2,221,cellular ketone metabolic process,BP,SLC45A3;GPD1
5083,GO:0012506,0.370434878637812,0.777673024379193,6,745,vesicle membrane,CC,LRP2;TF;ATP10B;GPNMB;EGFR;SNX22
15683,GO:0070507,0.370504542520623,0.861185257796976,2,182,regulation of microtubule cytoskeleton organization,BP,STMN4;TUBB4A
2849,GO:0005977,0.37054074815591,0.922571298034699,1,64,glycogen metabolic process,BP,PHKG1
4601,GO:0009952,0.370697669918787,0.860992959849995,2,199,anterior/posterior pattern specification,BP,PCSK6;DMRT2
10975,GO:0043010,0.37100722353794,0.826824361778338,3,308,camera-type eye development,BP,DCX;PDGFRA;EGFR
3782,GO:0007600,0.371065779252922,0.8046824115028,4,485,sensory perception,BP,LRP2;GJB6;PIEZO2;MBP
20079,GO:1903829,0.371279599509336,0.826599523501856,3,322,positive regulation of cellular protein localization,BP,NGFR;EGFR;ANK3
21191,GO:1990204,0.371711608209988,0.921702726068847,1,94,oxidoreductase complex,CC,GPD1
7133,GO:0030073,0.372083214912547,0.860122854719993,2,195,insulin secretion,BP,BAIAP3;GJA1
19233,GO:1901991,0.372313609188733,0.8599047246221,2,215,negative regulation of mitotic cell cycle phase transition,BP,GPNMB;GJC2
16160,GO:0071417,0.372439284240741,0.787947644583751,5,591,cellular response to organonitrogen compound,BP,NGFR;PDGFRA;EGFR;GJA1;GPD1
7206,GO:0030193,0.372657177828909,0.921464385225255,1,74,regulation of blood coagulation,BP,PDGFRA
17486,GO:0097194,0.373202733809515,0.921190234514385,1,76,execution phase of apoptosis,BP,BOK
22116,GO:2001234,0.374867457299817,0.858274223475213,2,212,negative regulation of apoptotic signaling pathway,BP,EYA2;BOK
11994,GO:0045682,0.37494131090997,0.920440390845092,1,72,regulation of epidermis development,BP,NGFR
7242,GO:0030234,0.375166166990587,0.764399207740619,7,914,enzyme regulator activity,MF,ERBB3;CAPN3;EGFR;GREM1;MAL;SPOCK3;COL28A1
14667,GO:0060562,0.375247023145269,0.823762225130526,3,314,epithelial tube morphogenesis,BP,LRP2;CTHRC1;GREM1
22025,GO:2001020,0.375309521465026,0.858031753615628,2,200,regulation of response to DNA damage stimulus,BP,EYA2;EGFR
8383,GO:0032432,0.375329108952545,0.920348213180146,1,66,actin filament bundle,CC,LDB3
8362,GO:0032410,0.375343485167332,0.92024168158684,1,73,negative regulation of transporter activity,BP,ANK3
2916,GO:0006073,0.37604614273545,0.920033052706735,1,65,cellular glucan metabolic process,BP,PHKG1
11448,GO:0044042,0.37604614273545,0.920033052706735,1,65,glucan metabolic process,BP,PHKG1
2926,GO:0006094,0.376106180847815,0.919851576521719,1,76,gluconeogenesis,BP,GPD1
532,GO:0001664,0.376359057803544,0.857253680649781,2,231,G protein-coupled receptor binding,MF,FZD7;CTHRC1
18680,GO:1900046,0.376489389857535,0.919686029932669,1,75,regulation of hemostasis,BP,PDGFRA
9050,GO:0033692,0.376675439803856,0.919758365922624,1,64,cellular polysaccharide biosynthetic process,BP,PHKG1
16538,GO:0072078,0.377121626281383,0.919487660764606,1,68,nephron tubule morphogenesis,BP,GREM1
20189,GO:1904035,0.377327583158671,0.919309152046486,1,74,regulation of epithelial cell apoptotic process,BP,BOK
7187,GO:0030166,0.377520808978489,0.919366084937668,1,64,proteoglycan biosynthetic process,BP,ACAN
5254,GO:0015031,0.377614932201103,0.73059445214396,13,1814,protein transport,BP,BAIAP3;NGFR;LRP2;TF;MLC1;PEX5L;RPS4Y1;EGFR;ANK3;GJA1;SNX22;MYO1D;APOD
8802,GO:0033077,0.377835041007117,0.91909903957374,1,72,T cell differentiation in thymus,BP,FZD7
9243,GO:0034308,0.377939942714539,0.918932173376128,1,82,primary alcohol metabolic process,BP,GPD1
13520,GO:0051046,0.378742594415044,0.782911937514858,5,622,regulation of secretion,BP,BAIAP3;ERBB3;EGFR;GJA1;LGI3
8592,GO:0032755,0.3790310265715,0.918477588631155,1,77,positive regulation of interleukin-6 production,BP,MBP
10771,GO:0042578,0.379566216522768,0.820613878572711,3,323,phosphoric ester hydrolase activity,MF,EYA2;PLCL1;ENPP2
4183,GO:0008652,0.37961601607134,0.918203508861884,1,77,cellular amino acid biosynthetic process,BP,FOLH1
16823,GO:0072599,0.379706322812304,0.91788168020222,1,111,establishment of protein localization to endoplasmic reticulum,BP,RPS4Y1
7138,GO:0030100,0.379818105011049,0.855131030467346,2,195,regulation of endocytosis,BP,TF;GREM1
3536,GO:0007031,0.381104796765469,0.917458118809412,1,81,peroxisome organization,BP,PEX5L
14223,GO:0055072,0.381546971947424,0.917307072587271,1,76,iron ion homeostasis,BP,TF
11054,GO:0043154,0.381769663047586,0.917155181803158,1,80,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,NGFR
3083,GO:0006368,0.381877251519301,0.917127108485326,1,78,transcription elongation from RNA polymerase II promoter,BP,SOX10
9212,GO:0034220,0.382353993087292,0.750683120370716,8,1026,ion transmembrane transport,BP,LRP2;CAPN3;ANK3;GJA1;PIEZO2;KCNJ6;DAPK1;GJC2
1471,GO:0003208,0.3831421112571,0.916662918544768,1,68,cardiac ventricle morphogenesis,BP,LRP2
137,GO:0000287,0.383690941015675,0.852580098181197,2,200,magnesium ion binding,MF,EYA2;ATP10B
1395,GO:0003073,0.383768164370692,0.916230499958622,1,78,regulation of systemic arterial blood pressure,BP,GJA1
16388,GO:0071805,0.384461261346925,0.852089861897473,2,196,potassium ion transmembrane transport,BP,ANK3;KCNJ6
2607,GO:0005546,0.384613670674384,0.915933377319304,1,70,phosphatidylinositol-4,5-bisphosphate binding,MF,FZD7
7718,GO:0031253,0.385856880052422,0.816031572306458,3,315,cell projection membrane,CC,LRP2;BVES;MYO1D
16544,GO:0072088,0.38646946587124,0.915046323569682,1,70,nephron epithelium morphogenesis,BP,GREM1
7352,GO:0030427,0.386615169364242,0.850731843895526,2,182,site of polarized growth,CC,STMN4;NGFR
13374,GO:0050818,0.387032819967977,0.914669004183262,1,78,regulation of coagulation,BP,PDGFRA
6482,GO:0019319,0.387132248280714,0.914609330205632,1,79,hexose biosynthetic process,BP,GPD1
7315,GO:0030335,0.387300343203485,0.792194268726976,4,471,positive regulation of cell migration,BP,PDGFRA;GPNMB;ENPP2;EGFR
7600,GO:0031016,0.387673410492015,0.91442488909908,1,73,pancreas development,BP,NKX6-2
10327,GO:0038024,0.387866287550972,0.914405807073847,1,68,cargo receptor activity,MF,ENPP2
12072,GO:0045833,0.38813339760273,0.914163484211813,1,76,negative regulation of lipid metabolic process,BP,APOD
13661,GO:0051279,0.389199667096807,0.913687903502931,1,73,regulation of release of sequestered calcium ion into cytosol,BP,CAPN3
11268,GO:0043507,0.389390559211767,0.913669875628047,1,68,positive regulation of JUN kinase activity,BP,TF
8979,GO:0033555,0.389595752545545,0.913482342569535,1,74,multicellular organismal response to stress,BP,GJA1
5516,GO:0015800,0.3896356779574,0.913535412912587,1,69,acidic amino acid transport,BP,GJA1
14550,GO:0060395,0.390648116819982,0.912999147388254,1,72,SMAD protein signal transduction,BP,TF
2594,GO:0005524,0.39074673818589,0.726780574932784,11,1358,ATP binding,MF,ERBB3;FGFR3;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;DNAH17;DAPK1
7020,GO:0022414,0.391514911381405,0.736335313751903,9,1224,reproductive process,BP,CLDN11;LRP2;GAL3ST1;PDGFRA;EGFR;GJA1;GJB1;DMRT2;BOK
20207,GO:1904063,0.391962497814405,0.912266392610075,1,79,negative regulation of cation transmembrane transport,BP,ANK3
4008,GO:0008344,0.393076654296628,0.911798855881118,1,73,adult locomotory behavior,BP,CNTN2
2,GO:0000003,0.393567470770521,0.734556767676879,9,1227,reproduction,BP,CLDN11;LRP2;GAL3ST1;PDGFRA;EGFR;GJA1;GJB1;DMRT2;BOK
6111,GO:0016925,0.393856180621932,0.911402104192765,1,74,protein sumoylation,BP,CAPN3
3417,GO:0006839,0.394393458134034,0.845375438213257,2,228,mitochondrial transport,BP,EYA2;BOK
161,GO:0000323,0.394450849144428,0.770226900061169,5,648,lytic vacuole,CC,LRP2;MLC1;ANK3;GJA1;ACAN
2718,GO:0005764,0.394450849144428,0.770226900061169,5,648,lysosome,CC,LRP2;MLC1;ANK3;GJA1;ACAN
14566,GO:0060415,0.394938656975682,0.91095941224037,1,68,muscle tissue morphogenesis,BP,LRP2
2940,GO:0006110,0.395140209946133,0.910812761075442,1,71,regulation of glycolytic process,BP,GPD1
4629,GO:0010035,0.395550257044154,0.78568407666529,4,507,response to inorganic substance,BP,TF;CAPN3;EGFR;ANK3
453,GO:0001523,0.395611349024099,0.910436099972251,1,82,retinoid metabolic process,BP,LRP2
19919,GO:1903533,0.39596650125842,0.910307873300739,1,78,regulation of protein targeting,BP,ANK3
16510,GO:0072028,0.396166722802944,0.910290252089585,1,72,nephron morphogenesis,BP,GREM1
12507,GO:0046785,0.396202735173096,0.910257873739048,1,73,microtubule polymerization,BP,TUBB4A
14654,GO:0060541,0.396560884014707,0.844035541956469,2,195,respiratory system development,BP,PDGFRA;EGFR
15064,GO:0061333,0.396989888661052,0.909881928626814,1,72,renal tubule morphogenesis,BP,GREM1
5620,GO:0015980,0.397060991600112,0.843545280642998,2,239,energy derivation by oxidation of organic compounds,BP,PHKG1;GPD1
3801,GO:0007623,0.397067424267199,0.843653142790515,2,205,circadian rhythm,BP,NGFR;EGFR
6214,GO:0017157,0.397682253766634,0.843233714759399,2,206,regulation of exocytosis,BP,BAIAP3;LGI3
13589,GO:0051149,0.397715360510805,0.909414248025234,1,80,positive regulation of muscle cell differentiation,BP,GREM1
10736,GO:0042493,0.397843584580015,0.807038831929805,3,361,response to drug,BP,SOX10;EGFR;APOD
19234,GO:1901992,0.399161942087293,0.908703774265132,1,79,positive regulation of mitotic cell cycle phase transition,BP,EGFR
19230,GO:1901988,0.399507819928225,0.841926461535788,2,226,negative regulation of cell cycle phase transition,BP,GPNMB;GJC2
14023,GO:0051966,0.400155234874812,0.908316673296423,1,71,regulation of synaptic transmission, glutamatergic,BP,EGFR
19806,GO:1903321,0.400529998723643,0.907992801814347,1,81,negative regulation of protein modification by small protein conjugation or removal,BP,CAPN3
14562,GO:0060411,0.401683505500868,0.90756359417356,1,70,cardiac septum morphogenesis,BP,LRP2
2032,GO:0004527,0.402927720468706,0.906819193051581,1,78,exonuclease activity,MF,ENPP2
2740,GO:0005789,0.403190366923343,0.740757745286675,7,963,endoplasmic reticulum membrane,CC,FA2H;ATP10B;MYRF;EGFR;GJA1;GJB1;BOK
11322,GO:0043583,0.40340860624508,0.839340819521697,2,205,ear development,BP,GJB6;CTHRC1
21519,GO:2000117,0.403607299228776,0.906379904827149,1,86,negative regulation of cysteine-type endopeptidase activity,BP,NGFR
12311,GO:0046364,0.404059171203509,0.906160819406464,1,85,monosaccharide biosynthetic process,BP,GPD1
4563,GO:0009798,0.404486438683616,0.906001575369265,1,80,axis specification,BP,PCSK6
18765,GO:1900182,0.40474168869761,0.905910222372635,1,77,positive regulation of protein localization to nucleus,BP,NGFR
5590,GO:0015914,0.405130881414989,0.905739299981118,1,75,phospholipid transport,BP,ATP10B
464,GO:0001540,0.405494850731462,0.905553434713087,1,75,amyloid-beta binding,MF,NGFR
18142,GO:0099518,0.405962267597472,0.905441994247588,1,67,vesicle cytoskeletal trafficking,BP,MYO1D
5543,GO:0015833,0.406001849573013,0.70535239159373,13,1851,peptide transport,BP,BAIAP3;NGFR;LRP2;TF;MLC1;PEX5L;RPS4Y1;EGFR;ANK3;GJA1;SNX22;MYO1D;APOD
8263,GO:0032271,0.407297074615039,0.836648392519777,2,210,regulation of protein polymerization,BP,TUBB4A;TMSB15A
13044,GO:0048667,0.407516223451992,0.759564782898428,5,573,cell morphogenesis involved in neuron differentiation,BP,NGFR;MAG;ANK3;KNDC1;CNTN2
14449,GO:0060271,0.408348541320988,0.799137212094394,3,335,cilium assembly,BP,DCX;TUBB4A;DNAH17
16796,GO:0072562,0.408356008957018,0.903885109510082,1,92,blood microparticle,CC,TF
131,GO:0000271,0.409116143673394,0.903753254450954,1,71,polysaccharide biosynthetic process,BP,PHKG1
10127,GO:0036126,0.410175445945043,0.903050537588227,1,82,sperm flagellum,CC,DNAH17
18198,GO:0099601,0.410917424054872,0.902788132206341,1,73,regulation of neurotransmitter receptor activity,BP,DAPK1
5037,GO:0010942,0.41096865847989,0.756623973005504,5,659,positive regulation of cell death,BP,NGFR;ST18;MAL;BOK;DAPK1
8904,GO:0033273,0.411192793886789,0.902509378781775,1,83,response to vitamin,BP,EGFR
1428,GO:0003151,0.411294993690583,0.90254728653571,1,76,outflow tract morphogenesis,BP,LRP2
638,GO:0001818,0.411354481160498,0.833759125010464,2,232,negative regulation of cytokine production,BP,GPNMB;APOD
11511,GO:0044267,0.411648769984776,0.670737534646377,31,4589,cellular protein metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;FOLH1;TF;CAPN3;PLCL1;CDK18;TRIM67;GAL3ST1;RPS4Y1;PDGFRA;GPNMB;ENPP2;EGFR;ST18;CNDP1;FZD7;PHKG1;GREM1;KNDC1;BOK;CNTN2;SPOCK3;DAPK1;MBP;GJC2;COL28A1
12613,GO:0046982,0.411836446611641,0.83347034075326,2,218,protein heterodimerization activity,MF,ERBB3;BOK
6028,GO:0016787,0.411842898694711,0.693864357981704,15,2132,hydrolase activity,MF,EYA2;FOLH1;CAPN3;TUBB4A;PLCL1;MYRF;CPM;ENPP2;PCSK6;CNDP1;ADAMTS4;KLK6;CARNS1;MYO1D;DNAH17
3813,GO:0008015,0.411896385472118,0.772652558822578,4,495,blood circulation,BP,BVES;EGFR;GJA1;SGCD
1515,GO:0003281,0.411936326245759,0.902323020953324,1,69,ventricular septum development,BP,LRP2
21082,GO:1905897,0.412038218742013,0.902033685722847,1,86,regulation of response to endoplasmic reticulum stress,BP,BOK
2942,GO:0006112,0.412395928465282,0.901987472617058,1,75,energy reserve metabolic process,BP,PHKG1
10811,GO:0042641,0.412549130674123,0.901953329433269,1,72,actomyosin,CC,LDB3
5140,GO:0014069,0.412549794278392,0.795942545904261,3,324,postsynaptic density,CC,NGFR;BCAS1;ANKS1B
17675,GO:0097581,0.413064404240502,0.901623275330824,1,76,lamellipodium organization,BP,ENPP2
14884,GO:0060964,0.413103549914436,0.901535475206587,1,81,regulation of gene silencing by miRNA,BP,EGFR
7922,GO:0031594,0.41332042276552,0.901518644310648,1,74,neuromuscular junction,CC,ANK3
15482,GO:0070167,0.413593153799345,0.901304632885944,1,79,regulation of biomineral tissue development,BP,GREM1
18418,GO:0110149,0.413593153799345,0.901304632885944,1,79,regulation of biomineralization,BP,GREM1
12088,GO:0045860,0.413753402543085,0.771156172940121,4,491,positive regulation of protein kinase activity,BP,ERBB3;TF;EGFR;GREM1
5941,GO:0016616,0.413908573638647,0.900901754264609,1,102,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,GPD1
3391,GO:0006796,0.414726276812156,0.680285717370004,20,2904,phosphate-containing compound metabolic process,BP,CRLF1;EYA2;ERBB3;FGFR3;TF;PLCL1;CDK18;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;PHKG1;GREM1;GPD1;KNDC1;MYO1D;DAPK1;MBP;GJC2
7059,GO:0022853,0.415065674431747,0.83127457739918,2,202,active ion transmembrane transporter activity,MF,SLC45A3;SLC5A11
13603,GO:0051171,0.415581138400609,0.664650885411334,35,5140,regulation of nitrogen compound metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;PLCL1;CDK18;TRIM67;MYRF;PDGFRA;GPNMB;ENPP2;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;GREM1;GPD1;KNDC1;DMRT2;BOK;CNTN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
17809,GO:0098655,0.415633683970956,0.740047565808013,6,777,cation transmembrane transport,BP,CAPN3;ANK3;PIEZO2;KCNJ6;DAPK1;GJC2
5269,GO:0015078,0.415754244020977,0.900036818299977,1,90,proton transmembrane transporter activity,MF,SLC45A3
13033,GO:0048644,0.416331536123384,0.899933178129469,1,74,muscle organ morphogenesis,BP,LRP2
5378,GO:0015291,0.416347392611423,0.830361833311716,2,205,secondary active transmembrane transporter activity,MF,SLC45A3;SLC5A11
6448,GO:0019217,0.417398238737328,0.899269103168369,1,81,regulation of fatty acid metabolic process,BP,SLC45A3
18015,GO:0098982,0.417473853209981,0.899359445518558,1,72,GABA-ergic synapse,CC,ACAN
15681,GO:0070498,0.41795500178106,0.89880958468043,1,96,interleukin-1-mediated signaling pathway,BP,ST18
94,GO:0000184,0.418281488949359,0.898476939968803,1,117,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,RPS4Y1
9105,GO:0033993,0.418448624197673,0.73761709242224,6,815,response to lipid,BP,SOX10;MLC1;GJB6;EGFR;GJA1;FZD7
8343,GO:0032388,0.418640342628536,0.828717271778976,2,212,positive regulation of intracellular transport,BP,MLC1;ANK3
4614,GO:0009987,0.418720726549912,0.708188880830346,89,13730,cellular process,BP,CRLF1;BAIAP3;ANLN;CLDN11;STMN4;NGFR;EYA2;BCAS1;ERBB3;FGFR3;CDH19;DCX;LRP2;FOLH1;TF;CAPN3;SOX10;MLC1;PLLP;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;CDK18;ATP10B;PPL;TRIM67;GJB6;LDB3;PLP1;MYRF;GAL3ST1;RPS4Y1;HAPLN2;PDGFRA;CPM;GPNMB;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;ACAN;TMSB15A;SLC45A3;ADAMTS4;SLC5A11;TMEM144;EDIL3;PHKG1;CTHRC1;GREM1;GPD1;KLK6;LGI3;GJB1;SGCD;KNDC1;MAL;CARNS1;DMRT2;SUSD5;UGT8;MYO1D;BOK;GPR62;CNTN2;ANKS1B;GLDN;DNAH17;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
8472,GO:0032555,0.419026552194389,0.693606865483215,13,1712,purine ribonucleotide binding,MF,ERBB3;FGFR3;TUBB4A;BVES;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;DNAH17;DAPK1
16906,GO:0080090,0.419976946303181,0.660040637611676,36,5300,regulation of primary metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;TF;CAPN3;SOX10;PLCL1;CDK18;TRIM67;MYRF;PDGFRA;GPNMB;ENPP2;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;SLC45A3;GREM1;GPD1;KNDC1;DMRT2;BOK;CNTN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
5106,GO:0014032,0.420275803612968,0.897759830608818,1,79,neural crest cell development,BP,SOX10
13104,GO:0048762,0.420655778052338,0.8272937489129,2,211,mesenchymal cell differentiation,BP,SOX10;GREM1
19135,GO:1901681,0.420808748334039,0.827140548239424,2,223,sulfur compound binding,MF,GPNMB;PCSK6
3261,GO:0006605,0.421020018242127,0.789222135809364,3,415,protein targeting,BP,PEX5L;RPS4Y1;ANK3
10526,GO:0042058,0.421276805947711,0.897182452910892,1,82,regulation of epidermal growth factor receptor signaling pathway,BP,EGFR
12614,GO:0046983,0.421726189450481,0.734798275495064,6,825,protein dimerization activity,MF,ERBB3;MAG;PDGFRA;GREM1;GPD1;BOK
19461,GO:1902554,0.421749452032688,0.896902927852929,1,84,serine/threonine protein kinase complex,CC,PHKG1
693,GO:0001892,0.421794599829688,0.896916625570121,1,81,embryonic placenta development,BP,EGFR
2281,GO:0004896,0.421888568664902,0.896792516248166,1,87,cytokine receptor activity,MF,CRLF1
10566,GO:0042147,0.421982308262845,0.896842435087611,1,79,retrograde transport, endosome to Golgi,BP,BAIAP3
19085,GO:1901606,0.421983300550082,0.896648426867989,1,96,alpha-amino acid catabolic process,BP,CARNS1
19010,GO:1901379,0.422223957982213,0.896698447208722,1,80,regulation of potassium ion transmembrane transport,BP,ANK3
12569,GO:0046914,0.422444415065913,0.724126137304364,7,939,transition metal ion binding,MF,TF;FA2H;TRIM67;CPM;ENPP2;ST18;MYT1
16118,GO:0071356,0.422601507871742,0.825771707531839,2,253,cellular response to tumor necrosis factor,BP,ST18;GPD1
16840,GO:0072676,0.422688819677021,0.896276554742715,1,95,lymphocyte migration,BP,APOD
8832,GO:0033138,0.422909312991773,0.896252672124714,1,86,positive regulation of peptidyl-serine phosphorylation,BP,EGFR
14953,GO:0061053,0.423607037514641,0.895978486290752,1,78,somite development,BP,DMRT2
9416,GO:0034637,0.424379871895088,0.895559276557175,1,78,cellular carbohydrate biosynthetic process,BP,PHKG1
8271,GO:0032279,0.425006318506245,0.786254697128213,3,330,asymmetric synapse,CC,NGFR;BCAS1;ANKS1B
1184,GO:0002683,0.426557473191106,0.784923320321205,3,389,negative regulation of immune system process,BP,GPNMB;GREM1;APOD
13434,GO:0050906,0.426767277179643,0.894055379833821,1,95,detection of stimulus involved in sensory perception,BP,PIEZO2
19141,GO:1901699,0.427002267204708,0.743176307003366,5,634,cellular response to nitrogen compound,BP,NGFR;PDGFRA;EGFR;GJA1;GPD1
14369,GO:0060147,0.427332510993478,0.893867185166905,1,84,regulation of posttranscriptional gene silencing,BP,EGFR
14886,GO:0060966,0.427332510993478,0.893867185166905,1,84,regulation of gene silencing by RNA,BP,EGFR
2751,GO:0005811,0.42743788739123,0.89376148662614,1,88,lipid droplet,CC,CLDN11
13427,GO:0050896,0.427648628901087,0.649837939477902,49,7419,response to stimulus,BP,CRLF1;BAIAP3;NGFR;EYA2;ERBB3;FGFR3;DCX;LRP2;TF;CAPN3;SOX10;MLC1;PLLP;MAG;BVES;PEX5L;PLCL1;PPL;TRIM67;GJB6;PLP1;PDGFRA;GPNMB;RAPGEF5;ENPP2;MOG;PCSK6;EGFR;ST18;ANK3;GJA1;PIEZO2;FZD7;CTHRC1;GREM1;GPD1;KLK6;SGCD;KNDC1;MAL;SUSD5;BOK;GPR62;CNTN2;ANKS1B;APOD;DAPK1;MBP;GJC2
3885,GO:0008144,0.428194728026546,0.893312263361991,1,91,drug binding,MF,LRP2
3844,GO:0008076,0.428593178367999,0.893187028503851,1,83,voltage-gated potassium channel complex,CC,KCNJ6
16066,GO:0071277,0.428621371989582,0.893211707333599,1,80,cellular response to calcium ion,BP,CAPN3
10582,GO:0042175,0.428686887654482,0.71863743149894,7,983,nuclear outer membrane-endoplasmic reticulum membrane network,CC,FA2H;ATP10B;MYRF;EGFR;GJA1;GJB1;BOK
2750,GO:0005802,0.429077204887794,0.821237649259182,2,218,trans-Golgi network,CC,BAIAP3;BOK
6170,GO:0017076,0.429234621444816,0.684294715005222,13,1726,purine nucleotide binding,MF,ERBB3;FGFR3;TUBB4A;BVES;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;DNAH17;DAPK1
12043,GO:0045778,0.429937749556186,0.892445036595231,1,83,positive regulation of ossification,BP,CTHRC1
14199,GO:0055017,0.429999746005377,0.892451204442879,1,80,cardiac muscle tissue growth,BP,GJA1
10918,GO:0042886,0.430136960215177,0.683440043727134,13,1882,amide transport,BP,BAIAP3;NGFR;LRP2;TF;MLC1;PEX5L;RPS4Y1;EGFR;ANK3;GJA1;SNX22;MYO1D;APOD
8470,GO:0032553,0.430517927518374,0.683118937053959,13,1727,ribonucleotide binding,MF,ERBB3;FGFR3;TUBB4A;BVES;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;DNAH17;DAPK1
21680,GO:2000379,0.430776382542368,0.891919155630133,1,88,positive regulation of reactive oxygen species metabolic process,BP,EGFR
2489,GO:0005249,0.4311217042161,0.891815851545323,1,81,voltage-gated potassium channel activity,MF,KCNJ6
3390,GO:0006793,0.431301453369824,0.664903243230391,20,2929,phosphorus metabolic process,BP,CRLF1;EYA2;ERBB3;FGFR3;TF;PLCL1;CDK18;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;PHKG1;GREM1;GPD1;KNDC1;MYO1D;DAPK1;MBP;GJC2
11246,GO:0043470,0.431684492173743,0.891517181753023,1,80,regulation of carbohydrate catabolic process,BP,GPD1
7008,GO:0022402,0.431764218668335,0.700839272390466,9,1239,cell cycle process,BP,ANLN;CAPN3;TUBB4A;CDK18;GPNMB;EGFR;ANK3;GJA1;GJC2
554,GO:0001701,0.43297635451025,0.779907445266742,3,355,in utero embryonic development,BP,SOX10;PDGFRA;EGFR
38,GO:0000079,0.433086829141964,0.890566977794089,1,94,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,EGFR
17882,GO:0098794,0.433207093616705,0.737912060111799,5,612,postsynapse,CC,NGFR;BCAS1;ANK3;CNTN2;ANKS1B
11267,GO:0043506,0.433490052186572,0.890496653352193,1,81,regulation of JUN kinase activity,BP,TF
3402,GO:0006813,0.433943019348389,0.817706273803678,2,218,potassium ion transport,BP,ANK3;KCNJ6
3721,GO:0007409,0.434705663039894,0.753986360612004,4,461,axonogenesis,BP,NGFR;MAG;ANK3;CNTN2
7298,GO:0030316,0.435385991498542,0.889380243691726,1,85,osteoclast differentiation,BP,TF
13148,GO:0048864,0.435554220517923,0.889311585827596,1,83,stem cell development,BP,SOX10
3526,GO:0007017,0.435557172243141,0.72284999918783,6,764,microtubule-based process,BP,STMN4;DCX;TUBB4A;GJA1;CNTN2;DNAH17
17724,GO:0097729,0.435853129773344,0.889092371411394,1,87,9+2 motile cilium,CC,DNAH17
4585,GO:0009894,0.435893952224112,0.71229653827457,7,946,regulation of catabolic process,BP,LRP2;TRIM67;EGFR;GJA1;GPD1;BOK;DAPK1
1624,GO:0003735,0.436239515843243,0.888418547483109,1,153,structural constituent of ribosome,MF,RPS4Y1
8461,GO:0032535,0.437271458948233,0.776485206179504,3,353,regulation of cellular component size,BP,MAG;TMSB15A;CNTN2
5720,GO:0016197,0.438418391127948,0.814439134048738,2,215,endosomal transport,BP,BAIAP3;BVES
5105,GO:0014031,0.438614924714858,0.887580742785169,1,83,mesenchymal cell development,BP,SOX10
9500,GO:0034766,0.439347173641762,0.887076758458851,1,90,negative regulation of ion transmembrane transport,BP,ANK3
17811,GO:0098657,0.439406001555735,0.813703621630776,2,217,import into cell,BP,LRP2;KCNJ6
8733,GO:0032963,0.440009401710852,0.88668755704493,1,91,collagen metabolic process,BP,KLK6
13429,GO:0050900,0.44017837091669,0.774066768853885,3,401,leukocyte migration,BP,MAG;GREM1;APOD
11661,GO:0044782,0.440221921303221,0.774117840500212,3,353,cilium organization,BP,DCX;TUBB4A;DNAH17
13075,GO:0048704,0.440572318219897,0.886365795778736,1,91,embryonic skeletal system morphogenesis,BP,PDGFRA
2575,GO:0005496,0.440963556765027,0.886141834460816,1,91,steroid binding,MF,APOD
542,GO:0001676,0.441008327581163,0.886042433092186,1,98,long-chain fatty acid metabolic process,BP,PLP1
15416,GO:0070062,0.441064015427619,0.67719373462737,12,1827,extracellular exosome,CC,BCAS1;LRP2;FOLH1;TF;TUBB4A;PPL;CPM;ERMN;EDIL3;GPD1;MYO1D;APOD
8549,GO:0032680,0.441111949500258,0.886003010650527,1,96,regulation of tumor necrosis factor production,BP,GPNMB
12776,GO:0048013,0.441916304152018,0.885642982323171,1,87,ephrin receptor signaling pathway,BP,ANKS1B
19231,GO:1901989,0.442481836024073,0.885270136271065,1,91,positive regulation of cell cycle phase transition,BP,EGFR
13387,GO:0050848,0.442604687168831,0.885210979404907,1,90,regulation of calcium-mediated signaling,BP,ERBB3
11086,GO:0043202,0.442664539347248,0.885188340939014,1,89,lysosomal lumen,CC,ACAN
18911,GO:1901135,0.442970470769452,0.705986537577667,7,991,carbohydrate derivative metabolic process,BP,FA2H;GAL3ST1;PCSK6;ACAN;GPD1;UGT8;SPOCK3
12132,GO:0045935,0.443146212760557,0.675300873706818,12,1689,positive regulation of nucleobase-containing compound metabolic process,BP,NGFR;EYA2;TF;CAPN3;SOX10;MYRF;EGFR;ST18;FZD7;GREM1;GPD1;DMRT2
4857,GO:0010717,0.443251414233455,0.884874683719411,1,87,regulation of epithelial to mesenchymal transition,BP,GREM1
13838,GO:0051606,0.443252052332829,0.810754495722881,2,246,detection of stimulus,BP,NGFR;PIEZO2
17934,GO:0098876,0.443370603296812,0.884858555848262,1,83,vesicle-mediated transport to the plasma membrane,BP,ANK3
1370,GO:0003013,0.443768480769608,0.746314477027665,4,516,circulatory system process,BP,BVES;EGFR;GJA1;SGCD
6971,GO:0021954,0.444521957003882,0.884221875500152,1,81,central nervous system neuron development,BP,CNTN2
5939,GO:0016614,0.444592669697631,0.883862488478159,1,111,oxidoreductase activity, acting on CH-OH group of donors,MF,GPD1
9490,GO:0034754,0.444960545045402,0.883715834022335,1,103,cellular hormone metabolic process,BP,PDGFRA
4506,GO:0009605,0.445116168037842,0.660483757085663,16,2383,response to external stimulus,BP,NGFR;TF;CAPN3;MAG;PPL;GJB6;PDGFRA;GPNMB;ENPP2;EGFR;GJA1;PIEZO2;GREM1;CNTN2;APOD;DAPK1
11036,GO:0043122,0.445574152819733,0.809063314381802,2,234,regulation of I-kappaB kinase/NF-kappaB signaling,BP,CAPN3;GJA1
12100,GO:0045893,0.446975571566948,0.681195138625964,10,1389,positive regulation of transcription, DNA-templated,BP,NGFR;TF;CAPN3;SOX10;MYRF;EGFR;ST18;FZD7;GREM1;DMRT2
19933,GO:1903555,0.447387005893788,0.882350013085692,1,98,regulation of tumor necrosis factor superfamily cytokine production,BP,GPNMB
9713,GO:0035418,0.447641724329595,0.882393650930057,1,82,protein localization to synapse,BP,ANKS1B
12367,GO:0046486,0.448315812924973,0.767522677188215,3,375,glycerolipid metabolic process,BP,GAL3ST1;ENPP2;GPD1
13699,GO:0051341,0.448412626288819,0.881770146496356,1,96,regulation of oxidoreductase activity,BP,EGFR
20186,GO:1904029,0.449064928628929,0.881366621411577,1,98,regulation of cyclin-dependent protein kinase activity,BP,EGFR
3594,GO:0007160,0.449235946986731,0.80641161927991,2,210,cell-matrix adhesion,BP,GREM1;APOD
18925,GO:1901184,0.449456380143497,0.88124949622677,1,88,regulation of ERBB signaling pathway,BP,EGFR
1865,GO:0004197,0.450021538566069,0.880929770614077,1,87,cysteine-type endopeptidase activity,MF,CAPN3
18186,GO:0099572,0.450810445550472,0.765541933203935,3,347,postsynaptic specialization,CC,NGFR;BCAS1;ANKS1B
18481,GO:0120162,0.450827340757729,0.880417180255644,1,90,positive regulation of cold-induced thermogenesis,BP,GJA1
16147,GO:0071396,0.451390523345583,0.739836452981896,4,526,cellular response to lipid,BP,SOX10;MLC1;EGFR;FZD7
4812,GO:0010639,0.45160798618575,0.764848131325692,3,367,negative regulation of organelle organization,BP,TUBB4A;TMSB15A;BOK
7256,GO:0030258,0.451853836741852,0.804350748140787,2,232,lipid modification,BP,FA2H;APOD
4149,GO:0008585,0.452021477871734,0.879723198242024,1,89,female gonad development,BP,PDGFRA
14512,GO:0060349,0.452218419201008,0.879631959009315,1,87,bone morphogenesis,BP,FGFR3
17539,GO:0097306,0.452248358172276,0.879683376394745,1,82,cellular response to alcohol,BP,MLC1
12571,GO:0046916,0.45246944451132,0.879325807633812,1,101,cellular transition metal ion homeostasis,BP,TF
16914,GO:0080134,0.452696705212239,0.681834001796478,9,1297,regulation of response to stress,BP,EYA2;TF;MLC1;PDGFRA;EGFR;GJA1;FZD7;BOK;APOD
14492,GO:0060326,0.452916027575057,0.803457118961195,2,260,cell chemotaxis,BP,PDGFRA;GREM1
13542,GO:0051087,0.453593317856063,0.878697732159731,1,97,chaperone binding,MF,LRP2
5107,GO:0014033,0.453839224237185,0.878668868454197,1,87,neural crest cell differentiation,BP,SOX10
13825,GO:0051591,0.453989018423114,0.878579619503496,1,87,response to cAMP,BP,GPD1
4746,GO:0010522,0.454375659615674,0.878286877994638,1,92,regulation of calcium ion transport into cytosol,BP,CAPN3
7064,GO:0022890,0.454515089782689,0.737193776331619,4,503,inorganic cation transmembrane transporter activity,MF,PIEZO2;KCNJ6;SLC45A3;SLC5A11
4174,GO:0008630,0.455189528331524,0.877723715912062,1,99,intrinsic apoptotic signaling pathway in response to DNA damage,BP,BOK
10998,GO:0043043,0.455707051467563,0.736064239420422,4,606,peptide biosynthetic process,BP,RPS4Y1;EGFR;CARNS1;DAPK1
13013,GO:0048609,0.456149784221723,0.717955971505927,5,687,multicellular organismal reproductive process,BP,CLDN11;GAL3ST1;PDGFRA;EGFR;GJA1
7013,GO:0022407,0.456162825341935,0.761063016367981,3,389,regulation of cell-cell adhesion,BP,GPNMB;ANK3;MBP
3665,GO:0007264,0.456221419648229,0.735753026316514,4,486,small GTPase mediated signal transduction,BP,NGFR;TRIM67;RAPGEF5;KNDC1
16540,GO:0072080,0.456282893385798,0.877221224219019,1,86,nephron tubule development,BP,GREM1
8524,GO:0032640,0.457166965937279,0.876516089804722,1,101,tumor necrosis factor production,BP,GPNMB
19936,GO:1903561,0.457300899033418,0.662144900747684,12,1845,extracellular vesicle,CC,BCAS1;LRP2;FOLH1;TF;TUBB4A;PPL;CPM;ERMN;EDIL3;GPD1;MYO1D;APOD
523,GO:0001654,0.457423266843708,0.760089195878354,3,354,eye development,BP,DCX;PDGFRA;EGFR
11102,GO:0043230,0.45835597651363,0.66116013853363,12,1847,extracellular organelle,CC,BCAS1;LRP2;FOLH1;TF;TUBB4A;PPL;CPM;ERMN;EDIL3;GPD1;MYO1D;APOD
3814,GO:0008016,0.4590490206591,0.798877351559493,2,230,regulation of heart contraction,BP,BVES;GJA1
14568,GO:0060419,0.459691871688348,0.87513809592015,1,88,heart growth,BP,GJA1
13407,GO:0050868,0.460348937512563,0.874580071007937,1,102,negative regulation of T cell activation,BP,GPNMB
1631,GO:0003777,0.461276342372508,0.874395373691401,1,74,microtubule motor activity,MF,DNAH17
9466,GO:0034705,0.461924991078731,0.873740829694174,1,91,potassium channel complex,CC,KCNJ6
14280,GO:0060021,0.462253423480962,0.873592150238642,1,87,roof of mouth development,BP,PDGFRA
13339,GO:0050772,0.462465581752205,0.873534663061991,1,82,positive regulation of axonogenesis,BP,NGFR
8680,GO:0032886,0.462565582310026,0.79619721695494,2,223,regulation of microtubule-based process,BP,STMN4;TUBB4A
18017,GO:0098984,0.462924103827541,0.755528597663691,3,351,neuron to neuron synapse,CC,NGFR;BCAS1;ANKS1B
8444,GO:0032504,0.463108825474297,0.711805170319995,5,695,multicellular organism reproduction,BP,CLDN11;GAL3ST1;PDGFRA;EGFR;GJA1
16355,GO:0071706,0.463263564836835,0.872789502261635,1,103,tumor necrosis factor superfamily cytokine production,BP,GPNMB
18622,GO:0150063,0.463404689246447,0.755112752985714,3,358,visual system development,BP,DCX;PDGFRA;EGFR
1189,GO:0002688,0.463931258263927,0.872323998175659,1,109,regulation of leukocyte chemotaxis,BP,GREM1
12401,GO:0046545,0.464261805706519,0.872284230328352,1,93,development of primary female sexual characteristics,BP,PDGFRA
5023,GO:0010923,0.464292479618403,0.872289880620775,1,91,negative regulation of phosphatase activity,BP,MYO1D
16155,GO:0071407,0.464637979572305,0.728442262925486,4,521,cellular response to organic cyclic compound,BP,SOX10;MLC1;EGFR;GPD1
9400,GO:0034612,0.464745442421941,0.794346044131122,2,273,response to tumor necrosis factor,BP,ST18;GPD1
15063,GO:0061326,0.464829566255203,0.871998235639123,1,88,renal tubule development,BP,GREM1
14888,GO:0060968,0.464843516094403,0.871914214264639,1,94,regulation of gene silencing,BP,EGFR
14906,GO:0060993,0.465043402254708,0.871866494397209,1,88,kidney morphogenesis,BP,GREM1
7445,GO:0030660,0.466926716752001,0.870529003698662,1,103,Golgi-associated vesicle membrane,CC,GJA1
3812,GO:0008013,0.466951223346311,0.870774607157579,1,82,beta-catenin binding,MF,GJA1
22119,GO:2001237,0.467365581487969,0.870308536966635,1,98,negative regulation of extrinsic apoptotic signaling pathway,BP,EYA2
2847,GO:0005975,0.468003973605554,0.725487484920217,4,543,carbohydrate metabolic process,BP,SLC45A3;PHKG1;GPD1;APOD
11303,GO:0043549,0.468106569122909,0.693863742806272,6,824,regulation of kinase activity,BP,ERBB3;FGFR3;TF;PDGFRA;EGFR;GREM1
13779,GO:0051493,0.468685474012039,0.724930558033392,4,511,regulation of cytoskeleton organization,BP,STMN4;TUBB4A;PDGFRA;TMSB15A
19695,GO:1903076,0.468837032648212,0.86942665705239,1,95,regulation of protein localization to plasma membrane,BP,EGFR
10718,GO:0042470,0.46907028764836,0.869214980334971,1,101,melanosome,CC,GPNMB
13107,GO:0048770,0.46907028764836,0.869214980334971,1,101,pigment granule,CC,GPNMB
10720,GO:0042472,0.469414915634358,0.869089899563479,1,93,inner ear morphogenesis,BP,CTHRC1
13871,GO:0051668,0.470025438128874,0.868720579740082,1,92,localization within membrane,BP,MAL
3404,GO:0006816,0.470394223897714,0.749201697580348,3,381,calcium ion transport,BP,CAPN3;GJA1;GJC2
18438,GO:0120034,0.470499302792397,0.868436547204155,1,91,positive regulation of plasma membrane bounded cell projection assembly,BP,ANLN
82,GO:0000166,0.470583774885458,0.642344083962824,14,1945,nucleotide binding,MF,ERBB3;FGFR3;TUBB4A;BVES;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;GPD1;CARNS1;MYO1D;DNAH17;DAPK1
18967,GO:1901265,0.470980786380396,0.641967665939078,14,1946,nucleoside phosphate binding,MF,ERBB3;FGFR3;TUBB4A;BVES;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;GPD1;CARNS1;MYO1D;DNAH17;DAPK1
5603,GO:0015931,0.47104011922154,0.789524615214456,2,242,nucleobase-containing compound transport,BP,GJA1;GJB1
20482,GO:1904659,0.471424766010423,0.867843075764291,1,92,glucose transmembrane transport,BP,SLC5A11
11248,GO:0043473,0.472011661333938,0.867449183865915,1,94,pigmentation,BP,SOX10
17813,GO:0098659,0.472126768648772,0.867427350810167,1,90,inorganic cation import across plasma membrane,BP,KCNJ6
18194,GO:0099587,0.472126768648772,0.867427350810167,1,90,inorganic ion import across plasma membrane,BP,KCNJ6
463,GO:0001539,0.472239620629196,0.867281860665352,1,96,cilium or flagellum-dependent cell motility,BP,DNAH17
14458,GO:0060285,0.472239620629196,0.867281860665352,1,96,cilium-dependent cell motility,BP,DNAH17
790,GO:0002027,0.472783496835907,0.866974958597867,1,93,regulation of heart rate,BP,BVES
13160,GO:0048880,0.472851513952541,0.747159809752967,3,363,sensory system development,BP,DCX;PDGFRA;EGFR
16915,GO:0080135,0.473625816045643,0.702426967905426,5,687,regulation of cellular response to stress,BP,EYA2;TF;EGFR;FZD7;BOK
3071,GO:0006354,0.474285823055724,0.865901987684336,1,104,DNA-templated transcription, elongation,BP,SOX10
8754,GO:0032991,0.474352294094493,0.611982841736101,30,4582,protein-containing complex,CC,CRLF1;ERBB3;FGFR3;CDH19;DCX;LRP2;TF;CAPN3;PEX5L;GJB6;LDB3;RPS4Y1;PDGFRA;EGFR;ST18;GJA1;KCNJ6;PHKG1;CTHRC1;GPD1;GJB1;SGCD;KNDC1;MYO1D;GPR62;GLDN;DNAH17;MBP;GJC2;COL28A1
6723,GO:0020037,0.474502024853597,0.865726305242538,1,108,heme binding,MF,FA2H
21489,GO:2000060,0.474592387885128,0.865782483522609,1,97,positive regulation of ubiquitin-dependent protein catabolic process,BP,TRIM67
2391,GO:0005085,0.474623471036637,0.786833198171975,2,209,guanyl-nucleotide exchange factor activity,MF,RAPGEF5;KNDC1
12126,GO:0045927,0.475263412351631,0.78623319820794,2,231,positive regulation of growth,BP,CAPN3;EGFR
19827,GO:1903362,0.475448627684,0.78604256393962,2,243,regulation of cellular protein catabolic process,BP,LRP2;TRIM67
18435,GO:0120031,0.475998500981989,0.718513297711233,4,512,plasma membrane bounded cell projection assembly,BP,ANLN;DCX;TUBB4A;DNAH17
15766,GO:0070661,0.476407525112228,0.785197265670012,2,270,leukocyte proliferation,BP,GPNMB;GREM1
11127,GO:0043266,0.477421230205682,0.864003443689231,1,95,regulation of potassium ion transport,BP,ANK3
8617,GO:0032787,0.477996869353431,0.716671650446405,4,581,monocarboxylic acid metabolic process,BP,FA2H;PLP1;SLC45A3;GPD1
20177,GO:1904019,0.478402174298881,0.863351008078877,1,97,epithelial cell apoptotic process,BP,BOK
17717,GO:0097711,0.478440374541818,0.863362634898136,1,94,ciliary basal body-plasma membrane docking,BP,TUBB4A
11509,GO:0044264,0.478892451603266,0.863124360538604,1,90,cellular polysaccharide metabolic process,BP,PHKG1
14113,GO:0052689,0.479147420692812,0.862737971521454,1,110,carboxylic ester hydrolase activity,MF,ENPP2
4765,GO:0010564,0.479722687888482,0.696926570422671,5,694,regulation of cell cycle process,BP,ANLN;TUBB4A;GPNMB;EGFR;GJC2
6603,GO:0019752,0.480426300270957,0.682577472418248,6,924,carboxylic acid metabolic process,BP,FOLH1;FA2H;PLP1;SLC45A3;GPD1;CARNS1
19596,GO:1902911,0.480504301137633,0.861985927432539,1,98,protein kinase complex,CC,PHKG1
12433,GO:0046620,0.480572876762848,0.861989739239098,1,94,regulation of organ growth,BP,GJA1
8755,GO:0032993,0.481751673061266,0.86112364727631,1,103,protein-DNA complex,CC,ST18
4153,GO:0008593,0.481781181348608,0.861183308419598,1,96,regulation of Notch signaling pathway,BP,EGFR
9330,GO:0034440,0.483771442257741,0.859769215555064,1,107,lipid oxidation,BP,APOD
2170,GO:0004725,0.483916391633868,0.859819688708549,1,94,protein tyrosine phosphatase activity,MF,EYA2
8366,GO:0032414,0.485379660063527,0.858814192947569,1,98,positive regulation of ion transmembrane transporter activity,BP,ANK3
11215,GO:0043406,0.485993020004219,0.777596239096379,2,244,positive regulation of MAP kinase activity,BP,TF;EGFR
1867,GO:0004222,0.486082122064326,0.858428779788636,1,92,metalloendopeptidase activity,MF,ADAMTS4
6765,GO:0021549,0.486275568576345,0.858275572671094,1,94,cerebellum development,BP,KNDC1
11457,GO:0044085,0.487025491800055,0.613862027943711,19,2823,cellular component biogenesis,BP,ANLN;CLDN11;CDH19;DCX;CAPN3;TUBB4A;GJB6;LDB3;HAPLN2;PDGFRA;ANK3;GJA1;TMSB15A;GREM1;GJB1;UGT8;BOK;DNAH17;APOD
4275,GO:0009063,0.48835405168773,0.856684423147159,1,115,cellular amino acid catabolic process,BP,CARNS1
5887,GO:0016525,0.489152717677178,0.856304732513651,1,100,negative regulation of angiogenesis,BP,NGFR
4445,GO:0009306,0.490131897014677,0.732244216516007,3,404,protein secretion,BP,BAIAP3;EGFR;GJA1
9804,GO:0035592,0.490131897014677,0.732244216516007,3,404,establishment of protein localization to extracellular region,BP,BAIAP3;EGFR;GJA1
9619,GO:0035249,0.490908714323002,0.855224953291738,1,93,synaptic transmission, glutamatergic,BP,EGFR
9667,GO:0035335,0.49128423865471,0.854935988588702,1,96,peptidyl-tyrosine dephosphorylation,BP,EYA2
13545,GO:0051091,0.491336083516872,0.773233909780802,2,249,positive regulation of DNA-binding transcription factor activity,BP,CAPN3;GREM1
9653,GO:0035305,0.491914830076861,0.854490614934809,1,98,negative regulation of dephosphorylation,BP,MYO1D
3678,GO:0007283,0.492216790843121,0.730413057606992,3,412,spermatogenesis,BP,CLDN11;GAL3ST1;GJA1
13123,GO:0048814,0.492249289522723,0.854372305091251,1,90,regulation of dendrite morphogenesis,BP,KNDC1
2825,GO:0005929,0.492280505928377,0.70396342436029,4,542,cilium,CC,DCX;TUBB4A;PDGFRA;DNAH17
8364,GO:0032412,0.492968577956198,0.771915079679465,2,244,regulation of ion transmembrane transporter activity,BP,ANK3;DAPK1
21914,GO:2000736,0.493140752295838,0.85352192200312,1,112,regulation of stem cell differentiation,BP,PDGFRA
9838,GO:0035639,0.493564279853971,0.627873686539675,12,1654,purine ribonucleoside triphosphate binding,MF,ERBB3;FGFR3;TUBB4A;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;DNAH17;DAPK1
7107,GO:0030031,0.496054280679343,0.7005723094168,4,527,cell projection assembly,BP,ANLN;DCX;TUBB4A;DNAH17
3182,GO:0006520,0.496493826290588,0.768863546402425,2,294,cellular amino acid metabolic process,BP,FOLH1;CARNS1
13527,GO:0051053,0.497003469308311,0.85106627646191,1,98,negative regulation of DNA metabolic process,BP,GJA1
21552,GO:2000181,0.497238993001519,0.850859255465003,1,102,negative regulation of blood vessel morphogenesis,BP,NGFR
19672,GO:1903038,0.497486536099523,0.850578350305246,1,113,negative regulation of leukocyte cell-cell adhesion,BP,GPNMB
11888,GO:0045446,0.498350615772418,0.850151189453491,1,98,endothelial cell differentiation,BP,HAPLN2
6729,GO:0021510,0.498997902059005,0.849651289540003,1,103,spinal cord development,BP,NKX6-2
8848,GO:0033157,0.500098188521183,0.7660037210363,2,251,regulation of intracellular protein transport,BP,ANK3;APOD
9497,GO:0034763,0.500351850494607,0.848652052042323,1,110,negative regulation of transmembrane transport,BP,ANK3
11583,GO:0044391,0.501800772576227,0.847244057268279,1,177,ribosomal subunit,CC,RPS4Y1
16344,GO:0071692,0.502735725645584,0.721155054646034,3,411,protein localization to extracellular region,BP,BAIAP3;EGFR;GJA1
12565,GO:0046906,0.502873629074093,0.846861340104842,1,116,tetrapyrrole binding,MF,FA2H
17403,GO:0097060,0.503107735962264,0.720897204486532,3,373,synaptic membrane,CC,ANK3;CNTNAP4;CNTN2
18588,GO:0140375,0.503149590636423,0.846653112881661,1,118,immune receptor activity,MF,CRLF1
2726,GO:0005773,0.503298281723588,0.675267956530823,5,734,vacuole,CC,LRP2;MLC1;ANK3;GJA1;ACAN
7383,GO:0030516,0.503458013987228,0.846701665756008,1,94,regulation of axon extension,BP,MAG
19069,GO:1901565,0.504757237622051,0.640280200023486,8,1201,organonitrogen compound catabolic process,BP,LRP2;CAPN3;TRIM67;ENPP2;EGFR;GJA1;ACAN;CARNS1
5009,GO:0010906,0.504959780401785,0.845584632122502,1,100,regulation of glucose metabolic process,BP,SLC45A3
15388,GO:0065008,0.505108396133883,0.588223239850643,24,3602,regulation of biological quality,BP,BAIAP3;NGFR;EYA2;TF;CAPN3;FA2H;MAG;BVES;PLCL1;ATP10B;GJB6;PDGFRA;ERMN;PCSK6;EGFR;ANK3;GJA1;PIEZO2;TMSB15A;KLK6;SGCD;BOK;CNTN2;MBP
3451,GO:0006892,0.505125671587435,0.845494345042593,1,98,post-Golgi vesicle-mediated transport,BP,ANK3
3921,GO:0008202,0.505539745865441,0.761381850341315,2,274,steroid metabolic process,BP,LRP2;PDGFRA
2823,GO:0005925,0.50567155775562,0.718557917618144,3,403,focal adhesion,CC,FGFR3;EGFR;GJA1
18848,GO:1900542,0.506217197676551,0.844674937529744,1,103,regulation of purine nucleotide metabolic process,BP,GPD1
3654,GO:0007249,0.506640554331675,0.760474050145298,2,268,I-kappaB kinase/NF-kappaB signaling,BP,CAPN3;GJA1
3025,GO:0006275,0.506642701912345,0.844366943908449,1,104,regulation of DNA replication,BP,EGFR
69,GO:0000139,0.507193149458583,0.671656147890484,5,708,Golgi membrane,CC,BAIAP3;GAL3ST1;EGFR;GJA1;BOK
7892,GO:0031532,0.507578661910613,0.843713281895643,1,104,actin cytoskeleton reorganization,BP,PDGFRA
19898,GO:1903508,0.508057473446049,0.623697555914196,10,1461,positive regulation of nucleic acid-templated transcription,BP,NGFR;TF;CAPN3;SOX10;MYRF;EGFR;ST18;FZD7;GREM1;DMRT2
8363,GO:0032411,0.508177492920437,0.843271801922696,1,106,positive regulation of transporter activity,BP,ANK3
2927,GO:0006096,0.508330231467951,0.843187115606835,1,104,glycolytic process,BP,GPD1
8180,GO:0032101,0.508768543171277,0.656167199325563,6,910,regulation of response to external stimulus,BP,CAPN3;PDGFRA;EGFR;GJA1;GREM1;APOD
16496,GO:0072009,0.508904562464192,0.842831750857184,1,100,nephron epithelium development,BP,GREM1
19510,GO:1902680,0.508966156228182,0.622819411174719,10,1462,positive regulation of RNA biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;MYRF;EGFR;ST18;FZD7;GREM1;DMRT2
12576,GO:0046928,0.509443169139376,0.842453443854197,1,100,regulation of neurotransmitter secretion,BP,BAIAP3
2954,GO:0006140,0.509630721076469,0.842262620935109,1,105,regulation of nucleotide metabolic process,BP,GPD1
17310,GO:0090596,0.509822087492921,0.757858102343318,2,247,sensory organ morphogenesis,BP,GJB6;CTHRC1
13433,GO:0050905,0.509906464193866,0.842140083492939,1,99,neuromuscular process,BP,NKX6-2
19948,GO:1903578,0.509931729220949,0.842028703294562,1,107,regulation of ATP metabolic process,BP,GPD1
9370,GO:0034504,0.510474266947421,0.757287319619775,2,252,protein localization to nucleus,BP,NGFR;APOD
18077,GO:0099094,0.510593558120228,0.841668822522305,1,98,ligand-gated cation channel activity,MF,KCNJ6
3652,GO:0007229,0.510680508001474,0.841569827031808,1,101,integrin-mediated signaling pathway,BP,PLP1
20078,GO:1903828,0.511077075038186,0.841210032117832,1,108,negative regulation of cellular protein localization,BP,APOD
3372,GO:0006766,0.511342769465558,0.84093352766157,1,117,vitamin metabolic process,BP,LRP2
3370,GO:0006757,0.511670536200262,0.840823336895983,1,105,ATP generation from ADP,BP,GPD1
7196,GO:0030175,0.512096829079637,0.840619613638472,1,97,filopodium,CC,ERMN
8546,GO:0032675,0.512667107617704,0.840004057266287,1,116,regulation of interleukin-6 production,BP,MBP
3938,GO:0008234,0.513106988328917,0.83978238276994,1,107,cysteine-type peptidase activity,MF,CAPN3
7004,GO:0022037,0.513366016147093,0.839655724080673,1,102,metencephalon development,BP,KNDC1
22,GO:0000041,0.513557396560555,0.839371040166619,1,116,transition metal ion transport,BP,TF
9566,GO:0035091,0.51360813883705,0.754658651236292,2,242,phosphatidylinositol binding,MF,FZD7;SNX22
3640,GO:0007215,0.513805552367321,0.839393329336304,1,98,glutamate receptor signaling pathway,BP,DAPK1
1371,GO:0003014,0.514449966428979,0.838815209186251,1,108,renal system process,BP,GJA1
19916,GO:1903530,0.514618789995094,0.683496670041251,4,573,regulation of secretion by cell,BP,BAIAP3;EGFR;GJA1;LGI3
2848,GO:0005976,0.514974157510759,0.838534449961925,1,100,polysaccharide metabolic process,BP,PHKG1
7124,GO:0030055,0.515396510140288,0.709812679100461,3,409,cell-substrate junction,CC,FGFR3;EGFR;GJA1
8105,GO:0031983,0.515512306755127,0.752839701108689,2,304,vesicle lumen,CC,TF;EGFR
3997,GO:0008324,0.516128627729772,0.682123303547367,4,547,cation transmembrane transporter activity,MF,PIEZO2;KCNJ6;SLC45A3;SLC5A11
11508,GO:0044262,0.516151568068152,0.752449820666943,2,251,cellular carbohydrate metabolic process,BP,SLC45A3;PHKG1
4538,GO:0009719,0.516440079532074,0.615572081033685,10,1466,response to endogenous stimulus,BP,NGFR;FGFR3;LRP2;SOX10;PDGFRA;PCSK6;EGFR;GJA1;GREM1;GPD1
6753,GO:0021537,0.516490013351323,0.75219334757726,2,242,telencephalon development,BP,EGFR;CNTN2
14227,GO:0055076,0.517088086265148,0.836808109092338,1,120,transition metal ion homeostasis,BP,TF
19407,GO:1902414,0.517481833728525,0.836737011063861,1,100,protein localization to cell junction,BP,ANKS1B
19605,GO:1902936,0.519299490238948,0.83536499046336,1,105,phosphatidylinositol bisphosphate binding,MF,FZD7
3790,GO:0007611,0.519862864378524,0.749279139676608,2,245,learning or memory,BP,EGFR;CNTN2
7578,GO:0030968,0.520877328958221,0.834104668507553,1,116,endoplasmic reticulum unfolded protein response,BP,BOK
2498,GO:0005267,0.521638828796475,0.833600642988363,1,111,potassium channel activity,MF,KCNJ6
13616,GO:0051209,0.523791614254832,0.832071568427253,1,107,release of sequestered calcium ion into cytosol,BP,CAPN3
7949,GO:0031647,0.523841024146396,0.745743839172381,2,270,regulation of protein stability,BP,TF;CAPN3
11288,GO:0043534,0.523996814997299,0.831898801708841,1,109,blood vessel endothelial cell migration,BP,GREM1
4935,GO:0010822,0.524261680500642,0.831642046085495,1,115,positive regulation of mitochondrion organization,BP,BOK
2882,GO:0006024,0.5243519097419,0.831683928729518,1,105,glycosaminoglycan biosynthetic process,BP,ACAN
3915,GO:0008194,0.524741223376817,0.831309921843263,1,113,UDP-glycosyltransferase activity,MF,UGT8
12854,GO:0048232,0.524786037995935,0.701218611360268,3,430,male gamete generation,BP,CLDN11;GAL3ST1;GJA1
12515,GO:0046822,0.525112200197448,0.831079634035151,1,109,regulation of nucleocytoplasmic transport,BP,APOD
13317,GO:0050728,0.526287505651641,0.830076395468687,1,123,negative regulation of inflammatory response,BP,APOD
16354,GO:0071705,0.52682353976613,0.587904310068707,14,2159,nitrogen compound transport,BP,BAIAP3;NGFR;LRP2;TF;MLC1;PEX5L;RPS4Y1;EGFR;ANK3;GJA1;SNX22;GJB1;MYO1D;APOD
13665,GO:0051283,0.527150800003884,0.829586895746296,1,108,negative regulation of sequestering of calcium ion,BP,CAPN3
2730,GO:0005777,0.527726095495596,0.828986190474059,1,126,peroxisome,CC,PEX5L
10772,GO:0042579,0.527726095495596,0.828986190474059,1,126,microbody,CC,PEX5L
3956,GO:0008270,0.529629448410518,0.650400355575621,5,717,zinc ion binding,MF,TRIM67;CPM;ENPP2;ST18;MYT1
9601,GO:0035195,0.530196332056443,0.827290569920142,1,111,gene silencing by miRNA,BP,EGFR
13664,GO:0051282,0.530694678288636,0.826940422155423,1,109,regulation of sequestering of calcium ion,BP,CAPN3
7067,GO:0022900,0.531166076690377,0.826207619233483,1,158,electron transport chain,BP,GPD1
2789,GO:0005874,0.53127592504202,0.695290540821081,3,397,microtubule,CC,DCX;TUBB4A;DNAH17
1127,GO:0002576,0.531409554967322,0.826302427116002,1,119,platelet degranulation,BP,TF
8437,GO:0032496,0.531739931828241,0.738744853686987,2,295,response to lipopolysaccharide,BP,GJB6;GJA1
3815,GO:0008017,0.532534741761882,0.738205800870333,2,245,microtubule binding,MF,DCX;GJB6
18913,GO:1901137,0.533214542119111,0.666003967701986,4,589,carbohydrate derivative biosynthetic process,BP,FA2H;GAL3ST1;ACAN;UGT8
637,GO:0001817,0.53326493559147,0.665933652766489,4,611,regulation of cytokine production,BP,GPNMB;MOG;APOD;MBP
8063,GO:0031902,0.53373931084435,0.824496697123707,1,125,late endosome membrane,CC,BAIAP3
12177,GO:0046031,0.534255659312028,0.824221702272724,1,113,ADP metabolic process,BP,GPD1
16828,GO:0072659,0.534445675798033,0.736446307008662,2,263,protein localization to plasma membrane,BP,EGFR;ANK3
3606,GO:0007173,0.535973459587265,0.822943129257745,1,111,epidermal growth factor receptor signaling pathway,BP,EGFR
2519,GO:0005319,0.537045568471792,0.822085717022021,1,115,lipid transporter activity,MF,APOD
13649,GO:0051258,0.53757474357259,0.733630108127972,2,272,protein polymerization,BP,TUBB4A;TMSB15A
18997,GO:1901343,0.537988722238208,0.821377325602141,1,114,negative regulation of vasculature development,BP,NGFR
20340,GO:1904375,0.538223371864166,0.821187741704226,1,115,regulation of protein localization to cell periphery,BP,EGFR
2604,GO:0005543,0.538265751021948,0.688749084055912,3,411,phospholipid binding,MF,BAIAP3;FZD7;SNX22
13318,GO:0050729,0.539045421138416,0.820437881680412,1,128,positive regulation of inflammatory response,BP,EGFR
13652,GO:0051261,0.539204286309815,0.820539138492469,1,106,protein depolymerization,BP,STMN4
15839,GO:0070838,0.539396701992948,0.687668612271849,3,422,divalent metal ion transport,BP,CAPN3;GJA1;GJC2
6080,GO:0016874,0.539704865815032,0.820023529627209,1,118,ligase activity,MF,CARNS1
13615,GO:0051208,0.540128507418875,0.819761034306868,1,112,sequestering of calcium ion,BP,CAPN3
3789,GO:0007610,0.54063446987562,0.658944437429966,4,559,behavior,BP,EGFR;GJA1;CNTNAP4;CNTN2
2262,GO:0004857,0.540750764311579,0.730697127054275,2,302,enzyme inhibitor activity,MF,SPOCK3;COL28A1
3769,GO:0007568,0.542307904230765,0.729349434299922,2,283,aging,BP,GJB6;APOD
2881,GO:0006023,0.542312415518111,0.81809048010553,1,111,aminoglycan biosynthetic process,BP,ACAN
10584,GO:0042177,0.542806186994036,0.817624513054818,1,119,negative regulation of protein catabolic process,BP,EGFR
13623,GO:0051224,0.543333521436667,0.817151090393806,1,126,negative regulation of protein transport,BP,APOD
3706,GO:0007368,0.543522722252972,0.817099858408038,1,116,determination of left/right symmetry,BP,PCSK6
19682,GO:1903052,0.543681424629006,0.816936683049279,1,120,positive regulation of proteolysis involved in cellular protein catabolic process,BP,TRIM67
8521,GO:0032635,0.543725460072398,0.816847121268581,1,126,interleukin-6 production,BP,MBP
6985,GO:0021987,0.544512403206035,0.816421006026733,1,108,cerebral cortex development,BP,EGFR
4924,GO:0010811,0.544644104558516,0.816239677215357,1,115,positive regulation of cell-substrate adhesion,BP,EDIL3
15093,GO:0061387,0.545067434414779,0.816001515358811,1,107,regulation of extent of cell growth,BP,MAG
1261,GO:0002790,0.546085920665032,0.681326817399454,3,440,peptide secretion,BP,BAIAP3;EGFR;GJA1
2739,GO:0005788,0.546106075543449,0.725942543361634,2,274,endoplasmic reticulum lumen,CC,TF;COL28A1
1549,GO:0003341,0.547178846721993,0.814200635396205,1,121,cilium movement,BP,DNAH17
13822,GO:0051588,0.548622138410384,0.813139727406599,1,114,regulation of neurotransmitter transport,BP,BAIAP3
16763,GO:0072511,0.549588680778771,0.678016387493677,3,428,divalent inorganic cation transport,BP,CAPN3;GJA1;GJC2
10569,GO:0042157,0.549600323048609,0.812259546848282,1,125,lipoprotein metabolic process,BP,APOD
2964,GO:0006165,0.550281199407363,0.811759667574102,1,121,nucleoside diphosphate phosphorylation,BP,GPD1
13414,GO:0050878,0.550495504986181,0.677139290806315,3,435,regulation of body fluid levels,BP,FA2H;PDGFRA;GJA1
3490,GO:0006954,0.551169439575701,0.648667502360869,4,642,inflammatory response,BP,PLP1;EGFR;GJA1;APOD
7875,GO:0031503,0.551889006317175,0.720671812075715,2,272,protein-containing complex localization,BP,SGCD;ANKS1B
1514,GO:0003279,0.552981070144651,0.809786546361081,1,106,cardiac septum development,BP,LRP2
12583,GO:0046939,0.553724814128676,0.809005812758763,1,123,nucleotide phosphorylation,BP,GPD1
13723,GO:0051384,0.554020224610078,0.808689883255895,1,132,response to glucocorticoid,BP,EGFR
20651,GO:1904950,0.555456036660275,0.80755744465619,1,130,negative regulation of establishment of protein localization,BP,APOD
8096,GO:0031965,0.555563850272016,0.717275058067773,2,276,nuclear membrane,CC,EGFR;BOK
917,GO:0002237,0.556792594277016,0.716044613944312,2,308,response to molecule of bacterial origin,BP,GJB6;GJA1
13641,GO:0051250,0.557319095575286,0.806009718389739,1,136,negative regulation of lymphocyte activation,BP,GPNMB
8261,GO:0032269,0.557359812908249,0.608945058503033,6,925,negative regulation of cellular protein metabolic process,BP,NGFR;CAPN3;GREM1;SPOCK3;DAPK1;COL28A1
7029,GO:0022612,0.559817329701113,0.804164013850449,1,117,gland morphogenesis,BP,EGFR
9600,GO:0035194,0.560967994985398,0.803197191764389,1,120,post-transcriptional gene silencing by RNA,BP,EGFR
11866,GO:0045333,0.561518161454584,0.802434682858991,1,161,cellular respiration,BP,GPD1
6259,GO:0018105,0.564171192565129,0.709271275660982,2,272,peptidyl-serine phosphorylation,BP,PLCL1;EGFR
5475,GO:0015711,0.564488064573482,0.663617612955566,3,447,organic anion transport,BP,LRP2;ATP10B;GJA1
5840,GO:0016441,0.56515834640167,0.799755208384929,1,121,posttranscriptional gene silencing,BP,EGFR
8877,GO:0033209,0.565628050801621,0.799095974338548,1,155,tumor necrosis factor-mediated signaling pathway,BP,ST18
5039,GO:0010948,0.566122214308863,0.707332117152052,2,306,negative regulation of cell cycle process,BP,GPNMB;GJC2
6091,GO:0016887,0.569410308120266,0.658911002159384,3,388,ATPase activity,MF,CARNS1;MYO1D;DNAH17
1469,GO:0003206,0.569699413138899,0.796001200562635,1,120,cardiac chamber morphogenesis,BP,LRP2
4328,GO:0009135,0.570183651759471,0.795556022391702,1,124,purine nucleoside diphosphate metabolic process,BP,GPD1
4369,GO:0009179,0.570183651759471,0.795556022391702,1,124,purine ribonucleoside diphosphate metabolic process,BP,GPD1
19917,GO:1903531,0.571161741116741,0.794612767105307,1,138,negative regulation of secretion by cell,BP,GJA1
7307,GO:0030326,0.571777516061862,0.794262644961928,1,120,embryonic limb morphogenesis,BP,GREM1
9580,GO:0035113,0.571777516061862,0.794262644961928,1,120,embryonic appendage morphogenesis,BP,GREM1
4476,GO:0009411,0.572040877711874,0.793934365528096,1,131,response to UV,BP,EGFR
11458,GO:0044087,0.572849021701267,0.593392918875515,6,884,regulation of cellular component biogenesis,BP,ANLN;TUBB4A;GJA1;TMSB15A;GREM1;APOD
13696,GO:0051338,0.573185550654806,0.593026669854436,6,927,regulation of transferase activity,BP,ERBB3;FGFR3;TF;PDGFRA;EGFR;GREM1
3824,GO:0008037,0.573532354567889,0.792678964231262,1,131,cell recognition,BP,CNTN2
4735,GO:0010508,0.573559524830122,0.792774582956225,1,119,positive regulation of autophagy,BP,DAPK1
12472,GO:0046683,0.574525341934049,0.791877397390135,1,127,response to organophosphorus,BP,GPD1
9406,GO:0034620,0.574837164602796,0.791541457955246,1,135,cellular response to unfolded protein,BP,BOK
17983,GO:0098936,0.575061574869818,0.791494656625847,1,120,intrinsic component of postsynaptic membrane,CC,CNTN2
4374,GO:0009185,0.57769296192877,0.789186859198111,1,127,ribonucleoside diphosphate metabolic process,BP,GPD1
4839,GO:0010675,0.577760508742423,0.789158953724939,1,124,regulation of cellular carbohydrate metabolic process,BP,SLC45A3
22124,GO:2001242,0.577797677936469,0.788909174948063,1,150,regulation of intrinsic apoptotic signaling pathway,BP,BOK
13316,GO:0050727,0.579135527065265,0.69489020713341,2,315,regulation of inflammatory response,BP,EGFR;APOD
4513,GO:0009617,0.580280055150765,0.647954759498035,3,498,response to bacterium,BP,TF;GJB6;GJA1
7790,GO:0031349,0.580294162821384,0.693751773482549,2,322,positive regulation of defense response,BP,EGFR;GJA1
14343,GO:0060090,0.580386085641757,0.69377796359712,2,282,molecular adaptor activity,MF,CAPN3;ANK3
11824,GO:0045211,0.580471296750237,0.693740321925869,2,269,postsynaptic membrane,CC,ANK3;CNTN2
17810,GO:0098656,0.581600044435735,0.692608125863945,2,280,anion transmembrane transport,BP,LRP2;GJA1
11132,GO:0043271,0.581647244467761,0.785738765122453,1,133,negative regulation of ion transport,BP,ANK3
5062,GO:0010976,0.581982094207306,0.692268455353669,2,271,positive regulation of neuron projection development,BP,NGFR;TRIM67
10556,GO:0042129,0.582259715713181,0.785075178564625,1,150,regulation of T cell proliferation,BP,GPNMB
15739,GO:0070588,0.584439193590764,0.68983293432616,2,284,calcium ion transmembrane transport,BP,CAPN3;GJC2
6406,GO:0019083,0.584726113998402,0.782805143372731,1,171,viral transcription,BP,RPS4Y1
13422,GO:0050890,0.58514865955239,0.689157111968796,2,279,cognition,BP,EGFR;CNTN2
13645,GO:0051254,0.58597749912782,0.545886712662547,10,1547,positive regulation of RNA metabolic process,BP,NGFR;TF;CAPN3;SOX10;MYRF;EGFR;ST18;FZD7;GREM1;DMRT2
21582,GO:2000241,0.586002948851458,0.781898335065748,1,140,regulation of reproductive process,BP,GJA1
1488,GO:0003231,0.586650533741431,0.781523221129141,1,120,cardiac ventricle development,BP,LRP2
3667,GO:0007266,0.587467114418642,0.780734627235293,1,127,Rho protein signal transduction,BP,NGFR
6208,GO:0017148,0.588071417998226,0.780194615316428,1,128,negative regulation of translation,BP,DAPK1
17171,GO:0090263,0.589489753341143,0.778846907162117,1,139,positive regulation of canonical Wnt signaling pathway,BP,EGFR
690,GO:0001889,0.589511194139745,0.778853670253722,1,136,liver development,BP,EGFR
5267,GO:0015075,0.590839271262547,0.589462070708366,5,761,ion transmembrane transporter activity,MF,GJA1;PIEZO2;KCNJ6;SLC45A3;SLC5A11
13052,GO:0048675,0.593222963206636,0.775736114474128,1,119,axon extension,BP,MAG
2303,GO:0004930,0.593734305210295,0.680513326299417,2,348,G protein-coupled receptor activity,MF,FZD7;GPR62
12585,GO:0046942,0.594439901137195,0.679929781663975,2,302,carboxylic acid transport,BP,LRP2;GJA1
2595,GO:0005525,0.5949439106776,0.679363070772137,2,326,GTP binding,MF,TUBB4A;DAPK1
8094,GO:0031960,0.595415083360355,0.773507510478463,1,148,response to corticosteroid,BP,EGFR
3389,GO:0006790,0.596353431981622,0.677946234585255,2,331,sulfur compound metabolic process,BP,ACAN;SPOCK3
17669,GO:0097553,0.596565429969177,0.772639080620197,1,129,calcium ion transmembrane import into cytosol,BP,CAPN3
16109,GO:0071347,0.596757311858171,0.772238039776939,1,157,cellular response to interleukin-1,BP,ST18
11546,GO:0044325,0.596770699134273,0.772454532744329,1,129,ion channel binding,MF,ANK3
14919,GO:0061008,0.598707659364964,0.770615208209828,1,139,hepaticobiliary system development,BP,EGFR
5852,GO:0016462,0.599087624016212,0.58091294805794,5,763,pyrophosphatase activity,MF,TUBB4A;ENPP2;CARNS1;MYO1D;DNAH17
5550,GO:0015849,0.599632924861049,0.674734103156118,2,305,organic acid transport,BP,LRP2;GJA1
2496,GO:0005261,0.59982857625229,0.674606838644505,2,283,cation channel activity,MF,PIEZO2;KCNJ6
7394,GO:0030534,0.59985615111087,0.769648195675894,1,131,adult behavior,BP,CNTN2
20701,GO:1905039,0.599931894104383,0.769569833318777,1,132,carboxylic acid transmembrane transport,BP,LRP2
5372,GO:0015276,0.600389848367842,0.76920395189736,1,127,ligand-gated ion channel activity,MF,KCNJ6
7046,GO:0022834,0.600389848367842,0.76920395189736,1,127,ligand-gated channel activity,MF,KCNJ6
16108,GO:0071346,0.600408361949779,0.768935694903228,1,157,cellular response to interferon-gamma,BP,DAPK1
3722,GO:0007411,0.600764240718457,0.673709209996797,2,271,axon guidance,BP,NGFR;CNTN2
6391,GO:0019058,0.600941105578074,0.673407950022739,2,309,viral life cycle,BP,MOG;EGFR
4270,GO:0009057,0.601352208643139,0.543649960850022,8,1303,macromolecule catabolic process,BP,LRP2;CAPN3;TRIM67;RPS4Y1;EGFR;GJA1;ACAN;PHKG1
8468,GO:0032550,0.601409928208699,0.672880033506549,2,330,purine ribonucleoside binding,MF,TUBB4A;DAPK1
97,GO:0000187,0.602227976342812,0.767398858595695,1,141,activation of MAPK activity,BP,TF
6047,GO:0016817,0.602295824529331,0.577563509892946,5,766,hydrolase activity, acting on acid anhydrides,MF,TUBB4A;ENPP2;CARNS1;MYO1D;DNAH17
6048,GO:0016818,0.602295824529331,0.577563509892946,5,766,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,TUBB4A;ENPP2;CARNS1;MYO1D;DNAH17
17626,GO:0097485,0.602576332850827,0.671880138206922,2,272,neuron projection guidance,BP,NGFR;CNTN2
20075,GO:1903825,0.602739692055728,0.76700300439144,1,133,organic acid transmembrane transport,BP,LRP2
3495,GO:0006959,0.602831128605214,0.766594287648312,1,179,humoral immune response,BP,TF
10852,GO:0042742,0.603406609616981,0.76611683897315,1,170,defense response to bacterium,BP,TF
4807,GO:0010634,0.603574778287172,0.766229129991698,1,134,positive regulation of epithelial cell migration,BP,ENPP2
656,GO:0001837,0.603932352745399,0.765873672816871,1,137,epithelial to mesenchymal transition,BP,GREM1
7135,GO:0030097,0.604361941806221,0.575365413661159,5,816,hemopoiesis,BP,ANLN;TF;BVES;PDGFRA;FZD7
2924,GO:0006090,0.604530896113295,0.765306335045669,1,139,pyruvate metabolic process,BP,GPD1
19569,GO:1902850,0.60475560042536,0.765135857955399,1,135,microtubule cytoskeleton organization involved in mitosis,BP,GJA1
3294,GO:0006650,0.605232211169553,0.66907872092726,2,307,glycerophospholipid metabolic process,BP,ENPP2;GPD1
13852,GO:0051641,0.605679999110029,0.492811220987374,20,3175,cellular localization,BP,BAIAP3;NGFR;TF;CAPN3;MLC1;TUBB4A;BVES;PEX5L;TRIM67;RPS4Y1;EGFR;ANK3;GJA1;TMSB15A;SGCD;MAL;UGT8;MYO1D;CNTN2;APOD
13851,GO:0051640,0.606049045199551,0.593270249288031,4,612,organelle localization,BP,TUBB4A;BVES;GJA1;MYO1D
12985,GO:0048545,0.606122805731099,0.668149208231908,2,316,response to steroid hormone,BP,SOX10;EGFR
685,GO:0001883,0.606161934836145,0.668065157934373,2,333,purine nucleoside binding,MF,TUBB4A;DAPK1
11245,GO:0043467,0.606182039833245,0.76380336268357,1,137,regulation of generation of precursor metabolites and energy,BP,GPD1
4325,GO:0009132,0.606683464711065,0.763296418392834,1,142,nucleoside diphosphate metabolic process,BP,GPD1
19070,GO:1901566,0.607357189268876,0.529860474891414,9,1556,organonitrogen compound biosynthetic process,BP,FOLH1;FA2H;GAL3ST1;RPS4Y1;EGFR;ACAN;CARNS1;UGT8;DAPK1
8467,GO:0032549,0.607660054912937,0.666540663144158,2,333,ribonucleoside binding,MF,TUBB4A;DAPK1
7053,GO:0022843,0.610060423396286,0.760261524934561,1,131,voltage-gated cation channel activity,MF,KCNJ6
3113,GO:0006413,0.611019686108432,0.758976554302653,1,186,translational initiation,BP,RPS4Y1
4627,GO:0010033,0.611524662507858,0.490709191439469,18,2931,response to organic substance,BP,CRLF1;BAIAP3;NGFR;FGFR3;LRP2;SOX10;MLC1;GJB6;PDGFRA;PCSK6;EGFR;ST18;GJA1;FZD7;GREM1;GPD1;BOK;DAPK1
636,GO:0001816,0.611910511998809,0.587050840892846,4,673,cytokine production,BP,GPNMB;MOG;APOD;MBP
18615,GO:0150034,0.612468461433842,0.661732270357289,2,293,distal axon,CC,STMN4;NGFR
4303,GO:0009101,0.614068120124415,0.660041958481376,2,307,glycoprotein biosynthetic process,BP,GAL3ST1;ACAN
11214,GO:0043405,0.615308952272108,0.658743487399259,2,313,regulation of MAP kinase activity,BP,TF;EGFR
6680,GO:0019901,0.615388286825285,0.583424712909386,4,620,protein kinase binding,MF,DCX;MAG;LDB3;EGFR
11518,GO:0044281,0.615608714557088,0.514884570006454,10,1726,small molecule metabolic process,BP,LRP2;FOLH1;FA2H;PLP1;ACAN;SLC45A3;GPD1;CARNS1;APOD;SPOCK3
7771,GO:0031329,0.616024531661145,0.563068549498067,5,803,regulation of cellular catabolic process,BP,LRP2;TRIM67;GPD1;BOK;DAPK1
11368,GO:0043687,0.61627286835356,0.657690172327492,2,334,post-translational protein modification,BP,FOLH1;TF
684,GO:0001882,0.616809758774513,0.657121544301045,2,339,nucleoside binding,MF,TUBB4A;DAPK1
3262,GO:0006606,0.617253994398368,0.753444732027759,1,135,protein import into nucleus,BP,APOD
3752,GO:0007519,0.618121393969775,0.75253692786614,1,144,skeletal muscle tissue development,BP,BVES
13404,GO:0050865,0.618488543478536,0.608636606373101,3,513,regulation of cell activation,BP,CAPN3;PDGFRA;GPNMB
7882,GO:0031514,0.618534535634021,0.752101512072145,1,149,motile cilium,CC,DNAH17
3434,GO:0006869,0.618752535679773,0.655163963007253,2,316,lipid transport,BP,ATP10B;APOD
7611,GO:0031047,0.620045036132843,0.750731931134678,1,140,gene silencing by RNA,BP,EGFR
7770,GO:0031328,0.620351640375188,0.504533662253188,11,1767,positive regulation of cellular biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;MYRF;EGFR;ST18;FZD7;SLC45A3;GREM1;DMRT2
3431,GO:0006865,0.622468656747704,0.748390933106184,1,141,amino acid transport,BP,GJA1
5270,GO:0015079,0.622833269154394,0.748012416222976,1,144,potassium ion transmembrane transporter activity,MF,KCNJ6
5143,GO:0014074,0.623218480445938,0.747666298541681,1,141,response to purine-containing compound,BP,GPD1
16448,GO:0071902,0.623657979267341,0.650034048791524,2,317,positive regulation of protein serine/threonine kinase activity,BP,TF;EGFR
3933,GO:0008217,0.625005641585791,0.745796326204706,1,158,regulation of blood pressure,BP,GJA1
6403,GO:0019080,0.625338814090552,0.745296103992427,1,187,viral gene expression,BP,RPS4Y1
1196,GO:0002695,0.626308582624383,0.744491980149679,1,163,negative regulation of leukocyte activation,BP,GPNMB
7093,GO:0030010,0.626355997722597,0.744664914880513,1,136,establishment of cell polarity,BP,GJA1
6375,GO:0019001,0.626528241392836,0.646944228120375,2,343,guanyl nucleotide binding,MF,TUBB4A;DAPK1
8478,GO:0032561,0.626528241392836,0.646944228120375,2,343,guanyl ribonucleotide binding,MF,TUBB4A;DAPK1
2728,GO:0005775,0.627041357390224,0.74379672836167,1,160,vacuolar lumen,CC,ACAN
10029,GO:0035967,0.627289277080479,0.743598107211887,1,154,cellular response to topologically incorrect protein,BP,BOK
4766,GO:0010565,0.627775819933093,0.743050155465241,1,164,regulation of cellular ketone metabolic process,BP,SLC45A3
7546,GO:0030902,0.627814961772059,0.743191520483825,1,141,hindbrain development,BP,KNDC1
3830,GO:0008047,0.627937244273294,0.598617420196028,3,474,enzyme activator activity,MF,ERBB3;GREM1;MAL
21487,GO:2000058,0.628936317574886,0.742006122461162,1,151,regulation of ubiquitin-dependent protein catabolic process,BP,TRIM67
17777,GO:0098588,0.629454461242605,0.490220631488656,12,1941,bounding membrane of organelle,CC,BAIAP3;LRP2;TF;SOX10;PEX5L;GAL3ST1;GPNMB;EGFR;GJA1;FZD7;BOK;GPR62
3772,GO:0007584,0.629995073231176,0.740925353617619,1,156,response to nutrient,BP,EGFR
3791,GO:0007612,0.630727313330333,0.740355049977011,1,138,learning,BP,CNTN2
6682,GO:0019903,0.631621646469107,0.739424577839554,1,143,protein phosphatase binding,MF,EGFR
7189,GO:0030168,0.631732546708236,0.739271609822266,1,148,platelet activation,BP,PDGFRA
9230,GO:0034249,0.63190736338395,0.739123977183745,1,145,negative regulation of cellular amide metabolic process,BP,DAPK1
12128,GO:0045931,0.632281811542326,0.738727198626554,1,148,positive regulation of mitotic cell cycle,BP,EGFR
7041,GO:0022804,0.633512686152746,0.639622545445565,2,306,active transmembrane transporter activity,MF,SLC45A3;SLC5A11
11017,GO:0043086,0.633592128667314,0.56383326138627,4,686,negative regulation of catalytic activity,BP,NGFR;MYO1D;SPOCK3;COL28A1
9260,GO:0034341,0.634192367303306,0.736641520981341,1,174,response to interferon-gamma,BP,DAPK1
16821,GO:0072594,0.635005917375615,0.590889456753132,3,542,establishment of protein localization to organelle,BP,PEX5L;RPS4Y1;APOD
3565,GO:0007088,0.635669332148405,0.735310665474724,1,153,regulation of mitotic nuclear division,BP,ANLN
15065,GO:0061337,0.635686246684389,0.735396443790906,1,141,cardiac conduction,BP,GJA1
14557,GO:0060402,0.636035386951614,0.735001874634845,1,146,calcium ion transport into cytosol,BP,CAPN3
7291,GO:0030307,0.636641250183697,0.734377084528333,1,148,positive regulation of cell growth,BP,EGFR
5271,GO:0015081,0.636741087641518,0.734377329382289,1,137,sodium ion transmembrane transporter activity,MF,SLC5A11
14652,GO:0060538,0.637323876338159,0.733658222326478,1,152,skeletal muscle organ development,BP,BVES
9577,GO:0035107,0.639070086257125,0.731983997437734,1,142,appendage morphogenesis,BP,GREM1
9578,GO:0035108,0.639070086257125,0.731983997437734,1,142,limb morphogenesis,BP,GREM1
5141,GO:0014070,0.639903620752855,0.53731254257561,5,833,response to organic cyclic compound,BP,SOX10;MLC1;EGFR;GJA1;GPD1
4582,GO:0009891,0.639925108913278,0.483583755871187,11,1794,positive regulation of biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;MYRF;EGFR;ST18;FZD7;SLC45A3;GREM1;DMRT2
12038,GO:0045766,0.640637263521434,0.73030236792503,1,153,positive regulation of angiogenesis,BP,GREM1
7048,GO:0022836,0.640982051836346,0.631564407481796,2,310,gated channel activity,MF,PIEZO2;KCNJ6
17654,GO:0097529,0.641479804719886,0.729262424276741,1,180,myeloid leukocyte migration,BP,GREM1
7490,GO:0030833,0.641593797897067,0.729314385724358,1,155,regulation of actin filament polymerization,BP,TMSB15A
21678,GO:2000377,0.641932199086498,0.72891039433838,1,163,regulation of reactive oxygen species metabolic process,BP,EGFR
13101,GO:0048754,0.642082098808668,0.728900674280056,1,145,branching morphogenesis of an epithelial tube,BP,GREM1
17879,GO:0098791,0.642625353912815,0.629735604025966,2,325,Golgi apparatus subcompartment,CC,BAIAP3;BOK
7017,GO:0022411,0.643034630771307,0.582141461521756,3,523,cellular component disassembly,BP,STMN4;ADAMTS4;BOK
3479,GO:0006936,0.644333529108713,0.627862748718902,2,329,muscle contraction,BP,GJA1;SGCD
13573,GO:0051130,0.644348183471729,0.506742157954578,7,1118,positive regulation of cellular component organization,BP,ANLN;NGFR;TF;TRIM67;ENPP2;GREM1;BOK
4733,GO:0010506,0.645631929928772,0.626454361602201,2,325,regulation of autophagy,BP,BOK;DAPK1
12978,GO:0048534,0.645636725429906,0.531009008825435,5,855,hematopoietic or lymphoid organ development,BP,ANLN;TF;BVES;PDGFRA;FZD7
19795,GO:1903305,0.646563522933713,0.724229948298233,1,154,regulation of regulated secretory pathway,BP,BAIAP3
15715,GO:0070555,0.647099449337001,0.723510077999728,1,178,response to interleukin-1,BP,ST18
13552,GO:0051098,0.647991593810395,0.623826191205569,2,340,regulation of binding,BP,PLCL1;CTHRC1
2748,GO:0005798,0.651223419684593,0.719287548894577,1,168,Golgi-associated vesicle,CC,GJA1
13122,GO:0048813,0.65124369151982,0.71949538544458,1,140,dendrite morphogenesis,BP,KNDC1
3112,GO:0006412,0.651447214022457,0.57275826497716,3,586,translation,BP,RPS4Y1;EGFR;DAPK1
10540,GO:0042098,0.65195906752043,0.718453445511341,1,178,T cell proliferation,BP,GPNMB
19084,GO:1901605,0.653949294005761,0.716350902229559,1,180,alpha-amino acid metabolic process,BP,CARNS1
345,GO:0000956,0.654184564508077,0.716015188517812,1,196,nuclear-transcribed mRNA catabolic process,BP,RPS4Y1
8727,GO:0032956,0.654796199225327,0.616334034016164,2,326,regulation of actin cytoskeleton organization,BP,PDGFRA;TMSB15A
3766,GO:0007565,0.654852682608345,0.715475221458972,1,168,female pregnancy,BP,GJA1
13602,GO:0051170,0.656360457141172,0.713969413307682,1,156,import into nucleus,BP,APOD
3508,GO:0006986,0.656856861028324,0.713333232224562,1,171,response to unfolded protein,BP,BOK
17816,GO:0098662,0.657663040670684,0.537282742727371,4,673,inorganic cation transmembrane transport,BP,CAPN3;ANK3;KCNJ6;GJC2
17881,GO:0098793,0.659002662135883,0.564408369867999,3,495,presynapse,CC,BAIAP3;CNTNAP4;LGI3
4907,GO:0010770,0.661354972637145,0.70870791618401,1,148,positive regulation of cell morphogenesis involved in differentiation,BP,NGFR
6639,GO:0019827,0.661819398095117,0.708148341286489,1,155,stem cell population maintenance,BP,FZD7
7086,GO:0023061,0.662474621810285,0.560459490479185,3,513,signal release,BP,BAIAP3;EGFR;GJA1
5021,GO:0010921,0.665639997674524,0.703991808979301,1,158,regulation of phosphatase activity,BP,MYO1D
18436,GO:0120032,0.667002622645024,0.702491619047706,1,160,regulation of plasma membrane bounded cell projection assembly,BP,ANLN
17846,GO:0098727,0.667128343572986,0.702378294446809,1,157,maintenance of cell number,BP,FZD7
3666,GO:0007265,0.667847696255067,0.601614298544883,2,327,Ras protein signal transduction,BP,NGFR;TRIM67
13340,GO:0050773,0.667930344344208,0.701588701954184,1,147,regulation of dendrite development,BP,KNDC1
8097,GO:0031966,0.668221966124169,0.553794718646517,3,620,mitochondrial membrane,CC,SOX10;GJA1;BOK
13391,GO:0050852,0.668341849561288,0.700846096838482,1,187,T cell receptor signaling pathway,BP,MOG
6010,GO:0016758,0.668368871838053,0.700937890180049,1,168,transferase activity, transferring hexosyl groups,MF,UGT8
9407,GO:0034622,0.669706664484228,0.504087416931978,5,912,cellular protein-containing complex assembly,BP,ANLN;TUBB4A;TMSB15A;GREM1;DNAH17
7185,GO:0030163,0.670266610155168,0.503482659515813,5,861,protein catabolic process,BP,LRP2;CAPN3;TRIM67;EGFR;GJA1
14625,GO:0060491,0.672056437723941,0.696921540338118,1,162,regulation of cell projection assembly,BP,ANLN
19591,GO:1902903,0.67378408588605,0.594773079892829,2,336,regulation of supramolecular fiber organization,BP,TUBB4A;TMSB15A
7198,GO:0030177,0.674125165359416,0.694559210018085,1,171,positive regulation of Wnt signaling pathway,BP,EGFR
7422,GO:0030595,0.675085262064472,0.693331470446802,1,197,leukocyte chemotaxis,BP,GREM1
11514,GO:0044272,0.675839477738165,0.692625566636148,1,174,sulfur compound biosynthetic process,BP,ACAN
8106,GO:0031984,0.676471698643244,0.59163260048155,2,347,organelle subcompartment,CC,BAIAP3;BOK
3839,GO:0008064,0.676814316384298,0.691561343781207,1,170,regulation of actin polymerization or depolymerization,BP,TMSB15A
4269,GO:0009056,0.67748024738422,0.430507972177897,14,2415,catabolic process,BP,LRP2;CAPN3;TRIM67;RPS4Y1;ENPP2;EGFR;GJA1;ACAN;PHKG1;GPD1;KLK6;CARNS1;BOK;DAPK1
14556,GO:0060401,0.678341679743659,0.689896655484084,1,163,cytosolic calcium ion transport,BP,CAPN3
10849,GO:0042734,0.678519861898872,0.689769745259734,1,154,presynaptic membrane,CC,CNTNAP4
7367,GO:0030496,0.679833044132655,0.688190742773193,1,166,midbody,CC,ANLN
6759,GO:0021543,0.680501162645093,0.687497548398808,1,158,pallium development,BP,EGFR
12558,GO:0046890,0.680584157192685,0.687269649194412,1,176,regulation of lipid biosynthetic process,BP,SLC45A3
4981,GO:0010876,0.681593269388944,0.585633188277847,2,357,lipid localization,BP,ATP10B;APOD
19224,GO:1901981,0.681682890818126,0.68612423554454,1,162,phosphatidylinositol phosphate binding,MF,FZD7
6152,GO:0017048,0.681758928955825,0.686131085962505,1,151,Rho GTPase binding,MF,ANLN
11037,GO:0043123,0.681920962284434,0.685731932323275,1,179,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,GJA1
13924,GO:0051783,0.681986925829323,0.685697074280603,1,173,regulation of nuclear division,BP,ANLN
7489,GO:0030832,0.682426094440411,0.685211133107183,1,171,regulation of actin filament length,BP,TMSB15A
7789,GO:0031348,0.682814545013878,0.684664405839057,1,187,negative regulation of defense response,BP,APOD
7115,GO:0030041,0.682834924285217,0.684731103518363,1,173,actin filament polymerization,BP,TMSB15A
8938,GO:0033365,0.683653137079919,0.488146422367129,5,903,protein localization to organelle,BP,NGFR;PEX5L;RPS4Y1;GJA1;APOD
13028,GO:0048639,0.684684090681522,0.682714866926534,1,160,positive regulation of developmental growth,BP,CAPN3
4758,GO:0010557,0.684829171446275,0.439368996502996,10,1685,positive regulation of macromolecule biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;MYRF;EGFR;ST18;FZD7;GREM1;DMRT2
4720,GO:0010468,0.686123489773262,0.398521555309758,26,4265,regulation of gene expression,BP,NGFR;ERBB3;TF;CAPN3;SOX10;CDK18;PLP1;MYRF;RPS4Y1;PDGFRA;GPNMB;MOG;EGFR;ST18;NKX6-2;ANK3;GJA1;FZD7;GREM1;DMRT2;CNTN2;APOD;MYT1;DAPK1;MBP;GJC2
2166,GO:0004721,0.686264049589309,0.680845206291937,1,167,phosphoprotein phosphatase activity,MF,EYA2
20176,GO:1904018,0.686400369277844,0.680644702189281,1,173,positive regulation of vasculature development,BP,GREM1
18121,GO:0099240,0.687032480249251,0.679998410761052,1,162,intrinsic component of synaptic membrane,CC,CNTN2
4698,GO:0010389,0.689212638032978,0.677301593567867,1,187,regulation of G2/M transition of mitotic cell cycle,BP,TUBB4A
4934,GO:0010821,0.689586900328523,0.676897850769893,1,182,regulation of mitochondrion organization,BP,BOK
13283,GO:0050670,0.689832028347914,0.676508439658482,1,200,regulation of lymphocyte proliferation,BP,GPNMB
9897,GO:0035725,0.690281936806664,0.676240908105355,1,161,sodium ion transmembrane transport,BP,ANK3
1097,GO:0002520,0.691365400526212,0.479210804868009,5,900,immune system development,BP,ANLN;TF;BVES;PDGFRA;FZD7
3670,GO:0007269,0.691611880670449,0.674642541998978,1,167,neurotransmitter secretion,BP,BAIAP3
18224,GO:0099643,0.691611880670449,0.674642541998978,1,167,signal release from synapse,BP,BAIAP3
8723,GO:0032944,0.691712462226713,0.674310118719178,1,201,regulation of mononuclear cell proliferation,BP,GPNMB
1468,GO:0003205,0.693537534792193,0.672425780999083,1,162,cardiac chamber development,BP,LRP2
17219,GO:0090316,0.697054289225782,0.668155211581307,1,178,positive regulation of intracellular protein transport,BP,ANK3
19113,GO:1901653,0.698053901228934,0.566026861043091,2,356,cellular response to peptide,BP,NGFR;GJA1
12047,GO:0045786,0.699559815933776,0.517128426179482,3,563,negative regulation of cell cycle,BP,GPNMB;EGFR;GJC2
1126,GO:0002573,0.699923252530209,0.664679011562329,1,187,myeloid leukocyte differentiation,BP,TF
2024,GO:0004518,0.700683040264384,0.663756939738116,1,189,nuclease activity,MF,ENPP2
3676,GO:0007276,0.701092489134035,0.515295664901218,3,554,gamete generation,BP,CLDN11;GAL3ST1;GJA1
13678,GO:0051301,0.701331847161783,0.515021147304086,3,543,cell division,BP,ANLN;ANK3;FZD7
10028,GO:0035966,0.702894241188962,0.66108002342717,1,192,response to topologically incorrect protein,BP,BOK
7720,GO:0031256,0.703465291476961,0.660568328257126,1,166,leading edge membrane,CC,MYO1D
13091,GO:0048736,0.703474865221529,0.660533465132822,1,169,appendage development,BP,GREM1
14389,GO:0060173,0.703474865221529,0.660533465132822,1,169,limb development,BP,GREM1
5719,GO:0016192,0.704180956070791,0.412298971258234,11,1878,vesicle-mediated transport,BP,BAIAP3;LRP2;TF;MLC1;BVES;ENPP2;ANK3;GREM1;LGI3;MYO1D;CNTN2
2699,GO:0005740,0.70564174311486,0.509687648280012,3,659,mitochondrial envelope,CC,SOX10;GJA1;BOK
11637,GO:0044706,0.706183189820729,0.657082640051053,1,194,multi-multicellular organism process,BP,GJA1
21167,GO:1990138,0.708393910966492,0.65457425716614,1,166,neuron projection extension,BP,MAG
12087,GO:0045859,0.709052788451853,0.477524885375341,4,726,regulation of protein kinase activity,BP,ERBB3;TF;EGFR;GREM1
7162,GO:0030133,0.70951707028776,0.551935998737584,2,381,transport vesicle,CC,FGFR3;LGI3
4019,GO:0008361,0.712427892802605,0.649559386742439,1,172,regulation of cell size,BP,MAG
6679,GO:0019900,0.712731681217176,0.473103947073726,4,702,kinase binding,MF,DCX;MAG;LDB3;EGFR
5390,GO:0015318,0.713292669504538,0.472419505940037,4,708,inorganic molecular entity transmembrane transporter activity,MF,PIEZO2;KCNJ6;SLC45A3;SLC5A11
11987,GO:0045666,0.713439069323953,0.547127661805827,2,353,positive regulation of neuron differentiation,BP,NGFR;TRIM67
3448,GO:0006888,0.714119692173483,0.647348498568067,1,188,endoplasmic reticulum to Golgi vesicle-mediated transport,BP,ANK3
7788,GO:0031347,0.71432669768047,0.499136469197764,3,596,regulation of defense response,BP,EGFR;GJA1;APOD
3817,GO:0008021,0.715698217246341,0.645354322273094,1,192,synaptic vesicle,CC,LGI3
11345,GO:0043624,0.716254376983825,0.644553397509512,1,211,cellular protein complex disassembly,BP,STMN4
12566,GO:0046907,0.716968997149646,0.408551979756921,9,1593,intracellular transport,BP,BAIAP3;NGFR;MLC1;BVES;PEX5L;RPS4Y1;ANK3;MYO1D;APOD
19538,GO:1902749,0.717256553080806,0.643349104912798,1,201,regulation of cell cycle G2/M phase transition,BP,TUBB4A
15347,GO:0062012,0.717700482136933,0.541696380645444,2,393,regulation of small molecule metabolic process,BP,SLC45A3;GPD1
5848,GO:0016458,0.719991377575443,0.640010963820162,1,183,gene silencing,BP,EGFR
11499,GO:0044242,0.724687567404243,0.633872859136682,1,209,cellular lipid catabolic process,BP,ENPP2
8739,GO:0032970,0.724850423533462,0.532692786007157,2,367,regulation of actin filament-based process,BP,PDGFRA;TMSB15A
19076,GO:1901575,0.725333848880026,0.387917867080885,11,1993,organic substance catabolic process,BP,LRP2;CAPN3;TRIM67;RPS4Y1;ENPP2;EGFR;GJA1;ACAN;PHKG1;GPD1;CARNS1
2484,GO:0005244,0.725489320986176,0.633004954503833,1,182,voltage-gated ion channel activity,MF,KCNJ6
7045,GO:0022832,0.725489320986176,0.633004954503833,1,182,voltage-gated channel activity,MF,KCNJ6
12541,GO:0046872,0.725947088566619,0.357845107725542,23,3712,metal ion binding,MF,BAIAP3;EYA2;CDH19;LRP2;FOLH1;TF;CAPN3;FA2H;TUBB4A;ATP10B;TRIM67;LDB3;CPM;ENPP2;ST18;CNDP1;ACAN;ADAMTS4;EDIL3;CARNS1;DMRT2;SPOCK3;MYT1
11296,GO:0043542,0.726660545491805,0.631431389763246,1,192,endothelial cell migration,BP,GREM1
13899,GO:0051726,0.730669962192604,0.418491152832279,6,1098,regulation of cell cycle,BP,ANLN;TUBB4A;CDK18;GPNMB;EGFR;GJC2
12046,GO:0045785,0.731587962232694,0.523970026350363,2,396,positive regulation of cell adhesion,BP,ANK3;EDIL3
12827,GO:0048167,0.732907533778129,0.623360121914158,1,183,regulation of synaptic plasticity,BP,CNTN2
3804,GO:0007626,0.733543392894486,0.622517557973869,1,184,locomotory behavior,BP,CNTN2
6681,GO:0019902,0.735601928588708,0.619774707323369,1,188,phosphatase binding,MF,EGFR
2586,GO:0005515,0.735715289169397,0.345016369695089,72,11691,protein binding,MF,CRLF1;BAIAP3;ANLN;CLDN11;STMN4;NGFR;EYA2;ERBB3;FGFR3;CDH19;DCX;LRP2;NKAIN1;TF;CAPN3;SOX10;MLC1;PLLP;FA2H;SEC14L5;TUBB4A;MAG;BVES;PEX5L;PLCL1;CDK18;ATP10B;PPL;GJB6;LDB3;PLP1;RPS4Y1;HAPLN2;PDGFRA;GPNMB;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;ANK3;GJA1;FZD7;KCNJ6;ACAN;TMSB15A;ADAMTS4;SLC5A11;TMEM144;EDIL3;PHKG1;CTHRC1;GREM1;GPD1;KLK6;MOBP;GJB1;KNDC1;MAL;DMRT2;MYO1D;BOK;GPR62;CNTN2;ANKS1B;GLDN;DNAH17;APOD;DAPK1;MBP;TMEM88B
6186,GO:0017111,0.735719147337493,0.444800687381241,4,720,nucleoside-triphosphatase activity,MF,TUBB4A;CARNS1;MYO1D;DNAH17
8668,GO:0032870,0.736157827887271,0.471824215926257,3,561,cellular response to hormone stimulus,BP,SOX10;EGFR;GJA1
3406,GO:0006820,0.736983040463168,0.470755215570796,3,574,anion transport,BP,LRP2;ATP10B;GJA1
3890,GO:0008154,0.737246907973828,0.617524125581397,1,199,actin polymerization or depolymerization,BP,TMSB15A
2467,GO:0005216,0.737752598548371,0.515998846254459,2,371,ion channel activity,MF,PIEZO2;KCNJ6
9651,GO:0035303,0.738277493301091,0.616194532636883,1,192,regulation of dephosphorylation,BP,MYO1D
12411,GO:0046578,0.738296775030537,0.616228712613999,1,183,regulation of Ras protein signal transduction,BP,TRIM67
13544,GO:0051090,0.742949060212155,0.509086738784588,2,402,regulation of DNA-binding transcription factor activity,BP,CAPN3;GREM1
3143,GO:0006464,0.743265910063047,0.33951772417432,22,3675,cellular protein modification process,BP,CRLF1;EYA2;ERBB3;FGFR3;FOLH1;TF;CAPN3;PLCL1;CDK18;GAL3ST1;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;PHKG1;GREM1;KNDC1;SPOCK3;DAPK1;MBP;GJC2
10158,GO:0036211,0.743265910063047,0.33951772417432,22,3675,protein modification process,BP,CRLF1;EYA2;ERBB3;FGFR3;FOLH1;TF;CAPN3;PLCL1;CDK18;GAL3ST1;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;PHKG1;GREM1;KNDC1;SPOCK3;DAPK1;MBP;GJC2
19680,GO:1903050,0.743537567751336,0.609026268002968,1,209,regulation of proteolysis involved in cellular protein catabolic process,BP,TRIM67
7474,GO:0030705,0.744029248400182,0.608499768384968,1,186,cytoskeleton-dependent intracellular transport,BP,MYO1D
17538,GO:0097305,0.744724699266177,0.607415908977741,1,209,response to alcohol,BP,MLC1
4114,GO:0008514,0.745469644932259,0.606436044297745,1,203,organic anion transmembrane transporter activity,MF,GJA1
17814,GO:0098660,0.746861054015086,0.430717879755484,4,753,inorganic ion transmembrane transport,BP,CAPN3;ANK3;KCNJ6;GJC2
2925,GO:0006091,0.747580912239474,0.502835700155023,2,451,generation of precursor metabolites and energy,BP,PHKG1;GPD1
11119,GO:0043254,0.74925540446596,0.500675473189224,2,405,regulation of protein-containing complex assembly,BP,TUBB4A;TMSB15A
12139,GO:0045944,0.749529271030513,0.395390819281249,6,1097,positive regulation of transcription by RNA polymerase II,BP,NGFR;SOX10;EGFR;ST18;GREM1;DMRT2
15614,GO:0070382,0.750000501244542,0.600186260396004,1,210,exocytic vesicle,CC,LGI3
13390,GO:0050851,0.750765629210229,0.599021368439444,1,232,antigen receptor-mediated signaling pathway,BP,MOG
13860,GO:0051650,0.75156031158893,0.59810429514572,1,197,establishment of vesicle localization,BP,MYO1D
4435,GO:0009266,0.753257817682059,0.595659404671899,1,212,response to temperature stimulus,BP,NGFR
10548,GO:0042110,0.755614588234362,0.492039026433381,2,431,T cell activation,BP,GPNMB;FZD7
4805,GO:0010632,0.758399101433588,0.588482015430405,1,205,regulation of epithelial cell migration,BP,ENPP2
3512,GO:0006996,0.758614858001808,0.323269654878079,21,3534,organelle organization,BP,BAIAP3;ANLN;STMN4;EYA2;DCX;TF;CAPN3;TUBB4A;PEX5L;PPL;LDB3;PDGFRA;ERMN;ANK3;GJA1;TMSB15A;UGT8;MYO1D;BOK;CNTN2;DNAH17
4670,GO:0010243,0.758871100469687,0.39705357178568,5,951,response to organonitrogen compound,BP,NGFR;PDGFRA;EGFR;GJA1;GPD1
817,GO:0002064,0.758999991126868,0.587667173900063,1,199,epithelial cell development,BP,HAPLN2
11061,GO:0043169,0.759540123293941,0.319556061935609,23,3786,cation binding,MF,BAIAP3;EYA2;CDH19;LRP2;FOLH1;TF;CAPN3;FA2H;TUBB4A;ATP10B;TRIM67;LDB3;CPM;ENPP2;ST18;CNDP1;ACAN;ADAMTS4;EDIL3;CARNS1;DMRT2;SPOCK3;MYT1
11463,GO:0044092,0.759762192579901,0.395901047248531,5,988,negative regulation of molecular function,BP,NGFR;ANK3;MYO1D;SPOCK3;COL28A1
19805,GO:1903320,0.761264824098452,0.584336258078215,1,219,regulation of protein modification by small protein conjugation or removal,BP,CAPN3
1369,GO:0003012,0.76154934670849,0.48396001826594,2,410,muscle system process,BP,GJA1;SGCD
5551,GO:0015850,0.761604457451362,0.583836559827039,1,222,organic hydroxy compound transport,BP,SLC5A11
13864,GO:0051656,0.762136470022848,0.483167378339879,2,402,establishment of organelle localization,BP,GJA1;MYO1D
14254,GO:0055114,0.764223299186815,0.408257631089569,4,881,oxidation-reduction process,BP,FA2H;PHKG1;GPD1;APOD
13650,GO:0051259,0.765292250447717,0.578573014119122,1,216,protein complex oligomerization,BP,BOK
12359,GO:0046474,0.766813426583205,0.576377636198216,1,215,glycerophospholipid biosynthetic process,BP,GPD1
12458,GO:0046651,0.769100394143291,0.572905822492901,1,246,lymphocyte proliferation,BP,GPNMB
16820,GO:0072593,0.769207312229232,0.572787735759886,1,237,reactive oxygen species metabolic process,BP,EGFR
12542,GO:0046873,0.771398618851787,0.470299854073057,2,391,metal ion transmembrane transporter activity,MF,KCNJ6;SLC5A11
8722,GO:0032943,0.772227203151123,0.568310811870518,1,248,mononuclear cell proliferation,BP,GPNMB
3597,GO:0007163,0.7725537022666,0.568010215611554,1,210,establishment or maintenance of cell polarity,BP,GJA1
2697,GO:0005737,0.772854091062022,0.295212516461305,61,10035,cytoplasm,CC,CRLF1;BAIAP3;ANLN;CLDN11;STMN4;NGFR;EYA2;BCAS1;FGFR3;DCX;LRP2;FOLH1;TF;CAPN3;SOX10;MLC1;FA2H;TUBB4A;MAG;PEX5L;PLCL1;CDK18;ATP10B;PPL;TRIM67;GJB6;LDB3;MYRF;GAL3ST1;RPS4Y1;PDGFRA;GPNMB;ERMN;PCSK6;EGFR;CNDP1;ANK3;GJA1;FZD7;KCNJ6;SNX22;ACAN;TMSB15A;PHKG1;CTHRC1;GPD1;KLK6;MOBP;LGI3;SGCD;MAL;CARNS1;MYO1D;BOK;GPR62;ANKS1B;DNAH17;APOD;MYT1;DAPK1;COL28A1
3547,GO:0007049,0.774488386025591,0.339472824229316,9,1658,cell cycle,BP,ANLN;CAPN3;TUBB4A;CDK18;GPNMB;EGFR;ANK3;GJA1;GJC2
3159,GO:0006486,0.774657685190968,0.564827939637478,1,223,protein glycosylation,BP,GAL3ST1
11221,GO:0043413,0.774657685190968,0.564827939637478,1,223,macromolecule glycosylation,BP,GAL3ST1
12180,GO:0046034,0.77764634670598,0.560230751000127,1,255,ATP metabolic process,BP,GPD1
3877,GO:0008134,0.777833322429304,0.416653316639797,3,611,transcription factor binding,MF,EYA2;SOX10;ENPP2
1594,GO:0003674,0.779030104714544,0.368747570158369,92,14660,molecular_function,MF,CRLF1;BAIAP3;ANLN;CLDN11;STMN4;NGFR;EYA2;ERBB3;FGFR3;CDH19;DCX;LRP2;NKAIN1;FOLH1;TF;CAPN3;SOX10;MLC1;PLLP;FA2H;SEC14L5;TUBB4A;MAG;BVES;PEX5L;PLCL1;CDK18;ATP10B;PPL;TRIM67;GJB6;LDB3;PLP1;MYRF;GAL3ST1;RPS4Y1;HAPLN2;PDGFRA;CPM;GPNMB;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;PIEZO2;FZD7;KCNJ6;SNX22;ACAN;TMSB15A;SLC45A3;ADAMTS4;SLC5A11;TMEM144;EDIL3;PHKG1;CTHRC1;GREM1;GPD1;KLK6;MOBP;LGI3;GJB1;KNDC1;MAL;CARNS1;DMRT2;SUSD5;UGT8;MYO1D;BOK;TMEM125;GPR62;CNTN2;ANKS1B;GLDN;DNAH17;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;TMEM88B;COL28A1
42,GO:0000086,0.779349094349706,0.557738939907871,1,239,G2/M transition of mitotic cell cycle,BP,TUBB4A
5639,GO:0016032,0.779613372155369,0.387930831564141,4,855,viral process,BP,RPS4Y1;PDGFRA;MOG;EGFR
6009,GO:0016757,0.779698785907369,0.557243727810796,1,232,transferase activity, transferring glycosyl groups,MF,UGT8
15221,GO:0061695,0.77977772379342,0.557120092749729,1,233,transferase complex, transferring phosphorus-containing groups,CC,PHKG1
3415,GO:0006836,0.781578095773063,0.554472437062106,1,218,neurotransmitter transport,BP,BAIAP3
3518,GO:0007005,0.783051582167282,0.453552934103407,2,482,mitochondrion organization,BP,EYA2;BOK
9464,GO:0034703,0.783098722859652,0.552211784322575,1,209,cation channel complex,CC,KCNJ6
13858,GO:0051648,0.783491536249248,0.551585061592104,1,214,vesicle localization,BP,MYO1D
2644,GO:0005635,0.783531353460773,0.452940662934457,2,432,nuclear envelope,CC,EGFR;BOK
4539,GO:0009725,0.785294665723937,0.380324208529572,4,809,response to hormone,BP,LRP2;SOX10;EGFR;GJA1
7229,GO:0030217,0.785461308441239,0.548476412889862,1,233,T cell differentiation,BP,FZD7
3012,GO:0006259,0.787004197253818,0.378004316742356,4,823,DNA metabolic process,BP,EYA2;EGFR;GJA1;GREM1
8978,GO:0033554,0.787197521798695,0.318302466676991,10,1882,cellular response to stress,BP,EYA2;TF;CAPN3;MAG;PDGFRA;EGFR;FZD7;BOK;APOD;DAPK1
5655,GO:0016054,0.789107385774811,0.542731175969581,1,262,organic acid catabolic process,BP,CARNS1
12324,GO:0046395,0.789107385774811,0.542731175969581,1,262,carboxylic acid catabolic process,BP,CARNS1
440,GO:0001505,0.790761448515755,0.54031304698296,1,226,regulation of neurotransmitter levels,BP,BAIAP3
13367,GO:0050808,0.791253652183838,0.44177817983077,2,393,synapse organization,BP,ANK3;CNTN2
15432,GO:0070085,0.791725485545385,0.538764483126733,1,235,glycosylation,BP,GAL3ST1
2574,GO:0005488,0.795796942698338,0.29768786726079,84,13523,binding,MF,CRLF1;BAIAP3;ANLN;CLDN11;STMN4;NGFR;EYA2;ERBB3;FGFR3;CDH19;DCX;LRP2;NKAIN1;FOLH1;TF;CAPN3;SOX10;MLC1;PLLP;FA2H;SEC14L5;TUBB4A;MAG;BVES;PEX5L;PLCL1;CDK18;ATP10B;PPL;TRIM67;GJB6;LDB3;PLP1;MYRF;RPS4Y1;HAPLN2;PDGFRA;CPM;GPNMB;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;FZD7;KCNJ6;SNX22;ACAN;TMSB15A;ADAMTS4;SLC5A11;TMEM144;EDIL3;PHKG1;CTHRC1;GREM1;GPD1;KLK6;MOBP;GJB1;KNDC1;MAL;CARNS1;DMRT2;SUSD5;MYO1D;BOK;GPR62;CNTN2;ANKS1B;GLDN;DNAH17;APOD;SPOCK3;MYT1;DAPK1;MBP;TMEM88B
13004,GO:0048588,0.796083797237023,0.531987138642031,1,218,developmental cell growth,BP,MAG
6029,GO:0016788,0.797235615864428,0.389533649419296,3,646,hydrolase activity, acting on ester bonds,MF,EYA2;PLCL1;ENPP2
5785,GO:0016311,0.79836269188554,0.431177839488116,2,435,dephosphorylation,BP,EYA2;MYO1D
19140,GO:1901698,0.798697235183299,0.344908252187125,5,1005,response to nitrogen compound,BP,NGFR;PDGFRA;EGFR;GJA1;GPD1
7455,GO:0030674,0.799545478008216,0.526389327795895,1,234,protein-macromolecule adaptor activity,MF,ANK3
11687,GO:0044839,0.80190122382954,0.522509369630663,1,255,cell cycle G2/M phase transition,BP,TUBB4A
6031,GO:0016791,0.802331631172338,0.521886299281946,1,238,phosphatase activity,MF,EYA2
4719,GO:0010467,0.803385444304874,0.262908120813933,29,5091,gene expression,BP,NGFR;ERBB3;TF;CAPN3;SOX10;CDK18;PLP1;MYRF;RPS4Y1;PDGFRA;CPM;GPNMB;MOG;PCSK6;EGFR;ST18;NKX6-2;ANK3;GJA1;FZD7;GREM1;KLK6;DMRT2;CNTN2;APOD;MYT1;DAPK1;MBP;GJC2
7015,GO:0022409,0.803443074134393,0.520013903316649,1,255,positive regulation of cell-cell adhesion,BP,ANK3
16704,GO:0072331,0.803566811879141,0.519825176404519,1,252,signal transduction by p53 class mediator,BP,BOK
11720,GO:0045017,0.806056271168106,0.515806771385846,1,243,glycerolipid biosynthetic process,BP,GPD1
17485,GO:0097193,0.807355265569924,0.513581329109644,1,267,intrinsic apoptotic signaling pathway,BP,BOK
14665,GO:0060560,0.809399455883351,0.510394181476831,1,225,developmental growth involved in morphogenesis,BP,MAG
11585,GO:0044403,0.809738142055444,0.346604828083563,4,900,symbiotic process,BP,RPS4Y1;PDGFRA;MOG;EGFR
12564,GO:0046903,0.812774393223601,0.304382162860131,7,1415,secretion,BP,BAIAP3;ERBB3;TF;PCSK6;EGFR;GJA1;LGI3
4185,GO:0008654,0.813778493793449,0.502982566526914,1,251,phospholipid biosynthetic process,BP,GPD1
1694,GO:0003924,0.814658527167264,0.501386847036805,1,283,GTPase activity,MF,TUBB4A
7645,GO:0031090,0.815740106415391,0.261742800692313,17,3179,organelle membrane,CC,BAIAP3;LRP2;TF;SOX10;FA2H;PEX5L;ATP10B;MYRF;GAL3ST1;GPNMB;EGFR;GJA1;FZD7;SNX22;GJB1;BOK;GPR62
6698,GO:0019953,0.816061341524984,0.362265776884294,3,677,sexual reproduction,BP,CLDN11;GAL3ST1;GJA1
11220,GO:0043412,0.816381789817529,0.253590585185589,22,3857,macromolecule modification,BP,CRLF1;EYA2;ERBB3;FGFR3;FOLH1;TF;CAPN3;PLCL1;CDK18;GAL3ST1;PDGFRA;GPNMB;ENPP2;EGFR;FZD7;PHKG1;GREM1;KNDC1;SPOCK3;DAPK1;MBP;GJC2
15384,GO:0065003,0.816740412793968,0.299101218141877,7,1437,protein-containing complex assembly,BP,ANLN;CAPN3;TUBB4A;TMSB15A;GREM1;BOK;DNAH17
1364,GO:0003007,0.817833362506291,0.496195068937463,1,238,heart morphogenesis,BP,LRP2
1098,GO:0002521,0.817895335024693,0.401315060459044,2,477,leukocyte differentiation,BP,TF;FZD7
9505,GO:0034774,0.818003090336398,0.495681585697034,1,299,secretory granule lumen,CC,TF
16446,GO:0071900,0.819795068078733,0.39834543723813,2,476,regulation of protein serine/threonine kinase activity,BP,TF;EGFR
19092,GO:1901615,0.819947363612233,0.398092337198515,2,486,organic hydroxy compound metabolic process,BP,LRP2;GPD1
14409,GO:0060205,0.821086301755811,0.490404048957951,1,302,cytoplasmic vesicle lumen,CC,TF
1009,GO:0002376,0.821259558180444,0.264191557602409,13,2560,immune system process,BP,ANLN;TF;MAG;BVES;PDGFRA;GPNMB;ENPP2;MOG;FZD7;GREM1;APOD;DAPK1;MBP
11104,GO:0043232,0.82195871047998,0.242963943094476,26,4543,intracellular non-membrane-bounded organelle,CC,ANLN;CLDN11;PLEKHH1;DCX;CAPN3;SOX10;TUBB4A;PPL;TRIM67;GJB6;LDB3;RPS4Y1;ERMN;ST18;NKX6-2;ANK3;TMSB15A;KLK6;MOBP;SGCD;DMRT2;MYO1D;DNAH17;APOD;MYT1;DAPK1
18397,GO:0110053,0.822867402372913,0.487513369287075,1,251,regulation of actin filament organization,BP,TMSB15A
3013,GO:0006260,0.823304328669191,0.486733505555522,1,257,DNA replication,BP,EGFR
11100,GO:0043228,0.825310057927767,0.238918690777017,26,4552,non-membrane-bounded organelle,CC,ANLN;CLDN11;PLEKHH1;DCX;CAPN3;SOX10;TUBB4A;PPL;TRIM67;GJB6;LDB3;RPS4Y1;ERMN;ST18;NKX6-2;ANK3;TMSB15A;KLK6;MOBP;SGCD;DMRT2;MYO1D;DNAH17;APOD;MYT1;DAPK1
9519,GO:0034976,0.82700327079344,0.480238203794008,1,272,response to endoplasmic reticulum stress,BP,BOK
5805,GO:0016358,0.827372009564129,0.479735750024087,1,237,dendrite development,BP,KNDC1
8790,GO:0033043,0.828265728437184,0.292519380718662,6,1196,regulation of organelle organization,BP,ANLN;STMN4;TUBB4A;PDGFRA;TMSB15A;BOK
3446,GO:0006886,0.828518425753134,0.303762793720441,5,1096,intracellular protein transport,BP,NGFR;PEX5L;RPS4Y1;ANK3;APOD
19112,GO:1901652,0.828949013078216,0.383840740662275,2,474,response to peptide,BP,NGFR;GJA1
17035,GO:0090068,0.830060653805608,0.474889379171049,1,263,positive regulation of cell cycle process,BP,EGFR
3027,GO:0006281,0.830360400492431,0.381555098876023,2,488,DNA repair,BP,EYA2;EGFR
17208,GO:0090305,0.830677931972542,0.473734766940493,1,280,nucleic acid phosphodiester bond hydrolysis,BP,ENPP2
428,GO:0001228,0.832402219941144,0.378286441232853,2,472,DNA-binding transcription activator activity, RNA polymerase II-specific,MF,SOX10;DMRT2
12484,GO:0046700,0.832830198941283,0.377493168235268,2,552,heterocycle catabolic process,BP,RPS4Y1;CARNS1
18508,GO:0140014,0.833273690905483,0.46916191030854,1,266,mitotic nuclear division,BP,ANLN
5645,GO:0016042,0.833410556716668,0.468837491364841,1,289,lipid catabolic process,BP,ENPP2
11512,GO:0044270,0.833524985446563,0.376367093060154,2,553,cellular nitrogen compound catabolic process,BP,RPS4Y1;CARNS1
419,GO:0001216,0.834798998592088,0.374396959036654,2,475,DNA-binding transcription activator activity,MF,SOX10;DMRT2
6574,GO:0019637,0.838291974316061,0.305440900373778,4,913,organophosphate metabolic process,BP,FGFR3;PDGFRA;ENPP2;GPD1
19671,GO:1903037,0.838855129026359,0.458996611377948,1,291,regulation of leukocyte cell-cell adhesion,BP,GPNMB
2698,GO:0005739,0.843456643199874,0.271251794735525,6,1424,mitochondrion,CC,EYA2;SOX10;GJA1;KLK6;MOBP;BOK
3467,GO:0006914,0.844247134138424,0.358818120173321,2,500,autophagy,BP,BOK;DAPK1
15322,GO:0061919,0.844247134138424,0.358818120173321,2,500,process utilizing autophagic mechanism,BP,BOK;DAPK1
3488,GO:0006952,0.844381235019912,0.269957597925047,6,1367,defense response,BP,TF;PLP1;EGFR;GJA1;APOD;DAPK1
13402,GO:0050863,0.844462229865036,0.44864044017354,1,302,regulation of T cell activation,BP,GPNMB
6528,GO:0019439,0.845316659910002,0.356955648851823,2,569,aromatic compound catabolic process,BP,RPS4Y1;CARNS1
4583,GO:0009892,0.846533885531599,0.227030275904356,15,2850,negative regulation of metabolic process,BP,NGFR;CAPN3;SOX10;PLCL1;RPS4Y1;GPNMB;EGFR;NKX6-2;GJA1;GREM1;MYO1D;APOD;SPOCK3;DAPK1;COL28A1
11405,GO:0043933,0.84747547466704,0.250529009441274,8,1694,protein-containing complex subunit organization,BP,ANLN;STMN4;CAPN3;TUBB4A;TMSB15A;GREM1;BOK;DNAH17
8720,GO:0032940,0.847870975779297,0.265022432644376,6,1302,secretion by cell,BP,BAIAP3;TF;PCSK6;EGFR;GJA1;LGI3
8749,GO:0032984,0.849711034103088,0.438780480997274,1,306,protein-containing complex disassembly,BP,STMN4
4479,GO:0009416,0.850643379340725,0.437069936673258,1,287,response to light stimulus,BP,EGFR
3487,GO:0006950,0.850944729716695,0.216049699296306,18,3430,response to stress,BP,EYA2;ERBB3;TF;CAPN3;MLC1;PLLP;MAG;BVES;PPL;PLP1;PDGFRA;EGFR;GJA1;FZD7;KLK6;BOK;APOD;DAPK1
4586,GO:0009895,0.852919362514423,0.432747777082984,1,281,negative regulation of catabolic process,BP,EGFR
3778,GO:0007596,0.853339072606484,0.431913512555894,1,290,blood coagulation,BP,PDGFRA
16107,GO:0071345,0.854173438136916,0.281571023552374,4,973,cellular response to cytokine stimulus,BP,CRLF1;ST18;GPD1;DAPK1
13406,GO:0050867,0.854750081819266,0.429139838465291,1,310,positive regulation of cell activation,BP,CAPN3
13604,GO:0051172,0.854890430833492,0.226878451407926,11,2143,negative regulation of nitrogen compound metabolic process,BP,NGFR;CAPN3;SOX10;EGFR;NKX6-2;GJA1;GREM1;APOD;SPOCK3;DAPK1;COL28A1
13373,GO:0050817,0.855596033641063,0.427559512739125,1,292,coagulation,BP,PDGFRA
3781,GO:0007599,0.857454951740999,0.423942450389556,1,295,hemostasis,BP,PDGFRA
12133,GO:0045936,0.859660956666648,0.332609114265212,2,517,negative regulation of phosphate metabolic process,BP,GREM1;MYO1D
4764,GO:0010563,0.860263492701412,0.331562236917417,2,518,negative regulation of phosphorus metabolic process,BP,GREM1;MYO1D
1637,GO:0003824,0.861243909838664,0.194092742855709,27,4902,catalytic activity,MF,EYA2;ERBB3;FGFR3;FOLH1;CAPN3;FA2H;TUBB4A;PLCL1;CDK18;MYRF;GAL3ST1;PDGFRA;CPM;ENPP2;PCSK6;EGFR;CNDP1;ADAMTS4;PHKG1;GPD1;KLK6;LGI3;CARNS1;UGT8;MYO1D;DNAH17;DAPK1
19002,GO:1901361,0.8621281525266,0.328234221357652,2,596,organic cyclic compound catabolic process,BP,RPS4Y1;CARNS1
11502,GO:0044248,0.865881402048174,0.215641254235295,10,2099,cellular catabolic process,BP,LRP2;TRIM67;RPS4Y1;ENPP2;ACAN;PHKG1;GPD1;CARNS1;BOK;DAPK1
3104,GO:0006402,0.866710036131433,0.405471902258062,1,347,mRNA catabolic process,BP,RPS4Y1
9463,GO:0034702,0.867015641058796,0.405048021391972,1,278,ion channel complex,CC,KCNJ6
3593,GO:0007159,0.868206697881914,0.402509801921823,1,321,leukocyte cell-cell adhesion,BP,GPNMB
4789,GO:0010608,0.868369043659597,0.317293305121335,2,547,posttranscriptional regulation of gene expression,BP,EGFR;DAPK1
11590,GO:0044419,0.870805144185276,0.217950218241925,8,1801,interspecies interaction between organisms,BP,TF;GJB6;RPS4Y1;PDGFRA;MOG;EGFR;GJA1;DAPK1
3147,GO:0006470,0.871838075039713,0.395157140361973,1,300,protein dephosphorylation,BP,EYA2
18585,GO:0140352,0.872943945610975,0.228573882071424,6,1351,export from cell,BP,BAIAP3;TF;PCSK6;EGFR;GJA1;LGI3
5935,GO:0016604,0.873276308293513,0.272659067598404,3,733,nuclear body,CC,RAPGEF5;ADAMTS4;ANKS1B
289,GO:0000790,0.874660953833734,0.23594890985826,5,1142,nuclear chromatin,CC,SOX10;ST18;NKX6-2;DMRT2;MYT1
2702,GO:0005743,0.874792937504244,0.388814400345601,1,407,mitochondrial inner membrane,CC,BOK
1036,GO:0002429,0.875181649508605,0.388147461102801,1,335,immune response-activating cell surface receptor signaling pathway,BP,MOG
1240,GO:0002757,0.875181649508605,0.388147461102801,1,335,immune response-activating signal transduction,BP,MOG
17871,GO:0098772,0.877139684602757,0.183701183400342,17,3282,molecular function regulator,MF,CRLF1;ERBB3;CAPN3;SOX10;MYRF;GPNMB;RAPGEF5;EGFR;ST18;NKX6-2;GREM1;KNDC1;MAL;DMRT2;SPOCK3;MYT1;COL28A1
427,GO:0001227,0.877238405634603,0.383901718504074,1,314,DNA-binding transcription repressor activity, RNA polymerase II-specific,MF,NKX6-2
2910,GO:0006066,0.878127985260824,0.381989962635469,1,330,alcohol metabolic process,BP,GPD1
420,GO:0001217,0.878184293315334,0.381910063048538,1,315,DNA-binding transcription repressor activity,MF,NKX6-2
5651,GO:0016050,0.878866861073555,0.380475624398419,1,313,vesicle organization,BP,BAIAP3
3500,GO:0006974,0.881743908386783,0.258364633961829,3,771,cellular response to DNA damage stimulus,BP,EYA2;EGFR;BOK
4110,GO:0008509,0.882481053305128,0.372788608160268,1,312,anion transmembrane transporter activity,MF,GJA1
7810,GO:0031400,0.883282178602839,0.290219691241101,2,556,negative regulation of protein modification process,BP,CAPN3;GREM1
7136,GO:0030098,0.883595344744755,0.3703608745761,1,325,lymphocyte differentiation,BP,FZD7
19437,GO:1902495,0.883807471948832,0.369975605418507,1,299,transmembrane transporter complex,CC,KCNJ6
5864,GO:0016491,0.884134193349178,0.288559763467688,2,646,oxidoreductase activity,MF,FA2H;GPD1
8098,GO:0031967,0.884330088959371,0.23410575292877,4,1067,organelle envelope,CC,SOX10;EGFR;GJA1;BOK
8102,GO:0031975,0.884330088959371,0.23410575292877,4,1067,envelope,CC,SOX10;EGFR;GJA1;BOK
366,GO:0000981,0.886578281093427,0.208071492880878,6,1324,DNA-binding transcription factor activity, RNA polymerase II-specific,MF,SOX10;MYRF;ST18;NKX6-2;DMRT2;MYT1
4343,GO:0009150,0.886740569631035,0.363512480106055,1,339,purine ribonucleotide metabolic process,BP,GPD1
1600,GO:0003682,0.887773209906752,0.281860460887702,2,529,chromatin binding,MF,SOX10;EGFR
21516,GO:2000113,0.887998074321044,0.205904171969696,6,1328,negative regulation of cellular macromolecule biosynthetic process,BP,CAPN3;SOX10;NKX6-2;GJA1;GREM1;DAPK1
21220,GO:1990351,0.88851905205325,0.35970212879962,1,307,transporter complex,CC,KCNJ6
4786,GO:0010605,0.890453007745932,0.173043564916327,13,2635,negative regulation of macromolecule metabolic process,BP,NGFR;CAPN3;SOX10;RPS4Y1;GPNMB;EGFR;NKX6-2;GJA1;GREM1;APOD;SPOCK3;DAPK1;COL28A1
3103,GO:0006401,0.893369339714136,0.348768937527496,1,382,RNA catabolic process,BP,RPS4Y1
4803,GO:0010629,0.893502976936007,0.180650101436398,9,1945,negative regulation of gene expression,BP,CAPN3;SOX10;RPS4Y1;GPNMB;EGFR;NKX6-2;GREM1;APOD;DAPK1
9137,GO:0034097,0.893712732572209,0.218701378102507,4,1051,response to cytokine,BP,CRLF1;ST18;GPD1;DAPK1
3466,GO:0006913,0.893824469922927,0.347852241963407,1,332,nucleocytoplasmic transport,BP,APOD
3116,GO:0006417,0.894984777305971,0.345220714891163,1,340,regulation of translation,BP,DAPK1
13601,GO:0051169,0.895518494223001,0.344026177875513,1,335,nuclear transport,BP,APOD
4428,GO:0009259,0.896666405265764,0.341380173775517,1,354,ribonucleotide metabolic process,BP,GPD1
3527,GO:0007018,0.896937889400214,0.340839330531927,1,321,microtubule-based movement,BP,DNAH17
1250,GO:0002768,0.898569125055605,0.337011560282706,1,366,immune response-regulating cell surface receptor signaling pathway,BP,MOG
2719,GO:0005765,0.899303529808432,0.335366797695427,1,346,lysosomal membrane,CC,LRP2
17920,GO:0098852,0.899303529808432,0.335366797695427,1,346,lytic vacuole membrane,CC,LRP2
1247,GO:0002764,0.899853434862723,0.334053013213668,1,369,immune response-regulating signaling pathway,BP,MOG
13530,GO:0051056,0.900512898307252,0.3326717004007,1,308,regulation of small GTPase mediated signal transduction,BP,TRIM67
6586,GO:0019693,0.901942034200557,0.329225141030064,1,364,ribose phosphate metabolic process,BP,GPD1
11636,GO:0044703,0.904639749368637,0.218140551477756,3,828,multi-organism reproductive process,BP,CLDN11;GAL3ST1;GJA1
12457,GO:0046649,0.904825215758213,0.248825409225619,2,620,lymphocyte activation,BP,GPNMB;FZD7
12048,GO:0045787,0.906320412957788,0.318960187377466,1,352,positive regulation of cell cycle,BP,EGFR
603,GO:0001775,0.906583598947978,0.185321438131697,5,1277,cell activation,BP,CAPN3;PDGFRA;GPNMB;EGFR;FZD7
4759,GO:0010558,0.906988217107613,0.176307116824899,6,1377,negative regulation of macromolecule biosynthetic process,BP,CAPN3;SOX10;NKX6-2;GJA1;GREM1;DAPK1
2962,GO:0006163,0.908003518234062,0.314904505831882,1,375,purine nucleotide metabolic process,BP,GPD1
12840,GO:0048193,0.908101491093171,0.31473044158925,1,345,Golgi vesicle transport,BP,ANK3
1609,GO:0003700,0.908759725828342,0.173484411384904,6,1382,DNA-binding transcription factor activity,MF,SOX10;MYRF;ST18;NKX6-2;DMRT2;MYT1
639,GO:0001819,0.911424319027471,0.306637135288892,1,386,positive regulation of cytokine production,BP,MBP
3447,GO:0006887,0.911652767965937,0.205295533606162,3,850,exocytosis,BP,BAIAP3;TF;LGI3
6661,GO:0019866,0.912219723313068,0.30459281388206,1,460,organelle inner membrane,CC,BOK
6452,GO:0019221,0.913202716336612,0.23189524098266,2,677,cytokine-mediated signaling pathway,BP,CRLF1;ST18
11062,GO:0043170,0.913573200176035,0.122923960151283,47,8271,macromolecule metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;FOLH1;TF;CAPN3;SOX10;BVES;PLCL1;CDK18;TRIM67;PLP1;MYRF;GAL3ST1;RPS4Y1;PDGFRA;CPM;GPNMB;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;FZD7;ACAN;ADAMTS4;PHKG1;GREM1;KLK6;KNDC1;DMRT2;BOK;CNTN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
7137,GO:0030099,0.914398923746949,0.299384907461608,1,370,myeloid cell differentiation,BP,TF
7766,GO:0031324,0.91480619324636,0.143186865181812,11,2317,negative regulation of cellular metabolic process,BP,NGFR;CAPN3;SOX10;NKX6-2;GJA1;GREM1;MYO1D;APOD;SPOCK3;DAPK1;COL28A1
11519,GO:0044282,0.915054669116393,0.297695068936093,1,412,small molecule catabolic process,BP,CARNS1
13859,GO:0051649,0.915439650087703,0.139937112152968,12,2552,establishment of localization in cell,BP,BAIAP3;NGFR;TF;CAPN3;MLC1;BVES;PEX5L;RPS4Y1;ANK3;GJA1;MYO1D;APOD
5937,GO:0016607,0.916237211486792,0.294829029651242,1,372,nuclear speck,CC,ADAMTS4
6291,GO:0018205,0.91663775923246,0.293856620592635,1,359,peptidyl-lysine modification,BP,CAPN3
13640,GO:0051249,0.91684156884302,0.293272270935965,1,402,regulation of lymphocyte activation,BP,GPNMB
926,GO:0002253,0.918062433165619,0.290217453434027,1,402,activation of immune response,BP,MOG
18013,GO:0098978,0.919992916975353,0.285446973331271,1,348,glutamatergic synapse,CC,ACAN
16768,GO:0072521,0.920311850692421,0.284546587386198,1,398,purine-containing compound metabolic process,BP,GPD1
134,GO:0000280,0.920832286120394,0.283259325594328,1,377,nuclear division,BP,ANLN
364,GO:0000978,0.921367143874165,0.171132828516675,4,1015,RNA polymerase II cis-regulatory region sequence-specific DNA binding,MF,SOX10;ST18;NKX6-2;MYT1
719,GO:0001933,0.921464845058791,0.281641654105606,1,380,negative regulation of protein phosphorylation,BP,GREM1
7769,GO:0031327,0.922618184285904,0.150996637801817,6,1426,negative regulation of cellular biosynthetic process,BP,CAPN3;SOX10;NKX6-2;GJA1;GREM1;DAPK1
2727,GO:0005774,0.924198153042148,0.274592429532375,1,393,vacuolar membrane,CC,LRP2
18129,GO:0099503,0.92487001407864,0.180313801612839,3,911,secretory vesicle,CC,TF;KLK6;LGI3
5998,GO:0016740,0.926740333339063,0.130855914341724,9,1986,transferase activity,MF,ERBB3;FGFR3;CDK18;GAL3ST1;PDGFRA;EGFR;PHKG1;UGT8;DAPK1
9229,GO:0034248,0.927487767858593,0.266001234426042,1,393,regulation of cellular amide metabolic process,BP,DAPK1
367,GO:0000987,0.929150190280387,0.157060902400882,4,1038,cis-regulatory region sequence-specific DNA binding,MF,SOX10;ST18;NKX6-2;MYT1
4581,GO:0009890,0.929694399600388,0.139212726152976,6,1454,negative regulation of biosynthetic process,BP,CAPN3;SOX10;NKX6-2;GJA1;GREM1;DAPK1
285,GO:0000785,0.930773018041573,0.144359574509179,5,1284,chromatin,CC,SOX10;ST18;NKX6-2;DMRT2;MYT1
13887,GO:0051704,0.931152045869902,0.168067842586153,3,894,multi-organism process,BP,CLDN11;GAL3ST1;GJA1
11507,GO:0044260,0.931538119413998,0.099781894688941,40,7240,cellular macromolecule metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;FOLH1;TF;CAPN3;SOX10;BVES;PLCL1;CDK18;TRIM67;MYRF;GAL3ST1;RPS4Y1;PDGFRA;GPNMB;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;ACAN;PHKG1;GREM1;KNDC1;DMRT2;BOK;CNTN2;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
4452,GO:0009314,0.931840597278331,0.254380965024866,1,404,response to radiation,BP,EGFR
11234,GO:0043434,0.931884964056815,0.254273480538092,1,396,response to peptide hormone,BP,GJA1
13888,GO:0051707,0.932487639496815,0.150891075496514,4,1183,response to other organism,BP,TF;GJB6;GJA1;DAPK1
11089,GO:0043207,0.932944527663135,0.150045602277891,4,1185,response to external biotic stimulus,BP,TF;GJB6;GJA1;DAPK1
363,GO:0000977,0.933367313212743,0.139807749382488,5,1257,RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,SOX10;ST18;NKX6-2;DMRT2;MYT1
7959,GO:0031667,0.93381702865462,0.248995592178038,1,421,response to nutrient levels,BP,EGFR
10646,GO:0042326,0.936543311559181,0.241510956562572,1,414,negative regulation of phosphorylation,BP,GREM1
8182,GO:0032103,0.936723511818182,0.240963989102331,1,451,positive regulation of response to external stimulus,BP,EGFR
12887,GO:0048285,0.94091278122624,0.229240702409785,1,419,organelle fission,BP,ANLN
4507,GO:0009607,0.941110898672862,0.13471482503501,4,1212,response to biotic stimulus,BP,TF;GJB6;GJA1;DAPK1
4313,GO:0009117,0.943159180416997,0.222763798418799,1,456,nucleotide metabolic process,BP,GPD1
3367,GO:0006753,0.945118974356367,0.217071207389897,1,463,nucleoside phosphate metabolic process,BP,GPD1
4616,GO:0009991,0.945781739199759,0.215144621789884,1,452,response to extracellular stimulus,BP,EGFR
111,GO:0000228,0.94594326470468,0.117172439165153,5,1344,nuclear chromosome,CC,SOX10;ST18;NKX6-2;DMRT2;MYT1
1604,GO:0003690,0.946570399365998,0.110150430878618,6,1508,double-stranded DNA binding,MF,SOX10;EGFR;ST18;NKX6-2;DMRT2;MYT1
7717,GO:0031252,0.946768704800768,0.212309104522478,1,399,cell leading edge,CC,MYO1D
7169,GO:0030141,0.948666006843211,0.153872292080736,2,759,secretory granule,CC,TF;KLK6
1195,GO:0002694,0.949229969886877,0.204895964077092,1,477,regulation of leukocyte activation,BP,GPNMB
9430,GO:0034655,0.9515531442645,0.197842219159639,1,513,nucleobase-containing compound catabolic process,BP,RPS4Y1
5907,GO:0016570,0.951894972390646,0.196887248273988,1,426,histone modification,BP,EYA2
11739,GO:0045055,0.952573241858363,0.144482872838117,2,749,regulated exocytosis,BP,BAIAP3;TF
11505,GO:0044257,0.953625363089651,0.141928939803547,2,726,cellular protein catabolic process,BP,LRP2;TRIM67
12099,GO:0045892,0.953720838249316,0.110140387471989,4,1150,negative regulation of transcription, DNA-templated,BP,CAPN3;SOX10;NKX6-2;GREM1
11314,GO:0043565,0.954650763244204,0.0956715325693187,6,1541,sequence-specific DNA binding,MF,SOX10;MYRF;ST18;NKX6-2;DMRT2;MYT1
5906,GO:0016569,0.955218805255841,0.186603611575469,1,436,covalent chromatin modification,BP,EYA2
362,GO:0000976,0.955303099238584,0.0996840439171563,5,1345,transcription regulatory region sequence-specific DNA binding,MF,SOX10;ST18;NKX6-2;DMRT2;MYT1
384,GO:0001067,0.955544442856358,0.0992245946224427,5,1346,regulatory region nucleic acid binding,MF,SOX10;ST18;NKX6-2;DMRT2;MYT1
12131,GO:0045934,0.955690453468371,0.0989446998554728,5,1360,negative regulation of nucleobase-containing compound metabolic process,BP,CAPN3;SOX10;NKX6-2;GJA1;GREM1
19453,GO:1902532,0.957394728592223,0.17971012016545,1,468,negative regulation of intracellular signal transduction,BP,TRIM67
11018,GO:0043087,0.958660187317497,0.175700101279788,1,437,regulation of GTPase activity,BP,BVES
19897,GO:1903507,0.961033261673487,0.0952719082314144,4,1186,negative regulation of nucleic acid-templated transcription,BP,CAPN3;SOX10;NKX6-2;GREM1
3396,GO:0006807,0.961184747399085,0.059154497860595,47,8631,nitrogen compound metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;FOLH1;TF;CAPN3;SOX10;FA2H;PLCL1;CDK18;TRIM67;MYRF;GAL3ST1;RPS4Y1;PDGFRA;CPM;GPNMB;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;ACAN;ADAMTS4;PHKG1;GREM1;GPD1;KLK6;KNDC1;CARNS1;DMRT2;UGT8;BOK;CNTN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
19509,GO:1902679,0.961262193693812,0.0947980857753563,4,1188,negative regulation of RNA biosynthetic process,BP,CAPN3;SOX10;NKX6-2;GREM1
11503,GO:0044249,0.96426425173722,0.0571147722836011,26,5302,cellular biosynthetic process,BP,NGFR;FOLH1;TF;CAPN3;SOX10;FA2H;CDK18;PLP1;MYRF;GAL3ST1;RPS4Y1;EGFR;ST18;NKX6-2;GJA1;FZD7;ACAN;SLC45A3;PHKG1;GREM1;GPD1;CARNS1;DMRT2;UGT8;MYT1;DAPK1
17262,GO:0090407,0.9648259690416,0.155343292121049,1,516,organophosphate biosynthetic process,BP,GPD1
11513,GO:0044271,0.964952027347545,0.0582274308794394,20,4289,cellular nitrogen compound biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;FA2H;CDK18;MYRF;GAL3ST1;RPS4Y1;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;CARNS1;DMRT2;UGT8;MYT1;DAPK1
14235,GO:0055086,0.965199904741834,0.154065116419472,1,536,nucleobase-containing small molecule metabolic process,BP,GPD1
1183,GO:0002682,0.96580752761886,0.0852669778169603,4,1313,regulation of immune system process,BP,GPNMB;MOG;GREM1;APOD
11460,GO:0044089,0.968098779624151,0.144151952223361,1,494,positive regulation of cellular component biogenesis,BP,ANLN
11497,GO:0044238,0.968238958583654,0.0492187118996553,49,9012,primary metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;FOLH1;TF;CAPN3;SOX10;FA2H;PLCL1;CDK18;TRIM67;PLP1;MYRF;GAL3ST1;RPS4Y1;PDGFRA;CPM;GPNMB;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;ACAN;SLC45A3;ADAMTS4;PHKG1;GREM1;GPD1;KLK6;KNDC1;CARNS1;DMRT2;UGT8;BOK;CNTN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
16353,GO:0071704,0.968808258483492,0.0485188677709581,52,9498,organic substance metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;FOLH1;TF;CAPN3;SOX10;FA2H;BVES;PLCL1;CDK18;TRIM67;PLP1;MYRF;GAL3ST1;RPS4Y1;PDGFRA;CPM;GPNMB;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;FZD7;ACAN;SLC45A3;ADAMTS4;PHKG1;GREM1;GPD1;KLK6;KNDC1;CARNS1;DMRT2;UGT8;BOK;CNTN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
13345,GO:0050778,0.969859623680489,0.137933396021345,1,566,positive regulation of immune response,BP,MOG
21395,GO:1990837,0.970168309319502,0.0704437168781876,5,1439,sequence-specific double-stranded DNA binding,MF,SOX10;ST18;NKX6-2;DMRT2;MYT1
17757,GO:0098542,0.970481397599735,0.0984978422072648,2,882,defense response to other organism,BP,TF;DAPK1
19077,GO:1901576,0.97259692473157,0.0447743879304213,26,5395,organic substance biosynthetic process,BP,NGFR;FOLH1;TF;CAPN3;SOX10;FA2H;CDK18;PLP1;MYRF;GAL3ST1;RPS4Y1;EGFR;ST18;NKX6-2;GJA1;FZD7;ACAN;SLC45A3;PHKG1;GREM1;GPD1;CARNS1;DMRT2;UGT8;MYT1;DAPK1
11510,GO:0044265,0.972826458677666,0.0779719513258246,3,1094,cellular macromolecule catabolic process,BP,LRP2;TRIM67;RPS4Y1
21418,GO:1990904,0.974449871995854,0.121297809652021,1,641,ribonucleoprotein complex,CC,RPS4Y1
13644,GO:0051253,0.974876321731202,0.0655503185363396,4,1273,negative regulation of RNA metabolic process,BP,CAPN3;SOX10;NKX6-2;GREM1
3072,GO:0006355,0.975509255704074,0.0456351887727004,13,3038,regulation of transcription, DNA-templated,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2;MYT1
6450,GO:0019219,0.97557131352054,0.0436148336219259,16,3567,regulation of nucleobase-containing compound metabolic process,BP,NGFR;EYA2;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;GPD1;DMRT2;MYT1
3074,GO:0006357,0.977405891989101,0.0464045478759804,9,2311,regulation of transcription by RNA polymerase II,BP,NGFR;SOX10;MYRF;EGFR;ST18;NKX6-2;GREM1;DMRT2;MYT1
4271,GO:0009058,0.977712806804476,0.0370253329757468,26,5463,biosynthetic process,BP,NGFR;FOLH1;TF;CAPN3;SOX10;FA2H;CDK18;PLP1;MYRF;GAL3ST1;RPS4Y1;EGFR;ST18;NKX6-2;GJA1;FZD7;ACAN;SLC45A3;PHKG1;GREM1;GPD1;CARNS1;DMRT2;UGT8;MYT1;DAPK1
3176,GO:0006511,0.979465375017529,0.102203350584482,1,580,ubiquitin-dependent protein catabolic process,BP,TRIM67
19896,GO:1903506,0.979829729580482,0.0382860984593975,13,3092,regulation of nucleic acid-templated transcription,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2;MYT1
22068,GO:2001141,0.980164195460979,0.0377103498969884,13,3097,regulation of RNA biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2;MYT1
6696,GO:0019941,0.980292896067079,0.0989312313405736,1,586,modification-dependent protein catabolic process,BP,TRIM67
21515,GO:2000112,0.980454860965063,0.0360707012405936,15,3462,regulation of cellular macromolecule biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;DMRT2;MYT1;DAPK1
3491,GO:0006955,0.981077433675866,0.0474221235017028,5,1706,immune response,BP,TF;ENPP2;MOG;DAPK1;MBP
11351,GO:0043632,0.981139644567466,0.0955452055340296,1,594,modification-dependent macromolecule catabolic process,BP,TRIM67
60,GO:0000122,0.981191130244051,0.0679438968843283,2,862,negative regulation of transcription by RNA polymerase II,BP,SOX10;NKX6-2
4811,GO:0010638,0.981994187953383,0.0920944591886275,1,587,positive regulation of organelle organization,BP,BOK
7768,GO:0031326,0.982383720516764,0.0323775212648149,16,3679,regulation of cellular biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;GJA1;FZD7;SLC45A3;GREM1;DMRT2;MYT1;DAPK1
9419,GO:0034641,0.984736706565843,0.0261096889698073,26,5606,cellular nitrogen compound metabolic process,BP,NGFR;EYA2;FOLH1;TF;CAPN3;SOX10;FA2H;CDK18;MYRF;GAL3ST1;RPS4Y1;CPM;ENPP2;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;GPD1;CARNS1;DMRT2;UGT8;MYT1;DAPK1
18544,GO:0140110,0.984848859797006,0.036691619711531,6,1809,transcription regulator activity,MF,SOX10;MYRF;ST18;NKX6-2;DMRT2;MYT1
9422,GO:0034645,0.98501057746072,0.0270106960526535,19,4326,cellular macromolecule biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;GAL3ST1;RPS4Y1;EGFR;ST18;NKX6-2;GJA1;FZD7;ACAN;PHKG1;GREM1;DMRT2;MYT1;DAPK1
11496,GO:0044237,0.985257206256872,0.0242094986302634,49,9298,cellular metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;FOLH1;TF;CAPN3;SOX10;FA2H;BVES;PLCL1;CDK18;TRIM67;PLP1;MYRF;GAL3ST1;RPS4Y1;PDGFRA;CPM;GPNMB;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;ACAN;SLC45A3;PHKG1;GREM1;GPD1;KNDC1;CARNS1;DMRT2;UGT8;MYO1D;BOK;CNTN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
2760,GO:0005829,0.985827381411246,0.025201227408157,21,4688,cytosol,CC,CRLF1;BAIAP3;NGFR;EYA2;DCX;CAPN3;TUBB4A;PEX5L;PPL;GJB6;MYRF;RPS4Y1;CNDP1;ANK3;PHKG1;GPD1;CARNS1;MYO1D;ANKS1B;APOD;MYT1
3068,GO:0006351,0.985841409470654,0.0277610628383674,13,3198,transcription, DNA-templated,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2;MYT1
5442,GO:0015630,0.985894179720547,0.0446565029539031,3,1135,microtubule cytoskeleton,CC,DCX;TUBB4A;DNAH17
4757,GO:0010556,0.985979708975318,0.0266388618131124,15,3554,regulation of macromolecule biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;DMRT2;MYT1;DAPK1
3081,GO:0006366,0.986154386938689,0.0299142694894712,9,2442,transcription by RNA polymerase II,BP,NGFR;SOX10;MYRF;EGFR;ST18;NKX6-2;GREM1;DMRT2;MYT1
4580,GO:0009889,0.986464264295322,0.0254427268479309,16,3754,regulation of biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;GJA1;FZD7;SLC45A3;GREM1;DMRT2;MYT1;DAPK1
11753,GO:0045087,0.987559687155175,0.068426772670763,1,719,innate immune response,BP,DAPK1
17701,GO:0097659,0.988065337000704,0.0237570795522792,13,3242,nucleic acid-templated transcription,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2;MYT1
3889,GO:0008152,0.988067761151925,0.019983988952675,53,9980,metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;FGFR3;LRP2;FOLH1;TF;CAPN3;SOX10;FA2H;BVES;PLCL1;CDK18;TRIM67;PLP1;MYRF;GAL3ST1;RPS4Y1;PDGFRA;CPM;GPNMB;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;FZD7;ACAN;SLC45A3;ADAMTS4;PHKG1;GREM1;GPD1;KLK6;KNDC1;CARNS1;DMRT2;UGT8;MYO1D;BOK;CNTN2;APOD;SPOCK3;MYT1;DAPK1;MBP;GJC2;COL28A1
13836,GO:0051603,0.988381307618099,0.0647552626090324,1,668,proteolysis involved in cellular protein catabolic process,BP,TRIM67
8606,GO:0032774,0.988610043241603,0.0227653858344353,13,3255,RNA biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2;MYT1
19436,GO:1902494,0.988868390425611,0.0364145346959026,3,1272,catalytic complex,CC,PHKG1;GPD1;DNAH17
4272,GO:0009059,0.990212332205362,0.0182404885178002,19,4441,macromolecule biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;GAL3ST1;RPS4Y1;EGFR;ST18;NKX6-2;GJA1;FZD7;ACAN;PHKG1;GREM1;DMRT2;MYT1;DAPK1
3057,GO:0006325,0.990545264610533,0.0547527262123533,1,656,chromatin organization,BP,EYA2
21194,GO:1990234,0.991571566780189,0.0498204700860341,1,717,transferase complex,CC,PHKG1
2684,GO:0005694,0.991847502794526,0.0225813495962092,5,1735,chromosome,CC,SOX10;ST18;NKX6-2;DMRT2;MYT1
13343,GO:0050776,0.992406814563115,0.0457100536641473,1,788,regulation of immune response,BP,MOG
5661,GO:0016071,0.992443355368267,0.0455284902203672,1,789,mRNA metabolic process,BP,RPS4Y1
17461,GO:0097159,0.992677169725079,0.0133747648719099,24,5302,organic cyclic compound binding,MF,ERBB3;FGFR3;SOX10;FA2H;TUBB4A;BVES;CDK18;ATP10B;MYRF;RPS4Y1;PDGFRA;ENPP2;EGFR;ST18;NKX6-2;PHKG1;GPD1;CARNS1;DMRT2;MYO1D;DNAH17;APOD;MYT1;DAPK1
13643,GO:0051252,0.99275655603019,0.0150430815480524,13,3341,regulation of RNA metabolic process,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2;MYT1
1596,GO:0003677,0.993896915486868,0.0154523550378329,7,2178,DNA binding,MF,SOX10;MYRF;EGFR;ST18;NKX6-2;DMRT2;MYT1
11861,GO:0045321,0.994066033304309,0.0255758041426777,2,1137,leukocyte activation,BP,GPNMB;FZD7
9429,GO:0034654,0.994547467703201,0.0113718931377276,14,3647,nucleobase-containing compound biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;DMRT2;MYT1
2642,GO:0005622,0.994922176421442,0.00974256396754116,70,12466,intracellular,CC,CRLF1;BAIAP3;ANLN;CLDN11;STMN4;PLEKHH1;NGFR;EYA2;BCAS1;FGFR3;DCX;LRP2;FOLH1;TF;CAPN3;SOX10;MLC1;FA2H;TUBB4A;MAG;PEX5L;PLCL1;CDK18;ATP10B;PPL;TRIM67;GJB6;LDB3;MYRF;GAL3ST1;RPS4Y1;PDGFRA;GPNMB;RAPGEF5;ERMN;PCSK6;EGFR;ST18;NKX6-2;CNDP1;ANK3;GJA1;FZD7;KCNJ6;SNX22;ACAN;TMSB15A;ADAMTS4;PHKG1;CTHRC1;GPD1;KLK6;MOBP;LGI3;SGCD;KNDC1;MAL;CARNS1;DMRT2;UGT8;MYO1D;BOK;GPR62;ANKS1B;DNAH17;APOD;MYT1;DAPK1;MBP;COL28A1
19004,GO:1901363,0.995055559610322,0.00934678760034059,23,5231,heterocyclic compound binding,MF,ERBB3;FGFR3;SOX10;FA2H;TUBB4A;BVES;CDK18;ATP10B;MYRF;RPS4Y1;PDGFRA;ENPP2;EGFR;ST18;NKX6-2;PHKG1;GPD1;CARNS1;DMRT2;MYO1D;DNAH17;MYT1;DAPK1
11098,GO:0043226,0.995566476913731,0.00830315295186266,65,11824,organelle,CC,BAIAP3;ANLN;CLDN11;STMN4;PLEKHH1;NGFR;EYA2;BCAS1;FGFR3;DCX;LRP2;FOLH1;TF;CAPN3;SOX10;MLC1;FA2H;TUBB4A;PEX5L;CDK18;ATP10B;PPL;TRIM67;GJB6;LDB3;MYRF;GAL3ST1;RPS4Y1;PDGFRA;CPM;GPNMB;RAPGEF5;ERMN;PCSK6;EGFR;ST18;NKX6-2;ANK3;GJA1;FZD7;KCNJ6;SNX22;ACAN;TMSB15A;ADAMTS4;EDIL3;GPD1;KLK6;MOBP;LGI3;GJB1;SGCD;MAL;DMRT2;UGT8;MYO1D;BOK;GPR62;ANKS1B;DNAH17;APOD;MYT1;DAPK1;MBP;COL28A1
6269,GO:0018130,0.995590896956518,0.00934773667056295,14,3704,heterocycle biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;DMRT2;MYT1
3098,GO:0006396,0.99561740212068,0.0289313149623843,1,859,RNA processing,BP,EGFR
6527,GO:0019438,0.995809394699452,0.00891895394128816,14,3714,aromatic compound biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;DMRT2;MYT1
11101,GO:0043229,0.995872727133388,0.00755535726719057,59,10994,intracellular organelle,CC,BAIAP3;ANLN;CLDN11;STMN4;PLEKHH1;NGFR;EYA2;FGFR3;DCX;LRP2;TF;CAPN3;SOX10;MLC1;FA2H;TUBB4A;PEX5L;CDK18;ATP10B;PPL;TRIM67;GJB6;LDB3;MYRF;GAL3ST1;RPS4Y1;PDGFRA;GPNMB;RAPGEF5;ERMN;PCSK6;EGFR;ST18;NKX6-2;ANK3;GJA1;FZD7;KCNJ6;SNX22;ACAN;TMSB15A;ADAMTS4;KLK6;MOBP;LGI3;SGCD;MAL;DMRT2;UGT8;MYO1D;BOK;GPR62;ANKS1B;DNAH17;APOD;MYT1;DAPK1;MBP;COL28A1
2693,GO:0005730,0.995886553570208,0.0274327790798375,1,849,nucleolus,CC,KLK6
1185,GO:0002684,0.995890665941434,0.0274080626578332,1,869,positive regulation of immune system process,BP,MOG
8393,GO:0032446,0.996615829508916,0.0232733577282599,1,844,protein modification by small protein conjugation,BP,CAPN3
19001,GO:1901360,0.997185568794903,0.00556904460467817,22,5341,organic cyclic compound metabolic process,BP,NGFR;EYA2;LRP2;FOLH1;TF;CAPN3;SOX10;CDK18;MYRF;RPS4Y1;PDGFRA;ENPP2;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;GPD1;CARNS1;DMRT2;MYT1
19003,GO:1901362,0.997415224442795,0.00570174304040286,14,3838,organic cyclic compound biosynthetic process,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;DMRT2;MYT1
8101,GO:0031974,0.997973746740565,0.0040950830288417,22,5447,membrane-enclosed lumen,CC,ANLN;NGFR;EYA2;LRP2;TF;SOX10;MYRF;RPS4Y1;PDGFRA;RAPGEF5;PCSK6;EGFR;ST18;NKX6-2;GJA1;ACAN;ADAMTS4;KLK6;DMRT2;ANKS1B;MYT1;COL28A1
11105,GO:0043233,0.997973746740565,0.0040950830288417,22,5447,organelle lumen,CC,ANLN;NGFR;EYA2;LRP2;TF;SOX10;MYRF;RPS4Y1;PDGFRA;RAPGEF5;PCSK6;EGFR;ST18;NKX6-2;GJA1;ACAN;ADAMTS4;KLK6;DMRT2;ANKS1B;MYT1;COL28A1
15398,GO:0070013,0.997973746740565,0.0040950830288417,22,5447,intracellular organelle lumen,CC,ANLN;NGFR;EYA2;LRP2;TF;SOX10;MYRF;RPS4Y1;PDGFRA;RAPGEF5;PCSK6;EGFR;ST18;NKX6-2;GJA1;ACAN;ADAMTS4;KLK6;DMRT2;ANKS1B;MYT1;COL28A1
11099,GO:0043227,0.998162799009269,0.00352034453218206,57,10968,membrane-bounded organelle,CC,BAIAP3;ANLN;STMN4;NGFR;EYA2;BCAS1;FGFR3;LRP2;FOLH1;TF;CAPN3;SOX10;MLC1;FA2H;TUBB4A;PEX5L;CDK18;ATP10B;PPL;MYRF;GAL3ST1;RPS4Y1;PDGFRA;CPM;GPNMB;RAPGEF5;ERMN;PCSK6;EGFR;ST18;NKX6-2;ANK3;GJA1;FZD7;KCNJ6;SNX22;ACAN;ADAMTS4;EDIL3;GPD1;KLK6;MOBP;LGI3;GJB1;SGCD;MAL;DMRT2;UGT8;MYO1D;BOK;GPR62;ANKS1B;APOD;MYT1;DAPK1;MBP;COL28A1
12365,GO:0046483,0.998426484192862,0.00329510076469901,20,5114,heterocycle metabolic process,BP,NGFR;EYA2;FOLH1;TF;CAPN3;SOX10;CDK18;MYRF;RPS4Y1;ENPP2;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;GPD1;CARNS1;DMRT2;MYT1
17207,GO:0090304,0.998426848115705,0.00341900526763095,17,4529,nucleic acid metabolic process,BP,NGFR;EYA2;TF;CAPN3;SOX10;CDK18;MYRF;RPS4Y1;ENPP2;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;DMRT2;MYT1
3350,GO:0006725,0.998689862509984,0.00277531766700196,20,5156,cellular aromatic compound metabolic process,BP,NGFR;EYA2;FOLH1;TF;CAPN3;SOX10;CDK18;MYRF;RPS4Y1;ENPP2;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;GPD1;CARNS1;DMRT2;MYT1
15761,GO:0070647,0.998987206797855,0.00827298887228033,1,1006,protein modification by small protein conjugation or removal,BP,CAPN3
2653,GO:0005654,0.999016756520522,0.00242604516263171,12,3641,nucleoplasm,CC,ANLN;NGFR;EYA2;SOX10;MYRF;RPS4Y1;PDGFRA;RAPGEF5;GJA1;ADAMTS4;ANKS1B;MYT1
8103,GO:0031981,0.99907504217113,0.00211250079580275,16,4451,nuclear lumen,CC,ANLN;NGFR;EYA2;SOX10;MYRF;RPS4Y1;PDGFRA;RAPGEF5;ST18;NKX6-2;GJA1;ADAMTS4;KLK6;DMRT2;ANKS1B;MYT1
5660,GO:0016070,0.999159497477831,0.00200289546411132,14,4103,RNA metabolic process,BP,NGFR;TF;CAPN3;SOX10;CDK18;MYRF;RPS4Y1;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2;MYT1
13660,GO:0051276,0.999376640288904,0.00541893729520307,1,1047,chromosome organization,BP,EYA2
2953,GO:0006139,0.999433108117485,0.00129512085583998,18,4966,nucleobase-containing compound metabolic process,BP,NGFR;EYA2;TF;CAPN3;SOX10;CDK18;MYRF;RPS4Y1;ENPP2;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;GPD1;DMRT2;MYT1
11103,GO:0043231,0.999596961942419,0.00082339647255852,45,9529,intracellular membrane-bounded organelle,CC,BAIAP3;ANLN;STMN4;NGFR;EYA2;FGFR3;LRP2;TF;CAPN3;SOX10;MLC1;FA2H;TUBB4A;PEX5L;CDK18;ATP10B;MYRF;GAL3ST1;RPS4Y1;PDGFRA;RAPGEF5;PCSK6;EGFR;ST18;NKX6-2;ANK3;GJA1;FZD7;KCNJ6;ACAN;ADAMTS4;KLK6;MOBP;SGCD;MAL;DMRT2;UGT8;MYO1D;BOK;ANKS1B;APOD;MYT1;DAPK1;MBP;COL28A1
1595,GO:0003676,0.999917393853582,0.00026473334462185,9,3512,nucleic acid binding,MF,SOX10;MYRF;RPS4Y1;ENPP2;EGFR;ST18;NKX6-2;DMRT2;MYT1
1617,GO:0003723,0.999947825244964,0.000595293335099999,1,1507,RNA binding,MF,RPS4Y1
2643,GO:0005634,0.999965539062342,8.53704761175065e-05,24,6572,nucleus,CC,ANLN;NGFR;EYA2;FGFR3;CAPN3;SOX10;TUBB4A;CDK18;MYRF;RPS4Y1;PDGFRA;RAPGEF5;EGFR;ST18;NKX6-2;GJA1;ADAMTS4;KLK6;DMRT2;BOK;ANKS1B;MYT1;DAPK1;MBP
13662,GO:0051280,0.999999999999989,0.933896912620203,0,12,negative regulation of release of sequestered calcium ion into cytosol,BP,
9855,GO:0035666,0.99999999999999,0.846497741360386,0,28,TRIF-dependent toll-like receptor signaling pathway,BP,
11758,GO:0045095,0.999999999999991,0.882573257033296,0,22,keratin filament,CC,
12888,GO:0048286,0.999999999999993,0.743689375501415,0,40,lung alveolus development,BP,
8122,GO:0032009,0.999999999999998,0.912525748889531,0,13,early phagosome,CC,
3574,GO:0007099,0.999999999999999,0.779587165229834,0,34,centriole replication,BP,
8449,GO:0032509,0.999999999999999,0.821680374362479,0,33,endosome transport via multivesicular body sorting pathway,BP,
4783,GO:0010596,1,0.733294362213574,0,46,negative regulation of endothelial cell migration,BP,
1,GO:0000002,1,0.857051069694094,0,23,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.988351732905197,0,2,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.98848763359408,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000012,1,0.933382929039442,0,10,single strand break repair,BP,
6,GO:0000014,1,0.941111952632812,0,9,single-stranded DNA endodeoxyribonuclease activity,MF,
7,GO:0000015,1,0.979071253749606,0,4,phosphopyruvate hydratase complex,CC,
8,GO:0000017,1,0.986603389580006,0,2,alpha-glucoside transport,BP,
9,GO:0000018,1,0.56520582794071,0,83,regulation of DNA recombination,BP,
10,GO:0000019,1,0.968204171028254,0,5,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.948702936202888,0,8,mitotic spindle elongation,BP,
12,GO:0000023,1,0.976317898211806,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.973422291425792,0,4,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.88233278982383,0,25,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.922886754979172,0,18,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.839584573562742,0,28,mannosyltransferase activity,MF,
17,GO:0000032,1,0.995630725828587,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.98495006360927,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.989699406740627,0,2,acyl binding,MF,
20,GO:0000036,1,0.996815956228427,0,1,acyl carrier activity,MF,
21,GO:0000038,1,0.815254118931198,0,32,very long-chain fatty acid metabolic process,BP,
23,GO:0000045,1,0.555762377091243,0,88,autophagosome assembly,BP,
24,GO:0000048,1,0.981612440492953,0,3,peptidyltransferase activity,MF,
25,GO:0000049,1,0.716374147923707,0,54,tRNA binding,MF,
26,GO:0000050,1,0.94460919218616,0,11,urea cycle,BP,
27,GO:0000052,1,0.946739953443253,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.995517150892817,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.924000267859335,0,14,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.961862906884299,0,7,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.958474010792665,0,8,ribosomal small subunit export from nucleus,BP,
32,GO:0000062,1,0.892957378328071,0,20,fatty-acyl-CoA binding,MF,
33,GO:0000064,1,0.965235995434112,0,5,L-ornithine transmembrane transporter activity,MF,
34,GO:0000070,1,0.367886210520786,0,150,mitotic sister chromatid segregation,BP,
35,GO:0000075,1,0.25815519772402,0,204,cell cycle checkpoint,BP,
36,GO:0000076,1,0.906839853195277,0,16,DNA replication checkpoint,BP,
37,GO:0000077,1,0.397031240200996,0,138,DNA damage checkpoint,BP,
39,GO:0000080,1,0.984671710184872,0,2,mitotic G1 phase,BP,
43,GO:0000095,1,0.994523830704485,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.798074504560225,0,37,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.904592958637627,0,16,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.923834055456922,0,14,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.9566719673558,0,6,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.959178611696963,0,6,sulfur amino acid transport,BP,
49,GO:0000103,1,0.982768173070269,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.980436691765404,0,4,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.986785259409861,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.925328226762743,0,12,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.979907992404535,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.992519724978507,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000112,1,0.993271832685958,0,1,nucleotide-excision repair factor 3 complex,CC,
56,GO:0000117,1,0.984738159843114,0,2,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
57,GO:0000118,1,0.579855759323122,0,75,histone deacetylase complex,CC,
58,GO:0000120,1,0.986378578979237,0,3,RNA polymerase I transcription regulator complex,CC,
59,GO:0000121,1,0.992762794096959,0,1,glycerol-1-phosphatase activity,MF,
61,GO:0000123,1,0.609214346503719,0,75,histone acetyltransferase complex,CC,
62,GO:0000124,1,0.948884012070372,0,8,SAGA complex,CC,
63,GO:0000125,1,0.977280520519408,0,3,PCAF complex,CC,
64,GO:0000126,1,0.976732556178065,0,3,transcription factor TFIIIB complex,CC,
65,GO:0000127,1,0.960233501887316,0,6,transcription factor TFIIIC complex,CC,
67,GO:0000137,1,0.8899044899089,0,17,Golgi cis cisterna,CC,
68,GO:0000138,1,0.949197237306883,0,9,Golgi trans cisterna,CC,
70,GO:0000145,1,0.897340582290115,0,15,exocyst,CC,
73,GO:0000150,1,0.988916005569056,0,2,recombinase activity,MF,
74,GO:0000151,1,0.165694028294405,0,268,ubiquitin ligase complex,CC,
75,GO:0000152,1,0.776781399885959,0,40,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.931884316533403,0,12,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.846155418560684,0,31,rRNA modification,BP,
78,GO:0000159,1,0.893774540784745,0,17,protein phosphatase type 2A complex,CC,
79,GO:0000160,1,0.992503375353695,0,1,phosphorelay signal transduction system,BP,
80,GO:0000164,1,0.911563929171893,0,14,protein phosphatase type 1 complex,CC,
83,GO:0000170,1,0.99626173993583,0,1,sphingosine hydroxylase activity,MF,
84,GO:0000171,1,0.982777442718955,0,3,ribonuclease MRP activity,MF,
85,GO:0000172,1,0.957132839616177,0,8,ribonuclease MRP complex,CC,
86,GO:0000173,1,0.995873622599238,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
87,GO:0000175,1,0.799411512388902,0,35,3'-5'-exoribonuclease activity,MF,
88,GO:0000176,1,0.93399839313055,0,15,nuclear exosome (RNase complex),CC,
89,GO:0000177,1,0.926222456748274,0,14,cytoplasmic exosome (RNase complex),CC,
90,GO:0000178,1,0.879384556418182,0,23,exosome (RNase complex),CC,
91,GO:0000179,1,0.978690369682121,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
92,GO:0000182,1,0.9546085632319,0,6,rDNA binding,MF,
93,GO:0000183,1,0.924538906565966,0,11,rDNA heterochromatin assembly,BP,
95,GO:0000185,1,0.929272655959359,0,12,activation of MAPKKK activity,BP,
98,GO:0000188,1,0.86105192431278,0,24,inactivation of MAPK activity,BP,
99,GO:0000209,1,0.123065045313022,0,319,protein polyubiquitination,BP,
100,GO:0000210,1,0.992553860657452,0,1,NAD+ diphosphatase activity,MF,
101,GO:0000212,1,0.928610823600571,0,10,meiotic spindle organization,BP,
102,GO:0000213,1,0.989226846217434,0,2,tRNA-intron endonuclease activity,MF,
103,GO:0000214,1,0.980267921298072,0,4,tRNA-intron endonuclease complex,CC,
104,GO:0000215,1,0.989929756897256,0,2,tRNA 2'-phosphotransferase activity,MF,
105,GO:0000217,1,0.794872115993707,0,33,DNA secondary structure binding,MF,
106,GO:0000220,1,0.970480709646921,0,4,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
107,GO:0000221,1,0.979465112785467,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
108,GO:0000224,1,0.993745061053687,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
109,GO:0000225,1,0.996537148002879,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
112,GO:0000229,1,0.996579981182951,0,1,cytoplasmic chromosome,CC,
113,GO:0000235,1,0.924766830987478,0,11,astral microtubule,CC,
114,GO:0000242,1,0.860697095561227,0,20,pericentriolar material,CC,
115,GO:0000243,1,0.974836832574701,0,5,commitment complex,CC,
116,GO:0000244,1,0.916195121971641,0,13,spliceosomal tri-snRNP complex assembly,BP,
117,GO:0000245,1,0.699078618183395,0,57,spliceosomal complex assembly,BP,
118,GO:0000246,1,0.992413345962523,0,1,delta24(24-1) sterol reductase activity,MF,
119,GO:0000247,1,0.996535355469023,0,1,C-8 sterol isomerase activity,MF,
120,GO:0000248,1,0.98568223945275,0,2,C-5 sterol desaturase activity,MF,
121,GO:0000250,1,0.992421201583323,0,1,lanosterol synthase activity,MF,
122,GO:0000252,1,0.995963125742741,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
123,GO:0000253,1,0.989117540896423,0,3,3-keto sterol reductase activity,MF,
124,GO:0000254,1,0.982906207302121,0,3,C-4 methylsterol oxidase activity,MF,
125,GO:0000255,1,0.996198903304679,0,1,allantoin metabolic process,BP,
126,GO:0000256,1,0.996198903304679,0,1,allantoin catabolic process,BP,
127,GO:0000257,1,0.996311898801228,0,1,nitrilase activity,MF,
128,GO:0000266,1,0.768245969252141,0,37,mitochondrial fission,BP,
130,GO:0000270,1,0.99336251476849,0,2,peptidoglycan metabolic process,BP,
136,GO:0000285,1,0.991599014119788,0,1,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
138,GO:0000288,1,0.645232112549108,0,68,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
139,GO:0000289,1,0.811593641212121,0,28,nuclear-transcribed mRNA poly(A) tail shortening,BP,
140,GO:0000290,1,0.952487775043367,0,8,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
141,GO:0000291,1,0.830316015640744,0,34,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
142,GO:0000293,1,0.972649091037006,0,4,ferric-chelate reductase activity,MF,
143,GO:0000294,1,0.985365171656378,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
144,GO:0000295,1,0.840887613530485,0,28,adenine nucleotide transmembrane transporter activity,MF,
145,GO:0000296,1,0.986873212041911,0,2,spermine transport,BP,
146,GO:0000298,1,0.977990025656706,0,4,endopolyphosphatase activity,MF,
147,GO:0000301,1,0.986065858301134,0,2,retrograde transport, vesicle recycling within Golgi,BP,
149,GO:0000303,1,0.866496124405346,0,26,response to superoxide,BP,
150,GO:0000304,1,0.994913821210277,0,1,response to singlet oxygen,BP,
151,GO:0000305,1,0.862299902834649,0,27,response to oxygen radical,BP,
152,GO:0000306,1,0.971903755071992,0,4,extrinsic component of vacuolar membrane,CC,
153,GO:0000307,1,0.77870001157009,0,42,cyclin-dependent protein kinase holoenzyme complex,CC,
154,GO:0000308,1,0.984693431785464,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
155,GO:0000309,1,0.979924588522983,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
156,GO:0000313,1,0.709828928966869,0,84,organellar ribosome,CC,
157,GO:0000314,1,0.899637929346044,0,27,organellar small ribosomal subunit,CC,
158,GO:0000315,1,0.796297808005032,0,55,organellar large ribosomal subunit,CC,
159,GO:0000320,1,0.984881870012933,0,2,re-entry into mitotic cell cycle,BP,
160,GO:0000322,1,0.990976700596246,0,2,storage vacuole,CC,
162,GO:0000333,1,0.992468032218389,0,1,telomerase catalytic core complex,CC,
163,GO:0000334,1,0.996401741060808,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
164,GO:0000338,1,0.951991044288354,0,10,protein deneddylation,BP,
165,GO:0000339,1,0.900267623731337,0,17,RNA cap binding,MF,
166,GO:0000340,1,0.936817632122043,0,10,RNA 7-methylguanosine cap binding,MF,
167,GO:0000346,1,0.928135019505339,0,13,transcription export complex,CC,
168,GO:0000347,1,0.969115079667883,0,6,THO complex,CC,
169,GO:0000349,1,0.987701262604927,0,2,generation of catalytic spliceosome for first transesterification step,BP,
170,GO:0000350,1,0.991432829389403,0,2,generation of catalytic spliceosome for second transesterification step,BP,
171,GO:0000354,1,0.983611631390212,0,2,cis assembly of pre-catalytic spliceosome,BP,
172,GO:0000375,1,0.12539286966772,0,337,RNA splicing, via transesterification reactions,BP,
173,GO:0000377,1,0.127565348070948,0,334,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
174,GO:0000378,1,0.99325505912211,0,1,RNA exon ligation,BP,
175,GO:0000379,1,0.984514994932976,0,3,tRNA-type intron splice site recognition and cleavage,BP,
176,GO:0000380,1,0.57793567986837,0,81,alternative mRNA splicing, via spliceosome,BP,
177,GO:0000381,1,0.619923252777517,0,70,regulation of alternative mRNA splicing, via spliceosome,BP,
178,GO:0000386,1,0.992530641923468,0,1,second spliceosomal transesterification activity,MF,
179,GO:0000387,1,0.805419570755489,0,39,spliceosomal snRNP assembly,BP,
180,GO:0000388,1,0.990892920097302,0,1,spliceosome conformational change to release U4 (or U4atac) and U1 (or U11),BP,
181,GO:0000389,1,0.962800055682872,0,6,mRNA 3'-splice site recognition,BP,
182,GO:0000390,1,0.985522871577326,0,2,spliceosomal complex disassembly,BP,
183,GO:0000393,1,0.970318489086461,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
184,GO:0000394,1,0.926529336502809,0,15,RNA splicing, via endonucleolytic cleavage and ligation,BP,
185,GO:0000395,1,0.962521642619677,0,6,mRNA 5'-splice site recognition,BP,
186,GO:0000398,1,0.127565348070948,0,334,mRNA splicing, via spliceosome,BP,
187,GO:0000400,1,0.887495777270819,0,17,four-way junction DNA binding,MF,
188,GO:0000403,1,0.962288102775546,0,5,Y-form DNA binding,MF,
189,GO:0000404,1,0.992519724978507,0,1,heteroduplex DNA loop binding,MF,
190,GO:0000405,1,0.941495245052672,0,8,bubble DNA binding,MF,
191,GO:0000406,1,0.985465232934344,0,2,double-strand/single-strand DNA junction binding,MF,
192,GO:0000407,1,0.807803995794196,0,30,phagophore assembly site,CC,
193,GO:0000408,1,0.975497540908368,0,5,EKC/KEOPS complex,CC,
194,GO:0000409,1,0.991081176282923,0,1,regulation of transcription by galactose,BP,
195,GO:0000411,1,0.991081176282923,0,1,positive regulation of transcription by galactose,BP,
196,GO:0000413,1,0.832014992204309,0,34,protein peptidyl-prolyl isomerization,BP,
197,GO:0000414,1,0.950633377898766,0,6,regulation of histone H3-K36 methylation,BP,
198,GO:0000415,1,0.99138120147466,0,1,negative regulation of histone H3-K36 methylation,BP,
199,GO:0000416,1,0.977355003410324,0,3,positive regulation of histone H3-K36 methylation,BP,
200,GO:0000417,1,0.992464418430856,0,1,HIR complex,CC,
201,GO:0000421,1,0.808674615068312,0,35,autophagosome membrane,CC,
202,GO:0000422,1,0.609619504896634,0,75,autophagy of mitochondrion,BP,
203,GO:0000423,1,0.84277286755389,0,23,mitophagy,BP,
204,GO:0000428,1,0.56021855466986,0,97,DNA-directed RNA polymerase complex,CC,
205,GO:0000429,1,0.976869096687131,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
206,GO:0000430,1,0.985661326351049,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
207,GO:0000431,1,0.991081176282923,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
208,GO:0000432,1,0.985661326351049,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
209,GO:0000435,1,0.991081176282923,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
210,GO:0000436,1,0.976869096687131,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
211,GO:0000438,1,0.987098851155582,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
212,GO:0000439,1,0.943337108443946,0,11,transcription factor TFIIH core complex,CC,
213,GO:0000444,1,0.973030341361019,0,4,MIS12/MIND type complex,CC,
214,GO:0000445,1,0.969115079667883,0,6,THO complex part of transcription export complex,CC,
215,GO:0000447,1,0.942909102996993,0,10,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
216,GO:0000448,1,0.99118769252961,0,1,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
217,GO:0000451,1,0.992529902975349,0,1,rRNA 2'-O-methylation,BP,
218,GO:0000453,1,0.992529902975349,0,1,enzyme-directed rRNA 2'-O-methylation,BP,
219,GO:0000454,1,0.989073120042102,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
220,GO:0000455,1,0.968206983801671,0,6,enzyme-directed rRNA pseudouridine synthesis,BP,
221,GO:0000459,1,0.955798389887648,0,9,exonucleolytic trimming involved in rRNA processing,BP,
222,GO:0000460,1,0.818661809049854,0,34,maturation of 5.8S rRNA,BP,
223,GO:0000461,1,0.996868223841777,0,1,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000462,1,0.811995493748002,0,35,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000463,1,0.922127826074624,0,13,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000466,1,0.866990035023565,0,24,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000467,1,0.955798389887648,0,9,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000469,1,0.853329847205284,0,27,cleavage involved in rRNA processing,BP,
229,GO:0000470,1,0.866023246053305,0,25,maturation of LSU-rRNA,BP,
230,GO:0000472,1,0.964705449823558,0,5,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000478,1,0.905687308628217,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
232,GO:0000479,1,0.905687308628217,0,15,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
233,GO:0000480,1,0.946711990797556,0,8,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000481,1,0.992520353313251,0,1,maturation of 5S rRNA,BP,
235,GO:0000491,1,0.958223872356698,0,8,small nucleolar ribonucleoprotein complex assembly,BP,
236,GO:0000492,1,0.969104695712223,0,6,box C/D snoRNP assembly,BP,
237,GO:0000493,1,0.988775872011898,0,2,box H/ACA snoRNP assembly,BP,
238,GO:0000494,1,0.991063637767373,0,2,box C/D snoRNA 3'-end processing,BP,
239,GO:0000495,1,0.986539066564025,0,2,box H/ACA snoRNA 3'-end processing,BP,
240,GO:0000502,1,0.751399859374137,0,59,proteasome complex,CC,
241,GO:0000506,1,0.961074314419945,0,8,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
243,GO:0000700,1,0.978565067064045,0,4,mismatch base pair DNA N-glycosylase activity,MF,
244,GO:0000701,1,0.991839940324953,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000702,1,0.983518702601652,0,4,oxidized base lesion DNA N-glycosylase activity,MF,
246,GO:0000703,1,0.992636491911569,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
247,GO:0000706,1,0.97896961541292,0,3,meiotic DNA double-strand break processing,BP,
248,GO:0000707,1,0.989974314378419,0,2,meiotic DNA recombinase assembly,BP,
249,GO:0000710,1,0.971203366334711,0,4,meiotic mismatch repair,BP,
250,GO:0000711,1,0.996241016743318,0,1,meiotic DNA repair synthesis,BP,
251,GO:0000712,1,0.909165711645673,0,14,resolution of meiotic recombination intermediates,BP,
252,GO:0000715,1,0.882691734173969,0,23,nucleotide-excision repair, DNA damage recognition,BP,
253,GO:0000717,1,0.878357900674531,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
254,GO:0000718,1,0.995727274618538,0,1,nucleotide-excision repair, DNA damage removal,BP,
255,GO:0000720,1,0.97427050206922,0,4,pyrimidine dimer repair by nucleotide-excision repair,BP,
256,GO:0000721,1,0.993766247491235,0,1,(R,R)-butanediol dehydrogenase activity,MF,
257,GO:0000722,1,0.90988962494678,0,13,telomere maintenance via recombination,BP,
258,GO:0000723,1,0.39590932844767,0,139,telomere maintenance,BP,
259,GO:0000724,1,0.41720955944668,0,124,double-strand break repair via homologous recombination,BP,
260,GO:0000725,1,0.414370388815905,0,125,recombinational repair,BP,
261,GO:0000726,1,0.600520786342597,0,74,non-recombinational repair,BP,
262,GO:0000727,1,0.924205633452643,0,12,double-strand break repair via break-induced replication,BP,
263,GO:0000729,1,0.855518461341968,0,22,DNA double-strand break processing,BP,
264,GO:0000730,1,0.966005155995673,0,6,DNA recombinase assembly,BP,
265,GO:0000731,1,0.744717473547388,0,47,DNA synthesis involved in DNA repair,BP,
266,GO:0000732,1,0.99232301188456,0,1,strand displacement,BP,
267,GO:0000733,1,0.943180158190281,0,8,DNA strand renaturation,BP,
268,GO:0000735,1,0.992300626802935,0,1,removal of nonhomologous ends,BP,
269,GO:0000737,1,0.835570013671249,0,30,DNA catabolic process, endonucleolytic,BP,
270,GO:0000738,1,0.958348607413143,0,8,DNA catabolic process, exonucleolytic,BP,
271,GO:0000741,1,0.995686812967221,0,1,karyogamy,BP,
272,GO:0000768,1,0.747716916483585,0,45,syncytium formation by plasma membrane fusion,BP,
273,GO:0000773,1,0.996661442422472,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
274,GO:0000774,1,0.942805805562357,0,10,adenyl-nucleotide exchange factor activity,MF,
275,GO:0000775,1,0.298566218368602,0,180,chromosome, centromeric region,CC,
276,GO:0000776,1,0.435022110133047,0,126,kinetochore,CC,
277,GO:0000777,1,0.541782096419321,0,95,condensed chromosome kinetochore,CC,
278,GO:0000778,1,0.908967915367088,0,17,condensed nuclear chromosome kinetochore,CC,
279,GO:0000779,1,0.49443471821732,0,109,condensed chromosome, centromeric region,CC,
280,GO:0000780,1,0.845311761814314,0,28,condensed nuclear chromosome, centromeric region,CC,
281,GO:0000781,1,0.411125989004583,0,130,chromosome, telomeric region,CC,
282,GO:0000782,1,0.931802036908987,0,11,telomere cap complex,CC,
283,GO:0000783,1,0.931802036908987,0,11,nuclear telomere cap complex,CC,
284,GO:0000784,1,0.511017919801,0,97,nuclear chromosome, telomeric region,CC,
286,GO:0000786,1,0.930745600494796,0,10,nucleosome,CC,
287,GO:0000788,1,0.980795399368579,0,3,nuclear nucleosome,CC,
288,GO:0000789,1,0.996579981182951,0,1,cytoplasmic chromatin,CC,
290,GO:0000791,1,0.812338705676386,0,32,euchromatin,CC,
291,GO:0000792,1,0.623823279634324,0,68,heterochromatin,CC,
292,GO:0000793,1,0.286713765519437,0,188,condensed chromosome,CC,
293,GO:0000794,1,0.573817052420894,0,84,condensed nuclear chromosome,CC,
294,GO:0000795,1,0.816352135199432,0,32,synaptonemal complex,CC,
295,GO:0000796,1,0.94195169335189,0,8,condensin complex,CC,
296,GO:0000797,1,0.976035822909097,0,3,condensin core heterodimer,CC,
297,GO:0000798,1,0.967671709259367,0,5,nuclear cohesin complex,CC,
298,GO:0000799,1,0.968768595604556,0,4,nuclear condensin complex,CC,
299,GO:0000800,1,0.911880106462833,0,13,lateral element,CC,
300,GO:0000801,1,0.965219674345134,0,6,central element,CC,
301,GO:0000803,1,0.852903926892193,0,23,sex chromosome,CC,
302,GO:0000805,1,0.953560393721232,0,6,X chromosome,CC,
303,GO:0000806,1,0.98659929941377,0,2,Y chromosome,CC,
304,GO:0000808,1,0.941095232401937,0,9,origin recognition complex,CC,
305,GO:0000811,1,0.981750299366299,0,3,GINS complex,CC,
306,GO:0000812,1,0.923801218260127,0,12,Swr1 complex,CC,
307,GO:0000813,1,0.942209914859652,0,10,ESCRT I complex,CC,
308,GO:0000814,1,0.985498947574205,0,3,ESCRT II complex,CC,
309,GO:0000815,1,0.947729612749128,0,10,ESCRT III complex,CC,
310,GO:0000818,1,0.984970370119741,0,3,nuclear MIS12/MIND complex,CC,
311,GO:0000819,1,0.30972265046994,0,175,sister chromatid segregation,BP,
312,GO:0000820,1,0.953691046240299,0,7,regulation of glutamine family amino acid metabolic process,BP,
313,GO:0000821,1,0.979920865475694,0,3,regulation of arginine metabolic process,BP,
314,GO:0000822,1,0.973589566751567,0,3,inositol hexakisphosphate binding,MF,
315,GO:0000823,1,0.995588137296728,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
316,GO:0000824,1,0.995588137296728,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
317,GO:0000825,1,0.988286846404117,0,2,inositol tetrakisphosphate 6-kinase activity,MF,
318,GO:0000827,1,0.969810620182965,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
319,GO:0000828,1,0.946799043095772,0,8,inositol hexakisphosphate kinase activity,MF,
320,GO:0000829,1,0.983847577166758,0,2,inositol heptakisphosphate kinase activity,MF,
321,GO:0000831,1,0.993271832685958,0,1,inositol hexakisphosphate 6-kinase activity,MF,
322,GO:0000832,1,0.966268915732602,0,5,inositol hexakisphosphate 5-kinase activity,MF,
323,GO:0000835,1,0.951982052165004,0,8,ER ubiquitin ligase complex,CC,
324,GO:0000836,1,0.951982052165004,0,8,Hrd1p ubiquitin ligase complex,CC,
325,GO:0000839,1,0.958436049980977,0,7,Hrd1p ubiquitin ligase ERAD-L complex,CC,
326,GO:0000900,1,0.899942622980269,0,15,translation repressor activity, mRNA regulatory element binding,MF,
332,GO:0000916,1,0.994645908656047,0,1,actomyosin contractile ring contraction,BP,
333,GO:0000917,1,0.995466792250196,0,1,division septum assembly,BP,
335,GO:0000922,1,0.358130209236692,0,150,spindle pole,CC,
336,GO:0000923,1,0.969903797476447,0,4,equatorial microtubule organizing center,CC,
337,GO:0000930,1,0.87344991805433,0,19,gamma-tubulin complex,CC,
338,GO:0000931,1,0.947809779675812,0,7,gamma-tubulin large complex,CC,
339,GO:0000932,1,0.584864744800216,0,81,P-body,CC,
340,GO:0000938,1,0.970310646953918,0,4,GARP complex,CC,
341,GO:0000939,1,0.975848605195128,0,5,condensed chromosome inner kinetochore,CC,
342,GO:0000940,1,0.915466457353442,0,13,condensed chromosome outer kinetochore,CC,
343,GO:0000941,1,0.990189033907862,0,2,condensed nuclear chromosome inner kinetochore,CC,
344,GO:0000942,1,0.976925573126749,0,4,condensed nuclear chromosome outer kinetochore,CC,
346,GO:0000957,1,0.955262374217437,0,6,mitochondrial RNA catabolic process,BP,
347,GO:0000958,1,0.978807542792435,0,3,mitochondrial mRNA catabolic process,BP,
348,GO:0000959,1,0.762351638649176,0,42,mitochondrial RNA metabolic process,BP,
349,GO:0000960,1,0.962512858389788,0,5,regulation of mitochondrial RNA catabolic process,BP,
350,GO:0000961,1,0.984537720196297,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000962,1,0.977632748693295,0,3,positive regulation of mitochondrial RNA catabolic process,BP,
352,GO:0000963,1,0.908121605762088,0,16,mitochondrial RNA processing,BP,
353,GO:0000964,1,0.982356323832082,0,3,mitochondrial RNA 5'-end processing,BP,
354,GO:0000965,1,0.970867742318214,0,5,mitochondrial RNA 3'-end processing,BP,
355,GO:0000966,1,0.880646887992713,0,22,RNA 5'-end processing,BP,
356,GO:0000967,1,0.964705449823558,0,5,rRNA 5'-end processing,BP,
357,GO:0000968,1,0.99325505912211,0,1,tRNA exon ligation,BP,
358,GO:0000971,1,0.99325505912211,0,1,tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate,BP,
359,GO:0000972,1,0.963986969082801,0,6,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
360,GO:0000973,1,0.988536718310638,0,2,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
361,GO:0000974,1,0.92742190785574,0,13,Prp19 complex,CC,
365,GO:0000979,1,0.884829471468399,0,20,RNA polymerase II core promoter sequence-specific DNA binding,MF,
368,GO:0000992,1,0.958130675862488,0,6,RNA polymerase III cis-regulatory region sequence-specific DNA binding,MF,
369,GO:0000993,1,0.780599578409473,0,37,RNA polymerase II complex binding,MF,
370,GO:0000994,1,0.995622277459049,0,1,RNA polymerase III core binding,MF,
371,GO:0000995,1,0.971222109343007,0,5,RNA polymerase III general transcription initiation factor activity,MF,
372,GO:0001002,1,0.977084181278937,0,3,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
373,GO:0001003,1,0.977084181278937,0,3,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
374,GO:0001006,1,0.958130675862488,0,6,RNA polymerase III type 3 promoter sequence-specific DNA binding,MF,
375,GO:0001010,1,0.992992677245858,0,1,RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity,MF,
376,GO:0001016,1,0.955050322905693,0,7,RNA polymerase III transcription regulatory region sequence-specific DNA binding,MF,
377,GO:0001018,1,0.980645573591793,0,3,mitochondrial promoter sequence-specific DNA binding,MF,
378,GO:0001025,1,0.970460446122962,0,3,RNA polymerase III general transcription initiation factor binding,MF,
379,GO:0001042,1,0.961736653382137,0,5,RNA polymerase I core binding,MF,
380,GO:0001046,1,0.769204075747858,0,41,core promoter sequence-specific DNA binding,MF,
381,GO:0001054,1,0.987732003005517,0,2,RNA polymerase I activity,MF,
382,GO:0001055,1,0.979623532407467,0,4,RNA polymerase II activity,MF,
383,GO:0001056,1,0.996484091047272,0,1,RNA polymerase III activity,MF,
385,GO:0001069,1,0.984375700487086,0,2,regulatory region RNA binding,MF,
386,GO:0001079,1,0.994728818783657,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
387,GO:0001080,1,0.994728818783657,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
388,GO:0001085,1,0.703116537268417,0,53,RNA polymerase II transcription factor binding,MF,
389,GO:0001091,1,0.885710799529849,0,19,RNA polymerase II general transcription initiation factor binding,MF,
390,GO:0001093,1,0.977424708368706,0,3,TFIIB-class transcription factor binding,MF,
391,GO:0001094,1,0.942194331030541,0,10,TFIID-class transcription factor complex binding,MF,
392,GO:0001096,1,0.986251689050774,0,2,TFIIF-class transcription factor complex binding,MF,
393,GO:0001097,1,0.985539097441217,0,2,TFIIH-class transcription factor complex binding,MF,
394,GO:0001098,1,0.694919841867193,0,56,basal transcription machinery binding,MF,
395,GO:0001099,1,0.694919841867193,0,56,basal RNA polymerase II transcription machinery binding,MF,
396,GO:0001100,1,0.99325505912211,0,1,negative regulation of exit from mitosis,BP,
398,GO:0001102,1,0.749362855791714,0,44,RNA polymerase II activating transcription factor binding,MF,
399,GO:0001103,1,0.794696597792443,0,35,RNA polymerase II repressing transcription factor binding,MF,
400,GO:0001112,1,0.992865464568248,0,1,DNA-templated transcription open complex formation,BP,
401,GO:0001113,1,0.992865464568248,0,1,transcription open complex formation at RNA polymerase II promoter,BP,
402,GO:0001120,1,0.992865464568248,0,1,protein-DNA complex remodeling,BP,
403,GO:0001139,1,0.991070741863145,0,2,RNA polymerase II complex recruiting activity,MF,
404,GO:0001147,1,0.981555842656702,0,2,transcription termination site sequence-specific DNA binding,MF,
405,GO:0001156,1,0.970460446122962,0,3,TFIIIC-class transcription factor complex binding,MF,
406,GO:0001161,1,0.92148781091338,0,14,intronic transcription regulatory region sequence-specific DNA binding,MF,
407,GO:0001162,1,0.933598108119767,0,12,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
408,GO:0001163,1,0.947037443424566,0,8,RNA polymerase I transcription regulatory region sequence-specific DNA binding,MF,
409,GO:0001164,1,0.947037443424566,0,8,RNA polymerase I core promoter sequence-specific DNA binding,MF,
410,GO:0001165,1,0.992320255531416,0,1,RNA polymerase I cis-regulatory region sequence-specific DNA binding,MF,
411,GO:0001172,1,0.983784231957533,0,2,transcription, RNA-templated,BP,
412,GO:0001173,1,0.991070741863145,0,2,DNA-templated transcriptional start site selection,BP,
413,GO:0001174,1,0.991070741863145,0,2,transcriptional start site selection at RNA polymerase II promoter,BP,
414,GO:0001179,1,0.99543955105118,0,1,RNA polymerase I general transcription initiation factor binding,MF,
415,GO:0001181,1,0.968334498868288,0,4,RNA polymerase I general transcription initiation factor activity,MF,
416,GO:0001188,1,0.942716131579865,0,9,RNA polymerase I preinitiation complex assembly,BP,
417,GO:0001192,1,0.996732509769986,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
418,GO:0001193,1,0.996732509769986,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
421,GO:0001221,1,0.697093367939281,0,49,transcription cofactor binding,MF,
422,GO:0001222,1,0.906753554979747,0,14,transcription corepressor binding,MF,
423,GO:0001223,1,0.804615602042139,0,28,transcription coactivator binding,MF,
424,GO:0001224,1,0.938070629059161,0,8,RNA polymerase II transcription cofactor binding,MF,
425,GO:0001225,1,0.948312131947426,0,6,RNA polymerase II transcription coactivator binding,MF,
426,GO:0001226,1,0.989206096483306,0,2,RNA polymerase II transcription corepressor binding,MF,
429,GO:0001300,1,0.985549131121354,0,2,chronological cell aging,BP,
430,GO:0001302,1,0.962036884656683,0,6,replicative cell aging,BP,
431,GO:0001306,1,0.996640898098766,0,1,age-dependent response to oxidative stress,BP,
432,GO:0001315,1,0.996640898098766,0,1,age-dependent response to reactive oxygen species,BP,
433,GO:0001325,1,0.902469355276824,0,14,formation of extrachromosomal circular DNA,BP,
434,GO:0001401,1,0.940642527635128,0,11,SAM complex,CC,
435,GO:0001405,1,0.971633313060655,0,5,PAM complex, Tim23 associated import motor,CC,
439,GO:0001504,1,0.76768329548275,0,41,neurotransmitter uptake,BP,
441,GO:0001507,1,0.986577716757652,0,2,acetylcholine catabolic process in synaptic cleft,BP,
443,GO:0001510,1,0.6459495685145,0,69,RNA methylation,BP,
444,GO:0001512,1,0.996547773841177,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
445,GO:0001514,1,0.95030765129233,0,8,selenocysteine incorporation,BP,
446,GO:0001515,1,0.981914194881001,0,4,opioid peptide activity,MF,
447,GO:0001516,1,0.875560266954359,0,25,prostaglandin biosynthetic process,BP,
448,GO:0001517,1,0.956158912184795,0,6,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
449,GO:0001518,1,0.859640957461254,0,17,voltage-gated sodium channel complex,CC,
450,GO:0001519,1,0.992500519191262,0,1,peptide amidation,BP,
451,GO:0001520,1,0.980773900673576,0,3,outer dense fiber,CC,
452,GO:0001522,1,0.911526797782007,0,18,pseudouridine synthesis,BP,
455,GO:0001527,1,0.927570416874822,0,10,microfibril,CC,
456,GO:0001530,1,0.87295813596513,0,25,lipopolysaccharide binding,MF,
457,GO:0001532,1,0.992659473189004,0,1,interleukin-21 receptor activity,MF,
459,GO:0001534,1,0.977277112911124,0,4,radial spoke,CC,
460,GO:0001535,1,0.993248595238605,0,1,radial spoke head,CC,
461,GO:0001536,1,0.99325505912211,0,1,radial spoke stalk,CC,
462,GO:0001537,1,0.97139869103468,0,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
465,GO:0001541,1,0.728183582292983,0,50,ovarian follicle development,BP,
466,GO:0001542,1,0.930661241005548,0,9,ovulation from ovarian follicle,BP,
467,GO:0001543,1,0.990724419306858,0,1,ovarian follicle rupture,BP,
468,GO:0001544,1,0.985554661927616,0,2,initiation of primordial ovarian follicle growth,BP,
469,GO:0001545,1,0.992461176348604,0,1,primary ovarian follicle growth,BP,
470,GO:0001546,1,0.985289898859487,0,3,preantral ovarian follicle growth,BP,
471,GO:0001547,1,0.948071840395515,0,8,antral ovarian follicle growth,BP,
472,GO:0001550,1,0.979551038898181,0,3,ovarian cumulus expansion,BP,
473,GO:0001552,1,0.995251826743223,0,1,ovarian follicle atresia,BP,
475,GO:0001554,1,0.948132798622805,0,7,luteolysis,BP,
476,GO:0001555,1,0.981453354283651,0,3,oocyte growth,BP,
477,GO:0001556,1,0.873955743008802,0,21,oocyte maturation,BP,
479,GO:0001560,1,0.974964677095667,0,3,regulation of cell growth by extracellular stimulus,BP,
480,GO:0001561,1,0.950916762058479,0,9,fatty acid alpha-oxidation,BP,
481,GO:0001562,1,0.867776337864719,0,25,response to protozoan,BP,
482,GO:0001567,1,0.996301838668311,0,1,cholesterol 25-hydroxylase activity,MF,
484,GO:0001569,1,0.810420634244557,0,32,branching involved in blood vessel morphogenesis,BP,
485,GO:0001570,1,0.574384134847029,0,78,vasculogenesis,BP,
486,GO:0001572,1,0.992226599128609,0,1,lactosylceramide biosynthetic process,BP,
487,GO:0001573,1,0.873925464043286,0,21,ganglioside metabolic process,BP,
488,GO:0001574,1,0.920028344062822,0,13,ganglioside biosynthetic process,BP,
489,GO:0001575,1,0.994883190736215,0,1,globoside metabolic process,BP,
490,GO:0001576,1,0.994883190736215,0,1,globoside biosynthetic process,BP,
492,GO:0001579,1,0.985546813078896,0,2,medium-chain fatty acid transport,BP,
493,GO:0001580,1,0.917209616361751,0,20,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
494,GO:0001581,1,0.992832537670157,0,1,detection of chemical stimulus involved in sensory perception of sour taste,BP,
495,GO:0001582,1,0.993696128496363,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
496,GO:0001587,1,0.992254580490769,0,1,Gq/11-coupled serotonin receptor activity,MF,
497,GO:0001588,1,0.986800107154123,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
498,GO:0001591,1,0.985835853815261,0,3,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
499,GO:0001595,1,0.987390902786944,0,3,angiotensin receptor activity,MF,
500,GO:0001596,1,0.994270196731744,0,1,angiotensin type I receptor activity,MF,
501,GO:0001601,1,0.981396635424678,0,3,peptide YY receptor activity,MF,
502,GO:0001602,1,0.988794552630677,0,2,pancreatic polypeptide receptor activity,MF,
503,GO:0001604,1,0.9926760430061,0,2,urotensin II receptor activity,MF,
504,GO:0001605,1,0.985318186759303,0,3,adrenomedullin receptor activity,MF,
505,GO:0001607,1,0.987643042237672,0,2,neuromedin U receptor activity,MF,
506,GO:0001609,1,0.978525367789288,0,4,G protein-coupled adenosine receptor activity,MF,
507,GO:0001614,1,0.897936793947429,0,20,purinergic nucleotide receptor activity,MF,
509,GO:0001621,1,0.984675997487887,0,3,G protein-coupled ADP receptor activity,MF,
510,GO:0001626,1,0.9926524730805,0,1,nociceptin receptor activity,MF,
511,GO:0001631,1,0.989862859517463,0,2,cysteinyl leukotriene receptor activity,MF,
512,GO:0001632,1,0.988699954267688,0,2,leukotriene B4 receptor activity,MF,
513,GO:0001635,1,0.974992656122057,0,4,calcitonin gene-related peptide receptor activity,MF,
514,GO:0001637,1,0.867956312872763,0,25,G protein-coupled chemoattractant receptor activity,MF,
515,GO:0001640,1,0.945983389561325,0,7,adenylate cyclase inhibiting G protein-coupled glutamate receptor activity,MF,
516,GO:0001641,1,0.9859820806285,0,2,group II metabotropic glutamate receptor activity,MF,
517,GO:0001642,1,0.969299649165559,0,4,group III metabotropic glutamate receptor activity,MF,
519,GO:0001650,1,0.453750227333452,0,121,fibrillar center,CC,
520,GO:0001651,1,0.996523552675938,0,1,dense fibrillar component,CC,
521,GO:0001652,1,0.967501582597458,0,6,granular component,CC,
522,GO:0001653,1,0.475758796062948,0,132,peptide receptor activity,MF,
529,GO:0001660,1,0.943216679126005,0,9,fever generation,BP,
530,GO:0001661,1,0.964704509341727,0,5,conditioned taste aversion,BP,
533,GO:0001665,1,0.968560944487277,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
534,GO:0001666,1,0.12137776038516,0,330,response to hypoxia,BP,
536,GO:0001669,1,0.591354549239534,0,86,acrosomal vesicle,CC,
537,GO:0001671,1,0.874734385855715,0,24,ATPase activator activity,MF,
538,GO:0001672,1,0.837918130213107,0,23,regulation of chromatin assembly or disassembly,BP,
539,GO:0001673,1,0.933493039888762,0,10,male germ cell nucleus,CC,
540,GO:0001674,1,0.988677374189494,0,2,female germ cell nucleus,CC,
541,GO:0001675,1,0.934486815465105,0,10,acrosome assembly,BP,
544,GO:0001680,1,0.994399259932995,0,1,tRNA 3'-terminal CCA addition,BP,
545,GO:0001681,1,0.99312579812412,0,1,sialate O-acetylesterase activity,MF,
546,GO:0001682,1,0.939745829784891,0,12,tRNA 5'-leader removal,BP,
547,GO:0001691,1,0.988527301577576,0,2,pseudophosphatase activity,MF,
548,GO:0001692,1,0.971046739553216,0,5,histamine metabolic process,BP,
549,GO:0001694,1,0.994054153807096,0,1,histamine biosynthetic process,BP,
550,GO:0001695,1,0.996715478354625,0,1,histamine catabolic process,BP,
551,GO:0001696,1,0.905630673134743,0,16,gastric acid secretion,BP,
552,GO:0001697,1,0.993163413695766,0,1,histamine-induced gastric acid secretion,BP,
553,GO:0001698,1,0.993163413695766,0,1,gastrin-induced gastric acid secretion,BP,
555,GO:0001702,1,0.83071160578051,0,24,gastrulation with mouth forming second,BP,
558,GO:0001706,1,0.695175861479639,0,52,endoderm formation,BP,
561,GO:0001709,1,0.775061463292214,0,39,cell fate determination,BP,
563,GO:0001711,1,0.918568496533806,0,14,endodermal cell fate commitment,BP,
565,GO:0001714,1,0.965136545990503,0,7,endodermal cell fate specification,BP,
567,GO:0001716,1,0.99496844187579,0,1,L-amino-acid oxidase activity,MF,
569,GO:0001726,1,0.289218667012684,0,171,ruffle,CC,
570,GO:0001727,1,0.95790258861144,0,6,lipid kinase activity,MF,
571,GO:0001729,1,0.985405274972511,0,2,ceramide kinase activity,MF,
572,GO:0001730,1,0.979920784954202,0,3,2'-5'-oligoadenylate synthetase activity,MF,
573,GO:0001731,1,0.930947495209151,0,10,formation of translation preinitiation complex,BP,
574,GO:0001732,1,0.92467634789231,0,15,formation of cytoplasmic translation initiation complex,BP,
576,GO:0001734,1,0.988492918759003,0,2,mRNA (N6-adenosine)-methyltransferase activity,MF,
577,GO:0001735,1,0.985708219171999,0,2,prenylcysteine oxidase activity,MF,
580,GO:0001739,1,0.975402890542407,0,4,sex chromatin,CC,
581,GO:0001740,1,0.983422019248165,0,2,Barr body,CC,
582,GO:0001741,1,0.933172172199329,0,11,XY body,CC,
583,GO:0001743,1,0.983993717357734,0,2,optic placode formation,BP,
584,GO:0001750,1,0.623726567846867,0,69,photoreceptor outer segment,CC,
585,GO:0001754,1,0.747444472973837,0,41,eye photoreceptor cell differentiation,BP,
588,GO:0001757,1,0.970399882927316,0,5,somite specification,BP,
589,GO:0001758,1,0.959875654326046,0,8,retinal dehydrogenase activity,MF,
590,GO:0001759,1,0.867234551709617,0,23,organ induction,BP,
591,GO:0001760,1,0.996439731715527,0,1,aminocarboxymuconate-semialdehyde decarboxylase activity,MF,
594,GO:0001765,1,0.945136545420162,0,10,membrane raft assembly,BP,
596,GO:0001767,1,0.920434714467503,0,12,establishment of lymphocyte polarity,BP,
597,GO:0001768,1,0.928819802561581,0,11,establishment of T cell polarity,BP,
598,GO:0001770,1,0.990979081603292,0,1,establishment of natural killer cell polarity,BP,
599,GO:0001771,1,0.918038725878023,0,14,immunological synapse formation,BP,
600,GO:0001772,1,0.787773450345015,0,38,immunological synapse,CC,
601,GO:0001773,1,0.859879866720456,0,27,myeloid dendritic cell activation,BP,
602,GO:0001774,1,0.763499579027784,0,42,microglial cell activation,BP,
604,GO:0001776,1,0.58998965400051,0,82,leukocyte homeostasis,BP,
605,GO:0001777,1,0.985933673008309,0,3,T cell homeostatic proliferation,BP,
606,GO:0001778,1,0.916272312225023,0,12,plasma membrane repair,BP,
607,GO:0001779,1,0.878207818542347,0,20,natural killer cell differentiation,BP,
608,GO:0001780,1,0.891421808452832,0,16,neutrophil homeostasis,BP,
609,GO:0001781,1,0.946273192349186,0,8,neutrophil apoptotic process,BP,
610,GO:0001782,1,0.832825945985814,0,28,B cell homeostasis,BP,
611,GO:0001783,1,0.857863879072467,0,24,B cell apoptotic process,BP,
612,GO:0001784,1,0.741541758972226,0,42,phosphotyrosine residue binding,MF,
613,GO:0001785,1,0.986284917379464,0,2,prostaglandin J receptor activity,MF,
614,GO:0001786,1,0.702734407271534,0,53,phosphatidylserine binding,MF,
615,GO:0001787,1,0.95240299183205,0,9,natural killer cell proliferation,BP,
616,GO:0001788,1,0.991791024416041,0,2,antibody-dependent cellular cytotoxicity,BP,
617,GO:0001791,1,0.988396282455866,0,2,IgM binding,MF,
618,GO:0001792,1,0.992416137278934,0,1,polymeric immunoglobulin receptor activity,MF,
619,GO:0001794,1,0.980815198569331,0,4,type IIa hypersensitivity,BP,
620,GO:0001796,1,0.980815198569331,0,4,regulation of type IIa hypersensitivity,BP,
621,GO:0001797,1,0.995953645462242,0,1,negative regulation of type IIa hypersensitivity,BP,
622,GO:0001798,1,0.984800674435316,0,3,positive regulation of type IIa hypersensitivity,BP,
623,GO:0001802,1,0.990403053715402,0,2,type III hypersensitivity,BP,
624,GO:0001803,1,0.990403053715402,0,2,regulation of type III hypersensitivity,BP,
625,GO:0001805,1,0.990403053715402,0,2,positive regulation of type III hypersensitivity,BP,
626,GO:0001806,1,0.978334179556777,0,4,type IV hypersensitivity,BP,
627,GO:0001807,1,0.98540380467847,0,3,regulation of type IV hypersensitivity,BP,
628,GO:0001808,1,0.995002550366776,0,1,negative regulation of type IV hypersensitivity,BP,
629,GO:0001809,1,0.996277473795601,0,1,positive regulation of type IV hypersensitivity,BP,
630,GO:0001810,1,0.98639513714032,0,3,regulation of type I hypersensitivity,BP,
631,GO:0001811,1,0.995953645462242,0,1,negative regulation of type I hypersensitivity,BP,
632,GO:0001812,1,0.990403053715402,0,2,positive regulation of type I hypersensitivity,BP,
633,GO:0001813,1,0.991791024416041,0,2,regulation of antibody-dependent cellular cytotoxicity,BP,
634,GO:0001814,1,0.995953645462242,0,1,negative regulation of antibody-dependent cellular cytotoxicity,BP,
635,GO:0001815,1,0.995820640236557,0,1,positive regulation of antibody-dependent cellular cytotoxicity,BP,
640,GO:0001820,1,0.937386681637341,0,11,serotonin secretion,BP,
641,GO:0001821,1,0.946798206737499,0,10,histamine secretion,BP,
644,GO:0001824,1,0.560504983422458,0,92,blastocyst development,BP,
645,GO:0001825,1,0.809880707544312,0,34,blastocyst formation,BP,
646,GO:0001826,1,0.962572998771807,0,5,inner cell mass cell differentiation,BP,
647,GO:0001827,1,0.992252048141424,0,1,inner cell mass cell fate commitment,BP,
648,GO:0001828,1,0.986515292886064,0,2,inner cell mass cellular morphogenesis,BP,
649,GO:0001829,1,0.926817175241723,0,12,trophectodermal cell differentiation,BP,
650,GO:0001831,1,0.986084835390021,0,2,trophectodermal cellular morphogenesis,BP,
651,GO:0001832,1,0.869196162143201,0,19,blastocyst growth,BP,
652,GO:0001833,1,0.910609807959399,0,13,inner cell mass cell proliferation,BP,
653,GO:0001834,1,0.974463857817729,0,3,trophectodermal cell proliferation,BP,
654,GO:0001835,1,0.850967669445115,0,26,blastocyst hatching,BP,
658,GO:0001839,1,0.961711295484805,0,6,neural plate morphogenesis,BP,
659,GO:0001840,1,0.937446329144276,0,9,neural plate development,BP,
661,GO:0001842,1,0.957975034988814,0,7,neural fold formation,BP,
663,GO:0001844,1,0.837603607818973,0,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
664,GO:0001845,1,0.920050563086537,0,14,phagolysosome assembly,BP,
665,GO:0001846,1,0.917419897358079,0,13,opsonin binding,MF,
666,GO:0001847,1,0.973509204378322,0,4,opsonin receptor activity,MF,
667,GO:0001848,1,0.891715099884787,0,17,complement binding,MF,
668,GO:0001849,1,0.961459720344209,0,6,complement component C1q complex binding,MF,
669,GO:0001850,1,0.995513823670867,0,1,complement component C3a binding,MF,
670,GO:0001851,1,0.966701980609363,0,5,complement component C3b binding,MF,
671,GO:0001855,1,0.985808578115961,0,2,complement component C4b binding,MF,
672,GO:0001856,1,0.994239394978761,0,1,complement component C5a binding,MF,
673,GO:0001861,1,0.989778504671728,0,1,complement component C4b receptor activity,MF,
674,GO:0001865,1,0.931941498263422,0,10,NK T cell differentiation,BP,
675,GO:0001866,1,0.966987545789326,0,6,NK T cell proliferation,BP,
676,GO:0001867,1,0.955845506746249,0,9,complement activation, lectin pathway,BP,
677,GO:0001868,1,0.987684773094503,0,2,regulation of complement activation, lectin pathway,BP,
678,GO:0001869,1,0.987684773094503,0,2,negative regulation of complement activation, lectin pathway,BP,
679,GO:0001872,1,0.989315896680482,0,2,(1->3)-beta-D-glucan binding,MF,
680,GO:0001875,1,0.967505434545462,0,5,lipopolysaccharide immune receptor activity,MF,
681,GO:0001878,1,0.979137776973406,0,4,response to yeast,BP,
682,GO:0001880,1,0.978750379252505,0,3,Mullerian duct regression,BP,
687,GO:0001886,1,0.914631396255261,0,12,endothelial cell morphogenesis,BP,
688,GO:0001887,1,0.973688944841397,0,4,selenium compound metabolic process,BP,
689,GO:0001888,1,0.98463593295958,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
692,GO:0001891,1,0.848183290580418,0,25,phagocytic cup,CC,
697,GO:0001905,1,0.975451172574097,0,3,activation of membrane attack complex,BP,
698,GO:0001906,1,0.51044787778222,0,128,cell killing,BP,
699,GO:0001907,1,0.985206092408694,0,3,killing by symbiont of host cells,BP,
700,GO:0001909,1,0.605900690225127,0,92,leukocyte mediated cytotoxicity,BP,
701,GO:0001910,1,0.70084970824625,0,65,regulation of leukocyte mediated cytotoxicity,BP,
702,GO:0001911,1,0.905937270278312,0,19,negative regulation of leukocyte mediated cytotoxicity,BP,
703,GO:0001912,1,0.784881877889905,0,44,positive regulation of leukocyte mediated cytotoxicity,BP,
704,GO:0001913,1,0.823255493860428,0,37,T cell mediated cytotoxicity,BP,
705,GO:0001914,1,0.860488188131449,0,29,regulation of T cell mediated cytotoxicity,BP,
706,GO:0001915,1,0.958760372329231,0,7,negative regulation of T cell mediated cytotoxicity,BP,
707,GO:0001916,1,0.894371727692648,0,22,positive regulation of T cell mediated cytotoxicity,BP,
708,GO:0001917,1,0.720817167711098,0,49,photoreceptor inner segment,CC,
709,GO:0001918,1,0.993216781892803,0,1,farnesylated protein binding,MF,
711,GO:0001920,1,0.974179077749076,0,4,negative regulation of receptor recycling,BP,
713,GO:0001922,1,0.976820136342103,0,3,B-1 B cell homeostasis,BP,
714,GO:0001923,1,0.969204536096967,0,5,B-1 B cell differentiation,BP,
715,GO:0001927,1,0.994445927308636,0,1,exocyst assembly,BP,
716,GO:0001928,1,0.994445927308636,0,1,regulation of exocyst assembly,BP,
717,GO:0001931,1,0.91980197899804,0,13,uropod,CC,
724,GO:0001938,1,0.558346858347765,0,86,positive regulation of endothelial cell proliferation,BP,
725,GO:0001939,1,0.948430852493207,0,7,female pronucleus,CC,
726,GO:0001940,1,0.962777452626247,0,5,male pronucleus,CC,
727,GO:0001941,1,0.747246394676831,0,40,postsynaptic membrane organization,BP,
730,GO:0001945,1,0.821334464091546,0,26,lymph vessel development,BP,
731,GO:0001946,1,0.893191130553654,0,15,lymphangiogenesis,BP,
732,GO:0001947,1,0.664550796600415,0,60,heart looping,BP,
734,GO:0001951,1,0.978697583665371,0,3,intestinal D-glucose absorption,BP,
737,GO:0001954,1,0.694862289927956,0,53,positive regulation of cell-matrix adhesion,BP,
738,GO:0001955,1,0.946717555012633,0,8,blood vessel maturation,BP,
740,GO:0001957,1,0.959868455165669,0,6,intramembranous ossification,BP,
742,GO:0001959,1,0.400093575367579,0,145,regulation of cytokine-mediated signaling pathway,BP,
743,GO:0001960,1,0.73954597448146,0,50,negative regulation of cytokine-mediated signaling pathway,BP,
744,GO:0001961,1,0.744151146697823,0,47,positive regulation of cytokine-mediated signaling pathway,BP,
746,GO:0001964,1,0.816454621535398,0,27,startle response,BP,
747,GO:0001965,1,0.85653535261819,0,24,G-protein alpha-subunit binding,MF,
748,GO:0001966,1,0.986415893915815,0,2,thigmotaxis,BP,
749,GO:0001967,1,0.926206588282923,0,11,suckling behavior,BP,
750,GO:0001968,1,0.83784937105044,0,25,fibronectin binding,MF,
751,GO:0001969,1,0.975451172574097,0,3,regulation of activation of membrane attack complex,BP,
752,GO:0001970,1,0.984646775680756,0,2,positive regulation of activation of membrane attack complex,BP,
753,GO:0001971,1,0.990662478540415,0,1,negative regulation of activation of membrane attack complex,BP,
754,GO:0001972,1,0.918867819908688,0,14,retinoic acid binding,MF,
756,GO:0001974,1,0.763430739203347,0,38,blood vessel remodeling,BP,
757,GO:0001975,1,0.814522629484889,0,32,response to amphetamine,BP,
758,GO:0001976,1,0.939043242067015,0,10,nervous system process involved in regulation of systemic arterial blood pressure,BP,
760,GO:0001978,1,0.994642016247773,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
761,GO:0001979,1,0.99578140581474,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
762,GO:0001980,1,0.996747387541176,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
763,GO:0001983,1,0.994642016247773,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
764,GO:0001985,1,0.994642016247773,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
765,GO:0001990,1,0.83372641562381,0,31,regulation of systemic arterial blood pressure by hormone,BP,
766,GO:0001991,1,0.918271747335858,0,14,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
767,GO:0001992,1,0.975148367204914,0,4,regulation of systemic arterial blood pressure by vasopressin,BP,
768,GO:0001993,1,0.945702494565137,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
769,GO:0001994,1,0.98882816726832,0,2,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
770,GO:0001996,1,0.962278348561661,0,6,positive regulation of heart rate by epinephrine-norepinephrine,BP,
771,GO:0001997,1,0.987783331394775,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
772,GO:0001998,1,0.995304437434514,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
773,GO:0001999,1,0.967690070392932,0,5,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
774,GO:0002001,1,0.967690070392932,0,5,renin secretion into blood stream,BP,
775,GO:0002002,1,0.94894833813932,0,9,regulation of angiotensin levels in blood,BP,
776,GO:0002003,1,0.94894833813932,0,9,angiotensin maturation,BP,
777,GO:0002007,1,0.99578140581474,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
779,GO:0002011,1,0.675956666126405,0,52,morphogenesis of an epithelial sheet,BP,
780,GO:0002016,1,0.966322630467153,0,6,regulation of blood volume by renin-angiotensin,BP,
781,GO:0002017,1,0.99539589996243,0,1,regulation of blood volume by renal aldosterone,BP,
782,GO:0002018,1,0.987956424354703,0,2,renin-angiotensin regulation of aldosterone production,BP,
783,GO:0002019,1,0.983153329241089,0,3,regulation of renal output by angiotensin,BP,
785,GO:0002021,1,0.865299621575275,0,22,response to dietary excess,BP,
786,GO:0002023,1,0.984080646641871,0,3,reduction of food intake in response to dietary excess,BP,
787,GO:0002024,1,0.939906931403195,0,9,diet induced thermogenesis,BP,
788,GO:0002025,1,0.9817425571381,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
789,GO:0002026,1,0.844377155119757,0,25,regulation of the force of heart contraction,BP,
792,GO:0002029,1,0.909835485480694,0,17,desensitization of G protein-coupled receptor signaling pathway,BP,
793,GO:0002030,1,0.993031215140746,0,1,inhibitory G protein-coupled receptor phosphorylation,BP,
794,GO:0002031,1,0.925427625028336,0,14,G protein-coupled receptor internalization,BP,
795,GO:0002032,1,0.990375694053875,0,2,desensitization of G protein-coupled receptor signaling pathway by arrestin,BP,
796,GO:0002034,1,0.977831533275287,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
797,GO:0002035,1,0.986240975420233,0,2,brain renin-angiotensin system,BP,
798,GO:0002036,1,0.957305823069971,0,6,regulation of L-glutamate import across plasma membrane,BP,
799,GO:0002037,1,0.994793353504923,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
800,GO:0002038,1,0.978615265805184,0,3,positive regulation of L-glutamate import across plasma membrane,BP,
801,GO:0002039,1,0.6425492644508,0,63,p53 binding,MF,
805,GO:0002046,1,0.991723534047019,0,2,opsin binding,MF,
806,GO:0002051,1,0.966830169347375,0,4,osteoblast fate commitment,BP,
808,GO:0002053,1,0.837717504308196,0,25,positive regulation of mesenchymal cell proliferation,BP,
809,GO:0002054,1,0.971890028261771,0,5,nucleobase binding,MF,
810,GO:0002055,1,0.996791317160635,0,1,adenine binding,MF,
811,GO:0002058,1,0.987592123894691,0,2,uracil binding,MF,
812,GO:0002059,1,0.994785623340246,0,1,thymine binding,MF,
813,GO:0002060,1,0.984102637762915,0,3,purine nucleobase binding,MF,
814,GO:0002061,1,0.987592123894691,0,2,pyrimidine nucleobase binding,MF,
818,GO:0002065,1,0.493261591616069,0,105,columnar/cuboidal epithelial cell differentiation,BP,
819,GO:0002066,1,0.683468513532427,0,56,columnar/cuboidal epithelial cell development,BP,
820,GO:0002067,1,0.740307879788382,0,45,glandular epithelial cell differentiation,BP,
821,GO:0002068,1,0.840985617991328,0,25,glandular epithelial cell development,BP,
822,GO:0002069,1,0.969132824098341,0,6,columnar/cuboidal epithelial cell maturation,BP,
823,GO:0002070,1,0.909951256627282,0,15,epithelial cell maturation,BP,
824,GO:0002071,1,0.989363687229213,0,2,glandular epithelial cell maturation,BP,
825,GO:0002072,1,0.935990833572406,0,8,optic cup morphogenesis involved in camera-type eye development,BP,
826,GO:0002074,1,0.96823424029473,0,4,extraocular skeletal muscle development,BP,
827,GO:0002076,1,0.881512585746555,0,19,osteoblast development,BP,
828,GO:0002077,1,0.996305624947991,0,1,acrosome matrix dispersal,BP,
829,GO:0002079,1,0.980059194522142,0,3,inner acrosomal membrane,CC,
830,GO:0002080,1,0.899307352268015,0,18,acrosomal membrane,CC,
831,GO:0002081,1,0.982382857662909,0,3,outer acrosomal membrane,CC,
832,GO:0002082,1,0.863348489971488,0,26,regulation of oxidative phosphorylation,BP,
833,GO:0002083,1,0.995890883982307,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
834,GO:0002084,1,0.947747345403452,0,9,protein depalmitoylation,BP,
835,GO:0002085,1,0.970229379528985,0,5,inhibition of neuroepithelial cell differentiation,BP,
836,GO:0002086,1,0.989352071374357,0,2,diaphragm contraction,BP,
837,GO:0002087,1,0.922558858438522,0,12,regulation of respiratory gaseous exchange by nervous system process,BP,
838,GO:0002088,1,0.613573299181065,0,70,lens development in camera-type eye,BP,
839,GO:0002089,1,0.87101612420131,0,18,lens morphogenesis in camera-type eye,BP,
841,GO:0002091,1,0.921903873027382,0,13,negative regulation of receptor internalization,BP,
843,GO:0002093,1,0.923190732757392,0,12,auditory receptor cell morphogenesis,BP,
844,GO:0002094,1,0.988560207639378,0,2,polyprenyltransferase activity,MF,
845,GO:0002095,1,0.986199167326443,0,2,caveolar macromolecular signaling complex,CC,
846,GO:0002096,1,0.984979142976253,0,2,polkadots,CC,
847,GO:0002097,1,0.894943096312372,0,19,tRNA wobble base modification,BP,
848,GO:0002098,1,0.915570758560329,0,15,tRNA wobble uridine modification,BP,
849,GO:0002100,1,0.987489612580829,0,2,tRNA wobble adenosine to inosine editing,BP,
850,GO:0002101,1,0.989875217020312,0,2,tRNA wobble cytosine modification,BP,
851,GO:0002102,1,0.805388477461539,0,29,podosome,CC,
852,GO:0002112,1,0.993501805286691,0,1,interleukin-33 receptor binding,MF,
853,GO:0002113,1,0.9943733711939,0,1,interleukin-33 binding,MF,
854,GO:0002114,1,0.986905512850866,0,2,interleukin-33 receptor activity,MF,
855,GO:0002115,1,0.886296616884473,0,18,store-operated calcium entry,BP,
856,GO:0002116,1,0.908886420263118,0,11,semaphorin receptor complex,CC,
857,GO:0002118,1,0.962904037851006,0,6,aggressive behavior,BP,
858,GO:0002121,1,0.985362793162555,0,2,inter-male aggressive behavior,BP,
859,GO:0002125,1,0.98796775989847,0,2,maternal aggressive behavior,BP,
860,GO:0002127,1,0.996217071516189,0,1,tRNA wobble base cytosine methylation,BP,
861,GO:0002128,1,0.9952082833299,0,1,tRNA nucleoside ribose methylation,BP,
862,GO:0002133,1,0.979628394808727,0,2,polycystin complex,CC,
863,GO:0002134,1,0.985587437185664,0,2,UTP binding,MF,
864,GO:0002135,1,0.993728670751326,0,1,CTP binding,MF,
865,GO:0002138,1,0.954845803034842,0,8,retinoic acid biosynthetic process,BP,
866,GO:0002139,1,0.960221388733344,0,5,stereocilia coupling link,CC,
867,GO:0002140,1,0.990818650640373,0,1,stereocilia tip link,CC,
868,GO:0002141,1,0.969122067797494,0,4,stereocilia ankle link,CC,
869,GO:0002142,1,0.969122067797494,0,4,stereocilia ankle link complex,CC,
870,GO:0002143,1,0.979905242341715,0,4,tRNA wobble position uridine thiolation,BP,
871,GO:0002144,1,0.994844773262842,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
872,GO:0002148,1,0.992690345055696,0,1,hypochlorous acid metabolic process,BP,
873,GO:0002149,1,0.992690345055696,0,1,hypochlorous acid biosynthetic process,BP,
874,GO:0002151,1,0.958099121649987,0,5,G-quadruplex RNA binding,MF,
875,GO:0002152,1,0.992577105170387,0,1,bile acid conjugation,BP,
876,GO:0002153,1,0.991100125048739,0,2,steroid receptor RNA activator RNA binding,MF,
877,GO:0002154,1,0.961526235179022,0,5,thyroid hormone mediated signaling pathway,BP,
878,GO:0002155,1,0.979896464531558,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
880,GO:0002159,1,0.96859699908077,0,4,desmosome assembly,BP,
881,GO:0002161,1,0.949869898914314,0,8,aminoacyl-tRNA editing activity,MF,
882,GO:0002162,1,0.930103519083004,0,9,dystroglycan binding,MF,
883,GO:0002169,1,0.986278191394225,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
884,GO:0002174,1,0.992985757593682,0,1,mammary stem cell proliferation,BP,
886,GO:0002176,1,0.971073391086823,0,6,male germ cell proliferation,BP,
887,GO:0002177,1,0.949428094894174,0,8,manchette,CC,
888,GO:0002178,1,0.934645212737746,0,11,palmitoyltransferase complex,CC,
889,GO:0002181,1,0.601992902193273,0,96,cytoplasmic translation,BP,
890,GO:0002182,1,0.941820740788281,0,9,cytoplasmic translational elongation,BP,
891,GO:0002183,1,0.82645705040825,0,33,cytoplasmic translational initiation,BP,
892,GO:0002184,1,0.976757293977149,0,3,cytoplasmic translational termination,BP,
893,GO:0002188,1,0.974610131047609,0,3,translation reinitiation,BP,
894,GO:0002189,1,0.978162208220651,0,4,ribose phosphate diphosphokinase complex,CC,
895,GO:0002190,1,0.97652656370767,0,5,cap-independent translational initiation,BP,
896,GO:0002191,1,0.982651396172892,0,3,cap-dependent translational initiation,BP,
897,GO:0002192,1,0.992641108066666,0,2,IRES-dependent translational initiation of linear mRNA,BP,
898,GO:0002193,1,0.975909288925543,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
899,GO:0002194,1,0.992825158104098,0,1,hepatocyte cell migration,BP,
900,GO:0002196,1,0.99535281446886,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
901,GO:0002199,1,0.967850759617131,0,6,zona pellucida receptor complex,CC,
902,GO:0002200,1,0.644475417532431,0,64,somatic diversification of immune receptors,BP,
903,GO:0002204,1,0.754473672949948,0,43,somatic recombination of immunoglobulin genes involved in immune response,BP,
904,GO:0002208,1,0.754473672949948,0,43,somatic diversification of immunoglobulins involved in immune response,BP,
906,GO:0002215,1,0.992553532471137,0,1,defense response to nematode,BP,
907,GO:0002218,1,0.474267078966982,0,124,activation of innate immune response,BP,
908,GO:0002220,1,0.558585347443007,0,100,innate immune response activating cell surface receptor signaling pathway,BP,
909,GO:0002221,1,0.312326585119323,0,176,pattern recognition receptor signaling pathway,BP,
910,GO:0002223,1,0.5658856248682,0,97,stimulatory C-type lectin receptor signaling pathway,BP,
911,GO:0002224,1,0.413536689853825,0,135,toll-like receptor signaling pathway,BP,
912,GO:0002225,1,0.991531079010238,0,2,positive regulation of antimicrobial peptide production,BP,
913,GO:0002227,1,0.952417330148879,0,12,innate immune response in mucosa,BP,
914,GO:0002228,1,0.728168269422156,0,56,natural killer cell mediated immunity,BP,
915,GO:0002230,1,0.863649011567215,0,23,positive regulation of defense response to virus by host,BP,
916,GO:0002232,1,0.969975662757468,0,6,leukocyte chemotaxis involved in inflammatory response,BP,
918,GO:0002238,1,0.973218544226741,0,4,response to molecule of fungal origin,BP,
920,GO:0002246,1,0.962252047746955,0,7,wound healing involved in inflammatory response,BP,
921,GO:0002248,1,0.966072887051277,0,6,connective tissue replacement involved in inflammatory response wound healing,BP,
922,GO:0002249,1,0.974786805173705,0,5,lymphocyte anergy,BP,
923,GO:0002250,1,0.112401454676308,0,360,adaptive immune response,BP,
924,GO:0002251,1,0.905019684071215,0,22,organ or tissue specific immune response,BP,
925,GO:0002252,1,0.00116415729043131,0,1064,immune effector process,BP,
927,GO:0002254,1,0.984150468619672,0,3,kinin cascade,BP,
928,GO:0002260,1,0.690934347931235,0,59,lymphocyte homeostasis,BP,
929,GO:0002262,1,0.384574363636409,0,146,myeloid cell homeostasis,BP,
930,GO:0002263,1,0.0169476468125549,0,653,cell activation involved in immune response,BP,
931,GO:0002265,1,0.965894915604595,0,4,astrocyte activation involved in immune response,BP,
932,GO:0002266,1,0.984287173561884,0,3,follicular dendritic cell activation,BP,
933,GO:0002268,1,0.988286612432084,0,2,follicular dendritic cell differentiation,BP,
934,GO:0002269,1,0.763499579027784,0,42,leukocyte activation involved in inflammatory response,BP,
935,GO:0002270,1,0.995124919208781,0,1,plasmacytoid dendritic cell activation,BP,
936,GO:0002274,1,0.0226014497941113,0,616,myeloid leukocyte activation,BP,
937,GO:0002275,1,0.0426520578879134,0,517,myeloid cell activation involved in immune response,BP,
938,GO:0002276,1,0.985210865143249,0,2,basophil activation involved in immune response,BP,
939,GO:0002277,1,0.983419699655795,0,3,myeloid dendritic cell activation involved in immune response,BP,
940,GO:0002278,1,0.978072744734084,0,4,eosinophil activation involved in immune response,BP,
941,GO:0002279,1,0.760495253627225,0,44,mast cell activation involved in immune response,BP,
942,GO:0002280,1,0.983513977418527,0,2,monocyte activation involved in immune response,BP,
943,GO:0002281,1,0.919023582807349,0,14,macrophage activation involved in immune response,BP,
944,GO:0002282,1,0.981395499421611,0,4,microglial cell activation involved in immune response,BP,
945,GO:0002283,1,0.0601163283831363,0,464,neutrophil activation involved in immune response,BP,
946,GO:0002285,1,0.378394739504184,0,150,lymphocyte activation involved in immune response,BP,
947,GO:0002286,1,0.582199873358946,0,84,T cell activation involved in immune response,BP,
948,GO:0002287,1,0.690960444816791,0,56,alpha-beta T cell activation involved in immune response,BP,
949,GO:0002290,1,0.993092034082734,0,1,gamma-delta T cell activation involved in immune response,BP,
950,GO:0002291,1,0.944026053712335,0,10,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
951,GO:0002292,1,0.660647025105793,0,63,T cell differentiation involved in immune response,BP,
952,GO:0002293,1,0.690960444816791,0,56,alpha-beta T cell differentiation involved in immune response,BP,
953,GO:0002294,1,0.695624712200313,0,55,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
954,GO:0002295,1,0.914011726247077,0,14,T-helper cell lineage commitment,BP,
955,GO:0002296,1,0.97385975372377,0,3,T-helper 1 cell lineage commitment,BP,
956,GO:0002298,1,0.995833820986594,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
957,GO:0002299,1,0.996027689458848,0,1,alpha-beta intraepithelial T cell differentiation,BP,
958,GO:0002300,1,0.996027689458848,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
959,GO:0002302,1,0.993319549320477,0,1,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
960,GO:0002304,1,0.996027689458848,0,1,gamma-delta intraepithelial T cell differentiation,BP,
961,GO:0002305,1,0.996027689458848,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
962,GO:0002309,1,0.976200161661228,0,4,T cell proliferation involved in immune response,BP,
963,GO:0002312,1,0.644814794795724,0,68,B cell activation involved in immune response,BP,
964,GO:0002313,1,0.890835752193795,0,19,mature B cell differentiation involved in immune response,BP,
965,GO:0002314,1,0.972410768842066,0,5,germinal center B cell differentiation,BP,
966,GO:0002315,1,0.935128874520154,0,9,marginal zone B cell differentiation,BP,
967,GO:0002316,1,0.988402886854124,0,2,follicular B cell differentiation,BP,
968,GO:0002317,1,0.988097597635271,0,3,plasma cell differentiation,BP,
969,GO:0002318,1,0.966018961349516,0,5,myeloid progenitor cell differentiation,BP,
970,GO:0002320,1,0.873009074913926,0,20,lymphoid progenitor cell differentiation,BP,
971,GO:0002322,1,0.959865156125855,0,6,B cell proliferation involved in immune response,BP,
972,GO:0002323,1,0.950209392683996,0,9,natural killer cell activation involved in immune response,BP,
973,GO:0002325,1,0.992572307535969,0,2,natural killer cell differentiation involved in immune response,BP,
974,GO:0002326,1,0.959535701982385,0,5,B cell lineage commitment,BP,
975,GO:0002327,1,0.926796647020476,0,9,immature B cell differentiation,BP,
976,GO:0002328,1,0.917701624772608,0,11,pro-B cell differentiation,BP,
977,GO:0002329,1,0.964553927956941,0,4,pre-B cell differentiation,BP,
978,GO:0002331,1,0.980238555523219,0,2,pre-B cell allelic exclusion,BP,
979,GO:0002332,1,0.991799658234766,0,1,transitional stage B cell differentiation,BP,
980,GO:0002333,1,0.991799658234766,0,1,transitional one stage B cell differentiation,BP,
981,GO:0002335,1,0.856756404286973,0,25,mature B cell differentiation,BP,
982,GO:0002336,1,0.992639680906928,0,1,B-1 B cell lineage commitment,BP,
983,GO:0002337,1,0.98887567595936,0,2,B-1a B cell differentiation,BP,
984,GO:0002339,1,0.984996494791204,0,3,B cell selection,BP,
985,GO:0002343,1,0.993547373109572,0,1,peripheral B cell selection,BP,
986,GO:0002344,1,0.993547373109572,0,1,B cell affinity maturation,BP,
987,GO:0002347,1,0.889034885889434,0,21,response to tumor cell,BP,
988,GO:0002349,1,0.962451324764254,0,7,histamine production involved in inflammatory response,BP,
989,GO:0002351,1,0.98214781735537,0,3,serotonin production involved in inflammatory response,BP,
990,GO:0002352,1,0.991394154600123,0,2,B cell negative selection,BP,
991,GO:0002353,1,0.984150468619672,0,3,plasma kallikrein-kinin cascade,BP,
992,GO:0002355,1,0.994019146685192,0,1,detection of tumor cell,BP,
993,GO:0002357,1,0.980437412825235,0,3,defense response to tumor cell,BP,
994,GO:0002358,1,0.996762136804637,0,1,B cell homeostatic proliferation,BP,
995,GO:0002360,1,0.852045346367651,0,24,T cell lineage commitment,BP,
996,GO:0002361,1,0.970489217256749,0,5,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
997,GO:0002362,1,0.986737884000346,0,2,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
998,GO:0002363,1,0.884871468616274,0,19,alpha-beta T cell lineage commitment,BP,
999,GO:0002364,1,0.992447789328309,0,1,NK T cell lineage commitment,BP,
1000,GO:0002366,1,0.0174707332389454,0,650,leukocyte activation involved in immune response,BP,
1001,GO:0002367,1,0.562066391083178,0,95,cytokine production involved in immune response,BP,
1002,GO:0002368,1,0.987879729342813,0,2,B cell cytokine production,BP,
1003,GO:0002369,1,0.7940786636778,0,39,T cell cytokine production,BP,
1004,GO:0002370,1,0.962544288320459,0,8,natural killer cell cytokine production,BP,
1005,GO:0002371,1,0.907539048035268,0,13,dendritic cell cytokine production,BP,
1006,GO:0002372,1,0.953407813721282,0,6,myeloid dendritic cell cytokine production,BP,
1007,GO:0002373,1,0.996696020579338,0,1,plasmacytoid dendritic cell cytokine production,BP,
1008,GO:0002374,1,0.970630129192393,0,4,cytokine secretion involved in immune response,BP,
1010,GO:0002377,1,0.542510828259088,0,100,immunoglobulin production,BP,
1011,GO:0002378,1,0.973861693712717,0,4,immunoglobulin biosynthetic process,BP,
1012,GO:0002379,1,0.995871794058111,0,1,immunoglobulin biosynthetic process involved in immune response,BP,
1013,GO:0002380,1,0.992351026063754,0,1,immunoglobulin secretion involved in immune response,BP,
1014,GO:0002381,1,0.723437422744776,0,51,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
1015,GO:0002383,1,0.995871794058111,0,1,immune response in brain or nervous system,BP,
1016,GO:0002384,1,0.988984699962375,0,2,hepatic immune response,BP,
1017,GO:0002385,1,0.918905690332032,0,19,mucosal immune response,BP,
1018,GO:0002386,1,0.987745199731005,0,2,immune response in mucosal-associated lymphoid tissue,BP,
1019,GO:0002396,1,0.969663920396076,0,7,MHC protein complex assembly,BP,
1020,GO:0002397,1,0.990870555192957,0,2,MHC class I protein complex assembly,BP,
1021,GO:0002398,1,0.992549053407681,0,1,MHC class Ib protein complex assembly,BP,
1022,GO:0002399,1,0.985947263106542,0,4,MHC class II protein complex assembly,BP,
1023,GO:0002407,1,0.870740409393325,0,23,dendritic cell chemotaxis,BP,
1024,GO:0002408,1,0.980236506051289,0,4,myeloid dendritic cell chemotaxis,BP,
1025,GO:0002413,1,0.99606239377017,0,1,tolerance induction to tumor cell,BP,
1026,GO:0002414,1,0.983452726471589,0,3,immunoglobulin transcytosis in epithelial cells,BP,
1027,GO:0002415,1,0.987745199731005,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1028,GO:0002416,1,0.995654817129484,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1029,GO:0002418,1,0.907227355802356,0,17,immune response to tumor cell,BP,
1030,GO:0002419,1,0.986216023702569,0,3,T cell mediated cytotoxicity directed against tumor cell target,BP,
1031,GO:0002420,1,0.962900911786517,0,6,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1032,GO:0002423,1,0.959076856891,0,7,natural killer cell mediated immune response to tumor cell,BP,
1033,GO:0002424,1,0.96592625946446,0,6,T cell mediated immune response to tumor cell,BP,
1034,GO:0002426,1,0.996473668370333,0,1,immunoglobulin production in mucosal tissue,BP,
1035,GO:0002428,1,0.974058850654383,0,6,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1037,GO:0002430,1,0.93840926923295,0,10,complement receptor mediated signaling pathway,BP,
1038,GO:0002431,1,0.582112377266811,0,81,Fc receptor mediated stimulatory signaling pathway,BP,
1039,GO:0002432,1,0.992377819620543,0,1,granuloma formation,BP,
1040,GO:0002433,1,0.603407964240598,0,75,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
1041,GO:0002434,1,0.978447586523287,0,4,immune complex clearance,BP,
1042,GO:0002436,1,0.985226085935349,0,3,immune complex clearance by monocytes and macrophages,BP,
1043,GO:0002437,1,0.759356282542484,0,49,inflammatory response to antigenic stimulus,BP,
1044,GO:0002438,1,0.885533142796191,0,22,acute inflammatory response to antigenic stimulus,BP,
1045,GO:0002439,1,0.982466478749166,0,4,chronic inflammatory response to antigenic stimulus,BP,
1046,GO:0002440,1,0.319599781272283,0,186,production of molecular mediator of immune response,BP,
1047,GO:0002441,1,0.962451324764254,0,7,histamine secretion involved in inflammatory response,BP,
1048,GO:0002442,1,0.98214781735537,0,3,serotonin secretion involved in inflammatory response,BP,
1049,GO:0002443,1,0.0120458110469926,0,721,leukocyte mediated immunity,BP,
1050,GO:0002444,1,0.0409226372162366,0,523,myeloid leukocyte mediated immunity,BP,
1051,GO:0002445,1,0.980815198569331,0,4,type II hypersensitivity,BP,
1052,GO:0002446,1,0.0568093502316664,0,473,neutrophil mediated immunity,BP,
1053,GO:0002447,1,0.978072744734084,0,4,eosinophil mediated immunity,BP,
1054,GO:0002448,1,0.756881727026044,0,45,mast cell mediated immunity,BP,
1055,GO:0002449,1,0.262772937216112,0,224,lymphocyte mediated immunity,BP,
1056,GO:0002450,1,0.995953645462242,0,1,B cell antigen processing and presentation,BP,
1057,GO:0002451,1,0.995995379654577,0,1,peripheral B cell tolerance induction,BP,
1058,GO:0002455,1,0.790773962704833,0,41,humoral immune response mediated by circulating immunoglobulin,BP,
1059,GO:0002456,1,0.580236316791542,0,93,T cell mediated immunity,BP,
1060,GO:0002457,1,0.972477905104675,0,5,T cell antigen processing and presentation,BP,
1061,GO:0002458,1,0.989094401434814,0,2,peripheral T cell tolerance induction,BP,
1062,GO:0002460,1,0.238803178644095,0,234,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1063,GO:0002461,1,0.975639971903881,0,5,tolerance induction dependent upon immune response,BP,
1064,GO:0002465,1,0.981253351150093,0,4,peripheral tolerance induction,BP,
1065,GO:0002467,1,0.906282404936499,0,15,germinal center formation,BP,
1066,GO:0002468,1,0.935841727524968,0,12,dendritic cell antigen processing and presentation,BP,
1067,GO:0002470,1,0.996518942899686,0,1,plasmacytoid dendritic cell antigen processing and presentation,BP,
1068,GO:0002472,1,0.992419860559889,0,1,macrophage antigen processing and presentation,BP,
1069,GO:0002474,1,0.618519908482399,0,93,antigen processing and presentation of peptide antigen via MHC class I,BP,
1070,GO:0002475,1,0.936663953643962,0,12,antigen processing and presentation via MHC class Ib,BP,
1071,GO:0002476,1,0.97731729037356,0,5,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1072,GO:0002477,1,0.988932908295421,0,3,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1073,GO:0002478,1,0.393575380888777,0,166,antigen processing and presentation of exogenous peptide antigen,BP,
1074,GO:0002479,1,0.720624632270936,0,69,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
1075,GO:0002480,1,0.965937168227621,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1076,GO:0002481,1,0.996666717035851,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1077,GO:0002483,1,0.914661705863853,0,16,antigen processing and presentation of endogenous peptide antigen,BP,
1078,GO:0002484,1,0.973116360017316,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,BP,
1079,GO:0002485,1,0.996044757766901,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent,BP,
1080,GO:0002486,1,0.973116360017316,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent,BP,
1081,GO:0002488,1,0.992465109004135,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1082,GO:0002489,1,0.992465109004135,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1083,GO:0002495,1,0.554055648371822,0,96,antigen processing and presentation of peptide antigen via MHC class II,BP,
1084,GO:0002501,1,0.976944813034168,0,6,peptide antigen assembly with MHC protein complex,BP,
1085,GO:0002502,1,0.990870555192957,0,2,peptide antigen assembly with MHC class I protein complex,BP,
1086,GO:0002503,1,0.985947263106542,0,4,peptide antigen assembly with MHC class II protein complex,BP,
1087,GO:0002504,1,0.549431173813751,0,97,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1088,GO:0002507,1,0.869591108076732,0,24,tolerance induction,BP,
1089,GO:0002508,1,0.988374417234087,0,2,central tolerance induction,BP,
1090,GO:0002509,1,0.99481780378576,0,1,central tolerance induction to self antigen,BP,
1091,GO:0002510,1,0.993523391118181,0,1,central B cell tolerance induction,BP,
1092,GO:0002513,1,0.96820003022506,0,5,tolerance induction to self antigen,BP,
1093,GO:0002514,1,0.981913935301131,0,3,B cell tolerance induction,BP,
1094,GO:0002517,1,0.934843035620727,0,12,T cell tolerance induction,BP,
1095,GO:0002518,1,0.996492397595218,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1096,GO:0002519,1,0.985999327228023,0,3,natural killer cell tolerance induction,BP,
1099,GO:0002522,1,0.988788269330753,0,2,leukocyte migration involved in immune response,BP,
1100,GO:0002523,1,0.913689975735026,0,16,leukocyte migration involved in inflammatory response,BP,
1101,GO:0002524,1,0.94828936984598,0,10,hypersensitivity,BP,
1102,GO:0002525,1,0.983649870589232,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1103,GO:0002526,1,0.585929355858226,0,94,acute inflammatory response,BP,
1104,GO:0002528,1,0.972274405143349,0,4,regulation of vascular permeability involved in acute inflammatory response,BP,
1107,GO:0002536,1,0.970770057079145,0,6,respiratory burst involved in inflammatory response,BP,
1108,GO:0002537,1,0.982585879549099,0,2,nitric oxide production involved in inflammatory response,BP,
1109,GO:0002538,1,0.986478886000058,0,2,arachidonic acid metabolite production involved in inflammatory response,BP,
1110,GO:0002540,1,0.986478886000058,0,2,leukotriene production involved in inflammatory response,BP,
1111,GO:0002541,1,0.983705048723935,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1112,GO:0002542,1,0.989440896426133,0,2,Factor XII activation,BP,
1113,GO:0002543,1,0.986488184425952,0,2,activation of blood coagulation via clotting cascade,BP,
1115,GO:0002545,1,0.995391269235499,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1117,GO:0002551,1,0.94274051303496,0,10,mast cell chemotaxis,BP,
1118,GO:0002553,1,0.962451324764254,0,7,histamine secretion by mast cell,BP,
1119,GO:0002554,1,0.98214781735537,0,3,serotonin secretion by platelet,BP,
1120,GO:0002560,1,0.992437007368856,0,1,basophil mediated immunity,BP,
1121,GO:0002561,1,0.992437007368856,0,1,basophil degranulation,BP,
1122,GO:0002562,1,0.683829686313728,0,56,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1123,GO:0002566,1,0.906482105226867,0,14,somatic diversification of immune receptors via somatic mutation,BP,
1124,GO:0002568,1,0.957227201745024,0,5,somatic diversification of T cell receptor genes,BP,
1125,GO:0002572,1,0.985352061739517,0,2,pro-T cell differentiation,BP,
1128,GO:0002577,1,0.896863709972766,0,20,regulation of antigen processing and presentation,BP,
1129,GO:0002578,1,0.949395843989494,0,9,negative regulation of antigen processing and presentation,BP,
1130,GO:0002579,1,0.955980545782814,0,9,positive regulation of antigen processing and presentation,BP,
1131,GO:0002580,1,0.974159518626406,0,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1132,GO:0002581,1,0.98067987512988,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1133,GO:0002582,1,0.993352510433714,0,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1134,GO:0002583,1,0.973268806859584,0,6,regulation of antigen processing and presentation of peptide antigen,BP,
1135,GO:0002584,1,0.979783263881918,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1136,GO:0002585,1,0.993352510433714,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,
1137,GO:0002586,1,0.982310922239684,0,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1138,GO:0002587,1,0.988885276575221,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1139,GO:0002588,1,0.993352510433714,0,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1140,GO:0002589,1,0.99079673049763,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1141,GO:0002590,1,0.99079673049763,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1142,GO:0002604,1,0.939112932115527,0,11,regulation of dendritic cell antigen processing and presentation,BP,
1143,GO:0002605,1,0.975832288723214,0,4,negative regulation of dendritic cell antigen processing and presentation,BP,
1144,GO:0002606,1,0.962380463764156,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1145,GO:0002616,1,0.992419860559889,0,1,regulation of macrophage antigen processing and presentation,BP,
1146,GO:0002617,1,0.992419860559889,0,1,negative regulation of macrophage antigen processing and presentation,BP,
1147,GO:0002622,1,0.995953645462242,0,1,regulation of B cell antigen processing and presentation,BP,
1148,GO:0002625,1,0.990759225340059,0,2,regulation of T cell antigen processing and presentation,BP,
1149,GO:0002626,1,0.99523977488528,0,1,negative regulation of T cell antigen processing and presentation,BP,
1150,GO:0002634,1,0.942419713910086,0,9,regulation of germinal center formation,BP,
1151,GO:0002635,1,0.982518633337622,0,2,negative regulation of germinal center formation,BP,
1152,GO:0002636,1,0.989319969740053,0,3,positive regulation of germinal center formation,BP,
1153,GO:0002637,1,0.714790076848557,0,56,regulation of immunoglobulin production,BP,
1154,GO:0002638,1,0.922867043160714,0,12,negative regulation of immunoglobulin production,BP,
1155,GO:0002639,1,0.816737162424178,0,35,positive regulation of immunoglobulin production,BP,
1156,GO:0002640,1,0.99325505912211,0,1,regulation of immunoglobulin biosynthetic process,BP,
1157,GO:0002642,1,0.99325505912211,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1158,GO:0002643,1,0.91009407053359,0,16,regulation of tolerance induction,BP,
1159,GO:0002644,1,0.994826800234742,0,1,negative regulation of tolerance induction,BP,
1160,GO:0002645,1,0.948746240073439,0,9,positive regulation of tolerance induction,BP,
1161,GO:0002646,1,0.993523391118181,0,1,regulation of central tolerance induction,BP,
1162,GO:0002648,1,0.993523391118181,0,1,positive regulation of central tolerance induction,BP,
1163,GO:0002649,1,0.992289691663676,0,1,regulation of tolerance induction to self antigen,BP,
1164,GO:0002651,1,0.992289691663676,0,1,positive regulation of tolerance induction to self antigen,BP,
1165,GO:0002652,1,0.984667121199159,0,3,regulation of tolerance induction dependent upon immune response,BP,
1166,GO:0002654,1,0.990331903719892,0,2,positive regulation of tolerance induction dependent upon immune response,BP,
1167,GO:0002658,1,0.990331903719892,0,2,regulation of peripheral tolerance induction,BP,
1168,GO:0002660,1,0.990331903719892,0,2,positive regulation of peripheral tolerance induction,BP,
1169,GO:0002661,1,0.985862513765061,0,2,regulation of B cell tolerance induction,BP,
1170,GO:0002663,1,0.985862513765061,0,2,positive regulation of B cell tolerance induction,BP,
1171,GO:0002664,1,0.945855560372679,0,10,regulation of T cell tolerance induction,BP,
1172,GO:0002666,1,0.968056644961773,0,6,positive regulation of T cell tolerance induction,BP,
1173,GO:0002667,1,0.974786805173705,0,5,regulation of T cell anergy,BP,
1174,GO:0002669,1,0.990369306009765,0,2,positive regulation of T cell anergy,BP,
1175,GO:0002673,1,0.786427146696809,0,42,regulation of acute inflammatory response,BP,
1176,GO:0002674,1,0.946656431770531,0,9,negative regulation of acute inflammatory response,BP,
1177,GO:0002675,1,0.856941647534689,0,28,positive regulation of acute inflammatory response,BP,
1178,GO:0002676,1,0.959112418205467,0,8,regulation of chronic inflammatory response,BP,
1179,GO:0002677,1,0.975123711571372,0,4,negative regulation of chronic inflammatory response,BP,
1180,GO:0002678,1,0.983584437054942,0,4,positive regulation of chronic inflammatory response,BP,
1181,GO:0002679,1,0.94315143174221,0,10,respiratory burst involved in defense response,BP,
1182,GO:0002681,1,0.957227201745024,0,5,somatic recombination of T cell receptor gene segments,BP,
1188,GO:0002687,1,0.477956313890022,0,128,positive regulation of leukocyte migration,BP,
1191,GO:0002690,1,0.614452458647385,0,86,positive regulation of leukocyte chemotaxis,BP,
1192,GO:0002691,1,0.825828888491251,0,30,regulation of cellular extravasation,BP,
1193,GO:0002692,1,0.946276130662724,0,9,negative regulation of cellular extravasation,BP,
1194,GO:0002693,1,0.89096208806712,0,18,positive regulation of cellular extravasation,BP,
1197,GO:0002696,1,0.157249502494169,0,298,positive regulation of leukocyte activation,BP,
1198,GO:0002697,1,0.115457576026646,0,348,regulation of immune effector process,BP,
1199,GO:0002698,1,0.512199662194242,0,108,negative regulation of immune effector process,BP,
1200,GO:0002699,1,0.310414310719488,0,193,positive regulation of immune effector process,BP,
1201,GO:0002700,1,0.468703907330641,0,125,regulation of production of molecular mediator of immune response,BP,
1202,GO:0002701,1,0.82472731418078,0,32,negative regulation of production of molecular mediator of immune response,BP,
1203,GO:0002702,1,0.595180762596999,0,87,positive regulation of production of molecular mediator of immune response,BP,
1204,GO:0002703,1,0.327165155469592,0,186,regulation of leukocyte mediated immunity,BP,
1205,GO:0002704,1,0.763091829878413,0,48,negative regulation of leukocyte mediated immunity,BP,
1206,GO:0002705,1,0.492190631705474,0,119,positive regulation of leukocyte mediated immunity,BP,
1207,GO:0002706,1,0.466221023149851,0,131,regulation of lymphocyte mediated immunity,BP,
1208,GO:0002707,1,0.810873724845277,0,38,negative regulation of lymphocyte mediated immunity,BP,
1209,GO:0002708,1,0.600286322643436,0,88,positive regulation of lymphocyte mediated immunity,BP,
1210,GO:0002709,1,0.69387870869579,0,65,regulation of T cell mediated immunity,BP,
1211,GO:0002710,1,0.914147741930983,0,17,negative regulation of T cell mediated immunity,BP,
1212,GO:0002711,1,0.77924172075848,0,44,positive regulation of T cell mediated immunity,BP,
1213,GO:0002712,1,0.759960844979897,0,45,regulation of B cell mediated immunity,BP,
1214,GO:0002713,1,0.933467734842013,0,11,negative regulation of B cell mediated immunity,BP,
1215,GO:0002714,1,0.836903737882146,0,30,positive regulation of B cell mediated immunity,BP,
1216,GO:0002715,1,0.807731988120992,0,38,regulation of natural killer cell mediated immunity,BP,
1217,GO:0002716,1,0.920586147660282,0,16,negative regulation of natural killer cell mediated immunity,BP,
1218,GO:0002717,1,0.873178678819043,0,24,positive regulation of natural killer cell mediated immunity,BP,
1219,GO:0002718,1,0.630098626811427,0,77,regulation of cytokine production involved in immune response,BP,
1220,GO:0002719,1,0.888619326894535,0,21,negative regulation of cytokine production involved in immune response,BP,
1221,GO:0002720,1,0.726680114662552,0,53,positive regulation of cytokine production involved in immune response,BP,
1222,GO:0002721,1,0.993547373109572,0,1,regulation of B cell cytokine production,BP,
1223,GO:0002724,1,0.840192740172723,0,30,regulation of T cell cytokine production,BP,
1224,GO:0002725,1,0.965543943188588,0,7,negative regulation of T cell cytokine production,BP,
1225,GO:0002726,1,0.888639439953824,0,20,positive regulation of T cell cytokine production,BP,
1226,GO:0002727,1,0.962544288320459,0,8,regulation of natural killer cell cytokine production,BP,
1227,GO:0002728,1,0.988794408498777,0,2,negative regulation of natural killer cell cytokine production,BP,
1228,GO:0002729,1,0.969954957833392,0,7,positive regulation of natural killer cell cytokine production,BP,
1229,GO:0002730,1,0.91481921879447,0,12,regulation of dendritic cell cytokine production,BP,
1230,GO:0002731,1,0.988627315408883,0,2,negative regulation of dendritic cell cytokine production,BP,
1231,GO:0002732,1,0.939728862603961,0,8,positive regulation of dendritic cell cytokine production,BP,
1232,GO:0002733,1,0.953407813721282,0,6,regulation of myeloid dendritic cell cytokine production,BP,
1233,GO:0002735,1,0.953407813721282,0,6,positive regulation of myeloid dendritic cell cytokine production,BP,
1234,GO:0002736,1,0.996696020579338,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1235,GO:0002737,1,0.996696020579338,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1236,GO:0002752,1,0.991416148428018,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1237,GO:0002753,1,0.670583229030597,0,59,cytoplasmic pattern recognition receptor signaling pathway,BP,
1238,GO:0002755,1,0.793853089707272,0,35,MyD88-dependent toll-like receptor signaling pathway,BP,
1239,GO:0002756,1,0.820086151591469,0,32,MyD88-independent toll-like receptor signaling pathway,BP,
1241,GO:0002758,1,0.555608882248369,0,101,innate immune response-activating signal transduction,BP,
1242,GO:0002759,1,0.979660083042511,0,4,regulation of antimicrobial humoral response,BP,
1243,GO:0002760,1,0.991531079010238,0,2,positive regulation of antimicrobial humoral response,BP,
1244,GO:0002761,1,0.508996572669559,0,104,regulation of myeloid leukocyte differentiation,BP,
1245,GO:0002762,1,0.744202963715625,0,44,negative regulation of myeloid leukocyte differentiation,BP,
1246,GO:0002763,1,0.733686980931443,0,49,positive regulation of myeloid leukocyte differentiation,BP,
1248,GO:0002765,1,0.957787946639727,0,8,immune response-inhibiting signal transduction,BP,
1249,GO:0002767,1,0.966065988326671,0,6,immune response-inhibiting cell surface receptor signaling pathway,BP,
1251,GO:0002769,1,0.990698413340725,0,2,natural killer cell inhibitory signaling pathway,BP,
1252,GO:0002774,1,0.979060258387673,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1253,GO:0002775,1,0.980861424951125,0,4,antimicrobial peptide production,BP,
1254,GO:0002777,1,0.996705355166693,0,1,antimicrobial peptide biosynthetic process,BP,
1255,GO:0002778,1,0.980861424951125,0,4,antibacterial peptide production,BP,
1256,GO:0002780,1,0.996705355166693,0,1,antibacterial peptide biosynthetic process,BP,
1257,GO:0002784,1,0.984104230053976,0,3,regulation of antimicrobial peptide production,BP,
1258,GO:0002785,1,0.992510364740564,0,1,negative regulation of antimicrobial peptide production,BP,
1259,GO:0002786,1,0.984104230053976,0,3,regulation of antibacterial peptide production,BP,
1260,GO:0002787,1,0.992510364740564,0,1,negative regulation of antibacterial peptide production,BP,
1263,GO:0002792,1,0.611920252505414,0,81,negative regulation of peptide secretion,BP,
1265,GO:0002803,1,0.991531079010238,0,2,positive regulation of antibacterial peptide production,BP,
1266,GO:0002812,1,0.996705355166693,0,1,biosynthetic process of antibacterial peptides active against Gram-negative bacteria,BP,
1267,GO:0002819,1,0.415464115834419,0,148,regulation of adaptive immune response,BP,
1268,GO:0002820,1,0.769125867698806,0,43,negative regulation of adaptive immune response,BP,
1269,GO:0002821,1,0.583583244403951,0,93,positive regulation of adaptive immune response,BP,
1270,GO:0002822,1,0.453423874095581,0,133,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1271,GO:0002823,1,0.789872753413132,0,38,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1272,GO:0002824,1,0.601658226507072,0,88,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1273,GO:0002825,1,0.870372550092689,0,24,regulation of T-helper 1 type immune response,BP,
1274,GO:0002826,1,0.957960477887461,0,7,negative regulation of T-helper 1 type immune response,BP,
1275,GO:0002827,1,0.908467058305013,0,17,positive regulation of T-helper 1 type immune response,BP,
1276,GO:0002828,1,0.848530144472349,0,28,regulation of type 2 immune response,BP,
1277,GO:0002829,1,0.934095650085512,0,11,negative regulation of type 2 immune response,BP,
1278,GO:0002830,1,0.91283859948806,0,16,positive regulation of type 2 immune response,BP,
1279,GO:0002831,1,0.1150378574144,0,350,regulation of response to biotic stimulus,BP,
1280,GO:0002832,1,0.601354232458414,0,83,negative regulation of response to biotic stimulus,BP,
1281,GO:0002833,1,0.272874935126772,0,213,positive regulation of response to biotic stimulus,BP,
1282,GO:0002834,1,0.926400229578307,0,13,regulation of response to tumor cell,BP,
1283,GO:0002835,1,0.986881872623582,0,2,negative regulation of response to tumor cell,BP,
1284,GO:0002836,1,0.945745986861181,0,10,positive regulation of response to tumor cell,BP,
1285,GO:0002837,1,0.926400229578307,0,13,regulation of immune response to tumor cell,BP,
1286,GO:0002838,1,0.986881872623582,0,2,negative regulation of immune response to tumor cell,BP,
1287,GO:0002839,1,0.945745986861181,0,10,positive regulation of immune response to tumor cell,BP,
1288,GO:0002840,1,0.969763109466326,0,5,regulation of T cell mediated immune response to tumor cell,BP,
1289,GO:0002842,1,0.97701651915961,0,4,positive regulation of T cell mediated immune response to tumor cell,BP,
1290,GO:0002843,1,0.99606239377017,0,1,regulation of tolerance induction to tumor cell,BP,
1291,GO:0002845,1,0.99606239377017,0,1,positive regulation of tolerance induction to tumor cell,BP,
1292,GO:0002849,1,0.994247087811546,0,1,regulation of peripheral T cell tolerance induction,BP,
1293,GO:0002851,1,0.994247087811546,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1294,GO:0002852,1,0.990132634748171,0,2,regulation of T cell mediated cytotoxicity directed against tumor cell target,BP,
1295,GO:0002854,1,0.990132634748171,0,2,positive regulation of T cell mediated cytotoxicity directed against tumor cell target,BP,
1296,GO:0002855,1,0.959076856891,0,7,regulation of natural killer cell mediated immune response to tumor cell,BP,
1297,GO:0002856,1,0.986881872623582,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1298,GO:0002857,1,0.971829129744681,0,5,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1299,GO:0002858,1,0.962900911786517,0,6,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1300,GO:0002859,1,0.986881872623582,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1301,GO:0002860,1,0.975703506610457,0,4,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1302,GO:0002861,1,0.881884550885245,0,25,regulation of inflammatory response to antigenic stimulus,BP,
1303,GO:0002862,1,0.949944808087097,0,11,negative regulation of inflammatory response to antigenic stimulus,BP,
1304,GO:0002863,1,0.940005662051922,0,12,positive regulation of inflammatory response to antigenic stimulus,BP,
1305,GO:0002864,1,0.926969718383492,0,14,regulation of acute inflammatory response to antigenic stimulus,BP,
1306,GO:0002865,1,0.979331029869347,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1307,GO:0002866,1,0.958385456474054,0,8,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1308,GO:0002870,1,0.974786805173705,0,5,T cell anergy,BP,
1309,GO:0002874,1,0.988041839537087,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1310,GO:0002875,1,0.995912405228962,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1311,GO:0002876,1,0.992097460792249,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1312,GO:0002877,1,0.983649870589232,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1313,GO:0002878,1,0.992730335419945,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1314,GO:0002879,1,0.99085371828356,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1315,GO:0002880,1,0.995391269235499,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1316,GO:0002882,1,0.995391269235499,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1317,GO:0002883,1,0.955144075521337,0,9,regulation of hypersensitivity,BP,
1318,GO:0002884,1,0.990976211316515,0,2,negative regulation of hypersensitivity,BP,
1319,GO:0002885,1,0.969611843489718,0,6,positive regulation of hypersensitivity,BP,
1320,GO:0002886,1,0.715228312383685,0,55,regulation of myeloid leukocyte mediated immunity,BP,
1321,GO:0002887,1,0.944221768879118,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1322,GO:0002888,1,0.820983272247897,0,32,positive regulation of myeloid leukocyte mediated immunity,BP,
1323,GO:0002889,1,0.759960844979897,0,45,regulation of immunoglobulin mediated immune response,BP,
1324,GO:0002890,1,0.933467734842013,0,11,negative regulation of immunoglobulin mediated immune response,BP,
1325,GO:0002891,1,0.836903737882146,0,30,positive regulation of immunoglobulin mediated immune response,BP,
1326,GO:0002892,1,0.980815198569331,0,4,regulation of type II hypersensitivity,BP,
1327,GO:0002893,1,0.995953645462242,0,1,negative regulation of type II hypersensitivity,BP,
1328,GO:0002894,1,0.984800674435316,0,3,positive regulation of type II hypersensitivity,BP,
1329,GO:0002895,1,0.993523391118181,0,1,regulation of central B cell tolerance induction,BP,
1330,GO:0002897,1,0.993523391118181,0,1,positive regulation of central B cell tolerance induction,BP,
1331,GO:0002901,1,0.982188294692324,0,4,mature B cell apoptotic process,BP,
1332,GO:0002902,1,0.895193270017907,0,18,regulation of B cell apoptotic process,BP,
1333,GO:0002903,1,0.935852943868308,0,11,negative regulation of B cell apoptotic process,BP,
1334,GO:0002904,1,0.984012797363353,0,3,positive regulation of B cell apoptotic process,BP,
1335,GO:0002905,1,0.982188294692324,0,4,regulation of mature B cell apoptotic process,BP,
1336,GO:0002906,1,0.982188294692324,0,4,negative regulation of mature B cell apoptotic process,BP,
1337,GO:0002911,1,0.974786805173705,0,5,regulation of lymphocyte anergy,BP,
1338,GO:0002913,1,0.990369306009765,0,2,positive regulation of lymphocyte anergy,BP,
1339,GO:0002920,1,0.719439708816636,0,57,regulation of humoral immune response,BP,
1340,GO:0002921,1,0.925447078710758,0,12,negative regulation of humoral immune response,BP,
1341,GO:0002922,1,0.93284175894711,0,14,positive regulation of humoral immune response,BP,
1342,GO:0002923,1,0.940805602601651,0,11,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1343,GO:0002924,1,0.963688163899259,0,6,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1344,GO:0002925,1,0.9762640863998,0,5,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1345,GO:0002926,1,0.992686732662962,0,1,tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation,BP,
1346,GO:0002930,1,0.987270981687164,0,2,trabecular meshwork development,BP,
1348,GO:0002933,1,0.980596544673449,0,4,lipid hydroxylation,BP,
1349,GO:0002934,1,0.931956981496655,0,9,desmosome organization,BP,
1350,GO:0002939,1,0.985307389955692,0,2,tRNA N1-guanine methylation,BP,
1351,GO:0002940,1,0.987918667742982,0,2,tRNA N2-guanine methylation,BP,
1352,GO:0002941,1,0.995845031675732,0,1,synoviocyte proliferation,BP,
1353,GO:0002943,1,0.978971348036561,0,4,tRNA dihydrouridine synthesis,BP,
1354,GO:0002944,1,0.984788921209553,0,2,cyclin K-CDK12 complex,CC,
1355,GO:0002945,1,0.985545154512478,0,2,cyclin K-CDK13 complex,CC,
1356,GO:0002946,1,0.990241248715977,0,2,tRNA C5-cytosine methylation,BP,
1357,GO:0002947,1,0.97780111970851,0,4,tumor necrosis factor receptor superfamily complex,CC,
1358,GO:0002949,1,0.987167906026047,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1359,GO:0002950,1,0.980250193763463,0,3,ceramide phosphoethanolamine synthase activity,MF,
1360,GO:0002951,1,0.988040061765055,0,2,leukotriene-C(4) hydrolase,MF,
1361,GO:0002953,1,0.995935366387734,0,1,5'-deoxynucleotidase activity,MF,
1366,GO:0003009,1,0.784693948969346,0,40,skeletal muscle contraction,BP,
1367,GO:0003010,1,0.968760179034979,0,5,voluntary skeletal muscle contraction,BP,
1368,GO:0003011,1,0.981558851214354,0,3,involuntary skeletal muscle contraction,BP,
1373,GO:0003016,1,0.816725344899595,0,31,respiratory system process,BP,
1374,GO:0003017,1,0.978234655339411,0,2,lymph circulation,BP,
1376,GO:0003025,1,0.977060178985895,0,3,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1377,GO:0003026,1,0.99325505912211,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1378,GO:0003027,1,0.99578140581474,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1379,GO:0003029,1,0.99578140581474,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1380,GO:0003032,1,0.987209663476445,0,2,detection of oxygen,BP,
1381,GO:0003044,1,0.785821999016032,0,41,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1382,GO:0003050,1,0.99216250195922,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1383,GO:0003051,1,0.986240975420233,0,2,angiotensin-mediated drinking behavior,BP,
1384,GO:0003056,1,0.948196681760674,0,7,regulation of vascular associated smooth muscle contraction,BP,
1385,GO:0003057,1,0.971882935200615,0,5,regulation of the force of heart contraction by chemical signal,BP,
1386,GO:0003058,1,0.996453316121395,0,1,hormonal regulation of the force of heart contraction,BP,
1387,GO:0003062,1,0.95940645896922,0,6,regulation of heart rate by chemical signal,BP,
1388,GO:0003064,1,0.988225147785372,0,2,regulation of heart rate by hormone,BP,
1389,GO:0003065,1,0.995596723704261,0,1,positive regulation of heart rate by epinephrine,BP,
1390,GO:0003068,1,0.996640898098766,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1391,GO:0003069,1,0.996640898098766,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1392,GO:0003070,1,0.996640898098766,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1394,GO:0003072,1,0.977831533275287,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1396,GO:0003081,1,0.891422283334942,0,20,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1397,GO:0003083,1,0.996808527066112,0,1,negative regulation of renal output by angiotensin,BP,
1398,GO:0003084,1,0.94039730937979,0,11,positive regulation of systemic arterial blood pressure,BP,
1399,GO:0003085,1,0.903123018569216,0,17,negative regulation of systemic arterial blood pressure,BP,
1400,GO:0003091,1,0.797560444609445,0,31,renal water homeostasis,BP,
1403,GO:0003095,1,0.995715233431222,0,1,pressure natriuresis,BP,
1404,GO:0003096,1,0.963131517395748,0,6,renal sodium ion transport,BP,
1405,GO:0003097,1,0.969117193070539,0,5,renal water transport,BP,
1406,GO:0003099,1,0.984279536352814,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1407,GO:0003100,1,0.966688534370653,0,6,regulation of systemic arterial blood pressure by endothelin,BP,
1409,GO:0003105,1,0.981867377431459,0,3,negative regulation of glomerular filtration,BP,
1410,GO:0003106,1,0.996808527066112,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1411,GO:0003127,1,0.982110794343191,0,2,detection of nodal flow,BP,
1413,GO:0003129,1,0.944851511660953,0,9,heart induction,BP,
1414,GO:0003130,1,0.988392623642642,0,2,BMP signaling pathway involved in heart induction,BP,
1415,GO:0003131,1,0.993149866754886,0,1,mesodermal-endodermal cell signaling,BP,
1416,GO:0003133,1,0.988392623642642,0,2,endodermal-mesodermal cell signaling,BP,
1417,GO:0003134,1,0.988392623642642,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1418,GO:0003137,1,0.972848191624468,0,4,Notch signaling pathway involved in heart induction,BP,
1419,GO:0003138,1,0.978544278759846,0,3,primary heart field specification,BP,
1421,GO:0003140,1,0.955917772555222,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1422,GO:0003142,1,0.994218906995635,0,1,cardiogenic plate morphogenesis,BP,
1423,GO:0003143,1,0.632595973064392,0,66,embryonic heart tube morphogenesis,BP,
1424,GO:0003147,1,0.996624313441655,0,1,neural crest cell migration involved in heart formation,BP,
1426,GO:0003149,1,0.944978174268357,0,9,membranous septum morphogenesis,BP,
1427,GO:0003150,1,0.964814595649961,0,5,muscular septum morphogenesis,BP,
1429,GO:0003156,1,0.795964066860728,0,36,regulation of animal organ formation,BP,
1430,GO:0003157,1,0.927023592434148,0,11,endocardium development,BP,
1432,GO:0003159,1,0.894591165996573,0,18,morphogenesis of an endothelium,BP,
1433,GO:0003160,1,0.963384907166995,0,6,endocardium morphogenesis,BP,
1435,GO:0003162,1,0.977001746077943,0,3,atrioventricular node development,BP,
1437,GO:0003164,1,0.968559447398375,0,5,His-Purkinje system development,BP,
1438,GO:0003165,1,0.987123595231555,0,2,Purkinje myocyte development,BP,
1439,GO:0003166,1,0.976583333321688,0,4,bundle of His development,BP,
1440,GO:0003167,1,0.99225310456162,0,1,atrioventricular bundle cell differentiation,BP,
1441,GO:0003168,1,0.995299683584611,0,1,Purkinje myocyte differentiation,BP,
1442,GO:0003169,1,0.982400573832989,0,2,coronary vein morphogenesis,BP,
1443,GO:0003170,1,0.644965324143202,0,58,heart valve development,BP,
1444,GO:0003171,1,0.833047272627296,0,24,atrioventricular valve development,BP,
1445,GO:0003172,1,0.991421871070426,0,1,sinoatrial valve development,BP,
1446,GO:0003174,1,0.925170107204665,0,10,mitral valve development,BP,
1447,GO:0003175,1,0.956098662435903,0,6,tricuspid valve development,BP,
1448,GO:0003176,1,0.798097935819943,0,32,aortic valve development,BP,
1449,GO:0003177,1,0.860715808873798,0,20,pulmonary valve development,BP,
1450,GO:0003178,1,0.989781107645331,0,1,coronary sinus valve development,BP,
1451,GO:0003179,1,0.689175660747755,0,49,heart valve morphogenesis,BP,
1452,GO:0003180,1,0.822830758700992,0,28,aortic valve morphogenesis,BP,
1453,GO:0003181,1,0.836429267989882,0,23,atrioventricular valve morphogenesis,BP,
1454,GO:0003182,1,0.989781107645331,0,1,coronary sinus valve morphogenesis,BP,
1455,GO:0003183,1,0.925170107204665,0,10,mitral valve morphogenesis,BP,
1456,GO:0003184,1,0.887368288974563,0,16,pulmonary valve morphogenesis,BP,
1457,GO:0003185,1,0.991421871070426,0,1,sinoatrial valve morphogenesis,BP,
1458,GO:0003186,1,0.959974749402965,0,5,tricuspid valve morphogenesis,BP,
1459,GO:0003188,1,0.920357550054744,0,12,heart valve formation,BP,
1460,GO:0003190,1,0.938662413425425,0,8,atrioventricular valve formation,BP,
1461,GO:0003192,1,0.97176360514089,0,3,mitral valve formation,BP,
1462,GO:0003193,1,0.995963984376661,0,1,pulmonary valve formation,BP,
1463,GO:0003195,1,0.986170390591882,0,2,tricuspid valve formation,BP,
1465,GO:0003198,1,0.894538478601901,0,17,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1466,GO:0003199,1,0.985448822933664,0,3,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1467,GO:0003203,1,0.783876113804049,0,35,endocardial cushion morphogenesis,BP,
1470,GO:0003207,1,0.92874802112824,0,11,cardiac chamber formation,BP,
1472,GO:0003209,1,0.822084566551847,0,26,cardiac atrium morphogenesis,BP,
1473,GO:0003210,1,0.996533556746551,0,1,cardiac atrium formation,BP,
1474,GO:0003211,1,0.93947375061866,0,9,cardiac ventricle formation,BP,
1475,GO:0003213,1,0.981550778932122,0,2,cardiac right atrium morphogenesis,BP,
1476,GO:0003214,1,0.908237940918752,0,13,cardiac left ventricle morphogenesis,BP,
1477,GO:0003215,1,0.879891981835755,0,18,cardiac right ventricle morphogenesis,BP,
1478,GO:0003218,1,0.992513428419899,0,1,cardiac left ventricle formation,BP,
1479,GO:0003219,1,0.979876677764827,0,3,cardiac right ventricle formation,BP,
1480,GO:0003220,1,0.976620716978332,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1481,GO:0003221,1,0.97701488948575,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1482,GO:0003222,1,0.883980474692455,0,16,ventricular trabecula myocardium morphogenesis,BP,
1484,GO:0003226,1,0.989190896352203,0,1,right ventricular compact myocardium morphogenesis,BP,
1485,GO:0003228,1,0.962119070499157,0,6,atrial cardiac muscle tissue development,BP,
1487,GO:0003230,1,0.784576847934346,0,32,cardiac atrium development,BP,
1489,GO:0003235,1,0.996533556746551,0,1,sinus venosus development,BP,
1490,GO:0003236,1,0.996533556746551,0,1,sinus venosus morphogenesis,BP,
1491,GO:0003241,1,0.975275497836068,0,4,growth involved in heart morphogenesis,BP,
1492,GO:0003245,1,0.988774077519348,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1493,GO:0003247,1,0.995896293794625,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1494,GO:0003249,1,0.968581333357024,0,3,cell proliferation involved in heart valve morphogenesis,BP,
1495,GO:0003250,1,0.968581333357024,0,3,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1496,GO:0003251,1,0.990068065470808,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1497,GO:0003252,1,0.978299903330763,0,2,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1498,GO:0003253,1,0.961900608850491,0,7,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1502,GO:0003259,1,0.996533556746551,0,1,cardioblast anterior-lateral migration,BP,
1503,GO:0003260,1,0.996533556746551,0,1,cardioblast migration,BP,
1504,GO:0003263,1,0.933958777039181,0,10,cardioblast proliferation,BP,
1505,GO:0003264,1,0.933958777039181,0,10,regulation of cardioblast proliferation,BP,
1506,GO:0003266,1,0.940193470650994,0,9,regulation of secondary heart field cardioblast proliferation,BP,
1507,GO:0003270,1,0.989781107645331,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1508,GO:0003271,1,0.994067958226944,0,1,smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1509,GO:0003272,1,0.848204023730944,0,24,endocardial cushion formation,BP,
1510,GO:0003273,1,0.96685573822262,0,4,cell migration involved in endocardial cushion formation,BP,
1511,GO:0003274,1,0.971206345481954,0,4,endocardial cushion fusion,BP,
1512,GO:0003275,1,0.980562321502192,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1513,GO:0003278,1,0.970261637372786,0,5,apoptotic process involved in heart morphogenesis,BP,
1516,GO:0003283,1,0.858300593496081,0,20,atrial septum development,BP,
1517,GO:0003284,1,0.970117547946473,0,4,septum primum development,BP,
1518,GO:0003285,1,0.987917733468061,0,2,septum secundum development,BP,
1519,GO:0003289,1,0.970117547946473,0,4,atrial septum primum morphogenesis,BP,
1520,GO:0003290,1,0.992583544005191,0,1,atrial septum secundum morphogenesis,BP,
1521,GO:0003292,1,0.987090042048373,0,2,cardiac septum cell differentiation,BP,
1522,GO:0003298,1,0.839646829558656,0,26,physiological muscle hypertrophy,BP,
1523,GO:0003299,1,0.85470469614632,0,21,muscle hypertrophy in response to stress,BP,
1524,GO:0003300,1,0.559437421656267,0,78,cardiac muscle hypertrophy,BP,
1525,GO:0003301,1,0.839646829558656,0,26,physiological cardiac muscle hypertrophy,BP,
1526,GO:0003306,1,0.937430465189176,0,10,Wnt signaling pathway involved in heart development,BP,
1527,GO:0003307,1,0.952102448990927,0,8,regulation of Wnt signaling pathway involved in heart development,BP,
1528,GO:0003308,1,0.957671869959212,0,7,negative regulation of Wnt signaling pathway involved in heart development,BP,
1529,GO:0003309,1,0.849893993168608,0,24,type B pancreatic cell differentiation,BP,
1530,GO:0003310,1,0.962063759958239,0,6,pancreatic A cell differentiation,BP,
1531,GO:0003312,1,0.988501624011433,0,2,pancreatic PP cell differentiation,BP,
1532,GO:0003318,1,0.996533556746551,0,1,cell migration to the midline involved in heart development,BP,
1533,GO:0003321,1,0.956651776938144,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1534,GO:0003322,1,0.991087852267484,0,1,pancreatic A cell development,BP,
1535,GO:0003323,1,0.87542372371689,0,20,type B pancreatic cell development,BP,
1536,GO:0003326,1,0.988501624011433,0,2,pancreatic A cell fate commitment,BP,
1537,GO:0003327,1,0.994924009284793,0,1,type B pancreatic cell fate commitment,BP,
1538,GO:0003329,1,0.988501624011433,0,2,pancreatic PP cell fate commitment,BP,
1539,GO:0003330,1,0.95131071386259,0,7,regulation of extracellular matrix constituent secretion,BP,
1540,GO:0003331,1,0.986947667696896,0,2,positive regulation of extracellular matrix constituent secretion,BP,
1541,GO:0003332,1,0.970444083912628,0,4,negative regulation of extracellular matrix constituent secretion,BP,
1542,GO:0003333,1,0.579313073701859,0,79,amino acid transmembrane transport,BP,
1543,GO:0003334,1,0.936517964294631,0,9,keratinocyte development,BP,
1544,GO:0003335,1,0.989519005007868,0,2,corneocyte development,BP,
1547,GO:0003339,1,0.953182931422778,0,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1548,GO:0003340,1,0.981919332207879,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1550,GO:0003342,1,0.988213209058072,0,2,proepicardium development,BP,
1551,GO:0003343,1,0.988213209058072,0,2,septum transversum development,BP,
1552,GO:0003344,1,0.931470482057732,0,9,pericardium morphogenesis,BP,
1553,GO:0003345,1,0.992483306425854,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1554,GO:0003348,1,0.957674950665265,0,6,cardiac endothelial cell differentiation,BP,
1555,GO:0003350,1,0.987384785155559,0,2,pulmonary myocardium development,BP,
1556,GO:0003351,1,0.831233817133263,0,27,epithelial cilium movement involved in extracellular fluid movement,BP,
1557,GO:0003352,1,0.857618435291358,0,25,regulation of cilium movement,BP,
1558,GO:0003353,1,0.948687756763776,0,10,positive regulation of cilium movement,BP,
1559,GO:0003354,1,0.995284192982024,0,1,negative regulation of cilium movement,BP,
1560,GO:0003356,1,0.921598151371077,0,11,regulation of cilium beat frequency,BP,
1561,GO:0003357,1,0.959988084480795,0,6,noradrenergic neuron differentiation,BP,
1562,GO:0003358,1,0.987100448164253,0,2,noradrenergic neuron development,BP,
1563,GO:0003359,1,0.993898281598366,0,1,noradrenergic neuron fate commitment,BP,
1564,GO:0003360,1,0.955461324899509,0,6,brainstem development,BP,
1565,GO:0003365,1,0.973505536384084,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1566,GO:0003366,1,0.984826968619471,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1567,GO:0003373,1,0.940089350180412,0,8,dynamin family protein polymerization involved in membrane fission,BP,
1568,GO:0003374,1,0.940089350180412,0,8,dynamin family protein polymerization involved in mitochondrial fission,BP,
1569,GO:0003376,1,0.939102657989629,0,10,sphingosine-1-phosphate receptor signaling pathway,BP,
1570,GO:0003382,1,0.785766737983432,0,32,epithelial cell morphogenesis,BP,
1571,GO:0003383,1,0.965848886886703,0,4,apical constriction,BP,
1572,GO:0003400,1,0.974404950177239,0,4,regulation of COPII vesicle coating,BP,
1573,GO:0003401,1,0.821532641280036,0,28,axis elongation,BP,
1574,GO:0003402,1,0.958251716186313,0,6,planar cell polarity pathway involved in axis elongation,BP,
1575,GO:0003404,1,0.986473686483327,0,2,optic vesicle morphogenesis,BP,
1576,GO:0003406,1,0.966119790608246,0,5,retinal pigment epithelium development,BP,
1577,GO:0003407,1,0.616312598144061,0,67,neural retina development,BP,
1578,GO:0003408,1,0.975137228271817,0,3,optic cup formation involved in camera-type eye development,BP,
1579,GO:0003409,1,0.99263850100107,0,1,optic cup structural organization,BP,
1580,GO:0003413,1,0.907604032424705,0,14,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1581,GO:0003414,1,0.992487864654582,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1582,GO:0003415,1,0.963697359425131,0,5,chondrocyte hypertrophy,BP,
1584,GO:0003417,1,0.880435731427407,0,19,growth plate cartilage development,BP,
1585,GO:0003418,1,0.940666250711364,0,9,growth plate cartilage chondrocyte differentiation,BP,
1586,GO:0003419,1,0.980248257004483,0,4,growth plate cartilage chondrocyte proliferation,BP,
1587,GO:0003420,1,0.986787299893913,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1588,GO:0003421,1,0.992482927498219,0,1,growth plate cartilage axis specification,BP,
1589,GO:0003422,1,0.985026690046686,0,2,growth plate cartilage morphogenesis,BP,
1590,GO:0003429,1,0.992487864654582,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1591,GO:0003430,1,0.978068519071764,0,3,growth plate cartilage chondrocyte growth,BP,
1592,GO:0003431,1,0.964800229198923,0,5,growth plate cartilage chondrocyte development,BP,
1593,GO:0003433,1,0.944748892152884,0,8,chondrocyte development involved in endochondral bone morphogenesis,BP,
1597,GO:0003678,1,0.582423598058971,0,73,DNA helicase activity,MF,
1598,GO:0003680,1,0.954491574614303,0,7,minor groove of adenine-thymine-rich DNA binding,MF,
1599,GO:0003681,1,0.992795776023984,0,1,bent DNA binding,MF,
1601,GO:0003684,1,0.657066451050102,0,63,damaged DNA binding,MF,
1602,GO:0003688,1,0.853072194400037,0,23,DNA replication origin binding,MF,
1603,GO:0003689,1,0.948656233205234,0,9,DNA clamp loader activity,MF,
1605,GO:0003691,1,0.943139865506631,0,9,double-stranded telomeric DNA binding,MF,
1606,GO:0003692,1,0.994636825739799,0,1,left-handed Z-DNA binding,MF,
1607,GO:0003696,1,0.973044282562831,0,4,satellite DNA binding,MF,
1608,GO:0003697,1,0.500931285473141,0,104,single-stranded DNA binding,MF,
1610,GO:0003707,1,0.827052573714153,0,25,steroid hormone receptor activity,MF,
1611,GO:0003711,1,0.985039633000778,0,2,transcription elongation regulator activity,MF,
1612,GO:0003712,1,0.0428428098057155,0,464,transcription coregulator activity,MF,
1613,GO:0003713,1,0.181415781344522,0,253,transcription coactivator activity,MF,
1614,GO:0003714,1,0.288856378403181,0,181,transcription corepressor activity,MF,
1615,GO:0003720,1,0.957273766374021,0,6,telomerase activity,MF,
1616,GO:0003721,1,0.992468032218389,0,1,telomerase RNA reverse transcriptase activity,MF,
1618,GO:0003724,1,0.600826730373159,0,72,RNA helicase activity,MF,
1619,GO:0003725,1,0.591273523228509,0,75,double-stranded RNA binding,MF,
1620,GO:0003726,1,0.970912878217485,0,4,double-stranded RNA adenosine deaminase activity,MF,
1621,GO:0003727,1,0.587199798776222,0,81,single-stranded RNA binding,MF,
1622,GO:0003729,1,0.159976417762071,0,274,mRNA binding,MF,
1623,GO:0003730,1,0.550080663698767,0,86,mRNA 3'-UTR binding,MF,
1625,GO:0003743,1,0.750882163055678,0,49,translation initiation factor activity,MF,
1626,GO:0003746,1,0.903448673043313,0,17,translation elongation factor activity,MF,
1627,GO:0003747,1,0.960310087230731,0,6,translation release factor activity,MF,
1628,GO:0003755,1,0.85838726166984,0,30,peptidyl-prolyl cis-trans isomerase activity,MF,
1629,GO:0003756,1,0.903794430397119,0,16,protein disulfide isomerase activity,MF,
1634,GO:0003796,1,0.992777198310996,0,2,lysozyme activity,MF,
1635,GO:0003810,1,0.953330913307193,0,7,protein-glutamine gamma-glutamyltransferase activity,MF,
1636,GO:0003823,1,0.760078567930277,0,52,antigen binding,MF,
1638,GO:0003826,1,0.98917790416258,0,2,alpha-ketoacid dehydrogenase activity,MF,
1639,GO:0003827,1,0.993006718779402,0,1,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1640,GO:0003828,1,0.953897015361806,0,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1641,GO:0003829,1,0.984459936694107,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1642,GO:0003830,1,0.99213064359094,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1643,GO:0003831,1,0.970866538073174,0,5,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1644,GO:0003834,1,0.986402667512831,0,2,beta-carotene 15,15'-monooxygenase activity,MF,
1645,GO:0003835,1,0.983631232794796,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1646,GO:0003836,1,0.979290980800367,0,3,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1647,GO:0003837,1,0.994929099003046,0,1,beta-ureidopropionase activity,MF,
1648,GO:0003839,1,0.989124482108885,0,3,gamma-glutamylcyclotransferase activity,MF,
1649,GO:0003841,1,0.905178933520446,0,14,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1650,GO:0003842,1,0.992670032423096,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1651,GO:0003844,1,0.992784167791999,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1652,GO:0003845,1,0.991664750417756,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1653,GO:0003846,1,0.986492089887953,0,2,2-acylglycerol O-acyltransferase activity,MF,
1654,GO:0003847,1,0.96621242098635,0,7,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1656,GO:0003854,1,0.98393263792693,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1657,GO:0003857,1,0.958863772440236,0,8,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1658,GO:0003858,1,0.985643885195816,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1659,GO:0003860,1,0.995279414301012,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1660,GO:0003863,1,0.98917790416258,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1661,GO:0003865,1,0.987943447199859,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1662,GO:0003867,1,0.992180852490147,0,1,4-aminobutyrate transaminase activity,MF,
1663,GO:0003868,1,0.995839436360958,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1664,GO:0003870,1,0.989302892711491,0,2,5-aminolevulinate synthase activity,MF,
1665,GO:0003872,1,0.979101656808645,0,3,6-phosphofructokinase activity,MF,
1666,GO:0003873,1,0.972890054719702,0,4,6-phosphofructo-2-kinase activity,MF,
1667,GO:0003874,1,0.996698971982734,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1668,GO:0003875,1,0.988202301170524,0,2,ADP-ribosylarginine hydrolase activity,MF,
1669,GO:0003876,1,0.984953721008785,0,2,AMP deaminase activity,MF,
1670,GO:0003878,1,0.992394543485971,0,1,ATP citrate synthase activity,MF,
1671,GO:0003880,1,0.988652778666709,0,2,protein C-terminal carboxyl O-methyltransferase activity,MF,
1672,GO:0003881,1,0.995409751658864,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1673,GO:0003882,1,0.993954672973478,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1674,GO:0003883,1,0.98578032418728,0,2,CTP synthase activity,MF,
1675,GO:0003884,1,0.991907776039247,0,2,D-amino-acid oxidase activity,MF,
1676,GO:0003886,1,0.976993359383724,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1677,GO:0003887,1,0.854811870962724,0,23,DNA-directed DNA polymerase activity,MF,
1678,GO:0003896,1,0.983877400253409,0,3,DNA primase activity,MF,
1679,GO:0003899,1,0.81370489059393,0,37,DNA-directed 5'-3' RNA polymerase activity,MF,
1680,GO:0003905,1,0.996593694428561,0,1,alkylbase DNA N-glycosylase activity,MF,
1681,GO:0003906,1,0.93691544286009,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1682,GO:0003908,1,0.996426940711074,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1683,GO:0003909,1,0.978001398461583,0,3,DNA ligase activity,MF,
1684,GO:0003910,1,0.978001398461583,0,3,DNA ligase (ATP) activity,MF,
1685,GO:0003912,1,0.995001289863616,0,1,DNA nucleotidylexotransferase activity,MF,
1686,GO:0003916,1,0.957574381786899,0,6,DNA topoisomerase activity,MF,
1687,GO:0003917,1,0.973302325455859,0,4,DNA topoisomerase type I (single strand cut, ATP-independent) activity,MF,
1688,GO:0003918,1,0.983845060724126,0,2,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity,MF,
1689,GO:0003919,1,0.995175350268869,0,1,FMN adenylyltransferase activity,MF,
1690,GO:0003920,1,0.991507533416697,0,2,GMP reductase activity,MF,
1691,GO:0003921,1,0.993920271747399,0,1,GMP synthase activity,MF,
1692,GO:0003922,1,0.993920271747399,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1693,GO:0003923,1,0.980421314514434,0,3,GPI-anchor transamidase activity,MF,
1695,GO:0003933,1,0.995221633881734,0,1,GTP cyclohydrolase activity,MF,
1696,GO:0003934,1,0.995221633881734,0,1,GTP cyclohydrolase I activity,MF,
1697,GO:0003937,1,0.994860156566715,0,1,IMP cyclohydrolase activity,MF,
1698,GO:0003938,1,0.989620134104431,0,2,IMP dehydrogenase activity,MF,
1699,GO:0003939,1,0.993766247491235,0,1,L-iditol 2-dehydrogenase activity,MF,
1700,GO:0003940,1,0.9946121621616,0,1,L-iduronidase activity,MF,
1701,GO:0003941,1,0.986164136681285,0,3,L-serine ammonia-lyase activity,MF,
1702,GO:0003943,1,0.986648836146454,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1703,GO:0003944,1,0.994578394712497,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1704,GO:0003945,1,0.969482993630273,0,5,N-acetyllactosamine synthase activity,MF,
1705,GO:0003947,1,0.992883906071983,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1706,GO:0003948,1,0.994883190736215,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1707,GO:0003950,1,0.86824220774092,0,22,NAD+ ADP-ribosyltransferase activity,MF,
1708,GO:0003951,1,0.887417524697496,0,16,NAD+ kinase activity,MF,
1709,GO:0003952,1,0.993971958673624,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1710,GO:0003953,1,0.896926048849079,0,16,NAD+ nucleosidase activity,MF,
1711,GO:0003954,1,0.867976398849833,0,38,NADH dehydrogenase activity,MF,
1712,GO:0003955,1,0.983069855779416,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1713,GO:0003956,1,0.98830331797796,0,3,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1714,GO:0003957,1,0.992285327488383,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1715,GO:0003958,1,0.956755172630101,0,6,NADPH-hemoprotein reductase activity,MF,
1716,GO:0003960,1,0.981801522171237,0,4,NADPH:quinone reductase activity,MF,
1717,GO:0003963,1,0.99325505912211,0,1,RNA-3'-phosphate cyclase activity,MF,
1718,GO:0003964,1,0.957273766374021,0,6,RNA-directed DNA polymerase activity,MF,
1719,GO:0003968,1,0.983784231957533,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1720,GO:0003972,1,0.99325505912211,0,1,RNA ligase (ATP) activity,MF,
1721,GO:0003973,1,0.983287304106688,0,3,(S)-2-hydroxy-acid oxidase activity,MF,
1722,GO:0003974,1,0.995940613199915,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1723,GO:0003975,1,0.994739160911841,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1724,GO:0003976,1,0.983075893918119,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1725,GO:0003977,1,0.986902040034855,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1726,GO:0003978,1,0.995940613199915,0,1,UDP-glucose 4-epimerase activity,MF,
1727,GO:0003979,1,0.992709890636222,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1728,GO:0003980,1,0.981229265076032,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1729,GO:0003983,1,0.994741745539943,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1730,GO:0003984,1,0.994319118502194,0,1,acetolactate synthase activity,MF,
1731,GO:0003985,1,0.979061564793796,0,4,acetyl-CoA C-acetyltransferase activity,MF,
1732,GO:0003986,1,0.979456922128006,0,5,acetyl-CoA hydrolase activity,MF,
1733,GO:0003987,1,0.978279310460011,0,3,acetate-CoA ligase activity,MF,
1734,GO:0003988,1,0.965763552533002,0,7,acetyl-CoA C-acyltransferase activity,MF,
1735,GO:0003989,1,0.989796212033453,0,1,acetyl-CoA carboxylase activity,MF,
1736,GO:0003990,1,0.987658928828224,0,2,acetylcholinesterase activity,MF,
1737,GO:0003993,1,0.973967568795314,0,6,acid phosphatase activity,MF,
1738,GO:0003994,1,0.977362698397944,0,3,aconitate hydratase activity,MF,
1739,GO:0003995,1,0.932183693542953,0,11,acyl-CoA dehydrogenase activity,MF,
1740,GO:0003996,1,0.918202653709645,0,13,acyl-CoA ligase activity,MF,
1741,GO:0003997,1,0.961300916698079,0,6,acyl-CoA oxidase activity,MF,
1742,GO:0003998,1,0.993307791751539,0,2,acylphosphatase activity,MF,
1743,GO:0003999,1,0.996791317160635,0,1,adenine phosphoribosyltransferase activity,MF,
1744,GO:0004000,1,0.936241117616499,0,10,adenosine deaminase activity,MF,
1745,GO:0004001,1,0.994969707860412,0,1,adenosine kinase activity,MF,
1746,GO:0004013,1,0.994357853524939,0,1,adenosylhomocysteinase activity,MF,
1747,GO:0004014,1,0.992661093381669,0,1,adenosylmethionine decarboxylase activity,MF,
1748,GO:0004016,1,0.918169136723153,0,10,adenylate cyclase activity,MF,
1749,GO:0004017,1,0.941076645537939,0,9,adenylate kinase activity,MF,
1750,GO:0004018,1,0.996154252202172,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1751,GO:0004020,1,0.986253473914406,0,2,adenylylsulfate kinase activity,MF,
1752,GO:0004021,1,0.987882749442014,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1753,GO:0004022,1,0.973213144302484,0,5,alcohol dehydrogenase (NAD+) activity,MF,
1754,GO:0004024,1,0.982182964236316,0,3,alcohol dehydrogenase activity, zinc-dependent,MF,
1755,GO:0004027,1,0.996466619956246,0,1,alcohol sulfotransferase activity,MF,
1756,GO:0004028,1,0.974179364527957,0,4,3-chloroallyl aldehyde dehydrogenase activity,MF,
1757,GO:0004029,1,0.908384768732657,0,14,aldehyde dehydrogenase (NAD+) activity,MF,
1758,GO:0004030,1,0.903978879329723,0,15,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1759,GO:0004031,1,0.9860413935459,0,2,aldehyde oxidase activity,MF,
1760,GO:0004032,1,0.95791549794718,0,11,alditol:NADP+ 1-oxidoreductase activity,MF,
1761,GO:0004033,1,0.891597558074507,0,25,aldo-keto reductase (NADP) activity,MF,
1762,GO:0004034,1,0.993873967922025,0,1,aldose 1-epimerase activity,MF,
1763,GO:0004035,1,0.986765728805568,0,2,alkaline phosphatase activity,MF,
1764,GO:0004037,1,0.996198903304679,0,1,allantoicase activity,MF,
1765,GO:0004040,1,0.991166692956274,0,2,amidase activity,MF,
1766,GO:0004042,1,0.994924009284793,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1767,GO:0004043,1,0.992532143845806,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1768,GO:0004044,1,0.99249782931365,0,1,amidophosphoribosyltransferase activity,MF,
1769,GO:0004045,1,0.986837995652802,0,3,aminoacyl-tRNA hydrolase activity,MF,
1770,GO:0004046,1,0.983326593291343,0,4,aminoacylase activity,MF,
1771,GO:0004047,1,0.991062157905317,0,2,aminomethyltransferase activity,MF,
1772,GO:0004051,1,0.993696128496363,0,1,arachidonate 5-lipoxygenase activity,MF,
1773,GO:0004052,1,0.981505966676354,0,3,arachidonate 12(S)-lipoxygenase activity,MF,
1774,GO:0004053,1,0.991370229159407,0,2,arginase activity,MF,
1775,GO:0004055,1,0.995517150892817,0,1,argininosuccinate synthase activity,MF,
1776,GO:0004056,1,0.995124919208781,0,1,argininosuccinate lyase activity,MF,
1777,GO:0004057,1,0.994557609039283,0,1,arginyltransferase activity,MF,
1778,GO:0004058,1,0.995056536444386,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1779,GO:0004059,1,0.9961703117629,0,1,aralkylamine N-acetyltransferase activity,MF,
1780,GO:0004060,1,0.987657861292751,0,3,arylamine N-acetyltransferase activity,MF,
1781,GO:0004061,1,0.995786241327855,0,1,arylformamidase activity,MF,
1782,GO:0004062,1,0.981415480554369,0,5,aryl sulfotransferase activity,MF,
1783,GO:0004063,1,0.992187532552697,0,2,aryldialkylphosphatase activity,MF,
1784,GO:0004064,1,0.973870755547557,0,6,arylesterase activity,MF,
1785,GO:0004065,1,0.919105183854102,0,12,arylsulfatase activity,MF,
1786,GO:0004066,1,0.98820525438222,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1787,GO:0004067,1,0.989610662440251,0,2,asparaginase activity,MF,
1788,GO:0004068,1,0.993376889315338,0,1,aspartate 1-decarboxylase activity,MF,
1789,GO:0004069,1,0.988761358705304,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1790,GO:0004070,1,0.990949215284694,0,1,aspartate carbamoyltransferase activity,MF,
1791,GO:0004074,1,0.993350763014972,0,2,biliverdin reductase (NAD(P)+) activity,MF,
1792,GO:0004075,1,0.993724002223076,0,1,biotin carboxylase activity,MF,
1793,GO:0004077,1,0.991583341144231,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1794,GO:0004078,1,0.991583341144231,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1795,GO:0004079,1,0.991583341144231,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1796,GO:0004080,1,0.991583341144231,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1797,GO:0004081,1,0.996664748998817,0,1,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1798,GO:0004082,1,0.983668011598906,0,4,bisphosphoglycerate mutase activity,MF,
1799,GO:0004084,1,0.986303815855716,0,2,branched-chain-amino-acid transaminase activity,MF,
1800,GO:0004085,1,0.987640529998262,0,2,butyryl-CoA dehydrogenase activity,MF,
1801,GO:0004087,1,0.991733095611559,0,1,carbamoyl-phosphate synthase (ammonia) activity,MF,
1802,GO:0004088,1,0.982756377191274,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1803,GO:0004089,1,0.930926222626583,0,14,carbonate dehydratase activity,MF,
1804,GO:0004090,1,0.982130020086304,0,5,carbonyl reductase (NADPH) activity,MF,
1805,GO:0004092,1,0.993159159769417,0,1,carnitine O-acetyltransferase activity,MF,
1806,GO:0004095,1,0.972205757395953,0,4,carnitine O-palmitoyltransferase activity,MF,
1807,GO:0004096,1,0.979102805215157,0,4,catalase activity,MF,
1808,GO:0004098,1,0.995339899012944,0,1,cerebroside-sulfatase activity,MF,
1809,GO:0004102,1,0.993912930582986,0,1,choline O-acetyltransferase activity,MF,
1810,GO:0004103,1,0.989328651027593,0,2,choline kinase activity,MF,
1811,GO:0004104,1,0.981139748226141,0,3,cholinesterase activity,MF,
1812,GO:0004105,1,0.987905033285606,0,2,choline-phosphate cytidylyltransferase activity,MF,
1813,GO:0004108,1,0.992925192127658,0,1,citrate (Si)-synthase activity,MF,
1814,GO:0004109,1,0.987239497750666,0,2,coproporphyrinogen oxidase activity,MF,
1815,GO:0004111,1,0.970906717675855,0,6,creatine kinase activity,MF,
1816,GO:0004112,1,0.841165161615127,0,23,cyclic-nucleotide phosphodiesterase activity,MF,
1817,GO:0004113,1,0.992029750685434,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1818,GO:0004114,1,0.853702174777471,0,21,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1819,GO:0004115,1,0.910009700538553,0,12,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1820,GO:0004117,1,0.9806766188943,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1821,GO:0004118,1,0.973458202117477,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1822,GO:0004119,1,0.98404717114225,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1823,GO:0004122,1,0.993598293270506,0,1,cystathionine beta-synthase activity,MF,
1824,GO:0004123,1,0.995691921465553,0,1,cystathionine gamma-lyase activity,MF,
1825,GO:0004126,1,0.951667731500622,0,10,cytidine deaminase activity,MF,
1826,GO:0004127,1,0.973022930863758,0,4,cytidylate kinase activity,MF,
1827,GO:0004128,1,0.96046975348683,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1828,GO:0004129,1,0.925378650358037,0,21,cytochrome-c oxidase activity,MF,
1829,GO:0004132,1,0.99503148018924,0,1,dCMP deaminase activity,MF,
1830,GO:0004133,1,0.990913874641184,0,1,glycogen debranching enzyme activity,MF,
1831,GO:0004134,1,0.990913874641184,0,1,4-alpha-glucanotransferase activity,MF,
1832,GO:0004135,1,0.990913874641184,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1833,GO:0004136,1,0.990262109657045,0,2,deoxyadenosine kinase activity,MF,
1834,GO:0004137,1,0.98575770016361,0,2,deoxycytidine kinase activity,MF,
1835,GO:0004138,1,0.990262109657045,0,2,deoxyguanosine kinase activity,MF,
1836,GO:0004139,1,0.995727274618538,0,1,deoxyribose-phosphate aldolase activity,MF,
1837,GO:0004140,1,0.98937037858482,0,2,dephospho-CoA kinase activity,MF,
1838,GO:0004142,1,0.982945315817053,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1839,GO:0004143,1,0.924329837815694,0,10,diacylglycerol kinase activity,MF,
1840,GO:0004144,1,0.986492089887953,0,2,diacylglycerol O-acyltransferase activity,MF,
1841,GO:0004145,1,0.985529115954952,0,3,diamine N-acetyltransferase activity,MF,
1842,GO:0004146,1,0.992478368997756,0,1,dihydrofolate reductase activity,MF,
1843,GO:0004148,1,0.992526557870833,0,1,dihydrolipoyl dehydrogenase activity,MF,
1844,GO:0004149,1,0.993111170536567,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1845,GO:0004151,1,0.990949215284694,0,1,dihydroorotase activity,MF,
1846,GO:0004152,1,0.994934185789107,0,1,dihydroorotate dehydrogenase activity,MF,
1847,GO:0004155,1,0.995872708604307,0,1,6,7-dihydropteridine reductase activity,MF,
1848,GO:0004157,1,0.994785623340246,0,1,dihydropyrimidinase activity,MF,
1849,GO:0004161,1,0.989349687133149,0,2,dimethylallyltranstransferase activity,MF,
1850,GO:0004163,1,0.995575194569266,0,1,diphosphomevalonate decarboxylase activity,MF,
1851,GO:0004164,1,0.995592434734726,0,1,diphthine synthase activity,MF,
1852,GO:0004165,1,0.979134328815234,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1853,GO:0004167,1,0.98792082845489,0,3,dopachrome isomerase activity,MF,
1854,GO:0004168,1,0.994599176567197,0,1,dolichol kinase activity,MF,
1855,GO:0004169,1,0.942131571541273,0,9,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1856,GO:0004170,1,0.995412054318856,0,1,dUTP diphosphatase activity,MF,
1857,GO:0004174,1,0.986915321135593,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1859,GO:0004176,1,0.968754462516283,0,5,ATP-dependent peptidase activity,MF,
1863,GO:0004185,1,0.970846596740393,0,5,serine-type carboxypeptidase activity,MF,
1864,GO:0004190,1,0.899576706530558,0,18,aspartic-type endopeptidase activity,MF,
1869,GO:0004298,1,0.937859777876682,0,18,threonine-type endopeptidase activity,MF,
1870,GO:0004300,1,0.947379957459193,0,10,enoyl-CoA hydratase activity,MF,
1871,GO:0004301,1,0.971461025204064,0,6,epoxide hydrolase activity,MF,
1872,GO:0004303,1,0.951372022813581,0,11,estradiol 17-beta-dehydrogenase activity,MF,
1873,GO:0004304,1,0.995613794103254,0,1,estrone sulfotransferase activity,MF,
1874,GO:0004305,1,0.975567716770624,0,4,ethanolamine kinase activity,MF,
1875,GO:0004306,1,0.995446385642235,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1876,GO:0004307,1,0.991119206413906,0,2,ethanolaminephosphotransferase activity,MF,
1877,GO:0004308,1,0.982543380566682,0,3,exo-alpha-sialidase activity,MF,
1878,GO:0004309,1,0.968778516507387,0,4,exopolyphosphatase activity,MF,
1879,GO:0004310,1,0.994834506269511,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1880,GO:0004311,1,0.981036059342672,0,3,farnesyltranstransferase activity,MF,
1881,GO:0004312,1,0.938768920193808,0,10,fatty acid synthase activity,MF,
1882,GO:0004313,1,0.990217175383171,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1883,GO:0004314,1,0.985497066803585,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1884,GO:0004315,1,0.986666892281735,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1885,GO:0004316,1,0.990217175383171,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1886,GO:0004317,1,0.990217175383171,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1887,GO:0004320,1,0.985923325248151,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1888,GO:0004321,1,0.977550706492571,0,4,fatty-acyl-CoA synthase activity,MF,
1889,GO:0004322,1,0.960800234260021,0,6,ferroxidase activity,MF,
1890,GO:0004324,1,0.995353986230992,0,1,ferredoxin-NADP+ reductase activity,MF,
1891,GO:0004325,1,0.990878595204199,0,1,ferrochelatase activity,MF,
1892,GO:0004326,1,0.993857025940025,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1893,GO:0004329,1,0.985134085757825,0,2,formate-tetrahydrofolate ligase activity,MF,
1894,GO:0004331,1,0.972890054719702,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1895,GO:0004332,1,0.986004906447971,0,3,fructose-bisphosphate aldolase activity,MF,
1896,GO:0004333,1,0.995592434734726,0,1,fumarate hydratase activity,MF,
1897,GO:0004334,1,0.996188984971283,0,1,fumarylacetoacetase activity,MF,
1898,GO:0004335,1,0.98907083828419,0,2,galactokinase activity,MF,
1899,GO:0004336,1,0.98886162292731,0,2,galactosylceramidase activity,MF,
1900,GO:0004337,1,0.989349687133149,0,2,geranyltranstransferase activity,MF,
1901,GO:0004339,1,0.991294757848014,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1902,GO:0004340,1,0.963017193552564,0,5,glucokinase activity,MF,
1903,GO:0004341,1,0.995284192982024,0,1,gluconolactonase activity,MF,
1904,GO:0004342,1,0.989680796658737,0,2,glucosamine-6-phosphate deaminase activity,MF,
1905,GO:0004343,1,0.992477266986897,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1906,GO:0004344,1,0.989890759836311,0,1,glucose dehydrogenase activity,MF,
1907,GO:0004345,1,0.984181458545355,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1908,GO:0004346,1,0.981682067438135,0,3,glucose-6-phosphatase activity,MF,
1909,GO:0004347,1,0.994885746935087,0,1,glucose-6-phosphate isomerase activity,MF,
1910,GO:0004348,1,0.982500164405991,0,3,glucosylceramidase activity,MF,
1911,GO:0004349,1,0.992559612793362,0,1,glutamate 5-kinase activity,MF,
1912,GO:0004350,1,0.992559612793362,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1913,GO:0004351,1,0.987725018207371,0,2,glutamate decarboxylase activity,MF,
1914,GO:0004352,1,0.986860287047165,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1915,GO:0004353,1,0.986860287047165,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1916,GO:0004356,1,0.992392971185947,0,1,glutamate-ammonia ligase activity,MF,
1917,GO:0004357,1,0.985372081326104,0,2,glutamate-cysteine ligase activity,MF,
1918,GO:0004359,1,0.980026907904169,0,3,glutaminase activity,MF,
1919,GO:0004360,1,0.983075200862996,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1920,GO:0004361,1,0.995757015106155,0,1,glutaryl-CoA dehydrogenase activity,MF,
1921,GO:0004362,1,0.994414807010626,0,1,glutathione-disulfide reductase activity,MF,
1922,GO:0004363,1,0.995332834261692,0,1,glutathione synthase activity,MF,
1923,GO:0004364,1,0.924274716558601,0,20,glutathione transferase activity,MF,
1924,GO:0004365,1,0.996372155485022,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1925,GO:0004366,1,0.984561848787981,0,2,glycerol-3-phosphate O-acyltransferase activity,MF,
1928,GO:0004370,1,0.981826646027975,0,2,glycerol kinase activity,MF,
1929,GO:0004372,1,0.98845812519745,0,2,glycine hydroxymethyltransferase activity,MF,
1930,GO:0004373,1,0.985378354531576,0,2,glycogen (starch) synthase activity,MF,
1931,GO:0004375,1,0.992488314549241,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1932,GO:0004376,1,0.968353358367727,0,5,glycolipid mannosyltransferase activity,MF,
1933,GO:0004377,1,0.993752109198549,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1934,GO:0004378,1,0.993028291962859,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1935,GO:0004379,1,0.984391524669062,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1936,GO:0004380,1,0.995995379654577,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1937,GO:0004381,1,0.995995379654577,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1938,GO:0004382,1,0.987558943984534,0,2,guanosine-diphosphatase activity,MF,
1939,GO:0004383,1,0.970798540873648,0,4,guanylate cyclase activity,MF,
1940,GO:0004385,1,0.936030712485942,0,9,guanylate kinase activity,MF,
1941,GO:0004386,1,0.324351179570844,0,152,helicase activity,MF,
1942,GO:0004392,1,0.991760225711119,0,2,heme oxygenase (decyclizing) activity,MF,
1943,GO:0004394,1,0.992441359044244,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1944,GO:0004395,1,0.996425863818555,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1945,GO:0004396,1,0.963017193552564,0,5,hexokinase activity,MF,
1946,GO:0004397,1,0.992743399714276,0,1,histidine ammonia-lyase activity,MF,
1947,GO:0004398,1,0.994054153807096,0,1,histidine decarboxylase activity,MF,
1948,GO:0004402,1,0.708884604876004,0,48,histone acetyltransferase activity,MF,
1949,GO:0004407,1,0.842930417707975,0,25,histone deacetylase activity,MF,
1950,GO:0004408,1,0.994368197260601,0,1,holocytochrome-c synthase activity,MF,
1951,GO:0004411,1,0.99528299885192,0,1,homogentisate 1,2-dioxygenase activity,MF,
1952,GO:0004415,1,0.972595038974209,0,5,hyalurononglucosaminidase activity,MF,
1953,GO:0004416,1,0.988965878979068,0,2,hydroxyacylglutathione hydrolase activity,MF,
1954,GO:0004418,1,0.9961703117629,0,1,hydroxymethylbilane synthase activity,MF,
1955,GO:0004419,1,0.989934110889434,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1956,GO:0004420,1,0.992345568117987,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1957,GO:0004421,1,0.986664364737054,0,2,hydroxymethylglutaryl-CoA synthase activity,MF,
1958,GO:0004422,1,0.996243042055326,0,1,hypoxanthine phosphoribosyltransferase activity,MF,
1959,GO:0004423,1,0.991699878654734,0,1,iduronate-2-sulfatase activity,MF,
1960,GO:0004427,1,0.988296596032948,0,3,inorganic diphosphatase activity,MF,
1961,GO:0004430,1,0.970039540085665,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1963,GO:0004438,1,0.875948378937871,0,17,phosphatidylinositol-3-phosphatase activity,MF,
1964,GO:0004439,1,0.934169973767441,0,9,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1965,GO:0004441,1,0.994876797432958,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1966,GO:0004445,1,0.957773636086386,0,6,inositol-polyphosphate 5-phosphatase activity,MF,
1967,GO:0004446,1,0.99311926768676,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1968,GO:0004447,1,0.992954783882042,0,1,iodide peroxidase activity,MF,
1969,GO:0004448,1,0.975694226092086,0,5,isocitrate dehydrogenase activity,MF,
1970,GO:0004449,1,0.985563322457113,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1971,GO:0004450,1,0.98998782076827,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1972,GO:0004452,1,0.994767570572313,0,1,isopentenyl-diphosphate delta-isomerase activity,MF,
1973,GO:0004454,1,0.994036626157236,0,1,ketohexokinase activity,MF,
1974,GO:0004457,1,0.977128401298596,0,5,lactate dehydrogenase activity,MF,
1975,GO:0004458,1,0.995013884957315,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
1976,GO:0004459,1,0.982025800943194,0,4,L-lactate dehydrogenase activity,MF,
1977,GO:0004461,1,0.984156457169145,0,3,lactose synthase activity,MF,
1978,GO:0004462,1,0.994994984081702,0,1,lactoylglutathione lyase activity,MF,
1979,GO:0004463,1,0.994921463338489,0,1,leukotriene-A4 hydrolase activity,MF,
1980,GO:0004464,1,0.983538167661502,0,5,leukotriene-C4 synthase activity,MF,
1981,GO:0004465,1,0.975014338338213,0,4,lipoprotein lipase activity,MF,
1982,GO:0004466,1,0.974672157795478,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
1983,GO:0004467,1,0.913765210956274,0,13,long-chain fatty acid-CoA ligase activity,MF,
1984,GO:0004468,1,0.968514048711976,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1985,GO:0004470,1,0.976043694494058,0,4,malic enzyme activity,MF,
1986,GO:0004471,1,0.979551850172891,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1987,GO:0004473,1,0.979551850172891,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1988,GO:0004474,1,0.991722215232139,0,1,malate synthase activity,MF,
1989,GO:0004475,1,0.995954509983753,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1990,GO:0004476,1,0.995630725828587,0,1,mannose-6-phosphate isomerase activity,MF,
1991,GO:0004477,1,0.981356367210935,0,3,methenyltetrahydrofolate cyclohydrolase activity,MF,
1992,GO:0004478,1,0.985797575898651,0,2,methionine adenosyltransferase activity,MF,
1993,GO:0004479,1,0.993292626999948,0,1,methionyl-tRNA formyltransferase activity,MF,
1994,GO:0004482,1,0.991473101845741,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
1995,GO:0004483,1,0.986555151512788,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
1996,GO:0004484,1,0.992359367347971,0,1,mRNA guanylyltransferase activity,MF,
1997,GO:0004485,1,0.986278191394225,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
1998,GO:0004486,1,0.981356367210935,0,3,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
1999,GO:0004487,1,0.981356367210935,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2000,GO:0004488,1,0.981356367210935,0,3,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2001,GO:0004489,1,0.990943136753218,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2002,GO:0004490,1,0.995978499549289,0,1,methylglutaconyl-CoA hydratase activity,MF,
2003,GO:0004491,1,0.994635528004373,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2004,GO:0004493,1,0.996734553541504,0,1,methylmalonyl-CoA epimerase activity,MF,
2005,GO:0004496,1,0.994922736401722,0,1,mevalonate kinase activity,MF,
2006,GO:0004497,1,0.621026202930827,0,78,monooxygenase activity,MF,
2007,GO:0004498,1,0.993857025940025,0,1,calcidiol 1-monooxygenase activity,MF,
2008,GO:0004499,1,0.970657408452533,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2009,GO:0004500,1,0.986155565453147,0,2,dopamine beta-monooxygenase activity,MF,
2010,GO:0004502,1,0.992130153452426,0,1,kynurenine 3-monooxygenase activity,MF,
2011,GO:0004503,1,0.993070232306683,0,1,monophenol monooxygenase activity,MF,
2012,GO:0004504,1,0.992500519191262,0,1,peptidylglycine monooxygenase activity,MF,
2013,GO:0004505,1,0.984286580131704,0,3,phenylalanine 4-monooxygenase activity,MF,
2014,GO:0004506,1,0.992911518010768,0,1,squalene monooxygenase activity,MF,
2015,GO:0004509,1,0.995037753200595,0,1,steroid 21-monooxygenase activity,MF,
2016,GO:0004510,1,0.989725182124456,0,2,tryptophan 5-monooxygenase activity,MF,
2017,GO:0004511,1,0.995335190731637,0,1,tyrosine 3-monooxygenase activity,MF,
2018,GO:0004512,1,0.994432956656684,0,1,inositol-3-phosphate synthase activity,MF,
2019,GO:0004513,1,0.994311382705325,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2020,GO:0004514,1,0.981732752586065,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2021,GO:0004515,1,0.971887217185739,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2022,GO:0004516,1,0.99325505912211,0,1,nicotinate phosphoribosyltransferase activity,MF,
2023,GO:0004517,1,0.977463400689933,0,3,nitric-oxide synthase activity,MF,
2025,GO:0004519,1,0.500426689103287,0,112,endonuclease activity,MF,
2026,GO:0004520,1,0.789525588232416,0,37,endodeoxyribonuclease activity,MF,
2027,GO:0004521,1,0.694235772319687,0,59,endoribonuclease activity,MF,
2028,GO:0004522,1,0.989576539541562,0,3,ribonuclease A activity,MF,
2029,GO:0004523,1,0.972099764817876,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2030,GO:0004525,1,0.970916457911997,0,4,ribonuclease III activity,MF,
2031,GO:0004526,1,0.950042061826249,0,10,ribonuclease P activity,MF,
2034,GO:0004529,1,0.876995299626022,0,22,exodeoxyribonuclease activity,MF,
2035,GO:0004530,1,0.968071812120417,0,5,deoxyribonuclease I activity,MF,
2036,GO:0004531,1,0.991655863926738,0,2,deoxyribonuclease II activity,MF,
2037,GO:0004532,1,0.77474273747099,0,39,exoribonuclease activity,MF,
2038,GO:0004534,1,0.972173136217493,0,3,5'-3' exoribonuclease activity,MF,
2039,GO:0004535,1,0.909114106993975,0,13,poly(A)-specific ribonuclease activity,MF,
2040,GO:0004536,1,0.704225002278052,0,56,deoxyribonuclease activity,MF,
2041,GO:0004540,1,0.520730871414098,0,105,ribonuclease activity,MF,
2042,GO:0004549,1,0.932738680409409,0,13,tRNA-specific ribonuclease activity,MF,
2043,GO:0004550,1,0.915266119833063,0,17,nucleoside diphosphate kinase activity,MF,
2045,GO:0004553,1,0.632037125174647,0,70,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
2046,GO:0004556,1,0.990570450737306,0,2,alpha-amylase activity,MF,
2047,GO:0004557,1,0.98876749610655,0,2,alpha-galactosidase activity,MF,
2048,GO:0004558,1,0.976317898211806,0,3,alpha-1,4-glucosidase activity,MF,
2049,GO:0004559,1,0.900511635312643,0,14,alpha-mannosidase activity,MF,
2050,GO:0004560,1,0.989700464946068,0,2,alpha-L-fucosidase activity,MF,
2051,GO:0004561,1,0.993233036942894,0,1,alpha-N-acetylglucosaminidase activity,MF,
2052,GO:0004563,1,0.981934978687933,0,3,beta-N-acetylhexosaminidase activity,MF,
2053,GO:0004565,1,0.962846929918814,0,6,beta-galactosidase activity,MF,
2054,GO:0004566,1,0.982220674767873,0,3,beta-glucuronidase activity,MF,
2055,GO:0004567,1,0.992626505154174,0,1,beta-mannosidase activity,MF,
2056,GO:0004568,1,0.981680045341635,0,3,chitinase activity,MF,
2057,GO:0004569,1,0.992324656493115,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2058,GO:0004571,1,0.949540439887541,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2059,GO:0004572,1,0.983567249167576,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2060,GO:0004573,1,0.99332830956738,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2061,GO:0004576,1,0.968630463141929,0,6,oligosaccharyl transferase activity,MF,
2062,GO:0004577,1,0.992847638958988,0,1,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2063,GO:0004578,1,0.992475928180309,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2064,GO:0004579,1,0.972012830999364,0,5,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2065,GO:0004581,1,0.9965212526871,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
2066,GO:0004582,1,0.989573153351681,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
2067,GO:0004583,1,0.98838112941616,0,2,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2068,GO:0004585,1,0.995872708604307,0,1,ornithine carbamoyltransferase activity,MF,
2069,GO:0004586,1,0.987387725099994,0,2,ornithine decarboxylase activity,MF,
2070,GO:0004587,1,0.995150811224064,0,1,ornithine-oxo-acid transaminase activity,MF,
2071,GO:0004588,1,0.99347830452103,0,1,orotate phosphoribosyltransferase activity,MF,
2072,GO:0004590,1,0.99347830452103,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2073,GO:0004591,1,0.977142642459496,0,3,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2074,GO:0004594,1,0.981747227932615,0,3,pantothenate kinase activity,MF,
2075,GO:0004595,1,0.994342348842009,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2076,GO:0004596,1,0.940835407995158,0,10,peptide alpha-N-acetyltransferase activity,MF,
2077,GO:0004597,1,0.992516782025686,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2078,GO:0004598,1,0.992500519191262,0,1,peptidylamidoglycolate lyase activity,MF,
2079,GO:0004601,1,0.806600258069879,0,45,peroxidase activity,MF,
2080,GO:0004602,1,0.935486042892699,0,17,glutathione peroxidase activity,MF,
2081,GO:0004603,1,0.996535355469023,0,1,phenylethanolamine N-methyltransferase activity,MF,
2082,GO:0004605,1,0.979104433651168,0,3,phosphatidate cytidylyltransferase activity,MF,
2083,GO:0004607,1,0.996323076880232,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2084,GO:0004608,1,0.996661442422472,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2085,GO:0004609,1,0.988235691164151,0,2,phosphatidylserine decarboxylase activity,MF,
2086,GO:0004610,1,0.995107588931649,0,1,phosphoacetylglucosamine mutase activity,MF,
2087,GO:0004611,1,0.988640653624115,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2088,GO:0004613,1,0.988640653624115,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2089,GO:0004614,1,0.981782876293571,0,3,phosphoglucomutase activity,MF,
2090,GO:0004615,1,0.990697120948889,0,2,phosphomannomutase activity,MF,
2091,GO:0004616,1,0.995244599721444,0,1,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2092,GO:0004617,1,0.995055285925821,0,1,phosphoglycerate dehydrogenase activity,MF,
2093,GO:0004618,1,0.994014161636307,0,1,phosphoglycerate kinase activity,MF,
2094,GO:0004619,1,0.983668011598906,0,4,phosphoglycerate mutase activity,MF,
2096,GO:0004621,1,0.994364317703459,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2098,GO:0004623,1,0.895926955436201,0,18,phospholipase A2 activity,MF,
2100,GO:0004630,1,0.96951763758711,0,5,phospholipase D activity,MF,
2101,GO:0004631,1,0.996390501186077,0,1,phosphomevalonate kinase activity,MF,
2102,GO:0004632,1,0.996428552875148,0,1,phosphopantothenate--cysteine ligase activity,MF,
2103,GO:0004633,1,0.994547215562359,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2104,GO:0004634,1,0.979071253749606,0,4,phosphopyruvate hydratase activity,MF,
2105,GO:0004637,1,0.992568875755814,0,1,phosphoribosylamine-glycine ligase activity,MF,
2106,GO:0004638,1,0.992614688101677,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2107,GO:0004639,1,0.992614688101677,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2108,GO:0004641,1,0.992568875755814,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2109,GO:0004642,1,0.991929215431822,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2110,GO:0004643,1,0.994860156566715,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2111,GO:0004644,1,0.992568875755814,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2112,GO:0004645,1,0.960136823087374,0,6,1,4-alpha-oligoglucan phosphorylase activity,MF,
2113,GO:0004647,1,0.985862276969216,0,3,phosphoserine phosphatase activity,MF,
2114,GO:0004648,1,0.994802366668867,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2115,GO:0004649,1,0.992419860559889,0,1,poly(ADP-ribose) glycohydrolase activity,MF,
2116,GO:0004651,1,0.988279534708128,0,2,polynucleotide 5'-phosphatase activity,MF,
2117,GO:0004652,1,0.957310489848093,0,6,polynucleotide adenylyltransferase activity,MF,
2118,GO:0004653,1,0.880455564719419,0,18,polypeptide N-acetylgalactosaminyltransferase activity,MF,
2119,GO:0004654,1,0.99231431172358,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2120,GO:0004655,1,0.992715375182131,0,1,porphobilinogen synthase activity,MF,
2121,GO:0004656,1,0.970592089366694,0,5,procollagen-proline 4-dioxygenase activity,MF,
2122,GO:0004657,1,0.994547215562359,0,1,proline dehydrogenase activity,MF,
2123,GO:0004658,1,0.989456511665608,0,2,propionyl-CoA carboxylase activity,MF,
2124,GO:0004659,1,0.899150379970503,0,17,prenyltransferase activity,MF,
2125,GO:0004660,1,0.989141116161601,0,2,protein farnesyltransferase activity,MF,
2126,GO:0004661,1,0.973041266969103,0,5,protein geranylgeranyltransferase activity,MF,
2127,GO:0004662,1,0.98931393794557,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2128,GO:0004663,1,0.979577117948187,0,4,Rab geranylgeranyltransferase activity,MF,
2129,GO:0004666,1,0.984531909640108,0,2,prostaglandin-endoperoxide synthase activity,MF,
2130,GO:0004667,1,0.988350423491304,0,3,prostaglandin-D synthase activity,MF,
2131,GO:0004668,1,0.972272638795266,0,4,protein-arginine deiminase activity,MF,
2132,GO:0004671,1,0.99222835526752,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2134,GO:0004673,1,0.996794233003685,0,1,protein histidine kinase activity,MF,
2136,GO:0004675,1,0.873371294630257,0,17,transmembrane receptor protein serine/threonine kinase activity,MF,
2137,GO:0004676,1,0.991001232941682,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2138,GO:0004677,1,0.976721717793234,0,2,DNA-dependent protein kinase activity,MF,
2139,GO:0004679,1,0.943754742303487,0,8,AMP-activated protein kinase activity,MF,
2141,GO:0004686,1,0.990796148533894,0,1,elongation factor-2 kinase activity,MF,
2142,GO:0004687,1,0.9665368607843,0,4,myosin light chain kinase activity,MF,
2144,GO:0004690,1,0.939902434020757,0,8,cyclic nucleotide-dependent protein kinase activity,MF,
2145,GO:0004691,1,0.954067390620437,0,6,cAMP-dependent protein kinase activity,MF,
2146,GO:0004692,1,0.985160147847921,0,2,cGMP-dependent protein kinase activity,MF,
2148,GO:0004694,1,0.970212012411492,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2149,GO:0004697,1,0.891653615430454,0,15,protein kinase C activity,MF,
2150,GO:0004698,1,0.891653615430454,0,15,calcium-dependent protein kinase C activity,MF,
2151,GO:0004699,1,0.985131678405869,0,2,calcium-independent protein kinase C activity,MF,
2152,GO:0004703,1,0.972019583707989,0,5,G protein-coupled receptor kinase activity,MF,
2153,GO:0004704,1,0.968405906639355,0,5,NF-kappaB-inducing kinase activity,MF,
2154,GO:0004705,1,0.981225524076425,0,3,JUN kinase activity,MF,
2155,GO:0004706,1,0.944159115849085,0,8,JUN kinase kinase kinase activity,MF,
2156,GO:0004707,1,0.884629008465906,0,19,MAP kinase activity,MF,
2157,GO:0004708,1,0.896711935118775,0,17,MAP kinase kinase activity,MF,
2159,GO:0004711,1,0.95467434825186,0,6,ribosomal protein S6 kinase activity,MF,
2160,GO:0004712,1,0.745136374744937,0,44,protein serine/threonine/tyrosine kinase activity,MF,
2163,GO:0004715,1,0.730242771722978,0,45,non-membrane spanning protein tyrosine kinase activity,MF,
2164,GO:0004719,1,0.980750313100952,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2165,GO:0004720,1,0.964917010284964,0,5,protein-lysine 6-oxidase activity,MF,
2167,GO:0004722,1,0.620022484938022,0,70,protein serine/threonine phosphatase activity,MF,
2168,GO:0004723,1,0.948698160070696,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2169,GO:0004724,1,0.930251114068729,0,11,magnesium-dependent protein serine/threonine phosphatase activity,MF,
2171,GO:0004726,1,0.943977015064004,0,9,non-membrane spanning protein tyrosine phosphatase activity,MF,
2172,GO:0004727,1,0.991382675032472,0,2,prenylated protein tyrosine phosphatase activity,MF,
2173,GO:0004729,1,0.995689879813765,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2174,GO:0004731,1,0.979618433815688,0,3,purine-nucleoside phosphorylase activity,MF,
2175,GO:0004733,1,0.992561722521317,0,1,pyridoxamine-phosphate oxidase activity,MF,
2176,GO:0004735,1,0.984497898280524,0,3,pyrroline-5-carboxylate reductase activity,MF,
2177,GO:0004736,1,0.992466058908537,0,1,pyruvate carboxylase activity,MF,
2178,GO:0004738,1,0.967479274175249,0,5,pyruvate dehydrogenase activity,MF,
2179,GO:0004739,1,0.988699322188593,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2180,GO:0004740,1,0.970371911043163,0,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2181,GO:0004741,1,0.984972558475477,0,2,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2182,GO:0004742,1,0.992396385942744,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2183,GO:0004743,1,0.986161447254743,0,2,pyruvate kinase activity,MF,
2184,GO:0004744,1,0.993564967264221,0,1,retinal isomerase activity,MF,
2185,GO:0004745,1,0.929645768979413,0,14,retinol dehydrogenase activity,MF,
2186,GO:0004747,1,0.996494335159329,0,1,ribokinase activity,MF,
2187,GO:0004748,1,0.977659770551712,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2188,GO:0004749,1,0.978162208220651,0,4,ribose phosphate diphosphokinase activity,MF,
2189,GO:0004750,1,0.994339766065707,0,1,ribulose-phosphate 3-epimerase activity,MF,
2190,GO:0004751,1,0.995493769338178,0,1,ribose-5-phosphate isomerase activity,MF,
2191,GO:0004753,1,0.9916563895918,0,1,saccharopine dehydrogenase activity,MF,
2192,GO:0004756,1,0.988071328849343,0,2,selenide, water dikinase activity,MF,
2193,GO:0004757,1,0.996187560289379,0,1,sepiapterin reductase activity,MF,
2194,GO:0004758,1,0.965759266346054,0,5,serine C-palmitoyltransferase activity,MF,
2195,GO:0004760,1,0.995957962710815,0,1,serine-pyruvate transaminase activity,MF,
2196,GO:0004766,1,0.99641500146339,0,1,spermidine synthase activity,MF,
2197,GO:0004767,1,0.970398575864426,0,5,sphingomyelin phosphodiesterase activity,MF,
2198,GO:0004768,1,0.978416834104516,0,3,stearoyl-CoA 9-desaturase activity,MF,
2199,GO:0004769,1,0.992979889746714,0,2,steroid delta-isomerase activity,MF,
2200,GO:0004771,1,0.940660845477156,0,9,sterol esterase activity,MF,
2201,GO:0004772,1,0.99258655662872,0,1,sterol O-acyltransferase activity,MF,
2202,GO:0004773,1,0.991376969569417,0,1,steryl-sulfatase activity,MF,
2203,GO:0004774,1,0.985124769267872,0,3,succinate-CoA ligase activity,MF,
2204,GO:0004775,1,0.985124769267872,0,3,succinate-CoA ligase (ADP-forming) activity,MF,
2205,GO:0004776,1,0.985124769267872,0,3,succinate-CoA ligase (GDP-forming) activity,MF,
2206,GO:0004777,1,0.992064186951491,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2207,GO:0004778,1,0.992460861830824,0,2,succinyl-CoA hydrolase activity,MF,
2208,GO:0004779,1,0.986253473914406,0,2,sulfate adenylyltransferase activity,MF,
2209,GO:0004781,1,0.986253473914406,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2210,GO:0004782,1,0.993376889315338,0,1,sulfinoalanine decarboxylase activity,MF,
2211,GO:0004784,1,0.980061451818973,0,5,superoxide dismutase activity,MF,
2212,GO:0004788,1,0.994183151197722,0,1,thiamine diphosphokinase activity,MF,
2213,GO:0004790,1,0.993700757557992,0,1,thioether S-methyltransferase activity,MF,
2214,GO:0004791,1,0.966258984751976,0,6,thioredoxin-disulfide reductase activity,MF,
2215,GO:0004792,1,0.986727768360608,0,3,thiosulfate sulfurtransferase activity,MF,
2216,GO:0004793,1,0.98845812519745,0,2,threonine aldolase activity,MF,
2217,GO:0004794,1,0.992233438343677,0,2,L-threonine ammonia-lyase activity,MF,
2218,GO:0004796,1,0.988405566046058,0,2,thromboxane-A synthase activity,MF,
2219,GO:0004797,1,0.988115827459809,0,2,thymidine kinase activity,MF,
2220,GO:0004798,1,0.989494377617044,0,2,thymidylate kinase activity,MF,
2221,GO:0004799,1,0.995988653036494,0,1,thymidylate synthase activity,MF,
2222,GO:0004800,1,0.986278752840148,0,2,thyroxine 5'-deiodinase activity,MF,
2223,GO:0004801,1,0.996448124713084,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2224,GO:0004802,1,0.988375145172452,0,2,transketolase activity,MF,
2225,GO:0004803,1,0.985087841739547,0,2,transposase activity,MF,
2226,GO:0004806,1,0.864208537227106,0,23,triglyceride lipase activity,MF,
2227,GO:0004807,1,0.996183274548778,0,1,triose-phosphate isomerase activity,MF,
2228,GO:0004809,1,0.983189056102638,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2229,GO:0004810,1,0.994399259932995,0,1,tRNA adenylyltransferase activity,MF,
2230,GO:0004812,1,0.874728894887777,0,22,aminoacyl-tRNA ligase activity,MF,
2231,GO:0004813,1,0.987623003124827,0,2,alanine-tRNA ligase activity,MF,
2232,GO:0004814,1,0.98997503742428,0,2,arginine-tRNA ligase activity,MF,
2233,GO:0004815,1,0.992606559055304,0,1,aspartate-tRNA ligase activity,MF,
2234,GO:0004816,1,0.994395374705974,0,1,asparagine-tRNA ligase activity,MF,
2235,GO:0004817,1,0.995414355263867,0,1,cysteine-tRNA ligase activity,MF,
2236,GO:0004818,1,0.992478259266742,0,1,glutamate-tRNA ligase activity,MF,
2237,GO:0004821,1,0.993842556574809,0,1,histidine-tRNA ligase activity,MF,
2238,GO:0004822,1,0.992533163168872,0,1,isoleucine-tRNA ligase activity,MF,
2239,GO:0004823,1,0.992430220768774,0,1,leucine-tRNA ligase activity,MF,
2240,GO:0004825,1,0.992875761387737,0,1,methionine-tRNA ligase activity,MF,
2241,GO:0004826,1,0.979056265568464,0,4,phenylalanine-tRNA ligase activity,MF,
2242,GO:0004827,1,0.994229146124489,0,1,proline-tRNA ligase activity,MF,
2243,GO:0004828,1,0.994922736401722,0,1,serine-tRNA ligase activity,MF,
2244,GO:0004829,1,0.994122180779848,0,1,threonine-tRNA ligase activity,MF,
2245,GO:0004830,1,0.993165120463862,0,1,tryptophan-tRNA ligase activity,MF,
2246,GO:0004831,1,0.994702939885281,0,1,tyrosine-tRNA ligase activity,MF,
2247,GO:0004832,1,0.992517278529714,0,1,valine-tRNA ligase activity,MF,
2248,GO:0004833,1,0.991807490833414,0,2,tryptophan 2,3-dioxygenase activity,MF,
2249,GO:0004835,1,0.99206108732589,0,1,tubulin-tyrosine ligase activity,MF,
2250,GO:0004838,1,0.993264350859525,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2251,GO:0004839,1,0.977935158558848,0,3,ubiquitin activating enzyme activity,MF,
2252,GO:0004842,1,0.071878636713982,0,382,ubiquitin-protein transferase activity,MF,
2253,GO:0004843,1,0.552943251894748,0,80,thiol-dependent ubiquitin-specific protease activity,MF,
2254,GO:0004844,1,0.979951044627951,0,4,uracil DNA N-glycosylase activity,MF,
2255,GO:0004849,1,0.979963882161307,0,4,uridine kinase activity,MF,
2256,GO:0004850,1,0.989627865743449,0,2,uridine phosphorylase activity,MF,
2257,GO:0004852,1,0.996319367218211,0,1,uroporphyrinogen-III synthase activity,MF,
2258,GO:0004853,1,0.99628136530465,0,1,uroporphyrinogen decarboxylase activity,MF,
2259,GO:0004854,1,0.98396125602656,0,2,xanthine dehydrogenase activity,MF,
2260,GO:0004855,1,0.991736530860661,0,1,xanthine oxidase activity,MF,
2261,GO:0004856,1,0.992505382166194,0,1,xylulokinase activity,MF,
2263,GO:0004859,1,0.965694226316797,0,8,phospholipase inhibitor activity,MF,
2264,GO:0004860,1,0.697655217341103,0,59,protein kinase inhibitor activity,MF,
2265,GO:0004861,1,0.938154879584719,0,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2266,GO:0004862,1,0.953241975264936,0,8,cAMP-dependent protein kinase inhibitor activity,MF,
2267,GO:0004864,1,0.790581588635255,0,38,protein phosphatase inhibitor activity,MF,
2268,GO:0004865,1,0.948620341676509,0,10,protein serine/threonine phosphatase inhibitor activity,MF,
2271,GO:0004869,1,0.782568112155162,0,44,cysteine-type endopeptidase inhibitor activity,MF,
2272,GO:0004873,1,0.99236608423337,0,2,asialoglycoprotein receptor activity,MF,
2273,GO:0004875,1,0.943730973566085,0,9,complement receptor activity,MF,
2274,GO:0004876,1,0.995225268069383,0,1,complement component C3a receptor activity,MF,
2275,GO:0004877,1,0.989778504671728,0,1,complement component C3b receptor activity,MF,
2276,GO:0004878,1,0.987532914959292,0,2,complement component C5a receptor activity,MF,
2277,GO:0004879,1,0.70058471016217,0,49,nuclear receptor activity,MF,
2278,GO:0004883,1,0.991243679091847,0,1,glucocorticoid receptor activity,MF,
2280,GO:0004890,1,0.888817091457596,0,17,GABA-A receptor activity,MF,
2282,GO:0004897,1,0.944491565297833,0,7,ciliary neurotrophic factor receptor activity,MF,
2283,GO:0004900,1,0.995462270159744,0,1,erythropoietin receptor activity,MF,
2284,GO:0004903,1,0.992393257963047,0,1,growth hormone receptor activity,MF,
2285,GO:0004904,1,0.970661254068473,0,5,interferon receptor activity,MF,
2286,GO:0004905,1,0.987815194900501,0,2,type I interferon receptor activity,MF,
2287,GO:0004906,1,0.989366039566378,0,2,interferon-gamma receptor activity,MF,
2288,GO:0004908,1,0.956717621699753,0,7,interleukin-1 receptor activity,MF,
2289,GO:0004909,1,0.987402390376924,0,2,interleukin-1, type I, activating receptor activity,MF,
2290,GO:0004910,1,0.989163072356866,0,2,interleukin-1, type II, blocking receptor activity,MF,
2291,GO:0004911,1,0.98133408228859,0,3,interleukin-2 receptor activity,MF,
2292,GO:0004912,1,0.992210598821725,0,1,interleukin-3 receptor activity,MF,
2293,GO:0004913,1,0.990199626239068,0,2,interleukin-4 receptor activity,MF,
2294,GO:0004914,1,0.987301527956227,0,2,interleukin-5 receptor activity,MF,
2295,GO:0004915,1,0.985211687601161,0,2,interleukin-6 receptor activity,MF,
2296,GO:0004917,1,0.991648778916829,0,2,interleukin-7 receptor activity,MF,
2297,GO:0004918,1,0.987187322509217,0,2,interleukin-8 receptor activity,MF,
2298,GO:0004920,1,0.987798283787937,0,2,interleukin-10 receptor activity,MF,
2299,GO:0004921,1,0.981026936383175,0,3,interleukin-11 receptor activity,MF,
2300,GO:0004923,1,0.956332364602822,0,5,leukemia inhibitory factor receptor activity,MF,
2301,GO:0004924,1,0.956332364602822,0,5,oncostatin-M receptor activity,MF,
2302,GO:0004925,1,0.988538788829517,0,1,prolactin receptor activity,MF,
2304,GO:0004931,1,0.961785060751721,0,7,extracellularly ATP-gated cation channel activity,MF,
2305,GO:0004935,1,0.952899768400225,0,8,adrenergic receptor activity,MF,
2306,GO:0004936,1,0.970626266790799,0,5,alpha-adrenergic receptor activity,MF,
2307,GO:0004937,1,0.982671340863105,0,3,alpha1-adrenergic receptor activity,MF,
2308,GO:0004938,1,0.98774469402108,0,2,alpha2-adrenergic receptor activity,MF,
2309,GO:0004939,1,0.9817425571381,0,3,beta-adrenergic receptor activity,MF,
2310,GO:0004940,1,0.993104745312481,0,1,beta1-adrenergic receptor activity,MF,
2311,GO:0004941,1,0.995015143240695,0,1,beta2-adrenergic receptor activity,MF,
2312,GO:0004945,1,0.987390902786944,0,3,angiotensin type II receptor activity,MF,
2313,GO:0004946,1,0.996251100705709,0,1,bombesin receptor activity,MF,
2314,GO:0004947,1,0.988867723221089,0,2,bradykinin receptor activity,MF,
2315,GO:0004948,1,0.984717840708756,0,2,calcitonin receptor activity,MF,
2316,GO:0004949,1,0.979954740781177,0,3,cannabinoid receptor activity,MF,
2317,GO:0004950,1,0.867956312872763,0,25,chemokine receptor activity,MF,
2318,GO:0004951,1,0.990642700245817,0,2,cholecystokinin receptor activity,MF,
2319,GO:0004952,1,0.972821042452152,0,5,dopamine neurotransmitter receptor activity,MF,
2320,GO:0004953,1,0.915991498864334,0,15,icosanoid receptor activity,MF,
2321,GO:0004954,1,0.93596313303345,0,11,prostanoid receptor activity,MF,
2322,GO:0004955,1,0.94122206270132,0,10,prostaglandin receptor activity,MF,
2323,GO:0004956,1,0.986284917379464,0,2,prostaglandin D receptor activity,MF,
2324,GO:0004957,1,0.97143576622563,0,5,prostaglandin E receptor activity,MF,
2325,GO:0004958,1,0.985245828479811,0,2,prostaglandin F receptor activity,MF,
2326,GO:0004960,1,0.994416103024581,0,1,thromboxane receptor activity,MF,
2327,GO:0004961,1,0.994416103024581,0,1,thromboxane A2 receptor activity,MF,
2328,GO:0004962,1,0.984959674705696,0,2,endothelin receptor activity,MF,
2329,GO:0004965,1,0.97671676957585,0,3,G protein-coupled GABA receptor activity,MF,
2330,GO:0004966,1,0.983042558208948,0,4,galanin receptor activity,MF,
2331,GO:0004967,1,0.988632891541473,0,2,glucagon receptor activity,MF,
2332,GO:0004968,1,0.992424200763125,0,1,gonadotropin-releasing hormone receptor activity,MF,
2333,GO:0004969,1,0.96754073273969,0,5,histamine receptor activity,MF,
2334,GO:0004970,1,0.854917111978371,0,19,ionotropic glutamate receptor activity,MF,
2335,GO:0004971,1,0.968269028878599,0,4,AMPA glutamate receptor activity,MF,
2336,GO:0004972,1,0.933498809643945,0,8,NMDA glutamate receptor activity,MF,
2337,GO:0004974,1,0.978676206103861,0,4,leukotriene receptor activity,MF,
2338,GO:0004977,1,0.981252488412298,0,4,melanocortin receptor activity,MF,
2339,GO:0004979,1,0.995430413442757,0,1,beta-endorphin receptor activity,MF,
2340,GO:0004980,1,0.989046495475786,0,2,melanocyte-stimulating hormone receptor activity,MF,
2341,GO:0004982,1,0.985456987230521,0,3,N-formyl peptide receptor activity,MF,
2342,GO:0004983,1,0.956946698665612,0,8,neuropeptide Y receptor activity,MF,
2343,GO:0004984,1,0.932733759645243,0,16,olfactory receptor activity,MF,
2344,GO:0004985,1,0.955763098231219,0,9,opioid receptor activity,MF,
2345,GO:0004990,1,0.992395254141827,0,1,oxytocin receptor activity,MF,
2346,GO:0004991,1,0.988157693305728,0,2,parathyroid hormone receptor activity,MF,
2347,GO:0004992,1,0.980434911013623,0,3,platelet activating factor receptor activity,MF,
2348,GO:0004993,1,0.879975142481085,0,22,G protein-coupled serotonin receptor activity,MF,
2349,GO:0004994,1,0.977386291255052,0,4,somatostatin receptor activity,MF,
2350,GO:0004995,1,0.982484104440784,0,3,tachykinin receptor activity,MF,
2351,GO:0004996,1,0.988956984446561,0,2,thyroid-stimulating hormone receptor activity,MF,
2352,GO:0004998,1,0.985148610797277,0,2,transferrin receptor activity,MF,
2353,GO:0004999,1,0.981653440656602,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2354,GO:0005000,1,0.963572449350904,0,6,vasopressin receptor activity,MF,
2355,GO:0005001,1,0.865199621039049,0,17,transmembrane receptor protein tyrosine phosphatase activity,MF,
2356,GO:0005003,1,0.870996108169711,0,19,ephrin receptor activity,MF,
2357,GO:0005004,1,0.94603234767682,0,7,GPI-linked ephrin receptor activity,MF,
2358,GO:0005005,1,0.882824565467894,0,17,transmembrane-ephrin receptor activity,MF,
2361,GO:0005008,1,0.991217346647788,0,1,hepatocyte growth factor-activated receptor activity,MF,
2362,GO:0005009,1,0.971433365265763,0,3,insulin-activated receptor activity,MF,
2363,GO:0005010,1,0.97078949321537,0,3,insulin-like growth factor-activated receptor activity,MF,
2364,GO:0005011,1,0.984766964171952,0,2,macrophage colony-stimulating factor receptor activity,MF,
2367,GO:0005019,1,0.987897859040221,0,2,platelet-derived growth factor beta-receptor activity,MF,
2368,GO:0005020,1,0.992049146936613,0,1,stem cell factor receptor activity,MF,
2370,GO:0005024,1,0.907474053944425,0,12,transforming growth factor beta-activated receptor activity,MF,
2371,GO:0005025,1,0.961731747440595,0,5,transforming growth factor beta receptor activity, type I,MF,
2372,GO:0005026,1,0.992289691663676,0,1,transforming growth factor beta receptor activity, type II,MF,
2373,GO:0005030,1,0.968912489150297,0,4,neurotrophin receptor activity,MF,
2374,GO:0005031,1,0.945537957865768,0,10,tumor necrosis factor-activated receptor activity,MF,
2375,GO:0005034,1,0.97005529664968,0,4,osmosensor activity,MF,
2377,GO:0005041,1,0.906525659210714,0,12,low-density lipoprotein particle receptor activity,MF,
2378,GO:0005042,1,0.951245584242182,0,6,netrin receptor activity,MF,
2379,GO:0005043,1,0.99251214454348,0,1,netrin receptor activity involved in chemorepulsion,MF,
2381,GO:0005046,1,0.985796305338414,0,3,KDEL sequence binding,MF,
2382,GO:0005047,1,0.982395602457548,0,3,signal recognition particle binding,MF,
2384,GO:0005049,1,0.925985232812528,0,10,nuclear export signal receptor activity,MF,
2386,GO:0005053,1,0.996145391638275,0,1,peroxisome matrix targeting signal-2 binding,MF,
2387,GO:0005055,1,0.990565689572856,0,2,laminin receptor activity,MF,
2388,GO:0005068,1,0.919513218965586,0,13,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2389,GO:0005078,1,0.915412497995424,0,11,MAP-kinase scaffold activity,MF,
2392,GO:0005086,1,0.860302991309766,0,19,ARF guanyl-nucleotide exchange factor activity,MF,
2393,GO:0005087,1,0.979600500112471,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2395,GO:0005089,1,0.616686496683425,0,59,Rho guanyl-nucleotide exchange factor activity,MF,
2396,GO:0005090,1,0.994679623323091,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2397,GO:0005092,1,0.904028818669003,0,16,GDP-dissociation inhibitor activity,MF,
2398,GO:0005093,1,0.988117894071491,0,2,Rab GDP-dissociation inhibitor activity,MF,
2399,GO:0005094,1,0.988649299260792,0,3,Rho GDP-dissociation inhibitor activity,MF,
2400,GO:0005095,1,0.913481528879778,0,14,GTPase inhibitor activity,MF,
2401,GO:0005096,1,0.151416691304601,0,252,GTPase activator activity,MF,
2403,GO:0005104,1,0.894084548067576,0,19,fibroblast growth factor receptor binding,MF,
2404,GO:0005105,1,0.983698156637063,0,4,type 1 fibroblast growth factor receptor binding,MF,
2406,GO:0005111,1,0.97868136911514,0,5,type 2 fibroblast growth factor receptor binding,MF,
2407,GO:0005112,1,0.839758297768194,0,22,Notch binding,MF,
2408,GO:0005113,1,0.951261970397938,0,8,patched binding,MF,
2409,GO:0005114,1,0.94518394658332,0,8,type II transforming growth factor beta receptor binding,MF,
2410,GO:0005115,1,0.991685564322805,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2411,GO:0005119,1,0.975824234154331,0,3,smoothened binding,MF,
2412,GO:0005123,1,0.894160910250917,0,19,death receptor binding,MF,
2413,GO:0005124,1,0.980622008326879,0,4,scavenger receptor binding,MF,
2417,GO:0005128,1,0.989039763008383,0,2,erythropoietin receptor binding,MF,
2418,GO:0005130,1,0.996098466353946,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2419,GO:0005131,1,0.971392963207446,0,4,growth hormone receptor binding,MF,
2420,GO:0005134,1,0.98179409636358,0,3,interleukin-2 receptor binding,MF,
2421,GO:0005135,1,0.992657543324271,0,1,interleukin-3 receptor binding,MF,
2422,GO:0005136,1,0.988462092257146,0,2,interleukin-4 receptor binding,MF,
2423,GO:0005137,1,0.994682215128908,0,1,interleukin-5 receptor binding,MF,
2424,GO:0005138,1,0.958979227583102,0,7,interleukin-6 receptor binding,MF,
2425,GO:0005139,1,0.98875144563683,0,2,interleukin-7 receptor binding,MF,
2426,GO:0005141,1,0.995912405228962,0,1,interleukin-10 receptor binding,MF,
2427,GO:0005142,1,0.994198459179084,0,1,interleukin-11 receptor binding,MF,
2428,GO:0005143,1,0.976207903910926,0,4,interleukin-12 receptor binding,MF,
2429,GO:0005144,1,0.996409506317867,0,1,interleukin-13 receptor binding,MF,
2430,GO:0005146,1,0.988366409348788,0,2,leukemia inhibitory factor receptor binding,MF,
2431,GO:0005147,1,0.995441831029351,0,1,oncostatin-M receptor binding,MF,
2432,GO:0005148,1,0.996501543909436,0,1,prolactin receptor binding,MF,
2433,GO:0005149,1,0.930259633563569,0,11,interleukin-1 receptor binding,MF,
2434,GO:0005150,1,0.988168974314634,0,2,interleukin-1, type I receptor binding,MF,
2435,GO:0005151,1,0.987610561111885,0,2,interleukin-1, type II receptor binding,MF,
2436,GO:0005152,1,0.986772497928194,0,2,interleukin-1 receptor antagonist activity,MF,
2437,GO:0005153,1,0.985962262627313,0,2,interleukin-8 receptor binding,MF,
2438,GO:0005154,1,0.806932769135633,0,30,epidermal growth factor receptor binding,MF,
2439,GO:0005157,1,0.985797354078382,0,3,macrophage colony-stimulating factor receptor binding,MF,
2440,GO:0005158,1,0.834491265922629,0,22,insulin receptor binding,MF,
2441,GO:0005159,1,0.914247396902019,0,13,insulin-like growth factor receptor binding,MF,
2442,GO:0005160,1,0.852820442571103,0,24,transforming growth factor beta receptor binding,MF,
2444,GO:0005163,1,0.982309078209092,0,4,nerve growth factor receptor binding,MF,
2445,GO:0005164,1,0.859100355448542,0,29,tumor necrosis factor receptor binding,MF,
2446,GO:0005165,1,0.930074966227447,0,11,neurotrophin receptor binding,MF,
2447,GO:0005166,1,0.99349751325715,0,1,neurotrophin p75 receptor binding,MF,
2448,GO:0005167,1,0.953034734744176,0,6,neurotrophin TRK receptor binding,MF,
2449,GO:0005168,1,0.953034734744176,0,6,neurotrophin TRKA receptor binding,MF,
2450,GO:0005169,1,0.991969217283285,0,1,neurotrophin TRKB receptor binding,MF,
2451,GO:0005170,1,0.991969217283285,0,1,neurotrophin TRKC receptor binding,MF,
2452,GO:0005171,1,0.990103355920679,0,2,hepatocyte growth factor receptor binding,MF,
2454,GO:0005173,1,0.967570053021287,0,4,stem cell factor receptor binding,MF,
2455,GO:0005174,1,0.989913641594438,0,2,CD40 receptor binding,MF,
2456,GO:0005175,1,0.996813843337313,0,1,CD27 receptor binding,MF,
2457,GO:0005176,1,0.983137908441715,0,3,ErbB-2 class receptor binding,MF,
2459,GO:0005179,1,0.710327532291287,0,72,hormone activity,MF,
2460,GO:0005183,1,0.9926378502127,0,2,gonadotropin hormone-releasing hormone activity,MF,
2461,GO:0005184,1,0.919330103986414,0,22,neuropeptide hormone activity,MF,
2465,GO:0005212,1,0.935983216666021,0,16,structural constituent of eye lens,MF,
2468,GO:0005217,1,0.804825514348857,0,26,intracellular ligand-gated ion channel activity,MF,
2469,GO:0005219,1,0.957355316431826,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2470,GO:0005220,1,0.967756537757911,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2471,GO:0005221,1,0.936691772644114,0,9,intracellular cyclic nucleotide activated cation channel activity,MF,
2472,GO:0005222,1,0.943027955188678,0,8,intracellular cAMP-activated cation channel activity,MF,
2473,GO:0005223,1,0.96009534560217,0,6,intracellular cGMP-activated cation channel activity,MF,
2474,GO:0005225,1,0.93335145277358,0,9,volume-sensitive anion channel activity,MF,
2475,GO:0005227,1,0.865375128824268,0,22,calcium activated cation channel activity,MF,
2476,GO:0005228,1,0.983932629919797,0,2,intracellular sodium activated potassium channel activity,MF,
2477,GO:0005229,1,0.892051642687022,0,16,intracellular calcium activated chloride channel activity,MF,
2478,GO:0005230,1,0.63110962520028,0,67,extracellular ligand-gated ion channel activity,MF,
2479,GO:0005231,1,0.842017088299806,0,28,excitatory extracellular ligand-gated ion channel activity,MF,
2480,GO:0005234,1,0.985259377013043,0,2,extracellularly glutamate-gated ion channel activity,MF,
2481,GO:0005237,1,0.901808221245734,0,14,inhibitory extracellular ligand-gated ion channel activity,MF,
2485,GO:0005245,1,0.733355065575658,0,42,voltage-gated calcium channel activity,MF,
2486,GO:0005246,1,0.785519321920056,0,42,calcium channel regulator activity,MF,
2487,GO:0005247,1,0.935534263100318,0,9,voltage-gated chloride channel activity,MF,
2488,GO:0005248,1,0.819143366177971,0,23,voltage-gated sodium channel activity,MF,
2490,GO:0005250,1,0.972026838943172,0,4,A-type (transient outward) potassium channel activity,MF,
2491,GO:0005251,1,0.818220108815934,0,29,delayed rectifier potassium channel activity,MF,
2492,GO:0005252,1,0.992471877123297,0,1,open rectifier potassium channel activity,MF,
2493,GO:0005253,1,0.593354483143361,0,77,anion channel activity,MF,
2494,GO:0005254,1,0.635104961749048,0,66,chloride channel activity,MF,
2495,GO:0005260,1,0.991506567773342,0,1,intracellularly ATP-gated chloride channel activity,MF,
2497,GO:0005262,1,0.43711553910883,0,108,calcium channel activity,MF,
2499,GO:0005272,1,0.705739369805105,0,43,sodium channel activity,MF,
2500,GO:0005275,1,0.981957651101969,0,3,amine transmembrane transporter activity,MF,
2501,GO:0005277,1,0.989528651051623,0,2,acetylcholine transmembrane transporter activity,MF,
2502,GO:0005280,1,0.985437473675498,0,2,amino acid:proton symporter activity,MF,
2503,GO:0005283,1,0.894516341577376,0,15,amino acid:sodium symporter activity,MF,
2504,GO:0005287,1,0.994165323664128,0,1,high-affinity basic amino acid transmembrane transporter activity,MF,
2505,GO:0005289,1,0.994165323664128,0,1,high-affinity arginine transmembrane transporter activity,MF,
2506,GO:0005290,1,0.96675912401476,0,5,L-histidine transmembrane transporter activity,MF,
2507,GO:0005292,1,0.994165323664128,0,1,high-affinity lysine transmembrane transporter activity,MF,
2508,GO:0005294,1,0.989609055075192,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2509,GO:0005295,1,0.968641041248975,0,4,neutral amino acid:sodium symporter activity,MF,
2510,GO:0005298,1,0.977013388849689,0,3,proline:sodium symporter activity,MF,
2511,GO:0005302,1,0.992743399714276,0,1,L-tyrosine transmembrane transporter activity,MF,
2512,GO:0005308,1,0.9795902538279,0,3,creatine transmembrane transporter activity,MF,
2513,GO:0005309,1,0.992537660842656,0,1,creatine:sodium symporter activity,MF,
2514,GO:0005310,1,0.773267156695598,0,36,dicarboxylic acid transmembrane transporter activity,MF,
2515,GO:0005313,1,0.901404206130412,0,14,L-glutamate transmembrane transporter activity,MF,
2516,GO:0005314,1,0.969519335638482,0,4,high-affinity glutamate transmembrane transporter activity,MF,
2517,GO:0005315,1,0.964758930985536,0,5,inorganic phosphate transmembrane transporter activity,MF,
2518,GO:0005316,1,0.992646289079112,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2520,GO:0005324,1,0.906309585932843,0,17,long-chain fatty acid transporter activity,MF,
2521,GO:0005326,1,0.892492397612558,0,17,neurotransmitter transmembrane transporter activity,MF,
2522,GO:0005328,1,0.992606559055304,0,1,neurotransmitter:sodium symporter activity,MF,
2523,GO:0005330,1,0.97262306524402,0,4,dopamine:sodium symporter activity,MF,
2524,GO:0005332,1,0.974964793134147,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2525,GO:0005334,1,0.980661674462119,0,3,norepinephrine:sodium symporter activity,MF,
2526,GO:0005335,1,0.980904399831389,0,3,serotonin:sodium symporter activity,MF,
2527,GO:0005337,1,0.96565726820282,0,6,nucleoside transmembrane transporter activity,MF,
2528,GO:0005338,1,0.930712082258827,0,12,nucleotide-sugar transmembrane transporter activity,MF,
2529,GO:0005342,1,0.393612799013877,0,138,organic acid transmembrane transporter activity,MF,
2530,GO:0005343,1,0.832370720168293,0,26,organic acid:sodium symporter activity,MF,
2531,GO:0005344,1,0.950889704830806,0,13,oxygen carrier activity,MF,
2532,GO:0005345,1,0.971447141743824,0,5,purine nucleobase transmembrane transporter activity,MF,
2533,GO:0005346,1,0.840887613530485,0,28,purine ribonucleotide transmembrane transporter activity,MF,
2534,GO:0005347,1,0.861472545950292,0,24,ATP transmembrane transporter activity,MF,
2535,GO:0005350,1,0.982515637016202,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2537,GO:0005353,1,0.975823684235753,0,4,fructose transmembrane transporter activity,MF,
2538,GO:0005354,1,0.992178753857273,0,1,galactose transmembrane transporter activity,MF,
2540,GO:0005362,1,0.987095309681924,0,2,low-affinity glucose:sodium symporter activity,MF,
2541,GO:0005365,1,0.972109374318016,0,3,myo-inositol transmembrane transporter activity,MF,
2542,GO:0005366,1,0.991026736607283,0,1,myo-inositol:proton symporter activity,MF,
2543,GO:0005367,1,0.980913085723868,0,2,myo-inositol:sodium symporter activity,MF,
2544,GO:0005368,1,0.97779305158687,0,3,taurine transmembrane transporter activity,MF,
2545,GO:0005369,1,0.991302627207241,0,1,taurine:sodium symporter activity,MF,
2546,GO:0005371,1,0.995957962710815,0,1,tricarboxylate secondary active transmembrane transporter activity,MF,
2547,GO:0005372,1,0.932867594907463,0,12,water transmembrane transporter activity,MF,
2548,GO:0005375,1,0.962489880554835,0,5,copper ion transmembrane transporter activity,MF,
2549,GO:0005381,1,0.93816321404031,0,10,iron ion transmembrane transporter activity,MF,
2550,GO:0005384,1,0.937585647922776,0,9,manganese ion transmembrane transporter activity,MF,
2551,GO:0005385,1,0.892405775186628,0,18,zinc ion transmembrane transporter activity,MF,
2552,GO:0005388,1,0.925273542033714,0,9,calcium transmembrane transporter activity, phosphorylative mechanism,MF,
2553,GO:0005391,1,0.934573006264896,0,11,sodium:potassium-exchanging ATPase activity,MF,
2556,GO:0005415,1,0.989565143186826,0,2,nucleoside:sodium symporter activity,MF,
2557,GO:0005416,1,0.881475218307705,0,17,amino acid:cation symporter activity,MF,
2558,GO:0005427,1,0.992503149269511,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2559,GO:0005432,1,0.936312737033162,0,9,calcium:sodium antiporter activity,MF,
2560,GO:0005436,1,0.956528727909739,0,7,sodium:phosphate symporter activity,MF,
2561,GO:0005451,1,0.915064716704256,0,12,monovalent cation:proton antiporter activity,MF,
2562,GO:0005452,1,0.913107286897434,0,12,inorganic anion exchanger activity,MF,
2563,GO:0005456,1,0.995544705891405,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2564,GO:0005457,1,0.992698457281054,0,1,GDP-fucose transmembrane transporter activity,MF,
2565,GO:0005459,1,0.982614538504497,0,4,UDP-galactose transmembrane transporter activity,MF,
2566,GO:0005460,1,0.996502974870515,0,1,UDP-glucose transmembrane transporter activity,MF,
2567,GO:0005461,1,0.981544216698752,0,3,UDP-glucuronic acid transmembrane transporter activity,MF,
2568,GO:0005462,1,0.96770001103981,0,5,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2569,GO:0005463,1,0.981544216698752,0,3,UDP-N-acetylgalactosamine transmembrane transporter activity,MF,
2570,GO:0005464,1,0.991130741288936,0,1,UDP-xylose transmembrane transporter activity,MF,
2571,GO:0005477,1,0.992538483050273,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2572,GO:0005483,1,0.980577044979413,0,3,soluble NSF attachment protein activity,MF,
2573,GO:0005484,1,0.81839883193144,0,34,SNAP receptor activity,MF,
2576,GO:0005497,1,0.981105799177164,0,4,androgen binding,MF,
2577,GO:0005499,1,0.969424799894124,0,5,vitamin D binding,MF,
2578,GO:0005501,1,0.871834330028728,0,25,retinoid binding,MF,
2579,GO:0005502,1,0.975534327317831,0,4,11-cis retinal binding,MF,
2580,GO:0005503,1,0.987472448395174,0,2,all-trans retinal binding,MF,
2581,GO:0005504,1,0.855461041597643,0,32,fatty acid binding,MF,
2583,GO:0005507,1,0.74177755125132,0,52,copper ion binding,MF,
2585,GO:0005513,1,0.91876216750953,0,13,detection of calcium ion,BP,
2588,GO:0005518,1,0.622311837652327,0,66,collagen binding,MF,
2589,GO:0005519,1,0.992471517079626,0,1,cytoskeletal regulatory protein binding,MF,
2591,GO:0005521,1,0.890973356129523,0,16,lamin binding,MF,
2592,GO:0005522,1,0.912515804244347,0,11,profilin binding,MF,
2593,GO:0005523,1,0.918050947517822,0,15,tropomyosin binding,MF,
2596,GO:0005527,1,0.949087795834029,0,10,macrolide binding,MF,
2597,GO:0005528,1,0.957491250988139,0,8,FK506 binding,MF,
2598,GO:0005534,1,0.977843970137413,0,4,galactose binding,MF,
2599,GO:0005536,1,0.926989469543192,0,11,glucose binding,MF,
2600,GO:0005537,1,0.917308088037059,0,15,mannose binding,MF,
2603,GO:0005542,1,0.952552367555588,0,10,folic acid binding,MF,
2605,GO:0005544,1,0.733914883727575,0,47,calcium-dependent phospholipid binding,MF,
2606,GO:0005545,1,0.897562693139915,0,14,1-phosphatidylinositol binding,MF,
2608,GO:0005547,1,0.763943516997316,0,35,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
2609,GO:0005548,1,0.754968981469845,0,41,phospholipid transporter activity,MF,
2610,GO:0005549,1,0.966221296638546,0,10,odorant binding,MF,
2613,GO:0005577,1,0.96149845620626,0,6,fibrinogen complex,CC,
2614,GO:0005579,1,0.970579829421801,0,4,membrane attack complex,CC,
2616,GO:0005582,1,0.991982224645088,0,1,collagen type XV trimer,CC,
2617,GO:0005583,1,0.905316181896059,0,12,fibrillar collagen trimer,CC,
2618,GO:0005584,1,0.983577188299528,0,2,collagen type I trimer,CC,
2619,GO:0005585,1,0.992126716462284,0,1,collagen type II trimer,CC,
2620,GO:0005586,1,0.991857192543709,0,1,collagen type III trimer,CC,
2621,GO:0005587,1,0.946268535426565,0,6,collagen type IV trimer,CC,
2622,GO:0005588,1,0.964973490677096,0,4,collagen type V trimer,CC,
2623,GO:0005589,1,0.978753630615914,0,3,collagen type VI trimer,CC,
2624,GO:0005590,1,0.989802465689289,0,1,collagen type VII trimer,CC,
2625,GO:0005591,1,0.993544088410586,0,1,collagen type VIII trimer,CC,
2626,GO:0005592,1,0.982445291933758,0,2,collagen type XI trimer,CC,
2627,GO:0005593,1,0.95300715842716,0,6,FACIT collagen trimer,CC,
2628,GO:0005594,1,0.979618228748459,0,3,collagen type IX trimer,CC,
2629,GO:0005595,1,0.98949053767693,0,1,collagen type XII trimer,CC,
2630,GO:0005596,1,0.991312186835538,0,1,collagen type XIV trimer,CC,
2631,GO:0005597,1,0.991792536280281,0,1,collagen type XVI trimer,CC,
2632,GO:0005598,1,0.993544088410586,0,1,short-chain collagen trimer,CC,
2633,GO:0005600,1,0.992834666964173,0,1,collagen type XIII trimer,CC,
2634,GO:0005602,1,0.993225861341418,0,2,complement component C1 complex,CC,
2636,GO:0005606,1,0.972107277259765,0,3,laminin-1 complex,CC,
2637,GO:0005607,1,0.983828372991527,0,2,laminin-2 complex,CC,
2638,GO:0005608,1,0.98142537899566,0,2,laminin-3 complex,CC,
2639,GO:0005610,1,0.971870274830501,0,3,laminin-5 complex,CC,
2640,GO:0005614,1,0.905498334517349,0,13,interstitial matrix,CC,
2645,GO:0005637,1,0.70641850383744,0,53,nuclear inner membrane,CC,
2646,GO:0005638,1,0.970830151943884,0,5,lamin filament,CC,
2647,GO:0005639,1,0.913107320260326,0,14,integral component of nuclear inner membrane,CC,
2649,GO:0005641,1,0.935840267830767,0,9,nuclear envelope lumen,CC,
2650,GO:0005642,1,0.954998873404918,0,6,annulate lamellae,CC,
2651,GO:0005643,1,0.59620639814046,0,75,nuclear pore,CC,
2652,GO:0005652,1,0.93477426661741,0,11,nuclear lamina,CC,
2654,GO:0005655,1,0.975316732386377,0,5,nucleolar ribonuclease P complex,CC,
2655,GO:0005656,1,0.984662851228709,0,3,nuclear pre-replicative complex,CC,
2656,GO:0005657,1,0.658767764235797,0,65,replication fork,CC,
2657,GO:0005658,1,0.969437967650395,0,5,alpha DNA polymerase:primase complex,CC,
2658,GO:0005662,1,0.917013050470624,0,14,DNA replication factor A complex,CC,
2659,GO:0005663,1,0.974428873925844,0,5,DNA replication factor C complex,CC,
2660,GO:0005664,1,0.941095232401937,0,9,nuclear origin of replication recognition complex,CC,
2661,GO:0005665,1,0.929063566513859,0,15,RNA polymerase II, core complex,CC,
2662,GO:0005666,1,0.90990826736412,0,18,RNA polymerase III complex,CC,
2663,GO:0005667,1,0.0788939634913252,0,381,transcription regulator complex,CC,
2664,GO:0005668,1,0.990759700254387,0,2,RNA polymerase transcription factor SL1 complex,CC,
2665,GO:0005669,1,0.828700895823308,0,32,transcription factor TFIID complex,CC,
2666,GO:0005671,1,0.914520836384133,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2667,GO:0005672,1,0.979986376071039,0,5,transcription factor TFIIA complex,CC,
2668,GO:0005673,1,0.988958823062643,0,2,transcription factor TFIIE complex,CC,
2669,GO:0005674,1,0.989911718958162,0,2,transcription factor TFIIF complex,CC,
2670,GO:0005675,1,0.936261068662535,0,12,transcription factor TFIIH holo complex,CC,
2671,GO:0005677,1,0.952652114933387,0,7,chromatin silencing complex,CC,
2672,GO:0005680,1,0.886055497718528,0,21,anaphase-promoting complex,CC,
2673,GO:0005681,1,0.350723376479629,0,178,spliceosomal complex,CC,
2674,GO:0005682,1,0.91915811551428,0,16,U5 snRNP,CC,
2675,GO:0005683,1,0.973290730651638,0,7,U7 snRNP,CC,
2676,GO:0005684,1,0.616074294155569,0,87,U2-type spliceosomal complex,CC,
2677,GO:0005685,1,0.917472280297064,0,18,U1 snRNP,CC,
2678,GO:0005686,1,0.914913638356791,0,19,U2 snRNP,CC,
2679,GO:0005687,1,0.959803899816304,0,10,U4 snRNP,CC,
2680,GO:0005688,1,0.964996229188389,0,8,U6 snRNP,CC,
2681,GO:0005689,1,0.877503491299827,0,27,U12-type spliceosomal complex,CC,
2682,GO:0005690,1,0.994617355566068,0,1,U4atac snRNP,CC,
2683,GO:0005691,1,0.992387446489806,0,1,U6atac snRNP,CC,
2685,GO:0005697,1,0.881761514744935,0,20,telomerase holoenzyme complex,CC,
2686,GO:0005712,1,0.984521762447969,0,2,chiasma,CC,
2687,GO:0005713,1,0.993910485981676,0,1,recombination nodule,CC,
2688,GO:0005715,1,0.993910485981676,0,1,late recombination nodule,CC,
2689,GO:0005719,1,0.848629744459133,0,25,nuclear euchromatin,CC,
2690,GO:0005720,1,0.825106211653787,0,27,nuclear heterochromatin,CC,
2691,GO:0005721,1,0.877828500112401,0,18,pericentric heterochromatin,CC,
2692,GO:0005726,1,0.961601036026232,0,5,perichromatin fibrils,CC,
2694,GO:0005731,1,0.995745180872483,0,1,nucleolus organizer region,CC,
2695,GO:0005732,1,0.899428264706649,0,22,small nucleolar ribonucleoprotein complex,CC,
2696,GO:0005736,1,0.950686012081115,0,10,RNA polymerase I complex,CC,
2701,GO:0005742,1,0.968792205118246,0,7,mitochondrial outer membrane translocase complex,CC,
2703,GO:0005744,1,0.939368977849001,0,12,TIM23 mitochondrial import inner membrane translocase complex,CC,
2704,GO:0005745,1,0.986370309620471,0,2,m-AAA complex,CC,
2705,GO:0005746,1,0.75496615722897,0,71,mitochondrial respirasome,CC,
2706,GO:0005747,1,0.857688615610072,0,41,mitochondrial respiratory chain complex I,CC,
2707,GO:0005749,1,0.980436691765404,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2708,GO:0005750,1,0.956736299449552,0,10,mitochondrial respiratory chain complex III,CC,
2709,GO:0005751,1,0.963832120183116,0,11,mitochondrial respiratory chain complex IV,CC,
2710,GO:0005753,1,0.994606968261175,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2711,GO:0005757,1,0.980452986710935,0,4,mitochondrial permeability transition pore complex,CC,
2712,GO:0005758,1,0.684643821219697,0,71,mitochondrial intermembrane space,CC,
2713,GO:0005759,1,0.0931750722151088,0,431,mitochondrial matrix,CC,
2714,GO:0005760,1,0.980827397010711,0,3,gamma DNA polymerase complex,CC,
2715,GO:0005761,1,0.709828928966869,0,84,mitochondrial ribosome,CC,
2716,GO:0005762,1,0.796297808005032,0,55,mitochondrial large ribosomal subunit,CC,
2717,GO:0005763,1,0.899637929346044,0,27,mitochondrial small ribosomal subunit,CC,
2720,GO:0005766,1,0.421194219087571,0,145,primary lysosome,CC,
2721,GO:0005767,1,0.920333000485251,0,15,secondary lysosome,CC,
2729,GO:0005776,1,0.551946999798917,0,90,autophagosome,CC,
2732,GO:0005779,1,0.917709161921465,0,15,integral component of peroxisomal membrane,CC,
2733,GO:0005782,1,0.758312849180489,0,51,peroxisomal matrix,CC,
2735,GO:0005784,1,0.975000642966457,0,5,Sec61 translocon complex,CC,
2736,GO:0005785,1,0.968286634808528,0,6,signal recognition particle receptor complex,CC,
2737,GO:0005786,1,0.970425697072957,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2738,GO:0005787,1,0.975580337880274,0,5,signal peptidase complex,CC,
2742,GO:0005791,1,0.631508108737594,0,78,rough endoplasmic reticulum,CC,
2743,GO:0005793,1,0.45912891803295,0,119,endoplasmic reticulum-Golgi intermediate compartment,CC,
2745,GO:0005795,1,0.414081501698412,0,131,Golgi stack,CC,
2747,GO:0005797,1,0.945158118549938,0,10,Golgi medial cisterna,CC,
2752,GO:0005813,1,0.0227382212650047,0,550,centrosome,CC,
2753,GO:0005814,1,0.406515644456792,0,126,centriole,CC,
2754,GO:0005815,1,0.00699993470149199,0,716,microtubule organizing center,CC,
2755,GO:0005818,1,0.924766830987478,0,11,aster,CC,
2756,GO:0005819,1,0.10023792191764,0,334,spindle,CC,
2758,GO:0005827,1,0.965348953348559,0,5,polar microtubule,CC,
2759,GO:0005828,1,0.943628219780189,0,7,kinetochore microtubule,CC,
2761,GO:0005832,1,0.951893944078338,0,9,chaperonin-containing T-complex,CC,
2762,GO:0005833,1,0.961897325709943,0,11,hemoglobin complex,CC,
2763,GO:0005834,1,0.830939362628802,0,32,heterotrimeric G-protein complex,CC,
2764,GO:0005838,1,0.908060379494146,0,21,proteasome regulatory particle,CC,
2765,GO:0005839,1,0.939724030377885,0,17,proteasome core complex,CC,
2768,GO:0005845,1,0.937041278985782,0,10,mRNA cap binding complex,CC,
2769,GO:0005846,1,0.980200857825661,0,3,nuclear cap binding complex,CC,
2770,GO:0005847,1,0.89069293973813,0,17,mRNA cleavage and polyadenylation specificity factor complex,CC,
2771,GO:0005848,1,0.994347515560857,0,1,mRNA cleavage stimulating factor complex,CC,
2772,GO:0005849,1,0.868537860413633,0,21,mRNA cleavage factor complex,CC,
2773,GO:0005850,1,0.97140796460573,0,4,eukaryotic translation initiation factor 2 complex,CC,
2774,GO:0005851,1,0.96860013264752,0,6,eukaryotic translation initiation factor 2B complex,CC,
2775,GO:0005852,1,0.920204932564907,0,16,eukaryotic translation initiation factor 3 complex,CC,
2776,GO:0005853,1,0.981107035523827,0,4,eukaryotic translation elongation factor 1 complex,CC,
2777,GO:0005854,1,0.985455899647798,0,3,nascent polypeptide-associated complex,CC,
2780,GO:0005859,1,0.926631748138143,0,12,muscle myosin complex,CC,
2781,GO:0005861,1,0.968783882946848,0,8,troponin complex,CC,
2782,GO:0005862,1,0.978126677724684,0,4,muscle thin filament tropomyosin,CC,
2783,GO:0005863,1,0.976850342876834,0,3,striated muscle myosin thick filament,CC,
2784,GO:0005865,1,0.893637811015344,0,21,striated muscle thin filament,CC,
2785,GO:0005868,1,0.888444103395897,0,18,cytoplasmic dynein complex,CC,
2786,GO:0005869,1,0.939017899486865,0,12,dynactin complex,CC,
2787,GO:0005871,1,0.693677256365642,0,48,kinesin complex,CC,
2788,GO:0005873,1,0.983804911165286,0,2,plus-end kinesin complex,CC,
2791,GO:0005876,1,0.653216250256735,0,62,spindle microtubule,CC,
2792,GO:0005879,1,0.95759878218335,0,6,axonemal microtubule,CC,
2793,GO:0005880,1,0.988722689475829,0,2,nuclear microtubule,CC,
2794,GO:0005881,1,0.622953139430244,0,69,cytoplasmic microtubule,CC,
2798,GO:0005885,1,0.951089102761718,0,11,Arp2/3 protein complex,CC,
2801,GO:0005889,1,0.992527733269507,0,1,potassium:proton exchanging ATPase complex,CC,
2802,GO:0005890,1,0.935350206618639,0,12,sodium:potassium-exchanging ATPase complex,CC,
2803,GO:0005891,1,0.741234203985477,0,40,voltage-gated calcium channel complex,CC,
2804,GO:0005892,1,0.909643376530872,0,15,acetylcholine-gated channel complex,CC,
2805,GO:0005893,1,0.985209341637316,0,2,interleukin-2 receptor complex,CC,
2806,GO:0005895,1,0.994682215128908,0,1,interleukin-5 receptor complex,CC,
2807,GO:0005896,1,0.981773314039477,0,3,interleukin-6 receptor complex,CC,
2808,GO:0005898,1,0.992467383473261,0,1,interleukin-13 receptor complex,CC,
2809,GO:0005899,1,0.961804932943811,0,4,insulin receptor complex,CC,
2810,GO:0005900,1,0.985277317394312,0,2,oncostatin-M receptor complex,CC,
2817,GO:0005914,1,0.992615209005673,0,1,spot adherens junction,CC,
2818,GO:0005915,1,0.94763824074543,0,7,zonula adherens,CC,
2824,GO:0005927,1,0.984728563822995,0,3,muscle tendon junction,CC,
2828,GO:0005942,1,0.834387584154737,0,25,phosphatidylinositol 3-kinase complex,CC,
2829,GO:0005943,1,0.97633473170247,0,3,phosphatidylinositol 3-kinase complex, class IA,CC,
2830,GO:0005944,1,0.976982652821822,0,3,phosphatidylinositol 3-kinase complex, class IB,CC,
2831,GO:0005945,1,0.979101656808645,0,3,6-phosphofructokinase complex,CC,
2832,GO:0005947,1,0.969653064650524,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2833,GO:0005948,1,0.994319118502194,0,1,acetolactate synthase complex,CC,
2834,GO:0005952,1,0.948500636129422,0,8,cAMP-dependent protein kinase complex,CC,
2835,GO:0005953,1,0.98931393794557,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2836,GO:0005954,1,0.964001134896197,0,5,calcium- and calmodulin-dependent protein kinase complex,CC,
2837,GO:0005955,1,0.962455186389047,0,5,calcineurin complex,CC,
2838,GO:0005956,1,0.985810887112649,0,3,protein kinase CK2 complex,CC,
2839,GO:0005958,1,0.976204934260294,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2840,GO:0005960,1,0.988633292096331,0,2,glycine cleavage complex,CC,
2842,GO:0005965,1,0.989141116161601,0,2,protein farnesyltransferase complex,CC,
2843,GO:0005967,1,0.968143758955232,0,5,mitochondrial pyruvate dehydrogenase complex,CC,
2844,GO:0005968,1,0.974696732259791,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2845,GO:0005969,1,0.99046862691875,0,1,serine-pyruvate aminotransferase complex,CC,
2846,GO:0005971,1,0.985365180812921,0,2,ribonucleoside-diphosphate reductase complex,CC,
2851,GO:0005979,1,0.816740861583478,0,26,regulation of glycogen biosynthetic process,BP,
2853,GO:0005981,1,0.965721958961451,0,5,regulation of glycogen catabolic process,BP,
2854,GO:0005982,1,0.991294757848014,0,1,starch metabolic process,BP,
2855,GO:0005983,1,0.991294757848014,0,1,starch catabolic process,BP,
2856,GO:0005984,1,0.942972034279812,0,9,disaccharide metabolic process,BP,
2857,GO:0005985,1,0.988614035645291,0,2,sucrose metabolic process,BP,
2858,GO:0005986,1,0.99606239377017,0,1,sucrose biosynthetic process,BP,
2859,GO:0005988,1,0.98184297822372,0,3,lactose metabolic process,BP,
2860,GO:0005989,1,0.98184297822372,0,3,lactose biosynthetic process,BP,
2861,GO:0005991,1,0.992957421892581,0,1,trehalose metabolic process,BP,
2863,GO:0005997,1,0.980670078742041,0,4,xylulose metabolic process,BP,
2864,GO:0005998,1,0.992505382166194,0,1,xylulose catabolic process,BP,
2865,GO:0005999,1,0.991295672407625,0,2,xylulose biosynthetic process,BP,
2866,GO:0006000,1,0.928635091010098,0,13,fructose metabolic process,BP,
2867,GO:0006001,1,0.975789085362891,0,4,fructose catabolic process,BP,
2868,GO:0006002,1,0.925549969550476,0,11,fructose 6-phosphate metabolic process,BP,
2869,GO:0006003,1,0.972890054719702,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2870,GO:0006004,1,0.904621195958915,0,14,fucose metabolic process,BP,
2872,GO:0006007,1,0.818675433258761,0,32,glucose catabolic process,BP,
2873,GO:0006011,1,0.967280698469136,0,5,UDP-glucose metabolic process,BP,
2874,GO:0006012,1,0.921649001636907,0,13,galactose metabolic process,BP,
2875,GO:0006013,1,0.941595727597423,0,9,mannose metabolic process,BP,
2876,GO:0006014,1,0.988517121989009,0,3,D-ribose metabolic process,BP,
2877,GO:0006015,1,0.971493644399892,0,5,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2878,GO:0006020,1,0.930116423806692,0,10,inositol metabolic process,BP,
2879,GO:0006021,1,0.983231260452244,0,3,inositol biosynthetic process,BP,
2886,GO:0006030,1,0.973494002114049,0,5,chitin metabolic process,BP,
2887,GO:0006032,1,0.973494002114049,0,5,chitin catabolic process,BP,
2888,GO:0006040,1,0.798701874938495,0,36,amino sugar metabolic process,BP,
2889,GO:0006041,1,0.977428532093242,0,4,glucosamine metabolic process,BP,
2890,GO:0006043,1,0.989680796658737,0,2,glucosamine catabolic process,BP,
2891,GO:0006044,1,0.89979580812814,0,16,N-acetylglucosamine metabolic process,BP,
2892,GO:0006045,1,0.984538775923214,0,2,N-acetylglucosamine biosynthetic process,BP,
2893,GO:0006046,1,0.985223913628312,0,3,N-acetylglucosamine catabolic process,BP,
2894,GO:0006047,1,0.91291052172263,0,15,UDP-N-acetylglucosamine metabolic process,BP,
2895,GO:0006048,1,0.936629866869745,0,11,UDP-N-acetylglucosamine biosynthetic process,BP,
2896,GO:0006049,1,0.993006718779402,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2897,GO:0006050,1,0.992177387032504,0,2,mannosamine metabolic process,BP,
2898,GO:0006051,1,0.992177387032504,0,2,N-acetylmannosamine metabolic process,BP,
2899,GO:0006054,1,0.938772630189985,0,11,N-acetylneuraminate metabolic process,BP,
2900,GO:0006055,1,0.996453316121395,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2901,GO:0006056,1,0.995630725828587,0,1,mannoprotein metabolic process,BP,
2902,GO:0006057,1,0.995630725828587,0,1,mannoprotein biosynthetic process,BP,
2903,GO:0006059,1,0.98640050910952,0,3,hexitol metabolic process,BP,
2904,GO:0006060,1,0.990051053660279,0,2,sorbitol metabolic process,BP,
2905,GO:0006061,1,0.99626173993583,0,1,sorbitol biosynthetic process,BP,
2906,GO:0006062,1,0.993766247491235,0,1,sorbitol catabolic process,BP,
2907,GO:0006063,1,0.956435805793028,0,8,uronic acid metabolic process,BP,
2908,GO:0006064,1,0.975543113841645,0,5,glucuronate catabolic process,BP,
2909,GO:0006065,1,0.978924918751826,0,3,UDP-glucuronate biosynthetic process,BP,
2911,GO:0006067,1,0.917646777059539,0,16,ethanol metabolic process,BP,
2912,GO:0006068,1,0.953142655086585,0,10,ethanol catabolic process,BP,
2913,GO:0006069,1,0.95024543480874,0,8,ethanol oxidation,BP,
2914,GO:0006071,1,0.899805409623152,0,16,glycerol metabolic process,BP,
2917,GO:0006081,1,0.707477391006366,0,58,cellular aldehyde metabolic process,BP,
2919,GO:0006083,1,0.985323422668229,0,2,acetate metabolic process,BP,
2920,GO:0006084,1,0.793178224301516,0,36,acetyl-CoA metabolic process,BP,
2921,GO:0006085,1,0.867801610405324,0,21,acetyl-CoA biosynthetic process,BP,
2922,GO:0006086,1,0.900242528333012,0,15,acetyl-CoA biosynthetic process from pyruvate,BP,
2923,GO:0006089,1,0.928899028731481,0,12,lactate metabolic process,BP,
2928,GO:0006097,1,0.98998782076827,0,2,glyoxylate cycle,BP,
2929,GO:0006098,1,0.926453962060447,0,14,pentose-phosphate shunt,BP,
2930,GO:0006099,1,0.825185452042353,0,33,tricarboxylic acid cycle,BP,
2931,GO:0006101,1,0.963063499239058,0,5,citrate metabolic process,BP,
2932,GO:0006102,1,0.969140826131232,0,6,isocitrate metabolic process,BP,
2933,GO:0006103,1,0.913381327156965,0,15,2-oxoglutarate metabolic process,BP,
2934,GO:0006104,1,0.970648162848761,0,5,succinyl-CoA metabolic process,BP,
2935,GO:0006105,1,0.971880620103888,0,5,succinate metabolic process,BP,
2936,GO:0006106,1,0.984402826039767,0,3,fumarate metabolic process,BP,
2937,GO:0006107,1,0.958754586348277,0,8,oxaloacetate metabolic process,BP,
2938,GO:0006108,1,0.962647739781502,0,7,malate metabolic process,BP,
2941,GO:0006111,1,0.769474409081395,0,37,regulation of gluconeogenesis,BP,
2943,GO:0006113,1,0.986142807120098,0,2,fermentation,BP,
2944,GO:0006114,1,0.964361850035378,0,6,glycerol biosynthetic process,BP,
2946,GO:0006117,1,0.993651353128436,0,1,acetaldehyde metabolic process,BP,
2947,GO:0006119,1,0.613995928861446,0,106,oxidative phosphorylation,BP,
2948,GO:0006120,1,0.833821544598556,0,46,mitochondrial electron transport, NADH to ubiquinone,BP,
2949,GO:0006121,1,0.98038173752137,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2950,GO:0006122,1,0.941299218468663,0,12,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2951,GO:0006123,1,0.936243052371679,0,16,mitochondrial electron transport, cytochrome c to oxygen,BP,
2955,GO:0006144,1,0.898539569897642,0,18,purine nucleobase metabolic process,BP,
2956,GO:0006145,1,0.968942683621002,0,4,purine nucleobase catabolic process,BP,
2957,GO:0006147,1,0.991912048384404,0,1,guanine catabolic process,BP,
2958,GO:0006148,1,0.994046636166459,0,1,inosine catabolic process,BP,
2959,GO:0006152,1,0.967118246881595,0,6,purine nucleoside catabolic process,BP,
2960,GO:0006154,1,0.989761011776325,0,2,adenosine catabolic process,BP,
2961,GO:0006157,1,0.996065573507639,0,1,deoxyadenosine catabolic process,BP,
2963,GO:0006164,1,0.382103451223353,0,155,purine nucleotide biosynthetic process,BP,
2965,GO:0006166,1,0.975692314803356,0,5,purine ribonucleoside salvage,BP,
2966,GO:0006167,1,0.984667043209294,0,4,AMP biosynthetic process,BP,
2967,GO:0006168,1,0.993046290868714,0,2,adenine salvage,BP,
2968,GO:0006170,1,0.990262109657045,0,2,dAMP biosynthetic process,BP,
2969,GO:0006171,1,0.918169136723153,0,10,cAMP biosynthetic process,BP,
2970,GO:0006172,1,0.968490157655204,0,5,ADP biosynthetic process,BP,
2971,GO:0006173,1,0.992524157394466,0,1,dADP biosynthetic process,BP,
2972,GO:0006174,1,0.99325505912211,0,1,dADP phosphorylation,BP,
2973,GO:0006175,1,0.994969707860412,0,1,dATP biosynthetic process,BP,
2974,GO:0006177,1,0.979906894762688,0,4,GMP biosynthetic process,BP,
2975,GO:0006178,1,0.996243042055326,0,1,guanine salvage,BP,
2976,GO:0006182,1,0.961524710153236,0,7,cGMP biosynthetic process,BP,
2977,GO:0006183,1,0.959334669560753,0,10,GTP biosynthetic process,BP,
2978,GO:0006185,1,0.996663430352124,0,1,dGDP biosynthetic process,BP,
2979,GO:0006186,1,0.99325505912211,0,1,dGDP phosphorylation,BP,
2980,GO:0006188,1,0.943224200444931,0,9,IMP biosynthetic process,BP,
2981,GO:0006189,1,0.961252266917271,0,6,'de novo' IMP biosynthetic process,BP,
2982,GO:0006193,1,0.996582024467971,0,1,ITP catabolic process,BP,
2983,GO:0006195,1,0.77186220206521,0,42,purine nucleotide catabolic process,BP,
2984,GO:0006196,1,0.984916287194351,0,2,AMP catabolic process,BP,
2985,GO:0006198,1,0.929678759189704,0,9,cAMP catabolic process,BP,
2986,GO:0006203,1,0.984639126366017,0,3,dGTP catabolic process,BP,
2987,GO:0006206,1,0.900779211579053,0,16,pyrimidine nucleobase metabolic process,BP,
2988,GO:0006207,1,0.955113468450261,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2989,GO:0006208,1,0.982293539944513,0,3,pyrimidine nucleobase catabolic process,BP,
2990,GO:0006210,1,0.982293539944513,0,3,thymine catabolic process,BP,
2991,GO:0006211,1,0.968625280309651,0,3,5-methylcytosine catabolic process,BP,
2992,GO:0006212,1,0.987592123894691,0,2,uracil catabolic process,BP,
2993,GO:0006213,1,0.847028537129299,0,32,pyrimidine nucleoside metabolic process,BP,
2994,GO:0006214,1,0.992769178814638,0,1,thymidine catabolic process,BP,
2995,GO:0006216,1,0.951667731500622,0,10,cytidine catabolic process,BP,
2996,GO:0006218,1,0.989627865743449,0,2,uridine catabolic process,BP,
2997,GO:0006220,1,0.795693897216577,0,44,pyrimidine nucleotide metabolic process,BP,
2998,GO:0006221,1,0.860829185198659,0,29,pyrimidine nucleotide biosynthetic process,BP,
2999,GO:0006222,1,0.943955931666101,0,10,UMP biosynthetic process,BP,
3000,GO:0006225,1,0.993104745312481,0,1,UDP biosynthetic process,BP,
3001,GO:0006226,1,0.990466097815245,0,2,dUMP biosynthetic process,BP,
3002,GO:0006227,1,0.989494377617044,0,2,dUDP biosynthetic process,BP,
3003,GO:0006228,1,0.960623491339408,0,9,UTP biosynthetic process,BP,
3004,GO:0006231,1,0.98502863957311,0,3,dTMP biosynthetic process,BP,
3005,GO:0006233,1,0.989494377617044,0,2,dTDP biosynthetic process,BP,
3006,GO:0006235,1,0.981943139361535,0,4,dTTP biosynthetic process,BP,
3007,GO:0006241,1,0.942961499635738,0,13,CTP biosynthetic process,BP,
3008,GO:0006244,1,0.939035649813524,0,13,pyrimidine nucleotide catabolic process,BP,
3009,GO:0006253,1,0.99656920672688,0,1,dCTP catabolic process,BP,
3010,GO:0006256,1,0.992991287943398,0,1,UDP catabolic process,BP,
3011,GO:0006258,1,0.990998732957324,0,2,UDP-glucose catabolic process,BP,
3014,GO:0006261,1,0.389954876089447,0,143,DNA-dependent DNA replication,BP,
3015,GO:0006264,1,0.92596563172505,0,12,mitochondrial DNA replication,BP,
3016,GO:0006265,1,0.940450810716671,0,9,DNA topological change,BP,
3017,GO:0006266,1,0.909855939122713,0,16,DNA ligation,BP,
3018,GO:0006267,1,0.945042015532696,0,8,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3019,GO:0006268,1,0.902637692863265,0,15,DNA unwinding involved in DNA replication,BP,
3020,GO:0006269,1,0.968677847234377,0,5,DNA replication, synthesis of RNA primer,BP,
3021,GO:0006270,1,0.784798838309458,0,38,DNA replication initiation,BP,
3022,GO:0006271,1,0.885061612400696,0,19,DNA strand elongation involved in DNA replication,BP,
3023,GO:0006272,1,0.973299614758849,0,4,leading strand elongation,BP,
3024,GO:0006273,1,0.96998658398819,0,4,lagging strand elongation,BP,
3026,GO:0006278,1,0.640461828321685,0,67,RNA-dependent DNA biosynthetic process,BP,
3029,GO:0006283,1,0.665347259416289,0,73,transcription-coupled nucleotide-excision repair,BP,
3030,GO:0006284,1,0.787426681433809,0,40,base-excision repair,BP,
3031,GO:0006285,1,0.952717506113278,0,10,base-excision repair, AP site formation,BP,
3032,GO:0006286,1,0.992575328929391,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3033,GO:0006287,1,0.962430401052185,0,6,base-excision repair, gap-filling,BP,
3034,GO:0006288,1,0.983915756178886,0,3,base-excision repair, DNA ligation,BP,
3035,GO:0006289,1,0.535622558791991,0,106,nucleotide-excision repair,BP,
3036,GO:0006290,1,0.941151135342871,0,9,pyrimidine dimer repair,BP,
3037,GO:0006293,1,0.876952631556222,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3038,GO:0006294,1,0.848219368191809,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3039,GO:0006295,1,0.876952631556222,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3040,GO:0006296,1,0.80714544836125,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3041,GO:0006297,1,0.876012445363368,0,23,nucleotide-excision repair, DNA gap filling,BP,
3042,GO:0006298,1,0.810474462238278,0,32,mismatch repair,BP,
3043,GO:0006301,1,0.736562130940392,0,49,postreplication repair,BP,
3044,GO:0006302,1,0.220237771194995,0,218,double-strand break repair,BP,
3045,GO:0006303,1,0.62853131554121,0,67,double-strand break repair via nonhomologous end joining,BP,
3046,GO:0006304,1,0.509258171365571,0,104,DNA modification,BP,
3047,GO:0006305,1,0.655379496013149,0,60,DNA alkylation,BP,
3048,GO:0006306,1,0.655379496013149,0,60,DNA methylation,BP,
3049,GO:0006307,1,0.945653978241712,0,10,DNA dealkylation involved in DNA repair,BP,
3050,GO:0006308,1,0.79265792503818,0,39,DNA catabolic process,BP,
3051,GO:0006309,1,0.865329763690873,0,24,apoptotic DNA fragmentation,BP,
3052,GO:0006310,1,0.185411741962469,0,249,DNA recombination,BP,
3053,GO:0006311,1,0.979055096074921,0,3,meiotic gene conversion,BP,
3054,GO:0006312,1,0.863120286987075,0,21,mitotic recombination,BP,
3055,GO:0006313,1,0.985087841739547,0,2,transposition, DNA-mediated,BP,
3056,GO:0006323,1,0.381233453634745,0,141,DNA packaging,BP,
3058,GO:0006333,1,0.411299561760412,0,131,chromatin assembly or disassembly,BP,
3059,GO:0006334,1,0.673676720165655,0,62,nucleosome assembly,BP,
3060,GO:0006335,1,0.949279206979447,0,8,DNA replication-dependent nucleosome assembly,BP,
3061,GO:0006336,1,0.81305295399442,0,34,DNA replication-independent nucleosome assembly,BP,
3062,GO:0006337,1,0.902629384714997,0,15,nucleosome disassembly,BP,
3063,GO:0006338,1,0.299905509980778,0,173,chromatin remodeling,BP,
3064,GO:0006342,1,0.79393083218027,0,34,chromatin silencing,BP,
3065,GO:0006346,1,0.885144137802336,0,17,DNA methylation-dependent heterochromatin assembly,BP,
3066,GO:0006348,1,0.942917647797836,0,10,chromatin silencing at telomere,BP,
3067,GO:0006349,1,0.884867478796358,0,17,regulation of gene expression by genetic imprinting,BP,
3069,GO:0006352,1,0.240031056449065,0,220,DNA-templated transcription, initiation,BP,
3070,GO:0006353,1,0.661070393117764,0,71,DNA-templated transcription, termination,BP,
3073,GO:0006356,1,0.838207328033363,0,27,regulation of transcription by RNA polymerase I,BP,
3075,GO:0006359,1,0.856237632211376,0,23,regulation of transcription by RNA polymerase III,BP,
3076,GO:0006360,1,0.703372316690687,0,56,transcription by RNA polymerase I,BP,
3077,GO:0006361,1,0.83436846260038,0,32,transcription initiation from RNA polymerase I promoter,BP,
3078,GO:0006362,1,0.860601875419405,0,27,transcription elongation from RNA polymerase I promoter,BP,
3079,GO:0006363,1,0.862332057032574,0,27,termination of RNA polymerase I transcription,BP,
3080,GO:0006364,1,0.312764707024687,0,205,rRNA processing,BP,
3082,GO:0006367,1,0.312899487435745,0,180,transcription initiation from RNA polymerase II promoter,BP,
3084,GO:0006369,1,0.810189227501003,0,35,termination of RNA polymerase II transcription,BP,
3085,GO:0006370,1,0.841767613003721,0,31,7-methylguanosine mRNA capping,BP,
3086,GO:0006376,1,0.813516706774645,0,31,mRNA splice site selection,BP,
3087,GO:0006378,1,0.749802068188138,0,42,mRNA polyadenylation,BP,
3088,GO:0006379,1,0.879115304464934,0,20,mRNA cleavage,BP,
3089,GO:0006382,1,0.946123368542295,0,8,adenosine to inosine editing,BP,
3090,GO:0006383,1,0.750105514546006,0,46,transcription by RNA polymerase III,BP,
3091,GO:0006384,1,0.942823702397689,0,8,transcription initiation from RNA polymerase III promoter,BP,
3092,GO:0006386,1,0.996769091059498,0,1,termination of RNA polymerase III transcription,BP,
3093,GO:0006388,1,0.933567826257524,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3094,GO:0006390,1,0.914179793572594,0,14,mitochondrial transcription,BP,
3095,GO:0006391,1,0.983448856559066,0,3,transcription initiation from mitochondrial promoter,BP,
3096,GO:0006392,1,0.99325505912211,0,1,transcription elongation from mitochondrial promoter,BP,
3097,GO:0006393,1,0.986555151512788,0,2,termination of mitochondrial transcription,BP,
3099,GO:0006397,1,0.0491968940855749,0,475,mRNA processing,BP,
3100,GO:0006398,1,0.968864818559632,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3101,GO:0006399,1,0.402755804936055,0,157,tRNA metabolic process,BP,
3102,GO:0006400,1,0.613544998632574,0,81,tRNA modification,BP,
3105,GO:0006403,1,0.234716380414174,0,219,RNA localization,BP,
3106,GO:0006404,1,0.982038714394439,0,3,RNA import into nucleus,BP,
3107,GO:0006405,1,0.416320652300433,0,133,RNA export from nucleus,BP,
3108,GO:0006406,1,0.497433260469935,0,105,mRNA export from nucleus,BP,
3109,GO:0006407,1,0.98649026111443,0,2,rRNA export from nucleus,BP,
3110,GO:0006408,1,0.990582413580039,0,2,snRNA export from nucleus,BP,
3111,GO:0006409,1,0.805815121115996,0,31,tRNA export from nucleus,BP,
3114,GO:0006414,1,0.547088396516497,0,125,translational elongation,BP,
3115,GO:0006415,1,0.632984216857352,0,101,translational termination,BP,
3117,GO:0006418,1,0.862291969419697,0,26,tRNA aminoacylation for protein translation,BP,
3118,GO:0006419,1,0.987623003124827,0,2,alanyl-tRNA aminoacylation,BP,
3119,GO:0006420,1,0.98997503742428,0,2,arginyl-tRNA aminoacylation,BP,
3120,GO:0006421,1,0.987042951124921,0,2,asparaginyl-tRNA aminoacylation,BP,
3121,GO:0006423,1,0.995414355263867,0,1,cysteinyl-tRNA aminoacylation,BP,
3122,GO:0006424,1,0.992478259266742,0,1,glutamyl-tRNA aminoacylation,BP,
3123,GO:0006427,1,0.993842556574809,0,1,histidyl-tRNA aminoacylation,BP,
3124,GO:0006428,1,0.992533163168872,0,1,isoleucyl-tRNA aminoacylation,BP,
3125,GO:0006429,1,0.992430220768774,0,1,leucyl-tRNA aminoacylation,BP,
3126,GO:0006431,1,0.992875761387737,0,1,methionyl-tRNA aminoacylation,BP,
3127,GO:0006432,1,0.985469444441353,0,3,phenylalanyl-tRNA aminoacylation,BP,
3128,GO:0006433,1,0.994229146124489,0,1,prolyl-tRNA aminoacylation,BP,
3129,GO:0006434,1,0.994922736401722,0,1,seryl-tRNA aminoacylation,BP,
3130,GO:0006435,1,0.994122180779848,0,1,threonyl-tRNA aminoacylation,BP,
3131,GO:0006436,1,0.993165120463862,0,1,tryptophanyl-tRNA aminoacylation,BP,
3132,GO:0006437,1,0.994702939885281,0,1,tyrosyl-tRNA aminoacylation,BP,
3133,GO:0006438,1,0.992517278529714,0,1,valyl-tRNA aminoacylation,BP,
3134,GO:0006446,1,0.617653947207316,0,76,regulation of translational initiation,BP,
3135,GO:0006447,1,0.98019366457835,0,3,regulation of translational initiation by iron,BP,
3136,GO:0006448,1,0.892477256026052,0,18,regulation of translational elongation,BP,
3137,GO:0006449,1,0.93260259710459,0,10,regulation of translational termination,BP,
3138,GO:0006450,1,0.92500777510358,0,14,regulation of translational fidelity,BP,
3139,GO:0006451,1,0.95030765129233,0,8,translational readthrough,BP,
3140,GO:0006457,1,0.310355312382828,0,201,protein folding,BP,
3141,GO:0006458,1,0.808151391212755,0,36,'de novo' protein folding,BP,
3142,GO:0006463,1,0.992498504331887,0,1,steroid hormone receptor complex assembly,BP,
3144,GO:0006465,1,0.939584808427128,0,11,signal peptide processing,BP,
3146,GO:0006469,1,0.245843698292132,0,215,negative regulation of protein kinase activity,BP,
3148,GO:0006471,1,0.829926005929593,0,29,protein ADP-ribosylation,BP,
3149,GO:0006473,1,0.285025332947929,0,186,protein acetylation,BP,
3150,GO:0006474,1,0.897828057990318,0,16,N-terminal protein amino acid acetylation,BP,
3151,GO:0006475,1,0.350001691648932,0,154,internal protein amino acid acetylation,BP,
3152,GO:0006476,1,0.52253405207242,0,92,protein deacetylation,BP,
3153,GO:0006477,1,0.954955771295924,0,7,protein sulfation,BP,
3154,GO:0006478,1,0.990238451033264,0,2,peptidyl-tyrosine sulfation,BP,
3155,GO:0006479,1,0.335872920815024,0,154,protein methylation,BP,
3156,GO:0006480,1,0.989973726793067,0,2,N-terminal protein amino acid methylation,BP,
3157,GO:0006481,1,0.988652778666709,0,2,C-terminal protein methylation,BP,
3158,GO:0006482,1,0.795304974121154,0,29,protein demethylation,BP,
3161,GO:0006488,1,0.880505036908261,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3162,GO:0006489,1,0.958812184604399,0,7,dolichyl diphosphate biosynthetic process,BP,
3163,GO:0006490,1,0.874996610842432,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3164,GO:0006491,1,0.871616339208087,0,18,N-glycan processing,BP,
3165,GO:0006493,1,0.558677304879301,0,84,protein O-linked glycosylation,BP,
3166,GO:0006497,1,0.572933234441354,0,89,protein lipidation,BP,
3167,GO:0006498,1,0.95932857206301,0,6,N-terminal protein lipidation,BP,
3168,GO:0006499,1,0.968698709685666,0,4,N-terminal protein myristoylation,BP,
3169,GO:0006500,1,0.990330212225995,0,2,N-terminal protein palmitoylation,BP,
3170,GO:0006501,1,0.960453572317405,0,6,C-terminal protein lipidation,BP,
3171,GO:0006505,1,0.83590647286296,0,31,GPI anchor metabolic process,BP,
3172,GO:0006506,1,0.840652504666591,0,30,GPI anchor biosynthetic process,BP,
3173,GO:0006507,1,0.994364317703459,0,1,GPI anchor release,BP,
3175,GO:0006509,1,0.767955133117318,0,40,membrane protein ectodomain proteolysis,BP,
3177,GO:0006513,1,0.641385302817906,0,64,protein monoubiquitination,BP,
3178,GO:0006515,1,0.827112547454763,0,28,protein quality control for misfolded or incompletely synthesized proteins,BP,
3179,GO:0006516,1,0.881361589760395,0,20,glycoprotein catabolic process,BP,
3180,GO:0006517,1,0.830802839019482,0,26,protein deglycosylation,BP,
3183,GO:0006521,1,0.759877825207384,0,58,regulation of cellular amino acid metabolic process,BP,
3184,GO:0006522,1,0.979915006796959,0,4,alanine metabolic process,BP,
3185,GO:0006524,1,0.979915006796959,0,4,alanine catabolic process,BP,
3186,GO:0006525,1,0.898745013948066,0,19,arginine metabolic process,BP,
3187,GO:0006526,1,0.976989798367707,0,5,arginine biosynthetic process,BP,
3188,GO:0006527,1,0.940462497988769,0,10,arginine catabolic process,BP,
3189,GO:0006528,1,0.974718427645559,0,5,asparagine metabolic process,BP,
3190,GO:0006529,1,0.98820525438222,0,2,asparagine biosynthetic process,BP,
3191,GO:0006530,1,0.994131044673793,0,1,asparagine catabolic process,BP,
3192,GO:0006531,1,0.976679216804318,0,5,aspartate metabolic process,BP,
3193,GO:0006532,1,0.988761358705304,0,2,aspartate biosynthetic process,BP,
3194,GO:0006533,1,0.98107809941266,0,4,aspartate catabolic process,BP,
3195,GO:0006534,1,0.938157292683655,0,11,cysteine metabolic process,BP,
3196,GO:0006535,1,0.993598293270506,0,1,cysteine biosynthetic process from serine,BP,
3197,GO:0006536,1,0.818887869296258,0,31,glutamate metabolic process,BP,
3198,GO:0006537,1,0.965683004899974,0,5,glutamate biosynthetic process,BP,
3199,GO:0006538,1,0.951998318222534,0,8,glutamate catabolic process,BP,
3200,GO:0006539,1,0.995344601049742,0,1,glutamate catabolic process via 2-oxoglutarate,BP,
3201,GO:0006540,1,0.987725018207371,0,2,glutamate decarboxylation to succinate,BP,
3202,GO:0006541,1,0.867157270088667,0,21,glutamine metabolic process,BP,
3203,GO:0006542,1,0.992392971185947,0,1,glutamine biosynthetic process,BP,
3204,GO:0006543,1,0.978573251336225,0,3,glutamine catabolic process,BP,
3205,GO:0006544,1,0.938120751324824,0,12,glycine metabolic process,BP,
3206,GO:0006545,1,0.984462267223262,0,3,glycine biosynthetic process,BP,
3207,GO:0006546,1,0.983616930638129,0,3,glycine catabolic process,BP,
3210,GO:0006549,1,0.977422847488481,0,5,isoleucine metabolic process,BP,
3211,GO:0006550,1,0.990703267080866,0,2,isoleucine catabolic process,BP,
3212,GO:0006551,1,0.951716081312191,0,8,leucine metabolic process,BP,
3213,GO:0006552,1,0.964936815058974,0,6,leucine catabolic process,BP,
3214,GO:0006553,1,0.918738855429789,0,13,lysine metabolic process,BP,
3215,GO:0006554,1,0.925131765815327,0,12,lysine catabolic process,BP,
3216,GO:0006555,1,0.906170007825978,0,16,methionine metabolic process,BP,
3217,GO:0006556,1,0.974145035871742,0,4,S-adenosylmethionine biosynthetic process,BP,
3218,GO:0006557,1,0.992661093381669,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3219,GO:0006558,1,0.952965494757949,0,10,L-phenylalanine metabolic process,BP,
3220,GO:0006559,1,0.952965494757949,0,10,L-phenylalanine catabolic process,BP,
3221,GO:0006560,1,0.9561578718717,0,8,proline metabolic process,BP,
3222,GO:0006561,1,0.97243208337058,0,5,proline biosynthetic process,BP,
3223,GO:0006562,1,0.983269161122914,0,3,proline catabolic process,BP,
3224,GO:0006563,1,0.947718705881767,0,10,L-serine metabolic process,BP,
3225,GO:0006564,1,0.963551688361576,0,7,L-serine biosynthetic process,BP,
3226,GO:0006565,1,0.978153933258392,0,4,L-serine catabolic process,BP,
3227,GO:0006566,1,0.983367374525504,0,4,threonine metabolic process,BP,
3228,GO:0006567,1,0.98825460036279,0,3,threonine catabolic process,BP,
3229,GO:0006568,1,0.950310898474293,0,10,tryptophan metabolic process,BP,
3230,GO:0006569,1,0.963799522042704,0,8,tryptophan catabolic process,BP,
3231,GO:0006570,1,0.956828598782196,0,9,tyrosine metabolic process,BP,
3232,GO:0006571,1,0.993411449905196,0,1,tyrosine biosynthetic process,BP,
3233,GO:0006572,1,0.977126455292086,0,5,tyrosine catabolic process,BP,
3234,GO:0006573,1,0.9608965520522,0,7,valine metabolic process,BP,
3235,GO:0006574,1,0.979810847204957,0,4,valine catabolic process,BP,
3237,GO:0006576,1,0.749362111640402,0,52,cellular biogenic amine metabolic process,BP,
3238,GO:0006577,1,0.894279582418556,0,17,amino-acid betaine metabolic process,BP,
3239,GO:0006578,1,0.955701273599552,0,7,amino-acid betaine biosynthetic process,BP,
3240,GO:0006579,1,0.980606116344325,0,3,amino-acid betaine catabolic process,BP,
3241,GO:0006580,1,0.986431775242431,0,2,ethanolamine metabolic process,BP,
3242,GO:0006581,1,0.986577716757652,0,2,acetylcholine catabolic process,BP,
3243,GO:0006582,1,0.861775623576567,0,21,melanin metabolic process,BP,
3244,GO:0006583,1,0.994209955984366,0,1,melanin biosynthetic process from tyrosine,BP,
3245,GO:0006584,1,0.734931977640085,0,49,catecholamine metabolic process,BP,
3246,GO:0006585,1,0.995335190731637,0,1,dopamine biosynthetic process from tyrosine,BP,
3247,GO:0006586,1,0.932302535893661,0,14,indolalkylamine metabolic process,BP,
3248,GO:0006589,1,0.986155565453147,0,2,octopamine biosynthetic process,BP,
3249,GO:0006590,1,0.871696602627459,0,19,thyroid hormone generation,BP,
3250,GO:0006591,1,0.952663459718767,0,9,ornithine metabolic process,BP,
3251,GO:0006592,1,0.992559612793362,0,1,ornithine biosynthetic process,BP,
3252,GO:0006593,1,0.995872708604307,0,1,ornithine catabolic process,BP,
3253,GO:0006595,1,0.925248730337828,0,16,polyamine metabolic process,BP,
3254,GO:0006596,1,0.937772124466789,0,13,polyamine biosynthetic process,BP,
3255,GO:0006597,1,0.988485596349817,0,2,spermine biosynthetic process,BP,
3256,GO:0006598,1,0.984050559748922,0,4,polyamine catabolic process,BP,
3257,GO:0006599,1,0.979783953948238,0,5,phosphagen metabolic process,BP,
3258,GO:0006600,1,0.963038784527099,0,8,creatine metabolic process,BP,
3259,GO:0006601,1,0.990303576819731,0,2,creatine biosynthetic process,BP,
3260,GO:0006603,1,0.979783953948238,0,5,phosphocreatine metabolic process,BP,
3263,GO:0006607,1,0.883739142744991,0,16,NLS-bearing protein import into nucleus,BP,
3264,GO:0006610,1,0.973473751252726,0,4,ribosomal protein import into nucleus,BP,
3265,GO:0006611,1,0.312978105065099,0,176,protein export from nucleus,BP,
3269,GO:0006616,1,0.954162185410631,0,8,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3270,GO:0006617,1,0.99122718307737,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3271,GO:0006620,1,0.935531311922494,0,11,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3272,GO:0006621,1,0.947970672794991,0,9,protein retention in ER lumen,BP,
3273,GO:0006622,1,0.86200158576649,0,20,protein targeting to lysosome,BP,
3274,GO:0006623,1,0.758956943539968,0,37,protein targeting to vacuole,BP,
3275,GO:0006624,1,0.991677135913829,0,2,vacuolar protein processing,BP,
3277,GO:0006626,1,0.584703727728179,0,92,protein targeting to mitochondrion,BP,
3278,GO:0006627,1,0.961240399748174,0,7,protein processing involved in protein targeting to mitochondrion,BP,
3282,GO:0006635,1,0.642211632821616,0,71,fatty acid beta-oxidation,BP,
3283,GO:0006636,1,0.744965789233742,0,52,unsaturated fatty acid biosynthetic process,BP,
3284,GO:0006637,1,0.56741603351595,0,93,acyl-CoA metabolic process,BP,
3285,GO:0006638,1,0.503559708068241,0,106,neutral lipid metabolic process,BP,
3286,GO:0006639,1,0.503559708068241,0,106,acylglycerol metabolic process,BP,
3287,GO:0006640,1,0.979575727051753,0,3,monoacylglycerol biosynthetic process,BP,
3288,GO:0006641,1,0.595531370095559,0,82,triglyceride metabolic process,BP,
3289,GO:0006642,1,0.966443660273071,0,4,triglyceride mobilization,BP,
3292,GO:0006646,1,0.912292685254986,0,14,phosphatidylethanolamine biosynthetic process,BP,
3293,GO:0006649,1,0.983646540309758,0,2,phospholipid transfer to membrane,BP,
3295,GO:0006651,1,0.955340619665822,0,7,diacylglycerol biosynthetic process,BP,
3297,GO:0006655,1,0.936963017764299,0,10,phosphatidylglycerol biosynthetic process,BP,
3298,GO:0006656,1,0.805742523954469,0,37,phosphatidylcholine biosynthetic process,BP,
3299,GO:0006657,1,0.960688994953221,0,7,CDP-choline pathway,BP,
3300,GO:0006658,1,0.852895105367269,0,26,phosphatidylserine metabolic process,BP,
3301,GO:0006659,1,0.975091399714201,0,4,phosphatidylserine biosynthetic process,BP,
3302,GO:0006660,1,0.985013212053556,0,3,phosphatidylserine catabolic process,BP,
3303,GO:0006661,1,0.448668375217532,0,114,phosphatidylinositol biosynthetic process,BP,
3304,GO:0006662,1,0.886183280346815,0,19,glycerol ether metabolic process,BP,
3305,GO:0006663,1,0.970404127017098,0,5,platelet activating factor biosynthetic process,BP,
3308,GO:0006666,1,0.992039739195357,0,1,3-keto-sphinganine metabolic process,BP,
3309,GO:0006667,1,0.982648709738281,0,3,sphinganine metabolic process,BP,
3310,GO:0006668,1,0.985636376296739,0,2,sphinganine-1-phosphate metabolic process,BP,
3311,GO:0006669,1,0.992948234523058,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3312,GO:0006670,1,0.908006942959161,0,15,sphingosine metabolic process,BP,
3313,GO:0006671,1,0.992384779517392,0,1,phytosphingosine metabolic process,BP,
3318,GO:0006680,1,0.975833573865181,0,4,glucosylceramide catabolic process,BP,
3321,GO:0006683,1,0.982074628361252,0,3,galactosylceramide catabolic process,BP,
3322,GO:0006684,1,0.928741360862326,0,12,sphingomyelin metabolic process,BP,
3323,GO:0006685,1,0.963813268756471,0,6,sphingomyelin catabolic process,BP,
3324,GO:0006686,1,0.963624740974069,0,6,sphingomyelin biosynthetic process,BP,
3327,GO:0006689,1,0.964790550858823,0,6,ganglioside catabolic process,BP,
3328,GO:0006690,1,0.599537033329075,0,93,icosanoid metabolic process,BP,
3329,GO:0006691,1,0.878739708832699,0,23,leukotriene metabolic process,BP,
3330,GO:0006692,1,0.793291851471267,0,43,prostanoid metabolic process,BP,
3331,GO:0006693,1,0.793291851471267,0,43,prostaglandin metabolic process,BP,
3332,GO:0006694,1,0.361859057892544,0,163,steroid biosynthetic process,BP,
3333,GO:0006695,1,0.660749139419022,0,63,cholesterol biosynthetic process,BP,
3334,GO:0006699,1,0.814206274717525,0,33,bile acid biosynthetic process,BP,
3335,GO:0006700,1,0.880353131450598,0,20,C21-steroid hormone biosynthetic process,BP,
3336,GO:0006701,1,0.966243975321266,0,5,progesterone biosynthetic process,BP,
3337,GO:0006702,1,0.957630247818698,0,7,androgen biosynthetic process,BP,
3338,GO:0006703,1,0.947835485496738,0,11,estrogen biosynthetic process,BP,
3339,GO:0006704,1,0.912775058255429,0,14,glucocorticoid biosynthetic process,BP,
3340,GO:0006705,1,0.938407922820478,0,9,mineralocorticoid biosynthetic process,BP,
3341,GO:0006706,1,0.889574273523857,0,22,steroid catabolic process,BP,
3342,GO:0006707,1,0.953060129205608,0,9,cholesterol catabolic process,BP,
3343,GO:0006710,1,0.974559282758093,0,5,androgen catabolic process,BP,
3344,GO:0006711,1,0.995613794103254,0,1,estrogen catabolic process,BP,
3345,GO:0006713,1,0.995598865000946,0,1,glucocorticoid catabolic process,BP,
3346,GO:0006714,1,0.992444871667169,0,2,sesquiterpenoid metabolic process,BP,
3349,GO:0006722,1,0.986531168858434,0,2,triterpenoid metabolic process,BP,
3351,GO:0006726,1,0.988556068486687,0,2,eye pigment biosynthetic process,BP,
3352,GO:0006729,1,0.967699583451662,0,7,tetrahydrobiopterin biosynthetic process,BP,
3353,GO:0006730,1,0.799684429047797,0,38,one-carbon metabolic process,BP,
3355,GO:0006735,1,0.852055424292368,0,26,NADH regeneration,BP,
3356,GO:0006738,1,0.994046636166459,0,1,nicotinamide riboside catabolic process,BP,
3357,GO:0006739,1,0.83552114643798,0,31,NADP metabolic process,BP,
3358,GO:0006740,1,0.914012650622172,0,16,NADPH regeneration,BP,
3359,GO:0006741,1,0.981755674540179,0,3,NADP biosynthetic process,BP,
3360,GO:0006742,1,0.984059543201111,0,3,NADP catabolic process,BP,
3361,GO:0006743,1,0.915059810450409,0,17,ubiquinone metabolic process,BP,
3362,GO:0006744,1,0.928933700907263,0,15,ubiquinone biosynthetic process,BP,
3363,GO:0006747,1,0.995175350268869,0,1,FAD biosynthetic process,BP,
3364,GO:0006749,1,0.811758964369936,0,42,glutathione metabolic process,BP,
3365,GO:0006750,1,0.915044932993811,0,15,glutathione biosynthetic process,BP,
3366,GO:0006751,1,0.970210975171932,0,6,glutathione catabolic process,BP,
3368,GO:0006754,1,0.843418658169545,0,29,ATP biosynthetic process,BP,
3369,GO:0006756,1,0.99325505912211,0,1,AMP phosphorylation,BP,
3373,GO:0006767,1,0.614030364745412,0,78,water-soluble vitamin metabolic process,BP,
3374,GO:0006768,1,0.945104172246106,0,9,biotin metabolic process,BP,
3375,GO:0006771,1,0.955926384651897,0,7,riboflavin metabolic process,BP,
3376,GO:0006772,1,0.983372659964589,0,3,thiamine metabolic process,BP,
3378,GO:0006776,1,0.957387353061586,0,7,vitamin A metabolic process,BP,
3379,GO:0006777,1,0.963064952063979,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3380,GO:0006778,1,0.819989259521314,0,34,porphyrin-containing compound metabolic process,BP,
3381,GO:0006779,1,0.853659028715215,0,26,porphyrin-containing compound biosynthetic process,BP,
3382,GO:0006780,1,0.991015790769685,0,2,uroporphyrinogen III biosynthetic process,BP,
3383,GO:0006781,1,0.994677031264593,0,1,succinyl-CoA pathway,BP,
3384,GO:0006782,1,0.952219358884758,0,9,protoporphyrinogen IX biosynthetic process,BP,
3385,GO:0006783,1,0.878137567804967,0,22,heme biosynthetic process,BP,
3386,GO:0006784,1,0.983956700921647,0,2,heme A biosynthetic process,BP,
3387,GO:0006787,1,0.985165219453117,0,4,porphyrin-containing compound catabolic process,BP,
3388,GO:0006788,1,0.991760225711119,0,2,heme oxidation,BP,
3392,GO:0006797,1,0.962110462196314,0,5,polyphosphate metabolic process,BP,
3393,GO:0006798,1,0.968778516507387,0,4,polyphosphate catabolic process,BP,
3395,GO:0006805,1,0.627807432522997,0,86,xenobiotic metabolic process,BP,
3397,GO:0006808,1,0.984057153577089,0,3,regulation of nitrogen utilization,BP,
3398,GO:0006809,1,0.657503324310626,0,64,nitric oxide biosynthetic process,BP,
3405,GO:0006817,1,0.855985366180215,0,24,phosphate ion transport,BP,
3407,GO:0006821,1,0.500834851340566,0,99,chloride transport,BP,
3408,GO:0006824,1,0.964108663017801,0,6,cobalt ion transport,BP,
3409,GO:0006825,1,0.887896703823933,0,18,copper ion transport,BP,
3411,GO:0006828,1,0.89621711339691,0,15,manganese ion transport,BP,
3412,GO:0006829,1,0.856276124985014,0,24,zinc ion transport,BP,
3413,GO:0006833,1,0.898407993499221,0,18,water transport,BP,
3416,GO:0006837,1,0.877401340560682,0,21,serotonin transport,BP,
3418,GO:0006842,1,0.973810932556246,0,4,tricarboxylic acid transport,BP,
3419,GO:0006843,1,0.995957962710815,0,1,mitochondrial citrate transmembrane transport,BP,
3420,GO:0006844,1,0.970873060136588,0,5,acyl carnitine transport,BP,
3421,GO:0006848,1,0.974855032482009,0,4,pyruvate transport,BP,
3422,GO:0006850,1,0.986555151512788,0,2,mitochondrial pyruvate transmembrane transport,BP,
3423,GO:0006851,1,0.867100091315844,0,23,mitochondrial calcium ion transmembrane transport,BP,
3424,GO:0006853,1,0.935324886088958,0,9,carnitine shuttle,BP,
3425,GO:0006855,1,0.943409498595756,0,8,drug transmembrane transport,BP,
3427,GO:0006858,1,0.818420451388918,0,30,extracellular transport,BP,
3429,GO:0006863,1,0.961756618539959,0,7,purine nucleobase transport,BP,
3430,GO:0006864,1,0.988501017888923,0,2,pyrimidine nucleotide transport,BP,
3432,GO:0006867,1,0.982370283711435,0,3,asparagine transport,BP,
3433,GO:0006868,1,0.942208499968745,0,9,glutamine transport,BP,
3438,GO:0006876,1,0.985220401877757,0,2,cellular cadmium ion homeostasis,BP,
3439,GO:0006878,1,0.917830663081192,0,14,cellular copper ion homeostasis,BP,
3441,GO:0006880,1,0.988343689579921,0,3,intracellular sequestering of iron ion,BP,
3442,GO:0006882,1,0.843332249179958,0,31,cellular zinc ion homeostasis,BP,
3443,GO:0006883,1,0.888128340436059,0,17,cellular sodium ion homeostasis,BP,
3444,GO:0006884,1,0.828080155944602,0,27,cell volume homeostasis,BP,
3445,GO:0006885,1,0.546239702633727,0,96,regulation of pH,BP,
3449,GO:0006890,1,0.583226799430833,0,81,retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum,BP,
3450,GO:0006891,1,0.811748337018034,0,32,intra-Golgi vesicle-mediated transport,BP,
3453,GO:0006895,1,0.886572175933252,0,15,Golgi to endosome transport,BP,
3454,GO:0006896,1,0.894833113672888,0,17,Golgi to vacuole transport,BP,
3457,GO:0006900,1,0.499360177170406,0,106,vesicle budding from membrane,BP,
3458,GO:0006901,1,0.642069283546526,0,68,vesicle coating,BP,
3459,GO:0006903,1,0.548961583437964,0,90,vesicle targeting,BP,
3460,GO:0006904,1,0.750507848870176,0,44,vesicle docking involved in exocytosis,BP,
3461,GO:0006906,1,0.554074676343182,0,92,vesicle fusion,BP,
3462,GO:0006907,1,0.867414510610884,0,22,pinocytosis,BP,
3463,GO:0006909,1,0.200711871346077,0,249,phagocytosis,BP,
3464,GO:0006910,1,0.918352757735025,0,14,phagocytosis, recognition,BP,
3465,GO:0006911,1,0.720657661617294,0,51,phagocytosis, engulfment,BP,
3471,GO:0006924,1,0.951333778965087,0,8,activation-induced cell death of T cells,BP,
3472,GO:0006925,1,0.883746017673977,0,19,inflammatory cell apoptotic process,BP,
3474,GO:0006929,1,0.82595670349995,0,26,substrate-dependent cell migration,BP,
3475,GO:0006930,1,0.939318835957532,0,9,substrate-dependent cell migration, cell extension,BP,
3476,GO:0006931,1,0.969914892518321,0,4,substrate-dependent cell migration, cell attachment to substrate,BP,
3477,GO:0006933,1,0.982556951491902,0,3,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3480,GO:0006937,1,0.375717926447808,0,149,regulation of muscle contraction,BP,
3481,GO:0006939,1,0.521182715006223,0,98,smooth muscle contraction,BP,
3482,GO:0006940,1,0.703686476999046,0,55,regulation of smooth muscle contraction,BP,
3484,GO:0006942,1,0.55861911513708,0,85,regulation of striated muscle contraction,BP,
3485,GO:0006948,1,0.992786080512339,0,1,induction by virus of host cell-cell fusion,BP,
3486,GO:0006949,1,0.742190681279561,0,46,syncytium formation,BP,
3489,GO:0006953,1,0.819020011510336,0,36,acute-phase response,BP,
3492,GO:0006956,1,0.734345069237333,0,53,complement activation,BP,
3493,GO:0006957,1,0.931323920579645,0,11,complement activation, alternative pathway,BP,
3494,GO:0006958,1,0.845389653886825,0,27,complement activation, classical pathway,BP,
3496,GO:0006968,1,0.76056498906317,0,48,cellular defense response,BP,
3498,GO:0006971,1,0.928459364131251,0,10,hypotonic response,BP,
3499,GO:0006972,1,0.849784873410559,0,25,hyperosmotic response,BP,
3501,GO:0006975,1,0.949766412882636,0,8,DNA damage induced protein phosphorylation,BP,
3502,GO:0006977,1,0.709367765380883,0,54,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3503,GO:0006978,1,0.895804992299954,0,17,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
3505,GO:0006982,1,0.992383489770649,0,2,response to lipid hydroperoxide,BP,
3506,GO:0006983,1,0.924591267903395,0,11,ER overload response,BP,
3509,GO:0006990,1,0.981187481328683,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3510,GO:0006991,1,0.899015254837492,0,15,response to sterol depletion,BP,
3511,GO:0006995,1,0.947222518423164,0,11,cellular response to nitrogen starvation,BP,
3513,GO:0006997,1,0.457550851663764,0,116,nucleus organization,BP,
3514,GO:0006998,1,0.728131574589443,0,50,nuclear envelope organization,BP,
3515,GO:0006999,1,0.905084119348931,0,14,nuclear pore organization,BP,
3516,GO:0007000,1,0.957505915504373,0,7,nucleolus organization,BP,
3517,GO:0007004,1,0.651241716952062,0,65,telomere maintenance via telomerase,BP,
3520,GO:0007007,1,0.855817812681082,0,29,inner mitochondrial membrane organization,BP,
3521,GO:0007008,1,0.966941501792839,0,6,outer mitochondrial membrane organization,BP,
3524,GO:0007014,1,0.992502700385995,0,1,actin ubiquitination,BP,
3529,GO:0007020,1,0.812774725364128,0,28,microtubule nucleation,BP,
3530,GO:0007021,1,0.95703008514241,0,9,tubulin complex assembly,BP,
3531,GO:0007023,1,0.973052828916402,0,5,post-chaperonin tubulin folding pathway,BP,
3532,GO:0007026,1,0.829812971845403,0,25,negative regulation of microtubule depolymerization,BP,
3533,GO:0007028,1,0.9252585059251,0,10,cytoplasm organization,BP,
3534,GO:0007029,1,0.656403546394244,0,62,endoplasmic reticulum organization,BP,
3535,GO:0007030,1,0.37476172130624,0,135,Golgi organization,BP,
3537,GO:0007032,1,0.626382023803802,0,71,endosome organization,BP,
3538,GO:0007033,1,0.345923216637186,0,161,vacuole organization,BP,
3539,GO:0007034,1,0.376065117706107,0,141,vacuolar transport,BP,
3542,GO:0007040,1,0.666658387561104,0,62,lysosome organization,BP,
3543,GO:0007041,1,0.481616577859543,0,102,lysosomal transport,BP,
3544,GO:0007042,1,0.956129983873416,0,9,lysosomal lumen acidification,BP,
3548,GO:0007050,1,0.240298414186077,0,219,cell cycle arrest,BP,
3549,GO:0007051,1,0.311294212972169,0,168,spindle organization,BP,
3550,GO:0007052,1,0.474705718215848,0,109,mitotic spindle organization,BP,
3551,GO:0007056,1,0.989203884487972,0,2,spindle assembly involved in female meiosis,BP,
3552,GO:0007057,1,0.989203884487972,0,2,spindle assembly involved in female meiosis I,BP,
3553,GO:0007059,1,0.142707186397484,0,290,chromosome segregation,BP,
3554,GO:0007060,1,0.97347593776306,0,4,male meiosis chromosome segregation,BP,
3555,GO:0007062,1,0.720521279069181,0,47,sister chromatid cohesion,BP,
3556,GO:0007063,1,0.875330432765006,0,18,regulation of sister chromatid cohesion,BP,
3557,GO:0007064,1,0.858635308778555,0,21,mitotic sister chromatid cohesion,BP,
3558,GO:0007066,1,0.996697204906057,0,1,female meiosis sister chromatid cohesion,BP,
3559,GO:0007072,1,0.995745180872483,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3560,GO:0007076,1,0.882940401671184,0,15,mitotic chromosome condensation,BP,
3561,GO:0007077,1,0.9256528772273,0,12,mitotic nuclear envelope disassembly,BP,
3562,GO:0007079,1,0.969231114410552,0,4,mitotic chromosome movement towards spindle pole,BP,
3563,GO:0007080,1,0.752277508174966,0,47,mitotic metaphase plate congression,BP,
3564,GO:0007084,1,0.947021677740522,0,10,mitotic nuclear envelope reassembly,BP,
3566,GO:0007089,1,0.972460077352893,0,4,traversing start control point of mitotic cell cycle,BP,
3567,GO:0007091,1,0.6883538591223,0,57,metaphase/anaphase transition of mitotic cell cycle,BP,
3568,GO:0007093,1,0.360482353521912,0,157,mitotic cell cycle checkpoint,BP,
3569,GO:0007094,1,0.803667900881679,0,34,mitotic spindle assembly checkpoint,BP,
3570,GO:0007095,1,0.867703799622114,0,20,mitotic G2 DNA damage checkpoint,BP,
3572,GO:0007097,1,0.818686543493686,0,23,nuclear migration,BP,
3573,GO:0007098,1,0.431866935915939,0,120,centrosome cycle,BP,
3575,GO:0007100,1,0.911111957789879,0,14,mitotic centrosome separation,BP,
3576,GO:0007113,1,0.985733254297336,0,3,endomitotic cell cycle,BP,
3577,GO:0007127,1,0.548794327433593,0,93,meiosis I,BP,
3578,GO:0007129,1,0.795705788176309,0,36,homologous chromosome pairing at meiosis,BP,
3579,GO:0007130,1,0.905639056072197,0,16,synaptonemal complex assembly,BP,
3580,GO:0007131,1,0.729720893135294,0,47,reciprocal meiotic recombination,BP,
3581,GO:0007135,1,0.940999451770003,0,10,meiosis II,BP,
3582,GO:0007140,1,0.779445906708797,0,37,male meiotic nuclear division,BP,
3583,GO:0007141,1,0.896066197850685,0,18,male meiosis I,BP,
3584,GO:0007143,1,0.838206985969944,0,26,female meiotic nuclear division,BP,
3585,GO:0007144,1,0.958176864750449,0,7,female meiosis I,BP,
3586,GO:0007146,1,0.99325505912211,0,1,meiotic recombination nodule assembly,BP,
3587,GO:0007147,1,0.992517278529714,0,1,female meiosis II,BP,
3591,GO:0007157,1,0.746403681613726,0,39,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
3592,GO:0007158,1,0.878418500269931,0,17,neuron cell-cell adhesion,BP,
3595,GO:0007161,1,0.963639914712856,0,4,calcium-independent cell-matrix adhesion,BP,
3602,GO:0007168,1,0.957503808212058,0,8,receptor guanylyl cyclase signaling pathway,BP,
3605,GO:0007172,1,0.949268501296278,0,8,signal complex assembly,BP,
3607,GO:0007174,1,0.989364470774331,0,2,epidermal growth factor catabolic process,BP,
3608,GO:0007175,1,0.911678131608001,0,14,negative regulation of epidermal growth factor-activated receptor activity,BP,
3609,GO:0007176,1,0.827511234007033,0,29,regulation of epidermal growth factor-activated receptor activity,BP,
3611,GO:0007179,1,0.27881970930622,0,181,transforming growth factor beta receptor signaling pathway,BP,
3612,GO:0007181,1,0.980676006603835,0,3,transforming growth factor beta receptor complex assembly,BP,
3613,GO:0007182,1,0.955129450792771,0,6,common-partner SMAD protein phosphorylation,BP,
3614,GO:0007183,1,0.912397086852573,0,13,SMAD protein complex assembly,BP,
3615,GO:0007185,1,0.950264622137788,0,6,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3617,GO:0007187,1,0.283710259263765,0,206,G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,
3618,GO:0007188,1,0.311939773360215,0,189,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,BP,
3619,GO:0007189,1,0.517764037452092,0,107,adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,
3620,GO:0007190,1,0.794987188871924,0,34,activation of adenylate cyclase activity,BP,
3621,GO:0007191,1,0.936941673859871,0,11,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3622,GO:0007193,1,0.590971687368017,0,80,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,BP,
3623,GO:0007194,1,0.884802891676064,0,19,negative regulation of adenylate cyclase activity,BP,
3624,GO:0007195,1,0.962997287665056,0,6,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3625,GO:0007196,1,0.945983389561325,0,7,adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,BP,
3626,GO:0007197,1,0.958934207056266,0,7,adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,BP,
3627,GO:0007198,1,0.964496149166131,0,7,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3628,GO:0007199,1,0.993650213761529,0,1,G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3629,GO:0007200,1,0.578007136452974,0,92,phospholipase C-activating G protein-coupled receptor signaling pathway,BP,
3632,GO:0007205,1,0.851141878368658,0,24,protein kinase C-activating G protein-coupled receptor signaling pathway,BP,
3633,GO:0007206,1,0.983041759350115,0,2,phospholipase C-activating G protein-coupled glutamate receptor signaling pathway,BP,
3634,GO:0007207,1,0.98187532475353,0,3,phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway,BP,
3635,GO:0007208,1,0.985023074134806,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3636,GO:0007210,1,0.8712089887039,0,24,serotonin receptor signaling pathway,BP,
3637,GO:0007212,1,0.786899477862313,0,38,dopamine receptor signaling pathway,BP,
3638,GO:0007213,1,0.903590908459177,0,17,G protein-coupled acetylcholine receptor signaling pathway,BP,
3641,GO:0007216,1,0.892806543471261,0,15,G protein-coupled glutamate receptor signaling pathway,BP,
3642,GO:0007217,1,0.966669872502892,0,7,tachykinin receptor signaling pathway,BP,
3643,GO:0007218,1,0.621387159670856,0,91,neuropeptide signaling pathway,BP,
3645,GO:0007220,1,0.936037001032568,0,10,Notch receptor processing,BP,
3646,GO:0007221,1,0.860414719489969,0,18,positive regulation of transcription of Notch receptor target,BP,
3647,GO:0007223,1,0.752636320034028,0,38,Wnt signaling pathway, calcium modulating pathway,BP,
3648,GO:0007224,1,0.390186591870619,0,134,smoothened signaling pathway,BP,
3649,GO:0007225,1,0.992257102319486,0,1,patched ligand maturation,BP,
3650,GO:0007227,1,0.973411369686518,0,4,signal transduction downstream of smoothened,BP,
3651,GO:0007228,1,0.98079349576331,0,3,positive regulation of hh target transcription factor activity,BP,
3653,GO:0007231,1,0.971902189710228,0,4,osmosensory signaling pathway,BP,
3655,GO:0007250,1,0.895366356071216,0,17,activation of NF-kappaB-inducing kinase activity,BP,
3656,GO:0007252,1,0.883273039293987,0,18,I-kappaB phosphorylation,BP,
3657,GO:0007253,1,0.960685057945453,0,8,cytoplasmic sequestering of NF-kappaB,BP,
3659,GO:0007256,1,0.919101149977767,0,11,activation of JNKK activity,BP,
3661,GO:0007258,1,0.974197568674224,0,4,JUN phosphorylation,BP,
3671,GO:0007270,1,0.938339029368987,0,8,neuron-neuron synaptic transmission,BP,
3672,GO:0007271,1,0.849002865048296,0,26,synaptic transmission, cholinergic,BP,
3674,GO:0007274,1,0.865729929341589,0,22,neuromuscular synaptic transmission,BP,
3677,GO:0007281,1,0.269258743462286,0,202,germ cell development,BP,
3679,GO:0007284,1,0.984841288043885,0,2,spermatogonial cell division,BP,
3680,GO:0007286,1,0.506704199237352,0,107,spermatid development,BP,
3681,GO:0007288,1,0.909504801826334,0,14,sperm axoneme assembly,BP,
3682,GO:0007289,1,0.909048242052811,0,14,spermatid nucleus differentiation,BP,
3683,GO:0007290,1,0.992244602600739,0,1,spermatid nucleus elongation,BP,
3684,GO:0007291,1,0.996670617483058,0,1,sperm individualization,BP,
3685,GO:0007292,1,0.461754558782112,0,117,female gamete generation,BP,
3686,GO:0007296,1,0.968822048874845,0,4,vitellogenesis,BP,
3687,GO:0007308,1,0.980387406958434,0,3,oocyte construction,BP,
3688,GO:0007309,1,0.980387406958434,0,3,oocyte axis specification,BP,
3689,GO:0007314,1,0.980387406958434,0,3,oocyte anterior/posterior axis specification,BP,
3690,GO:0007315,1,0.980387406958434,0,3,pole plasm assembly,BP,
3691,GO:0007320,1,0.947012628636179,0,9,insemination,BP,
3692,GO:0007338,1,0.503166984379343,0,114,single fertilization,BP,
3693,GO:0007339,1,0.849855758101308,0,29,binding of sperm to zona pellucida,BP,
3694,GO:0007340,1,0.822397649376986,0,31,acrosome reaction,BP,
3695,GO:0007341,1,0.97304082490147,0,6,penetration of zona pellucida,BP,
3696,GO:0007342,1,0.963745527872108,0,9,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3697,GO:0007343,1,0.985495658379075,0,2,egg activation,BP,
3698,GO:0007344,1,0.995686812967221,0,1,pronuclear fusion,BP,
3700,GO:0007349,1,0.996670617483058,0,1,cellularization,BP,
3703,GO:0007352,1,0.979198918565599,0,3,zygotic specification of dorsal/ventral axis,BP,
3705,GO:0007356,1,0.978354424277161,0,4,thorax and anterior abdomen determination,BP,
3708,GO:0007371,1,0.992498777094404,0,1,ventral midline determination,BP,
3709,GO:0007379,1,0.913869508463919,0,15,segment specification,BP,
3710,GO:0007386,1,0.965486250351185,0,5,compartment pattern specification,BP,
3711,GO:0007387,1,0.993365855498381,0,1,anterior compartment pattern formation,BP,
3712,GO:0007388,1,0.993365855498381,0,1,posterior compartment specification,BP,
3716,GO:0007400,1,0.993898281598366,0,1,neuroblast fate determination,BP,
3717,GO:0007402,1,0.991078548552801,0,2,ganglion mother cell fate determination,BP,
3718,GO:0007403,1,0.9925769027008,0,1,glial cell fate determination,BP,
3720,GO:0007406,1,0.956359964684989,0,6,negative regulation of neuroblast proliferation,BP,
3723,GO:0007412,1,0.981611965888279,0,3,axon target recognition,BP,
3725,GO:0007416,1,0.28850177692941,0,159,synapse assembly,BP,
3727,GO:0007418,1,0.972495390436446,0,4,ventral midline development,BP,
3733,GO:0007439,1,0.986689369563154,0,2,ectodermal digestive tract development,BP,
3734,GO:0007440,1,0.922521365892796,0,10,foregut morphogenesis,BP,
3735,GO:0007442,1,0.95018121471759,0,7,hindgut morphogenesis,BP,
3736,GO:0007468,1,0.983458280209937,0,3,regulation of rhodopsin gene expression,BP,
3737,GO:0007492,1,0.590344547344786,0,75,endoderm development,BP,
3738,GO:0007493,1,0.986813117141392,0,2,endodermal cell fate determination,BP,
3740,GO:0007495,1,0.992718552312644,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3741,GO:0007497,1,0.984662237788464,0,2,posterior midgut development,BP,
3743,GO:0007499,1,0.992300433744243,0,1,ectoderm and mesoderm interaction,BP,
3744,GO:0007500,1,0.988634783179596,0,2,mesodermal cell fate determination,BP,
3746,GO:0007506,1,0.987457192349074,0,2,gonadal mesoderm development,BP,
3748,GO:0007509,1,0.991276220347489,0,1,mesoderm migration involved in gastrulation,BP,
3749,GO:0007512,1,0.920305608804917,0,12,adult heart development,BP,
3751,GO:0007518,1,0.989753280576164,0,2,myoblast fate determination,BP,
3753,GO:0007520,1,0.806464860033866,0,34,myoblast fusion,BP,
3754,GO:0007521,1,0.984081662475491,0,2,muscle cell fate determination,BP,
3755,GO:0007522,1,0.991606712335286,0,1,visceral muscle development,BP,
3756,GO:0007525,1,0.976564302405349,0,2,somatic muscle development,BP,
3758,GO:0007529,1,0.984965953184816,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3759,GO:0007530,1,0.864795282329136,0,22,sex determination,BP,
3760,GO:0007531,1,0.989303662582116,0,1,mating type determination,BP,
3761,GO:0007533,1,0.989303662582116,0,1,mating type switching,BP,
3762,GO:0007538,1,0.984454663898127,0,2,primary sex determination,BP,
3763,GO:0007542,1,0.984454663898127,0,2,primary sex determination, germ-line,BP,
3765,GO:0007549,1,0.895997528319717,0,14,dosage compensation,BP,
3768,GO:0007567,1,0.900905114264435,0,16,parturition,BP,
3770,GO:0007569,1,0.516023717746948,0,100,cell aging,BP,
3771,GO:0007571,1,0.996640898098766,0,1,age-dependent general metabolic decline,BP,
3773,GO:0007585,1,0.672358439293283,0,61,respiratory gaseous exchange by respiratory system,BP,
3774,GO:0007586,1,0.54448459206479,0,101,digestion,BP,
3775,GO:0007588,1,0.721296208747274,0,52,excretion,BP,
3776,GO:0007589,1,0.586236565059113,0,81,body fluid secretion,BP,
3777,GO:0007595,1,0.740073077814713,0,42,lactation,BP,
3779,GO:0007597,1,0.92377425293194,0,14,blood coagulation, intrinsic pathway,BP,
3780,GO:0007598,1,0.977021423723564,0,4,blood coagulation, extrinsic pathway,BP,
3783,GO:0007601,1,0.312370007404988,0,180,visual perception,BP,
3784,GO:0007602,1,0.761586590709605,0,45,phototransduction,BP,
3785,GO:0007603,1,0.839500773208483,0,27,phototransduction, visible light,BP,
3787,GO:0007606,1,0.620033720804259,0,85,sensory perception of chemical stimulus,BP,
3788,GO:0007608,1,0.807495280817904,0,37,sensory perception of smell,BP,
3792,GO:0007613,1,0.435995961468718,0,115,memory,BP,
3793,GO:0007614,1,0.931852774127838,0,11,short-term memory,BP,
3794,GO:0007616,1,0.777402523666873,0,34,long-term memory,BP,
3795,GO:0007617,1,0.864819809821764,0,21,mating behavior,BP,
3796,GO:0007618,1,0.791044493672311,0,36,mating,BP,
3797,GO:0007619,1,0.980256865852339,0,3,courtship behavior,BP,
3798,GO:0007620,1,0.90789577279709,0,16,copulation,BP,
3799,GO:0007621,1,0.979190751270638,0,3,negative regulation of female receptivity,BP,
3800,GO:0007622,1,0.745874960830841,0,46,rhythmic behavior,BP,
3802,GO:0007624,1,0.985611591718577,0,2,ultradian rhythm,BP,
3806,GO:0007631,1,0.597502941118495,0,85,feeding behavior,BP,
3807,GO:0007632,1,0.699311037303884,0,49,visual behavior,BP,
3808,GO:0007634,1,0.988116491386263,0,2,optokinetic behavior,BP,
3809,GO:0007635,1,0.898353112476825,0,15,chemosensory behavior,BP,
3810,GO:0007638,1,0.891564755166263,0,14,mechanosensory behavior,BP,
3811,GO:0008009,1,0.869581824626639,0,34,chemokine activity,MF,
3816,GO:0008020,1,0.948776049795,0,10,G protein-coupled photoreceptor activity,MF,
3818,GO:0008022,1,0.286673809524397,0,184,protein C-terminus binding,MF,
3819,GO:0008023,1,0.722503210628832,0,47,transcription elongation factor complex,CC,
3820,GO:0008024,1,0.944127128426124,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3821,GO:0008028,1,0.716248241792408,0,52,monocarboxylic acid transmembrane transporter activity,MF,
3822,GO:0008033,1,0.50322500694933,0,118,tRNA processing,BP,
3823,GO:0008035,1,0.944617662296194,0,10,high-density lipoprotein particle binding,MF,
3826,GO:0008039,1,0.992888023392353,0,1,synaptic target recognition,BP,
3827,GO:0008043,1,0.993213094726051,0,2,intracellular ferritin complex,CC,
3828,GO:0008045,1,0.819171129320211,0,30,motor neuron axon guidance,BP,
3829,GO:0008046,1,0.93492184031479,0,9,axon guidance receptor activity,MF,
3831,GO:0008048,1,0.986342098317533,0,3,calcium sensitive guanylate cyclase activator activity,MF,
3832,GO:0008049,1,0.995330476245509,0,1,male courtship behavior,BP,
3833,GO:0008050,1,0.984856391085998,0,2,female courtship behavior,BP,
3834,GO:0008052,1,0.996660777118026,0,1,sensory organ boundary specification,BP,
3835,GO:0008053,1,0.859957016427069,0,24,mitochondrial fusion,BP,
3836,GO:0008057,1,0.990781891880971,0,1,eye pigment granule organization,BP,
3837,GO:0008061,1,0.959231627062882,0,7,chitin binding,MF,
3838,GO:0008063,1,0.952921077585958,0,7,Toll signaling pathway,BP,
3841,GO:0008066,1,0.802017258486312,0,27,glutamate receptor activity,MF,
3842,GO:0008068,1,0.992925192127658,0,1,extracellularly glutamate-gated chloride channel activity,MF,
3843,GO:0008073,1,0.988632422868055,0,3,ornithine decarboxylase inhibitor activity,MF,
3845,GO:0008078,1,0.98450574698114,0,3,mesodermal cell migration,BP,
3846,GO:0008079,1,0.960310087230731,0,6,translation termination factor activity,MF,
3847,GO:0008080,1,0.609417673281363,0,74,N-acetyltransferase activity,MF,
3849,GO:0008083,1,0.493007483166714,0,127,growth factor activity,MF,
3850,GO:0008088,1,0.612668148873363,0,68,axo-dendritic transport,BP,
3851,GO:0008089,1,0.726146690290395,0,46,anterograde axonal transport,BP,
3852,GO:0008090,1,0.855294955067835,0,19,retrograde axonal transport,BP,
3853,GO:0008091,1,0.919272560174462,0,9,spectrin,CC,
3856,GO:0008094,1,0.471510832415949,0,101,DNA-dependent ATPase activity,MF,
3857,GO:0008097,1,0.956262545113442,0,10,5S rRNA binding,MF,
3859,GO:0008106,1,0.915363846908593,0,20,alcohol dehydrogenase (NADP+) activity,MF,
3860,GO:0008107,1,0.992424910476249,0,1,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3861,GO:0008108,1,0.996343791150515,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3862,GO:0008109,1,0.984975011916252,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3863,GO:0008111,1,0.995170452071762,0,1,alpha-methylacyl-CoA racemase activity,MF,
3864,GO:0008112,1,0.996003740405974,0,1,nicotinamide N-methyltransferase activity,MF,
3865,GO:0008113,1,0.992511143113207,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3866,GO:0008115,1,0.994044132206603,0,1,sarcosine oxidase activity,MF,
3867,GO:0008116,1,0.991817574660415,0,1,prostaglandin-I synthase activity,MF,
3868,GO:0008117,1,0.984246927720481,0,2,sphinganine-1-phosphate aldolase activity,MF,
3869,GO:0008118,1,0.994532924588559,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3870,GO:0008119,1,0.992670707445004,0,1,thiopurine S-methyltransferase activity,MF,
3871,GO:0008120,1,0.995905266408568,0,1,ceramide glucosyltransferase activity,MF,
3872,GO:0008121,1,0.978470493697708,0,6,ubiquinol-cytochrome-c reductase activity,MF,
3873,GO:0008124,1,0.990815229244553,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3874,GO:0008126,1,0.968733785463865,0,5,acetylesterase activity,MF,
3875,GO:0008127,1,0.996389367665624,0,1,quercetin 2,3-dioxygenase activity,MF,
3876,GO:0008131,1,0.965498758744232,0,5,primary amine oxidase activity,MF,
3878,GO:0008135,1,0.619282259097562,0,78,translation factor activity, RNA binding,MF,
3879,GO:0008137,1,0.867976398849833,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3880,GO:0008138,1,0.787964998990984,0,39,protein tyrosine/serine/threonine phosphatase activity,MF,
3881,GO:0008139,1,0.856034368126687,0,21,nuclear localization sequence binding,MF,
3882,GO:0008140,1,0.947477669433382,0,9,cAMP response element binding protein binding,MF,
3883,GO:0008142,1,0.950111660413453,0,7,oxysterol binding,MF,
3884,GO:0008143,1,0.851693226015759,0,23,poly(A) binding,MF,
3887,GO:0008147,1,0.993674998801567,0,2,structural constituent of bone,MF,
3891,GO:0008156,1,0.821326674339076,0,29,negative regulation of DNA replication,BP,
3892,GO:0008157,1,0.826636509834522,0,28,protein phosphatase 1 binding,MF,
3893,GO:0008158,1,0.979860880688133,0,3,hedgehog receptor activity,MF,
3894,GO:0008160,1,0.993567175427501,0,1,protein tyrosine phosphatase activator activity,MF,
3895,GO:0008168,1,0.308988748458962,0,181,methyltransferase activity,MF,
3896,GO:0008169,1,0.972712995875774,0,5,C-methyltransferase activity,MF,
3897,GO:0008170,1,0.580880061123892,0,81,N-methyltransferase activity,MF,
3898,GO:0008171,1,0.901183673878989,0,17,O-methyltransferase activity,MF,
3899,GO:0008172,1,0.961497534414905,0,6,S-methyltransferase activity,MF,
3900,GO:0008173,1,0.689992251847959,0,59,RNA methyltransferase activity,MF,
3901,GO:0008174,1,0.928843870134109,0,11,mRNA methyltransferase activity,MF,
3902,GO:0008175,1,0.813571677917824,0,32,tRNA methyltransferase activity,MF,
3903,GO:0008176,1,0.992011312507434,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3904,GO:0008177,1,0.990652942964673,0,2,succinate dehydrogenase (ubiquinone) activity,MF,
3905,GO:0008179,1,0.911288954849017,0,13,adenylate cyclase binding,MF,
3906,GO:0008180,1,0.819166180256033,0,32,COP9 signalosome,CC,
3907,GO:0008184,1,0.978337799331193,0,3,glycogen phosphorylase activity,MF,
3908,GO:0008186,1,0.962601677576346,0,5,RNA-dependent ATPase activity,MF,
3909,GO:0008187,1,0.821421749950297,0,29,poly-pyrimidine tract binding,MF,
3910,GO:0008188,1,0.806237002005856,0,40,neuropeptide receptor activity,MF,
3911,GO:0008190,1,0.937439143816047,0,10,eukaryotic initiation factor 4E binding,MF,
3913,GO:0008192,1,0.988769256104954,0,2,RNA guanylyltransferase activity,MF,
3914,GO:0008193,1,0.996382529986173,0,1,tRNA guanylyltransferase activity,MF,
3916,GO:0008195,1,0.97598663313176,0,3,phosphatidate phosphatase activity,MF,
3919,GO:0008200,1,0.804095906654387,0,35,ion channel inhibitor activity,MF,
3922,GO:0008203,1,0.439068497657843,0,127,cholesterol metabolic process,BP,
3923,GO:0008206,1,0.760394012726823,0,44,bile acid metabolic process,BP,
3924,GO:0008207,1,0.839876181634564,0,30,C21-steroid hormone metabolic process,BP,
3925,GO:0008209,1,0.878092251727032,0,22,androgen metabolic process,BP,
3927,GO:0008211,1,0.882370866438298,0,21,glucocorticoid metabolic process,BP,
3928,GO:0008212,1,0.938407922820478,0,9,mineralocorticoid metabolic process,BP,
3929,GO:0008213,1,0.335872920815024,0,154,protein alkylation,BP,
3930,GO:0008214,1,0.795304974121154,0,29,protein dealkylation,BP,
3931,GO:0008215,1,0.976069525211812,0,5,spermine metabolic process,BP,
3932,GO:0008216,1,0.963220537051184,0,8,spermidine metabolic process,BP,
3935,GO:0008227,1,0.832571985357053,0,31,G protein-coupled amine receptor activity,MF,
3936,GO:0008228,1,0.951763855281124,0,8,opsonization,BP,
3943,GO:0008239,1,0.949042317951646,0,8,dipeptidyl-peptidase activity,MF,
3944,GO:0008240,1,0.977573979932601,0,3,tripeptidyl-peptidase activity,MF,
3945,GO:0008241,1,0.985203309432835,0,2,peptidyl-dipeptidase activity,MF,
3946,GO:0008242,1,0.524521842329953,0,88,omega peptidase activity,MF,
3947,GO:0008250,1,0.936512477961396,0,13,oligosaccharyltransferase complex,CC,
3948,GO:0008251,1,0.952358765532523,0,7,tRNA-specific adenosine deaminase activity,MF,
3949,GO:0008252,1,0.928646498621295,0,12,nucleotidase activity,MF,
3950,GO:0008253,1,0.934326294986955,0,11,5'-nucleotidase activity,MF,
3951,GO:0008260,1,0.988095444794141,0,2,3-oxoacid CoA-transferase activity,MF,
3952,GO:0008263,1,0.986617025065386,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3953,GO:0008265,1,0.993317609585772,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3954,GO:0008266,1,0.841011178877378,0,26,poly(U) RNA binding,MF,
3955,GO:0008269,1,0.994575796660225,0,1,JAK pathway signal transduction adaptor activity,MF,
3957,GO:0008271,1,0.928600002720028,0,10,secondary active sulfate transmembrane transporter activity,MF,
3958,GO:0008272,1,0.902946772298993,0,15,sulfate transport,BP,
3959,GO:0008273,1,0.971412531382885,0,4,calcium, potassium:sodium antiporter activity,MF,
3960,GO:0008274,1,0.947809779675812,0,7,gamma-tubulin ring complex,CC,
3961,GO:0008275,1,0.969157131966027,0,4,gamma-tubulin small complex,CC,
3962,GO:0008276,1,0.598123729464807,0,75,protein methyltransferase activity,MF,
3964,GO:0008278,1,0.93473797908306,0,9,cohesin complex,CC,
3965,GO:0008281,1,0.984471502638294,0,2,sulfonylurea receptor activity,MF,
3966,GO:0008282,1,0.977397773082092,0,3,inward rectifying potassium channel,CC,
3970,GO:0008286,1,0.396910598708776,0,135,insulin receptor signaling pathway,BP,
3971,GO:0008287,1,0.734008934859172,0,46,protein serine/threonine phosphatase complex,CC,
3973,GO:0008290,1,0.957656199735007,0,7,F-actin capping protein complex,CC,
3974,GO:0008291,1,0.97419620213629,0,4,acetylcholine metabolic process,BP,
3975,GO:0008292,1,0.987451755562286,0,2,acetylcholine biosynthetic process,BP,
3976,GO:0008294,1,0.980733784755647,0,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
3977,GO:0008295,1,0.979616115349016,0,4,spermidine biosynthetic process,BP,
3978,GO:0008296,1,0.94127762153325,0,11,3'-5'-exodeoxyribonuclease activity,MF,
3979,GO:0008297,1,0.943861643693627,0,9,single-stranded DNA exodeoxyribonuclease activity,MF,
3980,GO:0008298,1,0.931715947107702,0,12,intracellular mRNA localization,BP,
3981,GO:0008299,1,0.856603924157378,0,26,isoprenoid biosynthetic process,BP,
3982,GO:0008300,1,0.953021391531186,0,9,isoprenoid catabolic process,BP,
3983,GO:0008301,1,0.896915033709582,0,17,DNA binding, bending,MF,
3984,GO:0008303,1,0.970636406328997,0,5,caspase complex,CC,
3985,GO:0008305,1,0.789390028810454,0,31,integrin complex,CC,
3986,GO:0008306,1,0.603241638967012,0,72,associative learning,BP,
3988,GO:0008308,1,0.911110265383146,0,15,voltage-gated anion channel activity,MF,
3989,GO:0008309,1,0.978661184616572,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
3990,GO:0008310,1,0.96730578034787,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3991,GO:0008311,1,0.991320761017923,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3992,GO:0008312,1,0.965185516773557,0,7,7S RNA binding,MF,
3993,GO:0008315,1,0.980231004365714,0,3,G2/MI transition of meiotic cell cycle,BP,
3994,GO:0008318,1,0.956137248361945,0,7,protein prenyltransferase activity,MF,
3995,GO:0008320,1,0.907255026919862,0,17,protein transmembrane transporter activity,MF,
3996,GO:0008321,1,0.977323414161722,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
3998,GO:0008327,1,0.869830115869866,0,21,methyl-CpG binding,MF,
3999,GO:0008328,1,0.70038276415154,0,49,ionotropic glutamate receptor complex,CC,
4000,GO:0008330,1,0.939149734479444,0,10,protein tyrosine/threonine phosphatase activity,MF,
4001,GO:0008331,1,0.916057924405576,0,10,high voltage-gated calcium channel activity,MF,
4002,GO:0008332,1,0.970864035009894,0,3,low voltage-gated calcium channel activity,MF,
4003,GO:0008333,1,0.712765073552207,0,48,endosome to lysosome transport,BP,
4004,GO:0008334,1,0.876838722111381,0,22,histone mRNA metabolic process,BP,
4005,GO:0008336,1,0.99537267991254,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4006,GO:0008340,1,0.892559939498867,0,15,determination of adult lifespan,BP,
4007,GO:0008343,1,0.948352882709128,0,10,adult feeding behavior,BP,
4010,GO:0008348,1,0.992510364740564,0,1,negative regulation of antimicrobial humoral response,BP,
4011,GO:0008349,1,0.971343329682472,0,4,MAP kinase kinase kinase kinase activity,MF,
4012,GO:0008352,1,0.993469823305625,0,1,katanin complex,CC,
4013,GO:0008353,1,0.921063128777523,0,12,RNA polymerase II CTD heptapeptide repeat kinase activity,MF,
4014,GO:0008354,1,0.957704998823996,0,6,germ cell migration,BP,
4015,GO:0008355,1,0.984853248695715,0,2,olfactory learning,BP,
4016,GO:0008356,1,0.876972277759411,0,19,asymmetric cell division,BP,
4017,GO:0008358,1,0.980387406958434,0,3,maternal determination of anterior/posterior axis, embryo,BP,
4021,GO:0008373,1,0.875479392309024,0,20,sialyltransferase activity,MF,
4022,GO:0008374,1,0.77994614313472,0,36,O-acyltransferase activity,MF,
4023,GO:0008375,1,0.759407831871289,0,43,acetylglucosaminyltransferase activity,MF,
4024,GO:0008376,1,0.751107768583825,0,42,acetylgalactosaminyltransferase activity,MF,
4026,GO:0008379,1,0.982856260593856,0,5,thioredoxin peroxidase activity,MF,
4027,GO:0008380,1,0.0726189577893755,0,421,RNA splicing,BP,
4029,GO:0008384,1,0.985071035705317,0,2,IkappaB kinase activity,MF,
4030,GO:0008385,1,0.954787066058873,0,7,IkappaB kinase complex,CC,
4031,GO:0008386,1,0.995177797537924,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
4032,GO:0008387,1,0.994391490129299,0,1,steroid 7-alpha-hydroxylase activity,MF,
4033,GO:0008389,1,0.995645425333552,0,1,coumarin 7-hydroxylase activity,MF,
4034,GO:0008391,1,0.942475397958502,0,11,arachidonic acid monooxygenase activity,MF,
4035,GO:0008392,1,0.96235839478542,0,8,arachidonic acid epoxygenase activity,MF,
4036,GO:0008395,1,0.876458577163178,0,24,steroid hydroxylase activity,MF,
4037,GO:0008396,1,0.988516156946009,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4038,GO:0008397,1,0.992475363987705,0,1,sterol 12-alpha-hydroxylase activity,MF,
4039,GO:0008398,1,0.992818922545584,0,1,sterol 14-demethylase activity,MF,
4040,GO:0008401,1,0.968007760130372,0,6,retinoic acid 4-hydroxylase activity,MF,
4041,GO:0008403,1,0.992727863072114,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4042,GO:0008404,1,0.995441831029351,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4043,GO:0008405,1,0.995441831029351,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4045,GO:0008408,1,0.714067308649476,0,53,3'-5' exonuclease activity,MF,
4046,GO:0008409,1,0.885035219637288,0,17,5'-3' exonuclease activity,MF,
4047,GO:0008410,1,0.967884254858542,0,6,CoA-transferase activity,MF,
4048,GO:0008413,1,0.991873660911594,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4049,GO:0008417,1,0.917465670325676,0,12,fucosyltransferase activity,MF,
4050,GO:0008418,1,0.996570880710206,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4051,GO:0008419,1,0.993488954650228,0,1,RNA lariat debranching enzyme activity,MF,
4052,GO:0008420,1,0.955000631923423,0,7,RNA polymerase II CTD heptapeptide repeat phosphatase activity,MF,
4053,GO:0008422,1,0.969676509634696,0,5,beta-glucosidase activity,MF,
4054,GO:0008424,1,0.992645072560129,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4055,GO:0008425,1,0.992548859258005,0,2,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4056,GO:0008426,1,0.985658001819621,0,3,protein kinase C inhibitor activity,MF,
4057,GO:0008427,1,0.987260390880558,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4058,GO:0008428,1,0.980731266699986,0,3,ribonuclease inhibitor activity,MF,
4059,GO:0008429,1,0.936257400032289,0,11,phosphatidylethanolamine binding,MF,
4060,GO:0008430,1,0.972105658929384,0,5,selenium binding,MF,
4061,GO:0008431,1,0.986421720578187,0,2,vitamin E binding,MF,
4062,GO:0008432,1,0.94126645357303,0,9,JUN kinase binding,MF,
4063,GO:0008437,1,0.995095177514475,0,1,thyrotropin-releasing hormone activity,MF,
4064,GO:0008440,1,0.975533548414018,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4065,GO:0008441,1,0.993925171941381,0,1,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4066,GO:0008442,1,0.995159413471978,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4067,GO:0008443,1,0.952552623955025,0,7,phosphofructokinase activity,MF,
4068,GO:0008444,1,0.9946121621616,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4069,GO:0008445,1,0.995930100146436,0,1,D-aspartate oxidase activity,MF,
4070,GO:0008446,1,0.99582441735559,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4071,GO:0008448,1,0.995497122476627,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4072,GO:0008449,1,0.96988898118892,0,4,N-acetylglucosamine-6-sulfatase activity,MF,
4073,GO:0008452,1,0.99325505912211,0,1,RNA ligase activity,MF,
4074,GO:0008453,1,0.995957962710815,0,1,alanine-glyoxylate transaminase activity,MF,
4075,GO:0008454,1,0.980363911712033,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4076,GO:0008455,1,0.993376889315338,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4077,GO:0008456,1,0.992500590259723,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4078,GO:0008457,1,0.981980372678696,0,3,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4079,GO:0008458,1,0.985878158905793,0,2,carnitine O-octanoyltransferase activity,MF,
4080,GO:0008459,1,0.98541618418823,0,2,chondroitin 6-sulfotransferase activity,MF,
4081,GO:0008460,1,0.995330476245509,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4082,GO:0008465,1,0.996454349417187,0,1,glycerate dehydrogenase activity,MF,
4083,GO:0008466,1,0.988201541009839,0,2,glycogenin glucosyltransferase activity,MF,
4084,GO:0008467,1,0.965762329926008,0,6,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4085,GO:0008469,1,0.960262734370829,0,7,histone-arginine N-methyltransferase activity,MF,
4086,GO:0008470,1,0.992305044699667,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4087,GO:0008474,1,0.933583185642528,0,12,palmitoyl-(protein) hydrolase activity,MF,
4088,GO:0008475,1,0.97841660141082,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4089,GO:0008476,1,0.990238451033264,0,2,protein-tyrosine sulfotransferase activity,MF,
4090,GO:0008478,1,0.990817003295368,0,1,pyridoxal kinase activity,MF,
4091,GO:0008479,1,0.996343791150515,0,1,queuine tRNA-ribosyltransferase activity,MF,
4092,GO:0008480,1,0.992632413981784,0,1,sarcosine dehydrogenase activity,MF,
4093,GO:0008481,1,0.988410544394995,0,2,sphinganine kinase activity,MF,
4094,GO:0008482,1,0.994249653242241,0,1,sulfite oxidase activity,MF,
4095,GO:0008483,1,0.89830832856988,0,17,transaminase activity,MF,
4096,GO:0008484,1,0.898133996516188,0,15,sulfuric ester hydrolase activity,MF,
4097,GO:0008486,1,0.977990025656706,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4098,GO:0008488,1,0.99272992210506,0,1,gamma-glutamyl carboxylase activity,MF,
4100,GO:0008493,1,0.995433843353008,0,1,tetracycline transmembrane transporter activity,MF,
4101,GO:0008494,1,0.925716648314423,0,12,translation activator activity,MF,
4102,GO:0008495,1,0.992902975056294,0,1,protoheme IX farnesyltransferase activity,MF,
4103,GO:0008499,1,0.955548567398337,0,7,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
4104,GO:0008502,1,0.980169158649985,0,4,melatonin receptor activity,MF,
4105,GO:0008503,1,0.9316537476138,0,10,benzodiazepine receptor activity,MF,
4106,GO:0008504,1,0.941530460547677,0,9,monoamine transmembrane transporter activity,MF,
4108,GO:0008507,1,0.992527025493272,0,1,sodium:iodide symporter activity,MF,
4109,GO:0008508,1,0.982792411130545,0,4,bile acid:sodium symporter activity,MF,
4111,GO:0008510,1,0.951235906159887,0,6,sodium:bicarbonate symporter activity,MF,
4112,GO:0008511,1,0.983428572204347,0,2,sodium:potassium:chloride symporter activity,MF,
4113,GO:0008513,1,0.990091541724127,0,2,secondary active organic cation transmembrane transporter activity,MF,
4116,GO:0008517,1,0.970173339930981,0,4,folic acid transmembrane transporter activity,MF,
4117,GO:0008518,1,0.993132375617783,0,1,folate:anion antiporter activity,MF,
4118,GO:0008519,1,0.945679339636317,0,8,ammonium transmembrane transporter activity,MF,
4119,GO:0008520,1,0.985286709774917,0,2,L-ascorbate:sodium symporter activity,MF,
4120,GO:0008521,1,0.993471940349107,0,1,acetyl-CoA transmembrane transporter activity,MF,
4121,GO:0008523,1,0.992636451993886,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
4122,GO:0008525,1,0.920500077628077,0,11,phosphatidylcholine transporter activity,MF,
4123,GO:0008526,1,0.941021856464014,0,9,phosphatidylinositol transfer activity,MF,
4124,GO:0008527,1,0.947554226409789,0,12,taste receptor activity,MF,
4125,GO:0008528,1,0.482989200168531,0,130,G protein-coupled peptide receptor activity,MF,
4126,GO:0008531,1,0.993376889315338,0,1,riboflavin kinase activity,MF,
4127,GO:0008532,1,0.945234117701338,0,9,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4128,GO:0008534,1,0.987453861385989,0,3,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4129,GO:0008535,1,0.869856553487658,0,24,respiratory chain complex IV assembly,BP,
4130,GO:0008536,1,0.751540624324697,0,38,Ran GTPase binding,MF,
4131,GO:0008537,1,0.986112492436871,0,3,proteasome activator complex,CC,
4132,GO:0008540,1,0.943084278104693,0,12,proteasome regulatory particle, base subcomplex,CC,
4133,GO:0008541,1,0.970414069396997,0,7,proteasome regulatory particle, lid subcomplex,CC,
4134,GO:0008542,1,0.728879450029919,0,43,visual learning,BP,
4137,GO:0008545,1,0.985151265832237,0,2,JUN kinase kinase activity,MF,
4138,GO:0008553,1,0.904024849732672,0,16,proton-exporting ATPase activity, phosphorylative mechanism,MF,
4139,GO:0008554,1,0.927310963895787,0,12,sodium transmembrane transporter activity, phosphorylative mechanism,MF,
4140,GO:0008555,1,0.991945730248253,0,1,ATPase-coupled chloride transmembrane transporter activity,MF,
4141,GO:0008556,1,0.934573006264896,0,11,potassium transmembrane transporter activity, phosphorylative mechanism,MF,
4142,GO:0008559,1,0.953707453901372,0,6,ATPase-coupled xenobiotic transmembrane transporter activity,MF,
4143,GO:0008568,1,0.944347276491697,0,8,microtubule-severing ATPase activity,MF,
4145,GO:0008574,1,0.873946922400395,0,16,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4146,GO:0008579,1,0.991995691228082,0,1,JUN kinase phosphatase activity,MF,
4147,GO:0008582,1,0.962992896038738,0,5,regulation of synaptic growth at neuromuscular junction,BP,
4150,GO:0008589,1,0.555652718527847,0,81,regulation of smoothened signaling pathway,BP,
4151,GO:0008591,1,0.995568695093763,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
4152,GO:0008592,1,0.970634865271791,0,4,regulation of Toll signaling pathway,BP,
4154,GO:0008594,1,0.974250851075051,0,4,photoreceptor cell morphogenesis,BP,
4156,GO:0008597,1,0.982588294910322,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4157,GO:0008603,1,0.945870587800313,0,10,cAMP-dependent protein kinase regulator activity,MF,
4158,GO:0008607,1,0.98156051119693,0,3,phosphorylase kinase regulator activity,MF,
4159,GO:0008608,1,0.823527229774599,0,30,attachment of spindle microtubules to kinetochore,BP,
4160,GO:0008609,1,0.990656213277394,0,1,alkylglycerone-phosphate synthase activity,MF,
4162,GO:0008611,1,0.934459575406971,0,10,ether lipid biosynthetic process,BP,
4163,GO:0008612,1,0.984519150944623,0,3,peptidyl-lysine modification to peptidyl-hypusine,BP,
4164,GO:0008613,1,0.996806260693679,0,1,diuretic hormone activity,MF,
4165,GO:0008614,1,0.987402358496293,0,2,pyridoxine metabolic process,BP,
4166,GO:0008615,1,0.987402358496293,0,2,pyridoxine biosynthetic process,BP,
4167,GO:0008617,1,0.996649261931985,0,1,guanosine metabolic process,BP,
4168,GO:0008622,1,0.971706027893787,0,5,epsilon DNA polymerase complex,CC,
4169,GO:0008623,1,0.980001105427979,0,3,CHRAC,CC,
4171,GO:0008626,1,0.97493691424955,0,5,granzyme-mediated apoptotic signaling pathway,BP,
4172,GO:0008627,1,0.948274699165761,0,8,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4173,GO:0008628,1,0.986552777799145,0,3,hormone-mediated apoptotic signaling pathway,BP,
4175,GO:0008631,1,0.780926401153783,0,40,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
4178,GO:0008641,1,0.935194585692797,0,10,ubiquitin-like modifier activating enzyme activity,MF,
4181,GO:0008649,1,0.909676913761753,0,17,rRNA methyltransferase activity,MF,
4182,GO:0008650,1,0.992529902975349,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
4184,GO:0008653,1,0.994101958296384,0,1,lipopolysaccharide metabolic process,BP,
4186,GO:0008655,1,0.951595837168709,0,10,pyrimidine-containing compound salvage,BP,
4187,GO:0008656,1,0.911795866097646,0,15,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4188,GO:0008659,1,0.990217175383171,0,1,(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity,MF,
4189,GO:0008663,1,0.99325505912211,0,1,2',3'-cyclic-nucleotide 2'-phosphodiesterase activity,MF,
4190,GO:0008670,1,0.992437677007004,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
4191,GO:0008682,1,0.993636576197946,0,1,2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity,MF,
4192,GO:0008689,1,0.996425863818555,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4193,GO:0008693,1,0.990217175383171,0,1,3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity,MF,
4194,GO:0008700,1,0.99325505912211,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4195,GO:0008705,1,0.989135532617128,0,1,methionine synthase activity,MF,
4196,GO:0008709,1,0.996688504087539,0,1,cholate 7-alpha-dehydrogenase activity,MF,
4197,GO:0008720,1,0.995013884957315,0,1,D-lactate dehydrogenase activity,MF,
4198,GO:0008721,1,0.993883677960989,0,1,D-serine ammonia-lyase activity,MF,
4199,GO:0008725,1,0.996593694428561,0,1,DNA-3-methyladenine glycosylase activity,MF,
4200,GO:0008732,1,0.98845812519745,0,2,L-allo-threonine aldolase activity,MF,
4201,GO:0008745,1,0.99668880855454,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
4202,GO:0008746,1,0.988907391187314,0,2,NAD(P)+ transhydrogenase activity,MF,
4203,GO:0008747,1,0.996031774151255,0,1,N-acetylneuraminate lyase activity,MF,
4204,GO:0008753,1,0.992566440183764,0,1,NADPH dehydrogenase (quinone) activity,MF,
4205,GO:0008757,1,0.423303089085619,0,133,S-adenosylmethionine-dependent methyltransferase activity,MF,
4206,GO:0008761,1,0.991987082565636,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4207,GO:0008768,1,0.993391824260778,0,2,UDP-sugar diphosphatase activity,MF,
4208,GO:0008775,1,0.995520473736704,0,1,acetate CoA-transferase activity,MF,
4209,GO:0008781,1,0.992163408426654,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4210,GO:0008783,1,0.994601773904378,0,1,agmatinase activity,MF,
4211,GO:0008785,1,0.996021948974616,0,1,alkyl hydroperoxide reductase activity,MF,
4212,GO:0008792,1,0.99325505912211,0,1,arginine decarboxylase activity,MF,
4213,GO:0008794,1,0.996712148007702,0,1,arsenate reductase (glutaredoxin) activity,MF,
4214,GO:0008796,1,0.996664748998817,0,1,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4215,GO:0008798,1,0.985924403027662,0,2,beta-aspartyl-peptidase activity,MF,
4216,GO:0008800,1,0.995786241327855,0,1,beta-lactamase activity,MF,
4217,GO:0008802,1,0.992532143845806,0,1,betaine-aldehyde dehydrogenase activity,MF,
4218,GO:0008803,1,0.996664748998817,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4219,GO:0008808,1,0.992491251317947,0,1,cardiolipin synthase activity,MF,
4220,GO:0008812,1,0.992514365261699,0,1,choline dehydrogenase activity,MF,
4221,GO:0008817,1,0.992446847423883,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4222,GO:0008821,1,0.968606171817689,0,5,crossover junction endodeoxyribonuclease activity,MF,
4223,GO:0008823,1,0.976231992888798,0,3,cupric reductase activity,MF,
4224,GO:0008828,1,0.996800221570978,0,1,dATP pyrophosphohydrolase activity,MF,
4225,GO:0008832,1,0.992706799403571,0,1,dGTPase activity,MF,
4226,GO:0008843,1,0.994303650955748,0,1,endochitinase activity,MF,
4227,GO:0008852,1,0.993142330485845,0,1,exodeoxyribonuclease I activity,MF,
4228,GO:0008853,1,0.979565257128411,0,4,exodeoxyribonuclease III activity,MF,
4229,GO:0008859,1,0.996685749522015,0,1,exoribonuclease II activity,MF,
4230,GO:0008865,1,0.963017193552564,0,5,fructokinase activity,MF,
4231,GO:0008887,1,0.992678948123907,0,1,glycerate kinase activity,MF,
4232,GO:0008889,1,0.985514150212301,0,2,glycerophosphodiester phosphodiesterase activity,MF,
4233,GO:0008890,1,0.99599033786439,0,1,glycine C-acetyltransferase activity,MF,
4234,GO:0008891,1,0.995682715676617,0,1,glycolate oxidase activity,MF,
4235,GO:0008892,1,0.991912048384404,0,1,guanine deaminase activity,MF,
4236,GO:0008893,1,0.996627250553641,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4237,GO:0008894,1,0.993315672402422,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4238,GO:0008897,1,0.993095194544571,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4239,GO:0008900,1,0.981314361701794,0,3,potassium:proton exchanging ATPase activity,MF,
4240,GO:0008903,1,0.996575039571275,0,1,hydroxypyruvate isomerase activity,MF,
4241,GO:0008905,1,0.995954509983753,0,1,mannose-phosphate guanylyltransferase activity,MF,
4242,GO:0008929,1,0.996183274548778,0,1,methylglyoxal synthase activity,MF,
4243,GO:0008934,1,0.981568267790148,0,3,inositol monophosphate 1-phosphatase activity,MF,
4244,GO:0008937,1,0.995353986230992,0,1,ferredoxin-NAD(P) reductase activity,MF,
4245,GO:0008940,1,0.992418877101266,0,1,nitrate reductase activity,MF,
4246,GO:0008941,1,0.993813767208886,0,1,nitric oxide dioxygenase activity,MF,
4247,GO:0008946,1,0.992470052449699,0,1,oligonucleotidase activity,MF,
4248,GO:0008948,1,0.975455234371973,0,4,oxaloacetate decarboxylase activity,MF,
4249,GO:0008955,1,0.992474222482199,0,1,peptidoglycan glycosyltransferase activity,MF,
4250,GO:0008962,1,0.99363317693078,0,1,phosphatidylglycerophosphatase activity,MF,
4251,GO:0008963,1,0.994739160911841,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4252,GO:0008967,1,0.987853502788307,0,2,phosphoglycolate phosphatase activity,MF,
4253,GO:0008970,1,0.959309020036483,0,7,phospholipase A1 activity,MF,
4254,GO:0008973,1,0.99267274326113,0,1,phosphopentomutase activity,MF,
4255,GO:0008988,1,0.976601400301263,0,4,rRNA (adenine-N6-)-methyltransferase activity,MF,
4256,GO:0008995,1,0.993623003692494,0,1,ribonuclease E activity,MF,
4257,GO:0009000,1,0.993917823470783,0,1,selenocysteine lyase activity,MF,
4258,GO:0009007,1,0.984790047777114,0,2,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4259,GO:0009008,1,0.958690736178534,0,6,DNA-methyltransferase activity,MF,
4260,GO:0009013,1,0.992064186951491,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4261,GO:0009019,1,0.972058095001543,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4262,GO:0009020,1,0.9952082833299,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4263,GO:0009032,1,0.995854312720373,0,1,thymidine phosphorylase activity,MF,
4264,GO:0009041,1,0.982670828770208,0,3,uridylate kinase activity,MF,
4265,GO:0009048,1,0.895997528319717,0,14,dosage compensation by inactivation of X chromosome,BP,
4266,GO:0009051,1,0.976203311083832,0,4,pentose-phosphate shunt, oxidative branch,BP,
4267,GO:0009052,1,0.973868206353156,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4268,GO:0009055,1,0.629217568986395,0,96,electron transfer activity,MF,
4273,GO:0009060,1,0.673495500563482,0,75,aerobic respiration,BP,
4274,GO:0009062,1,0.514296709273642,0,108,fatty acid catabolic process,BP,
4276,GO:0009064,1,0.650011893738871,0,69,glutamine family amino acid metabolic process,BP,
4277,GO:0009065,1,0.856345943979412,0,25,glutamine family amino acid catabolic process,BP,
4278,GO:0009066,1,0.767823870444543,0,45,aspartate family amino acid metabolic process,BP,
4279,GO:0009067,1,0.87563732848636,0,20,aspartate family amino acid biosynthetic process,BP,
4280,GO:0009068,1,0.885052383599594,0,21,aspartate family amino acid catabolic process,BP,
4281,GO:0009069,1,0.829116735078815,0,33,serine family amino acid metabolic process,BP,
4282,GO:0009070,1,0.920032719891414,0,15,serine family amino acid biosynthetic process,BP,
4283,GO:0009071,1,0.939293281570568,0,12,serine family amino acid catabolic process,BP,
4285,GO:0009073,1,0.977046296101533,0,4,aromatic amino acid family biosynthetic process,BP,
4287,GO:0009078,1,0.979915006796959,0,4,pyruvate family amino acid metabolic process,BP,
4288,GO:0009080,1,0.979915006796959,0,4,pyruvate family amino acid catabolic process,BP,
4289,GO:0009081,1,0.860563541895408,0,25,branched-chain amino acid metabolic process,BP,
4290,GO:0009082,1,0.973081775730811,0,5,branched-chain amino acid biosynthetic process,BP,
4291,GO:0009083,1,0.872271497543702,0,22,branched-chain amino acid catabolic process,BP,
4292,GO:0009084,1,0.910445245774291,0,16,glutamine family amino acid biosynthetic process,BP,
4293,GO:0009085,1,0.984808612299637,0,2,lysine biosynthetic process,BP,
4294,GO:0009086,1,0.923487233731161,0,12,methionine biosynthetic process,BP,
4295,GO:0009087,1,0.992584827043261,0,1,methionine catabolic process,BP,
4296,GO:0009092,1,0.982131285799125,0,4,homoserine metabolic process,BP,
4297,GO:0009093,1,0.979037591010445,0,4,cysteine catabolic process,BP,
4298,GO:0009095,1,0.993411449905196,0,1,aromatic amino acid family biosynthetic process, prephenate pathway,BP,
4299,GO:0009097,1,0.986596229481468,0,3,isoleucine biosynthetic process,BP,
4300,GO:0009098,1,0.986303815855716,0,2,leucine biosynthetic process,BP,
4301,GO:0009099,1,0.980699954330689,0,3,valine biosynthetic process,BP,
4304,GO:0009104,1,0.994101958296384,0,1,lipopolysaccharide catabolic process,BP,
4305,GO:0009106,1,0.988384670282739,0,2,lipoate metabolic process,BP,
4306,GO:0009107,1,0.995827244315829,0,1,lipoate biosynthetic process,BP,
4307,GO:0009110,1,0.895007513593251,0,19,vitamin biosynthetic process,BP,
4308,GO:0009111,1,0.941131199413249,0,11,vitamin catabolic process,BP,
4309,GO:0009112,1,0.815200146457254,0,33,nucleobase metabolic process,BP,
4310,GO:0009113,1,0.945208770468973,0,10,purine nucleobase biosynthetic process,BP,
4311,GO:0009115,1,0.98396125602656,0,2,xanthine catabolic process,BP,
4312,GO:0009116,1,0.587013971600518,0,94,nucleoside metabolic process,BP,
4314,GO:0009119,1,0.688863425491868,0,65,ribonucleoside metabolic process,BP,
4315,GO:0009120,1,0.966327693859662,0,7,deoxyribonucleoside metabolic process,BP,
4316,GO:0009123,1,0.669854139665953,0,67,nucleoside monophosphate metabolic process,BP,
4317,GO:0009124,1,0.804523486601677,0,39,nucleoside monophosphate biosynthetic process,BP,
4318,GO:0009125,1,0.967359033578001,0,6,nucleoside monophosphate catabolic process,BP,
4319,GO:0009126,1,0.797957352750578,0,37,purine nucleoside monophosphate metabolic process,BP,
4320,GO:0009127,1,0.900810262380029,0,19,purine nucleoside monophosphate biosynthetic process,BP,
4321,GO:0009128,1,0.977854961211598,0,4,purine nucleoside monophosphate catabolic process,BP,
4322,GO:0009129,1,0.921829067400024,0,15,pyrimidine nucleoside monophosphate metabolic process,BP,
4323,GO:0009130,1,0.925546250458566,0,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4324,GO:0009131,1,0.995986966090815,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4326,GO:0009133,1,0.943470417028521,0,10,nucleoside diphosphate biosynthetic process,BP,
4327,GO:0009134,1,0.96574520571144,0,6,nucleoside diphosphate catabolic process,BP,
4329,GO:0009136,1,0.965257665635462,0,6,purine nucleoside diphosphate biosynthetic process,BP,
4330,GO:0009137,1,0.982675371882971,0,3,purine nucleoside diphosphate catabolic process,BP,
4331,GO:0009138,1,0.975782347502945,0,4,pyrimidine nucleoside diphosphate metabolic process,BP,
4332,GO:0009139,1,0.982670828770208,0,3,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4333,GO:0009140,1,0.992991287943398,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4334,GO:0009141,1,0.624280087693918,0,82,nucleoside triphosphate metabolic process,BP,
4335,GO:0009142,1,0.731993984687136,0,56,nucleoside triphosphate biosynthetic process,BP,
4336,GO:0009143,1,0.934110757149755,0,12,nucleoside triphosphate catabolic process,BP,
4337,GO:0009144,1,0.713451445472399,0,60,purine nucleoside triphosphate metabolic process,BP,
4338,GO:0009145,1,0.804983595360992,0,40,purine nucleoside triphosphate biosynthetic process,BP,
4339,GO:0009146,1,0.969176773214844,0,6,purine nucleoside triphosphate catabolic process,BP,
4340,GO:0009147,1,0.90427548672465,0,21,pyrimidine nucleoside triphosphate metabolic process,BP,
4341,GO:0009148,1,0.917537534742127,0,18,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4342,GO:0009149,1,0.991996840734465,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4344,GO:0009151,1,0.941445011698599,0,11,purine deoxyribonucleotide metabolic process,BP,
4345,GO:0009152,1,0.425801986544104,0,136,purine ribonucleotide biosynthetic process,BP,
4346,GO:0009153,1,0.974649772309264,0,5,purine deoxyribonucleotide biosynthetic process,BP,
4347,GO:0009154,1,0.830895659230904,0,29,purine ribonucleotide catabolic process,BP,
4348,GO:0009155,1,0.972501707543966,0,5,purine deoxyribonucleotide catabolic process,BP,
4349,GO:0009156,1,0.843115662818139,0,30,ribonucleoside monophosphate biosynthetic process,BP,
4350,GO:0009157,1,0.959416193082347,0,8,deoxyribonucleoside monophosphate biosynthetic process,BP,
4351,GO:0009158,1,0.981215424313273,0,3,ribonucleoside monophosphate catabolic process,BP,
4352,GO:0009159,1,0.989268817702124,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4353,GO:0009161,1,0.749362495752342,0,47,ribonucleoside monophosphate metabolic process,BP,
4354,GO:0009162,1,0.945947703559095,0,11,deoxyribonucleoside monophosphate metabolic process,BP,
4355,GO:0009163,1,0.839707315283583,0,35,nucleoside biosynthetic process,BP,
4356,GO:0009164,1,0.865377707298462,0,28,nucleoside catabolic process,BP,
4357,GO:0009165,1,0.263008895066537,0,216,nucleotide biosynthetic process,BP,
4358,GO:0009166,1,0.685468631424797,0,64,nucleotide catabolic process,BP,
4359,GO:0009167,1,0.808596352536853,0,34,purine ribonucleoside monophosphate metabolic process,BP,
4360,GO:0009168,1,0.909677130253029,0,17,purine ribonucleoside monophosphate biosynthetic process,BP,
4361,GO:0009169,1,0.981215424313273,0,3,purine ribonucleoside monophosphate catabolic process,BP,
4362,GO:0009170,1,0.986957700505914,0,3,purine deoxyribonucleoside monophosphate metabolic process,BP,
4363,GO:0009171,1,0.990262109657045,0,2,purine deoxyribonucleoside monophosphate biosynthetic process,BP,
4364,GO:0009173,1,0.943955931666101,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4365,GO:0009174,1,0.943955931666101,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4366,GO:0009176,1,0.976573080516158,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4367,GO:0009177,1,0.980508686151092,0,4,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4368,GO:0009178,1,0.995986966090815,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4370,GO:0009180,1,0.965257665635462,0,6,purine ribonucleoside diphosphate biosynthetic process,BP,
4371,GO:0009181,1,0.982675371882971,0,3,purine ribonucleoside diphosphate catabolic process,BP,
4372,GO:0009182,1,0.982539363016798,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4373,GO:0009183,1,0.989212277646779,0,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4375,GO:0009186,1,0.972215327947483,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4376,GO:0009187,1,0.769163399698008,0,35,cyclic nucleotide metabolic process,BP,
4377,GO:0009188,1,0.958599574443674,0,7,ribonucleoside diphosphate biosynthetic process,BP,
4378,GO:0009189,1,0.978818841367217,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,
4379,GO:0009190,1,0.876181209057157,0,18,cyclic nucleotide biosynthetic process,BP,
4380,GO:0009191,1,0.972356661341373,0,5,ribonucleoside diphosphate catabolic process,BP,
4381,GO:0009193,1,0.986143870638681,0,2,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4382,GO:0009194,1,0.993104745312481,0,1,pyrimidine ribonucleoside diphosphate biosynthetic process,BP,
4383,GO:0009195,1,0.992991287943398,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4384,GO:0009196,1,0.989494377617044,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4385,GO:0009197,1,0.989494377617044,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4386,GO:0009199,1,0.715523405844932,0,58,ribonucleoside triphosphate metabolic process,BP,
4387,GO:0009200,1,0.919475048571351,0,17,deoxyribonucleoside triphosphate metabolic process,BP,
4388,GO:0009201,1,0.779816393152393,0,45,ribonucleoside triphosphate biosynthetic process,BP,
4389,GO:0009202,1,0.970411373545211,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4390,GO:0009203,1,0.996582024467971,0,1,ribonucleoside triphosphate catabolic process,BP,
4391,GO:0009204,1,0.961417822306614,0,8,deoxyribonucleoside triphosphate catabolic process,BP,
4392,GO:0009205,1,0.742382020451309,0,52,purine ribonucleoside triphosphate metabolic process,BP,
4393,GO:0009206,1,0.809062213492089,0,39,purine ribonucleoside triphosphate biosynthetic process,BP,
4394,GO:0009207,1,0.996582024467971,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4395,GO:0009208,1,0.928353663800873,0,15,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4396,GO:0009209,1,0.934421863125718,0,14,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4397,GO:0009211,1,0.97408303194418,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4398,GO:0009212,1,0.981943139361535,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4399,GO:0009213,1,0.991996840734465,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4400,GO:0009214,1,0.898167782182578,0,14,cyclic nucleotide catabolic process,BP,
4401,GO:0009215,1,0.954660701447472,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4402,GO:0009216,1,0.988258351584719,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4403,GO:0009217,1,0.972501707543966,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4404,GO:0009218,1,0.883222215599361,0,23,pyrimidine ribonucleotide metabolic process,BP,
4405,GO:0009219,1,0.918356333282312,0,18,pyrimidine deoxyribonucleotide metabolic process,BP,
4406,GO:0009220,1,0.895280184286965,0,21,pyrimidine ribonucleotide biosynthetic process,BP,
4407,GO:0009221,1,0.966679273475457,0,7,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4408,GO:0009222,1,0.992991287943398,0,1,pyrimidine ribonucleotide catabolic process,BP,
4409,GO:0009223,1,0.945667329264246,0,12,pyrimidine deoxyribonucleotide catabolic process,BP,
4410,GO:0009225,1,0.811601057344305,0,35,nucleotide-sugar metabolic process,BP,
4411,GO:0009226,1,0.889167840089047,0,21,nucleotide-sugar biosynthetic process,BP,
4412,GO:0009227,1,0.984067762243746,0,3,nucleotide-sugar catabolic process,BP,
4413,GO:0009229,1,0.994183151197722,0,1,thiamine diphosphate biosynthetic process,BP,
4414,GO:0009231,1,0.993376889315338,0,1,riboflavin biosynthetic process,BP,
4415,GO:0009233,1,0.974100522021216,0,4,menaquinone metabolic process,BP,
4416,GO:0009234,1,0.992513428419899,0,1,menaquinone biosynthetic process,BP,
4417,GO:0009235,1,0.893306667980567,0,18,cobalamin metabolic process,BP,
4418,GO:0009237,1,0.993002477888305,0,1,siderophore metabolic process,BP,
4419,GO:0009240,1,0.981779728889718,0,4,isopentenyl diphosphate biosynthetic process,BP,
4421,GO:0009249,1,0.974922512935384,0,7,protein lipoylation,BP,
4424,GO:0009253,1,0.99336251476849,0,2,peptidoglycan catabolic process,BP,
4425,GO:0009256,1,0.963295942901259,0,5,10-formyltetrahydrofolate metabolic process,BP,
4426,GO:0009257,1,0.985134085757825,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4427,GO:0009258,1,0.98355783329597,0,2,10-formyltetrahydrofolate catabolic process,BP,
4429,GO:0009260,1,0.393322437391877,0,149,ribonucleotide biosynthetic process,BP,
4430,GO:0009261,1,0.825061173738057,0,30,ribonucleotide catabolic process,BP,
4431,GO:0009262,1,0.841576714282461,0,33,deoxyribonucleotide metabolic process,BP,
4432,GO:0009263,1,0.921104498896355,0,15,deoxyribonucleotide biosynthetic process,BP,
4433,GO:0009264,1,0.91571567823783,0,18,deoxyribonucleotide catabolic process,BP,
4434,GO:0009265,1,0.942165350778853,0,12,2'-deoxyribonucleotide biosynthetic process,BP,
4436,GO:0009267,1,0.375194818422989,0,147,cellular response to starvation,BP,
4438,GO:0009295,1,0.775890299011797,0,40,nucleoid,CC,
4439,GO:0009298,1,0.982377178863265,0,4,GDP-mannose biosynthetic process,BP,
4440,GO:0009299,1,0.883809365237651,0,17,mRNA transcription,BP,
4441,GO:0009301,1,0.65156077158553,0,70,snRNA transcription,BP,
4442,GO:0009303,1,0.845112710234624,0,27,rRNA transcription,BP,
4443,GO:0009304,1,0.949930649067394,0,8,tRNA transcription,BP,
4444,GO:0009305,1,0.991583341144231,0,1,protein biotinylation,BP,
4446,GO:0009308,1,0.50119456015814,0,128,amine metabolic process,BP,
4447,GO:0009309,1,0.898695771851445,0,21,amine biosynthetic process,BP,
4448,GO:0009310,1,0.895998044018429,0,20,amine catabolic process,BP,
4449,GO:0009311,1,0.722067761894435,0,50,oligosaccharide metabolic process,BP,
4450,GO:0009312,1,0.909125904579227,0,16,oligosaccharide biosynthetic process,BP,
4451,GO:0009313,1,0.931483415623651,0,11,oligosaccharide catabolic process,BP,
4453,GO:0009328,1,0.989944142172835,0,2,phenylalanine-tRNA ligase complex,CC,
4454,GO:0009330,1,0.991749694878503,0,1,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex,CC,
4456,GO:0009353,1,0.996358101077666,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4457,GO:0009360,1,0.993389009100353,0,1,DNA polymerase III complex,CC,
4458,GO:0009361,1,0.996181842065864,0,1,succinate-CoA ligase complex (ADP-forming),CC,
4459,GO:0009368,1,0.990743666572661,0,2,endopeptidase Clp complex,CC,
4460,GO:0009374,1,0.962054110983047,0,5,biotin binding,MF,
4461,GO:0009378,1,0.953425836644192,0,6,four-way junction helicase activity,MF,
4462,GO:0009383,1,0.980016740305112,0,3,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4463,GO:0009384,1,0.991987082565636,0,1,N-acylmannosamine kinase activity,MF,
4464,GO:0009386,1,0.990324401778844,0,2,translational attenuation,BP,
4465,GO:0009394,1,0.864536544615558,0,29,2'-deoxyribonucleotide metabolic process,BP,
4467,GO:0009396,1,0.951819788302137,0,8,folic acid-containing compound biosynthetic process,BP,
4468,GO:0009397,1,0.980338416579026,0,3,folic acid-containing compound catabolic process,BP,
4469,GO:0009398,1,0.993376889315338,0,1,FMN biosynthetic process,BP,
4470,GO:0009404,1,0.920463712988169,0,13,toxin metabolic process,BP,
4471,GO:0009405,1,0.983607811585219,0,2,pathogenesis,BP,
4472,GO:0009407,1,0.989785512087752,0,2,toxin catabolic process,BP,
4473,GO:0009408,1,0.363299034473714,0,152,response to heat,BP,
4474,GO:0009409,1,0.760397976275744,0,43,response to cold,BP,
4475,GO:0009410,1,0.593222154771909,0,96,response to xenobiotic stimulus,BP,
4477,GO:0009414,1,0.953773080861572,0,8,response to water deprivation,BP,
4478,GO:0009415,1,0.912246802404456,0,14,response to water,BP,
4480,GO:0009435,1,0.861258952173358,0,25,NAD biosynthetic process,BP,
4481,GO:0009436,1,0.989240007973287,0,2,glyoxylate catabolic process,BP,
4482,GO:0009437,1,0.92008797084682,0,13,carnitine metabolic process,BP,
4483,GO:0009438,1,0.977022671126192,0,5,methylglyoxal metabolic process,BP,
4484,GO:0009439,1,0.992736972140184,0,2,cyanate metabolic process,BP,
4485,GO:0009440,1,0.992736972140184,0,2,cyanate catabolic process,BP,
4486,GO:0009441,1,0.983349881027808,0,3,glycolate metabolic process,BP,
4487,GO:0009443,1,0.990817003295368,0,1,pyridoxal 5'-phosphate salvage,BP,
4488,GO:0009444,1,0.991981954438062,0,1,pyruvate oxidation,BP,
4489,GO:0009445,1,0.964770427323481,0,7,putrescine metabolic process,BP,
4490,GO:0009446,1,0.971320481441156,0,5,putrescine biosynthetic process,BP,
4491,GO:0009447,1,0.989072907006911,0,3,putrescine catabolic process,BP,
4492,GO:0009448,1,0.966422518103652,0,5,gamma-aminobutyric acid metabolic process,BP,
4493,GO:0009449,1,0.978997196496444,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4494,GO:0009450,1,0.984306463263968,0,2,gamma-aminobutyric acid catabolic process,BP,
4495,GO:0009451,1,0.419493897034752,0,144,RNA modification,BP,
4496,GO:0009452,1,0.835447696707834,0,32,7-methylguanosine RNA capping,BP,
4497,GO:0009566,1,0.423121731028457,0,141,fertilization,BP,
4500,GO:0009583,1,0.681987854503637,0,60,detection of light stimulus,BP,
4501,GO:0009584,1,0.723271455595026,0,50,detection of visible light,BP,
4502,GO:0009590,1,0.994977299481747,0,1,detection of gravity,BP,
4503,GO:0009593,1,0.662611250757627,0,76,detection of chemical stimulus,BP,
4504,GO:0009595,1,0.814727998346843,0,32,detection of biotic stimulus,BP,
4505,GO:0009597,1,0.968027406101338,0,5,detection of virus,BP,
4508,GO:0009608,1,0.976420962602152,0,4,response to symbiont,BP,
4509,GO:0009609,1,0.976420962602152,0,4,response to symbiotic bacterium,BP,
4512,GO:0009615,1,0.165732713103812,0,290,response to virus,BP,
4514,GO:0009620,1,0.826016271970735,0,39,response to fungus,BP,
4515,GO:0009624,1,0.990114463453821,0,2,response to nematode,BP,
4517,GO:0009629,1,0.945893983849066,0,10,response to gravity,BP,
4518,GO:0009631,1,0.984817533260789,0,2,cold acclimation,BP,
4519,GO:0009635,1,0.962699056408766,0,7,response to herbicide,BP,
4521,GO:0009637,1,0.985162395121468,0,2,response to blue light,BP,
4522,GO:0009642,1,0.941016011728116,0,9,response to light intensity,BP,
4523,GO:0009644,1,0.986934493967403,0,2,response to high light intensity,BP,
4524,GO:0009645,1,0.992555184585628,0,1,response to low light intensity stimulus,BP,
4525,GO:0009648,1,0.831089523749097,0,30,photoperiodism,BP,
4526,GO:0009649,1,0.824965432521416,0,31,entrainment of circadian clock,BP,
4531,GO:0009673,1,0.992510715702756,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4532,GO:0009674,1,0.983428572204347,0,2,potassium:sodium symporter activity,MF,
4533,GO:0009678,1,0.839505768282556,0,29,pyrophosphate hydrolysis-driven proton transmembrane transporter activity,MF,
4534,GO:0009692,1,0.993582687174415,0,1,ethylene metabolic process,BP,
4535,GO:0009698,1,0.972295117909804,0,6,phenylpropanoid metabolic process,BP,
4536,GO:0009712,1,0.734931977640085,0,49,catechol-containing compound metabolic process,BP,
4537,GO:0009713,1,0.890025299675682,0,19,catechol-containing compound biosynthetic process,BP,
4540,GO:0009726,1,0.97805569280745,0,3,detection of endogenous stimulus,BP,
4541,GO:0009730,1,0.978151949897419,0,4,detection of carbohydrate stimulus,BP,
4542,GO:0009732,1,0.978151949897419,0,4,detection of hexose stimulus,BP,
4543,GO:0009737,1,0.992395820850584,0,1,response to abscisic acid,BP,
4544,GO:0009738,1,0.992395820850584,0,1,abscisic acid-activated signaling pathway,BP,
4546,GO:0009744,1,0.971463153721811,0,4,response to sucrose,BP,
4549,GO:0009750,1,0.950241004378019,0,8,response to fructose,BP,
4550,GO:0009753,1,0.98546644934993,0,4,response to jasmonic acid,BP,
4551,GO:0009755,1,0.313176600471847,0,169,hormone-mediated signaling pathway,BP,
4552,GO:0009756,1,0.953392477280794,0,8,carbohydrate mediated signaling,BP,
4553,GO:0009757,1,0.966127792437574,0,6,hexose mediated signaling,BP,
4554,GO:0009758,1,0.990067536892281,0,1,carbohydrate utilization,BP,
4555,GO:0009785,1,0.985162395121468,0,2,blue light signaling pathway,BP,
4556,GO:0009786,1,0.965958908087791,0,5,regulation of asymmetric cell division,BP,
4557,GO:0009787,1,0.992395820850584,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4558,GO:0009789,1,0.992395820850584,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4560,GO:0009791,1,0.55300913510989,0,77,post-embryonic development,BP,
4562,GO:0009794,1,0.97512473205241,0,4,regulation of mitotic cell cycle, embryonic,BP,
4565,GO:0009804,1,0.972295117909804,0,6,coumarin metabolic process,BP,
4566,GO:0009810,1,0.994575796660225,0,1,stilbene metabolic process,BP,
4567,GO:0009812,1,0.968148796787332,0,6,flavonoid metabolic process,BP,
4568,GO:0009820,1,0.976329211747303,0,5,alkaloid metabolic process,BP,
4569,GO:0009822,1,0.991758594709062,0,2,alkaloid catabolic process,BP,
4570,GO:0009826,1,0.986782158248706,0,2,unidimensional cell growth,BP,
4571,GO:0009838,1,0.974485981324903,0,5,abscission,BP,
4572,GO:0009841,1,0.994185700814846,0,1,mitochondrial endopeptidase Clp complex,CC,
4575,GO:0009881,1,0.934690984422396,0,12,photoreceptor activity,MF,
4576,GO:0009882,1,0.985162395121468,0,2,blue light photoreceptor activity,MF,
4577,GO:0009886,1,0.919629206466496,0,12,post-embryonic animal morphogenesis,BP,
4589,GO:0009898,1,0.350082226724767,0,156,cytoplasmic side of plasma membrane,CC,
4590,GO:0009912,1,0.968956166862574,0,4,auditory receptor cell fate commitment,BP,
4593,GO:0009918,1,0.993481493912351,0,1,sterol delta7 reductase activity,MF,
4594,GO:0009922,1,0.960184917352038,0,6,fatty acid elongase activity,MF,
4596,GO:0009931,1,0.852330628222256,0,22,calcium-dependent protein serine/threonine kinase activity,MF,
4597,GO:0009946,1,0.985579649624357,0,3,proximal/distal axis specification,BP,
4599,GO:0009949,1,0.996007069956112,0,1,polarity specification of anterior/posterior axis,BP,
4600,GO:0009950,1,0.931132421391868,0,11,dorsal/ventral axis specification,BP,
4604,GO:0009955,1,0.994586188491571,0,1,adaxial/abaxial pattern specification,BP,
4605,GO:0009956,1,0.992479080081096,0,1,radial pattern formation,BP,
4606,GO:0009957,1,0.977388600995391,0,3,epidermal cell fate specification,BP,
4610,GO:0009972,1,0.951667731500622,0,10,cytidine deamination,BP,
4611,GO:0009975,1,0.881902381538038,0,16,cyclase activity,MF,
4612,GO:0009982,1,0.93088062036683,0,13,pseudouridine synthase activity,MF,
4615,GO:0009988,1,0.713509080781016,0,60,cell-cell recognition,BP,
4617,GO:0009992,1,0.971859028065512,0,5,cellular water homeostasis,BP,
4618,GO:0009994,1,0.752644422544147,0,44,oocyte differentiation,BP,
4623,GO:0010009,1,0.974533937125194,0,4,cytoplasmic side of endosome membrane,CC,
4624,GO:0010021,1,0.992744259439078,0,1,amylopectin biosynthetic process,BP,
4625,GO:0010025,1,0.986891612610964,0,2,wax biosynthetic process,BP,
4626,GO:0010032,1,0.94925025709045,0,7,meiotic chromosome condensation,BP,
4628,GO:0010034,1,0.992538759058992,0,1,response to acetate,BP,
4630,GO:0010037,1,0.992799221737581,0,1,response to carbon dioxide,BP,
4633,GO:0010040,1,0.975840597014713,0,4,response to iron(II) ion,BP,
4634,GO:0010041,1,0.969925810071165,0,5,response to iron(III) ion,BP,
4635,GO:0010042,1,0.876582635747663,0,19,response to manganese ion,BP,
4636,GO:0010043,1,0.783636274509142,0,47,response to zinc ion,BP,
4637,GO:0010044,1,0.975182557467585,0,4,response to aluminum ion,BP,
4638,GO:0010045,1,0.990712398212734,0,1,response to nickel cation,BP,
4639,GO:0010046,1,0.980285475572863,0,4,response to mycotoxin,BP,
4640,GO:0010070,1,0.994044132206603,0,1,zygote asymmetric cell division,BP,
4641,GO:0010085,1,0.994895965192756,0,1,polarity specification of proximal/distal axis,BP,
4643,GO:0010106,1,0.99523977488528,0,1,cellular response to iron ion starvation,BP,
4644,GO:0010121,1,0.995150811224064,0,1,arginine catabolic process to proline via ornithine,BP,
4645,GO:0010124,1,0.992036100977819,0,2,phenylacetate catabolic process,BP,
4646,GO:0010133,1,0.987256811412942,0,2,proline catabolic process to glutamate,BP,
4647,GO:0010138,1,0.976532541617574,0,5,pyrimidine ribonucleotide salvage,BP,
4648,GO:0010142,1,0.986664364737054,0,2,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4649,GO:0010155,1,0.903982990844594,0,20,regulation of proton transport,BP,
4650,GO:0010157,1,0.984302357097837,0,2,response to chlorate,BP,
4651,GO:0010159,1,0.980654273416826,0,3,specification of animal organ position,BP,
4652,GO:0010160,1,0.996660777118026,0,1,formation of animal organ boundary,BP,
4653,GO:0010164,1,0.995935366387734,0,1,response to cesium ion,BP,
4654,GO:0010165,1,0.804718527871557,0,31,response to X-ray,BP,
4655,GO:0010166,1,0.986891612610964,0,2,wax metabolic process,BP,
4657,GO:0010172,1,0.91692743077579,0,11,embryonic body morphogenesis,BP,
4658,GO:0010181,1,0.914968952767442,0,14,FMN binding,MF,
4659,GO:0010182,1,0.966127792437574,0,6,sugar mediated signaling pathway,BP,
4660,GO:0010185,1,0.993501805286691,0,1,regulation of cellular defense response,BP,
4661,GO:0010186,1,0.993501805286691,0,1,positive regulation of cellular defense response,BP,
4662,GO:0010189,1,0.99582347391602,0,1,vitamin E biosynthetic process,BP,
4663,GO:0010193,1,0.985089625016871,0,3,response to ozone,BP,
4664,GO:0010212,1,0.406028709345485,0,134,response to ionizing radiation,BP,
4665,GO:0010216,1,0.951910530133678,0,6,maintenance of DNA methylation,BP,
4666,GO:0010224,1,0.910146140131647,0,16,response to UV-B,BP,
4667,GO:0010225,1,0.90041065797089,0,16,response to UV-C,BP,
4668,GO:0010226,1,0.867390050984249,0,23,response to lithium ion,BP,
4671,GO:0010248,1,0.922312883622927,0,14,establishment or maintenance of transmembrane electrochemical gradient,BP,
4672,GO:0010255,1,0.966127792437574,0,6,glucose mediated signaling pathway,BP,
4674,GO:0010257,1,0.790885355378153,0,56,NADH dehydrogenase complex assembly,BP,
4675,GO:0010259,1,0.804981301184291,0,31,multicellular organism aging,BP,
4676,GO:0010260,1,0.987629151085237,0,2,animal organ senescence,BP,
4677,GO:0010265,1,0.960722198412149,0,6,SCF complex assembly,BP,
4678,GO:0010266,1,0.98044380209812,0,3,response to vitamin B1,BP,
4679,GO:0010269,1,0.960460964780358,0,6,response to selenium ion,BP,
4680,GO:0010272,1,0.993642250670861,0,1,response to silver ion,BP,
4681,GO:0010273,1,0.959409329224664,0,11,detoxification of copper ion,BP,
4682,GO:0010286,1,0.975270156110806,0,5,heat acclimation,BP,
4683,GO:0010288,1,0.870821005590971,0,21,response to lead ion,BP,
4684,GO:0010309,1,0.995830066241855,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4685,GO:0010310,1,0.907664152519758,0,18,regulation of hydrogen peroxide metabolic process,BP,
4686,GO:0010314,1,0.891198675676165,0,15,phosphatidylinositol-5-phosphate binding,MF,
4687,GO:0010324,1,0.647732351286796,0,68,membrane invagination,BP,
4688,GO:0010332,1,0.700782801294544,0,52,response to gamma radiation,BP,
4689,GO:0010335,1,0.992351701786639,0,1,response to non-ionic osmotic stress,BP,
4690,GO:0010340,1,0.969619326452004,0,5,carboxyl-O-methyltransferase activity,MF,
4691,GO:0010348,1,0.99325505912211,0,1,lithium:proton antiporter activity,MF,
4692,GO:0010359,1,0.933889799419823,0,9,regulation of anion channel activity,BP,
4693,GO:0010360,1,0.978770632024003,0,3,negative regulation of anion channel activity,BP,
4694,GO:0010369,1,0.901538107535853,0,15,chromocenter,CC,
4695,GO:0010370,1,0.987596883971089,0,2,perinucleolar chromocenter,CC,
4696,GO:0010385,1,0.96001316895271,0,5,double-stranded methylated DNA binding,MF,
4697,GO:0010387,1,0.978315732770903,0,4,COP9 signalosome assembly,BP,
4699,GO:0010390,1,0.82980855141508,0,27,histone monoubiquitination,BP,
4700,GO:0010420,1,0.996425863818555,0,1,3,4-dihydroxy-5-polyprenylbenzoic acid O-methyltransferase activity,MF,
4701,GO:0010421,1,0.938731349939286,0,11,hydrogen peroxide-mediated programmed cell death,BP,
4702,GO:0010428,1,0.991648387770277,0,1,methyl-CpNpG binding,MF,
4703,GO:0010430,1,0.973912840362747,0,4,fatty acid omega-oxidation,BP,
4704,GO:0010436,1,0.986402667512831,0,2,carotenoid dioxygenase activity,MF,
4705,GO:0010446,1,0.988026918855297,0,2,response to alkaline pH,BP,
4706,GO:0010447,1,0.879452315209299,0,21,response to acidic pH,BP,
4707,GO:0010452,1,0.895624789903355,0,14,histone H3-K36 methylation,BP,
4711,GO:0010457,1,0.907361997770269,0,12,centriole-centriole cohesion,BP,
4713,GO:0010459,1,0.948643362138817,0,10,negative regulation of heart rate,BP,
4714,GO:0010460,1,0.853384104933214,0,25,positive regulation of heart rate,BP,
4715,GO:0010463,1,0.738182855095396,0,43,mesenchymal cell proliferation,BP,
4716,GO:0010464,1,0.794331203690067,0,33,regulation of mesenchymal cell proliferation,BP,
4717,GO:0010465,1,0.984567131146892,0,2,nerve growth factor receptor activity,MF,
4723,GO:0010477,1,0.992672062861192,0,1,response to sulfur dioxide,BP,
4724,GO:0010481,1,0.988703685578276,0,2,epidermal cell division,BP,
4725,GO:0010482,1,0.988703685578276,0,2,regulation of epidermal cell division,BP,
4726,GO:0010484,1,0.938091929152652,0,8,H3 histone acetyltransferase activity,MF,
4727,GO:0010485,1,0.886594552910712,0,17,H4 histone acetyltransferase activity,MF,
4728,GO:0010494,1,0.598994981475828,0,71,cytoplasmic stress granule,CC,
4730,GO:0010498,1,0.0541175955681232,0,453,proteasomal protein catabolic process,BP,
4731,GO:0010499,1,0.924389463900638,0,19,proteasomal ubiquitin-independent protein catabolic process,BP,
4732,GO:0010501,1,0.944416975780024,0,8,RNA secondary structure unwinding,BP,
4734,GO:0010507,1,0.582916857829685,0,78,negative regulation of autophagy,BP,
4736,GO:0010509,1,0.991857192543709,0,1,polyamine homeostasis,BP,
4737,GO:0010510,1,0.943214662567823,0,8,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4738,GO:0010511,1,0.950744395003382,0,8,regulation of phosphatidylinositol biosynthetic process,BP,
4739,GO:0010512,1,0.986365291147034,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4740,GO:0010513,1,0.963891676320112,0,6,positive regulation of phosphatidylinositol biosynthetic process,BP,
4743,GO:0010519,1,0.969445680077173,0,5,negative regulation of phospholipase activity,BP,
4744,GO:0010520,1,0.971923016535682,0,4,regulation of reciprocal meiotic recombination,BP,
4745,GO:0010521,1,0.976007219019587,0,4,telomerase inhibitor activity,MF,
4747,GO:0010523,1,0.908550734202644,0,16,negative regulation of calcium ion transport into cytosol,BP,
4749,GO:0010525,1,0.992525061161122,0,1,regulation of transposition, RNA-mediated,BP,
4750,GO:0010526,1,0.992525061161122,0,1,negative regulation of transposition, RNA-mediated,BP,
4751,GO:0010528,1,0.888531241234256,0,19,regulation of transposition,BP,
4752,GO:0010529,1,0.888531241234256,0,19,negative regulation of transposition,BP,
4753,GO:0010533,1,0.974830679184206,0,5,regulation of activation of Janus kinase activity,BP,
4754,GO:0010536,1,0.982820694508946,0,3,positive regulation of activation of Janus kinase activity,BP,
4760,GO:0010559,1,0.772765507099063,0,40,regulation of glycoprotein biosynthetic process,BP,
4761,GO:0010560,1,0.859117968910145,0,22,positive regulation of glycoprotein biosynthetic process,BP,
4762,GO:0010561,1,0.929955416801262,0,12,negative regulation of glycoprotein biosynthetic process,BP,
4767,GO:0010566,1,0.894125128975489,0,17,regulation of ketone biosynthetic process,BP,
4768,GO:0010569,1,0.759304825632884,0,39,regulation of double-strand break repair via homologous recombination,BP,
4769,GO:0010571,1,0.94424346558589,0,7,positive regulation of nuclear cell cycle DNA replication,BP,
4770,GO:0010572,1,0.950506366265661,0,7,positive regulation of platelet activation,BP,
4771,GO:0010573,1,0.808584785159081,0,32,vascular endothelial growth factor production,BP,
4772,GO:0010574,1,0.825030470996695,0,29,regulation of vascular endothelial growth factor production,BP,
4773,GO:0010575,1,0.837132056489374,0,26,positive regulation of vascular endothelial growth factor production,BP,
4774,GO:0010578,1,0.99368689056014,0,1,regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway,BP,
4775,GO:0010585,1,0.995285386751004,0,1,glutamine secretion,BP,
4776,GO:0010586,1,0.838783908207719,0,25,miRNA metabolic process,BP,
4777,GO:0010587,1,0.956288230784783,0,6,miRNA catabolic process,BP,
4778,GO:0010591,1,0.807709869519284,0,31,regulation of lamellipodium assembly,BP,
4779,GO:0010592,1,0.856375862060332,0,22,positive regulation of lamellipodium assembly,BP,
4780,GO:0010593,1,0.983625053840711,0,2,negative regulation of lamellipodium assembly,BP,
4781,GO:0010594,1,0.367319072068974,0,147,regulation of endothelial cell migration,BP,
4782,GO:0010595,1,0.533337130290187,0,93,positive regulation of endothelial cell migration,BP,
4784,GO:0010603,1,0.93125880699326,0,9,regulation of cytoplasmic mRNA processing body assembly,BP,
4787,GO:0010606,1,0.950185385385342,0,6,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4788,GO:0010607,1,0.995203418878348,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4790,GO:0010609,1,0.987560167336238,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4791,GO:0010610,1,0.97616977504358,0,3,regulation of mRNA stability involved in response to stress,BP,
4792,GO:0010611,1,0.689740622307631,0,53,regulation of cardiac muscle hypertrophy,BP,
4793,GO:0010612,1,0.938755592702166,0,8,regulation of cardiac muscle adaptation,BP,
4794,GO:0010613,1,0.823223961855367,0,27,positive regulation of cardiac muscle hypertrophy,BP,
4795,GO:0010614,1,0.841761827927237,0,25,negative regulation of cardiac muscle hypertrophy,BP,
4796,GO:0010615,1,0.98492034294557,0,2,positive regulation of cardiac muscle adaptation,BP,
4797,GO:0010616,1,0.953135530060497,0,6,negative regulation of cardiac muscle adaptation,BP,
4798,GO:0010621,1,0.985765122537499,0,3,negative regulation of transcription by transcription factor localization,BP,
4799,GO:0010623,1,0.91864826362872,0,13,programmed cell death involved in cell development,BP,
4806,GO:0010633,1,0.66504742803939,0,61,negative regulation of epithelial cell migration,BP,
4808,GO:0010635,1,0.920928310537856,0,12,regulation of mitochondrial fusion,BP,
4809,GO:0010636,1,0.979840022499805,0,3,positive regulation of mitochondrial fusion,BP,
4810,GO:0010637,1,0.946173611790215,0,8,negative regulation of mitochondrial fusion,BP,
4814,GO:0010641,1,0.963242409927588,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4825,GO:0010656,1,0.800212688693639,0,35,negative regulation of muscle cell apoptotic process,BP,
4826,GO:0010657,1,0.664900985497612,0,63,muscle cell apoptotic process,BP,
4827,GO:0010658,1,0.783956651859525,0,37,striated muscle cell apoptotic process,BP,
4828,GO:0010659,1,0.794959362656542,0,35,cardiac muscle cell apoptotic process,BP,
4829,GO:0010660,1,0.680607807348041,0,60,regulation of muscle cell apoptotic process,BP,
4830,GO:0010661,1,0.855396354931861,0,24,positive regulation of muscle cell apoptotic process,BP,
4831,GO:0010662,1,0.796884356123866,0,35,regulation of striated muscle cell apoptotic process,BP,
4832,GO:0010663,1,0.918920401858217,0,12,positive regulation of striated muscle cell apoptotic process,BP,
4833,GO:0010664,1,0.860654592750144,0,24,negative regulation of striated muscle cell apoptotic process,BP,
4834,GO:0010665,1,0.808066627701782,0,33,regulation of cardiac muscle cell apoptotic process,BP,
4835,GO:0010666,1,0.918920401858217,0,12,positive regulation of cardiac muscle cell apoptotic process,BP,
4836,GO:0010667,1,0.879462755186909,0,21,negative regulation of cardiac muscle cell apoptotic process,BP,
4838,GO:0010669,1,0.872848005172423,0,21,epithelial structure maintenance,BP,
4841,GO:0010677,1,0.782703591903955,0,36,negative regulation of cellular carbohydrate metabolic process,BP,
4842,GO:0010692,1,0.931796306633926,0,9,regulation of alkaline phosphatase activity,BP,
4843,GO:0010693,1,0.980352337048957,0,3,negative regulation of alkaline phosphatase activity,BP,
4844,GO:0010694,1,0.950480606406353,0,6,positive regulation of alkaline phosphatase activity,BP,
4845,GO:0010698,1,0.986149694853036,0,3,acetyltransferase activator activity,MF,
4846,GO:0010700,1,0.973341238664802,0,5,negative regulation of norepinephrine secretion,BP,
4847,GO:0010701,1,0.979863024968226,0,3,positive regulation of norepinephrine secretion,BP,
4848,GO:0010705,1,0.98561853305171,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4849,GO:0010706,1,0.984550314315677,0,2,ganglioside biosynthetic process via lactosylceramide,BP,
4850,GO:0010710,1,0.982568511009313,0,3,regulation of collagen catabolic process,BP,
4851,GO:0010711,1,0.996777805129879,0,1,negative regulation of collagen catabolic process,BP,
4852,GO:0010712,1,0.812064483793974,0,35,regulation of collagen metabolic process,BP,
4853,GO:0010713,1,0.94265107208146,0,11,negative regulation of collagen metabolic process,BP,
4854,GO:0010714,1,0.877935089469169,0,21,positive regulation of collagen metabolic process,BP,
4855,GO:0010715,1,0.903263591411088,0,14,regulation of extracellular matrix disassembly,BP,
4856,GO:0010716,1,0.977238569183968,0,4,negative regulation of extracellular matrix disassembly,BP,
4858,GO:0010718,1,0.726322004461603,0,46,positive regulation of epithelial to mesenchymal transition,BP,
4859,GO:0010719,1,0.817346568438516,0,33,negative regulation of epithelial to mesenchymal transition,BP,
4862,GO:0010722,1,0.990937060031253,0,1,regulation of ferrochelatase activity,BP,
4863,GO:0010723,1,0.991490679054981,0,1,positive regulation of transcription from RNA polymerase II promoter in response to iron,BP,
4864,GO:0010724,1,0.974585520558556,0,4,regulation of definitive erythrocyte differentiation,BP,
4865,GO:0010725,1,0.988784622629792,0,2,regulation of primitive erythrocyte differentiation,BP,
4866,GO:0010726,1,0.975668220804918,0,4,positive regulation of hydrogen peroxide metabolic process,BP,
4867,GO:0010727,1,0.955886455999899,0,8,negative regulation of hydrogen peroxide metabolic process,BP,
4868,GO:0010728,1,0.964853516850769,0,6,regulation of hydrogen peroxide biosynthetic process,BP,
4869,GO:0010729,1,0.99045434413459,0,2,positive regulation of hydrogen peroxide biosynthetic process,BP,
4870,GO:0010730,1,0.974154940211655,0,4,negative regulation of hydrogen peroxide biosynthetic process,BP,
4871,GO:0010731,1,0.991099097755673,0,2,protein glutathionylation,BP,
4872,GO:0010732,1,0.991099097755673,0,2,regulation of protein glutathionylation,BP,
4873,GO:0010734,1,0.991099097755673,0,2,negative regulation of protein glutathionylation,BP,
4874,GO:0010735,1,0.980309536853854,0,3,positive regulation of transcription via serum response element binding,BP,
4875,GO:0010736,1,0.992405742985616,0,1,serum response element binding,MF,
4876,GO:0010737,1,0.801069489090916,0,30,protein kinase A signaling,BP,
4877,GO:0010738,1,0.867468542950495,0,20,regulation of protein kinase A signaling,BP,
4878,GO:0010739,1,0.957835363050418,0,7,positive regulation of protein kinase A signaling,BP,
4879,GO:0010742,1,0.811542279877478,0,31,macrophage derived foam cell differentiation,BP,
4880,GO:0010743,1,0.836596428985264,0,27,regulation of macrophage derived foam cell differentiation,BP,
4881,GO:0010744,1,0.903907587846943,0,16,positive regulation of macrophage derived foam cell differentiation,BP,
4882,GO:0010745,1,0.925606951956737,0,11,negative regulation of macrophage derived foam cell differentiation,BP,
4883,GO:0010746,1,0.961046941843109,0,5,regulation of long-chain fatty acid import across plasma membrane,BP,
4884,GO:0010747,1,0.992602153638054,0,1,positive regulation of long-chain fatty acid import across plasma membrane,BP,
4885,GO:0010748,1,0.96821197547204,0,4,negative regulation of long-chain fatty acid import across plasma membrane,BP,
4888,GO:0010751,1,0.978742762290028,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4889,GO:0010752,1,0.920029761081806,0,13,regulation of cGMP-mediated signaling,BP,
4890,GO:0010753,1,0.969816504871094,0,6,positive regulation of cGMP-mediated signaling,BP,
4891,GO:0010754,1,0.955950588599264,0,6,negative regulation of cGMP-mediated signaling,BP,
4892,GO:0010755,1,0.946146989889828,0,10,regulation of plasminogen activation,BP,
4893,GO:0010756,1,0.97563264824892,0,5,positive regulation of plasminogen activation,BP,
4894,GO:0010757,1,0.969785408999303,0,5,negative regulation of plasminogen activation,BP,
4895,GO:0010758,1,0.857192951787537,0,25,regulation of macrophage chemotaxis,BP,
4896,GO:0010759,1,0.905218842297147,0,16,positive regulation of macrophage chemotaxis,BP,
4897,GO:0010760,1,0.967087390449293,0,6,negative regulation of macrophage chemotaxis,BP,
4898,GO:0010761,1,0.734423800171392,0,43,fibroblast migration,BP,
4899,GO:0010762,1,0.798120377113602,0,32,regulation of fibroblast migration,BP,
4900,GO:0010763,1,0.90188673741864,0,14,positive regulation of fibroblast migration,BP,
4901,GO:0010764,1,0.964469523836186,0,6,negative regulation of fibroblast migration,BP,
4903,GO:0010766,1,0.87430574677142,0,18,negative regulation of sodium ion transport,BP,
4904,GO:0010767,1,0.984842170692245,0,2,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4905,GO:0010768,1,0.991366252550239,0,1,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4909,GO:0010780,1,0.991561133730953,0,1,meiotic DNA double-strand break formation involved in reciprocal meiotic recombination,BP,
4910,GO:0010789,1,0.99325505912211,0,1,meiotic sister chromatid cohesion involved in meiosis I,BP,
4911,GO:0010792,1,0.965763033660522,0,5,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4912,GO:0010793,1,0.955050572785483,0,6,regulation of mRNA export from nucleus,BP,
4913,GO:0010795,1,0.988950234263933,0,2,regulation of ubiquinone biosynthetic process,BP,
4914,GO:0010796,1,0.98623559167415,0,3,regulation of multivesicular body size,BP,
4915,GO:0010797,1,0.996479646140572,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4916,GO:0010799,1,0.749726050018713,0,43,regulation of peptidyl-threonine phosphorylation,BP,
4917,GO:0010800,1,0.821562113465091,0,29,positive regulation of peptidyl-threonine phosphorylation,BP,
4918,GO:0010801,1,0.897510269379681,0,17,negative regulation of peptidyl-threonine phosphorylation,BP,
4919,GO:0010803,1,0.731454640036999,0,51,regulation of tumor necrosis factor-mediated signaling pathway,BP,
4920,GO:0010804,1,0.920495149665119,0,16,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4921,GO:0010807,1,0.955924926377512,0,7,regulation of synaptic vesicle priming,BP,
4922,GO:0010808,1,0.991363997031284,0,1,positive regulation of synaptic vesicle priming,BP,
4926,GO:0010813,1,0.988269440907622,0,2,neuropeptide catabolic process,BP,
4927,GO:0010814,1,0.99207703213115,0,1,substance P catabolic process,BP,
4928,GO:0010815,1,0.974398677268268,0,4,bradykinin catabolic process,BP,
4929,GO:0010816,1,0.99207703213115,0,1,calcitonin catabolic process,BP,
4931,GO:0010818,1,0.870072208995847,0,25,T cell chemotaxis,BP,
4932,GO:0010819,1,0.916382021900414,0,15,regulation of T cell chemotaxis,BP,
4933,GO:0010820,1,0.919585041037896,0,14,positive regulation of T cell chemotaxis,BP,
4937,GO:0010824,1,0.73762594188159,0,43,regulation of centrosome duplication,BP,
4938,GO:0010825,1,0.942714171887278,0,8,positive regulation of centrosome duplication,BP,
4939,GO:0010826,1,0.916185363092718,0,13,negative regulation of centrosome duplication,BP,
4940,GO:0010827,1,0.638437932979711,0,64,regulation of glucose transmembrane transport,BP,
4941,GO:0010828,1,0.76250933286004,0,36,positive regulation of glucose transmembrane transport,BP,
4942,GO:0010829,1,0.909663510368245,0,16,negative regulation of glucose transmembrane transport,BP,
4943,GO:0010830,1,0.744461889479064,0,47,regulation of myotube differentiation,BP,
4944,GO:0010831,1,0.847697479240447,0,27,positive regulation of myotube differentiation,BP,
4945,GO:0010832,1,0.915026907359196,0,14,negative regulation of myotube differentiation,BP,
4946,GO:0010833,1,0.602713170425075,0,76,telomere maintenance via telomere lengthening,BP,
4947,GO:0010835,1,0.970489009612964,0,5,regulation of protein ADP-ribosylation,BP,
4948,GO:0010836,1,0.985687046358711,0,3,negative regulation of protein ADP-ribosylation,BP,
4949,GO:0010837,1,0.812362699056606,0,29,regulation of keratinocyte proliferation,BP,
4950,GO:0010838,1,0.927577022515407,0,11,positive regulation of keratinocyte proliferation,BP,
4951,GO:0010839,1,0.918220121455464,0,11,negative regulation of keratinocyte proliferation,BP,
4952,GO:0010840,1,0.984213214459026,0,3,regulation of circadian sleep/wake cycle, wakefulness,BP,
4953,GO:0010841,1,0.988622671831247,0,2,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
4954,GO:0010842,1,0.836985161472621,0,22,retina layer formation,BP,
4955,GO:0010844,1,0.992505698685532,0,1,recombination hotspot binding,MF,
4956,GO:0010845,1,0.971923016535682,0,4,positive regulation of reciprocal meiotic recombination,BP,
4957,GO:0010847,1,0.871341796633734,0,18,regulation of chromatin assembly,BP,
4958,GO:0010848,1,0.985098479689817,0,2,regulation of chromatin disassembly,BP,
4959,GO:0010849,1,0.994606968261175,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4960,GO:0010851,1,0.973352637296225,0,5,cyclase regulator activity,MF,
4961,GO:0010852,1,0.99435526848047,0,1,cyclase inhibitor activity,MF,
4962,GO:0010853,1,0.986342098317533,0,3,cyclase activator activity,MF,
4963,GO:0010854,1,0.992434973267728,0,1,adenylate cyclase regulator activity,MF,
4964,GO:0010855,1,0.992434973267728,0,1,adenylate cyclase inhibitor activity,MF,
4965,GO:0010856,1,0.971587346423479,0,5,adenylate cyclase activator activity,MF,
4966,GO:0010857,1,0.846753904733873,0,23,calcium-dependent protein kinase activity,MF,
4967,GO:0010858,1,0.987260390880558,0,3,calcium-dependent protein kinase regulator activity,MF,
4968,GO:0010859,1,0.992389206665289,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
4969,GO:0010862,1,0.751979892177948,0,44,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
4971,GO:0010866,1,0.898435935200601,0,17,regulation of triglyceride biosynthetic process,BP,
4972,GO:0010867,1,0.922645688078121,0,13,positive regulation of triglyceride biosynthetic process,BP,
4973,GO:0010868,1,0.984827629392161,0,2,negative regulation of triglyceride biosynthetic process,BP,
4974,GO:0010869,1,0.873882590033244,0,20,regulation of receptor biosynthetic process,BP,
4975,GO:0010870,1,0.931051632723666,0,12,positive regulation of receptor biosynthetic process,BP,
4976,GO:0010871,1,0.9619532612245,0,5,negative regulation of receptor biosynthetic process,BP,
4977,GO:0010872,1,0.950107029940191,0,9,regulation of cholesterol esterification,BP,
4978,GO:0010873,1,0.97274879928003,0,6,positive regulation of cholesterol esterification,BP,
4979,GO:0010874,1,0.838276111041417,0,27,regulation of cholesterol efflux,BP,
4980,GO:0010875,1,0.882089442559385,0,19,positive regulation of cholesterol efflux,BP,
4982,GO:0010877,1,0.990961288976737,0,2,lipid transport involved in lipid storage,BP,
4983,GO:0010878,1,0.878495997931967,0,18,cholesterol storage,BP,
4984,GO:0010879,1,0.994427769882656,0,1,cholesterol transport involved in cholesterol storage,BP,
4985,GO:0010880,1,0.826348561074196,0,27,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4986,GO:0010881,1,0.873589420046738,0,20,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
4987,GO:0010882,1,0.843182645446121,0,25,regulation of cardiac muscle contraction by calcium ion signaling,BP,
4988,GO:0010883,1,0.734403029689939,0,47,regulation of lipid storage,BP,
4989,GO:0010884,1,0.861308729681831,0,23,positive regulation of lipid storage,BP,
4990,GO:0010885,1,0.890030863983611,0,16,regulation of cholesterol storage,BP,
4991,GO:0010886,1,0.946997875970892,0,7,positive regulation of cholesterol storage,BP,
4992,GO:0010887,1,0.93987700328393,0,9,negative regulation of cholesterol storage,BP,
4993,GO:0010888,1,0.876242905628294,0,20,negative regulation of lipid storage,BP,
4994,GO:0010889,1,0.920534565293584,0,14,regulation of sequestering of triglyceride,BP,
4995,GO:0010890,1,0.955737470850214,0,9,positive regulation of sequestering of triglyceride,BP,
4996,GO:0010891,1,0.963183466098746,0,5,negative regulation of sequestering of triglyceride,BP,
4997,GO:0010893,1,0.906176372568204,0,15,positive regulation of steroid biosynthetic process,BP,
4998,GO:0010894,1,0.876074723094364,0,22,negative regulation of steroid biosynthetic process,BP,
4999,GO:0010896,1,0.941258037585955,0,10,regulation of triglyceride catabolic process,BP,
5000,GO:0010897,1,0.969571674708797,0,4,negative regulation of triglyceride catabolic process,BP,
5001,GO:0010898,1,0.970806863967084,0,6,positive regulation of triglyceride catabolic process,BP,
5002,GO:0010899,1,0.982380226994555,0,3,regulation of phosphatidylcholine catabolic process,BP,
5003,GO:0010900,1,0.996860200458305,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
5004,GO:0010901,1,0.993528385965469,0,2,regulation of very-low-density lipoprotein particle remodeling,BP,
5005,GO:0010902,1,0.996798139919164,0,1,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5006,GO:0010903,1,0.996719850943217,0,1,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5007,GO:0010904,1,0.994635528004373,0,1,regulation of UDP-glucose catabolic process,BP,
5008,GO:0010905,1,0.994635528004373,0,1,negative regulation of UDP-glucose catabolic process,BP,
5011,GO:0010908,1,0.978457541777558,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5012,GO:0010909,1,0.978457541777558,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5013,GO:0010911,1,0.944030923865099,0,8,regulation of isomerase activity,BP,
5014,GO:0010912,1,0.944030923865099,0,8,positive regulation of isomerase activity,BP,
5015,GO:0010915,1,0.989702035940217,0,3,regulation of very-low-density lipoprotein particle clearance,BP,
5016,GO:0010916,1,0.989702035940217,0,3,negative regulation of very-low-density lipoprotein particle clearance,BP,
5017,GO:0010917,1,0.938999702921655,0,12,negative regulation of mitochondrial membrane potential,BP,
5018,GO:0010918,1,0.940337695880029,0,10,positive regulation of mitochondrial membrane potential,BP,
5019,GO:0010919,1,0.924384974003621,0,12,regulation of inositol phosphate biosynthetic process,BP,
5020,GO:0010920,1,0.993106347255175,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5022,GO:0010922,1,0.807038575858983,0,30,positive regulation of phosphatase activity,BP,
5024,GO:0010924,1,0.993106347255175,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5025,GO:0010925,1,0.993106347255175,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5027,GO:0010931,1,0.990348663194196,0,1,macrophage tolerance induction,BP,
5028,GO:0010932,1,0.990348663194196,0,1,regulation of macrophage tolerance induction,BP,
5029,GO:0010933,1,0.990348663194196,0,1,positive regulation of macrophage tolerance induction,BP,
5030,GO:0010934,1,0.902346400363639,0,16,macrophage cytokine production,BP,
5031,GO:0010935,1,0.914844378210414,0,14,regulation of macrophage cytokine production,BP,
5032,GO:0010936,1,0.966635205454546,0,5,negative regulation of macrophage cytokine production,BP,
5033,GO:0010938,1,0.99251214454348,0,1,cytoplasmic microtubule depolymerization,BP,
5035,GO:0010940,1,0.955313819346873,0,9,positive regulation of necrotic cell death,BP,
5038,GO:0010944,1,0.944226983678491,0,9,negative regulation of transcription by competitive promoter binding,BP,
5040,GO:0010949,1,0.99344668091026,0,1,negative regulation of intestinal phytosterol absorption,BP,
5045,GO:0010955,1,0.852450219774092,0,27,negative regulation of protein processing,BP,
5046,GO:0010956,1,0.979831009353648,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5047,GO:0010957,1,0.970707029996528,0,5,negative regulation of vitamin D biosynthetic process,BP,
5048,GO:0010958,1,0.92141123510936,0,12,regulation of amino acid import across plasma membrane,BP,
5051,GO:0010961,1,0.963041167353775,0,5,cellular magnesium ion homeostasis,BP,
5052,GO:0010962,1,0.816740861583478,0,26,regulation of glucan biosynthetic process,BP,
5053,GO:0010963,1,0.989871605434429,0,2,regulation of L-arginine import,BP,
5054,GO:0010965,1,0.686143094964526,0,58,regulation of mitotic sister chromatid separation,BP,
5055,GO:0010966,1,0.95990499329866,0,6,regulation of phosphate transport,BP,
5056,GO:0010967,1,0.995786241327855,0,1,regulation of polyamine biosynthetic process,BP,
5057,GO:0010968,1,0.955128135428123,0,7,regulation of microtubule nucleation,BP,
5058,GO:0010970,1,0.342081950046284,0,151,transport along microtubule,BP,
5059,GO:0010971,1,0.844548796099694,0,26,positive regulation of G2/M transition of mitotic cell cycle,BP,
5060,GO:0010972,1,0.631894576747625,0,85,negative regulation of G2/M transition of mitotic cell cycle,BP,
5064,GO:0010979,1,0.986172972068697,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
5065,GO:0010980,1,0.986172972068697,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
5066,GO:0010982,1,0.986852543174211,0,2,regulation of high-density lipoprotein particle clearance,BP,
5067,GO:0010983,1,0.986852543174211,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5068,GO:0010984,1,0.921127530852564,0,15,regulation of lipoprotein particle clearance,BP,
5069,GO:0010985,1,0.962139673488599,0,7,negative regulation of lipoprotein particle clearance,BP,
5070,GO:0010986,1,0.975906943593382,0,4,positive regulation of lipoprotein particle clearance,BP,
5071,GO:0010988,1,0.943126124766504,0,10,regulation of low-density lipoprotein particle clearance,BP,
5072,GO:0010989,1,0.972153755381358,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5073,GO:0010990,1,0.958272402712556,0,6,regulation of SMAD protein complex assembly,BP,
5074,GO:0010991,1,0.965546966556519,0,5,negative regulation of SMAD protein complex assembly,BP,
5075,GO:0010992,1,0.944483959036249,0,9,ubiquitin recycling,BP,
5076,GO:0010994,1,0.966847950795828,0,6,free ubiquitin chain polymerization,BP,
5077,GO:0010996,1,0.840267841112376,0,25,response to auditory stimulus,BP,
5078,GO:0010997,1,0.95917583879826,0,7,anaphase-promoting complex binding,MF,
5079,GO:0010998,1,0.934173562776698,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5080,GO:0010999,1,0.992360188809566,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5084,GO:0012507,1,0.712465715086012,0,57,ER to Golgi transport vesicle membrane,CC,
5085,GO:0012510,1,0.922200547483386,0,13,trans-Golgi network transport vesicle membrane,CC,
5088,GO:0014004,1,0.966154444469562,0,5,microglia differentiation,BP,
5089,GO:0014005,1,0.971407441809292,0,4,microglia development,BP,
5090,GO:0014006,1,0.994593981600062,0,1,regulation of microglia differentiation,BP,
5091,GO:0014008,1,0.994593981600062,0,1,positive regulation of microglia differentiation,BP,
5094,GO:0014011,1,0.99325505912211,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5099,GO:0014016,1,0.98177092273369,0,3,neuroblast differentiation,BP,
5100,GO:0014017,1,0.993898281598366,0,1,neuroblast fate commitment,BP,
5102,GO:0014022,1,0.977985369731925,0,3,neural plate elongation,BP,
5103,GO:0014028,1,0.980466400521989,0,3,notochord formation,BP,
5104,GO:0014029,1,0.930843199956498,0,11,neural crest formation,BP,
5108,GO:0014034,1,0.981455891802138,0,3,neural crest cell fate commitment,BP,
5109,GO:0014036,1,0.989010492185666,0,2,neural crest cell fate specification,BP,
5111,GO:0014038,1,0.972015934249968,0,4,regulation of Schwann cell differentiation,BP,
5112,GO:0014040,1,0.976227619092891,0,3,positive regulation of Schwann cell differentiation,BP,
5113,GO:0014041,1,0.92793481821013,0,10,regulation of neuron maturation,BP,
5114,GO:0014042,1,0.959321662339725,0,5,positive regulation of neuron maturation,BP,
5115,GO:0014043,1,0.980577717847914,0,3,negative regulation of neuron maturation,BP,
5117,GO:0014045,1,0.9703405599679,0,5,establishment of endothelial blood-brain barrier,BP,
5118,GO:0014046,1,0.807578439208752,0,34,dopamine secretion,BP,
5120,GO:0014048,1,0.910601539279831,0,14,regulation of glutamate secretion,BP,
5121,GO:0014049,1,0.938838182994781,0,9,positive regulation of glutamate secretion,BP,
5122,GO:0014050,1,0.969942913109827,0,5,negative regulation of glutamate secretion,BP,
5123,GO:0014051,1,0.928388453022379,0,10,gamma-aminobutyric acid secretion,BP,
5124,GO:0014052,1,0.954617940623845,0,7,regulation of gamma-aminobutyric acid secretion,BP,
5125,GO:0014053,1,0.988730399927302,0,2,negative regulation of gamma-aminobutyric acid secretion,BP,
5126,GO:0014054,1,0.972921093181517,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5127,GO:0014055,1,0.981288702349627,0,3,acetylcholine secretion, neurotransmission,BP,
5128,GO:0014056,1,0.981288702349627,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5129,GO:0014057,1,0.987765754029469,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5130,GO:0014059,1,0.807578439208752,0,34,regulation of dopamine secretion,BP,
5131,GO:0014060,1,0.977033453262904,0,5,regulation of epinephrine secretion,BP,
5132,GO:0014061,1,0.931612603064568,0,12,regulation of norepinephrine secretion,BP,
5133,GO:0014062,1,0.954433444173388,0,8,regulation of serotonin secretion,BP,
5134,GO:0014063,1,0.968730317373373,0,5,negative regulation of serotonin secretion,BP,
5135,GO:0014064,1,0.992336503430008,0,1,positive regulation of serotonin secretion,BP,
5138,GO:0014067,1,0.922670192670612,0,12,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5142,GO:0014072,1,0.837390776126681,0,30,response to isoquinoline alkaloid,BP,
5144,GO:0014075,1,0.745560982410586,0,46,response to amine,BP,
5145,GO:0014701,1,0.920873903442856,0,9,junctional sarcoplasmic reticulum membrane,CC,
5147,GO:0014705,1,0.992424437769411,0,1,C zone,CC,
5149,GO:0014707,1,0.989131235904048,0,2,branchiomeric skeletal muscle development,BP,
5153,GO:0014721,1,0.968760179034979,0,5,twitch skeletal muscle contraction,BP,
5154,GO:0014722,1,0.972508499944972,0,5,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5155,GO:0014724,1,0.984158939627034,0,2,regulation of twitch skeletal muscle contraction,BP,
5156,GO:0014728,1,0.991556012226137,0,1,regulation of the force of skeletal muscle contraction,BP,
5158,GO:0014732,1,0.967333300767121,0,6,skeletal muscle atrophy,BP,
5159,GO:0014733,1,0.921221334225828,0,11,regulation of skeletal muscle adaptation,BP,
5160,GO:0014734,1,0.976705334754315,0,3,skeletal muscle hypertrophy,BP,
5161,GO:0014735,1,0.976789381744695,0,3,regulation of muscle atrophy,BP,
5162,GO:0014736,1,0.990067536892281,0,1,negative regulation of muscle atrophy,BP,
5163,GO:0014737,1,0.986589992089305,0,2,positive regulation of muscle atrophy,BP,
5164,GO:0014738,1,0.983819561770263,0,3,regulation of muscle hyperplasia,BP,
5165,GO:0014739,1,0.996823424679164,0,1,positive regulation of muscle hyperplasia,BP,
5166,GO:0014740,1,0.986955119771673,0,2,negative regulation of muscle hyperplasia,BP,
5167,GO:0014741,1,0.828849160624768,0,27,negative regulation of muscle hypertrophy,BP,
5168,GO:0014742,1,0.823223961855367,0,27,positive regulation of muscle hypertrophy,BP,
5169,GO:0014743,1,0.67913862414068,0,55,regulation of muscle hypertrophy,BP,
5170,GO:0014744,1,0.958998981139064,0,6,positive regulation of muscle adaptation,BP,
5171,GO:0014745,1,0.923385234994156,0,10,negative regulation of muscle adaptation,BP,
5172,GO:0014802,1,0.97363781510009,0,4,terminal cisterna,CC,
5173,GO:0014804,1,0.995200984732549,0,1,terminal cisterna lumen,CC,
5174,GO:0014805,1,0.983005541817017,0,4,smooth muscle adaptation,BP,
5175,GO:0014806,1,0.989990435550842,0,2,smooth muscle hyperplasia,BP,
5177,GO:0014808,1,0.806348393299097,0,30,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5178,GO:0014809,1,0.979280165280709,0,4,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5179,GO:0014810,1,0.996774127315725,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5180,GO:0014812,1,0.575789030944003,0,77,muscle cell migration,BP,
5181,GO:0014813,1,0.994435550372176,0,1,skeletal muscle satellite cell commitment,BP,
5182,GO:0014816,1,0.933752069941349,0,9,skeletal muscle satellite cell differentiation,BP,
5183,GO:0014819,1,0.926534016210895,0,12,regulation of skeletal muscle contraction,BP,
5184,GO:0014820,1,0.935061399176665,0,11,tonic smooth muscle contraction,BP,
5185,GO:0014821,1,0.89797673584831,0,19,phasic smooth muscle contraction,BP,
5186,GO:0014822,1,0.993698442190156,0,1,detection of wounding,BP,
5188,GO:0014824,1,0.946902343549869,0,9,artery smooth muscle contraction,BP,
5189,GO:0014825,1,0.996760354949418,0,1,stomach fundus smooth muscle contraction,BP,
5190,GO:0014826,1,0.977525496119812,0,4,vein smooth muscle contraction,BP,
5191,GO:0014827,1,0.966148031503111,0,6,intestine smooth muscle contraction,BP,
5192,GO:0014828,1,0.992049146936613,0,1,distal stomach smooth muscle contraction,BP,
5193,GO:0014829,1,0.85410289965511,0,23,vascular associated smooth muscle contraction,BP,
5194,GO:0014831,1,0.934359072861148,0,11,gastro-intestinal system smooth muscle contraction,BP,
5195,GO:0014832,1,0.952457252558141,0,7,urinary bladder smooth muscle contraction,BP,
5197,GO:0014835,1,0.994414807010626,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
5198,GO:0014839,1,0.978544425596471,0,4,myoblast migration involved in skeletal muscle regeneration,BP,
5199,GO:0014841,1,0.904487316627226,0,14,skeletal muscle satellite cell proliferation,BP,
5200,GO:0014842,1,0.913038372517289,0,13,regulation of skeletal muscle satellite cell proliferation,BP,
5201,GO:0014843,1,0.991156964088825,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5202,GO:0014846,1,0.984279038989779,0,2,esophagus smooth muscle contraction,BP,
5203,GO:0014847,1,0.996760354949418,0,1,proximal stomach smooth muscle contraction,BP,
5204,GO:0014848,1,0.952457252558141,0,7,urinary tract smooth muscle contraction,BP,
5206,GO:0014852,1,0.99308653099521,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5207,GO:0014853,1,0.99308653099521,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5208,GO:0014854,1,0.915822129327943,0,13,response to inactivity,BP,
5210,GO:0014856,1,0.900872062317336,0,15,skeletal muscle cell proliferation,BP,
5211,GO:0014857,1,0.909389289457918,0,14,regulation of skeletal muscle cell proliferation,BP,
5212,GO:0014858,1,0.980274918237441,0,3,positive regulation of skeletal muscle cell proliferation,BP,
5213,GO:0014859,1,0.971855768537763,0,4,negative regulation of skeletal muscle cell proliferation,BP,
5214,GO:0014861,1,0.991943534146207,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5215,GO:0014862,1,0.991556012226137,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
5216,GO:0014866,1,0.935744100305918,0,8,skeletal myofibril assembly,BP,
5217,GO:0014870,1,0.930917913953696,0,10,response to muscle inactivity,BP,
5218,GO:0014873,1,0.989378313590983,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5219,GO:0014874,1,0.919255417309795,0,12,response to stimulus involved in regulation of muscle adaptation,BP,
5220,GO:0014877,1,0.937243733454792,0,9,response to muscle inactivity involved in regulation of muscle adaptation,BP,
5221,GO:0014878,1,0.982844431659719,0,3,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5222,GO:0014883,1,0.959830492980815,0,6,transition between fast and slow fiber,BP,
5223,GO:0014886,1,0.992661418730472,0,1,transition between slow and fast fiber,BP,
5224,GO:0014887,1,0.85470469614632,0,21,cardiac muscle adaptation,BP,
5225,GO:0014888,1,0.758099389330995,0,41,striated muscle adaptation,BP,
5226,GO:0014889,1,0.936603040257775,0,10,muscle atrophy,BP,
5227,GO:0014891,1,0.960867955677934,0,7,striated muscle atrophy,BP,
5228,GO:0014894,1,0.937243733454792,0,9,response to denervation involved in regulation of muscle adaptation,BP,
5229,GO:0014895,1,0.996808527066112,0,1,smooth muscle hypertrophy,BP,
5230,GO:0014896,1,0.546292147968913,0,82,muscle hypertrophy,BP,
5231,GO:0014897,1,0.551843329582151,0,80,striated muscle hypertrophy,BP,
5232,GO:0014898,1,0.85470469614632,0,21,cardiac muscle hypertrophy in response to stress,BP,
5233,GO:0014900,1,0.979929256750166,0,4,muscle hyperplasia,BP,
5235,GO:0014902,1,0.537903802106703,0,93,myotube differentiation,BP,
5236,GO:0014904,1,0.82331961869172,0,29,myotube cell development,BP,
5237,GO:0014905,1,0.984158989282598,0,3,myoblast fusion involved in skeletal muscle regeneration,BP,
5238,GO:0014908,1,0.964224280423158,0,6,myotube differentiation involved in skeletal muscle regeneration,BP,
5239,GO:0014909,1,0.627752951938086,0,64,smooth muscle cell migration,BP,
5240,GO:0014910,1,0.65293857882074,0,58,regulation of smooth muscle cell migration,BP,
5241,GO:0014911,1,0.762371395932416,0,36,positive regulation of smooth muscle cell migration,BP,
5242,GO:0014912,1,0.864169987617921,0,21,negative regulation of smooth muscle cell migration,BP,
5243,GO:0014916,1,0.967964841208544,0,4,regulation of lung blood pressure,BP,
5244,GO:0015002,1,0.925378650358037,0,21,heme-copper terminal oxidase activity,MF,
5245,GO:0015012,1,0.821907734839764,0,26,heparan sulfate proteoglycan biosynthetic process,BP,
5246,GO:0015014,1,0.938862306377872,0,8,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5247,GO:0015015,1,0.956981536179785,0,6,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5248,GO:0015016,1,0.967558259087877,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5249,GO:0015018,1,0.984111391512842,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5250,GO:0015019,1,0.992027112446519,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5251,GO:0015020,1,0.910783838557905,0,14,glucuronosyltransferase activity,MF,
5255,GO:0015035,1,0.916201422348282,0,18,protein disulfide oxidoreductase activity,MF,
5256,GO:0015036,1,0.832974382965755,0,36,disulfide oxidoreductase activity,MF,
5257,GO:0015037,1,0.939856910865704,0,13,peptide disulfide oxidoreductase activity,MF,
5258,GO:0015038,1,0.980500403099639,0,5,glutathione disulfide oxidoreductase activity,MF,
5259,GO:0015039,1,0.995353986230992,0,1,NADPH-adrenodoxin reductase activity,MF,
5260,GO:0015052,1,0.99351257216207,0,1,beta3-adrenergic receptor activity,MF,
5261,GO:0015054,1,0.994806227636368,0,1,gastrin receptor activity,MF,
5262,GO:0015056,1,0.989493695290045,0,2,corticotrophin-releasing factor receptor activity,MF,
5263,GO:0015057,1,0.965796618902859,0,5,thrombin-activated receptor activity,MF,
5264,GO:0015067,1,0.993629781746396,0,1,amidinotransferase activity,MF,
5265,GO:0015068,1,0.993629781746396,0,1,glycine amidinotransferase activity,MF,
5266,GO:0015074,1,0.933186104609968,0,10,DNA integration,BP,
5272,GO:0015085,1,0.384389843718898,0,124,calcium ion transmembrane transporter activity,MF,
5273,GO:0015086,1,0.970219768500036,0,4,cadmium ion transmembrane transporter activity,MF,
5274,GO:0015087,1,0.977800346831936,0,3,cobalt ion transmembrane transporter activity,MF,
5275,GO:0015093,1,0.970177332384154,0,4,ferrous iron transmembrane transporter activity,MF,
5276,GO:0015094,1,0.992440341107594,0,1,lead ion transmembrane transporter activity,MF,
5277,GO:0015095,1,0.900875941655157,0,15,magnesium ion transmembrane transporter activity,MF,
5278,GO:0015098,1,0.99535281446886,0,1,molybdate ion transmembrane transporter activity,MF,
5279,GO:0015099,1,0.992440341107594,0,1,nickel cation transmembrane transporter activity,MF,
5280,GO:0015101,1,0.86337113422341,0,23,organic cation transmembrane transporter activity,MF,
5281,GO:0015103,1,0.407703030080267,0,128,inorganic anion transmembrane transporter activity,MF,
5282,GO:0015106,1,0.861763892591671,0,19,bicarbonate transmembrane transporter activity,MF,
5283,GO:0015108,1,0.528909287513314,0,90,chloride transmembrane transporter activity,MF,
5284,GO:0015111,1,0.977299237439774,0,3,iodide transmembrane transporter activity,MF,
5285,GO:0015112,1,0.993486820329795,0,1,nitrate transmembrane transporter activity,MF,
5286,GO:0015114,1,0.954091500771102,0,6,phosphate ion transmembrane transporter activity,MF,
5287,GO:0015116,1,0.909664129789208,0,14,sulfate transmembrane transporter activity,MF,
5288,GO:0015117,1,0.97962340552439,0,4,thiosulfate transmembrane transporter activity,MF,
5289,GO:0015119,1,0.980190334440723,0,3,hexose phosphate transmembrane transporter activity,MF,
5290,GO:0015125,1,0.915643938371183,0,14,bile acid transmembrane transporter activity,MF,
5291,GO:0015126,1,0.99223490144715,0,1,canalicular bile acid transmembrane transporter activity,MF,
5292,GO:0015127,1,0.992103373225629,0,1,bilirubin transmembrane transporter activity,MF,
5293,GO:0015129,1,0.967239317687652,0,5,lactate transmembrane transporter activity,MF,
5294,GO:0015130,1,0.992446562585314,0,1,mevalonate transmembrane transporter activity,MF,
5295,GO:0015131,1,0.97962340552439,0,4,oxaloacetate transmembrane transporter activity,MF,
5296,GO:0015132,1,0.992427940487434,0,1,prostaglandin transmembrane transporter activity,MF,
5297,GO:0015136,1,0.988446122651814,0,2,sialic acid transmembrane transporter activity,MF,
5298,GO:0015137,1,0.973810932556246,0,4,citrate transmembrane transporter activity,MF,
5299,GO:0015139,1,0.981283970256523,0,3,alpha-ketoglutarate transmembrane transporter activity,MF,
5300,GO:0015140,1,0.97962340552439,0,4,malate transmembrane transporter activity,MF,
5301,GO:0015141,1,0.96512985139207,0,6,succinate transmembrane transporter activity,MF,
5302,GO:0015142,1,0.973810932556246,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5303,GO:0015143,1,0.983666092536116,0,3,urate transmembrane transporter activity,MF,
5306,GO:0015146,1,0.980913085723868,0,2,pentose transmembrane transporter activity,MF,
5308,GO:0015150,1,0.980913085723868,0,2,fucose transmembrane transporter activity,MF,
5309,GO:0015151,1,0.986603389580006,0,2,alpha-glucoside transmembrane transporter activity,MF,
5310,GO:0015152,1,0.994837073854865,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5313,GO:0015165,1,0.943014719877227,0,10,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5315,GO:0015168,1,0.970295238564424,0,6,glycerol transmembrane transporter activity,MF,
5316,GO:0015171,1,0.618538880906892,0,70,amino acid transmembrane transporter activity,MF,
5317,GO:0015172,1,0.890332689818661,0,16,acidic amino acid transmembrane transporter activity,MF,
5318,GO:0015173,1,0.93475956635943,0,10,aromatic amino acid transmembrane transporter activity,MF,
5319,GO:0015174,1,0.909947733727672,0,14,basic amino acid transmembrane transporter activity,MF,
5320,GO:0015175,1,0.814579491400139,0,30,neutral amino acid transmembrane transporter activity,MF,
5321,GO:0015179,1,0.702629954616915,0,51,L-amino acid transmembrane transporter activity,MF,
5322,GO:0015180,1,0.953097262027225,0,7,L-alanine transmembrane transporter activity,MF,
5323,GO:0015181,1,0.951408647860072,0,7,arginine transmembrane transporter activity,MF,
5324,GO:0015182,1,0.982370283711435,0,3,L-asparagine transmembrane transporter activity,MF,
5325,GO:0015183,1,0.943914786104843,0,9,L-aspartate transmembrane transporter activity,MF,
5326,GO:0015184,1,0.980662777615447,0,3,L-cystine transmembrane transporter activity,MF,
5327,GO:0015185,1,0.955649403782196,0,7,gamma-aminobutyric acid transmembrane transporter activity,MF,
5328,GO:0015186,1,0.949258281193559,0,8,L-glutamine transmembrane transporter activity,MF,
5329,GO:0015187,1,0.954462526909882,0,7,glycine transmembrane transporter activity,MF,
5330,GO:0015188,1,0.991943534146207,0,1,L-isoleucine transmembrane transporter activity,MF,
5331,GO:0015189,1,0.970530066374207,0,4,L-lysine transmembrane transporter activity,MF,
5332,GO:0015190,1,0.966686689686303,0,5,L-leucine transmembrane transporter activity,MF,
5333,GO:0015191,1,0.993234856990322,0,1,L-methionine transmembrane transporter activity,MF,
5334,GO:0015193,1,0.963032935495077,0,5,L-proline transmembrane transporter activity,MF,
5335,GO:0015194,1,0.95715541014623,0,7,L-serine transmembrane transporter activity,MF,
5336,GO:0015195,1,0.992409588456598,0,1,L-threonine transmembrane transporter activity,MF,
5337,GO:0015196,1,0.986291070638035,0,2,L-tryptophan transmembrane transporter activity,MF,
5338,GO:0015199,1,0.991943534146207,0,1,amino-acid betaine transmembrane transporter activity,MF,
5339,GO:0015204,1,0.965814886411103,0,6,urea transmembrane transporter activity,MF,
5340,GO:0015205,1,0.957149763808323,0,7,nucleobase transmembrane transporter activity,MF,
5341,GO:0015207,1,0.988736552740234,0,2,adenine transmembrane transporter activity,MF,
5342,GO:0015211,1,0.988077864347206,0,2,purine nucleoside transmembrane transporter activity,MF,
5343,GO:0015212,1,0.995001289863616,0,1,cytidine transmembrane transporter activity,MF,
5344,GO:0015213,1,0.977766156818043,0,4,uridine transmembrane transporter activity,MF,
5345,GO:0015214,1,0.977766156818043,0,4,pyrimidine nucleoside transmembrane transporter activity,MF,
5346,GO:0015215,1,0.825285850733952,0,31,nucleotide transmembrane transporter activity,MF,
5347,GO:0015216,1,0.834413738759385,0,29,purine nucleotide transmembrane transporter activity,MF,
5348,GO:0015217,1,0.987228687314284,0,2,ADP transmembrane transporter activity,MF,
5349,GO:0015218,1,0.988501017888923,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5350,GO:0015220,1,0.972496525115193,0,4,choline transmembrane transporter activity,MF,
5351,GO:0015225,1,0.977707200800635,0,3,biotin transmembrane transporter activity,MF,
5352,GO:0015226,1,0.982534177177299,0,3,carnitine transmembrane transporter activity,MF,
5353,GO:0015227,1,0.976572419373927,0,4,acyl carnitine transmembrane transporter activity,MF,
5354,GO:0015228,1,0.987228687314284,0,2,coenzyme A transmembrane transporter activity,MF,
5355,GO:0015229,1,0.985286709774917,0,2,L-ascorbic acid transmembrane transporter activity,MF,
5356,GO:0015230,1,0.987340534177393,0,2,FAD transmembrane transporter activity,MF,
5357,GO:0015232,1,0.9429532670184,0,9,heme transmembrane transporter activity,MF,
5358,GO:0015233,1,0.992636451993886,0,1,pantothenate transmembrane transporter activity,MF,
5359,GO:0015234,1,0.981013632904444,0,3,thiamine transmembrane transporter activity,MF,
5360,GO:0015245,1,0.958041783330726,0,7,fatty acid transmembrane transporter activity,MF,
5361,GO:0015247,1,0.968899971232723,0,4,aminophospholipid flippase activity,MF,
5362,GO:0015248,1,0.815159296659346,0,30,sterol transporter activity,MF,
5363,GO:0015250,1,0.94737849544894,0,10,water channel activity,MF,
5364,GO:0015252,1,0.978876460937023,0,4,proton channel activity,MF,
5365,GO:0015254,1,0.9768563650422,0,5,glycerol channel activity,MF,
5366,GO:0015265,1,0.985384432089019,0,2,urea channel activity,MF,
5368,GO:0015269,1,0.944262306097006,0,10,calcium-activated potassium channel activity,MF,
5369,GO:0015271,1,0.916877924148485,0,12,outward rectifier potassium channel activity,MF,
5370,GO:0015272,1,0.958130942372389,0,6,ATP-activated inward rectifier potassium channel activity,MF,
5371,GO:0015275,1,0.977856981783144,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5373,GO:0015277,1,0.96092675222523,0,5,kainate selective glutamate receptor activity,MF,
5374,GO:0015278,1,0.866680004452743,0,16,calcium-release channel activity,MF,
5375,GO:0015279,1,0.932899584539224,0,9,store-operated calcium channel activity,MF,
5376,GO:0015280,1,0.930388871549016,0,10,ligand-gated sodium channel activity,MF,
5377,GO:0015288,1,0.977292903838525,0,5,porin activity,MF,
5379,GO:0015292,1,0.99325505912211,0,1,uniporter activity,MF,
5383,GO:0015296,1,0.861082551177372,0,20,anion:cation symporter activity,MF,
5384,GO:0015297,1,0.584314793822935,0,76,antiporter activity,MF,
5385,GO:0015298,1,0.805322218134518,0,29,solute:cation antiporter activity,MF,
5386,GO:0015299,1,0.871657369883728,0,18,solute:proton antiporter activity,MF,
5387,GO:0015301,1,0.834148377486185,0,25,anion:anion antiporter activity,MF,
5388,GO:0015315,1,0.980190334440723,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5389,GO:0015317,1,0.995813059083286,0,1,phosphate:proton symporter activity,MF,
5391,GO:0015319,1,0.992925192127658,0,1,sodium:inorganic phosphate symporter activity,MF,
5392,GO:0015322,1,0.992503149269511,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5393,GO:0015327,1,0.989609055075192,0,1,cystine:glutamate antiporter activity,MF,
5394,GO:0015328,1,0.989609055075192,0,1,cystine secondary active transmembrane transporter activity,MF,
5395,GO:0015333,1,0.991881361991299,0,1,peptide:proton symporter activity,MF,
5396,GO:0015343,1,0.99325505912211,0,1,siderophore transmembrane transporter activity,MF,
5397,GO:0015347,1,0.917871937793634,0,12,sodium-independent organic anion transmembrane transporter activity,MF,
5398,GO:0015349,1,0.956943828472384,0,6,thyroid hormone transmembrane transporter activity,MF,
5399,GO:0015350,1,0.9845075344276,0,2,methotrexate transmembrane transporter activity,MF,
5400,GO:0015355,1,0.937948366091554,0,11,secondary active monocarboxylate transmembrane transporter activity,MF,
5401,GO:0015362,1,0.992459889955456,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5402,GO:0015367,1,0.995618040134565,0,1,oxoglutarate:malate antiporter activity,MF,
5403,GO:0015368,1,0.928718650521621,0,10,calcium:cation antiporter activity,MF,
5404,GO:0015369,1,0.991894786230327,0,1,calcium:proton antiporter activity,MF,
5406,GO:0015373,1,0.917644082162521,0,12,anion:sodium symporter activity,MF,
5407,GO:0015375,1,0.985821374560652,0,2,glycine:sodium symporter activity,MF,
5408,GO:0015377,1,0.886972259226465,0,16,cation:chloride symporter activity,MF,
5409,GO:0015378,1,0.93104490409895,0,10,sodium:chloride symporter activity,MF,
5410,GO:0015379,1,0.936901608040477,0,8,potassium:chloride symporter activity,MF,
5411,GO:0015382,1,0.993038571577508,0,1,sodium:sulfate symporter activity,MF,
5412,GO:0015385,1,0.922548289900903,0,11,sodium:proton antiporter activity,MF,
5413,GO:0015386,1,0.928817814769839,0,10,potassium:proton antiporter activity,MF,
5414,GO:0015389,1,0.989565143186826,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5415,GO:0015390,1,0.994536822080751,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5416,GO:0015391,1,0.989565143186826,0,2,nucleobase:cation symporter activity,MF,
5417,GO:0015399,1,0.48901237021324,0,100,primary active transmembrane transporter activity,MF,
5418,GO:0015410,1,0.977782632439899,0,3,manganese transmembrane transporter activity, phosphorylative mechanism,MF,
5419,GO:0015420,1,0.98225503099386,0,3,ATPase-coupled vitamin B12 transmembrane transporter activity,MF,
5420,GO:0015431,1,0.99136061420642,0,1,ATPase-coupled glutathione S-conjugate transmembrane transporter activity,MF,
5421,GO:0015432,1,0.984830601179848,0,2,ATPase-coupled bile acid transmembrane transporter activity,MF,
5422,GO:0015433,1,0.970832349096716,0,4,ATPase-coupled peptide antigen transmembrane transporter activity,MF,
5423,GO:0015439,1,0.992920184257471,0,1,ATPase-coupled heme transmembrane transporter activity,MF,
5424,GO:0015440,1,0.970832349096716,0,4,ATPase-coupled peptide transmembrane transporter activity,MF,
5425,GO:0015450,1,0.975443281655635,0,5,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5426,GO:0015459,1,0.714581587878259,0,51,potassium channel regulator activity,MF,
5427,GO:0015464,1,0.891873893938663,0,18,acetylcholine receptor activity,MF,
5430,GO:0015491,1,0.839094475538517,0,24,cation:cation antiporter activity,MF,
5431,GO:0015495,1,0.993666205057768,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5432,GO:0015499,1,0.993481493912351,0,1,formate transmembrane transporter activity,MF,
5433,GO:0015501,1,0.969519335638482,0,4,glutamate:sodium symporter activity,MF,
5434,GO:0015526,1,0.980190334440723,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5435,GO:0015538,1,0.992628175398312,0,1,sialic acid:proton symporter activity,MF,
5436,GO:0015556,1,0.910981280211891,0,15,C4-dicarboxylate transmembrane transporter activity,MF,
5438,GO:0015605,1,0.799305851326746,0,36,organophosphate ester transmembrane transporter activity,MF,
5439,GO:0015607,1,0.992510016232465,0,1,ATPase-coupled fatty-acyl-CoA transmembrane transporter activity,MF,
5440,GO:0015616,1,0.958640685895384,0,5,DNA translocase activity,MF,
5444,GO:0015633,1,0.994867840195139,0,1,ATPase-coupled zinc transmembrane transporter activity,MF,
5445,GO:0015636,1,0.989263940069364,0,2,short-chain fatty acid transmembrane transporter activity,MF,
5446,GO:0015643,1,0.946361674947025,0,10,toxic substance binding,MF,
5447,GO:0015645,1,0.883273949587333,0,19,fatty acid ligase activity,MF,
5448,GO:0015651,1,0.939683654012987,0,10,quaternary ammonium group transmembrane transporter activity,MF,
5449,GO:0015658,1,0.951717720266874,0,7,branched-chain amino acid transmembrane transporter activity,MF,
5450,GO:0015660,1,0.993481493912351,0,1,formate efflux transmembrane transporter activity,MF,
5451,GO:0015662,1,0.801272391776826,0,32,ion transmembrane transporter activity, phosphorylative mechanism,MF,
5452,GO:0015665,1,0.985321182802365,0,3,alcohol transmembrane transporter activity,MF,
5453,GO:0015669,1,0.924842754046186,0,18,gas transport,BP,
5454,GO:0015670,1,0.978318715100837,0,4,carbon dioxide transport,BP,
5455,GO:0015671,1,0.945350832555657,0,14,oxygen transport,BP,
5457,GO:0015675,1,0.992440341107594,0,1,nickel cation transport,BP,
5458,GO:0015677,1,0.950918757112663,0,6,copper ion import,BP,
5459,GO:0015679,1,0.992243960320103,0,1,plasma membrane copper ion transport,BP,
5460,GO:0015680,1,0.988058737301746,0,2,protein maturation by copper ion transfer,BP,
5461,GO:0015689,1,0.99535281446886,0,1,molybdate ion transport,BP,
5462,GO:0015691,1,0.96543537985604,0,5,cadmium ion transport,BP,
5463,GO:0015692,1,0.992440341107594,0,1,lead ion transport,BP,
5464,GO:0015693,1,0.893610368430551,0,16,magnesium ion transport,BP,
5465,GO:0015694,1,0.992103373225629,0,1,mercury ion transport,BP,
5466,GO:0015695,1,0.736304592659649,0,48,organic cation transport,BP,
5467,GO:0015696,1,0.945679339636317,0,8,ammonium transport,BP,
5468,GO:0015697,1,0.922097012983863,0,13,quaternary ammonium group transport,BP,
5469,GO:0015698,1,0.344601318840729,0,153,inorganic anion transport,BP,
5470,GO:0015701,1,0.777053772127022,0,40,bicarbonate transport,BP,
5471,GO:0015705,1,0.958121579905983,0,5,iodide transport,BP,
5472,GO:0015706,1,0.993486820329795,0,1,nitrate transport,BP,
5473,GO:0015707,1,0.992484555067486,0,1,nitrite transport,BP,
5474,GO:0015709,1,0.97962340552439,0,4,thiosulfate transport,BP,
5476,GO:0015712,1,0.965052441989848,0,6,hexose phosphate transport,BP,
5477,GO:0015718,1,0.386774509222046,0,147,monocarboxylic acid transport,BP,
5478,GO:0015721,1,0.85572985155961,0,24,bile acid and bile salt transport,BP,
5479,GO:0015722,1,0.970091287122636,0,4,canalicular bile acid transport,BP,
5480,GO:0015723,1,0.992103373225629,0,1,bilirubin transport,BP,
5481,GO:0015724,1,0.993481493912351,0,1,formate transport,BP,
5482,GO:0015727,1,0.959893430953692,0,6,lactate transport,BP,
5483,GO:0015728,1,0.992446562585314,0,1,mevalonate transport,BP,
5484,GO:0015729,1,0.97962340552439,0,4,oxaloacetate transport,BP,
5485,GO:0015732,1,0.921140752455674,0,13,prostaglandin transport,BP,
5486,GO:0015734,1,0.95432094772804,0,6,taurine transport,BP,
5487,GO:0015739,1,0.97984244678141,0,4,sialic acid transport,BP,
5488,GO:0015740,1,0.844805445092363,0,24,C4-dicarboxylate transport,BP,
5489,GO:0015742,1,0.976197785487923,0,4,alpha-ketoglutarate transport,BP,
5490,GO:0015743,1,0.97962340552439,0,4,malate transport,BP,
5491,GO:0015744,1,0.96512985139207,0,6,succinate transport,BP,
5492,GO:0015746,1,0.973810932556246,0,4,citrate transport,BP,
5493,GO:0015747,1,0.977450525613988,0,4,urate transport,BP,
5496,GO:0015750,1,0.980913085723868,0,2,pentose transmembrane transport,BP,
5497,GO:0015755,1,0.975823684235753,0,4,fructose transmembrane transport,BP,
5498,GO:0015756,1,0.980913085723868,0,2,fucose transmembrane transport,BP,
5499,GO:0015757,1,0.98466463093325,0,2,galactose transmembrane transport,BP,
5500,GO:0015760,1,0.965052441989848,0,6,glucose-6-phosphate transport,BP,
5504,GO:0015774,1,0.992003194016043,0,1,polysaccharide transport,BP,
5505,GO:0015780,1,0.930893194678694,0,12,nucleotide-sugar transmembrane transport,BP,
5506,GO:0015782,1,0.995544705891405,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5507,GO:0015783,1,0.992698457281054,0,1,GDP-fucose transmembrane transport,BP,
5508,GO:0015786,1,0.99093711443583,0,2,UDP-glucose transmembrane transport,BP,
5509,GO:0015787,1,0.981544216698752,0,3,UDP-glucuronic acid transmembrane transport,BP,
5510,GO:0015789,1,0.981544216698752,0,3,UDP-N-acetylgalactosamine transmembrane transport,BP,
5511,GO:0015790,1,0.991130741288936,0,1,UDP-xylose transmembrane transport,BP,
5513,GO:0015793,1,0.970295238564424,0,6,glycerol transport,BP,
5514,GO:0015797,1,0.993481493912351,0,1,mannitol transport,BP,
5517,GO:0015801,1,0.915452758345204,0,13,aromatic amino acid transport,BP,
5518,GO:0015802,1,0.900250756637582,0,16,basic amino acid transport,BP,
5519,GO:0015803,1,0.917007604447102,0,12,branched-chain amino acid transport,BP,
5520,GO:0015804,1,0.776687927065136,0,37,neutral amino acid transport,BP,
5521,GO:0015805,1,0.994523830704485,0,1,S-adenosyl-L-methionine transport,BP,
5522,GO:0015807,1,0.643111784224361,0,64,L-amino acid transport,BP,
5523,GO:0015808,1,0.948432036048991,0,8,L-alanine transport,BP,
5524,GO:0015809,1,0.930325583306446,0,11,arginine transport,BP,
5525,GO:0015810,1,0.9390781040437,0,9,aspartate transmembrane transport,BP,
5526,GO:0015811,1,0.980662777615447,0,3,L-cystine transport,BP,
5527,GO:0015812,1,0.894031075040167,0,16,gamma-aminobutyric acid transport,BP,
5528,GO:0015813,1,0.846774827192311,0,23,L-glutamate transmembrane transport,BP,
5529,GO:0015816,1,0.928306574651218,0,11,glycine transport,BP,
5530,GO:0015817,1,0.987179183105566,0,2,histidine transport,BP,
5531,GO:0015818,1,0.991943534146207,0,1,isoleucine transport,BP,
5532,GO:0015819,1,0.990836780290473,0,1,lysine transport,BP,
5533,GO:0015820,1,0.943704096955138,0,8,leucine transport,BP,
5534,GO:0015821,1,0.993234856990322,0,1,methionine transport,BP,
5535,GO:0015822,1,0.951361392737537,0,7,ornithine transport,BP,
5536,GO:0015823,1,0.98680700275936,0,2,phenylalanine transport,BP,
5537,GO:0015824,1,0.933330388402571,0,9,proline transport,BP,
5538,GO:0015825,1,0.95715541014623,0,7,L-serine transport,BP,
5539,GO:0015826,1,0.992409588456598,0,1,threonine transport,BP,
5540,GO:0015827,1,0.96618853545632,0,5,tryptophan transport,BP,
5541,GO:0015828,1,0.992743399714276,0,1,tyrosine transport,BP,
5542,GO:0015829,1,0.992509240945133,0,1,valine transport,BP,
5544,GO:0015837,1,0.568124917780634,0,91,amine transport,BP,
5545,GO:0015838,1,0.961998464995475,0,6,amino-acid betaine transport,BP,
5546,GO:0015840,1,0.962662148043207,0,7,urea transport,BP,
5547,GO:0015842,1,0.979004364723841,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5548,GO:0015844,1,0.621501658068541,0,78,monoamine transport,BP,
5549,GO:0015846,1,0.961718712495263,0,7,polyamine transport,BP,
5552,GO:0015851,1,0.947600423807157,0,9,nucleobase transport,BP,
5553,GO:0015853,1,0.978875330134061,0,4,adenine transport,BP,
5554,GO:0015854,1,0.993785184100103,0,1,guanine transport,BP,
5555,GO:0015855,1,0.97640838708189,0,4,pyrimidine nucleobase transport,BP,
5556,GO:0015858,1,0.954672247641002,0,8,nucleoside transport,BP,
5557,GO:0015860,1,0.982679159809196,0,3,purine nucleoside transmembrane transport,BP,
5558,GO:0015861,1,0.995001289863616,0,1,cytidine transport,BP,
5559,GO:0015862,1,0.977766156818043,0,4,uridine transport,BP,
5560,GO:0015864,1,0.977766156818043,0,4,pyrimidine nucleoside transport,BP,
5562,GO:0015866,1,0.979702262284559,0,3,ADP transport,BP,
5565,GO:0015870,1,0.974908764838199,0,4,acetylcholine transport,BP,
5566,GO:0015871,1,0.956432302869055,0,6,choline transport,BP,
5567,GO:0015872,1,0.744596079447846,0,48,dopamine transport,BP,
5568,GO:0015874,1,0.876673569918162,0,21,norepinephrine transport,BP,
5569,GO:0015876,1,0.993471940349107,0,1,acetyl-CoA transport,BP,
5570,GO:0015878,1,0.977707200800635,0,3,biotin transport,BP,
5571,GO:0015879,1,0.977447893751496,0,4,carnitine transport,BP,
5572,GO:0015880,1,0.987228687314284,0,2,coenzyme A transport,BP,
5573,GO:0015881,1,0.9795902538279,0,3,creatine transmembrane transport,BP,
5574,GO:0015882,1,0.985286709774917,0,2,L-ascorbic acid transmembrane transport,BP,
5575,GO:0015883,1,0.987340534177393,0,2,FAD transport,BP,
5577,GO:0015886,1,0.9429532670184,0,9,heme transport,BP,
5578,GO:0015887,1,0.992636451993886,0,1,pantothenate transmembrane transport,BP,
5579,GO:0015888,1,0.974190332173119,0,4,thiamine transport,BP,
5580,GO:0015889,1,0.958503107788174,0,7,cobalamin transport,BP,
5581,GO:0015891,1,0.984740266842909,0,3,siderophore transport,BP,
5582,GO:0015893,1,0.928785144055048,0,10,drug transport,BP,
5583,GO:0015904,1,0.995433843353008,0,1,tetracycline transmembrane transport,BP,
5584,GO:0015908,1,0.599867229728295,0,81,fatty acid transport,BP,
5585,GO:0015909,1,0.683386844845586,0,62,long-chain fatty acid transport,BP,
5586,GO:0015910,1,0.971890169239572,0,4,long-chain fatty acid import into peroxisome,BP,
5587,GO:0015911,1,0.941186569883163,0,8,long-chain fatty acid import across plasma membrane,BP,
5588,GO:0015912,1,0.989263940069364,0,2,short-chain fatty acid transport,BP,
5589,GO:0015913,1,0.994308804999173,0,1,short-chain fatty acid import,BP,
5591,GO:0015916,1,0.986030356453845,0,2,fatty-acyl-CoA transport,BP,
5592,GO:0015917,1,0.968200698334933,0,4,aminophospholipid transport,BP,
5593,GO:0015918,1,0.560647869869913,0,87,sterol transport,BP,
5595,GO:0015920,1,0.988953728779206,0,2,lipopolysaccharide transport,BP,
5596,GO:0015922,1,0.995930100146436,0,1,aspartate oxidase activity,MF,
5597,GO:0015923,1,0.893864645881957,0,15,mannosidase activity,MF,
5598,GO:0015924,1,0.933928709237631,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5599,GO:0015925,1,0.952027590424451,0,8,galactosidase activity,MF,
5600,GO:0015926,1,0.924823235050684,0,11,glucosidase activity,MF,
5601,GO:0015928,1,0.989700464946068,0,2,fucosidase activity,MF,
5602,GO:0015929,1,0.936329878809178,0,11,hexosaminidase activity,MF,
5605,GO:0015934,1,0.651269571345052,0,110,large ribosomal subunit,CC,
5607,GO:0015936,1,0.916244845922358,0,15,coenzyme A metabolic process,BP,
5608,GO:0015937,1,0.947530945562573,0,10,coenzyme A biosynthetic process,BP,
5609,GO:0015938,1,0.996649261931985,0,1,coenzyme A catabolic process,BP,
5610,GO:0015939,1,0.961808782672737,0,7,pantothenate metabolic process,BP,
5611,GO:0015942,1,0.965200751392808,0,6,formate metabolic process,BP,
5612,GO:0015949,1,0.859053967799406,0,27,nucleobase-containing small molecule interconversion,BP,
5613,GO:0015959,1,0.967348520081849,0,6,diadenosine polyphosphate metabolic process,BP,
5614,GO:0015960,1,0.992503678523905,0,1,diadenosine polyphosphate biosynthetic process,BP,
5615,GO:0015961,1,0.974656768024777,0,5,diadenosine polyphosphate catabolic process,BP,
5616,GO:0015962,1,0.99659250144999,0,1,diadenosine triphosphate metabolic process,BP,
5617,GO:0015964,1,0.99659250144999,0,1,diadenosine triphosphate catabolic process,BP,
5618,GO:0015965,1,0.992503678523905,0,1,diadenosine tetraphosphate metabolic process,BP,
5619,GO:0015966,1,0.992503678523905,0,1,diadenosine tetraphosphate biosynthetic process,BP,
5621,GO:0015985,1,0.976974843632785,0,5,energy coupled proton transport, down electrochemical gradient,BP,
5622,GO:0015986,1,0.976974843632785,0,5,ATP synthesis coupled proton transport,BP,
5623,GO:0015988,1,0.996771628236777,0,1,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5624,GO:0015990,1,0.996771628236777,0,1,electron transport coupled proton transport,BP,
5625,GO:0016004,1,0.940618427651637,0,10,phospholipase activator activity,MF,
5626,GO:0016005,1,0.985834855490566,0,2,phospholipase A2 activator activity,MF,
5630,GO:0016013,1,0.975951889010116,0,4,syntrophin complex,CC,
5632,GO:0016018,1,0.932867124460007,0,13,cyclosporin A binding,MF,
5633,GO:0016019,1,0.992683869898816,0,2,peptidoglycan immune receptor activity,MF,
5636,GO:0016024,1,0.923078444126205,0,11,CDP-diacylglycerol biosynthetic process,BP,
5637,GO:0016028,1,0.9925153189923,0,1,rhabdomere,CC,
5638,GO:0016031,1,0.992595534101838,0,1,tRNA import into mitochondrion,BP,
5640,GO:0016034,1,0.996343791150515,0,1,maleylacetoacetate isomerase activity,MF,
5641,GO:0016035,1,0.974212884976203,0,4,zeta DNA polymerase complex,CC,
5642,GO:0016036,1,0.984734557681261,0,2,cellular response to phosphate starvation,BP,
5643,GO:0016037,1,0.993258767709841,0,1,light absorption,BP,
5644,GO:0016038,1,0.993258767709841,0,1,absorption of visible light,BP,
5647,GO:0016045,1,0.910617975481766,0,14,detection of bacterium,BP,
5648,GO:0016046,1,0.985864447002429,0,2,detection of fungus,BP,
5657,GO:0016056,1,0.855268862179836,0,24,rhodopsin mediated signaling pathway,BP,
5658,GO:0016064,1,0.541400877834746,0,102,immunoglobulin mediated immune response,BP,
5659,GO:0016068,1,0.98639513714032,0,3,type I hypersensitivity,BP,
5662,GO:0016072,1,0.291473257542125,0,214,rRNA metabolic process,BP,
5663,GO:0016073,1,0.821672310113075,0,33,snRNA metabolic process,BP,
5664,GO:0016074,1,0.933614223591668,0,13,snoRNA metabolic process,BP,
5665,GO:0016075,1,0.893078069449044,0,19,rRNA catabolic process,BP,
5666,GO:0016076,1,0.981727703288909,0,3,snRNA catabolic process,BP,
5667,GO:0016077,1,0.984855478889937,0,2,snoRNA catabolic process,BP,
5668,GO:0016078,1,0.933466169211094,0,11,tRNA catabolic process,BP,
5669,GO:0016079,1,0.436030267212363,0,117,synaptic vesicle exocytosis,BP,
5670,GO:0016080,1,0.975948960664557,0,3,synaptic vesicle targeting,BP,
5671,GO:0016081,1,0.919642878614898,0,11,synaptic vesicle docking,BP,
5672,GO:0016082,1,0.865004877834766,0,20,synaptic vesicle priming,BP,
5673,GO:0016093,1,0.958926908389269,0,8,polyprenol metabolic process,BP,
5674,GO:0016094,1,0.978497179112892,0,3,polyprenol biosynthetic process,BP,
5675,GO:0016095,1,0.985965631552217,0,3,polyprenol catabolic process,BP,
5676,GO:0016098,1,0.991840882156966,0,2,monoterpenoid metabolic process,BP,
5678,GO:0016102,1,0.948402397009343,0,9,diterpenoid biosynthetic process,BP,
5679,GO:0016103,1,0.979918592663307,0,4,diterpenoid catabolic process,BP,
5680,GO:0016104,1,0.992421201583323,0,1,triterpenoid biosynthetic process,BP,
5681,GO:0016107,1,0.992444871667169,0,2,sesquiterpenoid catabolic process,BP,
5682,GO:0016108,1,0.980054250296054,0,3,tetraterpenoid metabolic process,BP,
5683,GO:0016109,1,0.993564967264221,0,1,tetraterpenoid biosynthetic process,BP,
5684,GO:0016114,1,0.912836245736883,0,15,terpenoid biosynthetic process,BP,
5685,GO:0016115,1,0.972513650511943,0,6,terpenoid catabolic process,BP,
5686,GO:0016116,1,0.980054250296054,0,3,carotenoid metabolic process,BP,
5687,GO:0016117,1,0.993564967264221,0,1,carotenoid biosynthetic process,BP,
5688,GO:0016119,1,0.986402667512831,0,2,carotene metabolic process,BP,
5689,GO:0016121,1,0.986402667512831,0,2,carotene catabolic process,BP,
5690,GO:0016122,1,0.986710459293556,0,2,xanthophyll metabolic process,BP,
5691,GO:0016123,1,0.993564967264221,0,1,xanthophyll biosynthetic process,BP,
5692,GO:0016125,1,0.403119299816112,0,141,sterol metabolic process,BP,
5693,GO:0016126,1,0.644005398492638,0,68,sterol biosynthetic process,BP,
5694,GO:0016127,1,0.953060129205608,0,9,sterol catabolic process,BP,
5695,GO:0016128,1,0.993481493912351,0,1,phytosteroid metabolic process,BP,
5696,GO:0016129,1,0.993481493912351,0,1,phytosteroid biosynthetic process,BP,
5697,GO:0016131,1,0.993481493912351,0,1,brassinosteroid metabolic process,BP,
5698,GO:0016132,1,0.993481493912351,0,1,brassinosteroid biosynthetic process,BP,
5699,GO:0016137,1,0.910602689518867,0,19,glycoside metabolic process,BP,
5700,GO:0016139,1,0.949792648484994,0,9,glycoside catabolic process,BP,
5701,GO:0016149,1,0.992506338161669,0,1,translation release factor activity, codon specific,MF,
5702,GO:0016151,1,0.995678609066183,0,1,nickel cation binding,MF,
5703,GO:0016153,1,0.992601430907563,0,1,urocanate hydratase activity,MF,
5704,GO:0016154,1,0.995854312720373,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5705,GO:0016155,1,0.98355783329597,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5706,GO:0016160,1,0.981946464801854,0,3,amylase activity,MF,
5707,GO:0016165,1,0.981245589191792,0,3,linoleate 13S-lipoxygenase activity,MF,
5708,GO:0016167,1,0.978141454811077,0,3,glial cell-derived neurotrophic factor receptor activity,MF,
5709,GO:0016170,1,0.992124994036105,0,1,interleukin-15 receptor binding,MF,
5710,GO:0016174,1,0.937373236166092,0,9,NAD(P)H oxidase H2O2-forming activity,MF,
5711,GO:0016175,1,0.941547125827931,0,10,superoxide-generating NAD(P)H oxidase activity,MF,
5712,GO:0016176,1,0.952476845315051,0,8,superoxide-generating NADPH oxidase activator activity,MF,
5713,GO:0016180,1,0.870568536453685,0,23,snRNA processing,BP,
5714,GO:0016182,1,0.984748083411015,0,2,synaptic vesicle budding from endosome,BP,
5715,GO:0016185,1,0.9406403779963,0,8,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5716,GO:0016188,1,0.915803822223783,0,12,synaptic vesicle maturation,BP,
5717,GO:0016189,1,0.977748456215734,0,3,synaptic vesicle to endosome fusion,BP,
5718,GO:0016191,1,0.962886315899912,0,5,synaptic vesicle uncoating,BP,
5721,GO:0016198,1,0.950083584352255,0,7,axon choice point recognition,BP,
5722,GO:0016199,1,0.961563019218768,0,5,axon midline choice point recognition,BP,
5724,GO:0016203,1,0.991763992571907,0,1,muscle attachment,BP,
5725,GO:0016206,1,0.987295709094674,0,2,catechol O-methyltransferase activity,MF,
5726,GO:0016208,1,0.926677147477186,0,12,AMP binding,MF,
5727,GO:0016209,1,0.704918156948459,0,72,antioxidant activity,MF,
5728,GO:0016211,1,0.992392971185947,0,1,ammonia ligase activity,MF,
5729,GO:0016212,1,0.988517860766572,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5730,GO:0016213,1,0.985173590367782,0,2,linoleoyl-CoA desaturase activity,MF,
5731,GO:0016215,1,0.970956004363374,0,4,acyl-CoA desaturase activity,MF,
5732,GO:0016222,1,0.986790193812386,0,2,procollagen-proline 4-dioxygenase complex,CC,
5733,GO:0016226,1,0.901271280746529,0,20,iron-sulfur cluster assembly,BP,
5734,GO:0016229,1,0.881393854221355,0,28,steroid dehydrogenase activity,MF,
5735,GO:0016230,1,0.988837386872356,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5736,GO:0016232,1,0.993171117450712,0,1,HNK-1 sulfotransferase activity,MF,
5737,GO:0016233,1,0.765700949052406,0,38,telomere capping,BP,
5738,GO:0016234,1,0.586399413788158,0,75,inclusion body,CC,
5739,GO:0016235,1,0.76555472377585,0,38,aggresome,CC,
5740,GO:0016236,1,0.150413621267989,0,289,macroautophagy,BP,
5741,GO:0016237,1,0.957565412868617,0,5,lysosomal microautophagy,BP,
5742,GO:0016239,1,0.641716975194118,0,61,positive regulation of macroautophagy,BP,
5743,GO:0016240,1,0.973797063511966,0,4,autophagosome membrane docking,BP,
5744,GO:0016241,1,0.328585082511298,0,165,regulation of macroautophagy,BP,
5745,GO:0016242,1,0.80168562698414,0,31,negative regulation of macroautophagy,BP,
5746,GO:0016243,1,0.992468160929538,0,1,regulation of autophagosome size,BP,
5747,GO:0016246,1,0.897005593322195,0,16,RNA interference,BP,
5748,GO:0016247,1,0.430454063426183,0,138,channel regulator activity,MF,
5749,GO:0016248,1,0.798040643063303,0,36,channel inhibitor activity,MF,
5750,GO:0016250,1,0.99325505912211,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5751,GO:0016251,1,0.822544253113189,0,36,RNA polymerase II general transcription initiation factor activity,MF,
5752,GO:0016254,1,0.916003938828466,0,16,preassembly of GPI anchor in ER membrane,BP,
5753,GO:0016255,1,0.959821980323508,0,6,attachment of GPI anchor to protein,BP,
5754,GO:0016256,1,0.991803928232209,0,1,N-glycan processing to lysosome,BP,
5755,GO:0016259,1,0.979960780717573,0,3,selenocysteine metabolic process,BP,
5756,GO:0016260,1,0.988071328849343,0,2,selenocysteine biosynthetic process,BP,
5757,GO:0016262,1,0.980679454716591,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5758,GO:0016263,1,0.990843793911899,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5760,GO:0016266,1,0.720506556863038,0,47,O-glycan processing,BP,
5761,GO:0016267,1,0.990843793911899,0,2,O-glycan processing, core 1,BP,
5762,GO:0016272,1,0.975657326173938,0,7,prefoldin complex,CC,
5763,GO:0016273,1,0.935294100169209,0,11,arginine N-methyltransferase activity,MF,
5764,GO:0016274,1,0.935294100169209,0,11,protein-arginine N-methyltransferase activity,MF,
5765,GO:0016277,1,0.994071727941164,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5766,GO:0016278,1,0.701070005553684,0,48,lysine N-methyltransferase activity,MF,
5767,GO:0016279,1,0.70584779327123,0,47,protein-lysine N-methyltransferase activity,MF,
5768,GO:0016281,1,0.921071613103428,0,13,eukaryotic translation initiation factor 4F complex,CC,
5769,GO:0016282,1,0.924716220181269,0,16,eukaryotic 43S preinitiation complex,CC,
5770,GO:0016286,1,0.977106216091534,0,4,small conductance calcium-activated potassium channel activity,MF,
5771,GO:0016287,1,0.993409398134599,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5772,GO:0016289,1,0.89988906641043,0,20,CoA hydrolase activity,MF,
5773,GO:0016290,1,0.938492164937192,0,12,palmitoyl-CoA hydrolase activity,MF,
5774,GO:0016295,1,0.985923325248151,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5775,GO:0016296,1,0.985923325248151,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5776,GO:0016297,1,0.985923325248151,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5778,GO:0016300,1,0.978603271431171,0,3,tRNA (uracil) methyltransferase activity,MF,
5780,GO:0016303,1,0.918928187371562,0,10,1-phosphatidylinositol-3-kinase activity,MF,
5781,GO:0016307,1,0.898583152788312,0,14,phosphatidylinositol phosphate kinase activity,MF,
5782,GO:0016308,1,0.959214265729389,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5783,GO:0016309,1,0.985312435532211,0,2,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5786,GO:0016312,1,0.987605662045228,0,2,inositol bisphosphate phosphatase activity,MF,
5787,GO:0016314,1,0.972441713401397,0,4,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5788,GO:0016316,1,0.983715127839275,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5789,GO:0016320,1,0.986845044673251,0,2,endoplasmic reticulum membrane fusion,BP,
5790,GO:0016321,1,0.963298974839257,0,6,female meiosis chromosome segregation,BP,
5791,GO:0016322,1,0.922723488057082,0,12,neuron remodeling,BP,
5794,GO:0016327,1,0.908799117422114,0,16,apicolateral plasma membrane,CC,
5797,GO:0016332,1,0.992479134637304,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5798,GO:0016333,1,0.992979587148606,0,1,morphogenesis of follicular epithelium,BP,
5799,GO:0016334,1,0.992979587148606,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5802,GO:0016340,1,0.982713675658276,0,2,calcium-dependent cell-matrix adhesion,BP,
5804,GO:0016344,1,0.977343987949623,0,3,meiotic chromosome movement towards spindle pole,BP,
5806,GO:0016361,1,0.963036158053852,0,5,activin receptor activity, type I,MF,
5807,GO:0016362,1,0.977272700176872,0,2,activin receptor activity, type II,MF,
5808,GO:0016363,1,0.487254508001427,0,105,nuclear matrix,CC,
5809,GO:0016401,1,0.97463962232351,0,4,palmitoyl-CoA oxidase activity,MF,
5810,GO:0016402,1,0.993111976965801,0,1,pristanoyl-CoA oxidase activity,MF,
5811,GO:0016403,1,0.988846662702626,0,2,dimethylargininase activity,MF,
5812,GO:0016404,1,0.985684113349306,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5813,GO:0016405,1,0.857677828602896,0,23,CoA-ligase activity,MF,
5814,GO:0016406,1,0.958472502816737,0,6,carnitine O-acyltransferase activity,MF,
5815,GO:0016407,1,0.542133350195347,0,93,acetyltransferase activity,MF,
5816,GO:0016408,1,0.908071531094184,0,17,C-acyltransferase activity,MF,
5817,GO:0016409,1,0.772303844604335,0,39,palmitoyltransferase activity,MF,
5818,GO:0016410,1,0.560435078381638,0,87,N-acyltransferase activity,MF,
5819,GO:0016411,1,0.886990151228944,0,17,acylglycerol O-acyltransferase activity,MF,
5820,GO:0016413,1,0.953619881321479,0,7,O-acetyltransferase activity,MF,
5821,GO:0016414,1,0.985878158905793,0,2,O-octanoyltransferase activity,MF,
5822,GO:0016415,1,0.98260963003525,0,3,octanoyltransferase activity,MF,
5823,GO:0016416,1,0.964616132840989,0,5,O-palmitoyltransferase activity,MF,
5824,GO:0016417,1,0.811339686583844,0,32,S-acyltransferase activity,MF,
5825,GO:0016418,1,0.982687194878627,0,2,S-acetyltransferase activity,MF,
5826,GO:0016419,1,0.985497066803585,0,2,S-malonyltransferase activity,MF,
5827,GO:0016420,1,0.985497066803585,0,2,malonyltransferase activity,MF,
5828,GO:0016421,1,0.965917802097028,0,5,CoA carboxylase activity,MF,
5829,GO:0016422,1,0.983497283650324,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5830,GO:0016423,1,0.92375471989304,0,13,tRNA (guanine) methyltransferase activity,MF,
5831,GO:0016426,1,0.975923623712464,0,4,tRNA (adenine) methyltransferase activity,MF,
5832,GO:0016427,1,0.943280096537331,0,9,tRNA (cytosine) methyltransferase activity,MF,
5833,GO:0016428,1,0.974201708965777,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5834,GO:0016429,1,0.975923623712464,0,4,tRNA (adenine-N1-)-methyltransferase activity,MF,
5835,GO:0016432,1,0.985624627596419,0,2,tRNA-uridine aminocarboxypropyltransferase activity,MF,
5836,GO:0016433,1,0.957927554846125,0,8,rRNA (adenine) methyltransferase activity,MF,
5837,GO:0016434,1,0.973405228684036,0,4,rRNA (cytosine) methyltransferase activity,MF,
5838,GO:0016435,1,0.989391988595427,0,2,rRNA (guanine) methyltransferase activity,MF,
5839,GO:0016436,1,0.985443643443523,0,2,rRNA (uridine) methyltransferase activity,MF,
5841,GO:0016442,1,0.895976671726968,0,14,RISC complex,CC,
5842,GO:0016444,1,0.683829686313728,0,56,somatic cell DNA recombination,BP,
5843,GO:0016445,1,0.692306487073422,0,55,somatic diversification of immunoglobulins,BP,
5844,GO:0016446,1,0.914459178344752,0,13,somatic hypermutation of immunoglobulin genes,BP,
5845,GO:0016447,1,0.728127821224359,0,48,somatic recombination of immunoglobulin gene segments,BP,
5846,GO:0016453,1,0.975135010523225,0,5,C-acetyltransferase activity,MF,
5847,GO:0016454,1,0.965759266346054,0,5,C-palmitoyltransferase activity,MF,
5850,GO:0016460,1,0.890759181135214,0,17,myosin II complex,CC,
5851,GO:0016461,1,0.926373434913709,0,10,unconventional myosin complex,CC,
5853,GO:0016469,1,0.86274291460525,0,28,proton-transporting two-sector ATPase complex,CC,
5854,GO:0016471,1,0.914247332426851,0,16,vacuolar proton-transporting V-type ATPase complex,CC,
5855,GO:0016476,1,0.985074040939172,0,2,regulation of embryonic cell shape,BP,
5857,GO:0016479,1,0.97845323347743,0,3,negative regulation of transcription by RNA polymerase I,BP,
5858,GO:0016480,1,0.985837267576845,0,3,negative regulation of transcription by RNA polymerase III,BP,
5862,GO:0016487,1,0.992444871667169,0,2,farnesol metabolic process,BP,
5863,GO:0016488,1,0.992444871667169,0,2,farnesol catabolic process,BP,
5865,GO:0016492,1,0.988431751205902,0,2,G protein-coupled neurotensin receptor activity,MF,
5866,GO:0016493,1,0.884382625720718,0,22,C-C chemokine receptor activity,MF,
5867,GO:0016494,1,0.956330256223972,0,8,C-X-C chemokine receptor activity,MF,
5868,GO:0016495,1,0.992722568148623,0,1,C-X3-C chemokine receptor activity,MF,
5869,GO:0016496,1,0.992668018068283,0,1,substance P receptor activity,MF,
5870,GO:0016497,1,0.994041629215157,0,1,substance K receptor activity,MF,
5871,GO:0016499,1,0.99065714670964,0,2,orexin receptor activity,MF,
5872,GO:0016500,1,0.914918225534053,0,12,protein-hormone receptor activity,MF,
5873,GO:0016501,1,0.994898518097956,0,1,prostacyclin receptor activity,MF,
5874,GO:0016502,1,0.897936793947429,0,20,nucleotide receptor activity,MF,
5875,GO:0016503,1,0.996377936619852,0,1,pheromone receptor activity,MF,
5878,GO:0016507,1,0.992844364283243,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5879,GO:0016508,1,0.978879498652628,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5880,GO:0016509,1,0.985376716624348,0,2,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5881,GO:0016513,1,0.976974007152954,0,3,core-binding factor complex,CC,
5882,GO:0016514,1,0.891723748311585,0,17,SWI/SNF complex,CC,
5883,GO:0016517,1,0.995140962520074,0,1,interleukin-12 receptor activity,MF,
5884,GO:0016519,1,0.995025201341907,0,1,gastric inhibitory peptide receptor activity,MF,
5885,GO:0016520,1,0.988647398587363,0,2,growth hormone-releasing hormone receptor activity,MF,
5886,GO:0016521,1,0.992730335419945,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5891,GO:0016531,1,0.98075502446471,0,4,copper chaperone activity,MF,
5892,GO:0016532,1,0.986942803922636,0,2,superoxide dismutase copper chaperone activity,MF,
5893,GO:0016533,1,0.98301375815525,0,3,protein kinase 5 complex,CC,
5894,GO:0016538,1,0.767199791320461,0,46,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5895,GO:0016539,1,0.99096127715952,0,2,intein-mediated protein splicing,BP,
5897,GO:0016553,1,0.903041175685894,0,17,base conversion or substitution editing,BP,
5898,GO:0016554,1,0.954489657979741,0,9,cytidine to uridine editing,BP,
5899,GO:0016556,1,0.879154076005296,0,20,mRNA modification,BP,
5900,GO:0016557,1,0.98531836505078,0,3,peroxisome membrane biogenesis,BP,
5902,GO:0016559,1,0.955679205173294,0,9,peroxisome fission,BP,
5904,GO:0016561,1,0.987865606717017,0,2,protein import into peroxisome matrix, translocation,BP,
5905,GO:0016567,1,0.00562911646210017,0,770,protein ubiquitination,BP,
5908,GO:0016571,1,0.40457756802808,0,124,histone methylation,BP,
5909,GO:0016572,1,0.789608915105425,0,36,histone phosphorylation,BP,
5910,GO:0016573,1,0.361260349855736,0,149,histone acetylation,BP,
5911,GO:0016574,1,0.729604954862267,0,45,histone ubiquitination,BP,
5912,GO:0016575,1,0.592502282718771,0,75,histone deacetylation,BP,
5914,GO:0016577,1,0.804229518355828,0,27,histone demethylation,BP,
5915,GO:0016578,1,0.856740292565454,0,22,histone deubiquitination,BP,
5916,GO:0016579,1,0.207267241556529,0,239,protein deubiquitination,BP,
5917,GO:0016580,1,0.917131120680655,0,12,Sin3 complex,CC,
5918,GO:0016581,1,0.892395737893003,0,15,NuRD complex,CC,
5919,GO:0016584,1,0.964804871274916,0,5,nucleosome positioning,BP,
5920,GO:0016586,1,0.990724419306858,0,1,RSC-type complex,CC,
5921,GO:0016589,1,0.954452239064596,0,6,NURF complex,CC,
5922,GO:0016590,1,0.991599584262895,0,1,ACF complex,CC,
5923,GO:0016591,1,0.64000059477457,0,75,RNA polymerase II, holoenzyme,CC,
5924,GO:0016592,1,0.774870904960761,0,40,mediator complex,CC,
5925,GO:0016593,1,0.946887974093408,0,8,Cdc73/Paf1 complex,CC,
5926,GO:0016594,1,0.911279905670177,0,14,glycine binding,MF,
5927,GO:0016595,1,0.928971170018523,0,10,glutamate binding,MF,
5928,GO:0016596,1,0.99325505912211,0,1,thienylcyclohexylpiperidine binding,MF,
5929,GO:0016597,1,0.707983396129991,0,54,amino acid binding,MF,
5930,GO:0016598,1,0.990082319464227,0,2,protein arginylation,BP,
5931,GO:0016600,1,0.941607995944165,0,8,flotillin complex,CC,
5932,GO:0016601,1,0.773426457305216,0,37,Rac protein signal transduction,BP,
5933,GO:0016602,1,0.975707467040819,0,4,CCAAT-binding factor complex,CC,
5934,GO:0016603,1,0.990486163818116,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5936,GO:0016605,1,0.511837770019341,0,97,PML body,CC,
5938,GO:0016608,1,0.99367177372613,0,2,growth hormone-releasing hormone activity,MF,
5940,GO:0016615,1,0.962128187682024,0,7,malate dehydrogenase activity,MF,
5942,GO:0016618,1,0.996454349417187,0,1,hydroxypyruvate reductase activity,MF,
5943,GO:0016620,1,0.818816649344593,0,32,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5944,GO:0016623,1,0.9860413935459,0,2,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5945,GO:0016624,1,0.955638814349726,0,7,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5946,GO:0016627,1,0.727244849294607,0,55,oxidoreductase activity, acting on the CH-CH group of donors,MF,
5947,GO:0016628,1,0.87982882969935,0,24,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5948,GO:0016634,1,0.94493671183758,0,9,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5949,GO:0016635,1,0.98563399856081,0,3,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5950,GO:0016638,1,0.885788913494576,0,19,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
5951,GO:0016639,1,0.986860287047165,0,2,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5952,GO:0016641,1,0.907401835692499,0,15,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5953,GO:0016642,1,0.992488314549241,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5954,GO:0016645,1,0.862252719816466,0,24,oxidoreductase activity, acting on the CH-NH group of donors,MF,
5955,GO:0016646,1,0.909779669744124,0,15,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5956,GO:0016647,1,0.979872940152018,0,4,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5957,GO:0016649,1,0.986915321135593,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5958,GO:0016651,1,0.622307718261186,0,96,oxidoreductase activity, acting on NAD(P)H,MF,
5959,GO:0016652,1,0.988907391187314,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5960,GO:0016653,1,0.916305038632931,0,13,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5961,GO:0016655,1,0.810953031689039,0,53,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5962,GO:0016657,1,0.991507533416697,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5963,GO:0016661,1,0.982660603047116,0,3,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5964,GO:0016662,1,0.993598293270506,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5965,GO:0016667,1,0.750913551526669,0,53,oxidoreductase activity, acting on a sulfur group of donors,MF,
5966,GO:0016668,1,0.939396569122126,0,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5967,GO:0016670,1,0.943578838786214,0,9,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5968,GO:0016671,1,0.962713407150596,0,7,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5969,GO:0016672,1,0.992918444174798,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5970,GO:0016675,1,0.91964951377492,0,22,oxidoreductase activity, acting on a heme group of donors,MF,
5971,GO:0016676,1,0.925378650358037,0,21,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5972,GO:0016679,1,0.972189948922471,0,7,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5973,GO:0016681,1,0.978470493697708,0,6,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5974,GO:0016684,1,0.78867738058121,0,49,oxidoreductase activity, acting on peroxide as acceptor,MF,
5975,GO:0016701,1,0.873530361047245,0,24,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
5976,GO:0016702,1,0.873530361047245,0,24,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
5977,GO:0016705,1,0.423005126846065,0,134,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,
5978,GO:0016706,1,0.742464521506909,0,43,2-oxoglutarate-dependent dioxygenase activity,MF,
5979,GO:0016708,1,0.993813767208886,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
5980,GO:0016709,1,0.795608424741228,0,37,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
5981,GO:0016711,1,0.993582687174415,0,1,flavonoid 3'-monooxygenase activity,MF,
5982,GO:0016712,1,0.890047255612577,0,21,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
5983,GO:0016713,1,0.983238563497442,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
5984,GO:0016714,1,0.963083925175263,0,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
5985,GO:0016715,1,0.971380634260549,0,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
5986,GO:0016716,1,0.993070232306683,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen,MF,
5987,GO:0016717,1,0.964405001335081,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5988,GO:0016721,1,0.980061451818973,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
5989,GO:0016722,1,0.894106198185705,0,16,oxidoreductase activity, oxidizing metal ions,MF,
5990,GO:0016723,1,0.93604638202581,0,9,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
5991,GO:0016724,1,0.960800234260021,0,6,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
5992,GO:0016725,1,0.951969965463675,0,7,oxidoreductase activity, acting on CH or CH2 groups,MF,
5993,GO:0016726,1,0.98396125602656,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
5994,GO:0016727,1,0.991736530860661,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
5995,GO:0016728,1,0.977659770551712,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
5996,GO:0016730,1,0.995353986230992,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5997,GO:0016731,1,0.995353986230992,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
5999,GO:0016741,1,0.287323423389202,0,192,transferase activity, transferring one-carbon groups,MF,
6000,GO:0016742,1,0.949139000310562,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6001,GO:0016743,1,0.986858900136636,0,2,carboxyl- or carbamoyltransferase activity,MF,
6002,GO:0016744,1,0.979268374760518,0,4,transferase activity, transferring aldehyde or ketonic groups,MF,
6003,GO:0016746,1,0.242926923528628,0,217,transferase activity, transferring acyl groups,MF,
6004,GO:0016747,1,0.287416367997341,0,192,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
6005,GO:0016748,1,0.982487008146253,0,3,succinyltransferase activity,MF,
6006,GO:0016749,1,0.989302892711491,0,2,N-succinyltransferase activity,MF,
6007,GO:0016751,1,0.993111170536567,0,1,S-succinyltransferase activity,MF,
6008,GO:0016755,1,0.921835656836258,0,13,transferase activity, transferring amino-acyl groups,MF,
6011,GO:0016763,1,0.767683414061559,0,42,transferase activity, transferring pentosyl groups,MF,
6012,GO:0016765,1,0.766618316480904,0,51,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
6013,GO:0016768,1,0.995793948701714,0,1,spermine synthase activity,MF,
6014,GO:0016769,1,0.889337762953615,0,19,transferase activity, transferring nitrogenous groups,MF,
6017,GO:0016774,1,0.986617860066233,0,2,phosphotransferase activity, carboxyl group as acceptor,MF,
6018,GO:0016775,1,0.96779327680762,0,7,phosphotransferase activity, nitrogenous group as acceptor,MF,
6019,GO:0016776,1,0.786294854289606,0,39,phosphotransferase activity, phosphate group as acceptor,MF,
6020,GO:0016778,1,0.972471107162967,0,5,diphosphotransferase activity,MF,
6021,GO:0016779,1,0.509695581675787,0,110,nucleotidyltransferase activity,MF,
6022,GO:0016780,1,0.895159544756473,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6023,GO:0016781,1,0.988071328849343,0,2,phosphotransferase activity, paired acceptors,MF,
6025,GO:0016783,1,0.954909839720514,0,10,sulfurtransferase activity,MF,
6026,GO:0016784,1,0.996162311800852,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6027,GO:0016785,1,0.991792536280281,0,1,transferase activity, transferring selenium-containing groups,MF,
6030,GO:0016790,1,0.81613690474601,0,37,thiolester hydrolase activity,MF,
6032,GO:0016793,1,0.992706799403571,0,1,triphosphoric monoester hydrolase activity,MF,
6033,GO:0016794,1,0.996627250553641,0,1,diphosphoric monoester hydrolase activity,MF,
6034,GO:0016796,1,0.693485280232836,0,57,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6035,GO:0016798,1,0.507878734171942,0,107,hydrolase activity, acting on glycosyl bonds,MF,
6036,GO:0016799,1,0.813792000080076,0,34,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6037,GO:0016801,1,0.942798682744661,0,11,hydrolase activity, acting on ether bonds,MF,
6038,GO:0016802,1,0.994357853524939,0,1,trialkylsulfonium hydrolase activity,MF,
6039,GO:0016803,1,0.948151192614476,0,10,ether hydrolase activity,MF,
6041,GO:0016810,1,0.529889830320849,0,108,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
6042,GO:0016811,1,0.698767099007819,0,62,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
6043,GO:0016812,1,0.961880790805265,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6044,GO:0016813,1,0.94437223393798,0,10,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6045,GO:0016814,1,0.835823480077934,0,30,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
6046,GO:0016815,1,0.996311898801228,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6049,GO:0016822,1,0.988198594562198,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6050,GO:0016823,1,0.988198594562198,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6051,GO:0016826,1,0.99325505912211,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6052,GO:0016829,1,0.382918026498241,0,168,lyase activity,MF,
6053,GO:0016830,1,0.769530933691228,0,45,carbon-carbon lyase activity,MF,
6054,GO:0016831,1,0.83306711837502,0,31,carboxy-lyase activity,MF,
6055,GO:0016832,1,0.948719672197961,0,9,aldehyde-lyase activity,MF,
6056,GO:0016833,1,0.964072788567504,0,6,oxo-acid-lyase activity,MF,
6057,GO:0016835,1,0.682787476869973,0,69,carbon-oxygen lyase activity,MF,
6058,GO:0016836,1,0.74244799656306,0,54,hydro-lyase activity,MF,
6059,GO:0016838,1,0.98619721393763,0,3,carbon-oxygen lyase activity, acting on phosphates,MF,
6060,GO:0016840,1,0.935538440823018,0,13,carbon-nitrogen lyase activity,MF,
6061,GO:0016841,1,0.974455163944674,0,5,ammonia-lyase activity,MF,
6062,GO:0016842,1,0.966595326966908,0,7,amidine-lyase activity,MF,
6063,GO:0016843,1,0.99325505912211,0,1,amine-lyase activity,MF,
6064,GO:0016844,1,0.99325505912211,0,1,strictosidine synthase activity,MF,
6065,GO:0016846,1,0.959669032786737,0,10,carbon-sulfur lyase activity,MF,
6066,GO:0016849,1,0.877768237929109,0,17,phosphorus-oxygen lyase activity,MF,
6067,GO:0016853,1,0.462867787306745,0,137,isomerase activity,MF,
6068,GO:0016854,1,0.920909704111716,0,14,racemase and epimerase activity,MF,
6069,GO:0016855,1,0.993883677960989,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6070,GO:0016857,1,0.941495183206563,0,9,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6071,GO:0016859,1,0.845865509437344,0,33,cis-trans isomerase activity,MF,
6072,GO:0016860,1,0.788220073230875,0,44,intramolecular oxidoreductase activity,MF,
6073,GO:0016861,1,0.961851334464957,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
6074,GO:0016862,1,0.98877824065167,0,3,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6075,GO:0016863,1,0.948897733881634,0,11,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
6076,GO:0016864,1,0.903794430397119,0,16,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6077,GO:0016866,1,0.868713353676685,0,25,intramolecular transferase activity,MF,
6078,GO:0016868,1,0.94738637542874,0,10,intramolecular transferase activity, phosphotransferases,MF,
6079,GO:0016872,1,0.994432956656684,0,1,intramolecular lyase activity,MF,
6081,GO:0016875,1,0.874728894887777,0,22,ligase activity, forming carbon-oxygen bonds,MF,
6082,GO:0016877,1,0.784139440041375,0,37,ligase activity, forming carbon-sulfur bonds,MF,
6083,GO:0016878,1,0.838578338197602,0,27,acid-thiol ligase activity,MF,
6085,GO:0016880,1,0.985698819791694,0,2,acid-ammonia (or amide) ligase activity,MF,
6087,GO:0016882,1,0.989320266228322,0,2,cyclo-ligase activity,MF,
6088,GO:0016884,1,0.935185178743428,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6089,GO:0016885,1,0.958638070394489,0,6,ligase activity, forming carbon-carbon bonds,MF,
6090,GO:0016886,1,0.96484935469996,0,5,ligase activity, forming phosphoric ester bonds,MF,
6092,GO:0016888,1,0.89880608075897,0,16,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6093,GO:0016889,1,0.954812731592449,0,8,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6094,GO:0016890,1,0.988540279142147,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6095,GO:0016891,1,0.847849801424541,0,28,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6096,GO:0016892,1,0.975431677756842,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6097,GO:0016893,1,0.78548142454219,0,40,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6098,GO:0016894,1,0.931343627308104,0,14,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6099,GO:0016895,1,0.876995299626022,0,22,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6100,GO:0016896,1,0.782952909080906,0,37,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6101,GO:0016898,1,0.995013884957315,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6102,GO:0016899,1,0.975906873724998,0,4,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6103,GO:0016900,1,0.993252445474327,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6105,GO:0016903,1,0.780312066846848,0,39,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
6106,GO:0016907,1,0.963337939645587,0,6,G protein-coupled acetylcholine receptor activity,MF,
6107,GO:0016917,1,0.868097964510902,0,20,GABA receptor activity,MF,
6108,GO:0016918,1,0.938419426947022,0,13,retinal binding,MF,
6109,GO:0016920,1,0.990983509954519,0,1,pyroglutamyl-peptidase activity,MF,
6110,GO:0016922,1,0.50771839064129,0,96,nuclear receptor binding,MF,
6112,GO:0016926,1,0.947371099871476,0,7,protein desumoylation,BP,
6113,GO:0016929,1,0.947371099871476,0,7,SUMO-specific protease activity,MF,
6114,GO:0016933,1,0.973803004698706,0,4,extracellularly glycine-gated ion channel activity,MF,
6115,GO:0016934,1,0.973803004698706,0,4,extracellularly glycine-gated chloride channel activity,MF,
6116,GO:0016935,1,0.985422296229127,0,2,glycine-gated chloride channel complex,CC,
6117,GO:0016936,1,0.968603638977943,0,8,galactoside binding,MF,
6118,GO:0016938,1,0.992963395739844,0,1,kinesin I complex,CC,
6119,GO:0016939,1,0.976057237337058,0,3,kinesin II complex,CC,
6120,GO:0016941,1,0.978659178512273,0,3,natriuretic peptide receptor activity,MF,
6121,GO:0016942,1,0.967898136111167,0,5,insulin-like growth factor binding protein complex,CC,
6122,GO:0016964,1,0.987065584560306,0,1,alpha-2 macroglobulin receptor activity,MF,
6123,GO:0016971,1,0.979507634119539,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6124,GO:0016972,1,0.971918515106275,0,4,thiol oxidase activity,MF,
6125,GO:0016973,1,0.900623380260039,0,18,poly(A)+ mRNA export from nucleus,BP,
6126,GO:0016979,1,0.996248422052098,0,1,lipoate-protein ligase activity,MF,
6127,GO:0016992,1,0.995827244315829,0,1,lipoate synthase activity,MF,
6128,GO:0016997,1,0.982543380566682,0,3,alpha-sialidase activity,MF,
6129,GO:0016998,1,0.996662769038189,0,1,cell wall macromolecule catabolic process,BP,
6130,GO:0016999,1,0.987922551198868,0,2,antibiotic metabolic process,BP,
6131,GO:0017002,1,0.926417412307081,0,9,activin-activated receptor activity,MF,
6132,GO:0017003,1,0.994368197260601,0,1,protein-heme linkage,BP,
6133,GO:0017004,1,0.816234416933123,0,35,cytochrome complex assembly,BP,
6134,GO:0017005,1,0.992514365261699,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6135,GO:0017006,1,0.994368197260601,0,1,protein-tetrapyrrole linkage,BP,
6136,GO:0017014,1,0.91185889510647,0,14,protein nitrosylation,BP,
6137,GO:0017015,1,0.444823999337022,0,115,regulation of transforming growth factor beta receptor signaling pathway,BP,
6139,GO:0017017,1,0.933470956498658,0,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
6140,GO:0017018,1,0.967320050678761,0,4,myosin phosphatase activity,MF,
6141,GO:0017020,1,0.979108064778508,0,3,myosin phosphatase regulator activity,MF,
6143,GO:0017024,1,0.996720932041102,0,1,myosin I binding,MF,
6144,GO:0017025,1,0.862121583206024,0,26,TBP-class protein binding,MF,
6147,GO:0017040,1,0.970496004826861,0,5,N-acylsphingosine amidohydrolase activity,MF,
6148,GO:0017041,1,0.996238987162587,0,1,galactosylgalactosylglucosylceramidase activity,MF,
6149,GO:0017042,1,0.995810206885099,0,1,glycosylceramidase activity,MF,
6150,GO:0017045,1,0.99641500146339,0,1,corticotropin-releasing hormone activity,MF,
6151,GO:0017046,1,0.757559472900087,0,44,peptide hormone binding,MF,
6154,GO:0017050,1,0.981476771381218,0,3,D-erythro-sphingosine kinase activity,MF,
6155,GO:0017053,1,0.589347563991444,0,73,transcription repressor complex,CC,
6156,GO:0017054,1,0.989380602540573,0,2,negative cofactor 2 complex,CC,
6157,GO:0017055,1,0.986651951616502,0,2,negative regulation of RNA polymerase II transcription preinitiation complex assembly,BP,
6158,GO:0017056,1,0.852089390113674,0,23,structural constituent of nuclear pore,MF,
6159,GO:0017057,1,0.986558932857453,0,2,6-phosphogluconolactonase activity,MF,
6160,GO:0017059,1,0.952270390971999,0,8,serine C-palmitoyltransferase complex,CC,
6161,GO:0017060,1,0.989736043587838,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6162,GO:0017061,1,0.985486264680847,0,2,S-methyl-5-thioadenosine phosphorylase activity,MF,
6163,GO:0017062,1,0.943019441742894,0,10,respiratory chain complex III assembly,BP,
6164,GO:0017064,1,0.985551230253004,0,3,fatty acid amide hydrolase activity,MF,
6165,GO:0017065,1,0.996015357048065,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6166,GO:0017069,1,0.787753832327738,0,42,snRNA binding,MF,
6167,GO:0017070,1,0.924244857284386,0,14,U6 snRNA binding,MF,
6168,GO:0017071,1,0.992512235194697,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6171,GO:0017077,1,0.990155875462168,0,2,oxidative phosphorylation uncoupler activity,MF,
6172,GO:0017080,1,0.800707827757211,0,37,sodium channel regulator activity,MF,
6173,GO:0017081,1,0.904876014441721,0,15,chloride channel regulator activity,MF,
6174,GO:0017083,1,0.95698224648301,0,6,4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity,MF,
6175,GO:0017085,1,0.929133357694708,0,11,response to insecticide,BP,
6176,GO:0017089,1,0.989375799185689,0,2,glycolipid transfer activity,MF,
6177,GO:0017090,1,0.992983008495211,0,1,meprin A complex,CC,
6178,GO:0017091,1,0.843526869460411,0,26,AU-rich element binding,MF,
6179,GO:0017095,1,0.975614251290985,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6180,GO:0017098,1,0.993728670751326,0,1,sulfonylurea receptor binding,MF,
6181,GO:0017099,1,0.980704899308392,0,3,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6182,GO:0017101,1,0.986915166669269,0,3,aminoacyl-tRNA synthetase multienzyme complex,CC,
6183,GO:0017108,1,0.945340238170647,0,8,5'-flap endonuclease activity,MF,
6184,GO:0017109,1,0.985372081326104,0,2,glutamate-cysteine ligase complex,CC,
6185,GO:0017110,1,0.942465665753455,0,10,nucleoside-diphosphatase activity,MF,
6187,GO:0017112,1,0.782816879922709,0,32,Rab guanyl-nucleotide exchange factor activity,MF,
6188,GO:0017113,1,0.992769178814638,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6189,GO:0017116,1,0.889119838177907,0,18,single-stranded DNA helicase activity,MF,
6190,GO:0017118,1,0.996248422052098,0,1,lipoyltransferase activity,MF,
6191,GO:0017119,1,0.917864135134788,0,13,Golgi transport complex,CC,
6192,GO:0017121,1,0.901162631614275,0,15,plasma membrane phospholipid scrambling,BP,
6193,GO:0017122,1,0.991886401924937,0,1,protein N-acetylglucosaminyltransferase complex,CC,
6195,GO:0017125,1,0.992255632534769,0,1,deoxycytidyl transferase activity,MF,
6196,GO:0017126,1,0.988617157584972,0,2,nucleologenesis,BP,
6197,GO:0017128,1,0.947236765729033,0,8,phospholipid scramblase activity,MF,
6198,GO:0017129,1,0.988254580708349,0,2,triglyceride binding,MF,
6199,GO:0017130,1,0.991126559871638,0,1,poly(C) RNA binding,MF,
6201,GO:0017136,1,0.905831313385286,0,15,NAD-dependent histone deacetylase activity,MF,
6203,GO:0017143,1,0.987074116510783,0,2,insecticide metabolic process,BP,
6204,GO:0017144,1,0.822733331287864,0,33,drug metabolic process,BP,
6206,GO:0017146,1,0.911121328151744,0,11,NMDA selective glutamate receptor complex,CC,
6209,GO:0017150,1,0.978971348036561,0,4,tRNA dihydrouridine synthase activity,MF,
6210,GO:0017151,1,0.946115118495575,0,8,DEAD/H-box RNA helicase binding,MF,
6211,GO:0017153,1,0.955173770491758,0,6,sodium:dicarboxylate symporter activity,MF,
6212,GO:0017154,1,0.900896247663039,0,12,semaphorin receptor activity,MF,
6216,GO:0017159,1,0.983443289743165,0,3,pantetheine hydrolase activity,MF,
6217,GO:0017160,1,0.899242636371767,0,15,Ral GTPase binding,MF,
6218,GO:0017162,1,0.938946599703382,0,9,aryl hydrocarbon receptor binding,MF,
6219,GO:0017166,1,0.912714097849822,0,11,vinculin binding,MF,
6220,GO:0017168,1,0.992464418430856,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6221,GO:0017169,1,0.963982925339274,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6223,GO:0017172,1,0.995942357825884,0,1,cysteine dioxygenase activity,MF,
6224,GO:0017174,1,0.996607756044984,0,1,glycine N-methyltransferase activity,MF,
6225,GO:0017176,1,0.971436955477205,0,6,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6226,GO:0017177,1,0.986942495336157,0,2,glucosidase II complex,CC,
6227,GO:0017178,1,0.99325505912211,0,1,diphthine-ammonia ligase activity,MF,
6228,GO:0017182,1,0.957554171785845,0,7,peptidyl-diphthamide metabolic process,BP,
6229,GO:0017183,1,0.957554171785845,0,7,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6230,GO:0017185,1,0.94536134576292,0,8,peptidyl-lysine hydroxylation,BP,
6231,GO:0017186,1,0.990486163818116,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6232,GO:0017187,1,0.986030924548818,0,3,peptidyl-glutamic acid carboxylation,BP,
6233,GO:0017188,1,0.991667825944736,0,1,aspartate N-acetyltransferase activity,MF,
6234,GO:0017196,1,0.955548986250434,0,7,N-terminal peptidyl-methionine acetylation,BP,
6235,GO:0017198,1,0.992844522629793,0,2,N-terminal peptidyl-serine acetylation,BP,
6236,GO:0018002,1,0.992844522629793,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6237,GO:0018008,1,0.984391524669062,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6238,GO:0018009,1,0.994762408775374,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6239,GO:0018011,1,0.99325505912211,0,1,N-terminal peptidyl-alanine methylation,BP,
6240,GO:0018012,1,0.99325505912211,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6241,GO:0018013,1,0.99325505912211,0,1,N-terminal peptidyl-glycine methylation,BP,
6242,GO:0018016,1,0.99325505912211,0,1,N-terminal peptidyl-proline dimethylation,BP,
6243,GO:0018021,1,0.987979213541887,0,2,peptidyl-histidine methylation,BP,
6244,GO:0018022,1,0.455677973866037,0,106,peptidyl-lysine methylation,BP,
6245,GO:0018023,1,0.737978665669991,0,41,peptidyl-lysine trimethylation,BP,
6246,GO:0018024,1,0.744167768726815,0,39,histone-lysine N-methyltransferase activity,MF,
6247,GO:0018025,1,0.99325505912211,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6248,GO:0018026,1,0.953123365364306,0,7,peptidyl-lysine monomethylation,BP,
6249,GO:0018027,1,0.867434244138292,0,20,peptidyl-lysine dimethylation,BP,
6250,GO:0018032,1,0.992500519191262,0,1,protein amidation,BP,
6251,GO:0018057,1,0.964917010284964,0,5,peptidyl-lysine oxidation,BP,
6252,GO:0018063,1,0.994368197260601,0,1,cytochrome c-heme linkage,BP,
6253,GO:0018064,1,0.987979213541887,0,2,protein-histidine N-methyltransferase activity,MF,
6254,GO:0018076,1,0.964312104022074,0,4,N-terminal peptidyl-lysine acetylation,BP,
6255,GO:0018094,1,0.987239550195092,0,2,protein polyglycylation,BP,
6256,GO:0018095,1,0.930076462022176,0,11,protein polyglutamylation,BP,
6257,GO:0018101,1,0.972272638795266,0,4,protein citrullination,BP,
6258,GO:0018103,1,0.965031565943163,0,5,protein C-linked glycosylation,BP,
6260,GO:0018106,1,0.996794233003685,0,1,peptidyl-histidine phosphorylation,BP,
6261,GO:0018107,1,0.460969770038811,0,107,peptidyl-threonine phosphorylation,BP,
6263,GO:0018114,1,0.993883677960989,0,1,threonine racemase activity,MF,
6264,GO:0018117,1,0.995876361278093,0,1,protein adenylylation,BP,
6265,GO:0018119,1,0.91185889510647,0,14,peptidyl-cysteine S-nitrosylation,BP,
6266,GO:0018120,1,0.992376056372119,0,2,peptidyl-arginine ADP-ribosylation,BP,
6267,GO:0018125,1,0.984118424900618,0,3,peptidyl-cysteine methylation,BP,
6268,GO:0018126,1,0.846624272190214,0,25,protein hydroxylation,BP,
6270,GO:0018142,1,0.99325505912211,0,1,protein-DNA covalent cross-linking,BP,
6271,GO:0018143,1,0.99325505912211,0,1,nucleic acid-protein covalent cross-linking,BP,
6274,GO:0018153,1,0.987841837496035,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6275,GO:0018158,1,0.92304188861475,0,14,protein oxidation,BP,
6276,GO:0018160,1,0.9961703117629,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6277,GO:0018166,1,0.99206108732589,0,1,C-terminal protein-tyrosinylation,BP,
6278,GO:0018171,1,0.981200359262828,0,4,peptidyl-cysteine oxidation,BP,
6279,GO:0018175,1,0.995876361278093,0,1,protein nucleotidylation,BP,
6280,GO:0018192,1,0.993947281909514,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6282,GO:0018194,1,0.99325505912211,0,1,peptidyl-alanine modification,BP,
6283,GO:0018195,1,0.873181788476856,0,23,peptidyl-arginine modification,BP,
6284,GO:0018196,1,0.840583508592828,0,30,peptidyl-asparagine modification,BP,
6285,GO:0018197,1,0.976250699187482,0,3,peptidyl-aspartic acid modification,BP,
6286,GO:0018198,1,0.74839625382331,0,47,peptidyl-cysteine modification,BP,
6287,GO:0018199,1,0.978442503049774,0,4,peptidyl-glutamine modification,BP,
6289,GO:0018201,1,0.974228512018958,0,4,peptidyl-glycine modification,BP,
6290,GO:0018202,1,0.934585403892036,0,11,peptidyl-histidine modification,BP,
6292,GO:0018206,1,0.92935151214199,0,12,peptidyl-methionine modification,BP,
6293,GO:0018208,1,0.754833542536628,0,49,peptidyl-proline modification,BP,
6295,GO:0018210,1,0.431273619509607,0,116,peptidyl-threonine modification,BP,
6296,GO:0018211,1,0.965031565943163,0,5,peptidyl-tryptophan modification,BP,
6298,GO:0018214,1,0.986030924548818,0,3,protein carboxylation,BP,
6299,GO:0018216,1,0.917085585664129,0,14,peptidyl-arginine methylation,BP,
6300,GO:0018217,1,0.992468160929538,0,1,peptidyl-aspartic acid phosphorylation,BP,
6301,GO:0018230,1,0.863177736163115,0,23,peptidyl-L-cysteine S-palmitoylation,BP,
6302,GO:0018231,1,0.863177736163115,0,23,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6303,GO:0018242,1,0.941727669949747,0,8,protein O-linked glycosylation via serine,BP,
6304,GO:0018243,1,0.936069247056793,0,9,protein O-linked glycosylation via threonine,BP,
6305,GO:0018262,1,0.984283569282181,0,3,isopeptide cross-linking,BP,
6306,GO:0018271,1,0.991583341144231,0,1,biotin-protein ligase activity,MF,
6307,GO:0018272,1,0.995691921465553,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6308,GO:0018276,1,0.996398387260517,0,1,isopeptide cross-linking via N6-glycyl-L-lysine,BP,
6309,GO:0018277,1,0.994175506546752,0,1,protein deamination,BP,
6310,GO:0018279,1,0.848163625145464,0,29,protein N-linked glycosylation via asparagine,BP,
6311,GO:0018282,1,0.985124524027695,0,2,metal incorporation into metallo-sulfur cluster,BP,
6312,GO:0018283,1,0.985124524027695,0,2,iron incorporation into metallo-sulfur cluster,BP,
6313,GO:0018293,1,0.996487525515825,0,1,protein-FAD linkage,BP,
6314,GO:0018298,1,0.955668662377815,0,8,protein-chromophore linkage,BP,
6315,GO:0018307,1,0.990666030522389,0,2,enzyme active site formation,BP,
6316,GO:0018312,1,0.987904504483705,0,2,peptidyl-serine ADP-ribosylation,BP,
6317,GO:0018315,1,0.992418877101266,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6318,GO:0018317,1,0.965031565943163,0,5,protein C-linked glycosylation via tryptophan,BP,
6319,GO:0018322,1,0.99206108732589,0,1,protein tyrosinylation,BP,
6320,GO:0018323,1,0.996698971982734,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6321,GO:0018335,1,0.971131255193734,0,4,protein succinylation,BP,
6322,GO:0018342,1,0.935280091054748,0,10,protein prenylation,BP,
6323,GO:0018343,1,0.982430810938789,0,3,protein farnesylation,BP,
6324,GO:0018344,1,0.958322440060802,0,7,protein geranylgeranylation,BP,
6325,GO:0018345,1,0.800502479305446,0,35,protein palmitoylation,BP,
6326,GO:0018350,1,0.994107008887041,0,1,protein esterification,BP,
6327,GO:0018352,1,0.989874528749089,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6328,GO:0018364,1,0.970998184211008,0,5,peptidyl-glutamine methylation,BP,
6329,GO:0018377,1,0.968698709685666,0,4,protein myristoylation,BP,
6330,GO:0018393,1,0.354125155339596,0,152,internal peptidyl-lysine acetylation,BP,
6331,GO:0018394,1,0.334923847567451,0,160,peptidyl-lysine acetylation,BP,
6332,GO:0018395,1,0.992518692750008,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6333,GO:0018400,1,0.991224066660958,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6334,GO:0018401,1,0.947338625504698,0,9,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6335,GO:0018406,1,0.965031565943163,0,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6337,GO:0018423,1,0.996396704530763,0,1,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6338,GO:0018424,1,0.992468545037976,0,1,peptidyl-glutamic acid poly-ADP-ribosylation,BP,
6339,GO:0018444,1,0.976757293977149,0,3,translation release factor complex,CC,
6340,GO:0018455,1,0.969720003977439,0,6,alcohol dehydrogenase [NAD(P)+] activity,MF,
6341,GO:0018467,1,0.993503954465745,0,1,formaldehyde dehydrogenase activity,MF,
6342,GO:0018477,1,0.993167686169431,0,1,benzaldehyde dehydrogenase (NADP+) activity,MF,
6343,GO:0018478,1,0.994635528004373,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6344,GO:0018479,1,0.98371555052962,0,3,benzaldehyde dehydrogenase (NAD+) activity,MF,
6345,GO:0018549,1,0.995758979471029,0,1,methanethiol oxidase activity,MF,
6346,GO:0018585,1,0.994693874995553,0,1,fluorene oxygenase activity,MF,
6347,GO:0018601,1,0.995835695009094,0,1,4-nitrophenol 2-monooxygenase activity,MF,
6348,GO:0018636,1,0.988930841847604,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6349,GO:0018685,1,0.995715233431222,0,1,alkane 1-monooxygenase activity,MF,
6350,GO:0018729,1,0.995446385642235,0,1,propionate CoA-transferase activity,MF,
6351,GO:0018733,1,0.996500109358012,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6352,GO:0018738,1,0.996497229466253,0,1,S-formylglutathione hydrolase activity,MF,
6353,GO:0018773,1,0.995818748314625,0,1,acetylpyruvate hydrolase activity,MF,
6354,GO:0018812,1,0.973289247682012,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
6355,GO:0018858,1,0.987932699664101,0,2,benzoate-CoA ligase activity,MF,
6356,GO:0018871,1,0.995020174114203,0,1,1-aminocyclopropane-1-carboxylate metabolic process,BP,
6357,GO:0018872,1,0.986178671482752,0,2,arsonoacetate metabolic process,BP,
6358,GO:0018874,1,0.994959574349138,0,1,benzoate metabolic process,BP,
6359,GO:0018879,1,0.988178099210606,0,2,biphenyl metabolic process,BP,
6360,GO:0018885,1,0.995835695009094,0,1,carbon tetrachloride metabolic process,BP,
6361,GO:0018894,1,0.987074116510783,0,2,dibenzo-p-dioxin metabolic process,BP,
6362,GO:0018904,1,0.863101621438191,0,24,ether metabolic process,BP,
6363,GO:0018910,1,0.995835695009094,0,1,benzene metabolic process,BP,
6364,GO:0018916,1,0.98176766541454,0,4,nitrobenzene metabolic process,BP,
6365,GO:0018917,1,0.994693874995553,0,1,fluorene metabolic process,BP,
6366,GO:0018931,1,0.99626173993583,0,1,naphthalene metabolic process,BP,
6367,GO:0018958,1,0.52547011997029,0,98,phenol-containing compound metabolic process,BP,
6368,GO:0018960,1,0.995835695009094,0,1,4-nitrophenol metabolic process,BP,
6369,GO:0018963,1,0.988815256589003,0,2,phthalate metabolic process,BP,
6370,GO:0018964,1,0.992416388487182,0,1,propylene metabolic process,BP,
6371,GO:0018969,1,0.993041533608535,0,1,thiocyanate metabolic process,BP,
6372,GO:0018992,1,0.984454663898127,0,2,germ-line sex determination,BP,
6373,GO:0018993,1,0.985922665389844,0,2,somatic sex determination,BP,
6374,GO:0018995,1,0.672145129248623,0,60,host cellular component,CC,
6376,GO:0019002,1,0.980456266105631,0,3,GMP binding,MF,
6377,GO:0019003,1,0.654142150961069,0,72,GDP binding,MF,
6378,GO:0019005,1,0.692073114241661,0,59,SCF ubiquitin ligase complex,CC,
6379,GO:0019008,1,0.988703896066728,0,2,molybdopterin synthase complex,CC,
6380,GO:0019034,1,0.977271378329801,0,3,viral replication complex,CC,
6381,GO:0019035,1,0.983845060724126,0,2,viral integration complex,CC,
6382,GO:0019042,1,0.933189142230094,0,11,viral latency,BP,
6383,GO:0019043,1,0.950630523542169,0,9,establishment of viral latency,BP,
6384,GO:0019045,1,0.98166221294333,0,2,latent virus replication,BP,
6385,GO:0019046,1,0.98166221294333,0,2,release from viral latency,BP,
6386,GO:0019048,1,0.826167090795823,0,27,modulation by virus of host process,BP,
6387,GO:0019049,1,0.985459612099375,0,2,mitigation of host defenses by virus,BP,
6388,GO:0019050,1,0.983871684960167,0,3,suppression by virus of host apoptotic process,BP,
6389,GO:0019054,1,0.88707426093638,0,18,modulation by virus of host cellular process,BP,
6390,GO:0019056,1,0.993076404209305,0,1,modulation by virus of host transcription,BP,
6392,GO:0019060,1,0.992273837845881,0,2,intracellular transport of viral protein in host cell,BP,
6393,GO:0019061,1,0.99440185043739,0,1,uncoating of virus,BP,
6394,GO:0019062,1,0.953884027637152,0,7,virion attachment to host cell,BP,
6395,GO:0019064,1,0.964273814501379,0,6,fusion of virus membrane with host plasma membrane,BP,
6396,GO:0019065,1,0.947733245933799,0,7,receptor-mediated endocytosis of virus by host cell,BP,
6397,GO:0019068,1,0.791307309930347,0,40,virion assembly,BP,
6398,GO:0019072,1,0.983988693526583,0,2,viral genome packaging,BP,
6399,GO:0019074,1,0.983988693526583,0,2,viral RNA genome packaging,BP,
6400,GO:0019075,1,0.986555151512788,0,2,virus maturation,BP,
6401,GO:0019076,1,0.80783874302383,0,32,viral release from host cell,BP,
6402,GO:0019079,1,0.47489453387119,0,115,viral genome replication,BP,
6404,GO:0019081,1,0.913019967373769,0,14,viral translation,BP,
6405,GO:0019082,1,0.981460197358179,0,3,viral protein processing,BP,
6407,GO:0019085,1,0.985023685743168,0,2,early viral transcription,BP,
6408,GO:0019086,1,0.976711257183309,0,4,late viral transcription,BP,
6409,GO:0019087,1,0.984548480389207,0,2,transformation of host cell by virus,BP,
6410,GO:0019098,1,0.82560728301707,0,28,reproductive behavior,BP,
6411,GO:0019100,1,0.984454663898127,0,2,male germ-line sex determination,BP,
6412,GO:0019101,1,0.993019588637981,0,1,female somatic sex determination,BP,
6413,GO:0019102,1,0.992853697764998,0,1,male somatic sex determination,BP,
6414,GO:0019103,1,0.965914842388685,0,6,pyrimidine nucleotide binding,MF,
6415,GO:0019104,1,0.93994919051271,0,13,DNA N-glycosylase activity,MF,
6416,GO:0019107,1,0.971021858481318,0,5,myristoyltransferase activity,MF,
6417,GO:0019115,1,0.978948158580602,0,4,benzaldehyde dehydrogenase [NAD(P)+] activity,MF,
6418,GO:0019118,1,0.996311898801228,0,1,phenanthrene-epoxide hydrolase activity,MF,
6419,GO:0019119,1,0.996311898801228,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6420,GO:0019135,1,0.987971722752606,0,2,deoxyhypusine monooxygenase activity,MF,
6421,GO:0019136,1,0.978492494283984,0,4,deoxynucleoside kinase activity,MF,
6422,GO:0019144,1,0.992570350445672,0,2,ADP-sugar diphosphatase activity,MF,
6423,GO:0019145,1,0.993820945546778,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6424,GO:0019150,1,0.994958306762152,0,1,D-ribulokinase activity,MF,
6425,GO:0019153,1,0.995966557073652,0,1,protein-disulfide reductase (glutathione) activity,MF,
6426,GO:0019158,1,0.963017193552564,0,5,mannokinase activity,MF,
6427,GO:0019166,1,0.985601590477699,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6428,GO:0019171,1,0.990217175383171,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6429,GO:0019184,1,0.901842787881095,0,17,nonribosomal peptide biosynthetic process,BP,
6430,GO:0019185,1,0.978708028125424,0,3,snRNA-activating protein complex,CC,
6431,GO:0019187,1,0.992475928180309,0,1,beta-1,4-mannosyltransferase activity,MF,
6432,GO:0019198,1,0.865199621039049,0,17,transmembrane receptor protein phosphatase activity,MF,
6434,GO:0019200,1,0.870882021440584,0,21,carbohydrate kinase activity,MF,
6435,GO:0019202,1,0.985864348718722,0,2,amino acid kinase activity,MF,
6436,GO:0019203,1,0.951301338159322,0,8,carbohydrate phosphatase activity,MF,
6437,GO:0019205,1,0.77985876250338,0,42,nucleobase-containing compound kinase activity,MF,
6438,GO:0019206,1,0.954057464330457,0,9,nucleoside kinase activity,MF,
6440,GO:0019208,1,0.553209467404495,0,90,phosphatase regulator activity,MF,
6442,GO:0019210,1,0.684083688923069,0,62,kinase inhibitor activity,MF,
6443,GO:0019211,1,0.904808813560229,0,15,phosphatase activator activity,MF,
6444,GO:0019212,1,0.776023951753507,0,41,phosphatase inhibitor activity,MF,
6445,GO:0019213,1,0.773339087210348,0,39,deacetylase activity,MF,
6446,GO:0019215,1,0.911641547422499,0,14,intermediate filament binding,MF,
6449,GO:0019218,1,0.494163921840955,0,109,regulation of steroid metabolic process,BP,
6455,GO:0019227,1,0.944879417028827,0,8,neuronal action potential propagation,BP,
6458,GO:0019230,1,0.96719828442958,0,5,proprioception,BP,
6459,GO:0019233,1,0.56562362036237,0,89,sensory perception of pain,BP,
6460,GO:0019236,1,0.981458072819351,0,4,response to pheromone,BP,
6461,GO:0019237,1,0.956582097979266,0,6,centromeric DNA binding,MF,
6462,GO:0019238,1,0.971645068766209,0,5,cyclohydrolase activity,MF,
6463,GO:0019239,1,0.857151075323803,0,26,deaminase activity,MF,
6464,GO:0019240,1,0.961736164916517,0,5,citrulline biosynthetic process,BP,
6465,GO:0019242,1,0.996183274548778,0,1,methylglyoxal biosynthetic process,BP,
6466,GO:0019243,1,0.988965878979068,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6467,GO:0019244,1,0.996433366551158,0,1,lactate biosynthetic process from pyruvate,BP,
6468,GO:0019249,1,0.98459125214411,0,3,lactate biosynthetic process,BP,
6469,GO:0019254,1,0.980704591504759,0,3,carnitine metabolic process, CoA-linked,BP,
6470,GO:0019255,1,0.989874798407313,0,2,glucose 1-phosphate metabolic process,BP,
6471,GO:0019262,1,0.97363581421562,0,6,N-acetylneuraminate catabolic process,BP,
6472,GO:0019264,1,0.98845812519745,0,2,glycine biosynthetic process from serine,BP,
6473,GO:0019265,1,0.995957962710815,0,1,glycine biosynthetic process, by transamination of glyoxylate,BP,
6474,GO:0019276,1,0.985609925784707,0,2,UDP-N-acetylgalactosamine metabolic process,BP,
6475,GO:0019284,1,0.984370515038225,0,3,L-methionine salvage from S-adenosylmethionine,BP,
6476,GO:0019285,1,0.985101845085447,0,2,glycine betaine biosynthetic process from choline,BP,
6477,GO:0019287,1,0.986944538740146,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6478,GO:0019290,1,0.993002477888305,0,1,siderophore biosynthetic process,BP,
6479,GO:0019303,1,0.992992095053001,0,2,D-ribose catabolic process,BP,
6480,GO:0019317,1,0.940819744652645,0,8,fucose catabolic process,BP,
6483,GO:0019320,1,0.728248340303863,0,50,hexose catabolic process,BP,
6484,GO:0019321,1,0.933031944346904,0,14,pentose metabolic process,BP,
6485,GO:0019322,1,0.980890835099238,0,4,pentose biosynthetic process,BP,
6486,GO:0019323,1,0.976633758155947,0,5,pentose catabolic process,BP,
6487,GO:0019336,1,0.932555315597312,0,11,phenol-containing compound catabolic process,BP,
6488,GO:0019341,1,0.993582687174415,0,1,dibenzo-p-dioxin catabolic process,BP,
6489,GO:0019343,1,0.989317513449587,0,2,cysteine biosynthetic process via cystathionine,BP,
6490,GO:0019344,1,0.983548311468246,0,3,cysteine biosynthetic process,BP,
6491,GO:0019346,1,0.982131285799125,0,4,transsulfuration,BP,
6492,GO:0019348,1,0.973396211325091,0,5,dolichol metabolic process,BP,
6493,GO:0019359,1,0.845522107203134,0,28,nicotinamide nucleotide biosynthetic process,BP,
6494,GO:0019362,1,0.830739667982721,0,31,pyridine nucleotide metabolic process,BP,
6495,GO:0019363,1,0.845522107203134,0,28,pyridine nucleotide biosynthetic process,BP,
6496,GO:0019364,1,0.975228968706583,0,4,pyridine nucleotide catabolic process,BP,
6497,GO:0019365,1,0.99325505912211,0,1,pyridine nucleotide salvage,BP,
6498,GO:0019367,1,0.960184917352038,0,6,fatty acid elongation, saturated fatty acid,BP,
6499,GO:0019368,1,0.960184917352038,0,6,fatty acid elongation, unsaturated fatty acid,BP,
6500,GO:0019369,1,0.768863510708798,0,46,arachidonic acid metabolic process,BP,
6501,GO:0019370,1,0.939445116545255,0,12,leukotriene biosynthetic process,BP,
6502,GO:0019371,1,0.945020940264403,0,11,cyclooxygenase pathway,BP,
6503,GO:0019372,1,0.918695519135242,0,16,lipoxygenase pathway,BP,
6504,GO:0019373,1,0.943442558743999,0,11,epoxygenase P450 pathway,BP,
6507,GO:0019376,1,0.982074628361252,0,3,galactolipid catabolic process,BP,
6508,GO:0019377,1,0.913266397337572,0,15,glycolipid catabolic process,BP,
6509,GO:0019388,1,0.95398463965541,0,8,galactose catabolic process,BP,
6510,GO:0019389,1,0.98787627978963,0,2,glucuronoside metabolic process,BP,
6511,GO:0019391,1,0.98787627978963,0,2,glucuronoside catabolic process,BP,
6512,GO:0019395,1,0.530395988406703,0,102,fatty acid oxidation,BP,
6513,GO:0019400,1,0.887555398264961,0,19,alditol metabolic process,BP,
6514,GO:0019401,1,0.960755478766897,0,7,alditol biosynthetic process,BP,
6515,GO:0019402,1,0.996313148091886,0,1,galactitol metabolic process,BP,
6516,GO:0019405,1,0.963846279733681,0,5,alditol catabolic process,BP,
6517,GO:0019406,1,0.99626173993583,0,1,hexitol biosynthetic process,BP,
6518,GO:0019407,1,0.993766247491235,0,1,hexitol catabolic process,BP,
6519,GO:0019408,1,0.985753992134486,0,2,dolichol biosynthetic process,BP,
6520,GO:0019413,1,0.985323422668229,0,2,acetate biosynthetic process,BP,
6521,GO:0019417,1,0.985073611071982,0,2,sulfur oxidation,BP,
6522,GO:0019418,1,0.98324288063967,0,4,sulfide oxidation,BP,
6523,GO:0019427,1,0.985323422668229,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6524,GO:0019430,1,0.882322567896401,0,23,removal of superoxide radicals,BP,
6525,GO:0019432,1,0.810378236931048,0,31,triglyceride biosynthetic process,BP,
6526,GO:0019433,1,0.839470250143196,0,29,triglyceride catabolic process,BP,
6529,GO:0019441,1,0.983819766339773,0,4,tryptophan catabolic process to kynurenine,BP,
6530,GO:0019442,1,0.991941188996757,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6531,GO:0019448,1,0.979037591010445,0,4,L-cysteine catabolic process,BP,
6532,GO:0019449,1,0.993376889315338,0,1,L-cysteine catabolic process to hypotaurine,BP,
6533,GO:0019452,1,0.993376889315338,0,1,L-cysteine catabolic process to taurine,BP,
6534,GO:0019464,1,0.983616930638129,0,3,glycine decarboxylation via glycine cleavage system,BP,
6535,GO:0019470,1,0.974665325505927,0,4,4-hydroxyproline catabolic process,BP,
6536,GO:0019471,1,0.974665325505927,0,4,4-hydroxyproline metabolic process,BP,
6537,GO:0019474,1,0.973604863573894,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6538,GO:0019477,1,0.973604863573894,0,4,L-lysine catabolic process,BP,
6539,GO:0019478,1,0.991907776039247,0,2,D-amino acid catabolic process,BP,
6540,GO:0019482,1,0.975243169940045,0,4,beta-alanine metabolic process,BP,
6541,GO:0019483,1,0.987734572567744,0,2,beta-alanine biosynthetic process,BP,
6542,GO:0019493,1,0.995150811224064,0,1,arginine catabolic process to proline,BP,
6543,GO:0019509,1,0.972596875493786,0,5,L-methionine salvage from methylthioadenosine,BP,
6544,GO:0019510,1,0.994357853524939,0,1,S-adenosylhomocysteine catabolic process,BP,
6545,GO:0019511,1,0.913568913090582,0,14,peptidyl-proline hydroxylation,BP,
6546,GO:0019516,1,0.996433366551158,0,1,lactate oxidation,BP,
6547,GO:0019518,1,0.98825460036279,0,3,L-threonine catabolic process to glycine,BP,
6548,GO:0019519,1,0.993766247491235,0,1,pentitol metabolic process,BP,
6549,GO:0019520,1,0.988531408018345,0,2,aldonic acid metabolic process,BP,
6550,GO:0019521,1,0.988531408018345,0,2,D-gluconate metabolic process,BP,
6551,GO:0019527,1,0.993766247491235,0,1,pentitol catabolic process,BP,
6552,GO:0019530,1,0.954728691428165,0,7,taurine metabolic process,BP,
6553,GO:0019531,1,0.941670759402475,0,8,oxalate transmembrane transporter activity,MF,
6554,GO:0019532,1,0.937862157689652,0,9,oxalate transport,BP,
6555,GO:0019534,1,0.952626637268388,0,7,toxin transmembrane transporter activity,MF,
6557,GO:0019541,1,0.974129113487276,0,4,propionate metabolic process,BP,
6558,GO:0019542,1,0.985323422668229,0,2,propionate biosynthetic process,BP,
6559,GO:0019543,1,0.988640653624115,0,2,propionate catabolic process,BP,
6560,GO:0019544,1,0.995150811224064,0,1,arginine catabolic process to glutamate,BP,
6561,GO:0019547,1,0.991370229159407,0,2,arginine catabolic process to ornithine,BP,
6562,GO:0019550,1,0.988761358705304,0,2,glutamate catabolic process to aspartate,BP,
6563,GO:0019551,1,0.988761358705304,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6564,GO:0019556,1,0.975671077284,0,4,histidine catabolic process to glutamate and formamide,BP,
6565,GO:0019557,1,0.975671077284,0,4,histidine catabolic process to glutamate and formate,BP,
6566,GO:0019563,1,0.969894239885432,0,4,glycerol catabolic process,BP,
6567,GO:0019566,1,0.986555151512788,0,2,arabinose metabolic process,BP,
6568,GO:0019585,1,0.956435805793028,0,8,glucuronate metabolic process,BP,
6569,GO:0019605,1,0.990282708476754,0,2,butyrate metabolic process,BP,
6570,GO:0019606,1,0.995846892329136,0,1,2-oxobutyrate catabolic process,BP,
6571,GO:0019614,1,0.949155795519077,0,8,catechol-containing compound catabolic process,BP,
6572,GO:0019626,1,0.958308007272074,0,8,short-chain fatty acid catabolic process,BP,
6573,GO:0019627,1,0.939627093432475,0,12,urea metabolic process,BP,
6575,GO:0019640,1,0.975543113841645,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6576,GO:0019646,1,0.936243052371679,0,16,aerobic electron transport chain,BP,
6577,GO:0019659,1,0.986142807120098,0,2,glucose catabolic process to lactate,BP,
6578,GO:0019660,1,0.986142807120098,0,2,glycolytic fermentation,BP,
6579,GO:0019661,1,0.986142807120098,0,2,glucose catabolic process to lactate via pyruvate,BP,
6580,GO:0019673,1,0.9750096223855,0,6,GDP-mannose metabolic process,BP,
6582,GO:0019676,1,0.987161481388683,0,2,ammonia assimilation cycle,BP,
6583,GO:0019677,1,0.980291165714079,0,3,NAD catabolic process,BP,
6584,GO:0019682,1,0.963600231851204,0,7,glyceraldehyde-3-phosphate metabolic process,BP,
6585,GO:0019692,1,0.854519928996432,0,31,deoxyribose phosphate metabolic process,BP,
6587,GO:0019694,1,0.954728691428165,0,7,alkanesulfonate metabolic process,BP,
6588,GO:0019695,1,0.938236741704101,0,9,choline metabolic process,BP,
6589,GO:0019706,1,0.835389039420614,0,28,protein-cysteine S-palmitoyltransferase activity,MF,
6590,GO:0019707,1,0.835389039420614,0,28,protein-cysteine S-acyltransferase activity,MF,
6591,GO:0019720,1,0.963064952063979,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6593,GO:0019724,1,0.534138948343756,0,105,B cell mediated immunity,BP,
6597,GO:0019732,1,0.980917348016727,0,4,antifungal humoral response,BP,
6598,GO:0019740,1,0.976570179277706,0,4,nitrogen utilization,BP,
6599,GO:0019742,1,0.994065446234984,0,1,pentacyclic triterpenoid metabolic process,BP,
6600,GO:0019747,1,0.978849544044233,0,4,regulation of isoprenoid metabolic process,BP,
6601,GO:0019748,1,0.733755694719104,0,51,secondary metabolic process,BP,
6602,GO:0019751,1,0.478120619402998,0,111,polyol metabolic process,BP,
6604,GO:0019755,1,0.941782368916314,0,11,one-carbon compound transport,BP,
6605,GO:0019763,1,0.977999612698333,0,5,immunoglobulin receptor activity,MF,
6606,GO:0019767,1,0.996835469090974,0,1,IgE receptor activity,MF,
6607,GO:0019770,1,0.995953645462242,0,1,IgG receptor activity,MF,
6608,GO:0019772,1,0.995953645462242,0,1,low-affinity IgG receptor activity,MF,
6609,GO:0019773,1,0.976093961497718,0,7,proteasome core complex, alpha-subunit complex,CC,
6610,GO:0019774,1,0.970019637878512,0,9,proteasome core complex, beta-subunit complex,CC,
6611,GO:0019776,1,0.996444989876769,0,1,Atg8 ligase activity,MF,
6612,GO:0019777,1,0.990656233412857,0,2,Atg12 transferase activity,MF,
6613,GO:0019778,1,0.992153431733136,0,1,Atg12 activating enzyme activity,MF,
6614,GO:0019779,1,0.992153431733136,0,1,Atg8 activating enzyme activity,MF,
6615,GO:0019780,1,0.991324001812982,0,1,FAT10 activating enzyme activity,MF,
6616,GO:0019781,1,0.990369639422391,0,2,NEDD8 activating enzyme activity,MF,
6617,GO:0019782,1,0.992621579794284,0,1,ISG15 activating enzyme activity,MF,
6618,GO:0019783,1,0.895648065549783,0,17,ubiquitin-like protein-specific protease activity,MF,
6619,GO:0019784,1,0.965816466595718,0,7,NEDD8-specific protease activity,MF,
6620,GO:0019785,1,0.992458014121109,0,1,ISG15-specific protease activity,MF,
6621,GO:0019787,1,0.0633053106933884,0,402,ubiquitin-like protein transferase activity,MF,
6622,GO:0019788,1,0.971234181420496,0,6,NEDD8 transferase activity,MF,
6623,GO:0019789,1,0.890749896932682,0,17,SUMO transferase activity,MF,
6624,GO:0019797,1,0.979899979581028,0,3,procollagen-proline 3-dioxygenase activity,MF,
6625,GO:0019798,1,0.951077284917775,0,8,procollagen-proline dioxygenase activity,MF,
6626,GO:0019799,1,0.99325505912211,0,1,tubulin N-acetyltransferase activity,MF,
6628,GO:0019805,1,0.981241713636951,0,4,quinolinate biosynthetic process,BP,
6629,GO:0019806,1,0.991120150006773,0,1,bromide peroxidase activity,MF,
6630,GO:0019807,1,0.996285240102982,0,1,aspartoacylase activity,MF,
6631,GO:0019808,1,0.985968614142785,0,3,polyamine binding,MF,
6632,GO:0019809,1,0.993258548391288,0,2,spermidine binding,MF,
6633,GO:0019810,1,0.992661093381669,0,1,putrescine binding,MF,
6634,GO:0019811,1,0.992336503430008,0,1,cocaine binding,MF,
6635,GO:0019814,1,0.971869307021369,0,6,immunoglobulin complex,CC,
6636,GO:0019815,1,0.98166196195284,0,4,B cell receptor complex,CC,
6637,GO:0019825,1,0.864861619539427,0,29,oxygen binding,MF,
6638,GO:0019826,1,0.978427601469028,0,3,oxygen sensor activity,MF,
6640,GO:0019828,1,0.964351377677654,0,6,aspartic-type endopeptidase inhibitor activity,MF,
6641,GO:0019829,1,0.706883229429296,0,52,ATPase-coupled cation transmembrane transporter activity,MF,
6642,GO:0019834,1,0.98812348170715,0,3,phospholipase A2 inhibitor activity,MF,
6643,GO:0019835,1,0.907822729446092,0,19,cytolysis,BP,
6645,GO:0019840,1,0.866010451489628,0,26,isoprenoid binding,MF,
6646,GO:0019841,1,0.94996118353218,0,11,retinol binding,MF,
6647,GO:0019842,1,0.480543017485048,0,119,vitamin binding,MF,
6649,GO:0019852,1,0.938500220275182,0,11,L-ascorbic acid metabolic process,BP,
6650,GO:0019853,1,0.991464418105989,0,2,L-ascorbic acid biosynthetic process,BP,
6651,GO:0019855,1,0.954375360261226,0,9,calcium channel inhibitor activity,MF,
6652,GO:0019856,1,0.941525749030924,0,8,pyrimidine nucleobase biosynthetic process,BP,
6653,GO:0019857,1,0.968625280309651,0,3,5-methylcytosine metabolic process,BP,
6654,GO:0019858,1,0.989213408886681,0,2,cytosine metabolic process,BP,
6655,GO:0019859,1,0.982293539944513,0,3,thymine metabolic process,BP,
6656,GO:0019860,1,0.983630044515183,0,3,uracil metabolic process,BP,
6657,GO:0019862,1,0.99601700817132,0,1,IgA binding,MF,
6658,GO:0019863,1,0.985623250812895,0,4,IgE binding,MF,
6659,GO:0019864,1,0.959654893205342,0,9,IgG binding,MF,
6660,GO:0019865,1,0.911256704419966,0,18,immunoglobulin binding,MF,
6663,GO:0019869,1,0.934036436448594,0,10,chloride channel inhibitor activity,MF,
6664,GO:0019870,1,0.934329963627909,0,9,potassium channel inhibitor activity,MF,
6665,GO:0019871,1,0.948118685772239,0,8,sodium channel inhibitor activity,MF,
6666,GO:0019878,1,0.984808612299637,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6667,GO:0019882,1,0.289853558934014,0,217,antigen processing and presentation,BP,
6668,GO:0019883,1,0.883392884228495,0,22,antigen processing and presentation of endogenous antigen,BP,
6669,GO:0019884,1,0.376963152547999,0,173,antigen processing and presentation of exogenous antigen,BP,
6670,GO:0019885,1,0.914661705863853,0,16,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6671,GO:0019886,1,0.557785668877769,0,94,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
6673,GO:0019888,1,0.618606686515914,0,76,protein phosphatase regulator activity,MF,
6674,GO:0019894,1,0.743679273461078,0,40,kinesin binding,MF,
6675,GO:0019896,1,0.912963964486317,0,13,axonal transport of mitochondrion,BP,
6685,GO:0019907,1,0.988722324722507,0,3,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6686,GO:0019908,1,0.9299265713869,0,12,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6688,GO:0019912,1,0.994590085137988,0,1,cyclin-dependent protein kinase activating kinase activity,MF,
6689,GO:0019915,1,0.619247143905471,0,73,lipid storage,BP,
6690,GO:0019918,1,0.97480379995038,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6691,GO:0019919,1,0.9718405799188,0,5,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6694,GO:0019934,1,0.854222063424502,0,25,cGMP-mediated signaling,BP,
6697,GO:0019948,1,0.987400526170291,0,2,SUMO activating enzyme activity,MF,
6700,GO:0019956,1,0.822126652030162,0,32,chemokine binding,MF,
6701,GO:0019957,1,0.879181685723685,0,23,C-C chemokine binding,MF,
6702,GO:0019958,1,0.961127540284888,0,6,C-X-C chemokine binding,MF,
6703,GO:0019959,1,0.979567736336003,0,3,interleukin-8 binding,MF,
6704,GO:0019960,1,0.96063096323345,0,5,C-X3-C chemokine binding,MF,
6705,GO:0019961,1,0.984159662726524,0,2,interferon binding,MF,
6706,GO:0019962,1,0.991536675424652,0,1,type I interferon binding,MF,
6707,GO:0019964,1,0.992560662383874,0,1,interferon-gamma binding,MF,
6708,GO:0019966,1,0.957795077559528,0,7,interleukin-1 binding,MF,
6709,GO:0019969,1,0.992501669645374,0,1,interleukin-10 binding,MF,
6710,GO:0019970,1,0.981026936383175,0,3,interleukin-11 binding,MF,
6711,GO:0019972,1,0.996214297604249,0,1,interleukin-12 binding,MF,
6712,GO:0019975,1,0.996214297604249,0,1,interleukin-17 binding,MF,
6713,GO:0019976,1,0.98133408228859,0,3,interleukin-2 binding,MF,
6714,GO:0019981,1,0.985211687601161,0,2,interleukin-6 binding,MF,
6715,GO:0019985,1,0.784130963360649,0,39,translesion synthesis,BP,
6716,GO:0019988,1,0.993292626999948,0,1,charged-tRNA amino acid modification,BP,
6717,GO:0019992,1,0.916053561073252,0,12,diacylglycerol binding,MF,
6718,GO:0020003,1,0.983484760071461,0,3,symbiont-containing vacuole,CC,
6719,GO:0020005,1,0.990164029815297,0,2,symbiont-containing vacuole membrane,CC,
6720,GO:0020016,1,0.97763286207031,0,3,ciliary pocket,CC,
6721,GO:0020018,1,0.97763286207031,0,3,ciliary pocket membrane,CC,
6722,GO:0020027,1,0.921543959541772,0,15,hemoglobin metabolic process,BP,
6724,GO:0021501,1,0.994890857381385,0,1,prechordal plate formation,BP,
6725,GO:0021502,1,0.979742336492877,0,3,neural fold elevation formation,BP,
6726,GO:0021503,1,0.990239294960945,0,1,neural fold bending,BP,
6727,GO:0021508,1,0.99115473106816,0,1,floor plate formation,BP,
6728,GO:0021509,1,0.995129860713951,0,1,roof plate formation,BP,
6731,GO:0021512,1,0.992421565054381,0,1,spinal cord anterior/posterior patterning,BP,
6735,GO:0021516,1,0.897428572787693,0,19,dorsal spinal cord development,BP,
6737,GO:0021519,1,0.996409506317867,0,1,spinal cord association neuron specification,BP,
6741,GO:0021523,1,0.971840788291013,0,5,somatic motor neuron differentiation,BP,
6742,GO:0021524,1,0.984979304370284,0,3,visceral motor neuron differentiation,BP,
6743,GO:0021526,1,0.989566761386253,0,2,medial motor column neuron differentiation,BP,
6744,GO:0021527,1,0.937969478136337,0,11,spinal cord association neuron differentiation,BP,
6745,GO:0021528,1,0.99325505912211,0,1,commissural neuron differentiation in spinal cord,BP,
6746,GO:0021529,1,0.96559989965416,0,5,spinal cord oligodendrocyte cell differentiation,BP,
6747,GO:0021530,1,0.982792114952093,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6748,GO:0021532,1,0.777457957628888,0,38,neural tube patterning,BP,
6750,GO:0021534,1,0.90677760876392,0,15,cell proliferation in hindbrain,BP,
6751,GO:0021535,1,0.896912739841015,0,14,cell migration in hindbrain,BP,
6752,GO:0021536,1,0.639345728793158,0,69,diencephalon development,BP,
6754,GO:0021538,1,0.976305966839789,0,3,epithalamus development,BP,
6755,GO:0021539,1,0.995992020575815,0,1,subthalamus development,BP,
6756,GO:0021540,1,0.95712372783186,0,6,corpus callosum morphogenesis,BP,
6757,GO:0021541,1,0.992428972068244,0,1,ammon gyrus development,BP,
6758,GO:0021542,1,0.89416926221246,0,16,dentate gyrus development,BP,
6760,GO:0021544,1,0.842182688649071,0,24,subpallium development,BP,
6762,GO:0021546,1,0.966639310996498,0,6,rhombomere development,BP,
6763,GO:0021547,1,0.994890857381385,0,1,midbrain-hindbrain boundary initiation,BP,
6764,GO:0021548,1,0.942792359268228,0,9,pons development,BP,
6766,GO:0021550,1,0.993898281598366,0,1,medulla oblongata development,BP,
6767,GO:0021551,1,0.988476515404915,0,1,central nervous system morphogenesis,BP,
6768,GO:0021553,1,0.974936683056751,0,3,olfactory nerve development,BP,
6769,GO:0021554,1,0.914858826534559,0,13,optic nerve development,BP,
6770,GO:0021555,1,0.984616161278934,0,3,midbrain-hindbrain boundary morphogenesis,BP,
6771,GO:0021557,1,0.98469550497956,0,3,oculomotor nerve development,BP,
6772,GO:0021558,1,0.991998699726826,0,2,trochlear nerve development,BP,
6773,GO:0021559,1,0.929219366246186,0,11,trigeminal nerve development,BP,
6774,GO:0021560,1,0.986632990141894,0,2,abducens nerve development,BP,
6775,GO:0021561,1,0.93076719726949,0,10,facial nerve development,BP,
6776,GO:0021562,1,0.945165652190171,0,8,vestibulocochlear nerve development,BP,
6777,GO:0021563,1,0.961700569215958,0,5,glossopharyngeal nerve development,BP,
6778,GO:0021564,1,0.977800035754745,0,3,vagus nerve development,BP,
6779,GO:0021566,1,0.992168187035404,0,1,hypoglossal nerve development,BP,
6780,GO:0021568,1,0.991997484945331,0,2,rhombomere 2 development,BP,
6781,GO:0021569,1,0.984772859848323,0,3,rhombomere 3 development,BP,
6782,GO:0021570,1,0.995968269535977,0,1,rhombomere 4 development,BP,
6783,GO:0021571,1,0.985759207656142,0,2,rhombomere 5 development,BP,
6784,GO:0021572,1,0.992609562445407,0,1,rhombomere 6 development,BP,
6786,GO:0021577,1,0.986140988569696,0,2,hindbrain structural organization,BP,
6787,GO:0021578,1,0.958361855771883,0,6,hindbrain maturation,BP,
6788,GO:0021586,1,0.978945287700983,0,3,pons maturation,BP,
6790,GO:0021589,1,0.986140988569696,0,2,cerebellum structural organization,BP,
6791,GO:0021590,1,0.978978383331463,0,3,cerebellum maturation,BP,
6792,GO:0021591,1,0.786004253107084,0,32,ventricular system development,BP,
6793,GO:0021592,1,0.982742662677242,0,2,fourth ventricle development,BP,
6794,GO:0021593,1,0.988759732532087,0,2,rhombomere morphogenesis,BP,
6795,GO:0021594,1,0.993099161364753,0,1,rhombomere formation,BP,
6796,GO:0021595,1,0.993099161364753,0,1,rhombomere structural organization,BP,
6797,GO:0021598,1,0.986632990141894,0,2,abducens nerve morphogenesis,BP,
6798,GO:0021599,1,0.986632990141894,0,2,abducens nerve formation,BP,
6799,GO:0021602,1,0.82988469748624,0,27,cranial nerve morphogenesis,BP,
6800,GO:0021603,1,0.949942174577687,0,8,cranial nerve formation,BP,
6801,GO:0021604,1,0.93232521802876,0,10,cranial nerve structural organization,BP,
6802,GO:0021610,1,0.93076719726949,0,10,facial nerve morphogenesis,BP,
6803,GO:0021612,1,0.944332868876558,0,8,facial nerve structural organization,BP,
6804,GO:0021615,1,0.97240405388577,0,4,glossopharyngeal nerve morphogenesis,BP,
6805,GO:0021618,1,0.992168187035404,0,1,hypoglossal nerve morphogenesis,BP,
6806,GO:0021622,1,0.988457362999271,0,2,oculomotor nerve morphogenesis,BP,
6807,GO:0021623,1,0.988457362999271,0,2,oculomotor nerve formation,BP,
6808,GO:0021626,1,0.951384428366265,0,7,central nervous system maturation,BP,
6809,GO:0021631,1,0.954717132904132,0,6,optic nerve morphogenesis,BP,
6810,GO:0021633,1,0.987291894498626,0,2,optic nerve structural organization,BP,
6811,GO:0021634,1,0.992451971441975,0,1,optic nerve formation,BP,
6812,GO:0021636,1,0.962505677942321,0,5,trigeminal nerve morphogenesis,BP,
6813,GO:0021637,1,0.962505677942321,0,5,trigeminal nerve structural organization,BP,
6814,GO:0021639,1,0.995788171566758,0,1,trochlear nerve morphogenesis,BP,
6815,GO:0021642,1,0.995788171566758,0,1,trochlear nerve formation,BP,
6816,GO:0021644,1,0.988680853672592,0,2,vagus nerve morphogenesis,BP,
6817,GO:0021648,1,0.960291353577206,0,6,vestibulocochlear nerve morphogenesis,BP,
6818,GO:0021649,1,0.985865043136723,0,2,vestibulocochlear nerve structural organization,BP,
6819,GO:0021650,1,0.974063362198554,0,4,vestibulocochlear nerve formation,BP,
6820,GO:0021658,1,0.988759732532087,0,2,rhombomere 3 morphogenesis,BP,
6821,GO:0021659,1,0.993099161364753,0,1,rhombomere 3 structural organization,BP,
6822,GO:0021660,1,0.993099161364753,0,1,rhombomere 3 formation,BP,
6823,GO:0021664,1,0.993099161364753,0,1,rhombomere 5 morphogenesis,BP,
6824,GO:0021665,1,0.993099161364753,0,1,rhombomere 5 structural organization,BP,
6825,GO:0021666,1,0.993099161364753,0,1,rhombomere 5 formation,BP,
6826,GO:0021670,1,0.90732220842036,0,12,lateral ventricle development,BP,
6828,GO:0021678,1,0.969267019757344,0,5,third ventricle development,BP,
6829,GO:0021679,1,0.985521112926623,0,2,cerebellar molecular layer development,BP,
6830,GO:0021680,1,0.833091626647139,0,24,cerebellar Purkinje cell layer development,BP,
6832,GO:0021682,1,0.991763992571907,0,1,nerve maturation,BP,
6835,GO:0021685,1,0.990863179682464,0,1,cerebellar granular layer structural organization,BP,
6836,GO:0021686,1,0.995887266483741,0,1,cerebellar granular layer maturation,BP,
6837,GO:0021687,1,0.985521112926623,0,2,cerebellar molecular layer morphogenesis,BP,
6838,GO:0021688,1,0.992630991077856,0,1,cerebellar molecular layer formation,BP,
6839,GO:0021691,1,0.983021996543647,0,2,cerebellar Purkinje cell layer maturation,BP,
6841,GO:0021693,1,0.983560819603855,0,2,cerebellar Purkinje cell layer structural organization,BP,
6842,GO:0021694,1,0.919664395209127,0,11,cerebellar Purkinje cell layer formation,BP,
6846,GO:0021698,1,0.983560819603855,0,2,cerebellar cortex structural organization,BP,
6847,GO:0021699,1,0.978978383331463,0,3,cerebellar cortex maturation,BP,
6849,GO:0021702,1,0.919664395209127,0,11,cerebellar Purkinje cell differentiation,BP,
6850,GO:0021703,1,0.995788171566758,0,1,locus ceruleus development,BP,
6852,GO:0021718,1,0.986427005464421,0,2,superior olivary nucleus development,BP,
6853,GO:0021722,1,0.986427005464421,0,2,superior olivary nucleus maturation,BP,
6854,GO:0021730,1,0.983198951648405,0,2,trigeminal sensory nucleus development,BP,
6855,GO:0021740,1,0.983198951648405,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6856,GO:0021747,1,0.97700818060998,0,3,cochlear nucleus development,BP,
6857,GO:0021750,1,0.993898281598366,0,1,vestibular nucleus development,BP,
6858,GO:0021756,1,0.87136188246628,0,18,striatum development,BP,
6859,GO:0021757,1,0.992514365261699,0,1,caudate nucleus development,BP,
6860,GO:0021758,1,0.992514365261699,0,1,putamen development,BP,
6861,GO:0021759,1,0.972593432719221,0,4,globus pallidus development,BP,
6862,GO:0021761,1,0.494637234383323,0,100,limbic system development,BP,
6864,GO:0021764,1,0.957562255835956,0,5,amygdala development,BP,
6865,GO:0021766,1,0.587017870883777,0,75,hippocampus development,BP,
6866,GO:0021767,1,0.98985831976334,0,1,mammillary body development,BP,
6867,GO:0021768,1,0.992549995236071,0,1,nucleus accumbens development,BP,
6868,GO:0021769,1,0.973155287141507,0,4,orbitofrontal cortex development,BP,
6869,GO:0021771,1,0.991754271587228,0,1,lateral geniculate nucleus development,BP,
6870,GO:0021772,1,0.800077931505894,0,31,olfactory bulb development,BP,
6871,GO:0021773,1,0.96849578755216,0,4,striatal medium spiny neuron differentiation,BP,
6872,GO:0021775,1,0.973931445815664,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6873,GO:0021776,1,0.973931445815664,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6874,GO:0021778,1,0.964267068414871,0,5,oligodendrocyte cell fate specification,BP,
6875,GO:0021779,1,0.964267068414871,0,5,oligodendrocyte cell fate commitment,BP,
6876,GO:0021780,1,0.964267068414871,0,5,glial cell fate specification,BP,
6877,GO:0021781,1,0.913931709179248,0,13,glial cell fate commitment,BP,
6879,GO:0021783,1,0.902849227924238,0,15,preganglionic parasympathetic fiber development,BP,
6880,GO:0021784,1,0.989419914554638,0,2,postganglionic parasympathetic fiber development,BP,
6881,GO:0021785,1,0.949995315554506,0,6,branchiomotor neuron axon guidance,BP,
6882,GO:0021793,1,0.992584827043261,0,1,chemorepulsion of branchiomotor axon,BP,
6883,GO:0021794,1,0.927128970380634,0,12,thalamus development,BP,
6885,GO:0021796,1,0.958186028987905,0,6,cerebral cortex regionalization,BP,
6886,GO:0021797,1,0.983804154816056,0,3,forebrain anterior/posterior pattern specification,BP,
6887,GO:0021798,1,0.955820434488467,0,7,forebrain dorsal/ventral pattern formation,BP,
6888,GO:0021799,1,0.820547117744229,0,27,cerebral cortex radially oriented cell migration,BP,
6889,GO:0021800,1,0.950074454204637,0,6,cerebral cortex tangential migration,BP,
6890,GO:0021801,1,0.861639331802692,0,20,cerebral cortex radial glia guided migration,BP,
6891,GO:0021806,1,0.996146132746367,0,1,initiation of movement involved in cerebral cortex radial glia guided migration,BP,
6892,GO:0021808,1,0.996146132746367,0,1,cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration,BP,
6893,GO:0021812,1,0.985337210838415,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6894,GO:0021813,1,0.993620748008123,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6895,GO:0021814,1,0.96233123277677,0,5,cell motility involved in cerebral cortex radial glia guided migration,BP,
6896,GO:0021815,1,0.973499482727903,0,3,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6897,GO:0021817,1,0.973499482727903,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6898,GO:0021819,1,0.927728669473967,0,10,layer formation in cerebral cortex,BP,
6899,GO:0021823,1,0.983011956006117,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6900,GO:0021825,1,0.983011956006117,0,2,substrate-dependent cerebral cortex tangential migration,BP,
6902,GO:0021827,1,0.983011956006117,0,2,postnatal olfactory bulb interneuron migration,BP,
6903,GO:0021828,1,0.977763987395671,0,3,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6905,GO:0021831,1,0.993079507268143,0,1,embryonic olfactory bulb interneuron precursor migration,BP,
6906,GO:0021836,1,0.983011956006117,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6907,GO:0021840,1,0.986679340662049,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6908,GO:0021842,1,0.986679340662049,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6910,GO:0021846,1,0.815210113868739,0,27,cell proliferation in forebrain,BP,
6911,GO:0021847,1,0.978612629036411,0,3,ventricular zone neuroblast division,BP,
6912,GO:0021849,1,0.976065068620402,0,3,neuroblast division in subventricular zone,BP,
6913,GO:0021852,1,0.977955255467719,0,3,pyramidal neuron migration,BP,
6915,GO:0021854,1,0.897222436938124,0,18,hypothalamus development,BP,
6916,GO:0021855,1,0.977763987395671,0,3,hypothalamus cell migration,BP,
6917,GO:0021856,1,0.977763987395671,0,3,hypothalamic tangential migration using cell-axon interactions,BP,
6918,GO:0021859,1,0.925405732519029,0,10,pyramidal neuron differentiation,BP,
6919,GO:0021860,1,0.933944417386269,0,9,pyramidal neuron development,BP,
6920,GO:0021861,1,0.961460321345273,0,7,forebrain radial glial cell differentiation,BP,
6921,GO:0021869,1,0.959511316848105,0,6,forebrain ventricular zone progenitor cell division,BP,
6922,GO:0021870,1,0.991541223680552,0,1,Cajal-Retzius cell differentiation,BP,
6923,GO:0021871,1,0.873674482997341,0,21,forebrain regionalization,BP,
6924,GO:0021872,1,0.663455755648113,0,60,forebrain generation of neurons,BP,
6925,GO:0021873,1,0.960605805102833,0,5,forebrain neuroblast division,BP,
6926,GO:0021877,1,0.933066158027784,0,10,forebrain neuron fate commitment,BP,
6927,GO:0021879,1,0.707731494542891,0,51,forebrain neuron differentiation,BP,
6928,GO:0021882,1,0.988761406386382,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6929,GO:0021884,1,0.830884288596382,0,26,forebrain neuron development,BP,
6931,GO:0021886,1,0.974515380239104,0,4,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6932,GO:0021888,1,0.974515380239104,0,4,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6933,GO:0021889,1,0.918417203648672,0,12,olfactory bulb interneuron differentiation,BP,
6934,GO:0021891,1,0.947260909782518,0,7,olfactory bulb interneuron development,BP,
6936,GO:0021893,1,0.988761406386382,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6939,GO:0021896,1,0.980289407519017,0,2,forebrain astrocyte differentiation,BP,
6940,GO:0021897,1,0.980289407519017,0,2,forebrain astrocyte development,BP,
6941,GO:0021898,1,0.988761406386382,0,2,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6942,GO:0021902,1,0.948941458359842,0,7,commitment of neuronal cell to specific neuron type in forebrain,BP,
6943,GO:0021903,1,0.940337664694261,0,10,rostrocaudal neural tube patterning,BP,
6944,GO:0021904,1,0.856518552855523,0,23,dorsal/ventral neural tube patterning,BP,
6945,GO:0021905,1,0.991087852267484,0,1,forebrain-midbrain boundary formation,BP,
6946,GO:0021910,1,0.946236846325495,0,7,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6949,GO:0021914,1,0.978916322605935,0,3,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6951,GO:0021917,1,0.991087852267484,0,1,somatic motor neuron fate commitment,BP,
6952,GO:0021918,1,0.991087852267484,0,1,regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment,BP,
6953,GO:0021919,1,0.99253820801319,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
6954,GO:0021920,1,0.996409506317867,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
6955,GO:0021924,1,0.91203641593529,0,14,cell proliferation in external granule layer,BP,
6956,GO:0021930,1,0.91203641593529,0,14,cerebellar granule cell precursor proliferation,BP,
6957,GO:0021932,1,0.928548045446869,0,10,hindbrain radial glia guided cell migration,BP,
6958,GO:0021933,1,0.995887266483741,0,1,radial glia guided migration of cerebellar granule cell,BP,
6959,GO:0021934,1,0.98059013602082,0,2,hindbrain tangential cell migration,BP,
6960,GO:0021935,1,0.98059013602082,0,2,cerebellar granule cell precursor tangential migration,BP,
6961,GO:0021936,1,0.942945664159712,0,9,regulation of cerebellar granule cell precursor proliferation,BP,
6962,GO:0021937,1,0.967530330158851,0,5,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6963,GO:0021938,1,0.972495390436446,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6964,GO:0021940,1,0.954157612790348,0,7,positive regulation of cerebellar granule cell precursor proliferation,BP,
6965,GO:0021941,1,0.988254967717483,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
6966,GO:0021942,1,0.970155408722133,0,4,radial glia guided migration of Purkinje cell,BP,
6967,GO:0021943,1,0.968227805619069,0,4,formation of radial glial scaffolds,BP,
6968,GO:0021944,1,0.992619966211173,0,1,neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration,BP,
6969,GO:0021952,1,0.811148316109986,0,26,central nervous system projection neuron axonogenesis,BP,
6972,GO:0021955,1,0.761662499913625,0,35,central nervous system neuron axonogenesis,BP,
6973,GO:0021956,1,0.995112545938538,0,1,central nervous system interneuron axonogenesis,BP,
6974,GO:0021957,1,0.946524223575619,0,7,corticospinal tract morphogenesis,BP,
6975,GO:0021960,1,0.961370135998507,0,5,anterior commissure morphogenesis,BP,
6976,GO:0021965,1,0.972880003766211,0,3,spinal cord ventral commissure morphogenesis,BP,
6977,GO:0021966,1,0.988590139486689,0,2,corticospinal neuron axon guidance,BP,
6978,GO:0021972,1,0.99215055017653,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6979,GO:0021978,1,0.92854700460509,0,12,telencephalon regionalization,BP,
6980,GO:0021979,1,0.953589684341908,0,7,hypothalamus cell differentiation,BP,
6981,GO:0021983,1,0.780430378377636,0,40,pituitary gland development,BP,
6982,GO:0021984,1,0.943726205248954,0,11,adenohypophysis development,BP,
6983,GO:0021985,1,0.985946443684045,0,2,neurohypophysis development,BP,
6984,GO:0021986,1,0.976305966839789,0,3,habenula development,BP,
6986,GO:0021988,1,0.787703290602672,0,33,olfactory lobe development,BP,
6987,GO:0021989,1,0.991892552361565,0,1,olfactory cortex development,BP,
6988,GO:0021993,1,0.991997837756654,0,1,initiation of neural tube closure,BP,
6989,GO:0021997,1,0.982070226739708,0,2,neural plate axis specification,BP,
6990,GO:0021998,1,0.992518692750008,0,1,neural plate mediolateral regionalization,BP,
6991,GO:0021999,1,0.968116217621739,0,5,neural plate anterior/posterior regionalization,BP,
6992,GO:0022007,1,0.977985369731925,0,3,convergent extension involved in neural plate elongation,BP,
6994,GO:0022009,1,0.973825243549847,0,4,central nervous system vasculogenesis,BP,
6997,GO:0022012,1,0.990363148962319,0,1,subpallium cell proliferation in forebrain,BP,
6998,GO:0022013,1,0.990178593332939,0,1,pallium cell proliferation in forebrain,BP,
6999,GO:0022018,1,0.990363148962319,0,1,lateral ganglionic eminence cell proliferation,BP,
7000,GO:0022027,1,0.951576482620938,0,5,interkinetic nuclear migration,BP,
7001,GO:0022028,1,0.958917062615058,0,5,tangential migration from the subventricular zone to the olfactory bulb,BP,
7003,GO:0022030,1,0.861639331802692,0,20,telencephalon glial cell migration,BP,
7005,GO:0022038,1,0.866052816789369,0,20,corpus callosum development,BP,
7006,GO:0022400,1,0.861514049128863,0,23,regulation of rhodopsin mediated signaling pathway,BP,
7007,GO:0022401,1,0.909835485480694,0,17,negative adaptation of signaling pathway,BP,
7009,GO:0022403,1,0.984671710184872,0,2,cell cycle phase,BP,
7016,GO:0022410,1,0.881413111543352,0,23,circadian sleep/wake cycle process,BP,
7018,GO:0022412,1,0.159783951482407,0,280,cellular process involved in reproduction in multicellular organism,BP,
7019,GO:0022413,1,0.989303662582116,0,1,reproductive process in single-celled organism,BP,
7021,GO:0022417,1,0.970567062431704,0,7,protein maturation by protein folding,BP,
7022,GO:0022600,1,0.604012208518499,0,81,digestive system process,BP,
7026,GO:0022605,1,0.965138726032806,0,6,mammalian oogenesis stage,BP,
7030,GO:0022613,1,0.0923845320853019,0,404,ribonucleoprotein complex biogenesis,BP,
7031,GO:0022614,1,0.962623531147705,0,5,membrane to membrane docking,BP,
7032,GO:0022615,1,0.980195021751626,0,4,protein to membrane docking,BP,
7033,GO:0022616,1,0.844000555531491,0,25,DNA strand elongation,BP,
7035,GO:0022618,1,0.349663178769561,0,178,ribonucleoprotein complex assembly,BP,
7036,GO:0022624,1,0.895437323773018,0,24,proteasome accessory complex,CC,
7037,GO:0022625,1,0.821564835446602,0,54,cytosolic large ribosomal subunit,CC,
7042,GO:0022821,1,0.902245551913959,0,14,potassium ion antiporter activity,MF,
7043,GO:0022824,1,0.680830850905393,0,54,transmitter-gated ion channel activity,MF,
7047,GO:0022835,1,0.680830850905393,0,54,transmitter-gated channel activity,MF,
7049,GO:0022839,1,0.765947226319965,0,39,ion gated channel activity,MF,
7050,GO:0022840,1,0.910894778101216,0,16,leak channel activity,MF,
7051,GO:0022841,1,0.925368268649316,0,14,potassium ion leak channel activity,MF,
7052,GO:0022842,1,0.910894778101216,0,16,narrow pore channel activity,MF,
7054,GO:0022848,1,0.919513431327716,0,14,acetylcholine-gated cation-selective channel activity,MF,
7055,GO:0022849,1,0.956600237307614,0,5,glutamate-gated calcium ion channel activity,MF,
7056,GO:0022850,1,0.990051120128626,0,2,serotonin-gated cation-selective channel activity,MF,
7057,GO:0022851,1,0.913419412438315,0,12,GABA-gated chloride ion channel activity,MF,
7058,GO:0022852,1,0.985203113467987,0,2,glycine-gated chloride ion channel activity,MF,
7061,GO:0022858,1,0.94017873488343,0,9,alanine transmembrane transporter activity,MF,
7062,GO:0022884,1,0.893329603196253,0,19,macromolecule transmembrane transporter activity,MF,
7063,GO:0022889,1,0.944243333392065,0,9,serine transmembrane transporter activity,MF,
7065,GO:0022894,1,0.994487462707336,0,1,Intermediate conductance calcium-activated potassium channel activity,MF,
7070,GO:0023016,1,0.974461012630182,0,3,signal transduction by trans-phosphorylation,BP,
7072,GO:0023021,1,0.981669497363617,0,3,termination of signal transduction,BP,
7073,GO:0023023,1,0.882120969187218,0,24,MHC protein complex binding,MF,
7074,GO:0023024,1,0.970363379337241,0,6,MHC class I protein complex binding,MF,
7075,GO:0023025,1,0.978941907379416,0,3,MHC class Ib protein complex binding,MF,
7076,GO:0023026,1,0.921884465459868,0,16,MHC class II protein complex binding,MF,
7077,GO:0023029,1,0.956451706671534,0,7,MHC class Ib protein binding,MF,
7078,GO:0023030,1,0.992709890636222,0,1,MHC class Ib protein binding, via antigen binding groove,MF,
7079,GO:0023035,1,0.917071461880466,0,15,CD40 signaling pathway,BP,
7080,GO:0023041,1,0.96193555703059,0,6,neuronal signal transduction,BP,
7085,GO:0023058,1,0.909835485480694,0,17,adaptation of signaling pathway,BP,
7088,GO:0030002,1,0.931913929472898,0,10,cellular anion homeostasis,BP,
7090,GO:0030004,1,0.502731252899958,0,106,cellular monovalent inorganic cation homeostasis,BP,
7091,GO:0030007,1,0.906856672498598,0,14,cellular potassium ion homeostasis,BP,
7092,GO:0030008,1,0.924959339137602,0,14,TRAPP complex,CC,
7094,GO:0030011,1,0.883927148695899,0,18,maintenance of cell polarity,BP,
7095,GO:0030014,1,0.898188254989024,0,15,CCR4-NOT complex,CC,
7096,GO:0030015,1,0.965599078852626,0,5,CCR4-NOT core complex,CC,
7102,GO:0030023,1,0.926526634212019,0,9,extracellular matrix constituent conferring elasticity,MF,
7103,GO:0030026,1,0.992681400907057,0,1,cellular manganese ion homeostasis,BP,
7104,GO:0030027,1,0.256716372747717,0,189,lamellipodium,CC,
7108,GO:0030032,1,0.661292236955849,0,59,lamellipodium assembly,BP,
7109,GO:0030033,1,0.881640738251666,0,17,microvillus assembly,BP,
7110,GO:0030034,1,0.992539036042161,0,1,microvillar actin bundle assembly,BP,
7111,GO:0030035,1,0.969854120134202,0,4,microspike assembly,BP,
7113,GO:0030037,1,0.992153911192342,0,1,actin filament reorganization involved in cell cycle,BP,
7114,GO:0030038,1,0.494245380142522,0,99,contractile actin filament bundle assembly,BP,
7116,GO:0030042,1,0.682504938134816,0,52,actin filament depolymerization,BP,
7117,GO:0030043,1,0.978185326266411,0,4,actin filament fragmentation,BP,
7118,GO:0030046,1,0.952782140698126,0,7,parallel actin filament bundle assembly,BP,
7119,GO:0030047,1,0.972578628263204,0,4,actin modification,BP,
7121,GO:0030049,1,0.795132850174387,0,35,muscle filament sliding,BP,
7125,GO:0030056,1,0.949338811862496,0,5,hemidesmosome,CC,
7127,GO:0030060,1,0.982216338845487,0,4,L-malate dehydrogenase activity,MF,
7128,GO:0030061,1,0.954591587968872,0,7,mitochondrial crista,CC,
7129,GO:0030062,1,0.964020865922093,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7130,GO:0030070,1,0.986306008621892,0,2,insulin processing,BP,
7131,GO:0030071,1,0.699110731082961,0,55,regulation of mitotic metaphase/anaphase transition,BP,
7134,GO:0030091,1,0.966480161928725,0,7,protein repair,BP,
7139,GO:0030101,1,0.706456102715574,0,59,natural killer cell activation,BP,
7140,GO:0030103,1,0.989599700145221,0,2,vasopressin secretion,BP,
7142,GO:0030107,1,0.993092034082734,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7143,GO:0030108,1,0.996162311800852,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7144,GO:0030109,1,0.988463798013981,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7146,GO:0030116,1,0.985917273677386,0,4,glial cell-derived neurotrophic factor receptor binding,MF,
7147,GO:0030117,1,0.553344415300369,0,89,membrane coat,CC,
7148,GO:0030118,1,0.742449242502316,0,43,clathrin coat,CC,
7149,GO:0030119,1,0.778128048854248,0,37,AP-type membrane coat adaptor complex,CC,
7150,GO:0030120,1,0.709140495128061,0,52,vesicle coat,CC,
7151,GO:0030121,1,0.967479077453835,0,5,AP-1 adaptor complex,CC,
7152,GO:0030122,1,0.932945476069991,0,10,AP-2 adaptor complex,CC,
7153,GO:0030123,1,0.937446775949383,0,9,AP-3 adaptor complex,CC,
7154,GO:0030124,1,0.976785955826616,0,4,AP-4 adaptor complex,CC,
7155,GO:0030125,1,0.838706072259673,0,26,clathrin vesicle coat,CC,
7156,GO:0030126,1,0.9316947742484,0,12,COPI vesicle coat,CC,
7157,GO:0030127,1,0.900989798666386,0,15,COPII vesicle coat,CC,
7158,GO:0030128,1,0.925746367796545,0,11,clathrin coat of endocytic vesicle,CC,
7159,GO:0030130,1,0.929564626576899,0,11,clathrin coat of trans-Golgi network vesicle,CC,
7160,GO:0030131,1,0.862239994216265,0,22,clathrin adaptor complex,CC,
7161,GO:0030132,1,0.902899944202309,0,15,clathrin coat of coated pit,CC,
7163,GO:0030134,1,0.587816840756969,0,88,COPII-coated ER to Golgi transport vesicle,CC,
7166,GO:0030137,1,0.860432168301118,0,26,COPI-coated vesicle,CC,
7168,GO:0030140,1,0.823853226787307,0,29,trans-Golgi network transport vesicle,CC,
7170,GO:0030142,1,0.989534410494498,0,1,COPI-coated Golgi to ER transport vesicle,CC,
7171,GO:0030144,1,0.986489649744972,0,2,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7172,GO:0030145,1,0.669676880749096,0,60,manganese ion binding,MF,
7175,GO:0030150,1,0.914867697636574,0,17,protein import into mitochondrial matrix,BP,
7176,GO:0030151,1,0.987605299130583,0,2,molybdenum ion binding,MF,
7179,GO:0030156,1,0.996791685097646,0,1,benzodiazepine receptor binding,MF,
7180,GO:0030157,1,0.933777613214137,0,11,pancreatic juice secretion,BP,
7181,GO:0030158,1,0.982377519132171,0,2,protein xylosyltransferase activity,MF,
7182,GO:0030159,1,0.752762493264721,0,41,signaling receptor complex adaptor activity,MF,
7183,GO:0030160,1,0.967538464195185,0,4,synaptic receptor adaptor activity,MF,
7188,GO:0030167,1,0.973820824556506,0,4,proteoglycan catabolic process,BP,
7190,GO:0030169,1,0.906956995901972,0,14,low-density lipoprotein particle binding,MF,
7191,GO:0030170,1,0.764850069311831,0,44,pyridoxal phosphate binding,MF,
7192,GO:0030171,1,0.995728274300575,0,1,voltage-gated proton channel activity,MF,
7193,GO:0030172,1,0.989828745829451,0,3,troponin C binding,MF,
7194,GO:0030173,1,0.68733042785946,0,58,integral component of Golgi membrane,CC,
7195,GO:0030174,1,0.957132788690694,0,7,regulation of DNA-dependent DNA replication initiation,BP,
7197,GO:0030176,1,0.415054920050549,0,146,integral component of endoplasmic reticulum membrane,CC,
7201,GO:0030183,1,0.475886496169494,0,111,B cell differentiation,BP,
7202,GO:0030184,1,0.993285028471028,0,1,nitric oxide transmembrane transporter activity,MF,
7203,GO:0030185,1,0.985044944814586,0,3,nitric oxide transport,BP,
7204,GO:0030186,1,0.9961703117629,0,1,melatonin metabolic process,BP,
7205,GO:0030187,1,0.9961703117629,0,1,melatonin biosynthetic process,BP,
7207,GO:0030194,1,0.852463962345385,0,25,positive regulation of blood coagulation,BP,
7209,GO:0030197,1,0.985683464173924,0,2,extracellular matrix constituent, lubricant activity,MF,
7212,GO:0030200,1,0.981522455484685,0,3,heparan sulfate proteoglycan catabolic process,BP,
7213,GO:0030201,1,0.788177592760916,0,32,heparan sulfate proteoglycan metabolic process,BP,
7214,GO:0030202,1,0.926989402340061,0,10,heparin metabolic process,BP,
7217,GO:0030205,1,0.912084519290258,0,13,dermatan sulfate metabolic process,BP,
7218,GO:0030206,1,0.82732524035933,0,26,chondroitin sulfate biosynthetic process,BP,
7219,GO:0030207,1,0.910677940623511,0,14,chondroitin sulfate catabolic process,BP,
7220,GO:0030208,1,0.917029684503966,0,12,dermatan sulfate biosynthetic process,BP,
7221,GO:0030209,1,0.9946121621616,0,1,dermatan sulfate catabolic process,BP,
7222,GO:0030210,1,0.932014544843427,0,9,heparin biosynthetic process,BP,
7223,GO:0030211,1,0.9946121621616,0,1,heparin catabolic process,BP,
7224,GO:0030212,1,0.792122476975571,0,35,hyaluronan metabolic process,BP,
7225,GO:0030213,1,0.909013234462627,0,14,hyaluronan biosynthetic process,BP,
7226,GO:0030214,1,0.915398681187286,0,14,hyaluronan catabolic process,BP,
7227,GO:0030215,1,0.835756569054793,0,23,semaphorin receptor binding,MF,
7230,GO:0030218,1,0.47419797806871,0,113,erythrocyte differentiation,BP,
7231,GO:0030219,1,0.618521270750721,0,69,megakaryocyte differentiation,BP,
7232,GO:0030220,1,0.866756308010741,0,20,platelet formation,BP,
7233,GO:0030221,1,0.988328453803715,0,2,basophil differentiation,BP,
7234,GO:0030222,1,0.981385370332542,0,3,eosinophil differentiation,BP,
7235,GO:0030223,1,0.94845441761416,0,8,neutrophil differentiation,BP,
7236,GO:0030224,1,0.79654495035838,0,34,monocyte differentiation,BP,
7237,GO:0030225,1,0.777736200063976,0,41,macrophage differentiation,BP,
7238,GO:0030226,1,0.967721530512539,0,3,apolipoprotein receptor activity,MF,
7239,GO:0030228,1,0.888629869994639,0,15,lipoprotein particle receptor activity,MF,
7240,GO:0030229,1,0.97053453112596,0,4,very-low-density lipoprotein particle receptor activity,MF,
7241,GO:0030233,1,0.995885454443387,0,1,deoxynucleotide transmembrane transporter activity,MF,
7244,GO:0030237,1,0.985551555158017,0,2,female sex determination,BP,
7245,GO:0030238,1,0.911425624112853,0,14,male sex determination,BP,
7247,GO:0030240,1,0.948741404019157,0,6,skeletal muscle thin filament assembly,BP,
7248,GO:0030241,1,0.965195875799947,0,3,skeletal muscle myosin thick filament assembly,BP,
7249,GO:0030242,1,0.962441809586184,0,5,autophagy of peroxisome,BP,
7252,GO:0030249,1,0.980773681555954,0,4,guanylate cyclase regulator activity,MF,
7253,GO:0030250,1,0.986342098317533,0,3,guanylate cyclase activator activity,MF,
7254,GO:0030251,1,0.99435526848047,0,1,guanylate cyclase inhibitor activity,MF,
7255,GO:0030252,1,0.911807746327275,0,14,growth hormone secretion,BP,
7257,GO:0030259,1,0.940998934327469,0,10,lipid glycosylation,BP,
7258,GO:0030261,1,0.816677804460833,0,27,chromosome condensation,BP,
7259,GO:0030262,1,0.821714962192733,0,32,apoptotic nuclear changes,BP,
7260,GO:0030263,1,0.970425066564681,0,4,apoptotic chromosome condensation,BP,
7261,GO:0030264,1,0.99325505912211,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7262,GO:0030267,1,0.996454349417187,0,1,glyoxylate reductase (NADP) activity,MF,
7263,GO:0030272,1,0.996727318235424,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7264,GO:0030273,1,0.994034126100645,0,1,melanin-concentrating hormone receptor activity,MF,
7265,GO:0030274,1,0.958689538960811,0,6,LIM domain binding,MF,
7266,GO:0030275,1,0.915915008696961,0,14,LRR domain binding,MF,
7267,GO:0030276,1,0.631818377135845,0,64,clathrin binding,MF,
7268,GO:0030277,1,0.910603375679266,0,15,maintenance of gastrointestinal epithelium,BP,
7271,GO:0030280,1,0.96598713692372,0,5,structural constituent of skin epidermis,MF,
7273,GO:0030283,1,0.977853329859854,0,6,testosterone dehydrogenase [NAD(P)] activity,MF,
7274,GO:0030284,1,0.964305964712324,0,5,estrogen receptor activity,MF,
7275,GO:0030285,1,0.805950741117261,0,33,integral component of synaptic vesicle membrane,CC,
7277,GO:0030289,1,0.985073889317562,0,3,protein phosphatase 4 complex,CC,
7278,GO:0030290,1,0.9925282093816,0,1,sphingolipid activator protein activity,MF,
7279,GO:0030291,1,0.851847108329472,0,28,protein serine/threonine kinase inhibitor activity,MF,
7280,GO:0030292,1,0.986326357593663,0,2,protein tyrosine kinase inhibitor activity,MF,
7281,GO:0030294,1,0.994574497613248,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7285,GO:0030299,1,0.940643219985921,0,10,intestinal cholesterol absorption,BP,
7286,GO:0030300,1,0.977260454610038,0,4,regulation of intestinal cholesterol absorption,BP,
7287,GO:0030301,1,0.612631819283046,0,75,cholesterol transport,BP,
7288,GO:0030302,1,0.995885454443387,0,1,deoxynucleotide transport,BP,
7289,GO:0030305,1,0.988101250983053,0,2,heparanase activity,MF,
7290,GO:0030306,1,0.945563876137578,0,7,ADP-ribosylation factor binding,MF,
7293,GO:0030309,1,0.931000162911205,0,11,poly-N-acetyllactosamine metabolic process,BP,
7294,GO:0030311,1,0.93791778059407,0,10,poly-N-acetyllactosamine biosynthetic process,BP,
7295,GO:0030312,1,0.98597837200999,0,3,external encapsulating structure,CC,
7296,GO:0030314,1,0.943730037567844,0,7,junctional membrane complex,CC,
7299,GO:0030317,1,0.625994959536727,0,73,flagellated sperm motility,BP,
7301,GO:0030320,1,0.931913929472898,0,10,cellular monovalent inorganic anion homeostasis,BP,
7302,GO:0030321,1,0.969770392159925,0,5,transepithelial chloride transport,BP,
7303,GO:0030322,1,0.921358879050629,0,15,stabilization of membrane potential,BP,
7308,GO:0030327,1,0.978551751933441,0,3,prenylated protein catabolic process,BP,
7309,GO:0030328,1,0.985708219171999,0,2,prenylcysteine catabolic process,BP,
7310,GO:0030329,1,0.985708219171999,0,2,prenylcysteine metabolic process,BP,
7311,GO:0030330,1,0.514363721280755,0,102,DNA damage response, signal transduction by p53 class mediator,BP,
7312,GO:0030331,1,0.763895646242918,0,38,estrogen receptor binding,MF,
7313,GO:0030332,1,0.834769074196639,0,29,cyclin binding,MF,
7317,GO:0030337,1,0.985636919520619,0,3,DNA polymerase processivity factor activity,MF,
7318,GO:0030342,1,0.992727863072114,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7319,GO:0030343,1,0.990305623404685,0,2,vitamin D3 25-hydroxylase activity,MF,
7320,GO:0030345,1,0.992813789089444,0,1,structural constituent of tooth enamel,MF,
7321,GO:0030346,1,0.954215134000265,0,7,protein phosphatase 2B binding,MF,
7322,GO:0030348,1,0.980163774236828,0,3,syntaxin-3 binding,MF,
7323,GO:0030350,1,0.983971121473357,0,2,iron-responsive element binding,MF,
7324,GO:0030351,1,0.99311926768676,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7325,GO:0030354,1,0.996785678365679,0,1,melanin-concentrating hormone activity,MF,
7326,GO:0030366,1,0.996233554043952,0,1,molybdopterin synthase activity,MF,
7327,GO:0030368,1,0.94426612403794,0,8,interleukin-17 receptor activity,MF,
7328,GO:0030369,1,0.985115233075904,0,2,ICAM-3 receptor activity,MF,
7329,GO:0030371,1,0.838548749629823,0,25,translation repressor activity,MF,
7330,GO:0030374,1,0.673914670117367,0,54,nuclear receptor transcription coactivator activity,MF,
7331,GO:0030375,1,0.967608137331127,0,4,thyroid hormone receptor coactivator activity,MF,
7332,GO:0030377,1,0.99621290776435,0,1,urokinase plasminogen activator receptor activity,MF,
7333,GO:0030378,1,0.993883677960989,0,1,serine racemase activity,MF,
7334,GO:0030379,1,0.991011763221477,0,1,neurotensin receptor activity, non-G protein-coupled,MF,
7335,GO:0030382,1,0.989067320604531,0,1,sperm mitochondrion organization,BP,
7336,GO:0030387,1,0.996219837746443,0,1,fructosamine-3-kinase activity,MF,
7337,GO:0030388,1,0.961593385948248,0,7,fructose 1,6-bisphosphate metabolic process,BP,
7338,GO:0030389,1,0.993042205150471,0,2,fructosamine metabolic process,BP,
7339,GO:0030393,1,0.996219837746443,0,1,fructoselysine metabolic process,BP,
7340,GO:0030395,1,0.992558009841644,0,2,lactose binding,MF,
7341,GO:0030397,1,0.901004214550855,0,16,membrane disassembly,BP,
7342,GO:0030407,1,0.995351642309626,0,1,formimidoyltransferase activity,MF,
7343,GO:0030409,1,0.995351642309626,0,1,glutamate formimidoyltransferase activity,MF,
7344,GO:0030412,1,0.995351642309626,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7346,GO:0030421,1,0.996719850943217,0,1,defecation,BP,
7347,GO:0030422,1,0.936846100595444,0,10,production of siRNA involved in RNA interference,BP,
7348,GO:0030423,1,0.973729360366337,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
7353,GO:0030429,1,0.996144650033514,0,1,kynureninase activity,MF,
7354,GO:0030430,1,0.964386410474859,0,6,host cell cytoplasm,CC,
7355,GO:0030431,1,0.833987993703271,0,30,sleep,BP,
7356,GO:0030432,1,0.95084467831268,0,9,peristalsis,BP,
7357,GO:0030433,1,0.631896374897671,0,71,ubiquitin-dependent ERAD pathway,BP,
7358,GO:0030449,1,0.780247139656115,0,41,regulation of complement activation,BP,
7359,GO:0030450,1,0.979352114136606,0,3,regulation of complement activation, classical pathway,BP,
7360,GO:0030451,1,0.980597072370133,0,3,regulation of complement activation, alternative pathway,BP,
7361,GO:0030473,1,0.958508843088561,0,5,nuclear migration along microtubule,BP,
7362,GO:0030478,1,0.970850646893363,0,4,actin cap,CC,
7363,GO:0030485,1,0.984400195651888,0,3,smooth muscle contractile fiber,CC,
7364,GO:0030488,1,0.790614586908769,0,37,tRNA methylation,BP,
7365,GO:0030490,1,0.760353566515698,0,46,maturation of SSU-rRNA,BP,
7366,GO:0030492,1,0.969480934929816,0,8,hemoglobin binding,MF,
7368,GO:0030497,1,0.924294086706389,0,12,fatty acid elongation,BP,
7370,GO:0030501,1,0.771530624755761,0,37,positive regulation of bone mineralization,BP,
7372,GO:0030504,1,0.990367979936499,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7373,GO:0030505,1,0.981232336726472,0,2,inorganic diphosphate transport,BP,
7374,GO:0030506,1,0.85335647463991,0,18,ankyrin binding,MF,
7378,GO:0030511,1,0.816274367369567,0,29,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7379,GO:0030512,1,0.581433948773113,0,77,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
7380,GO:0030513,1,0.796961357708902,0,31,positive regulation of BMP signaling pathway,BP,
7382,GO:0030515,1,0.837040278496614,0,30,snoRNA binding,MF,
7385,GO:0030518,1,0.477985507057506,0,106,intracellular steroid hormone receptor signaling pathway,BP,
7386,GO:0030519,1,0.992475477155422,0,1,snoRNP binding,MF,
7387,GO:0030520,1,0.702185289306993,0,52,intracellular estrogen receptor signaling pathway,BP,
7388,GO:0030521,1,0.763153389445589,0,38,androgen receptor signaling pathway,BP,
7389,GO:0030522,1,0.191972642809191,0,240,intracellular receptor signaling pathway,BP,
7390,GO:0030523,1,0.992396385942744,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7391,GO:0030526,1,0.992210598821725,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7392,GO:0030527,1,0.995165549029046,0,1,structural constituent of chromatin,MF,
7393,GO:0030532,1,0.714978936943638,0,61,small nuclear ribonucleoprotein complex,CC,
7395,GO:0030538,1,0.982507357554716,0,3,embryonic genitalia morphogenesis,BP,
7398,GO:0030544,1,0.781257352545417,0,39,Hsp70 protein binding,MF,
7401,GO:0030547,1,0.87803989153353,0,23,receptor inhibitor activity,MF,
7402,GO:0030548,1,0.958485535573494,0,9,acetylcholine receptor regulator activity,MF,
7403,GO:0030549,1,0.996540270077804,0,1,acetylcholine receptor activator activity,MF,
7404,GO:0030550,1,0.969593697170571,0,6,acetylcholine receptor inhibitor activity,MF,
7407,GO:0030553,1,0.915689295418244,0,12,cGMP binding,MF,
7409,GO:0030572,1,0.992491251317947,0,1,phosphatidyltransferase activity,MF,
7410,GO:0030573,1,0.995137264487481,0,1,bile acid catabolic process,BP,
7412,GO:0030575,1,0.894004153682325,0,15,nuclear body organization,BP,
7413,GO:0030576,1,0.976261690154612,0,4,Cajal body organization,BP,
7414,GO:0030578,1,0.953699557025317,0,6,PML body organization,BP,
7415,GO:0030579,1,0.968010781153224,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
7416,GO:0030580,1,0.992548859258005,0,2,quinone cofactor methyltransferase activity,MF,
7417,GO:0030581,1,0.992273837845881,0,2,symbiont intracellular protein transport in host,BP,
7418,GO:0030586,1,0.9926432603516,0,1,[methionine synthase] reductase activity,MF,
7419,GO:0030592,1,0.982153524129887,0,3,DNA ADP-ribosylation,BP,
7420,GO:0030593,1,0.64070410680112,0,84,neutrophil chemotaxis,BP,
7421,GO:0030594,1,0.544963060833495,0,91,neurotransmitter receptor activity,MF,
7423,GO:0030611,1,0.996712148007702,0,1,arsenate reductase activity,MF,
7424,GO:0030613,1,0.989653637637035,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7425,GO:0030614,1,0.989653637637035,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7426,GO:0030619,1,0.961315236077847,0,7,U1 snRNA binding,MF,
7427,GO:0030620,1,0.977848241558051,0,4,U2 snRNA binding,MF,
7428,GO:0030621,1,0.965950499748789,0,5,U4 snRNA binding,MF,
7429,GO:0030622,1,0.986578567631015,0,2,U4atac snRNA binding,MF,
7430,GO:0030623,1,0.983362894669064,0,2,U5 snRNA binding,MF,
7431,GO:0030624,1,0.992387446489806,0,1,U6atac snRNA binding,MF,
7432,GO:0030626,1,0.987888118531474,0,2,U12 snRNA binding,MF,
7433,GO:0030627,1,0.996498191030085,0,1,pre-mRNA 5'-splice site binding,MF,
7434,GO:0030628,1,0.975107901989679,0,5,pre-mRNA 3'-splice site binding,MF,
7435,GO:0030629,1,0.990082966402078,0,2,U6 snRNA 3'-end binding,MF,
7436,GO:0030638,1,0.963254799273274,0,9,polyketide metabolic process,BP,
7437,GO:0030641,1,0.577398310805718,0,87,regulation of cellular pH,BP,
7438,GO:0030643,1,0.963873349342407,0,5,cellular phosphate ion homeostasis,BP,
7439,GO:0030644,1,0.966854951915581,0,5,cellular chloride ion homeostasis,BP,
7440,GO:0030647,1,0.963254799273274,0,9,aminoglycoside antibiotic metabolic process,BP,
7441,GO:0030653,1,0.992103373225629,0,1,beta-lactam antibiotic metabolic process,BP,
7442,GO:0030656,1,0.933891681841822,0,12,regulation of vitamin metabolic process,BP,
7443,GO:0030658,1,0.281619206103612,0,194,transport vesicle membrane,CC,
7447,GO:0030663,1,0.910203575784757,0,17,COPI-coated vesicle membrane,CC,
7449,GO:0030666,1,0.384721457983041,0,152,endocytic vesicle membrane,CC,
7450,GO:0030667,1,0.15635842710973,0,280,secretory granule membrane,CC,
7451,GO:0030669,1,0.799998638535222,0,37,clathrin-coated endocytic vesicle membrane,CC,
7452,GO:0030670,1,0.651356422089404,0,71,phagocytic vesicle membrane,CC,
7453,GO:0030672,1,0.517573484901759,0,100,synaptic vesicle membrane,CC,
7456,GO:0030676,1,0.859312528316497,0,19,Rac guanyl-nucleotide exchange factor activity,MF,
7457,GO:0030677,1,0.940504058113437,0,12,ribonuclease P complex,CC,
7458,GO:0030678,1,0.989965671653508,0,2,mitochondrial ribonuclease P complex,CC,
7459,GO:0030681,1,0.950042061826249,0,10,multimeric ribonuclease P complex,CC,
7460,GO:0030682,1,0.976412583790958,0,3,mitigation of host defenses by symbiont,BP,
7461,GO:0030683,1,0.985459612099375,0,2,mitigation of host immune response by virus,BP,
7462,GO:0030684,1,0.647503260629627,0,70,preribosome,CC,
7463,GO:0030686,1,0.848375439023282,0,25,90S preribosome,CC,
7464,GO:0030687,1,0.878081249082657,0,22,preribosome, large subunit precursor,CC,
7465,GO:0030688,1,0.908213562455872,0,15,preribosome, small subunit precursor,CC,
7466,GO:0030689,1,0.982161461503361,0,3,Noc complex,CC,
7467,GO:0030690,1,0.993176286450873,0,1,Noc1p-Noc2p complex,CC,
7468,GO:0030691,1,0.993176286450873,0,1,Noc2p-Noc3p complex,CC,
7469,GO:0030692,1,0.988910267398557,0,2,Noc4p-Nop14p complex,CC,
7470,GO:0030695,1,0.122553876307273,0,284,GTPase regulator activity,MF,
7471,GO:0030696,1,0.992737017186717,0,1,tRNA (m5U54) methyltransferase activity,MF,
7472,GO:0030697,1,0.992737017186717,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7473,GO:0030704,1,0.994934185789107,0,1,vitelline membrane formation,BP,
7475,GO:0030718,1,0.988550373750721,0,2,germ-line stem cell population maintenance,BP,
7476,GO:0030719,1,0.986254824961516,0,2,P granule organization,BP,
7477,GO:0030728,1,0.867727327968064,0,21,ovulation,BP,
7478,GO:0030729,1,0.992619431459416,0,1,acetoacetate-CoA ligase activity,MF,
7479,GO:0030730,1,0.904720335044197,0,17,sequestering of triglyceride,BP,
7480,GO:0030731,1,0.996652689122684,0,1,guanidinoacetate N-methyltransferase activity,MF,
7482,GO:0030748,1,0.993700757557992,0,1,amine N-methyltransferase activity,MF,
7483,GO:0030760,1,0.996003740405974,0,1,pyridine N-methyltransferase activity,MF,
7484,GO:0030791,1,0.993908042615335,0,1,arsenite methyltransferase activity,MF,
7485,GO:0030792,1,0.986178671482752,0,2,methylarsonite methyltransferase activity,MF,
7486,GO:0030808,1,0.806387574612926,0,34,regulation of nucleotide biosynthetic process,BP,
7487,GO:0030809,1,0.962797151846499,0,6,negative regulation of nucleotide biosynthetic process,BP,
7488,GO:0030810,1,0.903342726882326,0,17,positive regulation of nucleotide biosynthetic process,BP,
7491,GO:0030834,1,0.704935591926598,0,48,regulation of actin filament depolymerization,BP,
7492,GO:0030835,1,0.753541180942403,0,38,negative regulation of actin filament depolymerization,BP,
7493,GO:0030836,1,0.93535565845677,0,10,positive regulation of actin filament depolymerization,BP,
7495,GO:0030838,1,0.572174775475248,0,88,positive regulation of actin filament polymerization,BP,
7496,GO:0030842,1,0.991846469653628,0,1,regulation of intermediate filament depolymerization,BP,
7497,GO:0030844,1,0.991846469653628,0,1,positive regulation of intermediate filament depolymerization,BP,
7498,GO:0030845,1,0.993106347255175,0,1,phospholipase C-inhibiting G protein-coupled receptor signaling pathway,BP,
7499,GO:0030846,1,0.975613085768278,0,3,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7500,GO:0030849,1,0.987808701515933,0,2,autosome,CC,
7501,GO:0030850,1,0.716269576829011,0,47,prostate gland development,BP,
7502,GO:0030851,1,0.831718545114341,0,30,granulocyte differentiation,BP,
7503,GO:0030852,1,0.921754426312748,0,13,regulation of granulocyte differentiation,BP,
7504,GO:0030853,1,0.95230404462344,0,7,negative regulation of granulocyte differentiation,BP,
7505,GO:0030854,1,0.960691243322912,0,7,positive regulation of granulocyte differentiation,BP,
7507,GO:0030856,1,0.408797810108094,0,132,regulation of epithelial cell differentiation,BP,
7508,GO:0030857,1,0.765969011169147,0,41,negative regulation of epithelial cell differentiation,BP,
7509,GO:0030858,1,0.706124187361776,0,52,positive regulation of epithelial cell differentiation,BP,
7510,GO:0030859,1,0.855915045443604,0,22,polarized epithelial cell differentiation,BP,
7511,GO:0030860,1,0.98574012646884,0,2,regulation of polarized epithelial cell differentiation,BP,
7512,GO:0030862,1,0.991847881963631,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7517,GO:0030867,1,0.859265382608063,0,27,rough endoplasmic reticulum membrane,CC,
7518,GO:0030868,1,0.973387533228388,0,5,smooth endoplasmic reticulum membrane,CC,
7519,GO:0030870,1,0.96466218247621,0,5,Mre11 complex,CC,
7520,GO:0030874,1,0.995745180872483,0,1,nucleolar chromatin,CC,
7521,GO:0030877,1,0.911105795220294,0,12,beta-catenin destruction complex,CC,
7522,GO:0030878,1,0.879513013358931,0,21,thyroid gland development,BP,
7523,GO:0030879,1,0.400396417687647,0,129,mammary gland development,BP,
7524,GO:0030880,1,0.550841137798677,0,99,RNA polymerase complex,CC,
7525,GO:0030881,1,0.968509978822884,0,7,beta-2-microglobulin binding,MF,
7526,GO:0030882,1,0.969813524492669,0,5,lipid antigen binding,MF,
7527,GO:0030883,1,0.976516646160687,0,4,endogenous lipid antigen binding,MF,
7528,GO:0030884,1,0.976516646160687,0,4,exogenous lipid antigen binding,MF,
7529,GO:0030885,1,0.97472769300274,0,6,regulation of myeloid dendritic cell activation,BP,
7530,GO:0030886,1,0.986542334052009,0,3,negative regulation of myeloid dendritic cell activation,BP,
7531,GO:0030887,1,0.991367605150359,0,2,positive regulation of myeloid dendritic cell activation,BP,
7532,GO:0030888,1,0.705915512883924,0,57,regulation of B cell proliferation,BP,
7533,GO:0030889,1,0.900649814409427,0,17,negative regulation of B cell proliferation,BP,
7534,GO:0030890,1,0.806626944375828,0,36,positive regulation of B cell proliferation,BP,
7535,GO:0030891,1,0.982392077063948,0,3,VCB complex,CC,
7536,GO:0030892,1,0.982487284412246,0,3,mitotic cohesin complex,CC,
7537,GO:0030893,1,0.950314596691345,0,7,meiotic cohesin complex,CC,
7538,GO:0030894,1,0.861389157815117,0,25,replisome,CC,
7539,GO:0030895,1,0.988857323071995,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
7540,GO:0030896,1,0.977398391558683,0,4,checkpoint clamp complex,CC,
7541,GO:0030897,1,0.912246742560507,0,12,HOPS complex,CC,
7543,GO:0030899,1,0.9813790588263,0,3,calcium-dependent ATPase activity,MF,
7547,GO:0030903,1,0.885775590689387,0,18,notochord development,BP,
7548,GO:0030904,1,0.87525386316848,0,20,retromer complex,CC,
7549,GO:0030905,1,0.973302294591977,0,4,retromer, tubulation complex,CC,
7550,GO:0030906,1,0.97549493374045,0,4,retromer, cargo-selective complex,CC,
7551,GO:0030908,1,0.99096127715952,0,2,protein splicing,BP,
7552,GO:0030910,1,0.977882774381294,0,3,olfactory placode formation,BP,
7553,GO:0030911,1,0.944199409535906,0,8,TPR domain binding,MF,
7555,GO:0030914,1,0.932802299972368,0,11,STAGA complex,CC,
7556,GO:0030915,1,0.969575122556871,0,6,Smc5-Smc6 complex,CC,
7557,GO:0030916,1,0.955745922905181,0,8,otic vesicle formation,BP,
7558,GO:0030917,1,0.959103073128446,0,7,midbrain-hindbrain boundary development,BP,
7559,GO:0030920,1,0.992844522629793,0,2,peptidyl-serine acetylation,BP,
7560,GO:0030934,1,0.970888461876276,0,3,anchoring collagen complex,CC,
7561,GO:0030935,1,0.993544088410586,0,1,sheet-forming collagen trimer,CC,
7562,GO:0030936,1,0.992834666964173,0,1,transmembrane collagen trimer,CC,
7563,GO:0030942,1,0.984891513285919,0,3,endoplasmic reticulum signal peptide binding,MF,
7564,GO:0030943,1,0.981966606492433,0,3,mitochondrion targeting sequence binding,MF,
7565,GO:0030947,1,0.837557766139003,0,28,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7566,GO:0030948,1,0.931919536458761,0,11,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7567,GO:0030949,1,0.92304724552885,0,13,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7568,GO:0030950,1,0.96559348313104,0,5,establishment or maintenance of actin cytoskeleton polarity,BP,
7569,GO:0030951,1,0.970608797443931,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7570,GO:0030952,1,0.937203544788451,0,9,establishment or maintenance of cytoskeleton polarity,BP,
7571,GO:0030953,1,0.923967093752074,0,10,astral microtubule organization,BP,
7572,GO:0030954,1,0.992049667984302,0,1,astral microtubule nucleation,BP,
7573,GO:0030955,1,0.918674250287655,0,12,potassium ion binding,MF,
7574,GO:0030956,1,0.982666610978715,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7575,GO:0030957,1,0.942261992955889,0,10,Tat protein binding,MF,
7576,GO:0030961,1,0.99325505912211,0,1,peptidyl-arginine hydroxylation,BP,
7577,GO:0030964,1,0.857688615610072,0,41,NADH dehydrogenase complex,CC,
7579,GO:0030970,1,0.845731472312523,0,26,retrograde protein transport, ER to cytosol,BP,
7580,GO:0030971,1,0.645502895313114,0,67,receptor tyrosine kinase binding,MF,
7581,GO:0030974,1,0.989411586678564,0,2,thiamine pyrophosphate transmembrane transport,BP,
7582,GO:0030975,1,0.994183151197722,0,1,thiamine binding,MF,
7583,GO:0030976,1,0.955498673299625,0,7,thiamine pyrophosphate binding,MF,
7584,GO:0030977,1,0.99554908582904,0,1,taurine binding,MF,
7585,GO:0030981,1,0.975181409966811,0,3,cortical microtubule cytoskeleton,CC,
7586,GO:0030983,1,0.91659197271391,0,13,mismatched DNA binding,MF,
7587,GO:0030984,1,0.989805456808538,0,2,kininogen binding,MF,
7588,GO:0030990,1,0.837012228952332,0,27,intraciliary transport particle,CC,
7589,GO:0030991,1,0.946959441952787,0,7,intraciliary transport particle A,CC,
7590,GO:0030992,1,0.887273712373105,0,19,intraciliary transport particle B,CC,
7591,GO:0030997,1,0.977799663062979,0,3,regulation of centriole-centriole cohesion,BP,
7592,GO:0031000,1,0.873785085396857,0,17,response to caffeine,BP,
7593,GO:0031004,1,0.978699003500466,0,3,potassium ion-transporting ATPase complex,CC,
7594,GO:0031005,1,0.928829867678571,0,10,filamin binding,MF,
7595,GO:0031010,1,0.920311495564703,0,11,ISWI-type complex,CC,
7596,GO:0031011,1,0.924310619792943,0,15,Ino80 complex,CC,
7598,GO:0031013,1,0.978560474996833,0,5,troponin I binding,MF,
7599,GO:0031014,1,0.987060397493683,0,4,troponin T binding,MF,
7601,GO:0031017,1,0.960386807376505,0,6,exocrine pancreas development,BP,
7603,GO:0031021,1,0.99325505912211,0,1,interphase microtubule organizing center,CC,
7604,GO:0031022,1,0.980856772879867,0,2,nuclear migration along microfilament,BP,
7605,GO:0031023,1,0.397273520024764,0,131,microtubule organizing center organization,BP,
7607,GO:0031033,1,0.953009538284468,0,5,myosin filament organization,BP,
7608,GO:0031034,1,0.957960037226229,0,4,myosin filament assembly,BP,
7609,GO:0031038,1,0.994834506269511,0,1,myosin II filament organization,BP,
7610,GO:0031045,1,0.825668853038261,0,27,dense core granule,CC,
7612,GO:0031048,1,0.976604583255721,0,3,heterochromatin assembly by small RNA,BP,
7613,GO:0031049,1,0.98536456885605,0,2,programmed DNA elimination,BP,
7615,GO:0031052,1,0.98536456885605,0,2,chromosome breakage,BP,
7616,GO:0031053,1,0.912425086306554,0,13,primary miRNA processing,BP,
7617,GO:0031054,1,0.921713711579747,0,12,pre-miRNA processing,BP,
7618,GO:0031055,1,0.853002674366784,0,28,chromatin remodeling at centromere,BP,
7619,GO:0031056,1,0.376266269988339,0,138,regulation of histone modification,BP,
7620,GO:0031057,1,0.755921201533747,0,40,negative regulation of histone modification,BP,
7621,GO:0031058,1,0.547294386129867,0,86,positive regulation of histone modification,BP,
7622,GO:0031060,1,0.644843199613892,0,59,regulation of histone methylation,BP,
7623,GO:0031061,1,0.878329294833042,0,18,negative regulation of histone methylation,BP,
7624,GO:0031062,1,0.768032071247706,0,36,positive regulation of histone methylation,BP,
7625,GO:0031063,1,0.82894532053875,0,27,regulation of histone deacetylation,BP,
7626,GO:0031064,1,0.958975620929394,0,6,negative regulation of histone deacetylation,BP,
7627,GO:0031065,1,0.882635241982039,0,17,positive regulation of histone deacetylation,BP,
7629,GO:0031071,1,0.994134846490457,0,1,cysteine desulfurase activity,MF,
7630,GO:0031072,1,0.469443818320683,0,115,heat shock protein binding,MF,
7631,GO:0031073,1,0.994347515560857,0,1,cholesterol 26-hydroxylase activity,MF,
7632,GO:0031074,1,0.98105240728248,0,3,nucleocytoplasmic transport complex,CC,
7633,GO:0031076,1,0.741738765520261,0,39,embryonic camera-type eye development,BP,
7634,GO:0031077,1,0.95604707654566,0,7,post-embryonic camera-type eye development,BP,
7635,GO:0031078,1,0.931172392019585,0,10,histone deacetylase activity (H3-K14 specific),MF,
7636,GO:0031080,1,0.93408480681138,0,10,nuclear pore outer ring,CC,
7637,GO:0031082,1,0.892106168449023,0,19,BLOC complex,CC,
7638,GO:0031083,1,0.924978206172664,0,14,BLOC-1 complex,CC,
7639,GO:0031084,1,0.978289918729285,0,3,BLOC-2 complex,CC,
7640,GO:0031085,1,0.985896554003588,0,2,BLOC-3 complex,CC,
7641,GO:0031086,1,0.962818452529932,0,6,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7642,GO:0031087,1,0.969724661462279,0,5,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7643,GO:0031088,1,0.960530828408281,0,6,platelet dense granule membrane,CC,
7644,GO:0031089,1,0.94443469254746,0,11,platelet dense granule lumen,CC,
7646,GO:0031091,1,0.58755174800707,0,84,platelet alpha granule,CC,
7647,GO:0031092,1,0.892685030039028,0,16,platelet alpha granule membrane,CC,
7648,GO:0031093,1,0.682741933343672,0,62,platelet alpha granule lumen,CC,
7649,GO:0031094,1,0.918267882057168,0,10,platelet dense tubular network,CC,
7650,GO:0031095,1,0.930525589414628,0,8,platelet dense tubular network membrane,CC,
7656,GO:0031104,1,0.98853936183594,0,2,dendrite regeneration,BP,
7661,GO:0031112,1,0.78994659263231,0,33,positive regulation of microtubule polymerization or depolymerization,BP,
7663,GO:0031114,1,0.802497503912702,0,29,regulation of microtubule depolymerization,BP,
7665,GO:0031116,1,0.810003851378165,0,29,positive regulation of microtubule polymerization,BP,
7666,GO:0031117,1,0.975290582327127,0,4,positive regulation of microtubule depolymerization,BP,
7667,GO:0031118,1,0.954526395391875,0,10,rRNA pseudouridine synthesis,BP,
7668,GO:0031119,1,0.973100929293561,0,5,tRNA pseudouridine synthesis,BP,
7669,GO:0031120,1,0.987316350457903,0,3,snRNA pseudouridine synthesis,BP,
7670,GO:0031122,1,0.635610218645019,0,60,cytoplasmic microtubule organization,BP,
7671,GO:0031123,1,0.435860162662712,0,131,RNA 3'-end processing,BP,
7672,GO:0031124,1,0.539710541357131,0,94,mRNA 3'-end processing,BP,
7673,GO:0031125,1,0.952803658575162,0,10,rRNA 3'-end processing,BP,
7674,GO:0031126,1,0.952123132258575,0,10,snoRNA 3'-end processing,BP,
7675,GO:0031127,1,0.992424910476249,0,1,alpha-(1,2)-fucosyltransferase activity,MF,
7676,GO:0031128,1,0.799255878751091,0,34,developmental induction,BP,
7677,GO:0031129,1,0.992042881145803,0,1,inductive cell-cell signaling,BP,
7679,GO:0031134,1,0.981109245767512,0,3,sister chromatid biorientation,BP,
7681,GO:0031145,1,0.685551953074874,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7682,GO:0031146,1,0.620789620588331,0,87,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7683,GO:0031151,1,0.990777507243826,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7684,GO:0031161,1,0.992751211670069,0,1,phosphatidylinositol catabolic process,BP,
7685,GO:0031163,1,0.901271280746529,0,20,metallo-sulfur cluster assembly,BP,
7686,GO:0031166,1,0.96438041241231,0,5,integral component of vacuolar membrane,CC,
7687,GO:0031167,1,0.900113733491738,0,19,rRNA methylation,BP,
7689,GO:0031177,1,0.990217175383171,0,1,phosphopantetheine binding,MF,
7690,GO:0031179,1,0.98671294532156,0,2,peptide modification,BP,
7691,GO:0031201,1,0.751025280896195,0,47,SNARE complex,CC,
7692,GO:0031204,1,0.956242462559141,0,7,posttranslational protein targeting to membrane, translocation,BP,
7693,GO:0031205,1,0.9881711324625,0,2,endoplasmic reticulum Sec complex,CC,
7694,GO:0031207,1,0.991301502831932,0,1,Sec62/Sec63 complex,CC,
7695,GO:0031208,1,0.978233262907514,0,3,POZ domain binding,MF,
7696,GO:0031209,1,0.936388667861175,0,9,SCAR complex,CC,
7697,GO:0031210,1,0.855909868821604,0,23,phosphatidylcholine binding,MF,
7698,GO:0031211,1,0.952270390971999,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7699,GO:0031213,1,0.984612541203719,0,2,RSF complex,CC,
7701,GO:0031223,1,0.907127681812013,0,12,auditory behavior,BP,
7705,GO:0031227,1,0.39582305620386,0,153,intrinsic component of endoplasmic reticulum membrane,CC,
7706,GO:0031228,1,0.669477028335919,0,62,intrinsic component of Golgi membrane,CC,
7707,GO:0031229,1,0.913107320260326,0,14,intrinsic component of nuclear inner membrane,CC,
7708,GO:0031231,1,0.917709161921465,0,15,intrinsic component of peroxisomal membrane,CC,
7710,GO:0031233,1,0.893051901741482,0,20,intrinsic component of external side of plasma membrane,CC,
7711,GO:0031234,1,0.540656073252387,0,94,extrinsic component of cytoplasmic side of plasma membrane,CC,
7712,GO:0031235,1,0.954655980656509,0,6,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7713,GO:0031247,1,0.98834695036118,0,2,actin rod assembly,BP,
7714,GO:0031248,1,0.570531375307907,0,85,protein acetyltransferase complex,CC,
7715,GO:0031249,1,0.994024135805207,0,1,denatured protein binding,MF,
7716,GO:0031251,1,0.983837333662868,0,2,PAN complex,CC,
7719,GO:0031254,1,0.91980197899804,0,13,cell trailing edge,CC,
7721,GO:0031257,1,0.99325505912211,0,1,cell trailing edge membrane,CC,
7722,GO:0031258,1,0.850969743584092,0,22,lamellipodium membrane,CC,
7723,GO:0031259,1,0.99325505912211,0,1,uropod membrane,CC,
7724,GO:0031261,1,0.970537985483367,0,5,DNA replication preinitiation complex,CC,
7725,GO:0031262,1,0.983187167323534,0,4,Ndc80 complex,CC,
7726,GO:0031264,1,0.946468267762929,0,9,death-inducing signaling complex,CC,
7727,GO:0031265,1,0.963469658462985,0,6,CD95 death-inducing signaling complex,CC,
7729,GO:0031268,1,0.922103062695624,0,13,pseudopodium organization,BP,
7730,GO:0031269,1,0.922103062695624,0,13,pseudopodium assembly,BP,
7731,GO:0031271,1,0.99325505912211,0,1,lateral pseudopodium assembly,BP,
7732,GO:0031272,1,0.922103062695624,0,13,regulation of pseudopodium assembly,BP,
7733,GO:0031274,1,0.928369595305274,0,12,positive regulation of pseudopodium assembly,BP,
7734,GO:0031275,1,0.99325505912211,0,1,regulation of lateral pseudopodium assembly,BP,
7735,GO:0031279,1,0.752479871118319,0,43,regulation of cyclase activity,BP,
7736,GO:0031280,1,0.869855159830148,0,22,negative regulation of cyclase activity,BP,
7737,GO:0031281,1,0.883129128466995,0,18,positive regulation of cyclase activity,BP,
7738,GO:0031282,1,0.943466110080929,0,10,regulation of guanylate cyclase activity,BP,
7739,GO:0031283,1,0.983127060693358,0,3,negative regulation of guanylate cyclase activity,BP,
7740,GO:0031284,1,0.959665234638902,0,7,positive regulation of guanylate cyclase activity,BP,
7741,GO:0031289,1,0.992848735234983,0,1,actin phosphorylation,BP,
7742,GO:0031290,1,0.864207973988822,0,19,retinal ganglion cell axon guidance,BP,
7743,GO:0031291,1,0.97609334167406,0,4,Ran protein signal transduction,BP,
7745,GO:0031294,1,0.717635995351935,0,55,lymphocyte costimulation,BP,
7746,GO:0031295,1,0.720161158444301,0,54,T cell costimulation,BP,
7747,GO:0031296,1,0.989756800067077,0,3,B cell costimulation,BP,
7748,GO:0031297,1,0.803487456510436,0,31,replication fork processing,BP,
7749,GO:0031298,1,0.950935108687921,0,8,replication fork protection complex,CC,
7750,GO:0031300,1,0.101629640255069,0,368,intrinsic component of organelle membrane,CC,
7751,GO:0031301,1,0.121860000637397,0,339,integral component of organelle membrane,CC,
7752,GO:0031302,1,0.978737632152565,0,3,intrinsic component of endosome membrane,CC,
7753,GO:0031304,1,0.786220953792764,0,43,intrinsic component of mitochondrial inner membrane,CC,
7754,GO:0031305,1,0.786220953792764,0,43,integral component of mitochondrial inner membrane,CC,
7755,GO:0031306,1,0.867921157546707,0,22,intrinsic component of mitochondrial outer membrane,CC,
7756,GO:0031307,1,0.874657604530551,0,21,integral component of mitochondrial outer membrane,CC,
7757,GO:0031308,1,0.99325505912211,0,1,intrinsic component of nuclear outer membrane,CC,
7758,GO:0031309,1,0.99325505912211,0,1,integral component of nuclear outer membrane,CC,
7759,GO:0031310,1,0.96438041241231,0,5,intrinsic component of vacuolar membrane,CC,
7761,GO:0031313,1,0.940823979667698,0,9,extrinsic component of endosome membrane,CC,
7762,GO:0031314,1,0.944023212438613,0,10,extrinsic component of mitochondrial inner membrane,CC,
7764,GO:0031320,1,0.993766247491235,0,1,hexitol dehydrogenase activity,MF,
7772,GO:0031330,1,0.211845233846963,0,229,negative regulation of cellular catabolic process,BP,
7774,GO:0031332,1,0.895976671726968,0,14,RNAi effector complex,CC,
7776,GO:0031334,1,0.221752772699843,0,230,positive regulation of protein-containing complex assembly,BP,
7777,GO:0031335,1,0.978010340963056,0,3,regulation of sulfur amino acid metabolic process,BP,
7778,GO:0031337,1,0.994416103024581,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7779,GO:0031338,1,0.834358490608347,0,28,regulation of vesicle fusion,BP,
7780,GO:0031339,1,0.958804025698645,0,6,negative regulation of vesicle fusion,BP,
7781,GO:0031340,1,0.931317643553315,0,11,positive regulation of vesicle fusion,BP,
7782,GO:0031341,1,0.648109277376947,0,78,regulation of cell killing,BP,
7783,GO:0031342,1,0.897014308208213,0,21,negative regulation of cell killing,BP,
7784,GO:0031343,1,0.75053534130613,0,52,positive regulation of cell killing,BP,
7791,GO:0031362,1,0.911739362516101,0,16,anchored component of external side of plasma membrane,CC,
7792,GO:0031365,1,0.831955858978179,0,28,N-terminal protein amino acid modification,BP,
7793,GO:0031369,1,0.830473911829606,0,30,translation initiation factor binding,MF,
7794,GO:0031370,1,0.992255001527796,0,1,eukaryotic initiation factor 4G binding,MF,
7795,GO:0031371,1,0.954975006887489,0,8,ubiquitin conjugating enzyme complex,CC,
7796,GO:0031372,1,0.989835903983357,0,2,UBC13-MMS2 complex,CC,
7797,GO:0031379,1,0.983358953365058,0,2,RNA-directed RNA polymerase complex,CC,
7798,GO:0031380,1,0.990822494967088,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7799,GO:0031386,1,0.95312763803243,0,12,protein tag,MF,
7800,GO:0031389,1,0.993040051200457,0,1,Rad17 RFC-like complex,CC,
7801,GO:0031390,1,0.955585301381095,0,8,Ctf18 RFC-like complex,CC,
7802,GO:0031391,1,0.979992413899665,0,3,Elg1 RFC-like complex,CC,
7803,GO:0031392,1,0.950385004353449,0,9,regulation of prostaglandin biosynthetic process,BP,
7804,GO:0031393,1,0.985311261138079,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7805,GO:0031394,1,0.967638937548539,0,6,positive regulation of prostaglandin biosynthetic process,BP,
7806,GO:0031396,1,0.287961990610804,0,191,regulation of protein ubiquitination,BP,
7807,GO:0031397,1,0.633917284098627,0,72,negative regulation of protein ubiquitination,BP,
7808,GO:0031398,1,0.487527944422632,0,109,positive regulation of protein ubiquitination,BP,
7813,GO:0031403,1,0.983472249087229,0,2,lithium ion binding,MF,
7814,GO:0031404,1,0.914360245870545,0,13,chloride ion binding,MF,
7815,GO:0031405,1,0.989017831276059,0,1,lipoic acid binding,MF,
7817,GO:0031407,1,0.980701068403444,0,3,oxylipin metabolic process,BP,
7818,GO:0031408,1,0.986455002298607,0,2,oxylipin biosynthetic process,BP,
7820,GO:0031414,1,0.936813513173558,0,10,N-terminal protein acetyltransferase complex,CC,
7821,GO:0031415,1,0.972990648787765,0,5,NatA complex,CC,
7822,GO:0031416,1,0.988323517639421,0,2,NatB complex,CC,
7823,GO:0031417,1,0.97420713976055,0,3,NatC complex,CC,
7824,GO:0031418,1,0.879767313511369,0,20,L-ascorbic acid binding,MF,
7825,GO:0031419,1,0.94635381005743,0,8,cobalamin binding,MF,
7827,GO:0031422,1,0.992554520379323,0,1,RecQ family helicase-topoisomerase III complex,CC,
7829,GO:0031427,1,0.973918361356113,0,4,response to methotrexate,BP,
7830,GO:0031428,1,0.975476654746131,0,5,box C/D snoRNP complex,CC,
7831,GO:0031429,1,0.97650580583673,0,5,box H/ACA snoRNP complex,CC,
7832,GO:0031430,1,0.847809018272684,0,24,M band,CC,
7833,GO:0031431,1,0.98570847139642,0,2,Dbf4-dependent protein kinase complex,CC,
7835,GO:0031433,1,0.949358112058388,0,6,telethonin binding,MF,
7836,GO:0031434,1,0.913551231508261,0,13,mitogen-activated protein kinase kinase binding,MF,
7837,GO:0031435,1,0.887179851661927,0,17,mitogen-activated protein kinase kinase kinase binding,MF,
7838,GO:0031436,1,0.981391335638618,0,3,BRCA1-BARD1 complex,CC,
7839,GO:0031437,1,0.992380263846205,0,1,regulation of mRNA cleavage,BP,
7840,GO:0031439,1,0.992380263846205,0,1,positive regulation of mRNA cleavage,BP,
7841,GO:0031440,1,0.829235563886267,0,27,regulation of mRNA 3'-end processing,BP,
7842,GO:0031441,1,0.938431634405473,0,9,negative regulation of mRNA 3'-end processing,BP,
7843,GO:0031442,1,0.92918800632791,0,11,positive regulation of mRNA 3'-end processing,BP,
7844,GO:0031443,1,0.983700589390169,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7845,GO:0031444,1,0.984814562412132,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7846,GO:0031445,1,0.885213554080805,0,16,regulation of heterochromatin assembly,BP,
7847,GO:0031446,1,0.992540576994048,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7848,GO:0031448,1,0.992540576994048,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7849,GO:0031449,1,0.991556012226137,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7850,GO:0031452,1,0.966770125741358,0,4,negative regulation of heterochromatin assembly,BP,
7851,GO:0031453,1,0.922482979009767,0,11,positive regulation of heterochromatin assembly,BP,
7852,GO:0031455,1,0.985101845085447,0,2,glycine betaine metabolic process,BP,
7853,GO:0031456,1,0.985101845085447,0,2,glycine betaine biosynthetic process,BP,
7854,GO:0031460,1,0.992191960627403,0,1,glycine betaine transport,BP,
7855,GO:0031461,1,0.368735079932833,0,152,cullin-RING ubiquitin ligase complex,CC,
7856,GO:0031462,1,0.917678335295521,0,13,Cul2-RING ubiquitin ligase complex,CC,
7857,GO:0031463,1,0.777520479457076,0,36,Cul3-RING ubiquitin ligase complex,CC,
7858,GO:0031464,1,0.933013286690863,0,11,Cul4A-RING E3 ubiquitin ligase complex,CC,
7859,GO:0031465,1,0.969444840181862,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7860,GO:0031466,1,0.973225524204461,0,5,Cul5-RING ubiquitin ligase complex,CC,
7861,GO:0031467,1,0.975382770290134,0,4,Cul7-RING ubiquitin ligase complex,CC,
7862,GO:0031468,1,0.902358009287284,0,18,nuclear envelope reassembly,BP,
7863,GO:0031475,1,0.996093822411736,0,1,myosin V complex,CC,
7864,GO:0031477,1,0.990818650640373,0,1,myosin VII complex,CC,
7865,GO:0031489,1,0.908625511977259,0,16,myosin V binding,MF,
7866,GO:0031490,1,0.545617109219356,0,86,chromatin DNA binding,MF,
7867,GO:0031491,1,0.71155225315577,0,51,nucleosome binding,MF,
7868,GO:0031492,1,0.858442147618717,0,24,nucleosomal DNA binding,MF,
7869,GO:0031493,1,0.97112076032619,0,5,nucleosomal histone binding,MF,
7870,GO:0031494,1,0.989303662582116,0,1,regulation of mating type switching,BP,
7871,GO:0031497,1,0.486285566450989,0,108,chromatin assembly,BP,
7872,GO:0031498,1,0.889164880744325,0,17,chromatin disassembly,BP,
7873,GO:0031499,1,0.993079507268143,0,1,TRAMP complex,CC,
7874,GO:0031501,1,0.976336500071701,0,5,mannosyltransferase complex,CC,
7876,GO:0031506,1,0.995630725828587,0,1,cell wall glycoprotein biosynthetic process,BP,
7877,GO:0031507,1,0.758467735867676,0,39,heterochromatin assembly,BP,
7878,GO:0031508,1,0.98933236145058,0,2,pericentric heterochromatin assembly,BP,
7879,GO:0031509,1,0.995896293794625,0,1,subtelomeric heterochromatin assembly,BP,
7880,GO:0031510,1,0.987400526170291,0,2,SUMO activating enzyme complex,CC,
7881,GO:0031511,1,0.995914184490801,0,1,Mis6-Sim4 complex,CC,
7883,GO:0031515,1,0.982552065874204,0,3,tRNA (m1A) methyltransferase complex,CC,
7884,GO:0031519,1,0.740085977624895,0,43,PcG protein complex,CC,
7885,GO:0031523,1,0.980371887406081,0,3,Myb complex,CC,
7887,GO:0031527,1,0.874909895862883,0,18,filopodium membrane,CC,
7888,GO:0031528,1,0.84627790565574,0,24,microvillus membrane,CC,
7889,GO:0031529,1,0.72756865931488,0,50,ruffle organization,BP,
7890,GO:0031530,1,0.9926378502127,0,2,gonadotropin-releasing hormone receptor binding,MF,
7891,GO:0031531,1,0.996358101077666,0,1,thyrotropin-releasing hormone receptor binding,MF,
7893,GO:0031533,1,0.991473101845741,0,1,mRNA cap methyltransferase complex,CC,
7894,GO:0031536,1,0.986706785976026,0,3,positive regulation of exit from mitosis,BP,
7895,GO:0031543,1,0.924713114877066,0,12,peptidyl-proline dioxygenase activity,MF,
7896,GO:0031544,1,0.972912988603424,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7897,GO:0031545,1,0.950471717952139,0,8,peptidyl-proline 4-dioxygenase activity,MF,
7898,GO:0031547,1,0.944834629225123,0,7,brain-derived neurotrophic factor receptor signaling pathway,BP,
7899,GO:0031548,1,0.977319507037786,0,3,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7900,GO:0031549,1,0.99193693487057,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7901,GO:0031550,1,0.985264959889393,0,2,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7902,GO:0031554,1,0.968529171284016,0,4,regulation of DNA-templated transcription, termination,BP,
7903,GO:0031559,1,0.992421201583323,0,1,oxidosqualene cyclase activity,MF,
7904,GO:0031570,1,0.37106916947885,0,148,DNA integrity checkpoint,BP,
7905,GO:0031571,1,0.672941554230347,0,61,mitotic G1 DNA damage checkpoint,BP,
7906,GO:0031572,1,0.813436758182016,0,29,G2 DNA damage checkpoint,BP,
7907,GO:0031573,1,0.920557202778764,0,14,intra-S DNA damage checkpoint,BP,
7908,GO:0031577,1,0.803667900881679,0,34,spindle checkpoint,BP,
7911,GO:0031581,1,0.904536093049479,0,12,hemidesmosome assembly,BP,
7912,GO:0031583,1,0.994861437549621,0,1,phospholipase D-activating G protein-coupled receptor signaling pathway,BP,
7913,GO:0031584,1,0.971218806829494,0,5,activation of phospholipase D activity,BP,
7914,GO:0031585,1,0.957029993142453,0,5,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7915,GO:0031587,1,0.968331445737174,0,4,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7916,GO:0031588,1,0.947003718914,0,8,nucleotide-activated protein kinase complex,CC,
7918,GO:0031590,1,0.979038528145005,0,3,wybutosine metabolic process,BP,
7919,GO:0031591,1,0.979038528145005,0,3,wybutosine biosynthetic process,BP,
7920,GO:0031592,1,0.990511301285652,0,1,centrosomal corona,CC,
7921,GO:0031593,1,0.764058682772116,0,40,polyubiquitin modification-dependent protein binding,MF,
7923,GO:0031595,1,0.984615359453896,0,3,nuclear proteasome complex,CC,
7924,GO:0031597,1,0.955445370853118,0,8,cytosolic proteasome complex,CC,
7925,GO:0031616,1,0.926289828376769,0,13,spindle pole centrosome,CC,
7926,GO:0031617,1,0.983187167323534,0,4,NMS complex,CC,
7927,GO:0031618,1,0.933587529113239,0,9,nuclear pericentric heterochromatin,CC,
7928,GO:0031620,1,0.95710551490082,0,7,regulation of fever generation,BP,
7929,GO:0031622,1,0.964423727810977,0,6,positive regulation of fever generation,BP,
7931,GO:0031624,1,0.802606008876972,0,30,ubiquitin conjugating enzyme binding,MF,
7933,GO:0031626,1,0.992039214956296,0,1,beta-endorphin binding,MF,
7934,GO:0031627,1,0.985603959786,0,2,telomeric loop formation,BP,
7935,GO:0031628,1,0.954350264606847,0,8,opioid receptor binding,MF,
7936,GO:0031629,1,0.866634626096992,0,23,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7937,GO:0031630,1,0.929624996508744,0,11,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7938,GO:0031632,1,0.971038717754406,0,4,positive regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7939,GO:0031635,1,0.98762789295307,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7940,GO:0031638,1,0.759143772404108,0,47,zymogen activation,BP,
7941,GO:0031639,1,0.908621110683418,0,17,plasminogen activation,BP,
7942,GO:0031640,1,0.845986894712349,0,38,killing of cells of other organism,BP,
7944,GO:0031642,1,0.945980827512219,0,8,negative regulation of myelination,BP,
7947,GO:0031645,1,0.860206660368622,0,23,negative regulation of nervous system process,BP,
7951,GO:0031649,1,0.901296140844383,0,16,heat generation,BP,
7952,GO:0031650,1,0.925546615263209,0,12,regulation of heat generation,BP,
7953,GO:0031651,1,0.992442165171856,0,1,negative regulation of heat generation,BP,
7954,GO:0031652,1,0.939732784661935,0,10,positive regulation of heat generation,BP,
7955,GO:0031663,1,0.7193124023106,0,54,lipopolysaccharide-mediated signaling pathway,BP,
7956,GO:0031664,1,0.871644136824996,0,23,regulation of lipopolysaccharide-mediated signaling pathway,BP,
7957,GO:0031665,1,0.946909961909563,0,10,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7958,GO:0031666,1,0.945596293453766,0,9,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7960,GO:0031668,1,0.216576745122078,0,231,cellular response to extracellular stimulus,BP,
7961,GO:0031669,1,0.262010982864849,0,201,cellular response to nutrient levels,BP,
7962,GO:0031670,1,0.76582777672945,0,41,cellular response to nutrient,BP,
7963,GO:0031672,1,0.779892936090137,0,35,A band,CC,
7964,GO:0031673,1,0.985895995546858,0,1,H zone,CC,
7966,GO:0031680,1,0.950677182216581,0,10,G-protein beta/gamma-subunit complex,CC,
7967,GO:0031681,1,0.905281048235041,0,18,G-protein beta-subunit binding,MF,
7968,GO:0031682,1,0.958346650117131,0,6,G-protein gamma-subunit binding,MF,
7969,GO:0031683,1,0.889457919211236,0,19,G-protein beta/gamma-subunit complex binding,MF,
7970,GO:0031685,1,0.974924477791413,0,4,adenosine receptor binding,MF,
7971,GO:0031686,1,0.992791871346898,0,1,A1 adenosine receptor binding,MF,
7972,GO:0031687,1,0.989465987561633,0,2,A2A adenosine receptor binding,MF,
7973,GO:0031690,1,0.882291273636509,0,19,adrenergic receptor binding,MF,
7974,GO:0031691,1,0.989952597733943,0,2,alpha-1A adrenergic receptor binding,MF,
7975,GO:0031692,1,0.982511253618919,0,3,alpha-1B adrenergic receptor binding,MF,
7976,GO:0031694,1,0.978986182202054,0,4,alpha-2A adrenergic receptor binding,MF,
7977,GO:0031695,1,0.99393375885868,0,1,alpha-2B adrenergic receptor binding,MF,
7978,GO:0031696,1,0.986462794126365,0,2,alpha-2C adrenergic receptor binding,MF,
7979,GO:0031697,1,0.962099289262469,0,5,beta-1 adrenergic receptor binding,MF,
7980,GO:0031698,1,0.964073713140251,0,5,beta-2 adrenergic receptor binding,MF,
7981,GO:0031699,1,0.992442165171856,0,1,beta-3 adrenergic receptor binding,MF,
7982,GO:0031700,1,0.996200312448215,0,1,adrenomedullin receptor binding,MF,
7983,GO:0031701,1,0.946274603197055,0,8,angiotensin receptor binding,MF,
7984,GO:0031702,1,0.951424337427716,0,7,type 1 angiotensin receptor binding,MF,
7985,GO:0031703,1,0.993650213761529,0,1,type 2 angiotensin receptor binding,MF,
7986,GO:0031704,1,0.992691803075415,0,1,apelin receptor binding,MF,
7987,GO:0031705,1,0.981688661103742,0,4,bombesin receptor binding,MF,
7988,GO:0031707,1,0.994861437549621,0,1,endothelin A receptor binding,MF,
7989,GO:0031708,1,0.984998229441668,0,3,endothelin B receptor binding,MF,
7990,GO:0031710,1,0.996640545335859,0,1,neuromedin B receptor binding,MF,
7991,GO:0031711,1,0.98691697177814,0,2,bradykinin receptor binding,MF,
7992,GO:0031714,1,0.992073959707884,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7993,GO:0031715,1,0.992073959707884,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
7994,GO:0031716,1,0.996635212635427,0,1,calcitonin receptor binding,MF,
7995,GO:0031717,1,0.995887266483741,0,1,cannabinoid receptor binding,MF,
7996,GO:0031718,1,0.995887266483741,0,1,type 1 cannabinoid receptor binding,MF,
7997,GO:0031720,1,0.971818207352701,0,9,haptoglobin binding,MF,
7998,GO:0031721,1,0.987340704125563,0,4,hemoglobin alpha binding,MF,
7999,GO:0031724,1,0.996492397595218,0,1,CXCR5 chemokine receptor binding,MF,
8000,GO:0031726,1,0.9967656483946,0,1,CCR1 chemokine receptor binding,MF,
8001,GO:0031727,1,0.984293747884994,0,4,CCR2 chemokine receptor binding,MF,
8002,GO:0031728,1,0.993714466741168,0,2,CCR3 chemokine receptor binding,MF,
8003,GO:0031729,1,0.996829803170141,0,1,CCR4 chemokine receptor binding,MF,
8004,GO:0031730,1,0.973617081898757,0,4,CCR5 chemokine receptor binding,MF,
8005,GO:0031731,1,0.993618885711424,0,2,CCR6 chemokine receptor binding,MF,
8006,GO:0031732,1,0.993552031857419,0,2,CCR7 chemokine receptor binding,MF,
8007,GO:0031735,1,0.990058982796433,0,3,CCR10 chemokine receptor binding,MF,
8008,GO:0031737,1,0.992658184875354,0,1,CX3C chemokine receptor binding,MF,
8009,GO:0031739,1,0.994806227636368,0,1,cholecystokinin receptor binding,MF,
8010,GO:0031741,1,0.994806227636368,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8011,GO:0031748,1,0.951200218782241,0,9,D1 dopamine receptor binding,MF,
8012,GO:0031749,1,0.966426284774796,0,5,D2 dopamine receptor binding,MF,
8013,GO:0031750,1,0.981616368752706,0,3,D3 dopamine receptor binding,MF,
8014,GO:0031751,1,0.988358885374691,0,2,D4 dopamine receptor binding,MF,
8015,GO:0031752,1,0.979773729890934,0,3,D5 dopamine receptor binding,MF,
8016,GO:0031753,1,0.993213200523813,0,1,endothelial differentiation G protein-coupled receptor binding,MF,
8017,GO:0031755,1,0.993213200523813,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8018,GO:0031762,1,0.989952597733943,0,2,follicle-stimulating hormone receptor binding,MF,
8019,GO:0031763,1,0.996775772344871,0,1,galanin receptor binding,MF,
8020,GO:0031764,1,0.996775772344871,0,1,type 1 galanin receptor binding,MF,
8021,GO:0031765,1,0.996775772344871,0,1,type 2 galanin receptor binding,MF,
8022,GO:0031766,1,0.996775772344871,0,1,type 3 galanin receptor binding,MF,
8023,GO:0031768,1,0.996800221570978,0,1,ghrelin receptor binding,MF,
8024,GO:0031770,1,0.996861612811084,0,1,growth hormone-releasing hormone receptor binding,MF,
8025,GO:0031773,1,0.996800907774561,0,1,kisspeptin receptor binding,MF,
8026,GO:0031775,1,0.990350808556854,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8027,GO:0031776,1,0.996785678365679,0,1,melanin-concentrating hormone receptor binding,MF,
8028,GO:0031777,1,0.996785678365679,0,1,type 1 melanin-concentrating hormone receptor binding,MF,
8029,GO:0031779,1,0.984679673338154,0,4,melanocortin receptor binding,MF,
8030,GO:0031780,1,0.991350137598929,0,2,corticotropin hormone receptor binding,MF,
8031,GO:0031781,1,0.984679673338154,0,4,type 3 melanocortin receptor binding,MF,
8032,GO:0031782,1,0.984679673338154,0,4,type 4 melanocortin receptor binding,MF,
8033,GO:0031783,1,0.991350137598929,0,2,type 5 melanocortin receptor binding,MF,
8034,GO:0031798,1,0.990671198693614,0,1,type 1 metabotropic glutamate receptor binding,MF,
8035,GO:0031799,1,0.989825017263747,0,2,type 2 metabotropic glutamate receptor binding,MF,
8036,GO:0031800,1,0.984324315890388,0,3,type 3 metabotropic glutamate receptor binding,MF,
8037,GO:0031802,1,0.968923345103532,0,5,type 5 metabotropic glutamate receptor binding,MF,
8038,GO:0031811,1,0.992480601779452,0,1,G protein-coupled nucleotide receptor binding,MF,
8039,GO:0031812,1,0.992480601779452,0,1,P2Y1 nucleotide receptor binding,MF,
8040,GO:0031821,1,0.945786990824863,0,9,G protein-coupled serotonin receptor binding,MF,
8041,GO:0031826,1,0.974872311030161,0,5,type 2A serotonin receptor binding,MF,
8042,GO:0031834,1,0.993389130129582,0,2,neurokinin receptor binding,MF,
8043,GO:0031835,1,0.993389130129582,0,2,substance P receptor binding,MF,
8044,GO:0031838,1,0.968255175273196,0,10,haptoglobin-hemoglobin complex,CC,
8045,GO:0031839,1,0.996760354949418,0,1,type 1 neuromedin U receptor binding,MF,
8046,GO:0031840,1,0.996760354949418,0,1,type 2 neuromedin U receptor binding,MF,
8047,GO:0031848,1,0.933855372247165,0,10,protection from non-homologous end joining at telomere,BP,
8048,GO:0031849,1,0.977161068513541,0,4,olfactory receptor binding,MF,
8049,GO:0031852,1,0.972116265825932,0,4,mu-type opioid receptor binding,MF,
8050,GO:0031858,1,0.992730335419945,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8051,GO:0031859,1,0.99533754565038,0,1,platelet activating factor receptor binding,MF,
8052,GO:0031860,1,0.976676229754766,0,3,telomeric 3' overhang formation,BP,
8053,GO:0031862,1,0.984097987742279,0,2,prostanoid receptor binding,MF,
8054,GO:0031867,1,0.992487083049453,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8055,GO:0031870,1,0.991548047887057,0,1,thromboxane A2 receptor binding,MF,
8056,GO:0031871,1,0.980023654820164,0,3,proteinase activated receptor binding,MF,
8057,GO:0031877,1,0.991219026447721,0,1,somatostatin receptor binding,MF,
8058,GO:0031883,1,0.9948524675447,0,1,taste receptor binding,MF,
8059,GO:0031893,1,0.987075278448377,0,2,vasopressin receptor binding,MF,
8060,GO:0031894,1,0.992444734386019,0,1,V1A vasopressin receptor binding,MF,
8061,GO:0031896,1,0.994590085137988,0,1,V2 vasopressin receptor binding,MF,
8066,GO:0031905,1,0.983644489558312,0,3,early endosome lumen,CC,
8067,GO:0031906,1,0.978101863899857,0,6,late endosome lumen,CC,
8068,GO:0031907,1,0.758312849180489,0,51,microbody lumen,CC,
8069,GO:0031914,1,0.966203660362855,0,5,negative regulation of synaptic plasticity,BP,
8070,GO:0031915,1,0.919223043216198,0,11,positive regulation of synaptic plasticity,BP,
8071,GO:0031929,1,0.477118758727603,0,107,TOR signaling,BP,
8072,GO:0031930,1,0.996180407629392,0,1,mitochondria-nucleus signaling pathway,BP,
8073,GO:0031931,1,0.937657672187773,0,8,TORC1 complex,CC,
8074,GO:0031932,1,0.913209830512554,0,12,TORC2 complex,CC,
8075,GO:0031935,1,0.940043450514523,0,9,regulation of chromatin silencing,BP,
8076,GO:0031936,1,0.97156250532282,0,4,negative regulation of chromatin silencing,BP,
8077,GO:0031937,1,0.979525949693674,0,3,positive regulation of chromatin silencing,BP,
8078,GO:0031938,1,0.991210329150002,0,2,regulation of chromatin silencing at telomere,BP,
8079,GO:0031940,1,0.995896293794625,0,1,positive regulation of chromatin silencing at telomere,BP,
8081,GO:0031943,1,0.93506853590678,0,10,regulation of glucocorticoid metabolic process,BP,
8082,GO:0031944,1,0.96618885865783,0,5,negative regulation of glucocorticoid metabolic process,BP,
8083,GO:0031945,1,0.992480005246956,0,1,positive regulation of glucocorticoid metabolic process,BP,
8084,GO:0031946,1,0.941904681624529,0,8,regulation of glucocorticoid biosynthetic process,BP,
8085,GO:0031947,1,0.96618885865783,0,5,negative regulation of glucocorticoid biosynthetic process,BP,
8086,GO:0031948,1,0.992480005246956,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
8088,GO:0031953,1,0.916127351682624,0,12,negative regulation of protein autophosphorylation,BP,
8090,GO:0031956,1,0.934565157905188,0,10,medium-chain fatty acid-CoA ligase activity,MF,
8091,GO:0031957,1,0.942376518136033,0,9,very long-chain fatty acid-CoA ligase activity,MF,
8092,GO:0031958,1,0.905431680122723,0,14,corticosteroid receptor signaling pathway,BP,
8093,GO:0031959,1,0.991985464486564,0,1,mineralocorticoid receptor signaling pathway,BP,
8095,GO:0031962,1,0.991644673653576,0,1,mineralocorticoid receptor binding,MF,
8100,GO:0031970,1,0.640552623820358,0,80,organelle envelope lumen,CC,
8107,GO:0031985,1,0.512336703009137,0,101,Golgi cisterna,CC,
8108,GO:0031987,1,0.930388251126106,0,10,locomotion involved in locomotory behavior,BP,
8109,GO:0031989,1,0.996251100705709,0,1,bombesin receptor signaling pathway,BP,
8110,GO:0031990,1,0.983897159026965,0,2,mRNA export from nucleus in response to heat stress,BP,
8112,GO:0031995,1,0.949247350900274,0,8,insulin-like growth factor II binding,MF,
8113,GO:0031996,1,0.931264788954509,0,11,thioesterase binding,MF,
8114,GO:0031997,1,0.983341568085718,0,3,N-terminal myristoylation domain binding,MF,
8115,GO:0031998,1,0.866366410145691,0,19,regulation of fatty acid beta-oxidation,BP,
8116,GO:0031999,1,0.963712255342711,0,5,negative regulation of fatty acid beta-oxidation,BP,
8117,GO:0032000,1,0.928546139028782,0,10,positive regulation of fatty acid beta-oxidation,BP,
8118,GO:0032002,1,0.988548139296285,0,2,interleukin-28 receptor complex,CC,
8119,GO:0032006,1,0.554258851399473,0,86,regulation of TOR signaling,BP,
8120,GO:0032007,1,0.779838554248949,0,36,negative regulation of TOR signaling,BP,
8121,GO:0032008,1,0.777271874510423,0,38,positive regulation of TOR signaling,BP,
8123,GO:0032010,1,0.968844071771815,0,6,phagolysosome,CC,
8124,GO:0032011,1,0.857600790102138,0,19,ARF protein signal transduction,BP,
8125,GO:0032012,1,0.857600790102138,0,19,regulation of ARF protein signal transduction,BP,
8126,GO:0032014,1,0.983740296339858,0,2,positive regulation of ARF protein signal transduction,BP,
8127,GO:0032020,1,0.97063877729128,0,6,ISG15-protein conjugation,BP,
8128,GO:0032021,1,0.973289247682012,0,4,NELF complex,CC,
8129,GO:0032023,1,0.994391490129299,0,1,trypsinogen activation,BP,
8131,GO:0032025,1,0.946494714072121,0,9,response to cobalt ion,BP,
8133,GO:0032027,1,0.956666758948237,0,7,myosin light chain binding,MF,
8134,GO:0032028,1,0.986414174319505,0,2,myosin head/neck binding,MF,
8135,GO:0032029,1,0.988542673387492,0,1,myosin tail binding,MF,
8136,GO:0032034,1,0.991533833258284,0,1,myosin II head/neck binding,MF,
8137,GO:0032036,1,0.939443449870843,0,11,myosin heavy chain binding,MF,
8138,GO:0032038,1,0.985026454457753,0,3,myosin II heavy chain binding,MF,
8139,GO:0032039,1,0.890716724947569,0,15,integrator complex,CC,
8140,GO:0032040,1,0.812984128957729,0,33,small-subunit processome,CC,
8141,GO:0032041,1,0.931172392019585,0,10,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8142,GO:0032042,1,0.909497198186369,0,14,mitochondrial DNA metabolic process,BP,
8143,GO:0032044,1,0.988670242320606,0,2,DSIF complex,CC,
8145,GO:0032048,1,0.903452225245806,0,17,cardiolipin metabolic process,BP,
8146,GO:0032049,1,0.951434060835693,0,8,cardiolipin biosynthetic process,BP,
8147,GO:0032050,1,0.942661257398885,0,8,clathrin heavy chain binding,MF,
8148,GO:0032051,1,0.962521126339073,0,5,clathrin light chain binding,MF,
8149,GO:0032052,1,0.959530353812751,0,9,bile acid binding,MF,
8150,GO:0032053,1,0.969290297839281,0,4,ciliary basal body organization,BP,
8151,GO:0032055,1,0.961394342966475,0,6,negative regulation of translation in response to stress,BP,
8152,GO:0032056,1,0.945253816522572,0,8,positive regulation of translation in response to stress,BP,
8153,GO:0032057,1,0.972610299102825,0,4,negative regulation of translational initiation in response to stress,BP,
8154,GO:0032058,1,0.970632295601325,0,4,positive regulation of translational initiation in response to stress,BP,
8157,GO:0032069,1,0.876802503886443,0,22,regulation of nuclease activity,BP,
8158,GO:0032070,1,0.944723258678607,0,10,regulation of deoxyribonuclease activity,BP,
8159,GO:0032071,1,0.954531623087228,0,8,regulation of endodeoxyribonuclease activity,BP,
8160,GO:0032072,1,0.992577714522428,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8161,GO:0032074,1,0.957501569261201,0,7,negative regulation of nuclease activity,BP,
8162,GO:0032075,1,0.956208075203975,0,8,positive regulation of nuclease activity,BP,
8163,GO:0032076,1,0.990102808521925,0,2,negative regulation of deoxyribonuclease activity,BP,
8164,GO:0032077,1,0.972178198341232,0,5,positive regulation of deoxyribonuclease activity,BP,
8165,GO:0032078,1,0.996720392092626,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8166,GO:0032079,1,0.975746037197017,0,4,positive regulation of endodeoxyribonuclease activity,BP,
8167,GO:0032088,1,0.61006102282988,0,79,negative regulation of NF-kappaB transcription factor activity,BP,
8168,GO:0032089,1,0.985107548781917,0,2,NACHT domain binding,MF,
8169,GO:0032090,1,0.989285861214234,0,2,Pyrin domain binding,MF,
8170,GO:0032091,1,0.543508254666174,0,95,negative regulation of protein binding,BP,
8172,GO:0032093,1,0.99325505912211,0,1,SAM domain binding,MF,
8173,GO:0032094,1,0.821835673914322,0,33,response to food,BP,
8174,GO:0032095,1,0.908295922852103,0,18,regulation of response to food,BP,
8175,GO:0032096,1,0.937261118686146,0,12,negative regulation of response to food,BP,
8176,GO:0032097,1,0.989111998064378,0,3,positive regulation of response to food,BP,
8177,GO:0032098,1,0.902457810567421,0,20,regulation of appetite,BP,
8178,GO:0032099,1,0.937261118686146,0,12,negative regulation of appetite,BP,
8179,GO:0032100,1,0.989111998064378,0,3,positive regulation of appetite,BP,
8183,GO:0032104,1,0.871168414182097,0,24,regulation of response to extracellular stimulus,BP,
8184,GO:0032105,1,0.925073676381262,0,14,negative regulation of response to extracellular stimulus,BP,
8185,GO:0032106,1,0.977895743489816,0,5,positive regulation of response to extracellular stimulus,BP,
8186,GO:0032107,1,0.871168414182097,0,24,regulation of response to nutrient levels,BP,
8187,GO:0032108,1,0.925073676381262,0,14,negative regulation of response to nutrient levels,BP,
8188,GO:0032109,1,0.977895743489816,0,5,positive regulation of response to nutrient levels,BP,
8189,GO:0032116,1,0.98267882979106,0,2,SMC loading complex,CC,
8190,GO:0032119,1,0.958470034940616,0,7,sequestering of zinc ion,BP,
8191,GO:0032127,1,0.951947772683784,0,6,dense core granule membrane,CC,
8192,GO:0032129,1,0.988413287390073,0,2,histone deacetylase activity (H3-K9 specific),MF,
8193,GO:0032133,1,0.968246914860577,0,6,chromosome passenger complex,CC,
8194,GO:0032135,1,0.960104879954587,0,6,DNA insertion or deletion binding,MF,
8195,GO:0032137,1,0.979200930639367,0,3,guanine/thymine mispair binding,MF,
8196,GO:0032138,1,0.970893591260368,0,4,single base insertion or deletion binding,MF,
8197,GO:0032139,1,0.981496796168158,0,3,dinucleotide insertion or deletion binding,MF,
8198,GO:0032142,1,0.977614656594681,0,3,single guanine insertion binding,MF,
8199,GO:0032143,1,0.9852012371361,0,2,single thymine insertion binding,MF,
8200,GO:0032144,1,0.992180852490147,0,1,4-aminobutyrate transaminase complex,CC,
8201,GO:0032145,1,0.992180852490147,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8203,GO:0032148,1,0.827319777098462,0,29,activation of protein kinase B activity,BP,
8205,GO:0032154,1,0.711248249403632,0,49,cleavage furrow,CC,
8206,GO:0032156,1,0.992429086137985,0,1,septin cytoskeleton,CC,
8207,GO:0032181,1,0.985098481301754,0,2,dinucleotide repeat insertion binding,MF,
8208,GO:0032182,1,0.551495776545415,0,89,ubiquitin-like protein binding,MF,
8209,GO:0032183,1,0.888143361245089,0,15,SUMO binding,MF,
8210,GO:0032184,1,0.96132691600733,0,5,SUMO polymer binding,MF,
8212,GO:0032190,1,0.986853002002996,0,3,acrosin binding,MF,
8213,GO:0032194,1,0.992513428419899,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8214,GO:0032196,1,0.871647269052709,0,22,transposition,BP,
8215,GO:0032197,1,0.988427399850287,0,2,transposition, RNA-mediated,BP,
8216,GO:0032200,1,0.392223570546386,0,140,telomere organization,BP,
8217,GO:0032201,1,0.854229032177788,0,27,telomere maintenance via semi-conservative replication,BP,
8218,GO:0032202,1,0.974087363290193,0,5,telomere assembly,BP,
8219,GO:0032203,1,0.995447523178614,0,1,telomere formation via telomerase,BP,
8220,GO:0032204,1,0.589991350670552,0,76,regulation of telomere maintenance,BP,
8221,GO:0032205,1,0.782284750751781,0,33,negative regulation of telomere maintenance,BP,
8222,GO:0032206,1,0.723548335610032,0,49,positive regulation of telomere maintenance,BP,
8223,GO:0032207,1,0.993038571577508,0,1,regulation of telomere maintenance via recombination,BP,
8224,GO:0032208,1,0.993038571577508,0,1,negative regulation of telomere maintenance via recombination,BP,
8225,GO:0032210,1,0.709439353252528,0,51,regulation of telomere maintenance via telomerase,BP,
8226,GO:0032211,1,0.880253254903886,0,18,negative regulation of telomere maintenance via telomerase,BP,
8227,GO:0032212,1,0.805415638029097,0,34,positive regulation of telomere maintenance via telomerase,BP,
8228,GO:0032213,1,0.986074718384767,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8229,GO:0032214,1,0.986074718384767,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8230,GO:0032217,1,0.969023501991941,0,5,riboflavin transmembrane transporter activity,MF,
8231,GO:0032218,1,0.969023501991941,0,5,riboflavin transport,BP,
8232,GO:0032222,1,0.961547365140961,0,6,regulation of synaptic transmission, cholinergic,BP,
8233,GO:0032223,1,0.993649074839029,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8234,GO:0032224,1,0.97408341654966,0,4,positive regulation of synaptic transmission, cholinergic,BP,
8236,GO:0032226,1,0.962505206045783,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8237,GO:0032227,1,0.977587965660861,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8239,GO:0032229,1,0.958800894035967,0,7,negative regulation of synaptic transmission, GABAergic,BP,
8240,GO:0032230,1,0.920630811801542,0,12,positive regulation of synaptic transmission, GABAergic,BP,
8241,GO:0032231,1,0.501944124110379,0,96,regulation of actin filament bundle assembly,BP,
8242,GO:0032232,1,0.810797341598585,0,28,negative regulation of actin filament bundle assembly,BP,
8243,GO:0032233,1,0.663998222450599,0,60,positive regulation of actin filament bundle assembly,BP,
8244,GO:0032237,1,0.970512759730299,0,4,activation of store-operated calcium channel activity,BP,
8245,GO:0032238,1,0.988077864347206,0,2,adenosine transport,BP,
8246,GO:0032239,1,0.867311227456864,0,19,regulation of nucleobase-containing compound transport,BP,
8247,GO:0032240,1,0.976957188692969,0,3,negative regulation of nucleobase-containing compound transport,BP,
8248,GO:0032241,1,0.936653467979938,0,9,positive regulation of nucleobase-containing compound transport,BP,
8249,GO:0032242,1,0.988628342628196,0,2,regulation of nucleoside transport,BP,
8250,GO:0032243,1,0.995466792250196,0,1,negative regulation of nucleoside transport,BP,
8251,GO:0032244,1,0.993130726822913,0,1,positive regulation of nucleoside transport,BP,
8252,GO:0032252,1,0.878137793779056,0,15,secretory granule localization,BP,
8253,GO:0032253,1,0.9096760896779,0,11,dense core granule localization,BP,
8254,GO:0032259,1,0.126689393618645,0,306,methylation,BP,
8255,GO:0032261,1,0.969352346882804,0,6,purine nucleotide salvage,BP,
8256,GO:0032262,1,0.976532541617574,0,5,pyrimidine nucleotide salvage,BP,
8257,GO:0032263,1,0.996243042055326,0,1,GMP salvage,BP,
8258,GO:0032264,1,0.981252718899893,0,3,IMP salvage,BP,
8259,GO:0032266,1,0.739040055522072,0,42,phosphatidylinositol-3-phosphate binding,MF,
8265,GO:0032273,1,0.445395357089435,0,123,positive regulation of protein polymerization,BP,
8267,GO:0032275,1,0.942207478100287,0,9,luteinizing hormone secretion,BP,
8270,GO:0032278,1,0.956877569465614,0,7,positive regulation of gonadotropin secretion,BP,
8272,GO:0032280,1,0.919629506525108,0,11,symmetric synapse,CC,
8273,GO:0032281,1,0.851762610116178,0,26,AMPA glutamate receptor complex,CC,
8277,GO:0032289,1,0.971220275689705,0,4,central nervous system myelin formation,BP,
8278,GO:0032290,1,0.982620316114367,0,2,peripheral nervous system myelin formation,BP,
8281,GO:0032296,1,0.970916457911997,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8282,GO:0032298,1,0.994486164180976,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8283,GO:0032299,1,0.985844371821134,0,3,ribonuclease H2 complex,CC,
8284,GO:0032300,1,0.948769023740922,0,7,mismatch repair complex,CC,
8285,GO:0032301,1,0.9852012371361,0,2,MutSalpha complex,CC,
8286,GO:0032302,1,0.985098481301754,0,2,MutSbeta complex,CC,
8287,GO:0032303,1,0.931860754738207,0,12,regulation of icosanoid secretion,BP,
8288,GO:0032304,1,0.992121788343522,0,1,negative regulation of icosanoid secretion,BP,
8289,GO:0032305,1,0.939262161196047,0,11,positive regulation of icosanoid secretion,BP,
8290,GO:0032306,1,0.964341781210773,0,7,regulation of prostaglandin secretion,BP,
8291,GO:0032308,1,0.964341781210773,0,7,positive regulation of prostaglandin secretion,BP,
8292,GO:0032309,1,0.833795427474068,0,31,icosanoid secretion,BP,
8293,GO:0032310,1,0.942669021852202,0,10,prostaglandin secretion,BP,
8294,GO:0032311,1,0.992043532533489,0,2,angiogenin-PRI complex,CC,
8295,GO:0032324,1,0.963064952063979,0,6,molybdopterin cofactor biosynthetic process,BP,
8296,GO:0032328,1,0.920350393888923,0,12,alanine transport,BP,
8297,GO:0032329,1,0.95106843269226,0,8,serine transport,BP,
8300,GO:0032332,1,0.865203793226022,0,20,positive regulation of chondrocyte differentiation,BP,
8301,GO:0032341,1,0.943090564275952,0,8,aldosterone metabolic process,BP,
8302,GO:0032342,1,0.943090564275952,0,8,aldosterone biosynthetic process,BP,
8303,GO:0032344,1,0.952212818100924,0,7,regulation of aldosterone metabolic process,BP,
8304,GO:0032345,1,0.973495211800611,0,4,negative regulation of aldosterone metabolic process,BP,
8305,GO:0032346,1,0.98532169253161,0,2,positive regulation of aldosterone metabolic process,BP,
8306,GO:0032347,1,0.952212818100924,0,7,regulation of aldosterone biosynthetic process,BP,
8307,GO:0032348,1,0.973495211800611,0,4,negative regulation of aldosterone biosynthetic process,BP,
8308,GO:0032349,1,0.98532169253161,0,2,positive regulation of aldosterone biosynthetic process,BP,
8309,GO:0032350,1,0.814741536546665,0,31,regulation of hormone metabolic process,BP,
8310,GO:0032351,1,0.948801884673005,0,8,negative regulation of hormone metabolic process,BP,
8311,GO:0032352,1,0.913191181465257,0,13,positive regulation of hormone metabolic process,BP,
8312,GO:0032353,1,0.958920584281878,0,6,negative regulation of hormone biosynthetic process,BP,
8313,GO:0032354,1,0.899477910146672,0,14,response to follicle-stimulating hormone,BP,
8315,GO:0032356,1,0.938260992969426,0,10,oxidized DNA binding,MF,
8316,GO:0032357,1,0.943150283923218,0,9,oxidized purine DNA binding,MF,
8317,GO:0032358,1,0.996748342825382,0,1,oxidized pyrimidine DNA binding,MF,
8318,GO:0032361,1,0.995102627584936,0,1,pyridoxal phosphate catabolic process,BP,
8319,GO:0032364,1,0.956893057804502,0,7,oxygen homeostasis,BP,
8320,GO:0032365,1,0.774129027681772,0,37,intracellular lipid transport,BP,
8321,GO:0032366,1,0.86521888908839,0,21,intracellular sterol transport,BP,
8322,GO:0032367,1,0.86521888908839,0,21,intracellular cholesterol transport,BP,
8323,GO:0032368,1,0.55922511343481,0,93,regulation of lipid transport,BP,
8324,GO:0032369,1,0.869955291718051,0,20,negative regulation of lipid transport,BP,
8325,GO:0032370,1,0.695895002852038,0,60,positive regulation of lipid transport,BP,
8326,GO:0032371,1,0.759769083288894,0,44,regulation of sterol transport,BP,
8327,GO:0032372,1,0.944440053804221,0,9,negative regulation of sterol transport,BP,
8328,GO:0032373,1,0.847422968105047,0,26,positive regulation of sterol transport,BP,
8329,GO:0032374,1,0.763253359569395,0,43,regulation of cholesterol transport,BP,
8330,GO:0032375,1,0.944440053804221,0,9,negative regulation of cholesterol transport,BP,
8331,GO:0032376,1,0.847422968105047,0,26,positive regulation of cholesterol transport,BP,
8332,GO:0032377,1,0.957236696778238,0,7,regulation of intracellular lipid transport,BP,
8333,GO:0032378,1,0.98296208903686,0,2,negative regulation of intracellular lipid transport,BP,
8334,GO:0032379,1,0.985188998841157,0,3,positive regulation of intracellular lipid transport,BP,
8335,GO:0032380,1,0.957236696778238,0,7,regulation of intracellular sterol transport,BP,
8336,GO:0032381,1,0.98296208903686,0,2,negative regulation of intracellular sterol transport,BP,
8337,GO:0032382,1,0.985188998841157,0,3,positive regulation of intracellular sterol transport,BP,
8338,GO:0032383,1,0.957236696778238,0,7,regulation of intracellular cholesterol transport,BP,
8339,GO:0032384,1,0.98296208903686,0,2,negative regulation of intracellular cholesterol transport,BP,
8340,GO:0032385,1,0.985188998841157,0,3,positive regulation of intracellular cholesterol transport,BP,
8344,GO:0032389,1,0.987078534958138,0,2,MutLalpha complex,CC,
8345,GO:0032391,1,0.787301203251447,0,33,photoreceptor connecting cilium,CC,
8346,GO:0032392,1,0.461457182364343,0,111,DNA geometric change,BP,
8347,GO:0032393,1,0.96696334576393,0,7,MHC class I receptor activity,MF,
8348,GO:0032394,1,0.981246757194797,0,4,MHC class Ib receptor activity,MF,
8349,GO:0032395,1,0.963826707247687,0,9,MHC class II receptor activity,MF,
8350,GO:0032396,1,0.981535808784977,0,3,inhibitory MHC class I receptor activity,MF,
8351,GO:0032397,1,0.992207533241316,0,2,activating MHC class I receptor activity,MF,
8352,GO:0032398,1,0.992240590704835,0,2,MHC class Ib protein complex,CC,
8353,GO:0032400,1,0.854354209631526,0,25,melanosome localization,BP,
8354,GO:0032401,1,0.865533858718898,0,23,establishment of melanosome localization,BP,
8355,GO:0032402,1,0.873597829628791,0,22,melanosome transport,BP,
8356,GO:0032404,1,0.930597616600891,0,11,mismatch repair complex binding,MF,
8357,GO:0032405,1,0.960069468130967,0,6,MutLalpha complex binding,MF,
8358,GO:0032406,1,0.986466483065983,0,2,MutLbeta complex binding,MF,
8359,GO:0032407,1,0.955969989622942,0,7,MutSalpha complex binding,MF,
8360,GO:0032408,1,0.986466483065983,0,2,MutSbeta complex binding,MF,
8367,GO:0032415,1,0.970135598642462,0,6,regulation of sodium:proton antiporter activity,BP,
8368,GO:0032416,1,0.991092290422912,0,2,negative regulation of sodium:proton antiporter activity,BP,
8369,GO:0032417,1,0.978856868184015,0,4,positive regulation of sodium:proton antiporter activity,BP,
8370,GO:0032418,1,0.648703804216064,0,68,lysosome localization,BP,
8371,GO:0032419,1,0.994510840433996,0,1,extrinsic component of lysosome membrane,CC,
8372,GO:0032420,1,0.728709502209496,0,46,stereocilium,CC,
8373,GO:0032421,1,0.711313102354968,0,50,stereocilium bundle,CC,
8374,GO:0032422,1,0.972777384850013,0,4,purine-rich negative regulatory element binding,MF,
8375,GO:0032423,1,0.97147912348235,0,4,regulation of mismatch repair,BP,
8376,GO:0032425,1,0.978894336094565,0,3,positive regulation of mismatch repair,BP,
8377,GO:0032426,1,0.897129344742839,0,16,stereocilium tip,CC,
8378,GO:0032427,1,0.987056837246784,0,2,GBD domain binding,MF,
8379,GO:0032428,1,0.9925282093816,0,1,beta-N-acetylgalactosaminidase activity,MF,
8384,GO:0032433,1,0.883722477790066,0,16,filopodium tip,CC,
8385,GO:0032434,1,0.445226356551057,0,124,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8386,GO:0032435,1,0.811948243297016,0,33,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8387,GO:0032436,1,0.583952180527447,0,82,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8388,GO:0032437,1,0.943300924945037,0,9,cuticular plate,CC,
8389,GO:0032438,1,0.840742589150376,0,27,melanosome organization,BP,
8390,GO:0032440,1,0.996440786697383,0,1,2-alkenal reductase [NAD(P)+] activity,MF,
8391,GO:0032444,1,0.974139006078125,0,3,activin responsive factor complex,CC,
8392,GO:0032445,1,0.994283053758508,0,1,fructose import,BP,
8394,GO:0032447,1,0.980758559971574,0,4,protein urmylation,BP,
8395,GO:0032448,1,0.995995379654577,0,1,DNA hairpin binding,MF,
8396,GO:0032449,1,0.970124059418057,0,4,CBM complex,CC,
8397,GO:0032450,1,0.976317898211806,0,3,maltose alpha-glucosidase activity,MF,
8398,GO:0032451,1,0.771436884619568,0,34,demethylase activity,MF,
8399,GO:0032452,1,0.814639533228089,0,25,histone demethylase activity,MF,
8400,GO:0032453,1,0.949875055196542,0,6,histone demethylase activity (H3-K4 specific),MF,
8401,GO:0032454,1,0.908560290796912,0,12,histone demethylase activity (H3-K9 specific),MF,
8404,GO:0032458,1,0.992483035727622,0,1,slow endocytic recycling,BP,
8405,GO:0032459,1,0.987750717534311,0,2,regulation of protein oligomerization,BP,
8406,GO:0032460,1,0.992642060559616,0,1,negative regulation of protein oligomerization,BP,
8407,GO:0032461,1,0.995072770589658,0,1,positive regulation of protein oligomerization,BP,
8408,GO:0032462,1,0.992642060559616,0,1,regulation of protein homooligomerization,BP,
8409,GO:0032463,1,0.992642060559616,0,1,negative regulation of protein homooligomerization,BP,
8410,GO:0032465,1,0.575300938353237,0,79,regulation of cytokinesis,BP,
8411,GO:0032466,1,0.958154949042735,0,7,negative regulation of cytokinesis,BP,
8412,GO:0032467,1,0.809155177986055,0,31,positive regulation of cytokinesis,BP,
8413,GO:0032468,1,0.987777007070233,0,2,Golgi calcium ion homeostasis,BP,
8414,GO:0032469,1,0.854061504008879,0,23,endoplasmic reticulum calcium ion homeostasis,BP,
8415,GO:0032470,1,0.982962635836972,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8416,GO:0032471,1,0.954671523481073,0,8,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8417,GO:0032472,1,0.987777007070233,0,2,Golgi calcium ion transport,BP,
8418,GO:0032473,1,0.984787495018072,0,2,cytoplasmic side of mitochondrial outer membrane,CC,
8419,GO:0032474,1,0.970743844946128,0,4,otolith morphogenesis,BP,
8420,GO:0032475,1,0.993499658215524,0,1,otolith formation,BP,
8421,GO:0032479,1,0.466397875931879,0,114,regulation of type I interferon production,BP,
8422,GO:0032480,1,0.760116248409617,0,41,negative regulation of type I interferon production,BP,
8423,GO:0032481,1,0.628864208036555,0,69,positive regulation of type I interferon production,BP,
8424,GO:0032482,1,0.870946075228256,0,21,Rab protein signal transduction,BP,
8425,GO:0032483,1,0.944006667476739,0,7,regulation of Rab protein signal transduction,BP,
8426,GO:0032484,1,0.975927459422455,0,3,Ral protein signal transduction,BP,
8427,GO:0032485,1,0.975927459422455,0,3,regulation of Ral protein signal transduction,BP,
8428,GO:0032486,1,0.896711019143811,0,14,Rap protein signal transduction,BP,
8429,GO:0032487,1,0.964998809683232,0,4,regulation of Rap protein signal transduction,BP,
8430,GO:0032488,1,0.932163817336256,0,12,Cdc42 protein signal transduction,BP,
8431,GO:0032489,1,0.965182021804661,0,6,regulation of Cdc42 protein signal transduction,BP,
8432,GO:0032490,1,0.92153947343435,0,12,detection of molecule of bacterial origin,BP,
8433,GO:0032491,1,0.994021640738781,0,1,detection of molecule of fungal origin,BP,
8434,GO:0032493,1,0.947913288571076,0,8,response to bacterial lipoprotein,BP,
8435,GO:0032494,1,0.936797962755388,0,11,response to peptidoglycan,BP,
8436,GO:0032495,1,0.886084080979185,0,18,response to muramyl dipeptide,BP,
8438,GO:0032497,1,0.978831585256153,0,4,detection of lipopolysaccharide,BP,
8439,GO:0032498,1,0.99235338471682,0,1,detection of muramyl dipeptide,BP,
8440,GO:0032499,1,0.988999573269421,0,2,detection of peptidoglycan,BP,
8441,GO:0032500,1,0.99235338471682,0,1,muramyl dipeptide binding,MF,
8445,GO:0032505,1,0.989303662582116,0,1,reproduction of a single-celled organism,BP,
8448,GO:0032508,1,0.487240841272652,0,103,DNA duplex unwinding,BP,
8450,GO:0032510,1,0.94937630611493,0,7,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8451,GO:0032511,1,0.919439398772187,0,16,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8452,GO:0032515,1,0.719106823014411,0,53,negative regulation of phosphoprotein phosphatase activity,BP,
8453,GO:0032516,1,0.882742651346113,0,18,positive regulation of phosphoprotein phosphatase activity,BP,
8454,GO:0032525,1,0.940946278874562,0,11,somite rostral/caudal axis specification,BP,
8456,GO:0032527,1,0.739756387812421,0,45,protein exit from endoplasmic reticulum,BP,
8458,GO:0032530,1,0.917073207895106,0,12,regulation of microvillus organization,BP,
8459,GO:0032532,1,0.960804411693365,0,6,regulation of microvillus length,BP,
8460,GO:0032534,1,0.95450293060039,0,6,regulation of microvillus assembly,BP,
8463,GO:0032541,1,0.970490735446864,0,5,cortical endoplasmic reticulum,CC,
8464,GO:0032542,1,0.986294158180218,0,2,sulfiredoxin activity,MF,
8465,GO:0032543,1,0.544559963986373,0,129,mitochondrial translation,BP,
8466,GO:0032545,1,0.988952887485354,0,2,CURI complex,CC,
8469,GO:0032552,1,0.971895638576852,0,5,deoxyribonucleotide binding,MF,
8471,GO:0032554,1,0.975242350380401,0,4,purine deoxyribonucleotide binding,MF,
8473,GO:0032556,1,0.99656920672688,0,1,pyrimidine deoxyribonucleotide binding,MF,
8474,GO:0032557,1,0.980404201662795,0,3,pyrimidine ribonucleotide binding,MF,
8475,GO:0032558,1,0.982408545769729,0,3,adenyl deoxyribonucleotide binding,MF,
8477,GO:0032560,1,0.992706799403571,0,1,guanyl deoxyribonucleotide binding,MF,
8479,GO:0032564,1,0.98648150992931,0,2,dATP binding,MF,
8480,GO:0032567,1,0.992706799403571,0,1,dGTP binding,MF,
8482,GO:0032571,1,0.976357187099904,0,4,response to vitamin K,BP,
8483,GO:0032574,1,0.985053932641514,0,2,5'-3' RNA helicase activity,MF,
8484,GO:0032580,1,0.598057567096764,0,77,Golgi cisterna membrane,CC,
8485,GO:0032581,1,0.995474688231342,0,1,ER-dependent peroxisome organization,BP,
8486,GO:0032584,1,0.953587040827401,0,7,growth cone membrane,CC,
8487,GO:0032585,1,0.934430103757988,0,11,multivesicular body membrane,CC,
8488,GO:0032587,1,0.527917889221309,0,89,ruffle membrane,CC,
8491,GO:0032590,1,0.747849472816627,0,42,dendrite membrane,CC,
8492,GO:0032591,1,0.892134665509558,0,15,dendritic spine membrane,CC,
8493,GO:0032592,1,0.651907576126771,0,72,integral component of mitochondrial membrane,CC,
8494,GO:0032593,1,0.929795644458508,0,10,insulin-responsive compartment,CC,
8495,GO:0032594,1,0.961523538421772,0,7,protein transport within lipid bilayer,BP,
8496,GO:0032596,1,0.975055035717175,0,4,protein transport into membrane raft,BP,
8497,GO:0032601,1,0.980308373266002,0,3,connective tissue growth factor production,BP,
8499,GO:0032603,1,0.992569585814872,0,2,fractalkine production,BP,
8500,GO:0032604,1,0.931013495577548,0,12,granulocyte macrophage colony-stimulating factor production,BP,
8501,GO:0032605,1,0.992706799403571,0,1,hepatocyte growth factor production,BP,
8502,GO:0032606,1,0.46140812821617,0,116,type I interferon production,BP,
8503,GO:0032607,1,0.828585307098787,0,27,interferon-alpha production,BP,
8504,GO:0032608,1,0.720492911856782,0,48,interferon-beta production,BP,
8505,GO:0032609,1,0.560403225383344,0,99,interferon-gamma production,BP,
8506,GO:0032610,1,0.97354926122937,0,4,interleukin-1 alpha production,BP,
8507,GO:0032611,1,0.620980965935407,0,81,interleukin-1 beta production,BP,
8508,GO:0032612,1,0.581844098027029,0,92,interleukin-1 production,BP,
8509,GO:0032613,1,0.744078909602793,0,51,interleukin-10 production,BP,
8510,GO:0032615,1,0.72590896302972,0,52,interleukin-12 production,BP,
8511,GO:0032616,1,0.904337741291995,0,16,interleukin-13 production,BP,
8512,GO:0032618,1,0.991446458240993,0,2,interleukin-15 production,BP,
8513,GO:0032620,1,0.864940512665124,0,26,interleukin-17 production,BP,
8514,GO:0032621,1,0.944869704958012,0,8,interleukin-18 production,BP,
8515,GO:0032623,1,0.720983834351623,0,52,interleukin-2 production,BP,
8516,GO:0032625,1,0.989068357812649,0,2,interleukin-21 production,BP,
8517,GO:0032627,1,0.97218884052865,0,4,interleukin-23 production,BP,
8518,GO:0032632,1,0.98680758543352,0,2,interleukin-3 production,BP,
8519,GO:0032633,1,0.831803683309505,0,31,interleukin-4 production,BP,
8520,GO:0032634,1,0.915094051775712,0,13,interleukin-5 production,BP,
8522,GO:0032637,1,0.649432761787199,0,72,interleukin-8 production,BP,
8523,GO:0032639,1,0.995820640236557,0,1,TRAIL production,BP,
8526,GO:0032643,1,0.980308373266002,0,3,regulation of connective tissue growth factor production,BP,
8527,GO:0032645,1,0.935016928444024,0,11,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8528,GO:0032646,1,0.992706799403571,0,1,regulation of hepatocyte growth factor production,BP,
8529,GO:0032647,1,0.835204706581367,0,25,regulation of interferon-alpha production,BP,
8530,GO:0032648,1,0.725923542590158,0,47,regulation of interferon-beta production,BP,
8531,GO:0032649,1,0.599358334532231,0,89,regulation of interferon-gamma production,BP,
8532,GO:0032650,1,0.976644190224444,0,3,regulation of interleukin-1 alpha production,BP,
8533,GO:0032651,1,0.657737508716132,0,72,regulation of interleukin-1 beta production,BP,
8534,GO:0032652,1,0.618276096862298,0,82,regulation of interleukin-1 production,BP,
8535,GO:0032653,1,0.756836030870691,0,48,regulation of interleukin-10 production,BP,
8536,GO:0032655,1,0.736366035536685,0,50,regulation of interleukin-12 production,BP,
8537,GO:0032656,1,0.913928372176205,0,14,regulation of interleukin-13 production,BP,
8538,GO:0032658,1,0.995609539404835,0,1,regulation of interleukin-15 production,BP,
8539,GO:0032660,1,0.889530951037563,0,21,regulation of interleukin-17 production,BP,
8540,GO:0032661,1,0.959323891049377,0,6,regulation of interleukin-18 production,BP,
8541,GO:0032663,1,0.738902446565282,0,47,regulation of interleukin-2 production,BP,
8542,GO:0032667,1,0.97218884052865,0,4,regulation of interleukin-23 production,BP,
8543,GO:0032672,1,0.994280481325253,0,1,regulation of interleukin-3 production,BP,
8544,GO:0032673,1,0.840868671699943,0,29,regulation of interleukin-4 production,BP,
8545,GO:0032674,1,0.915094051775712,0,13,regulation of interleukin-5 production,BP,
8547,GO:0032677,1,0.674555991740494,0,66,regulation of interleukin-8 production,BP,
8548,GO:0032679,1,0.995820640236557,0,1,regulation of TRAIL production,BP,
8551,GO:0032683,1,0.992427247822258,0,1,negative regulation of connective tissue growth factor production,BP,
8552,GO:0032685,1,0.992660119957199,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8553,GO:0032686,1,0.992706799403571,0,1,negative regulation of hepatocyte growth factor production,BP,
8554,GO:0032687,1,0.96891666589607,0,5,negative regulation of interferon-alpha production,BP,
8555,GO:0032688,1,0.916700503070488,0,13,negative regulation of interferon-beta production,BP,
8556,GO:0032689,1,0.844367496601179,0,31,negative regulation of interferon-gamma production,BP,
8557,GO:0032690,1,0.992658184875354,0,1,negative regulation of interleukin-1 alpha production,BP,
8558,GO:0032691,1,0.886159956328458,0,22,negative regulation of interleukin-1 beta production,BP,
8559,GO:0032692,1,0.859591455507237,0,27,negative regulation of interleukin-1 production,BP,
8560,GO:0032693,1,0.924360235923655,0,14,negative regulation of interleukin-10 production,BP,
8561,GO:0032695,1,0.904371375375364,0,16,negative regulation of interleukin-12 production,BP,
8562,GO:0032696,1,0.981789222223297,0,3,negative regulation of interleukin-13 production,BP,
8563,GO:0032700,1,0.954074663833199,0,8,negative regulation of interleukin-17 production,BP,
8564,GO:0032701,1,0.988602222820553,0,2,negative regulation of interleukin-18 production,BP,
8565,GO:0032703,1,0.874718511374709,0,22,negative regulation of interleukin-2 production,BP,
8566,GO:0032707,1,0.985999395242061,0,2,negative regulation of interleukin-23 production,BP,
8567,GO:0032712,1,0.994280481325253,0,1,negative regulation of interleukin-3 production,BP,
8568,GO:0032713,1,0.963173033961253,0,6,negative regulation of interleukin-4 production,BP,
8569,GO:0032714,1,0.979452865986332,0,3,negative regulation of interleukin-5 production,BP,
8570,GO:0032715,1,0.799932912787165,0,36,negative regulation of interleukin-6 production,BP,
8571,GO:0032717,1,0.907090714569577,0,17,negative regulation of interleukin-8 production,BP,
8574,GO:0032723,1,0.987789592982823,0,2,positive regulation of connective tissue growth factor production,BP,
8575,GO:0032725,1,0.941934822177113,0,10,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8576,GO:0032727,1,0.862039748119785,0,20,positive regulation of interferon-alpha production,BP,
8577,GO:0032728,1,0.813140981091154,0,30,positive regulation of interferon-beta production,BP,
8578,GO:0032729,1,0.712573446687944,0,57,positive regulation of interferon-gamma production,BP,
8579,GO:0032730,1,0.98386876592189,0,2,positive regulation of interleukin-1 alpha production,BP,
8580,GO:0032731,1,0.760973878865629,0,46,positive regulation of interleukin-1 beta production,BP,
8581,GO:0032732,1,0.734880940773607,0,51,positive regulation of interleukin-1 production,BP,
8582,GO:0032733,1,0.822342890204576,0,34,positive regulation of interleukin-10 production,BP,
8583,GO:0032735,1,0.83298544092363,0,31,positive regulation of interleukin-12 production,BP,
8584,GO:0032736,1,0.930892936946139,0,11,positive regulation of interleukin-13 production,BP,
8585,GO:0032738,1,0.995609539404835,0,1,positive regulation of interleukin-15 production,BP,
8586,GO:0032740,1,0.932380772635749,0,13,positive regulation of interleukin-17 production,BP,
8587,GO:0032741,1,0.97754652637413,0,3,positive regulation of interleukin-18 production,BP,
8588,GO:0032743,1,0.838257890583031,0,26,positive regulation of interleukin-2 production,BP,
8589,GO:0032747,1,0.985995343426578,0,2,positive regulation of interleukin-23 production,BP,
8590,GO:0032753,1,0.871044906191246,0,23,positive regulation of interleukin-4 production,BP,
8591,GO:0032754,1,0.938952688222127,0,9,positive regulation of interleukin-5 production,BP,
8593,GO:0032757,1,0.746732892200787,0,49,positive regulation of interleukin-8 production,BP,
8594,GO:0032759,1,0.995820640236557,0,1,positive regulation of TRAIL production,BP,
8595,GO:0032760,1,0.752049472872951,0,46,positive regulation of tumor necrosis factor production,BP,
8596,GO:0032762,1,0.957999481008883,0,7,mast cell cytokine production,BP,
8597,GO:0032763,1,0.970536770223678,0,5,regulation of mast cell cytokine production,BP,
8598,GO:0032764,1,0.988615718926495,0,2,negative regulation of mast cell cytokine production,BP,
8599,GO:0032765,1,0.981714983380702,0,3,positive regulation of mast cell cytokine production,BP,
8600,GO:0032767,1,0.979692691698178,0,3,copper-dependent protein binding,MF,
8602,GO:0032769,1,0.934375361806577,0,11,negative regulation of monooxygenase activity,BP,
8603,GO:0032770,1,0.854213807057034,0,26,positive regulation of monooxygenase activity,BP,
8604,GO:0032771,1,0.992414112316059,0,1,regulation of monophenol monooxygenase activity,BP,
8605,GO:0032773,1,0.992414112316059,0,1,positive regulation of monophenol monooxygenase activity,BP,
8607,GO:0032775,1,0.984790047777114,0,2,DNA methylation on adenine,BP,
8608,GO:0032776,1,0.976993359383724,0,3,DNA methylation on cytosine,BP,
8609,GO:0032777,1,0.97602445559874,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8610,GO:0032780,1,0.909874311860662,0,17,negative regulation of ATPase activity,BP,
8611,GO:0032781,1,0.752493181681061,0,53,positive regulation of ATPase activity,BP,
8612,GO:0032782,1,0.956269837494903,0,7,bile acid secretion,BP,
8613,GO:0032783,1,0.959460872746007,0,5,super elongation complex,CC,
8614,GO:0032784,1,0.738949524616179,0,45,regulation of DNA-templated transcription, elongation,BP,
8615,GO:0032785,1,0.906523405170477,0,15,negative regulation of DNA-templated transcription, elongation,BP,
8616,GO:0032786,1,0.844314994162831,0,25,positive regulation of DNA-templated transcription, elongation,BP,
8618,GO:0032788,1,0.995914184490801,0,1,saturated monocarboxylic acid metabolic process,BP,
8619,GO:0032789,1,0.995914184490801,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8620,GO:0032790,1,0.948215596536932,0,8,ribosome disassembly,BP,
8621,GO:0032791,1,0.995682715676617,0,1,lead ion binding,MF,
8622,GO:0032792,1,0.970023912892093,0,5,negative regulation of CREB transcription factor activity,BP,
8623,GO:0032793,1,0.875081469807434,0,18,positive regulation of CREB transcription factor activity,BP,
8624,GO:0032794,1,0.898678803060315,0,14,GTPase activating protein binding,MF,
8625,GO:0032795,1,0.982313981162591,0,3,heterotrimeric G-protein binding,MF,
8626,GO:0032796,1,0.986689560710426,0,2,uropod organization,BP,
8627,GO:0032797,1,0.937381063883805,0,11,SMN complex,CC,
8628,GO:0032798,1,0.986555151512788,0,2,Swi5-Sfr1 complex,CC,
8629,GO:0032799,1,0.866231566036819,0,22,low-density lipoprotein receptor particle metabolic process,BP,
8630,GO:0032800,1,0.854741367153493,0,24,receptor biosynthetic process,BP,
8631,GO:0032801,1,0.787175190545468,0,34,receptor catabolic process,BP,
8632,GO:0032802,1,0.912098735987879,0,14,low-density lipoprotein particle receptor catabolic process,BP,
8633,GO:0032803,1,0.96118486385385,0,6,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8634,GO:0032804,1,0.988364492059556,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8635,GO:0032805,1,0.979535171123368,0,3,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8636,GO:0032806,1,0.883915292840223,0,20,carboxy-terminal domain protein kinase complex,CC,
8637,GO:0032807,1,0.983263818789525,0,3,DNA ligase IV complex,CC,
8639,GO:0032809,1,0.824495131844688,0,28,neuronal cell body membrane,CC,
8640,GO:0032810,1,0.988217983158894,0,2,sterol response element binding,MF,
8641,GO:0032811,1,0.984203184804777,0,3,negative regulation of epinephrine secretion,BP,
8642,GO:0032812,1,0.992716374461716,0,2,positive regulation of epinephrine secretion,BP,
8643,GO:0032813,1,0.780568410432612,0,45,tumor necrosis factor receptor superfamily binding,MF,
8644,GO:0032814,1,0.844274740924514,0,30,regulation of natural killer cell activation,BP,
8645,GO:0032815,1,0.962528363195551,0,8,negative regulation of natural killer cell activation,BP,
8646,GO:0032816,1,0.902625895021286,0,18,positive regulation of natural killer cell activation,BP,
8647,GO:0032817,1,0.959654444225592,0,8,regulation of natural killer cell proliferation,BP,
8648,GO:0032819,1,0.973754830166298,0,6,positive regulation of natural killer cell proliferation,BP,
8649,GO:0032823,1,0.934372706460343,0,11,regulation of natural killer cell differentiation,BP,
8650,GO:0032824,1,0.99668880855454,0,1,negative regulation of natural killer cell differentiation,BP,
8651,GO:0032825,1,0.948792141798376,0,8,positive regulation of natural killer cell differentiation,BP,
8652,GO:0032826,1,0.992572307535969,0,2,regulation of natural killer cell differentiation involved in immune response,BP,
8653,GO:0032827,1,0.99668880855454,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8654,GO:0032829,1,0.99010463260738,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8655,GO:0032831,1,0.99010463260738,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8656,GO:0032832,1,0.995833820986594,0,1,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8657,GO:0032834,1,0.995833820986594,0,1,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8659,GO:0032836,1,0.923998339746412,0,10,glomerular basement membrane development,BP,
8661,GO:0032839,1,0.787422638265262,0,34,dendrite cytoplasm,CC,
8662,GO:0032841,1,0.992519724978507,0,1,calcitonin binding,MF,
8663,GO:0032847,1,0.964133850663429,0,6,regulation of cellular pH reduction,BP,
8664,GO:0032848,1,0.992486142521301,0,1,negative regulation of cellular pH reduction,BP,
8665,GO:0032849,1,0.976744712153818,0,4,positive regulation of cellular pH reduction,BP,
8666,GO:0032868,1,0.171977073596479,0,260,response to insulin,BP,
8667,GO:0032869,1,0.238923591803791,0,208,cellular response to insulin stimulus,BP,
8670,GO:0032873,1,0.752263549355126,0,42,negative regulation of stress-activated MAPK cascade,BP,
8672,GO:0032875,1,0.971909292355098,0,4,regulation of DNA endoreduplication,BP,
8673,GO:0032876,1,0.994671846409404,0,1,negative regulation of DNA endoreduplication,BP,
8674,GO:0032877,1,0.984299608423451,0,2,positive regulation of DNA endoreduplication,BP,
8675,GO:0032878,1,0.848917787206973,0,21,regulation of establishment or maintenance of cell polarity,BP,
8678,GO:0032881,1,0.753071188520324,0,38,regulation of polysaccharide metabolic process,BP,
8679,GO:0032885,1,0.768645399262713,0,34,regulation of polysaccharide biosynthetic process,BP,
8681,GO:0032887,1,0.990917185225543,0,1,regulation of spindle elongation,BP,
8682,GO:0032888,1,0.990917185225543,0,1,regulation of mitotic spindle elongation,BP,
8683,GO:0032889,1,0.972973594599933,0,5,regulation of vacuole fusion, non-autophagic,BP,
8684,GO:0032890,1,0.702850082917028,0,54,regulation of organic acid transport,BP,
8685,GO:0032891,1,0.877068425132427,0,20,negative regulation of organic acid transport,BP,
8686,GO:0032892,1,0.818177023723435,0,31,positive regulation of organic acid transport,BP,
8687,GO:0032896,1,0.991895344472623,0,1,palmitoyl-CoA 9-desaturase activity,MF,
8688,GO:0032897,1,0.856979801013526,0,23,negative regulation of viral transcription,BP,
8690,GO:0032899,1,0.985663479529974,0,2,regulation of neurotrophin production,BP,
8691,GO:0032900,1,0.993130726822913,0,1,negative regulation of neurotrophin production,BP,
8692,GO:0032901,1,0.992481629833007,0,1,positive regulation of neurotrophin production,BP,
8694,GO:0032905,1,0.9272879409145,0,12,transforming growth factor beta1 production,BP,
8695,GO:0032906,1,0.94274760868737,0,8,transforming growth factor beta2 production,BP,
8696,GO:0032907,1,0.973848370001801,0,3,transforming growth factor beta3 production,BP,
8697,GO:0032908,1,0.933589347655804,0,11,regulation of transforming growth factor beta1 production,BP,
8698,GO:0032909,1,0.94274760868737,0,8,regulation of transforming growth factor beta2 production,BP,
8699,GO:0032910,1,0.973848370001801,0,3,regulation of transforming growth factor beta3 production,BP,
8700,GO:0032911,1,0.96863779742445,0,5,negative regulation of transforming growth factor beta1 production,BP,
8701,GO:0032912,1,0.985021630054066,0,2,negative regulation of transforming growth factor beta2 production,BP,
8702,GO:0032914,1,0.95653574988162,0,7,positive regulation of transforming growth factor beta1 production,BP,
8703,GO:0032915,1,0.990120787466309,0,2,positive regulation of transforming growth factor beta2 production,BP,
8704,GO:0032916,1,0.981286291708144,0,2,positive regulation of transforming growth factor beta3 production,BP,
8705,GO:0032917,1,0.993258548391288,0,2,polyamine acetylation,BP,
8706,GO:0032918,1,0.993258548391288,0,2,spermidine acetylation,BP,
8707,GO:0032919,1,0.996680162456057,0,1,spermine acetylation,BP,
8708,GO:0032920,1,0.996680162456057,0,1,putrescine acetylation,BP,
8710,GO:0032924,1,0.772893029244085,0,39,activin receptor signaling pathway,BP,
8711,GO:0032925,1,0.85816508647998,0,24,regulation of activin receptor signaling pathway,BP,
8712,GO:0032926,1,0.937614116094061,0,10,negative regulation of activin receptor signaling pathway,BP,
8713,GO:0032927,1,0.943420818025661,0,8,positive regulation of activin receptor signaling pathway,BP,
8715,GO:0032929,1,0.992507688959204,0,2,negative regulation of superoxide anion generation,BP,
8717,GO:0032933,1,0.91270214694296,0,13,SREBP signaling pathway,BP,
8719,GO:0032937,1,0.979547176103271,0,3,SREBP-SCAP-Insig complex,CC,
8721,GO:0032941,1,0.826190409096232,0,31,secretion by tissue,BP,
8725,GO:0032946,1,0.488739603913894,0,124,positive regulation of mononuclear cell proliferation,BP,
8726,GO:0032954,1,0.976687508552297,0,3,regulation of cytokinetic process,BP,
8728,GO:0032957,1,0.933187585270143,0,10,inositol trisphosphate metabolic process,BP,
8729,GO:0032958,1,0.850488736902273,0,24,inositol phosphate biosynthetic process,BP,
8730,GO:0032959,1,0.952354010840755,0,7,inositol trisphosphate biosynthetic process,BP,
8731,GO:0032960,1,0.966938349215779,0,5,regulation of inositol trisphosphate biosynthetic process,BP,
8732,GO:0032962,1,0.974348048839201,0,4,positive regulation of inositol trisphosphate biosynthetic process,BP,
8734,GO:0032964,1,0.779421827784588,0,40,collagen biosynthetic process,BP,
8735,GO:0032965,1,0.830201585247268,0,31,regulation of collagen biosynthetic process,BP,
8736,GO:0032966,1,0.945700041729544,0,10,negative regulation of collagen biosynthetic process,BP,
8737,GO:0032967,1,0.877935089469169,0,21,positive regulation of collagen biosynthetic process,BP,
8738,GO:0032968,1,0.921678009484801,0,11,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8740,GO:0032971,1,0.982523907192378,0,3,regulation of muscle filament sliding,BP,
8741,GO:0032972,1,0.996805933199831,0,1,regulation of muscle filament sliding speed,BP,
8742,GO:0032976,1,0.996762136804637,0,1,release of matrix enzymes from mitochondria,BP,
8743,GO:0032977,1,0.98810806257742,0,2,membrane insertase activity,MF,
8744,GO:0032978,1,0.984183319614168,0,3,protein insertion into membrane from inner side,BP,
8745,GO:0032979,1,0.984183319614168,0,3,protein insertion into mitochondrial inner membrane from matrix,BP,
8746,GO:0032981,1,0.790885355378153,0,56,mitochondrial respiratory chain complex I assembly,BP,
8747,GO:0032982,1,0.852260163212595,0,20,myosin filament,CC,
8748,GO:0032983,1,0.968089241359884,0,4,kainate selective glutamate receptor complex,CC,
8750,GO:0032986,1,0.89452886111858,0,17,protein-DNA complex disassembly,BP,
8751,GO:0032988,1,0.953598542892608,0,7,ribonucleoprotein complex disassembly,BP,
8756,GO:0032994,1,0.839175436784678,0,33,protein-lipid complex,CC,
8757,GO:0032996,1,0.995425834090599,0,1,Bcl3-Bcl10 complex,CC,
8758,GO:0032997,1,0.992609688240979,0,2,Fc receptor complex,CC,
8759,GO:0032998,1,0.992609688240979,0,2,Fc-epsilon receptor I complex,CC,
8761,GO:0033003,1,0.792808885258987,0,39,regulation of mast cell activation,BP,
8762,GO:0033004,1,0.933883064205935,0,12,negative regulation of mast cell activation,BP,
8763,GO:0033005,1,0.899785725383481,0,18,positive regulation of mast cell activation,BP,
8764,GO:0033006,1,0.836820498237499,0,30,regulation of mast cell activation involved in immune response,BP,
8765,GO:0033007,1,0.956412454427618,0,8,negative regulation of mast cell activation involved in immune response,BP,
8766,GO:0033008,1,0.922251834258558,0,14,positive regulation of mast cell activation involved in immune response,BP,
8767,GO:0033010,1,0.945590003801111,0,8,paranodal junction,CC,
8768,GO:0033011,1,0.984717644639259,0,3,perinuclear theca,CC,
8769,GO:0033013,1,0.7323341989966,0,52,tetrapyrrole metabolic process,BP,
8770,GO:0033014,1,0.853659028715215,0,26,tetrapyrrole biosynthetic process,BP,
8771,GO:0033015,1,0.985165219453117,0,4,tetrapyrrole catabolic process,BP,
8772,GO:0033017,1,0.764063732965661,0,36,sarcoplasmic reticulum membrane,CC,
8773,GO:0033018,1,0.946586367040952,0,9,sarcoplasmic reticulum lumen,CC,
8774,GO:0033023,1,0.981411548673203,0,3,mast cell homeostasis,BP,
8775,GO:0033024,1,0.981411548673203,0,3,mast cell apoptotic process,BP,
8776,GO:0033025,1,0.981411548673203,0,3,regulation of mast cell apoptotic process,BP,
8777,GO:0033026,1,0.988796836747895,0,2,negative regulation of mast cell apoptotic process,BP,
8778,GO:0033028,1,0.832846729044866,0,29,myeloid cell apoptotic process,BP,
8779,GO:0033029,1,0.949588487682146,0,7,regulation of neutrophil apoptotic process,BP,
8780,GO:0033030,1,0.984821144460624,0,2,negative regulation of neutrophil apoptotic process,BP,
8781,GO:0033031,1,0.974356943515514,0,4,positive regulation of neutrophil apoptotic process,BP,
8782,GO:0033032,1,0.851309396190547,0,25,regulation of myeloid cell apoptotic process,BP,
8783,GO:0033033,1,0.925715265779259,0,13,negative regulation of myeloid cell apoptotic process,BP,
8784,GO:0033034,1,0.955411153301467,0,7,positive regulation of myeloid cell apoptotic process,BP,
8786,GO:0033037,1,0.98380428631057,0,2,polysaccharide localization,BP,
8787,GO:0033038,1,0.972106505799142,0,8,bitter taste receptor activity,MF,
8788,GO:0033040,1,0.992832537670157,0,1,sour taste receptor activity,MF,
8789,GO:0033041,1,0.993696128496363,0,1,sweet taste receptor activity,MF,
8791,GO:0033044,1,0.107862041896643,0,319,regulation of chromosome organization,BP,
8792,GO:0033045,1,0.600539033276156,0,76,regulation of sister chromatid segregation,BP,
8793,GO:0033046,1,0.764525693470872,0,41,negative regulation of sister chromatid segregation,BP,
8794,GO:0033047,1,0.641254032847158,0,66,regulation of mitotic sister chromatid segregation,BP,
8795,GO:0033048,1,0.771311234066105,0,40,negative regulation of mitotic sister chromatid segregation,BP,
8796,GO:0033058,1,0.973199127456037,0,3,directional locomotion,BP,
8797,GO:0033059,1,0.713834694707079,0,52,cellular pigmentation,BP,
8798,GO:0033061,1,0.956939041816454,0,7,DNA recombinase mediator complex,CC,
8799,GO:0033063,1,0.976244240842009,0,4,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8800,GO:0033065,1,0.990307526334655,0,2,Rad51C-XRCC3 complex,CC,
8801,GO:0033076,1,0.986441265581873,0,3,isoquinoline alkaloid metabolic process,BP,
8803,GO:0033078,1,0.983895433962705,0,3,extrathymic T cell differentiation,BP,
8804,GO:0033079,1,0.945405918984289,0,10,immature T cell proliferation,BP,
8805,GO:0033080,1,0.955530574693108,0,8,immature T cell proliferation in thymus,BP,
8806,GO:0033081,1,0.858876632530751,0,25,regulation of T cell differentiation in thymus,BP,
8807,GO:0033082,1,0.988082549244125,0,2,regulation of extrathymic T cell differentiation,BP,
8808,GO:0033083,1,0.952572800981956,0,9,regulation of immature T cell proliferation,BP,
8809,GO:0033084,1,0.962773418753722,0,7,regulation of immature T cell proliferation in thymus,BP,
8810,GO:0033085,1,0.964088364434287,0,7,negative regulation of T cell differentiation in thymus,BP,
8811,GO:0033087,1,0.978727547132848,0,4,negative regulation of immature T cell proliferation,BP,
8812,GO:0033088,1,0.982898705467321,0,3,negative regulation of immature T cell proliferation in thymus,BP,
8813,GO:0033089,1,0.922968854589109,0,13,positive regulation of T cell differentiation in thymus,BP,
8814,GO:0033091,1,0.973282576597832,0,5,positive regulation of immature T cell proliferation,BP,
8815,GO:0033092,1,0.979528127409902,0,4,positive regulation of immature T cell proliferation in thymus,BP,
8816,GO:0033093,1,0.963070050636366,0,5,Weibel-Palade body,CC,
8817,GO:0033100,1,0.99472623237241,0,1,NuA3 histone acetyltransferase complex,CC,
8819,GO:0033108,1,0.658021176049564,0,90,mitochondrial respiratory chain complex assembly,BP,
8820,GO:0033116,1,0.652219193835816,0,68,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8821,GO:0033119,1,0.851724023516385,0,26,negative regulation of RNA splicing,BP,
8822,GO:0033120,1,0.793598837920349,0,35,positive regulation of RNA splicing,BP,
8823,GO:0033127,1,0.926401922180991,0,12,regulation of histone phosphorylation,BP,
8824,GO:0033128,1,0.98941510666158,0,2,negative regulation of histone phosphorylation,BP,
8825,GO:0033129,1,0.948298567167729,0,8,positive regulation of histone phosphorylation,BP,
8826,GO:0033130,1,0.932233026591478,0,11,acetylcholine receptor binding,MF,
8827,GO:0033131,1,0.948178571093513,0,9,regulation of glucokinase activity,BP,
8828,GO:0033132,1,0.977888469896069,0,4,negative regulation of glucokinase activity,BP,
8829,GO:0033133,1,0.969625145260628,0,5,positive regulation of glucokinase activity,BP,
8831,GO:0033137,1,0.850217482856976,0,25,negative regulation of peptidyl-serine phosphorylation,BP,
8833,GO:0033139,1,0.976625855314832,0,4,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8834,GO:0033140,1,0.991775904033769,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8835,GO:0033141,1,0.984725601540515,0,2,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8836,GO:0033142,1,0.976583437470244,0,3,progesterone receptor binding,MF,
8837,GO:0033143,1,0.617945547856743,0,70,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8838,GO:0033144,1,0.795414834004136,0,33,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8839,GO:0033145,1,0.927570270729955,0,11,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8840,GO:0033146,1,0.783694921878636,0,35,regulation of intracellular estrogen receptor signaling pathway,BP,
8841,GO:0033147,1,0.919299014538476,0,12,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8842,GO:0033148,1,0.939318619137674,0,9,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8843,GO:0033149,1,0.980253075012955,0,3,FFAT motif binding,MF,
8844,GO:0033150,1,0.990364767644916,0,2,cytoskeletal calyx,CC,
8845,GO:0033151,1,0.906769240676855,0,13,V(D)J recombination,BP,
8846,GO:0033152,1,0.96533522409418,0,5,immunoglobulin V(D)J recombination,BP,
8847,GO:0033153,1,0.957227201745024,0,5,T cell receptor V(D)J recombination,BP,
8850,GO:0033165,1,0.964244627945113,0,5,interphotoreceptor matrix,CC,
8851,GO:0033167,1,0.989293773553224,0,1,ARC complex,CC,
8852,GO:0033168,1,0.989293773553224,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8853,GO:0033169,1,0.902806300348771,0,13,histone H3-K9 demethylation,BP,
8854,GO:0033170,1,0.948656233205234,0,9,protein-DNA loading ATPase activity,MF,
8856,GO:0033176,1,0.874849466793656,0,25,proton-transporting V-type ATPase complex,CC,
8857,GO:0033177,1,0.944995779581058,0,10,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8858,GO:0033178,1,0.941282714118962,0,11,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8859,GO:0033179,1,0.944995779581058,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8860,GO:0033180,1,0.949329562325226,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8861,GO:0033181,1,0.981734500261442,0,4,plasma membrane proton-transporting V-type ATPase complex,CC,
8862,GO:0033182,1,0.91986233622896,0,12,regulation of histone ubiquitination,BP,
8863,GO:0033183,1,0.967994546119597,0,4,negative regulation of histone ubiquitination,BP,
8864,GO:0033184,1,0.964516080281714,0,5,positive regulation of histone ubiquitination,BP,
8865,GO:0033185,1,0.989573153351681,0,3,dolichol-phosphate-mannose synthase complex,CC,
8866,GO:0033186,1,0.977656801596704,0,3,CAF-1 complex,CC,
8867,GO:0033188,1,0.980250193763463,0,3,sphingomyelin synthase activity,MF,
8868,GO:0033189,1,0.896945592231974,0,17,response to vitamin A,BP,
8869,GO:0033192,1,0.962716550428738,0,5,calmodulin-dependent protein phosphatase activity,MF,
8870,GO:0033193,1,0.992141371525741,0,1,Lsd1/2 complex,CC,
8872,GO:0033197,1,0.935751575651251,0,11,response to vitamin E,BP,
8873,GO:0033198,1,0.804676905126159,0,34,response to ATP,BP,
8874,GO:0033202,1,0.924310619792943,0,15,DNA helicase complex,CC,
8875,GO:0033204,1,0.950042061826249,0,10,ribonuclease P RNA binding,MF,
8876,GO:0033206,1,0.962341278605416,0,5,meiotic cytokinesis,BP,
8878,GO:0033210,1,0.936197732418891,0,11,leptin-mediated signaling pathway,BP,
8879,GO:0033211,1,0.953964810964192,0,7,adiponectin-activated signaling pathway,BP,
8880,GO:0033212,1,0.957742018080399,0,7,iron import into cell,BP,
8881,GO:0033214,1,0.994152611553279,0,1,siderophore-dependent iron import into cell,BP,
8882,GO:0033215,1,0.993616242169373,0,1,reductive iron assimilation,BP,
8884,GO:0033220,1,0.963558643985346,0,5,ATPase-coupled amide-transporter activity,MF,
8885,GO:0033227,1,0.981284665076225,0,3,dsRNA transport,BP,
8886,GO:0033229,1,0.992500590259723,0,1,cysteine transmembrane transporter activity,MF,
8889,GO:0033235,1,0.922879836329967,0,13,positive regulation of protein sumoylation,BP,
8890,GO:0033238,1,0.681566422310342,0,75,regulation of cellular amine metabolic process,BP,
8891,GO:0033239,1,0.962364255145954,0,5,negative regulation of cellular amine metabolic process,BP,
8892,GO:0033240,1,0.950360914243329,0,9,positive regulation of cellular amine metabolic process,BP,
8893,GO:0033241,1,0.990038223672271,0,1,regulation of cellular amine catabolic process,BP,
8894,GO:0033242,1,0.990038223672271,0,1,negative regulation of cellular amine catabolic process,BP,
8895,GO:0033256,1,0.976922125153055,0,4,I-kappaB/NF-kappaB complex,CC,
8896,GO:0033257,1,0.988286612432084,0,2,Bcl3/NF-kappaB2 complex,CC,
8897,GO:0033260,1,0.688711559197184,0,58,nuclear DNA replication,BP,
8898,GO:0033262,1,0.891747218873549,0,16,regulation of nuclear cell cycle DNA replication,BP,
8899,GO:0033263,1,0.965073642451624,0,5,CORVET complex,CC,
8900,GO:0033265,1,0.987411533139954,0,2,choline binding,MF,
8905,GO:0033274,1,0.990943136753218,0,1,response to vitamin B2,BP,
8906,GO:0033275,1,0.795132850174387,0,35,actin-myosin filament sliding,BP,
8907,GO:0033276,1,0.91806880799393,0,13,transcription factor TFTC complex,CC,
8908,GO:0033277,1,0.985921749665335,0,2,abortive mitotic cell cycle,BP,
8909,GO:0033278,1,0.963258061041507,0,5,cell proliferation in midbrain,BP,
8910,GO:0033280,1,0.817614788914621,0,31,response to vitamin D,BP,
8911,GO:0033283,1,0.984830601179848,0,2,ATPase-coupled organic acid transmembrane transporter activity,MF,
8912,GO:0033284,1,0.984830601179848,0,2,ATPase-coupled carboxylic acid transmembrane transporter activity,MF,
8913,GO:0033285,1,0.984830601179848,0,2,ATPase-coupled monocarboxylic acid transmembrane transporter activity,MF,
8914,GO:0033290,1,0.931301329868642,0,14,eukaryotic 48S preinitiation complex,CC,
8915,GO:0033291,1,0.99687060107113,0,1,eukaryotic 80S initiation complex,CC,
8916,GO:0033292,1,0.936591923860416,0,9,T-tubule organization,BP,
8917,GO:0033293,1,0.7249710994452,0,59,monocarboxylic acid binding,MF,
8918,GO:0033299,1,0.965397526227612,0,6,secretion of lysosomal enzymes,BP,
8919,GO:0033300,1,0.955883404400838,0,7,dehydroascorbic acid transmembrane transporter activity,MF,
8920,GO:0033301,1,0.992501742510981,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8921,GO:0033306,1,0.98793239519143,0,2,phytol metabolic process,BP,
8922,GO:0033313,1,0.968393182359123,0,5,meiotic cell cycle checkpoint,BP,
8923,GO:0033314,1,0.944253600545687,0,9,mitotic DNA replication checkpoint,BP,
8924,GO:0033316,1,0.992866031482335,0,1,meiotic spindle assembly checkpoint,BP,
8925,GO:0033319,1,0.994872959551596,0,1,UDP-D-xylose metabolic process,BP,
8926,GO:0033320,1,0.994872959551596,0,1,UDP-D-xylose biosynthetic process,BP,
8927,GO:0033326,1,0.97481596445537,0,3,cerebrospinal fluid secretion,BP,
8929,GO:0033328,1,0.985295689283676,0,2,peroxisome membrane targeting sequence binding,MF,
8930,GO:0033341,1,0.984374510910861,0,2,regulation of collagen binding,BP,
8931,GO:0033342,1,0.993775703705492,0,1,negative regulation of collagen binding,BP,
8932,GO:0033343,1,0.990540524182423,0,1,positive regulation of collagen binding,BP,
8933,GO:0033344,1,0.774748496353858,0,39,cholesterol efflux,BP,
8934,GO:0033345,1,0.994131044673793,0,1,asparagine catabolic process via L-aspartate,BP,
8935,GO:0033353,1,0.956679414771357,0,7,S-adenosylmethionine cycle,BP,
8937,GO:0033364,1,0.984205216225959,0,2,mast cell secretory granule organization,BP,
8939,GO:0033366,1,0.978264058529632,0,4,protein localization to secretory granule,BP,
8940,GO:0033367,1,0.996442891634027,0,1,protein localization to mast cell secretory granule,BP,
8941,GO:0033368,1,0.996442891634027,0,1,protease localization to mast cell secretory granule,BP,
8942,GO:0033370,1,0.996442891634027,0,1,maintenance of protein location in mast cell secretory granule,BP,
8943,GO:0033371,1,0.996442891634027,0,1,T cell secretory granule organization,BP,
8944,GO:0033373,1,0.996442891634027,0,1,maintenance of protease location in mast cell secretory granule,BP,
8945,GO:0033374,1,0.996442891634027,0,1,protein localization to T cell secretory granule,BP,
8946,GO:0033375,1,0.996442891634027,0,1,protease localization to T cell secretory granule,BP,
8947,GO:0033377,1,0.996442891634027,0,1,maintenance of protein location in T cell secretory granule,BP,
8948,GO:0033379,1,0.996442891634027,0,1,maintenance of protease location in T cell secretory granule,BP,
8949,GO:0033380,1,0.996442891634027,0,1,granzyme B localization to T cell secretory granule,BP,
8950,GO:0033382,1,0.996442891634027,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
8951,GO:0033383,1,0.989349687133149,0,2,geranyl diphosphate metabolic process,BP,
8952,GO:0033384,1,0.989349687133149,0,2,geranyl diphosphate biosynthetic process,BP,
8953,GO:0033385,1,0.993179747112353,0,1,geranylgeranyl diphosphate metabolic process,BP,
8954,GO:0033386,1,0.993179747112353,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8955,GO:0033387,1,0.980726993687995,0,3,putrescine biosynthetic process from ornithine,BP,
8956,GO:0033388,1,0.994601773904378,0,1,putrescine biosynthetic process from arginine,BP,
8957,GO:0033389,1,0.994601773904378,0,1,putrescine biosynthetic process from arginine, using agmatinase,BP,
8958,GO:0033391,1,0.915874901707492,0,12,chromatoid body,CC,
8959,GO:0033396,1,0.994929099003046,0,1,beta-alanine biosynthetic process via 3-ureidopropionate,BP,
8960,GO:0033477,1,0.995122446774223,0,1,S-methylmethionine metabolic process,BP,
8961,GO:0033483,1,0.940171685461529,0,10,gas homeostasis,BP,
8962,GO:0033484,1,0.982533138367872,0,3,nitric oxide homeostasis,BP,
8963,GO:0033489,1,0.975899077040711,0,4,cholesterol biosynthetic process via desmosterol,BP,
8964,GO:0033490,1,0.975899077040711,0,4,cholesterol biosynthetic process via lathosterol,BP,
8965,GO:0033499,1,0.986219759608848,0,3,galactose catabolic process via UDP-galactose,BP,
8967,GO:0033503,1,0.974265320339786,0,4,HULC complex,CC,
8968,GO:0033504,1,0.956663444108688,0,6,floor plate development,BP,
8969,GO:0033505,1,0.986095385376404,0,2,floor plate morphogenesis,BP,
8970,GO:0033512,1,0.979439508847973,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
8971,GO:0033514,1,0.994044132206603,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
8972,GO:0033522,1,0.837837318429822,0,25,histone H2A ubiquitination,BP,
8973,GO:0033523,1,0.922317810922873,0,12,histone H2B ubiquitination,BP,
8974,GO:0033539,1,0.94623287567719,0,10,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
8975,GO:0033540,1,0.918292899855081,0,14,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
8976,GO:0033549,1,0.926418995891812,0,12,MAP kinase phosphatase activity,MF,
8977,GO:0033553,1,0.971910848120171,0,4,rDNA heterochromatin,CC,
8980,GO:0033557,1,0.986555151512788,0,2,Slx1-Slx4 complex,CC,
8981,GO:0033558,1,0.836805893229495,0,26,protein deacetylase activity,MF,
8982,GO:0033559,1,0.577242897478712,0,98,unsaturated fatty acid metabolic process,BP,
8984,GO:0033563,1,0.976608432024436,0,3,dorsal/ventral axon guidance,BP,
8985,GO:0033564,1,0.953341458555215,0,6,anterior/posterior axon guidance,BP,
8986,GO:0033565,1,0.97785726691702,0,3,ESCRT-0 complex,CC,
8987,GO:0033566,1,0.98732901665595,0,2,gamma-tubulin complex localization,BP,
8988,GO:0033567,1,0.985215620093687,0,2,DNA replication, Okazaki fragment processing,BP,
8990,GO:0033574,1,0.791988605339135,0,39,response to testosterone,BP,
8991,GO:0033577,1,0.989264567519027,0,2,protein glycosylation in endoplasmic reticulum,BP,
8992,GO:0033578,1,0.966461422835433,0,5,protein glycosylation in Golgi,BP,
8993,GO:0033588,1,0.965317245017367,0,6,Elongator holoenzyme complex,CC,
8995,GO:0033591,1,0.96730257436666,0,5,response to L-ascorbic acid,BP,
8996,GO:0033592,1,0.964347273806464,0,5,RNA strand annealing activity,MF,
8997,GO:0033593,1,0.988726747768562,0,1,BRCA2-MAGE-D1 complex,CC,
8999,GO:0033595,1,0.987222976226984,0,2,response to genistein,BP,
9000,GO:0033596,1,0.982046761668467,0,2,TSC1-TSC2 complex,CC,
9001,GO:0033597,1,0.99471717727404,0,1,mitotic checkpoint complex,CC,
9002,GO:0033598,1,0.837521842655081,0,26,mammary gland epithelial cell proliferation,BP,
9003,GO:0033599,1,0.897895469435843,0,16,regulation of mammary gland epithelial cell proliferation,BP,
9004,GO:0033600,1,0.968915248285854,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
9005,GO:0033601,1,0.949488157059545,0,7,positive regulation of mammary gland epithelial cell proliferation,BP,
9006,GO:0033602,1,0.96971946314016,0,4,negative regulation of dopamine secretion,BP,
9007,GO:0033603,1,0.962637878461003,0,6,positive regulation of dopamine secretion,BP,
9008,GO:0033604,1,0.932045429371284,0,11,negative regulation of catecholamine secretion,BP,
9009,GO:0033605,1,0.93637146592376,0,11,positive regulation of catecholamine secretion,BP,
9010,GO:0033609,1,0.99325505912211,0,1,oxalate metabolic process,BP,
9011,GO:0033612,1,0.861779585892824,0,24,receptor serine/threonine kinase binding,MF,
9012,GO:0033613,1,0.607848435705468,0,74,activating transcription factor binding,MF,
9013,GO:0033615,1,0.983170473507513,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9014,GO:0033617,1,0.890068024065811,0,21,mitochondrial cytochrome c oxidase assembly,BP,
9016,GO:0033622,1,0.849039503513738,0,24,integrin activation,BP,
9017,GO:0033623,1,0.906121006566583,0,15,regulation of integrin activation,BP,
9018,GO:0033624,1,0.976145221008737,0,3,negative regulation of integrin activation,BP,
9019,GO:0033625,1,0.948613742510676,0,9,positive regulation of integrin activation,BP,
9020,GO:0033626,1,0.988677880264227,0,2,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9021,GO:0033627,1,0.645389743800397,0,65,cell adhesion mediated by integrin,BP,
9022,GO:0033628,1,0.754820404433969,0,45,regulation of cell adhesion mediated by integrin,BP,
9023,GO:0033629,1,0.928737215521811,0,10,negative regulation of cell adhesion mediated by integrin,BP,
9024,GO:0033630,1,0.89152854461534,0,20,positive regulation of cell adhesion mediated by integrin,BP,
9025,GO:0033631,1,0.90303046884556,0,15,cell-cell adhesion mediated by integrin,BP,
9026,GO:0033632,1,0.938890785242412,0,10,regulation of cell-cell adhesion mediated by integrin,BP,
9027,GO:0033633,1,0.981553946661525,0,2,negative regulation of cell-cell adhesion mediated by integrin,BP,
9028,GO:0033634,1,0.973736745848493,0,5,positive regulation of cell-cell adhesion mediated by integrin,BP,
9029,GO:0033643,1,0.914839539504711,0,13,host cell part,CC,
9030,GO:0033646,1,0.921980762614441,0,12,host intracellular part,CC,
9031,GO:0033647,1,0.944831900613885,0,8,host intracellular organelle,CC,
9032,GO:0033648,1,0.944831900613885,0,8,host intracellular membrane-bounded organelle,CC,
9033,GO:0033650,1,0.995674493172775,0,1,host cell mitochondrion,CC,
9034,GO:0033655,1,0.964386410474859,0,6,host cell cytoplasm part,CC,
9035,GO:0033668,1,0.976438185178785,0,4,negative regulation by symbiont of host apoptotic process,BP,
9036,GO:0033673,1,0.221824656997129,0,231,negative regulation of kinase activity,BP,
9038,GO:0033677,1,0.979249165468657,0,3,DNA/RNA helicase activity,MF,
9039,GO:0033678,1,0.993463485285701,0,1,5'-3' DNA/RNA helicase activity,MF,
9040,GO:0033679,1,0.992305235802394,0,1,3'-5' DNA/RNA helicase activity,MF,
9041,GO:0033683,1,0.797925124616116,0,39,nucleotide-excision repair, DNA incision,BP,
9042,GO:0033684,1,0.963469517611423,0,6,regulation of luteinizing hormone secretion,BP,
9043,GO:0033685,1,0.990477773915554,0,2,negative regulation of luteinizing hormone secretion,BP,
9044,GO:0033686,1,0.972734720452641,0,4,positive regulation of luteinizing hormone secretion,BP,
9051,GO:0033693,1,0.985606778225494,0,2,neurofilament bundle assembly,BP,
9052,GO:0033695,1,0.995285386751004,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9053,GO:0033699,1,0.995055285925821,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9054,GO:0033700,1,0.95128734112392,0,8,phospholipid efflux,BP,
9055,GO:0033721,1,0.993167686169431,0,1,aldehyde dehydrogenase (NADP+) activity,MF,
9056,GO:0033735,1,0.996691232836623,0,1,aspartate dehydrogenase activity,MF,
9057,GO:0033737,1,0.993820945546778,0,1,1-pyrroline dehydrogenase activity,MF,
9058,GO:0033743,1,0.977752008271478,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9059,GO:0033744,1,0.996149830842483,0,1,L-methionine:thioredoxin-disulfide S-oxidoreductase activity,MF,
9060,GO:0033745,1,0.981337136975344,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
9061,GO:0033746,1,0.992518692750008,0,1,histone demethylase activity (H3-R2 specific),MF,
9062,GO:0033749,1,0.992518692750008,0,1,histone demethylase activity (H4-R3 specific),MF,
9063,GO:0033750,1,0.924000267859335,0,14,ribosome localization,BP,
9064,GO:0033754,1,0.996010391093328,0,1,indoleamine 2,3-dioxygenase activity,MF,
9065,GO:0033762,1,0.803364657217162,0,32,response to glucagon,BP,
9066,GO:0033764,1,0.897348073035744,0,25,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
9067,GO:0033765,1,0.987943447199859,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9068,GO:0033781,1,0.994890857381385,0,1,cholesterol 24-hydroxylase activity,MF,
9069,GO:0033783,1,0.994091867412586,0,1,25-hydroxycholesterol 7alpha-hydroxylase activity,MF,
9070,GO:0033787,1,0.99311926768676,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9071,GO:0033791,1,0.994290774062892,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9072,GO:0033798,1,0.986278752840148,0,2,thyroxine 5-deiodinase activity,MF,
9073,GO:0033814,1,0.996237631735038,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9074,GO:0033819,1,0.996685133878202,0,1,lipoyl(octanoyl) transferase activity,MF,
9075,GO:0033823,1,0.992915216962892,0,1,procollagen glucosyltransferase activity,MF,
9076,GO:0033829,1,0.985168255868651,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9077,GO:0033842,1,0.985182193316465,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9078,GO:0033857,1,0.983847577166758,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9079,GO:0033858,1,0.992731163560856,0,1,N-acetylgalactosamine kinase activity,MF,
9080,GO:0033860,1,0.946251375552459,0,10,regulation of NAD(P)H oxidase activity,BP,
9081,GO:0033861,1,0.990585430969047,0,2,negative regulation of NAD(P)H oxidase activity,BP,
9082,GO:0033862,1,0.986072015178764,0,2,UMP kinase activity,MF,
9083,GO:0033864,1,0.962334676250745,0,7,positive regulation of NAD(P)H oxidase activity,BP,
9084,GO:0033865,1,0.473445207677435,0,124,nucleoside bisphosphate metabolic process,BP,
9085,GO:0033866,1,0.661428385506124,0,63,nucleoside bisphosphate biosynthetic process,BP,
9086,GO:0033867,1,0.995883640207235,0,1,Fas-activated serine/threonine kinase activity,MF,
9087,GO:0033869,1,0.974855170191384,0,5,nucleoside bisphosphate catabolic process,BP,
9088,GO:0033871,1,0.995237360435577,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9089,GO:0033872,1,0.988843892841365,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9090,GO:0033875,1,0.473445207677435,0,124,ribonucleoside bisphosphate metabolic process,BP,
9091,GO:0033878,1,0.98254526284538,0,2,hormone-sensitive lipase activity,MF,
9092,GO:0033882,1,0.989135236184959,0,2,choloyl-CoA hydrolase activity,MF,
9093,GO:0033883,1,0.991683431462394,0,2,pyridoxal phosphatase activity,MF,
9094,GO:0033885,1,0.994575796660225,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9095,GO:0033897,1,0.996442891634027,0,1,ribonuclease T2 activity,MF,
9096,GO:0033906,1,0.989851823613554,0,2,hyaluronoglucuronidase activity,MF,
9097,GO:0033919,1,0.992479679234636,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9098,GO:0033925,1,0.992351701786639,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9099,GO:0033961,1,0.995683740874111,0,1,cis-stilbene-oxide hydrolase activity,MF,
9100,GO:0033962,1,0.862971779852009,0,19,P-body assembly,BP,
9101,GO:0033967,1,0.991063637767373,0,2,box C/D snoRNA metabolic process,BP,
9102,GO:0033979,1,0.979114808718021,0,3,box H/ACA snoRNA metabolic process,BP,
9103,GO:0033981,1,0.996822034218773,0,1,D-dopachrome decarboxylase activity,MF,
9104,GO:0033989,1,0.993407348688705,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9106,GO:0034014,1,0.994364317703459,0,1,response to triglyceride,BP,
9107,GO:0034030,1,0.661428385506124,0,63,ribonucleoside bisphosphate biosynthetic process,BP,
9108,GO:0034031,1,0.974855170191384,0,5,ribonucleoside bisphosphate catabolic process,BP,
9109,GO:0034032,1,0.473445207677435,0,124,purine nucleoside bisphosphate metabolic process,BP,
9110,GO:0034033,1,0.661428385506124,0,63,purine nucleoside bisphosphate biosynthetic process,BP,
9111,GO:0034034,1,0.974855170191384,0,5,purine nucleoside bisphosphate catabolic process,BP,
9112,GO:0034035,1,0.890261708636018,0,21,purine ribonucleoside bisphosphate metabolic process,BP,
9113,GO:0034036,1,0.959860580519335,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9114,GO:0034038,1,0.996505826039662,0,1,deoxyhypusine synthase activity,MF,
9115,GO:0034039,1,0.990815265681807,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9116,GO:0034040,1,0.959848733882149,0,5,ATPase-coupled lipid transmembrane transporter activity,MF,
9117,GO:0034041,1,0.992920808018553,0,1,ATPase-coupled sterol transmembrane transporter activity,MF,
9118,GO:0034045,1,0.891694910400034,0,16,phagophore assembly site membrane,CC,
9119,GO:0034046,1,0.942111293373903,0,8,poly(G) binding,MF,
9120,GO:0034056,1,0.970896545408371,0,4,estrogen response element binding,MF,
9121,GO:0034057,1,0.986303656731138,0,2,RNA strand-exchange activity,MF,
9122,GO:0034058,1,0.937294434336307,0,9,endosomal vesicle fusion,BP,
9123,GO:0034059,1,0.983260688418138,0,2,response to anoxia,BP,
9124,GO:0034061,1,0.818231759534952,0,29,DNA polymerase activity,MF,
9125,GO:0034062,1,0.803030426039252,0,39,5'-3' RNA polymerase activity,MF,
9126,GO:0034063,1,0.838552223357278,0,23,stress granule assembly,BP,
9127,GO:0034066,1,0.989667404829459,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9128,GO:0034067,1,0.818005520379025,0,25,protein localization to Golgi apparatus,BP,
9129,GO:0034080,1,0.862214329493973,0,26,CENP-A containing nucleosome assembly,BP,
9130,GO:0034085,1,0.949982330809529,0,7,establishment of sister chromatid cohesion,BP,
9131,GO:0034086,1,0.934474758640603,0,9,maintenance of sister chromatid cohesion,BP,
9132,GO:0034087,1,0.981960593808481,0,2,establishment of mitotic sister chromatid cohesion,BP,
9133,GO:0034088,1,0.934474758640603,0,9,maintenance of mitotic sister chromatid cohesion,BP,
9134,GO:0034091,1,0.963787507319831,0,5,regulation of maintenance of sister chromatid cohesion,BP,
9135,GO:0034092,1,0.975388846389661,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
9136,GO:0034093,1,0.98810893881131,0,2,positive regulation of maintenance of sister chromatid cohesion,BP,
9138,GO:0034098,1,0.952131742269963,0,7,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9139,GO:0034101,1,0.454515825278325,0,121,erythrocyte homeostasis,BP,
9145,GO:0034111,1,0.904058260432692,0,15,negative regulation of homotypic cell-cell adhesion,BP,
9150,GO:0034116,1,0.926843330712352,0,14,positive regulation of heterotypic cell-cell adhesion,BP,
9151,GO:0034117,1,0.996843498798613,0,1,erythrocyte aggregation,BP,
9152,GO:0034118,1,0.996843498798613,0,1,regulation of erythrocyte aggregation,BP,
9153,GO:0034120,1,0.996843498798613,0,1,positive regulation of erythrocyte aggregation,BP,
9154,GO:0034121,1,0.647905610722116,0,65,regulation of toll-like receptor signaling pathway,BP,
9155,GO:0034122,1,0.784104133063408,0,36,negative regulation of toll-like receptor signaling pathway,BP,
9156,GO:0034123,1,0.855325689746876,0,24,positive regulation of toll-like receptor signaling pathway,BP,
9157,GO:0034124,1,0.978896990539808,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9158,GO:0034125,1,0.991054892290525,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9159,GO:0034127,1,0.951029487780717,0,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9160,GO:0034128,1,0.955652853147927,0,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9161,GO:0034130,1,0.993117642408701,0,1,toll-like receptor 1 signaling pathway,BP,
9162,GO:0034134,1,0.910108460998648,0,14,toll-like receptor 2 signaling pathway,BP,
9163,GO:0034135,1,0.941249462062439,0,9,regulation of toll-like receptor 2 signaling pathway,BP,
9164,GO:0034136,1,0.969236132030894,0,4,negative regulation of toll-like receptor 2 signaling pathway,BP,
9165,GO:0034137,1,0.963375141285309,0,6,positive regulation of toll-like receptor 2 signaling pathway,BP,
9166,GO:0034138,1,0.878159237587617,0,20,toll-like receptor 3 signaling pathway,BP,
9167,GO:0034139,1,0.941689153385141,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9168,GO:0034140,1,0.978050947983227,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9169,GO:0034141,1,0.956154205451079,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9170,GO:0034142,1,0.807655697802865,0,33,toll-like receptor 4 signaling pathway,BP,
9171,GO:0034143,1,0.88738952043359,0,18,regulation of toll-like receptor 4 signaling pathway,BP,
9172,GO:0034144,1,0.952772544394217,0,7,negative regulation of toll-like receptor 4 signaling pathway,BP,
9173,GO:0034145,1,0.946288463446077,0,9,positive regulation of toll-like receptor 4 signaling pathway,BP,
9174,GO:0034146,1,0.984848971454632,0,2,toll-like receptor 5 signaling pathway,BP,
9175,GO:0034147,1,0.992372857018491,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9176,GO:0034148,1,0.992372857018491,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9177,GO:0034150,1,0.991663250672266,0,1,toll-like receptor 6 signaling pathway,BP,
9178,GO:0034154,1,0.93613865191276,0,10,toll-like receptor 7 signaling pathway,BP,
9179,GO:0034155,1,0.968458675173173,0,5,regulation of toll-like receptor 7 signaling pathway,BP,
9180,GO:0034156,1,0.995760941551611,0,1,negative regulation of toll-like receptor 7 signaling pathway,BP,
9181,GO:0034157,1,0.972582678793092,0,4,positive regulation of toll-like receptor 7 signaling pathway,BP,
9182,GO:0034158,1,0.98442245872546,0,2,toll-like receptor 8 signaling pathway,BP,
9183,GO:0034159,1,0.991929767529472,0,1,regulation of toll-like receptor 8 signaling pathway,BP,
9184,GO:0034161,1,0.991929767529472,0,1,positive regulation of toll-like receptor 8 signaling pathway,BP,
9185,GO:0034162,1,0.847449671023429,0,24,toll-like receptor 9 signaling pathway,BP,
9186,GO:0034163,1,0.938462228067525,0,9,regulation of toll-like receptor 9 signaling pathway,BP,
9187,GO:0034164,1,0.979523294204897,0,3,negative regulation of toll-like receptor 9 signaling pathway,BP,
9188,GO:0034165,1,0.972281585315526,0,4,positive regulation of toll-like receptor 9 signaling pathway,BP,
9189,GO:0034166,1,0.992633272570065,0,1,toll-like receptor 10 signaling pathway,BP,
9190,GO:0034182,1,0.963787507319831,0,5,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9191,GO:0034183,1,0.975388846389661,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9192,GO:0034184,1,0.98810893881131,0,2,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9193,GO:0034185,1,0.879351469535011,0,17,apolipoprotein binding,MF,
9194,GO:0034186,1,0.970202455857535,0,5,apolipoprotein A-I binding,MF,
9195,GO:0034188,1,0.980405034088008,0,2,apolipoprotein A-I receptor activity,MF,
9196,GO:0034189,1,0.97766146011139,0,4,very-low-density lipoprotein particle binding,MF,
9197,GO:0034190,1,0.969351887963447,0,5,apolipoprotein receptor binding,MF,
9198,GO:0034191,1,0.976664223723296,0,4,apolipoprotein A-I receptor binding,MF,
9199,GO:0034196,1,0.974185941642054,0,5,acylglycerol transport,BP,
9200,GO:0034197,1,0.974185941642054,0,5,triglyceride transport,BP,
9201,GO:0034198,1,0.767475798238829,0,42,cellular response to amino acid starvation,BP,
9202,GO:0034199,1,0.878514263322488,0,17,activation of protein kinase A activity,BP,
9203,GO:0034201,1,0.963445049998518,0,6,response to oleic acid,BP,
9204,GO:0034203,1,0.992090267926231,0,1,glycolipid translocation,BP,
9206,GO:0034205,1,0.775102029649464,0,36,amyloid-beta formation,BP,
9207,GO:0034211,1,0.98980976425874,0,1,GTP-dependent protein kinase activity,MF,
9208,GO:0034212,1,0.671656924489242,0,57,peptide N-acetyltransferase activity,MF,
9209,GO:0034213,1,0.996049592385331,0,1,quinolinate catabolic process,BP,
9210,GO:0034214,1,0.946847062319701,0,7,protein hexamerization,BP,
9213,GO:0034224,1,0.994470584302603,0,1,cellular response to zinc ion starvation,BP,
9214,GO:0034227,1,0.976034202639745,0,5,tRNA thio-modification,BP,
9215,GO:0034230,1,0.985562606949748,0,2,enkephalin processing,BP,
9216,GO:0034231,1,0.992255842724011,0,1,islet amyloid polypeptide processing,BP,
9217,GO:0034235,1,0.966259960784759,0,6,GPI anchor binding,MF,
9218,GO:0034236,1,0.907934726474941,0,13,protein kinase A catalytic subunit binding,MF,
9219,GO:0034237,1,0.818946791704045,0,25,protein kinase A regulatory subunit binding,MF,
9220,GO:0034238,1,0.975546072087797,0,5,macrophage fusion,BP,
9221,GO:0034239,1,0.97934238303823,0,4,regulation of macrophage fusion,BP,
9222,GO:0034241,1,0.97934238303823,0,4,positive regulation of macrophage fusion,BP,
9223,GO:0034242,1,0.983401720832029,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9224,GO:0034243,1,0.840323578038996,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
9225,GO:0034244,1,0.920296372709437,0,13,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
9226,GO:0034245,1,0.992489565702042,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9227,GO:0034246,1,0.986499280555005,0,2,mitochondrial transcription factor activity,MF,
9228,GO:0034247,1,0.996398387260517,0,1,snoRNA splicing,BP,
9231,GO:0034250,1,0.381592201358555,0,150,positive regulation of cellular amide metabolic process,BP,
9232,GO:0034255,1,0.994728818783657,0,1,regulation of urea metabolic process,BP,
9233,GO:0034260,1,0.733516363798477,0,45,negative regulation of GTPase activity,BP,
9234,GO:0034263,1,0.992180386555922,0,1,positive regulation of autophagy in response to ER overload,BP,
9235,GO:0034271,1,0.979785323261995,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9236,GO:0034272,1,0.979785323261995,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9237,GO:0034274,1,0.977505436469419,0,3,Atg12-Atg5-Atg16 complex,CC,
9238,GO:0034275,1,0.988171623249312,0,2,kynurenic acid metabolic process,BP,
9239,GO:0034276,1,0.988171623249312,0,2,kynurenic acid biosynthetic process,BP,
9241,GO:0034285,1,0.971463153721811,0,4,response to disaccharide,BP,
9242,GO:0034287,1,0.978151949897419,0,4,detection of monosaccharide stimulus,BP,
9244,GO:0034309,1,0.923292443715809,0,11,primary alcohol biosynthetic process,BP,
9245,GO:0034310,1,0.941851813417843,0,13,primary alcohol catabolic process,BP,
9246,GO:0034311,1,0.875360519168823,0,23,diol metabolic process,BP,
9247,GO:0034312,1,0.888293168929215,0,20,diol biosynthetic process,BP,
9248,GO:0034314,1,0.804074922557428,0,35,Arp2/3 complex-mediated actin nucleation,BP,
9249,GO:0034315,1,0.880768302445741,0,19,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9250,GO:0034316,1,0.964742347047954,0,6,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9253,GO:0034331,1,0.80410133979399,0,30,cell junction maintenance,BP,
9255,GO:0034333,1,0.91786189953054,0,12,adherens junction assembly,BP,
9256,GO:0034334,1,0.961506619208357,0,5,adherens junction maintenance,BP,
9257,GO:0034337,1,0.995447523178614,0,1,RNA folding,BP,
9258,GO:0034338,1,0.961574076667579,0,6,short-chain carboxylesterase activity,MF,
9259,GO:0034340,1,0.619380849694761,0,79,response to type I interferon,BP,
9261,GO:0034342,1,0.99325505912211,0,1,response to type III interferon,BP,
9262,GO:0034343,1,0.977844175981308,0,3,type III interferon production,BP,
9263,GO:0034344,1,0.977844175981308,0,3,regulation of type III interferon production,BP,
9264,GO:0034346,1,0.992857590763343,0,1,positive regulation of type III interferon production,BP,
9265,GO:0034349,1,0.904599309234726,0,15,glial cell apoptotic process,BP,
9266,GO:0034350,1,0.934460214871596,0,10,regulation of glial cell apoptotic process,BP,
9267,GO:0034351,1,0.946890984718289,0,8,negative regulation of glial cell apoptotic process,BP,
9268,GO:0034352,1,0.986879274205506,0,2,positive regulation of glial cell apoptotic process,BP,
9269,GO:0034353,1,0.99325505912211,0,1,RNA pyrophosphohydrolase activity,MF,
9270,GO:0034354,1,0.973207004381521,0,6,'de novo' NAD biosynthetic process from tryptophan,BP,
9271,GO:0034355,1,0.99325505912211,0,1,NAD salvage,BP,
9272,GO:0034356,1,0.927753595364169,0,11,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
9273,GO:0034358,1,0.852502128719852,0,30,plasma lipoprotein particle,CC,
9274,GO:0034359,1,0.987435442130859,0,1,mature chylomicron,CC,
9275,GO:0034360,1,0.987435442130859,0,1,chylomicron remnant,CC,
9276,GO:0034361,1,0.921793347592605,0,15,very-low-density lipoprotein particle,CC,
9277,GO:0034362,1,0.940386777618322,0,11,low-density lipoprotein particle,CC,
9278,GO:0034363,1,0.977624017294602,0,4,intermediate-density lipoprotein particle,CC,
9279,GO:0034364,1,0.904962514787622,0,22,high-density lipoprotein particle,CC,
9280,GO:0034365,1,0.99004954996669,0,3,discoidal high-density lipoprotein particle,CC,
9281,GO:0034366,1,0.975786450523428,0,6,spherical high-density lipoprotein particle,CC,
9282,GO:0034367,1,0.866093906838256,0,25,protein-containing complex remodeling,BP,
9283,GO:0034368,1,0.87232619912168,0,24,protein-lipid complex remodeling,BP,
9284,GO:0034369,1,0.87232619912168,0,24,plasma lipoprotein particle remodeling,BP,
9285,GO:0034370,1,0.958686129649752,0,8,triglyceride-rich lipoprotein particle remodeling,BP,
9286,GO:0034371,1,0.97028776627006,0,5,chylomicron remodeling,BP,
9287,GO:0034372,1,0.970888570553131,0,7,very-low-density lipoprotein particle remodeling,BP,
9288,GO:0034373,1,0.995951048679701,0,1,intermediate-density lipoprotein particle remodeling,BP,
9289,GO:0034374,1,0.92444636844584,0,13,low-density lipoprotein particle remodeling,BP,
9290,GO:0034375,1,0.927032704597925,0,15,high-density lipoprotein particle remodeling,BP,
9291,GO:0034377,1,0.86046890613571,0,24,plasma lipoprotein particle assembly,BP,
9292,GO:0034378,1,0.950726358294675,0,8,chylomicron assembly,BP,
9293,GO:0034379,1,0.931030705322514,0,11,very-low-density lipoprotein particle assembly,BP,
9294,GO:0034380,1,0.934916060831444,0,11,high-density lipoprotein particle assembly,BP,
9295,GO:0034381,1,0.750321485498747,0,47,plasma lipoprotein particle clearance,BP,
9296,GO:0034382,1,0.959804730615982,0,7,chylomicron remnant clearance,BP,
9297,GO:0034383,1,0.823924020620625,0,30,low-density lipoprotein particle clearance,BP,
9298,GO:0034384,1,0.936683246073624,0,11,high-density lipoprotein particle clearance,BP,
9299,GO:0034385,1,0.921793347592605,0,15,triglyceride-rich plasma lipoprotein particle,CC,
9300,GO:0034386,1,0.992180852490147,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
9301,GO:0034388,1,0.96709471567324,0,5,Pwp2p-containing subcomplex of 90S preribosome,CC,
9302,GO:0034389,1,0.864099879275403,0,24,lipid droplet organization,BP,
9303,GO:0034390,1,0.881692695043007,0,20,smooth muscle cell apoptotic process,BP,
9304,GO:0034391,1,0.881692695043007,0,20,regulation of smooth muscle cell apoptotic process,BP,
9305,GO:0034392,1,0.959555567770475,0,6,negative regulation of smooth muscle cell apoptotic process,BP,
9306,GO:0034393,1,0.930928529854766,0,12,positive regulation of smooth muscle cell apoptotic process,BP,
9307,GO:0034394,1,0.653660116106568,0,62,protein localization to cell surface,BP,
9308,GO:0034395,1,0.980269852067843,0,3,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9309,GO:0034397,1,0.950855269832969,0,7,telomere localization,BP,
9310,GO:0034398,1,0.988071832943591,0,2,telomere tethering at nuclear periphery,BP,
9311,GO:0034399,1,0.419952401207037,0,127,nuclear periphery,CC,
9312,GO:0034401,1,0.570862153152623,0,80,chromatin organization involved in regulation of transcription,BP,
9313,GO:0034402,1,0.985946912421668,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9314,GO:0034404,1,0.568475866286008,0,100,nucleobase-containing small molecule biosynthetic process,BP,
9316,GO:0034414,1,0.987046029919185,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9317,GO:0034416,1,0.99311926768676,0,1,bisphosphoglycerate phosphatase activity,MF,
9318,GO:0034417,1,0.99311926768676,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9319,GO:0034418,1,0.988785938908197,0,2,urate biosynthetic process,BP,
9320,GO:0034421,1,0.979502800071791,0,3,post-translational protein acetylation,BP,
9321,GO:0034423,1,0.993527733145221,0,1,autophagosome lumen,CC,
9322,GO:0034427,1,0.954930708721285,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9323,GO:0034431,1,0.977990025656706,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9324,GO:0034432,1,0.977990025656706,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9325,GO:0034433,1,0.934658567734086,0,12,steroid esterification,BP,
9326,GO:0034434,1,0.934658567734086,0,12,sterol esterification,BP,
9327,GO:0034435,1,0.934658567734086,0,12,cholesterol esterification,BP,
9328,GO:0034436,1,0.975532241990211,0,4,glycoprotein transport,BP,
9331,GO:0034441,1,0.992372941881417,0,2,plasma lipoprotein particle oxidation,BP,
9334,GO:0034444,1,0.996782578226241,0,1,regulation of plasma lipoprotein oxidation,BP,
9335,GO:0034445,1,0.996782578226241,0,1,negative regulation of plasma lipoprotein oxidation,BP,
9337,GO:0034447,1,0.957007953452367,0,8,very-low-density lipoprotein particle clearance,BP,
9338,GO:0034448,1,0.979116990234936,0,4,EGO complex,CC,
9339,GO:0034450,1,0.914607984895145,0,13,ubiquitin-ubiquitin ligase activity,MF,
9340,GO:0034451,1,0.530347065427503,0,91,centriolar satellite,CC,
9341,GO:0034452,1,0.908025697396877,0,11,dynactin binding,MF,
9342,GO:0034453,1,0.843295931099665,0,21,microtubule anchoring,BP,
9343,GO:0034454,1,0.919602778218024,0,10,microtubule anchoring at centrosome,BP,
9344,GO:0034455,1,0.985092888053536,0,2,t-UTP complex,CC,
9345,GO:0034456,1,0.988952887485354,0,2,UTP-C complex,CC,
9346,GO:0034457,1,0.986993283229565,0,3,Mpp10 complex,CC,
9347,GO:0034458,1,0.977746583870268,0,3,3'-5' RNA helicase activity,MF,
9348,GO:0034462,1,0.97494565658341,0,3,small-subunit processome assembly,BP,
9349,GO:0034463,1,0.99687060107113,0,1,90S preribosome assembly,BP,
9350,GO:0034464,1,0.946695406870906,0,8,BBSome,CC,
9351,GO:0034465,1,0.976739037512252,0,4,response to carbon monoxide,BP,
9352,GO:0034466,1,0.993256912061493,0,1,chromaffin granule lumen,CC,
9353,GO:0034470,1,0.127192981641031,0,348,ncRNA processing,BP,
9354,GO:0034471,1,0.894201385496274,0,20,ncRNA 5'-end processing,BP,
9355,GO:0034472,1,0.895125099382949,0,19,snRNA 3'-end processing,BP,
9356,GO:0034473,1,0.988752723140668,0,3,U1 snRNA 3'-end processing,BP,
9357,GO:0034474,1,0.991020635020331,0,1,U2 snRNA 3'-end processing,BP,
9358,GO:0034475,1,0.969440967108021,0,8,U4 snRNA 3'-end processing,BP,
9359,GO:0034476,1,0.988752723140668,0,3,U5 snRNA 3'-end processing,BP,
9360,GO:0034477,1,0.986448159550186,0,2,U6 snRNA 3'-end processing,BP,
9361,GO:0034478,1,0.9929899013298,0,1,phosphatidylglycerol catabolic process,BP,
9362,GO:0034481,1,0.968158459482915,0,5,chondroitin sulfotransferase activity,MF,
9363,GO:0034483,1,0.904721178799589,0,14,heparan sulfate sulfotransferase activity,MF,
9364,GO:0034485,1,0.987219143981437,0,2,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9365,GO:0034497,1,0.91863010427004,0,12,protein localization to phagophore assembly site,BP,
9366,GO:0034498,1,0.947631988634005,0,8,early endosome to Golgi transport,BP,
9367,GO:0034499,1,0.967677308419251,0,5,late endosome to Golgi transport,BP,
9368,GO:0034501,1,0.908964015511901,0,16,protein localization to kinetochore,BP,
9369,GO:0034502,1,0.619439754290069,0,73,protein localization to chromosome,BP,
9371,GO:0034505,1,0.879757398611352,0,18,tooth mineralization,BP,
9372,GO:0034506,1,0.992465109004135,0,1,chromosome, centromeric core domain,CC,
9373,GO:0034508,1,0.792681450696866,0,37,centromere complex assembly,BP,
9374,GO:0034511,1,0.942989711305204,0,8,U3 snoRNA binding,MF,
9375,GO:0034512,1,0.992475477155422,0,1,box C/D snoRNA binding,MF,
9376,GO:0034513,1,0.97650580583673,0,5,box H/ACA snoRNA binding,MF,
9377,GO:0034514,1,0.994295923386915,0,1,mitochondrial unfolded protein response,BP,
9378,GO:0034515,1,0.985706646507604,0,2,proteasome storage granule,CC,
9379,GO:0034516,1,0.996144650033514,0,1,response to vitamin B6,BP,
9380,GO:0034518,1,0.930716810784891,0,11,RNA cap binding complex,CC,
9381,GO:0034545,1,0.995818748314625,0,1,fumarylpyruvate hydrolase activity,MF,
9382,GO:0034551,1,0.943019441742894,0,10,mitochondrial respiratory chain complex III assembly,BP,
9383,GO:0034552,1,0.993058525114028,0,2,respiratory chain complex II assembly,BP,
9384,GO:0034553,1,0.993058525114028,0,2,mitochondrial respiratory chain complex II assembly,BP,
9385,GO:0034584,1,0.9852387473384,0,2,piRNA binding,MF,
9386,GO:0034587,1,0.909755910158419,0,14,piRNA metabolic process,BP,
9387,GO:0034589,1,0.992409588456598,0,1,hydroxyproline transport,BP,
9388,GO:0034590,1,0.992409588456598,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9389,GO:0034592,1,0.996424245301714,0,1,synaptic vesicle lumen,CC,
9390,GO:0034593,1,0.849230718002685,0,21,phosphatidylinositol bisphosphate phosphatase activity,MF,
9391,GO:0034594,1,0.960009554865485,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9392,GO:0034595,1,0.912944148211208,0,12,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9393,GO:0034596,1,0.953565706270145,0,6,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9394,GO:0034597,1,0.983715127839275,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9396,GO:0034603,1,0.967479274175249,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9397,GO:0034604,1,0.967479274175249,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
9398,GO:0034605,1,0.454870905109477,0,115,cellular response to heat,BP,
9399,GO:0034611,1,0.992470052449699,0,1,oligoribonucleotidase activity,MF,
9403,GO:0034616,1,0.913288939849506,0,13,response to laminar fluid shear stress,BP,
9404,GO:0034617,1,0.97290266144388,0,4,tetrahydrobiopterin binding,MF,
9405,GO:0034618,1,0.967052384597543,0,5,arginine binding,MF,
9408,GO:0034625,1,0.960184917352038,0,6,fatty acid elongation, monounsaturated fatty acid,BP,
9409,GO:0034626,1,0.960184917352038,0,6,fatty acid elongation, polyunsaturated fatty acid,BP,
9410,GO:0034627,1,0.973207004381521,0,6,'de novo' NAD biosynthetic process,BP,
9412,GO:0034632,1,0.989841424624983,0,2,retinol transmembrane transporter activity,MF,
9413,GO:0034633,1,0.989841424624983,0,2,retinol transport,BP,
9418,GO:0034640,1,0.992686732662962,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
9420,GO:0034643,1,0.85521561442815,0,22,establishment of mitochondrion localization, microtubule-mediated,BP,
9421,GO:0034644,1,0.605284780282437,0,77,cellular response to UV,BP,
9423,GO:0034647,1,0.964009922806483,0,4,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9424,GO:0034648,1,0.966058948055319,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9425,GO:0034649,1,0.992481629833007,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9426,GO:0034650,1,0.935401761264451,0,9,cortisol metabolic process,BP,
9427,GO:0034651,1,0.939937188908263,0,8,cortisol biosynthetic process,BP,
9428,GO:0034653,1,0.979918592663307,0,4,retinoic acid catabolic process,BP,
9431,GO:0034656,1,0.779182155267125,0,45,nucleobase-containing small molecule catabolic process,BP,
9432,GO:0034657,1,0.974735073667237,0,4,GID complex,CC,
9433,GO:0034660,1,0.0807335605199167,0,417,ncRNA metabolic process,BP,
9434,GO:0034661,1,0.817024527159443,0,31,ncRNA catabolic process,BP,
9435,GO:0034663,1,0.946263394529702,0,9,endoplasmic reticulum chaperone complex,CC,
9436,GO:0034665,1,0.984779201271266,0,2,integrin alpha1-beta1 complex,CC,
9437,GO:0034666,1,0.97605632255013,0,3,integrin alpha2-beta1 complex,CC,
9438,GO:0034667,1,0.984707688581217,0,2,integrin alpha3-beta1 complex,CC,
9439,GO:0034668,1,0.976690998123234,0,3,integrin alpha4-beta1 complex,CC,
9440,GO:0034669,1,0.984826968619471,0,2,integrin alpha4-beta7 complex,CC,
9441,GO:0034670,1,0.989555229038954,0,1,chemotaxis to arachidonic acid,BP,
9442,GO:0034673,1,0.979733869998653,0,3,inhibin-betaglycan-ActRII complex,CC,
9443,GO:0034674,1,0.984969694258696,0,2,integrin alpha5-beta1 complex,CC,
9444,GO:0034676,1,0.991726510427589,0,1,integrin alpha6-beta4 complex,CC,
9445,GO:0034677,1,0.992495731749345,0,1,integrin alpha7-beta1 complex,CC,
9446,GO:0034678,1,0.977629190840152,0,3,integrin alpha8-beta1 complex,CC,
9447,GO:0034679,1,0.992470911703894,0,1,integrin alpha9-beta1 complex,CC,
9448,GO:0034680,1,0.984598759493391,0,2,integrin alpha10-beta1 complex,CC,
9449,GO:0034681,1,0.984683371617901,0,2,integrin alpha11-beta1 complex,CC,
9450,GO:0034683,1,0.983316996699657,0,2,integrin alphav-beta3 complex,CC,
9451,GO:0034684,1,0.983722030769227,0,2,integrin alphav-beta5 complex,CC,
9452,GO:0034685,1,0.985176769218953,0,2,integrin alphav-beta6 complex,CC,
9453,GO:0034686,1,0.981212867485142,0,2,integrin alphav-beta8 complex,CC,
9454,GO:0034687,1,0.985115233075904,0,2,integrin alphaL-beta2 complex,CC,
9455,GO:0034688,1,0.9852738174035,0,2,integrin alphaM-beta2 complex,CC,
9456,GO:0034689,1,0.985311631194504,0,2,integrin alphaX-beta2 complex,CC,
9457,GO:0034693,1,0.993925171941381,0,1,U11/U12 snRNP,CC,
9458,GO:0034694,1,0.820060592274106,0,30,response to prostaglandin,BP,
9459,GO:0034695,1,0.867464377730597,0,22,response to prostaglandin E,BP,
9460,GO:0034696,1,0.988514632912133,0,2,response to prostaglandin F,BP,
9461,GO:0034698,1,0.83775432015075,0,24,response to gonadotropin,BP,
9462,GO:0034699,1,0.978156758348573,0,3,response to luteinizing hormone,BP,
9465,GO:0034704,1,0.62574810988456,0,61,calcium channel complex,CC,
9467,GO:0034706,1,0.803239860947659,0,26,sodium channel complex,CC,
9468,GO:0034707,1,0.752382936939775,0,42,chloride channel complex,CC,
9469,GO:0034708,1,0.525171777428109,0,96,methyltransferase complex,CC,
9470,GO:0034709,1,0.953608612544036,0,12,methylosome,CC,
9471,GO:0034711,1,0.971187177460774,0,5,inhibin binding,MF,
9472,GO:0034713,1,0.938300118552926,0,9,type I transforming growth factor beta receptor binding,MF,
9473,GO:0034714,1,0.979493234151587,0,3,type III transforming growth factor beta receptor binding,MF,
9474,GO:0034715,1,0.978334763218108,0,6,pICln-Sm protein complex,CC,
9475,GO:0034718,1,0.991918151237279,0,1,SMN-Gemin2 complex,CC,
9476,GO:0034719,1,0.914431408933386,0,18,SMN-Sm protein complex,CC,
9477,GO:0034720,1,0.942010811532991,0,7,histone H3-K4 demethylation,BP,
9478,GO:0034721,1,0.956029849740711,0,5,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9479,GO:0034722,1,0.996136459553227,0,1,gamma-glutamyl-peptidase activity,MF,
9480,GO:0034723,1,0.949279206979447,0,8,DNA replication-dependent nucleosome organization,BP,
9481,GO:0034724,1,0.80675812294863,0,35,DNA replication-independent nucleosome organization,BP,
9482,GO:0034727,1,0.957565412868617,0,5,piecemeal microautophagy of the nucleus,BP,
9483,GO:0034728,1,0.534447973616505,0,95,nucleosome organization,BP,
9484,GO:0034729,1,0.97980683038455,0,3,histone H3-K79 methylation,BP,
9485,GO:0034736,1,0.99258655662872,0,1,cholesterol O-acyltransferase activity,MF,
9486,GO:0034739,1,0.98349450687431,0,3,histone deacetylase activity (H4-K16 specific),MF,
9487,GO:0034750,1,0.984669922764408,0,2,Scrib-APC-beta-catenin complex,CC,
9488,GO:0034751,1,0.981742761532133,0,3,aryl hydrocarbon receptor complex,CC,
9489,GO:0034752,1,0.991448744677046,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9491,GO:0034755,1,0.905139231612758,0,16,iron ion transmembrane transport,BP,
9493,GO:0034757,1,0.983714208819131,0,3,negative regulation of iron ion transport,BP,
9494,GO:0034759,1,0.983714208819131,0,3,regulation of iron ion transmembrane transport,BP,
9495,GO:0034760,1,0.983714208819131,0,3,negative regulation of iron ion transmembrane transport,BP,
9502,GO:0034769,1,0.987394477017258,0,2,basement membrane disassembly,BP,
9503,GO:0034770,1,0.950224985980162,0,6,histone H4-K20 methylation,BP,
9504,GO:0034773,1,0.970403722231032,0,4,histone H4-K20 trimethylation,BP,
9507,GO:0034776,1,0.93390965322889,0,10,response to histamine,BP,
9508,GO:0034777,1,0.994504345906639,0,1,recycling endosome lumen,CC,
9509,GO:0034875,1,0.995285386751004,0,1,caffeine oxidase activity,MF,
9510,GO:0034899,1,0.994904897403138,0,1,trimethylamine monooxygenase activity,MF,
9511,GO:0034959,1,0.99207703213115,0,1,endothelin maturation,BP,
9512,GO:0034963,1,0.991063637767373,0,2,box C/D snoRNA processing,BP,
9513,GO:0034964,1,0.986539066564025,0,2,box H/ACA snoRNA processing,BP,
9514,GO:0034968,1,0.47712797520138,0,99,histone lysine methylation,BP,
9515,GO:0034969,1,0.941573100408203,0,10,histone arginine methylation,BP,
9516,GO:0034970,1,0.986496803265818,0,2,histone H3-R2 methylation,BP,
9517,GO:0034971,1,0.987695947452729,0,2,histone H3-R17 methylation,BP,
9518,GO:0034975,1,0.947223696152761,0,8,protein folding in endoplasmic reticulum,BP,
9520,GO:0034979,1,0.899254577072313,0,16,NAD-dependent protein deacetylase activity,MF,
9521,GO:0034982,1,0.933226952532774,0,12,mitochondrial protein processing,BP,
9522,GO:0034983,1,0.946882458944881,0,8,peptidyl-lysine deacetylation,BP,
9524,GO:0034987,1,0.963794784522282,0,6,immunoglobulin receptor binding,MF,
9525,GO:0034988,1,0.984213642475008,0,2,Fc-gamma receptor I complex binding,MF,
9526,GO:0034990,1,0.982487284412246,0,3,nuclear mitotic cohesin complex,CC,
9527,GO:0034991,1,0.967671709259367,0,5,nuclear meiotic cohesin complex,CC,
9528,GO:0034992,1,0.931423051271335,0,8,microtubule organizing center attachment site,CC,
9529,GO:0034993,1,0.931423051271335,0,8,meiotic nuclear membrane microtubule tethering complex,CC,
9530,GO:0034998,1,0.987155499149099,0,2,oligosaccharyltransferase I complex,CC,
9531,GO:0035000,1,0.993171117450712,0,1,oligosaccharyltransferase III complex,CC,
9532,GO:0035004,1,0.914870508694126,0,11,phosphatidylinositol 3-kinase activity,MF,
9533,GO:0035005,1,0.943641975922046,0,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
9534,GO:0035014,1,0.887791160017446,0,17,phosphatidylinositol 3-kinase regulator activity,MF,
9535,GO:0035019,1,0.632536505457867,0,70,somatic stem cell population maintenance,BP,
9536,GO:0035020,1,0.88286339763344,0,17,regulation of Rac protein signal transduction,BP,
9537,GO:0035021,1,0.968634578402354,0,4,negative regulation of Rac protein signal transduction,BP,
9538,GO:0035022,1,0.972834681532354,0,4,positive regulation of Rac protein signal transduction,BP,
9539,GO:0035023,1,0.580328529156599,0,77,regulation of Rho protein signal transduction,BP,
9540,GO:0035024,1,0.852568276395912,0,21,negative regulation of Rho protein signal transduction,BP,
9541,GO:0035025,1,0.833813206391234,0,28,positive regulation of Rho protein signal transduction,BP,
9542,GO:0035026,1,0.984997265703392,0,2,leading edge cell differentiation,BP,
9543,GO:0035032,1,0.96167171891759,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9544,GO:0035033,1,0.978620412688494,0,4,histone deacetylase regulator activity,MF,
9545,GO:0035034,1,0.987650114276664,0,2,histone acetyltransferase regulator activity,MF,
9546,GO:0035035,1,0.820095656505102,0,28,histone acetyltransferase binding,MF,
9547,GO:0035036,1,0.792319696855954,0,43,sperm-egg recognition,BP,
9548,GO:0035037,1,0.992343497629272,0,1,sperm entry,BP,
9549,GO:0035038,1,0.987165190868311,0,2,female pronucleus assembly,BP,
9550,GO:0035039,1,0.994298498770425,0,1,male pronucleus assembly,BP,
9551,GO:0035050,1,0.602640805626232,0,73,embryonic heart tube development,BP,
9553,GO:0035054,1,0.980114709814091,0,3,embryonic heart tube anterior/posterior pattern specification,BP,
9554,GO:0035060,1,0.976719815934154,0,3,brahma complex,CC,
9555,GO:0035061,1,0.961160552719181,0,5,interchromatin granule,CC,
9556,GO:0035063,1,0.974929263784815,0,3,nuclear speck organization,BP,
9557,GO:0035064,1,0.650140620480685,0,62,methylated histone binding,MF,
9558,GO:0035065,1,0.70096958806368,0,54,regulation of histone acetylation,BP,
9559,GO:0035066,1,0.827846764746158,0,29,positive regulation of histone acetylation,BP,
9560,GO:0035067,1,0.903581041269615,0,16,negative regulation of histone acetylation,BP,
9562,GO:0035087,1,0.974661582337746,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9563,GO:0035088,1,0.726468224599596,0,45,establishment or maintenance of apical/basal cell polarity,BP,
9564,GO:0035089,1,0.877731838174446,0,19,establishment of apical/basal cell polarity,BP,
9565,GO:0035090,1,0.935342118747962,0,11,maintenance of apical/basal cell polarity,BP,
9567,GO:0035092,1,0.958291750009484,0,6,sperm chromatin condensation,BP,
9568,GO:0035093,1,0.969311037916787,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9569,GO:0035094,1,0.769927437891015,0,41,response to nicotine,BP,
9570,GO:0035095,1,0.949564267610378,0,7,behavioral response to nicotine,BP,
9571,GO:0035097,1,0.596576495362783,0,71,histone methyltransferase complex,CC,
9572,GO:0035098,1,0.903082545140449,0,14,ESC/E(Z) complex,CC,
9573,GO:0035101,1,0.972222293666047,0,4,FACT complex,CC,
9574,GO:0035102,1,0.907537636625355,0,14,PRC1 complex,CC,
9575,GO:0035103,1,0.99432685821291,0,1,sterol regulatory element binding protein cleavage,BP,
9576,GO:0035106,1,0.980421307045677,0,3,operant conditioning,BP,
9579,GO:0035112,1,0.915617160004739,0,13,genitalia morphogenesis,BP,
9581,GO:0035115,1,0.814705909819969,0,32,embryonic forelimb morphogenesis,BP,
9582,GO:0035116,1,0.838110736259834,0,28,embryonic hindlimb morphogenesis,BP,
9583,GO:0035120,1,0.988852137285306,0,1,post-embryonic appendage morphogenesis,BP,
9584,GO:0035127,1,0.988852137285306,0,1,post-embryonic limb morphogenesis,BP,
9585,GO:0035128,1,0.988852137285306,0,1,post-embryonic forelimb morphogenesis,BP,
9586,GO:0035136,1,0.764683809194828,0,40,forelimb morphogenesis,BP,
9587,GO:0035137,1,0.789347693945427,0,36,hindlimb morphogenesis,BP,
9588,GO:0035145,1,0.891483999684012,0,18,exon-exon junction complex,CC,
9591,GO:0035162,1,0.856670270379146,0,22,embryonic hemopoiesis,BP,
9592,GO:0035166,1,0.978045394700457,0,3,post-embryonic hemopoiesis,BP,
9593,GO:0035173,1,0.906280455323229,0,15,histone kinase activity,MF,
9594,GO:0035174,1,0.965618885946149,0,6,histone serine kinase activity,MF,
9595,GO:0035175,1,0.995760941551611,0,1,histone kinase activity (H3-S10 specific),MF,
9596,GO:0035176,1,0.697896915028637,0,48,social behavior,BP,
9597,GO:0035184,1,0.964561406449202,0,5,histone threonine kinase activity,MF,
9598,GO:0035188,1,0.850967669445115,0,26,hatching,BP,
9599,GO:0035189,1,0.98567529935597,0,2,Rb-E2F complex,CC,
9603,GO:0035197,1,0.929512910097221,0,10,siRNA binding,MF,
9604,GO:0035198,1,0.830851869176219,0,27,miRNA binding,MF,
9605,GO:0035226,1,0.992817891297176,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9606,GO:0035227,1,0.992817891297176,0,1,regulation of glutamate-cysteine ligase activity,BP,
9607,GO:0035229,1,0.992817891297176,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9608,GO:0035234,1,0.951064985532647,0,7,ectopic germ cell programmed cell death,BP,
9609,GO:0035235,1,0.819569467865867,0,25,ionotropic glutamate receptor signaling pathway,BP,
9610,GO:0035238,1,0.99325505912211,0,1,vitamin A biosynthetic process,BP,
9612,GO:0035240,1,0.956938739619476,0,8,dopamine binding,MF,
9613,GO:0035241,1,0.971622600512851,0,5,protein-arginine omega-N monomethyltransferase activity,MF,
9614,GO:0035242,1,0.9718405799188,0,5,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9615,GO:0035243,1,0.97480379995038,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9616,GO:0035246,1,0.935294100169209,0,11,peptidyl-arginine N-methylation,BP,
9617,GO:0035247,1,0.947346839415676,0,9,peptidyl-arginine omega-N-methylation,BP,
9618,GO:0035248,1,0.99308418330458,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9621,GO:0035251,1,0.941842358748948,0,9,UDP-glucosyltransferase activity,MF,
9622,GO:0035252,1,0.956446025852819,0,6,UDP-xylosyltransferase activity,MF,
9623,GO:0035253,1,0.922828855335285,0,11,ciliary rootlet,CC,
9624,GO:0035254,1,0.729739523821199,0,45,glutamate receptor binding,MF,
9625,GO:0035255,1,0.823204316067405,0,27,ionotropic glutamate receptor binding,MF,
9626,GO:0035256,1,0.938359581900344,0,11,G protein-coupled glutamate receptor binding,MF,
9627,GO:0035257,1,0.383789781094881,0,137,nuclear hormone receptor binding,MF,
9628,GO:0035258,1,0.582109898262139,0,76,steroid hormone receptor binding,MF,
9629,GO:0035259,1,0.891979397889464,0,15,glucocorticoid receptor binding,MF,
9630,GO:0035261,1,0.978846043170771,0,2,external genitalia morphogenesis,BP,
9631,GO:0035262,1,0.984468594973184,0,2,gonad morphogenesis,BP,
9632,GO:0035264,1,0.372404605062751,0,139,multicellular organism growth,BP,
9634,GO:0035267,1,0.894397317025648,0,19,NuA4 histone acetyltransferase complex,CC,
9635,GO:0035268,1,0.871741436342257,0,20,protein mannosylation,BP,
9636,GO:0035269,1,0.907582494421557,0,15,protein O-linked mannosylation,BP,
9639,GO:0035276,1,0.987054673278715,0,2,ethanol binding,MF,
9640,GO:0035278,1,0.899795350010986,0,14,miRNA mediated inhibition of translation,BP,
9641,GO:0035279,1,0.98583002779056,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9642,GO:0035280,1,0.950841427479109,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9643,GO:0035281,1,0.988571117756935,0,2,pre-miRNA export from nucleus,BP,
9645,GO:0035283,1,0.981451525668262,0,3,central nervous system segmentation,BP,
9646,GO:0035284,1,0.981451525668262,0,3,brain segmentation,BP,
9647,GO:0035290,1,0.970469740489098,0,4,trunk segmentation,BP,
9650,GO:0035299,1,0.99237995967727,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9652,GO:0035304,1,0.426298113054615,0,129,regulation of protein dephosphorylation,BP,
9654,GO:0035306,1,0.685517149959056,0,54,positive regulation of dephosphorylation,BP,
9655,GO:0035307,1,0.75564679674922,0,41,positive regulation of protein dephosphorylation,BP,
9656,GO:0035308,1,0.69351489877471,0,58,negative regulation of protein dephosphorylation,BP,
9657,GO:0035312,1,0.949131601368935,0,8,5'-3' exodeoxyribonuclease activity,MF,
9658,GO:0035313,1,0.888917704708135,0,15,wound healing, spreading of epidermal cells,BP,
9659,GO:0035315,1,0.762623294156125,0,38,hair cell differentiation,BP,
9660,GO:0035325,1,0.93286169290145,0,12,Toll-like receptor binding,MF,
9661,GO:0035327,1,0.877378653584998,0,20,transcriptionally active chromatin,CC,
9662,GO:0035329,1,0.720644299168027,0,42,hippo signaling,BP,
9663,GO:0035330,1,0.884262589570179,0,16,regulation of hippo signaling,BP,
9664,GO:0035331,1,0.917856535440285,0,11,negative regulation of hippo signaling,BP,
9665,GO:0035332,1,0.975873229949807,0,3,positive regulation of hippo signaling,BP,
9666,GO:0035333,1,0.956450365458924,0,7,Notch receptor processing, ligand-dependent,BP,
9668,GO:0035336,1,0.859206036368547,0,23,long-chain fatty-acyl-CoA metabolic process,BP,
9669,GO:0035337,1,0.786892532922078,0,37,fatty-acyl-CoA metabolic process,BP,
9670,GO:0035338,1,0.886051380312519,0,18,long-chain fatty-acyl-CoA biosynthetic process,BP,
9671,GO:0035339,1,0.981498487171209,0,4,SPOTS complex,CC,
9672,GO:0035344,1,0.993785184100103,0,1,hypoxanthine transport,BP,
9673,GO:0035349,1,0.987228687314284,0,2,coenzyme A transmembrane transport,BP,
9674,GO:0035350,1,0.987340534177393,0,2,FAD transmembrane transport,BP,
9675,GO:0035351,1,0.992920184257471,0,1,heme transmembrane transport,BP,
9676,GO:0035352,1,0.994427769882656,0,1,NAD transmembrane transport,BP,
9677,GO:0035354,1,0.9857568820371,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9678,GO:0035355,1,0.991663250672266,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9679,GO:0035356,1,0.959573520425118,0,7,cellular triglyceride homeostasis,BP,
9680,GO:0035357,1,0.868855686319043,0,21,peroxisome proliferator activated receptor signaling pathway,BP,
9681,GO:0035358,1,0.916992982699221,0,14,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9682,GO:0035359,1,0.982392739082721,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9683,GO:0035360,1,0.946746028419707,0,9,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9684,GO:0035363,1,0.975153038886659,0,4,histone locus body,CC,
9685,GO:0035364,1,0.993785184100103,0,1,thymine transport,BP,
9686,GO:0035368,1,0.971135290593901,0,5,selenocysteine insertion sequence binding,MF,
9687,GO:0035370,1,0.988045608074992,0,2,UBC13-UEV1A complex,CC,
9688,GO:0035371,1,0.83670100415288,0,22,microtubule plus-end,CC,
9689,GO:0035372,1,0.881536882136245,0,17,protein localization to microtubule,BP,
9690,GO:0035373,1,0.975384556648522,0,3,chondroitin sulfate proteoglycan binding,MF,
9691,GO:0035374,1,0.942164312844748,0,9,chondroitin sulfate binding,MF,
9692,GO:0035375,1,0.990643688638927,0,1,zymogen binding,MF,
9693,GO:0035376,1,0.949310894217322,0,8,sterol import,BP,
9694,GO:0035377,1,0.977144119179482,0,3,transepithelial water transport,BP,
9695,GO:0035378,1,0.993285028471028,0,1,carbon dioxide transmembrane transport,BP,
9696,GO:0035379,1,0.993285028471028,0,1,carbon dioxide transmembrane transporter activity,MF,
9697,GO:0035381,1,0.953612970759819,0,8,ATP-gated ion channel activity,MF,
9698,GO:0035383,1,0.56741603351595,0,93,thioester metabolic process,BP,
9699,GO:0035384,1,0.721065480813957,0,49,thioester biosynthetic process,BP,
9700,GO:0035385,1,0.961440048830543,0,5,Roundabout signaling pathway,BP,
9701,GO:0035397,1,0.992786080512339,0,1,helper T cell enhancement of adaptive immune response,BP,
9702,GO:0035400,1,0.991985464486564,0,1,histone tyrosine kinase activity,MF,
9703,GO:0035401,1,0.991985464486564,0,1,histone kinase activity (H3-Y41 specific),MF,
9704,GO:0035402,1,0.986334438729118,0,2,histone kinase activity (H3-T11 specific),MF,
9705,GO:0035403,1,0.982092280808205,0,2,histone kinase activity (H3-T6 specific),MF,
9706,GO:0035404,1,0.927996345427103,0,12,histone-serine phosphorylation,BP,
9707,GO:0035405,1,0.964561406449202,0,5,histone-threonine phosphorylation,BP,
9708,GO:0035406,1,0.991985464486564,0,1,histone-tyrosine phosphorylation,BP,
9709,GO:0035407,1,0.986334438729118,0,2,histone H3-T11 phosphorylation,BP,
9710,GO:0035408,1,0.982092280808205,0,2,histone H3-T6 phosphorylation,BP,
9711,GO:0035409,1,0.991985464486564,0,1,histone H3-Y41 phosphorylation,BP,
9712,GO:0035410,1,0.993167713696979,0,2,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9714,GO:0035425,1,0.96093480355554,0,7,autocrine signaling,BP,
9715,GO:0035426,1,0.963985740376358,0,5,extracellular matrix-cell signaling,BP,
9716,GO:0035434,1,0.959462700823953,0,6,copper ion transmembrane transport,BP,
9717,GO:0035435,1,0.916951952818433,0,13,phosphate ion transmembrane transport,BP,
9719,GO:0035441,1,0.974715065468176,0,3,cell migration involved in vasculogenesis,BP,
9720,GO:0035442,1,0.971117828224207,0,4,dipeptide transmembrane transport,BP,
9722,GO:0035444,1,0.992440341107594,0,1,nickel cation transmembrane transport,BP,
9723,GO:0035445,1,0.992778481987959,0,1,borate transmembrane transport,BP,
9724,GO:0035455,1,0.880754100309248,0,20,response to interferon-alpha,BP,
9725,GO:0035456,1,0.873276082850372,0,25,response to interferon-beta,BP,
9726,GO:0035457,1,0.929708178294498,0,10,cellular response to interferon-alpha,BP,
9727,GO:0035458,1,0.899569426360247,0,18,cellular response to interferon-beta,BP,
9728,GO:0035459,1,0.864860155765217,0,20,vesicle cargo loading,BP,
9730,GO:0035469,1,0.963112244968949,0,5,determination of pancreatic left/right asymmetry,BP,
9731,GO:0035470,1,0.979911749059466,0,4,positive regulation of vascular wound healing,BP,
9732,GO:0035473,1,0.970082991150938,0,4,lipase binding,MF,
9733,GO:0035480,1,0.972848191624468,0,4,regulation of Notch signaling pathway involved in heart induction,BP,
9734,GO:0035481,1,0.972848191624468,0,4,positive regulation of Notch signaling pathway involved in heart induction,BP,
9735,GO:0035482,1,0.978651931632768,0,6,gastric motility,BP,
9736,GO:0035483,1,0.982726735411004,0,5,gastric emptying,BP,
9737,GO:0035485,1,0.995479190051093,0,1,adenine/guanine mispair binding,MF,
9738,GO:0035490,1,0.992737439110689,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9739,GO:0035491,1,0.992737439110689,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9740,GO:0035493,1,0.900028724437092,0,17,SNARE complex assembly,BP,
9741,GO:0035494,1,0.981281374737275,0,3,SNARE complex disassembly,BP,
9742,GO:0035497,1,0.908477604221264,0,14,cAMP response element binding,MF,
9745,GO:0035500,1,0.985696229142941,0,2,MH2 domain binding,MF,
9746,GO:0035501,1,0.993149866754886,0,1,MH1 domain binding,MF,
9747,GO:0035502,1,0.968287233278962,0,5,metanephric part of ureteric bud development,BP,
9748,GO:0035504,1,0.996124438356641,0,1,regulation of myosin light chain kinase activity,BP,
9749,GO:0035505,1,0.996124438356641,0,1,positive regulation of myosin light chain kinase activity,BP,
9750,GO:0035507,1,0.94750952558731,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9751,GO:0035508,1,0.991819846276588,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9752,GO:0035509,1,0.963882142211355,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9753,GO:0035510,1,0.823797144112969,0,30,DNA dealkylation,BP,
9754,GO:0035511,1,0.966840745832943,0,6,oxidative DNA demethylation,BP,
9755,GO:0035513,1,0.967567526266974,0,5,oxidative RNA demethylation,BP,
9756,GO:0035514,1,0.97397992333966,0,5,DNA demethylase activity,MF,
9757,GO:0035515,1,0.967567526266974,0,5,oxidative RNA demethylase activity,MF,
9758,GO:0035516,1,0.981130636479414,0,3,oxidative DNA demethylase activity,MF,
9759,GO:0035517,1,0.966999750280537,0,4,PR-DUB complex,CC,
9760,GO:0035518,1,0.896846761042183,0,16,histone H2A monoubiquitination,BP,
9761,GO:0035519,1,0.980973628962987,0,4,protein K29-linked ubiquitination,BP,
9762,GO:0035520,1,0.932159181304291,0,9,monoubiquitinated protein deubiquitination,BP,
9763,GO:0035521,1,0.971802215719014,0,4,monoubiquitinated histone deubiquitination,BP,
9764,GO:0035522,1,0.971802215719014,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9765,GO:0035523,1,0.966909375595953,0,4,protein K29-linked deubiquitination,BP,
9766,GO:0035524,1,0.948686390392497,0,7,proline transmembrane transport,BP,
9767,GO:0035525,1,0.993651353128436,0,1,NF-kappaB p50/p65 complex,CC,
9768,GO:0035526,1,0.984728688937867,0,2,retrograde transport, plasma membrane to Golgi,BP,
9769,GO:0035529,1,0.956513544540284,0,8,NADH pyrophosphatase activity,MF,
9770,GO:0035538,1,0.992665026525438,0,1,carbohydrate response element binding,MF,
9771,GO:0035539,1,0.991873660911594,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9772,GO:0035542,1,0.939381218939612,0,9,regulation of SNARE complex assembly,BP,
9773,GO:0035543,1,0.99273199371895,0,1,positive regulation of SNARE complex assembly,BP,
9774,GO:0035544,1,0.978493962012753,0,3,negative regulation of SNARE complex assembly,BP,
9775,GO:0035545,1,0.979951612264951,0,2,determination of left/right asymmetry in nervous system,BP,
9776,GO:0035552,1,0.988449120520249,0,2,oxidative single-stranded DNA demethylation,BP,
9777,GO:0035553,1,0.981109310182617,0,3,oxidative single-stranded RNA demethylation,BP,
9779,GO:0035561,1,0.862878947299868,0,21,regulation of chromatin binding,BP,
9780,GO:0035562,1,0.947532533878019,0,7,negative regulation of chromatin binding,BP,
9781,GO:0035563,1,0.917522579514826,0,13,positive regulation of chromatin binding,BP,
9782,GO:0035564,1,0.974930790001719,0,3,regulation of kidney size,BP,
9783,GO:0035566,1,0.992451971441975,0,1,regulation of metanephros size,BP,
9785,GO:0035568,1,0.99325505912211,0,1,N-terminal peptidyl-proline methylation,BP,
9786,GO:0035570,1,0.99325505912211,0,1,N-terminal peptidyl-serine methylation,BP,
9787,GO:0035572,1,0.99325505912211,0,1,N-terminal peptidyl-serine dimethylation,BP,
9788,GO:0035573,1,0.99325505912211,0,1,N-terminal peptidyl-serine trimethylation,BP,
9789,GO:0035574,1,0.984861798177303,0,2,histone H4-K20 demethylation,BP,
9790,GO:0035575,1,0.984861798177303,0,2,histone demethylase activity (H4-K20 specific),MF,
9791,GO:0035577,1,0.707033632613842,0,54,azurophil granule membrane,CC,
9792,GO:0035578,1,0.619439196752989,0,85,azurophil granule lumen,CC,
9793,GO:0035579,1,0.557815229337435,0,88,specific granule membrane,CC,
9794,GO:0035580,1,0.724900487145714,0,59,specific granule lumen,CC,
9796,GO:0035582,1,0.975987466234976,0,4,sequestering of BMP in extracellular matrix,BP,
9797,GO:0035583,1,0.963396026787506,0,4,sequestering of TGFbeta in extracellular matrix,BP,
9798,GO:0035584,1,0.880257904062969,0,20,calcium-mediated signaling using intracellular calcium source,BP,
9799,GO:0035585,1,0.970169204913969,0,4,calcium-mediated signaling using extracellular calcium source,BP,
9801,GO:0035589,1,0.933640358854513,0,13,G protein-coupled purinergic nucleotide receptor signaling pathway,BP,
9803,GO:0035591,1,0.618416388945075,0,67,signaling adaptor activity,MF,
9806,GO:0035596,1,0.987732537418699,0,2,methylthiotransferase activity,MF,
9807,GO:0035597,1,0.995045273001708,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9808,GO:0035598,1,0.992651222684083,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9809,GO:0035600,1,0.987732537418699,0,2,tRNA methylthiolation,BP,
9810,GO:0035601,1,0.492330949363739,0,102,protein deacylation,BP,
9811,GO:0035602,1,0.992454394882222,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell,BP,
9812,GO:0035603,1,0.992454394882222,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9813,GO:0035604,1,0.992454394882222,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9814,GO:0035605,1,0.996372155485022,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9815,GO:0035606,1,0.993222890008283,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9816,GO:0035607,1,0.984312759928919,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9819,GO:0035610,1,0.970726014941581,0,4,protein side chain deglutamylation,BP,
9820,GO:0035611,1,0.993124979249781,0,1,protein branching point deglutamylation,BP,
9821,GO:0035612,1,0.926651130164068,0,9,AP-2 adaptor complex binding,MF,
9822,GO:0035613,1,0.916889979189214,0,12,RNA stem-loop binding,MF,
9823,GO:0035615,1,0.895769440385747,0,16,clathrin adaptor activity,MF,
9824,GO:0035616,1,0.97711593276694,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9825,GO:0035617,1,0.967611448982675,0,5,stress granule disassembly,BP,
9826,GO:0035621,1,0.987824118994949,0,2,ER to Golgi ceramide transport,BP,
9827,GO:0035622,1,0.981266976567918,0,2,intrahepatic bile duct development,BP,
9828,GO:0035623,1,0.992676863524341,0,1,renal glucose absorption,BP,
9829,GO:0035624,1,0.971031909556987,0,4,receptor transactivation,BP,
9830,GO:0035627,1,0.925852577016781,0,11,ceramide transport,BP,
9832,GO:0035631,1,0.931446082594049,0,11,CD40 receptor complex,CC,
9833,GO:0035632,1,0.991752507402384,0,2,mitochondrial prohibitin complex,CC,
9835,GO:0035634,1,0.975874172819199,0,4,response to stilbenoid,BP,
9836,GO:0035635,1,0.896513286844659,0,14,entry of bacterium into host cell,BP,
9839,GO:0035640,1,0.84909440577898,0,23,exploration behavior,BP,
9840,GO:0035641,1,0.921137612670246,0,12,locomotory exploration behavior,BP,
9841,GO:0035642,1,0.992930240754572,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9842,GO:0035643,1,0.995782374051263,0,1,L-DOPA receptor activity,MF,
9843,GO:0035644,1,0.992893957604813,0,1,phosphoanandamide dephosphorylation,BP,
9844,GO:0035645,1,0.992414621102312,0,1,enteric smooth muscle cell differentiation,BP,
9845,GO:0035646,1,0.940934878515135,0,10,endosome to melanosome transport,BP,
9846,GO:0035650,1,0.971624027010662,0,5,AP-1 adaptor complex binding,MF,
9847,GO:0035651,1,0.985254338246584,0,3,AP-3 adaptor complex binding,MF,
9848,GO:0035655,1,0.952546222244159,0,8,interleukin-18-mediated signaling pathway,BP,
9849,GO:0035657,1,0.992223736063427,0,1,eRF1 methyltransferase complex,CC,
9850,GO:0035658,1,0.9745265022027,0,4,Mon1-Ccz1 complex,CC,
9851,GO:0035662,1,0.986222319425195,0,4,Toll-like receptor 4 binding,MF,
9852,GO:0035663,1,0.980513124724176,0,3,Toll-like receptor 2 binding,MF,
9853,GO:0035664,1,0.995609539404835,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9854,GO:0035665,1,0.995609539404835,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9856,GO:0035668,1,0.976523909592465,0,3,TRAM-dependent toll-like receptor signaling pathway,BP,
9857,GO:0035669,1,0.976523909592465,0,3,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9858,GO:0035671,1,0.984453234799292,0,3,enone reductase activity,MF,
9861,GO:0035674,1,0.988680831373707,0,2,tricarboxylic acid transmembrane transport,BP,
9862,GO:0035675,1,0.985939283148784,0,2,neuromast hair cell development,BP,
9863,GO:0035677,1,0.992390662544981,0,1,posterior lateral line neuromast hair cell development,BP,
9864,GO:0035683,1,0.984368768414925,0,2,memory T cell extravasation,BP,
9865,GO:0035684,1,0.983169757864064,0,3,helper T cell extravasation,BP,
9866,GO:0035685,1,0.986336874452022,0,2,helper T cell diapedesis,BP,
9867,GO:0035686,1,0.971218057597396,0,5,sperm fibrous sheath,CC,
9869,GO:0035691,1,0.984466959923876,0,3,macrophage migration inhibitory factor signaling pathway,BP,
9870,GO:0035692,1,0.98854868347984,0,2,macrophage migration inhibitory factor receptor complex,CC,
9871,GO:0035693,1,0.996373315223691,0,1,NOS2-CD74 complex,CC,
9872,GO:0035694,1,0.973758342827912,0,4,mitochondrial protein catabolic process,BP,
9873,GO:0035695,1,0.992408931696148,0,1,mitophagy by induced vacuole formation,BP,
9874,GO:0035696,1,0.958928614775449,0,6,monocyte extravasation,BP,
9875,GO:0035697,1,0.984667461812062,0,3,CD8-positive, alpha-beta T cell extravasation,BP,
9876,GO:0035698,1,0.990775834167858,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9877,GO:0035700,1,0.989478010183,0,2,astrocyte chemotaxis,BP,
9878,GO:0035701,1,0.946403320612842,0,8,hematopoietic stem cell migration,BP,
9879,GO:0035702,1,0.984501723249548,0,2,monocyte homeostasis,BP,
9880,GO:0035704,1,0.993835340362938,0,1,helper T cell chemotaxis,BP,
9881,GO:0035705,1,0.993835340362938,0,1,T-helper 17 cell chemotaxis,BP,
9882,GO:0035708,1,0.992553532471137,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9883,GO:0035709,1,0.982341266500097,0,3,memory T cell activation,BP,
9884,GO:0035710,1,0.57619794452965,0,87,CD4-positive, alpha-beta T cell activation,BP,
9885,GO:0035711,1,0.979067078243064,0,4,T-helper 1 cell activation,BP,
9886,GO:0035712,1,0.985263297671969,0,2,T-helper 2 cell activation,BP,
9887,GO:0035713,1,0.992553532471137,0,1,response to nitrogen dioxide,BP,
9888,GO:0035715,1,0.993835340362938,0,1,chemokine (C-C motif) ligand 2 binding,MF,
9889,GO:0035716,1,0.993835340362938,0,1,chemokine (C-C motif) ligand 12 binding,MF,
9890,GO:0035717,1,0.987319932835039,0,2,chemokine (C-C motif) ligand 7 binding,MF,
9891,GO:0035718,1,0.992528102477989,0,2,macrophage migration inhibitory factor binding,MF,
9892,GO:0035720,1,0.983309288488244,0,3,intraciliary anterograde transport,BP,
9893,GO:0035721,1,0.931718978231792,0,9,intraciliary retrograde transport,BP,
9894,GO:0035722,1,0.780931020005646,0,44,interleukin-12-mediated signaling pathway,BP,
9895,GO:0035723,1,0.913517071626669,0,13,interleukin-15-mediated signaling pathway,BP,
9896,GO:0035724,1,0.991147196399667,0,1,CD24 biosynthetic process,BP,
9898,GO:0035726,1,0.957879520232151,0,7,common myeloid progenitor cell proliferation,BP,
9899,GO:0035727,1,0.95047511919031,0,8,lysophosphatidic acid binding,MF,
9900,GO:0035728,1,0.876269534786935,0,19,response to hepatocyte growth factor,BP,
9901,GO:0035729,1,0.889699460682417,0,17,cellular response to hepatocyte growth factor stimulus,BP,
9902,GO:0035730,1,0.996683279248134,0,1,S-nitrosoglutathione binding,MF,
9903,GO:0035731,1,0.996683279248134,0,1,dinitrosyl-iron complex binding,MF,
9904,GO:0035732,1,0.996683279248134,0,1,nitric oxide storage,BP,
9905,GO:0035733,1,0.942037836887307,0,8,hepatic stellate cell activation,BP,
9906,GO:0035735,1,0.772138080769537,0,38,intraciliary transport involved in cilium assembly,BP,
9907,GO:0035739,1,0.947822404180687,0,11,CD4-positive, alpha-beta T cell proliferation,BP,
9908,GO:0035740,1,0.9593171932062,0,7,CD8-positive, alpha-beta T cell proliferation,BP,
9909,GO:0035743,1,0.897412227672358,0,19,CD4-positive, alpha-beta T cell cytokine production,BP,
9910,GO:0035744,1,0.964077327370971,0,7,T-helper 1 cell cytokine production,BP,
9911,GO:0035745,1,0.934039469784167,0,12,T-helper 2 cell cytokine production,BP,
9912,GO:0035746,1,0.996473668370333,0,1,granzyme A production,BP,
9913,GO:0035747,1,0.965572466682753,0,7,natural killer cell chemotaxis,BP,
9914,GO:0035748,1,0.957288784701142,0,6,myelin sheath abaxonal region,CC,
9916,GO:0035750,1,0.991951759892856,0,1,protein localization to myelin sheath abaxonal region,BP,
9917,GO:0035751,1,0.931685765850422,0,13,regulation of lysosomal lumen pH,BP,
9918,GO:0035752,1,0.995338722526488,0,1,lysosomal lumen pH elevation,BP,
9919,GO:0035754,1,0.956936801321193,0,8,B cell chemotaxis,BP,
9920,GO:0035755,1,0.993666205057768,0,1,cardiolipin hydrolase activity,MF,
9921,GO:0035757,1,0.994677031264593,0,1,chemokine (C-C motif) ligand 19 binding,MF,
9922,GO:0035758,1,0.994677031264593,0,1,chemokine (C-C motif) ligand 21 binding,MF,
9923,GO:0035759,1,0.99010835185984,0,2,mesangial cell-matrix adhesion,BP,
9924,GO:0035766,1,0.968428702818818,0,5,cell chemotaxis to fibroblast growth factor,BP,
9925,GO:0035767,1,0.850452769370257,0,24,endothelial cell chemotaxis,BP,
9926,GO:0035768,1,0.968428702818818,0,5,endothelial cell chemotaxis to fibroblast growth factor,BP,
9927,GO:0035770,1,0.209633048717982,0,229,ribonucleoprotein granule,CC,
9928,GO:0035771,1,0.95739587795077,0,7,interleukin-4-mediated signaling pathway,BP,
9929,GO:0035772,1,0.995660015016158,0,1,interleukin-13-mediated signaling pathway,BP,
9932,GO:0035780,1,0.993200755047622,0,1,CD80 biosynthetic process,BP,
9933,GO:0035781,1,0.989100332495669,0,2,CD86 biosynthetic process,BP,
9934,GO:0035782,1,0.996473668370333,0,1,mature natural killer cell chemotaxis,BP,
9935,GO:0035783,1,0.984781057005379,0,3,CD4-positive, alpha-beta T cell costimulation,BP,
9936,GO:0035787,1,0.970357845305417,0,4,cell migration involved in kidney development,BP,
9937,GO:0035788,1,0.978222955236897,0,3,cell migration involved in metanephros development,BP,
9938,GO:0035789,1,0.978222955236897,0,3,metanephric mesenchymal cell migration,BP,
9940,GO:0035791,1,0.898564793158864,0,14,platelet-derived growth factor receptor-beta signaling pathway,BP,
9941,GO:0035793,1,0.978222955236897,0,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9943,GO:0035795,1,0.971948410796669,0,5,negative regulation of mitochondrial membrane permeability,BP,
9944,GO:0035799,1,0.970451677723157,0,4,ureter maturation,BP,
9945,GO:0035800,1,0.988801449538242,0,2,deubiquitinase activator activity,MF,
9946,GO:0035801,1,0.988528550635013,0,2,adrenal cortex development,BP,
9947,GO:0035802,1,0.988528550635013,0,2,adrenal cortex formation,BP,
9948,GO:0035803,1,0.987478860030689,0,3,egg coat formation,BP,
9949,GO:0035804,1,0.992507102685002,0,2,structural constituent of egg coat,MF,
9950,GO:0035805,1,0.98597837200999,0,3,egg coat,CC,
9951,GO:0035809,1,0.885042174704195,0,20,regulation of urine volume,BP,
9952,GO:0035810,1,0.915923399879874,0,14,positive regulation of urine volume,BP,
9953,GO:0035811,1,0.979672497670707,0,3,negative regulation of urine volume,BP,
9954,GO:0035812,1,0.895645420269794,0,19,renal sodium excretion,BP,
9955,GO:0035813,1,0.899936100403637,0,18,regulation of renal sodium excretion,BP,
9956,GO:0035814,1,0.976924522964926,0,4,negative regulation of renal sodium excretion,BP,
9957,GO:0035815,1,0.933848151731469,0,12,positive regulation of renal sodium excretion,BP,
9958,GO:0035821,1,0.545081915387218,0,96,modulation of process of other organism,BP,
9959,GO:0035822,1,0.970569464626505,0,4,gene conversion,BP,
9960,GO:0035825,1,0.724898413769265,0,48,homologous recombination,BP,
9961,GO:0035838,1,0.976053354967988,0,3,growing cell tip,CC,
9962,GO:0035841,1,0.983492760622339,0,2,new growing cell tip,CC,
9963,GO:0035844,1,0.975272282796206,0,4,cloaca development,BP,
9964,GO:0035845,1,0.932776295915963,0,10,photoreceptor cell outer segment organization,BP,
9966,GO:0035851,1,0.987830164728351,0,2,Krueppel-associated box domain binding,MF,
9967,GO:0035853,1,0.992355725458932,0,1,chromosome passenger complex localization to spindle midzone,BP,
9968,GO:0035854,1,0.988784622629792,0,2,eosinophil fate commitment,BP,
9969,GO:0035855,1,0.886405279292082,0,16,megakaryocyte development,BP,
9970,GO:0035859,1,0.919311706640726,0,13,Seh1-associated complex,CC,
9971,GO:0035860,1,0.9450575959506,0,8,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
9972,GO:0035861,1,0.717593807277755,0,50,site of double-strand break,CC,
9973,GO:0035862,1,0.991576790400752,0,1,dITP metabolic process,BP,
9974,GO:0035863,1,0.991576790400752,0,1,dITP catabolic process,BP,
9975,GO:0035864,1,0.919582828252355,0,12,response to potassium ion,BP,
9976,GO:0035865,1,0.938073003021852,0,9,cellular response to potassium ion,BP,
9977,GO:0035866,1,0.973545972509674,0,3,alphav-beta3 integrin-PKCalpha complex,CC,
9978,GO:0035867,1,0.963438388985709,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
9979,GO:0035868,1,0.976017290326571,0,3,alphav-beta3 integrin-HMGB1 complex,CC,
9980,GO:0035869,1,0.675562415011406,0,58,ciliary transition zone,CC,
9981,GO:0035870,1,0.98818731256966,0,2,dITP diphosphatase activity,MF,
9982,GO:0035871,1,0.935659255980565,0,8,protein K11-linked deubiquitination,BP,
9983,GO:0035872,1,0.791300040744221,0,35,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
9984,GO:0035873,1,0.959893430953692,0,6,lactate transmembrane transport,BP,
9985,GO:0035877,1,0.980575018711931,0,3,death effector domain binding,MF,
9986,GO:0035878,1,0.948742193423956,0,8,nail development,BP,
9987,GO:0035879,1,0.980008235312866,0,3,plasma membrane lactate transport,BP,
9988,GO:0035880,1,0.982455440158839,0,3,embryonic nail plate morphogenesis,BP,
9989,GO:0035881,1,0.953578559589963,0,7,amacrine cell differentiation,BP,
9990,GO:0035883,1,0.841180229742843,0,26,enteroendocrine cell differentiation,BP,
9991,GO:0035886,1,0.847090356267551,0,25,vascular associated smooth muscle cell differentiation,BP,
9992,GO:0035887,1,0.995691921465553,0,1,aortic smooth muscle cell differentiation,BP,
9993,GO:0035890,1,0.80783874302383,0,32,exit from host,BP,
9994,GO:0035891,1,0.80783874302383,0,32,exit from host cell,BP,
9995,GO:0035898,1,0.98011917345496,0,3,parathyroid hormone secretion,BP,
9996,GO:0035900,1,0.966453700630758,0,6,response to isolation stress,BP,
9997,GO:0035902,1,0.880072571744538,0,21,response to immobilization stress,BP,
9999,GO:0035905,1,0.966806421449746,0,5,ascending aorta development,BP,
10000,GO:0035906,1,0.992479679234636,0,1,descending aorta development,BP,
10002,GO:0035909,1,0.798617659751355,0,30,aorta morphogenesis,BP,
10003,GO:0035910,1,0.974134173736668,0,4,ascending aorta morphogenesis,BP,
10004,GO:0035912,1,0.94599495272581,0,8,dorsal aorta morphogenesis,BP,
10005,GO:0035914,1,0.656424654593586,0,61,skeletal muscle cell differentiation,BP,
10006,GO:0035915,1,0.981186144397705,0,4,pore formation in membrane of other organism,BP,
10007,GO:0035921,1,0.994865279593209,0,1,desmosome disassembly,BP,
10008,GO:0035922,1,0.995963984376661,0,1,foramen ovale closure,BP,
10010,GO:0035925,1,0.846455866917036,0,25,mRNA 3'-UTR AU-rich region binding,MF,
10011,GO:0035927,1,0.978312801007677,0,4,RNA import into mitochondrion,BP,
10012,GO:0035928,1,0.985611805987381,0,3,rRNA import into mitochondrion,BP,
10013,GO:0035929,1,0.9027926426445,0,18,steroid hormone secretion,BP,
10014,GO:0035930,1,0.930340648447128,0,13,corticosteroid hormone secretion,BP,
10015,GO:0035931,1,0.974317259021307,0,4,mineralocorticoid secretion,BP,
10016,GO:0035932,1,0.974317259021307,0,4,aldosterone secretion,BP,
10017,GO:0035933,1,0.954875896004428,0,9,glucocorticoid secretion,BP,
10018,GO:0035934,1,0.983179063647841,0,4,corticosterone secretion,BP,
10019,GO:0035935,1,0.9926531008435,0,1,androgen secretion,BP,
10020,GO:0035936,1,0.983784099721895,0,2,testosterone secretion,BP,
10021,GO:0035938,1,0.979847693725077,0,3,estradiol secretion,BP,
10022,GO:0035945,1,0.993873967922025,0,1,mitochondrial ncRNA surveillance,BP,
10023,GO:0035946,1,0.993873967922025,0,1,mitochondrial mRNA surveillance,BP,
10024,GO:0035962,1,0.981673793401944,0,3,response to interleukin-13,BP,
10025,GO:0035963,1,0.981673793401944,0,3,cellular response to interleukin-13,BP,
10026,GO:0035964,1,0.961985213907283,0,6,COPI-coated vesicle budding,BP,
10027,GO:0035965,1,0.956943786268016,0,7,cardiolipin acyl-chain remodeling,BP,
10030,GO:0035970,1,0.867547439584008,0,22,peptidyl-threonine dephosphorylation,BP,
10031,GO:0035971,1,0.996473668370333,0,1,peptidyl-histidine dephosphorylation,BP,
10032,GO:0035973,1,0.937735602619915,0,9,aggrephagy,BP,
10033,GO:0035976,1,0.97849256679566,0,4,transcription factor AP-1 complex,CC,
10034,GO:0035977,1,0.971644394813235,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10035,GO:0035978,1,0.987415599759447,0,2,histone H2A-S139 phosphorylation,BP,
10036,GO:0035981,1,0.988437693959186,0,2,tongue muscle cell differentiation,BP,
10037,GO:0035983,1,0.977594459229175,0,3,response to trichostatin A,BP,
10038,GO:0035984,1,0.977594459229175,0,3,cellular response to trichostatin A,BP,
10039,GO:0035985,1,0.980498138676912,0,4,senescence-associated heterochromatin focus,CC,
10040,GO:0035986,1,0.984921733002587,0,3,senescence-associated heterochromatin focus assembly,BP,
10041,GO:0035987,1,0.730427992791875,0,44,endodermal cell differentiation,BP,
10043,GO:0035989,1,0.962650113734926,0,6,tendon development,BP,
10044,GO:0035990,1,0.987127892878896,0,3,tendon cell differentiation,BP,
10045,GO:0035992,1,0.987127892878896,0,3,tendon formation,BP,
10046,GO:0035993,1,0.990141178367974,0,2,deltoid tuberosity development,BP,
10047,GO:0035994,1,0.87649339472483,0,18,response to muscle stretch,BP,
10048,GO:0035995,1,0.966786347453694,0,4,detection of muscle stretch,BP,
10049,GO:0035998,1,0.995221633881734,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10050,GO:0035999,1,0.942701011124292,0,10,tetrahydrofolate interconversion,BP,
10051,GO:0036002,1,0.797201911760108,0,36,pre-mRNA binding,MF,
10052,GO:0036003,1,0.866290495370954,0,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
10053,GO:0036004,1,0.996460514402533,0,1,GAF domain binding,MF,
10054,GO:0036005,1,0.924329983216195,0,12,response to macrophage colony-stimulating factor,BP,
10055,GO:0036006,1,0.924329983216195,0,12,cellular response to macrophage colony-stimulating factor stimulus,BP,
10056,GO:0036009,1,0.988774047633276,0,2,protein-glutamine N-methyltransferase activity,MF,
10057,GO:0036010,1,0.840427615479353,0,23,protein localization to endosome,BP,
10058,GO:0036015,1,0.967041073078379,0,5,response to interleukin-3,BP,
10059,GO:0036016,1,0.967041073078379,0,5,cellular response to interleukin-3,BP,
10060,GO:0036017,1,0.970807982814051,0,7,response to erythropoietin,BP,
10061,GO:0036018,1,0.973861624692952,0,6,cellular response to erythropoietin,BP,
10062,GO:0036019,1,0.877302112660827,0,19,endolysosome,CC,
10063,GO:0036020,1,0.905180114903057,0,14,endolysosome membrane,CC,
10064,GO:0036021,1,0.969232509605035,0,5,endolysosome lumen,CC,
10065,GO:0036022,1,0.983550656627257,0,3,limb joint morphogenesis,BP,
10066,GO:0036023,1,0.983550656627257,0,3,embryonic skeletal limb joint morphogenesis,BP,
10067,GO:0036024,1,0.994303650955748,0,1,protein C inhibitor-TMPRSS7 complex,CC,
10068,GO:0036025,1,0.994303650955748,0,1,protein C inhibitor-TMPRSS11E complex,CC,
10069,GO:0036026,1,0.994303650955748,0,1,protein C inhibitor-PLAT complex,CC,
10070,GO:0036027,1,0.994303650955748,0,1,protein C inhibitor-PLAU complex,CC,
10071,GO:0036028,1,0.994303650955748,0,1,protein C inhibitor-thrombin complex,CC,
10072,GO:0036029,1,0.994303650955748,0,1,protein C inhibitor-KLK3 complex,CC,
10073,GO:0036030,1,0.994303650955748,0,1,protein C inhibitor-plasma kallikrein complex,CC,
10074,GO:0036033,1,0.953021255514205,0,5,mediator complex binding,MF,
10075,GO:0036034,1,0.994218906995635,0,1,mediator complex assembly,BP,
10076,GO:0036035,1,0.893505713058948,0,16,osteoclast development,BP,
10077,GO:0036037,1,0.857322371039055,0,25,CD8-positive, alpha-beta T cell activation,BP,
10078,GO:0036038,1,0.928694726368004,0,13,MKS complex,CC,
10079,GO:0036041,1,0.953895212255407,0,11,long-chain fatty acid binding,MF,
10080,GO:0036042,1,0.971541456656866,0,6,long-chain fatty acyl-CoA binding,MF,
10081,GO:0036046,1,0.992746850990672,0,1,protein demalonylation,BP,
10082,GO:0036047,1,0.992746850990672,0,1,peptidyl-lysine demalonylation,BP,
10083,GO:0036048,1,0.988522579221137,0,2,protein desuccinylation,BP,
10084,GO:0036049,1,0.988522579221137,0,2,peptidyl-lysine desuccinylation,BP,
10085,GO:0036053,1,0.993355888538386,0,1,glomerular endothelium fenestra,CC,
10086,GO:0036054,1,0.992746850990672,0,1,protein-malonyllysine demalonylase activity,MF,
10087,GO:0036055,1,0.988522579221137,0,2,protein-succinyllysine desuccinylase activity,MF,
10088,GO:0036056,1,0.937624118246067,0,8,filtration diaphragm,CC,
10089,GO:0036057,1,0.937624118246067,0,8,slit diaphragm,CC,
10090,GO:0036058,1,0.992464765002689,0,1,filtration diaphragm assembly,BP,
10091,GO:0036060,1,0.992464765002689,0,1,slit diaphragm assembly,BP,
10092,GO:0036064,1,0.398459720698761,0,136,ciliary basal body,CC,
10093,GO:0036065,1,0.899554432855308,0,15,fucosylation,BP,
10094,GO:0036066,1,0.972810864154244,0,4,protein O-linked fucosylation,BP,
10095,GO:0036071,1,0.985520911701689,0,2,N-glycan fucosylation,BP,
10096,GO:0036072,1,0.959868455165669,0,6,direct ossification,BP,
10098,GO:0036080,1,0.992698457281054,0,1,purine nucleotide-sugar transmembrane transporter activity,MF,
10099,GO:0036085,1,0.992698457281054,0,1,GDP-fucose import into Golgi lumen,BP,
10100,GO:0036088,1,0.995961406871488,0,1,D-serine catabolic process,BP,
10101,GO:0036089,1,0.954402149652174,0,7,cleavage furrow formation,BP,
10102,GO:0036090,1,0.99015314604374,0,2,cleavage furrow ingression,BP,
10103,GO:0036091,1,0.968062294091117,0,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10104,GO:0036092,1,0.889862843679236,0,14,phosphatidylinositol-3-phosphate biosynthetic process,BP,
10105,GO:0036093,1,0.971073391086823,0,6,germ cell proliferation,BP,
10107,GO:0036100,1,0.981449613055694,0,3,leukotriene catabolic process,BP,
10108,GO:0036101,1,0.981449613055694,0,3,leukotriene B4 catabolic process,BP,
10109,GO:0036102,1,0.981449613055694,0,3,leukotriene B4 metabolic process,BP,
10110,GO:0036105,1,0.992520038295476,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10111,GO:0036109,1,0.926647853392089,0,12,alpha-linolenic acid metabolic process,BP,
10112,GO:0036111,1,0.985966243715513,0,2,very long-chain fatty-acyl-CoA metabolic process,BP,
10113,GO:0036112,1,0.982521590079624,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10114,GO:0036113,1,0.992510016232465,0,1,very long-chain fatty-acyl-CoA catabolic process,BP,
10115,GO:0036114,1,0.996077424379586,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10116,GO:0036115,1,0.988616522095227,0,2,fatty-acyl-CoA catabolic process,BP,
10117,GO:0036116,1,0.996077424379586,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10118,GO:0036117,1,0.988589216177543,0,2,hyaluranon cable,CC,
10119,GO:0036118,1,0.981138752442522,0,3,hyaluranon cable assembly,BP,
10120,GO:0036119,1,0.869860983895578,0,19,response to platelet-derived growth factor,BP,
10121,GO:0036120,1,0.876048124395824,0,18,cellular response to platelet-derived growth factor stimulus,BP,
10122,GO:0036121,1,0.987121695364937,0,2,double-stranded DNA helicase activity,MF,
10124,GO:0036123,1,0.964998415579403,0,6,histone H3-K9 dimethylation,BP,
10125,GO:0036124,1,0.895210687593929,0,15,histone H3-K9 trimethylation,BP,
10126,GO:0036125,1,0.992844364283243,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10128,GO:0036128,1,0.957473687732388,0,7,CatSper complex,CC,
10129,GO:0036130,1,0.996467631790623,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10130,GO:0036131,1,0.996467631790623,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10131,GO:0036132,1,0.982129839563887,0,3,13-prostaglandin reductase activity,MF,
10132,GO:0036134,1,0.994822945403712,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10133,GO:0036135,1,0.971490626454381,0,3,Schwann cell migration,BP,
10134,GO:0036137,1,0.988517860766572,0,2,kynurenine aminotransferase activity,MF,
10135,GO:0036138,1,0.991077839101146,0,1,peptidyl-histidine hydroxylation,BP,
10136,GO:0036139,1,0.991077839101146,0,1,peptidyl-histidine dioxygenase activity,MF,
10137,GO:0036140,1,0.991077839101146,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10138,GO:0036143,1,0.996744008372575,0,1,kringle domain binding,MF,
10139,GO:0036145,1,0.995615918204781,0,1,dendritic cell homeostasis,BP,
10140,GO:0036146,1,0.99325505912211,0,1,cellular response to mycotoxin,BP,
10141,GO:0036148,1,0.916777830896338,0,13,phosphatidylglycerol acyl-chain remodeling,BP,
10142,GO:0036149,1,0.931141186319711,0,11,phosphatidylinositol acyl-chain remodeling,BP,
10143,GO:0036150,1,0.913848020790374,0,14,phosphatidylserine acyl-chain remodeling,BP,
10144,GO:0036151,1,0.874503811167196,0,22,phosphatidylcholine acyl-chain remodeling,BP,
10145,GO:0036152,1,0.898163401603657,0,17,phosphatidylethanolamine acyl-chain remodeling,BP,
10146,GO:0036153,1,0.993183219456954,0,1,triglyceride acyl-chain remodeling,BP,
10147,GO:0036155,1,0.967356747165248,0,5,acylglycerol acyl-chain remodeling,BP,
10148,GO:0036156,1,0.966396424677075,0,3,inner dynein arm,CC,
10151,GO:0036159,1,0.933651616528285,0,10,inner dynein arm assembly,BP,
10152,GO:0036164,1,0.996583246013743,0,1,cell-abiotic substrate adhesion,BP,
10153,GO:0036166,1,0.961176956108908,0,6,phenotypic switching,BP,
10154,GO:0036179,1,0.993279357225516,0,1,osteoclast maturation,BP,
10155,GO:0036186,1,0.985197345706666,0,2,early phagosome membrane,CC,
10156,GO:0036194,1,0.988184474095279,0,3,muscle cell projection,CC,
10157,GO:0036195,1,0.988184474095279,0,3,muscle cell projection membrane,CC,
10159,GO:0036213,1,0.994645908656047,0,1,contractile ring contraction,BP,
10160,GO:0036215,1,0.977099691033409,0,3,response to stem cell factor,BP,
10161,GO:0036216,1,0.977099691033409,0,3,cellular response to stem cell factor stimulus,BP,
10162,GO:0036218,1,0.975354533438913,0,4,dTTP diphosphatase activity,MF,
10163,GO:0036219,1,0.996800221570978,0,1,GTP diphosphatase activity,MF,
10164,GO:0036228,1,0.986635660600288,0,2,protein localization to nuclear inner membrane,BP,
10165,GO:0036230,1,0.055066209810843,0,479,granulocyte activation,BP,
10166,GO:0036245,1,0.988398418780507,0,2,cellular response to menadione,BP,
10167,GO:0036250,1,0.99528299885192,0,1,peroxisome transport along microtubule,BP,
10168,GO:0036255,1,0.992488314549241,0,1,response to methylamine,BP,
10169,GO:0036257,1,0.833783179030511,0,31,multivesicular body organization,BP,
10170,GO:0036258,1,0.839506543851911,0,30,multivesicular body assembly,BP,
10171,GO:0036260,1,0.835447696707834,0,32,RNA capping,BP,
10172,GO:0036261,1,0.992505224701326,0,1,7-methylguanosine cap hypermethylation,BP,
10173,GO:0036265,1,0.980442023811114,0,4,RNA (guanine-N7)-methylation,BP,
10174,GO:0036266,1,0.993715847912815,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10175,GO:0036268,1,0.99006278034269,0,1,swimming,BP,
10176,GO:0036269,1,0.987498545200231,0,2,swimming behavior,BP,
10177,GO:0036284,1,0.986826925449583,0,2,tubulobulbar complex,CC,
10178,GO:0036289,1,0.941736756657959,0,8,peptidyl-serine autophosphorylation,BP,
10179,GO:0036290,1,0.99246592438391,0,1,protein trans-autophosphorylation,BP,
10180,GO:0036292,1,0.985274531070807,0,2,DNA rewinding,BP,
10181,GO:0036293,1,0.111810564229043,0,341,response to decreased oxygen levels,BP,
10182,GO:0036294,1,0.290056857636398,0,196,cellular response to decreased oxygen levels,BP,
10183,GO:0036295,1,0.923931720580325,0,13,cellular response to increased oxygen levels,BP,
10184,GO:0036296,1,0.853392089558829,0,26,response to increased oxygen levels,BP,
10185,GO:0036297,1,0.725418878939279,0,48,interstrand cross-link repair,BP,
10186,GO:0036298,1,0.986466483065983,0,2,recombinational interstrand cross-link repair,BP,
10187,GO:0036301,1,0.967761012578321,0,5,macrophage colony-stimulating factor production,BP,
10188,GO:0036302,1,0.944097012730622,0,7,atrioventricular canal development,BP,
10189,GO:0036303,1,0.855358887631973,0,20,lymph vessel morphogenesis,BP,
10190,GO:0036304,1,0.987827811042402,0,2,umbilical cord morphogenesis,BP,
10191,GO:0036306,1,0.995963984376661,0,1,embryonic heart tube elongation,BP,
10192,GO:0036309,1,0.974732638199774,0,2,protein localization to M-band,BP,
10193,GO:0036310,1,0.9492323268205,0,7,annealing helicase activity,MF,
10194,GO:0036312,1,0.934124272618783,0,8,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
10195,GO:0036313,1,0.993999231311346,0,1,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10198,GO:0036316,1,0.987043768800253,0,2,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
10199,GO:0036317,1,0.99325505912211,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10200,GO:0036321,1,0.99325505912211,0,1,ghrelin secretion,BP,
10201,GO:0036323,1,0.992258568503559,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10202,GO:0036324,1,0.967869386103833,0,5,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10203,GO:0036325,1,0.994461498392785,0,1,vascular endothelial growth factor receptor-3 signaling pathway,BP,
10204,GO:0036326,1,0.992258568503559,0,1,VEGF-A-activated receptor activity,MF,
10205,GO:0036327,1,0.992258568503559,0,1,VEGF-B-activated receptor activity,MF,
10206,GO:0036328,1,0.992038428288137,0,1,VEGF-C-activated receptor activity,MF,
10207,GO:0036331,1,0.994500449429262,0,1,avascular cornea development in camera-type eye,BP,
10208,GO:0036332,1,0.992258568503559,0,1,placental growth factor-activated receptor activity,MF,
10209,GO:0036333,1,0.993528819933978,0,1,hepatocyte homeostasis,BP,
10210,GO:0036335,1,0.983117994326422,0,3,intestinal stem cell homeostasis,BP,
10211,GO:0036336,1,0.84001614801854,0,28,dendritic cell migration,BP,
10212,GO:0036337,1,0.964536903345317,0,5,Fas signaling pathway,BP,
10213,GO:0036342,1,0.890003167558282,0,17,post-anal tail morphogenesis,BP,
10214,GO:0036343,1,0.979662584987348,0,4,psychomotor behavior,BP,
10215,GO:0036344,1,0.862899459806185,0,21,platelet morphogenesis,BP,
10216,GO:0036345,1,0.988846884653396,0,2,platelet maturation,BP,
10217,GO:0036351,1,0.994295923386915,0,1,histone H2A-K13 ubiquitination,BP,
10218,GO:0036352,1,0.994295923386915,0,1,histone H2A-K15 ubiquitination,BP,
10219,GO:0036353,1,0.952745542826165,0,7,histone H2A-K119 monoubiquitination,BP,
10220,GO:0036359,1,0.995338722526488,0,1,renal potassium excretion,BP,
10221,GO:0036361,1,0.993883677960989,0,1,racemase activity, acting on amino acids and derivatives,MF,
10222,GO:0036363,1,0.933428689227525,0,9,transforming growth factor beta activation,BP,
10223,GO:0036364,1,0.985742139919947,0,2,transforming growth factor beta1 activation,BP,
10224,GO:0036366,1,0.992421685995568,0,1,transforming growth factor beta3 activation,BP,
10225,GO:0036369,1,0.962580664507154,0,5,transcription factor catabolic process,BP,
10226,GO:0036371,1,0.985285129334463,0,2,protein localization to T-tubule,BP,
10227,GO:0036372,1,0.996673191506359,0,1,opsin transport,BP,
10228,GO:0036373,1,0.99325505912211,0,1,L-fucose mutarotase activity,MF,
10229,GO:0036374,1,0.981612440492953,0,3,glutathione hydrolase activity,MF,
10230,GO:0036376,1,0.908108543052975,0,15,sodium ion export across plasma membrane,BP,
10231,GO:0036378,1,0.984221598084008,0,3,calcitriol biosynthetic process from calciol,BP,
10232,GO:0036379,1,0.869689779949559,0,25,myofilament,CC,
10233,GO:0036387,1,0.984662851228709,0,3,pre-replicative complex,CC,
10234,GO:0036388,1,0.945042015532696,0,8,pre-replicative complex assembly,BP,
10235,GO:0036392,1,0.992502700385995,0,1,chemokine (C-C motif) ligand 20 production,BP,
10236,GO:0036393,1,0.993041533608535,0,1,thiocyanate peroxidase activity,MF,
10237,GO:0036396,1,0.96268121004317,0,6,RNA N6-methyladenosine methyltransferase complex,CC,
10238,GO:0036398,1,0.993986818403754,0,1,TCR signalosome,CC,
10239,GO:0036402,1,0.988374065333117,0,3,proteasome-activating ATPase activity,MF,
10240,GO:0036403,1,0.993542994515977,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10241,GO:0036404,1,0.989293773553224,0,1,conversion of ds siRNA to ss siRNA,BP,
10242,GO:0036409,1,0.985616201568598,0,2,histone H3-K14 acetyltransferase complex,CC,
10243,GO:0036413,1,0.986832108406927,0,2,histone H3-R26 citrullination,BP,
10244,GO:0036414,1,0.972272638795266,0,4,histone citrullination,BP,
10245,GO:0036415,1,0.983803999959223,0,2,regulation of tRNA stability,BP,
10246,GO:0036416,1,0.983803999959223,0,2,tRNA stabilization,BP,
10247,GO:0036435,1,0.978001284835293,0,4,K48-linked polyubiquitin modification-dependent protein binding,MF,
10248,GO:0036438,1,0.973698107481918,0,4,maintenance of lens transparency,BP,
10249,GO:0036440,1,0.992925192127658,0,1,citrate synthase activity,MF,
10250,GO:0036444,1,0.93282592373895,0,10,calcium import into the mitochondrion,BP,
10251,GO:0036446,1,0.969382655330575,0,4,myofibroblast differentiation,BP,
10252,GO:0036449,1,0.940571776001244,0,7,microtubule minus-end,CC,
10253,GO:0036451,1,0.986555151512788,0,2,cap mRNA methylation,BP,
10254,GO:0036452,1,0.860457703215569,0,26,ESCRT complex,CC,
10255,GO:0036454,1,0.967898136111167,0,5,growth factor complex,CC,
10256,GO:0036456,1,0.996149830842483,0,1,L-methionine-(S)-S-oxide reductase activity,MF,
10257,GO:0036457,1,0.988082871346411,0,1,keratohyalin granule,CC,
10258,GO:0036458,1,0.9946121621616,0,1,hepatocyte growth factor binding,MF,
10259,GO:0036461,1,0.992763154107062,0,2,BLOC-2 complex binding,MF,
10260,GO:0036462,1,0.938454272987742,0,10,TRAIL-activated apoptotic signaling pathway,BP,
10261,GO:0036464,1,0.224826598130819,0,219,cytoplasmic ribonucleoprotein granule,CC,
10262,GO:0036465,1,0.602773998160259,0,71,synaptic vesicle recycling,BP,
10263,GO:0036466,1,0.953837079974209,0,6,synaptic vesicle recycling via endosome,BP,
10264,GO:0036468,1,0.995056536444386,0,1,L-dopa decarboxylase activity,MF,
10265,GO:0036470,1,0.996698971982734,0,1,tyrosine 3-monooxygenase activator activity,MF,
10266,GO:0036471,1,0.996698971982734,0,1,cellular response to glyoxal,BP,
10267,GO:0036473,1,0.600817311382159,0,78,cell death in response to oxidative stress,BP,
10268,GO:0036474,1,0.857706025113731,0,25,cell death in response to hydrogen peroxide,BP,
10269,GO:0036475,1,0.831140965789986,0,26,neuron death in response to oxidative stress,BP,
10270,GO:0036476,1,0.978232090459748,0,4,neuron death in response to hydrogen peroxide,BP,
10272,GO:0036478,1,0.996698971982734,0,1,L-dopa decarboxylase activator activity,MF,
10273,GO:0036479,1,0.98980976425874,0,1,peroxidase inhibitor activity,MF,
10274,GO:0036480,1,0.953823670304861,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10275,GO:0036481,1,0.975848354779927,0,5,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10276,GO:0036482,1,0.990188024119418,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10277,GO:0036483,1,0.992329368544028,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10278,GO:0036484,1,0.970469740489098,0,4,trunk neural crest cell migration,BP,
10279,GO:0036486,1,0.970469740489098,0,4,ventral trunk neural crest cell migration,BP,
10280,GO:0036487,1,0.990038223672271,0,1,nitric-oxide synthase inhibitor activity,MF,
10281,GO:0036488,1,0.992230595066636,0,2,CHOP-C/EBP complex,CC,
10282,GO:0036490,1,0.930513500678188,0,10,regulation of translation in response to endoplasmic reticulum stress,BP,
10283,GO:0036491,1,0.952734432814454,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10284,GO:0036492,1,0.958360225666787,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10285,GO:0036493,1,0.965901317208138,0,5,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10286,GO:0036494,1,0.991828357166544,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10287,GO:0036496,1,0.990320535257717,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10288,GO:0036497,1,0.99413231174732,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10289,GO:0036498,1,0.66400369161325,0,62,IRE1-mediated unfolded protein response,BP,
10291,GO:0036500,1,0.939594057730225,0,10,ATF6-mediated unfolded protein response,BP,
10292,GO:0036501,1,0.992385374939229,0,1,UFD1-NPL4 complex,CC,
10293,GO:0036502,1,0.992761890498294,0,1,Derlin-1-VIMP complex,CC,
10294,GO:0036503,1,0.551231992293737,0,92,ERAD pathway,BP,
10295,GO:0036505,1,0.98694972989299,0,2,prosaposin receptor activity,MF,
10296,GO:0036506,1,0.978787260041971,0,3,maintenance of unfolded protein,BP,
10297,GO:0036507,1,0.870245370855019,0,19,protein demannosylation,BP,
10298,GO:0036508,1,0.870245370855019,0,19,protein alpha-1,2-demannosylation,BP,
10299,GO:0036509,1,0.988647329020406,0,2,trimming of terminal mannose on B branch,BP,
10300,GO:0036510,1,0.98024485629876,0,3,trimming of terminal mannose on C branch,BP,
10301,GO:0036511,1,0.988647329020406,0,2,trimming of first mannose on A branch,BP,
10302,GO:0036512,1,0.988647329020406,0,2,trimming of second mannose on A branch,BP,
10303,GO:0036513,1,0.951158445603748,0,7,Derlin-1 retrotranslocation complex,CC,
10304,GO:0036514,1,0.958245875462656,0,5,dopaminergic neuron axon guidance,BP,
10305,GO:0036515,1,0.965029790375457,0,4,serotonergic neuron axon guidance,BP,
10306,GO:0036517,1,0.991685564322805,0,1,chemoattraction of serotonergic neuron axon,BP,
10307,GO:0036518,1,0.984716194898832,0,2,chemorepulsion of dopaminergic neuron axon,BP,
10308,GO:0036520,1,0.985031387575391,0,2,astrocyte-dopaminergic neuron signaling,BP,
10309,GO:0036524,1,0.996698971982734,0,1,protein deglycase activity,MF,
10310,GO:0036525,1,0.992931160620994,0,2,protein deglycation,BP,
10311,GO:0036526,1,0.996698971982734,0,1,peptidyl-cysteine deglycation,BP,
10312,GO:0036527,1,0.996698971982734,0,1,peptidyl-arginine deglycation,BP,
10313,GO:0036528,1,0.996698971982734,0,1,peptidyl-lysine deglycation,BP,
10314,GO:0036529,1,0.996698971982734,0,1,protein deglycation, glyoxal removal,BP,
10315,GO:0036530,1,0.996698971982734,0,1,protein deglycation, methylglyoxal removal,BP,
10316,GO:0036531,1,0.996698971982734,0,1,glutathione deglycation,BP,
10317,GO:0038001,1,0.965956062921844,0,4,paracrine signaling,BP,
10318,GO:0038002,1,0.991955316106877,0,1,endocrine signaling,BP,
10319,GO:0038003,1,0.935733990578505,0,12,opioid receptor signaling pathway,BP,
10320,GO:0038007,1,0.912763177712124,0,12,netrin-activated signaling pathway,BP,
10321,GO:0038009,1,0.996304995047058,0,1,regulation of signal transduction by receptor internalization,BP,
10322,GO:0038016,1,0.986055252236576,0,2,insulin receptor internalization,BP,
10323,GO:0038018,1,0.983679989083005,0,2,Wnt receptor catabolic process,BP,
10324,GO:0038020,1,0.98894460310163,0,1,insulin receptor recycling,BP,
10325,GO:0038021,1,0.992420105350758,0,1,leptin receptor activity,MF,
10328,GO:0038025,1,0.985006969956547,0,2,reelin receptor activity,MF,
10329,GO:0038026,1,0.945901699882658,0,7,reelin-mediated signaling pathway,BP,
10330,GO:0038027,1,0.959517239330687,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10331,GO:0038028,1,0.971091492159836,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
10334,GO:0038033,1,0.966426086053805,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10336,GO:0038036,1,0.953210597630777,0,8,sphingosine-1-phosphate receptor activity,MF,
10337,GO:0038037,1,0.953790541471525,0,7,G protein-coupled receptor dimeric complex,CC,
10338,GO:0038038,1,0.991085070344566,0,1,G protein-coupled receptor homodimeric complex,CC,
10339,GO:0038039,1,0.97671676957585,0,3,G protein-coupled receptor heterodimeric complex,CC,
10340,GO:0038041,1,0.988885796112704,0,2,cross-receptor inhibition within G protein-coupled receptor heterodimer,BP,
10341,GO:0038043,1,0.987301527956227,0,2,interleukin-5-mediated signaling pathway,BP,
10342,GO:0038046,1,0.995634936794179,0,1,enkephalin receptor activity,MF,
10343,GO:0038047,1,0.995430413442757,0,1,morphine receptor activity,MF,
10344,GO:0038048,1,0.992162026672152,0,1,dynorphin receptor activity,MF,
10345,GO:0038060,1,0.992614688101677,0,1,nitric oxide-cGMP-mediated signaling pathway,BP,
10347,GO:0038062,1,0.979158605746029,0,3,protein tyrosine kinase collagen receptor activity,MF,
10348,GO:0038063,1,0.913209553630292,0,11,collagen-activated tyrosine kinase receptor signaling pathway,BP,
10349,GO:0038064,1,0.958644717493637,0,6,collagen receptor activity,MF,
10350,GO:0038065,1,0.894063872827834,0,14,collagen-activated signaling pathway,BP,
10351,GO:0038066,1,0.758618071622158,0,43,p38MAPK cascade,BP,
10356,GO:0038089,1,0.949871774878533,0,7,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10358,GO:0038092,1,0.915350539398219,0,15,nodal signaling pathway,BP,
10359,GO:0038093,1,0.345243728578126,0,171,Fc receptor signaling pathway,BP,
10360,GO:0038094,1,0.595441802713487,0,78,Fc-gamma receptor signaling pathway,BP,
10361,GO:0038095,1,0.527523233787605,0,106,Fc-epsilon receptor signaling pathway,BP,
10362,GO:0038096,1,0.603407964240598,0,75,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
10363,GO:0038097,1,0.991981954438062,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10365,GO:0038100,1,0.982042208897097,0,3,nodal binding,MF,
10366,GO:0038101,1,0.9957232701252,0,1,sequestering of nodal from receptor via nodal binding,BP,
10367,GO:0038102,1,0.988813220233137,0,2,activin receptor antagonist activity,MF,
10368,GO:0038107,1,0.963145299013504,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10369,GO:0038108,1,0.973432585775156,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10370,GO:0038109,1,0.977099691033409,0,3,Kit signaling pathway,BP,
10371,GO:0038110,1,0.925273019287934,0,11,interleukin-2-mediated signaling pathway,BP,
10372,GO:0038111,1,0.895327279068267,0,16,interleukin-7-mediated signaling pathway,BP,
10373,GO:0038112,1,0.987187322509217,0,2,interleukin-8-mediated signaling pathway,BP,
10374,GO:0038113,1,0.950334893994889,0,7,interleukin-9-mediated signaling pathway,BP,
10375,GO:0038114,1,0.951675070256492,0,7,interleukin-21-mediated signaling pathway,BP,
10376,GO:0038115,1,0.994677031264593,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10377,GO:0038116,1,0.973260884590426,0,4,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10378,GO:0038117,1,0.994677031264593,0,1,C-C motif chemokine 19 receptor activity,MF,
10379,GO:0038118,1,0.996620610494782,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10380,GO:0038121,1,0.994677031264593,0,1,C-C motif chemokine 21 receptor activity,MF,
10381,GO:0038123,1,0.975172035921496,0,4,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10382,GO:0038124,1,0.975382651896665,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10385,GO:0038129,1,0.983202937133321,0,3,ERBB3 signaling pathway,BP,
10388,GO:0038133,1,0.995005070714897,0,1,ERBB2-ERBB3 signaling pathway,BP,
10390,GO:0038145,1,0.966433293913193,0,6,macrophage colony-stimulating factor signaling pathway,BP,
10391,GO:0038146,1,0.976093125440642,0,4,chemokine (C-X-C motif) ligand 12 signaling pathway,BP,
10392,GO:0038147,1,0.995618040134565,0,1,C-X-C motif chemokine 12 receptor activity,MF,
10393,GO:0038154,1,0.981026936383175,0,3,interleukin-11-mediated signaling pathway,BP,
10394,GO:0038155,1,0.956039574053433,0,7,interleukin-23-mediated signaling pathway,BP,
10395,GO:0038156,1,0.981280661074433,0,3,interleukin-3-mediated signaling pathway,BP,
10396,GO:0038158,1,0.988458737458482,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10397,GO:0038159,1,0.995618040134565,0,1,C-X-C chemokine receptor CXCR4 signaling pathway,BP,
10398,GO:0038160,1,0.995618040134565,0,1,CXCL12-activated CXCR4 signaling pathway,BP,
10399,GO:0038161,1,0.981870372672396,0,2,prolactin signaling pathway,BP,
10400,GO:0038162,1,0.983947784793419,0,3,erythropoietin-mediated signaling pathway,BP,
10401,GO:0038163,1,0.969614415855045,0,5,thrombopoietin-mediated signaling pathway,BP,
10402,GO:0038164,1,0.992513243047183,0,1,thrombopoietin receptor activity,MF,
10403,GO:0038165,1,0.951971257378736,0,6,oncostatin-M-mediated signaling pathway,BP,
10404,GO:0038166,1,0.930869269728182,0,11,angiotensin-activated signaling pathway,BP,
10405,GO:0038167,1,0.991954769328028,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10406,GO:0038168,1,0.991954769328028,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10407,GO:0038169,1,0.977386291255052,0,4,somatostatin receptor signaling pathway,BP,
10408,GO:0038170,1,0.977386291255052,0,4,somatostatin signaling pathway,BP,
10409,GO:0038171,1,0.938806235270654,0,9,cannabinoid signaling pathway,BP,
10410,GO:0038172,1,0.980491548971177,0,3,interleukin-33-mediated signaling pathway,BP,
10411,GO:0038177,1,0.996509134323158,0,1,death receptor agonist activity,MF,
10412,GO:0038178,1,0.987532914959292,0,2,complement component C5a signaling pathway,BP,
10414,GO:0038180,1,0.925229340595272,0,12,nerve growth factor signaling pathway,BP,
10415,GO:0038181,1,0.98322412355563,0,3,bile acid receptor activity,MF,
10416,GO:0038182,1,0.996136459553227,0,1,G protein-coupled bile acid receptor activity,MF,
10417,GO:0038183,1,0.98322412355563,0,3,bile acid signaling pathway,BP,
10418,GO:0038184,1,0.996136459553227,0,1,cell surface bile acid receptor signaling pathway,BP,
10419,GO:0038185,1,0.994728818783657,0,1,intracellular bile acid receptor signaling pathway,BP,
10420,GO:0038186,1,0.992268935463032,0,1,lithocholic acid receptor activity,MF,
10421,GO:0038187,1,0.880318294629414,0,20,pattern recognition receptor activity,MF,
10422,GO:0038188,1,0.990642700245817,0,2,cholecystokinin signaling pathway,BP,
10423,GO:0038189,1,0.973163924868271,0,4,neuropilin signaling pathway,BP,
10424,GO:0038190,1,0.98646081816534,0,2,VEGF-activated neuropilin signaling pathway,BP,
10425,GO:0038191,1,0.968690695225097,0,4,neuropilin binding,MF,
10426,GO:0038192,1,0.995025201341907,0,1,gastric inhibitory peptide signaling pathway,BP,
10427,GO:0038193,1,0.994416103024581,0,1,thromboxane A2 signaling pathway,BP,
10428,GO:0038194,1,0.988956984446561,0,2,thyroid-stimulating hormone signaling pathway,BP,
10429,GO:0038195,1,0.99621290776435,0,1,urokinase plasminogen activator signaling pathway,BP,
10430,GO:0038201,1,0.892833809799818,0,15,TOR complex,CC,
10431,GO:0038202,1,0.765642863443785,0,39,TORC1 signaling,BP,
10432,GO:0038203,1,0.947179855484599,0,8,TORC2 signaling,BP,
10433,GO:0039003,1,0.984991601333973,0,2,pronephric field specification,BP,
10434,GO:0039007,1,0.991847881963631,0,1,pronephric nephron morphogenesis,BP,
10435,GO:0039008,1,0.991847881963631,0,1,pronephric nephron tubule morphogenesis,BP,
10436,GO:0039017,1,0.984991601333973,0,2,pattern specification involved in pronephros development,BP,
10437,GO:0039019,1,0.984423219445424,0,2,pronephric nephron development,BP,
10438,GO:0039020,1,0.991847881963631,0,1,pronephric nephron tubule development,BP,
10439,GO:0039022,1,0.991847881963631,0,1,pronephric duct development,BP,
10440,GO:0039023,1,0.991847881963631,0,1,pronephric duct morphogenesis,BP,
10441,GO:0039506,1,0.985357513237995,0,2,modulation by virus of host molecular function,BP,
10442,GO:0039507,1,0.985357513237995,0,2,suppression by virus of host molecular function,BP,
10443,GO:0039513,1,0.993269958212675,0,1,suppression by virus of host catalytic activity,BP,
10444,GO:0039514,1,0.992034489406777,0,1,suppression by virus of host JAK-STAT cascade,BP,
10445,GO:0039516,1,0.993269958212675,0,1,modulation by virus of host catalytic activity,BP,
10446,GO:0039519,1,0.98034976448613,0,3,modulation by virus of host autophagy,BP,
10447,GO:0039520,1,0.988103932242201,0,2,induction by virus of host autophagy,BP,
10448,GO:0039521,1,0.992153431733136,0,1,suppression by virus of host autophagy,BP,
10449,GO:0039526,1,0.97617691711848,0,4,modulation by virus of host apoptotic process,BP,
10450,GO:0039528,1,0.843713452914439,0,25,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10451,GO:0039529,1,0.86859984024908,0,20,RIG-I signaling pathway,BP,
10452,GO:0039530,1,0.948832730443043,0,8,MDA-5 signaling pathway,BP,
10453,GO:0039531,1,0.889082700853622,0,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10454,GO:0039532,1,0.942259469445398,0,9,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10455,GO:0039533,1,0.964502648447834,0,5,regulation of MDA-5 signaling pathway,BP,
10456,GO:0039534,1,0.982632055011587,0,3,negative regulation of MDA-5 signaling pathway,BP,
10457,GO:0039535,1,0.900414777426541,0,14,regulation of RIG-I signaling pathway,BP,
10458,GO:0039536,1,0.954262170346689,0,7,negative regulation of RIG-I signaling pathway,BP,
10459,GO:0039552,1,0.978696444895436,0,3,RIG-I binding,MF,
10460,GO:0039562,1,0.992034489406777,0,1,suppression by virus of host STAT activity,BP,
10461,GO:0039563,1,0.992034489406777,0,1,suppression by virus of host STAT1 activity,BP,
10462,GO:0039564,1,0.992034489406777,0,1,suppression by virus of host STAT2 activity,BP,
10463,GO:0039650,1,0.993269958212675,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10464,GO:0039654,1,0.99325505912211,0,1,fusion of virus membrane with host endosome membrane,BP,
10465,GO:0039656,1,0.981601548324614,0,3,modulation by virus of host gene expression,BP,
10466,GO:0039663,1,0.957767437873061,0,7,membrane fusion involved in viral entry into host cell,BP,
10467,GO:0039689,1,0.98010862254054,0,3,negative stranded viral RNA replication,BP,
10468,GO:0039692,1,0.895529970024609,0,18,single stranded viral RNA replication via double stranded DNA intermediate,BP,
10469,GO:0039694,1,0.807650601232725,0,33,viral RNA genome replication,BP,
10470,GO:0039695,1,0.992305235802394,0,1,DNA-templated viral transcription,BP,
10471,GO:0039702,1,0.889196161296176,0,21,viral budding via host ESCRT complex,BP,
10472,GO:0039706,1,0.933672151501506,0,11,co-receptor binding,MF,
10473,GO:0039713,1,0.992571170284062,0,1,viral factory,CC,
10474,GO:0039714,1,0.992571170284062,0,1,cytoplasmic viral factory,CC,
10478,GO:0040009,1,0.955096652497398,0,6,regulation of growth rate,BP,
10479,GO:0040010,1,0.989718472096635,0,2,positive regulation of growth rate,BP,
10483,GO:0040014,1,0.657073785432092,0,63,regulation of multicellular organism growth,BP,
10484,GO:0040015,1,0.929945177706718,0,11,negative regulation of multicellular organism growth,BP,
10485,GO:0040016,1,0.966037336726911,0,5,embryonic cleavage,BP,
10487,GO:0040018,1,0.814909090931304,0,30,positive regulation of multicellular organism growth,BP,
10489,GO:0040020,1,0.837691414175991,0,28,regulation of meiotic nuclear division,BP,
10490,GO:0040029,1,0.414030774792471,0,129,regulation of gene expression, epigenetic,BP,
10491,GO:0040030,1,0.989353333576773,0,2,regulation of molecular function, epigenetic,BP,
10492,GO:0040031,1,0.961486877414952,0,7,snRNA modification,BP,
10493,GO:0040032,1,0.995366849228044,0,1,post-embryonic body morphogenesis,BP,
10494,GO:0040033,1,0.899795350010986,0,14,negative regulation of translation, ncRNA-mediated,BP,
10495,GO:0040034,1,0.92061840402086,0,13,regulation of development, heterochronic,BP,
10498,GO:0040038,1,0.976129950212521,0,3,polar body extrusion after meiotic divisions,BP,
10499,GO:0040040,1,0.991552029684377,0,1,thermosensory behavior,BP,
10500,GO:0042000,1,0.994042880589517,0,1,translocation of peptides or proteins into host,BP,
10501,GO:0042007,1,0.98881110912898,0,2,interleukin-18 binding,MF,
10502,GO:0042008,1,0.986038071682239,0,2,interleukin-18 receptor activity,MF,
10503,GO:0042010,1,0.984333461243297,0,3,interleukin-15 receptor activity,MF,
10504,GO:0042011,1,0.992786080512339,0,1,interleukin-16 binding,MF,
10505,GO:0042012,1,0.992786080512339,0,1,interleukin-16 receptor activity,MF,
10506,GO:0042015,1,0.980830080642231,0,3,interleukin-20 binding,MF,
10507,GO:0042019,1,0.987836385301909,0,2,interleukin-23 binding,MF,
10508,GO:0042020,1,0.995140962520074,0,1,interleukin-23 receptor activity,MF,
10509,GO:0042022,1,0.987836385301909,0,2,interleukin-12 receptor complex,CC,
10510,GO:0042023,1,0.965351922753821,0,5,DNA endoreduplication,BP,
10511,GO:0042025,1,0.956044268408182,0,6,host cell nucleus,CC,
10512,GO:0042026,1,0.874534656818157,0,22,protein refolding,BP,
10513,GO:0042030,1,0.969226290266594,0,4,ATPase inhibitor activity,MF,
10514,GO:0042033,1,0.996543373289718,0,1,chemokine biosynthetic process,BP,
10515,GO:0042035,1,0.901142185755012,0,14,regulation of cytokine biosynthetic process,BP,
10516,GO:0042036,1,0.964167569108308,0,5,negative regulation of cytokine biosynthetic process,BP,
10517,GO:0042038,1,0.99325505912211,0,1,peptidyl-histidine methylation, to form tele-methylhistidine,BP,
10518,GO:0042040,1,0.992418877101266,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10519,GO:0042043,1,0.902563226562377,0,14,neurexin family protein binding,MF,
10520,GO:0042044,1,0.858981559112573,0,24,fluid transport,BP,
10521,GO:0042045,1,0.941098655084026,0,8,epithelial fluid transport,BP,
10522,GO:0042048,1,0.931658267976901,0,9,olfactory behavior,BP,
10523,GO:0042053,1,0.893018781228547,0,18,regulation of dopamine metabolic process,BP,
10524,GO:0042054,1,0.685054224086002,0,53,histone methyltransferase activity,MF,
10530,GO:0042069,1,0.893018781228547,0,18,regulation of catecholamine metabolic process,BP,
10531,GO:0042073,1,0.715305363907082,0,49,intraciliary transport,BP,
10532,GO:0042074,1,0.91267023302213,0,14,cell migration involved in gastrulation,BP,
10533,GO:0042078,1,0.983378489855023,0,3,germ-line stem cell division,BP,
10534,GO:0042083,1,0.995988653036494,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10535,GO:0042084,1,0.989135532617128,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10536,GO:0042088,1,0.785583320240176,0,41,T-helper 1 type immune response,BP,
10537,GO:0042089,1,0.88156887302839,0,18,cytokine biosynthetic process,BP,
10538,GO:0042092,1,0.815934362646044,0,35,type 2 immune response,BP,
10539,GO:0042093,1,0.698545646107525,0,54,T-helper cell differentiation,BP,
10541,GO:0042100,1,0.637577225668487,0,74,B cell proliferation,BP,
10542,GO:0042101,1,0.9123183029551,0,17,T cell receptor complex,CC,
10543,GO:0042102,1,0.596192152102026,0,90,positive regulation of T cell proliferation,BP,
10544,GO:0042104,1,0.894528156684574,0,20,positive regulation of activated T cell proliferation,BP,
10545,GO:0042105,1,0.979713858019265,0,5,alpha-beta T cell receptor complex,CC,
10546,GO:0042107,1,0.877272172940532,0,19,cytokine metabolic process,BP,
10547,GO:0042108,1,0.977870145080966,0,3,positive regulation of cytokine biosynthetic process,BP,
10549,GO:0042113,1,0.241083787778244,0,219,B cell activation,BP,
10550,GO:0042116,1,0.568324418637389,0,87,macrophage activation,BP,
10551,GO:0042117,1,0.94447710756398,0,9,monocyte activation,BP,
10552,GO:0042118,1,0.940935111124606,0,9,endothelial cell activation,BP,
10553,GO:0042119,1,0.0568006558611277,0,474,neutrophil activation,BP,
10554,GO:0042126,1,0.989952892397967,0,2,nitrate metabolic process,BP,
10558,GO:0042132,1,0.99606239377017,0,1,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10559,GO:0042133,1,0.8317401250766,0,28,neurotransmitter metabolic process,BP,
10560,GO:0042135,1,0.928426100617011,0,11,neurotransmitter catabolic process,BP,
10561,GO:0042136,1,0.897286152137759,0,16,neurotransmitter biosynthetic process,BP,
10562,GO:0042137,1,0.988295388833843,0,2,sequestering of neurotransmitter,BP,
10563,GO:0042138,1,0.979205772720647,0,3,meiotic DNA double-strand break formation,BP,
10564,GO:0042140,1,0.99325505912211,0,1,late meiotic recombination nodule assembly,BP,
10565,GO:0042144,1,0.972973594599933,0,5,vacuole fusion, non-autophagic,BP,
10567,GO:0042148,1,0.967124785938321,0,5,strand invasion,BP,
10568,GO:0042149,1,0.727759003328638,0,47,cellular response to glucose starvation,BP,
10570,GO:0042158,1,0.559772526859168,0,93,lipoprotein biosynthetic process,BP,
10571,GO:0042159,1,0.905062493042091,0,15,lipoprotein catabolic process,BP,
10574,GO:0042162,1,0.783560781150604,0,35,telomeric DNA binding,MF,
10575,GO:0042163,1,0.996214297604249,0,1,interleukin-12 beta subunit binding,MF,
10576,GO:0042165,1,0.877489617453271,0,20,neurotransmitter binding,MF,
10577,GO:0042166,1,0.9256408229824,0,12,acetylcholine binding,MF,
10578,GO:0042167,1,0.985165219453117,0,4,heme catabolic process,BP,
10579,GO:0042168,1,0.855515661086497,0,28,heme metabolic process,BP,
10580,GO:0042169,1,0.750367777217516,0,40,SH2 domain binding,MF,
10581,GO:0042171,1,0.894978653622473,0,16,lysophosphatidic acid acyltransferase activity,MF,
10585,GO:0042178,1,0.9445944242198,0,11,xenobiotic catabolic process,BP,
10587,GO:0042181,1,0.808402374825564,0,36,ketone biosynthetic process,BP,
10588,GO:0042182,1,0.947415087888808,0,10,ketone catabolic process,BP,
10589,GO:0042197,1,0.995835695009094,0,1,halogenated hydrocarbon metabolic process,BP,
10590,GO:0042214,1,0.981800645235944,0,3,terpene metabolic process,BP,
10591,GO:0042218,1,0.995020174114203,0,1,1-aminocyclopropane-1-carboxylate biosynthetic process,BP,
10592,GO:0042219,1,0.853346780688955,0,26,cellular modified amino acid catabolic process,BP,
10593,GO:0042220,1,0.748136959217179,0,44,response to cocaine,BP,
10595,GO:0042245,1,0.986094183079146,0,2,RNA repair,BP,
10597,GO:0042247,1,0.992979587148606,0,1,establishment of planar polarity of follicular epithelium,BP,
10599,GO:0042253,1,0.985454870206678,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10600,GO:0042254,1,0.206851182379111,0,277,ribosome biogenesis,BP,
10601,GO:0042255,1,0.748511728453761,0,57,ribosome assembly,BP,
10602,GO:0042256,1,0.973645128769332,0,5,mature ribosome assembly,BP,
10603,GO:0042262,1,0.978912085015884,0,5,DNA protection,BP,
10604,GO:0042264,1,0.983660712781447,0,2,peptidyl-aspartic acid hydroxylation,BP,
10605,GO:0042265,1,0.991077839101146,0,1,peptidyl-asparagine hydroxylation,BP,
10606,GO:0042267,1,0.749649501064408,0,51,natural killer cell mediated cytotoxicity,BP,
10607,GO:0042268,1,0.990120748274494,0,2,regulation of cytolysis,BP,
10608,GO:0042269,1,0.822549819641611,0,35,regulation of natural killer cell mediated cytotoxicity,BP,
10609,GO:0042270,1,0.976531612098645,0,5,protection from natural killer cell mediated cytotoxicity,BP,
10610,GO:0042271,1,0.984212468296822,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
10611,GO:0042272,1,0.995330476245509,0,1,nuclear RNA export factor complex,CC,
10612,GO:0042273,1,0.70908721662916,0,66,ribosomal large subunit biogenesis,BP,
10613,GO:0042274,1,0.688048783374196,0,68,ribosomal small subunit biogenesis,BP,
10614,GO:0042275,1,0.996092270369282,0,1,error-free postreplication DNA repair,BP,
10615,GO:0042276,1,0.882963684494018,0,21,error-prone translesion synthesis,BP,
10617,GO:0042278,1,0.718430140460069,0,56,purine nucleoside metabolic process,BP,
10618,GO:0042281,1,0.992596928971034,0,1,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10619,GO:0042282,1,0.992345568117987,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10620,GO:0042283,1,0.995753079518185,0,1,dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10621,GO:0042284,1,0.991736287697605,0,2,sphingolipid delta-4 desaturase activity,MF,
10622,GO:0042285,1,0.956446025852819,0,6,xylosyltransferase activity,MF,
10623,GO:0042287,1,0.848030051559949,0,28,MHC protein binding,MF,
10624,GO:0042288,1,0.895363514590126,0,18,MHC class I protein binding,MF,
10625,GO:0042289,1,0.968190645553742,0,6,MHC class II protein binding,MF,
10626,GO:0042292,1,0.993947281909514,0,1,URM1 activating enzyme activity,MF,
10627,GO:0042296,1,0.980978086451075,0,4,ISG15 transferase activity,MF,
10628,GO:0042297,1,0.936647799641248,0,7,vocal learning,BP,
10629,GO:0042300,1,0.992421201583323,0,1,beta-amyrin synthase activity,MF,
10630,GO:0042301,1,0.936901648821609,0,10,phosphate ion binding,MF,
10634,GO:0042307,1,0.759649027349705,0,39,positive regulation of protein import into nucleus,BP,
10636,GO:0042309,1,0.993256912061493,0,1,homoiothermy,BP,
10638,GO:0042311,1,0.836079030877411,0,29,vasodilation,BP,
10639,GO:0042313,1,0.994861437549621,0,1,protein kinase C deactivation,BP,
10640,GO:0042316,1,0.992103373225629,0,1,penicillin metabolic process,BP,
10641,GO:0042320,1,0.981944231860593,0,4,regulation of circadian sleep/wake cycle, REM sleep,BP,
10642,GO:0042321,1,0.976113025766502,0,5,negative regulation of circadian sleep/wake cycle, sleep,BP,
10643,GO:0042322,1,0.99322657692595,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10644,GO:0042323,1,0.989223052204408,0,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
10648,GO:0042328,1,0.98515902345483,0,2,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10650,GO:0042335,1,0.977916812243246,0,3,cuticle development,BP,
10653,GO:0042350,1,0.99582441735559,0,1,GDP-L-fucose biosynthetic process,BP,
10654,GO:0042351,1,0.99582441735559,0,1,'de novo' GDP-L-fucose biosynthetic process,BP,
10655,GO:0042354,1,0.940819744652645,0,8,L-fucose metabolic process,BP,
10656,GO:0042355,1,0.940819744652645,0,8,L-fucose catabolic process,BP,
10657,GO:0042357,1,0.989794551158487,0,2,thiamine diphosphate metabolic process,BP,
10659,GO:0042360,1,0.985142562098805,0,3,vitamin E metabolic process,BP,
10660,GO:0042361,1,0.981449613055694,0,3,menaquinone catabolic process,BP,
10661,GO:0042362,1,0.928885714712199,0,13,fat-soluble vitamin biosynthetic process,BP,
10662,GO:0042363,1,0.948872623502092,0,9,fat-soluble vitamin catabolic process,BP,
10663,GO:0042364,1,0.963555083706092,0,6,water-soluble vitamin biosynthetic process,BP,
10664,GO:0042365,1,0.991845809837703,0,2,water-soluble vitamin catabolic process,BP,
10665,GO:0042368,1,0.946210509977992,0,10,vitamin D biosynthetic process,BP,
10666,GO:0042369,1,0.986629108876018,0,2,vitamin D catabolic process,BP,
10667,GO:0042371,1,0.992513428419899,0,1,vitamin K biosynthetic process,BP,
10668,GO:0042373,1,0.964090290380953,0,7,vitamin K metabolic process,BP,
10669,GO:0042374,1,0.978088356072884,0,4,phylloquinone metabolic process,BP,
10670,GO:0042376,1,0.978088356072884,0,4,phylloquinone catabolic process,BP,
10671,GO:0042377,1,0.981449613055694,0,3,vitamin K catabolic process,BP,
10672,GO:0042379,1,0.822600673641151,0,44,chemokine receptor binding,MF,
10673,GO:0042382,1,0.959246833931889,0,6,paraspeckles,CC,
10676,GO:0042392,1,0.989156629206091,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10677,GO:0042393,1,0.222549703068281,0,211,histone binding,MF,
10678,GO:0042396,1,0.979783953948238,0,5,phosphagen biosynthetic process,BP,
10680,GO:0042401,1,0.901851612562022,0,20,cellular biogenic amine biosynthetic process,BP,
10681,GO:0042402,1,0.905022814587621,0,19,cellular biogenic amine catabolic process,BP,
10682,GO:0042403,1,0.858881066110366,0,22,thyroid hormone metabolic process,BP,
10683,GO:0042404,1,0.986278752840148,0,2,thyroid hormone catabolic process,BP,
10684,GO:0042405,1,0.911417924679171,0,11,nuclear inclusion body,CC,
10685,GO:0042406,1,0.969959439628192,0,5,extrinsic component of endoplasmic reticulum membrane,CC,
10686,GO:0042407,1,0.91411807187267,0,16,cristae formation,BP,
10687,GO:0042412,1,0.989345848123596,0,2,taurine biosynthetic process,BP,
10688,GO:0042413,1,0.993849785144909,0,1,carnitine catabolic process,BP,
10689,GO:0042414,1,0.98217700438777,0,3,epinephrine metabolic process,BP,
10690,GO:0042415,1,0.934797941632146,0,10,norepinephrine metabolic process,BP,
10691,GO:0042416,1,0.93560048501737,0,11,dopamine biosynthetic process,BP,
10692,GO:0042417,1,0.793191481196702,0,36,dopamine metabolic process,BP,
10693,GO:0042418,1,0.991886543230581,0,2,epinephrine biosynthetic process,BP,
10694,GO:0042420,1,0.956003884727544,0,7,dopamine catabolic process,BP,
10695,GO:0042421,1,0.962201799961712,0,6,norepinephrine biosynthetic process,BP,
10696,GO:0042423,1,0.890025299675682,0,19,catecholamine biosynthetic process,BP,
10697,GO:0042424,1,0.949155795519077,0,8,catecholamine catabolic process,BP,
10698,GO:0042426,1,0.957411155334686,0,6,choline catabolic process,BP,
10699,GO:0042427,1,0.984831996519884,0,3,serotonin biosynthetic process,BP,
10700,GO:0042428,1,0.930772089103725,0,10,serotonin metabolic process,BP,
10701,GO:0042430,1,0.889818254925229,0,20,indole-containing compound metabolic process,BP,
10702,GO:0042435,1,0.981059808161249,0,4,indole-containing compound biosynthetic process,BP,
10703,GO:0042436,1,0.963799522042704,0,8,indole-containing compound catabolic process,BP,
10704,GO:0042438,1,0.868309341349486,0,20,melanin biosynthetic process,BP,
10705,GO:0042439,1,0.953255366493175,0,8,ethanolamine-containing compound metabolic process,BP,
10706,GO:0042440,1,0.683206676675708,0,62,pigment metabolic process,BP,
10707,GO:0042441,1,0.988556068486687,0,2,eye pigment metabolic process,BP,
10709,GO:0042446,1,0.711144169656398,0,55,hormone biosynthetic process,BP,
10710,GO:0042447,1,0.934849608750739,0,11,hormone catabolic process,BP,
10711,GO:0042448,1,0.925739135462644,0,14,progesterone metabolic process,BP,
10712,GO:0042450,1,0.991017543746026,0,2,arginine biosynthetic process via ornithine,BP,
10713,GO:0042451,1,0.904088478502132,0,21,purine nucleoside biosynthetic process,BP,
10714,GO:0042454,1,0.910805493764312,0,18,ribonucleoside catabolic process,BP,
10715,GO:0042455,1,0.904088478502132,0,21,ribonucleoside biosynthetic process,BP,
10717,GO:0042462,1,0.808190329798373,0,30,eye photoreceptor cell development,BP,
10721,GO:0042473,1,0.946904159051649,0,9,outer ear morphogenesis,BP,
10722,GO:0042474,1,0.894380542556775,0,20,middle ear morphogenesis,BP,
10725,GO:0042478,1,0.985678589184152,0,2,regulation of eye photoreceptor cell development,BP,
10726,GO:0042480,1,0.985678589184152,0,2,negative regulation of eye photoreceptor cell development,BP,
10729,GO:0042483,1,0.972538840302062,0,4,negative regulation of odontogenesis,BP,
10732,GO:0042489,1,0.98701153262155,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10734,GO:0042491,1,0.808803106889664,0,30,inner ear auditory receptor cell differentiation,BP,
10735,GO:0042492,1,0.922537289115184,0,11,gamma-delta T cell differentiation,BP,
10737,GO:0042494,1,0.960814973605995,0,5,detection of bacterial lipoprotein,BP,
10738,GO:0042495,1,0.9857568820371,0,2,detection of triacyl bacterial lipopeptide,BP,
10739,GO:0042496,1,0.984313160800966,0,2,detection of diacyl bacterial lipopeptide,BP,
10740,GO:0042497,1,0.992588749188074,0,1,triacyl lipopeptide binding,MF,
10741,GO:0042500,1,0.962243450375096,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10742,GO:0042501,1,0.958720572178004,0,7,serine phosphorylation of STAT protein,BP,
10745,GO:0042532,1,0.928761883409999,0,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10746,GO:0042537,1,0.903470096401475,0,21,benzene-containing compound metabolic process,BP,
10747,GO:0042538,1,0.939562623275329,0,10,hyperosmotic salinity response,BP,
10748,GO:0042539,1,0.983563282274859,0,2,hypotonic salinity response,BP,
10749,GO:0042541,1,0.946488392130405,0,10,hemoglobin biosynthetic process,BP,
10750,GO:0042542,1,0.457491989904853,0,129,response to hydrogen peroxide,BP,
10751,GO:0042543,1,0.996845352430309,0,1,protein N-linked glycosylation via arginine,BP,
10752,GO:0042546,1,0.995630725828587,0,1,cell wall biogenesis,BP,
10756,GO:0042555,1,0.919702143326072,0,12,MCM complex,CC,
10758,GO:0042559,1,0.932505097963783,0,13,pteridine-containing compound biosynthetic process,BP,
10759,GO:0042560,1,0.980338416579026,0,3,pteridine-containing compound catabolic process,BP,
10761,GO:0042564,1,0.992395254141827,0,1,NLS-dependent protein nuclear import complex,CC,
10762,GO:0042565,1,0.988571117756935,0,2,RNA nuclear export complex,CC,
10763,GO:0042567,1,0.971123683176646,0,4,insulin-like growth factor ternary complex,CC,
10764,GO:0042568,1,0.996679535224359,0,1,insulin-like growth factor binary complex,CC,
10765,GO:0042571,1,0.990026290693406,0,2,immunoglobulin complex, circulating,CC,
10766,GO:0042572,1,0.803380928341294,0,39,retinol metabolic process,BP,
10767,GO:0042573,1,0.8946042321626,0,20,retinoic acid metabolic process,BP,
10768,GO:0042574,1,0.909442501091913,0,15,retinal metabolic process,BP,
10769,GO:0042575,1,0.87785569826331,0,21,DNA polymerase complex,CC,
10770,GO:0042577,1,0.97659971591827,0,4,lipid phosphatase activity,MF,
10773,GO:0042581,1,0.38777486734594,0,154,specific granule,CC,
10774,GO:0042582,1,0.421194219087571,0,145,azurophil granule,CC,
10775,GO:0042583,1,0.932423881360947,0,10,chromaffin granule,CC,
10776,GO:0042584,1,0.950021090973681,0,7,chromaffin granule membrane,CC,
10777,GO:0042585,1,0.994503047059694,0,1,germinal vesicle,CC,
10778,GO:0042586,1,0.996535355469023,0,1,peptide deformylase activity,MF,
10779,GO:0042587,1,0.952311856072484,0,7,glycogen granule,CC,
10780,GO:0042588,1,0.917872346662774,0,14,zymogen granule,CC,
10781,GO:0042589,1,0.937686878647924,0,10,zymogen granule membrane,CC,
10782,GO:0042590,1,0.702443242452785,0,74,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
10785,GO:0042594,1,0.296353071211077,0,183,response to starvation,BP,
10786,GO:0042595,1,0.989220845585637,0,2,behavioral response to starvation,BP,
10788,GO:0042599,1,0.921663016162463,0,14,lamellar body,CC,
10789,GO:0042602,1,0.996740573362814,0,1,riboflavin reductase (NADPH) activity,MF,
10790,GO:0042605,1,0.898863340642946,0,21,peptide antigen binding,MF,
10791,GO:0042608,1,0.956906497855484,0,9,T cell receptor binding,MF,
10792,GO:0042609,1,0.949783272294834,0,9,CD4 receptor binding,MF,
10793,GO:0042610,1,0.981891532773398,0,4,CD8 receptor binding,MF,
10794,GO:0042611,1,0.917971358745429,0,22,MHC protein complex,CC,
10795,GO:0042612,1,0.969869694086217,0,8,MHC class I protein complex,CC,
10796,GO:0042613,1,0.946505691368102,0,14,MHC class II protein complex,CC,
10797,GO:0042622,1,0.900333692569793,0,16,photoreceptor outer segment membrane,CC,
10798,GO:0042625,1,0.685390214251664,0,56,ATPase-coupled ion transmembrane transporter activity,MF,
10799,GO:0042626,1,0.501411400188224,0,95,ATPase-coupled transmembrane transporter activity,MF,
10800,GO:0042627,1,0.95210862836546,0,9,chylomicron,CC,
10801,GO:0042628,1,0.994436847309884,0,1,mating plug formation,BP,
10802,GO:0042629,1,0.877970250770064,0,21,mast cell granule,CC,
10803,GO:0042631,1,0.985029659120607,0,2,cellular response to water deprivation,BP,
10804,GO:0042632,1,0.638291627920302,0,70,cholesterol homeostasis,BP,
10807,GO:0042635,1,0.934974711088414,0,12,positive regulation of hair cycle,BP,
10809,GO:0042637,1,0.976027341074337,0,4,catagen,BP,
10810,GO:0042640,1,0.963778048191801,0,5,anagen,BP,
10812,GO:0042645,1,0.775890299011797,0,40,mitochondrial nucleoid,CC,
10813,GO:0042658,1,0.996373315223691,0,1,MHC class II protein binding, via antigen binding groove,MF,
10815,GO:0042660,1,0.991156964088825,0,1,positive regulation of cell fate specification,BP,
10816,GO:0042661,1,0.971865730363617,0,5,regulation of mesodermal cell fate specification,BP,
10817,GO:0042662,1,0.987292661375598,0,3,negative regulation of mesodermal cell fate specification,BP,
10818,GO:0042663,1,0.992117455950071,0,2,regulation of endodermal cell fate specification,BP,
10819,GO:0042664,1,0.996533556746551,0,1,negative regulation of endodermal cell fate specification,BP,
10822,GO:0042667,1,0.992506177480911,0,1,auditory receptor cell fate specification,BP,
10823,GO:0042669,1,0.992506177480911,0,1,regulation of inner ear auditory receptor cell fate specification,BP,
10824,GO:0042670,1,0.940307934875197,0,9,retinal cone cell differentiation,BP,
10826,GO:0042693,1,0.933425500510951,0,12,muscle cell fate commitment,BP,
10827,GO:0042695,1,0.974983753323313,0,4,thelarche,BP,
10829,GO:0042699,1,0.989952597733943,0,2,follicle-stimulating hormone signaling pathway,BP,
10830,GO:0042700,1,0.992304470900223,0,1,luteinizing hormone signaling pathway,BP,
10831,GO:0042701,1,0.977594779751563,0,4,progesterone secretion,BP,
10832,GO:0042704,1,0.98481800738666,0,2,uterine wall breakdown,BP,
10833,GO:0042706,1,0.994934185789107,0,1,eye photoreceptor cell fate commitment,BP,
10834,GO:0042709,1,0.985124769267872,0,3,succinate-CoA ligase complex,CC,
10835,GO:0042710,1,0.994152611553279,0,1,biofilm formation,BP,
10836,GO:0042711,1,0.932823341624614,0,10,maternal behavior,BP,
10837,GO:0042713,1,0.969541931735703,0,4,sperm ejaculation,BP,
10838,GO:0042719,1,0.978742659455271,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10839,GO:0042720,1,0.992874126997344,0,2,mitochondrial inner membrane peptidase complex,CC,
10840,GO:0042721,1,0.982181713594264,0,3,TIM22 mitochondrial import inner membrane insertion complex,CC,
10841,GO:0042723,1,0.964698819774558,0,6,thiamine-containing compound metabolic process,BP,
10842,GO:0042726,1,0.948737842763211,0,8,flavin-containing compound metabolic process,BP,
10843,GO:0042727,1,0.988583869273553,0,2,flavin-containing compound biosynthetic process,BP,
10844,GO:0042728,1,0.99248346894442,0,1,flavin-containing compound catabolic process,BP,
10845,GO:0042730,1,0.891271578254382,0,20,fibrinolysis,BP,
10846,GO:0042731,1,0.973714130018984,0,4,PH domain binding,MF,
10847,GO:0042732,1,0.985914241361732,0,3,D-xylose metabolic process,BP,
10848,GO:0042733,1,0.682491920369451,0,56,embryonic digit morphogenesis,BP,
10850,GO:0042737,1,0.91095729940405,0,17,drug catabolic process,BP,
10851,GO:0042738,1,0.919683787645248,0,15,exogenous drug catabolic process,BP,
10854,GO:0042744,1,0.868984036719393,0,29,hydrogen peroxide catabolic process,BP,
10855,GO:0042745,1,0.866447692614744,0,26,circadian sleep/wake cycle,BP,
10856,GO:0042746,1,0.984213214459026,0,3,circadian sleep/wake cycle, wakefulness,BP,
10857,GO:0042747,1,0.966954810629935,0,7,circadian sleep/wake cycle, REM sleep,BP,
10858,GO:0042748,1,0.948528082576886,0,9,circadian sleep/wake cycle, non-REM sleep,BP,
10859,GO:0042749,1,0.897932432969852,0,20,regulation of circadian sleep/wake cycle,BP,
10860,GO:0042752,1,0.460194563424672,0,115,regulation of circadian rhythm,BP,
10861,GO:0042753,1,0.905921811529143,0,16,positive regulation of circadian rhythm,BP,
10862,GO:0042754,1,0.912047738502651,0,14,negative regulation of circadian rhythm,BP,
10863,GO:0042755,1,0.861884758034252,0,25,eating behavior,BP,
10864,GO:0042756,1,0.953669871155745,0,8,drinking behavior,BP,
10865,GO:0042758,1,0.947278955891943,0,9,long-chain fatty acid catabolic process,BP,
10867,GO:0042760,1,0.95954194393251,0,6,very long-chain fatty acid catabolic process,BP,
10868,GO:0042761,1,0.924915013401797,0,12,very long-chain fatty acid biosynthetic process,BP,
10869,GO:0042762,1,0.907745361293597,0,13,regulation of sulfur metabolic process,BP,
10870,GO:0042765,1,0.970636406328997,0,5,GPI-anchor transamidase complex,CC,
10871,GO:0042766,1,0.965455409504763,0,4,nucleosome mobilization,BP,
10872,GO:0042769,1,0.811404560535879,0,37,DNA damage response, detection of DNA damage,BP,
10873,GO:0042770,1,0.44146585087464,0,124,signal transduction in response to DNA damage,BP,
10874,GO:0042771,1,0.765077307755773,0,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
10875,GO:0042772,1,0.892710953915093,0,18,DNA damage response, signal transduction resulting in transcription,BP,
10876,GO:0042773,1,0.709549369361609,0,81,ATP synthesis coupled electron transport,BP,
10877,GO:0042774,1,0.99325505912211,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10878,GO:0042775,1,0.71438438380108,0,80,mitochondrial ATP synthesis coupled electron transport,BP,
10879,GO:0042776,1,0.983610354117569,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10880,GO:0042779,1,0.98385654916514,0,3,tRNA 3'-trailer cleavage,BP,
10881,GO:0042780,1,0.957609767895905,0,8,tRNA 3'-end processing,BP,
10882,GO:0042781,1,0.987046029919185,0,2,3'-tRNA processing endoribonuclease activity,MF,
10883,GO:0042788,1,0.86490742987704,0,32,polysomal ribosome,CC,
10884,GO:0042789,1,0.921950924837023,0,11,mRNA transcription by RNA polymerase II,BP,
10885,GO:0042790,1,0.922359644110546,0,13,nucleolar large rRNA transcription by RNA polymerase I,BP,
10886,GO:0042791,1,0.960233501887316,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10887,GO:0042795,1,0.656519309758477,0,69,snRNA transcription by RNA polymerase II,BP,
10888,GO:0042796,1,0.95130385019382,0,8,snRNA transcription by RNA polymerase III,BP,
10889,GO:0042797,1,0.957094647322099,0,7,tRNA transcription by RNA polymerase III,BP,
10890,GO:0042799,1,0.988147709421252,0,1,histone methyltransferase activity (H4-K20 specific),MF,
10891,GO:0042800,1,0.881951738194968,0,17,histone methyltransferase activity (H3-K4 specific),MF,
10895,GO:0042806,1,0.973986817070156,0,5,fucose binding,MF,
10896,GO:0042809,1,0.898363452667811,0,15,vitamin D receptor binding,MF,
10898,GO:0042816,1,0.965907483897626,0,5,vitamin B6 metabolic process,BP,
10899,GO:0042819,1,0.978333879292904,0,3,vitamin B6 biosynthetic process,BP,
10900,GO:0042820,1,0.995102627584936,0,1,vitamin B6 catabolic process,BP,
10901,GO:0042822,1,0.978629219645049,0,3,pyridoxal phosphate metabolic process,BP,
10902,GO:0042823,1,0.98344634122469,0,2,pyridoxal phosphate biosynthetic process,BP,
10903,GO:0042824,1,0.952371701172791,0,8,MHC class I peptide loading complex,CC,
10904,GO:0042825,1,0.985475058814081,0,2,TAP complex,CC,
10905,GO:0042826,1,0.475759049748327,0,109,histone deacetylase binding,MF,
10906,GO:0042827,1,0.900243379832846,0,18,platelet dense granule,CC,
10907,GO:0042832,1,0.873381034321948,0,24,defense response to protozoan,BP,
10908,GO:0042834,1,0.949537760153017,0,9,peptidoglycan binding,MF,
10909,GO:0042835,1,0.984790964122687,0,2,BRE binding,MF,
10910,GO:0042839,1,0.996162311800852,0,1,D-glucuronate metabolic process,BP,
10911,GO:0042840,1,0.996162311800852,0,1,D-glucuronate catabolic process,BP,
10912,GO:0042843,1,0.996596070566681,0,1,D-xylose catabolic process,BP,
10913,GO:0042851,1,0.983889193785371,0,3,L-alanine metabolic process,BP,
10914,GO:0042853,1,0.983889193785371,0,3,L-alanine catabolic process,BP,
10915,GO:0042866,1,0.965655239891454,0,6,pyruvate biosynthetic process,BP,
10916,GO:0042868,1,0.993222175064048,0,1,antisense RNA metabolic process,BP,
10917,GO:0042883,1,0.984759592300239,0,2,cysteine transport,BP,
10920,GO:0042903,1,0.987722955752742,0,2,tubulin deacetylase activity,MF,
10921,GO:0042904,1,0.975886512008915,0,4,9-cis-retinoic acid biosynthetic process,BP,
10922,GO:0042905,1,0.975886512008915,0,4,9-cis-retinoic acid metabolic process,BP,
10923,GO:0042908,1,0.790758177837076,0,34,xenobiotic transport,BP,
10924,GO:0042910,1,0.826825342646758,0,27,xenobiotic transmembrane transporter activity,MF,
10925,GO:0042918,1,0.95432094772804,0,6,alkanesulfonate transport,BP,
10926,GO:0042921,1,0.912753761564513,0,13,glucocorticoid receptor signaling pathway,BP,
10927,GO:0042922,1,0.996760354949418,0,1,neuromedin U receptor binding,MF,
10928,GO:0042923,1,0.874974020401932,0,23,neuropeptide binding,MF,
10929,GO:0042924,1,0.987643042237672,0,2,neuromedin U binding,MF,
10930,GO:0042930,1,0.99325505912211,0,1,enterobactin transport,BP,
10931,GO:0042931,1,0.99325505912211,0,1,enterobactin transmembrane transporter activity,MF,
10933,GO:0042938,1,0.971117828224207,0,4,dipeptide transport,BP,
10935,GO:0042940,1,0.948805866980607,0,7,D-amino acid transport,BP,
10936,GO:0042941,1,0.995225268069383,0,1,D-alanine transport,BP,
10937,GO:0042942,1,0.981883268431051,0,3,D-serine transport,BP,
10938,GO:0042943,1,0.985459869241205,0,2,D-amino acid transmembrane transporter activity,MF,
10939,GO:0042945,1,0.992906621287743,0,1,D-serine transmembrane transporter activity,MF,
10940,GO:0042946,1,0.979947895538977,0,3,glucoside transport,BP,
10941,GO:0042947,1,0.979947895538977,0,3,glucoside transmembrane transporter activity,MF,
10942,GO:0042953,1,0.916306197315596,0,11,lipoprotein transport,BP,
10943,GO:0042959,1,0.97779305158687,0,3,alkanesulfonate transmembrane transporter activity,MF,
10944,GO:0042969,1,0.99325505912211,0,1,lactone transport,BP,
10945,GO:0042971,1,0.99325505912211,0,1,lactone transmembrane transporter activity,MF,
10946,GO:0042974,1,0.823384699131857,0,27,retinoic acid receptor binding,MF,
10947,GO:0042975,1,0.918627505121184,0,11,peroxisome proliferator activated receptor binding,MF,
10948,GO:0042976,1,0.93462799366656,0,10,activation of Janus kinase activity,BP,
10949,GO:0042978,1,0.985721205526457,0,2,ornithine decarboxylase activator activity,MF,
10950,GO:0042979,1,0.974514305570321,0,5,ornithine decarboxylase regulator activity,MF,
10953,GO:0042983,1,0.92097248050094,0,13,amyloid precursor protein biosynthetic process,BP,
10954,GO:0042984,1,0.92097248050094,0,13,regulation of amyloid precursor protein biosynthetic process,BP,
10955,GO:0042985,1,0.96422464098341,0,6,negative regulation of amyloid precursor protein biosynthetic process,BP,
10956,GO:0042986,1,0.971463864411609,0,4,positive regulation of amyloid precursor protein biosynthetic process,BP,
10957,GO:0042987,1,0.728269034478784,0,46,amyloid precursor protein catabolic process,BP,
10958,GO:0042988,1,0.992046278134186,0,1,X11-like protein binding,MF,
10960,GO:0042994,1,0.907490819776189,0,16,cytoplasmic sequestering of transcription factor,BP,
10962,GO:0042996,1,0.950451717335083,0,8,regulation of Golgi to plasma membrane protein transport,BP,
10963,GO:0042997,1,0.969506725502654,0,5,negative regulation of Golgi to plasma membrane protein transport,BP,
10964,GO:0042998,1,0.980351815728822,0,3,positive regulation of Golgi to plasma membrane protein transport,BP,
10965,GO:0042999,1,0.992317851261805,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10966,GO:0043000,1,0.978579195067276,0,3,Golgi to plasma membrane CFTR protein transport,BP,
10968,GO:0043002,1,0.992317851261805,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10969,GO:0043004,1,0.992317851261805,0,1,cytoplasmic sequestering of CFTR protein,BP,
10972,GO:0043007,1,0.986044358782845,0,2,maintenance of rDNA,BP,
10973,GO:0043008,1,0.948873899718014,0,8,ATP-dependent protein binding,MF,
10976,GO:0043011,1,0.910556420603535,0,16,myeloid dendritic cell differentiation,BP,
10977,GO:0043012,1,0.993616242169373,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
10978,GO:0043014,1,0.794343606043361,0,34,alpha-tubulin binding,MF,
10979,GO:0043015,1,0.827509295102795,0,27,gamma-tubulin binding,MF,
10980,GO:0043020,1,0.940436436602093,0,11,NADPH oxidase complex,CC,
10981,GO:0043021,1,0.463128329627044,0,120,ribonucleoprotein complex binding,MF,
10982,GO:0043022,1,0.720783164154101,0,50,ribosome binding,MF,
10983,GO:0043023,1,0.927839243708887,0,12,ribosomal large subunit binding,MF,
10984,GO:0043024,1,0.90178655190601,0,17,ribosomal small subunit binding,MF,
10986,GO:0043027,1,0.866683851580538,0,23,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
10987,GO:0043028,1,0.78460340261976,0,39,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
10988,GO:0043029,1,0.799502901624895,0,36,T cell homeostasis,BP,
10989,GO:0043030,1,0.733752091857153,0,48,regulation of macrophage activation,BP,
10990,GO:0043031,1,0.914225395458355,0,15,negative regulation of macrophage activation,BP,
10991,GO:0043032,1,0.873419113498655,0,21,positive regulation of macrophage activation,BP,
10992,GO:0043033,1,0.990913874641184,0,1,isoamylase complex,CC,
10994,GO:0043035,1,0.962466307569014,0,5,chromatin insulator sequence binding,MF,
10995,GO:0043038,1,0.840983676935924,0,30,amino acid activation,BP,
10996,GO:0043039,1,0.847323093586625,0,29,tRNA aminoacylation,BP,
10997,GO:0043041,1,0.992530890009822,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
10999,GO:0043044,1,0.636188772368346,0,69,ATP-dependent chromatin remodeling,BP,
11000,GO:0043045,1,0.957275808284959,0,6,DNA methylation involved in embryo development,BP,
11001,GO:0043046,1,0.891643634185282,0,17,DNA methylation involved in gamete generation,BP,
11002,GO:0043047,1,0.92989283432389,0,11,single-stranded telomeric DNA binding,MF,
11003,GO:0043048,1,0.994599176567197,0,1,dolichyl monophosphate biosynthetic process,BP,
11004,GO:0043049,1,0.992825158104098,0,1,otic placode formation,BP,
11005,GO:0043060,1,0.993910485981676,0,1,meiotic metaphase I plate congression,BP,
11007,GO:0043063,1,0.992191730676133,0,1,intercellular bridge organization,BP,
11013,GO:0043073,1,0.922916062946822,0,12,germ cell nucleus,CC,
11014,GO:0043083,1,0.890193137307472,0,16,synaptic cleft,CC,
11015,GO:0043084,1,0.947063425034595,0,8,penile erection,BP,
11019,GO:0043090,1,0.741859463859169,0,42,amino acid import,BP,
11020,GO:0043094,1,0.848188462341598,0,31,cellular metabolic compound salvage,BP,
11021,GO:0043095,1,0.996800907774561,0,1,regulation of GTP cyclohydrolase I activity,BP,
11022,GO:0043096,1,0.989138944301271,0,3,purine nucleobase salvage,BP,
11023,GO:0043097,1,0.951595837168709,0,10,pyrimidine nucleoside salvage,BP,
11024,GO:0043101,1,0.928329745002443,0,14,purine-containing compound salvage,BP,
11025,GO:0043102,1,0.961878526746887,0,7,amino acid salvage,BP,
11026,GO:0043103,1,0.992323246159071,0,2,hypoxanthine salvage,BP,
11027,GO:0043105,1,0.996800907774561,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11028,GO:0043111,1,0.973118872622576,0,4,replication fork arrest,BP,
11030,GO:0043113,1,0.667760765691868,0,55,receptor clustering,BP,
11031,GO:0043114,1,0.744528700740374,0,44,regulation of vascular permeability,BP,
11032,GO:0043116,1,0.902211999242746,0,15,negative regulation of vascular permeability,BP,
11033,GO:0043117,1,0.896006456724795,0,17,positive regulation of vascular permeability,BP,
11034,GO:0043120,1,0.966572655734854,0,5,tumor necrosis factor binding,MF,
11038,GO:0043124,1,0.739109943553765,0,43,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11040,GO:0043126,1,0.996124438356641,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11041,GO:0043128,1,0.996124438356641,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11042,GO:0043129,1,0.952494563782604,0,8,surfactant homeostasis,BP,
11043,GO:0043130,1,0.637473042553148,0,71,ubiquitin binding,MF,
11044,GO:0043131,1,0.992064186951491,0,1,erythrocyte enucleation,BP,
11045,GO:0043132,1,0.987221590717841,0,2,NAD transport,BP,
11046,GO:0043136,1,0.987900505280338,0,2,glycerol-3-phosphatase activity,MF,
11047,GO:0043137,1,0.979455642985692,0,4,DNA replication, removal of RNA primer,BP,
11048,GO:0043138,1,0.876404165025841,0,18,3'-5' DNA helicase activity,MF,
11049,GO:0043139,1,0.958118930537207,0,7,5'-3' DNA helicase activity,MF,
11050,GO:0043144,1,0.948692233594275,0,11,snoRNA processing,BP,
11051,GO:0043149,1,0.494245380142522,0,99,stress fiber assembly,BP,
11052,GO:0043152,1,0.979531590328079,0,4,induction of bacterial agglutination,BP,
11053,GO:0043153,1,0.844028048634058,0,27,entrainment of circadian clock by photoperiod,BP,
11055,GO:0043159,1,0.983994013575077,0,3,acrosomal matrix,CC,
11056,GO:0043161,1,0.0761719499546014,0,401,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,
11057,GO:0043162,1,0.872678144960977,0,22,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11058,GO:0043163,1,0.986691638938213,0,2,cell envelope organization,BP,
11063,GO:0043171,1,0.852719751464506,0,24,peptide catabolic process,BP,
11064,GO:0043173,1,0.940208648613123,0,12,nucleotide salvage,BP,
11065,GO:0043174,1,0.92845315237119,0,15,nucleoside salvage,BP,
11066,GO:0043175,1,0.741945468542881,0,44,RNA polymerase core enzyme binding,MF,
11067,GO:0043176,1,0.932428336392218,0,12,amine binding,MF,
11070,GO:0043179,1,0.994861437549621,0,1,rhythmic excitation,BP,
11071,GO:0043181,1,0.992522497599313,0,1,vacuolar sequestering,BP,
11072,GO:0043183,1,0.983842119277528,0,3,vascular endothelial growth factor receptor 1 binding,MF,
11074,GO:0043185,1,0.994903621882618,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11075,GO:0043186,1,0.884497337349679,0,17,P granule,CC,
11076,GO:0043189,1,0.894397317025648,0,19,H4/H2A histone acetyltransferase complex,CC,
11077,GO:0043190,1,0.962380205373344,0,5,ATP-binding cassette (ABC) transporter complex,CC,
11079,GO:0043195,1,0.69602541867721,0,52,terminal bouton,CC,
11080,GO:0043196,1,0.951108906039023,0,8,varicosity,CC,
11082,GO:0043198,1,0.764894144540403,0,37,dendritic shaft,CC,
11083,GO:0043199,1,0.973636207726323,0,4,sulfate binding,MF,
11085,GO:0043201,1,0.912253604559729,0,12,response to leucine,BP,
11087,GO:0043203,1,0.953138819743926,0,8,axon hillock,CC,
11092,GO:0043210,1,0.99554908582904,0,1,alkanesulfonate binding,MF,
11095,GO:0043219,1,0.975811342371673,0,4,lateral loop,CC,
11097,GO:0043225,1,0.991945730248253,0,1,ATPase-coupled inorganic anion transmembrane transporter activity,MF,
11107,GO:0043236,1,0.830987903417054,0,27,laminin binding,MF,
11108,GO:0043237,1,0.964598504021228,0,5,laminin-1 binding,MF,
11109,GO:0043240,1,0.94251658593615,0,9,Fanconi anaemia nuclear complex,CC,
11110,GO:0043242,1,0.588912586134493,0,72,negative regulation of protein-containing complex disassembly,BP,
11111,GO:0043243,1,0.7954902526533,0,33,positive regulation of protein-containing complex disassembly,BP,
11112,GO:0043244,1,0.439201756792192,0,112,regulation of protein-containing complex disassembly,BP,
11113,GO:0043247,1,0.914102070715618,0,13,telomere maintenance in response to DNA damage,BP,
11114,GO:0043248,1,0.947382073051338,0,12,proteasome assembly,BP,
11115,GO:0043249,1,0.910894761811781,0,15,erythrocyte maturation,BP,
11116,GO:0043250,1,0.996119897357755,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11117,GO:0043251,1,0.996119897357755,0,1,sodium-dependent organic anion transport,BP,
11118,GO:0043252,1,0.912477888286974,0,13,sodium-independent organic anion transport,BP,
11120,GO:0043255,1,0.549606119853213,0,82,regulation of carbohydrate biosynthetic process,BP,
11121,GO:0043256,1,0.901624328460588,0,12,laminin complex,CC,
11122,GO:0043257,1,0.991663822527997,0,1,laminin-8 complex,CC,
11123,GO:0043259,1,0.971153496487178,0,3,laminin-10 complex,CC,
11124,GO:0043260,1,0.9711764753274,0,3,laminin-11 complex,CC,
11125,GO:0043262,1,0.985371526511483,0,2,adenosine-diphosphatase activity,MF,
11126,GO:0043265,1,0.992755624438986,0,1,ectoplasm,CC,
11129,GO:0043268,1,0.729241180109423,0,44,positive regulation of potassium ion transport,BP,
11133,GO:0043273,1,0.991929767529472,0,1,CTPase activity,MF,
11134,GO:0043274,1,0.913128535927906,0,13,phospholipase binding,MF,
11135,GO:0043276,1,0.80649168703268,0,30,anoikis,BP,
11136,GO:0043277,1,0.731157356695309,0,48,apoptotic cell clearance,BP,
11137,GO:0043278,1,0.837390776126681,0,30,response to morphine,BP,
11138,GO:0043279,1,0.5251875086138,0,98,response to alkaloid,BP,
11141,GO:0043291,1,0.974317106128152,0,3,RAVE complex,CC,
11143,GO:0043293,1,0.986678420651152,0,2,apoptosome,CC,
11144,GO:0043295,1,0.945575207723387,0,12,glutathione binding,MF,
11147,GO:0043299,1,0.0458111465657639,0,506,leukocyte degranulation,BP,
11148,GO:0043300,1,0.764276544814275,0,44,regulation of leukocyte degranulation,BP,
11149,GO:0043301,1,0.933820601390491,0,12,negative regulation of leukocyte degranulation,BP,
11150,GO:0043302,1,0.870423280253726,0,23,positive regulation of leukocyte degranulation,BP,
11151,GO:0043303,1,0.766087997410736,0,43,mast cell degranulation,BP,
11152,GO:0043304,1,0.842968523016868,0,29,regulation of mast cell degranulation,BP,
11153,GO:0043305,1,0.970275020586058,0,6,negative regulation of mast cell degranulation,BP,
11154,GO:0043306,1,0.922251834258558,0,14,positive regulation of mast cell degranulation,BP,
11155,GO:0043307,1,0.97354814455557,0,5,eosinophil activation,BP,
11156,GO:0043308,1,0.978072744734084,0,4,eosinophil degranulation,BP,
11157,GO:0043309,1,0.983271906459584,0,3,regulation of eosinophil degranulation,BP,
11158,GO:0043310,1,0.993835340362938,0,1,negative regulation of eosinophil degranulation,BP,
11159,GO:0043311,1,0.989371709783297,0,2,positive regulation of eosinophil degranulation,BP,
11160,GO:0043312,1,0.0610738583269599,0,461,neutrophil degranulation,BP,
11161,GO:0043313,1,0.94318634376617,0,8,regulation of neutrophil degranulation,BP,
11162,GO:0043314,1,0.983173399752848,0,2,negative regulation of neutrophil degranulation,BP,
11163,GO:0043315,1,0.972123866096491,0,4,positive regulation of neutrophil degranulation,BP,
11164,GO:0043316,1,0.981814480539647,0,3,cytotoxic T cell degranulation,BP,
11165,GO:0043317,1,0.988542712686948,0,2,regulation of cytotoxic T cell degranulation,BP,
11166,GO:0043318,1,0.988542712686948,0,2,negative regulation of cytotoxic T cell degranulation,BP,
11167,GO:0043320,1,0.963293888345769,0,6,natural killer cell degranulation,BP,
11168,GO:0043321,1,0.981352914995233,0,3,regulation of natural killer cell degranulation,BP,
11169,GO:0043322,1,0.996405079345363,0,1,negative regulation of natural killer cell degranulation,BP,
11170,GO:0043323,1,0.981352914995233,0,3,positive regulation of natural killer cell degranulation,BP,
11171,GO:0043324,1,0.988556068486687,0,2,pigment metabolic process involved in developmental pigmentation,BP,
11172,GO:0043325,1,0.834341928139676,0,24,phosphatidylinositol-3,4-bisphosphate binding,MF,
11173,GO:0043328,1,0.975257241879981,0,5,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11174,GO:0043330,1,0.844356812069705,0,26,response to exogenous dsRNA,BP,
11175,GO:0043331,1,0.806372204143929,0,33,response to dsRNA,BP,
11176,GO:0043333,1,0.996109231309014,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
11177,GO:0043335,1,0.984331184873219,0,3,protein unfolding,BP,
11178,GO:0043337,1,0.992491251317947,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11179,GO:0043353,1,0.947444679650608,0,8,enucleate erythrocyte differentiation,BP,
11180,GO:0043354,1,0.992064186951491,0,1,enucleate erythrocyte maturation,BP,
11181,GO:0043366,1,0.982772014449787,0,3,beta selection,BP,
11182,GO:0043367,1,0.626623492489178,0,70,CD4-positive, alpha-beta T cell differentiation,BP,
11183,GO:0043368,1,0.809020784174149,0,33,positive T cell selection,BP,
11184,GO:0043369,1,0.876772135352915,0,20,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
11185,GO:0043370,1,0.760672917668456,0,42,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11186,GO:0043371,1,0.872572397580597,0,19,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11187,GO:0043372,1,0.857182678390714,0,26,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11188,GO:0043373,1,0.895789434255009,0,17,CD4-positive, alpha-beta T cell lineage commitment,BP,
11189,GO:0043374,1,0.909644358955457,0,14,CD8-positive, alpha-beta T cell differentiation,BP,
11190,GO:0043375,1,0.984990103927723,0,2,CD8-positive, alpha-beta T cell lineage commitment,BP,
11191,GO:0043376,1,0.958981065613631,0,6,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11192,GO:0043377,1,0.989027256172204,0,2,negative regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11193,GO:0043378,1,0.96962383054362,0,4,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11194,GO:0043379,1,0.946780772222156,0,8,memory T cell differentiation,BP,
11195,GO:0043380,1,0.956208619149874,0,7,regulation of memory T cell differentiation,BP,
11196,GO:0043381,1,0.992419860559889,0,1,negative regulation of memory T cell differentiation,BP,
11197,GO:0043382,1,0.970758852226998,0,5,positive regulation of memory T cell differentiation,BP,
11198,GO:0043383,1,0.927355416034815,0,12,negative T cell selection,BP,
11199,GO:0043385,1,0.989785512087752,0,2,mycotoxin metabolic process,BP,
11200,GO:0043387,1,0.989785512087752,0,2,mycotoxin catabolic process,BP,
11201,GO:0043388,1,0.709788911247185,0,54,positive regulation of DNA binding,BP,
11202,GO:0043392,1,0.733869915866984,0,50,negative regulation of DNA binding,BP,
11205,GO:0043395,1,0.89713645664988,0,15,heparan sulfate proteoglycan binding,MF,
11206,GO:0043396,1,0.985002415880544,0,2,corticotropin-releasing hormone secretion,BP,
11207,GO:0043397,1,0.985002415880544,0,2,regulation of corticotropin-releasing hormone secretion,BP,
11208,GO:0043398,1,0.977466186889337,0,4,HLH domain binding,MF,
11209,GO:0043400,1,0.97489147450297,0,5,cortisol secretion,BP,
11210,GO:0043401,1,0.405689976106549,0,128,steroid hormone mediated signaling pathway,BP,
11211,GO:0043402,1,0.972556138614831,0,3,glucocorticoid mediated signaling pathway,BP,
11213,GO:0043404,1,0.989493695290045,0,2,corticotropin-releasing hormone receptor activity,MF,
11216,GO:0043407,1,0.646246390809452,0,69,negative regulation of MAP kinase activity,BP,
11218,GO:0043409,1,0.354711676500401,0,155,negative regulation of MAPK cascade,BP,
11222,GO:0043414,1,0.166365754525116,0,261,macromolecule methylation,BP,
11225,GO:0043417,1,0.99606398466736,0,1,negative regulation of skeletal muscle tissue regeneration,BP,
11226,GO:0043418,1,0.980390958929225,0,3,homocysteine catabolic process,BP,
11227,GO:0043420,1,0.984748232236552,0,3,anthranilate metabolic process,BP,
11228,GO:0043422,1,0.929062694220048,0,11,protein kinase B binding,MF,
11229,GO:0043423,1,0.992397230544953,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11230,GO:0043425,1,0.834165725582858,0,26,bHLH transcription factor binding,MF,
11231,GO:0043426,1,0.960749173380379,0,5,MRF binding,MF,
11232,GO:0043430,1,0.996109231309014,0,1,2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
11233,GO:0043433,1,0.377004438474265,0,152,negative regulation of DNA-binding transcription factor activity,BP,
11235,GO:0043435,1,0.968011701873326,0,5,response to corticotropin-releasing hormone,BP,
11237,GO:0043438,1,0.993070232306683,0,1,acetoacetic acid metabolic process,BP,
11238,GO:0043449,1,0.986047249182141,0,2,cellular alkene metabolic process,BP,
11239,GO:0043455,1,0.927604192881542,0,10,regulation of secondary metabolic process,BP,
11240,GO:0043456,1,0.989399539543111,0,2,regulation of pentose-phosphate shunt,BP,
11241,GO:0043457,1,0.853982210540811,0,25,regulation of cellular respiration,BP,
11242,GO:0043461,1,0.979274755038797,0,4,proton-transporting ATP synthase complex assembly,BP,
11243,GO:0043462,1,0.658729252228041,0,76,regulation of ATPase activity,BP,
11244,GO:0043465,1,0.986142807120098,0,2,regulation of fermentation,BP,
11247,GO:0043471,1,0.94298730975701,0,9,regulation of cellular carbohydrate catabolic process,BP,
11249,GO:0043474,1,0.988556068486687,0,2,pigment metabolic process involved in pigmentation,BP,
11250,GO:0043476,1,0.921916139806892,0,12,pigment accumulation,BP,
11251,GO:0043482,1,0.921916139806892,0,12,cellular pigment accumulation,BP,
11252,GO:0043484,1,0.373602106881483,0,145,regulation of RNA splicing,BP,
11253,GO:0043485,1,0.940934878515135,0,10,endosome to pigment granule transport,BP,
11254,GO:0043486,1,0.798370355683605,0,38,histone exchange,BP,
11255,GO:0043487,1,0.334663077506518,0,175,regulation of RNA stability,BP,
11256,GO:0043488,1,0.353444522258278,0,167,regulation of mRNA stability,BP,
11257,GO:0043489,1,0.736999372287977,0,44,RNA stabilization,BP,
11258,GO:0043490,1,0.973582919037135,0,4,malate-aspartate shuttle,BP,
11260,GO:0043495,1,0.888748960859479,0,18,protein-membrane adaptor activity,MF,
11261,GO:0043496,1,0.991537243903476,0,1,regulation of protein homodimerization activity,BP,
11262,GO:0043500,1,0.514103648365619,0,99,muscle adaptation,BP,
11263,GO:0043501,1,0.870244244872229,0,22,skeletal muscle adaptation,BP,
11264,GO:0043502,1,0.585421955074932,0,76,regulation of muscle adaptation,BP,
11265,GO:0043503,1,0.981522697301653,0,4,skeletal muscle fiber adaptation,BP,
11266,GO:0043504,1,0.958304949828842,0,6,mitochondrial DNA repair,BP,
11269,GO:0043508,1,0.924199365327412,0,13,negative regulation of JUN kinase activity,BP,
11270,GO:0043509,1,0.994671846409404,0,1,activin A complex,CC,
11271,GO:0043511,1,0.990930668695074,0,2,inhibin complex,CC,
11272,GO:0043512,1,0.990930668695074,0,2,inhibin A complex,CC,
11273,GO:0043513,1,0.996238987162587,0,1,inhibin B complex,CC,
11274,GO:0043514,1,0.996214297604249,0,1,interleukin-12 complex,CC,
11275,GO:0043515,1,0.957163730017933,0,6,kinetochore binding,MF,
11276,GO:0043516,1,0.827464200770323,0,31,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11277,GO:0043517,1,0.909233649817815,0,15,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11278,GO:0043518,1,0.926595437507604,0,13,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11279,GO:0043519,1,0.994834506269511,0,1,regulation of myosin II filament organization,BP,
11280,GO:0043522,1,0.957754004351055,0,8,leucine zipper domain binding,MF,
11283,GO:0043525,1,0.711477590270654,0,54,positive regulation of neuron apoptotic process,BP,
11284,GO:0043527,1,0.974701357110806,0,5,tRNA methyltransferase complex,CC,
11285,GO:0043531,1,0.787452561794132,0,33,ADP binding,MF,
11286,GO:0043532,1,0.991177630938818,0,1,angiostatin binding,MF,
11287,GO:0043533,1,0.961049791334544,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11289,GO:0043535,1,0.565983778708298,0,84,regulation of blood vessel endothelial cell migration,BP,
11290,GO:0043536,1,0.713279687346643,0,50,positive regulation of blood vessel endothelial cell migration,BP,
11291,GO:0043537,1,0.80628350200136,0,32,negative regulation of blood vessel endothelial cell migration,BP,
11292,GO:0043538,1,0.992848735234983,0,1,regulation of actin phosphorylation,BP,
11293,GO:0043539,1,0.79424899617748,0,37,protein serine/threonine kinase activator activity,MF,
11294,GO:0043540,1,0.995697015410691,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11295,GO:0043541,1,0.98914394290889,0,2,UDP-N-acetylglucosamine transferase complex,CC,
11297,GO:0043543,1,0.213788398619197,0,229,protein acylation,BP,
11298,GO:0043544,1,0.992526557870833,0,1,lipoamide binding,MF,
11299,GO:0043545,1,0.963064952063979,0,6,molybdopterin cofactor metabolic process,BP,
11300,GO:0043546,1,0.970883925124825,0,4,molybdopterin cofactor binding,MF,
11301,GO:0043547,1,0.0704191168254623,0,365,positive regulation of GTPase activity,BP,
11302,GO:0043548,1,0.809836995942114,0,28,phosphatidylinositol 3-kinase binding,MF,
11307,GO:0043553,1,0.986400197929055,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11308,GO:0043555,1,0.874456323670045,0,20,regulation of translation in response to stress,BP,
11309,GO:0043558,1,0.91421801161566,0,14,regulation of translational initiation in response to stress,BP,
11310,GO:0043559,1,0.950404260726263,0,6,insulin binding,MF,
11311,GO:0043560,1,0.922285469367959,0,10,insulin receptor substrate binding,MF,
11312,GO:0043562,1,0.947222518423164,0,11,cellular response to nitrogen levels,BP,
11313,GO:0043564,1,0.987357940025836,0,2,Ku70:Ku80 complex,CC,
11315,GO:0043567,1,0.895103502180172,0,18,regulation of insulin-like growth factor receptor signaling pathway,BP,
11316,GO:0043568,1,0.938966024913519,0,9,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11317,GO:0043569,1,0.959306760816172,0,6,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
11318,GO:0043570,1,0.956729290180542,0,6,maintenance of DNA repeat elements,BP,
11320,GO:0043576,1,0.8585612638921,0,22,regulation of respiratory gaseous exchange,BP,
11321,GO:0043578,1,0.970550440704749,0,3,nuclear matrix organization,BP,
11323,GO:0043584,1,0.897583916465017,0,15,nose development,BP,
11324,GO:0043585,1,0.975440086319671,0,3,nose morphogenesis,BP,
11326,GO:0043587,1,0.934001813204386,0,10,tongue morphogenesis,BP,
11328,GO:0043589,1,0.923351208354899,0,10,skin morphogenesis,BP,
11329,GO:0043596,1,0.777159879615411,0,40,nuclear replication fork,CC,
11330,GO:0043601,1,0.869198943019047,0,23,nuclear replisome,CC,
11331,GO:0043602,1,0.993813767208886,0,1,nitrate catabolic process,BP,
11334,GO:0043605,1,0.986663547939245,0,3,cellular amide catabolic process,BP,
11335,GO:0043606,1,0.975671077284,0,4,formamide metabolic process,BP,
11336,GO:0043610,1,0.990067536892281,0,1,regulation of carbohydrate utilization,BP,
11337,GO:0043614,1,0.984477867113022,0,2,multi-eIF complex,CC,
11338,GO:0043615,1,0.960504545996799,0,7,astrocyte cell migration,BP,
11339,GO:0043616,1,0.762364425002333,0,38,keratinocyte proliferation,BP,
11340,GO:0043618,1,0.559752897131199,0,103,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
11341,GO:0043619,1,0.930198040580208,0,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
11342,GO:0043620,1,0.538686749475342,0,108,regulation of DNA-templated transcription in response to stress,BP,
11344,GO:0043622,1,0.969784654229452,0,4,cortical microtubule organization,BP,
11346,GO:0043625,1,0.977793851625988,0,4,delta DNA polymerase complex,CC,
11347,GO:0043626,1,0.996344392528905,0,1,PCNA complex,CC,
11348,GO:0043627,1,0.648020628257039,0,70,response to estrogen,BP,
11349,GO:0043628,1,0.814706468257294,0,36,ncRNA 3'-end processing,BP,
11350,GO:0043631,1,0.749802068188138,0,42,RNA polyadenylation,BP,
11352,GO:0043633,1,0.96589004078551,0,7,polyadenylation-dependent RNA catabolic process,BP,
11353,GO:0043634,1,0.973373137479031,0,6,polyadenylation-dependent ncRNA catabolic process,BP,
11354,GO:0043647,1,0.638802451615181,0,64,inositol phosphate metabolic process,BP,
11355,GO:0043648,1,0.592717289695016,0,87,dicarboxylic acid metabolic process,BP,
11356,GO:0043649,1,0.910232057743067,0,17,dicarboxylic acid catabolic process,BP,
11357,GO:0043650,1,0.92296973778888,0,13,dicarboxylic acid biosynthetic process,BP,
11358,GO:0043651,1,0.895783176155697,0,18,linoleic acid metabolic process,BP,
11359,GO:0043652,1,0.900055061323872,0,16,engulfment of apoptotic cell,BP,
11360,GO:0043653,1,0.948998351984899,0,9,mitochondrial fragmentation involved in apoptotic process,BP,
11361,GO:0043654,1,0.962416107941732,0,6,recognition of apoptotic cell,BP,
11362,GO:0043656,1,0.921980762614441,0,12,host intracellular region,CC,
11363,GO:0043657,1,0.672145129248623,0,60,host cell,CC,
11364,GO:0043666,1,0.495212316993162,0,107,regulation of phosphoprotein phosphatase activity,BP,
11365,GO:0043679,1,0.442187845302124,0,122,axon terminus,CC,
11366,GO:0043682,1,0.981692214842973,0,2,copper transmembrane transporter activity, phosphorylative mechanism,MF,
11367,GO:0043686,1,0.98365175939212,0,3,co-translational protein modification,BP,
11369,GO:0043691,1,0.9238377256164,0,14,reverse cholesterol transport,BP,
11370,GO:0043696,1,0.946371589718796,0,8,dedifferentiation,BP,
11371,GO:0043697,1,0.946371589718796,0,8,cell dedifferentiation,BP,
11372,GO:0043715,1,0.995072770589658,0,1,2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity,MF,
11373,GO:0043716,1,0.995072770589658,0,1,2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity,MF,
11374,GO:0043727,1,0.992614688101677,0,1,5-amino-4-imidazole carboxylate lyase activity,MF,
11375,GO:0043733,1,0.996593694428561,0,1,DNA-3-methylbase glycosylase activity,MF,
11376,GO:0043734,1,0.985179968407602,0,3,DNA-N1-methyladenine dioxygenase activity,MF,
11377,GO:0043739,1,0.992672062861192,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11378,GO:0043754,1,0.989017831276059,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11379,GO:0043783,1,0.994198459179084,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11380,GO:0043795,1,0.99626173993583,0,1,glyceraldehyde oxidoreductase activity,MF,
11381,GO:0043812,1,0.969356520380909,0,4,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11382,GO:0043813,1,0.984431069938834,0,2,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11383,GO:0043843,1,0.993696128496363,0,1,ADP-specific glucokinase activity,MF,
11384,GO:0043849,1,0.993010271552,0,1,Ras palmitoyltransferase activity,MF,
11385,GO:0043855,1,0.936691772644114,0,9,cyclic nucleotide-gated ion channel activity,MF,
11386,GO:0043865,1,0.993234856990322,0,1,methionine transmembrane transporter activity,MF,
11387,GO:0043874,1,0.995072770589658,0,1,acireductone synthase activity,MF,
11388,GO:0043878,1,0.966254691769672,0,5,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity,MF,
11389,GO:0043890,1,0.994155152483101,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11390,GO:0043891,1,0.996372155485022,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11393,GO:0043902,1,0.798827867472274,0,34,positive regulation of multi-organism process,BP,
11394,GO:0043903,1,0.280164608726302,0,204,regulation of symbiotic process,BP,
11395,GO:0043914,1,0.992477488277374,0,1,NADPH:sulfur oxidoreductase activity,MF,
11396,GO:0043915,1,0.995770717736093,0,1,L-seryl-tRNA(Sec) kinase activity,MF,
11397,GO:0043916,1,0.996593694428561,0,1,DNA-7-methylguanine glycosylase activity,MF,
11398,GO:0043921,1,0.987354409997957,0,2,modulation by host of viral transcription,BP,
11399,GO:0043922,1,0.928555997486161,0,11,negative regulation by host of viral transcription,BP,
11400,GO:0043923,1,0.889920645111053,0,17,positive regulation by host of viral transcription,BP,
11401,GO:0043924,1,0.98641912363374,0,1,suramin binding,MF,
11402,GO:0043928,1,0.839297055107039,0,32,exonucleolytic catabolism of deadenylated mRNA,BP,
11406,GO:0043946,1,0.995687835832135,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11407,GO:0043947,1,0.995687835832135,0,1,positive regulation by host of symbiont catalytic activity,BP,
11410,GO:0043951,1,0.84745249373738,0,24,negative regulation of cAMP-mediated signaling,BP,
11411,GO:0043954,1,0.669070574450257,0,55,cellular component maintenance,BP,
11412,GO:0043966,1,0.685852372527417,0,56,histone H3 acetylation,BP,
11413,GO:0043967,1,0.628606419894095,0,69,histone H4 acetylation,BP,
11414,GO:0043968,1,0.906721742028108,0,16,histone H2A acetylation,BP,
11415,GO:0043969,1,0.975942800227936,0,3,histone H2B acetylation,BP,
11416,GO:0043970,1,0.913470584169828,0,13,histone H3-K9 acetylation,BP,
11417,GO:0043972,1,0.963888019916241,0,5,histone H3-K23 acetylation,BP,
11418,GO:0043973,1,0.994584889571345,0,1,histone H3-K4 acetylation,BP,
11419,GO:0043974,1,0.983743995672241,0,2,histone H3-K27 acetylation,BP,
11420,GO:0043977,1,0.992948234523058,0,1,histone H2A-K5 acetylation,BP,
11421,GO:0043979,1,0.992740832877466,0,1,histone H2B-K5 acetylation,BP,
11422,GO:0043980,1,0.992948234523058,0,1,histone H2B-K12 acetylation,BP,
11423,GO:0043981,1,0.897455889813369,0,16,histone H4-K5 acetylation,BP,
11424,GO:0043982,1,0.897455889813369,0,16,histone H4-K8 acetylation,BP,
11425,GO:0043983,1,0.957510848647766,0,7,histone H4-K12 acetylation,BP,
11426,GO:0043984,1,0.86677127687735,0,20,histone H4-K16 acetylation,BP,
11427,GO:0043985,1,0.964039990474268,0,6,histone H4-R3 methylation,BP,
11428,GO:0043987,1,0.969176308099861,0,5,histone H3-S10 phosphorylation,BP,
11429,GO:0043988,1,0.982112622035369,0,3,histone H3-S28 phosphorylation,BP,
11430,GO:0043990,1,0.992798727823778,0,1,histone H2A-S1 phosphorylation,BP,
11431,GO:0043994,1,0.963888019916241,0,5,histone acetyltransferase activity (H3-K23 specific),MF,
11432,GO:0043995,1,0.939699579197128,0,9,histone acetyltransferase activity (H4-K5 specific),MF,
11433,GO:0043996,1,0.939699579197128,0,9,histone acetyltransferase activity (H4-K8 specific),MF,
11434,GO:0043997,1,0.992770099454922,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11435,GO:0043998,1,0.992618366602837,0,1,H2A histone acetyltransferase activity,MF,
11436,GO:0044003,1,0.78331089769081,0,36,modulation by symbiont of host process,BP,
11437,GO:0044010,1,0.994152611553279,0,1,single-species biofilm formation,BP,
11438,GO:0044020,1,0.977987560129395,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11439,GO:0044026,1,0.983472897169873,0,3,DNA hypermethylation,BP,
11440,GO:0044027,1,0.990912502246626,0,2,hypermethylation of CpG island,BP,
11441,GO:0044028,1,0.98529616692891,0,2,DNA hypomethylation,BP,
11442,GO:0044029,1,0.98529616692891,0,2,hypomethylation of CpG island,BP,
11443,GO:0044030,1,0.87695459665234,0,19,regulation of DNA methylation,BP,
11444,GO:0044033,1,0.995897193514659,0,1,multi-organism metabolic process,BP,
11445,GO:0044035,1,0.995897193514659,0,1,multi-organism catabolic process,BP,
11446,GO:0044036,1,0.99230792728531,0,2,cell wall macromolecule metabolic process,BP,
11447,GO:0044038,1,0.995630725828587,0,1,cell wall macromolecule biosynthetic process,BP,
11449,GO:0044053,1,0.994042880589517,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11451,GO:0044058,1,0.832459578828643,0,32,regulation of digestive system process,BP,
11453,GO:0044062,1,0.88176685231444,0,21,regulation of excretion,BP,
11454,GO:0044065,1,0.905667271399992,0,15,regulation of respiratory system process,BP,
11455,GO:0044068,1,0.846414706010627,0,25,modulation by symbiont of host cellular process,BP,
11456,GO:0044070,1,0.554279117453003,0,90,regulation of anion transport,BP,
11459,GO:0044088,1,0.753745576619348,0,44,regulation of vacuole organization,BP,
11461,GO:0044090,1,0.931251146375565,0,10,positive regulation of vacuole organization,BP,
11465,GO:0044094,1,0.971747337634307,0,4,host cell nuclear part,CC,
11466,GO:0044105,1,0.996752585941193,0,1,L-xylulose reductase (NAD+) activity,MF,
11467,GO:0044106,1,0.525896234902185,0,120,cellular amine metabolic process,BP,
11468,GO:0044107,1,0.984221598084008,0,3,cellular alcohol metabolic process,BP,
11469,GO:0044108,1,0.984221598084008,0,3,cellular alcohol biosynthetic process,BP,
11470,GO:0044110,1,0.99668880855454,0,1,growth involved in symbiotic interaction,BP,
11471,GO:0044111,1,0.987298509160411,0,2,development involved in symbiotic interaction,BP,
11472,GO:0044115,1,0.995897193514659,0,1,development of symbiont involved in interaction with host,BP,
11473,GO:0044117,1,0.99668880855454,0,1,growth of symbiont in host,BP,
11474,GO:0044145,1,0.995897193514659,0,1,modulation of development of symbiont involved in interaction with host,BP,
11475,GO:0044147,1,0.995897193514659,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
11476,GO:0044154,1,0.905832667771309,0,14,histone H3-K14 acetylation,BP,
11477,GO:0044183,1,0.873013630777984,0,25,protein folding chaperone,MF,
11478,GO:0044190,1,0.995674493172775,0,1,host cell mitochondrial envelope,CC,
11479,GO:0044194,1,0.973534556195046,0,5,cytolytic granule,CC,
11480,GO:0044205,1,0.979497932355435,0,3,'de novo' UMP biosynthetic process,BP,
11481,GO:0044206,1,0.976532541617574,0,5,UMP salvage,BP,
11482,GO:0044207,1,0.992441561262139,0,1,translation initiation ternary complex,CC,
11483,GO:0044208,1,0.996154252202172,0,1,'de novo' AMP biosynthetic process,BP,
11484,GO:0044209,1,0.991777000958806,0,2,AMP salvage,BP,
11485,GO:0044210,1,0.98578032418728,0,2,'de novo' CTP biosynthetic process,BP,
11486,GO:0044211,1,0.986768827240502,0,3,CTP salvage,BP,
11487,GO:0044214,1,0.916239573981261,0,11,spanning component of plasma membrane,CC,
11488,GO:0044216,1,0.985346759849556,0,2,other organism cell,CC,
11489,GO:0044217,1,0.985346759849556,0,2,other organism part,CC,
11490,GO:0044218,1,0.99339510110805,0,1,other organism cell membrane,CC,
11491,GO:0044220,1,0.992216416832442,0,1,host cell perinuclear region of cytoplasm,CC,
11493,GO:0044228,1,0.992260865203238,0,1,host cell surface,CC,
11494,GO:0044232,1,0.847989767177793,0,25,organelle membrane contact site,CC,
11495,GO:0044233,1,0.903290802948397,0,16,mitochondria-associated endoplasmic reticulum membrane,CC,
11498,GO:0044241,1,0.928649210362386,0,12,lipid digestion,BP,
11500,GO:0044245,1,0.981616217090218,0,3,polysaccharide digestion,BP,
11506,GO:0044258,1,0.994107008887041,0,1,intestinal lipid catabolic process,BP,
11517,GO:0044278,1,0.996761692975591,0,1,cell wall disruption in other organism,BP,
11522,GO:0044292,1,0.920120548501216,0,12,dendrite terminus,CC,
11523,GO:0044294,1,0.939857134775594,0,8,dendritic growth cone,CC,
11524,GO:0044295,1,0.811442874645057,0,27,axonal growth cone,CC,
11526,GO:0044298,1,0.807964155541571,0,31,cell body membrane,CC,
11527,GO:0044300,1,0.95410147999497,0,7,cerebellar mossy fiber,CC,
11528,GO:0044301,1,0.988515303676041,0,2,climbing fiber,CC,
11529,GO:0044302,1,0.958941522628829,0,5,dentate gyrus mossy fiber,CC,
11531,GO:0044305,1,0.848704363044636,0,23,calyx of Held,CC,
11532,GO:0044306,1,0.392276000858986,0,139,neuron projection terminus,CC,
11533,GO:0044307,1,0.969583918175396,0,3,dendritic branch,CC,
11534,GO:0044308,1,0.974703933982715,0,3,axonal spine,CC,
11536,GO:0044313,1,0.974529303272093,0,3,protein K6-linked deubiquitination,BP,
11537,GO:0044314,1,0.982180840374815,0,4,protein K27-linked ubiquitination,BP,
11538,GO:0044316,1,0.986215104083832,0,2,cone cell pedicle,CC,
11539,GO:0044317,1,0.996301838668311,0,1,rod spherule,CC,
11540,GO:0044319,1,0.827325128691772,0,27,wound healing, spreading of cells,BP,
11541,GO:0044320,1,0.896424593390024,0,17,cellular response to leptin stimulus,BP,
11543,GO:0044322,1,0.859545496748318,0,22,endoplasmic reticulum quality control compartment,CC,
11544,GO:0044323,1,0.959592671728884,0,6,retinoic acid-responsive element binding,MF,
11545,GO:0044324,1,0.996713262992809,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
11547,GO:0044326,1,0.952309186648104,0,7,dendritic spine neck,CC,
11548,GO:0044327,1,0.930164121351949,0,11,dendritic spine head,CC,
11549,GO:0044331,1,0.834868513448436,0,25,cell-cell adhesion mediated by cadherin,BP,
11550,GO:0044332,1,0.992362313737938,0,1,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11551,GO:0044333,1,0.995398212808038,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11552,GO:0044334,1,0.985103017019555,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11553,GO:0044335,1,0.989381442032872,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11554,GO:0044336,1,0.978182456609352,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11555,GO:0044338,1,0.988558209934254,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11556,GO:0044339,1,0.980778467682471,0,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
11557,GO:0044340,1,0.963841134964875,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
11558,GO:0044341,1,0.964377592839782,0,6,sodium-dependent phosphate transport,BP,
11559,GO:0044342,1,0.895360141458094,0,19,type B pancreatic cell proliferation,BP,
11560,GO:0044343,1,0.992362313737938,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11562,GO:0044345,1,0.992362313737938,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11563,GO:0044346,1,0.871434207186383,0,20,fibroblast apoptotic process,BP,
11564,GO:0044349,1,0.995727274618538,0,1,DNA excision,BP,
11565,GO:0044351,1,0.938175646620867,0,9,macropinocytosis,BP,
11566,GO:0044352,1,0.957273029091818,0,6,pinosome,CC,
11567,GO:0044354,1,0.957273029091818,0,6,macropinosome,CC,
11568,GO:0044355,1,0.996205929672335,0,1,clearance of foreign intracellular DNA,BP,
11569,GO:0044357,1,0.995513823670867,0,1,regulation of rRNA stability,BP,
11570,GO:0044359,1,0.957294078769806,0,8,modulation of molecular function in other organism,BP,
11571,GO:0044362,1,0.969848279773595,0,6,negative regulation of molecular function in other organism,BP,
11572,GO:0044374,1,0.992500165481802,0,1,sequence-specific DNA binding, bending,MF,
11573,GO:0044375,1,0.989133437852136,0,3,regulation of peroxisome size,BP,
11574,GO:0044377,1,0.992500165481802,0,1,RNA polymerase II cis-regulatory region sequence-specific DNA binding, bending,MF,
11575,GO:0044378,1,0.987706292016199,0,2,non-sequence-specific DNA binding, bending,MF,
11576,GO:0044379,1,0.992461695877957,0,1,protein localization to actin cortical patch,BP,
11577,GO:0044380,1,0.653878224553818,0,56,protein localization to cytoskeleton,BP,
11578,GO:0044381,1,0.9854878274401,0,2,glucose import in response to insulin stimulus,BP,
11579,GO:0044387,1,0.951113099121157,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11580,GO:0044388,1,0.976956925680279,0,5,small protein activating enzyme binding,MF,
11582,GO:0044390,1,0.777720629677032,0,36,ubiquitin-like protein conjugating enzyme binding,MF,
11584,GO:0044393,1,0.970887284448861,0,4,microspike,CC,
11586,GO:0044406,1,0.931824062036233,0,11,adhesion of symbiont to host,BP,
11587,GO:0044407,1,0.994152611553279,0,1,single-species biofilm formation in or on host organism,BP,
11589,GO:0044417,1,0.950383232917533,0,9,translocation of molecules into host,BP,
11591,GO:0044458,1,0.883337165461688,0,20,motile cilium assembly,BP,
11592,GO:0044466,1,0.992460861830824,0,2,glutaryl-CoA hydrolase activity,MF,
11593,GO:0044467,1,0.975965306352714,0,3,glial cell-derived neurotrophic factor secretion,BP,
11594,GO:0044501,1,0.984744276122055,0,2,modulation of signal transduction in other organism,BP,
11595,GO:0044508,1,0.992765517626142,0,1,glucagon-like peptide 1 receptor activity,MF,
11596,GO:0044524,1,0.995691921465553,0,1,protein sulfhydration,BP,
11597,GO:0044528,1,0.955637507825351,0,7,regulation of mitochondrial mRNA stability,BP,
11598,GO:0044530,1,0.978325360151843,0,3,supraspliceosomal complex,CC,
11599,GO:0044531,1,0.965285169087925,0,6,modulation of programmed cell death in other organism,BP,
11600,GO:0044532,1,0.965285169087925,0,6,modulation of apoptotic process in other organism,BP,
11601,GO:0044533,1,0.996372155485022,0,1,positive regulation of apoptotic process in other organism,BP,
11602,GO:0044539,1,0.89410203512505,0,16,long-chain fatty acid import into cell,BP,
11603,GO:0044540,1,0.995691921465553,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11604,GO:0044545,1,0.953733741194021,0,7,NSL complex,CC,
11605,GO:0044546,1,0.907042688023412,0,14,NLRP3 inflammasome complex assembly,BP,
11606,GO:0044547,1,0.966552790856519,0,5,DNA topoisomerase binding,MF,
11607,GO:0044548,1,0.917614679849623,0,14,S100 protein binding,MF,
11608,GO:0044549,1,0.996800907774561,0,1,GTP cyclohydrolase binding,MF,
11609,GO:0044550,1,0.862224601973319,0,21,secondary metabolite biosynthetic process,BP,
11610,GO:0044557,1,0.957791575166289,0,7,relaxation of smooth muscle,BP,
11611,GO:0044565,1,0.989133796316686,0,2,dendritic cell proliferation,BP,
11612,GO:0044571,1,0.980624624636538,0,5,[2Fe-2S] cluster assembly,BP,
11613,GO:0044594,1,0.993407348688705,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11614,GO:0044595,1,0.996425863818555,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11615,GO:0044596,1,0.996425863818555,0,1,3-demethylubiquinol-10 3-O-methyltransferase activity,MF,
11616,GO:0044597,1,0.963254799273274,0,9,daunorubicin metabolic process,BP,
11617,GO:0044598,1,0.963254799273274,0,9,doxorubicin metabolic process,BP,
11618,GO:0044599,1,0.99325505912211,0,1,AP-5 adaptor complex,CC,
11619,GO:0044601,1,0.995876361278093,0,1,protein denucleotidylation,BP,
11620,GO:0044602,1,0.995876361278093,0,1,protein deadenylylation,BP,
11621,GO:0044603,1,0.995876361278093,0,1,protein adenylylhydrolase activity,MF,
11622,GO:0044609,1,0.988052436619809,0,2,DBIRD complex,CC,
11623,GO:0044610,1,0.994427769882656,0,1,FMN transmembrane transporter activity,MF,
11624,GO:0044611,1,0.975778843976891,0,3,nuclear pore inner ring,CC,
11625,GO:0044613,1,0.957611644039265,0,8,nuclear pore central transport channel,CC,
11626,GO:0044614,1,0.97482445691824,0,3,nuclear pore cytoplasmic filaments,CC,
11627,GO:0044615,1,0.927236727553949,0,12,nuclear pore nuclear basket,CC,
11628,GO:0044620,1,0.996815956228427,0,1,ACP phosphopantetheine attachment site binding,MF,
11629,GO:0044648,1,0.954835394595338,0,6,histone H3-K4 dimethylation,BP,
11630,GO:0044650,1,0.9435188610083,0,9,adhesion of symbiont to host cell,BP,
11631,GO:0044651,1,0.996406188665148,0,1,adhesion of symbiont to host epithelial cell,BP,
11632,GO:0044657,1,0.99372110036174,0,2,pore formation in membrane of other organism during symbiotic interaction,BP,
11633,GO:0044665,1,0.827943737573112,0,28,MLL1/2 complex,CC,
11634,GO:0044666,1,0.927612551532041,0,11,MLL3/4 complex,CC,
11635,GO:0044691,1,0.96159227272959,0,5,tooth eruption,BP,
11638,GO:0044715,1,0.996485565388498,0,1,8-oxo-dGDP phosphatase activity,MF,
11639,GO:0044721,1,0.99528299885192,0,1,protein import into peroxisome matrix, substrate release,BP,
11640,GO:0044722,1,0.992482927498219,0,1,renal phosphate excretion,BP,
11641,GO:0044725,1,0.988936154246414,0,1,chromatin reprogramming in the zygote,BP,
11642,GO:0044727,1,0.988936154246414,0,1,DNA demethylation of male pronucleus,BP,
11643,GO:0044728,1,0.568852800243712,0,82,DNA methylation or demethylation,BP,
11644,GO:0044729,1,0.985712416494289,0,2,hemi-methylated DNA-binding,MF,
11645,GO:0044730,1,0.995897193514659,0,1,bone sialoprotein binding,MF,
11646,GO:0044736,1,0.986555151512788,0,2,acid-sensing ion channel activity,MF,
11648,GO:0044752,1,0.979722713972008,0,3,response to human chorionic gonadotropin,BP,
11649,GO:0044753,1,0.982912726497435,0,2,amphisome,CC,
11650,GO:0044754,1,0.948266055421128,0,9,autolysosome,CC,
11651,GO:0044764,1,0.892918728466201,0,16,multi-organism cellular process,BP,
11652,GO:0044766,1,0.664159483741941,0,61,multi-organism transport,BP,
11653,GO:0044769,1,0.897517142862295,0,19,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11655,GO:0044771,1,0.961855170699055,0,6,meiotic cell cycle phase transition,BP,
11657,GO:0044773,1,0.540784157065563,0,94,mitotic DNA damage checkpoint,BP,
11658,GO:0044774,1,0.515785929423041,0,101,mitotic DNA integrity checkpoint,BP,
11659,GO:0044778,1,0.994736575917216,0,1,meiotic DNA integrity checkpoint,BP,
11660,GO:0044779,1,0.992866031482335,0,1,meiotic spindle checkpoint,BP,
11662,GO:0044783,1,0.667926646144227,0,62,G1 DNA damage checkpoint,BP,
11663,GO:0044784,1,0.685148414230667,0,58,metaphase/anaphase transition of cell cycle,BP,
11664,GO:0044785,1,0.988259798324501,0,2,metaphase/anaphase transition of meiotic cell cycle,BP,
11665,GO:0044786,1,0.664759660748372,0,63,cell cycle DNA replication,BP,
11666,GO:0044788,1,0.854459806011938,0,25,modulation by host of viral process,BP,
11667,GO:0044789,1,0.969289237919508,0,4,modulation by host of viral release from host cell,BP,
11668,GO:0044791,1,0.969289237919508,0,4,positive regulation by host of viral release from host cell,BP,
11669,GO:0044793,1,0.945223888526821,0,9,negative regulation by host of viral process,BP,
11670,GO:0044794,1,0.908239548515347,0,14,positive regulation by host of viral process,BP,
11671,GO:0044795,1,0.996534456882027,0,1,trans-Golgi network to recycling endosome transport,BP,
11672,GO:0044796,1,0.996344392528905,0,1,DNA polymerase processivity factor complex,CC,
11673,GO:0044800,1,0.957767437873061,0,7,multi-organism membrane fusion,BP,
11674,GO:0044803,1,0.935834347651588,0,10,multi-organism membrane organization,BP,
11675,GO:0044804,1,0.904168432515343,0,14,autophagy of nucleus,BP,
11676,GO:0044805,1,0.957910482218124,0,5,late nucleophagy,BP,
11677,GO:0044806,1,0.947449624939849,0,7,G-quadruplex DNA unwinding,BP,
11678,GO:0044815,1,0.876679004982199,0,18,DNA packaging complex,CC,
11679,GO:0044818,1,0.830348260239152,0,27,mitotic G2/M transition checkpoint,BP,
11680,GO:0044819,1,0.668384286540112,0,62,mitotic G1/S transition checkpoint,BP,
11681,GO:0044821,1,0.988071832943591,0,2,meiotic telomere tethering at nuclear periphery,BP,
11682,GO:0044827,1,0.908857949642163,0,15,modulation by host of viral genome replication,BP,
11683,GO:0044828,1,0.96755001124034,0,5,negative regulation by host of viral genome replication,BP,
11684,GO:0044829,1,0.951986482571976,0,7,positive regulation by host of viral genome replication,BP,
11685,GO:0044830,1,0.981050677606631,0,3,modulation by host of viral RNA genome replication,BP,
11689,GO:0044848,1,0.92623741740534,0,11,biological phase,BP,
11690,GO:0044849,1,0.911606456206838,0,15,estrous cycle,BP,
11691,GO:0044851,1,0.940665132357094,0,9,hair cycle phase,BP,
11693,GO:0044854,1,0.97306220151701,0,5,plasma membrane raft assembly,BP,
11694,GO:0044855,1,0.985491736144884,0,2,plasma membrane raft distribution,BP,
11695,GO:0044856,1,0.985491736144884,0,2,plasma membrane raft localization,BP,
11697,GO:0044858,1,0.993318579134512,0,1,plasma membrane raft polarization,BP,
11698,GO:0044860,1,0.974291457093774,0,4,protein localization to plasma membrane raft,BP,
11699,GO:0044861,1,0.987114806027742,0,2,protein transport into plasma membrane raft,BP,
11700,GO:0044866,1,0.99526624345881,0,1,modulation by host of viral exo-alpha-sialidase activity,BP,
11701,GO:0044867,1,0.99526624345881,0,1,modulation by host of viral catalytic activity,BP,
11702,GO:0044868,1,0.986641544297319,0,2,modulation by host of viral molecular function,BP,
11703,GO:0044869,1,0.99526624345881,0,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11704,GO:0044870,1,0.99526624345881,0,1,modulation by host of viral glycoprotein metabolic process,BP,
11705,GO:0044871,1,0.99526624345881,0,1,negative regulation by host of viral glycoprotein metabolic process,BP,
11706,GO:0044872,1,0.905438431441165,0,12,lipoprotein localization,BP,
11707,GO:0044873,1,0.988150080662306,0,1,lipoprotein localization to membrane,BP,
11709,GO:0044878,1,0.981104759993308,0,4,mitotic cytokinesis checkpoint,BP,
11710,GO:0045002,1,0.961236935523,0,6,double-strand break repair via single-strand annealing,BP,
11711,GO:0045003,1,0.944551006646317,0,9,double-strand break repair via synthesis-dependent strand annealing,BP,
11712,GO:0045004,1,0.983176035474278,0,2,DNA replication proofreading,BP,
11713,GO:0045005,1,0.756734450412509,0,40,DNA-dependent DNA replication maintenance of fidelity,BP,
11714,GO:0045006,1,0.94126278541331,0,13,DNA deamination,BP,
11715,GO:0045007,1,0.987439927616895,0,3,depurination,BP,
11716,GO:0045008,1,0.960318561064789,0,8,depyrimidination,BP,
11718,GO:0045010,1,0.739476298368398,0,47,actin nucleation,BP,
11719,GO:0045016,1,0.992613134525609,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11721,GO:0045019,1,0.913376029340499,0,14,negative regulation of nitric oxide biosynthetic process,BP,
11722,GO:0045022,1,0.774464763782275,0,37,early endosome to late endosome transport,BP,
11723,GO:0045023,1,0.752660932782895,0,41,G0 to G1 transition,BP,
11724,GO:0045025,1,0.986234885471271,0,2,mitochondrial degradosome,CC,
11725,GO:0045026,1,0.95000308640204,0,11,plasma membrane fusion,BP,
11726,GO:0045027,1,0.987460153017347,0,2,DNA end binding,MF,
11727,GO:0045028,1,0.933640358854513,0,13,G protein-coupled purinergic nucleotide receptor activity,MF,
11728,GO:0045029,1,0.989336065503989,0,2,G protein-coupled UDP receptor activity,MF,
11729,GO:0045030,1,0.991582403527875,0,2,G protein-coupled UTP receptor activity,MF,
11730,GO:0045031,1,0.988005289592639,0,2,G protein-coupled ATP receptor activity,MF,
11731,GO:0045039,1,0.971508425318065,0,7,protein insertion into mitochondrial inner membrane,BP,
11732,GO:0045040,1,0.974156531420702,0,5,protein insertion into mitochondrial outer membrane,BP,
11733,GO:0045041,1,0.985036713688411,0,3,protein import into mitochondrial intermembrane space,BP,
11734,GO:0045046,1,0.960382981191643,0,6,protein import into peroxisome membrane,BP,
11736,GO:0045048,1,0.956417463455432,0,7,protein insertion into ER membrane,BP,
11737,GO:0045053,1,0.947341802673034,0,5,protein retention in Golgi apparatus,BP,
11738,GO:0045054,1,0.957376739826409,0,7,constitutive secretory pathway,BP,
11741,GO:0045058,1,0.73959350512692,0,46,T cell selection,BP,
11742,GO:0045059,1,0.927792912431985,0,13,positive thymic T cell selection,BP,
11743,GO:0045060,1,0.934383073875085,0,11,negative thymic T cell selection,BP,
11744,GO:0045061,1,0.875583706243678,0,21,thymic T cell selection,BP,
11745,GO:0045062,1,0.995762901349205,0,1,extrathymic T cell selection,BP,
11746,GO:0045063,1,0.882914139894551,0,19,T-helper 1 cell differentiation,BP,
11747,GO:0045064,1,0.920002812160156,0,14,T-helper 2 cell differentiation,BP,
11748,GO:0045065,1,0.981585591082052,0,3,cytotoxic T cell differentiation,BP,
11749,GO:0045066,1,0.82338500073178,0,30,regulatory T cell differentiation,BP,
11750,GO:0045069,1,0.564133002681929,0,90,regulation of viral genome replication,BP,
11751,GO:0045070,1,0.784716443244175,0,35,positive regulation of viral genome replication,BP,
11752,GO:0045071,1,0.730742612733639,0,52,negative regulation of viral genome replication,BP,
11754,GO:0045088,1,0.19907146323604,0,263,regulation of innate immune response,BP,
11755,GO:0045089,1,0.334331562815522,0,181,positive regulation of innate immune response,BP,
11756,GO:0045091,1,0.899315769828359,0,17,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11757,GO:0045092,1,0.986038071682239,0,2,interleukin-18 receptor complex,CC,
11759,GO:0045098,1,0.985462681077816,0,3,type III intermediate filament,CC,
11762,GO:0045105,1,0.991846469653628,0,1,intermediate filament polymerization or depolymerization,BP,
11763,GO:0045106,1,0.991846469653628,0,1,intermediate filament depolymerization,BP,
11764,GO:0045108,1,0.991846469653628,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
11765,GO:0045109,1,0.886275228590988,0,18,intermediate filament organization,BP,
11766,GO:0045110,1,0.966220755923692,0,5,intermediate filament bundle assembly,BP,
11768,GO:0045112,1,0.967902008394154,0,5,integrin biosynthetic process,BP,
11769,GO:0045113,1,0.977467656235102,0,4,regulation of integrin biosynthetic process,BP,
11770,GO:0045116,1,0.927596240949154,0,14,protein neddylation,BP,
11771,GO:0045117,1,0.932042891232889,0,11,azole transmembrane transport,BP,
11772,GO:0045120,1,0.9126367316993,0,13,pronucleus,CC,
11774,GO:0045123,1,0.667571798735482,0,62,cellular extravasation,BP,
11776,GO:0045125,1,0.919965749067211,0,15,bioactive lipid receptor activity,MF,
11777,GO:0045127,1,0.996002072472747,0,1,N-acetylglucosamine kinase activity,MF,
11778,GO:0045130,1,0.993354895208228,0,1,keratan sulfotransferase activity,MF,
11779,GO:0045131,1,0.992923936346247,0,1,pre-mRNA branch point binding,MF,
11780,GO:0045132,1,0.628372892012829,0,71,meiotic chromosome segregation,BP,
11781,GO:0045134,1,0.974080347436271,0,4,uridine-diphosphatase activity,MF,
11782,GO:0045136,1,0.950382028785297,0,8,development of secondary sexual characteristics,BP,
11784,GO:0045141,1,0.950855269832969,0,7,meiotic telomere clustering,BP,
11785,GO:0045142,1,0.984838026638262,0,2,triplex DNA binding,MF,
11787,GO:0045144,1,0.948097646510462,0,9,meiotic sister chromatid segregation,BP,
11788,GO:0045145,1,0.975771588904434,0,4,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11789,GO:0045153,1,0.996482613061879,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11790,GO:0045155,1,0.988386093589918,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11791,GO:0045159,1,0.911812751039215,0,13,myosin II binding,MF,
11796,GO:0045167,1,0.995755048455636,0,1,asymmetric protein localization involved in cell fate determination,BP,
11797,GO:0045168,1,0.988853411838881,0,2,cell-cell signaling involved in cell fate commitment,BP,
11798,GO:0045171,1,0.652967712691216,0,66,intercellular bridge,CC,
11799,GO:0045174,1,0.992918444174798,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11803,GO:0045179,1,0.951489554684046,0,8,apical cortex,CC,
11804,GO:0045180,1,0.95770397895135,0,5,basal cortex,CC,
11805,GO:0045182,1,0.445658576555471,0,127,translation regulator activity,MF,
11806,GO:0045183,1,0.99325505912211,0,1,translation factor activity, non-nucleic acid binding,MF,
11809,GO:0045186,1,0.990752314068758,0,1,zonula adherens assembly,BP,
11810,GO:0045187,1,0.915253950296888,0,17,regulation of circadian sleep/wake cycle, sleep,BP,
11811,GO:0045188,1,0.95800343373023,0,8,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11812,GO:0045190,1,0.754473672949948,0,43,isotype switching,BP,
11813,GO:0045191,1,0.827474608560598,0,29,regulation of isotype switching,BP,
11814,GO:0045196,1,0.978152046286004,0,3,establishment or maintenance of neuroblast polarity,BP,
11815,GO:0045197,1,0.741886195435828,0,42,establishment or maintenance of epithelial cell apical/basal polarity,BP,
11816,GO:0045198,1,0.903693607408947,0,15,establishment of epithelial cell apical/basal polarity,BP,
11817,GO:0045199,1,0.935342118747962,0,11,maintenance of epithelial cell apical/basal polarity,BP,
11818,GO:0045200,1,0.978152046286004,0,3,establishment of neuroblast polarity,BP,
11820,GO:0045204,1,0.97717308706658,0,3,MAPK export from nucleus,BP,
11821,GO:0045208,1,0.99253113898602,0,1,MAPK phosphatase export from nucleus,BP,
11822,GO:0045209,1,0.99253113898602,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11823,GO:0045210,1,0.983616165069328,0,2,FasL biosynthetic process,BP,
11825,GO:0045212,1,0.993649074839029,0,1,neurotransmitter receptor biosynthetic process,BP,
11826,GO:0045213,1,0.983822468173711,0,3,neurotransmitter receptor metabolic process,BP,
11829,GO:0045217,1,0.921421808427802,0,12,cell-cell junction maintenance,BP,
11830,GO:0045218,1,0.9782356912694,0,3,zonula adherens maintenance,BP,
11831,GO:0045219,1,0.991904820512466,0,1,regulation of FasL production,BP,
11832,GO:0045221,1,0.991904820512466,0,1,negative regulation of FasL production,BP,
11833,GO:0045222,1,0.996532655061261,0,1,CD4 biosynthetic process,BP,
11834,GO:0045223,1,0.996532655061261,0,1,regulation of CD4 production,BP,
11835,GO:0045225,1,0.996532655061261,0,1,negative regulation of CD4 production,BP,
11836,GO:0045226,1,0.981077987438951,0,3,extracellular polysaccharide biosynthetic process,BP,
11837,GO:0045229,1,0.986691638938213,0,2,external encapsulating structure organization,BP,
11838,GO:0045234,1,0.995605276079038,0,1,protein palmitoleylation,BP,
11839,GO:0045236,1,0.927845229206428,0,16,CXCR chemokine receptor binding,MF,
11840,GO:0045237,1,0.992658184875354,0,1,CXCR1 chemokine receptor binding,MF,
11841,GO:0045239,1,0.916632359950854,0,14,tricarboxylic acid cycle enzyme complex,CC,
11842,GO:0045240,1,0.934605808333806,0,10,dihydrolipoyl dehydrogenase complex,CC,
11843,GO:0045244,1,0.994193353797425,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11844,GO:0045252,1,0.960355410324331,0,6,oxoglutarate dehydrogenase complex,CC,
11845,GO:0045254,1,0.954622488208934,0,7,pyruvate dehydrogenase complex,CC,
11846,GO:0045257,1,0.980436691765404,0,4,succinate dehydrogenase complex (ubiquinone),CC,
11847,GO:0045259,1,0.994606968261175,0,1,proton-transporting ATP synthase complex,CC,
11848,GO:0045271,1,0.857688615610072,0,41,respiratory chain complex I,CC,
11849,GO:0045273,1,0.980436691765404,0,4,respiratory chain complex II,CC,
11850,GO:0045275,1,0.956736299449552,0,10,respiratory chain complex III,CC,
11851,GO:0045277,1,0.954749464742498,0,14,respiratory chain complex IV,CC,
11852,GO:0045281,1,0.980436691765404,0,4,succinate dehydrogenase complex,CC,
11853,GO:0045283,1,0.980436691765404,0,4,fumarate reductase complex,CC,
11854,GO:0045292,1,0.817014801521722,0,31,mRNA cis splicing, via spliceosome,BP,
11855,GO:0045293,1,0.96268121004317,0,6,mRNA editing complex,CC,
11856,GO:0045294,1,0.926221678254568,0,10,alpha-catenin binding,MF,
11857,GO:0045295,1,0.899772039164759,0,12,gamma-catenin binding,MF,
11859,GO:0045298,1,0.984357384575968,0,2,tubulin complex,CC,
11860,GO:0045309,1,0.689921552680313,0,53,protein phosphorylated amino acid binding,MF,
11862,GO:0045322,1,0.941686495418651,0,8,unmethylated CpG binding,MF,
11863,GO:0045324,1,0.880950474081599,0,23,late endosome to vacuole transport,BP,
11864,GO:0045329,1,0.970159291298472,0,5,carnitine biosynthetic process,BP,
11867,GO:0045334,1,0.723624371603097,0,54,clathrin-coated endocytic vesicle,CC,
11868,GO:0045335,1,0.431451257255445,0,133,phagocytic vesicle,CC,
11869,GO:0045337,1,0.976154647869424,0,4,farnesyl diphosphate biosynthetic process,BP,
11870,GO:0045338,1,0.971111087292984,0,5,farnesyl diphosphate metabolic process,BP,
11871,GO:0045340,1,0.99239579362026,0,2,mercury ion binding,MF,
11872,GO:0045341,1,0.963480355711293,0,5,MHC class I biosynthetic process,BP,
11873,GO:0045342,1,0.916981001939341,0,14,MHC class II biosynthetic process,BP,
11874,GO:0045343,1,0.963480355711293,0,5,regulation of MHC class I biosynthetic process,BP,
11875,GO:0045344,1,0.994363024691098,0,1,negative regulation of MHC class I biosynthetic process,BP,
11876,GO:0045345,1,0.968944022577166,0,4,positive regulation of MHC class I biosynthetic process,BP,
11877,GO:0045346,1,0.923930334879439,0,13,regulation of MHC class II biosynthetic process,BP,
11878,GO:0045347,1,0.967578306757737,0,6,negative regulation of MHC class II biosynthetic process,BP,
11879,GO:0045348,1,0.950999199926372,0,8,positive regulation of MHC class II biosynthetic process,BP,
11880,GO:0045352,1,0.995613794103254,0,1,interleukin-1 type I receptor antagonist activity,MF,
11881,GO:0045353,1,0.995613794103254,0,1,interleukin-1 type II receptor antagonist activity,MF,
11882,GO:0045423,1,0.985454870206678,0,2,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11883,GO:0045425,1,0.985454870206678,0,2,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11884,GO:0045428,1,0.708204333829799,0,53,regulation of nitric oxide biosynthetic process,BP,
11885,GO:0045429,1,0.792225129596473,0,36,positive regulation of nitric oxide biosynthetic process,BP,
11886,GO:0045444,1,0.239997917669902,0,212,fat cell differentiation,BP,
11889,GO:0045448,1,0.97512473205241,0,4,mitotic cell cycle, embryonic,BP,
11891,GO:0045454,1,0.734090211358719,0,55,cell redox homeostasis,BP,
11892,GO:0045471,1,0.509473448768664,0,111,response to ethanol,BP,
11893,GO:0045472,1,0.91471914309657,0,13,response to ether,BP,
11894,GO:0045475,1,0.901811837469919,0,13,locomotor rhythm,BP,
11895,GO:0045485,1,0.992376279394365,0,1,omega-6 fatty acid desaturase activity,MF,
11896,GO:0045494,1,0.764606940062329,0,37,photoreceptor cell maintenance,BP,
11897,GO:0045495,1,0.879229461962447,0,18,pole plasm,CC,
11898,GO:0045499,1,0.803877070728664,0,28,chemorepellent activity,MF,
11899,GO:0045503,1,0.955161905756587,0,6,dynein light chain binding,MF,
11900,GO:0045504,1,0.935799038782282,0,10,dynein heavy chain binding,MF,
11902,GO:0045509,1,0.985422207441787,0,2,interleukin-27 receptor activity,MF,
11903,GO:0045513,1,0.996214297604249,0,1,interleukin-27 binding,MF,
11904,GO:0045515,1,0.996543373289718,0,1,interleukin-18 receptor binding,MF,
11905,GO:0045519,1,0.996628710723769,0,1,interleukin-23 receptor binding,MF,
11906,GO:0045523,1,0.993195334212145,0,2,interleukin-27 receptor binding,MF,
11907,GO:0045540,1,0.751131257623405,0,42,regulation of cholesterol biosynthetic process,BP,
11908,GO:0045541,1,0.974174919482863,0,5,negative regulation of cholesterol biosynthetic process,BP,
11909,GO:0045542,1,0.956679353497216,0,6,positive regulation of cholesterol biosynthetic process,BP,
11911,GO:0045547,1,0.984927839464583,0,2,dehydrodolichyl diphosphate synthase activity,MF,
11912,GO:0045550,1,0.992444871667169,0,2,geranylgeranyl reductase activity,MF,
11913,GO:0045569,1,0.972908829043919,0,5,TRAIL binding,MF,
11914,GO:0045575,1,0.985210865143249,0,2,basophil activation,BP,
11915,GO:0045576,1,0.715677305623942,0,55,mast cell activation,BP,
11916,GO:0045577,1,0.834503013114726,0,28,regulation of B cell differentiation,BP,
11917,GO:0045578,1,0.972423545669893,0,5,negative regulation of B cell differentiation,BP,
11918,GO:0045579,1,0.923951674722195,0,13,positive regulation of B cell differentiation,BP,
11919,GO:0045580,1,0.417571250703438,0,136,regulation of T cell differentiation,BP,
11920,GO:0045581,1,0.787411580607888,0,38,negative regulation of T cell differentiation,BP,
11921,GO:0045582,1,0.588555043753655,0,84,positive regulation of T cell differentiation,BP,
11922,GO:0045583,1,0.988401681023053,0,2,regulation of cytotoxic T cell differentiation,BP,
11923,GO:0045585,1,0.988401681023053,0,2,positive regulation of cytotoxic T cell differentiation,BP,
11924,GO:0045586,1,0.933578770370935,0,9,regulation of gamma-delta T cell differentiation,BP,
11925,GO:0045588,1,0.947242422112521,0,7,positive regulation of gamma-delta T cell differentiation,BP,
11926,GO:0045589,1,0.84005537185579,0,27,regulation of regulatory T cell differentiation,BP,
11927,GO:0045590,1,0.972529595834559,0,5,negative regulation of regulatory T cell differentiation,BP,
11928,GO:0045591,1,0.936890343620628,0,11,positive regulation of regulatory T cell differentiation,BP,
11932,GO:0045598,1,0.427055013712894,0,126,regulation of fat cell differentiation,BP,
11933,GO:0045599,1,0.744082542354163,0,43,negative regulation of fat cell differentiation,BP,
11934,GO:0045600,1,0.63983553673785,0,67,positive regulation of fat cell differentiation,BP,
11935,GO:0045601,1,0.79280935668444,0,33,regulation of endothelial cell differentiation,BP,
11936,GO:0045602,1,0.933953879355597,0,9,negative regulation of endothelial cell differentiation,BP,
11937,GO:0045603,1,0.896388165104309,0,16,positive regulation of endothelial cell differentiation,BP,
11938,GO:0045604,1,0.719081942975659,0,50,regulation of epidermal cell differentiation,BP,
11939,GO:0045605,1,0.941766190208046,0,10,negative regulation of epidermal cell differentiation,BP,
11940,GO:0045606,1,0.873678060966583,0,20,positive regulation of epidermal cell differentiation,BP,
11941,GO:0045607,1,0.955067004031947,0,7,regulation of inner ear auditory receptor cell differentiation,BP,
11942,GO:0045608,1,0.975208148925855,0,4,negative regulation of inner ear auditory receptor cell differentiation,BP,
11943,GO:0045616,1,0.799518539161252,0,32,regulation of keratinocyte differentiation,BP,
11944,GO:0045617,1,0.975449000225711,0,4,negative regulation of keratinocyte differentiation,BP,
11945,GO:0045618,1,0.905465963666893,0,14,positive regulation of keratinocyte differentiation,BP,
11946,GO:0045619,1,0.347751034709855,0,164,regulation of lymphocyte differentiation,BP,
11947,GO:0045620,1,0.75943738809685,0,45,negative regulation of lymphocyte differentiation,BP,
11948,GO:0045621,1,0.539860800502771,0,97,positive regulation of lymphocyte differentiation,BP,
11949,GO:0045622,1,0.819211073755858,0,31,regulation of T-helper cell differentiation,BP,
11950,GO:0045623,1,0.899847857522691,0,15,negative regulation of T-helper cell differentiation,BP,
11951,GO:0045624,1,0.893345513546857,0,19,positive regulation of T-helper cell differentiation,BP,
11952,GO:0045625,1,0.943395033218064,0,10,regulation of T-helper 1 cell differentiation,BP,
11953,GO:0045626,1,0.978717834872679,0,3,negative regulation of T-helper 1 cell differentiation,BP,
11954,GO:0045627,1,0.967180766256279,0,6,positive regulation of T-helper 1 cell differentiation,BP,
11955,GO:0045628,1,0.934000603238747,0,11,regulation of T-helper 2 cell differentiation,BP,
11956,GO:0045629,1,0.975777639458396,0,4,negative regulation of T-helper 2 cell differentiation,BP,
11957,GO:0045630,1,0.957196388302621,0,7,positive regulation of T-helper 2 cell differentiation,BP,
11958,GO:0045631,1,0.955067004031947,0,7,regulation of mechanoreceptor differentiation,BP,
11959,GO:0045632,1,0.975208148925855,0,4,negative regulation of mechanoreceptor differentiation,BP,
11960,GO:0045634,1,0.953709755735945,0,6,regulation of melanocyte differentiation,BP,
11961,GO:0045636,1,0.957575431331181,0,5,positive regulation of melanocyte differentiation,BP,
11962,GO:0045637,1,0.245483997096261,0,210,regulation of myeloid cell differentiation,BP,
11963,GO:0045638,1,0.618016328007188,0,74,negative regulation of myeloid cell differentiation,BP,
11964,GO:0045639,1,0.562757421191657,0,88,positive regulation of myeloid cell differentiation,BP,
11965,GO:0045643,1,0.992517678961122,0,1,regulation of eosinophil differentiation,BP,
11966,GO:0045645,1,0.992517678961122,0,1,positive regulation of eosinophil differentiation,BP,
11967,GO:0045646,1,0.728091608027571,0,47,regulation of erythrocyte differentiation,BP,
11968,GO:0045647,1,0.935019959456442,0,10,negative regulation of erythrocyte differentiation,BP,
11969,GO:0045648,1,0.808417138059299,0,31,positive regulation of erythrocyte differentiation,BP,
11970,GO:0045649,1,0.887906623750019,0,20,regulation of macrophage differentiation,BP,
11971,GO:0045650,1,0.968594728595064,0,6,negative regulation of macrophage differentiation,BP,
11972,GO:0045651,1,0.916721688841503,0,14,positive regulation of macrophage differentiation,BP,
11973,GO:0045652,1,0.703214453090883,0,52,regulation of megakaryocyte differentiation,BP,
11974,GO:0045653,1,0.981924799297311,0,4,negative regulation of megakaryocyte differentiation,BP,
11975,GO:0045654,1,0.948620231517901,0,9,positive regulation of megakaryocyte differentiation,BP,
11976,GO:0045655,1,0.883301869052786,0,19,regulation of monocyte differentiation,BP,
11977,GO:0045656,1,0.956435702646703,0,6,negative regulation of monocyte differentiation,BP,
11978,GO:0045657,1,0.935047307047194,0,11,positive regulation of monocyte differentiation,BP,
11979,GO:0045658,1,0.979987409671145,0,3,regulation of neutrophil differentiation,BP,
11980,GO:0045659,1,0.984786639587785,0,2,negative regulation of neutrophil differentiation,BP,
11981,GO:0045660,1,0.995127390523675,0,1,positive regulation of neutrophil differentiation,BP,
11983,GO:0045662,1,0.868655143145663,0,25,negative regulation of myoblast differentiation,BP,
11984,GO:0045663,1,0.878142661496863,0,19,positive regulation of myoblast differentiation,BP,
11991,GO:0045670,1,0.692434632451204,0,55,regulation of osteoclast differentiation,BP,
11992,GO:0045671,1,0.832584153827323,0,26,negative regulation of osteoclast differentiation,BP,
11993,GO:0045672,1,0.87944890833138,0,20,positive regulation of osteoclast differentiation,BP,
11996,GO:0045684,1,0.815549444114291,0,33,positive regulation of epidermis development,BP,
12000,GO:0045703,1,0.996467631790623,0,1,ketoreductase activity,MF,
12001,GO:0045713,1,0.942571302401497,0,9,low-density lipoprotein particle receptor biosynthetic process,BP,
12002,GO:0045714,1,0.946884370017569,0,8,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12003,GO:0045715,1,0.983316996699657,0,2,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12004,GO:0045716,1,0.978751395980287,0,4,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12005,GO:0045717,1,0.918579001223908,0,13,negative regulation of fatty acid biosynthetic process,BP,
12006,GO:0045719,1,0.961992979279207,0,5,negative regulation of glycogen biosynthetic process,BP,
12007,GO:0045720,1,0.988434268144018,0,2,negative regulation of integrin biosynthetic process,BP,
12008,GO:0045721,1,0.913737096467551,0,13,negative regulation of gluconeogenesis,BP,
12009,GO:0045722,1,0.915760305327649,0,12,positive regulation of gluconeogenesis,BP,
12011,GO:0045724,1,0.86913694202987,0,19,positive regulation of cilium assembly,BP,
12012,GO:0045725,1,0.893274056163126,0,14,positive regulation of glycogen biosynthetic process,BP,
12013,GO:0045726,1,0.984952088175762,0,2,positive regulation of integrin biosynthetic process,BP,
12014,GO:0045727,1,0.458455208436551,0,124,positive regulation of translation,BP,
12015,GO:0045728,1,0.994702939885281,0,1,respiratory burst after phagocytosis,BP,
12016,GO:0045730,1,0.859006713365065,0,27,respiratory burst,BP,
12018,GO:0045736,1,0.83076653366636,0,29,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12020,GO:0045738,1,0.820825232804589,0,28,negative regulation of DNA repair,BP,
12023,GO:0045741,1,0.926631620788816,0,12,positive regulation of epidermal growth factor-activated receptor activity,BP,
12024,GO:0045742,1,0.804140068886255,0,32,positive regulation of epidermal growth factor receptor signaling pathway,BP,
12025,GO:0045743,1,0.95741292194169,0,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12026,GO:0045744,1,0.765375087597307,0,44,negative regulation of G protein-coupled receptor signaling pathway,BP,
12029,GO:0045747,1,0.705332601123705,0,49,positive regulation of Notch signaling pathway,BP,
12030,GO:0045751,1,0.992678251437419,0,1,negative regulation of Toll signaling pathway,BP,
12031,GO:0045759,1,0.955008655100258,0,8,negative regulation of action potential,BP,
12033,GO:0045761,1,0.813704187753982,0,30,regulation of adenylate cyclase activity,BP,
12034,GO:0045762,1,0.93513599816994,0,8,positive regulation of adenylate cyclase activity,BP,
12035,GO:0045763,1,0.982237211535603,0,2,negative regulation of cellular amino acid metabolic process,BP,
12036,GO:0045764,1,0.985908401847276,0,3,positive regulation of cellular amino acid metabolic process,BP,
12039,GO:0045769,1,0.988972961420853,0,1,negative regulation of asymmetric cell division,BP,
12040,GO:0045773,1,0.725657010950984,0,41,positive regulation of axon extension,BP,
12041,GO:0045776,1,0.781159442366077,0,40,negative regulation of blood pressure,BP,
12042,GO:0045777,1,0.833562523821558,0,31,positive regulation of blood pressure,BP,
12044,GO:0045779,1,0.931879093529285,0,12,negative regulation of bone resorption,BP,
12049,GO:0045792,1,0.936134053324816,0,10,negative regulation of cell size,BP,
12050,GO:0045793,1,0.94097661443907,0,9,positive regulation of cell size,BP,
12051,GO:0045794,1,0.960469630611518,0,5,negative regulation of cell volume,BP,
12052,GO:0045795,1,0.991096200288108,0,1,positive regulation of cell volume,BP,
12053,GO:0045796,1,0.99344668091026,0,1,negative regulation of intestinal cholesterol absorption,BP,
12054,GO:0045797,1,0.99432685821291,0,1,positive regulation of intestinal cholesterol absorption,BP,
12055,GO:0045798,1,0.966770125741358,0,4,negative regulation of chromatin assembly or disassembly,BP,
12056,GO:0045799,1,0.915227586186887,0,12,positive regulation of chromatin assembly or disassembly,BP,
12057,GO:0045806,1,0.771529583178609,0,41,negative regulation of endocytosis,BP,
12059,GO:0045813,1,0.995568695093763,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
12060,GO:0045814,1,0.694487862805079,0,53,negative regulation of gene expression, epigenetic,BP,
12061,GO:0045815,1,0.743992266535421,0,45,positive regulation of gene expression, epigenetic,BP,
12062,GO:0045819,1,0.992476600089725,0,1,positive regulation of glycogen catabolic process,BP,
12063,GO:0045820,1,0.917091740985732,0,13,negative regulation of glycolytic process,BP,
12065,GO:0045822,1,0.869928731521371,0,21,negative regulation of heart contraction,BP,
12066,GO:0045823,1,0.785164291028343,0,38,positive regulation of heart contraction,BP,
12067,GO:0045824,1,0.72502338367152,0,53,negative regulation of innate immune response,BP,
12068,GO:0045827,1,0.98945231680571,0,2,negative regulation of isoprenoid metabolic process,BP,
12069,GO:0045828,1,0.992541287326394,0,1,positive regulation of isoprenoid metabolic process,BP,
12070,GO:0045829,1,0.96865251234574,0,5,negative regulation of isotype switching,BP,
12071,GO:0045830,1,0.878059346524992,0,20,positive regulation of isotype switching,BP,
12074,GO:0045835,1,0.9447384202175,0,9,negative regulation of meiotic nuclear division,BP,
12075,GO:0045836,1,0.919564392275145,0,13,positive regulation of meiotic nuclear division,BP,
12076,GO:0045837,1,0.93529241177445,0,13,negative regulation of membrane potential,BP,
12078,GO:0045839,1,0.728302394078646,0,50,negative regulation of mitotic nuclear division,BP,
12079,GO:0045840,1,0.710028117902805,0,51,positive regulation of mitotic nuclear division,BP,
12080,GO:0045841,1,0.793364621148274,0,36,negative regulation of mitotic metaphase/anaphase transition,BP,
12081,GO:0045842,1,0.917125991423115,0,13,positive regulation of mitotic metaphase/anaphase transition,BP,
12084,GO:0045848,1,0.994728818783657,0,1,positive regulation of nitrogen utilization,BP,
12085,GO:0045851,1,0.727662424114568,0,56,pH reduction,BP,
12086,GO:0045852,1,0.965448879050002,0,5,pH elevation,BP,
12091,GO:0045869,1,0.92030904164651,0,14,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12092,GO:0045870,1,0.983845060724126,0,2,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12093,GO:0045872,1,0.989828522046269,0,2,positive regulation of rhodopsin gene expression,BP,
12094,GO:0045875,1,0.966828374381032,0,4,negative regulation of sister chromatid cohesion,BP,
12095,GO:0045876,1,0.950753481570223,0,7,positive regulation of sister chromatid cohesion,BP,
12096,GO:0045879,1,0.787177247561721,0,32,negative regulation of smoothened signaling pathway,BP,
12097,GO:0045880,1,0.780122152797061,0,35,positive regulation of smoothened signaling pathway,BP,
12098,GO:0045887,1,0.990836780290473,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12101,GO:0045898,1,0.92300352415447,0,13,regulation of RNA polymerase II transcription preinitiation complex assembly,BP,
12102,GO:0045899,1,0.942773978238448,0,10,positive regulation of RNA polymerase II transcription preinitiation complex assembly,BP,
12103,GO:0045900,1,0.975468983695749,0,4,negative regulation of translational elongation,BP,
12104,GO:0045901,1,0.970828785641385,0,5,positive regulation of translational elongation,BP,
12105,GO:0045903,1,0.98448211233312,0,3,positive regulation of translational fidelity,BP,
12106,GO:0045905,1,0.974625899332011,0,4,positive regulation of translational termination,BP,
12107,GO:0045906,1,0.945393191222204,0,7,negative regulation of vasoconstriction,BP,
12109,GO:0045910,1,0.819545520975359,0,28,negative regulation of DNA recombination,BP,
12110,GO:0045911,1,0.781994785044397,0,36,positive regulation of DNA recombination,BP,
12111,GO:0045912,1,0.748349455572901,0,42,negative regulation of carbohydrate metabolic process,BP,
12113,GO:0045914,1,0.979771319292063,0,3,negative regulation of catecholamine metabolic process,BP,
12114,GO:0045915,1,0.964833406413108,0,6,positive regulation of catecholamine metabolic process,BP,
12115,GO:0045916,1,0.947596756898674,0,8,negative regulation of complement activation,BP,
12116,GO:0045917,1,0.976429068958252,0,4,positive regulation of complement activation,BP,
12117,GO:0045918,1,0.994593981600062,0,1,negative regulation of cytolysis,BP,
12118,GO:0045919,1,0.995502701526833,0,1,positive regulation of cytolysis,BP,
12119,GO:0045920,1,0.830547995229835,0,30,negative regulation of exocytosis,BP,
12120,GO:0045921,1,0.569925340701091,0,85,positive regulation of exocytosis,BP,
12121,GO:0045922,1,0.850172194447676,0,24,negative regulation of fatty acid metabolic process,BP,
12123,GO:0045924,1,0.959020278425466,0,6,regulation of female receptivity,BP,
12124,GO:0045925,1,0.98516425725923,0,2,positive regulation of female receptivity,BP,
12129,GO:0045932,1,0.870238142840707,0,21,negative regulation of muscle contraction,BP,
12130,GO:0045933,1,0.783109969043968,0,40,positive regulation of muscle contraction,BP,
12135,GO:0045938,1,0.972341712995027,0,6,positive regulation of circadian sleep/wake cycle, sleep,BP,
12136,GO:0045939,1,0.876074723094364,0,22,negative regulation of steroid metabolic process,BP,
12137,GO:0045940,1,0.875829593170343,0,22,positive regulation of steroid metabolic process,BP,
12138,GO:0045943,1,0.872410090421786,0,20,positive regulation of transcription by RNA polymerase I,BP,
12140,GO:0045945,1,0.921626411468644,0,11,positive regulation of transcription by RNA polymerase III,BP,
12141,GO:0045947,1,0.884239001206771,0,19,negative regulation of translational initiation,BP,
12142,GO:0045948,1,0.825978302779551,0,28,positive regulation of translational initiation,BP,
12143,GO:0045950,1,0.981541779042162,0,3,negative regulation of mitotic recombination,BP,
12144,GO:0045951,1,0.994692579726466,0,1,positive regulation of mitotic recombination,BP,
12145,GO:0045953,1,0.927677015817416,0,15,negative regulation of natural killer cell mediated cytotoxicity,BP,
12146,GO:0045954,1,0.889503319764419,0,20,positive regulation of natural killer cell mediated cytotoxicity,BP,
12147,GO:0045955,1,0.944227310890263,0,8,negative regulation of calcium ion-dependent exocytosis,BP,
12148,GO:0045956,1,0.885450377061427,0,18,positive regulation of calcium ion-dependent exocytosis,BP,
12149,GO:0045957,1,0.980597072370133,0,3,negative regulation of complement activation, alternative pathway,BP,
12150,GO:0045959,1,0.979352114136606,0,3,negative regulation of complement activation, classical pathway,BP,
12151,GO:0045963,1,0.979771319292063,0,3,negative regulation of dopamine metabolic process,BP,
12152,GO:0045964,1,0.964833406413108,0,6,positive regulation of dopamine metabolic process,BP,
12153,GO:0045967,1,0.978600527861469,0,2,negative regulation of growth rate,BP,
12154,GO:0045974,1,0.899795350010986,0,14,regulation of translation, ncRNA-mediated,BP,
12155,GO:0045976,1,0.985111083791772,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12156,GO:0045977,1,0.996194664242819,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12157,GO:0045980,1,0.88001317195607,0,20,negative regulation of nucleotide metabolic process,BP,
12159,GO:0045986,1,0.917666349870096,0,13,negative regulation of smooth muscle contraction,BP,
12160,GO:0045987,1,0.844574235995707,0,27,positive regulation of smooth muscle contraction,BP,
12161,GO:0045988,1,0.951548653726867,0,7,negative regulation of striated muscle contraction,BP,
12162,GO:0045989,1,0.926514085779687,0,13,positive regulation of striated muscle contraction,BP,
12163,GO:0045990,1,0.969448736990629,0,5,carbon catabolite regulation of transcription,BP,
12164,GO:0045991,1,0.969448736990629,0,5,carbon catabolite activation of transcription,BP,
12166,GO:0045993,1,0.992360188809566,0,1,negative regulation of translational initiation by iron,BP,
12167,GO:0045994,1,0.987740763389865,0,2,positive regulation of translational initiation by iron,BP,
12169,GO:0046005,1,0.996861612811084,0,1,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12170,GO:0046006,1,0.815488018372692,0,35,regulation of activated T cell proliferation,BP,
12171,GO:0046007,1,0.918973924828238,0,13,negative regulation of activated T cell proliferation,BP,
12172,GO:0046010,1,0.981601819227179,0,4,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12173,GO:0046013,1,0.989136720071485,0,2,regulation of T cell homeostatic proliferation,BP,
12174,GO:0046015,1,0.974095018277984,0,5,regulation of transcription by glucose,BP,
12175,GO:0046016,1,0.978174861290452,0,4,positive regulation of transcription by glucose,BP,
12176,GO:0046030,1,0.950452747340763,0,7,inositol trisphosphate phosphatase activity,MF,
12178,GO:0046032,1,0.996071118269615,0,1,ADP catabolic process,BP,
12179,GO:0046033,1,0.932880789719182,0,12,AMP metabolic process,BP,
12181,GO:0046036,1,0.942961499635738,0,13,CTP metabolic process,BP,
12182,GO:0046037,1,0.912979479342778,0,14,GMP metabolic process,BP,
12183,GO:0046038,1,0.996243042055326,0,1,GMP catabolic process,BP,
12184,GO:0046039,1,0.877458308623756,0,23,GTP metabolic process,BP,
12185,GO:0046040,1,0.935649229727541,0,10,IMP metabolic process,BP,
12186,GO:0046041,1,0.990114394485959,0,2,ITP metabolic process,BP,
12187,GO:0046048,1,0.986143870638681,0,2,UDP metabolic process,BP,
12188,GO:0046049,1,0.943955931666101,0,10,UMP metabolic process,BP,
12189,GO:0046051,1,0.954386892075939,0,10,UTP metabolic process,BP,
12190,GO:0046053,1,0.990262109657045,0,2,dAMP metabolic process,BP,
12191,GO:0046054,1,0.996663430352124,0,1,dGMP metabolic process,BP,
12192,GO:0046056,1,0.985829130058425,0,2,dADP metabolic process,BP,
12193,GO:0046058,1,0.843702197111513,0,21,cAMP metabolic process,BP,
12194,GO:0046060,1,0.977404944823643,0,5,dATP metabolic process,BP,
12195,GO:0046061,1,0.985636468118899,0,3,dATP catabolic process,BP,
12196,GO:0046065,1,0.99656920672688,0,1,dCTP metabolic process,BP,
12197,GO:0046066,1,0.989940765330428,0,2,dGDP metabolic process,BP,
12198,GO:0046068,1,0.917128239677562,0,13,cGMP metabolic process,BP,
12199,GO:0046069,1,0.964481935075287,0,5,cGMP catabolic process,BP,
12200,GO:0046070,1,0.981339336369435,0,4,dGTP metabolic process,BP,
12201,GO:0046072,1,0.989494377617044,0,2,dTDP metabolic process,BP,
12202,GO:0046073,1,0.98502863957311,0,3,dTMP metabolic process,BP,
12203,GO:0046075,1,0.981943139361535,0,4,dTTP metabolic process,BP,
12204,GO:0046077,1,0.989494377617044,0,2,dUDP metabolic process,BP,
12205,GO:0046078,1,0.982533227587636,0,4,dUMP metabolic process,BP,
12206,GO:0046079,1,0.995986966090815,0,1,dUMP catabolic process,BP,
12207,GO:0046080,1,0.995412054318856,0,1,dUTP metabolic process,BP,
12208,GO:0046081,1,0.995412054318856,0,1,dUTP catabolic process,BP,
12209,GO:0046083,1,0.985666315844839,0,3,adenine metabolic process,BP,
12210,GO:0046084,1,0.985666315844839,0,3,adenine biosynthetic process,BP,
12211,GO:0046085,1,0.957741263589796,0,7,adenosine metabolic process,BP,
12212,GO:0046086,1,0.992460650919098,0,1,adenosine biosynthetic process,BP,
12213,GO:0046087,1,0.951667731500622,0,10,cytidine metabolic process,BP,
12214,GO:0046090,1,0.996065573507639,0,1,deoxyadenosine metabolic process,BP,
12215,GO:0046092,1,0.992116094965223,0,1,deoxycytidine metabolic process,BP,
12216,GO:0046098,1,0.981076988603457,0,3,guanine metabolic process,BP,
12217,GO:0046099,1,0.996243042055326,0,1,guanine biosynthetic process,BP,
12218,GO:0046100,1,0.987071575847557,0,3,hypoxanthine metabolic process,BP,
12219,GO:0046101,1,0.987071575847557,0,3,hypoxanthine biosynthetic process,BP,
12220,GO:0046102,1,0.983867986751407,0,3,inosine metabolic process,BP,
12221,GO:0046103,1,0.989761011776325,0,2,inosine biosynthetic process,BP,
12222,GO:0046104,1,0.977586302142592,0,4,thymidine metabolic process,BP,
12223,GO:0046105,1,0.996551266760848,0,1,thymidine biosynthetic process,BP,
12224,GO:0046108,1,0.989627865743449,0,2,uridine metabolic process,BP,
12225,GO:0046110,1,0.980089294448737,0,3,xanthine metabolic process,BP,
12226,GO:0046111,1,0.996065573507639,0,1,xanthine biosynthetic process,BP,
12227,GO:0046112,1,0.889907547430436,0,18,nucleobase biosynthetic process,BP,
12228,GO:0046113,1,0.958715939067142,0,6,nucleobase catabolic process,BP,
12229,GO:0046120,1,0.996551266760848,0,1,deoxyribonucleoside biosynthetic process,BP,
12230,GO:0046121,1,0.984637289833346,0,3,deoxyribonucleoside catabolic process,BP,
12231,GO:0046122,1,0.99272788399309,0,2,purine deoxyribonucleoside metabolic process,BP,
12232,GO:0046124,1,0.996065573507639,0,1,purine deoxyribonucleoside catabolic process,BP,
12233,GO:0046125,1,0.977586302142592,0,4,pyrimidine deoxyribonucleoside metabolic process,BP,
12234,GO:0046126,1,0.996551266760848,0,1,pyrimidine deoxyribonucleoside biosynthetic process,BP,
12235,GO:0046127,1,0.992769178814638,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12236,GO:0046128,1,0.731579418544647,0,53,purine ribonucleoside metabolic process,BP,
12237,GO:0046129,1,0.904088478502132,0,21,purine ribonucleoside biosynthetic process,BP,
12238,GO:0046130,1,0.967118246881595,0,6,purine ribonucleoside catabolic process,BP,
12239,GO:0046131,1,0.941791932731875,0,12,pyrimidine ribonucleoside metabolic process,BP,
12240,GO:0046133,1,0.941791932731875,0,12,pyrimidine ribonucleoside catabolic process,BP,
12241,GO:0046134,1,0.928859575384267,0,14,pyrimidine nucleoside biosynthetic process,BP,
12242,GO:0046135,1,0.898678295733597,0,21,pyrimidine nucleoside catabolic process,BP,
12243,GO:0046136,1,0.976434391718747,0,4,positive regulation of vitamin metabolic process,BP,
12244,GO:0046137,1,0.967277093904951,0,6,negative regulation of vitamin metabolic process,BP,
12245,GO:0046144,1,0.995961406871488,0,1,D-alanine family amino acid metabolic process,BP,
12246,GO:0046146,1,0.967699583451662,0,7,tetrahydrobiopterin metabolic process,BP,
12247,GO:0046148,1,0.712788149373217,0,54,pigment biosynthetic process,BP,
12248,GO:0046149,1,0.985165219453117,0,4,pigment catabolic process,BP,
12249,GO:0046160,1,0.983956700921647,0,2,heme a metabolic process,BP,
12250,GO:0046164,1,0.759350021596216,0,46,alcohol catabolic process,BP,
12251,GO:0046165,1,0.400004868159632,0,141,alcohol biosynthetic process,BP,
12252,GO:0046166,1,0.991032177832456,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12253,GO:0046167,1,0.981826646027975,0,2,glycerol-3-phosphate biosynthetic process,BP,
12255,GO:0046173,1,0.702107083057896,0,57,polyol biosynthetic process,BP,
12256,GO:0046174,1,0.855842749614338,0,22,polyol catabolic process,BP,
12257,GO:0046176,1,0.988531408018345,0,2,aldonic acid catabolic process,BP,
12258,GO:0046177,1,0.988531408018345,0,2,D-gluconate catabolic process,BP,
12259,GO:0046184,1,0.912011514027233,0,13,aldehyde biosynthetic process,BP,
12260,GO:0046185,1,0.945796686438349,0,11,aldehyde catabolic process,BP,
12261,GO:0046189,1,0.764727362701394,0,41,phenol-containing compound biosynthetic process,BP,
12262,GO:0046203,1,0.995786241327855,0,1,spermidine catabolic process,BP,
12263,GO:0046204,1,0.996680162456057,0,1,nor-spermidine metabolic process,BP,
12264,GO:0046208,1,0.990730154264351,0,2,spermine catabolic process,BP,
12265,GO:0046209,1,0.638776935914636,0,68,nitric oxide metabolic process,BP,
12266,GO:0046210,1,0.993813767208886,0,1,nitric oxide catabolic process,BP,
12267,GO:0046218,1,0.963799522042704,0,8,indolalkylamine catabolic process,BP,
12268,GO:0046219,1,0.981059808161249,0,4,indolalkylamine biosynthetic process,BP,
12269,GO:0046222,1,0.989785512087752,0,2,aflatoxin metabolic process,BP,
12270,GO:0046223,1,0.989785512087752,0,2,aflatoxin catabolic process,BP,
12271,GO:0046226,1,0.992160619690299,0,2,coumarin catabolic process,BP,
12272,GO:0046247,1,0.986402667512831,0,2,terpene catabolic process,BP,
12273,GO:0046271,1,0.992160619690299,0,2,phenylpropanoid catabolic process,BP,
12274,GO:0046272,1,0.994575796660225,0,1,stilbene catabolic process,BP,
12275,GO:0046292,1,0.977584079653126,0,4,formaldehyde metabolic process,BP,
12276,GO:0046293,1,0.992244602600739,0,1,formaldehyde biosynthetic process,BP,
12277,GO:0046294,1,0.985226055730331,0,3,formaldehyde catabolic process,BP,
12278,GO:0046295,1,0.996698971982734,0,1,glycolate biosynthetic process,BP,
12279,GO:0046296,1,0.995682715676617,0,1,glycolate catabolic process,BP,
12280,GO:0046305,1,0.989345848123596,0,2,alkanesulfonate biosynthetic process,BP,
12281,GO:0046314,1,0.979783953948238,0,5,phosphocreatine biosynthetic process,BP,
12282,GO:0046316,1,0.99325505912211,0,1,gluconokinase activity,MF,
12283,GO:0046317,1,0.992086717074059,0,1,regulation of glucosylceramide biosynthetic process,BP,
12284,GO:0046318,1,0.992086717074059,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12285,GO:0046320,1,0.803101469596048,0,31,regulation of fatty acid oxidation,BP,
12286,GO:0046321,1,0.904113704991386,0,14,positive regulation of fatty acid oxidation,BP,
12287,GO:0046322,1,0.929406430213142,0,11,negative regulation of fatty acid oxidation,BP,
12288,GO:0046323,1,0.645773327082118,0,61,glucose import,BP,
12289,GO:0046324,1,0.710696113664144,0,48,regulation of glucose import,BP,
12290,GO:0046325,1,0.934610624521469,0,11,negative regulation of glucose import,BP,
12291,GO:0046326,1,0.786182204682756,0,32,positive regulation of glucose import,BP,
12292,GO:0046327,1,0.988640653624115,0,2,glycerol biosynthetic process from pyruvate,BP,
12294,GO:0046329,1,0.791290442198354,0,34,negative regulation of JNK cascade,BP,
12296,GO:0046331,1,0.988853411838881,0,2,lateral inhibition,BP,
12297,GO:0046332,1,0.549869562293034,0,79,SMAD binding,MF,
12298,GO:0046333,1,0.986155565453147,0,2,octopamine metabolic process,BP,
12299,GO:0046337,1,0.866207308299006,0,22,phosphatidylethanolamine metabolic process,BP,
12300,GO:0046338,1,0.978779175436062,0,3,phosphatidylethanolamine catabolic process,BP,
12301,GO:0046339,1,0.864006370791254,0,20,diacylglycerol metabolic process,BP,
12302,GO:0046340,1,0.984277987491954,0,2,diacylglycerol catabolic process,BP,
12303,GO:0046341,1,0.918837827748209,0,12,CDP-diacylglycerol metabolic process,BP,
12304,GO:0046348,1,0.941189669193342,0,12,amino sugar catabolic process,BP,
12305,GO:0046349,1,0.922138823110362,0,13,amino sugar biosynthetic process,BP,
12306,GO:0046351,1,0.97797614415593,0,4,disaccharide biosynthetic process,BP,
12307,GO:0046356,1,0.991421321483694,0,2,acetyl-CoA catabolic process,BP,
12308,GO:0046359,1,0.995299683584611,0,1,butyrate catabolic process,BP,
12309,GO:0046360,1,0.994816518056245,0,1,2-oxobutyrate biosynthetic process,BP,
12310,GO:0046361,1,0.99068471876661,0,2,2-oxobutyrate metabolic process,BP,
12312,GO:0046365,1,0.698981950365351,0,59,monosaccharide catabolic process,BP,
12313,GO:0046368,1,0.988499889052417,0,2,GDP-L-fucose metabolic process,BP,
12314,GO:0046370,1,0.990051053660279,0,2,fructose biosynthetic process,BP,
12315,GO:0046373,1,0.986555151512788,0,2,L-arabinose metabolic process,BP,
12316,GO:0046379,1,0.981077987438951,0,3,extracellular polysaccharide metabolic process,BP,
12317,GO:0046380,1,0.992492141976319,0,1,N-acetylneuraminate biosynthetic process,BP,
12318,GO:0046381,1,0.996453316121395,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12319,GO:0046385,1,0.942165350778853,0,12,deoxyribose phosphate biosynthetic process,BP,
12320,GO:0046386,1,0.908999981929211,0,19,deoxyribose phosphate catabolic process,BP,
12321,GO:0046390,1,0.377796606972526,0,156,ribose phosphate biosynthetic process,BP,
12322,GO:0046391,1,0.971493644399892,0,5,5-phosphoribose 1-diphosphate metabolic process,BP,
12325,GO:0046398,1,0.971556153448561,0,4,UDP-glucuronate metabolic process,BP,
12326,GO:0046403,1,0.995727274618538,0,1,polynucleotide 3'-phosphatase activity,MF,
12327,GO:0046404,1,0.982635525765107,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12328,GO:0046415,1,0.953172133136525,0,8,urate metabolic process,BP,
12329,GO:0046416,1,0.985840446190295,0,3,D-amino acid metabolic process,BP,
12331,GO:0046426,1,0.883545077507951,0,19,negative regulation of receptor signaling pathway via JAK-STAT,BP,
12334,GO:0046436,1,0.995961406871488,0,1,D-alanine metabolic process,BP,
12335,GO:0046437,1,0.993883677960989,0,1,D-amino acid biosynthetic process,BP,
12336,GO:0046439,1,0.979037591010445,0,4,L-cysteine metabolic process,BP,
12337,GO:0046440,1,0.973604863573894,0,4,L-lysine metabolic process,BP,
12338,GO:0046443,1,0.995175350268869,0,1,FAD metabolic process,BP,
12339,GO:0046444,1,0.993376889315338,0,1,FMN metabolic process,BP,
12340,GO:0046448,1,0.993971958673624,0,1,tropane alkaloid metabolic process,BP,
12341,GO:0046449,1,0.991779987068906,0,1,creatinine metabolic process,BP,
12342,GO:0046452,1,0.987376793451599,0,2,dihydrofolate metabolic process,BP,
12343,GO:0046456,1,0.797293676344081,0,42,icosanoid biosynthetic process,BP,
12344,GO:0046457,1,0.875560266954359,0,25,prostanoid biosynthetic process,BP,
12345,GO:0046458,1,0.992495412096442,0,1,hexadecanal metabolic process,BP,
12346,GO:0046459,1,0.914704080480041,0,16,short-chain fatty acid metabolic process,BP,
12347,GO:0046460,1,0.780113121321858,0,37,neutral lipid biosynthetic process,BP,
12348,GO:0046461,1,0.799518166438148,0,37,neutral lipid catabolic process,BP,
12349,GO:0046462,1,0.946969255671073,0,9,monoacylglycerol metabolic process,BP,
12350,GO:0046463,1,0.780113121321858,0,37,acylglycerol biosynthetic process,BP,
12351,GO:0046464,1,0.799518166438148,0,37,acylglycerol catabolic process,BP,
12352,GO:0046465,1,0.958812184604399,0,7,dolichyl diphosphate metabolic process,BP,
12355,GO:0046469,1,0.95123995887529,0,8,platelet activating factor metabolic process,BP,
12357,GO:0046471,1,0.831431700690281,0,29,phosphatidylglycerol metabolic process,BP,
12362,GO:0046477,1,0.951556733956258,0,8,glycosylceramide catabolic process,BP,
12363,GO:0046478,1,0.992226599128609,0,1,lactosylceramide metabolic process,BP,
12364,GO:0046479,1,0.918036259624714,0,14,glycosphingolipid catabolic process,BP,
12366,GO:0046485,1,0.892247521893181,0,17,ether lipid metabolic process,BP,
12368,GO:0046487,1,0.959547122599235,0,8,glyoxylate metabolic process,BP,
12369,GO:0046488,1,0.316159161982501,0,165,phosphatidylinositol metabolic process,BP,
12370,GO:0046490,1,0.981779728889718,0,4,isopentenyl diphosphate metabolic process,BP,
12371,GO:0046491,1,0.996734553541504,0,1,L-methylmalonyl-CoA metabolic process,BP,
12372,GO:0046495,1,0.994046636166459,0,1,nicotinamide riboside metabolic process,BP,
12373,GO:0046496,1,0.830739667982721,0,31,nicotinamide nucleotide metabolic process,BP,
12374,GO:0046498,1,0.987675788557121,0,3,S-adenosylhomocysteine metabolic process,BP,
12375,GO:0046499,1,0.992661093381669,0,1,S-adenosylmethioninamine metabolic process,BP,
12376,GO:0046500,1,0.906093375563342,0,16,S-adenosylmethionine metabolic process,BP,
12377,GO:0046501,1,0.936316815165091,0,11,protoporphyrinogen IX metabolic process,BP,
12378,GO:0046502,1,0.991015790769685,0,2,uroporphyrinogen III metabolic process,BP,
12380,GO:0046504,1,0.934459575406971,0,10,glycerol ether biosynthetic process,BP,
12381,GO:0046511,1,0.986336409479546,0,2,sphinganine biosynthetic process,BP,
12382,GO:0046512,1,0.917969480648853,0,13,sphingosine biosynthetic process,BP,
12384,GO:0046514,1,0.890927216894047,0,19,ceramide catabolic process,BP,
12385,GO:0046519,1,0.897400969364444,0,17,sphingoid metabolic process,BP,
12386,GO:0046520,1,0.917969480648853,0,13,sphingoid biosynthetic process,BP,
12387,GO:0046521,1,0.995430413442757,0,1,sphingoid catabolic process,BP,
12388,GO:0046523,1,0.992787520802643,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12389,GO:0046525,1,0.995729273406413,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12390,GO:0046526,1,0.993766247491235,0,1,D-xylulose reductase activity,MF,
12391,GO:0046527,1,0.895721388631239,0,16,glucosyltransferase activity,MF,
12393,GO:0046532,1,0.946133767952145,0,8,regulation of photoreceptor cell differentiation,BP,
12394,GO:0046533,1,0.946133767952145,0,8,negative regulation of photoreceptor cell differentiation,BP,
12395,GO:0046538,1,0.996741560518907,0,1,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12396,GO:0046539,1,0.996715478354625,0,1,histamine N-methyltransferase activity,MF,
12397,GO:0046540,1,0.85998988822523,0,30,U4/U6 x U5 tri-snRNP complex,CC,
12398,GO:0046541,1,0.946308885312738,0,10,saliva secretion,BP,
12399,GO:0046543,1,0.960742049085179,0,6,development of secondary female sexual characteristics,BP,
12400,GO:0046544,1,0.992088747285053,0,1,development of secondary male sexual characteristics,BP,
12403,GO:0046548,1,0.93598265856987,0,9,retinal rod cell development,BP,
12404,GO:0046549,1,0.940307934875197,0,9,retinal cone cell development,BP,
12405,GO:0046552,1,0.994934185789107,0,1,photoreceptor cell fate commitment,BP,
12406,GO:0046554,1,0.996380236801434,0,1,malate dehydrogenase (NADP+) activity,MF,
12407,GO:0046556,1,0.986555151512788,0,2,alpha-L-arabinofuranosidase activity,MF,
12408,GO:0046570,1,0.996432299799149,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12409,GO:0046573,1,0.98811377284588,0,3,lactonohydrolase activity,MF,
12410,GO:0046577,1,0.992495412096442,0,1,long-chain-alcohol oxidase activity,MF,
12412,GO:0046579,1,0.642005379811675,0,65,positive regulation of Ras protein signal transduction,BP,
12414,GO:0046581,1,0.95590044147862,0,6,intercellular canaliculus,CC,
12415,GO:0046586,1,0.989628475731403,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12416,GO:0046587,1,0.992890982785859,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12417,GO:0046588,1,0.996714373104892,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12418,GO:0046592,1,0.985744764398134,0,3,polyamine oxidase activity,MF,
12419,GO:0046596,1,0.82858079639657,0,32,regulation of viral entry into host cell,BP,
12420,GO:0046597,1,0.918600329156952,0,15,negative regulation of viral entry into host cell,BP,
12421,GO:0046598,1,0.947316573217556,0,10,positive regulation of viral entry into host cell,BP,
12422,GO:0046599,1,0.8510311302956,0,22,regulation of centriole replication,BP,
12423,GO:0046600,1,0.937154000115345,0,9,negative regulation of centriole replication,BP,
12424,GO:0046601,1,0.956115810070306,0,6,positive regulation of centriole replication,BP,
12425,GO:0046602,1,0.943415235699703,0,9,regulation of mitotic centrosome separation,BP,
12426,GO:0046603,1,0.996217763793484,0,1,negative regulation of mitotic centrosome separation,BP,
12427,GO:0046604,1,0.981476268239045,0,3,positive regulation of mitotic centrosome separation,BP,
12428,GO:0046605,1,0.665929467285517,0,58,regulation of centrosome cycle,BP,
12429,GO:0046606,1,0.907939222527317,0,15,negative regulation of centrosome cycle,BP,
12430,GO:0046607,1,0.925241173193254,0,11,positive regulation of centrosome cycle,BP,
12431,GO:0046618,1,0.984398972653912,0,2,drug export,BP,
12432,GO:0046619,1,0.983993717357734,0,2,optic placode formation involved in camera-type eye formation,BP,
12435,GO:0046622,1,0.721748406988716,0,46,positive regulation of organ growth,BP,
12436,GO:0046623,1,0.972028022879791,0,3,sphingolipid floppase activity,MF,
12437,GO:0046624,1,0.927509950340573,0,11,sphingolipid transporter activity,MF,
12439,GO:0046626,1,0.668451048223954,0,59,regulation of insulin receptor signaling pathway,BP,
12440,GO:0046627,1,0.818352897992839,0,30,negative regulation of insulin receptor signaling pathway,BP,
12441,GO:0046628,1,0.863021061470461,0,20,positive regulation of insulin receptor signaling pathway,BP,
12442,GO:0046629,1,0.887926774873476,0,17,gamma-delta T cell activation,BP,
12443,GO:0046631,1,0.43105002947271,0,134,alpha-beta T cell activation,BP,
12444,GO:0046632,1,0.526667794181991,0,97,alpha-beta T cell differentiation,BP,
12445,GO:0046633,1,0.823976862718758,0,34,alpha-beta T cell proliferation,BP,
12446,GO:0046634,1,0.581965373944153,0,89,regulation of alpha-beta T cell activation,BP,
12447,GO:0046635,1,0.701855948426532,0,59,positive regulation of alpha-beta T cell activation,BP,
12448,GO:0046636,1,0.801963029057341,0,36,negative regulation of alpha-beta T cell activation,BP,
12449,GO:0046637,1,0.688442531316551,0,58,regulation of alpha-beta T cell differentiation,BP,
12450,GO:0046638,1,0.767138146177321,0,43,positive regulation of alpha-beta T cell differentiation,BP,
12451,GO:0046639,1,0.853310972197415,0,23,negative regulation of alpha-beta T cell differentiation,BP,
12452,GO:0046640,1,0.840950084750404,0,31,regulation of alpha-beta T cell proliferation,BP,
12453,GO:0046641,1,0.894622515787419,0,20,positive regulation of alpha-beta T cell proliferation,BP,
12454,GO:0046642,1,0.954289515095337,0,10,negative regulation of alpha-beta T cell proliferation,BP,
12455,GO:0046643,1,0.920030315787206,0,11,regulation of gamma-delta T cell activation,BP,
12456,GO:0046645,1,0.933497697038044,0,9,positive regulation of gamma-delta T cell activation,BP,
12459,GO:0046653,1,0.898931718185555,0,17,tetrahydrofolate metabolic process,BP,
12460,GO:0046654,1,0.960851380128458,0,6,tetrahydrofolate biosynthetic process,BP,
12461,GO:0046655,1,0.889016429472874,0,18,folic acid metabolic process,BP,
12462,GO:0046657,1,0.996727318235424,0,1,folic acid catabolic process,BP,
12466,GO:0046666,1,0.972832733384709,0,5,retinal cell programmed cell death,BP,
12467,GO:0046668,1,0.980454703714451,0,3,regulation of retinal cell programmed cell death,BP,
12468,GO:0046671,1,0.992486142521301,0,1,negative regulation of retinal cell programmed cell death,BP,
12469,GO:0046676,1,0.813716205576863,0,33,negative regulation of insulin secretion,BP,
12470,GO:0046677,1,0.75376491979144,0,45,response to antibiotic,BP,
12471,GO:0046680,1,0.994878076411831,0,1,response to DDT,BP,
12473,GO:0046684,1,0.979141482806107,0,4,response to pyrethroid,BP,
12474,GO:0046685,1,0.819998374283174,0,33,response to arsenic-containing substance,BP,
12476,GO:0046687,1,0.996586890788437,0,1,response to chromate,BP,
12477,GO:0046688,1,0.837802589082031,0,33,response to copper ion,BP,
12478,GO:0046689,1,0.949228700150616,0,9,response to mercury ion,BP,
12479,GO:0046690,1,0.992555184585628,0,1,response to tellurium ion,BP,
12480,GO:0046691,1,0.985386317428055,0,2,intracellular canaliculus,CC,
12481,GO:0046695,1,0.985202929641593,0,3,SLIK (SAGA-like) complex,CC,
12482,GO:0046696,1,0.979065077334536,0,4,lipopolysaccharide receptor complex,CC,
12485,GO:0046703,1,0.96130914382797,0,8,natural killer cell lectin-like receptor binding,MF,
12486,GO:0046704,1,0.993104745312481,0,1,CDP metabolic process,BP,
12487,GO:0046705,1,0.993104745312481,0,1,CDP biosynthetic process,BP,
12488,GO:0046707,1,0.987680666443132,0,2,IDP metabolic process,BP,
12489,GO:0046709,1,0.987680666443132,0,2,IDP catabolic process,BP,
12490,GO:0046710,1,0.936030712485942,0,9,GDP metabolic process,BP,
12491,GO:0046711,1,0.996663430352124,0,1,GDP biosynthetic process,BP,
12492,GO:0046713,1,0.992778481987959,0,1,borate transport,BP,
12493,GO:0046715,1,0.992778481987959,0,1,active borate transmembrane transporter activity,MF,
12495,GO:0046717,1,0.783203429081808,0,38,acid secretion,BP,
12497,GO:0046719,1,0.956174961667496,0,7,regulation by virus of viral protein levels in host cell,BP,
12498,GO:0046724,1,0.98946553675234,0,2,oxalic acid secretion,BP,
12499,GO:0046725,1,0.992530148409052,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12500,GO:0046726,1,0.970877364846627,0,4,positive regulation by virus of viral protein levels in host cell,BP,
12501,GO:0046745,1,0.99325505912211,0,1,viral capsid secondary envelopment,BP,
12502,GO:0046755,1,0.859455198602565,0,26,viral budding,BP,
12504,GO:0046778,1,0.988445957443334,0,2,modification by virus of host mRNA processing,BP,
12505,GO:0046782,1,0.681401691428084,0,61,regulation of viral transcription,BP,
12506,GO:0046784,1,0.956081328294705,0,8,viral mRNA export from host cell nucleus,BP,
12508,GO:0046786,1,0.992183642931096,0,1,viral replication complex formation and maintenance,BP,
12509,GO:0046789,1,0.992706799403571,0,1,host cell surface receptor binding,MF,
12510,GO:0046790,1,0.953134158370966,0,7,virion binding,MF,
12511,GO:0046794,1,0.670903358112814,0,59,transport of virus,BP,
12512,GO:0046811,1,0.988615586177009,0,2,histone deacetylase inhibitor activity,MF,
12513,GO:0046812,1,0.992706799403571,0,1,host cell surface binding,MF,
12514,GO:0046813,1,0.967231618790769,0,5,receptor-mediated virion attachment to host cell,BP,
12517,GO:0046824,1,0.634507666996548,0,65,positive regulation of nucleocytoplasmic transport,BP,
12518,GO:0046825,1,0.760374166613029,0,41,regulation of protein export from nucleus,BP,
12519,GO:0046826,1,0.969268598042581,0,6,negative regulation of protein export from nucleus,BP,
12520,GO:0046827,1,0.867518070396645,0,21,positive regulation of protein export from nucleus,BP,
12521,GO:0046831,1,0.883953054477009,0,16,regulation of RNA export from nucleus,BP,
12522,GO:0046832,1,0.981406960741199,0,2,negative regulation of RNA export from nucleus,BP,
12523,GO:0046833,1,0.943135982503865,0,8,positive regulation of RNA export from nucleus,BP,
12524,GO:0046834,1,0.63042750276667,0,63,lipid phosphorylation,BP,
12525,GO:0046835,1,0.865938583276379,0,22,carbohydrate phosphorylation,BP,
12526,GO:0046836,1,0.963042856615064,0,7,glycolipid transport,BP,
12527,GO:0046838,1,0.891573063277559,0,16,phosphorylated carbohydrate dephosphorylation,BP,
12528,GO:0046839,1,0.794891488950561,0,31,phospholipid dephosphorylation,BP,
12529,GO:0046847,1,0.660966896681746,0,56,filopodium assembly,BP,
12530,GO:0046848,1,0.996847924981452,0,1,hydroxyapatite binding,MF,
12535,GO:0046854,1,0.700708030307302,0,49,phosphatidylinositol phosphorylation,BP,
12536,GO:0046855,1,0.898048108234828,0,15,inositol phosphate dephosphorylation,BP,
12537,GO:0046856,1,0.808017216789676,0,28,phosphatidylinositol dephosphorylation,BP,
12538,GO:0046864,1,0.989841424624983,0,2,isoprenoid transport,BP,
12539,GO:0046865,1,0.989841424624983,0,2,terpenoid transport,BP,
12540,GO:0046870,1,0.974383694004977,0,4,cadmium ion binding,MF,
12543,GO:0046874,1,0.977364659018253,0,5,quinolinate metabolic process,BP,
12545,GO:0046877,1,0.968899544908724,0,6,regulation of saliva secretion,BP,
12546,GO:0046878,1,0.989858785284462,0,2,positive regulation of saliva secretion,BP,
12548,GO:0046880,1,0.95994982030058,0,6,regulation of follicle-stimulating hormone secretion,BP,
12549,GO:0046881,1,0.95994982030058,0,6,positive regulation of follicle-stimulating hormone secretion,BP,
12550,GO:0046882,1,0.983702942503978,0,3,negative regulation of follicle-stimulating hormone secretion,BP,
12552,GO:0046884,1,0.952510101365697,0,7,follicle-stimulating hormone secretion,BP,
12553,GO:0046885,1,0.879893287935485,0,18,regulation of hormone biosynthetic process,BP,
12554,GO:0046886,1,0.945482481273275,0,8,positive regulation of hormone biosynthetic process,BP,
12559,GO:0046898,1,0.972459982064733,0,4,response to cycloheximide,BP,
12560,GO:0046899,1,0.986808801976725,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12561,GO:0046900,1,0.990016977623315,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
12562,GO:0046901,1,0.993857025940025,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12567,GO:0046911,1,0.996514293846025,0,1,metal chelating activity,MF,
12568,GO:0046912,1,0.964180245853262,0,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12570,GO:0046915,1,0.801995424387983,0,34,transition metal ion transmembrane transporter activity,MF,
12572,GO:0046920,1,0.945066364613979,0,8,alpha-(1->3)-fucosyltransferase activity,MF,
12573,GO:0046921,1,0.992645072560129,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12574,GO:0046922,1,0.985472484680231,0,2,peptide-O-fucosyltransferase activity,MF,
12575,GO:0046923,1,0.973308380668261,0,5,ER retention sequence binding,MF,
12577,GO:0046929,1,0.928364290405182,0,10,negative regulation of neurotransmitter secretion,BP,
12578,GO:0046930,1,0.892715724485148,0,19,pore complex,CC,
12579,GO:0046931,1,0.88326050601435,0,19,pore complex assembly,BP,
12580,GO:0046933,1,0.996590505863498,0,1,proton-transporting ATP synthase activity, rotational mechanism,MF,
12581,GO:0046934,1,0.96512503381245,0,5,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,
12582,GO:0046935,1,0.914779528681855,0,13,1-phosphatidylinositol-3-kinase regulator activity,MF,
12584,GO:0046940,1,0.914823497712417,0,14,nucleoside monophosphate phosphorylation,BP,
12586,GO:0046943,1,0.396395081501934,0,137,carboxylic acid transmembrane transporter activity,MF,
12587,GO:0046946,1,0.985431222247799,0,2,hydroxylysine metabolic process,BP,
12588,GO:0046947,1,0.985431222247799,0,2,hydroxylysine biosynthetic process,BP,
12589,GO:0046949,1,0.828939764174403,0,29,fatty-acyl-CoA biosynthetic process,BP,
12590,GO:0046950,1,0.934049534743615,0,11,cellular ketone body metabolic process,BP,
12591,GO:0046951,1,0.945309447075223,0,9,ketone body biosynthetic process,BP,
12592,GO:0046952,1,0.975627345127144,0,4,ketone body catabolic process,BP,
12593,GO:0046958,1,0.955217063031875,0,6,nonassociative learning,BP,
12594,GO:0046959,1,0.967944099650715,0,4,habituation,BP,
12595,GO:0046960,1,0.986800107154123,0,2,sensitization,BP,
12596,GO:0046961,1,0.897517142862295,0,19,proton-transporting ATPase activity, rotational mechanism,MF,
12597,GO:0046963,1,0.989971820392049,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12598,GO:0046964,1,0.989971820392049,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12599,GO:0046965,1,0.877778748457964,0,18,retinoid X receptor binding,MF,
12600,GO:0046966,1,0.814800863885574,0,29,thyroid hormone receptor binding,MF,
12601,GO:0046967,1,0.968382153607191,0,4,cytosol to endoplasmic reticulum transport,BP,
12602,GO:0046968,1,0.98495077709224,0,2,peptide antigen transport,BP,
12603,GO:0046969,1,0.988413287390073,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12604,GO:0046970,1,0.995237360435577,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12605,GO:0046972,1,0.93432033791279,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
12606,GO:0046974,1,0.920046300805732,0,10,histone methyltransferase activity (H3-K9 specific),MF,
12607,GO:0046975,1,0.924008053979448,0,10,histone methyltransferase activity (H3-K36 specific),MF,
12608,GO:0046976,1,0.965897665441258,0,5,histone methyltransferase activity (H3-K27 specific),MF,
12609,GO:0046977,1,0.95592249914664,0,8,TAP binding,MF,
12610,GO:0046978,1,0.967341229255991,0,5,TAP1 binding,MF,
12611,GO:0046979,1,0.982014887575711,0,3,TAP2 binding,MF,
12612,GO:0046980,1,0.992465109004135,0,1,tapasin binding,MF,
12615,GO:0046984,1,0.97637483847506,0,4,regulation of hemoglobin biosynthetic process,BP,
12616,GO:0046985,1,0.983892834890112,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12617,GO:0046986,1,0.992360188809566,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12618,GO:0046997,1,0.985485625313975,0,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
12619,GO:0047006,1,0.992524195712151,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12620,GO:0047012,1,0.995963125742741,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12621,GO:0047015,1,0.996688504087539,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
12622,GO:0047016,1,0.994630336647563,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12623,GO:0047017,1,0.996467631790623,0,1,prostaglandin-F synthase activity,MF,
12624,GO:0047020,1,0.992930249093013,0,2,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12625,GO:0047021,1,0.996450206267593,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12626,GO:0047023,1,0.973286018210032,0,7,androsterone dehydrogenase activity,MF,
12627,GO:0047024,1,0.996090716293749,0,1,5alpha-androstane-3beta,17beta-diol dehydrogenase activity,MF,
12628,GO:0047025,1,0.989252447481284,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12629,GO:0047035,1,0.981102882721602,0,5,testosterone dehydrogenase (NAD+) activity,MF,
12630,GO:0047042,1,0.996289098226441,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12631,GO:0047044,1,0.987641775609854,0,3,androstan-3-alpha,17-beta-diol dehydrogenase activity,MF,
12632,GO:0047045,1,0.985458214951396,0,4,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
12633,GO:0047057,1,0.993252445474327,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12634,GO:0047058,1,0.996695129032028,0,1,vitamin-K-epoxide reductase (warfarin-insensitive) activity,MF,
12635,GO:0047066,1,0.993336020484874,0,2,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12636,GO:0047086,1,0.98546644934993,0,4,ketosteroid monooxygenase activity,MF,
12637,GO:0047092,1,0.994091867412586,0,1,27-hydroxycholesterol 7-alpha-monooxygenase activity,MF,
12638,GO:0047102,1,0.993928850253101,0,1,aminomuconate-semialdehyde dehydrogenase activity,MF,
12639,GO:0047105,1,0.993820945546778,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12640,GO:0047115,1,0.985564207417337,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12641,GO:0047117,1,0.990217175383171,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12642,GO:0047127,1,0.996299939335848,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12643,GO:0047130,1,0.9916563895918,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12644,GO:0047131,1,0.9916563895918,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12645,GO:0047134,1,0.978850372036851,0,4,protein-disulfide reductase activity,MF,
12646,GO:0047144,1,0.986535084325977,0,2,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
12647,GO:0047150,1,0.993830536486497,0,1,betaine-homocysteine S-methyltransferase activity,MF,
12648,GO:0047159,1,0.984469812411101,0,2,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12649,GO:0047166,1,0.995311557046695,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12650,GO:0047173,1,0.99219563124848,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12651,GO:0047179,1,0.989462536045791,0,3,platelet-activating factor acetyltransferase activity,MF,
12652,GO:0047184,1,0.969842375486778,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12653,GO:0047186,1,0.992481413553357,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
12654,GO:0047191,1,0.99247445228052,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12655,GO:0047192,1,0.979853445926676,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12656,GO:0047220,1,0.99322397839951,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12657,GO:0047223,1,0.993110364836213,0,1,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12658,GO:0047237,1,0.978218051360294,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12659,GO:0047238,1,0.956070571003103,0,6,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12660,GO:0047256,1,0.992450724934662,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12662,GO:0047273,1,0.992629859998205,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12663,GO:0047275,1,0.987264030497551,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12664,GO:0047276,1,0.99325505912211,0,1,N-acetyllactosaminide 3-alpha-galactosyltransferase activity,MF,
12665,GO:0047277,1,0.995232527497766,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12666,GO:0047280,1,0.992320624149615,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12667,GO:0047288,1,0.988085919529884,0,2,monosialoganglioside sialyltransferase activity,MF,
12668,GO:0047290,1,0.990493445768287,0,2,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12669,GO:0047291,1,0.994311382705325,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12670,GO:0047293,1,0.995890883982307,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12671,GO:0047298,1,0.992180852490147,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12672,GO:0047322,1,0.981931351130513,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12673,GO:0047323,1,0.994772730685266,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12674,GO:0047325,1,0.992666684062571,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12675,GO:0047326,1,0.995588137296728,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12676,GO:0047341,1,0.992577307963612,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12677,GO:0047369,1,0.99325505912211,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12678,GO:0047372,1,0.93447625040954,0,11,acylglycerol lipase activity,MF,
12679,GO:0047374,1,0.984123044455268,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12680,GO:0047381,1,0.995664163087036,0,1,dodecanoyl-[acyl-carrier-protein] hydrolase activity,MF,
12681,GO:0047389,1,0.984669541480723,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12682,GO:0047390,1,0.992476152744622,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12684,GO:0047394,1,0.994496553151589,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12685,GO:0047395,1,0.992985757593682,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12686,GO:0047408,1,0.988244889978308,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12687,GO:0047409,1,0.988244889978308,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12688,GO:0047412,1,0.9955719471602,0,1,N-(long-chain-acyl)ethanolamine deacylase activity,MF,
12689,GO:0047419,1,0.995497122476627,0,1,N-acetylgalactosamine-6-phosphate deacetylase activity,MF,
12690,GO:0047429,1,0.948960882182822,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12691,GO:0047444,1,0.996453316121395,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12692,GO:0047451,1,0.990217175383171,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12693,GO:0047464,1,0.992120800181255,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12695,GO:0047485,1,0.521216559199611,0,103,protein N-terminus binding,MF,
12696,GO:0047493,1,0.980250193763463,0,3,ceramide cholinephosphotransferase activity,MF,
12697,GO:0047496,1,0.717806191521218,0,45,vesicle transport along microtubule,BP,
12698,GO:0047497,1,0.85521561442815,0,22,mitochondrion transport along microtubule,BP,
12699,GO:0047498,1,0.945214082618542,0,9,calcium-dependent phospholipase A2 activity,MF,
12700,GO:0047499,1,0.953124340774997,0,8,calcium-independent phospholipase A2 activity,MF,
12701,GO:0047522,1,0.982129839563887,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
12702,GO:0047536,1,0.994532924588559,0,1,2-aminoadipate transaminase activity,MF,
12703,GO:0047545,1,0.991536675424652,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12704,GO:0047555,1,0.931776537735428,0,10,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12705,GO:0047560,1,0.992039739195357,0,1,3-dehydrosphinganine reductase activity,MF,
12706,GO:0047598,1,0.993481493912351,0,1,7-dehydrocholesterol reductase activity,MF,
12707,GO:0047603,1,0.996532655061261,0,1,acetoacetyl-CoA hydrolase activity,MF,
12708,GO:0047609,1,0.993412476660722,0,1,acetylputrescine deacetylase activity,MF,
12709,GO:0047611,1,0.993412476660722,0,1,acetylspermidine deacetylase activity,MF,
12710,GO:0047617,1,0.907204458357038,0,18,acyl-CoA hydrolase activity,MF,
12711,GO:0047620,1,0.992985757593682,0,1,acylglycerol kinase activity,MF,
12712,GO:0047621,1,0.995818748314625,0,1,acylpyruvate hydrolase activity,MF,
12713,GO:0047623,1,0.984953721008785,0,2,adenosine-phosphate deaminase activity,MF,
12714,GO:0047631,1,0.979290240547443,0,5,ADP-ribose diphosphatase activity,MF,
12715,GO:0047635,1,0.987882749442014,0,2,alanine-oxo-acid transaminase activity,MF,
12716,GO:0047655,1,0.984389042755396,0,4,allyl-alcohol dehydrogenase activity,MF,
12717,GO:0047658,1,0.995786241327855,0,1,alpha-amino-acid esterase activity,MF,
12718,GO:0047661,1,0.993883677960989,0,1,amino-acid racemase activity,MF,
12719,GO:0047676,1,0.925497626190628,0,11,arachidonate-CoA ligase activity,MF,
12720,GO:0047677,1,0.993806601762081,0,1,arachidonate 8(R)-lipoxygenase activity,MF,
12721,GO:0047685,1,0.996114576668281,0,1,amine sulfotransferase activity,MF,
12722,GO:0047693,1,0.996800221570978,0,1,ATP diphosphatase activity,MF,
12723,GO:0047696,1,0.986674272049351,0,2,beta-adrenergic receptor kinase activity,MF,
12724,GO:0047704,1,0.995137264487481,0,1,bile-salt sulfotransferase activity,MF,
12725,GO:0047708,1,0.991489445632139,0,2,biotinidase activity,MF,
12726,GO:0047710,1,0.988903452042763,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
12727,GO:0047718,1,0.988761720490513,0,3,indanol dehydrogenase activity,MF,
12728,GO:0047726,1,0.993813767208886,0,1,iron-cytochrome-c reductase activity,MF,
12730,GO:0047734,1,0.99325505912211,0,1,CDP-glycerol diphosphatase activity,MF,
12731,GO:0047743,1,0.996497229466253,0,1,chlordecone reductase activity,MF,
12732,GO:0047747,1,0.988489164676426,0,2,cholate-CoA ligase activity,MF,
12733,GO:0047749,1,0.994347515560857,0,1,cholestanetriol 26-monooxygenase activity,MF,
12734,GO:0047750,1,0.993219315976929,0,2,cholestenol delta-isomerase activity,MF,
12735,GO:0047751,1,0.987943447199859,0,2,cholestenone 5-alpha-reductase activity,MF,
12736,GO:0047756,1,0.982489468910814,0,3,chondroitin 4-sulfotransferase activity,MF,
12737,GO:0047757,1,0.98234664592366,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12738,GO:0047760,1,0.95806333198715,0,7,butyrate-CoA ligase activity,MF,
12739,GO:0047777,1,0.991722215232139,0,1,(S)-citramalyl-CoA lyase activity,MF,
12740,GO:0047780,1,0.985867315444046,0,2,citrate dehydratase activity,MF,
12741,GO:0047787,1,0.996467631790623,0,1,delta4-3-oxosteroid 5beta-reductase activity,MF,
12742,GO:0047800,1,0.992502035130105,0,1,cysteamine dioxygenase activity,MF,
12743,GO:0047801,1,0.994777889074627,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12744,GO:0047837,1,0.996596070566681,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
12745,GO:0047840,1,0.99656920672688,0,1,dCTP diphosphatase activity,MF,
12746,GO:0047844,1,0.961969110530654,0,8,deoxycytidine deaminase activity,MF,
12747,GO:0047860,1,0.996419366827364,0,1,diiodophenylpyruvate reductase activity,MF,
12748,GO:0047865,1,0.992800706824123,0,1,dimethylglycine dehydrogenase activity,MF,
12749,GO:0047874,1,0.994821660195476,0,1,dolichyldiphosphatase activity,MF,
12750,GO:0047886,1,0.995910623791134,0,1,farnesol dehydrogenase activity,MF,
12751,GO:0047888,1,0.995230109019562,0,1,fatty acid peroxidase activity,MF,
12752,GO:0047894,1,0.988597675593146,0,3,flavonol 3-sulfotransferase activity,MF,
12753,GO:0047915,1,0.99581495773931,0,1,ganglioside galactosyltransferase activity,MF,
12754,GO:0047933,1,0.990209186569315,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12755,GO:0047936,1,0.989890759836311,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12756,GO:0047939,1,0.996162311800852,0,1,L-glucuronate reductase activity,MF,
12757,GO:0047941,1,0.996162311800852,0,1,glucuronolactone reductase activity,MF,
12758,GO:0047946,1,0.994931642765082,0,1,glutamine N-acyltransferase activity,MF,
12760,GO:0047961,1,0.991245718668893,0,2,glycine N-acyltransferase activity,MF,
12761,GO:0047963,1,0.992577105170387,0,1,glycine N-choloyltransferase activity,MF,
12762,GO:0047975,1,0.99325505912211,0,1,guanosine phosphorylase activity,MF,
12763,GO:0047977,1,0.987623487339275,0,2,hepoxilin-epoxide hydrolase activity,MF,
12764,GO:0047988,1,0.995344601049742,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
12765,GO:0047992,1,0.99325505912211,0,1,hydroxylysine kinase activity,MF,
12766,GO:0047994,1,0.996532655061261,0,1,hydroxymethylglutaryl-CoA hydrolase activity,MF,
12767,GO:0048002,1,0.362564285784731,0,180,antigen processing and presentation of peptide antigen,BP,
12768,GO:0048003,1,0.961619312278506,0,6,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12769,GO:0048006,1,0.976516646160687,0,4,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12770,GO:0048007,1,0.961619312278506,0,6,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12772,GO:0048009,1,0.805345329535014,0,30,insulin-like growth factor receptor signaling pathway,BP,
12773,GO:0048010,1,0.553117780222946,0,89,vascular endothelial growth factor receptor signaling pathway,BP,
12775,GO:0048012,1,0.903712441275797,0,16,hepatocyte growth factor receptor signaling pathway,BP,
12777,GO:0048014,1,0.965353115789218,0,4,Tie signaling pathway,BP,
12782,GO:0048019,1,0.917290967971429,0,15,receptor antagonist activity,MF,
12783,GO:0048020,1,0.901435199130585,0,24,CCR chemokine receptor binding,MF,
12784,GO:0048021,1,0.927604192881542,0,10,regulation of melanin biosynthetic process,BP,
12785,GO:0048022,1,0.97624872590416,0,3,negative regulation of melanin biosynthetic process,BP,
12786,GO:0048023,1,0.960165023903484,0,6,positive regulation of melanin biosynthetic process,BP,
12787,GO:0048024,1,0.500223903957784,0,105,regulation of mRNA splicing, via spliceosome,BP,
12788,GO:0048025,1,0.869852869611772,0,22,negative regulation of mRNA splicing, via spliceosome,BP,
12789,GO:0048026,1,0.883215357698994,0,21,positive regulation of mRNA splicing, via spliceosome,BP,
12790,GO:0048027,1,0.853303236891012,0,26,mRNA 5'-UTR binding,MF,
12791,GO:0048029,1,0.672370528158026,0,64,monosaccharide binding,MF,
12792,GO:0048030,1,0.98842251971096,0,3,disaccharide binding,MF,
12793,GO:0048033,1,0.992902975056294,0,1,heme o metabolic process,BP,
12794,GO:0048034,1,0.992902975056294,0,1,heme O biosynthetic process,BP,
12795,GO:0048038,1,0.931894613311089,0,15,quinone binding,MF,
12796,GO:0048039,1,0.973530653208038,0,6,ubiquinone binding,MF,
12797,GO:0048040,1,0.994872959551596,0,1,UDP-glucuronate decarboxylase activity,MF,
12799,GO:0048048,1,0.751803538351364,0,37,embryonic eye morphogenesis,BP,
12800,GO:0048050,1,0.96668531686578,0,6,post-embryonic eye morphogenesis,BP,
12802,GO:0048069,1,0.963821894131149,0,6,eye pigmentation,BP,
12803,GO:0048070,1,0.900099975482062,0,15,regulation of developmental pigmentation,BP,
12804,GO:0048073,1,0.979870387469561,0,3,regulation of eye pigmentation,BP,
12805,GO:0048074,1,0.994934185789107,0,1,negative regulation of eye pigmentation,BP,
12806,GO:0048075,1,0.99240787545144,0,1,positive regulation of eye pigmentation,BP,
12807,GO:0048086,1,0.994934185789107,0,1,negative regulation of developmental pigmentation,BP,
12808,GO:0048087,1,0.934481374619453,0,9,positive regulation of developmental pigmentation,BP,
12809,GO:0048096,1,0.912600721045409,0,13,chromatin-mediated maintenance of transcription,BP,
12810,GO:0048101,1,0.9806766188943,0,3,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
12811,GO:0048102,1,0.935494760041784,0,11,autophagic cell death,BP,
12813,GO:0048104,1,0.965898506860729,0,4,establishment of body hair or bristle planar orientation,BP,
12814,GO:0048105,1,0.965898506860729,0,4,establishment of body hair planar orientation,BP,
12815,GO:0048133,1,0.983378489855023,0,3,male germ-line stem cell asymmetric division,BP,
12820,GO:0048147,1,0.850843271086185,0,27,negative regulation of fibroblast proliferation,BP,
12821,GO:0048148,1,0.932234119668322,0,12,behavioral response to cocaine,BP,
12822,GO:0048149,1,0.942860567299876,0,9,behavioral response to ethanol,BP,
12823,GO:0048156,1,0.738111963535491,0,44,tau protein binding,MF,
12824,GO:0048160,1,0.992304470900223,0,1,primary follicle stage,BP,
12825,GO:0048162,1,0.985289898859487,0,3,multi-layer follicle stage,BP,
12826,GO:0048165,1,0.979551038898181,0,3,fused antrum stage,BP,
12829,GO:0048169,1,0.836729434158568,0,25,regulation of long-term neuronal synaptic plasticity,BP,
12830,GO:0048170,1,0.963380923551317,0,5,positive regulation of long-term neuronal synaptic plasticity,BP,
12831,GO:0048172,1,0.889390499046351,0,16,regulation of short-term neuronal synaptic plasticity,BP,
12832,GO:0048174,1,0.992455237799069,0,1,negative regulation of short-term neuronal synaptic plasticity,BP,
12833,GO:0048175,1,0.992706799403571,0,1,hepatocyte growth factor biosynthetic process,BP,
12834,GO:0048176,1,0.992706799403571,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
12835,GO:0048178,1,0.992706799403571,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
12836,GO:0048179,1,0.951786846879232,0,6,activin receptor complex,CC,
12837,GO:0048180,1,0.994671846409404,0,1,activin complex,CC,
12838,GO:0048185,1,0.905176098432434,0,14,activin binding,MF,
12839,GO:0048188,1,0.923561517892273,0,11,Set1C/COMPASS complex,CC,
12841,GO:0048194,1,0.58854255176573,0,79,Golgi vesicle budding,BP,
12842,GO:0048199,1,0.625244575420811,0,72,vesicle targeting, to, from or within Golgi,BP,
12843,GO:0048200,1,0.961985213907283,0,6,Golgi transport vesicle coating,BP,
12844,GO:0048203,1,0.988404886501096,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12845,GO:0048205,1,0.961985213907283,0,6,COPI coating of Golgi vesicle,BP,
12846,GO:0048207,1,0.659031959765593,0,64,vesicle targeting, rough ER to cis-Golgi,BP,
12847,GO:0048208,1,0.659031959765593,0,64,COPII vesicle coating,BP,
12848,GO:0048209,1,0.966638195268194,0,5,regulation of vesicle targeting, to, from or within Golgi,BP,
12849,GO:0048210,1,0.979115761115039,0,4,Golgi vesicle fusion to target membrane,BP,
12850,GO:0048211,1,0.985751652458301,0,2,Golgi vesicle docking,BP,
12851,GO:0048213,1,0.988835693332594,0,2,Golgi vesicle prefusion complex stabilization,BP,
12852,GO:0048219,1,0.992190579975177,0,1,inter-Golgi cisterna vesicle-mediated transport,BP,
12853,GO:0048227,1,0.949695175385965,0,8,plasma membrane to endosome transport,BP,
12855,GO:0048237,1,0.986750667459887,0,3,rough endoplasmic reticulum lumen,CC,
12856,GO:0048239,1,0.987893361525938,0,2,negative regulation of DNA recombination at telomere,BP,
12857,GO:0048240,1,0.90745160774484,0,17,sperm capacitation,BP,
12858,GO:0048241,1,0.957911591451336,0,8,epinephrine transport,BP,
12859,GO:0048242,1,0.977033453262904,0,5,epinephrine secretion,BP,
12860,GO:0048243,1,0.924165771899665,0,13,norepinephrine secretion,BP,
12861,GO:0048244,1,0.995846892329136,0,1,phytanoyl-CoA dioxygenase activity,MF,
12862,GO:0048245,1,0.950198093018634,0,11,eosinophil chemotaxis,BP,
12863,GO:0048246,1,0.819831148094767,0,35,macrophage chemotaxis,BP,
12864,GO:0048247,1,0.779716159801465,0,48,lymphocyte chemotaxis,BP,
12865,GO:0048248,1,0.97991267744785,0,5,CXCR3 chemokine receptor binding,MF,
12866,GO:0048250,1,0.991495058463061,0,2,iron import into the mitochondrion,BP,
12867,GO:0048251,1,0.927756636940232,0,10,elastic fiber assembly,BP,
12868,GO:0048254,1,0.979796729445449,0,4,snoRNA localization,BP,
12869,GO:0048255,1,0.768520793732625,0,38,mRNA stabilization,BP,
12870,GO:0048256,1,0.939720920355003,0,9,flap endonuclease activity,MF,
12871,GO:0048257,1,0.987353893654612,0,2,3'-flap endonuclease activity,MF,
12874,GO:0048261,1,0.86761854307001,0,23,negative regulation of receptor-mediated endocytosis,BP,
12877,GO:0048264,1,0.992892170859916,0,1,determination of ventral identity,BP,
12878,GO:0048265,1,0.833673912503413,0,28,response to pain,BP,
12879,GO:0048266,1,0.917793537418538,0,13,behavioral response to pain,BP,
12880,GO:0048268,1,0.89422236651962,0,16,clathrin coat assembly,BP,
12881,GO:0048269,1,0.988089266260539,0,2,methionine adenosyltransferase complex,CC,
12882,GO:0048270,1,0.994892134582798,0,1,methionine adenosyltransferase regulator activity,MF,
12883,GO:0048273,1,0.969477156401135,0,5,mitogen-activated protein kinase p38 binding,MF,
12885,GO:0048280,1,0.964705467906637,0,6,vesicle fusion with Golgi apparatus,BP,
12886,GO:0048284,1,0.449942560051955,0,126,organelle fusion,BP,
12889,GO:0048289,1,0.960568071839447,0,6,isotype switching to IgE isotypes,BP,
12890,GO:0048290,1,0.963706621843186,0,6,isotype switching to IgA isotypes,BP,
12891,GO:0048291,1,0.921518190983339,0,12,isotype switching to IgG isotypes,BP,
12892,GO:0048293,1,0.960568071839447,0,6,regulation of isotype switching to IgE isotypes,BP,
12893,GO:0048294,1,0.979451234340316,0,3,negative regulation of isotype switching to IgE isotypes,BP,
12894,GO:0048295,1,0.980724714856962,0,3,positive regulation of isotype switching to IgE isotypes,BP,
12895,GO:0048296,1,0.970878765896144,0,5,regulation of isotype switching to IgA isotypes,BP,
12896,GO:0048297,1,0.994767570572313,0,1,negative regulation of isotype switching to IgA isotypes,BP,
12897,GO:0048298,1,0.975986812541344,0,4,positive regulation of isotype switching to IgA isotypes,BP,
12898,GO:0048302,1,0.926808870496458,0,11,regulation of isotype switching to IgG isotypes,BP,
12899,GO:0048304,1,0.946149863194279,0,8,positive regulation of isotype switching to IgG isotypes,BP,
12900,GO:0048305,1,0.906074632953159,0,19,immunoglobulin secretion,BP,
12902,GO:0048308,1,0.913516036006506,0,15,organelle inheritance,BP,
12903,GO:0048311,1,0.884452764513081,0,16,mitochondrion distribution,BP,
12904,GO:0048312,1,0.940643120617792,0,8,intracellular distribution of mitochondria,BP,
12905,GO:0048313,1,0.913516036006506,0,15,Golgi inheritance,BP,
12906,GO:0048318,1,0.959502988353188,0,7,axial mesoderm development,BP,
12907,GO:0048319,1,0.978792828635701,0,3,axial mesoderm morphogenesis,BP,
12908,GO:0048320,1,0.987407865444112,0,2,axial mesoderm formation,BP,
12909,GO:0048321,1,0.994895965192756,0,1,axial mesodermal cell differentiation,BP,
12910,GO:0048322,1,0.994895965192756,0,1,axial mesodermal cell fate commitment,BP,
12911,GO:0048327,1,0.994895965192756,0,1,axial mesodermal cell fate specification,BP,
12914,GO:0048338,1,0.992518692750008,0,1,mesoderm structural organization,BP,
12915,GO:0048339,1,0.887153611014934,0,17,paraxial mesoderm development,BP,
12916,GO:0048340,1,0.936170052564572,0,9,paraxial mesoderm morphogenesis,BP,
12917,GO:0048341,1,0.961567029448088,0,6,paraxial mesoderm formation,BP,
12918,GO:0048342,1,0.99582818551698,0,1,paraxial mesodermal cell differentiation,BP,
12919,GO:0048343,1,0.99582818551698,0,1,paraxial mesodermal cell fate commitment,BP,
12920,GO:0048352,1,0.992518692750008,0,1,paraxial mesoderm structural organization,BP,
12921,GO:0048365,1,0.618472170433322,0,65,Rac GTPase binding,MF,
12922,GO:0048368,1,0.915699261650404,0,15,lateral mesoderm development,BP,
12923,GO:0048369,1,0.974223629034618,0,4,lateral mesoderm morphogenesis,BP,
12924,GO:0048370,1,0.974223629034618,0,4,lateral mesoderm formation,BP,
12925,GO:0048371,1,0.978172436896724,0,3,lateral mesodermal cell differentiation,BP,
12926,GO:0048372,1,0.984376535666763,0,2,lateral mesodermal cell fate commitment,BP,
12927,GO:0048377,1,0.984376535666763,0,2,lateral mesodermal cell fate specification,BP,
12928,GO:0048378,1,0.984376535666763,0,2,regulation of lateral mesodermal cell fate specification,BP,
12929,GO:0048382,1,0.95602875859658,0,7,mesendoderm development,BP,
12930,GO:0048384,1,0.822906038281966,0,32,retinoic acid receptor signaling pathway,BP,
12931,GO:0048385,1,0.906380482175056,0,17,regulation of retinoic acid receptor signaling pathway,BP,
12932,GO:0048386,1,0.969128526802929,0,5,positive regulation of retinoic acid receptor signaling pathway,BP,
12933,GO:0048387,1,0.946668521600745,0,9,negative regulation of retinoic acid receptor signaling pathway,BP,
12934,GO:0048388,1,0.984206306572028,0,3,endosomal lumen acidification,BP,
12935,GO:0048389,1,0.991002126217525,0,2,intermediate mesoderm development,BP,
12936,GO:0048390,1,0.995611667834955,0,1,intermediate mesoderm morphogenesis,BP,
12937,GO:0048391,1,0.995611667834955,0,1,intermediate mesoderm formation,BP,
12938,GO:0048392,1,0.995611667834955,0,1,intermediate mesodermal cell differentiation,BP,
12939,GO:0048403,1,0.975581553550108,0,3,brain-derived neurotrophic factor binding,MF,
12946,GO:0048475,1,0.553344415300369,0,89,coated membrane,CC,
12947,GO:0048476,1,0.974844353607737,0,5,Holliday junction resolvase complex,CC,
12948,GO:0048477,1,0.625142519447796,0,73,oogenesis,BP,
12949,GO:0048478,1,0.946546678678331,0,8,replication fork protection,BP,
12952,GO:0048485,1,0.866871670001027,0,20,sympathetic nervous system development,BP,
12953,GO:0048486,1,0.899967653725883,0,16,parasympathetic nervous system development,BP,
12955,GO:0048488,1,0.644659781454746,0,61,synaptic vesicle endocytosis,BP,
12956,GO:0048489,1,0.753447976386917,0,42,synaptic vesicle transport,BP,
12957,GO:0048490,1,0.894392136554506,0,18,anterograde synaptic vesicle transport,BP,
12958,GO:0048495,1,0.947109463604385,0,7,Roundabout binding,MF,
12959,GO:0048496,1,0.966937341445537,0,4,maintenance of animal organ identity,BP,
12960,GO:0048499,1,0.97852589691679,0,4,synaptic vesicle membrane organization,BP,
12961,GO:0048500,1,0.953163454318963,0,9,signal recognition particle,CC,
12962,GO:0048505,1,0.923957168447492,0,12,regulation of timing of cell differentiation,BP,
12964,GO:0048512,1,0.751073100972598,0,45,circadian behavior,BP,
12967,GO:0048515,1,0.486093908632203,0,113,spermatid differentiation,BP,
12971,GO:0048521,1,0.930591898263117,0,14,negative regulation of behavior,BP,
12974,GO:0048524,1,0.517574631689068,0,104,positive regulation of viral process,BP,
12975,GO:0048525,1,0.586778496108239,0,85,negative regulation of viral process,BP,
12976,GO:0048531,1,0.946795321181257,0,9,beta-1,3-galactosyltransferase activity,MF,
12977,GO:0048532,1,0.890881788331591,0,16,anatomical structure arrangement,BP,
12979,GO:0048535,1,0.90929989405774,0,16,lymph node development,BP,
12980,GO:0048536,1,0.812768295965859,0,32,spleen development,BP,
12981,GO:0048537,1,0.958167372117958,0,7,mucosa-associated lymphoid tissue development,BP,
12982,GO:0048538,1,0.737790014709815,0,44,thymus development,BP,
12983,GO:0048539,1,0.943968764732695,0,9,bone marrow development,BP,
12984,GO:0048541,1,0.958167372117958,0,7,Peyer's patch development,BP,
12987,GO:0048548,1,0.917825535742084,0,13,regulation of pinocytosis,BP,
12988,GO:0048549,1,0.946623290906041,0,8,positive regulation of pinocytosis,BP,
12989,GO:0048550,1,0.969595204718533,0,5,negative regulation of pinocytosis,BP,
12991,GO:0048560,1,0.989216853064765,0,2,establishment of anatomical structure orientation,BP,
12992,GO:0048561,1,0.994542018802344,0,1,establishment of animal organ orientation,BP,
12994,GO:0048563,1,0.950313828013302,0,8,post-embryonic animal organ morphogenesis,BP,
12997,GO:0048567,1,0.993698442190156,0,1,ectodermal digestive tract morphogenesis,BP,
12999,GO:0048569,1,0.901245453937203,0,15,post-embryonic animal organ development,BP,
13000,GO:0048570,1,0.939761895381022,0,9,notochord morphogenesis,BP,
13006,GO:0048592,1,0.349695116052442,0,144,eye morphogenesis,BP,
13007,GO:0048593,1,0.430451430320314,0,116,camera-type eye morphogenesis,BP,
13008,GO:0048596,1,0.80159318559501,0,28,embryonic camera-type eye morphogenesis,BP,
13009,GO:0048597,1,0.987814278430439,0,3,post-embryonic camera-type eye morphogenesis,BP,
13011,GO:0048599,1,0.773147613035013,0,39,oocyte development,BP,
13014,GO:0048611,1,0.986689369563154,0,2,embryonic ectodermal digestive tract development,BP,
13015,GO:0048613,1,0.993698442190156,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13016,GO:0048617,1,0.932052706617333,0,9,embryonic foregut morphogenesis,BP,
13017,GO:0048619,1,0.98002782140999,0,3,embryonic hindgut morphogenesis,BP,
13018,GO:0048625,1,0.968772954063202,0,5,myoblast fate commitment,BP,
13019,GO:0048627,1,0.97972212124717,0,3,myoblast development,BP,
13020,GO:0048630,1,0.960906275197146,0,6,skeletal muscle tissue growth,BP,
13021,GO:0048631,1,0.969872404036221,0,4,regulation of skeletal muscle tissue growth,BP,
13022,GO:0048632,1,0.984389522447989,0,2,negative regulation of skeletal muscle tissue growth,BP,
13023,GO:0048633,1,0.985255016346831,0,2,positive regulation of skeletal muscle tissue growth,BP,
13030,GO:0048641,1,0.746888058493941,0,42,regulation of skeletal muscle tissue development,BP,
13031,GO:0048642,1,0.927775399661476,0,11,negative regulation of skeletal muscle tissue development,BP,
13032,GO:0048643,1,0.879923230776131,0,19,positive regulation of skeletal muscle tissue development,BP,
13041,GO:0048664,1,0.967457468386524,0,6,neuron fate determination,BP,
13045,GO:0048668,1,0.832208263065386,0,25,collateral sprouting,BP,
13046,GO:0048669,1,0.980785228031605,0,3,collateral sprouting in absence of injury,BP,
13047,GO:0048670,1,0.881444277973061,0,18,regulation of collateral sprouting,BP,
13048,GO:0048671,1,0.941198856298825,0,8,negative regulation of collateral sprouting,BP,
13049,GO:0048672,1,0.936550236039802,0,10,positive regulation of collateral sprouting,BP,
13050,GO:0048673,1,0.995992020575815,0,1,collateral sprouting of intact axon in response to injury,BP,
13051,GO:0048674,1,0.987065584560306,0,1,collateral sprouting of injured axon,BP,
13053,GO:0048677,1,0.955793575101819,0,5,axon extension involved in regeneration,BP,
13055,GO:0048679,1,0.838015869201669,0,25,regulation of axon regeneration,BP,
13056,GO:0048680,1,0.950322039564709,0,8,positive regulation of axon regeneration,BP,
13057,GO:0048681,1,0.909280709615693,0,13,negative regulation of axon regeneration,BP,
13058,GO:0048682,1,0.955793575101819,0,5,sprouting of injured axon,BP,
13059,GO:0048683,1,0.995992020575815,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,
13060,GO:0048685,1,0.995992020575815,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,
13061,GO:0048686,1,0.963808439818347,0,4,regulation of sprouting of injured axon,BP,
13062,GO:0048687,1,0.980230638312201,0,2,positive regulation of sprouting of injured axon,BP,
13063,GO:0048688,1,0.98324997565712,0,2,negative regulation of sprouting of injured axon,BP,
13064,GO:0048690,1,0.963808439818347,0,4,regulation of axon extension involved in regeneration,BP,
13065,GO:0048691,1,0.980230638312201,0,2,positive regulation of axon extension involved in regeneration,BP,
13066,GO:0048692,1,0.98324997565712,0,2,negative regulation of axon extension involved in regeneration,BP,
13067,GO:0048693,1,0.987065584560306,0,1,regulation of collateral sprouting of injured axon,BP,
13068,GO:0048694,1,0.987065584560306,0,1,positive regulation of collateral sprouting of injured axon,BP,
13069,GO:0048696,1,0.996130464954528,0,1,regulation of collateral sprouting in absence of injury,BP,
13070,GO:0048697,1,0.996130464954528,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13073,GO:0048702,1,0.93581946399179,0,9,embryonic neurocranium morphogenesis,BP,
13074,GO:0048703,1,0.930354454502812,0,10,embryonic viscerocranium morphogenesis,BP,
13082,GO:0048712,1,0.928010014273097,0,11,negative regulation of astrocyte differentiation,BP,
13084,GO:0048714,1,0.876450420836265,0,22,positive regulation of oligodendrocyte differentiation,BP,
13085,GO:0048715,1,0.922862740488654,0,13,negative regulation of oligodendrocyte differentiation,BP,
13094,GO:0048741,1,0.840339045711955,0,26,skeletal muscle fiber development,BP,
13095,GO:0048742,1,0.946870285787266,0,8,regulation of skeletal muscle fiber development,BP,
13096,GO:0048743,1,0.969331885333659,0,5,positive regulation of skeletal muscle fiber development,BP,
13097,GO:0048745,1,0.849963560881193,0,22,smooth muscle tissue development,BP,
13099,GO:0048752,1,0.953062295844833,0,7,semicircular canal morphogenesis,BP,
13100,GO:0048753,1,0.834414224591497,0,28,pigment granule organization,BP,
13102,GO:0048755,1,0.926045587217047,0,10,branching morphogenesis of a nerve,BP,
13103,GO:0048757,1,0.940934878515135,0,10,pigment granule maturation,BP,
13105,GO:0048763,1,0.952967485102739,0,4,calcium-induced calcium release activity,MF,
13106,GO:0048769,1,0.964631841731346,0,3,sarcomerogenesis,BP,
13109,GO:0048786,1,0.578985246937886,0,74,presynaptic active zone,CC,
13110,GO:0048787,1,0.80582814824172,0,30,presynaptic active zone membrane,CC,
13111,GO:0048788,1,0.94803879481897,0,5,cytoskeleton of presynaptic active zone,CC,
13112,GO:0048789,1,0.992179920376533,0,1,cytoskeletal matrix organization at active zone,BP,
13113,GO:0048790,1,0.953191742787961,0,5,maintenance of presynaptic active zone structure,BP,
13114,GO:0048791,1,0.841267535937328,0,23,calcium ion-regulated exocytosis of neurotransmitter,BP,
13115,GO:0048792,1,0.992573706915642,0,1,spontaneous exocytosis of neurotransmitter,BP,
13116,GO:0048793,1,0.955965140352599,0,6,pronephros development,BP,
13119,GO:0048807,1,0.98588828856674,0,3,female genitalia morphogenesis,BP,
13120,GO:0048808,1,0.976832678993152,0,4,male genitalia morphogenesis,BP,
13124,GO:0048817,1,0.984535327400088,0,2,negative regulation of hair follicle maturation,BP,
13125,GO:0048818,1,0.969862016422665,0,5,positive regulation of hair follicle maturation,BP,
13126,GO:0048819,1,0.940665132357094,0,9,regulation of hair follicle maturation,BP,
13127,GO:0048820,1,0.887883652405007,0,16,hair follicle maturation,BP,
13128,GO:0048821,1,0.810220247014512,0,32,erythrocyte development,BP,
13129,GO:0048822,1,0.977405311446028,0,3,enucleate erythrocyte development,BP,
13131,GO:0048840,1,0.958788284620336,0,6,otolith development,BP,
13132,GO:0048841,1,0.781568136104325,0,31,regulation of axon extension involved in axon guidance,BP,
13133,GO:0048842,1,0.940060029798403,0,7,positive regulation of axon extension involved in axon guidance,BP,
13134,GO:0048843,1,0.823005520438197,0,25,negative regulation of axon extension involved in axon guidance,BP,
13136,GO:0048845,1,0.935004718341031,0,9,venous blood vessel morphogenesis,BP,
13137,GO:0048846,1,0.749794932765596,0,36,axon extension involved in axon guidance,BP,
13138,GO:0048850,1,0.991685564322805,0,1,hypophysis morphogenesis,BP,
13139,GO:0048852,1,0.986416685942286,0,2,diencephalon morphogenesis,BP,
13140,GO:0048853,1,0.936085422677051,0,10,forebrain morphogenesis,BP,
13141,GO:0048854,1,0.780629518751137,0,33,brain morphogenesis,BP,
13145,GO:0048859,1,0.974354974648441,0,5,formation of anatomical boundary,BP,
13146,GO:0048861,1,0.945201747688977,0,7,leukemia inhibitory factor signaling pathway,BP,
13149,GO:0048865,1,0.957113189480814,0,8,stem cell fate commitment,BP,
13150,GO:0048866,1,0.979142510045049,0,4,stem cell fate specification,BP,
13151,GO:0048867,1,0.985030714187938,0,3,stem cell fate determination,BP,
13155,GO:0048872,1,0.210673700731123,0,240,homeostasis of number of cells,BP,
13156,GO:0048873,1,0.842157269025733,0,27,homeostasis of number of cells within a tissue,BP,
13157,GO:0048874,1,0.992033963528895,0,1,host-mediated regulation of intestinal microbiota composition,BP,
13158,GO:0048875,1,0.940915837771611,0,10,chemical homeostasis within a tissue,BP,
13161,GO:0048881,1,0.992390662544981,0,1,mechanosensory lateral line system development,BP,
13162,GO:0048882,1,0.985939283148784,0,2,lateral line development,BP,
13163,GO:0048884,1,0.985939283148784,0,2,neuromast development,BP,
13164,GO:0048886,1,0.985939283148784,0,2,neuromast hair cell differentiation,BP,
13165,GO:0048915,1,0.992390662544981,0,1,posterior lateral line system development,BP,
13166,GO:0048916,1,0.992390662544981,0,1,posterior lateral line development,BP,
13167,GO:0048919,1,0.992390662544981,0,1,posterior lateral line neuromast development,BP,
13168,GO:0048923,1,0.992390662544981,0,1,posterior lateral line neuromast hair cell differentiation,BP,
13169,GO:0048925,1,0.985939283148784,0,2,lateral line system development,BP,
13170,GO:0048934,1,0.910193859447397,0,13,peripheral nervous system neuron differentiation,BP,
13171,GO:0048935,1,0.910193859447397,0,13,peripheral nervous system neuron development,BP,
13172,GO:0048936,1,0.980264119611916,0,3,peripheral nervous system neuron axonogenesis,BP,
13173,GO:0050000,1,0.624622738212554,0,72,chromosome localization,BP,
13174,GO:0050011,1,0.995978499549289,0,1,itaconyl-CoA hydratase activity,MF,
13175,GO:0050023,1,0.995437269298472,0,1,L-fuconate dehydratase activity,MF,
13176,GO:0050031,1,0.994044132206603,0,1,L-pipecolate oxidase activity,MF,
13177,GO:0050038,1,0.996752585941193,0,1,L-xylulose reductase (NADP+) activity,MF,
13178,GO:0050051,1,0.981449613055694,0,3,leukotriene-B4 20-monooxygenase activity,MF,
13179,GO:0050061,1,0.992495412096442,0,1,long-chain-aldehyde dehydrogenase activity,MF,
13180,GO:0050072,1,0.956333681356356,0,7,m7G(5')pppN diphosphatase activity,MF,
13181,GO:0050080,1,0.994614758928299,0,1,malonyl-CoA decarboxylase activity,MF,
13182,GO:0050104,1,0.996122926697365,0,1,L-gulonate 3-dehydrogenase activity,MF,
13183,GO:0050115,1,0.99219563124848,0,1,myosin-light-chain-phosphatase activity,MF,
13184,GO:0050121,1,0.996160119652135,0,1,N-acylglucosamine 2-epimerase activity,MF,
13185,GO:0050124,1,0.992492141976319,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13186,GO:0050129,1,0.992706031430078,0,1,N-formylglutamate deformylase activity,MF,
13187,GO:0050135,1,0.896926048849079,0,16,NAD(P)+ nucleosidase activity,MF,
13188,GO:0050136,1,0.867976398849833,0,38,NADH dehydrogenase (quinone) activity,MF,
13189,GO:0050145,1,0.865556713936399,0,21,nucleoside monophosphate kinase activity,MF,
13190,GO:0050152,1,0.996416095363099,0,1,omega-amidase activity,MF,
13191,GO:0050155,1,0.995150811224064,0,1,ornithine(lysine) transaminase activity,MF,
13192,GO:0050178,1,0.993674621020972,0,2,phenylpyruvate tautomerase activity,MF,
13193,GO:0050185,1,0.988861782328096,0,1,phosphatidylinositol deacylase activity,MF,
13194,GO:0050196,1,0.984257642223838,0,2,[phosphorylase] phosphatase activity,MF,
13195,GO:0050197,1,0.986829883030607,0,2,phytanate-CoA ligase activity,MF,
13196,GO:0050200,1,0.984469812411101,0,2,plasmalogen synthase activity,MF,
13197,GO:0050211,1,0.97956466070836,0,3,procollagen galactosyltransferase activity,MF,
13198,GO:0050218,1,0.973823606821989,0,4,propionate-CoA ligase activity,MF,
13199,GO:0050220,1,0.986958717878252,0,3,prostaglandin-E synthase activity,MF,
13200,GO:0050221,1,0.996450206267593,0,1,prostaglandin-E2 9-reductase activity,MF,
13201,GO:0050251,1,0.989051640619847,0,2,retinol isomerase activity,MF,
13202,GO:0050252,1,0.986492089887953,0,2,retinol O-fatty-acyltransferase activity,MF,
13203,GO:0050253,1,0.973012747635034,0,4,retinyl-palmitate esterase activity,MF,
13204,GO:0050254,1,0.985149409312151,0,3,rhodopsin kinase activity,MF,
13205,GO:0050255,1,0.993766247491235,0,1,ribitol 2-dehydrogenase activity,MF,
13206,GO:0050262,1,0.986555151512788,0,2,ribosylnicotinamide kinase activity,MF,
13207,GO:0050265,1,0.993147347968154,0,1,RNA uridylyltransferase activity,MF,
13208,GO:0050277,1,0.992486860958686,0,1,sedoheptulokinase activity,MF,
13209,GO:0050290,1,0.992256262882633,0,1,sphingomyelin phosphodiesterase D activity,MF,
13210,GO:0050291,1,0.960199931058599,0,6,sphingosine N-acyltransferase activity,MF,
13211,GO:0050294,1,0.983752518521466,0,4,steroid sulfotransferase activity,MF,
13212,GO:0050295,1,0.98663452622412,0,2,steryl-beta-glucosidase activity,MF,
13213,GO:0050308,1,0.951301338159322,0,8,sugar-phosphatase activity,MF,
13214,GO:0050309,1,0.981682067438135,0,3,sugar-terminal-phosphatase activity,MF,
13215,GO:0050313,1,0.996680162456057,0,1,sulfur dioxygenase activity,MF,
13217,GO:0050333,1,0.995585985414469,0,1,thiamin-triphosphatase activity,MF,
13218,GO:0050337,1,0.996837340375666,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
13219,GO:0050346,1,0.99325505912211,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13220,GO:0050347,1,0.98848763359408,0,2,trans-octaprenyltranstransferase activity,MF,
13221,GO:0050353,1,0.993101550136763,0,1,trimethyllysine dioxygenase activity,MF,
13222,GO:0050355,1,0.992359367347971,0,1,triphosphatase activity,MF,
13223,GO:0050405,1,0.981931351130513,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13224,GO:0050421,1,0.993598293270506,0,1,nitrite reductase (NO-forming) activity,MF,
13225,GO:0050427,1,0.890261708636018,0,21,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
13226,GO:0050428,1,0.959860580519335,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13227,GO:0050429,1,0.991330193268898,0,1,calcium-dependent phospholipase C activity,MF,
13228,GO:0050431,1,0.848717679235765,0,22,transforming growth factor beta binding,MF,
13229,GO:0050432,1,0.730838094765669,0,51,catecholamine secretion,BP,
13230,GO:0050433,1,0.742992232205374,0,49,regulation of catecholamine secretion,BP,
13231,GO:0050434,1,0.775956376208763,0,41,positive regulation of viral transcription,BP,
13232,GO:0050435,1,0.722707390203381,0,45,amyloid-beta metabolic process,BP,
13233,GO:0050436,1,0.974906384685113,0,3,microfibril binding,MF,
13234,GO:0050444,1,0.9926432603516,0,1,aquacobalamin reductase (NADPH) activity,MF,
13235,GO:0050459,1,0.99325505912211,0,1,ethanolamine-phosphate phospho-lyase activity,MF,
13236,GO:0050462,1,0.996453316121395,0,1,N-acetylneuraminate synthase activity,MF,
13237,GO:0050473,1,0.981245589191792,0,3,arachidonate 15-lipoxygenase activity,MF,
13238,GO:0050479,1,0.99325505912211,0,1,glyceryl-ether monooxygenase activity,MF,
13239,GO:0050480,1,0.994754663009123,0,1,imidazolonepropionase activity,MF,
13240,GO:0050482,1,0.88177402133944,0,22,arachidonic acid secretion,BP,
13241,GO:0050486,1,0.992624849189583,0,1,intramolecular transferase activity, transferring hydroxy groups,MF,
13242,GO:0050497,1,0.987732537418699,0,2,transferase activity, transferring alkylthio groups,MF,
13243,GO:0050501,1,0.976309964706365,0,4,hyaluronan synthase activity,MF,
13244,GO:0050508,1,0.977736161593556,0,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
13245,GO:0050509,1,0.98515902345483,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13246,GO:0050510,1,0.970603541925714,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13247,GO:0050512,1,0.994883190736215,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13248,GO:0050528,1,0.994101958296384,0,1,acyloxyacyl hydrolase activity,MF,
13249,GO:0050542,1,0.974786537979073,0,6,icosanoid binding,MF,
13250,GO:0050543,1,0.975686896626927,0,6,icosatetraenoic acid binding,MF,
13251,GO:0050544,1,0.979030345169835,0,5,arachidonic acid binding,MF,
13252,GO:0050560,1,0.992606559055304,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13253,GO:0050561,1,0.992478259266742,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13254,GO:0050567,1,0.982666610978715,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13255,GO:0050571,1,0.995945840618664,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13256,GO:0050610,1,0.992918444174798,0,2,methylarsonate reductase activity,MF,
13257,GO:0050613,1,0.988502511399164,0,2,delta14-sterol reductase activity,MF,
13258,GO:0050614,1,0.992413345962523,0,1,delta24-sterol reductase activity,MF,
13259,GO:0050632,1,0.996237631735038,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13260,GO:0050633,1,0.986420511641049,0,3,acetyl-CoA C-myristoyltransferase activity,MF,
13261,GO:0050646,1,0.995666233695995,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13262,GO:0050647,1,0.995666233695995,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13263,GO:0050648,1,0.995666233695995,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13264,GO:0050649,1,0.990444741977761,0,2,testosterone 6-beta-hydroxylase activity,MF,
13265,GO:0050650,1,0.805944266324071,0,31,chondroitin sulfate proteoglycan biosynthetic process,BP,
13266,GO:0050651,1,0.899864073165018,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13267,GO:0050652,1,0.992501307034778,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13268,GO:0050653,1,0.985031391999384,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13270,GO:0050655,1,0.895010541231083,0,16,dermatan sulfate proteoglycan metabolic process,BP,
13271,GO:0050656,1,0.95841835540028,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13272,GO:0050657,1,0.289913870626743,0,184,nucleic acid transport,BP,
13273,GO:0050658,1,0.289913870626743,0,184,RNA transport,BP,
13274,GO:0050659,1,0.984082924522615,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13275,GO:0050660,1,0.60073229316463,0,78,flavin adenine dinucleotide binding,MF,
13277,GO:0050663,1,0.675745295939941,0,62,cytokine secretion,BP,
13278,GO:0050664,1,0.904476469360016,0,16,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13279,GO:0050665,1,0.923402375300717,0,13,hydrogen peroxide biosynthetic process,BP,
13280,GO:0050666,1,0.988280739491224,0,2,regulation of homocysteine metabolic process,BP,
13281,GO:0050667,1,0.930078366424633,0,12,homocysteine metabolic process,BP,
13282,GO:0050668,1,0.994416103024581,0,1,positive regulation of homocysteine metabolic process,BP,
13284,GO:0050671,1,0.491706692562885,0,123,positive regulation of lymphocyte proliferation,BP,
13287,GO:0050674,1,0.996826939881114,0,1,urothelial cell proliferation,BP,
13288,GO:0050675,1,0.996826939881114,0,1,regulation of urothelial cell proliferation,BP,
13289,GO:0050677,1,0.996826939881114,0,1,positive regulation of urothelial cell proliferation,BP,
13293,GO:0050681,1,0.827396056580364,0,27,androgen receptor binding,MF,
13294,GO:0050682,1,0.975808158526547,0,3,AF-2 domain binding,MF,
13295,GO:0050683,1,0.992451794785168,0,1,AF-1 domain binding,MF,
13296,GO:0050684,1,0.385386860493081,0,143,regulation of mRNA processing,BP,
13297,GO:0050685,1,0.827281308621568,0,31,positive regulation of mRNA processing,BP,
13298,GO:0050686,1,0.8162235961444,0,31,negative regulation of mRNA processing,BP,
13299,GO:0050687,1,0.869448490427393,0,21,negative regulation of defense response to virus,BP,
13300,GO:0050688,1,0.659300440302774,0,63,regulation of defense response to virus,BP,
13301,GO:0050689,1,0.984109719184929,0,3,negative regulation of defense response to virus by host,BP,
13302,GO:0050690,1,0.837704474426514,0,29,regulation of defense response to virus by virus,BP,
13303,GO:0050691,1,0.817708105469407,0,32,regulation of defense response to virus by host,BP,
13304,GO:0050692,1,0.980261485407098,0,3,DNA binding domain binding,MF,
13305,GO:0050693,1,0.963390492488208,0,6,LBD domain binding,MF,
13307,GO:0050698,1,0.986419994127644,0,2,proteoglycan sulfotransferase activity,MF,
13308,GO:0050699,1,0.835372734053998,0,30,WW domain binding,MF,
13309,GO:0050700,1,0.914125060884166,0,14,CARD domain binding,MF,
13310,GO:0050707,1,0.730910919498986,0,50,regulation of cytokine secretion,BP,
13312,GO:0050709,1,0.631296108802486,0,75,negative regulation of protein secretion,BP,
13313,GO:0050710,1,0.912593573372071,0,15,negative regulation of cytokine secretion,BP,
13315,GO:0050715,1,0.849043849105097,0,27,positive regulation of cytokine secretion,BP,
13321,GO:0050732,1,0.740345242712443,0,47,negative regulation of peptidyl-tyrosine phosphorylation,BP,
13322,GO:0050733,1,0.96955256264176,0,5,RS domain binding,MF,
13324,GO:0050747,1,0.970358500315237,0,5,positive regulation of lipoprotein metabolic process,BP,
13326,GO:0050750,1,0.882640013748803,0,18,low-density lipoprotein particle receptor binding,MF,
13327,GO:0050755,1,0.996543373289718,0,1,chemokine metabolic process,BP,
13328,GO:0050757,1,0.990102854443755,0,2,thymidylate synthase biosynthetic process,BP,
13329,GO:0050758,1,0.990102854443755,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13330,GO:0050760,1,0.993515812408459,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13331,GO:0050764,1,0.591736391382333,0,85,regulation of phagocytosis,BP,
13332,GO:0050765,1,0.896635415572048,0,17,negative regulation of phagocytosis,BP,
13333,GO:0050766,1,0.689033046257783,0,62,positive regulation of phagocytosis,BP,
13341,GO:0050774,1,0.894136813222998,0,16,negative regulation of dendrite morphogenesis,BP,
13342,GO:0050775,1,0.76022955123315,0,37,positive regulation of dendrite morphogenesis,BP,
13344,GO:0050777,1,0.452484175926931,0,132,negative regulation of immune response,BP,
13346,GO:0050779,1,0.78095151000024,0,34,RNA destabilization,BP,
13347,GO:0050780,1,0.897566679773015,0,17,dopamine receptor binding,MF,
13348,GO:0050783,1,0.993971958673624,0,1,cocaine metabolic process,BP,
13349,GO:0050785,1,0.996340173474856,0,1,advanced glycation end-product receptor activity,MF,
13350,GO:0050786,1,0.963380834374853,0,10,RAGE receptor binding,MF,
13351,GO:0050787,1,0.988828147068739,0,2,detoxification of mercury ion,BP,
13354,GO:0050792,1,0.300620734836825,0,192,regulation of viral process,BP,
13359,GO:0050798,1,0.792464410305217,0,39,activated T cell proliferation,BP,
13361,GO:0050802,1,0.892352824258091,0,21,circadian sleep/wake cycle, sleep,BP,
13362,GO:0050803,1,0.197982738608999,0,220,regulation of synapse structure or activity,BP,
13364,GO:0050805,1,0.605289531246156,0,71,negative regulation of synaptic transmission,BP,
13366,GO:0050807,1,0.214793943377789,0,209,regulation of synapse organization,BP,
13368,GO:0050810,1,0.577853293710707,0,84,regulation of steroid biosynthetic process,BP,
13370,GO:0050812,1,0.943214662567823,0,8,regulation of acyl-CoA biosynthetic process,BP,
13371,GO:0050815,1,0.95077152777169,0,8,phosphoserine residue binding,MF,
13372,GO:0050816,1,0.980641994150779,0,3,phosphothreonine residue binding,MF,
13376,GO:0050820,1,0.845241464329995,0,26,positive regulation of coagulation,BP,
13377,GO:0050821,1,0.339590669779209,0,167,protein stabilization,BP,
13378,GO:0050822,1,0.992549053407681,0,1,peptide stabilization,BP,
13379,GO:0050823,1,0.992549053407681,0,1,peptide antigen stabilization,BP,
13380,GO:0050829,1,0.787209671120696,0,49,defense response to Gram-negative bacterium,BP,
13381,GO:0050830,1,0.739857616367605,0,60,defense response to Gram-positive bacterium,BP,
13382,GO:0050832,1,0.893632681833342,0,27,defense response to fungus,BP,
13383,GO:0050833,1,0.974855032482009,0,4,pyruvate transmembrane transporter activity,MF,
13385,GO:0050840,1,0.690805534860705,0,53,extracellular matrix binding,MF,
13386,GO:0050847,1,0.929540496472174,0,9,progesterone receptor signaling pathway,BP,
13388,GO:0050849,1,0.832387588874941,0,29,negative regulation of calcium-mediated signaling,BP,
13392,GO:0050853,1,0.682156596872184,0,60,B cell receptor signaling pathway,BP,
13393,GO:0050854,1,0.661758406240789,0,65,regulation of antigen receptor-mediated signaling pathway,BP,
13394,GO:0050855,1,0.845117479169377,0,26,regulation of B cell receptor signaling pathway,BP,
13395,GO:0050856,1,0.771479376316353,0,42,regulation of T cell receptor signaling pathway,BP,
13396,GO:0050857,1,0.870282886096828,0,22,positive regulation of antigen receptor-mediated signaling pathway,BP,
13397,GO:0050858,1,0.838551213103994,0,30,negative regulation of antigen receptor-mediated signaling pathway,BP,
13398,GO:0050859,1,0.961838014004937,0,7,negative regulation of B cell receptor signaling pathway,BP,
13399,GO:0050860,1,0.871869197377673,0,23,negative regulation of T cell receptor signaling pathway,BP,
13400,GO:0050861,1,0.949180253783801,0,8,positive regulation of B cell receptor signaling pathway,BP,
13401,GO:0050862,1,0.920623688738053,0,14,positive regulation of T cell receptor signaling pathway,BP,
13403,GO:0050864,1,0.502005198448297,0,111,regulation of B cell activation,BP,
13408,GO:0050869,1,0.822868994397628,0,32,negative regulation of B cell activation,BP,
13409,GO:0050870,1,0.296837528810359,0,197,positive regulation of T cell activation,BP,
13410,GO:0050871,1,0.662069100694482,0,68,positive regulation of B cell activation,BP,
13411,GO:0050872,1,0.915549042732662,0,14,white fat cell differentiation,BP,
13412,GO:0050873,1,0.74393999785171,0,46,brown fat cell differentiation,BP,
13415,GO:0050879,1,0.711157289201119,0,52,multicellular organismal movement,BP,
13416,GO:0050881,1,0.711157289201119,0,52,musculoskeletal movement,BP,
13417,GO:0050882,1,0.937245761048419,0,7,voluntary musculoskeletal movement,BP,
13418,GO:0050883,1,0.989897688644556,0,2,musculoskeletal movement, spinal reflex action,BP,
13419,GO:0050884,1,0.90422947648163,0,15,neuromuscular process controlling posture,BP,
13424,GO:0050892,1,0.819752370864372,0,30,intestinal absorption,BP,
13425,GO:0050893,1,0.974634227325629,0,4,sensory processing,BP,
13426,GO:0050894,1,0.991219026447721,0,1,determination of affect,BP,
13428,GO:0050897,1,0.980131153458591,0,3,cobalt ion binding,MF,
13430,GO:0050901,1,0.829189154929737,0,29,leukocyte tethering or rolling,BP,
13431,GO:0050902,1,0.98646739263629,0,2,leukocyte adhesive activation,BP,
13432,GO:0050904,1,0.963865556237014,0,5,diapedesis,BP,
13435,GO:0050907,1,0.821924018429034,0,42,detection of chemical stimulus involved in sensory perception,BP,
13436,GO:0050908,1,0.885774320328473,0,17,detection of light stimulus involved in visual perception,BP,
13437,GO:0050909,1,0.788218567584133,0,44,sensory perception of taste,BP,
13438,GO:0050910,1,0.931292387501883,0,11,detection of mechanical stimulus involved in sensory perception of sound,BP,
13439,GO:0050911,1,0.932733759645243,0,16,detection of chemical stimulus involved in sensory perception of smell,BP,
13440,GO:0050912,1,0.894030270432153,0,24,detection of chemical stimulus involved in sensory perception of taste,BP,
13441,GO:0050913,1,0.889860539129237,0,24,sensory perception of bitter taste,BP,
13442,GO:0050915,1,0.972875134006239,0,4,sensory perception of sour taste,BP,
13443,GO:0050916,1,0.968302821763608,0,5,sensory perception of sweet taste,BP,
13444,GO:0050917,1,0.961267015644038,0,6,sensory perception of umami taste,BP,
13446,GO:0050919,1,0.697036649618987,0,46,negative chemotaxis,BP,
13448,GO:0050921,1,0.450735186875409,0,133,positive regulation of chemotaxis,BP,
13450,GO:0050923,1,0.967569209828505,0,4,regulation of negative chemotaxis,BP,
13451,GO:0050924,1,0.99215055017653,0,1,positive regulation of negative chemotaxis,BP,
13452,GO:0050925,1,0.982512956631726,0,2,negative regulation of negative chemotaxis,BP,
13453,GO:0050926,1,0.85741514995961,0,25,regulation of positive chemotaxis,BP,
13454,GO:0050927,1,0.86433500041698,0,24,positive regulation of positive chemotaxis,BP,
13455,GO:0050928,1,0.992005866688499,0,1,negative regulation of positive chemotaxis,BP,
13456,GO:0050929,1,0.99215055017653,0,1,induction of negative chemotaxis,BP,
13457,GO:0050930,1,0.936433326282187,0,13,induction of positive chemotaxis,BP,
13459,GO:0050932,1,0.940881116042219,0,8,regulation of pigment cell differentiation,BP,
13460,GO:0050942,1,0.944695322229572,0,7,positive regulation of pigment cell differentiation,BP,
13461,GO:0050951,1,0.869363128948939,0,21,sensory perception of temperature stimulus,BP,
13462,GO:0050953,1,0.305101968754399,0,183,sensory perception of light stimulus,BP,
13464,GO:0050955,1,0.969275868110434,0,4,thermoception,BP,
13465,GO:0050957,1,0.953524314605626,0,6,equilibrioception,BP,
13466,GO:0050960,1,0.977293828704692,0,3,detection of temperature stimulus involved in thermoception,BP,
13467,GO:0050961,1,0.896808227768974,0,17,detection of temperature stimulus involved in sensory perception,BP,
13468,GO:0050962,1,0.885774320328473,0,17,detection of light stimulus involved in sensory perception,BP,
13469,GO:0050965,1,0.910726032866191,0,15,detection of temperature stimulus involved in sensory perception of pain,BP,
13470,GO:0050966,1,0.920970648368757,0,12,detection of mechanical stimulus involved in sensory perception of pain,BP,
13471,GO:0050968,1,0.985752805545584,0,2,detection of chemical stimulus involved in sensory perception of pain,BP,
13473,GO:0050975,1,0.970901758401355,0,5,sensory perception of touch,BP,
13474,GO:0050976,1,0.979555777851126,0,3,detection of mechanical stimulus involved in sensory perception of touch,BP,
13476,GO:0050992,1,0.994767570572313,0,1,dimethylallyl diphosphate biosynthetic process,BP,
13477,GO:0050993,1,0.994767570572313,0,1,dimethylallyl diphosphate metabolic process,BP,
13478,GO:0050994,1,0.723948296463747,0,49,regulation of lipid catabolic process,BP,
13479,GO:0050995,1,0.880608697951728,0,19,negative regulation of lipid catabolic process,BP,
13480,GO:0050996,1,0.878472546056334,0,20,positive regulation of lipid catabolic process,BP,
13481,GO:0050997,1,0.855909868821604,0,23,quaternary ammonium group binding,MF,
13482,GO:0050998,1,0.906245595342983,0,14,nitric-oxide synthase binding,MF,
13484,GO:0051000,1,0.887457431739029,0,19,positive regulation of nitric-oxide synthase activity,BP,
13485,GO:0051001,1,0.960602625755852,0,7,negative regulation of nitric-oxide synthase activity,BP,
13487,GO:0051005,1,0.975973074711085,0,4,negative regulation of lipoprotein lipase activity,BP,
13488,GO:0051006,1,0.966966616108224,0,7,positive regulation of lipoprotein lipase activity,BP,
13489,GO:0051008,1,0.995233736235471,0,1,Hsp27 protein binding,MF,
13490,GO:0051010,1,0.849005228834804,0,20,microtubule plus-end binding,MF,
13491,GO:0051011,1,0.917679234042563,0,11,microtubule minus-end binding,MF,
13492,GO:0051012,1,0.983936147417157,0,2,microtubule sliding,BP,
13493,GO:0051013,1,0.925330641848735,0,11,microtubule severing,BP,
13494,GO:0051014,1,0.907238568264446,0,15,actin filament severing,BP,
13496,GO:0051016,1,0.872726660254603,0,20,barbed-end actin filament capping,BP,
13497,GO:0051017,1,0.350515039386308,0,148,actin filament bundle assembly,BP,
13498,GO:0051018,1,0.695140313085751,0,47,protein kinase A binding,MF,
13499,GO:0051019,1,0.79837804612354,0,33,mitogen-activated protein kinase binding,MF,
13501,GO:0051021,1,0.977182323128616,0,4,GDP-dissociation inhibitor binding,MF,
13502,GO:0051022,1,0.980986424562566,0,3,Rho GDP-dissociation inhibitor binding,MF,
13503,GO:0051023,1,0.92229667132556,0,16,regulation of immunoglobulin secretion,BP,
13504,GO:0051024,1,0.959163448916256,0,9,positive regulation of immunoglobulin secretion,BP,
13505,GO:0051025,1,0.979111076075762,0,3,negative regulation of immunoglobulin secretion,BP,
13506,GO:0051026,1,0.968684937349724,0,5,chiasma assembly,BP,
13507,GO:0051028,1,0.385412979213784,0,140,mRNA transport,BP,
13508,GO:0051029,1,0.972294490195483,0,5,rRNA transport,BP,
13509,GO:0051030,1,0.983053319332939,0,4,snRNA transport,BP,
13510,GO:0051031,1,0.796671081388928,0,33,tRNA transport,BP,
13511,GO:0051032,1,0.984666154790113,0,2,nucleic acid transmembrane transporter activity,MF,
13512,GO:0051033,1,0.984666154790113,0,2,RNA transmembrane transporter activity,MF,
13513,GO:0051036,1,0.972426617578505,0,5,regulation of endosome size,BP,
13514,GO:0051040,1,0.985460339336658,0,2,regulation of calcium-independent cell-cell adhesion,BP,
13515,GO:0051041,1,0.992658184875354,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13516,GO:0051042,1,0.992749461167348,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13517,GO:0051043,1,0.874387878186356,0,21,regulation of membrane protein ectodomain proteolysis,BP,
13518,GO:0051044,1,0.921114461648863,0,13,positive regulation of membrane protein ectodomain proteolysis,BP,
13519,GO:0051045,1,0.949313116620453,0,8,negative regulation of membrane protein ectodomain proteolysis,BP,
13529,GO:0051055,1,0.741199503917047,0,47,negative regulation of lipid biosynthetic process,BP,
13531,GO:0051057,1,0.605733553653773,0,72,positive regulation of small GTPase mediated signal transduction,BP,
13533,GO:0051059,1,0.827047281375812,0,31,NF-kappaB binding,MF,
13534,GO:0051066,1,0.991113863288785,0,2,dihydrobiopterin metabolic process,BP,
13535,GO:0051068,1,0.992526557870833,0,1,dihydrolipoamide metabolic process,BP,
13536,GO:0051081,1,0.901004214550855,0,16,nuclear envelope disassembly,BP,
13537,GO:0051082,1,0.55593660367491,0,102,unfolded protein binding,MF,
13538,GO:0051083,1,0.990315678848845,0,2,'de novo' cotranslational protein folding,BP,
13539,GO:0051084,1,0.822774152571173,0,32,'de novo' posttranslational protein folding,BP,
13540,GO:0051085,1,0.843516530582302,0,28,chaperone cofactor-dependent protein refolding,BP,
13541,GO:0051086,1,0.995193674674666,0,1,chaperone mediated protein folding independent of cofactor,BP,
13543,GO:0051089,1,0.992476152744622,0,1,constitutive protein ectodomain proteolysis,BP,
13549,GO:0051095,1,0.928072478695768,0,12,regulation of helicase activity,BP,
13550,GO:0051096,1,0.956022982836894,0,7,positive regulation of helicase activity,BP,
13551,GO:0051097,1,0.970776994533527,0,5,negative regulation of helicase activity,BP,
13554,GO:0051100,1,0.380705125858826,0,152,negative regulation of binding,BP,
13555,GO:0051101,1,0.483853745113755,0,115,regulation of DNA binding,BP,
13556,GO:0051102,1,0.992461250925561,0,1,DNA ligation involved in DNA recombination,BP,
13557,GO:0051103,1,0.96153825947131,0,7,DNA ligation involved in DNA repair,BP,
13558,GO:0051105,1,0.96219378249159,0,6,regulation of DNA ligation,BP,
13559,GO:0051106,1,0.968939716925035,0,5,positive regulation of DNA ligation,BP,
13560,GO:0051107,1,0.993040051200457,0,1,negative regulation of DNA ligation,BP,
13563,GO:0051120,1,0.986090522680391,0,2,hepoxilin A3 synthase activity,MF,
13564,GO:0051121,1,0.951875848727737,0,9,hepoxilin metabolic process,BP,
13565,GO:0051122,1,0.951875848727737,0,9,hepoxilin biosynthetic process,BP,
13566,GO:0051123,1,0.867879860556131,0,24,RNA polymerase II preinitiation complex assembly,BP,
13567,GO:0051124,1,0.920218812173878,0,10,synaptic growth at neuromuscular junction,BP,
13568,GO:0051125,1,0.824905055782418,0,28,regulation of actin nucleation,BP,
13569,GO:0051126,1,0.95432107838763,0,8,negative regulation of actin nucleation,BP,
13570,GO:0051127,1,0.89259761029098,0,15,positive regulation of actin nucleation,BP,
13574,GO:0051131,1,0.896077049036791,0,20,chaperone-mediated protein complex assembly,BP,
13575,GO:0051132,1,0.95168204053864,0,9,NK T cell activation,BP,
13576,GO:0051133,1,0.963009997814371,0,7,regulation of NK T cell activation,BP,
13577,GO:0051134,1,0.987929814815757,0,2,negative regulation of NK T cell activation,BP,
13578,GO:0051135,1,0.974778810310315,0,5,positive regulation of NK T cell activation,BP,
13579,GO:0051136,1,0.959968410464777,0,6,regulation of NK T cell differentiation,BP,
13580,GO:0051138,1,0.971550201899447,0,4,positive regulation of NK T cell differentiation,BP,
13581,GO:0051139,1,0.908181395621849,0,13,metal ion:proton antiporter activity,MF,
13582,GO:0051140,1,0.978495799502726,0,4,regulation of NK T cell proliferation,BP,
13583,GO:0051141,1,0.992520564274694,0,1,negative regulation of NK T cell proliferation,BP,
13584,GO:0051142,1,0.985870622929243,0,3,positive regulation of NK T cell proliferation,BP,
13585,GO:0051145,1,0.700355698741076,0,54,smooth muscle cell differentiation,BP,
13590,GO:0051150,1,0.817605714438732,0,30,regulation of smooth muscle cell differentiation,BP,
13591,GO:0051151,1,0.893480776424227,0,16,negative regulation of smooth muscle cell differentiation,BP,
13592,GO:0051152,1,0.9374494843717,0,11,positive regulation of smooth muscle cell differentiation,BP,
13596,GO:0051156,1,0.864513411899745,0,24,glucose 6-phosphate metabolic process,BP,
13597,GO:0051160,1,0.993766247491235,0,1,L-xylitol catabolic process,BP,
13598,GO:0051164,1,0.993766247491235,0,1,L-xylitol metabolic process,BP,
13599,GO:0051167,1,0.975543113841645,0,5,xylulose 5-phosphate metabolic process,BP,
13600,GO:0051168,1,0.275758146373056,0,193,nuclear export,BP,
13607,GO:0051176,1,0.978564147029737,0,3,positive regulation of sulfur metabolic process,BP,
13608,GO:0051177,1,0.948097646510462,0,9,meiotic sister chromatid cohesion,BP,
13611,GO:0051189,1,0.963064952063979,0,6,prosthetic group metabolic process,BP,
13612,GO:0051192,1,0.996815956228427,0,1,prosthetic group binding,MF,
13613,GO:0051204,1,0.786539896897721,0,43,protein insertion into mitochondrial membrane,BP,
13617,GO:0051213,1,0.561071003911836,0,86,dioxygenase activity,MF,
13619,GO:0051219,1,0.555389572273582,0,83,phosphoprotein binding,MF,
13620,GO:0051220,1,0.859659240793821,0,23,cytoplasmic sequestering of protein,BP,
13624,GO:0051225,1,0.484744193764928,0,104,spindle assembly,BP,
13625,GO:0051228,1,0.984596164766413,0,2,mitotic spindle disassembly,BP,
13626,GO:0051230,1,0.984596164766413,0,2,spindle disassembly,BP,
13627,GO:0051231,1,0.943145296765727,0,9,spindle elongation,BP,
13628,GO:0051232,1,0.994144993319831,0,1,meiotic spindle elongation,BP,
13629,GO:0051233,1,0.786071536178216,0,35,spindle midzone,CC,
13632,GO:0051236,1,0.28182342621053,0,187,establishment of RNA localization,BP,
13633,GO:0051238,1,0.944218104251657,0,11,sequestering of metal ion,BP,
13642,GO:0051251,1,0.200207295285065,0,260,positive regulation of lymphocyte activation,BP,
13646,GO:0051255,1,0.931098341972375,0,11,spindle midzone assembly,BP,
13647,GO:0051256,1,0.957402690289578,0,7,mitotic spindle midzone assembly,BP,
13648,GO:0051257,1,0.98640027703808,0,2,meiotic spindle midzone assembly,BP,
13651,GO:0051260,1,0.331239346352698,0,167,protein homooligomerization,BP,
13653,GO:0051262,1,0.57543413953748,0,83,protein tetramerization,BP,
13654,GO:0051264,1,0.993183219456954,0,1,mono-olein transacylation activity,MF,
13655,GO:0051265,1,0.993183219456954,0,1,diolein transacylation activity,MF,
13656,GO:0051267,1,0.992674109458785,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13666,GO:0051284,1,0.921204991401878,0,13,positive regulation of sequestering of calcium ion,BP,
13667,GO:0051286,1,0.948019808844305,0,7,cell tip,CC,
13669,GO:0051289,1,0.701760788882474,0,55,protein homotetramerization,BP,
13670,GO:0051290,1,0.897977438231087,0,15,protein heterotetramerization,BP,
13671,GO:0051291,1,0.859830535520528,0,21,protein heterooligomerization,BP,
13672,GO:0051292,1,0.937024585520746,0,9,nuclear pore complex assembly,BP,
13675,GO:0051295,1,0.967081566205705,0,4,establishment of meiotic spindle localization,BP,
13676,GO:0051298,1,0.624976303263434,0,65,centrosome duplication,BP,
13677,GO:0051299,1,0.904269928826721,0,15,centrosome separation,BP,
13679,GO:0051302,1,0.366094597303319,0,150,regulation of cell division,BP,
13680,GO:0051303,1,0.624622738212554,0,72,establishment of chromosome localization,BP,
13681,GO:0051304,1,0.566317759098238,0,86,chromosome separation,BP,
13682,GO:0051305,1,0.94726528555368,0,7,chromosome movement towards spindle pole,BP,
13683,GO:0051306,1,0.674076501870959,0,61,mitotic sister chromatid separation,BP,
13684,GO:0051307,1,0.874010689459262,0,20,meiotic chromosome separation,BP,
13685,GO:0051308,1,0.99325505912211,0,1,male meiosis chromosome separation,BP,
13686,GO:0051309,1,0.988071506850958,0,2,female meiosis chromosome separation,BP,
13687,GO:0051310,1,0.686685837713005,0,59,metaphase plate congression,BP,
13688,GO:0051311,1,0.993910485981676,0,1,meiotic metaphase plate congression,BP,
13689,GO:0051315,1,0.908778762040021,0,15,attachment of mitotic spindle microtubules to kinetochore,BP,
13690,GO:0051316,1,0.99325505912211,0,1,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
13691,GO:0051318,1,0.984671710184872,0,2,G1 phase,BP,
13692,GO:0051321,1,0.253985656611033,0,205,meiotic cell cycle,BP,
13693,GO:0051325,1,0.984671710184872,0,2,interphase,BP,
13694,GO:0051329,1,0.984671710184872,0,2,mitotic interphase,BP,
13697,GO:0051339,1,0.750088818026865,0,44,regulation of lyase activity,BP,
13698,GO:0051340,1,0.951440790837462,0,10,regulation of ligase activity,BP,
13700,GO:0051342,1,0.945494988055557,0,9,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13701,GO:0051343,1,0.976320245015275,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13702,GO:0051344,1,0.961518746708967,0,6,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13706,GO:0051348,1,0.188895986621865,0,259,negative regulation of transferase activity,BP,
13707,GO:0051349,1,0.883261193270898,0,18,positive regulation of lyase activity,BP,
13708,GO:0051350,1,0.86039741941693,0,24,negative regulation of lyase activity,BP,
13709,GO:0051351,1,0.962653558238809,0,8,positive regulation of ligase activity,BP,
13710,GO:0051352,1,0.988356732702416,0,2,negative regulation of ligase activity,BP,
13711,GO:0051353,1,0.740970916512306,0,48,positive regulation of oxidoreductase activity,BP,
13712,GO:0051354,1,0.85179411530518,0,26,negative regulation of oxidoreductase activity,BP,
13713,GO:0051355,1,0.992490373839655,0,1,proprioception involved in equilibrioception,BP,
13714,GO:0051365,1,0.980107245963086,0,3,cellular response to potassium ion starvation,BP,
13716,GO:0051373,1,0.971540151081641,0,5,FATZ binding,MF,
13717,GO:0051377,1,0.974384522380978,0,4,mannose-ethanolamine phosphotransferase activity,MF,
13718,GO:0051378,1,0.932428336392218,0,12,serotonin binding,MF,
13719,GO:0051379,1,0.972186712601354,0,5,epinephrine binding,MF,
13720,GO:0051380,1,0.977515651785087,0,4,norepinephrine binding,MF,
13721,GO:0051382,1,0.902894906308626,0,15,kinetochore assembly,BP,
13722,GO:0051383,1,0.873440370058361,0,20,kinetochore organization,BP,
13724,GO:0051385,1,0.850231352771627,0,27,response to mineralocorticoid,BP,
13725,GO:0051386,1,0.931885569289336,0,11,regulation of neurotrophin TRK receptor signaling pathway,BP,
13726,GO:0051387,1,0.982642815036048,0,3,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
13727,GO:0051388,1,0.960059725393424,0,6,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
13728,GO:0051389,1,0.981087023539126,0,2,inactivation of MAPKK activity,BP,
13729,GO:0051391,1,0.992474164909478,0,1,tRNA acetylation,BP,
13731,GO:0051394,1,0.996304995047058,0,1,regulation of nerve growth factor receptor activity,BP,
13735,GO:0051409,1,0.937995302579114,0,10,response to nitrosative stress,BP,
13736,GO:0051410,1,0.98541618846452,0,3,detoxification of nitrogen compound,BP,
13737,GO:0051412,1,0.904107062149629,0,16,response to corticosterone,BP,
13738,GO:0051413,1,0.993808988803786,0,1,response to cortisone,BP,
13739,GO:0051414,1,0.964152698386906,0,5,response to cortisol,BP,
13740,GO:0051415,1,0.96335982172861,0,5,microtubule nucleation by interphase microtubule organizing center,BP,
13741,GO:0051418,1,0.930363735030918,0,9,microtubule nucleation by microtubule organizing center,BP,
13742,GO:0051424,1,0.989204369615101,0,2,corticotropin-releasing hormone binding,MF,
13743,GO:0051425,1,0.975308109399884,0,3,PTB domain binding,MF,
13744,GO:0051427,1,0.340294841696783,0,161,hormone receptor binding,MF,
13745,GO:0051428,1,0.918280993510226,0,17,peptide hormone receptor binding,MF,
13746,GO:0051429,1,0.97721041485642,0,5,corticotropin-releasing hormone receptor binding,MF,
13747,GO:0051430,1,0.980986672282981,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
13748,GO:0051431,1,0.989433556864252,0,3,corticotropin-releasing hormone receptor 2 binding,MF,
13749,GO:0051433,1,0.992334022107597,0,1,BH2 domain binding,MF,
13750,GO:0051434,1,0.971842035288878,0,5,BH3 domain binding,MF,
13751,GO:0051438,1,0.722172542261977,0,52,regulation of ubiquitin-protein transferase activity,BP,
13752,GO:0051443,1,0.80664104263272,0,33,positive regulation of ubiquitin-protein transferase activity,BP,
13753,GO:0051444,1,0.915028745836581,0,16,negative regulation of ubiquitin-protein transferase activity,BP,
13754,GO:0051445,1,0.746284397880418,0,45,regulation of meiotic cell cycle,BP,
13755,GO:0051446,1,0.866262995089491,0,21,positive regulation of meiotic cell cycle,BP,
13756,GO:0051447,1,0.916491066364635,0,14,negative regulation of meiotic cell cycle,BP,
13757,GO:0051450,1,0.88899565248332,0,18,myoblast proliferation,BP,
13758,GO:0051451,1,0.917598041299824,0,13,myoblast migration,BP,
13759,GO:0051452,1,0.73813010155838,0,53,intracellular pH reduction,BP,
13760,GO:0051453,1,0.60173793140095,0,80,regulation of intracellular pH,BP,
13761,GO:0051454,1,0.973082158838606,0,4,intracellular pH elevation,BP,
13762,GO:0051455,1,0.99325505912211,0,1,monopolar spindle attachment to meiosis I kinetochore,BP,
13763,GO:0051457,1,0.867054165310092,0,22,maintenance of protein location in nucleus,BP,
13764,GO:0051458,1,0.964644084160974,0,7,corticotropin secretion,BP,
13765,GO:0051459,1,0.970774541194479,0,6,regulation of corticotropin secretion,BP,
13766,GO:0051460,1,0.99548929186194,0,1,negative regulation of corticotropin secretion,BP,
13767,GO:0051461,1,0.975174396677799,0,5,positive regulation of corticotropin secretion,BP,
13768,GO:0051462,1,0.97489147450297,0,5,regulation of cortisol secretion,BP,
13769,GO:0051463,1,0.991426111999536,0,1,negative regulation of cortisol secretion,BP,
13770,GO:0051464,1,0.983323824726419,0,4,positive regulation of cortisol secretion,BP,
13771,GO:0051466,1,0.992691803075415,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13773,GO:0051481,1,0.909590189887692,0,12,negative regulation of cytosolic calcium ion concentration,BP,
13774,GO:0051482,1,0.833410882841188,0,31,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,BP,
13775,GO:0051489,1,0.738018577694302,0,42,regulation of filopodium assembly,BP,
13776,GO:0051490,1,0.982326003430711,0,3,negative regulation of filopodium assembly,BP,
13777,GO:0051491,1,0.816382049342756,0,28,positive regulation of filopodium assembly,BP,
13778,GO:0051492,1,0.548433505687596,0,84,regulation of stress fiber assembly,BP,
13781,GO:0051495,1,0.242424878896261,0,212,positive regulation of cytoskeleton organization,BP,
13782,GO:0051496,1,0.70922361579056,0,50,positive regulation of stress fiber assembly,BP,
13783,GO:0051497,1,0.825488424750518,0,26,negative regulation of stress fiber assembly,BP,
13784,GO:0051499,1,0.989589093551881,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13785,GO:0051500,1,0.989589093551881,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13787,GO:0051525,1,0.965391634894435,0,5,NFAT protein binding,MF,
13788,GO:0051536,1,0.695705981490317,0,61,iron-sulfur cluster binding,MF,
13789,GO:0051537,1,0.8999874251943,0,19,2 iron, 2 sulfur cluster binding,MF,
13790,GO:0051538,1,0.982459044865555,0,3,3 iron, 4 sulfur cluster binding,MF,
13791,GO:0051539,1,0.782605098027525,0,40,4 iron, 4 sulfur cluster binding,MF,
13792,GO:0051540,1,0.695705981490317,0,61,metal cluster binding,MF,
13793,GO:0051541,1,0.960138345282762,0,6,elastin metabolic process,BP,
13794,GO:0051542,1,0.984456411019548,0,2,elastin biosynthetic process,BP,
13795,GO:0051543,1,0.994188251123794,0,1,regulation of elastin biosynthetic process,BP,
13796,GO:0051545,1,0.994188251123794,0,1,negative regulation of elastin biosynthetic process,BP,
13797,GO:0051546,1,0.887505640622851,0,17,keratinocyte migration,BP,
13798,GO:0051547,1,0.908723733456354,0,13,regulation of keratinocyte migration,BP,
13799,GO:0051548,1,0.991849293856569,0,1,negative regulation of keratinocyte migration,BP,
13800,GO:0051549,1,0.916198032400932,0,12,positive regulation of keratinocyte migration,BP,
13801,GO:0051552,1,0.991408023303973,0,1,flavone metabolic process,BP,
13802,GO:0051560,1,0.85406637522333,0,24,mitochondrial calcium ion homeostasis,BP,
13803,GO:0051561,1,0.934593572699449,0,11,positive regulation of mitochondrial calcium ion concentration,BP,
13804,GO:0051562,1,0.974940857772524,0,4,negative regulation of mitochondrial calcium ion concentration,BP,
13805,GO:0051563,1,0.984161765087971,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13806,GO:0051567,1,0.754185340602033,0,36,histone H3-K9 methylation,BP,
13807,GO:0051568,1,0.690216741466849,0,50,histone H3-K4 methylation,BP,
13808,GO:0051569,1,0.823580898431193,0,27,regulation of histone H3-K4 methylation,BP,
13809,GO:0051570,1,0.852654561134825,0,21,regulation of histone H3-K9 methylation,BP,
13810,GO:0051571,1,0.882491774959408,0,17,positive regulation of histone H3-K4 methylation,BP,
13811,GO:0051572,1,0.962025170784997,0,5,negative regulation of histone H3-K4 methylation,BP,
13812,GO:0051573,1,0.925564289501691,0,11,negative regulation of histone H3-K9 methylation,BP,
13813,GO:0051574,1,0.930854293905555,0,9,positive regulation of histone H3-K9 methylation,BP,
13814,GO:0051575,1,0.964631885324934,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13815,GO:0051580,1,0.907906340425237,0,16,regulation of neurotransmitter uptake,BP,
13816,GO:0051581,1,0.979550948318371,0,3,negative regulation of neurotransmitter uptake,BP,
13817,GO:0051582,1,0.978511578672486,0,4,positive regulation of neurotransmitter uptake,BP,
13818,GO:0051583,1,0.942138963361699,0,11,dopamine uptake involved in synaptic transmission,BP,
13819,GO:0051584,1,0.959528433234708,0,8,regulation of dopamine uptake involved in synaptic transmission,BP,
13820,GO:0051585,1,0.99273199371895,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13821,GO:0051586,1,0.985911188653711,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13823,GO:0051589,1,0.909365873046773,0,13,negative regulation of neurotransmitter transport,BP,
13827,GO:0051593,1,0.950458156070807,0,9,response to folic acid,BP,
13828,GO:0051594,1,0.978151949897419,0,4,detection of glucose,BP,
13829,GO:0051595,1,0.984234133717256,0,3,response to methylglyoxal,BP,
13830,GO:0051596,1,0.985700904618165,0,3,methylglyoxal catabolic process,BP,
13831,GO:0051597,1,0.953510904921587,0,7,response to methylmercury,BP,
13832,GO:0051598,1,0.987599685598846,0,2,meiotic recombination checkpoint,BP,
13833,GO:0051599,1,0.963389282155192,0,5,response to hydrostatic pressure,BP,
13834,GO:0051601,1,0.955307031966105,0,7,exocyst localization,BP,
13839,GO:0051607,1,0.262712438931599,0,213,defense response to virus,BP,
13840,GO:0051608,1,0.926714750673628,0,13,histamine transport,BP,
13841,GO:0051610,1,0.928870525732848,0,11,serotonin uptake,BP,
13842,GO:0051611,1,0.971896906113229,0,4,regulation of serotonin uptake,BP,
13843,GO:0051612,1,0.979550948318371,0,3,negative regulation of serotonin uptake,BP,
13844,GO:0051615,1,0.978799736056995,0,3,histamine uptake,BP,
13845,GO:0051620,1,0.948651004019792,0,8,norepinephrine uptake,BP,
13846,GO:0051621,1,0.988319607927375,0,2,regulation of norepinephrine uptake,BP,
13847,GO:0051622,1,0.99273199371895,0,1,negative regulation of norepinephrine uptake,BP,
13848,GO:0051623,1,0.995555640589588,0,1,positive regulation of norepinephrine uptake,BP,
13849,GO:0051625,1,0.984907650258642,0,2,epinephrine uptake,BP,
13850,GO:0051639,1,0.928842778102485,0,10,actin filament network formation,BP,
13853,GO:0051642,1,0.805419242682416,0,28,centrosome localization,BP,
13854,GO:0051643,1,0.948211385845089,0,7,endoplasmic reticulum localization,BP,
13855,GO:0051645,1,0.912786655065523,0,13,Golgi localization,BP,
13856,GO:0051646,1,0.734312255941894,0,43,mitochondrion localization,BP,
13857,GO:0051647,1,0.795661686294349,0,28,nucleus localization,BP,
13863,GO:0051654,1,0.848357944859223,0,23,establishment of mitochondrion localization,BP,
13865,GO:0051657,1,0.921028260148369,0,10,maintenance of organelle location,BP,
13866,GO:0051659,1,0.987035241708706,0,2,maintenance of mitochondrion location,BP,
13867,GO:0051660,1,0.938600200939277,0,9,establishment of centrosome localization,BP,
13868,GO:0051661,1,0.95568036754314,0,5,maintenance of centrosome location,BP,
13870,GO:0051666,1,0.995466792250196,0,1,actin cortical patch localization,BP,
13872,GO:0051673,1,0.9655656043117,0,8,membrane disruption in other organism,BP,
13874,GO:0051683,1,0.958713473071094,0,7,establishment of Golgi localization,BP,
13875,GO:0051684,1,0.976220523590338,0,3,maintenance of Golgi location,BP,
13876,GO:0051685,1,0.99325505912211,0,1,maintenance of ER location,BP,
13877,GO:0051686,1,0.988332743558059,0,1,establishment of ER localization,BP,
13878,GO:0051691,1,0.995810206885099,0,1,cellular oligosaccharide metabolic process,BP,
13879,GO:0051692,1,0.995810206885099,0,1,cellular oligosaccharide catabolic process,BP,
13880,GO:0051693,1,0.772164004613964,0,35,actin filament capping,BP,
13881,GO:0051694,1,0.95424219468278,0,7,pointed-end actin filament capping,BP,
13882,GO:0051695,1,0.992335442110789,0,1,actin filament uncapping,BP,
13883,GO:0051697,1,0.993055001079962,0,1,protein delipidation,BP,
13885,GO:0051702,1,0.651118652701612,0,73,interaction with symbiont,BP,
13886,GO:0051703,1,0.693801081848887,0,49,intraspecies interaction between organisms,BP,
13889,GO:0051709,1,0.933399643584846,0,12,regulation of killing of cells of other organism,BP,
13890,GO:0051712,1,0.944126237558842,0,10,positive regulation of killing of cells of other organism,BP,
13891,GO:0051715,1,0.986375167745913,0,3,cytolysis in other organism,BP,
13893,GO:0051717,1,0.985024076887795,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
13894,GO:0051721,1,0.811151006048439,0,30,protein phosphatase 2A binding,MF,
13895,GO:0051722,1,0.9939300769568,0,1,protein C-terminal methylesterase activity,MF,
13896,GO:0051723,1,0.9939300769568,0,1,protein methylesterase activity,MF,
13897,GO:0051724,1,0.994427769882656,0,1,NAD transmembrane transporter activity,MF,
13898,GO:0051725,1,0.970494480711267,0,5,protein de-ADP-ribosylation,BP,
13900,GO:0051728,1,0.984379008888548,0,2,cell cycle switching, mitotic to meiotic cell cycle,BP,
13901,GO:0051729,1,0.984379008888548,0,2,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13902,GO:0051731,1,0.973974699117362,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
13903,GO:0051732,1,0.995686812967221,0,1,polyribonucleotide kinase activity,MF,
13904,GO:0051733,1,0.982635525765107,0,3,polydeoxyribonucleotide kinase activity,MF,
13905,GO:0051734,1,0.982635525765107,0,3,ATP-dependent polynucleotide kinase activity,MF,
13906,GO:0051736,1,0.995686812967221,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
13907,GO:0051747,1,0.992713177249613,0,2,cytosine C-5 DNA demethylase activity,MF,
13908,GO:0051748,1,0.994741745539943,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
13909,GO:0051750,1,0.996425863818555,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
13910,GO:0051751,1,0.992406010996839,0,1,alpha-1,4-mannosyltransferase activity,MF,
13911,GO:0051754,1,0.972720671862495,0,4,meiotic sister chromatid cohesion, centromeric,BP,
13912,GO:0051758,1,0.991345398229153,0,1,homologous chromosome movement towards spindle pole in meiosis I anaphase,BP,
13913,GO:0051764,1,0.92900686511792,0,11,actin crosslink formation,BP,
13914,GO:0051765,1,0.988286846404117,0,2,inositol tetrakisphosphate kinase activity,MF,
13915,GO:0051766,1,0.968377851396736,0,5,inositol trisphosphate kinase activity,MF,
13916,GO:0051767,1,0.883556921195874,0,18,nitric-oxide synthase biosynthetic process,BP,
13917,GO:0051769,1,0.883556921195874,0,18,regulation of nitric-oxide synthase biosynthetic process,BP,
13918,GO:0051770,1,0.897075839688285,0,15,positive regulation of nitric-oxide synthase biosynthetic process,BP,
13919,GO:0051771,1,0.984946591580406,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
13920,GO:0051775,1,0.916467905074183,0,13,response to redox state,BP,
13921,GO:0051780,1,0.992446562585314,0,1,behavioral response to nutrient,BP,
13922,GO:0051781,1,0.626300306827351,0,73,positive regulation of cell division,BP,
13923,GO:0051782,1,0.902858595872242,0,15,negative regulation of cell division,BP,
13925,GO:0051784,1,0.699952658769849,0,56,negative regulation of nuclear division,BP,
13926,GO:0051785,1,0.652724902022983,0,64,positive regulation of nuclear division,BP,
13927,GO:0051786,1,0.992629859998205,0,1,all-trans-retinol 13,14-reductase activity,MF,
13928,GO:0051787,1,0.852622919537677,0,26,misfolded protein binding,MF,
13929,GO:0051788,1,0.850966117418918,0,24,response to misfolded protein,BP,
13930,GO:0051790,1,0.976700460408657,0,4,short-chain fatty acid biosynthetic process,BP,
13931,GO:0051791,1,0.935610657606926,0,12,medium-chain fatty acid metabolic process,BP,
13932,GO:0051792,1,0.969646260887985,0,6,medium-chain fatty acid biosynthetic process,BP,
13933,GO:0051793,1,0.971302879961832,0,5,medium-chain fatty acid catabolic process,BP,
13934,GO:0051794,1,0.976027341074337,0,4,regulation of timing of catagen,BP,
13935,GO:0051795,1,0.983489242733088,0,3,positive regulation of timing of catagen,BP,
13936,GO:0051796,1,0.992414112316059,0,1,negative regulation of timing of catagen,BP,
13938,GO:0051798,1,0.942074693205036,0,11,positive regulation of hair follicle development,BP,
13940,GO:0051800,1,0.991849293856569,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
13941,GO:0051801,1,0.986375167745913,0,3,cytolysis in other organism involved in symbiotic interaction,BP,
13942,GO:0051817,1,0.563171762533706,0,88,modulation of process of other organism involved in symbiotic interaction,BP,
13943,GO:0051823,1,0.93479514838156,0,9,regulation of synapse structural plasticity,BP,
13944,GO:0051835,1,0.97226968223889,0,4,positive regulation of synapse structural plasticity,BP,
13945,GO:0051838,1,0.986375167745913,0,3,cytolysis by host of symbiont cells,BP,
13946,GO:0051851,1,0.713671960759884,0,53,modulation by host of symbiont process,BP,
13948,GO:0051864,1,0.939239555381655,0,8,histone demethylase activity (H3-K36 specific),MF,
13949,GO:0051865,1,0.633240401502491,0,66,protein autoubiquitination,BP,
13950,GO:0051866,1,0.988991365203974,0,2,general adaptation syndrome,BP,
13951,GO:0051867,1,0.996424245301714,0,1,general adaptation syndrome, behavioral process,BP,
13952,GO:0051870,1,0.985729776810427,0,3,methotrexate binding,MF,
13953,GO:0051873,1,0.942691269562882,0,15,killing by host of symbiont cells,BP,
13954,GO:0051875,1,0.84649754488119,0,26,pigment granule localization,BP,
13955,GO:0051877,1,0.986385498499256,0,2,pigment granule aggregation in cell center,BP,
13956,GO:0051879,1,0.778544828681415,0,38,Hsp90 protein binding,MF,
13957,GO:0051880,1,0.928135878240495,0,10,G-quadruplex DNA binding,MF,
13960,GO:0051883,1,0.932120840493234,0,17,killing of cells in other organism involved in symbiotic interaction,BP,
13961,GO:0051884,1,0.963778048191801,0,5,regulation of timing of anagen,BP,
13962,GO:0051885,1,0.986146338612848,0,2,positive regulation of timing of anagen,BP,
13963,GO:0051886,1,0.992061604374255,0,1,negative regulation of timing of anagen,BP,
13964,GO:0051890,1,0.950981506730118,0,7,regulation of cardioblast differentiation,BP,
13965,GO:0051891,1,0.958246313227309,0,6,positive regulation of cardioblast differentiation,BP,
13966,GO:0051892,1,0.992421927553956,0,1,negative regulation of cardioblast differentiation,BP,
13968,GO:0051894,1,0.83617816397221,0,24,positive regulation of focal adhesion assembly,BP,
13972,GO:0051898,1,0.750051143852945,0,42,negative regulation of protein kinase B signaling,BP,
13975,GO:0051901,1,0.951209761925913,0,9,positive regulation of mitochondrial depolarization,BP,
13977,GO:0051903,1,0.988689611048316,0,2,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
13978,GO:0051904,1,0.86556601486267,0,23,pigment granule transport,BP,
13979,GO:0051905,1,0.857575435539005,0,24,establishment of pigment granule localization,BP,
13980,GO:0051908,1,0.992706031430078,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
13981,GO:0051913,1,0.988448241439148,0,1,regulation of synaptic plasticity by chemical substance,BP,
13982,GO:0051914,1,0.988448241439148,0,1,positive regulation of synaptic plasticity by chemical substance,BP,
13983,GO:0051915,1,0.988448241439148,0,1,induction of synaptic plasticity by chemical substance,BP,
13984,GO:0051916,1,0.987061818591582,0,2,granulocyte colony-stimulating factor binding,MF,
13985,GO:0051917,1,0.94174511391195,0,10,regulation of fibrinolysis,BP,
13986,GO:0051918,1,0.958320688809295,0,7,negative regulation of fibrinolysis,BP,
13987,GO:0051919,1,0.983652112056247,0,3,positive regulation of fibrinolysis,BP,
13988,GO:0051920,1,0.975532824187619,0,7,peroxiredoxin activity,MF,
13989,GO:0051923,1,0.915128452716731,0,16,sulfation,BP,
13991,GO:0051926,1,0.728000016383778,0,52,negative regulation of calcium ion transport,BP,
13993,GO:0051930,1,0.838582065446016,0,29,regulation of sensory perception of pain,BP,
13994,GO:0051931,1,0.833018090133407,0,30,regulation of sensory perception,BP,
13996,GO:0051933,1,0.968522664638556,0,4,amino acid neurotransmitter reuptake,BP,
13997,GO:0051934,1,0.942138963361699,0,11,catecholamine uptake involved in synaptic transmission,BP,
13998,GO:0051935,1,0.968522664638556,0,4,glutamate reuptake,BP,
13999,GO:0051937,1,0.670778196743327,0,66,catecholamine transport,BP,
14000,GO:0051938,1,0.89815449422222,0,14,L-glutamate import,BP,
14001,GO:0051939,1,0.973616689495838,0,4,gamma-aminobutyric acid import,BP,
14002,GO:0051940,1,0.959528433234708,0,8,regulation of catecholamine uptake involved in synaptic transmission,BP,
14003,GO:0051941,1,0.975969898766499,0,3,regulation of amino acid uptake involved in synaptic transmission,BP,
14004,GO:0051943,1,0.992495731749345,0,1,positive regulation of amino acid uptake involved in synaptic transmission,BP,
14005,GO:0051944,1,0.985911188653711,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14006,GO:0051945,1,0.99273199371895,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14007,GO:0051946,1,0.975969898766499,0,3,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14008,GO:0051951,1,0.992495731749345,0,1,positive regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14009,GO:0051952,1,0.59393717419372,0,83,regulation of amine transport,BP,
14010,GO:0051953,1,0.861775130344221,0,24,negative regulation of amine transport,BP,
14011,GO:0051954,1,0.802378891915229,0,34,positive regulation of amine transport,BP,
14012,GO:0051955,1,0.795609426519864,0,34,regulation of amino acid transport,BP,
14013,GO:0051956,1,0.924144697751658,0,13,negative regulation of amino acid transport,BP,
14014,GO:0051957,1,0.874472893198057,0,19,positive regulation of amino acid transport,BP,
14015,GO:0051958,1,0.9845075344276,0,2,methotrexate transport,BP,
14020,GO:0051963,1,0.488361484304114,0,95,regulation of synapse assembly,BP,
14021,GO:0051964,1,0.942120329170471,0,8,negative regulation of synapse assembly,BP,
14022,GO:0051965,1,0.649524195555803,0,58,positive regulation of synapse assembly,BP,
14024,GO:0051967,1,0.934056020749368,0,10,negative regulation of synaptic transmission, glutamatergic,BP,
14026,GO:0051969,1,0.920930586670441,0,14,regulation of transmission of nerve impulse,BP,
14027,GO:0051970,1,0.979423749498654,0,4,negative regulation of transmission of nerve impulse,BP,
14028,GO:0051971,1,0.963718893379879,0,6,positive regulation of transmission of nerve impulse,BP,
14031,GO:0051974,1,0.933097165807004,0,11,negative regulation of telomerase activity,BP,
14032,GO:0051977,1,0.994623846563876,0,1,lysophospholipid transport,BP,
14033,GO:0051978,1,0.994623846563876,0,1,lysophospholipid:sodium symporter activity,MF,
14034,GO:0051983,1,0.524143405799012,0,94,regulation of chromosome segregation,BP,
14035,GO:0051984,1,0.813716373911441,0,30,positive regulation of chromosome segregation,BP,
14036,GO:0051985,1,0.764525693470872,0,41,negative regulation of chromosome segregation,BP,
14037,GO:0051987,1,0.965382944611944,0,6,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14038,GO:0051988,1,0.917448149832184,0,13,regulation of attachment of spindle microtubules to kinetochore,BP,
14039,GO:0051990,1,0.993623003692494,0,1,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
14040,GO:0051996,1,0.994834506269511,0,1,squalene synthase activity,MF,
14041,GO:0051998,1,0.969619326452004,0,5,protein carboxyl O-methyltransferase activity,MF,
14042,GO:0052025,1,0.99372110036174,0,2,modification by symbiont of host cell membrane,BP,
14043,GO:0052026,1,0.993076404209305,0,1,modulation by symbiont of host transcription,BP,
14044,GO:0052027,1,0.984744276122055,0,2,modulation by symbiont of host signal transduction pathway,BP,
14045,GO:0052029,1,0.992034489406777,0,1,suppression by symbiont of host signal transduction pathway,BP,
14046,GO:0052040,1,0.946310314386876,0,9,modulation by symbiont of host programmed cell death,BP,
14047,GO:0052041,1,0.976438185178785,0,4,negative regulation by symbiont of host programmed cell death,BP,
14048,GO:0052042,1,0.985206092408694,0,3,positive regulation by symbiont of host programmed cell death,BP,
14049,GO:0052043,1,0.99372110036174,0,2,modification by symbiont of host cellular component,BP,
14050,GO:0052053,1,0.993269958212675,0,1,negative regulation by symbiont of host catalytic activity,BP,
14051,GO:0052055,1,0.985357513237995,0,2,modulation by symbiont of host molecular function,BP,
14052,GO:0052056,1,0.985357513237995,0,2,negative regulation by symbiont of host molecular function,BP,
14053,GO:0052111,1,0.99372110036174,0,2,modification by symbiont of host structure,BP,
14055,GO:0052148,1,0.993269958212675,0,1,modulation by symbiont of host catalytic activity,BP,
14056,GO:0052150,1,0.965285169087925,0,6,modulation by symbiont of host apoptotic process,BP,
14057,GO:0052151,1,0.985206092408694,0,3,positive regulation by symbiont of host apoptotic process,BP,
14058,GO:0052173,1,0.976412583790958,0,3,response to defenses of other organism,BP,
14059,GO:0052185,1,0.99372110036174,0,2,modification of structure of other organism involved in symbiotic interaction,BP,
14060,GO:0052188,1,0.99372110036174,0,2,modification of cellular component in other organism involved in symbiotic interaction,BP,
14061,GO:0052199,1,0.988567736516303,0,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14062,GO:0052200,1,0.976412583790958,0,3,response to host defenses,BP,
14063,GO:0052203,1,0.984304370111289,0,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14064,GO:0052204,1,0.969848279773595,0,6,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
14065,GO:0052205,1,0.957294078769806,0,8,modulation of molecular function in other organism involved in symbiotic interaction,BP,
14066,GO:0052214,1,0.995897193514659,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
14067,GO:0052227,1,0.995897193514659,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
14068,GO:0052229,1,0.995897193514659,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
14069,GO:0052248,1,0.965285169087925,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14070,GO:0052312,1,0.993076404209305,0,1,modulation of transcription in other organism involved in symbiotic interaction,BP,
14071,GO:0052314,1,0.990414552819829,0,2,phytoalexin metabolic process,BP,
14072,GO:0052330,1,0.985206092408694,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14073,GO:0052332,1,0.99372110036174,0,2,modification by organism of membrane in other organism involved in symbiotic interaction,BP,
14074,GO:0052360,1,0.995897193514659,0,1,catabolism by host of symbiont macromolecule,BP,
14075,GO:0052361,1,0.995897193514659,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
14076,GO:0052362,1,0.995897193514659,0,1,catabolism by host of symbiont protein,BP,
14077,GO:0052363,1,0.995897193514659,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14078,GO:0052364,1,0.995897193514659,0,1,catabolism by host of substance in symbiont,BP,
14079,GO:0052372,1,0.793681569974677,0,38,modulation by symbiont of entry into host,BP,
14080,GO:0052381,1,0.994772730685266,0,1,tRNA dimethylallyltransferase activity,MF,
14081,GO:0052403,1,0.99526624345881,0,1,negative regulation by host of symbiont catalytic activity,BP,
14082,GO:0052405,1,0.984262652048003,0,4,negative regulation by host of symbiont molecular function,BP,
14083,GO:0052416,1,0.995897193514659,0,1,metabolism by host of symbiont macromolecule,BP,
14084,GO:0052417,1,0.995897193514659,0,1,metabolism by host of symbiont protein,BP,
14085,GO:0052418,1,0.995897193514659,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14086,GO:0052419,1,0.995897193514659,0,1,metabolism by host of substance in symbiont,BP,
14087,GO:0052422,1,0.990974284129706,0,2,modulation by host of symbiont catalytic activity,BP,
14088,GO:0052428,1,0.971523768814663,0,6,modulation by host of symbiont molecular function,BP,
14089,GO:0052433,1,0.965285169087925,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14090,GO:0052501,1,0.996372155485022,0,1,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14093,GO:0052590,1,0.991634106227436,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14094,GO:0052591,1,0.991634106227436,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14095,GO:0052593,1,0.986069044221009,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14096,GO:0052594,1,0.986069044221009,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14097,GO:0052595,1,0.986069044221009,0,2,aliphatic-amine oxidase activity,MF,
14098,GO:0052596,1,0.986069044221009,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14099,GO:0052629,1,0.946542868334462,0,7,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14100,GO:0052630,1,0.994257352924376,0,1,UDP-N-acetylgalactosamine diphosphorylase activity,MF,
14101,GO:0052642,1,0.990146602328805,0,2,lysophosphatidic acid phosphatase activity,MF,
14103,GO:0052650,1,0.945109649225313,0,12,NADP-retinol dehydrogenase activity,MF,
14104,GO:0052651,1,0.966720572579034,0,6,monoacylglycerol catabolic process,BP,
14105,GO:0052652,1,0.876181209057157,0,18,cyclic purine nucleotide metabolic process,BP,
14106,GO:0052654,1,0.986303815855716,0,2,L-leucine transaminase activity,MF,
14107,GO:0052655,1,0.986303815855716,0,2,L-valine transaminase activity,MF,
14108,GO:0052656,1,0.986303815855716,0,2,L-isoleucine transaminase activity,MF,
14109,GO:0052657,1,0.996243042055326,0,1,guanine phosphoribosyltransferase activity,MF,
14110,GO:0052658,1,0.957543284572685,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14111,GO:0052659,1,0.964918227451014,0,5,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14112,GO:0052666,1,0.9952082833299,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14114,GO:0052692,1,0.996238987162587,0,1,raffinose alpha-galactosidase activity,MF,
14115,GO:0052695,1,0.980418575132718,0,3,cellular glucuronidation,BP,
14116,GO:0052717,1,0.987489612580829,0,2,tRNA-specific adenosine-34 deaminase activity,MF,
14117,GO:0052718,1,0.987489612580829,0,2,tRNA-specific adenosine-34 deaminase complex,CC,
14118,GO:0052723,1,0.969810620182965,0,4,inositol hexakisphosphate 1-kinase activity,MF,
14119,GO:0052724,1,0.969810620182965,0,4,inositol hexakisphosphate 3-kinase activity,MF,
14120,GO:0052725,1,0.992666684062571,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14121,GO:0052726,1,0.992666684062571,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14122,GO:0052731,1,0.994835790131219,0,1,phosphocholine phosphatase activity,MF,
14123,GO:0052732,1,0.994835790131219,0,1,phosphoethanolamine phosphatase activity,MF,
14124,GO:0052735,1,0.972931180930887,0,4,tRNA (cytosine-3-)-methyltransferase activity,MF,
14125,GO:0052739,1,0.96534253998977,0,6,phosphatidylserine 1-acylhydrolase activity,MF,
14126,GO:0052740,1,0.969545649740333,0,5,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
14127,GO:0052742,1,0.891373300047927,0,14,phosphatidylinositol kinase activity,MF,
14128,GO:0052743,1,0.950462462974839,0,7,inositol tetrakisphosphate phosphatase activity,MF,
14129,GO:0052744,1,0.869590266368092,0,18,phosphatidylinositol monophosphate phosphatase activity,MF,
14130,GO:0052745,1,0.914232028339856,0,13,inositol phosphate phosphatase activity,MF,
14131,GO:0052746,1,0.985101958453674,0,2,inositol phosphorylation,BP,
14132,GO:0052751,1,0.996644406897703,0,1,GDP-mannose hydrolase activity,MF,
14133,GO:0052794,1,0.982543380566682,0,3,exo-alpha-(2->3)-sialidase activity,MF,
14134,GO:0052795,1,0.982543380566682,0,3,exo-alpha-(2->6)-sialidase activity,MF,
14135,GO:0052796,1,0.982543380566682,0,3,exo-alpha-(2->8)-sialidase activity,MF,
14136,GO:0052798,1,0.994860156566715,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14139,GO:0052812,1,0.96512503381245,0,5,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14140,GO:0052813,1,0.96512503381245,0,5,phosphatidylinositol bisphosphate kinase activity,MF,
14141,GO:0052814,1,0.992495412096442,0,1,medium-chain-aldehyde dehydrogenase activity,MF,
14142,GO:0052815,1,0.989135236184959,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14143,GO:0052816,1,0.992577105170387,0,1,long-chain acyl-CoA hydrolase activity,MF,
14144,GO:0052817,1,0.992577105170387,0,1,very long chain acyl-CoA hydrolase activity,MF,
14145,GO:0052821,1,0.996593694428561,0,1,DNA-7-methyladenine glycosylase activity,MF,
14146,GO:0052822,1,0.996593694428561,0,1,DNA-3-methylguanine glycosylase activity,MF,
14147,GO:0052824,1,0.994142455443838,0,1,dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity,MF,
14148,GO:0052826,1,0.99311926768676,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14149,GO:0052827,1,0.99311926768676,0,1,inositol pentakisphosphate phosphatase activity,MF,
14150,GO:0052832,1,0.981568267790148,0,3,inositol monophosphate 3-phosphatase activity,MF,
14151,GO:0052833,1,0.981568267790148,0,3,inositol monophosphate 4-phosphatase activity,MF,
14152,GO:0052834,1,0.981568267790148,0,3,inositol monophosphate phosphatase activity,MF,
14153,GO:0052840,1,0.977990025656706,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14154,GO:0052842,1,0.977990025656706,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14155,GO:0052851,1,0.976231992888798,0,3,ferric-chelate reductase (NADPH) activity,MF,
14156,GO:0052852,1,0.991680934823751,0,2,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14157,GO:0052853,1,0.991680934823751,0,2,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14158,GO:0052854,1,0.991680934823751,0,2,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14159,GO:0052856,1,0.99666737040473,0,1,NADHX epimerase activity,MF,
14160,GO:0052857,1,0.99666737040473,0,1,NADPHX epimerase activity,MF,
14161,GO:0052858,1,0.992529171934399,0,1,peptidyl-lysine acetyltransferase activity,MF,
14162,GO:0052866,1,0.795906952155587,0,30,phosphatidylinositol phosphate phosphatase activity,MF,
14163,GO:0052869,1,0.992255422272306,0,1,arachidonic acid omega-hydroxylase activity,MF,
14164,GO:0052884,1,0.993564967264221,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14165,GO:0052885,1,0.993564967264221,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14166,GO:0052890,1,0.987640529998262,0,2,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14167,GO:0052894,1,0.994922736401722,0,1,norspermine:oxygen oxidoreductase activity,MF,
14168,GO:0052895,1,0.994922736401722,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14169,GO:0052899,1,0.995786241327855,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14170,GO:0052901,1,0.990730154264351,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14171,GO:0052902,1,0.995786241327855,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14172,GO:0052903,1,0.995786241327855,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14173,GO:0052904,1,0.995786241327855,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14174,GO:0052905,1,0.979899979581028,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
14175,GO:0052906,1,0.991998910162976,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14176,GO:0052907,1,0.99325505912211,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14177,GO:0052909,1,0.99325505912211,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14178,GO:0052917,1,0.994142455443838,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14179,GO:0052918,1,0.991424698261851,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14180,GO:0052925,1,0.996096146666314,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14181,GO:0052926,1,0.991424698261851,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14182,GO:0052927,1,0.994399259932995,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14183,GO:0052928,1,0.994399259932995,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14184,GO:0052929,1,0.994399259932995,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14188,GO:0055005,1,0.980148020453054,0,3,ventricular cardiac myofibril assembly,BP,
14192,GO:0055009,1,0.966108769080296,0,5,atrial cardiac muscle tissue morphogenesis,BP,
14194,GO:0055011,1,0.99110167987007,0,2,atrial cardiac muscle cell differentiation,BP,
14195,GO:0055012,1,0.900816146840573,0,15,ventricular cardiac muscle cell differentiation,BP,
14197,GO:0055014,1,0.99110167987007,0,2,atrial cardiac muscle cell development,BP,
14198,GO:0055015,1,0.937702462592882,0,10,ventricular cardiac muscle cell development,BP,
14200,GO:0055018,1,0.995611667834955,0,1,regulation of cardiac muscle fiber development,BP,
14201,GO:0055020,1,0.995611667834955,0,1,positive regulation of cardiac muscle fiber development,BP,
14204,GO:0055023,1,0.792504943788881,0,32,positive regulation of cardiac muscle tissue growth,BP,
14208,GO:0055028,1,0.990917185225543,0,1,cortical microtubule,CC,
14209,GO:0055029,1,0.564482776795584,0,96,nuclear DNA-directed RNA polymerase complex,CC,
14212,GO:0055048,1,0.990917185225543,0,1,anastral spindle assembly,BP,
14213,GO:0055056,1,0.957570484989469,0,6,D-glucose transmembrane transporter activity,MF,
14214,GO:0055057,1,0.89682911287453,0,14,neuroblast division,BP,
14215,GO:0055059,1,0.956539063897918,0,6,asymmetric neuroblast division,BP,
14216,GO:0055062,1,0.942358261879735,0,8,phosphate ion homeostasis,BP,
14217,GO:0055064,1,0.910461886876723,0,13,chloride ion homeostasis,BP,
14219,GO:0055067,1,0.393936262997835,0,144,monovalent inorganic cation homeostasis,BP,
14220,GO:0055069,1,0.836889411195976,0,32,zinc ion homeostasis,BP,
14221,GO:0055070,1,0.902620753709408,0,17,copper ion homeostasis,BP,
14222,GO:0055071,1,0.985015848025814,0,2,manganese ion homeostasis,BP,
14224,GO:0055073,1,0.982104914425457,0,3,cadmium ion homeostasis,BP,
14229,GO:0055078,1,0.75882536562053,0,43,sodium ion homeostasis,BP,
14231,GO:0055081,1,0.698659278501503,0,52,anion homeostasis,BP,
14233,GO:0055083,1,0.857932527091048,0,21,monovalent inorganic anion homeostasis,BP,
14236,GO:0055087,1,0.981093930551324,0,3,Ski complex,CC,
14237,GO:0055088,1,0.453466436482222,0,123,lipid homeostasis,BP,
14238,GO:0055089,1,0.9086601698281,0,14,fatty acid homeostasis,BP,
14239,GO:0055090,1,0.8550985575247,0,27,acylglycerol homeostasis,BP,
14240,GO:0055091,1,0.929466358540826,0,12,phospholipid homeostasis,BP,
14241,GO:0055092,1,0.633488974502479,0,71,sterol homeostasis,BP,
14242,GO:0055093,1,0.886308812567642,0,19,response to hyperoxia,BP,
14243,GO:0055094,1,0.824682635502718,0,29,response to lipoprotein particle,BP,
14244,GO:0055095,1,0.980042674593998,0,3,lipoprotein particle mediated signaling,BP,
14245,GO:0055096,1,0.980042674593998,0,3,low-density lipoprotein particle mediated signaling,BP,
14246,GO:0055100,1,0.979865433229734,0,3,adiponectin binding,MF,
14247,GO:0055102,1,0.952093659733719,0,11,lipase inhibitor activity,MF,
14249,GO:0055105,1,0.976986744083884,0,6,ubiquitin-protein transferase inhibitor activity,MF,
14250,GO:0055106,1,0.912708521730135,0,17,ubiquitin-protein transferase regulator activity,MF,
14251,GO:0055108,1,0.995161868590964,0,1,Golgi to transport vesicle transport,BP,
14252,GO:0055111,1,0.991793106269829,0,1,ingression involved in gastrulation with mouth forming second,BP,
14253,GO:0055113,1,0.988927709473492,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14255,GO:0055117,1,0.598322510817757,0,74,regulation of cardiac muscle contraction,BP,
14256,GO:0055118,1,0.959329648257496,0,6,negative regulation of cardiac muscle contraction,BP,
14257,GO:0055119,1,0.897787784346016,0,16,relaxation of cardiac muscle,BP,
14258,GO:0055120,1,0.996624313441655,0,1,striated muscle dense body,CC,
14260,GO:0055129,1,0.97243208337058,0,5,L-proline biosynthetic process,BP,
14261,GO:0055130,1,0.995961406871488,0,1,D-alanine catabolic process,BP,
14262,GO:0055131,1,0.965576337199759,0,6,C3HC4-type RING finger domain binding,MF,
14263,GO:0060001,1,0.990112518216829,0,1,minus-end directed microfilament motor activity,MF,
14264,GO:0060002,1,0.980490390869051,0,2,plus-end directed microfilament motor activity,MF,
14265,GO:0060003,1,0.978605264088127,0,3,copper ion export,BP,
14266,GO:0060004,1,0.884701190245398,0,18,reflex,BP,
14267,GO:0060005,1,0.970168417050078,0,4,vestibular reflex,BP,
14268,GO:0060007,1,0.992439311784763,0,1,linear vestibuloocular reflex,BP,
14269,GO:0060008,1,0.881063635931791,0,18,Sertoli cell differentiation,BP,
14270,GO:0060009,1,0.903924127242294,0,14,Sertoli cell development,BP,
14271,GO:0060010,1,0.992627896029414,0,1,Sertoli cell fate commitment,BP,
14272,GO:0060011,1,0.981418327740684,0,3,Sertoli cell proliferation,BP,
14273,GO:0060012,1,0.959992104124371,0,6,synaptic transmission, glycinergic,BP,
14274,GO:0060013,1,0.949218181804071,0,7,righting reflex,BP,
14275,GO:0060014,1,0.993019588637981,0,1,granulosa cell differentiation,BP,
14276,GO:0060017,1,0.958771936361663,0,6,parathyroid gland development,BP,
14277,GO:0060018,1,0.977635884662098,0,3,astrocyte fate commitment,BP,
14278,GO:0060019,1,0.935329214925513,0,12,radial glial cell differentiation,BP,
14279,GO:0060020,1,0.948847500027082,0,8,Bergmann glial cell differentiation,BP,
14281,GO:0060022,1,0.955719029011151,0,6,hard palate development,BP,
14282,GO:0060023,1,0.962943346603194,0,5,soft palate development,BP,
14283,GO:0060024,1,0.971441138809532,0,4,rhythmic synaptic transmission,BP,
14284,GO:0060025,1,0.977183723391278,0,3,regulation of synaptic activity,BP,
14285,GO:0060026,1,0.902454088265501,0,15,convergent extension,BP,
14286,GO:0060027,1,0.944099349081663,0,8,convergent extension involved in gastrulation,BP,
14287,GO:0060028,1,0.953917589801056,0,7,convergent extension involved in axis elongation,BP,
14288,GO:0060029,1,0.961672097240398,0,6,convergent extension involved in organogenesis,BP,
14289,GO:0060031,1,0.987012119677772,0,2,mediolateral intercalation,BP,
14290,GO:0060032,1,0.983775764274081,0,2,notochord regression,BP,
14291,GO:0060033,1,0.898530892245483,0,16,anatomical structure regression,BP,
14292,GO:0060034,1,0.992473876289443,0,1,notochord cell differentiation,BP,
14293,GO:0060035,1,0.992473876289443,0,1,notochord cell development,BP,
14294,GO:0060037,1,0.849009470652083,0,24,pharyngeal system development,BP,
14296,GO:0060039,1,0.859779447111412,0,19,pericardium development,BP,
14297,GO:0060040,1,0.972402727439449,0,5,retinal bipolar neuron differentiation,BP,
14299,GO:0060042,1,0.674127007581092,0,54,retina morphogenesis in camera-type eye,BP,
14302,GO:0060045,1,0.835715268298612,0,24,positive regulation of cardiac muscle cell proliferation,BP,
14303,GO:0060046,1,0.923974891874541,0,13,regulation of acrosome reaction,BP,
14306,GO:0060049,1,0.907722623674895,0,14,regulation of protein glycosylation,BP,
14307,GO:0060050,1,0.938403681265692,0,9,positive regulation of protein glycosylation,BP,
14308,GO:0060051,1,0.988924540799065,0,2,negative regulation of protein glycosylation,BP,
14309,GO:0060052,1,0.961206270720635,0,6,neurofilament cytoskeleton organization,BP,
14310,GO:0060053,1,0.985260726607095,0,2,neurofilament cytoskeleton,CC,
14312,GO:0060055,1,0.840677142968073,0,26,angiogenesis involved in wound healing,BP,
14313,GO:0060056,1,0.956538544540045,0,7,mammary gland involution,BP,
14314,GO:0060057,1,0.989055849723549,0,2,apoptotic process involved in mammary gland involution,BP,
14315,GO:0060058,1,0.989055849723549,0,2,positive regulation of apoptotic process involved in mammary gland involution,BP,
14316,GO:0060059,1,0.948509305209431,0,6,embryonic retina morphogenesis in camera-type eye,BP,
14317,GO:0060060,1,0.983195777288577,0,2,post-embryonic retina morphogenesis in camera-type eye,BP,
14318,GO:0060061,1,0.982798220719427,0,3,Spemann organizer formation,BP,
14319,GO:0060064,1,0.996130464954528,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
14320,GO:0060065,1,0.86196128641525,0,20,uterus development,BP,
14321,GO:0060066,1,0.988363141806899,0,2,oviduct development,BP,
14322,GO:0060067,1,0.991685564322805,0,1,cervix development,BP,
14326,GO:0060072,1,0.991437142402064,0,1,large conductance calcium-activated potassium channel activity,MF,
14327,GO:0060073,1,0.951831690761632,0,7,micturition,BP,
14328,GO:0060074,1,0.83708921654403,0,24,synapse maturation,BP,
14329,GO:0060075,1,0.938475761780049,0,9,regulation of resting membrane potential,BP,
14330,GO:0060076,1,0.679046492231463,0,51,excitatory synapse,CC,
14331,GO:0060077,1,0.88980042887703,0,17,inhibitory synapse,CC,
14332,GO:0060078,1,0.373797219873334,0,137,regulation of postsynaptic membrane potential,BP,
14333,GO:0060079,1,0.500281226168344,0,99,excitatory postsynaptic potential,BP,
14334,GO:0060080,1,0.888309333897421,0,16,inhibitory postsynaptic potential,BP,
14335,GO:0060081,1,0.92835517071353,0,11,membrane hyperpolarization,BP,
14336,GO:0060082,1,0.996051199785396,0,1,eye blink reflex,BP,
14337,GO:0060083,1,0.983948480960692,0,2,smooth muscle contraction involved in micturition,BP,
14338,GO:0060084,1,0.979299127513608,0,3,synaptic transmission involved in micturition,BP,
14339,GO:0060086,1,0.978932377391449,0,3,circadian temperature homeostasis,BP,
14340,GO:0060087,1,0.965936225636026,0,6,relaxation of vascular associated smooth muscle,BP,
14341,GO:0060088,1,0.936550262327082,0,10,auditory receptor cell stereocilium organization,BP,
14344,GO:0060091,1,0.956832655034035,0,7,kinocilium,CC,
14345,GO:0060099,1,0.905509071175592,0,15,regulation of phagocytosis, engulfment,BP,
14346,GO:0060100,1,0.915753816156631,0,13,positive regulation of phagocytosis, engulfment,BP,
14347,GO:0060101,1,0.99537500933713,0,1,negative regulation of phagocytosis, engulfment,BP,
14348,GO:0060112,1,0.992302248007228,0,2,generation of ovulation cycle rhythm,BP,
14350,GO:0060117,1,0.886583038284183,0,17,auditory receptor cell development,BP,
14352,GO:0060120,1,0.968956166862574,0,4,inner ear receptor cell fate commitment,BP,
14354,GO:0060123,1,0.931601915181344,0,11,regulation of growth hormone secretion,BP,
14355,GO:0060124,1,0.958079997618068,0,8,positive regulation of growth hormone secretion,BP,
14356,GO:0060125,1,0.983002514625846,0,2,negative regulation of growth hormone secretion,BP,
14357,GO:0060126,1,0.983377126336987,0,3,somatotropin secreting cell differentiation,BP,
14358,GO:0060127,1,0.994505644773911,0,1,prolactin secreting cell differentiation,BP,
14359,GO:0060128,1,0.989399097239357,0,2,corticotropin hormone secreting cell differentiation,BP,
14360,GO:0060129,1,0.981958014957791,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
14361,GO:0060133,1,0.996303102595273,0,1,somatotropin secreting cell development,BP,
14362,GO:0060134,1,0.89531500564041,0,15,prepulse inhibition,BP,
14364,GO:0060136,1,0.964275295969031,0,6,embryonic process involved in female pregnancy,BP,
14365,GO:0060137,1,0.950275436976944,0,8,maternal process involved in parturition,BP,
14366,GO:0060139,1,0.988793695136793,0,2,positive regulation of apoptotic process by virus,BP,
14367,GO:0060142,1,0.882277163005825,0,23,regulation of syncytium formation by plasma membrane fusion,BP,
14368,GO:0060143,1,0.889632293287237,0,21,positive regulation of syncytium formation by plasma membrane fusion,BP,
14371,GO:0060149,1,0.873651515923263,0,20,negative regulation of posttranscriptional gene silencing,BP,
14372,GO:0060151,1,0.984786649786698,0,2,peroxisome localization,BP,
14373,GO:0060152,1,0.984786649786698,0,2,microtubule-based peroxisome localization,BP,
14374,GO:0060155,1,0.946810150162535,0,9,platelet dense granule organization,BP,
14375,GO:0060157,1,0.976451808817167,0,4,urinary bladder development,BP,
14376,GO:0060158,1,0.956723986127423,0,8,phospholipase C-activating dopamine receptor signaling pathway,BP,
14377,GO:0060159,1,0.931088903129228,0,11,regulation of dopamine receptor signaling pathway,BP,
14378,GO:0060160,1,0.975551856695055,0,4,negative regulation of dopamine receptor signaling pathway,BP,
14379,GO:0060161,1,0.965582939818521,0,5,positive regulation of dopamine receptor signaling pathway,BP,
14380,GO:0060163,1,0.990404096160551,0,2,subpallium neuron fate commitment,BP,
14381,GO:0060164,1,0.982851090337496,0,3,regulation of timing of neuron differentiation,BP,
14382,GO:0060165,1,0.993898281598366,0,1,regulation of timing of subpallium neuron differentiation,BP,
14383,GO:0060166,1,0.982782545268531,0,3,olfactory pit development,BP,
14386,GO:0060169,1,0.996065573507639,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14387,GO:0060170,1,0.62874282055765,0,66,ciliary membrane,CC,
14388,GO:0060171,1,0.972949156307762,0,3,stereocilium membrane,CC,
14390,GO:0060174,1,0.924692567852882,0,11,limb bud formation,BP,
14391,GO:0060175,1,0.990964142990014,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14392,GO:0060177,1,0.988513187887608,0,2,regulation of angiotensin metabolic process,BP,
14393,GO:0060178,1,0.994445927308636,0,1,regulation of exocyst localization,BP,
14394,GO:0060179,1,0.940249178462196,0,8,male mating behavior,BP,
14395,GO:0060180,1,0.952548991369274,0,7,female mating behavior,BP,
14396,GO:0060182,1,0.993031215140746,0,1,apelin receptor activity,MF,
14397,GO:0060183,1,0.985773431810886,0,2,apelin receptor signaling pathway,BP,
14398,GO:0060184,1,0.984379008888548,0,2,cell cycle switching,BP,
14399,GO:0060187,1,0.933134992050889,0,9,cell pole,CC,
14401,GO:0060192,1,0.931554398986438,0,12,negative regulation of lipase activity,BP,
14403,GO:0060197,1,0.983289547804842,0,3,cloacal septation,BP,
14404,GO:0060198,1,0.929864737492269,0,12,clathrin-sculpted vesicle,CC,
14405,GO:0060199,1,0.976197506494417,0,4,clathrin-sculpted glutamate transport vesicle,CC,
14406,GO:0060200,1,0.982492870538367,0,3,clathrin-sculpted acetylcholine transport vesicle,CC,
14407,GO:0060201,1,0.982492870538367,0,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
14408,GO:0060203,1,0.976197506494417,0,4,clathrin-sculpted glutamate transport vesicle membrane,CC,
14410,GO:0060211,1,0.914003885494929,0,12,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14411,GO:0060212,1,0.995529313122427,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14412,GO:0060213,1,0.914003885494929,0,12,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14413,GO:0060214,1,0.979026363310335,0,4,endocardium formation,BP,
14414,GO:0060215,1,0.945656783528738,0,8,primitive hemopoiesis,BP,
14415,GO:0060216,1,0.86241931875819,0,21,definitive hemopoiesis,BP,
14416,GO:0060217,1,0.992141371525741,0,1,hemangioblast cell differentiation,BP,
14417,GO:0060218,1,0.620594007005899,0,84,hematopoietic stem cell differentiation,BP,
14418,GO:0060219,1,0.844736895407206,0,24,camera-type eye photoreceptor cell differentiation,BP,
14419,GO:0060220,1,0.994934185789107,0,1,camera-type eye photoreceptor cell fate commitment,BP,
14420,GO:0060221,1,0.918648176417117,0,12,retinal rod cell differentiation,BP,
14421,GO:0060228,1,0.990126653209626,0,3,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
14422,GO:0060229,1,0.937315218886578,0,11,lipase activator activity,MF,
14423,GO:0060230,1,0.993299715660821,0,2,lipoprotein lipase activator activity,MF,
14425,GO:0060232,1,0.972197292560106,0,4,delamination,BP,
14426,GO:0060234,1,0.990809317458871,0,1,neuroblast delamination,BP,
14427,GO:0060235,1,0.967821506085127,0,4,lens induction in camera-type eye,BP,
14428,GO:0060236,1,0.792167626478525,0,34,regulation of mitotic spindle organization,BP,
14429,GO:0060242,1,0.948063549863237,0,8,contact inhibition,BP,
14430,GO:0060243,1,0.992426318130508,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14431,GO:0060244,1,0.981416612450475,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
14432,GO:0060245,1,0.948063549863237,0,8,detection of cell density,BP,
14435,GO:0060252,1,0.909608424907923,0,15,positive regulation of glial cell proliferation,BP,
14437,GO:0060254,1,0.995544705891405,0,1,regulation of N-terminal protein palmitoylation,BP,
14439,GO:0060259,1,0.893769128372582,0,18,regulation of feeding behavior,BP,
14440,GO:0060260,1,0.788556894635284,0,35,regulation of transcription initiation from RNA polymerase II promoter,BP,
14441,GO:0060261,1,0.823138738462284,0,29,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
14442,GO:0060262,1,0.995544705891405,0,1,negative regulation of N-terminal protein palmitoylation,BP,
14443,GO:0060263,1,0.929010226041229,0,13,regulation of respiratory burst,BP,
14444,GO:0060264,1,0.973946387052191,0,5,regulation of respiratory burst involved in inflammatory response,BP,
14445,GO:0060265,1,0.992261687558209,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14446,GO:0060266,1,0.978347289361508,0,4,negative regulation of respiratory burst involved in inflammatory response,BP,
14447,GO:0060267,1,0.971644744648318,0,5,positive regulation of respiratory burst,BP,
14448,GO:0060268,1,0.96963625095781,0,5,negative regulation of respiratory burst,BP,
14450,GO:0060272,1,0.937288013023656,0,11,embryonic skeletal joint morphogenesis,BP,
14451,GO:0060278,1,0.98177137278312,0,3,regulation of ovulation,BP,
14452,GO:0060279,1,0.987417110979506,0,2,positive regulation of ovulation,BP,
14453,GO:0060280,1,0.994283053758508,0,1,negative regulation of ovulation,BP,
14454,GO:0060281,1,0.928467445137521,0,11,regulation of oocyte development,BP,
14455,GO:0060282,1,0.966080388681436,0,5,positive regulation of oocyte development,BP,
14456,GO:0060283,1,0.973407808498168,0,4,negative regulation of oocyte development,BP,
14459,GO:0060287,1,0.925877186507005,0,11,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14460,GO:0060290,1,0.949329877123624,0,8,transdifferentiation,BP,
14461,GO:0060291,1,0.550976280126071,0,83,long-term synaptic potentiation,BP,
14462,GO:0060292,1,0.799419161724628,0,31,long-term synaptic depression,BP,
14463,GO:0060293,1,0.884497337349679,0,17,germ plasm,CC,
14464,GO:0060294,1,0.584912852904242,0,85,cilium movement involved in cell motility,BP,
14465,GO:0060295,1,0.911173169057238,0,17,regulation of cilium movement involved in cell motility,BP,
14466,GO:0060296,1,0.961280236641283,0,6,regulation of cilium beat frequency involved in ciliary motility,BP,
14467,GO:0060297,1,0.954559032112271,0,6,regulation of sarcomere organization,BP,
14468,GO:0060298,1,0.978319283091929,0,3,positive regulation of sarcomere organization,BP,
14469,GO:0060299,1,0.996304995047058,0,1,negative regulation of sarcomere organization,BP,
14470,GO:0060300,1,0.977782549971298,0,4,regulation of cytokine activity,BP,
14471,GO:0060301,1,0.993871543672424,0,1,positive regulation of cytokine activity,BP,
14472,GO:0060302,1,0.991308445382015,0,2,negative regulation of cytokine activity,BP,
14473,GO:0060304,1,0.951885145973006,0,6,regulation of phosphatidylinositol dephosphorylation,BP,
14474,GO:0060305,1,0.993106347255175,0,1,regulation of cell diameter,BP,
14475,GO:0060306,1,0.797641212150296,0,31,regulation of membrane repolarization,BP,
14476,GO:0060307,1,0.866423353465147,0,20,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
14477,GO:0060309,1,0.990054376450959,0,2,elastin catabolic process,BP,
14478,GO:0060310,1,0.996777805129879,0,1,regulation of elastin catabolic process,BP,
14479,GO:0060311,1,0.996777805129879,0,1,negative regulation of elastin catabolic process,BP,
14480,GO:0060312,1,0.954171183160501,0,7,regulation of blood vessel remodeling,BP,
14481,GO:0060313,1,0.980004874468925,0,3,negative regulation of blood vessel remodeling,BP,
14482,GO:0060314,1,0.851161380005574,0,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,
14483,GO:0060315,1,0.941007114836889,0,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14484,GO:0060316,1,0.951495390839344,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14485,GO:0060317,1,0.816536650128522,0,31,cardiac epithelial to mesenchymal transition,BP,
14486,GO:0060318,1,0.961676284468149,0,6,definitive erythrocyte differentiation,BP,
14487,GO:0060319,1,0.974220358584282,0,4,primitive erythrocyte differentiation,BP,
14493,GO:0060327,1,0.984878898822492,0,2,cytoplasmic actin-based contraction involved in cell motility,BP,
14494,GO:0060330,1,0.872260539387067,0,23,regulation of response to interferon-gamma,BP,
14495,GO:0060331,1,0.969394500981121,0,6,negative regulation of response to interferon-gamma,BP,
14496,GO:0060332,1,0.959640603342935,0,6,positive regulation of response to interferon-gamma,BP,
14497,GO:0060333,1,0.608883732165321,0,85,interferon-gamma-mediated signaling pathway,BP,
14498,GO:0060334,1,0.872260539387067,0,23,regulation of interferon-gamma-mediated signaling pathway,BP,
14499,GO:0060335,1,0.959640603342935,0,6,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14500,GO:0060336,1,0.969394500981121,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14501,GO:0060337,1,0.633742963231668,0,76,type I interferon signaling pathway,BP,
14502,GO:0060338,1,0.815590023777313,0,31,regulation of type I interferon-mediated signaling pathway,BP,
14503,GO:0060339,1,0.924055740641997,0,12,negative regulation of type I interferon-mediated signaling pathway,BP,
14504,GO:0060340,1,0.925278613536182,0,11,positive regulation of type I interferon-mediated signaling pathway,BP,
14506,GO:0060342,1,0.973933827437587,0,4,photoreceptor inner segment membrane,CC,
14508,GO:0060345,1,0.992608555360218,0,1,spleen trabecula formation,BP,
14510,GO:0060347,1,0.926205084974934,0,13,heart trabecula formation,BP,
14514,GO:0060351,1,0.818213980170431,0,29,cartilage development involved in endochondral bone morphogenesis,BP,
14515,GO:0060352,1,0.930324337614442,0,11,cell adhesion molecule production,BP,
14516,GO:0060353,1,0.944194638169097,0,9,regulation of cell adhesion molecule production,BP,
14517,GO:0060354,1,0.971213853954686,0,4,negative regulation of cell adhesion molecule production,BP,
14518,GO:0060355,1,0.978004508895027,0,4,positive regulation of cell adhesion molecule production,BP,
14519,GO:0060357,1,0.986754213609008,0,2,regulation of leucine import,BP,
14520,GO:0060358,1,0.986754213609008,0,2,negative regulation of leucine import,BP,
14521,GO:0060359,1,0.979994559795144,0,3,response to ammonium ion,BP,
14522,GO:0060363,1,0.956933562593747,0,7,cranial suture morphogenesis,BP,
14523,GO:0060364,1,0.977827647167047,0,3,frontal suture morphogenesis,BP,
14524,GO:0060366,1,0.990363148962319,0,1,lambdoid suture morphogenesis,BP,
14525,GO:0060367,1,0.990363148962319,0,1,sagittal suture morphogenesis,BP,
14526,GO:0060368,1,0.924589422262478,0,11,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14527,GO:0060369,1,0.951002687024663,0,7,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14528,GO:0060370,1,0.991731664147801,0,1,susceptibility to T cell mediated cytotoxicity,BP,
14529,GO:0060371,1,0.953736140242902,0,6,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14530,GO:0060372,1,0.948047669336201,0,7,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14531,GO:0060373,1,0.963991159284754,0,5,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14532,GO:0060374,1,0.962187314174518,0,5,mast cell differentiation,BP,
14533,GO:0060375,1,0.984872469985454,0,2,regulation of mast cell differentiation,BP,
14534,GO:0060377,1,0.992674109458785,0,1,negative regulation of mast cell differentiation,BP,
14535,GO:0060378,1,0.986246352642422,0,2,regulation of brood size,BP,
14537,GO:0060380,1,0.994949428157739,0,1,regulation of single-stranded telomeric DNA binding,BP,
14538,GO:0060381,1,0.994949428157739,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14539,GO:0060382,1,0.98385431900933,0,2,regulation of DNA strand elongation,BP,
14540,GO:0060383,1,0.992454902064336,0,1,positive regulation of DNA strand elongation,BP,
14541,GO:0060384,1,0.818728040811597,0,26,innervation,BP,
14542,GO:0060385,1,0.956847221522132,0,6,axonogenesis involved in innervation,BP,
14543,GO:0060386,1,0.991747406078768,0,1,synapse assembly involved in innervation,BP,
14545,GO:0060390,1,0.841647942791176,0,25,regulation of SMAD protein signal transduction,BP,
14546,GO:0060391,1,0.896750066766034,0,15,positive regulation of SMAD protein signal transduction,BP,
14547,GO:0060392,1,0.969829108320827,0,5,negative regulation of SMAD protein signal transduction,BP,
14551,GO:0060396,1,0.872491407764248,0,19,growth hormone receptor signaling pathway,BP,
14552,GO:0060397,1,0.919002063491247,0,11,growth hormone receptor signaling pathway via JAK-STAT,BP,
14553,GO:0060398,1,0.969521524383612,0,5,regulation of growth hormone receptor signaling pathway,BP,
14554,GO:0060399,1,0.980483126419138,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14555,GO:0060400,1,0.988822439813682,0,2,negative regulation of growth hormone receptor signaling pathway,BP,
14558,GO:0060404,1,0.99251214454348,0,1,axonemal microtubule depolymerization,BP,
14559,GO:0060405,1,0.961961023751429,0,6,regulation of penile erection,BP,
14560,GO:0060406,1,0.973847882960924,0,4,positive regulation of penile erection,BP,
14561,GO:0060407,1,0.996065573507639,0,1,negative regulation of penile erection,BP,
14563,GO:0060412,1,0.74780296855576,0,40,ventricular septum morphogenesis,BP,
14564,GO:0060413,1,0.90684171512871,0,13,atrial septum morphogenesis,BP,
14565,GO:0060414,1,0.975592343910782,0,3,aorta smooth muscle tissue morphogenesis,BP,
14567,GO:0060416,1,0.79792957365282,0,32,response to growth hormone,BP,
14570,GO:0060421,1,0.769806265277943,0,36,positive regulation of heart growth,BP,
14571,GO:0060422,1,0.994350099493485,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14572,GO:0060423,1,0.980271436985993,0,3,foregut regionalization,BP,
14573,GO:0060424,1,0.980271436985993,0,3,lung field specification,BP,
14574,GO:0060425,1,0.713255812024158,0,50,lung morphogenesis,BP,
14575,GO:0060426,1,0.96902758385349,0,5,lung vasculature development,BP,
14576,GO:0060428,1,0.796178471059064,0,35,lung epithelium development,BP,
14578,GO:0060430,1,0.945401292153332,0,8,lung saccule development,BP,
14579,GO:0060431,1,0.972958393604277,0,4,primary lung bud formation,BP,
14580,GO:0060432,1,0.996826939881114,0,1,lung pattern specification process,BP,
14581,GO:0060433,1,0.941150358965311,0,10,bronchus development,BP,
14582,GO:0060434,1,0.986031638319283,0,2,bronchus morphogenesis,BP,
14583,GO:0060435,1,0.993192936476269,0,2,bronchiole development,BP,
14584,GO:0060436,1,0.996826939881114,0,1,bronchiole morphogenesis,BP,
14585,GO:0060437,1,0.964089006531804,0,6,lung growth,BP,
14586,GO:0060438,1,0.879334367872073,0,19,trachea development,BP,
14587,GO:0060439,1,0.931180461220982,0,11,trachea morphogenesis,BP,
14588,GO:0060440,1,0.962588307546679,0,6,trachea formation,BP,
14589,GO:0060441,1,0.822602030389882,0,29,epithelial tube branching involved in lung morphogenesis,BP,
14590,GO:0060442,1,0.919826041803286,0,12,branching involved in prostate gland morphogenesis,BP,
14591,GO:0060443,1,0.733304484160913,0,43,mammary gland morphogenesis,BP,
14592,GO:0060444,1,0.842653785239065,0,23,branching involved in mammary gland duct morphogenesis,BP,
14593,GO:0060445,1,0.848355830555545,0,23,branching involved in salivary gland morphogenesis,BP,
14594,GO:0060447,1,0.983600862867403,0,3,bud outgrowth involved in lung branching,BP,
14595,GO:0060448,1,0.977008047111539,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14596,GO:0060449,1,0.959037095497678,0,7,bud elongation involved in lung branching,BP,
14597,GO:0060452,1,0.936546632381303,0,11,positive regulation of cardiac muscle contraction,BP,
14598,GO:0060453,1,0.946326532601182,0,9,regulation of gastric acid secretion,BP,
14599,GO:0060454,1,0.985154724869932,0,2,positive regulation of gastric acid secretion,BP,
14600,GO:0060455,1,0.981224318331701,0,4,negative regulation of gastric acid secretion,BP,
14601,GO:0060456,1,0.95112860355736,0,9,positive regulation of digestive system process,BP,
14602,GO:0060457,1,0.931329937287047,0,13,negative regulation of digestive system process,BP,
14603,GO:0060458,1,0.989730417896949,0,2,right lung development,BP,
14604,GO:0060459,1,0.990923207630996,0,2,left lung development,BP,
14605,GO:0060460,1,0.994895965192756,0,1,left lung morphogenesis,BP,
14606,GO:0060461,1,0.993698442190156,0,1,right lung morphogenesis,BP,
14607,GO:0060462,1,0.959913009141102,0,6,lung lobe development,BP,
14608,GO:0060463,1,0.959913009141102,0,6,lung lobe morphogenesis,BP,
14609,GO:0060465,1,0.977313045526469,0,3,pharynx development,BP,
14610,GO:0060466,1,0.991147196399667,0,1,activation of meiosis involved in egg activation,BP,
14611,GO:0060467,1,0.984088980641594,0,3,negative regulation of fertilization,BP,
14612,GO:0060474,1,0.989498100369141,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
14613,GO:0060478,1,0.956686551551169,0,7,acrosomal vesicle exocytosis,BP,
14614,GO:0060479,1,0.876123471219557,0,21,lung cell differentiation,BP,
14615,GO:0060480,1,0.988171183918961,0,3,lung goblet cell differentiation,BP,
14616,GO:0060481,1,0.980738488902789,0,4,lobar bronchus epithelium development,BP,
14617,GO:0060482,1,0.973361027500171,0,5,lobar bronchus development,BP,
14618,GO:0060484,1,0.943862070537623,0,9,lung-associated mesenchyme development,BP,
14620,GO:0060486,1,0.971883349134382,0,4,club cell differentiation,BP,
14622,GO:0060488,1,0.980772691952279,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14623,GO:0060489,1,0.980772691952279,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14624,GO:0060490,1,0.980772691952279,0,2,lateral sprouting involved in lung morphogenesis,BP,
14626,GO:0060492,1,0.980271436985993,0,3,lung induction,BP,
14627,GO:0060495,1,0.996826939881114,0,1,cell-cell signaling involved in lung development,BP,
14628,GO:0060496,1,0.996826939881114,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
14629,GO:0060501,1,0.959163102774645,0,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
14630,GO:0060502,1,0.932667841021466,0,10,epithelial cell proliferation involved in lung morphogenesis,BP,
14631,GO:0060503,1,0.995611667834955,0,1,bud dilation involved in lung branching,BP,
14632,GO:0060509,1,0.961230830230104,0,5,type I pneumocyte differentiation,BP,
14633,GO:0060510,1,0.971030411300969,0,5,type II pneumocyte differentiation,BP,
14634,GO:0060512,1,0.828569564361959,0,27,prostate gland morphogenesis,BP,
14635,GO:0060513,1,0.937846122682757,0,10,prostatic bud formation,BP,
14636,GO:0060514,1,0.992853697764998,0,1,prostate induction,BP,
14637,GO:0060515,1,0.992853697764998,0,1,prostate field specification,BP,
14638,GO:0060516,1,0.988514509875222,0,2,primary prostatic bud elongation,BP,
14639,GO:0060517,1,0.99247770910114,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14640,GO:0060520,1,0.992853697764998,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
14641,GO:0060523,1,0.97998658469378,0,3,prostate epithelial cord elongation,BP,
14642,GO:0060525,1,0.918398178730937,0,11,prostate glandular acinus development,BP,
14643,GO:0060526,1,0.955305136643132,0,6,prostate glandular acinus morphogenesis,BP,
14644,GO:0060527,1,0.955305136643132,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
14645,GO:0060528,1,0.968846059508159,0,4,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
14646,GO:0060529,1,0.984812338769688,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
14647,GO:0060532,1,0.984940000320905,0,2,bronchus cartilage development,BP,
14648,GO:0060534,1,0.943059294307486,0,8,trachea cartilage development,BP,
14649,GO:0060535,1,0.971263288799055,0,4,trachea cartilage morphogenesis,BP,
14650,GO:0060536,1,0.929770324203744,0,11,cartilage morphogenesis,BP,
14653,GO:0060539,1,0.95072478742858,0,8,diaphragm development,BP,
14655,GO:0060542,1,0.991721069797367,0,1,regulation of strand invasion,BP,
14657,GO:0060545,1,0.982510647175466,0,3,positive regulation of necroptotic process,BP,
14661,GO:0060556,1,0.955477560082757,0,8,regulation of vitamin D biosynthetic process,BP,
14662,GO:0060557,1,0.991985408600871,0,2,positive regulation of vitamin D biosynthetic process,BP,
14663,GO:0060558,1,0.964459851520049,0,6,regulation of calcidiol 1-monooxygenase activity,BP,
14664,GO:0060559,1,0.991985408600871,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
14666,GO:0060561,1,0.856351976826448,0,23,apoptotic process involved in morphogenesis,BP,
14668,GO:0060563,1,0.712231355749892,0,50,neuroepithelial cell differentiation,BP,
14669,GO:0060566,1,0.988910336026141,0,1,positive regulation of DNA-templated transcription, termination,BP,
14670,GO:0060567,1,0.986555151512788,0,2,negative regulation of DNA-templated transcription, termination,BP,
14672,GO:0060572,1,0.901437107064066,0,16,morphogenesis of an epithelial bud,BP,
14674,GO:0060574,1,0.979553853088566,0,4,intestinal epithelial cell maturation,BP,
14675,GO:0060575,1,0.882966631210277,0,20,intestinal epithelial cell differentiation,BP,
14676,GO:0060576,1,0.925615011088901,0,13,intestinal epithelial cell development,BP,
14677,GO:0060577,1,0.995963984376661,0,1,pulmonary vein morphogenesis,BP,
14679,GO:0060580,1,0.994924009284793,0,1,ventral spinal cord interneuron fate determination,BP,
14681,GO:0060582,1,0.994924009284793,0,1,cell fate determination involved in pattern specification,BP,
14682,GO:0060584,1,0.97746516917641,0,4,regulation of prostaglandin-endoperoxide synthase activity,BP,
14683,GO:0060585,1,0.97746516917641,0,4,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
14684,GO:0060586,1,0.948295788612141,0,8,multicellular organismal iron ion homeostasis,BP,
14687,GO:0060589,1,0.0967278972162931,0,323,nucleoside-triphosphatase regulator activity,MF,
14688,GO:0060590,1,0.793240673585015,0,39,ATPase regulator activity,MF,
14689,GO:0060591,1,0.978075515320775,0,3,chondroblast differentiation,BP,
14690,GO:0060592,1,0.9535403745289,0,7,mammary gland formation,BP,
14691,GO:0060594,1,0.979770207922799,0,3,mammary gland specification,BP,
14692,GO:0060595,1,0.989305033755939,0,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
14693,GO:0060596,1,0.977524789493196,0,3,mammary placode formation,BP,
14694,GO:0060598,1,0.996457439356758,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
14695,GO:0060599,1,0.984598078556694,0,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14696,GO:0060600,1,0.92871095082854,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
14697,GO:0060601,1,0.912855820940743,0,13,lateral sprouting from an epithelium,BP,
14698,GO:0060602,1,0.885657028191535,0,18,branch elongation of an epithelium,BP,
14699,GO:0060603,1,0.795347274210677,0,31,mammary gland duct morphogenesis,BP,
14700,GO:0060605,1,0.968753843856291,0,5,tube lumen cavitation,BP,
14702,GO:0060611,1,0.994009180698039,0,1,mammary gland fat development,BP,
14703,GO:0060612,1,0.752898062906007,0,41,adipose tissue development,BP,
14704,GO:0060613,1,0.952092532492645,0,7,fat pad development,BP,
14705,GO:0060615,1,0.989305033755939,0,2,mammary gland bud formation,BP,
14706,GO:0060620,1,0.98040700558588,0,2,regulation of cholesterol import,BP,
14707,GO:0060623,1,0.987433292117295,0,2,regulation of chromosome condensation,BP,
14709,GO:0060628,1,0.892633240112612,0,16,regulation of ER to Golgi vesicle-mediated transport,BP,
14710,GO:0060631,1,0.957696792182402,0,6,regulation of meiosis I,BP,
14711,GO:0060632,1,0.785992119699752,0,38,regulation of microtubule-based movement,BP,
14712,GO:0060633,1,0.965518014648502,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
14713,GO:0060638,1,0.950477737912771,0,8,mesenchymal-epithelial cell signaling,BP,
14714,GO:0060644,1,0.893808318113708,0,16,mammary gland epithelial cell differentiation,BP,
14715,GO:0060648,1,0.984786085785175,0,3,mammary gland bud morphogenesis,BP,
14716,GO:0060661,1,0.991523272889358,0,2,submandibular salivary gland formation,BP,
14717,GO:0060662,1,0.968753843856291,0,5,salivary gland cavitation,BP,
14718,GO:0060664,1,0.974049038031421,0,5,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
14719,GO:0060665,1,0.976387568778798,0,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
14720,GO:0060666,1,0.959299067617085,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
14721,GO:0060667,1,0.989305033755939,0,2,branch elongation involved in salivary gland morphogenesis,BP,
14722,GO:0060668,1,0.992519517040727,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
14723,GO:0060669,1,0.864367264239491,0,22,embryonic placenta morphogenesis,BP,
14724,GO:0060670,1,0.940604683977291,0,10,branching involved in labyrinthine layer morphogenesis,BP,
14725,GO:0060671,1,0.988409736526159,0,2,epithelial cell differentiation involved in embryonic placenta development,BP,
14726,GO:0060672,1,0.988409736526159,0,2,epithelial cell morphogenesis involved in placental branching,BP,
14727,GO:0060674,1,0.809216277080343,0,30,placenta blood vessel development,BP,
14730,GO:0060677,1,0.939131165919043,0,8,ureteric bud elongation,BP,
14731,GO:0060678,1,0.994435550372176,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
14732,GO:0060681,1,0.9732611968276,0,4,branch elongation involved in ureteric bud branching,BP,
14733,GO:0060682,1,0.993311805709434,0,1,primary ureteric bud growth,BP,
14734,GO:0060683,1,0.993249516607105,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
14735,GO:0060684,1,0.966406829544698,0,6,epithelial-mesenchymal cell signaling,BP,
14736,GO:0060685,1,0.96104711819388,0,6,regulation of prostatic bud formation,BP,
14737,GO:0060686,1,0.971848444037214,0,4,negative regulation of prostatic bud formation,BP,
14738,GO:0060687,1,0.9586888863908,0,6,regulation of branching involved in prostate gland morphogenesis,BP,
14740,GO:0060689,1,0.978816180673106,0,3,cell differentiation involved in salivary gland development,BP,
14741,GO:0060690,1,0.995561088920931,0,1,epithelial cell differentiation involved in salivary gland development,BP,
14742,GO:0060691,1,0.995561088920931,0,1,epithelial cell maturation involved in salivary gland development,BP,
14743,GO:0060693,1,0.945859192082187,0,9,regulation of branching involved in salivary gland morphogenesis,BP,
14744,GO:0060694,1,0.995447523178614,0,1,regulation of cholesterol transporter activity,BP,
14745,GO:0060696,1,0.96699774184973,0,6,regulation of phospholipid catabolic process,BP,
14746,GO:0060697,1,0.990035525998757,0,2,positive regulation of phospholipid catabolic process,BP,
14747,GO:0060698,1,0.985307400561116,0,2,endoribonuclease inhibitor activity,MF,
14748,GO:0060699,1,0.975803036632946,0,4,regulation of endoribonuclease activity,BP,
14749,GO:0060700,1,0.945779408242065,0,9,regulation of ribonuclease activity,BP,
14750,GO:0060701,1,0.985307400561116,0,2,negative regulation of ribonuclease activity,BP,
14751,GO:0060702,1,0.985307400561116,0,2,negative regulation of endoribonuclease activity,BP,
14752,GO:0060703,1,0.993360864384152,0,1,deoxyribonuclease inhibitor activity,MF,
14753,GO:0060706,1,0.865439284105019,0,23,cell differentiation involved in embryonic placenta development,BP,
14754,GO:0060707,1,0.921426541296129,0,13,trophoblast giant cell differentiation,BP,
14755,GO:0060710,1,0.960751688035306,0,6,chorio-allantoic fusion,BP,
14756,GO:0060711,1,0.754893650253961,0,43,labyrinthine layer development,BP,
14757,GO:0060712,1,0.982712100649602,0,3,spongiotrophoblast layer development,BP,
14758,GO:0060713,1,0.892379717572816,0,18,labyrinthine layer morphogenesis,BP,
14759,GO:0060715,1,0.979736171568261,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14760,GO:0060716,1,0.885475717397542,0,19,labyrinthine layer blood vessel development,BP,
14761,GO:0060717,1,0.950832996512546,0,7,chorion development,BP,
14762,GO:0060718,1,0.962781756468187,0,5,chorionic trophoblast cell differentiation,BP,
14763,GO:0060720,1,0.987178868619586,0,2,spongiotrophoblast cell proliferation,BP,
14764,GO:0060721,1,0.987178868619586,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14765,GO:0060722,1,0.987178868619586,0,2,cell proliferation involved in embryonic placenta development,BP,
14766,GO:0060723,1,0.987178868619586,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
14767,GO:0060729,1,0.966781226135522,0,5,intestinal epithelial structure maintenance,BP,
14768,GO:0060730,1,0.986242741351091,0,2,regulation of intestinal epithelial structure maintenance,BP,
14769,GO:0060731,1,0.992650600045045,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14770,GO:0060732,1,0.937941907949744,0,10,positive regulation of inositol phosphate biosynthetic process,BP,
14771,GO:0060733,1,0.984408196753319,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14772,GO:0060734,1,0.992292841578227,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14773,GO:0060735,1,0.996309394743907,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14774,GO:0060736,1,0.917537621457706,0,11,prostate gland growth,BP,
14775,GO:0060737,1,0.972613326326939,0,4,prostate gland morphogenetic growth,BP,
14776,GO:0060738,1,0.98882453652693,0,2,epithelial-mesenchymal signaling involved in prostate gland development,BP,
14777,GO:0060739,1,0.990688377603021,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14778,GO:0060740,1,0.831186376913946,0,26,prostate gland epithelium morphogenesis,BP,
14779,GO:0060741,1,0.983959746694385,0,3,prostate gland stromal morphogenesis,BP,
14780,GO:0060742,1,0.921306107731004,0,11,epithelial cell differentiation involved in prostate gland development,BP,
14781,GO:0060743,1,0.979500940386724,0,3,epithelial cell maturation involved in prostate gland development,BP,
14782,GO:0060744,1,0.974983753323313,0,4,mammary gland branching involved in thelarche,BP,
14783,GO:0060745,1,0.948464233788342,0,6,mammary gland branching involved in pregnancy,BP,
14784,GO:0060746,1,0.932823341624614,0,10,parental behavior,BP,
14785,GO:0060748,1,0.97350543420802,0,3,tertiary branching involved in mammary gland duct morphogenesis,BP,
14786,GO:0060749,1,0.891181372182512,0,17,mammary gland alveolus development,BP,
14787,GO:0060750,1,0.970260958705415,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
14788,GO:0060751,1,0.970260958705415,0,4,branch elongation involved in mammary gland duct branching,BP,
14789,GO:0060752,1,0.99344668091026,0,1,intestinal phytosterol absorption,BP,
14790,GO:0060753,1,0.968526211914035,0,6,regulation of mast cell chemotaxis,BP,
14791,GO:0060754,1,0.972249285270911,0,5,positive regulation of mast cell chemotaxis,BP,
14792,GO:0060759,1,0.375043963388627,0,154,regulation of response to cytokine stimulus,BP,
14793,GO:0060760,1,0.711891891603377,0,53,positive regulation of response to cytokine stimulus,BP,
14794,GO:0060761,1,0.724959083539255,0,53,negative regulation of response to cytokine stimulus,BP,
14795,GO:0060762,1,0.976857738232297,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
14796,GO:0060763,1,0.985423830198345,0,2,mammary duct terminal end bud growth,BP,
14797,GO:0060764,1,0.988454039760463,0,2,cell-cell signaling involved in mammary gland development,BP,
14798,GO:0060765,1,0.839729522854308,0,25,regulation of androgen receptor signaling pathway,BP,
14799,GO:0060766,1,0.906082541823033,0,14,negative regulation of androgen receptor signaling pathway,BP,
14800,GO:0060767,1,0.931961877242865,0,11,epithelial cell proliferation involved in prostate gland development,BP,
14801,GO:0060768,1,0.93903005123934,0,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14802,GO:0060769,1,0.981547559164603,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14803,GO:0060770,1,0.966571946548529,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14804,GO:0060775,1,0.987012119677772,0,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14805,GO:0060781,1,0.996007069956112,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
14806,GO:0060782,1,0.996007069956112,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
14807,GO:0060783,1,0.996007069956112,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
14808,GO:0060784,1,0.99247770910114,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14809,GO:0060788,1,0.924060179098964,0,11,ectodermal placode formation,BP,
14810,GO:0060789,1,0.975384492813354,0,4,hair follicle placode formation,BP,
14812,GO:0060796,1,0.994218906995635,0,1,regulation of transcription involved in primary germ layer cell fate commitment,BP,
14813,GO:0060800,1,0.98047441726018,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
14814,GO:0060802,1,0.994895965192756,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
14815,GO:0060803,1,0.996140934553785,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
14816,GO:0060804,1,0.992749461167348,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14817,GO:0060806,1,0.995803532066746,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
14818,GO:0060807,1,0.994218906995635,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
14819,GO:0060809,1,0.985060095756368,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
14820,GO:0060816,1,0.981813933925042,0,2,random inactivation of X chromosome,BP,
14821,GO:0060819,1,0.982812769788898,0,2,inactivation of X chromosome by genetic imprinting,BP,
14822,GO:0060820,1,0.990100865865178,0,1,inactivation of X chromosome by heterochromatin assembly,BP,
14823,GO:0060821,1,0.990100865865178,0,1,inactivation of X chromosome by DNA methylation,BP,
14824,GO:0060823,1,0.992458489616274,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14825,GO:0060825,1,0.991246929901444,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14826,GO:0060827,1,0.992458489616274,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14828,GO:0060829,1,0.992458489616274,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14829,GO:0060830,1,0.981609796161852,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
14830,GO:0060831,1,0.900500062466674,0,14,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
14831,GO:0060836,1,0.945305338806828,0,7,lymphatic endothelial cell differentiation,BP,
14832,GO:0060837,1,0.942263855858687,0,9,blood vessel endothelial cell differentiation,BP,
14833,GO:0060838,1,0.978803005900322,0,3,lymphatic endothelial cell fate commitment,BP,
14834,GO:0060839,1,0.953249072132633,0,7,endothelial cell fate commitment,BP,
14836,GO:0060841,1,0.889721832866982,0,15,venous blood vessel development,BP,
14837,GO:0060842,1,0.960159762305019,0,6,arterial endothelial cell differentiation,BP,
14838,GO:0060843,1,0.989781107645331,0,1,venous endothelial cell differentiation,BP,
14839,GO:0060844,1,0.986860368995858,0,2,arterial endothelial cell fate commitment,BP,
14840,GO:0060846,1,0.980811624474848,0,3,blood vessel endothelial cell fate commitment,BP,
14841,GO:0060847,1,0.980811624474848,0,3,endothelial cell fate specification,BP,
14842,GO:0060849,1,0.985357653440654,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
14844,GO:0060853,1,0.992630991077856,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
14845,GO:0060856,1,0.933943735637566,0,11,establishment of blood-brain barrier,BP,
14846,GO:0060857,1,0.994396669710221,0,1,establishment of glial blood-brain barrier,BP,
14847,GO:0060872,1,0.936883857267533,0,9,semicircular canal development,BP,
14848,GO:0060873,1,0.990363148962319,0,1,anterior semicircular canal development,BP,
14849,GO:0060875,1,0.990363148962319,0,1,lateral semicircular canal development,BP,
14850,GO:0060876,1,0.990825232562745,0,2,semicircular canal formation,BP,
14851,GO:0060879,1,0.996826939881114,0,1,semicircular canal fusion,BP,
14852,GO:0060896,1,0.943635909138286,0,8,neural plate pattern specification,BP,
14853,GO:0060897,1,0.960871057707555,0,6,neural plate regionalization,BP,
14854,GO:0060900,1,0.910859807446908,0,12,embryonic camera-type eye formation,BP,
14855,GO:0060901,1,0.992414112316059,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
14856,GO:0060903,1,0.964619306106204,0,5,positive regulation of meiosis I,BP,
14857,GO:0060904,1,0.992472708438387,0,1,regulation of protein folding in endoplasmic reticulum,BP,
14858,GO:0060907,1,0.946439585852639,0,9,positive regulation of macrophage cytokine production,BP,
14859,GO:0060911,1,0.942075404574899,0,10,cardiac cell fate commitment,BP,
14860,GO:0060912,1,0.987512563773743,0,2,cardiac cell fate specification,BP,
14861,GO:0060913,1,0.984197762088281,0,3,cardiac cell fate determination,BP,
14863,GO:0060915,1,0.989305033755939,0,2,mesenchymal cell differentiation involved in lung development,BP,
14864,GO:0060916,1,0.964423949474251,0,5,mesenchymal cell proliferation involved in lung development,BP,
14867,GO:0060922,1,0.987090042048373,0,2,atrioventricular node cell differentiation,BP,
14868,GO:0060923,1,0.963710754621383,0,6,cardiac muscle cell fate commitment,BP,
14870,GO:0060927,1,0.995299683584611,0,1,cardiac pacemaker cell fate commitment,BP,
14871,GO:0060928,1,0.987090042048373,0,2,atrioventricular node cell development,BP,
14872,GO:0060929,1,0.995299683584611,0,1,atrioventricular node cell fate commitment,BP,
14874,GO:0060932,1,0.987588831534066,0,2,His-Purkinje system cell differentiation,BP,
14875,GO:0060935,1,0.978078392198196,0,3,cardiac fibroblast cell differentiation,BP,
14876,GO:0060936,1,0.978078392198196,0,3,cardiac fibroblast cell development,BP,
14877,GO:0060938,1,0.978078392198196,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
14878,GO:0060939,1,0.978078392198196,0,3,epicardium-derived cardiac fibroblast cell development,BP,
14879,GO:0060940,1,0.98661386279569,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
14880,GO:0060947,1,0.943094201211277,0,8,cardiac vascular smooth muscle cell differentiation,BP,
14881,GO:0060948,1,0.975963484068629,0,3,cardiac vascular smooth muscle cell development,BP,
14882,GO:0060956,1,0.957674950665265,0,6,endocardial cell differentiation,BP,
14883,GO:0060957,1,0.992952812232911,0,1,endocardial cell fate commitment,BP,
14885,GO:0060965,1,0.888039341403471,0,18,negative regulation of gene silencing by miRNA,BP,
14887,GO:0060967,1,0.873651515923263,0,20,negative regulation of gene silencing by RNA,BP,
14889,GO:0060969,1,0.8487732945403,0,24,negative regulation of gene silencing,BP,
14890,GO:0060971,1,0.972570451854468,0,4,embryonic heart tube left/right pattern formation,BP,
14891,GO:0060972,1,0.854556123022084,0,22,left/right pattern formation,BP,
14893,GO:0060974,1,0.993169452167819,0,2,cell migration involved in heart formation,BP,
14894,GO:0060975,1,0.996533556746551,0,1,cardioblast migration to the midline involved in heart field formation,BP,
14897,GO:0060978,1,0.977178313252158,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
14898,GO:0060979,1,0.964995340978159,0,4,vasculogenesis involved in coronary vascular morphogenesis,BP,
14899,GO:0060980,1,0.992513428419899,0,1,cell migration involved in coronary vasculogenesis,BP,
14900,GO:0060981,1,0.991746261575441,0,1,cell migration involved in coronary angiogenesis,BP,
14903,GO:0060987,1,0.994283053758508,0,1,lipid tube,CC,
14904,GO:0060988,1,0.98017440257687,0,3,lipid tube assembly,BP,
14905,GO:0060992,1,0.956517151257749,0,6,response to fungicide,BP,
14907,GO:0060994,1,0.992503983685789,0,1,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
14908,GO:0060995,1,0.984893598799838,0,2,cell-cell signaling involved in kidney development,BP,
14909,GO:0060996,1,0.478174911240114,0,96,dendritic spine development,BP,
14910,GO:0060997,1,0.631516667961588,0,59,dendritic spine morphogenesis,BP,
14911,GO:0060998,1,0.568218079958233,0,73,regulation of dendritic spine development,BP,
14912,GO:0060999,1,0.72452077688272,0,42,positive regulation of dendritic spine development,BP,
14913,GO:0061000,1,0.911410851455023,0,12,negative regulation of dendritic spine development,BP,
14914,GO:0061001,1,0.70275517385112,0,45,regulation of dendritic spine morphogenesis,BP,
14915,GO:0061002,1,0.949597557631519,0,7,negative regulation of dendritic spine morphogenesis,BP,
14916,GO:0061003,1,0.856111181738527,0,20,positive regulation of dendritic spine morphogenesis,BP,
14917,GO:0061004,1,0.957311303754415,0,8,pattern specification involved in kidney development,BP,
14920,GO:0061009,1,0.966112790990607,0,5,common bile duct development,BP,
14921,GO:0061010,1,0.983632518325035,0,2,gall bladder development,BP,
14922,GO:0061013,1,0.300073656176019,0,189,regulation of mRNA catabolic process,BP,
14923,GO:0061014,1,0.701427947703311,0,49,positive regulation of mRNA catabolic process,BP,
14924,GO:0061015,1,0.992400059165026,0,2,snRNA import into nucleus,BP,
14926,GO:0061025,1,0.394950031332833,0,143,membrane fusion,BP,
14927,GO:0061026,1,0.962259536729615,0,5,cardiac muscle tissue regeneration,BP,
14928,GO:0061027,1,0.987827811042402,0,2,umbilical cord development,BP,
14929,GO:0061028,1,0.732007008805144,0,44,establishment of endothelial barrier,BP,
14931,GO:0061030,1,0.982580731960763,0,3,epithelial cell differentiation involved in mammary gland alveolus development,BP,
14932,GO:0061031,1,0.990556867637096,0,2,endodermal digestive tract morphogenesis,BP,
14933,GO:0061032,1,0.987110140826857,0,2,visceral serous pericardium development,BP,
14934,GO:0061033,1,0.984294723999031,0,3,secretion by lung epithelial cell involved in lung growth,BP,
14935,GO:0061034,1,0.992042881145803,0,1,olfactory bulb mitral cell layer development,BP,
14937,GO:0061036,1,0.817191672372031,0,28,positive regulation of cartilage development,BP,
14939,GO:0061038,1,0.955133148492613,0,6,uterus morphogenesis,BP,
14940,GO:0061040,1,0.990068065470808,0,1,female gonad morphogenesis,BP,
14942,GO:0061042,1,0.895038592034769,0,17,vascular wound healing,BP,
14943,GO:0061043,1,0.9467869250475,0,9,regulation of vascular wound healing,BP,
14944,GO:0061044,1,0.973631039031784,0,4,negative regulation of vascular wound healing,BP,
14946,GO:0061046,1,0.96459955303667,0,6,regulation of branching involved in lung morphogenesis,BP,
14947,GO:0061047,1,0.975968806340691,0,4,positive regulation of branching involved in lung morphogenesis,BP,
14948,GO:0061048,1,0.995845031675732,0,1,negative regulation of branching involved in lung morphogenesis,BP,
14949,GO:0061049,1,0.839646829558656,0,26,cell growth involved in cardiac muscle cell development,BP,
14950,GO:0061050,1,0.890189857069152,0,18,regulation of cell growth involved in cardiac muscle cell development,BP,
14951,GO:0061051,1,0.948387486248816,0,8,positive regulation of cell growth involved in cardiac muscle cell development,BP,
14952,GO:0061052,1,0.938667320025457,0,10,negative regulation of cell growth involved in cardiac muscle cell development,BP,
14954,GO:0061054,1,0.987653466448306,0,2,dermatome development,BP,
14956,GO:0061056,1,0.979145146206164,0,4,sclerotome development,BP,
14958,GO:0061072,1,0.937079078368178,0,9,iris morphogenesis,BP,
14959,GO:0061073,1,0.969184287675306,0,4,ciliary body morphogenesis,BP,
14960,GO:0061074,1,0.961416721592373,0,6,regulation of neural retina development,BP,
14961,GO:0061075,1,0.988761406386382,0,2,positive regulation of neural retina development,BP,
14962,GO:0061076,1,0.99275919239589,0,1,negative regulation of neural retina development,BP,
14963,GO:0061077,1,0.722792644770572,0,54,chaperone-mediated protein folding,BP,
14964,GO:0061078,1,0.99684265558581,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
14965,GO:0061081,1,0.883002393181073,0,19,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
14966,GO:0061082,1,0.821468254088345,0,30,myeloid leukocyte cytokine production,BP,
14967,GO:0061083,1,0.9737702363441,0,4,regulation of protein refolding,BP,
14968,GO:0061084,1,0.9737702363441,0,4,negative regulation of protein refolding,BP,
14969,GO:0061085,1,0.945008491272548,0,8,regulation of histone H3-K27 methylation,BP,
14970,GO:0061086,1,0.978618402907932,0,3,negative regulation of histone H3-K27 methylation,BP,
14971,GO:0061087,1,0.959862748098008,0,6,positive regulation of histone H3-K27 methylation,BP,
14972,GO:0061088,1,0.973837189319104,0,4,regulation of sequestering of zinc ion,BP,
14973,GO:0061090,1,0.994076757423231,0,1,positive regulation of sequestering of zinc ion,BP,
14974,GO:0061091,1,0.968515929135473,0,4,regulation of phospholipid translocation,BP,
14975,GO:0061092,1,0.968515929135473,0,4,positive regulation of phospholipid translocation,BP,
14978,GO:0061099,1,0.850489794620561,0,25,negative regulation of protein tyrosine kinase activity,BP,
14979,GO:0061100,1,0.993898281598366,0,1,lung neuroendocrine cell differentiation,BP,
14980,GO:0061101,1,0.957397009492543,0,8,neuroendocrine cell differentiation,BP,
14981,GO:0061102,1,0.990115928629697,0,2,stomach neuroendocrine cell differentiation,BP,
14982,GO:0061103,1,0.993898281598366,0,1,carotid body glomus cell differentiation,BP,
14983,GO:0061104,1,0.987100448164253,0,2,adrenal chromaffin cell differentiation,BP,
14984,GO:0061105,1,0.996194664242819,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14985,GO:0061106,1,0.996194664242819,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
14986,GO:0061107,1,0.983067684896576,0,3,seminal vesicle development,BP,
14987,GO:0061108,1,0.994436847309884,0,1,seminal vesicle epithelium development,BP,
14988,GO:0061110,1,0.977733392305338,0,3,dense core granule biogenesis,BP,
14989,GO:0061113,1,0.977644460708234,0,3,pancreas morphogenesis,BP,
14990,GO:0061114,1,0.992825158104098,0,1,branching involved in pancreas morphogenesis,BP,
14991,GO:0061115,1,0.996826939881114,0,1,lung proximal/distal axis specification,BP,
14993,GO:0061133,1,0.966272514695651,0,7,endopeptidase activator activity,MF,
14996,GO:0061136,1,0.313678294088818,0,179,regulation of proteasomal protein catabolic process,BP,
14998,GO:0061140,1,0.953683527240895,0,9,lung secretory cell differentiation,BP,
14999,GO:0061141,1,0.980446788049711,0,3,lung ciliated cell differentiation,BP,
15000,GO:0061143,1,0.993117642408701,0,1,alveolar primary septum development,BP,
15001,GO:0061144,1,0.99278896603214,0,1,alveolar secondary septum development,BP,
15002,GO:0061145,1,0.984940000320905,0,2,lung smooth muscle development,BP,
15003,GO:0061146,1,0.980619740499679,0,3,Peyer's patch morphogenesis,BP,
15004,GO:0061149,1,0.995611667834955,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
15005,GO:0061150,1,0.995611667834955,0,1,renal system segmentation,BP,
15006,GO:0061151,1,0.995611667834955,0,1,BMP signaling pathway involved in renal system segmentation,BP,
15007,GO:0061152,1,0.989084245233766,0,2,trachea submucosa development,BP,
15008,GO:0061153,1,0.989084245233766,0,2,trachea gland development,BP,
15009,GO:0061154,1,0.894591165996573,0,18,endothelial tube morphogenesis,BP,
15010,GO:0061155,1,0.995611667834955,0,1,pulmonary artery endothelial tube morphogenesis,BP,
15012,GO:0061157,1,0.798720745155498,0,31,mRNA destabilization,BP,
15013,GO:0061158,1,0.88728231465849,0,17,3'-UTR-mediated mRNA destabilization,BP,
15014,GO:0061159,1,0.992171487544469,0,1,establishment of bipolar cell polarity involved in cell morphogenesis,BP,
15015,GO:0061162,1,0.860071946511152,0,21,establishment of monopolar cell polarity,BP,
15016,GO:0061171,1,0.992171487544469,0,1,establishment of bipolar cell polarity,BP,
15018,GO:0061179,1,0.961684159071278,0,8,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15019,GO:0061180,1,0.62347788293445,0,66,mammary gland epithelium development,BP,
15020,GO:0061181,1,0.981327072167552,0,3,regulation of chondrocyte development,BP,
15021,GO:0061182,1,0.995979348592151,0,1,negative regulation of chondrocyte development,BP,
15022,GO:0061183,1,0.987653466448306,0,2,regulation of dermatome development,BP,
15023,GO:0061184,1,0.992480005246956,0,1,positive regulation of dermatome development,BP,
15024,GO:0061185,1,0.995137264487481,0,1,negative regulation of dermatome development,BP,
15025,GO:0061187,1,0.976308908136247,0,3,regulation of ribosomal DNA heterochromatin assembly,BP,
15026,GO:0061188,1,0.983570486368549,0,2,negative regulation of ribosomal DNA heterochromatin assembly,BP,
15027,GO:0061189,1,0.996007069956112,0,1,positive regulation of sclerotome development,BP,
15028,GO:0061190,1,0.996007069956112,0,1,regulation of sclerotome development,BP,
15029,GO:0061193,1,0.989152270120241,0,2,taste bud development,BP,
15030,GO:0061196,1,0.958682139731957,0,6,fungiform papilla development,BP,
15031,GO:0061197,1,0.964068654647988,0,5,fungiform papilla morphogenesis,BP,
15032,GO:0061198,1,0.978802107000247,0,3,fungiform papilla formation,BP,
15033,GO:0061200,1,0.953093672771525,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
15034,GO:0061202,1,0.953093672771525,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
15035,GO:0061205,1,0.977316999552073,0,3,paramesonephric duct development,BP,
15036,GO:0061209,1,0.975756451919807,0,4,cell proliferation involved in mesonephros development,BP,
15039,GO:0061218,1,0.983469099374915,0,3,negative regulation of mesonephros development,BP,
15040,GO:0061227,1,0.991002126217525,0,2,pattern specification involved in mesonephros development,BP,
15041,GO:0061245,1,0.726468224599596,0,45,establishment or maintenance of bipolar cell polarity,BP,
15042,GO:0061289,1,0.984893598799838,0,2,Wnt signaling pathway involved in kidney development,BP,
15043,GO:0061290,1,0.984893598799838,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15045,GO:0061299,1,0.921441776534351,0,11,retina vasculature morphogenesis in camera-type eye,BP,
15046,GO:0061300,1,0.986950161253634,0,2,cerebellum vasculature development,BP,
15047,GO:0061301,1,0.990820847309063,0,1,cerebellum vasculature morphogenesis,BP,
15049,GO:0061303,1,0.947494629379745,0,9,cornea development in camera-type eye,BP,
15050,GO:0061304,1,0.950445416232574,0,6,retinal blood vessel morphogenesis,BP,
15051,GO:0061307,1,0.938705689704207,0,11,cardiac neural crest cell differentiation involved in heart development,BP,
15052,GO:0061308,1,0.938705689704207,0,11,cardiac neural crest cell development involved in heart development,BP,
15053,GO:0061309,1,0.950174506331738,0,9,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15054,GO:0061311,1,0.827665426277995,0,29,cell surface receptor signaling pathway involved in heart development,BP,
15055,GO:0061312,1,0.96678026641362,0,6,BMP signaling pathway involved in heart development,BP,
15056,GO:0061314,1,0.923818586654041,0,11,Notch signaling involved in heart development,BP,
15057,GO:0061316,1,0.982433158880185,0,3,canonical Wnt signaling pathway involved in heart development,BP,
15058,GO:0061317,1,0.989781168305386,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15059,GO:0061318,1,0.887416781420094,0,16,renal filtration cell differentiation,BP,
15060,GO:0061323,1,0.892883826944028,0,16,cell proliferation involved in heart morphogenesis,BP,
15061,GO:0061324,1,0.9925769027008,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15062,GO:0061325,1,0.977060248515855,0,4,cell proliferation involved in outflow tract morphogenesis,BP,
15066,GO:0061339,1,0.860071946511152,0,21,establishment or maintenance of monopolar cell polarity,BP,
15067,GO:0061341,1,0.983713318897808,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
15068,GO:0061343,1,0.962397995652754,0,5,cell adhesion involved in heart morphogenesis,BP,
15069,GO:0061346,1,0.983713318897808,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
15070,GO:0061347,1,0.991685564322805,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
15071,GO:0061348,1,0.991685564322805,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
15072,GO:0061349,1,0.991685564322805,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
15073,GO:0061350,1,0.991685564322805,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
15075,GO:0061354,1,0.991685564322805,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
15076,GO:0061355,1,0.970056172751165,0,5,Wnt protein secretion,BP,
15077,GO:0061356,1,0.974339259856963,0,4,regulation of Wnt protein secretion,BP,
15078,GO:0061357,1,0.978813006764159,0,3,positive regulation of Wnt protein secretion,BP,
15079,GO:0061358,1,0.995430413442757,0,1,negative regulation of Wnt protein secretion,BP,
15080,GO:0061360,1,0.992451971441975,0,1,optic chiasma development,BP,
15081,GO:0061364,1,0.975918930025008,0,3,apoptotic process involved in luteolysis,BP,
15082,GO:0061365,1,0.966966616108224,0,7,positive regulation of triglyceride lipase activity,BP,
15083,GO:0061366,1,0.989844255997464,0,2,behavioral response to chemical pain,BP,
15084,GO:0061368,1,0.989844255997464,0,2,behavioral response to formalin induced pain,BP,
15085,GO:0061369,1,0.992480005246956,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
15086,GO:0061370,1,0.968355440269157,0,6,testosterone biosynthetic process,BP,
15087,GO:0061371,1,0.652035120131433,0,63,determination of heart left/right asymmetry,BP,
15088,GO:0061373,1,0.98985831976334,0,1,mammillary axonal complex development,BP,
15089,GO:0061377,1,0.891181372182512,0,17,mammary gland lobule development,BP,
15091,GO:0061384,1,0.799875003971538,0,32,heart trabecula morphogenesis,BP,
15092,GO:0061386,1,0.981657524816129,0,2,closure of optic fissure,BP,
15094,GO:0061394,1,0.990762227998611,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15095,GO:0061395,1,0.995746170208323,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15096,GO:0061400,1,0.99325505912211,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
15097,GO:0061402,1,0.98738647193956,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15098,GO:0061408,1,0.994702939885281,0,1,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15099,GO:0061418,1,0.677470748477488,0,72,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15100,GO:0061419,1,0.956707597223171,0,6,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15101,GO:0061428,1,0.975197176622154,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15103,GO:0061433,1,0.995237360435577,0,1,cellular response to caloric restriction,BP,
15109,GO:0061441,1,0.986029283605249,0,2,renal artery morphogenesis,BP,
15110,GO:0061443,1,0.984599393619824,0,2,endocardial cushion cell differentiation,BP,
15111,GO:0061444,1,0.991587899369133,0,1,endocardial cushion cell development,BP,
15112,GO:0061445,1,0.992952812232911,0,1,endocardial cushion cell fate commitment,BP,
15116,GO:0061459,1,0.956994900920652,0,6,L-arginine transmembrane transporter activity,MF,
15117,GO:0061462,1,0.763382817781144,0,40,protein localization to lysosome,BP,
15118,GO:0061463,1,0.99325505912211,0,1,O-acetyl-ADP-ribose deacetylase activity,MF,
15119,GO:0061469,1,0.936386079318919,0,11,regulation of type B pancreatic cell proliferation,BP,
15120,GO:0061470,1,0.96651028980518,0,5,T follicular helper cell differentiation,BP,
15121,GO:0061474,1,0.993731007432785,0,1,phagolysosome membrane,CC,
15122,GO:0061476,1,0.992799221737581,0,1,response to anticoagulant,BP,
15123,GO:0061481,1,0.996748342825382,0,1,response to TNF agonist,BP,
15124,GO:0061484,1,0.971234890932022,0,4,hematopoietic stem cell homeostasis,BP,
15125,GO:0061485,1,0.990757240690246,0,1,memory T cell proliferation,BP,
15127,GO:0061507,1,0.993132375617783,0,1,cyclic-GMP-AMP binding,MF,
15128,GO:0061508,1,0.99325505912211,0,1,CDP phosphorylation,BP,
15129,GO:0061511,1,0.952546250677619,0,7,centriole elongation,BP,
15130,GO:0061512,1,0.683628275363948,0,56,protein localization to cilium,BP,
15131,GO:0061513,1,0.980190334440723,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15132,GO:0061514,1,0.995622277459049,0,1,interleukin-34-mediated signaling pathway,BP,
15133,GO:0061515,1,0.63620935983723,0,66,myeloid cell development,BP,
15134,GO:0061517,1,0.939923214826202,0,10,macrophage proliferation,BP,
15135,GO:0061518,1,0.958735074430535,0,7,microglial cell proliferation,BP,
15136,GO:0061519,1,0.99252494747582,0,1,macrophage homeostasis,BP,
15137,GO:0061523,1,0.99251214454348,0,1,cilium disassembly,BP,
15138,GO:0061525,1,0.942511150476015,0,8,hindgut development,BP,
15139,GO:0061526,1,0.974908764838199,0,4,acetylcholine secretion,BP,
15140,GO:0061528,1,0.983345969428703,0,2,aspartate secretion,BP,
15141,GO:0061534,1,0.988240443328973,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15142,GO:0061535,1,0.965462865620196,0,4,glutamate secretion, neurotransmission,BP,
15143,GO:0061536,1,0.992691803075415,0,1,glycine secretion,BP,
15144,GO:0061537,1,0.992691803075415,0,1,glycine secretion, neurotransmission,BP,
15145,GO:0061542,1,0.996425863818555,0,1,3-demethylubiquinol-n 3-O-methyltransferase activity,MF,
15146,GO:0061547,1,0.985378354531576,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15147,GO:0061548,1,0.899552579892365,0,15,ganglion development,BP,
15148,GO:0061549,1,0.943678312729454,0,8,sympathetic ganglion development,BP,
15149,GO:0061550,1,0.955894484994527,0,6,cranial ganglion development,BP,
15150,GO:0061551,1,0.96304600377661,0,5,trigeminal ganglion development,BP,
15151,GO:0061552,1,0.985865043136723,0,2,ganglion morphogenesis,BP,
15153,GO:0061565,1,0.99325505912211,0,1,dAMP phosphorylation,BP,
15154,GO:0061566,1,0.99325505912211,0,1,CMP phosphorylation,BP,
15155,GO:0061567,1,0.99325505912211,0,1,dCMP phosphorylation,BP,
15156,GO:0061568,1,0.99325505912211,0,1,GDP phosphorylation,BP,
15157,GO:0061569,1,0.99325505912211,0,1,UDP phosphorylation,BP,
15158,GO:0061570,1,0.99325505912211,0,1,dCDP phosphorylation,BP,
15159,GO:0061571,1,0.99325505912211,0,1,TDP phosphorylation,BP,
15160,GO:0061572,1,0.350515039386308,0,148,actin filament bundle organization,BP,
15161,GO:0061574,1,0.974354276227708,0,4,ASAP complex,CC,
15162,GO:0061575,1,0.952542739296108,0,9,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15163,GO:0061577,1,0.907979977933581,0,14,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15164,GO:0061578,1,0.924089334982619,0,11,Lys63-specific deubiquitinase activity,MF,
15165,GO:0061580,1,0.992450002283949,0,1,colon epithelial cell migration,BP,
15166,GO:0061582,1,0.983940192715914,0,2,intestinal epithelial cell migration,BP,
15167,GO:0061586,1,0.992612619702809,0,1,positive regulation of transcription by transcription factor localization,BP,
15168,GO:0061588,1,0.963672555184722,0,5,calcium activated phospholipid scrambling,BP,
15169,GO:0061589,1,0.971821719148778,0,4,calcium activated phosphatidylserine scrambling,BP,
15170,GO:0061590,1,0.963672555184722,0,5,calcium activated phosphatidylcholine scrambling,BP,
15171,GO:0061591,1,0.963672555184722,0,5,calcium activated galactosylceramide scrambling,BP,
15172,GO:0061598,1,0.992418877101266,0,1,molybdopterin adenylyltransferase activity,MF,
15173,GO:0061599,1,0.992418877101266,0,1,molybdopterin molybdotransferase activity,MF,
15174,GO:0061604,1,0.993947281909514,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15175,GO:0061605,1,0.993947281909514,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15176,GO:0061608,1,0.877045030408646,0,18,nuclear import signal receptor activity,MF,
15177,GO:0061609,1,0.994006691782729,0,1,fructose-1-phosphate aldolase activity,MF,
15178,GO:0061611,1,0.995630725828587,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15180,GO:0061615,1,0.842240428813723,0,28,glycolytic process through fructose-6-phosphate,BP,
15181,GO:0061617,1,0.964930054222471,0,7,MICOS complex,CC,
15182,GO:0061620,1,0.848908882822431,0,27,glycolytic process through glucose-6-phosphate,BP,
15183,GO:0061621,1,0.852055424292368,0,26,canonical glycolysis,BP,
15184,GO:0061622,1,0.996313148091886,0,1,glycolytic process through glucose-1-phosphate,BP,
15185,GO:0061623,1,0.996313148091886,0,1,glycolytic process from galactose,BP,
15186,GO:0061624,1,0.975789085362891,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
15187,GO:0061626,1,0.957529435496945,0,7,pharyngeal arch artery morphogenesis,BP,
15188,GO:0061627,1,0.995122446774223,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15189,GO:0061628,1,0.974813068312798,0,3,H3K27me3 modified histone binding,MF,
15190,GO:0061629,1,0.179929223606058,0,257,RNA polymerase II-specific DNA-binding transcription factor binding,MF,
15191,GO:0061630,1,0.173262280751319,0,254,ubiquitin protein ligase activity,MF,
15192,GO:0061631,1,0.794143120010849,0,38,ubiquitin conjugating enzyme activity,MF,
15193,GO:0061632,1,0.99351041460083,0,1,RNA lariat debranching enzyme activator activity,MF,
15194,GO:0061635,1,0.940763525829063,0,11,regulation of protein complex stability,BP,
15196,GO:0061641,1,0.862214329493973,0,26,CENP-A containing chromatin organization,BP,
15197,GO:0061642,1,0.968243975674716,0,4,chemoattraction of axon,BP,
15198,GO:0061643,1,0.955209668905352,0,6,chemorepulsion of axon,BP,
15199,GO:0061646,1,0.992168187035404,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15200,GO:0061647,1,0.697615799436145,0,47,histone H3-K9 modification,BP,
15201,GO:0061649,1,0.978656907091851,0,3,ubiquitin modification-dependent histone binding,MF,
15202,GO:0061650,1,0.7886255435942,0,40,ubiquitin-like protein conjugating enzyme activity,MF,
15203,GO:0061654,1,0.99632799772119,0,1,NEDD8 conjugating enzyme activity,MF,
15204,GO:0061656,1,0.996492397595218,0,1,SUMO conjugating enzyme activity,MF,
15205,GO:0061657,1,0.996564148848047,0,1,UFM1 conjugating enzyme activity,MF,
15206,GO:0061659,1,0.163926213936948,0,263,ubiquitin-like protein ligase activity,MF,
15207,GO:0061663,1,0.983730419239664,0,3,NEDD8 ligase activity,MF,
15208,GO:0061665,1,0.953480001906666,0,8,SUMO ligase activity,MF,
15209,GO:0061666,1,0.99325505912211,0,1,UFM1 ligase activity,MF,
15210,GO:0061668,1,0.963399241905418,0,6,mitochondrial ribosome assembly,BP,
15211,GO:0061669,1,0.950757813706151,0,7,spontaneous neurotransmitter secretion,BP,
15212,GO:0061670,1,0.996122926697365,0,1,evoked neurotransmitter secretion,BP,
15213,GO:0061673,1,0.948139368521499,0,8,mitotic spindle astral microtubule,CC,
15214,GO:0061676,1,0.948883764645478,0,7,importin-alpha family protein binding,MF,
15215,GO:0061682,1,0.99423170743865,0,1,seminal vesicle morphogenesis,BP,
15216,GO:0061684,1,0.901653978705475,0,16,chaperone-mediated autophagy,BP,
15217,GO:0061685,1,0.99325505912211,0,1,diphthine methylesterase activity,MF,
15218,GO:0061687,1,0.947135410844049,0,13,detoxification of inorganic compound,BP,
15219,GO:0061689,1,0.973452842463448,0,4,tricellular tight junction,CC,
15220,GO:0061690,1,0.996522633854899,0,1,lipoamidase activity,MF,
15222,GO:0061697,1,0.988522579221137,0,2,protein-glutaryllysine deglutarylase activity,MF,
15223,GO:0061698,1,0.988522579221137,0,2,protein deglutarylation,BP,
15224,GO:0061699,1,0.988522579221137,0,2,peptidyl-lysine deglutarylation,BP,
15225,GO:0061700,1,0.943114179850709,0,9,GATOR2 complex,CC,
15226,GO:0061702,1,0.918673838823303,0,14,inflammasome complex,CC,
15227,GO:0061709,1,0.942074505108696,0,9,reticulophagy,BP,
15228,GO:0061711,1,0.990351149600888,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
15229,GO:0061712,1,0.992651222684083,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15230,GO:0061713,1,0.990270874643977,0,2,anterior neural tube closure,BP,
15231,GO:0061714,1,0.993200785948841,0,2,folic acid receptor activity,MF,
15232,GO:0061715,1,0.992674109458785,0,1,miRNA 2'-O-methylation,BP,
15233,GO:0061718,1,0.852055424292368,0,26,glucose catabolic process to pyruvate,BP,
15234,GO:0061723,1,0.985220285196432,0,2,glycophagy,BP,
15235,GO:0061724,1,0.952975533960646,0,7,lipophagy,BP,
15236,GO:0061726,1,0.609619504896634,0,75,mitochondrion disassembly,BP,
15237,GO:0061727,1,0.985700904618165,0,3,methylglyoxal catabolic process to lactate,BP,
15238,GO:0061731,1,0.977659770551712,0,3,ribonucleoside-diphosphate reductase activity,MF,
15239,GO:0061732,1,0.96178322772473,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15240,GO:0061733,1,0.698680025829147,0,50,peptide-lysine-N-acetyltransferase activity,MF,
15241,GO:0061734,1,0.95805818573471,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15242,GO:0061736,1,0.991757417324615,0,1,engulfment of target by autophagosome,BP,
15243,GO:0061737,1,0.975016854410619,0,5,leukotriene signaling pathway,BP,
15244,GO:0061738,1,0.98236649901455,0,3,late endosomal microautophagy,BP,
15245,GO:0061739,1,0.981027633275609,0,3,protein lipidation involved in autophagosome assembly,BP,
15246,GO:0061740,1,0.980723596926408,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15247,GO:0061741,1,0.988177475974339,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15248,GO:0061743,1,0.973663297464865,0,5,motor learning,BP,
15249,GO:0061744,1,0.944795460586721,0,9,motor behavior,BP,
15250,GO:0061749,1,0.984119675906263,0,2,forked DNA-dependent helicase activity,MF,
15251,GO:0061750,1,0.994270196731744,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15252,GO:0061751,1,0.992003194016043,0,1,neutral sphingomyelin phosphodiesterase activity,MF,
15253,GO:0061752,1,0.988303402443859,0,2,telomeric repeat-containing RNA binding,MF,
15254,GO:0061753,1,0.991757417324615,0,1,substrate localization to autophagosome,BP,
15255,GO:0061756,1,0.759705476502092,0,42,leukocyte adhesion to vascular endothelial cell,BP,
15256,GO:0061757,1,0.975439358827019,0,4,leukocyte adhesion to arterial endothelial cell,BP,
15257,GO:0061760,1,0.982128858438283,0,4,antifungal innate immune response,BP,
15258,GO:0061762,1,0.947909647816037,0,7,CAMKK-AMPK signaling cascade,BP,
15259,GO:0061763,1,0.986838992675196,0,2,multivesicular body-lysosome fusion,BP,
15260,GO:0061767,1,0.991644673653576,0,1,negative regulation of lung blood pressure,BP,
15261,GO:0061768,1,0.992207447543228,0,1,magnesium:sodium antiporter activity,MF,
15262,GO:0061769,1,0.986555151512788,0,2,ribosylnicotinate kinase activity,MF,
15263,GO:0061770,1,0.994702939885281,0,1,translation elongation factor binding,MF,
15264,GO:0061771,1,0.983834318793755,0,3,response to caloric restriction,BP,
15265,GO:0061772,1,0.992580181249192,0,1,xenobiotic transport across blood-nerve barrier,BP,
15266,GO:0061778,1,0.892051642687022,0,16,intracellular chloride channel activity,MF,
15267,GO:0061780,1,0.989352680569835,0,1,mitotic cohesin loading,BP,
15268,GO:0061782,1,0.992455237799069,0,1,vesicle fusion with vesicle,BP,
15269,GO:0061783,1,0.989489678888473,0,3,peptidoglycan muralytic activity,MF,
15270,GO:0061789,1,0.971525148590858,0,3,dense core granule priming,BP,
15272,GO:0061795,1,0.9869500897403,0,2,Golgi lumen acidification,BP,
15273,GO:0061798,1,0.992442165171856,0,1,GTP 3',8'-cyclase activity,MF,
15274,GO:0061799,1,0.992442165171856,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15275,GO:0061809,1,0.896926048849079,0,16,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15276,GO:0061811,1,0.996149830842483,0,1,ADP-ribosyl cyclase activity,MF,
15277,GO:0061812,1,0.996149830842483,0,1,cyclic ADP-ribose hydrolase,MF,
15278,GO:0061817,1,0.965927182346488,0,5,endoplasmic reticulum-plasma membrane tethering,BP,
15279,GO:0061819,1,0.978757121563233,0,3,telomeric DNA-containing double minutes formation,BP,
15280,GO:0061820,1,0.942994221699106,0,8,telomeric D-loop disassembly,BP,
15281,GO:0061821,1,0.969354161898992,0,4,telomeric D-loop binding,MF,
15282,GO:0061825,1,0.992477156159595,0,1,podosome core,CC,
15283,GO:0061827,1,0.938508964786847,0,10,sperm head,CC,
15284,GO:0061828,1,0.990671198693614,0,1,apical tubulobulbar complex,CC,
15285,GO:0061829,1,0.990671198693614,0,1,basal tubulobulbar complex,CC,
15286,GO:0061830,1,0.991458937290796,0,1,concave side of sperm head,CC,
15287,GO:0061831,1,0.990350808556854,0,1,apical ectoplasmic specialization,CC,
15288,GO:0061832,1,0.990573587124092,0,1,basal ectoplasmic specialization,CC,
15289,GO:0061833,1,0.986977940674181,0,2,protein localization to tricellular tight junction,BP,
15290,GO:0061837,1,0.991779987068906,0,1,neuropeptide processing,BP,
15291,GO:0061842,1,0.80150995718702,0,29,microtubule organizing center localization,BP,
15292,GO:0061844,1,0.840277752827539,0,44,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
15293,GO:0061845,1,0.992666684062571,0,1,neuron projection branch point,CC,
15294,GO:0061846,1,0.992666684062571,0,1,dendritic spine cytoplasm,CC,
15295,GO:0061847,1,0.986897274334321,0,2,response to cholecystokinin,BP,
15296,GO:0061849,1,0.984119675906263,0,2,telomeric G-quadruplex DNA binding,MF,
15297,GO:0061850,1,0.996725737755439,0,1,growth cone leading edge,CC,
15298,GO:0061851,1,0.989525592277082,0,2,leading edge of lamellipodium,CC,
15299,GO:0061857,1,0.985788713288594,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
15300,GO:0061860,1,0.983698753556435,0,2,DNA clamp unloader activity,MF,
15301,GO:0061863,1,0.991227147391992,0,1,microtubule plus end polymerase,MF,
15302,GO:0061868,1,0.990305805369873,0,1,hepatic stellate cell migration,BP,
15303,GO:0061869,1,0.990305805369873,0,1,regulation of hepatic stellate cell migration,BP,
15304,GO:0061870,1,0.990305805369873,0,1,positive regulation of hepatic stellate cell migration,BP,
15305,GO:0061880,1,0.995776556119596,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
15306,GO:0061881,1,0.995776556119596,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
15307,GO:0061884,1,0.987603004537884,0,2,regulation of mini excitatory postsynaptic potential,BP,
15308,GO:0061885,1,0.987603004537884,0,2,positive regulation of mini excitatory postsynaptic potential,BP,
15309,GO:0061888,1,0.972986798008109,0,4,regulation of astrocyte activation,BP,
15310,GO:0061889,1,0.985309518731548,0,2,negative regulation of astrocyte activation,BP,
15311,GO:0061890,1,0.990953637171565,0,1,positive regulation of astrocyte activation,BP,
15312,GO:0061891,1,0.981034659568771,0,3,calcium ion sensor activity,MF,
15313,GO:0061896,1,0.992280925394114,0,1,all-trans retinol 3,4-desaturase activity,MF,
15314,GO:0061897,1,0.992280925394114,0,1,all-trans retinal 3,4-desaturase activity,MF,
15315,GO:0061898,1,0.992280925394114,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
15316,GO:0061899,1,0.992280925394114,0,1,11-cis-retinal 3,4-desaturase activity,MF,
15318,GO:0061901,1,0.987619160481722,0,2,regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15319,GO:0061903,1,0.987619160481722,0,2,positive regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15320,GO:0061909,1,0.987841635131703,0,2,autophagosome-lysosome fusion,BP,
15321,GO:0061912,1,0.674047007242145,0,56,selective autophagy,BP,
15323,GO:0061920,1,0.99006278034269,0,1,protein propionyltransferase activity,MF,
15324,GO:0061921,1,0.99006278034269,0,1,peptidyl-lysine propionylation,BP,
15325,GO:0061928,1,0.992569922771697,0,2,glutathione specific gamma-glutamylcyclotransferase activity,MF,
15326,GO:0061929,1,0.99325505912211,0,1,gamma-glutamylaminecyclotransferase activity,MF,
15327,GO:0061930,1,0.992064186951491,0,1,regulation of erythrocyte enucleation,BP,
15328,GO:0061931,1,0.992064186951491,0,1,positive regulation of erythrocyte enucleation,BP,
15329,GO:0061944,1,0.992400848212105,0,1,negative regulation of protein K48-linked ubiquitination,BP,
15330,GO:0061945,1,0.981164942738384,0,3,regulation of protein K48-linked ubiquitination,BP,
15332,GO:0061952,1,0.908653217017125,0,17,midbody abscission,BP,
15333,GO:0061953,1,0.981525913381266,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
15334,GO:0061966,1,0.985166817095134,0,2,establishment of left/right asymmetry,BP,
15335,GO:0061975,1,0.982535725522247,0,3,articular cartilage development,BP,
15336,GO:0061980,1,0.774774347158198,0,36,regulatory RNA binding,MF,
15337,GO:0061981,1,0.996144650033514,0,1,3-hydroxykynureninase activity,MF,
15338,GO:0061982,1,0.531338146337091,0,98,meiosis I cell cycle process,BP,
15339,GO:0061983,1,0.940999451770003,0,10,meiosis II cell cycle process,BP,
15340,GO:0061986,1,0.994049141089785,0,1,negative regulation of transcription by glucose,BP,
15341,GO:0061987,1,0.994049141089785,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
15342,GO:0061999,1,0.99360949731014,0,1,regulation of cardiac endothelial to mesenchymal transition,BP,
15343,GO:0062000,1,0.99360949731014,0,1,positive regulation of cardiac endothelial to mesenchymal transition,BP,
15344,GO:0062002,1,0.992960070375333,0,1,regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,BP,
15345,GO:0062003,1,0.992960070375333,0,1,negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,BP,
15346,GO:0062009,1,0.844069689582007,0,22,secondary palate development,BP,
15349,GO:0062014,1,0.572824243932691,0,85,negative regulation of small molecule metabolic process,BP,
15351,GO:0062025,1,0.992258149961942,0,1,regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
15352,GO:0062026,1,0.992258149961942,0,1,negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process,BP,
15353,GO:0062028,1,0.964163704489834,0,5,regulation of stress granule assembly,BP,
15354,GO:0062029,1,0.985614865928653,0,2,positive regulation of stress granule assembly,BP,
15355,GO:0062030,1,0.996240340690927,0,1,negative regulation of stress granule assembly,BP,
15356,GO:0062033,1,0.875836574378356,0,19,positive regulation of mitotic sister chromatid segregation,BP,
15357,GO:0062035,1,0.992280120968723,0,1,sensory perception of cold stimulus,BP,
15358,GO:0062036,1,0.992394115883539,0,1,sensory perception of hot stimulus,BP,
15359,GO:0062037,1,0.969354161898992,0,4,D-loop DNA binding,MF,
15360,GO:0062042,1,0.935902141026497,0,9,regulation of cardiac epithelial to mesenchymal transition,BP,
15361,GO:0062043,1,0.94025133474251,0,8,positive regulation of cardiac epithelial to mesenchymal transition,BP,
15362,GO:0062044,1,0.987455846810857,0,2,negative regulation of cardiac epithelial to mesenchymal transition,BP,
15363,GO:0062050,1,0.993184959998107,0,1,GPI-mannose ethanolamine phosphate phosphodiesterase activity,MF,
15364,GO:0062061,1,0.988622982018869,0,2,TAP complex binding,MF,
15365,GO:0062064,1,0.992475477155422,0,1,box C/D snoRNP complex binding,MF,
15366,GO:0062065,1,0.992475477155422,0,1,box H/ACA snoRNP complex binding,MF,
15367,GO:0062069,1,0.992519829229105,0,1,GARP complex binding,MF,
15368,GO:0062072,1,0.994046636166459,0,1,H3K9me3 modified histone binding,MF,
15369,GO:0062094,1,0.982132298406547,0,3,stomach development,BP,
15372,GO:0062100,1,0.982510647175466,0,3,positive regulation of programmed necrotic cell death,BP,
15373,GO:0062105,1,0.974491495103029,0,4,RNA 2'-O-methyltransferase activity,MF,
15374,GO:0062111,1,0.990252414440994,0,2,zinc ion import into organelle,BP,
15375,GO:0062125,1,0.851883532087887,0,28,regulation of mitochondrial gene expression,BP,
15376,GO:0062149,1,0.864036035521091,0,22,detection of stimulus involved in sensory perception of pain,BP,
15378,GO:0062207,1,0.56820221523671,0,83,regulation of pattern recognition receptor signaling pathway,BP,
15379,GO:0062208,1,0.792553140035004,0,34,positive regulation of pattern recognition receptor signaling pathway,BP,
15380,GO:0062232,1,0.982543917336631,0,3,prostanoid catabolic process,BP,
15381,GO:0062237,1,0.73157178726767,0,45,protein localization to postsynapse,BP,
15382,GO:0065001,1,0.974371909570647,0,4,specification of axis polarity,BP,
15385,GO:0065004,1,0.369598824862568,0,157,protein-DNA complex assembly,BP,
15386,GO:0065005,1,0.843383677396536,0,27,protein-lipid complex assembly,BP,
15390,GO:0065010,1,0.972182029053825,0,5,extracellular membrane-bounded organelle,CC,
15391,GO:0070001,1,0.899576706530558,0,18,aspartic-type peptidase activity,MF,
15392,GO:0070003,1,0.907634677339314,0,23,threonine-type peptidase activity,MF,
15393,GO:0070004,1,0.981812971428009,0,3,cysteine-type exopeptidase activity,MF,
15394,GO:0070006,1,0.855714678805958,0,22,metalloaminopeptidase activity,MF,
15395,GO:0070008,1,0.944227276329844,0,9,serine-type exopeptidase activity,MF,
15396,GO:0070009,1,0.977573979932601,0,3,serine-type aminopeptidase activity,MF,
15397,GO:0070012,1,0.979140012936438,0,3,oligopeptidase activity,MF,
15399,GO:0070016,1,0.925514547789394,0,10,armadillo repeat domain binding,MF,
15400,GO:0070025,1,0.993598293270506,0,1,carbon monoxide binding,MF,
15401,GO:0070026,1,0.986455215438394,0,3,nitric oxide binding,MF,
15402,GO:0070032,1,0.979433670881969,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
15403,GO:0070033,1,0.981932955352568,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
15404,GO:0070034,1,0.871593766385166,0,21,telomerase RNA binding,MF,
15405,GO:0070037,1,0.996621353896318,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15406,GO:0070042,1,0.992860950878364,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
15407,GO:0070044,1,0.977687034172274,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15408,GO:0070050,1,0.805761926370496,0,32,neuron cellular homeostasis,BP,
15409,GO:0070051,1,0.963135353563634,0,5,fibrinogen binding,MF,
15410,GO:0070052,1,0.984495411470965,0,2,collagen V binding,MF,
15411,GO:0070053,1,0.980608166108241,0,3,thrombospondin receptor activity,MF,
15412,GO:0070054,1,0.99246592438391,0,1,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15414,GO:0070060,1,0.989880289196958,0,1,'de novo' actin filament nucleation,BP,
15415,GO:0070061,1,0.970136627599225,0,5,fructose binding,MF,
15417,GO:0070063,1,0.66371466352807,0,61,RNA polymerase binding,MF,
15418,GO:0070064,1,0.883199713021953,0,17,proline-rich region binding,MF,
15419,GO:0070069,1,0.905733951222683,0,24,cytochrome complex,CC,
15420,GO:0070070,1,0.971152015279274,0,5,proton-transporting V-type ATPase complex assembly,BP,
15421,GO:0070071,1,0.951018695335672,0,9,proton-transporting two-sector ATPase complex assembly,BP,
15422,GO:0070072,1,0.971152015279274,0,5,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15423,GO:0070075,1,0.996826939881114,0,1,tear secretion,BP,
15424,GO:0070076,1,0.810304618527494,0,26,histone lysine demethylation,BP,
15425,GO:0070077,1,0.992518692750008,0,1,histone arginine demethylation,BP,
15426,GO:0070078,1,0.992518692750008,0,1,histone H3-R2 demethylation,BP,
15427,GO:0070079,1,0.992518692750008,0,1,histone H4-R3 demethylation,BP,
15428,GO:0070080,1,0.989043883959152,0,2,titin Z domain binding,MF,
15429,GO:0070081,1,0.971826944970598,0,5,clathrin-sculpted monoamine transport vesicle,CC,
15430,GO:0070083,1,0.971826944970598,0,5,clathrin-sculpted monoamine transport vesicle membrane,CC,
15431,GO:0070084,1,0.979191240983943,0,3,protein initiator methionine removal,BP,
15433,GO:0070086,1,0.969700923439816,0,5,ubiquitin-dependent endocytosis,BP,
15434,GO:0070087,1,0.949639517452209,0,6,chromo shadow domain binding,MF,
15435,GO:0070089,1,0.991631251060807,0,1,chloride-activated potassium channel activity,MF,
15436,GO:0070091,1,0.951221054522721,0,9,glucagon secretion,BP,
15437,GO:0070092,1,0.951221054522721,0,9,regulation of glucagon secretion,BP,
15438,GO:0070093,1,0.982190431094839,0,4,negative regulation of glucagon secretion,BP,
15439,GO:0070094,1,0.986936374483137,0,2,positive regulation of glucagon secretion,BP,
15440,GO:0070095,1,0.969618597392267,0,5,fructose-6-phosphate binding,MF,
15441,GO:0070096,1,0.992595534101838,0,1,mitochondrial outer membrane translocase complex assembly,BP,
15442,GO:0070097,1,0.946777953860532,0,7,delta-catenin binding,MF,
15443,GO:0070098,1,0.679834529040395,0,72,chemokine-mediated signaling pathway,BP,
15444,GO:0070099,1,0.941102820846618,0,9,regulation of chemokine-mediated signaling pathway,BP,
15445,GO:0070100,1,0.956382404558006,0,6,negative regulation of chemokine-mediated signaling pathway,BP,
15446,GO:0070101,1,0.984030774656422,0,3,positive regulation of chemokine-mediated signaling pathway,BP,
15448,GO:0070103,1,0.978068497864011,0,4,regulation of interleukin-6-mediated signaling pathway,BP,
15449,GO:0070104,1,0.995772666138557,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15450,GO:0070105,1,0.982221435684019,0,3,positive regulation of interleukin-6-mediated signaling pathway,BP,
15452,GO:0070110,1,0.980422566269231,0,3,ciliary neurotrophic factor receptor complex,CC,
15453,GO:0070119,1,0.992448069628726,0,1,ciliary neurotrophic factor binding,MF,
15454,GO:0070120,1,0.965479686252091,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15455,GO:0070121,1,0.991847881963631,0,1,Kupffer's vesicle development,BP,
15456,GO:0070122,1,0.909796431528758,0,17,isopeptidase activity,MF,
15457,GO:0070123,1,0.991349905518113,0,1,transforming growth factor beta receptor activity, type III,MF,
15458,GO:0070124,1,0.989936092251214,0,2,mitochondrial translational initiation,BP,
15459,GO:0070125,1,0.705313884180064,0,85,mitochondrial translational elongation,BP,
15460,GO:0070126,1,0.700343388312818,0,86,mitochondrial translational termination,BP,
15461,GO:0070127,1,0.955107911586104,0,7,tRNA aminoacylation for mitochondrial protein translation,BP,
15462,GO:0070129,1,0.86795188392543,0,25,regulation of mitochondrial translation,BP,
15463,GO:0070130,1,0.99325505912211,0,1,negative regulation of mitochondrial translation,BP,
15464,GO:0070131,1,0.913290155456444,0,16,positive regulation of mitochondrial translation,BP,
15465,GO:0070137,1,0.976327329229067,0,3,ubiquitin-like protein-specific endopeptidase activity,MF,
15466,GO:0070138,1,0.977611068754437,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
15467,GO:0070139,1,0.976327329229067,0,3,SUMO-specific endopeptidase activity,MF,
15468,GO:0070140,1,0.977611068754437,0,3,SUMO-specific isopeptidase activity,MF,
15470,GO:0070142,1,0.921799941143043,0,11,synaptic vesicle budding,BP,
15471,GO:0070143,1,0.992234466979565,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15472,GO:0070145,1,0.992606559055304,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15473,GO:0070158,1,0.994922736401722,0,1,mitochondrial seryl-tRNA aminoacylation,BP,
15474,GO:0070159,1,0.994122180779848,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15477,GO:0070162,1,0.958591506793874,0,6,adiponectin secretion,BP,
15478,GO:0070163,1,0.958591506793874,0,6,regulation of adiponectin secretion,BP,
15479,GO:0070164,1,0.972387551546378,0,4,negative regulation of adiponectin secretion,BP,
15480,GO:0070165,1,0.985816217353638,0,2,positive regulation of adiponectin secretion,BP,
15481,GO:0070166,1,0.923022163163366,0,11,enamel mineralization,BP,
15484,GO:0070169,1,0.75747242444535,0,41,positive regulation of biomineral tissue development,BP,
15485,GO:0070170,1,0.967597218855951,0,5,regulation of tooth mineralization,BP,
15486,GO:0070171,1,0.985338796655267,0,2,negative regulation of tooth mineralization,BP,
15487,GO:0070172,1,0.988451607731653,0,2,positive regulation of tooth mineralization,BP,
15488,GO:0070173,1,0.99347088155495,0,1,regulation of enamel mineralization,BP,
15489,GO:0070176,1,0.99557735691295,0,1,DRM complex,CC,
15490,GO:0070178,1,0.989869534894684,0,2,D-serine metabolic process,BP,
15491,GO:0070179,1,0.993883677960989,0,1,D-serine biosynthetic process,BP,
15492,GO:0070180,1,0.986176830556059,0,4,large ribosomal subunit rRNA binding,MF,
15493,GO:0070181,1,0.955382718865911,0,10,small ribosomal subunit rRNA binding,MF,
15494,GO:0070182,1,0.889954613463073,0,18,DNA polymerase binding,MF,
15495,GO:0070183,1,0.993165120463862,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
15496,GO:0070184,1,0.994702939885281,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15497,GO:0070187,1,0.963869631185793,0,6,shelterin complex,CC,
15498,GO:0070189,1,0.959005794317913,0,8,kynurenine metabolic process,BP,
15499,GO:0070191,1,0.99325505912211,0,1,methionine-R-sulfoxide reductase activity,MF,
15500,GO:0070192,1,0.692455990052782,0,55,chromosome organization involved in meiotic cell cycle,BP,
15501,GO:0070193,1,0.888937859583968,0,19,synaptonemal complex organization,BP,
15502,GO:0070194,1,0.987965851052415,0,2,synaptonemal complex disassembly,BP,
15503,GO:0070195,1,0.992393257963047,0,1,growth hormone receptor complex,CC,
15504,GO:0070197,1,0.988071832943591,0,2,meiotic attachment of telomere to nuclear envelope,BP,
15505,GO:0070198,1,0.817229923354102,0,29,protein localization to chromosome, telomeric region,BP,
15506,GO:0070199,1,0.858603820021899,0,23,establishment of protein localization to chromosome,BP,
15507,GO:0070200,1,0.885098097191402,0,18,establishment of protein localization to telomere,BP,
15509,GO:0070202,1,0.932799947052092,0,12,regulation of establishment of protein localization to chromosome,BP,
15510,GO:0070203,1,0.939138427418886,0,11,regulation of establishment of protein localization to telomere,BP,
15511,GO:0070206,1,0.903922380286377,0,17,protein trimerization,BP,
15512,GO:0070207,1,0.914630219052227,0,15,protein homotrimerization,BP,
15513,GO:0070208,1,0.991900921870578,0,1,protein heterotrimerization,BP,
15514,GO:0070209,1,0.979268645858943,0,3,ASTRA complex,CC,
15515,GO:0070212,1,0.942038452486592,0,8,protein poly-ADP-ribosylation,BP,
15516,GO:0070213,1,0.920747243717771,0,11,protein auto-ADP-ribosylation,BP,
15517,GO:0070221,1,0.98324288063967,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15518,GO:0070227,1,0.674025272610109,0,66,lymphocyte apoptotic process,BP,
15519,GO:0070228,1,0.753547173445162,0,49,regulation of lymphocyte apoptotic process,BP,
15520,GO:0070229,1,0.851843520565894,0,27,negative regulation of lymphocyte apoptotic process,BP,
15521,GO:0070230,1,0.927903852973045,0,14,positive regulation of lymphocyte apoptotic process,BP,
15522,GO:0070231,1,0.775705649443586,0,44,T cell apoptotic process,BP,
15523,GO:0070232,1,0.850902134659921,0,29,regulation of T cell apoptotic process,BP,
15524,GO:0070233,1,0.906705284983373,0,17,negative regulation of T cell apoptotic process,BP,
15525,GO:0070234,1,0.949875109960707,0,10,positive regulation of T cell apoptotic process,BP,
15526,GO:0070235,1,0.977560065223259,0,4,regulation of activation-induced cell death of T cells,BP,
15527,GO:0070236,1,0.982186857566315,0,3,negative regulation of activation-induced cell death of T cells,BP,
15528,GO:0070238,1,0.995833820986594,0,1,activated T cell autonomous cell death,BP,
15529,GO:0070239,1,0.995833820986594,0,1,regulation of activated T cell autonomous cell death,BP,
15530,GO:0070241,1,0.995833820986594,0,1,positive regulation of activated T cell autonomous cell death,BP,
15531,GO:0070242,1,0.901557863788971,0,17,thymocyte apoptotic process,BP,
15532,GO:0070243,1,0.931680882364288,0,12,regulation of thymocyte apoptotic process,BP,
15533,GO:0070244,1,0.960651558842639,0,7,negative regulation of thymocyte apoptotic process,BP,
15534,GO:0070245,1,0.969854850515961,0,5,positive regulation of thymocyte apoptotic process,BP,
15535,GO:0070246,1,0.996392763016546,0,1,natural killer cell apoptotic process,BP,
15536,GO:0070247,1,0.996392763016546,0,1,regulation of natural killer cell apoptotic process,BP,
15537,GO:0070251,1,0.994298498770425,0,1,pristanate-CoA ligase activity,MF,
15539,GO:0070253,1,0.979679485297901,0,4,somatostatin secretion,BP,
15540,GO:0070254,1,0.942189949536198,0,10,mucus secretion,BP,
15541,GO:0070255,1,0.945224972230641,0,9,regulation of mucus secretion,BP,
15542,GO:0070256,1,0.989223052204408,0,2,negative regulation of mucus secretion,BP,
15543,GO:0070257,1,0.961851237200003,0,6,positive regulation of mucus secretion,BP,
15544,GO:0070259,1,0.985819403308548,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15545,GO:0070260,1,0.99325505912211,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15546,GO:0070262,1,0.886079797967622,0,20,peptidyl-serine dephosphorylation,BP,
15549,GO:0070267,1,0.992526325319672,0,1,oncosis,BP,
15551,GO:0070269,1,0.944026411100199,0,10,pyroptosis,BP,
15552,GO:0070273,1,0.828902366584098,0,26,phosphatidylinositol-4-phosphate binding,MF,
15553,GO:0070274,1,0.995087717902534,0,1,RES complex,CC,
15554,GO:0070278,1,0.933443769967081,0,10,extracellular matrix constituent secretion,BP,
15555,GO:0070279,1,0.764850069311831,0,44,vitamin B6 binding,MF,
15556,GO:0070280,1,0.992488314549241,0,1,pyridoxal binding,MF,
15558,GO:0070287,1,0.992517278529714,0,1,ferritin receptor activity,MF,
15559,GO:0070288,1,0.993213094726051,0,2,ferritin complex,CC,
15560,GO:0070290,1,0.976617123744174,0,3,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15561,GO:0070291,1,0.973066422914182,0,5,N-acylethanolamine metabolic process,BP,
15562,GO:0070292,1,0.985910767556043,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
15563,GO:0070293,1,0.907565533029637,0,16,renal absorption,BP,
15564,GO:0070294,1,0.972510995783513,0,4,renal sodium ion absorption,BP,
15565,GO:0070295,1,0.982854591395421,0,3,renal water absorption,BP,
15566,GO:0070296,1,0.781482012294689,0,35,sarcoplasmic reticulum calcium ion transport,BP,
15567,GO:0070300,1,0.87879395784925,0,19,phosphatidic acid binding,MF,
15568,GO:0070301,1,0.577241963840962,0,87,cellular response to hydrogen peroxide,BP,
15570,GO:0070303,1,0.752263549355126,0,42,negative regulation of stress-activated protein kinase signaling cascade,BP,
15572,GO:0070305,1,0.95277126206548,0,6,response to cGMP,BP,
15573,GO:0070306,1,0.799864468600289,0,32,lens fiber cell differentiation,BP,
15574,GO:0070307,1,0.923576445593085,0,12,lens fiber cell development,BP,
15575,GO:0070309,1,0.965212329141059,0,5,lens fiber cell morphogenesis,BP,
15578,GO:0070316,1,0.755686972084201,0,40,regulation of G0 to G1 transition,BP,
15579,GO:0070317,1,0.77110777445619,0,37,negative regulation of G0 to G1 transition,BP,
15580,GO:0070318,1,0.980054176458306,0,3,positive regulation of G0 to G1 transition,BP,
15581,GO:0070319,1,0.984191782761751,0,2,Golgi to plasma membrane transport vesicle,CC,
15582,GO:0070320,1,0.993447727017397,0,1,inward rectifier potassium channel inhibitor activity,MF,
15583,GO:0070324,1,0.960438479421236,0,7,thyroid hormone binding,MF,
15584,GO:0070325,1,0.85845176125279,0,21,lipoprotein particle receptor binding,MF,
15585,GO:0070326,1,0.973894919564655,0,4,very-low-density lipoprotein particle receptor binding,MF,
15586,GO:0070327,1,0.942749474118509,0,9,thyroid hormone transport,BP,
15587,GO:0070328,1,0.8550985575247,0,27,triglyceride homeostasis,BP,
15588,GO:0070330,1,0.922030085298429,0,14,aromatase activity,MF,
15589,GO:0070335,1,0.990949215284694,0,1,aspartate binding,MF,
15590,GO:0070336,1,0.977810050300349,0,3,flap-structured DNA binding,MF,
15591,GO:0070337,1,0.991721069797367,0,1,3'-flap-structured DNA binding,MF,
15592,GO:0070339,1,0.964413738805561,0,6,response to bacterial lipopeptide,BP,
15593,GO:0070340,1,0.977537677243776,0,3,detection of bacterial lipopeptide,BP,
15594,GO:0070341,1,0.943698216572143,0,9,fat cell proliferation,BP,
15595,GO:0070343,1,0.98570611847226,0,3,white fat cell proliferation,BP,
15596,GO:0070344,1,0.943698216572143,0,9,regulation of fat cell proliferation,BP,
15597,GO:0070345,1,0.963790198366041,0,5,negative regulation of fat cell proliferation,BP,
15598,GO:0070346,1,0.986648576530294,0,3,positive regulation of fat cell proliferation,BP,
15599,GO:0070350,1,0.98570611847226,0,3,regulation of white fat cell proliferation,BP,
15600,GO:0070352,1,0.9932433094687,0,2,positive regulation of white fat cell proliferation,BP,
15601,GO:0070358,1,0.95006464039432,0,7,actin polymerization-dependent cell motility,BP,
15602,GO:0070365,1,0.924939358749011,0,13,hepatocyte differentiation,BP,
15603,GO:0070366,1,0.991568310765406,0,2,regulation of hepatocyte differentiation,BP,
15604,GO:0070367,1,0.995017659130702,0,1,negative regulation of hepatocyte differentiation,BP,
15605,GO:0070368,1,0.996533556746551,0,1,positive regulation of hepatocyte differentiation,BP,
15606,GO:0070369,1,0.975545457392384,0,3,beta-catenin-TCF7L2 complex,CC,
15607,GO:0070370,1,0.975270156110806,0,5,cellular heat acclimation,BP,
15610,GO:0070373,1,0.637703981055679,0,68,negative regulation of ERK1 and ERK2 cascade,BP,
15612,GO:0070375,1,0.986113234047447,0,2,ERK5 cascade,BP,
15613,GO:0070381,1,0.985132654879353,0,2,endosome to plasma membrane transport vesicle,CC,
15615,GO:0070383,1,0.954834375696349,0,9,DNA cytosine deamination,BP,
15616,GO:0070384,1,0.975220150232495,0,4,Harderian gland development,BP,
15617,GO:0070390,1,0.977573184673904,0,5,transcription export complex 2,CC,
15618,GO:0070391,1,0.944135088533387,0,10,response to lipoteichoic acid,BP,
15619,GO:0070392,1,0.996620610494782,0,1,detection of lipoteichoic acid,BP,
15620,GO:0070401,1,0.984908320092136,0,3,NADP+ binding,MF,
15621,GO:0070402,1,0.912734320620048,0,15,NADPH binding,MF,
15622,GO:0070403,1,0.923546751786965,0,14,NAD+ binding,MF,
15623,GO:0070404,1,0.986929308078782,0,3,NADH binding,MF,
15624,GO:0070407,1,0.992771947167084,0,1,oxidation-dependent protein catabolic process,BP,
15625,GO:0070408,1,0.991733095611559,0,1,carbamoyl phosphate metabolic process,BP,
15626,GO:0070409,1,0.991733095611559,0,1,carbamoyl phosphate biosynthetic process,BP,
15627,GO:0070410,1,0.90987572572954,0,12,co-SMAD binding,MF,
15628,GO:0070411,1,0.894404552530545,0,14,I-SMAD binding,MF,
15629,GO:0070412,1,0.835608914224972,0,23,R-SMAD binding,MF,
15630,GO:0070413,1,0.992957421892581,0,1,trehalose metabolism in response to stress,BP,
15631,GO:0070417,1,0.941345754035517,0,9,cellular response to cold,BP,
15632,GO:0070418,1,0.984485122242897,0,2,DNA-dependent protein kinase complex,CC,
15633,GO:0070419,1,0.951700309375564,0,7,nonhomologous end joining complex,CC,
15634,GO:0070421,1,0.992590527917628,0,1,DNA ligase III-XRCC1 complex,CC,
15635,GO:0070423,1,0.795286744593187,0,34,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15636,GO:0070424,1,0.935831369155831,0,9,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15637,GO:0070425,1,0.985320464881946,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15638,GO:0070426,1,0.973707352014597,0,4,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15639,GO:0070427,1,0.968053034530598,0,5,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15640,GO:0070428,1,0.978160638861239,0,3,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15641,GO:0070429,1,0.992372857018491,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15642,GO:0070430,1,0.985679659979411,0,2,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15643,GO:0070431,1,0.925538096686333,0,12,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15644,GO:0070432,1,0.965363194182225,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15645,GO:0070433,1,0.985320464881946,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15646,GO:0070434,1,0.979748424659551,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15648,GO:0070436,1,0.985126337272503,0,2,Grb2-EGFR complex,CC,
15649,GO:0070442,1,0.996290380568259,0,1,integrin alphaIIb-beta3 complex,CC,
15652,GO:0070446,1,0.995237360435577,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15654,GO:0070453,1,0.992922678879628,0,2,regulation of heme biosynthetic process,BP,
15655,GO:0070458,1,0.98541618846452,0,3,cellular detoxification of nitrogen compound,BP,
15657,GO:0070460,1,0.978086382748256,0,3,thyroid-stimulating hormone secretion,BP,
15658,GO:0070461,1,0.856974309875482,0,23,SAGA-type complex,CC,
15659,GO:0070462,1,0.99251214454348,0,1,plus-end specific microtubule depolymerization,BP,
15660,GO:0070463,1,0.992558573673618,0,1,tubulin-dependent ATPase activity,MF,
15661,GO:0070469,1,0.728983534815391,0,78,respirasome,CC,
15662,GO:0070471,1,0.945144377149756,0,9,uterine smooth muscle contraction,BP,
15663,GO:0070472,1,0.951187288660458,0,8,regulation of uterine smooth muscle contraction,BP,
15664,GO:0070473,1,0.995225268069383,0,1,negative regulation of uterine smooth muscle contraction,BP,
15665,GO:0070474,1,0.967957743591742,0,5,positive regulation of uterine smooth muscle contraction,BP,
15666,GO:0070475,1,0.96099696790392,0,7,rRNA base methylation,BP,
15667,GO:0070476,1,0.996838710838752,0,1,rRNA (guanine-N7)-methylation,BP,
15668,GO:0070478,1,0.992436155851584,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15669,GO:0070481,1,0.993013841368773,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15670,GO:0070482,1,0.0966776878475155,0,364,response to oxygen levels,BP,
15671,GO:0070483,1,0.992718552312644,0,1,detection of hypoxia,BP,
15672,GO:0070486,1,0.917889991272455,0,14,leukocyte aggregation,BP,
15673,GO:0070487,1,0.958087971315566,0,6,monocyte aggregation,BP,
15674,GO:0070488,1,0.993716421726053,0,2,neutrophil aggregation,BP,
15675,GO:0070489,1,0.98775406656994,0,2,T cell aggregation,BP,
15676,GO:0070491,1,0.620609370331609,0,71,repressing transcription factor binding,MF,
15677,GO:0070492,1,0.943979597558805,0,11,oligosaccharide binding,MF,
15678,GO:0070493,1,0.91874079973619,0,12,thrombin-activated receptor signaling pathway,BP,
15679,GO:0070494,1,0.980008766629535,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15680,GO:0070495,1,0.980008766629535,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15682,GO:0070506,1,0.986936191785515,0,2,high-density lipoprotein particle receptor activity,MF,
15684,GO:0070508,1,0.949310894217322,0,8,cholesterol import,BP,
15685,GO:0070509,1,0.585140187911744,0,74,calcium ion import,BP,
15686,GO:0070510,1,0.990958336475357,0,1,regulation of histone H4-K20 methylation,BP,
15687,GO:0070512,1,0.990958336475357,0,1,positive regulation of histone H4-K20 methylation,BP,
15688,GO:0070513,1,0.948939615041687,0,10,death domain binding,MF,
15689,GO:0070516,1,0.983474152370534,0,4,CAK-ERCC2 complex,CC,
15690,GO:0070522,1,0.972154021660537,0,4,ERCC4-ERCC1 complex,CC,
15691,GO:0070524,1,0.996251769189158,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15692,GO:0070525,1,0.930301867187103,0,14,tRNA threonylcarbamoyladenosine metabolic process,BP,
15694,GO:0070528,1,0.829260150776164,0,29,protein kinase C signaling,BP,
15695,GO:0070530,1,0.884143715936811,0,17,K63-linked polyubiquitin modification-dependent protein binding,MF,
15696,GO:0070531,1,0.961783179067501,0,6,BRCA1-A complex,CC,
15697,GO:0070534,1,0.708236955240623,0,52,protein K63-linked ubiquitination,BP,
15698,GO:0070535,1,0.954634197853529,0,6,histone H2A K63-linked ubiquitination,BP,
15699,GO:0070536,1,0.819565776629232,0,27,protein K63-linked deubiquitination,BP,
15700,GO:0070537,1,0.979695840740325,0,3,histone H2A K63-linked deubiquitination,BP,
15701,GO:0070538,1,0.992836025580552,0,2,oleic acid binding,MF,
15702,GO:0070539,1,0.992545381917436,0,1,linoleic acid binding,MF,
15703,GO:0070541,1,0.980038645934277,0,3,response to platinum ion,BP,
15704,GO:0070542,1,0.58146629220857,0,83,response to fatty acid,BP,
15705,GO:0070543,1,0.994926554507968,0,1,response to linoleic acid,BP,
15706,GO:0070544,1,0.939239555381655,0,8,histone H3-K36 demethylation,BP,
15707,GO:0070545,1,0.988806412855908,0,2,PeBoW complex,CC,
15708,GO:0070547,1,0.993264350859525,0,1,L-tyrosine aminotransferase activity,MF,
15709,GO:0070548,1,0.983075200862996,0,2,L-glutamine aminotransferase activity,MF,
15710,GO:0070550,1,0.989352680569835,0,1,rDNA condensation,BP,
15711,GO:0070551,1,0.99325505912211,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
15712,GO:0070552,1,0.980929899026862,0,3,BRISC complex,CC,
15713,GO:0070553,1,0.99325505912211,0,1,nicotinic acid receptor activity,MF,
15714,GO:0070554,1,0.987073207861743,0,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,
15716,GO:0070557,1,0.990954052715566,0,2,PCNA-p21 complex,CC,
15717,GO:0070560,1,0.986407432600668,0,2,protein secretion by platelet,BP,
15718,GO:0070561,1,0.938555034085497,0,9,vitamin D receptor signaling pathway,BP,
15719,GO:0070562,1,0.959163286487361,0,6,regulation of vitamin D receptor signaling pathway,BP,
15720,GO:0070563,1,0.987005291294755,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
15721,GO:0070564,1,0.988661541527576,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
15722,GO:0070566,1,0.874007399553628,0,20,adenylyltransferase activity,MF,
15723,GO:0070567,1,0.955305239350135,0,8,cytidylyltransferase activity,MF,
15724,GO:0070568,1,0.977457962700023,0,4,guanylyltransferase activity,MF,
15725,GO:0070569,1,0.971417703051921,0,5,uridylyltransferase activity,MF,
15726,GO:0070570,1,0.822697415957342,0,28,regulation of neuron projection regeneration,BP,
15727,GO:0070571,1,0.903905653855164,0,14,negative regulation of neuron projection regeneration,BP,
15728,GO:0070572,1,0.945648999191121,0,9,positive regulation of neuron projection regeneration,BP,
15730,GO:0070574,1,0.96543537985604,0,5,cadmium ion transmembrane transport,BP,
15731,GO:0070576,1,0.986356745053916,0,2,vitamin D 24-hydroxylase activity,MF,
15732,GO:0070577,1,0.850761911976748,0,21,lysine-acetylated histone binding,MF,
15733,GO:0070578,1,0.943469082087391,0,9,RISC-loading complex,CC,
15734,GO:0070579,1,0.962457314496815,0,4,methylcytosine dioxygenase activity,MF,
15735,GO:0070584,1,0.875782095403853,0,22,mitochondrion morphogenesis,BP,
15736,GO:0070585,1,0.452772175760621,0,134,protein localization to mitochondrion,BP,
15740,GO:0070589,1,0.995630725828587,0,1,cellular component macromolecule biosynthetic process,BP,
15742,GO:0070601,1,0.936550034171828,0,10,centromeric sister chromatid cohesion,BP,
15743,GO:0070602,1,0.974460545098601,0,4,regulation of centromeric sister chromatid cohesion,BP,
15744,GO:0070603,1,0.61474468566914,0,72,SWI/SNF superfamily-type complex,CC,
15745,GO:0070611,1,0.993521223190077,0,1,histone methyltransferase activity (H3-R2 specific),MF,
15746,GO:0070612,1,0.993521223190077,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
15748,GO:0070615,1,0.983356229997523,0,2,nucleosome-dependent ATPase activity,MF,
15749,GO:0070618,1,0.993413503995573,0,1,Grb2-Sos complex,CC,
15750,GO:0070625,1,0.994903621882618,0,1,zymogen granule exocytosis,BP,
15751,GO:0070626,1,0.996154252202172,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
15752,GO:0070628,1,0.903824542995319,0,16,proteasome binding,MF,
15753,GO:0070633,1,0.839350095117403,0,24,transepithelial transport,BP,
15754,GO:0070634,1,0.98638510107378,0,2,transepithelial ammonium transport,BP,
15755,GO:0070637,1,0.994046636166459,0,1,pyridine nucleoside metabolic process,BP,
15756,GO:0070638,1,0.994046636166459,0,1,pyridine nucleoside catabolic process,BP,
15757,GO:0070640,1,0.976146816980362,0,4,vitamin D3 metabolic process,BP,
15758,GO:0070643,1,0.98310327156758,0,3,vitamin D 25-hydroxylase activity,MF,
15759,GO:0070644,1,0.976729634612871,0,3,vitamin D response element binding,MF,
15760,GO:0070646,1,0.186064524365475,0,256,protein modification by small protein removal,BP,
15762,GO:0070649,1,0.976129950212521,0,3,formin-nucleated actin cable assembly,BP,
15763,GO:0070651,1,0.993013841368773,0,1,nonfunctional rRNA decay,BP,
15764,GO:0070652,1,0.953097154773617,0,8,HAUS complex,CC,
15765,GO:0070653,1,0.996719850943217,0,1,high-density lipoprotein particle receptor binding,MF,
15767,GO:0070662,1,0.963677086088023,0,5,mast cell proliferation,BP,
15770,GO:0070665,1,0.462244596685556,0,133,positive regulation of leukocyte proliferation,BP,
15771,GO:0070666,1,0.971402842989557,0,4,regulation of mast cell proliferation,BP,
15772,GO:0070667,1,0.979301501005547,0,3,negative regulation of mast cell proliferation,BP,
15773,GO:0070668,1,0.984823231982662,0,2,positive regulation of mast cell proliferation,BP,
15774,GO:0070669,1,0.915664067080139,0,13,response to interleukin-2,BP,
15775,GO:0070670,1,0.82354583093823,0,32,response to interleukin-4,BP,
15776,GO:0070671,1,0.763874452427173,0,47,response to interleukin-12,BP,
15777,GO:0070672,1,0.906244056551882,0,14,response to interleukin-15,BP,
15778,GO:0070673,1,0.9333459626395,0,11,response to interleukin-18,BP,
15779,GO:0070676,1,0.986411642566949,0,3,intralumenal vesicle formation,BP,
15780,GO:0070678,1,0.993427947168018,0,1,preprotein binding,MF,
15782,GO:0070681,1,0.982666610978715,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
15783,GO:0070682,1,0.983026806408546,0,3,proteasome regulatory particle assembly,BP,
15784,GO:0070684,1,0.996553004076129,0,1,seminal clot liquefaction,BP,
15785,GO:0070685,1,0.994825515423969,0,1,macropinocytic cup,CC,
15786,GO:0070694,1,0.99325505912211,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
15787,GO:0070695,1,0.960257569677813,0,5,FHF complex,CC,
15788,GO:0070696,1,0.882913814367048,0,20,transmembrane receptor protein serine/threonine kinase binding,MF,
15789,GO:0070697,1,0.954416770403531,0,8,activin receptor binding,MF,
15790,GO:0070698,1,0.98312968115695,0,3,type I activin receptor binding,MF,
15791,GO:0070699,1,0.97877352695388,0,3,type II activin receptor binding,MF,
15792,GO:0070700,1,0.925116351477572,0,12,BMP receptor binding,MF,
15793,GO:0070704,1,0.98568223945275,0,2,sterol desaturase activity,MF,
15794,GO:0070715,1,0.992650600045045,0,1,sodium-dependent organic cation transport,BP,
15795,GO:0070716,1,0.993917823470783,0,1,mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication,BP,
15796,GO:0070717,1,0.815018653879156,0,29,poly-purine tract binding,MF,
15798,GO:0070724,1,0.978294624865608,0,3,BMP receptor complex,CC,
15800,GO:0070728,1,0.951378712199182,0,7,leucine binding,MF,
15801,GO:0070733,1,0.995876361278093,0,1,protein adenylyltransferase activity,MF,
15802,GO:0070734,1,0.893249897657654,0,15,histone H3-K27 methylation,BP,
15803,GO:0070735,1,0.99258397034247,0,1,protein-glycine ligase activity,MF,
15804,GO:0070736,1,0.99258397034247,0,1,protein-glycine ligase activity, initiating,MF,
15805,GO:0070739,1,0.949164748034121,0,8,protein-glutamic acid ligase activity,MF,
15806,GO:0070740,1,0.949164748034121,0,8,tubulin-glutamic acid ligase activity,MF,
15808,GO:0070742,1,0.905428259369723,0,14,C2H2 zinc finger domain binding,MF,
15809,GO:0070743,1,0.996628710723769,0,1,interleukin-23 complex,CC,
15810,GO:0070757,1,0.927273606461491,0,11,interleukin-35-mediated signaling pathway,BP,
15811,GO:0070761,1,0.971035959714931,0,5,pre-snoRNP complex,CC,
15812,GO:0070762,1,0.99325505912211,0,1,nuclear pore transmembrane ring,CC,
15813,GO:0070765,1,0.961881670477068,0,6,gamma-secretase complex,CC,
15814,GO:0070772,1,0.992786080512339,0,1,PAS complex,CC,
15815,GO:0070774,1,0.98656635426314,0,2,phytoceramidase activity,MF,
15816,GO:0070775,1,0.936987240057007,0,9,H3 histone acetyltransferase complex,CC,
15817,GO:0070776,1,0.943353878629618,0,8,MOZ/MORF histone acetyltransferase complex,CC,
15818,GO:0070777,1,0.966318461468961,0,4,D-aspartate transport,BP,
15819,GO:0070778,1,0.92599971797746,0,11,L-aspartate transmembrane transport,BP,
15820,GO:0070779,1,0.966318461468961,0,4,D-aspartate import across plasma membrane,BP,
15821,GO:0070781,1,0.987490435155635,0,2,response to biotin,BP,
15822,GO:0070782,1,0.965910473149548,0,5,phosphatidylserine exposure on apoptotic cell surface,BP,
15823,GO:0070813,1,0.973098284731923,0,5,hydrogen sulfide metabolic process,BP,
15824,GO:0070814,1,0.976340369326239,0,4,hydrogen sulfide biosynthetic process,BP,
15825,GO:0070815,1,0.971095143702498,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
15826,GO:0070816,1,0.925946602915976,0,12,phosphorylation of RNA polymerase II C-terminal domain,BP,
15827,GO:0070818,1,0.995689879813765,0,1,protoporphyrinogen oxidase activity,MF,
15828,GO:0070820,1,0.389658941816699,0,155,tertiary granule,CC,
15829,GO:0070821,1,0.625260309148018,0,70,tertiary granule membrane,CC,
15830,GO:0070822,1,0.901012839266618,0,15,Sin3-type complex,CC,
15831,GO:0070826,1,0.992440341107594,0,1,paraferritin complex,CC,
15832,GO:0070827,1,0.960792552443434,0,5,chromatin maintenance,BP,
15833,GO:0070828,1,0.71129403827474,0,47,heterochromatin organization,BP,
15834,GO:0070829,1,0.974863859756917,0,3,heterochromatin maintenance,BP,
15836,GO:0070831,1,0.889065471260214,0,15,basement membrane assembly,BP,
15837,GO:0070836,1,0.97746572547112,0,4,caveola assembly,BP,
15838,GO:0070837,1,0.955883404400838,0,7,dehydroascorbic acid transport,BP,
15840,GO:0070839,1,0.919724835613264,0,11,divalent metal ion export,BP,
15841,GO:0070840,1,0.855591947034905,0,20,dynein complex binding,MF,
15842,GO:0070841,1,0.860698104192424,0,22,inclusion body assembly,BP,
15843,GO:0070842,1,0.968139206252446,0,5,aggresome assembly,BP,
15844,GO:0070843,1,0.992450002283949,0,1,misfolded protein transport,BP,
15845,GO:0070844,1,0.992450002283949,0,1,polyubiquitinated protein transport,BP,
15846,GO:0070845,1,0.992450002283949,0,1,polyubiquitinated misfolded protein transport,BP,
15847,GO:0070846,1,0.992450002283949,0,1,Hsp90 deacetylation,BP,
15848,GO:0070847,1,0.956343378930395,0,8,core mediator complex,CC,
15852,GO:0070852,1,0.951511974085639,0,7,cell body fiber,CC,
15853,GO:0070853,1,0.981603803317425,0,2,myosin VI binding,MF,
15854,GO:0070856,1,0.991544635510388,0,1,myosin VI light chain binding,MF,
15855,GO:0070857,1,0.943794281281556,0,9,regulation of bile acid biosynthetic process,BP,
15856,GO:0070858,1,0.986128120964423,0,2,negative regulation of bile acid biosynthetic process,BP,
15857,GO:0070859,1,0.981249475862198,0,3,positive regulation of bile acid biosynthetic process,BP,
15858,GO:0070860,1,0.994319118502194,0,1,RNA polymerase I core factor complex,CC,
15859,GO:0070861,1,0.825335070726631,0,27,regulation of protein exit from endoplasmic reticulum,BP,
15860,GO:0070862,1,0.937139292402722,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
15861,GO:0070863,1,0.903625606639103,0,14,positive regulation of protein exit from endoplasmic reticulum,BP,
15862,GO:0070868,1,0.965211061560026,0,4,heterochromatin organization involved in chromatin silencing,BP,
15863,GO:0070873,1,0.800202290862963,0,30,regulation of glycogen metabolic process,BP,
15864,GO:0070874,1,0.961992979279207,0,5,negative regulation of glycogen metabolic process,BP,
15865,GO:0070875,1,0.886545891913342,0,15,positive regulation of glycogen metabolic process,BP,
15866,GO:0070876,1,0.972399871350241,0,4,SOSS complex,CC,
15867,GO:0070877,1,0.985673813210377,0,2,microprocessor complex,CC,
15868,GO:0070878,1,0.943099556308702,0,8,primary miRNA binding,MF,
15869,GO:0070881,1,0.992543896580655,0,1,regulation of proline transport,BP,
15870,GO:0070883,1,0.962640362419042,0,6,pre-miRNA binding,MF,
15872,GO:0070885,1,0.912626820530304,0,14,negative regulation of calcineurin-NFAT signaling cascade,BP,
15875,GO:0070888,1,0.756682748889579,0,43,E-box binding,MF,
15876,GO:0070889,1,0.987752340731016,0,2,platelet alpha granule organization,BP,
15877,GO:0070890,1,0.985286709774917,0,2,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
15878,GO:0070891,1,0.980880465448245,0,4,lipoteichoic acid binding,MF,
15879,GO:0070892,1,0.994926554507968,0,1,lipoteichoic acid immune receptor activity,MF,
15880,GO:0070893,1,0.985201984837996,0,2,transposon integration,BP,
15881,GO:0070894,1,0.985201984837996,0,2,regulation of transposon integration,BP,
15882,GO:0070895,1,0.985201984837996,0,2,negative regulation of transposon integration,BP,
15883,GO:0070897,1,0.802908297569123,0,35,transcription preinitiation complex assembly,BP,
15884,GO:0070898,1,0.981474740671475,0,2,RNA polymerase III preinitiation complex assembly,BP,
15885,GO:0070899,1,0.992896947893392,0,1,mitochondrial tRNA wobble uridine modification,BP,
15886,GO:0070900,1,0.956802276204782,0,8,mitochondrial tRNA modification,BP,
15887,GO:0070901,1,0.977604704804848,0,4,mitochondrial tRNA methylation,BP,
15888,GO:0070902,1,0.995843168797445,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
15889,GO:0070904,1,0.985286709774917,0,2,transepithelial L-ascorbic acid transport,BP,
15890,GO:0070905,1,0.975893646357384,0,4,serine binding,MF,
15891,GO:0070911,1,0.849695729052479,0,26,global genome nucleotide-excision repair,BP,
15892,GO:0070914,1,0.922870483011917,0,12,UV-damage excision repair,BP,
15893,GO:0070915,1,0.971791629051824,0,5,lysophosphatidic acid receptor activity,MF,
15896,GO:0070922,1,0.939449184600141,0,9,small RNA loading onto RISC,BP,
15898,GO:0070926,1,0.992483902775256,0,1,regulation of ATP:ADP antiporter activity,BP,
15899,GO:0070931,1,0.991745403154524,0,1,Golgi-associated vesicle lumen,CC,
15900,GO:0070932,1,0.869690213851585,0,20,histone H3 deacetylation,BP,
15901,GO:0070933,1,0.928873096616237,0,11,histone H4 deacetylation,BP,
15902,GO:0070934,1,0.961407684536195,0,5,CRD-mediated mRNA stabilization,BP,
15903,GO:0070935,1,0.877696484234364,0,19,3'-UTR-mediated mRNA stabilization,BP,
15904,GO:0070936,1,0.702381358739055,0,54,protein K48-linked ubiquitination,BP,
15905,GO:0070937,1,0.954144923486483,0,6,CRD-mediated mRNA stability complex,CC,
15907,GO:0070939,1,0.976991409304425,0,3,Dsl1/NZR complex,CC,
15908,GO:0070940,1,0.967005796844992,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
15909,GO:0070942,1,0.960719034484766,0,9,neutrophil mediated cytotoxicity,BP,
15910,GO:0070943,1,0.971415615287145,0,7,neutrophil-mediated killing of symbiont cell,BP,
15911,GO:0070944,1,0.97512448873799,0,6,neutrophil-mediated killing of bacterium,BP,
15912,GO:0070945,1,0.981578082068743,0,4,neutrophil-mediated killing of gram-negative bacterium,BP,
15913,GO:0070946,1,0.996704781088441,0,1,neutrophil-mediated killing of gram-positive bacterium,BP,
15914,GO:0070947,1,0.992915247270778,0,2,neutrophil-mediated killing of fungus,BP,
15915,GO:0070948,1,0.97435105070506,0,5,regulation of neutrophil mediated cytotoxicity,BP,
15916,GO:0070949,1,0.985197836548086,0,3,regulation of neutrophil mediated killing of symbiont cell,BP,
15917,GO:0070950,1,0.988958786386497,0,2,regulation of neutrophil mediated killing of bacterium,BP,
15918,GO:0070951,1,0.988958786386497,0,2,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15919,GO:0070953,1,0.996197492223484,0,1,regulation of neutrophil mediated killing of fungus,BP,
15920,GO:0070960,1,0.989292276990579,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
15921,GO:0070961,1,0.989292276990579,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
15922,GO:0070962,1,0.993068696442627,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
15923,GO:0070963,1,0.993068696442627,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15924,GO:0070965,1,0.996197492223484,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
15925,GO:0070966,1,0.970207523386026,0,4,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
15926,GO:0070971,1,0.833272145929623,0,24,endoplasmic reticulum exit site,CC,
15928,GO:0070973,1,0.943079040567911,0,7,protein localization to endoplasmic reticulum exit site,BP,
15929,GO:0070974,1,0.992853697764998,0,1,POU domain binding,MF,
15930,GO:0070975,1,0.990821945732842,0,1,FHA domain binding,MF,
15931,GO:0070976,1,0.993366855546675,0,1,TIR domain binding,MF,
15933,GO:0070979,1,0.860533961824114,0,27,protein K11-linked ubiquitination,BP,
15934,GO:0070981,1,0.994265057587886,0,1,L-asparagine biosynthetic process,BP,
15935,GO:0070982,1,0.990035375090203,0,2,L-asparagine metabolic process,BP,
15936,GO:0070984,1,0.992440953238175,0,1,SET domain binding,MF,
15937,GO:0070985,1,0.988722324722507,0,3,transcription factor TFIIK complex,CC,
15938,GO:0070986,1,0.899719892162495,0,14,left/right axis specification,BP,
15939,GO:0070987,1,0.881101638156768,0,21,error-free translesion synthesis,BP,
15940,GO:0070988,1,0.646403932964138,0,61,demethylation,BP,
15941,GO:0070989,1,0.905792652875728,0,15,oxidative demethylation,BP,
15942,GO:0070990,1,0.97269900168545,0,7,snRNP binding,MF,
15943,GO:0070991,1,0.979869365888911,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
15944,GO:0070992,1,0.99687060107113,0,1,translation initiation complex,CC,
15945,GO:0070993,1,0.917721243313935,0,17,translation preinitiation complex,CC,
15946,GO:0070995,1,0.973662120666484,0,4,NADPH oxidation,BP,
15947,GO:0070996,1,0.987803925878487,0,3,type 1 melanocortin receptor binding,MF,
15949,GO:0071000,1,0.989625325777744,0,2,response to magnetism,BP,
15950,GO:0071001,1,0.982554344514273,0,3,U4/U6 snRNP,CC,
15951,GO:0071004,1,0.914941660686208,0,16,U2-type prespliceosome,CC,
15952,GO:0071005,1,0.765638566608743,0,49,U2-type precatalytic spliceosome,CC,
15953,GO:0071006,1,0.941772218445654,0,9,U2-type catalytic step 1 spliceosome,CC,
15954,GO:0071007,1,0.852771376229842,0,30,U2-type catalytic step 2 spliceosome,CC,
15955,GO:0071008,1,0.979313664313278,0,3,U2-type post-mRNA release spliceosomal complex,CC,
15956,GO:0071010,1,0.914941660686208,0,16,prespliceosome,CC,
15957,GO:0071011,1,0.754744485925822,0,51,precatalytic spliceosome,CC,
15958,GO:0071012,1,0.941772218445654,0,9,catalytic step 1 spliceosome,CC,
15959,GO:0071013,1,0.611502521576731,0,83,catalytic step 2 spliceosome,CC,
15960,GO:0071014,1,0.923770594326857,0,13,post-mRNA release spliceosomal complex,CC,
15961,GO:0071020,1,0.991432829389403,0,2,post-spliceosomal complex,CC,
15962,GO:0071021,1,0.995762901349205,0,1,U2-type post-spliceosomal complex,CC,
15963,GO:0071025,1,0.925923995237044,0,15,RNA surveillance,BP,
15964,GO:0071026,1,0.993873967922025,0,1,cytoplasmic RNA surveillance,BP,
15965,GO:0071027,1,0.938193968272798,0,13,nuclear RNA surveillance,BP,
15966,GO:0071028,1,0.938193968272798,0,13,nuclear mRNA surveillance,BP,
15967,GO:0071029,1,0.973373137479031,0,6,nuclear ncRNA surveillance,BP,
15968,GO:0071030,1,0.989013502876199,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15969,GO:0071031,1,0.991165809946717,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15970,GO:0071033,1,0.976113319335665,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15971,GO:0071034,1,0.975283292444515,0,4,CUT catabolic process,BP,
15972,GO:0071035,1,0.973373137479031,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15973,GO:0071036,1,0.993222175064048,0,1,nuclear polyadenylation-dependent snoRNA catabolic process,BP,
15974,GO:0071037,1,0.993222175064048,0,1,nuclear polyadenylation-dependent snRNA catabolic process,BP,
15975,GO:0071038,1,0.973373137479031,0,6,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15976,GO:0071039,1,0.993222175064048,0,1,nuclear polyadenylation-dependent CUT catabolic process,BP,
15977,GO:0071040,1,0.993222175064048,0,1,nuclear polyadenylation-dependent antisense transcript catabolic process,BP,
15978,GO:0071041,1,0.993222175064048,0,1,antisense RNA transcript catabolic process,BP,
15979,GO:0071042,1,0.981152602700915,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15980,GO:0071043,1,0.975283292444515,0,4,CUT metabolic process,BP,
15981,GO:0071044,1,0.93634608698205,0,9,histone mRNA catabolic process,BP,
15982,GO:0071045,1,0.995885454443387,0,1,nuclear histone mRNA catabolic process,BP,
15983,GO:0071046,1,0.973373137479031,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15984,GO:0071047,1,0.981152602700915,0,4,polyadenylation-dependent mRNA catabolic process,BP,
15985,GO:0071048,1,0.989013502876199,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
15986,GO:0071049,1,0.991165809946717,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
15987,GO:0071051,1,0.966852216479618,0,7,polyadenylation-dependent snoRNA 3'-end processing,BP,
15988,GO:0071062,1,0.980550032822946,0,3,alphav-beta3 integrin-vitronectin complex,CC,
15989,GO:0071065,1,0.98574463898253,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
15990,GO:0071071,1,0.897133610997055,0,17,regulation of phospholipid biosynthetic process,BP,
15991,GO:0071072,1,0.962277985944228,0,5,negative regulation of phospholipid biosynthetic process,BP,
15992,GO:0071073,1,0.93772090154508,0,11,positive regulation of phospholipid biosynthetic process,BP,
15993,GO:0071074,1,0.987077022118487,0,2,eukaryotic initiation factor eIF2 binding,MF,
15994,GO:0071077,1,0.973435658628496,0,4,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15995,GO:0071103,1,0.176225192429476,0,251,DNA conformation change,BP,
15996,GO:0071104,1,0.947205768020685,0,8,response to interleukin-9,BP,
15997,GO:0071105,1,0.988975500418504,0,2,response to interleukin-11,BP,
15998,GO:0071106,1,0.987228687314284,0,2,adenosine 3',5'-bisphosphate transmembrane transport,BP,
16000,GO:0071108,1,0.805873811748737,0,27,protein K48-linked deubiquitination,BP,
16001,GO:0071109,1,0.98054551163743,0,2,superior temporal gyrus development,BP,
16002,GO:0071110,1,0.991583341144231,0,1,histone biotinylation,BP,
16003,GO:0071133,1,0.99274771897635,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16004,GO:0071139,1,0.985062861005754,0,2,resolution of recombination intermediates,BP,
16005,GO:0071140,1,0.985062861005754,0,2,resolution of mitotic recombination intermediates,BP,
16006,GO:0071141,1,0.928147604702016,0,9,SMAD protein complex,CC,
16007,GO:0071144,1,0.93455382657956,0,8,heteromeric SMAD protein complex,CC,
16008,GO:0071148,1,0.981792610862136,0,2,TEAD-1-YAP complex,CC,
16009,GO:0071149,1,0.986716727605131,0,2,TEAD-2-YAP complex,CC,
16010,GO:0071156,1,0.533907797817905,0,100,regulation of cell cycle arrest,BP,
16011,GO:0071157,1,0.89025973837283,0,20,negative regulation of cell cycle arrest,BP,
16012,GO:0071158,1,0.60869092415985,0,77,positive regulation of cell cycle arrest,BP,
16013,GO:0071159,1,0.990420129294887,0,2,NF-kappaB complex,CC,
16014,GO:0071163,1,0.985275446906107,0,3,DNA replication preinitiation complex assembly,BP,
16015,GO:0071164,1,0.992505224701326,0,1,RNA trimethylguanosine synthase activity,MF,
16016,GO:0071166,1,0.446266480031802,0,123,ribonucleoprotein complex localization,BP,
16017,GO:0071168,1,0.868873324404329,0,21,protein localization to chromatin,BP,
16018,GO:0071169,1,0.976692294516064,0,4,establishment of protein localization to chromatin,BP,
16019,GO:0071173,1,0.803667900881679,0,34,spindle assembly checkpoint,BP,
16020,GO:0071174,1,0.803667900881679,0,34,mitotic spindle checkpoint,BP,
16021,GO:0071203,1,0.963747649891219,0,5,WASH complex,CC,
16022,GO:0071204,1,0.966003305976708,0,6,histone pre-mRNA 3'end processing complex,CC,
16025,GO:0071207,1,0.988066479662238,0,2,histone pre-mRNA stem-loop binding,MF,
16026,GO:0071208,1,0.985432772151572,0,4,histone pre-mRNA DCP binding,MF,
16027,GO:0071209,1,0.986780711138476,0,3,U7 snRNA binding,MF,
16028,GO:0071211,1,0.972638303675002,0,4,protein targeting to vacuole involved in autophagy,BP,
16030,GO:0071215,1,0.992395820850584,0,1,cellular response to abscisic acid stimulus,BP,
16031,GO:0071216,1,0.280641667860827,0,209,cellular response to biotic stimulus,BP,
16032,GO:0071218,1,0.861215193245,0,22,cellular response to misfolded protein,BP,
16033,GO:0071219,1,0.325833559641185,0,188,cellular response to molecule of bacterial origin,BP,
16034,GO:0071220,1,0.964413738805561,0,6,cellular response to bacterial lipoprotein,BP,
16035,GO:0071221,1,0.964413738805561,0,6,cellular response to bacterial lipopeptide,BP,
16036,GO:0071222,1,0.340582641414717,0,180,cellular response to lipopolysaccharide,BP,
16037,GO:0071223,1,0.944135088533387,0,10,cellular response to lipoteichoic acid,BP,
16038,GO:0071224,1,0.966021158901312,0,6,cellular response to peptidoglycan,BP,
16039,GO:0071225,1,0.944926966190314,0,9,cellular response to muramyl dipeptide,BP,
16040,GO:0071226,1,0.973218544226741,0,4,cellular response to molecule of fungal origin,BP,
16041,GO:0071228,1,0.996588902822327,0,1,cellular response to tumor cell,BP,
16044,GO:0071231,1,0.993200785948841,0,2,cellular response to folic acid,BP,
16045,GO:0071233,1,0.932744340214079,0,9,cellular response to leucine,BP,
16046,GO:0071236,1,0.914583034090226,0,13,cellular response to antibiotic,BP,
16048,GO:0071242,1,0.979994559795144,0,3,cellular response to ammonium ion,BP,
16049,GO:0071243,1,0.894382488597198,0,20,cellular response to arsenic-containing substance,BP,
16050,GO:0071245,1,0.992514839993871,0,1,cellular response to carbon monoxide,BP,
16051,GO:0071247,1,0.996586890788437,0,1,cellular response to chromate,BP,
16053,GO:0071250,1,0.991408023303973,0,1,cellular response to nitrite,BP,
16055,GO:0071256,1,0.971938260760455,0,6,translocon complex,CC,
16056,GO:0071257,1,0.931909290290937,0,10,cellular response to electrical stimulus,BP,
16057,GO:0071258,1,0.992446562585314,0,1,cellular response to gravity,BP,
16058,GO:0071259,1,0.989625325777744,0,2,cellular response to magnetism,BP,
16060,GO:0071261,1,0.996859910582115,0,1,Ssh1 translocon complex,CC,
16061,GO:0071262,1,0.984408196753319,0,2,regulation of translational initiation in response to starvation,BP,
16062,GO:0071264,1,0.984408196753319,0,2,positive regulation of translational initiation in response to starvation,BP,
16063,GO:0071265,1,0.961878526746887,0,7,L-methionine biosynthetic process,BP,
16064,GO:0071267,1,0.961878526746887,0,7,L-methionine salvage,BP,
16067,GO:0071279,1,0.982429666642415,0,3,cellular response to cobalt ion,BP,
16068,GO:0071280,1,0.895254315976195,0,21,cellular response to copper ion,BP,
16070,GO:0071283,1,0.991561692154931,0,2,cellular response to iron(III) ion,BP,
16071,GO:0071284,1,0.968238540976913,0,4,cellular response to lead ion,BP,
16072,GO:0071285,1,0.923429275706767,0,14,cellular response to lithium ion,BP,
16074,GO:0071287,1,0.917545317238047,0,12,cellular response to manganese ion,BP,
16075,GO:0071288,1,0.987847839341867,0,2,cellular response to mercury ion,BP,
16076,GO:0071294,1,0.909003352489657,0,19,cellular response to zinc ion,BP,
16077,GO:0071295,1,0.826355172618813,0,29,cellular response to vitamin,BP,
16078,GO:0071298,1,0.992577307963612,0,1,cellular response to L-ascorbic acid,BP,
16080,GO:0071301,1,0.990826340024239,0,1,cellular response to vitamin B1,BP,
16081,GO:0071305,1,0.8755420164419,0,20,cellular response to vitamin D,BP,
16082,GO:0071306,1,0.987094329375596,0,2,cellular response to vitamin E,BP,
16083,GO:0071307,1,0.986550032531282,0,2,cellular response to vitamin K,BP,
16085,GO:0071312,1,0.798039738487404,0,33,cellular response to alkaloid,BP,
16086,GO:0071313,1,0.91812008459003,0,10,cellular response to caffeine,BP,
16087,GO:0071314,1,0.985173680438489,0,3,cellular response to cocaine,BP,
16088,GO:0071315,1,0.96968240437137,0,5,cellular response to morphine,BP,
16089,GO:0071316,1,0.953112054060423,0,9,cellular response to nicotine,BP,
16090,GO:0071317,1,0.96968240437137,0,5,cellular response to isoquinoline alkaloid,BP,
16091,GO:0071318,1,0.893125663642854,0,18,cellular response to ATP,BP,
16093,GO:0071321,1,0.95277126206548,0,6,cellular response to cGMP,BP,
16095,GO:0071324,1,0.99213991488741,0,1,cellular response to disaccharide stimulus,BP,
16097,GO:0071329,1,0.99213991488741,0,1,cellular response to sucrose stimulus,BP,
16099,GO:0071332,1,0.968549975200316,0,5,cellular response to fructose stimulus,BP,
16101,GO:0071335,1,0.996826939881114,0,1,hair follicle cell proliferation,BP,
16102,GO:0071336,1,0.996826939881114,0,1,regulation of hair follicle cell proliferation,BP,
16103,GO:0071338,1,0.996826939881114,0,1,positive regulation of hair follicle cell proliferation,BP,
16104,GO:0071339,1,0.827943737573112,0,28,MLL1 complex,CC,
16105,GO:0071340,1,0.929460991581986,0,11,skeletal muscle acetylcholine-gated channel clustering,BP,
16106,GO:0071344,1,0.992371999985685,0,2,diphosphate metabolic process,BP,
16110,GO:0071348,1,0.992241169701182,0,1,cellular response to interleukin-11,BP,
16111,GO:0071349,1,0.768788407598558,0,46,cellular response to interleukin-12,BP,
16112,GO:0071350,1,0.913517071626669,0,13,cellular response to interleukin-15,BP,
16113,GO:0071351,1,0.952546222244159,0,8,cellular response to interleukin-18,BP,
16114,GO:0071352,1,0.918690044128264,0,12,cellular response to interleukin-2,BP,
16115,GO:0071353,1,0.832871658876955,0,30,cellular response to interleukin-4,BP,
16117,GO:0071355,1,0.950334893994889,0,7,cellular response to interleukin-9,BP,
16119,GO:0071357,1,0.633742963231668,0,76,cellular response to type I interferon,BP,
16120,GO:0071359,1,0.88928530895746,0,18,cellular response to dsRNA,BP,
16121,GO:0071360,1,0.91976630265666,0,13,cellular response to exogenous dsRNA,BP,
16122,GO:0071361,1,0.913046915282414,0,13,cellular response to ethanol,BP,
16123,GO:0071362,1,0.951133011380342,0,7,cellular response to ether,BP,
16126,GO:0071371,1,0.888652012494856,0,16,cellular response to gonadotropin stimulus,BP,
16127,GO:0071372,1,0.927958974632072,0,10,cellular response to follicle-stimulating hormone stimulus,BP,
16128,GO:0071373,1,0.986692905849079,0,2,cellular response to luteinizing hormone stimulus,BP,
16130,GO:0071375,1,0.131394898357854,0,295,cellular response to peptide hormone stimulus,BP,
16131,GO:0071376,1,0.968011701873326,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16132,GO:0071377,1,0.850178578403335,0,23,cellular response to glucagon stimulus,BP,
16133,GO:0071378,1,0.866768502196379,0,20,cellular response to growth hormone stimulus,BP,
16134,GO:0071379,1,0.860198249968881,0,21,cellular response to prostaglandin stimulus,BP,
16135,GO:0071380,1,0.899436753300919,0,15,cellular response to prostaglandin E stimulus,BP,
16139,GO:0071386,1,0.974800302563658,0,3,cellular response to corticosterone stimulus,BP,
16140,GO:0071387,1,0.992039214956296,0,1,cellular response to cortisol stimulus,BP,
16141,GO:0071389,1,0.958012365284761,0,6,cellular response to mineralocorticoid stimulus,BP,
16142,GO:0071391,1,0.9079430125561,0,14,cellular response to estrogen stimulus,BP,
16145,GO:0071394,1,0.943268133068348,0,9,cellular response to testosterone stimulus,BP,
16146,GO:0071395,1,0.98546644934993,0,4,cellular response to jasmonic acid stimulus,BP,
16149,GO:0071398,1,0.696147121141565,0,53,cellular response to fatty acid,BP,
16150,GO:0071400,1,0.981307951938487,0,3,cellular response to oleic acid,BP,
16151,GO:0071401,1,0.994364317703459,0,1,cellular response to triglyceride,BP,
16152,GO:0071402,1,0.812705534529692,0,31,cellular response to lipoprotein particle stimulus,BP,
16153,GO:0071403,1,0.985505032314848,0,2,cellular response to high density lipoprotein particle stimulus,BP,
16154,GO:0071404,1,0.883893445854214,0,19,cellular response to low-density lipoprotein particle stimulus,BP,
16156,GO:0071409,1,0.978398906590656,0,3,cellular response to cycloheximide,BP,
16157,GO:0071412,1,0.994383722993668,0,1,cellular response to genistein,BP,
16158,GO:0071413,1,0.994383722993668,0,1,cellular response to hydroxyisoflavone,BP,
16159,GO:0071415,1,0.899952230664323,0,13,cellular response to purine-containing compound,BP,
16161,GO:0071418,1,0.99185284954076,0,2,cellular response to amine stimulus,BP,
16162,GO:0071420,1,0.947335209022237,0,7,cellular response to histamine,BP,
16163,GO:0071421,1,0.937585647922776,0,9,manganese ion transmembrane transport,BP,
16164,GO:0071422,1,0.96512985139207,0,6,succinate transmembrane transport,BP,
16165,GO:0071423,1,0.97962340552439,0,4,malate transmembrane transport,BP,
16166,GO:0071424,1,0.99325505912211,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
16167,GO:0071425,1,0.860372551074823,0,23,hematopoietic stem cell proliferation,BP,
16168,GO:0071426,1,0.448701468328029,0,122,ribonucleoprotein complex export from nucleus,BP,
16169,GO:0071427,1,0.497433260469935,0,105,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16170,GO:0071428,1,0.914886813144487,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16171,GO:0071431,1,0.805815121115996,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16172,GO:0071437,1,0.903544321034216,0,14,invadopodium,CC,
16173,GO:0071438,1,0.966974570474725,0,5,invadopodium membrane,CC,
16174,GO:0071439,1,0.944920527305855,0,8,clathrin complex,CC,
16175,GO:0071440,1,0.960718138537694,0,6,regulation of histone H3-K14 acetylation,BP,
16176,GO:0071441,1,0.992486473496815,0,1,negative regulation of histone H3-K14 acetylation,BP,
16177,GO:0071442,1,0.974568718646281,0,4,positive regulation of histone H3-K14 acetylation,BP,
16178,GO:0071444,1,0.996880389349991,0,1,cellular response to pheromone,BP,
16180,GO:0071449,1,0.996709339155523,0,1,cellular response to lipid hydroperoxide,BP,
16181,GO:0071450,1,0.879417906558769,0,24,cellular response to oxygen radical,BP,
16182,GO:0071451,1,0.879417906558769,0,24,cellular response to superoxide,BP,
16183,GO:0071453,1,0.262625701561621,0,212,cellular response to oxygen levels,BP,
16184,GO:0071454,1,0.990796148533894,0,1,cellular response to anoxia,BP,
16185,GO:0071455,1,0.959539838467368,0,6,cellular response to hyperoxia,BP,
16186,GO:0071456,1,0.313506111242687,0,186,cellular response to hypoxia,BP,
16187,GO:0071458,1,0.968291776449383,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16188,GO:0071459,1,0.887774415358062,0,20,protein localization to chromosome, centromeric region,BP,
16189,GO:0071460,1,0.992786053820995,0,2,cellular response to cell-matrix adhesion,BP,
16190,GO:0071461,1,0.981778882452778,0,3,cellular response to redox state,BP,
16191,GO:0071462,1,0.977256462052405,0,3,cellular response to water stimulus,BP,
16192,GO:0071464,1,0.992109875391931,0,1,cellular response to hydrostatic pressure,BP,
16193,GO:0071466,1,0.609878613575665,0,91,cellular response to xenobiotic stimulus,BP,
16194,GO:0071467,1,0.891055450004696,0,19,cellular response to pH,BP,
16195,GO:0071468,1,0.936478137983491,0,10,cellular response to acidic pH,BP,
16196,GO:0071469,1,0.988026918855297,0,2,cellular response to alkaline pH,BP,
16198,GO:0071471,1,0.992351701786639,0,1,cellular response to non-ionic osmotic stress,BP,
16200,GO:0071474,1,0.907106672661192,0,15,cellular hyperosmotic response,BP,
16201,GO:0071475,1,0.957658923646289,0,7,cellular hyperosmotic salinity response,BP,
16202,GO:0071476,1,0.945322469345845,0,8,cellular hypotonic response,BP,
16203,GO:0071477,1,0.983563282274859,0,2,cellular hypotonic salinity response,BP,
16204,GO:0071478,1,0.327933601380016,0,170,cellular response to radiation,BP,
16205,GO:0071479,1,0.643935398879403,0,66,cellular response to ionizing radiation,BP,
16206,GO:0071480,1,0.83135465630583,0,28,cellular response to gamma radiation,BP,
16207,GO:0071481,1,0.914662008038186,0,12,cellular response to X-ray,BP,
16208,GO:0071482,1,0.480176708667671,0,113,cellular response to light stimulus,BP,
16209,GO:0071483,1,0.985162395121468,0,2,cellular response to blue light,BP,
16210,GO:0071484,1,0.992003194016043,0,1,cellular response to light intensity,BP,
16211,GO:0071486,1,0.992003194016043,0,1,cellular response to high light intensity,BP,
16212,GO:0071492,1,0.980648001884735,0,3,cellular response to UV-A,BP,
16213,GO:0071493,1,0.957200541842722,0,8,cellular response to UV-B,BP,
16214,GO:0071494,1,0.958302376472098,0,7,cellular response to UV-C,BP,
16217,GO:0071498,1,0.888989079272644,0,18,cellular response to fluid shear stress,BP,
16218,GO:0071499,1,0.958085722344668,0,7,cellular response to laminar fluid shear stress,BP,
16219,GO:0071500,1,0.964317548840534,0,6,cellular response to nitrosative stress,BP,
16220,GO:0071501,1,0.905514444909729,0,14,cellular response to sterol depletion,BP,
16221,GO:0071502,1,0.971020247154735,0,5,cellular response to temperature stimulus,BP,
16222,GO:0071503,1,0.970091198613109,0,4,response to heparin,BP,
16223,GO:0071504,1,0.970091198613109,0,4,cellular response to heparin,BP,
16224,GO:0071505,1,0.98588190793742,0,2,response to mycophenolic acid,BP,
16225,GO:0071506,1,0.98588190793742,0,2,cellular response to mycophenolic acid,BP,
16226,GO:0071513,1,0.994547215562359,0,1,phosphopantothenoylcysteine decarboxylase complex,CC,
16227,GO:0071514,1,0.845511459763606,0,24,genetic imprinting,BP,
16228,GO:0071515,1,0.989303662582116,0,1,genetic imprinting at mating-type locus,BP,
16229,GO:0071517,1,0.989303662582116,0,1,maintenance of imprinting at mating-type locus,BP,
16230,GO:0071526,1,0.728472977927807,0,40,semaphorin-plexin signaling pathway,BP,
16231,GO:0071527,1,0.994170413662504,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16232,GO:0071528,1,0.992481954187928,0,1,tRNA re-export from nucleus,BP,
16233,GO:0071529,1,0.993641114876386,0,1,cementum mineralization,BP,
16234,GO:0071532,1,0.961234480683975,0,5,ankyrin repeat binding,MF,
16235,GO:0071535,1,0.974411844890236,0,4,RING-like zinc finger domain binding,MF,
16236,GO:0071539,1,0.787901711410641,0,31,protein localization to centrosome,BP,
16237,GO:0071540,1,0.988108786889545,0,2,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16238,GO:0071541,1,0.965997463596577,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16239,GO:0071542,1,0.816430323818562,0,32,dopaminergic neuron differentiation,BP,
16240,GO:0071543,1,0.977990025656706,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16241,GO:0071544,1,0.996330447290537,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16242,GO:0071545,1,0.887984916695251,0,17,inositol phosphate catabolic process,BP,
16243,GO:0071546,1,0.95741477039209,0,6,pi-body,CC,
16244,GO:0071547,1,0.967850705761266,0,5,piP-body,CC,
16247,GO:0071550,1,0.952533467438366,0,9,death-inducing signaling complex assembly,BP,
16248,GO:0071553,1,0.985281009859204,0,3,G protein-coupled pyrimidinergic nucleotide receptor activity,MF,
16249,GO:0071554,1,0.99230792728531,0,2,cell wall organization or biogenesis,BP,
16250,GO:0071556,1,0.889963367963681,0,25,integral component of lumenal side of endoplasmic reticulum membrane,CC,
16251,GO:0071557,1,0.960503603367244,0,5,histone H3-K27 demethylation,BP,
16252,GO:0071558,1,0.960503603367244,0,5,histone demethylase activity (H3-K27 specific),MF,
16253,GO:0071559,1,0.191101316013376,0,235,response to transforming growth factor beta,BP,
16254,GO:0071560,1,0.201598593384308,0,229,cellular response to transforming growth factor beta stimulus,BP,
16255,GO:0071561,1,0.99211584680128,0,1,nucleus-vacuole junction,CC,
16256,GO:0071564,1,0.922570823373487,0,12,npBAF complex,CC,
16257,GO:0071565,1,0.902148229070295,0,15,nBAF complex,CC,
16258,GO:0071566,1,0.992969422860702,0,1,UFM1 activating enzyme activity,MF,
16259,GO:0071567,1,0.994148801577663,0,1,UFM1 hydrolase activity,MF,
16260,GO:0071568,1,0.989842146709558,0,2,UFM1 transferase activity,MF,
16261,GO:0071569,1,0.968605790807423,0,6,protein ufmylation,BP,
16262,GO:0071573,1,0.99298782644476,0,1,shelterin complex assembly,BP,
16263,GO:0071577,1,0.88083325402228,0,20,zinc ion transmembrane transport,BP,
16264,GO:0071578,1,0.95414762220124,0,7,zinc ion import across plasma membrane,BP,
16265,GO:0071579,1,0.988215061618698,0,2,regulation of zinc ion transport,BP,
16266,GO:0071580,1,0.995070275787515,0,1,regulation of zinc ion transmembrane transport,BP,
16267,GO:0071581,1,0.995070275787515,0,1,regulation of zinc ion transmembrane import,BP,
16268,GO:0071582,1,0.995070275787515,0,1,negative regulation of zinc ion transport,BP,
16269,GO:0071583,1,0.995070275787515,0,1,negative regulation of zinc ion transmembrane transport,BP,
16270,GO:0071584,1,0.995070275787515,0,1,negative regulation of zinc ion transmembrane import,BP,
16271,GO:0071585,1,0.995070275787515,0,1,detoxification of cadmium ion,BP,
16272,GO:0071586,1,0.988934337457455,0,2,CAAX-box protein processing,BP,
16273,GO:0071593,1,0.971565386783502,0,5,lymphocyte aggregation,BP,
16274,GO:0071595,1,0.986555151512788,0,2,Nem1-Spo7 phosphatase complex,CC,
16275,GO:0071596,1,0.973312633221034,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16276,GO:0071598,1,0.982194368149672,0,3,neuronal ribonucleoprotein granule,CC,
16277,GO:0071599,1,0.907080087961675,0,15,otic vesicle development,BP,
16278,GO:0071600,1,0.941704307968253,0,10,otic vesicle morphogenesis,BP,
16279,GO:0071602,1,0.992384779517392,0,1,phytosphingosine biosynthetic process,BP,
16280,GO:0071603,1,0.977518210677131,0,3,endothelial cell-cell adhesion,BP,
16281,GO:0071604,1,0.783660610995111,0,36,transforming growth factor beta production,BP,
16283,GO:0071606,1,0.995154499671731,0,1,chemokine (C-C motif) ligand 4 production,BP,
16284,GO:0071608,1,0.962933069506878,0,6,macrophage inflammatory protein-1 alpha production,BP,
16285,GO:0071609,1,0.931164076320321,0,11,chemokine (C-C motif) ligand 5 production,BP,
16286,GO:0071610,1,0.993808988803786,0,1,chemokine (C-C motif) ligand 1 production,BP,
16287,GO:0071611,1,0.970871465123183,0,5,granulocyte colony-stimulating factor production,BP,
16288,GO:0071612,1,0.988554332420202,0,1,IP-10 production,BP,
16289,GO:0071613,1,0.983261702189496,0,3,granzyme B production,BP,
16290,GO:0071614,1,0.995441831029351,0,1,linoleic acid epoxygenase activity,MF,
16291,GO:0071616,1,0.721065480813957,0,49,acyl-CoA biosynthetic process,BP,
16292,GO:0071617,1,0.885718389647109,0,18,lysophospholipid acyltransferase activity,MF,
16293,GO:0071619,1,0.994405736711206,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16294,GO:0071621,1,0.567866220620366,0,103,granulocyte chemotaxis,BP,
16295,GO:0071622,1,0.769619375363631,0,45,regulation of granulocyte chemotaxis,BP,
16296,GO:0071623,1,0.97804455480412,0,3,negative regulation of granulocyte chemotaxis,BP,
16297,GO:0071624,1,0.871640861184711,0,26,positive regulation of granulocyte chemotaxis,BP,
16298,GO:0071625,1,0.864302863816717,0,18,vocalization behavior,BP,
16299,GO:0071626,1,0.989702640527098,0,2,mastication,BP,
16300,GO:0071629,1,0.995885454443387,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16301,GO:0071630,1,0.976480911658094,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
16302,GO:0071633,1,0.979767543241392,0,3,dihydroceramidase activity,MF,
16303,GO:0071634,1,0.795114514441688,0,34,regulation of transforming growth factor beta production,BP,
16304,GO:0071635,1,0.951825023234905,0,8,negative regulation of transforming growth factor beta production,BP,
16305,GO:0071636,1,0.885797134133372,0,19,positive regulation of transforming growth factor beta production,BP,
16308,GO:0071639,1,0.956707471480369,0,8,positive regulation of monocyte chemotactic protein-1 production,BP,
16309,GO:0071640,1,0.962933069506878,0,6,regulation of macrophage inflammatory protein 1 alpha production,BP,
16310,GO:0071641,1,0.980283045271531,0,3,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16311,GO:0071642,1,0.985635959711974,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16312,GO:0071643,1,0.995154499671731,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
16313,GO:0071644,1,0.995154499671731,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
16314,GO:0071649,1,0.935076544128995,0,10,regulation of chemokine (C-C motif) ligand 5 production,BP,
16315,GO:0071650,1,0.977648344734161,0,4,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16316,GO:0071651,1,0.956464717435512,0,6,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16317,GO:0071652,1,0.993808988803786,0,1,regulation of chemokine (C-C motif) ligand 1 production,BP,
16318,GO:0071654,1,0.993808988803786,0,1,positive regulation of chemokine (C-C motif) ligand 1 production,BP,
16319,GO:0071655,1,0.975044498113901,0,4,regulation of granulocyte colony-stimulating factor production,BP,
16320,GO:0071656,1,0.994280481325253,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16321,GO:0071657,1,0.980654485076743,0,3,positive regulation of granulocyte colony-stimulating factor production,BP,
16322,GO:0071658,1,0.988554332420202,0,1,regulation of IP-10 production,BP,
16323,GO:0071660,1,0.988554332420202,0,1,positive regulation of IP-10 production,BP,
16324,GO:0071661,1,0.983261702189496,0,3,regulation of granzyme B production,BP,
16325,GO:0071663,1,0.983261702189496,0,3,positive regulation of granzyme B production,BP,
16326,GO:0071664,1,0.968326707277737,0,4,catenin-TCF7L2 complex,CC,
16327,GO:0071665,1,0.992602153638054,0,1,gamma-catenin-TCF7L2 complex,CC,
16328,GO:0071670,1,0.948642036104128,0,9,smooth muscle cell chemotaxis,BP,
16329,GO:0071671,1,0.963499378491725,0,7,regulation of smooth muscle cell chemotaxis,BP,
16330,GO:0071672,1,0.981102896700019,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16331,GO:0071673,1,0.978940717016025,0,4,positive regulation of smooth muscle cell chemotaxis,BP,
16335,GO:0071677,1,0.90327137650542,0,20,positive regulation of mononuclear cell migration,BP,
16336,GO:0071678,1,0.99064259991085,0,1,olfactory bulb axon guidance,BP,
16337,GO:0071679,1,0.913622997689416,0,12,commissural neuron axon guidance,BP,
16338,GO:0071680,1,0.961455912992863,0,5,response to indole-3-methanol,BP,
16339,GO:0071681,1,0.961455912992863,0,5,cellular response to indole-3-methanol,BP,
16340,GO:0071682,1,0.900879217049073,0,20,endocytic vesicle lumen,CC,
16341,GO:0071684,1,0.850967669445115,0,26,organism emergence from protective structure,BP,
16342,GO:0071688,1,0.965195875799947,0,3,striated muscle myosin thick filament assembly,BP,
16343,GO:0071691,1,0.966139223743499,0,3,cardiac muscle thin filament assembly,BP,
16345,GO:0071694,1,0.951142971405069,0,7,maintenance of protein location in extracellular region,BP,
16347,GO:0071696,1,0.918392565894357,0,12,ectodermal placode development,BP,
16348,GO:0071697,1,0.924060179098964,0,11,ectodermal placode morphogenesis,BP,
16349,GO:0071698,1,0.977882774381294,0,3,olfactory placode development,BP,
16350,GO:0071699,1,0.977882774381294,0,3,olfactory placode morphogenesis,BP,
16351,GO:0071701,1,0.992209699771076,0,1,regulation of MAPK export from nucleus,BP,
16356,GO:0071707,1,0.996423704947948,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16358,GO:0071711,1,0.805855783274664,0,29,basement membrane organization,BP,
16359,GO:0071712,1,0.930927327677808,0,11,ER-associated misfolded protein catabolic process,BP,
16360,GO:0071714,1,0.992427940487434,0,1,icosanoid transmembrane transporter activity,MF,
16361,GO:0071715,1,0.807676557000105,0,35,icosanoid transport,BP,
16362,GO:0071716,1,0.98353151999677,0,2,leukotriene transport,BP,
16363,GO:0071723,1,0.946461184681085,0,9,lipopeptide binding,MF,
16364,GO:0071724,1,0.975382651896665,0,4,response to diacyl bacterial lipopeptide,BP,
16365,GO:0071725,1,0.981795425392984,0,3,response to triacyl bacterial lipopeptide,BP,
16366,GO:0071726,1,0.975382651896665,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16367,GO:0071727,1,0.981795425392984,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16368,GO:0071731,1,0.893302472094272,0,19,response to nitric oxide,BP,
16369,GO:0071732,1,0.912050080319227,0,15,cellular response to nitric oxide,BP,
16370,GO:0071733,1,0.97453979913866,0,4,transcriptional activation by promoter-enhancer looping,BP,
16371,GO:0071763,1,0.959574250137902,0,6,nuclear membrane organization,BP,
16372,GO:0071765,1,0.992430896243086,0,1,nuclear inner membrane organization,BP,
16376,GO:0071782,1,0.879507991758947,0,20,endoplasmic reticulum tubular network,CC,
16377,GO:0071786,1,0.894990275124478,0,17,endoplasmic reticulum tubular network organization,BP,
16378,GO:0071787,1,0.975314376623765,0,4,endoplasmic reticulum tubular network formation,BP,
16379,GO:0071791,1,0.986033011569423,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16380,GO:0071796,1,0.996398387260517,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
16381,GO:0071797,1,0.974956091994165,0,4,LUBAC complex,CC,
16382,GO:0071798,1,0.968594341339952,0,5,response to prostaglandin D,BP,
16383,GO:0071799,1,0.968594341339952,0,5,cellular response to prostaglandin D stimulus,BP,
16384,GO:0071800,1,0.889080956203305,0,17,podosome assembly,BP,
16385,GO:0071801,1,0.914252108427609,0,13,regulation of podosome assembly,BP,
16386,GO:0071802,1,0.992435512489629,0,1,negative regulation of podosome assembly,BP,
16387,GO:0071803,1,0.939324909581213,0,9,positive regulation of podosome assembly,BP,
16390,GO:0071812,1,0.992766429723015,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16391,GO:0071813,1,0.850199008354669,0,24,lipoprotein particle binding,MF,
16392,GO:0071814,1,0.850199008354669,0,24,protein-lipid complex binding,MF,
16393,GO:0071816,1,0.976942418544524,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16394,GO:0071817,1,0.976200423748337,0,4,MMXD complex,CC,
16395,GO:0071818,1,0.982563213787761,0,3,BAT3 complex,CC,
16396,GO:0071819,1,0.989385623445002,0,2,DUBm complex,CC,
16397,GO:0071820,1,0.996194664242819,0,1,N-box binding,MF,
16398,GO:0071821,1,0.987680051518567,0,2,FANCM-MHF complex,CC,
16399,GO:0071824,1,0.29164847327156,0,191,protein-DNA complex subunit organization,BP,
16400,GO:0071825,1,0.760037575561483,0,44,protein-lipid complex subunit organization,BP,
16401,GO:0071826,1,0.333267502959579,0,185,ribonucleoprotein complex subunit organization,BP,
16402,GO:0071827,1,0.77545090243588,0,41,plasma lipoprotein particle organization,BP,
16403,GO:0071830,1,0.959804730615982,0,7,triglyceride-rich lipoprotein particle clearance,BP,
16404,GO:0071831,1,0.996514293846025,0,1,intermediate-density lipoprotein particle clearance,BP,
16405,GO:0071837,1,0.895453710270897,0,16,HMG box domain binding,MF,
16406,GO:0071838,1,0.952045108552687,0,7,cell proliferation in bone marrow,BP,
16407,GO:0071839,1,0.963625733213895,0,6,apoptotic process in bone marrow cell,BP,
16409,GO:0071846,1,0.989290788462073,0,2,actin filament debranching,BP,
16410,GO:0071847,1,0.985837433721791,0,2,TNFSF11-mediated signaling pathway,BP,
16411,GO:0071848,1,0.992766429723015,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16412,GO:0071850,1,0.902654634975481,0,16,mitotic cell cycle arrest,BP,
16413,GO:0071855,1,0.891214908985406,0,26,neuropeptide receptor binding,MF,
16414,GO:0071863,1,0.959141125413976,0,6,regulation of cell proliferation in bone marrow,BP,
16415,GO:0071864,1,0.959141125413976,0,6,positive regulation of cell proliferation in bone marrow,BP,
16416,GO:0071865,1,0.969511256442229,0,5,regulation of apoptotic process in bone marrow cell,BP,
16417,GO:0071866,1,0.969511256442229,0,5,negative regulation of apoptotic process in bone marrow cell,BP,
16418,GO:0071867,1,0.561569294563437,0,89,response to monoamine,BP,
16419,GO:0071868,1,0.571763897271267,0,86,cellular response to monoamine stimulus,BP,
16420,GO:0071869,1,0.561569294563437,0,89,response to catecholamine,BP,
16421,GO:0071870,1,0.571763897271267,0,86,cellular response to catecholamine stimulus,BP,
16422,GO:0071871,1,0.894398217569697,0,15,response to epinephrine,BP,
16423,GO:0071872,1,0.910557289009672,0,12,cellular response to epinephrine stimulus,BP,
16424,GO:0071873,1,0.978059208204874,0,3,response to norepinephrine,BP,
16425,GO:0071874,1,0.986536674619832,0,2,cellular response to norepinephrine stimulus,BP,
16426,GO:0071875,1,0.840200389557883,0,26,adrenergic receptor signaling pathway,BP,
16427,GO:0071877,1,0.996330447290537,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16428,GO:0071878,1,0.977307309130907,0,3,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16429,GO:0071879,1,0.985630605401531,0,2,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16430,GO:0071880,1,0.854126442122783,0,23,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16431,GO:0071881,1,0.988841650391981,0,2,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16432,GO:0071882,1,0.992483902775256,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16433,GO:0071885,1,0.989973726793067,0,2,N-terminal protein N-methyltransferase activity,MF,
16434,GO:0071886,1,0.985023074134806,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16435,GO:0071887,1,0.546809080284797,0,99,leukocyte apoptotic process,BP,
16436,GO:0071888,1,0.945094056151985,0,9,macrophage apoptotic process,BP,
16437,GO:0071889,1,0.811186046101704,0,30,14-3-3 protein binding,MF,
16438,GO:0071890,1,0.9920302778541,0,1,bicarbonate binding,MF,
16439,GO:0071893,1,0.995611667834955,0,1,BMP signaling pathway involved in nephric duct formation,BP,
16440,GO:0071894,1,0.987386289092847,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
16441,GO:0071895,1,0.967952707005373,0,5,odontoblast differentiation,BP,
16442,GO:0071896,1,0.954184161797638,0,6,protein localization to adherens junction,BP,
16444,GO:0071898,1,0.981440623996822,0,3,regulation of estrogen receptor binding,BP,
16445,GO:0071899,1,0.981440623996822,0,3,negative regulation of estrogen receptor binding,BP,
16447,GO:0071901,1,0.446539514218785,0,126,negative regulation of protein serine/threonine kinase activity,BP,
16449,GO:0071907,1,0.949051681948472,0,7,determination of digestive tract left/right asymmetry,BP,
16450,GO:0071908,1,0.991937485430931,0,1,determination of intestine left/right asymmetry,BP,
16451,GO:0071909,1,0.991937485430931,0,1,determination of stomach left/right asymmetry,BP,
16452,GO:0071910,1,0.955510268943143,0,6,determination of liver left/right asymmetry,BP,
16453,GO:0071911,1,0.992227477747027,0,1,synchronous neurotransmitter secretion,BP,
16454,GO:0071913,1,0.995957962710815,0,1,citrate secondary active transmembrane transporter activity,MF,
16455,GO:0071914,1,0.985019965406131,0,2,prominosome,CC,
16456,GO:0071916,1,0.991881361991299,0,1,dipeptide transmembrane transporter activity,MF,
16457,GO:0071918,1,0.965814886411103,0,6,urea transmembrane transport,BP,
16458,GO:0071919,1,0.992601912364866,0,1,G-quadruplex DNA formation,BP,
16459,GO:0071920,1,0.988420046870327,0,2,cleavage body,CC,
16460,GO:0071921,1,0.964395400688414,0,5,cohesin loading,BP,
16461,GO:0071922,1,0.970946339166974,0,4,regulation of cohesin loading,BP,
16462,GO:0071926,1,0.958018277833903,0,6,endocannabinoid signaling pathway,BP,
16463,GO:0071929,1,0.986073429945397,0,2,alpha-tubulin acetylation,BP,
16464,GO:0071930,1,0.977529008892551,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16465,GO:0071931,1,0.98255140762491,0,3,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16466,GO:0071932,1,0.976757220359403,0,3,replication fork reversal,BP,
16467,GO:0071933,1,0.919671984818466,0,12,Arp2/3 complex binding,MF,
16468,GO:0071934,1,0.981013632904444,0,3,thiamine transmembrane transport,BP,
16469,GO:0071936,1,0.93053637699528,0,9,coreceptor activity involved in Wnt signaling pathway,MF,
16470,GO:0071938,1,0.993117642408701,0,1,vitamin A transport,BP,
16471,GO:0071939,1,0.993117642408701,0,1,vitamin A import,BP,
16472,GO:0071941,1,0.939627093432475,0,12,nitrogen cycle metabolic process,BP,
16473,GO:0071942,1,0.981674026346873,0,3,XPC complex,CC,
16475,GO:0071947,1,0.966058704975331,0,4,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16476,GO:0071949,1,0.81188108861571,0,31,FAD binding,MF,
16477,GO:0071951,1,0.993292626999948,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16478,GO:0071953,1,0.975503128236413,0,4,elastic fiber,CC,
16479,GO:0071954,1,0.992553532471137,0,1,chemokine (C-C motif) ligand 11 production,BP,
16480,GO:0071955,1,0.974385078046316,0,3,recycling endosome to Golgi transport,BP,
16481,GO:0071960,1,0.996725737755439,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
16482,GO:0071962,1,0.984827343032173,0,3,mitotic sister chromatid cohesion, centromeric,BP,
16483,GO:0071963,1,0.988060867191483,0,2,establishment or maintenance of cell polarity regulating cell shape,BP,
16484,GO:0071971,1,0.955942137647591,0,7,extracellular exosome assembly,BP,
16485,GO:0071976,1,0.992641463159267,0,1,cell gliding,BP,
16486,GO:0071985,1,0.792004665835074,0,38,multivesicular body sorting pathway,BP,
16487,GO:0071986,1,0.960660198443105,0,6,Ragulator complex,CC,
16488,GO:0071987,1,0.969811719347555,0,4,WD40-repeat domain binding,MF,
16489,GO:0071988,1,0.984232887864122,0,2,protein localization to spindle pole body,BP,
16491,GO:0072003,1,0.981227339452838,0,3,kidney rudiment formation,BP,
16492,GO:0072004,1,0.984991601333973,0,2,kidney field specification,BP,
16494,GO:0072007,1,0.957043402871578,0,7,mesangial cell differentiation,BP,
16495,GO:0072008,1,0.96149657830525,0,6,glomerular mesangial cell differentiation,BP,
16497,GO:0072010,1,0.869281219911419,0,19,glomerular epithelium development,BP,
16498,GO:0072011,1,0.989211510305906,0,2,glomerular endothelium development,BP,
16500,GO:0072014,1,0.953078984418066,0,6,proximal tubule development,BP,
16501,GO:0072015,1,0.920960591870393,0,10,glomerular visceral epithelial cell development,BP,
16502,GO:0072016,1,0.993523391118181,0,1,glomerular parietal epithelial cell development,BP,
16503,GO:0072017,1,0.914461688814063,0,11,distal tubule development,BP,
16504,GO:0072019,1,0.994754663009123,0,1,proximal convoluted tubule development,BP,
16505,GO:0072021,1,0.975833944454439,0,3,ascending thin limb development,BP,
16506,GO:0072023,1,0.996127455660783,0,1,thick ascending limb development,BP,
16507,GO:0072024,1,0.996127455660783,0,1,macula densa development,BP,
16508,GO:0072025,1,0.975040507115529,0,4,distal convoluted tubule development,BP,
16509,GO:0072027,1,0.993747408866496,0,1,connecting tubule development,BP,
16511,GO:0072033,1,0.935899885556382,0,8,renal vesicle formation,BP,
16512,GO:0072034,1,0.977969617410487,0,3,renal vesicle induction,BP,
16513,GO:0072036,1,0.992498777094404,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16514,GO:0072038,1,0.968694647279697,0,5,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
16515,GO:0072039,1,0.97756797674988,0,3,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16516,GO:0072040,1,0.97756797674988,0,3,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16517,GO:0072044,1,0.903018257511523,0,14,collecting duct development,BP,
16518,GO:0072046,1,0.996178971238019,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16519,GO:0072047,1,0.981650476119684,0,4,proximal/distal pattern formation involved in nephron development,BP,
16520,GO:0072048,1,0.957311303754415,0,8,renal system pattern specification,BP,
16521,GO:0072049,1,0.972711002315812,0,5,comma-shaped body morphogenesis,BP,
16522,GO:0072050,1,0.958178604218844,0,7,S-shaped body morphogenesis,BP,
16523,GO:0072051,1,0.996127455660783,0,1,juxtaglomerular apparatus development,BP,
16524,GO:0072053,1,0.985111300527232,0,2,renal inner medulla development,BP,
16525,GO:0072054,1,0.985111300527232,0,2,renal outer medulla development,BP,
16526,GO:0072055,1,0.992109875391931,0,1,renal cortex development,BP,
16527,GO:0072059,1,0.992109875391931,0,1,cortical collecting duct development,BP,
16528,GO:0072060,1,0.992479134637304,0,1,outer medullary collecting duct development,BP,
16529,GO:0072061,1,0.981828369846122,0,3,inner medullary collecting duct development,BP,
16530,GO:0072069,1,0.981176589269832,0,3,DCT cell differentiation,BP,
16531,GO:0072070,1,0.940118365245457,0,9,loop of Henle development,BP,
16532,GO:0072071,1,0.991582450867617,0,2,kidney interstitial fibroblast differentiation,BP,
16534,GO:0072074,1,0.887226804956743,0,18,kidney mesenchyme development,BP,
16535,GO:0072075,1,0.907014057507381,0,14,metanephric mesenchyme development,BP,
16536,GO:0072076,1,0.977137930227119,0,3,nephrogenic mesenchyme development,BP,
16541,GO:0072081,1,0.981650476119684,0,4,specification of nephron tubule identity,BP,
16542,GO:0072086,1,0.986216963326329,0,3,specification of loop of Henle identity,BP,
16547,GO:0072092,1,0.971440915272597,0,3,ureteric bud invasion,BP,
16548,GO:0072093,1,0.964151776976956,0,4,metanephric renal vesicle formation,BP,
16549,GO:0072095,1,0.980627769887802,0,3,regulation of branch elongation involved in ureteric bud branching,BP,
16550,GO:0072096,1,0.995611667834955,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
16551,GO:0072097,1,0.995611667834955,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
16552,GO:0072098,1,0.991002126217525,0,2,anterior/posterior pattern specification involved in kidney development,BP,
16553,GO:0072099,1,0.995611667834955,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
16554,GO:0072100,1,0.995611667834955,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
16555,GO:0072101,1,0.995611667834955,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
16559,GO:0072106,1,0.974765808368617,0,4,regulation of ureteric bud formation,BP,
16560,GO:0072107,1,0.974765808368617,0,4,positive regulation of ureteric bud formation,BP,
16561,GO:0072108,1,0.974464268482899,0,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
16562,GO:0072109,1,0.905685064902732,0,15,glomerular mesangium development,BP,
16563,GO:0072110,1,0.935443696927231,0,10,glomerular mesangial cell proliferation,BP,
16564,GO:0072111,1,0.88245191593754,0,19,cell proliferation involved in kidney development,BP,
16565,GO:0072112,1,0.887416781420094,0,16,glomerular visceral epithelial cell differentiation,BP,
16566,GO:0072114,1,0.991847881963631,0,1,pronephros morphogenesis,BP,
16567,GO:0072124,1,0.943233521057459,0,9,regulation of glomerular mesangial cell proliferation,BP,
16568,GO:0072125,1,0.981091157468328,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16569,GO:0072126,1,0.96142009274604,0,6,positive regulation of glomerular mesangial cell proliferation,BP,
16570,GO:0072127,1,0.994435550372176,0,1,renal capsule development,BP,
16571,GO:0072128,1,0.994435550372176,0,1,renal capsule morphogenesis,BP,
16572,GO:0072129,1,0.994435550372176,0,1,renal capsule formation,BP,
16573,GO:0072130,1,0.994435550372176,0,1,renal capsule specification,BP,
16574,GO:0072131,1,0.97236115406772,0,4,kidney mesenchyme morphogenesis,BP,
16575,GO:0072132,1,0.707270960181658,0,51,mesenchyme morphogenesis,BP,
16576,GO:0072133,1,0.97236115406772,0,4,metanephric mesenchyme morphogenesis,BP,
16577,GO:0072134,1,0.982606570943903,0,2,nephrogenic mesenchyme morphogenesis,BP,
16578,GO:0072135,1,0.981116445836215,0,3,kidney mesenchymal cell proliferation,BP,
16579,GO:0072136,1,0.981116445836215,0,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
16580,GO:0072137,1,0.970608597863328,0,3,condensed mesenchymal cell proliferation,BP,
16581,GO:0072138,1,0.982807639734578,0,3,mesenchymal cell proliferation involved in ureteric bud development,BP,
16582,GO:0072139,1,0.986048776343063,0,2,glomerular parietal epithelial cell differentiation,BP,
16583,GO:0072141,1,0.991582450867617,0,2,renal interstitial fibroblast development,BP,
16584,GO:0072143,1,0.963447077294095,0,6,mesangial cell development,BP,
16585,GO:0072144,1,0.967929743303028,0,5,glomerular mesangial cell development,BP,
16586,GO:0072148,1,0.905265846103102,0,14,epithelial cell fate commitment,BP,
16587,GO:0072156,1,0.971260825362011,0,3,distal tubule morphogenesis,BP,
16588,GO:0072160,1,0.902084955089818,0,13,nephron tubule epithelial cell differentiation,BP,
16589,GO:0072161,1,0.957216997393143,0,7,mesenchymal cell differentiation involved in kidney development,BP,
16590,GO:0072162,1,0.973102191668382,0,4,metanephric mesenchymal cell differentiation,BP,
16593,GO:0072165,1,0.995370348857352,0,1,anterior mesonephric tubule development,BP,
16594,GO:0072166,1,0.988301640872892,0,2,posterior mesonephric tubule development,BP,
16595,GO:0072167,1,0.995370348857352,0,1,specification of mesonephric tubule identity,BP,
16596,GO:0072168,1,0.995370348857352,0,1,specification of anterior mesonephric tubule identity,BP,
16597,GO:0072169,1,0.995370348857352,0,1,specification of posterior mesonephric tubule identity,BP,
16598,GO:0072170,1,0.855336421444806,0,22,metanephric tubule development,BP,
16601,GO:0072173,1,0.926700588901678,0,11,metanephric tubule morphogenesis,BP,
16602,GO:0072174,1,0.959606392760704,0,6,metanephric tubule formation,BP,
16604,GO:0072176,1,0.90445805247148,0,14,nephric duct development,BP,
16605,GO:0072177,1,0.953194211800564,0,7,mesonephric duct development,BP,
16606,GO:0072178,1,0.935569347502954,0,10,nephric duct morphogenesis,BP,
16607,GO:0072179,1,0.977258488544547,0,4,nephric duct formation,BP,
16608,GO:0072180,1,0.985964092086213,0,3,mesonephric duct morphogenesis,BP,
16609,GO:0072181,1,0.996178971238019,0,1,mesonephric duct formation,BP,
16610,GO:0072182,1,0.917117982179484,0,11,regulation of nephron tubule epithelial cell differentiation,BP,
16611,GO:0072183,1,0.987934729052917,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16612,GO:0072184,1,0.995370348857352,0,1,renal vesicle progenitor cell differentiation,BP,
16613,GO:0072185,1,0.989575082478708,0,2,metanephric cap development,BP,
16614,GO:0072186,1,0.989575082478708,0,2,metanephric cap morphogenesis,BP,
16615,GO:0072189,1,0.890448308676521,0,17,ureter development,BP,
16616,GO:0072190,1,0.983546834380854,0,3,ureter urothelium development,BP,
16617,GO:0072191,1,0.977702888363953,0,4,ureter smooth muscle development,BP,
16618,GO:0072192,1,0.995611667834955,0,1,ureter epithelial cell differentiation,BP,
16619,GO:0072193,1,0.977702888363953,0,4,ureter smooth muscle cell differentiation,BP,
16620,GO:0072194,1,0.983572792854976,0,3,kidney smooth muscle tissue development,BP,
16621,GO:0072195,1,0.996007069956112,0,1,kidney smooth muscle cell differentiation,BP,
16622,GO:0072197,1,0.960918852823669,0,6,ureter morphogenesis,BP,
16623,GO:0072198,1,0.985114335295324,0,3,mesenchymal cell proliferation involved in ureter development,BP,
16624,GO:0072199,1,0.985114335295324,0,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,
16625,GO:0072200,1,0.995611667834955,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
16626,GO:0072201,1,0.948384106230965,0,8,negative regulation of mesenchymal cell proliferation,BP,
16628,GO:0072203,1,0.934840611144962,0,10,cell proliferation involved in metanephros development,BP,
16629,GO:0072204,1,0.984893598799838,0,2,cell-cell signaling involved in metanephros development,BP,
16630,GO:0072205,1,0.930034584471938,0,10,metanephric collecting duct development,BP,
16631,GO:0072206,1,0.996127455660783,0,1,metanephric juxtaglomerular apparatus development,BP,
16632,GO:0072207,1,0.842181492397983,0,24,metanephric epithelium development,BP,
16633,GO:0072208,1,0.987516382134857,0,2,metanephric smooth muscle tissue development,BP,
16634,GO:0072209,1,0.986470933285138,0,2,metanephric mesangial cell differentiation,BP,
16636,GO:0072213,1,0.994435550372176,0,1,metanephric capsule development,BP,
16637,GO:0072214,1,0.992109875391931,0,1,metanephric cortex development,BP,
16638,GO:0072215,1,0.872501599979336,0,20,regulation of metanephros development,BP,
16639,GO:0072216,1,0.922759892079938,0,12,positive regulation of metanephros development,BP,
16640,GO:0072217,1,0.956093163076736,0,7,negative regulation of metanephros development,BP,
16641,GO:0072218,1,0.975833944454439,0,3,metanephric ascending thin limb development,BP,
16642,GO:0072219,1,0.992109875391931,0,1,metanephric cortical collecting duct development,BP,
16643,GO:0072221,1,0.975040507115529,0,4,metanephric distal convoluted tubule development,BP,
16644,GO:0072223,1,0.964346694002475,0,5,metanephric glomerular mesangium development,BP,
16646,GO:0072227,1,0.996127455660783,0,1,metanephric macula densa development,BP,
16647,GO:0072229,1,0.994754663009123,0,1,metanephric proximal convoluted tubule development,BP,
16648,GO:0072233,1,0.996127455660783,0,1,metanephric thick ascending limb development,BP,
16649,GO:0072234,1,0.871012018074466,0,19,metanephric nephron tubule development,BP,
16650,GO:0072235,1,0.955172301026727,0,6,metanephric distal tubule development,BP,
16651,GO:0072236,1,0.968493005498614,0,4,metanephric loop of Henle development,BP,
16652,GO:0072237,1,0.982240245283169,0,2,metanephric proximal tubule development,BP,
16654,GO:0072240,1,0.981176589269832,0,3,metanephric DCT cell differentiation,BP,
16655,GO:0072243,1,0.863761383857184,0,20,metanephric nephron epithelium development,BP,
16656,GO:0072244,1,0.991687281689402,0,1,metanephric glomerular epithelium development,BP,
16657,GO:0072248,1,0.991687281689402,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
16658,GO:0072249,1,0.991687281689402,0,1,metanephric glomerular visceral epithelial cell development,BP,
16659,GO:0072254,1,0.986470933285138,0,2,metanephric glomerular mesangial cell differentiation,BP,
16660,GO:0072255,1,0.993069464019609,0,1,metanephric glomerular mesangial cell development,BP,
16661,GO:0072257,1,0.942086199489511,0,7,metanephric nephron tubule epithelial cell differentiation,BP,
16662,GO:0072258,1,0.995370348857352,0,1,metanephric interstitial fibroblast differentiation,BP,
16663,GO:0072259,1,0.995370348857352,0,1,metanephric interstitial fibroblast development,BP,
16664,GO:0072262,1,0.977575415453412,0,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
16665,GO:0072265,1,0.994435550372176,0,1,metanephric capsule morphogenesis,BP,
16666,GO:0072266,1,0.994435550372176,0,1,metanephric capsule formation,BP,
16667,GO:0072267,1,0.994435550372176,0,1,metanephric capsule specification,BP,
16668,GO:0072268,1,0.985328119932476,0,3,pattern specification involved in metanephros development,BP,
16669,GO:0072272,1,0.99545093309741,0,1,proximal/distal pattern formation involved in metanephric nephron development,BP,
16671,GO:0072274,1,0.991687281689402,0,1,metanephric glomerular basement membrane development,BP,
16675,GO:0072278,1,0.979971049198125,0,3,metanephric comma-shaped body morphogenesis,BP,
16676,GO:0072282,1,0.943670059862383,0,8,metanephric nephron tubule morphogenesis,BP,
16678,GO:0072284,1,0.96533128986382,0,5,metanephric S-shaped body morphogenesis,BP,
16679,GO:0072285,1,0.992498777094404,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16680,GO:0072286,1,0.993747408866496,0,1,metanephric connecting tubule development,BP,
16681,GO:0072287,1,0.987420264090517,0,1,metanephric distal tubule morphogenesis,BP,
16682,GO:0072289,1,0.970589592570867,0,4,metanephric nephron tubule formation,BP,
16683,GO:0072298,1,0.970628129824557,0,4,regulation of metanephric glomerulus development,BP,
16684,GO:0072299,1,0.992898749510363,0,1,negative regulation of metanephric glomerulus development,BP,
16685,GO:0072300,1,0.977571711454946,0,3,positive regulation of metanephric glomerulus development,BP,
16686,GO:0072301,1,0.985712416494289,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
16687,GO:0072302,1,0.992898749510363,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
16688,GO:0072303,1,0.992762794096959,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16689,GO:0072304,1,0.984991601333973,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16690,GO:0072305,1,0.984991601333973,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16691,GO:0072307,1,0.942086199489511,0,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16692,GO:0072308,1,0.992530148409052,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16693,GO:0072309,1,0.984991601333973,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16694,GO:0072310,1,0.914990896720048,0,11,glomerular epithelial cell development,BP,
16695,GO:0072311,1,0.881662346997918,0,17,glomerular epithelial cell differentiation,BP,
16696,GO:0072312,1,0.991687281689402,0,1,metanephric glomerular epithelial cell differentiation,BP,
16697,GO:0072313,1,0.991687281689402,0,1,metanephric glomerular epithelial cell development,BP,
16698,GO:0072318,1,0.958091884421124,0,6,clathrin coat disassembly,BP,
16699,GO:0072319,1,0.952959936907715,0,7,vesicle uncoating,BP,
16700,GO:0072320,1,0.972655974991305,0,4,volume-sensitive chloride channel activity,MF,
16701,GO:0072321,1,0.945153605475948,0,11,chaperone-mediated protein transport,BP,
16702,GO:0072329,1,0.459564432694949,0,129,monocarboxylic acid catabolic process,BP,
16706,GO:0072334,1,0.982614538504497,0,4,UDP-galactose transmembrane transport,BP,
16708,GO:0072338,1,0.979800812772098,0,3,cellular lactam metabolic process,BP,
16709,GO:0072340,1,0.995786241327855,0,1,cellular lactam catabolic process,BP,
16710,GO:0072341,1,0.601853037411396,0,82,modified amino acid binding,MF,
16711,GO:0072343,1,0.991873208402617,0,2,pancreatic stellate cell proliferation,BP,
16712,GO:0072344,1,0.972422090221543,0,4,rescue of stalled ribosome,BP,
16713,GO:0072345,1,0.965450562070876,0,5,NAADP-sensitive calcium-release channel activity,MF,
16716,GO:0072350,1,0.92523205674173,0,13,tricarboxylic acid metabolic process,BP,
16717,GO:0072354,1,0.995760941551611,0,1,histone kinase activity (H3-T3 specific),MF,
16718,GO:0072355,1,0.995760941551611,0,1,histone H3-T3 phosphorylation,BP,
16719,GO:0072356,1,0.992465109004135,0,1,chromosome passenger complex localization to kinetochore,BP,
16720,GO:0072357,1,0.952140220115839,0,7,PTW/PP1 phosphatase complex,CC,
16722,GO:0072376,1,0.877616301375717,0,22,protein activation cascade,BP,
16723,GO:0072378,1,0.877616301375717,0,22,blood coagulation, fibrin clot formation,BP,
16724,GO:0072379,1,0.969028754723332,0,5,ER membrane insertion complex,CC,
16725,GO:0072380,1,0.986227810806512,0,2,TRC complex,CC,
16726,GO:0072382,1,0.987313990147635,0,1,minus-end-directed vesicle transport along microtubule,BP,
16727,GO:0072383,1,0.943345807094436,0,7,plus-end-directed vesicle transport along microtubule,BP,
16728,GO:0072384,1,0.563931532646639,0,79,organelle transport along microtubule,BP,
16729,GO:0072385,1,0.95774803547648,0,5,minus-end-directed organelle transport along microtubule,BP,
16730,GO:0072386,1,0.935535343987744,0,8,plus-end-directed organelle transport along microtubule,BP,
16731,GO:0072387,1,0.987694715866634,0,2,flavin adenine dinucleotide metabolic process,BP,
16732,GO:0072388,1,0.995175350268869,0,1,flavin adenine dinucleotide biosynthetic process,BP,
16733,GO:0072389,1,0.99248346894442,0,1,flavin adenine dinucleotide catabolic process,BP,
16734,GO:0072393,1,0.905332717877704,0,12,microtubule anchoring at microtubule organizing center,BP,
16735,GO:0072394,1,0.995871794058111,0,1,detection of stimulus involved in cell cycle checkpoint,BP,
16736,GO:0072395,1,0.634576793152725,0,69,signal transduction involved in cell cycle checkpoint,BP,
16737,GO:0072396,1,0.955669427528592,0,6,response to cell cycle checkpoint signaling,BP,
16738,GO:0072401,1,0.64095033281873,0,68,signal transduction involved in DNA integrity checkpoint,BP,
16739,GO:0072402,1,0.955669427528592,0,6,response to DNA integrity checkpoint signaling,BP,
16740,GO:0072413,1,0.695641915656554,0,56,signal transduction involved in mitotic cell cycle checkpoint,BP,
16741,GO:0072414,1,0.990987939263863,0,1,response to mitotic cell cycle checkpoint signaling,BP,
16742,GO:0072421,1,0.995871794058111,0,1,detection of DNA damage stimulus involved in DNA damage checkpoint,BP,
16743,GO:0072422,1,0.64095033281873,0,68,signal transduction involved in DNA damage checkpoint,BP,
16744,GO:0072423,1,0.955669427528592,0,6,response to DNA damage checkpoint signaling,BP,
16745,GO:0072425,1,0.920540903367527,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
16746,GO:0072428,1,0.995423541794903,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
16747,GO:0072429,1,0.981664135449203,0,3,response to intra-S DNA damage checkpoint signaling,BP,
16748,GO:0072431,1,0.700620148104856,0,55,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
16749,GO:0072432,1,0.990987939263863,0,1,response to G1 DNA damage checkpoint signaling,BP,
16750,GO:0072434,1,0.981873296915975,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
16751,GO:0072487,1,0.972715724713763,0,4,MSL complex,CC,
16752,GO:0072488,1,0.945679339636317,0,8,ammonium transmembrane transport,BP,
16753,GO:0072492,1,0.995674493172775,0,1,host cell mitochondrial intermembrane space,CC,
16755,GO:0072498,1,0.915358067545013,0,15,embryonic skeletal joint development,BP,
16756,GO:0072501,1,0.963873349342407,0,5,cellular divalent inorganic anion homeostasis,BP,
16757,GO:0072502,1,0.963873349342407,0,5,cellular trivalent inorganic anion homeostasis,BP,
16759,GO:0072505,1,0.942358261879735,0,8,divalent inorganic anion homeostasis,BP,
16760,GO:0072506,1,0.942358261879735,0,8,trivalent inorganic anion homeostasis,BP,
16762,GO:0072509,1,0.323682064030627,0,149,divalent inorganic cation transmembrane transporter activity,MF,
16764,GO:0072513,1,0.978567380673282,0,3,positive regulation of secondary heart field cardioblast proliferation,BP,
16765,GO:0072517,1,0.992571170284062,0,1,host cell viral assembly compartment,CC,
16766,GO:0072518,1,0.982636346767109,0,2,Rho-dependent protein serine/threonine kinase activity,MF,
16767,GO:0072520,1,0.927140012961272,0,11,seminiferous tubule development,BP,
16769,GO:0072522,1,0.35964104449031,0,165,purine-containing compound biosynthetic process,BP,
16770,GO:0072523,1,0.745331419080813,0,47,purine-containing compound catabolic process,BP,
16771,GO:0072524,1,0.797577452193855,0,37,pyridine-containing compound metabolic process,BP,
16772,GO:0072525,1,0.827171874825746,0,31,pyridine-containing compound biosynthetic process,BP,
16773,GO:0072526,1,0.960860223844208,0,7,pyridine-containing compound catabolic process,BP,
16774,GO:0072527,1,0.644177290217409,0,78,pyrimidine-containing compound metabolic process,BP,
16775,GO:0072528,1,0.818794067501332,0,37,pyrimidine-containing compound biosynthetic process,BP,
16776,GO:0072529,1,0.818913694872213,0,36,pyrimidine-containing compound catabolic process,BP,
16777,GO:0072530,1,0.948782603725647,0,9,purine-containing compound transmembrane transport,BP,
16778,GO:0072531,1,0.935282525845489,0,11,pyrimidine-containing compound transmembrane transport,BP,
16779,GO:0072534,1,0.982497018294254,0,2,perineuronal net,CC,
16780,GO:0072535,1,0.986942307565985,0,2,tumor necrosis factor (ligand) superfamily member 11 production,BP,
16781,GO:0072536,1,0.987836385301909,0,2,interleukin-23 receptor complex,CC,
16782,GO:0072537,1,0.922692715052878,0,11,fibroblast activation,BP,
16783,GO:0072538,1,0.846120578409944,0,25,T-helper 17 type immune response,BP,
16784,GO:0072539,1,0.862579084149944,0,22,T-helper 17 cell differentiation,BP,
16785,GO:0072540,1,0.945492141633873,0,10,T-helper 17 cell lineage commitment,BP,
16786,GO:0072542,1,0.925448397207545,0,12,protein phosphatase activator activity,MF,
16787,GO:0072544,1,0.995782374051263,0,1,L-DOPA binding,MF,
16788,GO:0072545,1,0.990507427551141,0,2,tyrosine binding,MF,
16789,GO:0072546,1,0.933844086430138,0,10,ER membrane protein complex,CC,
16790,GO:0072553,1,0.966673176817745,0,5,terminal button organization,BP,
16791,GO:0072554,1,0.986822380267092,0,2,blood vessel lumenization,BP,
16792,GO:0072557,1,0.977207939316949,0,4,IPAF inflammasome complex,CC,
16793,GO:0072558,1,0.981795020723706,0,4,NLRP1 inflammasome complex,CC,
16794,GO:0072559,1,0.954410335724084,0,8,NLRP3 inflammasome complex,CC,
16795,GO:0072560,1,0.989363687229213,0,2,type B pancreatic cell maturation,BP,
16797,GO:0072563,1,0.988741426723384,0,2,endothelial microparticle,CC,
16798,GO:0072564,1,0.990792451539154,0,2,blood microparticle formation,BP,
16799,GO:0072566,1,0.981047445726023,0,3,chemokine (C-X-C motif) ligand 1 production,BP,
16801,GO:0072570,1,0.984384882493705,0,2,ADP-D-ribose binding,MF,
16802,GO:0072571,1,0.991647816325828,0,1,mono-ADP-D-ribose binding,MF,
16803,GO:0072572,1,0.994752080287959,0,1,poly-ADP-D-ribose binding,MF,
16804,GO:0072573,1,0.992372857018491,0,1,tolerance induction to lipopolysaccharide,BP,
16805,GO:0072574,1,0.88749181183857,0,19,hepatocyte proliferation,BP,
16806,GO:0072575,1,0.88749181183857,0,19,epithelial cell proliferation involved in liver morphogenesis,BP,
16807,GO:0072576,1,0.879622769614262,0,20,liver morphogenesis,BP,
16808,GO:0072577,1,0.707076797440922,0,52,endothelial cell apoptotic process,BP,
16809,GO:0072578,1,0.90137435732023,0,13,neurotransmitter-gated ion channel clustering,BP,
16810,GO:0072579,1,0.992418877101266,0,1,glycine receptor clustering,BP,
16811,GO:0072583,1,0.718699545243685,0,44,clathrin-dependent endocytosis,BP,
16813,GO:0072586,1,0.992347967347288,0,1,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) regulator activity,MF,
16814,GO:0072587,1,0.992347967347288,0,1,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity,MF,
16815,GO:0072588,1,0.97650580583673,0,5,box H/ACA RNP complex,CC,
16816,GO:0072589,1,0.983910485268586,0,4,box H/ACA scaRNP complex,CC,
16817,GO:0072590,1,0.980921325327532,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
16818,GO:0072591,1,0.991688426663366,0,1,citrate-L-glutamate ligase activity,MF,
16819,GO:0072592,1,0.975282690531094,0,5,oxygen metabolic process,BP,
16824,GO:0072655,1,0.459295461959973,0,132,establishment of protein localization to mitochondrion,BP,
16825,GO:0072656,1,0.967229714888456,0,5,maintenance of protein location in mitochondrion,BP,
16832,GO:0072665,1,0.645078594516849,0,64,protein localization to vacuole,BP,
16833,GO:0072666,1,0.713374703652198,0,49,establishment of protein localization to vacuole,BP,
16834,GO:0072669,1,0.966658720610568,0,7,tRNA-splicing ligase complex,CC,
16835,GO:0072671,1,0.993715847912815,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
16836,GO:0072672,1,0.944349999054139,0,9,neutrophil extravasation,BP,
16838,GO:0072674,1,0.948785427173509,0,7,multinuclear osteoclast differentiation,BP,
16839,GO:0072675,1,0.955701745624954,0,6,osteoclast fusion,BP,
16841,GO:0072677,1,0.931969183759879,0,14,eosinophil migration,BP,
16843,GO:0072679,1,0.967669798679381,0,6,thymocyte migration,BP,
16844,GO:0072680,1,0.99274771897635,0,1,extracellular matrix-dependent thymocyte migration,BP,
16845,GO:0072681,1,0.99274771897635,0,1,fibronectin-dependent thymocyte migration,BP,
16846,GO:0072682,1,0.992582695342739,0,1,eosinophil extravasation,BP,
16847,GO:0072683,1,0.932033905230992,0,11,T cell extravasation,BP,
16848,GO:0072684,1,0.992489222315228,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
16849,GO:0072686,1,0.426543305756691,0,121,mitotic spindle,CC,
16850,GO:0072687,1,0.945359999016321,0,9,meiotic spindle,CC,
16851,GO:0072695,1,0.987893361525938,0,2,regulation of DNA recombination at telomere,BP,
16852,GO:0072697,1,0.926077036379817,0,11,protein localization to cell cortex,BP,
16853,GO:0072698,1,0.674393317951725,0,52,protein localization to microtubule cytoskeleton,BP,
16854,GO:0072702,1,0.991803074431045,0,1,response to methyl methanesulfonate,BP,
16855,GO:0072703,1,0.991803074431045,0,1,cellular response to methyl methanesulfonate,BP,
16856,GO:0072706,1,0.993671937021785,0,1,response to sodium dodecyl sulfate,BP,
16857,GO:0072707,1,0.993671937021785,0,1,cellular response to sodium dodecyl sulfate,BP,
16858,GO:0072708,1,0.970323510928325,0,5,response to sorbitol,BP,
16859,GO:0072709,1,0.983374115873832,0,3,cellular response to sorbitol,BP,
16860,GO:0072710,1,0.932726407859764,0,10,response to hydroxyurea,BP,
16861,GO:0072711,1,0.939064391006677,0,9,cellular response to hydroxyurea,BP,
16862,GO:0072714,1,0.995701080102347,0,1,response to selenite ion,BP,
16863,GO:0072715,1,0.995701080102347,0,1,cellular response to selenite ion,BP,
16864,GO:0072716,1,0.974778164075119,0,4,response to actinomycin D,BP,
16865,GO:0072717,1,0.981398905653202,0,3,cellular response to actinomycin D,BP,
16866,GO:0072718,1,0.940285476459636,0,9,response to cisplatin,BP,
16867,GO:0072719,1,0.961202588116766,0,6,cellular response to cisplatin,BP,
16868,GO:0072720,1,0.986555151512788,0,2,response to dithiothreitol,BP,
16869,GO:0072721,1,0.99325505912211,0,1,cellular response to dithiothreitol,BP,
16870,GO:0072733,1,0.983341047228131,0,3,response to staurosporine,BP,
16871,GO:0072734,1,0.983341047228131,0,3,cellular response to staurosporine,BP,
16872,GO:0072737,1,0.988380787072292,0,2,response to diamide,BP,
16873,GO:0072738,1,0.988380787072292,0,2,cellular response to diamide,BP,
16874,GO:0072739,1,0.988649361398685,0,2,response to anisomycin,BP,
16875,GO:0072740,1,0.995363345957794,0,1,cellular response to anisomycin,BP,
16876,GO:0072749,1,0.995555640589588,0,1,cellular response to cytochalasin B,BP,
16877,GO:0072750,1,0.996405079345363,0,1,cellular response to leptomycin B,BP,
16878,GO:0072752,1,0.984748751013256,0,2,cellular response to rapamycin,BP,
16879,GO:0072755,1,0.992496118118737,0,1,cellular response to benomyl,BP,
16880,GO:0072757,1,0.972863720546801,0,4,cellular response to camptothecin,BP,
16881,GO:0075044,1,0.953024633316195,0,7,positive regulation by symbiont of host autophagy,BP,
16882,GO:0075071,1,0.953024633316195,0,7,modulation by symbiont of host autophagy,BP,
16883,GO:0075136,1,0.976412583790958,0,3,response to host,BP,
16884,GO:0075294,1,0.947316573217556,0,10,positive regulation by symbiont of entry into host,BP,
16885,GO:0075341,1,0.994348807479912,0,1,host cell PML body,CC,
16886,GO:0075506,1,0.986009621579639,0,2,entry of viral genome into host nucleus through nuclear pore complex via importin,BP,
16887,GO:0075509,1,0.947733245933799,0,7,endocytosis involved in viral entry into host cell,BP,
16888,GO:0075512,1,0.991178189788172,0,1,clathrin-dependent endocytosis of virus by host cell,BP,
16889,GO:0075519,1,0.996806260693679,0,1,microtubule-dependent intracellular transport of viral material,BP,
16890,GO:0075521,1,0.996806260693679,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
16891,GO:0075522,1,0.935357671007149,0,10,IRES-dependent viral translational initiation,BP,
16892,GO:0075525,1,0.972103882344631,0,5,viral translational termination-reinitiation,BP,
16893,GO:0075606,1,0.996806260693679,0,1,transport of viral material towards nucleus,BP,
16894,GO:0075713,1,0.955251970114968,0,8,establishment of integrated proviral latency,BP,
16895,GO:0075732,1,0.970408173906212,0,4,viral penetration into host nucleus,BP,
16896,GO:0075733,1,0.708037238949131,0,52,intracellular transport of virus,BP,
16897,GO:0080008,1,0.810724035979352,0,31,Cul4-RING E3 ubiquitin ligase complex,CC,
16898,GO:0080009,1,0.905945190901829,0,15,mRNA methylation,BP,
16899,GO:0080019,1,0.986891612610964,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
16900,GO:0080025,1,0.84242058598681,0,25,phosphatidylinositol-3,5-bisphosphate binding,MF,
16901,GO:0080030,1,0.973543509948233,0,4,methyl indole-3-acetate esterase activity,MF,
16902,GO:0080033,1,0.991408023303973,0,1,response to nitrite,BP,
16903,GO:0080048,1,0.99325505912211,0,1,GDP-D-glucose phosphorylase activity,MF,
16904,GO:0080058,1,0.996316885027758,0,1,protein deglutathionylation,BP,
16905,GO:0080084,1,0.977084181278937,0,3,5S rDNA binding,MF,
16907,GO:0080101,1,0.996661442422472,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
16908,GO:0080111,1,0.85280727959408,0,24,DNA demethylation,BP,
16909,GO:0080120,1,0.988934337457455,0,2,CAAX-box protein maturation,BP,
16910,GO:0080121,1,0.987228687314284,0,2,AMP transport,BP,
16911,GO:0080122,1,0.987228687314284,0,2,AMP transmembrane transporter activity,MF,
16912,GO:0080129,1,0.996588902822327,0,1,proteasome core complex assembly,BP,
16916,GO:0080144,1,0.968307602479545,0,4,amino acid homeostasis,BP,
16917,GO:0080146,1,0.995691921465553,0,1,L-cysteine desulfhydrase activity,MF,
16918,GO:0080154,1,0.883694160216876,0,20,regulation of fertilization,BP,
16919,GO:0080163,1,0.994098172595178,0,1,regulation of protein serine/threonine phosphatase activity,BP,
16920,GO:0080170,1,0.996210122310012,0,1,hydrogen peroxide transmembrane transport,BP,
16921,GO:0080171,1,0.666658387561104,0,62,lytic vacuole organization,BP,
16922,GO:0080182,1,0.868549270221923,0,18,histone H3-K4 trimethylation,BP,
16924,GO:0085017,1,0.991060049921919,0,1,entry into host cell by a symbiont-containing vacuole,BP,
16925,GO:0085018,1,0.993285028471028,0,1,maintenance of symbiont-containing vacuole by host,BP,
16926,GO:0085020,1,0.957122426763013,0,8,protein K6-linked ubiquitination,BP,
16928,GO:0085032,1,0.992651847028307,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
16932,GO:0086004,1,0.749206182350931,0,37,regulation of cardiac muscle cell contraction,BP,
16933,GO:0086005,1,0.782475517265481,0,32,ventricular cardiac muscle cell action potential,BP,
16934,GO:0086006,1,0.963378994620427,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
16935,GO:0086007,1,0.954772511008471,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
16936,GO:0086008,1,0.910612940748033,0,14,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
16937,GO:0086009,1,0.743955919943459,0,42,membrane repolarization,BP,
16939,GO:0086011,1,0.844487887072068,0,25,membrane repolarization during action potential,BP,
16941,GO:0086013,1,0.862232993858953,0,22,membrane repolarization during cardiac muscle cell action potential,BP,
16943,GO:0086015,1,0.926492101402537,0,8,SA node cell action potential,BP,
16944,GO:0086016,1,0.920750131759893,0,9,AV node cell action potential,BP,
16945,GO:0086017,1,0.979220629518625,0,3,Purkinje myocyte action potential,BP,
16946,GO:0086018,1,0.926492101402537,0,8,SA node cell to atrial cardiac muscle cell signaling,BP,
16948,GO:0086020,1,0.990678559279126,0,1,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
16949,GO:0086021,1,0.990678559279126,0,1,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
16950,GO:0086023,1,0.945886827196312,0,7,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
16951,GO:0086024,1,0.99041258849186,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
16953,GO:0086027,1,0.920750131759893,0,9,AV node cell to bundle of His cell signaling,BP,
16954,GO:0086028,1,0.957420237176153,0,6,bundle of His cell to Purkinje myocyte signaling,BP,
16955,GO:0086029,1,0.959523380902474,0,5,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
16956,GO:0086030,1,0.994997507045214,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
16957,GO:0086036,1,0.954263107522328,0,7,regulation of cardiac muscle cell membrane potential,BP,
16958,GO:0086038,1,0.99325505912211,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16959,GO:0086039,1,0.990350808556854,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
16960,GO:0086040,1,0.992323194960459,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16961,GO:0086041,1,0.990902843244899,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
16962,GO:0086042,1,0.946665418959483,0,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16963,GO:0086043,1,0.957420237176153,0,6,bundle of His cell action potential,BP,
16964,GO:0086045,1,0.9543593039789,0,5,membrane depolarization during AV node cell action potential,BP,
16965,GO:0086046,1,0.95373780780019,0,5,membrane depolarization during SA node cell action potential,BP,
16966,GO:0086047,1,0.979220629518625,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
16967,GO:0086048,1,0.975361084921955,0,3,membrane depolarization during bundle of His cell action potential,BP,
16968,GO:0086050,1,0.993098366555018,0,1,membrane repolarization during bundle of His cell action potential,BP,
16969,GO:0086052,1,0.993098366555018,0,1,membrane repolarization during SA node cell action potential,BP,
16970,GO:0086053,1,0.990678559279126,0,1,AV node cell to bundle of His cell communication by electrical coupling,BP,
16971,GO:0086056,1,0.971118345995289,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16972,GO:0086057,1,0.992485100449134,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
16973,GO:0086059,1,0.981416773462467,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
16974,GO:0086060,1,0.990216110017388,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
16975,GO:0086061,1,0.990216110017388,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
16976,GO:0086062,1,0.98666257062779,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
16977,GO:0086063,1,0.990216110017388,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
16981,GO:0086067,1,0.912160227518348,0,10,AV node cell to bundle of His cell communication,BP,
16982,GO:0086068,1,0.959523380902474,0,5,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
16983,GO:0086069,1,0.905275230596329,0,13,bundle of His cell to Purkinje myocyte communication,BP,
16984,GO:0086070,1,0.917849174171177,0,9,SA node cell to atrial cardiac muscle cell communication,BP,
16985,GO:0086072,1,0.993903159607298,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16986,GO:0086073,1,0.952475385035176,0,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16988,GO:0086077,1,0.990678559279126,0,1,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
16990,GO:0086082,1,0.993903159607298,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
16991,GO:0086083,1,0.959493288101735,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16992,GO:0086087,1,0.993098366555018,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
16993,GO:0086089,1,0.972245424625115,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
16994,GO:0086090,1,0.993098366555018,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
16995,GO:0086091,1,0.752499495602177,0,37,regulation of heart rate by cardiac conduction,BP,
16996,GO:0086092,1,0.98811634848889,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
16997,GO:0086096,1,0.996330447290537,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
16998,GO:0086097,1,0.986649110182535,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,
16999,GO:0086098,1,0.985957799562971,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17000,GO:0086100,1,0.950589564970709,0,7,endothelin receptor signaling pathway,BP,
17001,GO:0086103,1,0.9257680761646,0,11,G protein-coupled receptor signaling pathway involved in heart process,BP,
17002,GO:0089700,1,0.96969904476479,0,4,protein kinase D signaling,BP,
17003,GO:0089701,1,0.982447476409704,0,4,U2AF complex,CC,
17004,GO:0089709,1,0.961116456706079,0,6,L-histidine transmembrane transport,BP,
17005,GO:0089717,1,0.872950135668933,0,17,spanning component of membrane,CC,
17006,GO:0089718,1,0.760633546227943,0,38,amino acid import across plasma membrane,BP,
17007,GO:0089720,1,0.950529848975786,0,10,caspase binding,MF,
17008,GO:0090009,1,0.947401350321528,0,8,primitive streak formation,BP,
17009,GO:0090010,1,0.994895965192756,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17010,GO:0090022,1,0.841469113483278,0,31,regulation of neutrophil chemotaxis,BP,
17011,GO:0090023,1,0.874592770129304,0,25,positive regulation of neutrophil chemotaxis,BP,
17012,GO:0090024,1,0.97804455480412,0,3,negative regulation of neutrophil chemotaxis,BP,
17014,GO:0090026,1,0.923640430991837,0,15,positive regulation of monocyte chemotaxis,BP,
17016,GO:0090030,1,0.922545116870901,0,11,regulation of steroid hormone biosynthetic process,BP,
17017,GO:0090031,1,0.97922534650378,0,3,positive regulation of steroid hormone biosynthetic process,BP,
17018,GO:0090032,1,0.96618885865783,0,5,negative regulation of steroid hormone biosynthetic process,BP,
17019,GO:0090034,1,0.995957962710815,0,1,regulation of chaperone-mediated protein complex assembly,BP,
17020,GO:0090035,1,0.995957962710815,0,1,positive regulation of chaperone-mediated protein complex assembly,BP,
17021,GO:0090036,1,0.883619744334904,0,17,regulation of protein kinase C signaling,BP,
17022,GO:0090037,1,0.942189892589929,0,9,positive regulation of protein kinase C signaling,BP,
17023,GO:0090038,1,0.968799789186973,0,4,negative regulation of protein kinase C signaling,BP,
17024,GO:0090042,1,0.906968967977567,0,13,tubulin deacetylation,BP,
17025,GO:0090043,1,0.927353698666627,0,10,regulation of tubulin deacetylation,BP,
17026,GO:0090044,1,0.995957962710815,0,1,positive regulation of tubulin deacetylation,BP,
17027,GO:0090045,1,0.945660531671031,0,8,positive regulation of deacetylase activity,BP,
17028,GO:0090049,1,0.78281096677692,0,36,regulation of cell migration involved in sprouting angiogenesis,BP,
17029,GO:0090050,1,0.881789042329736,0,19,positive regulation of cell migration involved in sprouting angiogenesis,BP,
17030,GO:0090051,1,0.901225684479544,0,15,negative regulation of cell migration involved in sprouting angiogenesis,BP,
17031,GO:0090063,1,0.96359887691537,0,5,positive regulation of microtubule nucleation,BP,
17032,GO:0090065,1,0.988695274285722,0,2,regulation of production of siRNA involved in RNA interference,BP,
17034,GO:0090067,1,0.992336503430008,0,1,regulation of thalamus size,BP,
17036,GO:0090069,1,0.901751622797135,0,15,regulation of ribosome biogenesis,BP,
17037,GO:0090070,1,0.944377900221162,0,9,positive regulation of ribosome biogenesis,BP,
17038,GO:0090071,1,0.962577056201967,0,5,negative regulation of ribosome biogenesis,BP,
17039,GO:0090074,1,0.991537243903476,0,1,negative regulation of protein homodimerization activity,BP,
17040,GO:0090075,1,0.841911095545982,0,27,relaxation of muscle,BP,
17041,GO:0090076,1,0.98454359989782,0,2,relaxation of skeletal muscle,BP,
17042,GO:0090077,1,0.811542279877478,0,31,foam cell differentiation,BP,
17043,GO:0090079,1,0.537098691604052,0,100,translation regulator activity, nucleic acid binding,MF,
17044,GO:0090080,1,0.980778983884556,0,3,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17045,GO:0090081,1,0.9792309173857,0,4,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17046,GO:0090082,1,0.9792309173857,0,4,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17047,GO:0090083,1,0.902685227821181,0,15,regulation of inclusion body assembly,BP,
17048,GO:0090084,1,0.929890282213011,0,10,negative regulation of inclusion body assembly,BP,
17049,GO:0090085,1,0.932520420123337,0,11,regulation of protein deubiquitination,BP,
17050,GO:0090086,1,0.988417175411372,0,3,negative regulation of protein deubiquitination,BP,
17052,GO:0090088,1,0.989349630498951,0,2,regulation of oligopeptide transport,BP,
17053,GO:0090089,1,0.989349630498951,0,2,regulation of dipeptide transport,BP,
17055,GO:0090091,1,0.957921769420181,0,6,positive regulation of extracellular matrix disassembly,BP,
17057,GO:0090094,1,0.989575082478708,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17058,GO:0090095,1,0.994178054058743,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17059,GO:0090096,1,0.994178054058743,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17060,GO:0090100,1,0.494535169613593,0,102,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17064,GO:0090107,1,0.980564928028782,0,3,regulation of high-density lipoprotein particle assembly,BP,
17065,GO:0090108,1,0.984184286629045,0,2,positive regulation of high-density lipoprotein particle assembly,BP,
17067,GO:0090110,1,0.89510045721984,0,15,COPII-coated vesicle cargo loading,BP,
17068,GO:0090113,1,0.974404950177239,0,4,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17069,GO:0090114,1,0.623258858209193,0,71,COPII-coated vesicle budding,BP,
17070,GO:0090116,1,0.976993359383724,0,3,C-5 methylation of cytosine,BP,
17071,GO:0090118,1,0.954038462992462,0,6,receptor-mediated endocytosis involved in cholesterol transport,BP,
17072,GO:0090119,1,0.98744449896909,0,2,vesicle-mediated cholesterol transport,BP,
17073,GO:0090122,1,0.99506777997479,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17074,GO:0090128,1,0.905612549045554,0,13,regulation of synapse maturation,BP,
17075,GO:0090129,1,0.940100239522534,0,8,positive regulation of synapse maturation,BP,
17077,GO:0090131,1,0.974930381922143,0,5,mesenchyme migration,BP,
17079,GO:0090133,1,0.996625417482978,0,1,mesendoderm migration,BP,
17080,GO:0090134,1,0.996625417482978,0,1,cell migration involved in mesendoderm migration,BP,
17081,GO:0090135,1,0.981903585695058,0,3,actin filament branching,BP,
17083,GO:0090138,1,0.992510016232465,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
17084,GO:0090140,1,0.850726592241096,0,23,regulation of mitochondrial fission,BP,
17085,GO:0090141,1,0.904493297067703,0,15,positive regulation of mitochondrial fission,BP,
17086,GO:0090143,1,0.996811061737655,0,1,nucleoid organization,BP,
17087,GO:0090144,1,0.996811061737655,0,1,mitochondrial nucleoid organization,BP,
17088,GO:0090148,1,0.895121353299559,0,15,membrane fission,BP,
17089,GO:0090149,1,0.986645147896915,0,2,mitochondrial membrane fission,BP,
17091,GO:0090151,1,0.769854217501886,0,47,establishment of protein localization to mitochondrial membrane,BP,
17092,GO:0090152,1,0.992467903165036,0,1,establishment of protein localization to mitochondrial membrane involved in mitochondrial fission,BP,
17093,GO:0090153,1,0.907052440607595,0,16,regulation of sphingolipid biosynthetic process,BP,
17094,GO:0090154,1,0.944233651547082,0,9,positive regulation of sphingolipid biosynthetic process,BP,
17095,GO:0090155,1,0.964388785664397,0,6,negative regulation of sphingolipid biosynthetic process,BP,
17096,GO:0090156,1,0.970661194811626,0,5,cellular sphingolipid homeostasis,BP,
17097,GO:0090158,1,0.970770296422835,0,5,endoplasmic reticulum membrane organization,BP,
17098,GO:0090160,1,0.941596586410665,0,9,Golgi to lysosome transport,BP,
17099,GO:0090161,1,0.895387016524956,0,14,Golgi ribbon formation,BP,
17100,GO:0090162,1,0.806839852292271,0,30,establishment of epithelial cell polarity,BP,
17101,GO:0090164,1,0.984202269836947,0,2,asymmetric Golgi ribbon formation,BP,
17102,GO:0090166,1,0.958945281658293,0,7,Golgi disassembly,BP,
17103,GO:0090168,1,0.974644907375337,0,4,Golgi reassembly,BP,
17104,GO:0090169,1,0.850967620518353,0,24,regulation of spindle assembly,BP,
17105,GO:0090170,1,0.977434243691205,0,4,regulation of Golgi inheritance,BP,
17106,GO:0090171,1,0.992487864654582,0,1,chondrocyte morphogenesis,BP,
17107,GO:0090174,1,0.535453882984233,0,97,organelle membrane fusion,BP,
17109,GO:0090176,1,0.977328068108483,0,3,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17111,GO:0090178,1,0.900327471823458,0,14,regulation of establishment of planar polarity involved in neural tube closure,BP,
17112,GO:0090179,1,0.907310741491325,0,13,planar cell polarity pathway involved in neural tube closure,BP,
17113,GO:0090181,1,0.689859471354158,0,56,regulation of cholesterol metabolic process,BP,
17114,GO:0090182,1,0.990979166549053,0,2,regulation of secretion of lysosomal enzymes,BP,
17117,GO:0090185,1,0.917721800302221,0,14,negative regulation of kidney development,BP,
17118,GO:0090186,1,0.967129328806917,0,5,regulation of pancreatic juice secretion,BP,
17119,GO:0090187,1,0.994929099003046,0,1,positive regulation of pancreatic juice secretion,BP,
17120,GO:0090188,1,0.972059971340786,0,4,negative regulation of pancreatic juice secretion,BP,
17123,GO:0090191,1,0.990575449290622,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
17124,GO:0090192,1,0.924496119259774,0,12,regulation of glomerulus development,BP,
17125,GO:0090193,1,0.942325097523903,0,9,positive regulation of glomerulus development,BP,
17126,GO:0090194,1,0.981091157468328,0,3,negative regulation of glomerulus development,BP,
17127,GO:0090199,1,0.775237414856632,0,46,regulation of release of cytochrome c from mitochondria,BP,
17128,GO:0090200,1,0.866225092109304,0,27,positive regulation of release of cytochrome c from mitochondria,BP,
17129,GO:0090201,1,0.89413823468567,0,19,negative regulation of release of cytochrome c from mitochondria,BP,
17130,GO:0090202,1,0.97453979913866,0,4,gene looping,BP,
17131,GO:0090204,1,0.983897056610571,0,3,protein localization to nuclear pore,BP,
17132,GO:0090205,1,0.945276750704142,0,8,positive regulation of cholesterol metabolic process,BP,
17133,GO:0090206,1,0.974174919482863,0,5,negative regulation of cholesterol metabolic process,BP,
17134,GO:0090207,1,0.826460757480422,0,31,regulation of triglyceride metabolic process,BP,
17135,GO:0090208,1,0.895688931120516,0,19,positive regulation of triglyceride metabolic process,BP,
17136,GO:0090209,1,0.951526456121865,0,7,negative regulation of triglyceride metabolic process,BP,
17137,GO:0090210,1,0.978507648748749,0,3,regulation of establishment of blood-brain barrier,BP,
17138,GO:0090212,1,0.986027758567727,0,2,negative regulation of establishment of blood-brain barrier,BP,
17139,GO:0090214,1,0.987178868619586,0,2,spongiotrophoblast layer developmental growth,BP,
17140,GO:0090215,1,0.992519829229105,0,1,regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity,BP,
17141,GO:0090216,1,0.992519829229105,0,1,positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity,BP,
17143,GO:0090219,1,0.979258642451953,0,3,negative regulation of lipid kinase activity,BP,
17144,GO:0090220,1,0.950855269832969,0,7,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17145,GO:0090222,1,0.981770545608964,0,2,centrosome-templated microtubule nucleation,BP,
17146,GO:0090224,1,0.770197262937067,0,38,regulation of spindle organization,BP,
17147,GO:0090226,1,0.996753980183996,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
17148,GO:0090230,1,0.97002723951225,0,4,regulation of centromere complex assembly,BP,
17149,GO:0090231,1,0.915595895852634,0,14,regulation of spindle checkpoint,BP,
17150,GO:0090232,1,0.95587318961737,0,7,positive regulation of spindle checkpoint,BP,
17151,GO:0090233,1,0.99343209438584,0,1,negative regulation of spindle checkpoint,BP,
17152,GO:0090234,1,0.977617739379357,0,3,regulation of kinetochore assembly,BP,
17153,GO:0090235,1,0.940038300823931,0,8,regulation of metaphase plate congression,BP,
17154,GO:0090237,1,0.963278098679661,0,6,regulation of arachidonic acid secretion,BP,
17155,GO:0090238,1,0.970926442719078,0,5,positive regulation of arachidonic acid secretion,BP,
17156,GO:0090239,1,0.918082588095677,0,14,regulation of histone H4 acetylation,BP,
17157,GO:0090240,1,0.96000787022369,0,7,positive regulation of histone H4 acetylation,BP,
17158,GO:0090241,1,0.966787798381759,0,6,negative regulation of histone H4 acetylation,BP,
17159,GO:0090242,1,0.992654361513219,0,1,retinoic acid receptor signaling pathway involved in somitogenesis,BP,
17160,GO:0090244,1,0.972718170555223,0,4,Wnt signaling pathway involved in somitogenesis,BP,
17161,GO:0090245,1,0.966804530492441,0,4,axis elongation involved in somitogenesis,BP,
17162,GO:0090246,1,0.992362313737938,0,1,convergent extension involved in somitogenesis,BP,
17163,GO:0090247,1,0.993623003692494,0,1,cell motility involved in somitogenic axis elongation,BP,
17164,GO:0090249,1,0.993623003692494,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17165,GO:0090251,1,0.988721348701948,0,1,protein localization involved in establishment of planar polarity,BP,
17166,GO:0090257,1,0.238410369353231,0,213,regulation of muscle system process,BP,
17167,GO:0090258,1,0.97348912492893,0,4,negative regulation of mitochondrial fission,BP,
17168,GO:0090259,1,0.964304735400551,0,5,regulation of retinal ganglion cell axon guidance,BP,
17169,GO:0090260,1,0.984673864336456,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17170,GO:0090261,1,0.98052680695453,0,4,positive regulation of inclusion body assembly,BP,
17172,GO:0090264,1,0.985226085935349,0,3,regulation of immune complex clearance by monocytes and macrophages,BP,
17173,GO:0090265,1,0.989229300900307,0,2,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17174,GO:0090266,1,0.915595895852634,0,14,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17175,GO:0090267,1,0.95587318961737,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17176,GO:0090269,1,0.945306119424164,0,8,fibroblast growth factor production,BP,
17177,GO:0090270,1,0.945306119424164,0,8,regulation of fibroblast growth factor production,BP,
17178,GO:0090271,1,0.964148511823276,0,5,positive regulation of fibroblast growth factor production,BP,
17179,GO:0090272,1,0.980464165571182,0,3,negative regulation of fibroblast growth factor production,BP,
17180,GO:0090273,1,0.986033931417575,0,2,regulation of somatostatin secretion,BP,
17181,GO:0090274,1,0.992730335419945,0,1,positive regulation of somatostatin secretion,BP,
17182,GO:0090275,1,0.99325505912211,0,1,negative regulation of somatostatin secretion,BP,
17185,GO:0090278,1,0.786330639048493,0,39,negative regulation of peptide hormone secretion,BP,
17186,GO:0090279,1,0.806479368909628,0,34,regulation of calcium ion import,BP,
17187,GO:0090280,1,0.891528159541064,0,18,positive regulation of calcium ion import,BP,
17188,GO:0090281,1,0.977627206955742,0,5,negative regulation of calcium ion import,BP,
17189,GO:0090282,1,0.992881566806306,0,1,positive regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
17190,GO:0090283,1,0.979918397794195,0,3,regulation of protein glycosylation in Golgi,BP,
17191,GO:0090284,1,0.990894022430283,0,1,positive regulation of protein glycosylation in Golgi,BP,
17192,GO:0090285,1,0.988924540799065,0,2,negative regulation of protein glycosylation in Golgi,BP,
17196,GO:0090290,1,0.996629438717017,0,1,positive regulation of osteoclast proliferation,BP,
17198,GO:0090292,1,0.970550440704749,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17199,GO:0090293,1,0.994728818783657,0,1,nitrogen catabolite regulation of transcription,BP,
17200,GO:0090294,1,0.994728818783657,0,1,nitrogen catabolite activation of transcription,BP,
17201,GO:0090296,1,0.9739158461965,0,4,regulation of mitochondrial DNA replication,BP,
17202,GO:0090297,1,0.996412808538561,0,1,positive regulation of mitochondrial DNA replication,BP,
17203,GO:0090298,1,0.984801510423947,0,2,negative regulation of mitochondrial DNA replication,BP,
17204,GO:0090299,1,0.995850606966582,0,1,regulation of neural crest formation,BP,
17205,GO:0090301,1,0.995850606966582,0,1,negative regulation of neural crest formation,BP,
17206,GO:0090303,1,0.720664534870244,0,51,positive regulation of wound healing,BP,
17209,GO:0090306,1,0.970873541738556,0,4,spindle assembly involved in meiosis,BP,
17210,GO:0090307,1,0.66964458575009,0,59,mitotic spindle assembly,BP,
17211,GO:0090308,1,0.920069185741027,0,11,regulation of DNA methylation-dependent heterochromatin assembly,BP,
17212,GO:0090309,1,0.936066125581639,0,9,positive regulation of DNA methylation-dependent heterochromatin assembly,BP,
17213,GO:0090310,1,0.982921865146668,0,2,negative regulation of DNA methylation-dependent heterochromatin assembly,BP,
17214,GO:0090311,1,0.743855640911136,0,42,regulation of protein deacetylation,BP,
17215,GO:0090312,1,0.868787181524564,0,20,positive regulation of protein deacetylation,BP,
17218,GO:0090315,1,0.968363803529416,0,5,negative regulation of protein targeting to membrane,BP,
17222,GO:0090323,1,0.99684265558581,0,1,prostaglandin secretion involved in immune response,BP,
17223,GO:0090324,1,0.961640463434422,0,6,negative regulation of oxidative phosphorylation,BP,
17224,GO:0090325,1,0.974773426357402,0,4,regulation of locomotion involved in locomotory behavior,BP,
17225,GO:0090326,1,0.992642060559616,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17226,GO:0090327,1,0.992442165171856,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17227,GO:0090329,1,0.718586494898041,0,50,regulation of DNA-dependent DNA replication,BP,
17228,GO:0090330,1,0.868277848070608,0,20,regulation of platelet aggregation,BP,
17229,GO:0090331,1,0.922142144088768,0,12,negative regulation of platelet aggregation,BP,
17230,GO:0090335,1,0.845119312662333,0,23,regulation of brown fat cell differentiation,BP,
17231,GO:0090336,1,0.890359116455264,0,16,positive regulation of brown fat cell differentiation,BP,
17232,GO:0090340,1,0.994929099003046,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17233,GO:0090341,1,0.996030141837984,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17234,GO:0090342,1,0.741733237062849,0,46,regulation of cell aging,BP,
17235,GO:0090343,1,0.930213407748054,0,14,positive regulation of cell aging,BP,
17236,GO:0090344,1,0.850527639676733,0,23,negative regulation of cell aging,BP,
17237,GO:0090345,1,0.989826982946246,0,2,cellular organohalogen metabolic process,BP,
17238,GO:0090346,1,0.989826982946246,0,2,cellular organofluorine metabolic process,BP,
17239,GO:0090347,1,0.995988653036494,0,1,regulation of cellular organohalogen metabolic process,BP,
17240,GO:0090348,1,0.995988653036494,0,1,regulation of cellular organofluorine metabolic process,BP,
17241,GO:0090349,1,0.995988653036494,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17242,GO:0090350,1,0.995988653036494,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17243,GO:0090357,1,0.996439731715527,0,1,regulation of tryptophan metabolic process,BP,
17244,GO:0090360,1,0.982234890633812,0,3,platelet-derived growth factor production,BP,
17245,GO:0090361,1,0.982234890633812,0,3,regulation of platelet-derived growth factor production,BP,
17246,GO:0090362,1,0.987229136648958,0,2,positive regulation of platelet-derived growth factor production,BP,
17247,GO:0090370,1,0.971283608903912,0,4,negative regulation of cholesterol efflux,BP,
17248,GO:0090381,1,0.955952687829963,0,7,regulation of heart induction,BP,
17249,GO:0090382,1,0.761880636920675,0,46,phagosome maturation,BP,
17250,GO:0090383,1,0.862249447505954,0,27,phagosome acidification,BP,
17251,GO:0090384,1,0.995338722526488,0,1,phagosome-lysosome docking,BP,
17252,GO:0090385,1,0.950642884921177,0,9,phagosome-lysosome fusion,BP,
17253,GO:0090386,1,0.983134958412599,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
17254,GO:0090387,1,0.983134958412599,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
17255,GO:0090389,1,0.990671743829371,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17256,GO:0090394,1,0.923665675161021,0,11,negative regulation of excitatory postsynaptic potential,BP,
17257,GO:0090398,1,0.661218782757993,0,64,cellular senescence,BP,
17258,GO:0090399,1,0.911811543567497,0,13,replicative senescence,BP,
17259,GO:0090400,1,0.94754129448315,0,8,stress-induced premature senescence,BP,
17260,GO:0090402,1,0.988348196188972,0,2,oncogene-induced cell senescence,BP,
17261,GO:0090403,1,0.972138087407305,0,4,oxidative stress-induced premature senescence,BP,
17263,GO:0090409,1,0.994365610802903,0,1,malonyl-CoA synthetase activity,MF,
17264,GO:0090410,1,0.994365610802903,0,1,malonate catabolic process,BP,
17265,GO:0090416,1,0.993682281764436,0,1,nicotinate transmembrane transporter activity,MF,
17266,GO:0090420,1,0.99626173993583,0,1,naphthalene-containing compound metabolic process,BP,
17267,GO:0090422,1,0.989411586678564,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
17268,GO:0090425,1,0.992825158104098,0,1,acinar cell differentiation,BP,
17269,GO:0090427,1,0.981120787769285,0,3,activation of meiosis,BP,
17270,GO:0090429,1,0.995871794058111,0,1,detection of endogenous biotic stimulus,BP,
17271,GO:0090435,1,0.951784091075179,0,8,protein localization to nuclear envelope,BP,
17272,GO:0090443,1,0.977868313596525,0,3,FAR/SIN/STRIPAK complex,CC,
17273,GO:0090461,1,0.968307602479545,0,4,glutamate homeostasis,BP,
17274,GO:0090472,1,0.992436582510968,0,1,dibasic protein processing,BP,
17275,GO:0090480,1,0.992698457281054,0,1,purine nucleotide-sugar transmembrane transport,BP,
17276,GO:0090481,1,0.937744652876411,0,11,pyrimidine nucleotide-sugar transmembrane transport,BP,
17277,GO:0090482,1,0.837637732743114,0,27,vitamin transmembrane transporter activity,MF,
17278,GO:0090486,1,0.99325505912211,0,1,small RNA 2'-O-methyltransferase,MF,
17279,GO:0090493,1,0.909634540624554,0,17,catecholamine uptake,BP,
17280,GO:0090494,1,0.913699087712649,0,16,dopamine uptake,BP,
17281,GO:0090498,1,0.971828325851478,0,4,extrinsic component of Golgi membrane,CC,
17282,GO:0090500,1,0.97820961649609,0,4,endocardial cushion to mesenchymal transition,BP,
17283,GO:0090501,1,0.408490363529609,0,144,RNA phosphodiester bond hydrolysis,BP,
17284,GO:0090502,1,0.622928882328767,0,75,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
17285,GO:0090503,1,0.765899252532035,0,42,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17286,GO:0090504,1,0.818147135345925,0,28,epiboly,BP,
17287,GO:0090505,1,0.827325128691772,0,27,epiboly involved in wound healing,BP,
17288,GO:0090520,1,0.931588041934194,0,11,sphingolipid mediated signaling pathway,BP,
17290,GO:0090522,1,0.993029021720516,0,1,vesicle tethering involved in exocytosis,BP,
17291,GO:0090527,1,0.931808711265412,0,10,actin filament reorganization,BP,
17292,GO:0090529,1,0.995466792250196,0,1,cell septum assembly,BP,
17293,GO:0090533,1,0.897758910092232,0,18,cation-transporting ATPase complex,CC,
17294,GO:0090534,1,0.995760941551611,0,1,calcium ion-transporting ATPase complex,CC,
17295,GO:0090537,1,0.984310868858174,0,2,CERF complex,CC,
17296,GO:0090541,1,0.98569362437319,0,2,MIT domain binding,MF,
17297,GO:0090543,1,0.807494514171262,0,30,Flemming body,CC,
17298,GO:0090545,1,0.892395737893003,0,15,CHD-type complex,CC,
17299,GO:0090554,1,0.958583918485556,0,5,phosphatidylcholine floppase activity,MF,
17300,GO:0090555,1,0.983088838605024,0,2,phosphatidylethanolamine flippase activity,MF,
17301,GO:0090556,1,0.980405034088008,0,2,phosphatidylserine floppase activity,MF,
17302,GO:0090557,1,0.92179727831912,0,10,establishment of endothelial intestinal barrier,BP,
17304,GO:0090560,1,0.994709412589711,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17305,GO:0090571,1,0.966270262450871,0,6,RNA polymerase II transcription repressor complex,CC,
17306,GO:0090575,1,0.372710222627719,0,152,RNA polymerase II transcription regulator complex,CC,
17307,GO:0090576,1,0.937882184161943,0,9,RNA polymerase III transcription regulator complex,CC,
17308,GO:0090579,1,0.97453979913866,0,4,dsDNA loop formation,BP,
17309,GO:0090594,1,0.931571720679729,0,13,inflammatory response to wounding,BP,
17311,GO:0090598,1,0.976832678993152,0,4,male anatomical structure morphogenesis,BP,
17312,GO:0090599,1,0.96016685428354,0,5,alpha-glucosidase activity,MF,
17313,GO:0090600,1,0.992479679234636,0,1,alpha-1,3-glucosidase activity,MF,
17314,GO:0090601,1,0.992064186951491,0,1,enucleation,BP,
17315,GO:0090611,1,0.970749925987499,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17316,GO:0090615,1,0.987652113479395,0,2,mitochondrial mRNA processing,BP,
17317,GO:0090616,1,0.99231431172358,0,1,mitochondrial mRNA 3'-end processing,BP,
17318,GO:0090618,1,0.983698753556435,0,2,DNA clamp unloading,BP,
17319,GO:0090624,1,0.986555151512788,0,2,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17320,GO:0090625,1,0.99325505912211,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17321,GO:0090630,1,0.499305475110306,0,95,activation of GTPase activity,BP,
17322,GO:0090634,1,0.985258393005457,0,3,microglial cell mediated cytotoxicity,BP,
17323,GO:0090646,1,0.931588150980878,0,12,mitochondrial tRNA processing,BP,
17324,GO:0090647,1,0.950127237910107,0,8,modulation of age-related behavioral decline,BP,
17325,GO:0090648,1,0.99145440663405,0,1,response to environmental enrichment,BP,
17326,GO:0090649,1,0.937125417772204,0,10,response to oxygen-glucose deprivation,BP,
17327,GO:0090650,1,0.944206150385733,0,8,cellular response to oxygen-glucose deprivation,BP,
17328,GO:0090651,1,0.980940220406176,0,3,apical cytoplasm,CC,
17329,GO:0090656,1,0.902469355276824,0,14,t-circle formation,BP,
17330,GO:0090657,1,0.929747742174404,0,10,telomeric loop disassembly,BP,
17332,GO:0090660,1,0.97584107966123,0,4,cerebrospinal fluid circulation,BP,
17333,GO:0090661,1,0.983910485268586,0,4,box H/ACA telomerase RNP complex,CC,
17334,GO:0090663,1,0.992942506836296,0,2,galanin-activated signaling pathway,BP,
17336,GO:0090666,1,0.972859843119461,0,5,scaRNA localization to Cajal body,BP,
17337,GO:0090667,1,0.990553255023901,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
17338,GO:0090668,1,0.990553255023901,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
17339,GO:0090669,1,0.974885332642388,0,4,telomerase RNA stabilization,BP,
17340,GO:0090670,1,0.899613721516429,0,19,RNA localization to Cajal body,BP,
17341,GO:0090671,1,0.899613721516429,0,19,telomerase RNA localization to Cajal body,BP,
17342,GO:0090672,1,0.899613721516429,0,19,telomerase RNA localization,BP,
17343,GO:0090673,1,0.96633567057037,0,5,endothelial cell-matrix adhesion,BP,
17344,GO:0090674,1,0.975271891285259,0,4,endothelial cell-matrix adhesion via fibronectin,BP,
17345,GO:0090675,1,0.992426318130508,0,1,intermicrovillar adhesion,BP,
17346,GO:0090677,1,0.969778144605611,0,5,reversible differentiation,BP,
17347,GO:0090678,1,0.988540300431572,0,2,cell dedifferentiation involved in phenotypic switching,BP,
17348,GO:0090679,1,0.98102255472986,0,3,cell differentiation involved in phenotypic switching,BP,
17349,GO:0090685,1,0.899613721516429,0,19,RNA localization to nucleus,BP,
17350,GO:0090694,1,0.98267882979106,0,2,Scc2-Scc4 cohesin loading complex,CC,
17351,GO:0090713,1,0.93538413151569,0,11,immunological memory process,BP,
17352,GO:0090715,1,0.946780772222156,0,8,immunological memory formation process,BP,
17353,GO:0090716,1,0.987969431978205,0,3,adaptive immune memory response,BP,
17354,GO:0090720,1,0.989864071187073,0,1,primary adaptive immune response,BP,
17355,GO:0090721,1,0.989864071187073,0,1,primary adaptive immune response involving T cells and B cells,BP,
17356,GO:0090722,1,0.976229079846856,0,4,receptor-receptor interaction,MF,
17357,GO:0090724,1,0.975069876313559,0,4,central region of growth cone,CC,
17358,GO:0090725,1,0.996725737755439,0,1,peripheral region of growth cone,CC,
17359,GO:0090730,1,0.993969485913662,0,1,Las1 complex,CC,
17360,GO:0090731,1,0.996514293846025,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17361,GO:0090734,1,0.626929056438262,0,68,site of DNA damage,CC,
17362,GO:0090735,1,0.966005155995673,0,6,DNA repair complex assembly,BP,
17363,GO:0090737,1,0.902469355276824,0,14,telomere maintenance via telomere trimming,BP,
17365,GO:0095500,1,0.860689514599707,0,25,acetylcholine receptor signaling pathway,BP,
17367,GO:0097003,1,0.98728322419076,0,2,adipokinetic hormone receptor activity,MF,
17368,GO:0097006,1,0.616215392117439,0,77,regulation of plasma lipoprotein particle levels,BP,
17369,GO:0097009,1,0.785447611318139,0,35,energy homeostasis,BP,
17370,GO:0097010,1,0.978434695163666,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17371,GO:0097011,1,0.948719714433473,0,8,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
17372,GO:0097012,1,0.948719714433473,0,8,response to granulocyte macrophage colony-stimulating factor,BP,
17373,GO:0097013,1,0.980405814992109,0,4,phagocytic vesicle lumen,CC,
17375,GO:0097016,1,0.977768788863903,0,4,L27 domain binding,MF,
17376,GO:0097017,1,0.987178012610772,0,2,renal protein absorption,BP,
17377,GO:0097018,1,0.993818551343362,0,1,renal albumin absorption,BP,
17378,GO:0097020,1,0.992603608922999,0,1,COPII adaptor activity,MF,
17379,GO:0097021,1,0.960438292151814,0,6,lymphocyte migration into lymphoid organs,BP,
17380,GO:0097022,1,0.983993711402528,0,2,lymphocyte migration into lymph node,BP,
17381,GO:0097025,1,0.969974462862851,0,5,MPP7-DLG1-LIN7 complex,CC,
17382,GO:0097026,1,0.978792865279037,0,4,dendritic cell dendrite assembly,BP,
17383,GO:0097027,1,0.954134117339916,0,8,ubiquitin-protein transferase activator activity,MF,
17384,GO:0097028,1,0.796314135730723,0,41,dendritic cell differentiation,BP,
17385,GO:0097029,1,0.981338518214738,0,4,mature conventional dendritic cell differentiation,BP,
17387,GO:0097036,1,0.996214297604249,0,1,regulation of plasma membrane sterol distribution,BP,
17388,GO:0097037,1,0.981981145518072,0,3,heme export,BP,
17389,GO:0097038,1,0.868510789529667,0,20,perinuclear endoplasmic reticulum,CC,
17390,GO:0097039,1,0.97201602141468,0,4,protein linear polyubiquitination,BP,
17391,GO:0097045,1,0.992240093194178,0,1,phosphatidylserine exposure on blood platelet,BP,
17392,GO:0097048,1,0.937854554410806,0,11,dendritic cell apoptotic process,BP,
17394,GO:0097050,1,0.931108020415149,0,10,type B pancreatic cell apoptotic process,BP,
17395,GO:0097051,1,0.97569013105569,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17396,GO:0097052,1,0.971022975689272,0,5,L-kynurenine metabolic process,BP,
17397,GO:0097053,1,0.99009666850319,0,2,L-kynurenine catabolic process,BP,
17398,GO:0097055,1,0.987892874297563,0,2,agmatine biosynthetic process,BP,
17399,GO:0097056,1,0.982582682418348,0,3,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17400,GO:0097057,1,0.991085439999475,0,2,TRAF2-GSTP1 complex,CC,
17402,GO:0097059,1,0.990741587458864,0,2,CNTFR-CLCF1 complex,CC,
17404,GO:0097061,1,0.549087472463499,0,79,dendritic spine organization,BP,
17405,GO:0097062,1,0.879598469062009,0,18,dendritic spine maintenance,BP,
17406,GO:0097064,1,0.787401359376895,0,35,ncRNA export from nucleus,BP,
17407,GO:0097065,1,0.959493803829859,0,6,anterior head development,BP,
17408,GO:0097066,1,0.856691799111294,0,23,response to thyroid hormone,BP,
17409,GO:0097067,1,0.892789611472815,0,16,cellular response to thyroid hormone stimulus,BP,
17410,GO:0097068,1,0.970928308795112,0,4,response to thyroxine,BP,
17411,GO:0097069,1,0.985372081326104,0,2,cellular response to thyroxine stimulus,BP,
17412,GO:0097070,1,0.963484025848165,0,5,ductus arteriosus closure,BP,
17413,GO:0097079,1,0.992681400907057,0,1,selenite:proton symporter activity,MF,
17414,GO:0097080,1,0.992681400907057,0,1,plasma membrane selenite transport,BP,
17415,GO:0097084,1,0.945377613190187,0,9,vascular associated smooth muscle cell development,BP,
17416,GO:0097086,1,0.99251142507962,0,1,amniotic stem cell differentiation,BP,
17417,GO:0097089,1,0.985227496560467,0,3,methyl-branched fatty acid metabolic process,BP,
17419,GO:0097091,1,0.880761344461628,0,16,synaptic vesicle clustering,BP,
17420,GO:0097094,1,0.899280680474464,0,15,craniofacial suture morphogenesis,BP,
17421,GO:0097100,1,0.970924356755962,0,5,supercoiled DNA binding,MF,
17422,GO:0097101,1,0.980811624474848,0,3,blood vessel endothelial cell fate specification,BP,
17423,GO:0097102,1,0.986547237800793,0,2,endothelial tip cell fate specification,BP,
17424,GO:0097104,1,0.906359848579578,0,12,postsynaptic membrane assembly,BP,
17425,GO:0097105,1,0.923662242675073,0,10,presynaptic membrane assembly,BP,
17426,GO:0097106,1,0.774918906128254,0,32,postsynaptic density organization,BP,
17427,GO:0097107,1,0.866806266360103,0,18,postsynaptic density assembly,BP,
17428,GO:0097108,1,0.975768225329224,0,3,hedgehog family protein binding,MF,
17429,GO:0097109,1,0.961770909618228,0,5,neuroligin family protein binding,MF,
17430,GO:0097110,1,0.65071969043518,0,60,scaffold protein binding,MF,
17431,GO:0097111,1,0.982515845116252,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17432,GO:0097112,1,0.969394661354578,0,4,gamma-aminobutyric acid receptor clustering,BP,
17433,GO:0097113,1,0.932632611992699,0,9,AMPA glutamate receptor clustering,BP,
17434,GO:0097114,1,0.968610472914272,0,4,NMDA glutamate receptor clustering,BP,
17435,GO:0097115,1,0.992179920376533,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17436,GO:0097116,1,0.973651290931261,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17437,GO:0097117,1,0.990939821953302,0,1,guanylate kinase-associated protein clustering,BP,
17438,GO:0097118,1,0.965060040521485,0,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,
17439,GO:0097119,1,0.929048639914947,0,9,postsynaptic density protein 95 clustering,BP,
17441,GO:0097123,1,0.989846814342307,0,2,cyclin A1-CDK2 complex,CC,
17442,GO:0097124,1,0.979405293137458,0,4,cyclin A2-CDK2 complex,CC,
17443,GO:0097125,1,0.990586756312094,0,2,cyclin B1-CDK1 complex,CC,
17444,GO:0097129,1,0.992642526002834,0,2,cyclin D2-CDK4 complex,CC,
17445,GO:0097132,1,0.98860080533616,0,1,cyclin D2-CDK6 complex,CC,
17446,GO:0097134,1,0.983324762872933,0,3,cyclin E1-CDK2 complex,CC,
17447,GO:0097135,1,0.987851858314198,0,2,cyclin E2-CDK2 complex,CC,
17448,GO:0097136,1,0.963072713960346,0,6,Bcl-2 family protein complex,CC,
17449,GO:0097144,1,0.996762136804637,0,1,BAX complex,CC,
17450,GO:0097145,1,0.991394154600123,0,2,BAK complex,CC,
17451,GO:0097149,1,0.977822856045634,0,3,centralspindlin complex,CC,
17452,GO:0097150,1,0.831974695334993,0,23,neuronal stem cell population maintenance,BP,
17453,GO:0097151,1,0.944417548408506,0,7,positive regulation of inhibitory postsynaptic potential,BP,
17454,GO:0097152,1,0.92854749191951,0,12,mesenchymal cell apoptotic process,BP,
17455,GO:0097153,1,0.93644006663786,0,13,cysteine-type endopeptidase activity involved in apoptotic process,MF,
17457,GO:0097155,1,0.972980505888262,0,3,fasciculation of sensory neuron axon,BP,
17458,GO:0097156,1,0.983876061007762,0,2,fasciculation of motor neuron axon,BP,
17459,GO:0097157,1,0.924375406558289,0,12,pre-mRNA intronic binding,MF,
17460,GO:0097158,1,0.991129559101623,0,2,pre-mRNA intronic pyrimidine-rich binding,MF,
17462,GO:0097161,1,0.991388821048341,0,1,DH domain binding,MF,
17463,GO:0097162,1,0.9926531008435,0,1,MADS box domain binding,MF,
17464,GO:0097163,1,0.996050396343886,0,1,sulfur carrier activity,MF,
17465,GO:0097164,1,0.847926076369518,0,24,ammonium ion metabolic process,BP,
17466,GO:0097165,1,0.96180050625791,0,6,nuclear stress granule,CC,
17467,GO:0097166,1,0.985315001263615,0,2,lens epithelial cell proliferation,BP,
17468,GO:0097167,1,0.974485788745618,0,4,circadian regulation of translation,BP,
17469,GO:0097168,1,0.974338167270414,0,5,mesenchymal stem cell proliferation,BP,
17470,GO:0097169,1,0.985897954934104,0,4,AIM2 inflammasome complex,CC,
17471,GO:0097176,1,0.973985553157424,0,5,epoxide metabolic process,BP,
17472,GO:0097177,1,0.981779232456556,0,4,mitochondrial ribosome binding,MF,
17473,GO:0097178,1,0.780468933131053,0,39,ruffle assembly,BP,
17474,GO:0097179,1,0.983682978615432,0,4,protease inhibitor complex,CC,
17475,GO:0097180,1,0.990206886214801,0,2,serine protease inhibitor complex,CC,
17476,GO:0097181,1,0.994303650955748,0,1,protein C inhibitor-coagulation factor V complex,CC,
17477,GO:0097182,1,0.994303650955748,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
17478,GO:0097183,1,0.994303650955748,0,1,protein C inhibitor-coagulation factor XI complex,CC,
17479,GO:0097186,1,0.887853583903723,0,17,amelogenesis,BP,
17480,GO:0097187,1,0.959548114503027,0,6,dentinogenesis,BP,
17481,GO:0097188,1,0.993642250670861,0,1,dentin mineralization,BP,
17487,GO:0097195,1,0.981969469851628,0,3,pilomotor reflex,BP,
17488,GO:0097196,1,0.98853978205361,0,2,Shu complex,CC,
17489,GO:0097197,1,0.937492529279765,0,10,tetraspanin-enriched microdomain,CC,
17490,GO:0097198,1,0.959595192271876,0,5,histone H3-K36 trimethylation,BP,
17491,GO:0097199,1,0.952377557311323,0,9,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17492,GO:0097200,1,0.952558268492302,0,8,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
17493,GO:0097201,1,0.92729747985702,0,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17494,GO:0097202,1,0.908373911565799,0,15,activation of cysteine-type endopeptidase activity,BP,
17496,GO:0097208,1,0.967117520461072,0,6,alveolar lamellar body,CC,
17497,GO:0097209,1,0.974401821297884,0,4,epidermal lamellar body,CC,
17498,GO:0097210,1,0.968496476969765,0,5,response to gonadotropin-releasing hormone,BP,
17499,GO:0097211,1,0.968496476969765,0,5,cellular response to gonadotropin-releasing hormone,BP,
17500,GO:0097212,1,0.986554028336949,0,3,lysosomal membrane organization,BP,
17501,GO:0097213,1,0.991350738681113,0,2,regulation of lysosomal membrane permeability,BP,
17502,GO:0097214,1,0.996838257139271,0,1,positive regulation of lysosomal membrane permeability,BP,
17503,GO:0097222,1,0.99231431172358,0,1,mitochondrial mRNA polyadenylation,BP,
17504,GO:0097224,1,0.95671028170294,0,7,sperm connecting piece,CC,
17505,GO:0097225,1,0.875012125243581,0,22,sperm midpiece,CC,
17506,GO:0097227,1,0.991458937290796,0,1,sperm annulus,CC,
17507,GO:0097228,1,0.873956653215065,0,20,sperm principal piece,CC,
17508,GO:0097229,1,0.989632764868683,0,2,sperm end piece,CC,
17509,GO:0097232,1,0.983905022248929,0,2,lamellar body membrane,CC,
17510,GO:0097233,1,0.983905022248929,0,2,alveolar lamellar body membrane,CC,
17511,GO:0097237,1,0.573988491548313,0,105,cellular response to toxic substance,BP,
17512,GO:0097238,1,0.992972925893608,0,2,cellular response to methylglyoxal,BP,
17513,GO:0097240,1,0.988071832943591,0,2,chromosome attachment to the nuclear envelope,BP,
17514,GO:0097241,1,0.976679099530428,0,4,hematopoietic stem cell migration to bone marrow,BP,
17516,GO:0097243,1,0.991953267330792,0,2,flavonoid binding,MF,
17517,GO:0097250,1,0.977245532997297,0,6,mitochondrial respirasome assembly,BP,
17518,GO:0097252,1,0.97059109747353,0,4,oligodendrocyte apoptotic process,BP,
17519,GO:0097254,1,0.99481780378576,0,1,renal tubular secretion,BP,
17520,GO:0097255,1,0.977375963281578,0,5,R2TP complex,CC,
17522,GO:0097267,1,0.973452155630208,0,4,omega-hydroxylase P450 pathway,BP,
17523,GO:0097268,1,0.978282064465909,0,3,cytoophidium,CC,
17524,GO:0097272,1,0.98762988258586,0,2,ammonium homeostasis,BP,
17525,GO:0097273,1,0.991723360648217,0,1,creatinine homeostasis,BP,
17526,GO:0097274,1,0.98434637735923,0,2,urea homeostasis,BP,
17527,GO:0097275,1,0.991723360648217,0,1,cellular ammonium homeostasis,BP,
17528,GO:0097276,1,0.991723360648217,0,1,cellular creatinine homeostasis,BP,
17529,GO:0097277,1,0.991723360648217,0,1,cellular urea homeostasis,BP,
17530,GO:0097278,1,0.947805287299261,0,8,complement-dependent cytotoxicity,BP,
17531,GO:0097281,1,0.995871794058111,0,1,immune complex formation,BP,
17532,GO:0097283,1,0.970869340555095,0,5,keratinocyte apoptotic process,BP,
17533,GO:0097284,1,0.925172390382239,0,12,hepatocyte apoptotic process,BP,
17534,GO:0097291,1,0.995097661938063,0,1,renal phosphate ion absorption,BP,
17535,GO:0097296,1,0.973910616854203,0,4,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
17536,GO:0097298,1,0.992477156159595,0,1,regulation of nucleus size,BP,
17540,GO:0097309,1,0.986555151512788,0,2,cap1 mRNA methylation,BP,
17541,GO:0097310,1,0.99325505912211,0,1,cap2 mRNA methylation,BP,
17542,GO:0097320,1,0.884209943410336,0,18,plasma membrane tubulation,BP,
17543,GO:0097322,1,0.948591163898186,0,8,7SK snRNA binding,MF,
17544,GO:0097323,1,0.989278325567532,0,2,B cell adhesion,BP,
17545,GO:0097324,1,0.981987287754763,0,2,melanocyte migration,BP,
17546,GO:0097325,1,0.978272653038934,0,3,melanocyte proliferation,BP,
17547,GO:0097326,1,0.992049146936613,0,1,melanocyte adhesion,BP,
17548,GO:0097327,1,0.966226297693962,0,6,response to antineoplastic agent,BP,
17549,GO:0097332,1,0.989215934495059,0,2,response to antipsychotic drug,BP,
17550,GO:0097338,1,0.977496815033431,0,3,response to clozapine,BP,
17551,GO:0097340,1,0.942768380057319,0,10,inhibition of cysteine-type endopeptidase activity,BP,
17552,GO:0097341,1,0.942768380057319,0,10,zymogen inhibition,BP,
17553,GO:0097342,1,0.962133376790828,0,6,ripoptosome,CC,
17554,GO:0097343,1,0.975343709125292,0,3,ripoptosome assembly,BP,
17555,GO:0097344,1,0.988886330906667,0,2,Rix1 complex,CC,
17557,GO:0097346,1,0.860914932174931,0,25,INO80-type complex,CC,
17558,GO:0097350,1,0.967857256722769,0,5,neutrophil clearance,BP,
17559,GO:0097352,1,0.794318632102937,0,37,autophagosome maturation,BP,
17560,GO:0097354,1,0.935280091054748,0,10,prenylation,BP,
17561,GO:0097355,1,0.995896293794625,0,1,protein localization to heterochromatin,BP,
17562,GO:0097356,1,0.985583357145205,0,2,perinucleolar compartment,CC,
17563,GO:0097359,1,0.981229265076032,0,2,UDP-glucosylation,BP,
17565,GO:0097361,1,0.985024126108386,0,2,CIA complex,CC,
17566,GO:0097362,1,0.986466483065983,0,2,MCM8-MCM9 complex,CC,
17567,GO:0097363,1,0.978549539255841,0,3,protein O-GlcNAc transferase activity,MF,
17569,GO:0097368,1,0.963355728653426,0,5,establishment of Sertoli cell barrier,BP,
17570,GO:0097370,1,0.99325505912211,0,1,protein O-GlcNAcylation via threonine,BP,
17571,GO:0097371,1,0.949914276217978,0,7,MDM2/MDM4 family protein binding,MF,
17572,GO:0097372,1,0.995745180872483,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17573,GO:0097374,1,0.982281060813083,0,3,sensory neuron axon guidance,BP,
17574,GO:0097376,1,0.990604971381375,0,2,interneuron axon guidance,BP,
17575,GO:0097377,1,0.994344932008708,0,1,spinal cord interneuron axon guidance,BP,
17576,GO:0097378,1,0.994344932008708,0,1,dorsal spinal cord interneuron axon guidance,BP,
17577,GO:0097380,1,0.994344932008708,0,1,dorsal spinal cord interneuron anterior axon guidance,BP,
17578,GO:0097381,1,0.902084587926768,0,16,photoreceptor disc membrane,CC,
17579,GO:0097384,1,0.934459575406971,0,10,cellular lipid biosynthetic process,BP,
17581,GO:0097393,1,0.988852137285306,0,1,telomeric repeat-containing RNA transcription,BP,
17582,GO:0097394,1,0.988852137285306,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17583,GO:0097396,1,0.961487486472348,0,6,response to interleukin-17,BP,
17584,GO:0097398,1,0.961487486472348,0,6,cellular response to interleukin-17,BP,
17585,GO:0097400,1,0.961487486472348,0,6,interleukin-17-mediated signaling pathway,BP,
17586,GO:0097401,1,0.992925192127658,0,1,synaptic vesicle lumen acidification,BP,
17587,GO:0097402,1,0.984602903247797,0,2,neuroblast migration,BP,
17588,GO:0097403,1,0.992880400843032,0,1,cellular response to raffinose,BP,
17589,GO:0097409,1,0.995209498639171,0,1,glial cytoplasmic inclusion,CC,
17590,GO:0097411,1,0.965061275761904,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17591,GO:0097413,1,0.961394452215325,0,7,Lewy body,CC,
17592,GO:0097414,1,0.995209498639171,0,1,classical Lewy body,CC,
17593,GO:0097418,1,0.963433548069611,0,5,neurofibrillary tangle,CC,
17595,GO:0097422,1,0.966668085339294,0,5,tubular endosome,CC,
17596,GO:0097427,1,0.958656310786219,0,6,microtubule bundle,CC,
17597,GO:0097428,1,0.956325755615586,0,10,protein maturation by iron-sulfur cluster transfer,BP,
17598,GO:0097431,1,0.809881020424933,0,29,mitotic spindle pole,CC,
17599,GO:0097433,1,0.969513063655068,0,5,dense body,CC,
17602,GO:0097441,1,0.948507609937764,0,7,basal dendrite,CC,
17603,GO:0097442,1,0.975932041441594,0,3,CA3 pyramidal cell dendrite,CC,
17604,GO:0097443,1,0.955404505016832,0,6,sorting endosome,CC,
17605,GO:0097444,1,0.975407071483996,0,4,spine apparatus,CC,
17609,GO:0097451,1,0.984976695808571,0,2,glial limiting end-foot,CC,
17610,GO:0097452,1,0.984157581946006,0,3,GAIT complex,CC,
17612,GO:0097454,1,0.978565285018156,0,3,Schwann cell microvillus,CC,
17613,GO:0097457,1,0.965860535211376,0,4,hippocampal mossy fiber,CC,
17614,GO:0097462,1,0.995209498639171,0,1,Lewy neurite,CC,
17615,GO:0097466,1,0.971644394813235,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17616,GO:0097468,1,0.938731349939286,0,11,programmed cell death in response to reactive oxygen species,BP,
17617,GO:0097470,1,0.920947366196845,0,11,ribbon synapse,CC,
17619,GO:0097473,1,0.992003194016043,0,1,retinal rod cell apoptotic process,BP,
17620,GO:0097474,1,0.985678589184152,0,2,retinal cone cell apoptotic process,BP,
17621,GO:0097475,1,0.969010800740769,0,4,motor neuron migration,BP,
17622,GO:0097476,1,0.98231291703033,0,2,spinal cord motor neuron migration,BP,
17623,GO:0097477,1,0.98231291703033,0,2,lateral motor column neuron migration,BP,
17624,GO:0097479,1,0.676267204054428,0,55,synaptic vesicle localization,BP,
17625,GO:0097484,1,0.796005536019831,0,33,dendrite extension,BP,
17627,GO:0097486,1,0.98181943785286,0,5,multivesicular body lumen,CC,
17630,GO:0097490,1,0.970469740489098,0,4,sympathetic neuron projection extension,BP,
17631,GO:0097491,1,0.970469740489098,0,4,sympathetic neuron projection guidance,BP,
17632,GO:0097493,1,0.895781283666277,0,11,structural molecule activity conferring elasticity,MF,
17633,GO:0097494,1,0.947298077195175,0,9,regulation of vesicle size,BP,
17634,GO:0097497,1,0.992741259400488,0,1,blood vessel endothelial cell delamination,BP,
17635,GO:0097498,1,0.987009282960076,0,2,endothelial tube lumen extension,BP,
17636,GO:0097499,1,0.926064039616913,0,11,protein localization to non-motile cilium,BP,
17637,GO:0097500,1,0.970038445272194,0,4,receptor localization to non-motile cilium,BP,
17638,GO:0097501,1,0.947488172387931,0,13,stress response to metal ion,BP,
17639,GO:0097502,1,0.808191546655672,0,33,mannosylation,BP,
17640,GO:0097503,1,0.875479392309024,0,20,sialylation,BP,
17641,GO:0097504,1,0.928526039287684,0,12,Gemini of coiled bodies,CC,
17642,GO:0097505,1,0.991738248330923,0,1,Rad6-Rad18 complex,CC,
17643,GO:0097506,1,0.979951044627951,0,4,deaminated base DNA N-glycosylase activity,MF,
17644,GO:0097510,1,0.994978564031778,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17645,GO:0097512,1,0.977199272190136,0,5,cardiac myofibril,CC,
17646,GO:0097513,1,0.972765438012493,0,3,myosin II filament,CC,
17648,GO:0097519,1,0.991267238382462,0,1,DNA recombinase complex,CC,
17649,GO:0097524,1,0.957083499295256,0,6,sperm plasma membrane,CC,
17650,GO:0097525,1,0.745211379052585,0,55,spliceosomal snRNP complex,CC,
17651,GO:0097526,1,0.85998988822523,0,30,spliceosomal tri-snRNP complex,CC,
17652,GO:0097527,1,0.956476003054335,0,8,necroptotic signaling pathway,BP,
17653,GO:0097528,1,0.98991839090452,0,2,execution phase of necroptosis,BP,
17655,GO:0097530,1,0.513684472144316,0,119,granulocyte migration,BP,
17656,GO:0097531,1,0.935277785036913,0,11,mast cell migration,BP,
17657,GO:0097532,1,0.988458063786118,0,2,stress response to acid chemical,BP,
17658,GO:0097533,1,0.988458063786118,0,2,cellular stress response to acid chemical,BP,
17659,GO:0097534,1,0.99064259991085,0,1,lymphoid lineage cell migration,BP,
17660,GO:0097535,1,0.99064259991085,0,1,lymphoid lineage cell migration into thymus,BP,
17661,GO:0097536,1,0.99481780378576,0,1,thymus epithelium morphogenesis,BP,
17662,GO:0097539,1,0.923265302978708,0,10,ciliary transition fiber,CC,
17663,GO:0097541,1,0.99325505912211,0,1,axonemal basal plate,CC,
17664,GO:0097542,1,0.752019407194906,0,42,ciliary tip,CC,
17665,GO:0097543,1,0.985655887944344,0,2,ciliary inversin compartment,CC,
17666,GO:0097546,1,0.838090045120251,0,27,ciliary base,CC,
17667,GO:0097549,1,0.625807621494622,0,67,chromatin organization involved in negative regulation of transcription,BP,
17668,GO:0097550,1,0.953461523521347,0,9,transcription preinitiation complex,CC,
17670,GO:0097573,1,0.996316885027758,0,1,glutathione oxidoreductase activity,MF,
17671,GO:0097574,1,0.983835684746828,0,2,lateral part of cell,CC,
17672,GO:0097575,1,0.983835684746828,0,2,lateral cell cortex,CC,
17673,GO:0097576,1,0.972973594599933,0,5,vacuole fusion,BP,
17674,GO:0097577,1,0.985136943381457,0,4,sequestering of iron ion,BP,
17676,GO:0097598,1,0.98524090156549,0,2,sperm cytoplasmic droplet,CC,
17677,GO:0097602,1,0.858234867949307,0,23,cullin family protein binding,MF,
17678,GO:0097603,1,0.988031851308544,0,2,temperature-gated ion channel activity,MF,
17679,GO:0097604,1,0.995551272773648,0,1,temperature-gated cation channel activity,MF,
17680,GO:0097617,1,0.911942098488483,0,13,annealing activity,MF,
17681,GO:0097621,1,0.994339766065707,0,1,monoamine oxidase activity,MF,
17682,GO:0097623,1,0.899574034700892,0,16,potassium ion export across plasma membrane,BP,
17683,GO:0097629,1,0.97797828725103,0,3,extrinsic component of omegasome membrane,CC,
17684,GO:0097630,1,0.99325505912211,0,1,intrinsic component of omegasome membrane,CC,
17685,GO:0097631,1,0.99325505912211,0,1,integral component of omegasome membrane,CC,
17686,GO:0097632,1,0.985325937311449,0,2,extrinsic component of phagophore assembly site membrane,CC,
17687,GO:0097635,1,0.984371712588654,0,2,extrinsic component of autophagosome membrane,CC,
17688,GO:0097636,1,0.985501468239393,0,2,intrinsic component of autophagosome membrane,CC,
17689,GO:0097637,1,0.985501468239393,0,2,integral component of autophagosome membrane,CC,
17690,GO:0097638,1,0.956917064215665,0,6,L-arginine import across plasma membrane,BP,
17691,GO:0097639,1,0.988174905460668,0,2,L-lysine import across plasma membrane,BP,
17692,GO:0097640,1,0.994490059844545,0,1,L-ornithine import across plasma membrane,BP,
17693,GO:0097642,1,0.968287636442877,0,6,calcitonin family receptor activity,MF,
17694,GO:0097643,1,0.982456852655947,0,4,amylin receptor activity,MF,
17695,GO:0097644,1,0.978315718968254,0,4,calcitonin family binding,MF,
17696,GO:0097646,1,0.971028617617714,0,6,calcitonin family receptor signaling pathway,BP,
17697,GO:0097647,1,0.978723148233823,0,5,amylin receptor signaling pathway,BP,
17698,GO:0097648,1,0.943540930445125,0,9,G protein-coupled receptor complex,CC,
17699,GO:0097651,1,0.968872780885049,0,4,phosphatidylinositol 3-kinase complex, class I,CC,
17700,GO:0097655,1,0.99325505912211,0,1,serpin family protein binding,MF,
17702,GO:0097676,1,0.966416555382806,0,4,histone H3-K36 dimethylation,BP,
17703,GO:0097677,1,0.947493161814569,0,7,STAT family protein binding,MF,
17704,GO:0097680,1,0.95836160762726,0,6,double-strand break repair via classical nonhomologous end joining,BP,
17705,GO:0097681,1,0.964089370199062,0,4,double-strand break repair via alternative nonhomologous end joining,BP,
17706,GO:0097682,1,0.994839640885498,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
17707,GO:0097688,1,0.932632611992699,0,9,glutamate receptor clustering,BP,
17708,GO:0097692,1,0.940278293476942,0,8,histone H3-K4 monomethylation,BP,
17709,GO:0097694,1,0.972438772318952,0,3,establishment of RNA localization to telomere,BP,
17710,GO:0097695,1,0.972438772318952,0,3,establishment of protein-containing complex localization to telomere,BP,
17712,GO:0097698,1,0.996137953212963,0,1,telomere maintenance via base-excision repair,BP,
17713,GO:0097699,1,0.992363289161547,0,1,vascular endothelial cell response to fluid shear stress,BP,
17714,GO:0097707,1,0.989393591154071,0,2,ferroptosis,BP,
17716,GO:0097709,1,0.941973749748738,0,9,connective tissue replacement,BP,
17718,GO:0097712,1,0.99325505912211,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
17721,GO:0097722,1,0.625994959536727,0,73,sperm motility,BP,
17722,GO:0097726,1,0.996565418379988,0,1,LEM domain binding,MF,
17723,GO:0097728,1,0.987381142791216,0,1,9+0 motile cilium,CC,
17725,GO:0097730,1,0.401603812259305,0,135,non-motile cilium,CC,
17726,GO:0097731,1,0.468289417132448,0,113,9+0 non-motile cilium,CC,
17727,GO:0097732,1,0.956832655034035,0,7,9+2 non-motile cilium,CC,
17728,GO:0097733,1,0.526645949890019,0,93,photoreceptor cell cilium,CC,
17729,GO:0097734,1,0.896326144556932,0,18,extracellular exosome biogenesis,BP,
17730,GO:0097742,1,0.972755881543972,0,4,de novo centriole assembly,BP,
17731,GO:0097744,1,0.992370022455993,0,1,urate salt excretion,BP,
17732,GO:0097745,1,0.989965671653508,0,2,mitochondrial tRNA 5'-end processing,BP,
17734,GO:0097747,1,0.803030426039252,0,39,RNA polymerase activity,MF,
17735,GO:0097749,1,0.969354619662386,0,4,membrane tubulation,BP,
17736,GO:0097750,1,0.984355443558912,0,2,endosome membrane tubulation,BP,
17737,GO:0097752,1,0.988935781793319,0,2,regulation of DNA stability,BP,
17738,GO:0097753,1,0.985870294794314,0,2,membrane bending,BP,
17741,GO:0098038,1,0.992568686560971,0,1,non-replicative transposition, DNA-mediated,BP,
17742,GO:0098502,1,0.992575328929391,0,2,DNA dephosphorylation,BP,
17743,GO:0098505,1,0.937701638120924,0,10,G-rich strand telomeric DNA binding,MF,
17744,GO:0098506,1,0.995727274618538,0,1,polynucleotide 3' dephosphorylation,BP,
17745,GO:0098507,1,0.988279534708128,0,2,polynucleotide 5' dephosphorylation,BP,
17746,GO:0098508,1,0.988392418511203,0,2,endothelial to hematopoietic transition,BP,
17747,GO:0098518,1,0.984056379790571,0,3,polynucleotide phosphatase activity,MF,
17748,GO:0098519,1,0.973738733084622,0,4,nucleotide phosphatase activity, acting on free nucleotides,MF,
17749,GO:0098528,1,0.960809211878744,0,6,skeletal muscle fiber differentiation,BP,
17750,GO:0098530,1,0.991721069797367,0,1,positive regulation of strand invasion,BP,
17751,GO:0098531,1,0.70058471016217,0,49,ligand-activated transcription factor activity,MF,
17752,GO:0098532,1,0.967126802211916,0,4,histone H3-K27 trimethylation,BP,
17753,GO:0098533,1,0.863948928375208,0,23,ATPase dependent transmembrane transport complex,CC,
17754,GO:0098534,1,0.767169938112889,0,37,centriole assembly,BP,
17755,GO:0098535,1,0.972755881543972,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
17756,GO:0098536,1,0.973247134628499,0,4,deuterosome,CC,
17758,GO:0098543,1,0.897733674946,0,16,detection of other organism,BP,
17759,GO:0098547,1,0.994466690110443,0,1,lumenal side of Golgi membrane,CC,
17761,GO:0098553,1,0.889963367963681,0,25,lumenal side of endoplasmic reticulum membrane,CC,
17762,GO:0098554,1,0.924674208718938,0,14,cytoplasmic side of endoplasmic reticulum membrane,CC,
17763,GO:0098556,1,0.983260250303768,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
17764,GO:0098559,1,0.981153036826367,0,3,cytoplasmic side of early endosome membrane,CC,
17765,GO:0098560,1,0.987019805137579,0,2,cytoplasmic side of late endosome membrane,CC,
17766,GO:0098562,1,0.30706922494143,0,178,cytoplasmic side of membrane,CC,
17767,GO:0098563,1,0.753023650433128,0,46,intrinsic component of synaptic vesicle membrane,CC,
17768,GO:0098573,1,0.646871686832305,0,73,intrinsic component of mitochondrial membrane,CC,
17769,GO:0098574,1,0.97522655681732,0,4,cytoplasmic side of lysosomal membrane,CC,
17770,GO:0098575,1,0.989521806107005,0,2,lumenal side of lysosomal membrane,CC,
17771,GO:0098576,1,0.865979596271434,0,30,lumenal side of membrane,CC,
17772,GO:0098577,1,0.991126559871638,0,1,inactive sex chromosome,CC,
17773,GO:0098581,1,0.874844564107238,0,21,detection of external biotic stimulus,BP,
17774,GO:0098582,1,0.992514365261699,0,1,innate vocalization behavior,BP,
17775,GO:0098583,1,0.989702640527098,0,2,learned vocalization behavior,BP,
17776,GO:0098586,1,0.736204847007949,0,47,cellular response to virus,BP,
17780,GO:0098591,1,0.960203952600934,0,5,external side of apical plasma membrane,CC,
17781,GO:0098592,1,0.978099091236719,0,3,cytoplasmic side of apical plasma membrane,CC,
17782,GO:0098594,1,0.996790948232028,0,1,mucin granule,CC,
17783,GO:0098595,1,0.994474478822419,0,1,perivitelline space,CC,
17784,GO:0098596,1,0.936647799641248,0,7,imitative learning,BP,
17785,GO:0098597,1,0.925625939350434,0,8,observational learning,BP,
17786,GO:0098598,1,0.926996391809143,0,9,learned vocalization behavior or vocal learning,BP,
17787,GO:0098599,1,0.933583185642528,0,12,palmitoyl hydrolase activity,MF,
17789,GO:0098629,1,0.99325505912211,0,1,trans-Golgi network membrane organization,BP,
17790,GO:0098630,1,0.994152611553279,0,1,aggregation of unicellular organisms,BP,
17793,GO:0098633,1,0.986564335253178,0,2,collagen fibril binding,MF,
17794,GO:0098634,1,0.949288069667741,0,7,cell-matrix adhesion mediator activity,MF,
17795,GO:0098636,1,0.765436891473584,0,36,protein complex involved in cell adhesion,CC,
17796,GO:0098637,1,0.992476711570874,0,1,protein complex involved in cell-matrix adhesion,CC,
17797,GO:0098639,1,0.960080316825692,0,5,collagen binding involved in cell-matrix adhesion,MF,
17798,GO:0098640,1,0.988763660847114,0,2,integrin binding involved in cell-matrix adhesion,MF,
17799,GO:0098641,1,0.906074148701938,0,18,cadherin binding involved in cell-cell adhesion,MF,
17800,GO:0098642,1,0.940156080165366,0,7,network-forming collagen trimer,CC,
17801,GO:0098643,1,0.905316181896059,0,12,banded collagen fibril,CC,
17802,GO:0098644,1,0.842392082278254,0,20,complex of collagen trimers,CC,
17803,GO:0098645,1,0.940156080165366,0,7,collagen network,CC,
17804,GO:0098646,1,0.993544088410586,0,1,collagen sheet,CC,
17805,GO:0098647,1,0.978753630615914,0,3,collagen beaded filament,CC,
17806,GO:0098648,1,0.989802465689289,0,1,collagen anchoring fibril,CC,
17807,GO:0098651,1,0.932613397977196,0,8,basement membrane collagen trimer,CC,
17808,GO:0098652,1,0.989802465689289,0,1,collagen type VII anchoring fibril,CC,
17812,GO:0098658,1,0.983512962304905,0,2,inorganic anion import across plasma membrane,BP,
17815,GO:0098661,1,0.46989456808939,0,106,inorganic anion transmembrane transport,BP,
17817,GO:0098664,1,0.879975142481085,0,22,G protein-coupled serotonin receptor signaling pathway,BP,
17818,GO:0098674,1,0.990025297902358,0,1,extrinsic component of neuronal dense core vesicle membrane,CC,
17819,GO:0098675,1,0.988000361012915,0,2,intrinsic component of neuronal dense core vesicle membrane,CC,
17820,GO:0098680,1,0.992468032218389,0,1,template-free RNA nucleotidyltransferase,MF,
17821,GO:0098683,1,0.990618119213824,0,1,cochlear hair cell ribbon synapse,CC,
17822,GO:0098684,1,0.95443821199989,0,7,photoreceptor ribbon synapse,CC,
17823,GO:0098685,1,0.55892224022892,0,81,Schaffer collateral - CA1 synapse,CC,
17824,GO:0098686,1,0.802890598935425,0,31,hippocampal mossy fiber to CA3 synapse,CC,
17825,GO:0098687,1,0.129487462012266,0,301,chromosomal region,CC,
17826,GO:0098688,1,0.890846397623739,0,16,parallel fiber to Purkinje cell synapse,CC,
17827,GO:0098690,1,0.954539507251047,0,7,glycinergic synapse,CC,
17828,GO:0098691,1,0.930605165302701,0,12,dopaminergic synapse,CC,
17829,GO:0098693,1,0.451643354964041,0,110,regulation of synaptic vesicle cycle,BP,
17830,GO:0098694,1,0.992744259439078,0,1,regulation of synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
17831,GO:0098695,1,0.989355478351545,0,1,inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels,MF,
17832,GO:0098696,1,0.94771903304139,0,8,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,BP,
17833,GO:0098698,1,0.849829777289744,0,21,postsynaptic specialization assembly,BP,
17834,GO:0098700,1,0.95143586873627,0,8,neurotransmitter loading into synaptic vesicle,BP,
17835,GO:0098703,1,0.865341164613961,0,20,calcium ion import across plasma membrane,BP,
17836,GO:0098704,1,0.958964694835136,0,6,carbohydrate import across plasma membrane,BP,
17837,GO:0098705,1,0.992243960320103,0,1,copper ion import across plasma membrane,BP,
17838,GO:0098708,1,0.964480608015783,0,5,glucose import across plasma membrane,BP,
17839,GO:0098711,1,0.984559513820537,0,3,iron ion import across plasma membrane,BP,
17840,GO:0098712,1,0.904560611612447,0,13,L-glutamate import across plasma membrane,BP,
17841,GO:0098713,1,0.966438227525175,0,5,leucine import across plasma membrane,BP,
17842,GO:0098718,1,0.992409588456598,0,1,serine import across plasma membrane,BP,
17843,GO:0098719,1,0.879828384803711,0,17,sodium ion import across plasma membrane,BP,
17844,GO:0098722,1,0.940632789368961,0,9,asymmetric stem cell division,BP,
17845,GO:0098725,1,0.99325505912211,0,1,symmetric cell division,BP,
17847,GO:0098728,1,0.983378489855023,0,3,germline stem cell asymmetric division,BP,
17848,GO:0098732,1,0.484924027290281,0,105,macromolecule deacylation,BP,
17849,GO:0098734,1,0.933583185642528,0,12,macromolecule depalmitoylation,BP,
17850,GO:0098735,1,0.96180370751203,0,4,positive regulation of the force of heart contraction,BP,
17851,GO:0098736,1,0.990038223672271,0,1,negative regulation of the force of heart contraction,BP,
17856,GO:0098745,1,0.995697015410691,0,1,Dcp1-Dcp2 complex,CC,
17857,GO:0098746,1,0.992227477747027,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
17858,GO:0098749,1,0.978747313572226,0,3,cerebellar neuron development,BP,
17859,GO:0098751,1,0.791898412098014,0,32,bone cell development,BP,
17860,GO:0098753,1,0.994221465848789,0,1,anchored component of the cytoplasmic side of the plasma membrane,CC,
17861,GO:0098754,1,0.554157481497829,0,116,detoxification,BP,
17862,GO:0098756,1,0.951675070256492,0,7,response to interleukin-21,BP,
17863,GO:0098757,1,0.951675070256492,0,7,cellular response to interleukin-21,BP,
17864,GO:0098758,1,0.980041908179851,0,3,response to interleukin-8,BP,
17865,GO:0098759,1,0.980041908179851,0,3,cellular response to interleukin-8,BP,
17866,GO:0098760,1,0.83840157616298,0,27,response to interleukin-7,BP,
17867,GO:0098761,1,0.83840157616298,0,27,cellular response to interleukin-7,BP,
17868,GO:0098763,1,0.984671710184872,0,2,mitotic cell cycle phase,BP,
17869,GO:0098770,1,0.981184498870349,0,2,FBXO family protein binding,MF,
17873,GO:0098779,1,0.932630344226193,0,9,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
17874,GO:0098780,1,0.87454739589474,0,19,response to mitochondrial depolarisation,BP,
17875,GO:0098781,1,0.545783085406799,0,98,ncRNA transcription,BP,
17876,GO:0098782,1,0.995551272773648,0,1,mechanosensitived potassium channel activity,MF,
17877,GO:0098787,1,0.913677777122012,0,13,mRNA cleavage involved in mRNA processing,BP,
17878,GO:0098789,1,0.920619625050207,0,12,pre-mRNA cleavage required for polyadenylation,BP,
17880,GO:0098792,1,0.939332543586413,0,9,xenophagy,BP,
17883,GO:0098795,1,0.98583002779056,0,2,mRNA cleavage involved in gene silencing,BP,
17886,GO:0098798,1,0.371235442731685,0,217,mitochondrial protein complex,CC,
17887,GO:0098799,1,0.898777704046398,0,20,outer mitochondrial membrane protein complex,CC,
17888,GO:0098800,1,0.651316032174565,0,97,inner mitochondrial membrane protein complex,CC,
17891,GO:0098803,1,0.776455973114772,0,66,respiratory chain complex,CC,
17893,GO:0098808,1,0.988497748176686,0,2,mRNA cap binding,MF,
17894,GO:0098809,1,0.993598293270506,0,1,nitrite reductase activity,MF,
17895,GO:0098810,1,0.81788491044593,0,31,neurotransmitter reuptake,BP,
17896,GO:0098813,1,0.210457799586753,0,233,nuclear chromosome segregation,BP,
17897,GO:0098814,1,0.918411973630783,0,12,spontaneous synaptic transmission,BP,
17898,GO:0098815,1,0.722199355140043,0,44,modulation of excitatory postsynaptic potential,BP,
17899,GO:0098816,1,0.987603004537884,0,2,mini excitatory postsynaptic potential,BP,
17900,GO:0098821,1,0.961394437176389,0,5,BMP receptor activity,MF,
17901,GO:0098822,1,0.993947281909514,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
17902,GO:0098826,1,0.975169922842943,0,4,endoplasmic reticulum tubular network membrane,CC,
17903,GO:0098827,1,0.856292248653075,0,24,endoplasmic reticulum subcompartment,CC,
17904,GO:0098828,1,0.944417548408506,0,7,modulation of inhibitory postsynaptic potential,BP,
17905,GO:0098829,1,0.991316124421369,0,1,intestinal folate absorption,BP,
17906,GO:0098830,1,0.992222189646489,0,1,presynaptic endosome,CC,
17907,GO:0098831,1,0.873398274641297,0,15,presynaptic active zone cytoplasmic component,CC,
17908,GO:0098833,1,0.940668650251507,0,9,presynaptic endocytic zone,CC,
17909,GO:0098835,1,0.955874891191847,0,7,presynaptic endocytic zone membrane,CC,
17910,GO:0098837,1,0.946696369968865,0,8,postsynaptic recycling endosome,CC,
17912,GO:0098839,1,0.509618644151546,0,90,postsynaptic density membrane,CC,
17913,GO:0098840,1,0.638726898526845,0,64,protein transport along microtubule,BP,
17914,GO:0098842,1,0.981442486860609,0,3,postsynaptic early endosome,CC,
17915,GO:0098843,1,0.93657935032821,0,10,postsynaptic endocytic zone,CC,
17916,GO:0098844,1,0.962091510659323,0,5,postsynaptic endocytic zone membrane,CC,
17917,GO:0098845,1,0.911112462077077,0,14,postsynaptic endosome,CC,
17918,GO:0098847,1,0.92097644716923,0,13,sequence-specific single stranded DNA binding,MF,
17919,GO:0098850,1,0.977348913570575,0,4,extrinsic component of synaptic vesicle membrane,CC,
17921,GO:0098855,1,0.975633694255985,0,3,HCN channel complex,CC,
17922,GO:0098856,1,0.936789131207965,0,11,intestinal lipid absorption,BP,
17926,GO:0098867,1,0.993519057325487,0,1,intramembranous bone growth,BP,
17928,GO:0098869,1,0.638291413866705,0,87,cellular oxidant detoxification,BP,
17929,GO:0098870,1,0.944879417028827,0,8,action potential propagation,BP,
17930,GO:0098871,1,0.964435652476156,0,5,postsynaptic actin cytoskeleton,CC,
17931,GO:0098872,1,0.991085070344566,0,1,G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
17932,GO:0098874,1,0.992084683805971,0,1,spike train,BP,
17933,GO:0098875,1,0.992259195762914,0,1,epididymosome,CC,
17935,GO:0098877,1,0.902504822571294,0,15,neurotransmitter receptor transport to plasma membrane,BP,
17936,GO:0098878,1,0.693389485986642,0,51,neurotransmitter receptor complex,CC,
17937,GO:0098879,1,0.975237041381916,0,3,structural constituent of postsynaptic specialization,MF,
17938,GO:0098880,1,0.950842188353102,0,6,maintenance of postsynaptic specialization structure,BP,
17939,GO:0098882,1,0.956903393425345,0,4,structural constituent of presynaptic active zone,MF,
17940,GO:0098883,1,0.941145939200193,0,11,synapse pruning,BP,
17941,GO:0098884,1,0.868088723112318,0,20,postsynaptic neurotransmitter receptor internalization,BP,
17942,GO:0098885,1,0.924902966506207,0,11,modification of postsynaptic actin cytoskeleton,BP,
17943,GO:0098886,1,0.985381683762496,0,2,modification of dendritic spine,BP,
17944,GO:0098887,1,0.945441423573587,0,8,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
17945,GO:0098888,1,0.952707107868291,0,6,extrinsic component of presynaptic membrane,CC,
17946,GO:0098889,1,0.555248064352435,0,82,intrinsic component of presynaptic membrane,CC,
17947,GO:0098890,1,0.928301230502999,0,9,extrinsic component of postsynaptic membrane,CC,
17948,GO:0098891,1,0.99223054425052,0,1,extrinsic component of presynaptic active zone membrane,CC,
17949,GO:0098892,1,0.951593390856323,0,6,extrinsic component of postsynaptic specialization membrane,CC,
17950,GO:0098894,1,0.98485932159734,0,2,extrinsic component of presynaptic endocytic zone membrane,CC,
17951,GO:0098895,1,0.971985572315803,0,4,postsynaptic endosome membrane,CC,
17952,GO:0098896,1,0.992743829319231,0,1,postsynaptic early endosome membrane,CC,
17953,GO:0098897,1,0.992046278134186,0,1,spine apparatus membrane,CC,
17954,GO:0098898,1,0.985530262000679,0,2,dense core granule lumen,CC,
17958,GO:0098903,1,0.940864347492755,0,8,regulation of membrane repolarization during action potential,BP,
17959,GO:0098904,1,0.98040424830947,0,2,regulation of AV node cell action potential,BP,
17960,GO:0098905,1,0.996753980183996,0,1,regulation of bundle of His cell action potential,BP,
17961,GO:0098907,1,0.976964854910933,0,2,regulation of SA node cell action potential,BP,
17962,GO:0098908,1,0.97072237652117,0,5,regulation of neuronal action potential,BP,
17963,GO:0098909,1,0.94429491391226,0,8,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
17964,GO:0098910,1,0.952852749865341,0,5,regulation of atrial cardiac muscle cell action potential,BP,
17965,GO:0098911,1,0.882489793141605,0,15,regulation of ventricular cardiac muscle cell action potential,BP,
17966,GO:0098912,1,0.970631774537877,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
17967,GO:0098914,1,0.958027014774389,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
17968,GO:0098915,1,0.908672602211768,0,14,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
17970,GO:0098917,1,0.927018043836185,0,10,retrograde trans-synaptic signaling,BP,
17971,GO:0098918,1,0.880553977290165,0,15,structural constituent of synapse,MF,
17972,GO:0098919,1,0.975237041381916,0,3,structural constituent of postsynaptic density,MF,
17973,GO:0098920,1,0.965209019412195,0,5,retrograde trans-synaptic signaling by lipid,BP,
17974,GO:0098921,1,0.965209019412195,0,5,retrograde trans-synaptic signaling by endocannabinoid,BP,
17975,GO:0098922,1,0.990025297902358,0,1,extrinsic component of dense core granule membrane,CC,
17976,GO:0098923,1,0.990947004700222,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
17977,GO:0098924,1,0.990947004700222,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
17978,GO:0098926,1,0.814747589195514,0,33,postsynaptic signal transduction,BP,
17980,GO:0098928,1,0.97232687148073,0,2,presynaptic signal transduction,BP,
17981,GO:0098930,1,0.663190308644629,0,57,axonal transport,BP,
17982,GO:0098935,1,0.925398521196962,0,10,dendritic transport,BP,
17984,GO:0098937,1,0.953402451642095,0,6,anterograde dendritic transport,BP,
17985,GO:0098939,1,0.984141163759374,0,2,dendritic transport of mitochondrion,BP,
17986,GO:0098942,1,0.984007668056721,0,2,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
17987,GO:0098943,1,0.963818259017503,0,7,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
17988,GO:0098944,1,0.986555151512788,0,2,postsynaptic recycling endosome membrane,CC,
17989,GO:0098945,1,0.875606654444036,0,18,intrinsic component of presynaptic active zone membrane,CC,
17990,GO:0098948,1,0.582119548825869,0,75,intrinsic component of postsynaptic specialization membrane,CC,
17991,GO:0098949,1,0.986555151512788,0,2,intrinsic component of postsynaptic endosome membrane,CC,
17992,GO:0098951,1,0.986555151512788,0,2,intrinsic component of postsynaptic recycling endosome membrane,CC,
17993,GO:0098952,1,0.992046278134186,0,1,intrinsic component of spine apparatus membrane,CC,
17994,GO:0098953,1,0.947983825303382,0,9,receptor diffusion trapping,BP,
17995,GO:0098956,1,0.988000361012915,0,2,intrinsic component of dense core granule membrane,CC,
17996,GO:0098957,1,0.965140377254147,0,5,anterograde axonal transport of mitochondrion,BP,
17997,GO:0098958,1,0.986913542866676,0,2,retrograde axonal transport of mitochondrion,BP,
17998,GO:0098960,1,0.662497131027019,0,60,postsynaptic neurotransmitter receptor activity,MF,
17999,GO:0098961,1,0.977691817790223,0,3,dendritic transport of ribonucleoprotein complex,BP,
18000,GO:0098962,1,0.878353572544187,0,17,regulation of postsynaptic neurotransmitter receptor activity,BP,
18001,GO:0098963,1,0.977691817790223,0,3,dendritic transport of messenger ribonucleoprotein complex,BP,
18003,GO:0098967,1,0.969567757910601,0,5,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
18004,GO:0098968,1,0.992034489406777,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18005,GO:0098969,1,0.902504822571294,0,15,neurotransmitter receptor transport to postsynaptic membrane,BP,
18006,GO:0098970,1,0.947983825303382,0,9,postsynaptic neurotransmitter receptor diffusion trapping,BP,
18007,GO:0098971,1,0.968058176868689,0,4,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18008,GO:0098972,1,0.991288576855342,0,1,anterograde dendritic transport of mitochondrion,BP,
18009,GO:0098973,1,0.98363113442605,0,3,structural constituent of postsynaptic actin cytoskeleton,MF,
18010,GO:0098974,1,0.923965519115263,0,11,postsynaptic actin cytoskeleton organization,BP,
18011,GO:0098976,1,0.92941970723887,0,9,excitatory chemical synaptic transmission,BP,
18012,GO:0098977,1,0.99199407983913,0,1,inhibitory chemical synaptic transmission,BP,
18014,GO:0098981,1,0.941733250911879,0,9,cholinergic synapse,CC,
18016,GO:0098983,1,0.968936994972361,0,4,symmetric, GABA-ergic, inhibitory synapse,CC,
18018,GO:0098985,1,0.951845131363654,0,6,asymmetric, glutamatergic, excitatory synapse,CC,
18019,GO:0098988,1,0.945983389561325,0,7,G protein-coupled glutamate receptor activity,MF,
18020,GO:0098989,1,0.987056802353956,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18021,GO:0098992,1,0.918772577981837,0,12,neuronal dense core vesicle,CC,
18022,GO:0098993,1,0.934469323941684,0,13,anchored component of synaptic vesicle membrane,CC,
18023,GO:0098998,1,0.992743829319231,0,1,extrinsic component of postsynaptic early endosome membrane,CC,
18024,GO:0098999,1,0.985233888895281,0,2,extrinsic component of postsynaptic endosome membrane,CC,
18025,GO:0099003,1,0.217405611754381,0,212,vesicle-mediated transport in synapse,BP,
18026,GO:0099004,1,0.944916526633339,0,8,calmodulin dependent kinase signaling pathway,BP,
18027,GO:0099010,1,0.887546423867084,0,17,modification of postsynaptic structure,BP,
18028,GO:0099011,1,0.949653389204507,0,6,neuronal dense core vesicle exocytosis,BP,
18029,GO:0099012,1,0.970258227470248,0,4,neuronal dense core vesicle membrane,CC,
18030,GO:0099013,1,0.985530262000679,0,2,neuronal dense core vesicle lumen,CC,
18031,GO:0099020,1,0.993120895894487,0,1,perinuclear endoplasmic reticulum lumen,CC,
18032,GO:0099022,1,0.946422755669184,0,8,vesicle tethering,BP,
18033,GO:0099023,1,0.64255941364596,0,64,vesicle tethering complex,CC,
18034,GO:0099024,1,0.68089234260186,0,60,plasma membrane invagination,BP,
18036,GO:0099026,1,0.938427063777963,0,9,anchored component of presynaptic membrane,CC,
18037,GO:0099029,1,0.974377542991697,0,4,anchored component of presynaptic active zone membrane,CC,
18038,GO:0099030,1,0.979144788188863,0,3,anchored component of postsynaptic specialization membrane,CC,
18039,GO:0099031,1,0.979144788188863,0,3,anchored component of postsynaptic density membrane,CC,
18040,GO:0099033,1,0.986555151512788,0,2,anchored component of postsynaptic recycling endosome membrane,CC,
18041,GO:0099034,1,0.986555151512788,0,2,anchored component of postsynaptic endosome membrane,CC,
18042,GO:0099038,1,0.982641468828982,0,2,ceramide floppase activity,MF,
18043,GO:0099039,1,0.963627881257278,0,4,sphingolipid translocation,BP,
18044,GO:0099040,1,0.982641468828982,0,2,ceramide translocation,BP,
18045,GO:0099041,1,0.963596056019501,0,5,vesicle tethering to Golgi,BP,
18046,GO:0099044,1,0.989080213032163,0,2,vesicle tethering to endoplasmic reticulum,BP,
18047,GO:0099046,1,0.996205929672335,0,1,clearance of foreign intracellular nucleic acids,BP,
18048,GO:0099050,1,0.99332928609167,0,1,vesicle scission,BP,
18049,GO:0099053,1,0.980212620127667,0,3,activating signal cointegrator 1 complex,CC,
18050,GO:0099054,1,0.687909349395627,0,48,presynapse assembly,BP,
18051,GO:0099055,1,0.441494948133973,0,115,integral component of postsynaptic membrane,CC,
18052,GO:0099056,1,0.591881240877369,0,73,integral component of presynaptic membrane,CC,
18053,GO:0099059,1,0.898657244983943,0,14,integral component of presynaptic active zone membrane,CC,
18054,GO:0099060,1,0.594584970460878,0,72,integral component of postsynaptic specialization membrane,CC,
18055,GO:0099061,1,0.696126580357677,0,49,integral component of postsynaptic density membrane,CC,
18056,GO:0099065,1,0.992046278134186,0,1,integral component of spine apparatus membrane,CC,
18057,GO:0099066,1,0.988000361012915,0,2,integral component of neuronal dense core vesicle membrane,CC,
18058,GO:0099068,1,0.787258084591852,0,31,postsynapse assembly,BP,
18059,GO:0099072,1,0.647226065374077,0,64,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,
18060,GO:0099073,1,0.985031917734443,0,2,mitochondrion-derived vesicle,CC,
18061,GO:0099074,1,0.986157346381701,0,2,mitochondrion to lysosome transport,BP,
18062,GO:0099075,1,0.986157346381701,0,2,mitochondrion-derived vesicle mediated transport,BP,
18063,GO:0099077,1,0.991725365074557,0,1,histone-dependent DNA binding,MF,
18064,GO:0099078,1,0.981977714824681,0,4,BORC complex,CC,
18067,GO:0099082,1,0.98497809367574,0,2,retrograde trans-synaptic signaling by neuropeptide,BP,
18068,GO:0099083,1,0.992466593190375,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18069,GO:0099084,1,0.765729171373263,0,34,postsynaptic specialization organization,BP,
18070,GO:0099086,1,0.816352135199432,0,32,synaptonemal structure,CC,
18071,GO:0099087,1,0.993038571577508,0,1,anterograde axonal transport of messenger ribonucleoprotein complex,BP,
18072,GO:0099088,1,0.993038571577508,0,1,axonal transport of messenger ribonucleoprotein complex,BP,
18073,GO:0099089,1,0.988332743558059,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
18074,GO:0099091,1,0.86328009329417,0,21,postsynaptic specialization, intracellular component,CC,
18075,GO:0099092,1,0.886118358917289,0,17,postsynaptic density, intracellular component,CC,
18076,GO:0099093,1,0.985203961271278,0,2,calcium export from the mitochondrion,BP,
18078,GO:0099095,1,0.875657839138524,0,18,ligand-gated anion channel activity,MF,
18079,GO:0099098,1,0.992686732662962,0,1,microtubule polymerization based movement,BP,
18080,GO:0099103,1,0.97842055878193,0,4,channel activator activity,MF,
18081,GO:0099104,1,0.97842055878193,0,4,potassium channel activator activity,MF,
18082,GO:0099106,1,0.510796414297049,0,111,ion channel regulator activity,MF,
18083,GO:0099111,1,0.283771941857687,0,178,microtubule-based transport,BP,
18084,GO:0099115,1,0.984793715175191,0,2,chromosome, subtelomeric region,CC,
18085,GO:0099116,1,0.926942296392136,0,15,tRNA 5'-end processing,BP,
18086,GO:0099118,1,0.638726898526845,0,64,microtubule-based protein transport,BP,
18087,GO:0099122,1,0.94385227702746,0,8,RNA polymerase II C-terminal domain binding,MF,
18088,GO:0099142,1,0.991506567773342,0,1,intracellularly ATP-gated ion channel activity,MF,
18090,GO:0099146,1,0.681555552572058,0,52,intrinsic component of postsynaptic density membrane,CC,
18091,GO:0099147,1,0.95623837074341,0,5,extrinsic component of postsynaptic density membrane,CC,
18092,GO:0099149,1,0.92005576760074,0,12,regulation of postsynaptic neurotransmitter receptor internalization,BP,
18093,GO:0099150,1,0.909739996364381,0,13,regulation of postsynaptic specialization assembly,BP,
18094,GO:0099151,1,0.914004328730106,0,12,regulation of postsynaptic density assembly,BP,
18095,GO:0099152,1,0.986047335217165,0,2,regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18096,GO:0099154,1,0.98888551507992,0,2,serotonergic synapse,CC,
18097,GO:0099156,1,0.992612619702809,0,1,cell-cell signaling via exosome,BP,
18098,GO:0099158,1,0.992743829319231,0,1,regulation of recycling endosome localization within postsynapse,BP,
18099,GO:0099159,1,0.944544155175838,0,8,regulation of modification of postsynaptic structure,BP,
18100,GO:0099160,1,0.992502477567624,0,1,postsynaptic intermediate filament cytoskeleton,CC,
18101,GO:0099161,1,0.992455237799069,0,1,regulation of presynaptic dense core granule exocytosis,BP,
18102,GO:0099163,1,0.990947004700222,0,1,synaptic signaling by nitric oxide,BP,
18103,GO:0099170,1,0.902111945370091,0,14,postsynaptic modulation of chemical synaptic transmission,BP,
18104,GO:0099171,1,0.90261709092267,0,15,presynaptic modulation of chemical synaptic transmission,BP,
18105,GO:0099172,1,0.676458995858445,0,51,presynapse organization,BP,
18106,GO:0099173,1,0.298450357944218,0,163,postsynapse organization,BP,
18107,GO:0099174,1,0.779094828161662,0,34,regulation of presynapse organization,BP,
18108,GO:0099175,1,0.480200287733757,0,100,regulation of postsynapse organization,BP,
18110,GO:0099178,1,0.987992523184821,0,2,regulation of retrograde trans-synaptic signaling by endocanabinoid,BP,
18111,GO:0099179,1,0.96905112332329,0,4,regulation of synaptic membrane adhesion,BP,
18112,GO:0099180,1,0.990252414440994,0,2,zinc ion import into synaptic vesicle,BP,
18113,GO:0099181,1,0.992457373369911,0,1,structural constituent of presynapse,MF,
18114,GO:0099183,1,0.970673468458025,0,4,trans-synaptic signaling by BDNF, modulating synaptic transmission,BP,
18115,GO:0099184,1,0.985243486712105,0,2,structural constituent of postsynaptic intermediate filament cytoskeleton,MF,
18116,GO:0099185,1,0.985243486712105,0,2,postsynaptic intermediate filament cytoskeleton organization,BP,
18117,GO:0099186,1,0.936109135790646,0,9,structural constituent of postsynapse,MF,
18118,GO:0099188,1,0.917032500055371,0,12,postsynaptic cytoskeleton organization,BP,
18119,GO:0099189,1,0.990537816546912,0,1,postsynaptic spectrin-associated cytoskeleton,CC,
18120,GO:0099191,1,0.970673468458025,0,4,trans-synaptic signaling by BDNF,BP,
18122,GO:0099243,1,0.902196612030907,0,13,extrinsic component of synaptic membrane,CC,
18123,GO:0099400,1,0.98980976425874,0,1,caveola neck,CC,
18124,GO:0099403,1,0.978593726492786,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18125,GO:0099404,1,0.978593726492786,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18126,GO:0099500,1,0.866634626096992,0,23,vesicle fusion to plasma membrane,BP,
18127,GO:0099501,1,0.517573484901759,0,100,exocytic vesicle membrane,CC,
18128,GO:0099502,1,0.971038717754406,0,4,calcium-dependent activation of synaptic vesicle fusion,BP,
18130,GO:0099504,1,0.24932965999924,0,192,synaptic vesicle cycle,BP,
18131,GO:0099505,1,0.951125906306777,0,6,regulation of presynaptic membrane potential,BP,
18132,GO:0099507,1,0.975049631781978,0,3,ligand-gated ion channel activity involved in regulation of presynaptic membrane potential,MF,
18133,GO:0099508,1,0.975470333102473,0,3,voltage-gated ion channel activity involved in regulation of presynaptic membrane potential,MF,
18134,GO:0099509,1,0.898516452274887,0,16,regulation of presynaptic cytosolic calcium ion concentration,BP,
18135,GO:0099510,1,0.990006976835094,0,2,calcium ion binding involved in regulation of cytosolic calcium ion concentration,MF,
18136,GO:0099511,1,0.960630526098563,0,6,voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels,MF,
18139,GO:0099514,1,0.894392136554506,0,18,synaptic vesicle cytoskeletal transport,BP,
18141,GO:0099517,1,0.894392136554506,0,18,synaptic vesicle transport along microtubule,BP,
18143,GO:0099519,1,0.9096760896779,0,11,dense core granule cytoskeletal transport,BP,
18144,GO:0099520,1,0.992531388854905,0,1,ion antiporter activity involved in regulation of presynaptic membrane potential,MF,
18145,GO:0099522,1,0.831177700236239,0,25,region of cytosol,CC,
18146,GO:0099523,1,0.896964196693404,0,14,presynaptic cytosol,CC,
18147,GO:0099524,1,0.87762124604335,0,18,postsynaptic cytosol,CC,
18148,GO:0099525,1,0.949653389204507,0,6,presynaptic dense core vesicle exocytosis,BP,
18149,GO:0099526,1,0.97232687148073,0,2,presynapse to nucleus signaling pathway,BP,
18150,GO:0099527,1,0.946701408729811,0,8,postsynapse to nucleus signaling pathway,BP,
18151,GO:0099528,1,0.940943142990887,0,9,G protein-coupled neurotransmitter receptor activity,MF,
18152,GO:0099529,1,0.720326986377224,0,47,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18153,GO:0099530,1,0.967519283233654,0,4,G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18154,GO:0099532,1,0.932602618595894,0,9,synaptic vesicle endosomal processing,BP,
18155,GO:0099533,1,0.971587886099191,0,4,positive regulation of presynaptic cytosolic calcium concentration,BP,
18156,GO:0099534,1,0.990006976835094,0,2,calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration,MF,
18160,GO:0099538,1,0.972585532867932,0,4,synaptic signaling via neuropeptide,BP,
18161,GO:0099540,1,0.976076605879555,0,3,trans-synaptic signaling by neuropeptide,BP,
18162,GO:0099541,1,0.939169113496013,0,8,trans-synaptic signaling by lipid,BP,
18163,GO:0099542,1,0.939169113496013,0,8,trans-synaptic signaling by endocannabinoid,BP,
18164,GO:0099543,1,0.990947004700222,0,1,trans-synaptic signaling by soluble gas,BP,
18166,GO:0099545,1,0.941039362688392,0,8,trans-synaptic signaling by trans-synaptic complex,BP,
18167,GO:0099546,1,0.991763135110938,0,1,protein catabolic process, modulating synaptic transmission,BP,
18168,GO:0099547,1,0.978174671101026,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
18169,GO:0099548,1,0.990947004700222,0,1,trans-synaptic signaling by nitric oxide,BP,
18170,GO:0099550,1,0.915004693256563,0,12,trans-synaptic signaling, modulating synaptic transmission,BP,
18171,GO:0099551,1,0.983498119052252,0,2,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18172,GO:0099552,1,0.974939194029094,0,3,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
18173,GO:0099553,1,0.974939194029094,0,3,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
18174,GO:0099557,1,0.979431355678111,0,3,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18175,GO:0099558,1,0.882467514263251,0,16,maintenance of synapse structure,BP,
18176,GO:0099560,1,0.799196273484519,0,28,synaptic membrane adhesion,BP,
18177,GO:0099562,1,0.967897966006203,0,4,maintenance of postsynaptic density structure,BP,
18178,GO:0099563,1,0.849410590641428,0,23,modification of synaptic structure,BP,
18179,GO:0099564,1,0.992666684062571,0,1,modification of synaptic structure, modulating synaptic transmission,BP,
18180,GO:0099565,1,0.474342021008115,0,106,chemical synaptic transmission, postsynaptic,BP,
18181,GO:0099566,1,0.893964916192994,0,13,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18182,GO:0099567,1,0.993747408866496,0,1,calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18184,GO:0099569,1,0.94803879481897,0,5,presynaptic cytoskeleton,CC,
18185,GO:0099571,1,0.94814087367532,0,7,postsynaptic cytoskeleton,CC,
18187,GO:0099575,1,0.982326710415071,0,3,regulation of protein catabolic process at presynapse, modulating synaptic transmission,BP,
18188,GO:0099576,1,0.967755110724683,0,4,regulation of protein catabolic process at postsynapse, modulating synaptic transmission,BP,
18189,GO:0099578,1,0.987989038718168,0,2,regulation of translation at postsynapse, modulating synaptic transmission,BP,
18190,GO:0099579,1,0.985549067086488,0,2,G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18191,GO:0099580,1,0.983648952946817,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18192,GO:0099582,1,0.993130726822913,0,1,neurotransmitter receptor activity involved in regulation of presynaptic cytosolic calcium ion concentration,MF,
18193,GO:0099583,1,0.973599196366676,0,3,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18195,GO:0099588,1,0.992073703372733,0,1,positive regulation of postsynaptic cytosolic calcium concentration,BP,
18196,GO:0099589,1,0.879975142481085,0,22,serotonin receptor activity,MF,
18197,GO:0099590,1,0.838953776632012,0,27,neurotransmitter receptor internalization,BP,
18199,GO:0099602,1,0.958485535573494,0,9,neurotransmitter receptor regulator activity,MF,
18200,GO:0099604,1,0.805796767676392,0,25,ligand-gated calcium channel activity,MF,
18201,GO:0099606,1,0.990131600965941,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
18202,GO:0099607,1,0.98662058512108,0,2,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18203,GO:0099608,1,0.992084683805971,0,1,regulation of action potential firing pattern,BP,
18204,GO:0099609,1,0.983438760710378,0,2,microtubule lateral binding,MF,
18206,GO:0099617,1,0.988860678986352,0,2,matrix side of mitochondrial inner membrane,CC,
18207,GO:0099622,1,0.790545389184853,0,34,cardiac muscle cell membrane repolarization,BP,
18208,GO:0099623,1,0.841224333084904,0,24,regulation of cardiac muscle cell membrane repolarization,BP,
18209,GO:0099624,1,0.930360556930181,0,10,atrial cardiac muscle cell membrane repolarization,BP,
18210,GO:0099625,1,0.843819938206098,0,24,ventricular cardiac muscle cell membrane repolarization,BP,
18211,GO:0099626,1,0.960630526098563,0,6,voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels,MF,
18212,GO:0099628,1,0.947983825303382,0,9,neurotransmitter receptor diffusion trapping,BP,
18213,GO:0099629,1,0.983136539634954,0,2,postsynaptic specialization of symmetric synapse,CC,
18214,GO:0099631,1,0.993077659190011,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
18215,GO:0099633,1,0.871449452202352,0,21,protein localization to postsynaptic specialization membrane,BP,
18216,GO:0099634,1,0.429391647189994,0,116,postsynaptic specialization membrane,CC,
18217,GO:0099635,1,0.971587886099191,0,4,voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels,MF,
18218,GO:0099637,1,0.729893922296928,0,46,neurotransmitter receptor transport,BP,
18219,GO:0099638,1,0.930163882834791,0,10,endosome to plasma membrane protein transport,BP,
18220,GO:0099639,1,0.945441423573587,0,8,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18221,GO:0099640,1,0.907345052378308,0,13,axo-dendritic protein transport,BP,
18222,GO:0099641,1,0.935088283925926,0,9,anterograde axonal protein transport,BP,
18223,GO:0099642,1,0.980189508408764,0,2,retrograde axonal protein transport,BP,
18225,GO:0099645,1,0.871449452202352,0,21,neurotransmitter receptor localization to postsynaptic specialization membrane,BP,
18226,GO:0099699,1,0.341561408257742,0,150,integral component of synaptic membrane,CC,
18227,GO:0099703,1,0.971587886099191,0,4,induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration,BP,
18229,GO:0100001,1,0.982596603514974,0,2,regulation of skeletal muscle contraction by action potential,BP,
18230,GO:0100002,1,0.993090458175472,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
18231,GO:0100012,1,0.9792309173857,0,4,regulation of heart induction by canonical Wnt signaling pathway,BP,
18232,GO:0100026,1,0.992464348804153,0,1,positive regulation of DNA repair by transcription from RNA polymerase II promoter,BP,
18233,GO:0101002,1,0.497080909536251,0,123,ficolin-1-rich granule,CC,
18234,GO:0101003,1,0.692135009348496,0,56,ficolin-1-rich granule membrane,CC,
18235,GO:0101005,1,0.552943251894748,0,80,ubiquitinyl hydrolase activity,MF,
18236,GO:0101006,1,0.985552748308656,0,3,protein histidine phosphatase activity,MF,
18237,GO:0101020,1,0.971675438543731,0,5,estrogen 16-alpha-hydroxylase activity,MF,
18238,GO:0101021,1,0.993582687174415,0,1,estrogen 2-hydroxylase activity,MF,
18239,GO:0101023,1,0.868488942046402,0,20,vascular endothelial cell proliferation,BP,
18240,GO:0101030,1,0.990273880491295,0,2,tRNA-guanine transglycosylation,BP,
18241,GO:0101031,1,0.884814824882585,0,23,chaperone complex,CC,
18242,GO:0102007,1,0.98811377284588,0,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18243,GO:0102008,1,0.992135045089912,0,1,cytosolic dipeptidase activity,MF,
18244,GO:0102009,1,0.99536100842981,0,1,proline dipeptidase activity,MF,
18245,GO:0102076,1,0.993101550136763,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18246,GO:0102077,1,0.989935167984493,0,2,oleamide hydrolase activity,MF,
18247,GO:0102084,1,0.987295709094674,0,2,L-dopa O-methyltransferase activity,MF,
18248,GO:0102092,1,0.983847577166758,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
18250,GO:0102113,1,0.991077839101146,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
18251,GO:0102121,1,0.973587664754817,0,4,ceramidase activity,MF,
18252,GO:0102131,1,0.990217175383171,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
18253,GO:0102132,1,0.990217175383171,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18254,GO:0102140,1,0.982160008615393,0,2,heparan sulfate N-deacetylase activity,MF,
18255,GO:0102148,1,0.98932783559106,0,2,N-acetyl-beta-D-galactosaminidase activity,MF,
18256,GO:0102158,1,0.973289247682012,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
18257,GO:0102193,1,0.991761479203919,0,2,protein-ribulosamine 3-kinase activity,MF,
18258,GO:0102194,1,0.996219837746443,0,1,protein-fructosamine 3-kinase activity,MF,
18259,GO:0102200,1,0.992033963528895,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity,MF,
18260,GO:0102250,1,0.978337799331193,0,3,linear malto-oligosaccharide phosphorylase activity,MF,
18261,GO:0102258,1,0.992490257774477,0,1,1,3-diacylglycerol acylhydrolase activity,MF,
18262,GO:0102259,1,0.992490257774477,0,1,1,2-diacylglycerol acylhydrolase activity,MF,
18263,GO:0102264,1,0.99325505912211,0,1,tRNA-dihydrouridine20 synthase activity,MF,
18264,GO:0102279,1,0.99219563124848,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18265,GO:0102336,1,0.960184917352038,0,6,3-oxo-arachidoyl-CoA synthase activity,MF,
18266,GO:0102337,1,0.960184917352038,0,6,3-oxo-cerotoyl-CoA synthase activity,MF,
18267,GO:0102338,1,0.960184917352038,0,6,3-oxo-lignoceronyl-CoA synthase activity,MF,
18268,GO:0102339,1,0.993735685605755,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18269,GO:0102340,1,0.993735685605755,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18270,GO:0102341,1,0.993735685605755,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18271,GO:0102342,1,0.993735685605755,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18272,GO:0102343,1,0.973289247682012,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
18273,GO:0102344,1,0.973289247682012,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
18274,GO:0102345,1,0.973289247682012,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
18275,GO:0102389,1,0.993471940349107,0,1,polyprenol reductase activity,MF,
18276,GO:0102390,1,0.99351041460083,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18277,GO:0102391,1,0.939768477150159,0,9,decanoate-CoA ligase activity,MF,
18278,GO:0102420,1,0.984561848787981,0,2,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
18279,GO:0102483,1,0.995810206885099,0,1,scopolin beta-glucosidase activity,MF,
18280,GO:0102485,1,0.976209822655234,0,3,dATP phosphohydrolase activity,MF,
18281,GO:0102486,1,0.976209822655234,0,3,dCTP phosphohydrolase activity,MF,
18282,GO:0102487,1,0.976209822655234,0,3,dUTP phosphohydrolase activity,MF,
18283,GO:0102488,1,0.976209822655234,0,3,dTTP phosphohydrolase activity,MF,
18284,GO:0102489,1,0.976209822655234,0,3,GTP phosphohydrolase activity,MF,
18285,GO:0102490,1,0.976209822655234,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18286,GO:0102491,1,0.976209822655234,0,3,dGTP phosphohydrolase activity,MF,
18287,GO:0102499,1,0.978337799331193,0,3,SHG alpha-glucan phosphorylase activity,MF,
18288,GO:0102500,1,0.990913874641184,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
18289,GO:0102521,1,0.992617307923411,0,1,tRNA-4-demethylwyosine synthase activity,MF,
18290,GO:0102522,1,0.994562805677027,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18291,GO:0102524,1,0.99325505912211,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
18292,GO:0102545,1,0.935344328266113,0,10,phosphatidyl phospholipase B activity,MF,
18293,GO:0102552,1,0.995827244315829,0,1,lipoyl synthase activity (acting on glycine-cleavage complex H protein,MF,
18294,GO:0102553,1,0.995827244315829,0,1,lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein),MF,
18295,GO:0102555,1,0.996685133878202,0,1,octanoyl transferase activity (acting on glycine-cleavage complex H protein),MF,
18296,GO:0102559,1,0.991669541923331,0,1,protein-(glutamine-N5) methyltransferase activity,MF,
18297,GO:0102567,1,0.916170301788807,0,14,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
18298,GO:0102568,1,0.916170301788807,0,14,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
18299,GO:0102704,1,0.993028291962859,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18300,GO:0102707,1,0.993700757557992,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
18301,GO:0102732,1,0.995588137296728,0,1,myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity,MF,
18302,GO:0102751,1,0.988201541009839,0,2,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
18303,GO:0102752,1,0.992784167791999,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
18304,GO:0102756,1,0.960184917352038,0,6,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
18305,GO:0102758,1,0.996521713468092,0,1,very-long-chain enoyl-CoA reductase activity,MF,
18306,GO:0102769,1,0.995905266408568,0,1,dihydroceramide glucosyltransferase activity,MF,
18307,GO:0102773,1,0.985405274972511,0,2,dihydroceramide kinase activity,MF,
18308,GO:0102797,1,0.992160599406998,0,1,geranial:oxygen oxidoreductase activity,MF,
18309,GO:0102798,1,0.992160599406998,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
18310,GO:0102867,1,0.993317609585772,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18311,GO:0102938,1,0.987295709094674,0,2,orcinol O-methyltransferase activity,MF,
18312,GO:0102953,1,0.981612440492953,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
18313,GO:0102965,1,0.986891612610964,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
18314,GO:0102991,1,0.950232881920891,0,10,myristoyl-CoA hydrolase activity,MF,
18315,GO:0103025,1,0.990570450737306,0,2,alpha-amylase activity (releasing maltohexaose),MF,
18316,GO:0103045,1,0.994924009284793,0,1,methione N-acyltransferase activity,MF,
18317,GO:0103046,1,0.992135045089912,0,1,alanylglutamate dipeptidase activity,MF,
18318,GO:0103053,1,0.99034818398424,0,2,1-ethyladenine demethylase activity,MF,
18319,GO:0103066,1,0.995963125742741,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
18320,GO:0103067,1,0.995963125742741,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
18321,GO:0103068,1,0.981612440492953,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
18322,GO:0103073,1,0.989935167984493,0,2,anandamide amidohydrolase activity,MF,
18324,GO:0106001,1,0.958311550867986,0,6,intestinal hexose absorption,BP,
18325,GO:0106003,1,0.991211748293703,0,1,amyloid-beta complex,CC,
18326,GO:0106004,1,0.992011312507434,0,2,tRNA (guanine-N7)-methylation,BP,
18327,GO:0106005,1,0.991473101845741,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
18328,GO:0106006,1,0.976979737788167,0,3,cytoskeletal protein-membrane anchor activity,MF,
18329,GO:0106014,1,0.974262465119322,0,5,regulation of inflammatory response to wounding,BP,
18330,GO:0106015,1,0.986062060131501,0,3,negative regulation of inflammatory response to wounding,BP,
18331,GO:0106016,1,0.991041996325412,0,2,positive regulation of inflammatory response to wounding,BP,
18332,GO:0106017,1,0.975695818763523,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
18333,GO:0106018,1,0.931798018606472,0,9,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
18334,GO:0106019,1,0.918946658916287,0,11,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
18335,GO:0106020,1,0.986965593930578,0,2,regulation of vesicle docking,BP,
18336,GO:0106022,1,0.992478314144187,0,1,positive regulation of vesicle docking,BP,
18337,GO:0106027,1,0.513539114011057,0,87,neuron projection organization,BP,
18338,GO:0106028,1,0.992199513435282,0,1,neuron projection retraction,BP,
18339,GO:0106029,1,0.983895444367943,0,3,tRNA pseudouridine synthase activity,MF,
18341,GO:0106035,1,0.996613856327904,0,1,protein maturation by [4Fe-4S] cluster transfer,BP,
18342,GO:0106040,1,0.991573088695961,0,1,regulation of GABA-A receptor activity,BP,
18343,GO:0106044,1,0.996698971982734,0,1,guanine deglycation,BP,
18344,GO:0106045,1,0.996698971982734,0,1,guanine deglycation, methylglyoxal removal,BP,
18345,GO:0106046,1,0.996698971982734,0,1,guanine deglycation, glyoxal removal,BP,
18346,GO:0106047,1,0.993412476660722,0,1,polyamine deacetylation,BP,
18347,GO:0106048,1,0.993412476660722,0,1,spermidine deacetylation,BP,
18348,GO:0106049,1,0.934089347159094,0,11,regulation of cellular response to osmotic stress,BP,
18349,GO:0106050,1,0.988495334107678,0,2,tRNA 2'-O-methyltransferase activity,MF,
18351,GO:0106057,1,0.912626820530304,0,14,negative regulation of calcineurin-mediated signaling,BP,
18353,GO:0106064,1,0.991722215232139,0,1,regulation of cobalamin metabolic process,BP,
18354,GO:0106068,1,0.966481620893257,0,7,SUMO ligase complex,CC,
18355,GO:0106070,1,0.925211715828109,0,12,regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,
18356,GO:0106071,1,0.967393870158923,0,5,positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,
18357,GO:0106072,1,0.948133941556943,0,9,negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,
18358,GO:0106073,1,0.982243534011594,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
18359,GO:0106074,1,0.949869898914314,0,8,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
18360,GO:0106075,1,0.992770099454922,0,1,peptide N-succinyltransferase activity,MF,
18361,GO:0106077,1,0.971131255193734,0,4,histone succinylation,BP,
18362,GO:0106078,1,0.992770099454922,0,1,histone succinyltransferase activity,MF,
18363,GO:0106083,1,0.931423051271335,0,8,nuclear membrane protein complex,CC,
18364,GO:0106088,1,0.991100653947099,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
18365,GO:0106089,1,0.991100653947099,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
18366,GO:0106091,1,0.991445150297391,0,2,glial cell projection elongation,BP,
18367,GO:0106094,1,0.931423051271335,0,8,nuclear membrane microtubule tethering complex,CC,
18368,GO:0106096,1,0.991746261575441,0,1,response to ceramide,BP,
18369,GO:0106101,1,0.995474688231342,0,1,ER-dependent peroxisome localization,BP,
18370,GO:0106104,1,0.959121795258313,0,5,regulation of glutamate receptor clustering,BP,
18371,GO:0106105,1,0.99325505912211,0,1,Ala-tRNA(Thr) hydrolase activity,MF,
18373,GO:0106118,1,0.751131257623405,0,42,regulation of sterol biosynthetic process,BP,
18374,GO:0106119,1,0.974174919482863,0,5,negative regulation of sterol biosynthetic process,BP,
18375,GO:0106120,1,0.956679353497216,0,6,positive regulation of sterol biosynthetic process,BP,
18376,GO:0106121,1,0.991722215232139,0,1,positive regulation of cobalamin metabolic process,BP,
18377,GO:0106130,1,0.993046290868714,0,2,purine phosphoribosyltransferase activity,MF,
18378,GO:0106134,1,0.970168003902513,0,4,positive regulation of cardiac muscle cell contraction,BP,
18379,GO:0106135,1,0.987151945156203,0,2,negative regulation of cardiac muscle cell contraction,BP,
18380,GO:0106137,1,0.992532651688149,0,1,IkappaB kinase complex binding,MF,
18381,GO:0106138,1,0.991506567773342,0,1,Sec61 translocon complex binding,MF,
18382,GO:0106140,1,0.979201843947702,0,3,P-TEFb complex binding,MF,
18383,GO:0106153,1,0.996535804182251,0,1,phosphorylated histone binding,MF,
18384,GO:0110008,1,0.992842734888487,0,1,ncRNA deadenylation,BP,
18385,GO:0110009,1,0.976129950212521,0,3,formin-nucleated actin cable organization,BP,
18386,GO:0110011,1,0.9573699714141,0,5,regulation of basement membrane organization,BP,
18387,GO:0110017,1,0.992641108066666,0,2,cap-independent translational initiation of linear mRNA,BP,
18388,GO:0110020,1,0.514206417058545,0,92,regulation of actomyosin structure organization,BP,
18389,GO:0110021,1,0.980015962703527,0,3,cardiac muscle myoblast proliferation,BP,
18390,GO:0110022,1,0.980015962703527,0,3,regulation of cardiac muscle myoblast proliferation,BP,
18391,GO:0110024,1,0.980015962703527,0,3,positive regulation of cardiac muscle myoblast proliferation,BP,
18392,GO:0110025,1,0.985596383764956,0,2,DNA strand resection involved in replication fork processing,BP,
18393,GO:0110026,1,0.992837878362186,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
18394,GO:0110028,1,0.990917185225543,0,1,positive regulation of mitotic spindle organization,BP,
18395,GO:0110030,1,0.980231004365714,0,3,regulation of G2/MI transition of meiotic cell cycle,BP,
18396,GO:0110032,1,0.980231004365714,0,3,positive regulation of G2/MI transition of meiotic cell cycle,BP,
18398,GO:0110057,1,0.991884722711064,0,1,regulation of blood vessel endothelial cell differentiation,BP,
18399,GO:0110059,1,0.991884722711064,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
18400,GO:0110061,1,0.982636346767109,0,2,regulation of angiotensin-activated signaling pathway,BP,
18401,GO:0110070,1,0.99526624345881,0,1,cellularization cleavage furrow,CC,
18402,GO:0110075,1,0.989393591154071,0,2,regulation of ferroptosis,BP,
18403,GO:0110076,1,0.989393591154071,0,2,negative regulation of ferroptosis,BP,
18404,GO:0110077,1,0.992978904879283,0,1,vesicle-mediated intercellular transport,BP,
18405,GO:0110088,1,0.974706946888531,0,4,hippocampal neuron apoptotic process,BP,
18406,GO:0110089,1,0.974706946888531,0,4,regulation of hippocampal neuron apoptotic process,BP,
18407,GO:0110090,1,0.989116367704751,0,2,positive regulation of hippocampal neuron apoptotic process,BP,
18408,GO:0110091,1,0.985433641775764,0,2,negative regulation of hippocampal neuron apoptotic process,BP,
18409,GO:0110095,1,0.963634450167684,0,8,cellular detoxification of aldehyde,BP,
18410,GO:0110096,1,0.954813715817864,0,10,cellular response to aldehyde,BP,
18411,GO:0110097,1,0.994325567994985,0,1,regulation of calcium import into the mitochondrion,BP,
18412,GO:0110104,1,0.97632924361779,0,3,mRNA alternative polyadenylation,BP,
18415,GO:0110112,1,0.98869397948518,0,2,regulation of lipid transporter activity,BP,
18416,GO:0110113,1,0.993215885492504,0,1,positive regulation of lipid transporter activity,BP,
18420,GO:0110151,1,0.75747242444535,0,41,positive regulation of biomineralization,BP,
18421,GO:0110154,1,0.928407492728631,0,12,RNA decapping,BP,
18422,GO:0110156,1,0.928407492728631,0,12,methylguanosine-cap decapping,BP,
18424,GO:0120001,1,0.991710157655747,0,2,apical plasma membrane urothelial plaque,CC,
18426,GO:0120009,1,0.794109941071992,0,36,intermembrane lipid transfer,BP,
18427,GO:0120013,1,0.807485069924728,0,34,lipid transfer activity,MF,
18428,GO:0120014,1,0.901024439905566,0,17,phospholipid transfer activity,MF,
18429,GO:0120015,1,0.891590361913346,0,18,sterol transfer activity,MF,
18430,GO:0120016,1,0.965291885659352,0,6,sphingolipid transfer activity,MF,
18431,GO:0120017,1,0.965291885659352,0,6,ceramide transfer activity,MF,
18432,GO:0120019,1,0.99582347391602,0,1,phosphatidylcholine transfer activity,MF,
18433,GO:0120020,1,0.898701106787681,0,17,cholesterol transfer activity,MF,
18437,GO:0120033,1,0.859458275042675,0,24,negative regulation of plasma membrane bounded cell projection assembly,BP,
18442,GO:0120040,1,0.962443394893064,0,6,regulation of macrophage proliferation,BP,
18443,GO:0120041,1,0.968740492905541,0,5,positive regulation of macrophage proliferation,BP,
18444,GO:0120042,1,0.993501805286691,0,1,negative regulation of macrophage proliferation,BP,
18445,GO:0120043,1,0.992349330399232,0,1,stereocilium shaft,CC,
18446,GO:0120044,1,0.984737495024281,0,2,stereocilium base,CC,
18447,GO:0120045,1,0.993863069178394,0,1,stereocilium maintenance,BP,
18448,GO:0120048,1,0.99325505912211,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
18449,GO:0120049,1,0.985813722522634,0,2,snRNA (adenine-N6)-methylation,BP,
18450,GO:0120054,1,0.996800221570978,0,1,intestinal motility,BP,
18451,GO:0120055,1,0.996800221570978,0,1,small intestinal transit,BP,
18452,GO:0120057,1,0.996800221570978,0,1,regulation of small intestinal transit,BP,
18453,GO:0120058,1,0.996800221570978,0,1,positive regulation of small intestinal transit,BP,
18454,GO:0120060,1,0.993014098395755,0,2,regulation of gastric emptying,BP,
18455,GO:0120061,1,0.993014098395755,0,2,negative regulation of gastric emptying,BP,
18456,GO:0120063,1,0.988834997818736,0,2,stomach smooth muscle contraction,BP,
18457,GO:0120064,1,0.992049146936613,0,1,stomach pylorus smooth muscle contraction,BP,
18458,GO:0120065,1,0.992049146936613,0,1,pyloric antrum smooth muscle contraction,BP,
18459,GO:0120068,1,0.996760354949418,0,1,regulation of stomach fundus smooth muscle contraction,BP,
18460,GO:0120069,1,0.996760354949418,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
18461,GO:0120071,1,0.992049146936613,0,1,regulation of pyloric antrum smooth muscle contraction,BP,
18462,GO:0120072,1,0.992049146936613,0,1,positive regulation of pyloric antrum smooth muscle contraction,BP,
18463,GO:0120077,1,0.991100653947099,0,1,angiogenic sprout fusion,BP,
18464,GO:0120078,1,0.991100653947099,0,1,cell adhesion involved in sprouting angiogenesis,BP,
18465,GO:0120092,1,0.992604096939124,0,1,crotonyl-CoA hydratase activity,MF,
18466,GO:0120093,1,0.992604096939124,0,1,regulation of peptidyl-lysine crotonylation,BP,
18467,GO:0120094,1,0.992604096939124,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
18468,GO:0120103,1,0.933699421987592,0,9,centriolar subdistal appendage,CC,
18469,GO:0120111,1,0.540392879666969,0,86,neuron projection cytoplasm,CC,
18470,GO:0120114,1,0.670411904445475,0,73,Sm-like protein family complex,CC,
18471,GO:0120115,1,0.971551211360923,0,7,Lsm2-8 complex,CC,
18472,GO:0120117,1,0.992641463159267,0,1,T cell meandering migration,BP,
18473,GO:0120127,1,0.994470584302603,0,1,response to zinc ion starvation,BP,
18474,GO:0120134,1,0.987381142791216,0,1,proximal portion of axoneme,CC,
18475,GO:0120135,1,0.990223302374688,0,1,distal portion of axoneme,CC,
18476,GO:0120146,1,0.973545295827026,0,5,sulfatide binding,MF,
18477,GO:0120147,1,0.994844773262842,0,1,Formylglycine-generating oxidase activity,MF,
18478,GO:0120153,1,0.996337752721494,0,1,calcium-dependent carbohydrate binding,MF,
18479,GO:0120160,1,0.985173449771583,0,2,intraciliary transport particle A binding,MF,
18483,GO:0120168,1,0.992394115883539,0,1,detection of hot stimulus involved in thermoception,BP,
18484,GO:0120169,1,0.992280120968723,0,1,detection of cold stimulus involved in thermoception,BP,
18485,GO:0120170,1,0.965646825247196,0,5,intraciliary transport particle B binding,MF,
18486,GO:0120178,1,0.801044723391387,0,38,steroid hormone biosynthetic process,BP,
18487,GO:0120180,1,0.960733246746904,0,5,cell-substrate junction disassembly,BP,
18488,GO:0120181,1,0.960733246746904,0,5,focal adhesion disassembly,BP,
18489,GO:0120182,1,0.960733246746904,0,5,regulation of focal adhesion disassembly,BP,
18490,GO:0120183,1,0.960733246746904,0,5,positive regulation of focal adhesion disassembly,BP,
18491,GO:0120187,1,0.989352680569835,0,1,positive regulation of protein localization to chromatin,BP,
18492,GO:0120188,1,0.987340592113436,0,2,regulation of bile acid secretion,BP,
18493,GO:0120189,1,0.99223490144715,0,1,positive regulation of bile acid secretion,BP,
18494,GO:0120191,1,0.986555151512788,0,2,negative regulation of termination of RNA polymerase II transcription,BP,
18497,GO:0120222,1,0.990885480912164,0,1,regulation of blastocyst development,BP,
18498,GO:0120227,1,0.880473295771402,0,22,acyl-CoA binding,MF,
18499,GO:0120252,1,0.9501782891918,0,9,hydrocarbon metabolic process,BP,
18500,GO:0120253,1,0.98105147312236,0,3,hydrocarbon catabolic process,BP,
18501,GO:0120254,1,0.54332580689675,0,102,olefinic compound metabolic process,BP,
18502,GO:0120255,1,0.837662972759023,0,28,olefinic compound biosynthetic process,BP,
18503,GO:0120256,1,0.994575796660225,0,1,olefinic compound catabolic process,BP,
18504,GO:0140007,1,0.977016217865452,0,4,KICSTOR complex,CC,
18505,GO:0140009,1,0.972980437692426,0,4,L-aspartate import across plasma membrane,BP,
18506,GO:0140010,1,0.992500590259723,0,1,D-aspartate transmembrane transporter activity,MF,
18507,GO:0140013,1,0.394382684990394,0,142,meiotic nuclear division,BP,
18509,GO:0140029,1,0.588720057838527,0,81,exocytic process,BP,
18510,GO:0140030,1,0.389690635470548,0,134,modification-dependent protein binding,MF,
18511,GO:0140031,1,0.974466759499984,0,4,phosphorylation-dependent protein binding,MF,
18512,GO:0140033,1,0.850761911976748,0,21,acetylation-dependent protein binding,MF,
18513,GO:0140034,1,0.650140620480685,0,62,methylation-dependent protein binding,MF,
18514,GO:0140035,1,0.926511733528443,0,11,ubiquitination-like modification-dependent protein binding,MF,
18515,GO:0140036,1,0.939025015751373,0,9,ubiquitin-dependent protein binding,MF,
18516,GO:0140037,1,0.986682667662801,0,2,sumo-dependent protein binding,MF,
18517,GO:0140039,1,0.984542616415829,0,2,cell-cell adhesion in response to extracellular stimulus,BP,
18518,GO:0140041,1,0.996698971982734,0,1,cellular detoxification of methylglyoxal,BP,
18519,GO:0140042,1,0.949107432584742,0,9,lipid droplet formation,BP,
18520,GO:0140049,1,0.995854312720373,0,1,regulation of endocardial cushion to mesenchymal transition,BP,
18521,GO:0140051,1,0.995854312720373,0,1,positive regulation of endocardial cushion to mesenchymal transition,BP,
18522,GO:0140052,1,0.931605116076901,0,10,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
18523,GO:0140053,1,0.458439818557435,0,156,mitochondrial gene expression,BP,
18526,GO:0140059,1,0.956993029265045,0,7,dendrite arborization,BP,
18527,GO:0140064,1,0.99006278034269,0,1,peptide crotonyltransferase activity,MF,
18528,GO:0140065,1,0.99006278034269,0,1,peptide butyryltransferase activity,MF,
18529,GO:0140066,1,0.98273962966387,0,2,peptidyl-lysine crotonylation,BP,
18530,GO:0140067,1,0.99006278034269,0,1,peptidyl-lysine butyrylation,BP,
18531,GO:0140068,1,0.99006278034269,0,1,histone crotonyltransferase activity,MF,
18532,GO:0140069,1,0.99006278034269,0,1,histone butyryltransferase activity,MF,
18533,GO:0140074,1,0.985707903731207,0,2,cardiac endothelial to mesenchymal transition,BP,
18534,GO:0140078,1,0.966972942769405,0,7,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18535,GO:0140081,1,0.990421759059792,0,2,glycosylated region protein binding,MF,
18536,GO:0140090,1,0.982986034610389,0,3,membrane curvature sensor activity,MF,
18538,GO:0140097,1,0.269583169371764,0,194,catalytic activity, acting on DNA,MF,
18539,GO:0140098,1,0.120446103210915,0,333,catalytic activity, acting on RNA,MF,
18540,GO:0140101,1,0.562439663329141,0,96,catalytic activity, acting on a tRNA,MF,
18541,GO:0140102,1,0.909676913761753,0,17,catalytic activity, acting on a rRNA,MF,
18542,GO:0140103,1,0.883163509328859,0,19,catalytic activity, acting on a glycoprotein,MF,
18545,GO:0140112,1,0.885964201037866,0,20,extracellular vesicle biogenesis,BP,
18547,GO:0140131,1,0.905245966830018,0,17,positive regulation of lymphocyte chemotaxis,BP,
18548,GO:0140135,1,0.973505770016882,0,4,mechanosensitive cation channel activity,MF,
18549,GO:0140142,1,0.812047134780281,0,28,nucleocytoplasmic carrier activity,MF,
18550,GO:0140157,1,0.975217612921917,0,3,ammonium import across plasma membrane,BP,
18551,GO:0140161,1,0.951030291698889,0,9,monocarboxylate:sodium symporter activity,MF,
18552,GO:0140192,1,0.975834720147492,0,3,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18553,GO:0140193,1,0.996330447290537,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18554,GO:0140194,1,0.996330447290537,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18555,GO:0140196,1,0.990947004700222,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18556,GO:0140199,1,0.984751056470082,0,2,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18557,GO:0140200,1,0.99041258849186,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
18558,GO:0140205,1,0.981573926090719,0,2,oligopeptide import across plasma membrane,BP,
18559,GO:0140206,1,0.981573926090719,0,2,dipeptide import across plasma membrane,BP,
18560,GO:0140212,1,0.957764288092931,0,6,regulation of long-chain fatty acid import into cell,BP,
18561,GO:0140213,1,0.96821197547204,0,4,negative regulation of long-chain fatty acid import into cell,BP,
18562,GO:0140214,1,0.989212834482747,0,2,positive regulation of long-chain fatty acid import into cell,BP,
18563,GO:0140223,1,0.798176280097939,0,40,general transcription initiation factor activity,MF,
18564,GO:0140238,1,0.644659781454746,0,61,presynaptic endocytosis,BP,
18565,GO:0140239,1,0.868088723112318,0,20,postsynaptic endocytosis,BP,
18566,GO:0140243,1,0.978174671101026,0,3,regulation of translation at synapse,BP,
18567,GO:0140245,1,0.987989038718168,0,2,regulation of translation at postsynapse,BP,
18568,GO:0140246,1,0.991763135110938,0,1,protein catabolic process at synapse,BP,
18569,GO:0140253,1,0.747716916483585,0,45,cell-cell fusion,BP,
18570,GO:0140261,1,0.99138120147466,0,1,BCOR complex,CC,
18571,GO:0140271,1,0.958964694835136,0,6,hexose import across plasma membrane,BP,
18573,GO:0140296,1,0.759087834766827,0,44,general transcription initiation factor binding,MF,
18574,GO:0140297,1,0.109092313371925,0,329,DNA-binding transcription factor binding,MF,
18575,GO:0140299,1,0.931112530548588,0,10,small molecule sensor activity,MF,
18576,GO:0140303,1,0.863238411207305,0,19,intramembrane lipid transporter activity,MF,
18577,GO:0140312,1,0.889136565820707,0,17,cargo adaptor activity,MF,
18578,GO:0140318,1,0.907255026919862,0,17,protein transporter activity,MF,
18579,GO:0140321,1,0.992153431733136,0,1,negative regulation by symbiont of host autophagy,BP,
18580,GO:0140323,1,0.834148377486185,0,25,solute:anion antiporter activity,MF,
18581,GO:0140326,1,0.911369520110537,0,11,ATPase-coupled intramembrane lipid transporter activity,MF,
18582,GO:0140327,1,0.95250951603205,0,6,flippase activity,MF,
18583,GO:0140328,1,0.949354583347369,0,6,floppase activity,MF,
18584,GO:0140333,1,0.983088838605024,0,2,glycerophospholipid flippase activity,MF,
18586,GO:0140353,1,0.820259133719003,0,33,lipid export from cell,BP,
18587,GO:0140354,1,0.89410203512505,0,16,lipid import into cell,BP,
18589,GO:0140410,1,0.951235906159887,0,6,solute:bicarbonate symporter activity,MF,
18590,GO:0140414,1,0.996815956228427,0,1,phosphopantetheine-dependent carrier activity,MF,
18591,GO:0140445,1,0.931802036908987,0,11,chromosome, telomeric repeat region,CC,
18593,GO:0140455,1,0.995885454443387,0,1,cytoplasm protein quality control,BP,
18594,GO:0140457,1,0.814639533228089,0,25,protein demethylase activity,MF,
18595,GO:0140461,1,0.995896293794625,0,1,subtelomeric heterochromatin organization,BP,
18596,GO:0140462,1,0.98933236145058,0,2,pericentric heterochromatin organization,BP,
18598,GO:0140507,1,0.97493691424955,0,5,granzyme-mediated programmed cell death signaling pathway,BP,
18599,GO:0150001,1,0.981162506114477,0,2,primary dendrite,CC,
18600,GO:0150002,1,0.984344997989594,0,2,distal dendrite,CC,
18601,GO:0150003,1,0.9550486933757,0,6,regulation of spontaneous synaptic transmission,BP,
18602,GO:0150005,1,0.981660201630913,0,4,enzyme activator complex,CC,
18603,GO:0150007,1,0.9832354279548,0,2,clathrin-dependent synaptic vesicle endocytosis,BP,
18604,GO:0150011,1,0.89168536648653,0,14,regulation of neuron projection arborization,BP,
18605,GO:0150012,1,0.93925735737817,0,8,positive regulation of neuron projection arborization,BP,
18606,GO:0150014,1,0.991783411295803,0,1,apical distal dendrite,CC,
18607,GO:0150018,1,0.978058022638892,0,3,basal dendrite development,BP,
18608,GO:0150019,1,0.978058022638892,0,3,basal dendrite morphogenesis,BP,
18609,GO:0150020,1,0.978058022638892,0,3,basal dendrite arborization,BP,
18610,GO:0150024,1,0.994926554507968,0,1,oxidised low-density lipoprotein particle clearance,BP,
18611,GO:0150025,1,0.994926554507968,0,1,oxidised low-density lipoprotein particle receptor activity,MF,
18612,GO:0150031,1,0.986392185850922,0,2,regulation of protein localization to lysosome,BP,
18613,GO:0150032,1,0.995000029141892,0,1,positive regulation of protein localization to lysosome,BP,
18614,GO:0150033,1,0.991349342054098,0,1,negative regulation of protein localization to lysosome,BP,
18616,GO:0150051,1,0.954555177087817,0,5,postsynaptic Golgi apparatus,CC,
18617,GO:0150052,1,0.909739996364381,0,13,regulation of postsynapse assembly,BP,
18618,GO:0150056,1,0.989258974540017,0,2,amylin receptor complex 1,CC,
18619,GO:0150057,1,0.989317737150367,0,2,amylin receptor complex 2,CC,
18620,GO:0150058,1,0.988885796112704,0,2,amylin receptor complex 3,CC,
18621,GO:0150062,1,0.977706569686286,0,4,complement-mediated synapse pruning,BP,
18623,GO:0150064,1,0.98102247568813,0,3,vertebrate eye-specific patterning,BP,
18624,GO:0150065,1,0.921609267222716,0,11,regulation of deacetylase activity,BP,
18625,GO:0150066,1,0.981999654354215,0,2,negative regulation of deacetylase activity,BP,
18626,GO:0150070,1,0.994461498392785,0,1,regulation of arginase activity,BP,
18627,GO:0150072,1,0.994461498392785,0,1,positive regulation of arginase activity,BP,
18628,GO:0150073,1,0.994461498392785,0,1,regulation of protein-glutamine gamma-glutamyltransferase activity,BP,
18629,GO:0150074,1,0.994461498392785,0,1,positive regulation of protein-glutamine gamma-glutamyltransferase activity,BP,
18631,GO:0150077,1,0.832987735778368,0,29,regulation of neuroinflammatory response,BP,
18632,GO:0150078,1,0.935071074881012,0,12,positive regulation of neuroinflammatory response,BP,
18633,GO:0150079,1,0.929196736991272,0,11,negative regulation of neuroinflammatory response,BP,
18634,GO:0150089,1,0.992722568148623,0,1,multiple spine synapse organization,BP,
18635,GO:0150090,1,0.992722568148623,0,1,multiple spine synapse organization, single dendrite,BP,
18636,GO:0150093,1,0.950555275603936,0,7,amyloid-beta clearance by transcytosis,BP,
18637,GO:0150094,1,0.940918156569992,0,7,amyloid-beta clearance by cellular catabolic process,BP,
18638,GO:0150098,1,0.985031387575391,0,2,glial cell-neuron signaling,BP,
18639,GO:0150100,1,0.992814805989691,0,2,RNA binding involved in posttranscriptional gene silencing,MF,
18640,GO:0150104,1,0.936192794584437,0,11,transport across blood-brain barrier,BP,
18641,GO:0150105,1,0.907060041492045,0,13,protein localization to cell-cell junction,BP,
18642,GO:0150106,1,0.991933904800663,0,1,regulation of protein localization to cell-cell junction,BP,
18645,GO:0150117,1,0.810644304458231,0,28,positive regulation of cell-substrate junction organization,BP,
18647,GO:0150146,1,0.885264672139296,0,19,cell junction disassembly,BP,
18648,GO:0150147,1,0.97911462779167,0,3,cell-cell junction disassembly,BP,
18649,GO:0150172,1,0.953545745303043,0,8,regulation of phosphatidylcholine metabolic process,BP,
18650,GO:0150173,1,0.981366706395942,0,3,positive regulation of phosphatidylcholine metabolic process,BP,
18651,GO:0150200,1,0.996514293846025,0,1,regulation of transport across blood-brain barrier,BP,
18652,GO:0150201,1,0.996514293846025,0,1,positive regulation of transport across blood-brain barrier,BP,
18654,GO:1900003,1,0.976182978282472,0,4,regulation of serine-type endopeptidase activity,BP,
18655,GO:1900004,1,0.976182978282472,0,4,negative regulation of serine-type endopeptidase activity,BP,
18656,GO:1900005,1,0.989778504671728,0,1,positive regulation of serine-type endopeptidase activity,BP,
18657,GO:1900006,1,0.587273118017573,0,71,positive regulation of dendrite development,BP,
18658,GO:1900010,1,0.99548929186194,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18659,GO:1900011,1,0.99548929186194,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18662,GO:1900017,1,0.889666085469696,0,18,positive regulation of cytokine production involved in inflammatory response,BP,
18665,GO:1900022,1,0.992546285568801,0,1,regulation of D-erythro-sphingosine kinase activity,BP,
18666,GO:1900024,1,0.733466073883356,0,48,regulation of substrate adhesion-dependent cell spreading,BP,
18667,GO:1900025,1,0.920418284223593,0,12,negative regulation of substrate adhesion-dependent cell spreading,BP,
18668,GO:1900026,1,0.803110948896539,0,35,positive regulation of substrate adhesion-dependent cell spreading,BP,
18669,GO:1900027,1,0.852905109178384,0,26,regulation of ruffle assembly,BP,
18670,GO:1900028,1,0.966602253410147,0,6,negative regulation of ruffle assembly,BP,
18671,GO:1900029,1,0.929063655281033,0,12,positive regulation of ruffle assembly,BP,
18672,GO:1900034,1,0.598291813951217,0,75,regulation of cellular response to heat,BP,
18673,GO:1900035,1,0.993355888538386,0,1,negative regulation of cellular response to heat,BP,
18674,GO:1900036,1,0.994244522954111,0,1,positive regulation of cellular response to heat,BP,
18675,GO:1900037,1,0.922016314607838,0,13,regulation of cellular response to hypoxia,BP,
18676,GO:1900038,1,0.957061791455714,0,7,negative regulation of cellular response to hypoxia,BP,
18677,GO:1900039,1,0.989130024671994,0,2,positive regulation of cellular response to hypoxia,BP,
18678,GO:1900044,1,0.912790963256159,0,12,regulation of protein K63-linked ubiquitination,BP,
18679,GO:1900045,1,0.949927569194782,0,7,negative regulation of protein K63-linked ubiquitination,BP,
18682,GO:1900048,1,0.852463962345385,0,25,positive regulation of hemostasis,BP,
18683,GO:1900052,1,0.989034998102376,0,2,regulation of retinoic acid biosynthetic process,BP,
18684,GO:1900053,1,0.996467631790623,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18685,GO:1900054,1,0.992541287326394,0,1,positive regulation of retinoic acid biosynthetic process,BP,
18686,GO:1900060,1,0.973762774859739,0,5,negative regulation of ceramide biosynthetic process,BP,
18687,GO:1900062,1,0.992502477567624,0,1,regulation of replicative cell aging,BP,
18688,GO:1900063,1,0.976138328892256,0,3,regulation of peroxisome organization,BP,
18689,GO:1900069,1,0.973565000577393,0,4,regulation of cellular hyperosmotic salinity response,BP,
18690,GO:1900073,1,0.996001237716016,0,1,regulation of neuromuscular synaptic transmission,BP,
18691,GO:1900075,1,0.996001237716016,0,1,positive regulation of neuromuscular synaptic transmission,BP,
18692,GO:1900076,1,0.63089641669113,0,68,regulation of cellular response to insulin stimulus,BP,
18693,GO:1900077,1,0.806237499309134,0,32,negative regulation of cellular response to insulin stimulus,BP,
18694,GO:1900078,1,0.848113829548975,0,23,positive regulation of cellular response to insulin stimulus,BP,
18695,GO:1900079,1,0.995338722526488,0,1,regulation of arginine biosynthetic process,BP,
18696,GO:1900081,1,0.990038223672271,0,1,regulation of arginine catabolic process,BP,
18697,GO:1900082,1,0.990038223672271,0,1,negative regulation of arginine catabolic process,BP,
18699,GO:1900085,1,0.993447727017397,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18702,GO:1900094,1,0.963145299013504,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18703,GO:1900095,1,0.989130256891919,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18704,GO:1900098,1,0.995561088920931,0,1,regulation of plasma cell differentiation,BP,
18705,GO:1900100,1,0.995561088920931,0,1,positive regulation of plasma cell differentiation,BP,
18707,GO:1900102,1,0.926253068110651,0,12,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18709,GO:1900104,1,0.981138752442522,0,3,regulation of hyaluranon cable assembly,BP,
18710,GO:1900106,1,0.981138752442522,0,3,positive regulation of hyaluranon cable assembly,BP,
18711,GO:1900107,1,0.960509659649213,0,7,regulation of nodal signaling pathway,BP,
18712,GO:1900108,1,0.985267088174994,0,3,negative regulation of nodal signaling pathway,BP,
18713,GO:1900109,1,0.986154344734541,0,3,regulation of histone H3-K9 dimethylation,BP,
18714,GO:1900110,1,0.992252606504413,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18715,GO:1900111,1,0.993854610991543,0,1,positive regulation of histone H3-K9 dimethylation,BP,
18716,GO:1900112,1,0.931181645575169,0,10,regulation of histone H3-K9 trimethylation,BP,
18717,GO:1900113,1,0.970439275961549,0,5,negative regulation of histone H3-K9 trimethylation,BP,
18718,GO:1900114,1,0.976924429393741,0,3,positive regulation of histone H3-K9 trimethylation,BP,
18722,GO:1900118,1,0.929827415993722,0,11,negative regulation of execution phase of apoptosis,BP,
18725,GO:1900121,1,0.919407874555657,0,13,negative regulation of receptor binding,BP,
18727,GO:1900125,1,0.941230729720722,0,8,regulation of hyaluronan biosynthetic process,BP,
18728,GO:1900126,1,0.969656390956323,0,4,negative regulation of hyaluronan biosynthetic process,BP,
18729,GO:1900127,1,0.970693882057082,0,4,positive regulation of hyaluronan biosynthetic process,BP,
18730,GO:1900130,1,0.992520038295476,0,1,regulation of lipid binding,BP,
18731,GO:1900131,1,0.992520038295476,0,1,negative regulation of lipid binding,BP,
18732,GO:1900133,1,0.978938575107784,0,3,regulation of renin secretion into blood stream,BP,
18733,GO:1900134,1,0.992490723325481,0,1,negative regulation of renin secretion into blood stream,BP,
18734,GO:1900135,1,0.986346357305842,0,2,positive regulation of renin secretion into blood stream,BP,
18735,GO:1900138,1,0.988407416623689,0,2,negative regulation of phospholipase A2 activity,BP,
18736,GO:1900139,1,0.992121788343522,0,1,negative regulation of arachidonic acid secretion,BP,
18737,GO:1900141,1,0.984183674822053,0,2,regulation of oligodendrocyte apoptotic process,BP,
18738,GO:1900142,1,0.993818551343362,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
18739,GO:1900143,1,0.990305805369873,0,1,positive regulation of oligodendrocyte apoptotic process,BP,
18740,GO:1900145,1,0.97260827473201,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18741,GO:1900146,1,0.992231481160557,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18742,GO:1900147,1,0.971490626454381,0,3,regulation of Schwann cell migration,BP,
18743,GO:1900148,1,0.99325505912211,0,1,negative regulation of Schwann cell migration,BP,
18744,GO:1900149,1,0.978089265025629,0,2,positive regulation of Schwann cell migration,BP,
18745,GO:1900150,1,0.984635842054656,0,3,regulation of defense response to fungus,BP,
18746,GO:1900151,1,0.880607602491244,0,18,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18747,GO:1900152,1,0.995529313122427,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18748,GO:1900153,1,0.880607602491244,0,18,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18753,GO:1900159,1,0.994152611553279,0,1,positive regulation of bone mineralization involved in bone maturation,BP,
18754,GO:1900161,1,0.993215885492504,0,1,regulation of phospholipid scramblase activity,BP,
18755,GO:1900163,1,0.993215885492504,0,1,positive regulation of phospholipid scramblase activity,BP,
18756,GO:1900164,1,0.963145299013504,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18757,GO:1900166,1,0.975965306352714,0,3,regulation of glial cell-derived neurotrophic factor secretion,BP,
18758,GO:1900168,1,0.975965306352714,0,3,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18759,GO:1900169,1,0.981149052684361,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18760,GO:1900170,1,0.99325505912211,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18761,GO:1900175,1,0.97260827473201,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18762,GO:1900176,1,0.992231481160557,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18766,GO:1900186,1,0.97669073953186,0,4,negative regulation of clathrin-dependent endocytosis,BP,
18767,GO:1900190,1,0.994152611553279,0,1,regulation of single-species biofilm formation,BP,
18768,GO:1900191,1,0.994152611553279,0,1,negative regulation of single-species biofilm formation,BP,
18769,GO:1900193,1,0.952609154972057,0,8,regulation of oocyte maturation,BP,
18770,GO:1900194,1,0.982363193974771,0,3,negative regulation of oocyte maturation,BP,
18771,GO:1900195,1,0.982154769900084,0,3,positive regulation of oocyte maturation,BP,
18772,GO:1900200,1,0.984991601333973,0,2,mesenchymal cell apoptotic process involved in metanephros development,BP,
18773,GO:1900204,1,0.984991601333973,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18774,GO:1900205,1,0.984991601333973,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18775,GO:1900208,1,0.984401310135824,0,4,regulation of cardiolipin metabolic process,BP,
18776,GO:1900210,1,0.991861725685985,0,2,positive regulation of cardiolipin metabolic process,BP,
18777,GO:1900211,1,0.984991601333973,0,2,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18778,GO:1900212,1,0.984991601333973,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18779,GO:1900214,1,0.984991601333973,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18780,GO:1900215,1,0.984991601333973,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18781,GO:1900217,1,0.984991601333973,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18782,GO:1900218,1,0.984991601333973,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18783,GO:1900220,1,0.983296569647059,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18784,GO:1900221,1,0.909778074783337,0,14,regulation of amyloid-beta clearance,BP,
18785,GO:1900222,1,0.956182265404266,0,7,negative regulation of amyloid-beta clearance,BP,
18786,GO:1900223,1,0.959196056378461,0,6,positive regulation of amyloid-beta clearance,BP,
18787,GO:1900224,1,0.984155020159468,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18788,GO:1900225,1,0.91752082332828,0,12,regulation of NLRP3 inflammasome complex assembly,BP,
18789,GO:1900226,1,0.972678013246901,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18790,GO:1900227,1,0.949605503013381,0,7,positive regulation of NLRP3 inflammasome complex assembly,BP,
18791,GO:1900228,1,0.994152611553279,0,1,regulation of single-species biofilm formation in or on host organism,BP,
18792,GO:1900229,1,0.994152611553279,0,1,negative regulation of single-species biofilm formation in or on host organism,BP,
18793,GO:1900234,1,0.991928663226472,0,1,regulation of Kit signaling pathway,BP,
18794,GO:1900235,1,0.991928663226472,0,1,negative regulation of Kit signaling pathway,BP,
18795,GO:1900238,1,0.978222955236897,0,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
18796,GO:1900239,1,0.961176956108908,0,6,regulation of phenotypic switching,BP,
18797,GO:1900240,1,0.984329551230839,0,2,negative regulation of phenotypic switching,BP,
18798,GO:1900241,1,0.989733405545177,0,2,positive regulation of phenotypic switching,BP,
18799,GO:1900242,1,0.882916810139983,0,17,regulation of synaptic vesicle endocytosis,BP,
18800,GO:1900243,1,0.992015457543922,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18801,GO:1900244,1,0.951433237160609,0,7,positive regulation of synaptic vesicle endocytosis,BP,
18802,GO:1900245,1,0.975216476545714,0,3,positive regulation of MDA-5 signaling pathway,BP,
18803,GO:1900246,1,0.951759008694407,0,6,positive regulation of RIG-I signaling pathway,BP,
18804,GO:1900247,1,0.941820740788281,0,9,regulation of cytoplasmic translational elongation,BP,
18805,GO:1900248,1,0.983576354295645,0,2,negative regulation of cytoplasmic translational elongation,BP,
18806,GO:1900259,1,0.995363345957794,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18807,GO:1900260,1,0.995363345957794,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18808,GO:1900262,1,0.95544580221009,0,9,regulation of DNA-directed DNA polymerase activity,BP,
18809,GO:1900264,1,0.95544580221009,0,9,positive regulation of DNA-directed DNA polymerase activity,BP,
18810,GO:1900271,1,0.725498337289866,0,45,regulation of long-term synaptic potentiation,BP,
18811,GO:1900272,1,0.925273251504429,0,12,negative regulation of long-term synaptic potentiation,BP,
18814,GO:1900275,1,0.984431131369811,0,2,negative regulation of phospholipase C activity,BP,
18815,GO:1900276,1,0.992571170284062,0,1,regulation of proteinase activated receptor activity,BP,
18816,GO:1900279,1,0.988612935355404,0,2,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18817,GO:1900280,1,0.996030141837984,0,1,negative regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18818,GO:1900281,1,0.992553532471137,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18819,GO:1900363,1,0.892712610259684,0,16,regulation of mRNA polyadenylation,BP,
18820,GO:1900364,1,0.944477183362696,0,8,negative regulation of mRNA polyadenylation,BP,
18821,GO:1900365,1,0.971818361039723,0,4,positive regulation of mRNA polyadenylation,BP,
18822,GO:1900368,1,0.97217502394001,0,4,regulation of RNA interference,BP,
18823,GO:1900369,1,0.983817656893355,0,2,negative regulation of RNA interference,BP,
18824,GO:1900370,1,0.991938586215591,0,1,positive regulation of RNA interference,BP,
18825,GO:1900371,1,0.809275043598165,0,33,regulation of purine nucleotide biosynthetic process,BP,
18826,GO:1900372,1,0.962797151846499,0,6,negative regulation of purine nucleotide biosynthetic process,BP,
18827,GO:1900373,1,0.903342726882326,0,17,positive regulation of purine nucleotide biosynthetic process,BP,
18828,GO:1900376,1,0.927604192881542,0,10,regulation of secondary metabolite biosynthetic process,BP,
18829,GO:1900377,1,0.97624872590416,0,3,negative regulation of secondary metabolite biosynthetic process,BP,
18830,GO:1900378,1,0.960165023903484,0,6,positive regulation of secondary metabolite biosynthetic process,BP,
18832,GO:1900407,1,0.625093752940144,0,72,regulation of cellular response to oxidative stress,BP,
18833,GO:1900408,1,0.768020549199604,0,41,negative regulation of cellular response to oxidative stress,BP,
18834,GO:1900409,1,0.89949004617554,0,17,positive regulation of cellular response to oxidative stress,BP,
18835,GO:1900424,1,0.914991465435096,0,15,regulation of defense response to bacterium,BP,
18836,GO:1900425,1,0.968460376196892,0,5,negative regulation of defense response to bacterium,BP,
18837,GO:1900426,1,0.958060686543384,0,8,positive regulation of defense response to bacterium,BP,
18839,GO:1900450,1,0.977715328841281,0,3,negative regulation of glutamate receptor signaling pathway,BP,
18840,GO:1900451,1,0.902240982044674,0,15,positive regulation of glutamate receptor signaling pathway,BP,
18841,GO:1900452,1,0.901240518951302,0,14,regulation of long-term synaptic depression,BP,
18842,GO:1900453,1,0.981964994057888,0,3,negative regulation of long-term synaptic depression,BP,
18843,GO:1900454,1,0.955834702803196,0,6,positive regulation of long-term synaptic depression,BP,
18844,GO:1900477,1,0.994911272420949,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18845,GO:1900480,1,0.993339085907434,0,1,regulation of diacylglycerol biosynthetic process,BP,
18846,GO:1900533,1,0.996077424379586,0,1,palmitic acid metabolic process,BP,
18847,GO:1900535,1,0.996077424379586,0,1,palmitic acid biosynthetic process,BP,
18849,GO:1900543,1,0.882943737071285,0,19,negative regulation of purine nucleotide metabolic process,BP,
18851,GO:1900619,1,0.97419620213629,0,4,acetate ester metabolic process,BP,
18852,GO:1900620,1,0.987451755562286,0,2,acetate ester biosynthetic process,BP,
18853,GO:1900623,1,0.976961398338172,0,3,regulation of monocyte aggregation,BP,
18854,GO:1900625,1,0.976961398338172,0,3,positive regulation of monocyte aggregation,BP,
18855,GO:1900673,1,0.980697963354425,0,3,olefin metabolic process,BP,
18856,GO:1900736,1,0.981017453961273,0,4,regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,BP,
18857,GO:1900737,1,0.992571170284062,0,1,negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,BP,
18858,GO:1900738,1,0.988360692569472,0,3,positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,BP,
18859,GO:1900739,1,0.85860836169428,0,26,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18860,GO:1900740,1,0.85860836169428,0,26,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18861,GO:1900744,1,0.78654744026336,0,37,regulation of p38MAPK cascade,BP,
18862,GO:1900745,1,0.854812523104236,0,25,positive regulation of p38MAPK cascade,BP,
18863,GO:1900746,1,0.900216005880093,0,16,regulation of vascular endothelial growth factor signaling pathway,BP,
18864,GO:1900747,1,0.957793130919286,0,7,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18865,GO:1900748,1,0.959585262102315,0,5,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18866,GO:1900749,1,0.992650600045045,0,1,(R)-carnitine transport,BP,
18868,GO:1900753,1,0.99239497018192,0,1,doxorubicin transport,BP,
18869,GO:1900756,1,0.984112491915632,0,2,protein processing in phagocytic vesicle,BP,
18871,GO:1900826,1,0.996304995047058,0,1,negative regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18873,GO:1900864,1,0.956802276204782,0,8,mitochondrial RNA modification,BP,
18874,GO:1900923,1,0.989054681326879,0,2,regulation of glycine import across plasma membrane,BP,
18875,GO:1900924,1,0.989054681326879,0,2,negative regulation of glycine import across plasma membrane,BP,
18876,GO:1901000,1,0.973565000577393,0,4,regulation of response to salt stress,BP,
18877,GO:1901003,1,0.986142807120098,0,2,negative regulation of fermentation,BP,
18878,GO:1901004,1,0.996418278043757,0,1,ubiquinone-6 metabolic process,BP,
18879,GO:1901006,1,0.996418278043757,0,1,ubiquinone-6 biosynthetic process,BP,
18882,GO:1901018,1,0.850149604680324,0,24,positive regulation of potassium ion transmembrane transporter activity,BP,
18883,GO:1901019,1,0.583958843628962,0,82,regulation of calcium ion transmembrane transporter activity,BP,
18884,GO:1901020,1,0.828203334664924,0,32,negative regulation of calcium ion transmembrane transporter activity,BP,
18885,GO:1901021,1,0.781091587063047,0,37,positive regulation of calcium ion transmembrane transporter activity,BP,
18886,GO:1901026,1,0.975343709125292,0,3,ripoptosome assembly involved in necroptotic process,BP,
18890,GO:1901031,1,0.813474593427822,0,33,regulation of response to reactive oxygen species,BP,
18891,GO:1901032,1,0.910459493409003,0,15,negative regulation of response to reactive oxygen species,BP,
18892,GO:1901033,1,0.94966753259344,0,9,positive regulation of response to reactive oxygen species,BP,
18893,GO:1901052,1,0.989264908416605,0,2,sarcosine metabolic process,BP,
18894,GO:1901053,1,0.992632413981784,0,1,sarcosine catabolic process,BP,
18895,GO:1901068,1,0.8067057500079,0,36,guanosine-containing compound metabolic process,BP,
18896,GO:1901069,1,0.996243042055326,0,1,guanosine-containing compound catabolic process,BP,
18897,GO:1901070,1,0.946744577956079,0,13,guanosine-containing compound biosynthetic process,BP,
18898,GO:1901071,1,0.871629288758192,0,22,glucosamine-containing compound metabolic process,BP,
18899,GO:1901072,1,0.95910565022678,0,8,glucosamine-containing compound catabolic process,BP,
18900,GO:1901073,1,0.984538775923214,0,2,glucosamine-containing compound biosynthetic process,BP,
18901,GO:1901074,1,0.981256735643173,0,3,regulation of engulfment of apoptotic cell,BP,
18902,GO:1901076,1,0.987759358466991,0,2,positive regulation of engulfment of apoptotic cell,BP,
18903,GO:1901077,1,0.9432066817056,0,10,regulation of relaxation of muscle,BP,
18904,GO:1901078,1,0.972779240318654,0,4,negative regulation of relaxation of muscle,BP,
18905,GO:1901079,1,0.989151311814531,0,2,positive regulation of relaxation of muscle,BP,
18906,GO:1901086,1,0.992103373225629,0,1,benzylpenicillin metabolic process,BP,
18907,GO:1901096,1,0.918676566332293,0,12,regulation of autophagosome maturation,BP,
18908,GO:1901097,1,0.971892324017473,0,4,negative regulation of autophagosome maturation,BP,
18909,GO:1901098,1,0.948341730739852,0,7,positive regulation of autophagosome maturation,BP,
18914,GO:1901142,1,0.96385206677602,0,5,insulin metabolic process,BP,
18915,GO:1901143,1,0.98465711514461,0,2,insulin catabolic process,BP,
18916,GO:1901145,1,0.97756797674988,0,3,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18917,GO:1901147,1,0.984991601333973,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18918,GO:1901159,1,0.975543113841645,0,5,xylulose 5-phosphate biosynthetic process,BP,
18919,GO:1901160,1,0.907008387534663,0,14,primary amino compound metabolic process,BP,
18920,GO:1901162,1,0.972906661438483,0,5,primary amino compound biosynthetic process,BP,
18923,GO:1901165,1,0.963632341044897,0,6,positive regulation of trophoblast cell migration,BP,
18924,GO:1901166,1,0.961023665981952,0,5,neural crest cell migration involved in autonomic nervous system development,BP,
18927,GO:1901186,1,0.794627050455583,0,34,positive regulation of ERBB signaling pathway,BP,
18928,GO:1901187,1,0.985620296265869,0,2,regulation of ephrin receptor signaling pathway,BP,
18929,GO:1901189,1,0.994186975883146,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18930,GO:1901193,1,0.996559892621918,0,1,regulation of formation of translation preinitiation complex,BP,
18931,GO:1901194,1,0.996559892621918,0,1,negative regulation of formation of translation preinitiation complex,BP,
18932,GO:1901201,1,0.896620923409609,0,14,regulation of extracellular matrix assembly,BP,
18933,GO:1901202,1,0.994203567229265,0,1,negative regulation of extracellular matrix assembly,BP,
18934,GO:1901203,1,0.923792548131152,0,10,positive regulation of extracellular matrix assembly,BP,
18935,GO:1901207,1,0.985123854492259,0,2,regulation of heart looping,BP,
18936,GO:1901208,1,0.992596928971034,0,1,negative regulation of heart looping,BP,
18937,GO:1901210,1,0.992596928971034,0,1,regulation of cardiac chamber formation,BP,
18938,GO:1901211,1,0.992596928971034,0,1,negative regulation of cardiac chamber formation,BP,
18942,GO:1901216,1,0.549321028057058,0,91,positive regulation of neuron death,BP,
18943,GO:1901219,1,0.992596928971034,0,1,regulation of cardiac chamber morphogenesis,BP,
18944,GO:1901220,1,0.992596928971034,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18946,GO:1901223,1,0.866576949476118,0,20,negative regulation of NIK/NF-kappaB signaling,BP,
18949,GO:1901229,1,0.993623003692494,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18950,GO:1901231,1,0.993623003692494,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18951,GO:1901232,1,0.993623003692494,0,1,regulation of convergent extension involved in axis elongation,BP,
18952,GO:1901233,1,0.993623003692494,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18953,GO:1901235,1,0.992650600045045,0,1,(R)-carnitine transmembrane transporter activity,MF,
18954,GO:1901246,1,0.98995591499241,0,2,regulation of lung ciliated cell differentiation,BP,
18955,GO:1901247,1,0.996409506317867,0,1,negative regulation of lung ciliated cell differentiation,BP,
18956,GO:1901248,1,0.993523391118181,0,1,positive regulation of lung ciliated cell differentiation,BP,
18957,GO:1901249,1,0.996409506317867,0,1,regulation of lung goblet cell differentiation,BP,
18958,GO:1901251,1,0.996409506317867,0,1,positive regulation of lung goblet cell differentiation,BP,
18959,GO:1901252,1,0.989110989194671,0,2,regulation of intracellular transport of viral material,BP,
18960,GO:1901253,1,0.996696020579338,0,1,negative regulation of intracellular transport of viral material,BP,
18961,GO:1901254,1,0.992390081388357,0,1,positive regulation of intracellular transport of viral material,BP,
18962,GO:1901255,1,0.987183510134643,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18963,GO:1901256,1,0.967761012578321,0,5,regulation of macrophage colony-stimulating factor production,BP,
18964,GO:1901257,1,0.994280481325253,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18965,GO:1901258,1,0.980654485076743,0,3,positive regulation of macrophage colony-stimulating factor production,BP,
18968,GO:1901291,1,0.995315111793295,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18969,GO:1901292,1,0.660206342745736,0,70,nucleoside phosphate catabolic process,BP,
18970,GO:1901293,1,0.259435273625962,0,219,nucleoside phosphate biosynthetic process,BP,
18971,GO:1901295,1,0.989781168305386,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18972,GO:1901296,1,0.995568695093763,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18973,GO:1901297,1,0.994186975883146,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18974,GO:1901298,1,0.947114751032852,0,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18975,GO:1901299,1,0.971113777662362,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18976,GO:1901300,1,0.975294413229057,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18977,GO:1901301,1,0.985722326924698,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18978,GO:1901303,1,0.993360864384152,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18979,GO:1901304,1,0.995786241327855,0,1,regulation of spermidine biosynthetic process,BP,
18980,GO:1901307,1,0.995786241327855,0,1,positive regulation of spermidine biosynthetic process,BP,
18981,GO:1901308,1,0.99432685821291,0,1,regulation of sterol regulatory element binding protein cleavage,BP,
18982,GO:1901310,1,0.99432685821291,0,1,positive regulation of sterol regulatory element binding protein cleavage,BP,
18983,GO:1901314,1,0.967994546119597,0,4,regulation of histone H2A K63-linked ubiquitination,BP,
18984,GO:1901315,1,0.967994546119597,0,4,negative regulation of histone H2A K63-linked ubiquitination,BP,
18985,GO:1901317,1,0.947895117896964,0,11,regulation of flagellated sperm motility,BP,
18986,GO:1901318,1,0.995284192982024,0,1,negative regulation of flagellated sperm motility,BP,
18987,GO:1901321,1,0.955952687829963,0,7,positive regulation of heart induction,BP,
18988,GO:1901328,1,0.995555640589588,0,1,response to cytochalasin B,BP,
18989,GO:1901329,1,0.980763704415008,0,3,regulation of odontoblast differentiation,BP,
18990,GO:1901331,1,0.992737439110689,0,1,positive regulation of odontoblast differentiation,BP,
18991,GO:1901337,1,0.986030356453845,0,2,thioester transport,BP,
18992,GO:1901338,1,0.929093817417685,0,13,catecholamine binding,MF,
18993,GO:1901339,1,0.951600112205002,0,7,regulation of store-operated calcium channel activity,BP,
18994,GO:1901340,1,0.992448627079208,0,1,negative regulation of store-operated calcium channel activity,BP,
18995,GO:1901341,1,0.965853834072825,0,5,positive regulation of store-operated calcium channel activity,BP,
18998,GO:1901344,1,0.996405079345363,0,1,response to leptomycin B,BP,
18999,GO:1901346,1,0.994500449429262,0,1,negative regulation of vasculature development involved in avascular cornea development in camera-type eye,BP,
19000,GO:1901355,1,0.979534211863953,0,3,response to rapamycin,BP,
19005,GO:1901373,1,0.996237631735038,0,1,lipid hydroperoxide transport,BP,
19006,GO:1901374,1,0.964697519509746,0,6,acetate ester transport,BP,
19007,GO:1901375,1,0.989528651051623,0,2,acetate ester transmembrane transporter activity,MF,
19008,GO:1901376,1,0.989785512087752,0,2,organic heteropentacyclic compound metabolic process,BP,
19009,GO:1901377,1,0.989785512087752,0,2,organic heteropentacyclic compound catabolic process,BP,
19012,GO:1901381,1,0.767954981287712,0,37,positive regulation of potassium ion transmembrane transport,BP,
19014,GO:1901383,1,0.985053694869056,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
19015,GO:1901385,1,0.812110141699766,0,34,regulation of voltage-gated calcium channel activity,BP,
19016,GO:1901386,1,0.926649997197616,0,13,negative regulation of voltage-gated calcium channel activity,BP,
19017,GO:1901387,1,0.930758657643352,0,12,positive regulation of voltage-gated calcium channel activity,BP,
19018,GO:1901388,1,0.947047097960691,0,7,regulation of transforming growth factor beta activation,BP,
19019,GO:1901389,1,0.993728670751326,0,1,negative regulation of transforming growth factor beta activation,BP,
19020,GO:1901390,1,0.992436582510968,0,1,positive regulation of transforming growth factor beta activation,BP,
19021,GO:1901392,1,0.992436582510968,0,1,regulation of transforming growth factor beta1 activation,BP,
19022,GO:1901394,1,0.992436582510968,0,1,positive regulation of transforming growth factor beta1 activation,BP,
19023,GO:1901398,1,0.992421685995568,0,1,regulation of transforming growth factor beta3 activation,BP,
19024,GO:1901401,1,0.984702884343319,0,3,regulation of tetrapyrrole metabolic process,BP,
19025,GO:1901403,1,0.991722215232139,0,1,positive regulation of tetrapyrrole metabolic process,BP,
19026,GO:1901407,1,0.980602830055705,0,3,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
19027,GO:1901409,1,0.994405736711206,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
19028,GO:1901419,1,0.992395820850584,0,1,regulation of response to alcohol,BP,
19029,GO:1901421,1,0.992395820850584,0,1,positive regulation of response to alcohol,BP,
19030,GO:1901423,1,0.996586890788437,0,1,response to benzene,BP,
19031,GO:1901463,1,0.992922678879628,0,2,regulation of tetrapyrrole biosynthetic process,BP,
19032,GO:1901474,1,0.937516590133979,0,10,azole transmembrane transporter activity,MF,
19033,GO:1901475,1,0.974855032482009,0,4,pyruvate transmembrane transport,BP,
19034,GO:1901480,1,0.994623846563876,0,1,oleate transmembrane transporter activity,MF,
19035,GO:1901483,1,0.9806670849447,0,3,regulation of transcription factor catabolic process,BP,
19036,GO:1901485,1,0.9806670849447,0,3,positive regulation of transcription factor catabolic process,BP,
19037,GO:1901490,1,0.9634993434948,0,5,regulation of lymphangiogenesis,BP,
19038,GO:1901491,1,0.976797948431224,0,3,negative regulation of lymphangiogenesis,BP,
19039,GO:1901492,1,0.986388747229746,0,2,positive regulation of lymphangiogenesis,BP,
19040,GO:1901494,1,0.989609055075192,0,1,regulation of cysteine metabolic process,BP,
19041,GO:1901503,1,0.928564799674307,0,11,ether biosynthetic process,BP,
19042,GO:1901505,1,0.713398041429463,0,55,carbohydrate derivative transmembrane transporter activity,MF,
19043,GO:1901506,1,0.99432685821291,0,1,regulation of acylglycerol transport,BP,
19044,GO:1901508,1,0.99432685821291,0,1,positive regulation of acylglycerol transport,BP,
19045,GO:1901509,1,0.960792765730894,0,6,regulation of endothelial tube morphogenesis,BP,
19046,GO:1901522,1,0.848500579784892,0,23,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
19047,GO:1901523,1,0.964314101089964,0,6,icosanoid catabolic process,BP,
19048,GO:1901524,1,0.879991362775236,0,16,regulation of mitophagy,BP,
19049,GO:1901525,1,0.956548772357188,0,6,negative regulation of mitophagy,BP,
19050,GO:1901526,1,0.919999724539808,0,10,positive regulation of mitophagy,BP,
19051,GO:1901529,1,0.969744333698349,0,4,positive regulation of anion channel activity,BP,
19052,GO:1901532,1,0.623025952662605,0,83,regulation of hematopoietic progenitor cell differentiation,BP,
19053,GO:1901533,1,0.95401186548734,0,8,negative regulation of hematopoietic progenitor cell differentiation,BP,
19054,GO:1901534,1,0.962451051421162,0,5,positive regulation of hematopoietic progenitor cell differentiation,BP,
19055,GO:1901535,1,0.95038988569463,0,6,regulation of DNA demethylation,BP,
19056,GO:1901536,1,0.98581604074993,0,2,negative regulation of DNA demethylation,BP,
19057,GO:1901537,1,0.964069269139859,0,4,positive regulation of DNA demethylation,BP,
19058,GO:1901538,1,0.957275808284959,0,6,changes to DNA methylation involved in embryo development,BP,
19059,GO:1901545,1,0.992880400843032,0,1,response to raffinose,BP,
19060,GO:1901550,1,0.903439575062114,0,15,regulation of endothelial cell development,BP,
19061,GO:1901551,1,0.985034096998901,0,2,negative regulation of endothelial cell development,BP,
19062,GO:1901552,1,0.961006793804354,0,6,positive regulation of endothelial cell development,BP,
19063,GO:1901555,1,0.991058938608315,0,1,response to paclitaxel,BP,
19064,GO:1901557,1,0.992470052449699,0,1,response to fenofibrate,BP,
19065,GO:1901558,1,0.986894264554255,0,2,response to metformin,BP,
19066,GO:1901561,1,0.992496118118737,0,1,response to benomyl,BP,
19067,GO:1901563,1,0.965163023500893,0,5,response to camptothecin,BP,
19071,GO:1901567,1,0.870417083048778,0,26,fatty acid derivative binding,MF,
19072,GO:1901568,1,0.439121703561178,0,141,fatty acid derivative metabolic process,BP,
19073,GO:1901569,1,0.930086351741208,0,12,fatty acid derivative catabolic process,BP,
19074,GO:1901570,1,0.619383871834046,0,81,fatty acid derivative biosynthetic process,BP,
19075,GO:1901571,1,0.807676557000105,0,35,fatty acid derivative transport,BP,
19078,GO:1901580,1,0.988852137285306,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19079,GO:1901581,1,0.988852137285306,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19080,GO:1901582,1,0.988852137285306,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19081,GO:1901585,1,0.993157463409371,0,1,regulation of acid-sensing ion channel activity,BP,
19082,GO:1901588,1,0.976735554680379,0,3,dendritic microtubule,CC,
19083,GO:1901594,1,0.992447319830623,0,1,response to capsazepine,BP,
19086,GO:1901607,1,0.688916099980436,0,61,alpha-amino acid biosynthetic process,BP,
19087,GO:1901608,1,0.973789344797773,0,4,regulation of vesicle transport along microtubule,BP,
19088,GO:1901609,1,0.996352169792451,0,1,negative regulation of vesicle transport along microtubule,BP,
19089,GO:1901610,1,0.977355404759038,0,3,positive regulation of vesicle transport along microtubule,BP,
19090,GO:1901611,1,0.925916250313108,0,13,phosphatidylglycerol binding,MF,
19091,GO:1901612,1,0.945269372774773,0,9,cardiolipin binding,MF,
19093,GO:1901616,1,0.681365806057747,0,63,organic hydroxy compound catabolic process,BP,
19094,GO:1901617,1,0.231634609967104,0,227,organic hydroxy compound biosynthetic process,BP,
19096,GO:1901620,1,0.946761530914769,0,8,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
19097,GO:1901621,1,0.958511787400737,0,6,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
19098,GO:1901622,1,0.993641114876386,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
19099,GO:1901623,1,0.882768409230346,0,22,regulation of lymphocyte chemotaxis,BP,
19100,GO:1901624,1,0.985247449031366,0,3,negative regulation of lymphocyte chemotaxis,BP,
19101,GO:1901626,1,0.911026750036645,0,13,regulation of postsynaptic membrane organization,BP,
19102,GO:1901627,1,0.99424195867487,0,1,negative regulation of postsynaptic membrane organization,BP,
19103,GO:1901628,1,0.973225916160007,0,4,positive regulation of postsynaptic membrane organization,BP,
19104,GO:1901629,1,0.990476182743638,0,1,regulation of presynaptic membrane organization,BP,
19105,GO:1901631,1,0.990476182743638,0,1,positive regulation of presynaptic membrane organization,BP,
19106,GO:1901639,1,0.991576790400752,0,1,XDP catabolic process,BP,
19107,GO:1901640,1,0.991576790400752,0,1,XTP binding,MF,
19108,GO:1901641,1,0.991576790400752,0,1,ITP binding,MF,
19109,GO:1901642,1,0.96565726820282,0,6,nucleoside transmembrane transport,BP,
19110,GO:1901645,1,0.995845031675732,0,1,regulation of synoviocyte proliferation,BP,
19111,GO:1901647,1,0.995845031675732,0,1,positive regulation of synoviocyte proliferation,BP,
19116,GO:1901656,1,0.97249382890613,0,4,glycoside transport,BP,
19117,GO:1901657,1,0.522993157724989,0,116,glycosyl compound metabolic process,BP,
19118,GO:1901658,1,0.821866788149181,0,37,glycosyl compound catabolic process,BP,
19119,GO:1901659,1,0.822074719065535,0,38,glycosyl compound biosynthetic process,BP,
19120,GO:1901660,1,0.926694745846623,0,10,calcium ion export,BP,
19121,GO:1901661,1,0.854232125867487,0,32,quinone metabolic process,BP,
19122,GO:1901662,1,0.978088356072884,0,4,quinone catabolic process,BP,
19123,GO:1901663,1,0.928933700907263,0,15,quinone biosynthetic process,BP,
19124,GO:1901664,1,0.982803149554894,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
19125,GO:1901666,1,0.982803149554894,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
19126,GO:1901668,1,0.974487309420328,0,5,regulation of superoxide dismutase activity,BP,
19127,GO:1901671,1,0.981106097017209,0,4,positive regulation of superoxide dismutase activity,BP,
19128,GO:1901673,1,0.901056895454274,0,17,regulation of mitotic spindle assembly,BP,
19129,GO:1901674,1,0.983743995672241,0,2,regulation of histone H3-K27 acetylation,BP,
19130,GO:1901675,1,0.99119999665199,0,1,negative regulation of histone H3-K27 acetylation,BP,
19131,GO:1901676,1,0.992478478634651,0,1,positive regulation of histone H3-K27 acetylation,BP,
19132,GO:1901678,1,0.923121761557168,0,13,iron coordination entity transport,BP,
19133,GO:1901679,1,0.959199128808116,0,7,nucleotide transmembrane transport,BP,
19134,GO:1901680,1,0.989609055075192,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
19137,GO:1901685,1,0.930812390299978,0,19,glutathione derivative metabolic process,BP,
19138,GO:1901687,1,0.930812390299978,0,19,glutathione derivative biosynthetic process,BP,
19139,GO:1901696,1,0.993542994515977,0,1,cannabinoid biosynthetic process,BP,
19144,GO:1901702,1,0.983666092536116,0,3,salt transmembrane transporter activity,MF,
19145,GO:1901706,1,0.993627520566558,0,1,mesenchymal cell differentiation involved in bone development,BP,
19146,GO:1901707,1,0.996405079345363,0,1,leptomycin B binding,MF,
19147,GO:1901722,1,0.924814757189205,0,12,regulation of cell proliferation involved in kidney development,BP,
19148,GO:1901723,1,0.967575816908406,0,5,negative regulation of cell proliferation involved in kidney development,BP,
19149,GO:1901724,1,0.955820515366926,0,7,positive regulation of cell proliferation involved in kidney development,BP,
19150,GO:1901725,1,0.928847947440219,0,9,regulation of histone deacetylase activity,BP,
19151,GO:1901726,1,0.981999654354215,0,2,negative regulation of histone deacetylase activity,BP,
19152,GO:1901727,1,0.953086157744979,0,6,positive regulation of histone deacetylase activity,BP,
19153,GO:1901731,1,0.978970339837612,0,3,positive regulation of platelet aggregation,BP,
19154,GO:1901739,1,0.91207684175641,0,17,regulation of myoblast fusion,BP,
19155,GO:1901740,1,0.991742233837852,0,2,negative regulation of myoblast fusion,BP,
19156,GO:1901741,1,0.919677804851832,0,15,positive regulation of myoblast fusion,BP,
19157,GO:1901748,1,0.981612440492953,0,3,leukotriene D4 metabolic process,BP,
19158,GO:1901750,1,0.981612440492953,0,3,leukotriene D4 biosynthetic process,BP,
19159,GO:1901751,1,0.98790038878978,0,2,leukotriene A4 metabolic process,BP,
19160,GO:1901753,1,0.993696128496363,0,1,leukotriene A4 biosynthetic process,BP,
19161,GO:1901796,1,0.336522975667596,0,168,regulation of signal transduction by p53 class mediator,BP,
19162,GO:1901797,1,0.85175074689837,0,27,negative regulation of signal transduction by p53 class mediator,BP,
19163,GO:1901798,1,0.877251690734572,0,22,positive regulation of signal transduction by p53 class mediator,BP,
19164,GO:1901799,1,0.719634335368265,0,51,negative regulation of proteasomal protein catabolic process,BP,
19165,GO:1901800,1,0.510157269002459,0,104,positive regulation of proteasomal protein catabolic process,BP,
19166,GO:1901804,1,0.989906520407504,0,2,beta-glucoside metabolic process,BP,
19167,GO:1901805,1,0.989906520407504,0,2,beta-glucoside catabolic process,BP,
19168,GO:1901810,1,0.99325505912211,0,1,beta-carotene metabolic process,BP,
19169,GO:1901825,1,0.993564967264221,0,1,zeaxanthin metabolic process,BP,
19170,GO:1901827,1,0.993564967264221,0,1,zeaxanthin biosynthetic process,BP,
19171,GO:1901834,1,0.995697015410691,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19172,GO:1901835,1,0.995697015410691,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19173,GO:1901836,1,0.939247020554948,0,10,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19174,GO:1901838,1,0.943262824625475,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19175,GO:1901841,1,0.923344177464316,0,13,regulation of high voltage-gated calcium channel activity,BP,
19176,GO:1901842,1,0.978107261963012,0,4,negative regulation of high voltage-gated calcium channel activity,BP,
19177,GO:1901843,1,0.971839483124649,0,4,positive regulation of high voltage-gated calcium channel activity,BP,
19178,GO:1901844,1,0.942619624540112,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19179,GO:1901846,1,0.992346941266634,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19180,GO:1901856,1,0.973901514705668,0,4,negative regulation of cellular respiration,BP,
19181,GO:1901857,1,0.965703599651285,0,7,positive regulation of cellular respiration,BP,
19182,GO:1901858,1,0.974435295746993,0,4,regulation of mitochondrial DNA metabolic process,BP,
19183,GO:1901859,1,0.99335291039182,0,1,negative regulation of mitochondrial DNA metabolic process,BP,
19184,GO:1901860,1,0.991408023303973,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
19188,GO:1901873,1,0.968578083992308,0,4,regulation of post-translational protein modification,BP,
19189,GO:1901874,1,0.97799237321421,0,3,negative regulation of post-translational protein modification,BP,
19190,GO:1901876,1,0.992572515706041,0,2,regulation of calcium ion binding,BP,
19191,GO:1901877,1,0.992572515706041,0,2,negative regulation of calcium ion binding,BP,
19192,GO:1901879,1,0.554616290387969,0,80,regulation of protein depolymerization,BP,
19193,GO:1901880,1,0.624961005325709,0,63,negative regulation of protein depolymerization,BP,
19194,GO:1901881,1,0.901883221435216,0,16,positive regulation of protein depolymerization,BP,
19197,GO:1901890,1,0.505627190084426,0,93,positive regulation of cell junction assembly,BP,
19198,GO:1901894,1,0.941709225175069,0,9,regulation of ATPase-coupled calcium transmembrane transporter activity,BP,
19199,GO:1901895,1,0.979825140131626,0,3,negative regulation of ATPase-coupled calcium transmembrane transporter activity,BP,
19200,GO:1901896,1,0.964195566848314,0,5,positive regulation of ATPase-coupled calcium transmembrane transporter activity,BP,
19201,GO:1901897,1,0.960799872580928,0,6,regulation of relaxation of cardiac muscle,BP,
19202,GO:1901898,1,0.982902310726273,0,2,negative regulation of relaxation of cardiac muscle,BP,
19203,GO:1901899,1,0.989151311814531,0,2,positive regulation of relaxation of cardiac muscle,BP,
19204,GO:1901906,1,0.977990025656706,0,4,diadenosine pentaphosphate metabolic process,BP,
19205,GO:1901907,1,0.977990025656706,0,4,diadenosine pentaphosphate catabolic process,BP,
19206,GO:1901908,1,0.977990025656706,0,4,diadenosine hexaphosphate metabolic process,BP,
19207,GO:1901909,1,0.977990025656706,0,4,diadenosine hexaphosphate catabolic process,BP,
19208,GO:1901910,1,0.977990025656706,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
19209,GO:1901911,1,0.977990025656706,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
19210,GO:1901917,1,0.993292626999948,0,1,regulation of exoribonuclease activity,BP,
19211,GO:1901919,1,0.993292626999948,0,1,positive regulation of exoribonuclease activity,BP,
19212,GO:1901950,1,0.9096760896779,0,11,dense core granule transport,BP,
19213,GO:1901951,1,0.984592711675985,0,2,regulation of anterograde dense core granule transport,BP,
19214,GO:1901953,1,0.984592711675985,0,2,positive regulation of anterograde dense core granule transport,BP,
19215,GO:1901962,1,0.994523830704485,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
19216,GO:1901963,1,0.988220814779393,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19217,GO:1901964,1,0.995611667834955,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19218,GO:1901970,1,0.917125991423115,0,13,positive regulation of mitotic sister chromatid separation,BP,
19219,GO:1901976,1,0.821674836408123,0,31,regulation of cell cycle checkpoint,BP,
19220,GO:1901977,1,0.963453329612788,0,6,negative regulation of cell cycle checkpoint,BP,
19221,GO:1901978,1,0.942607368694387,0,9,positive regulation of cell cycle checkpoint,BP,
19222,GO:1901979,1,0.969092727017439,0,5,regulation of inward rectifier potassium channel activity,BP,
19223,GO:1901980,1,0.986051795256425,0,2,positive regulation of inward rectifier potassium channel activity,BP,
19225,GO:1901983,1,0.623021461452917,0,71,regulation of protein acetylation,BP,
19226,GO:1901984,1,0.872748202564781,0,22,negative regulation of protein acetylation,BP,
19227,GO:1901985,1,0.759460259037982,0,41,positive regulation of protein acetylation,BP,
19228,GO:1901986,1,0.996260416614264,0,1,response to ketamine,BP,
19235,GO:1901993,1,0.961855170699055,0,6,regulation of meiotic cell cycle phase transition,BP,
19236,GO:1901994,1,0.985831279296582,0,2,negative regulation of meiotic cell cycle phase transition,BP,
19237,GO:1901995,1,0.975682795586684,0,4,positive regulation of meiotic cell cycle phase transition,BP,
19238,GO:1901998,1,0.783078998776575,0,39,toxin transport,BP,
19239,GO:1901999,1,0.996188984971283,0,1,homogentisate metabolic process,BP,
19240,GO:1902000,1,0.996188984971283,0,1,homogentisate catabolic process,BP,
19241,GO:1902001,1,0.855502599269324,0,21,fatty acid transmembrane transport,BP,
19242,GO:1902003,1,0.806202245279342,0,30,regulation of amyloid-beta formation,BP,
19243,GO:1902004,1,0.881422173032017,0,18,positive regulation of amyloid-beta formation,BP,
19244,GO:1902010,1,0.992553860657452,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
19245,GO:1902017,1,0.720410365186095,0,48,regulation of cilium assembly,BP,
19246,GO:1902018,1,0.930187152018722,0,11,negative regulation of cilium assembly,BP,
19247,GO:1902019,1,0.911173169057238,0,17,regulation of cilium-dependent cell motility,BP,
19248,GO:1902020,1,0.995284192982024,0,1,negative regulation of cilium-dependent cell motility,BP,
19249,GO:1902022,1,0.964365533362788,0,5,L-lysine transport,BP,
19250,GO:1902023,1,0.934685411267986,0,10,L-arginine transport,BP,
19251,GO:1902031,1,0.974552293576126,0,4,regulation of NADP metabolic process,BP,
19252,GO:1902033,1,0.94329236314138,0,9,regulation of hematopoietic stem cell proliferation,BP,
19253,GO:1902035,1,0.963051331637127,0,6,positive regulation of hematopoietic stem cell proliferation,BP,
19254,GO:1902036,1,0.67995519162703,0,70,regulation of hematopoietic stem cell differentiation,BP,
19255,GO:1902037,1,0.980007502118691,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19256,GO:1902038,1,0.992570208786896,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19258,GO:1902042,1,0.801714008935273,0,37,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19260,GO:1902044,1,0.979347352907929,0,3,regulation of Fas signaling pathway,BP,
19261,GO:1902045,1,0.994193353797425,0,1,negative regulation of Fas signaling pathway,BP,
19262,GO:1902047,1,0.967172493598241,0,6,polyamine transmembrane transport,BP,
19263,GO:1902064,1,0.992521630582713,0,1,regulation of transcription from RNA polymerase II promoter involved in spermatogenesis,BP,
19264,GO:1902065,1,0.930409330404914,0,11,response to L-glutamate,BP,
19265,GO:1902071,1,0.99651615819142,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19266,GO:1902073,1,0.99651615819142,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19267,GO:1902074,1,0.933976247538353,0,12,response to salt,BP,
19268,GO:1902075,1,0.963054319420223,0,7,cellular response to salt,BP,
19269,GO:1902076,1,0.988620308305733,0,1,regulation of lateral motor column neuron migration,BP,
19270,GO:1902078,1,0.988620308305733,0,1,positive regulation of lateral motor column neuron migration,BP,
19271,GO:1902080,1,0.988332818325206,0,2,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19272,GO:1902081,1,0.995760941551611,0,1,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19273,GO:1902082,1,0.992540576994048,0,1,positive regulation of calcium ion import into sarcoplasmic reticulum,BP,
19274,GO:1902083,1,0.959978816841838,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19275,GO:1902093,1,0.955477132400969,0,9,positive regulation of flagellated sperm motility,BP,
19276,GO:1902098,1,0.992268935463032,0,1,calcitriol binding,MF,
19277,GO:1902099,1,0.69585570906154,0,56,regulation of metaphase/anaphase transition of cell cycle,BP,
19278,GO:1902100,1,0.793364621148274,0,36,negative regulation of metaphase/anaphase transition of cell cycle,BP,
19279,GO:1902101,1,0.91286769902155,0,14,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19280,GO:1902102,1,0.988259798324501,0,2,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19281,GO:1902103,1,0.992866031482335,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19282,GO:1902104,1,0.99536100842981,0,1,positive regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19283,GO:1902105,1,0.188505070059554,0,258,regulation of leukocyte differentiation,BP,
19284,GO:1902106,1,0.568097646525834,0,89,negative regulation of leukocyte differentiation,BP,
19285,GO:1902107,1,0.396977449972356,0,145,positive regulation of leukocyte differentiation,BP,
19287,GO:1902109,1,0.991347809616768,0,2,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19289,GO:1902115,1,0.287587299580842,0,176,regulation of organelle assembly,BP,
19290,GO:1902116,1,0.792574290832451,0,36,negative regulation of organelle assembly,BP,
19291,GO:1902117,1,0.634000372195964,0,61,positive regulation of organelle assembly,BP,
19292,GO:1902121,1,0.992268935463032,0,1,lithocholic acid binding,MF,
19293,GO:1902122,1,0.994728818783657,0,1,chenodeoxycholic acid binding,MF,
19294,GO:1902159,1,0.988300267410538,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19295,GO:1902161,1,0.991506567773342,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19296,GO:1902162,1,0.986224932428285,0,3,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19297,GO:1902164,1,0.986224932428285,0,3,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19298,GO:1902165,1,0.915518596210611,0,16,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19299,GO:1902166,1,0.924940826526806,0,14,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19300,GO:1902167,1,0.996837800321798,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19301,GO:1902170,1,0.890231267480291,0,18,cellular response to reactive nitrogen species,BP,
19302,GO:1902172,1,0.970869340555095,0,5,regulation of keratinocyte apoptotic process,BP,
19303,GO:1902174,1,0.982059270880681,0,3,positive regulation of keratinocyte apoptotic process,BP,
19304,GO:1902175,1,0.865611112413784,0,24,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19305,GO:1902176,1,0.907433657637008,0,17,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19306,GO:1902177,1,0.971497438470863,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19308,GO:1902186,1,0.826180026044869,0,28,regulation of viral release from host cell,BP,
19309,GO:1902187,1,0.902524420393835,0,14,negative regulation of viral release from host cell,BP,
19310,GO:1902188,1,0.91620398755267,0,14,positive regulation of viral release from host cell,BP,
19311,GO:1902202,1,0.975851974258823,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19312,GO:1902203,1,0.992154869422285,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19313,GO:1902204,1,0.995081494367191,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19314,GO:1902205,1,0.995772666138557,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19315,GO:1902206,1,0.995772666138557,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19316,GO:1902211,1,0.99325505912211,0,1,regulation of prolactin signaling pathway,BP,
19317,GO:1902213,1,0.99325505912211,0,1,positive regulation of prolactin signaling pathway,BP,
19318,GO:1902214,1,0.982165074113033,0,3,regulation of interleukin-4-mediated signaling pathway,BP,
19319,GO:1902215,1,0.995772666138557,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19320,GO:1902216,1,0.986335227429329,0,2,positive regulation of interleukin-4-mediated signaling pathway,BP,
19321,GO:1902217,1,0.996355733896213,0,1,erythrocyte apoptotic process,BP,
19322,GO:1902218,1,0.963958290179357,0,6,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19323,GO:1902219,1,0.967260779415296,0,5,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19324,GO:1902220,1,0.996586890788437,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19325,GO:1902221,1,0.952965494757949,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
19326,GO:1902222,1,0.952965494757949,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
19327,GO:1902224,1,0.927572296944357,0,12,ketone body metabolic process,BP,
19328,GO:1902225,1,0.99325505912211,0,1,negative regulation of acrosome reaction,BP,
19329,GO:1902226,1,0.985946273740312,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19330,GO:1902227,1,0.991888994820189,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19331,GO:1902228,1,0.994009180698039,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19332,GO:1902229,1,0.81903169580012,0,36,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19333,GO:1902230,1,0.848730184396633,0,29,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19334,GO:1902231,1,0.971908749332493,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19335,GO:1902232,1,0.988252056956316,0,2,regulation of positive thymic T cell selection,BP,
19336,GO:1902233,1,0.995772666138557,0,1,negative regulation of positive thymic T cell selection,BP,
19338,GO:1902236,1,0.894352123539884,0,18,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19340,GO:1902238,1,0.992435727392954,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19341,GO:1902239,1,0.992435727392954,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19342,GO:1902250,1,0.996355733896213,0,1,regulation of erythrocyte apoptotic process,BP,
19343,GO:1902251,1,0.996355733896213,0,1,negative regulation of erythrocyte apoptotic process,BP,
19344,GO:1902253,1,0.859139045004142,0,27,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19345,GO:1902254,1,0.889621330592842,0,19,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19346,GO:1902255,1,0.982536523129063,0,5,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19347,GO:1902256,1,0.980562321502192,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19348,GO:1902257,1,0.988429075171211,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19351,GO:1902261,1,0.971108470426433,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19352,GO:1902262,1,0.972548672504104,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19353,GO:1902263,1,0.978860293871432,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
19354,GO:1902267,1,0.974514305570321,0,5,regulation of polyamine transmembrane transport,BP,
19355,GO:1902268,1,0.988632422868055,0,3,negative regulation of polyamine transmembrane transport,BP,
19356,GO:1902269,1,0.985721205526457,0,2,positive regulation of polyamine transmembrane transport,BP,
19357,GO:1902270,1,0.992650600045045,0,1,(R)-carnitine transmembrane transport,BP,
19358,GO:1902271,1,0.988235406626552,0,2,D3 vitamins binding,MF,
19359,GO:1902275,1,0.290586689620913,0,172,regulation of chromatin organization,BP,
19360,GO:1902282,1,0.92994769793105,0,11,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
19361,GO:1902283,1,0.99246592438391,0,1,negative regulation of primary amine oxidase activity,BP,
19362,GO:1902284,1,0.749794932765596,0,36,neuron projection extension involved in neuron projection guidance,BP,
19363,GO:1902285,1,0.894681548488758,0,13,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19364,GO:1902287,1,0.901954737980859,0,12,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19365,GO:1902292,1,0.963583759334407,0,5,cell cycle DNA replication initiation,BP,
19366,GO:1902296,1,0.992644466817449,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19367,GO:1902298,1,0.983279578681104,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19368,GO:1902299,1,0.945042015532696,0,8,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19370,GO:1902306,1,0.912110625077511,0,13,negative regulation of sodium ion transmembrane transport,BP,
19372,GO:1902308,1,0.969560911490685,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19373,GO:1902309,1,0.979313552174553,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19374,GO:1902310,1,0.990043464950887,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19375,GO:1902311,1,0.995634936794179,0,1,regulation of copper ion transmembrane transport,BP,
19376,GO:1902315,1,0.963583759334407,0,5,nuclear cell cycle DNA replication initiation,BP,
19377,GO:1902319,1,0.992644466817449,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19378,GO:1902336,1,0.98646081816534,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19379,GO:1902337,1,0.92628340703993,0,11,regulation of apoptotic process involved in morphogenesis,BP,
19380,GO:1902338,1,0.966254007792223,0,5,negative regulation of apoptotic process involved in morphogenesis,BP,
19381,GO:1902339,1,0.966340341283448,0,5,positive regulation of apoptotic process involved in morphogenesis,BP,
19382,GO:1902356,1,0.97962340552439,0,4,oxaloacetate(2-) transmembrane transport,BP,
19383,GO:1902358,1,0.909664129789208,0,14,sulfate transmembrane transport,BP,
19384,GO:1902359,1,0.988283630197882,0,2,Notch signaling pathway involved in somitogenesis,BP,
19385,GO:1902362,1,0.993198988529747,0,1,melanocyte apoptotic process,BP,
19386,GO:1902363,1,0.990917185225543,0,1,regulation of protein localization to spindle pole body,BP,
19387,GO:1902365,1,0.990917185225543,0,1,positive regulation of protein localization to spindle pole body,BP,
19388,GO:1902366,1,0.988283630197882,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19389,GO:1902367,1,0.988283630197882,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19390,GO:1902369,1,0.684434912690452,0,54,negative regulation of RNA catabolic process,BP,
19391,GO:1902370,1,0.983803999959223,0,2,regulation of tRNA catabolic process,BP,
19392,GO:1902371,1,0.983803999959223,0,2,negative regulation of tRNA catabolic process,BP,
19393,GO:1902373,1,0.729916064952966,0,45,negative regulation of mRNA catabolic process,BP,
19394,GO:1902374,1,0.995513823670867,0,1,regulation of rRNA catabolic process,BP,
19395,GO:1902378,1,0.993871543672424,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19396,GO:1902379,1,0.988523489984764,0,2,chemoattractant activity involved in axon guidance,MF,
19397,GO:1902380,1,0.994024135805207,0,1,positive regulation of endoribonuclease activity,BP,
19398,GO:1902387,1,0.969865648806962,0,5,ceramide 1-phosphate binding,MF,
19399,GO:1902388,1,0.96934165246531,0,5,ceramide 1-phosphate transfer activity,MF,
19400,GO:1902389,1,0.96934165246531,0,5,ceramide 1-phosphate transport,BP,
19401,GO:1902396,1,0.954506166942825,0,6,protein localization to bicellular tight junction,BP,
19402,GO:1902400,1,0.700620148104856,0,55,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
19403,GO:1902402,1,0.695641915656554,0,56,signal transduction involved in mitotic DNA damage checkpoint,BP,
19404,GO:1902403,1,0.695641915656554,0,56,signal transduction involved in mitotic DNA integrity checkpoint,BP,
19405,GO:1902410,1,0.874850371450483,0,23,mitotic cytokinetic process,BP,
19406,GO:1902412,1,0.958754511778242,0,6,regulation of mitotic cytokinesis,BP,
19408,GO:1902415,1,0.943981426311142,0,10,regulation of mRNA binding,BP,
19409,GO:1902416,1,0.954812746078082,0,8,positive regulation of mRNA binding,BP,
19410,GO:1902423,1,0.982402954071713,0,3,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19411,GO:1902425,1,0.982402954071713,0,3,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19412,GO:1902426,1,0.99343209438584,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19413,GO:1902430,1,0.910532622455051,0,13,negative regulation of amyloid-beta formation,BP,
19414,GO:1902435,1,0.981262410768201,0,2,regulation of male mating behavior,BP,
19415,GO:1902437,1,0.981262410768201,0,2,positive regulation of male mating behavior,BP,
19416,GO:1902440,1,0.99325505912211,0,1,protein localization to mitotic spindle pole body,BP,
19417,GO:1902442,1,0.992499051465178,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19418,GO:1902443,1,0.992499051465178,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19419,GO:1902444,1,0.996506299842542,0,1,riboflavin binding,MF,
19420,GO:1902445,1,0.987990629254919,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19421,GO:1902455,1,0.960043520047046,0,6,negative regulation of stem cell population maintenance,BP,
19422,GO:1902459,1,0.940017739069116,0,8,positive regulation of stem cell population maintenance,BP,
19423,GO:1902460,1,0.979504939015472,0,4,regulation of mesenchymal stem cell proliferation,BP,
19424,GO:1902462,1,0.979504939015472,0,4,positive regulation of mesenchymal stem cell proliferation,BP,
19425,GO:1902463,1,0.980727684177134,0,3,protein localization to cell leading edge,BP,
19426,GO:1902464,1,0.992379044838024,0,1,regulation of histone H3-K27 trimethylation,BP,
19427,GO:1902466,1,0.992379044838024,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19428,GO:1902473,1,0.841357801175679,0,25,regulation of protein localization to synapse,BP,
19429,GO:1902474,1,0.922241292412037,0,11,positive regulation of protein localization to synapse,BP,
19430,GO:1902475,1,0.681173854421443,0,56,L-alpha-amino acid transmembrane transport,BP,
19431,GO:1902476,1,0.54603731299885,0,85,chloride transmembrane transport,BP,
19432,GO:1902480,1,0.994016653649385,0,1,protein localization to mitotic spindle,BP,
19433,GO:1902488,1,0.990067536892281,0,1,cholangiocyte apoptotic process,BP,
19434,GO:1902490,1,0.995154499671731,0,1,regulation of sperm capacitation,BP,
19435,GO:1902493,1,0.570531375307907,0,85,acetyltransferase complex,CC,
19438,GO:1902498,1,0.961641093555213,0,5,regulation of protein autoubiquitination,BP,
19439,GO:1902499,1,0.979902002781249,0,3,positive regulation of protein autoubiquitination,BP,
19440,GO:1902504,1,0.992920184257471,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19441,GO:1902510,1,0.94392495220782,0,11,regulation of apoptotic DNA fragmentation,BP,
19442,GO:1902511,1,0.979253213924151,0,3,negative regulation of apoptotic DNA fragmentation,BP,
19443,GO:1902512,1,0.981418901151189,0,5,positive regulation of apoptotic DNA fragmentation,BP,
19444,GO:1902513,1,0.934746699687875,0,10,regulation of organelle transport along microtubule,BP,
19445,GO:1902514,1,0.925434336734092,0,12,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19446,GO:1902523,1,0.970015579358237,0,4,positive regulation of protein K63-linked ubiquitination,BP,
19447,GO:1902524,1,0.98867893353915,0,2,positive regulation of protein K48-linked ubiquitination,BP,
19448,GO:1902525,1,0.965612207432609,0,6,regulation of protein monoubiquitination,BP,
19449,GO:1902527,1,0.972906719703173,0,5,positive regulation of protein monoubiquitination,BP,
19450,GO:1902528,1,0.990260372006341,0,1,regulation of protein linear polyubiquitination,BP,
19451,GO:1902530,1,0.990260372006341,0,1,positive regulation of protein linear polyubiquitination,BP,
19455,GO:1902544,1,0.989443991128399,0,2,regulation of DNA N-glycosylase activity,BP,
19456,GO:1902546,1,0.996748342825382,0,1,positive regulation of DNA N-glycosylase activity,BP,
19457,GO:1902547,1,0.884238625107167,0,18,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19458,GO:1902548,1,0.940804492838424,0,9,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19459,GO:1902551,1,0.993147347968154,0,1,regulation of catalase activity,BP,
19460,GO:1902553,1,0.993147347968154,0,1,positive regulation of catalase activity,BP,
19462,GO:1902555,1,0.845687988204486,0,29,endoribonuclease complex,CC,
19463,GO:1902559,1,0.989971820392049,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19464,GO:1902560,1,0.991507533416697,0,2,GMP reductase complex,CC,
19465,GO:1902562,1,0.76298976587086,0,42,H4 histone acetyltransferase complex,CC,
19466,GO:1902563,1,0.92661227845082,0,12,regulation of neutrophil activation,BP,
19467,GO:1902564,1,0.969111227033509,0,5,negative regulation of neutrophil activation,BP,
19468,GO:1902565,1,0.972123866096491,0,4,positive regulation of neutrophil activation,BP,
19469,GO:1902566,1,0.978723500721801,0,4,regulation of eosinophil activation,BP,
19470,GO:1902567,1,0.989238571442275,0,2,negative regulation of eosinophil activation,BP,
19471,GO:1902568,1,0.989371709783297,0,2,positive regulation of eosinophil activation,BP,
19472,GO:1902569,1,0.99537500933713,0,1,negative regulation of activation of Janus kinase activity,BP,
19473,GO:1902570,1,0.925481624210434,0,13,protein localization to nucleolus,BP,
19474,GO:1902571,1,0.976182978282472,0,4,regulation of serine-type peptidase activity,BP,
19475,GO:1902572,1,0.976182978282472,0,4,negative regulation of serine-type peptidase activity,BP,
19476,GO:1902573,1,0.989778504671728,0,1,positive regulation of serine-type peptidase activity,BP,
19477,GO:1902576,1,0.974237662023829,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19478,GO:1902579,1,0.664159483741941,0,61,multi-organism localization,BP,
19479,GO:1902586,1,0.994510840433996,0,1,multi-organism intercellular transport,BP,
19480,GO:1902595,1,0.989696204831641,0,2,regulation of DNA replication origin binding,BP,
19481,GO:1902600,1,0.519470850508908,0,115,proton transmembrane transport,BP,
19482,GO:1902603,1,0.982534177177299,0,3,carnitine transmembrane transport,BP,
19483,GO:1902605,1,0.993306024928175,0,1,heterotrimeric G-protein complex assembly,BP,
19484,GO:1902606,1,0.993181171699799,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19485,GO:1902608,1,0.993181171699799,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19486,GO:1902612,1,0.993296441976419,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
19487,GO:1902613,1,0.993296441976419,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19488,GO:1902616,1,0.976572419373927,0,4,acyl carnitine transmembrane transport,BP,
19489,GO:1902617,1,0.968363088665613,0,5,response to fluoride,BP,
19490,GO:1902618,1,0.991608993820477,0,1,cellular response to fluoride,BP,
19491,GO:1902622,1,0.804794815871559,0,38,regulation of neutrophil migration,BP,
19492,GO:1902623,1,0.970844211236124,0,4,negative regulation of neutrophil migration,BP,
19493,GO:1902624,1,0.855029245362384,0,28,positive regulation of neutrophil migration,BP,
19494,GO:1902626,1,0.989647040711407,0,3,assembly of large subunit precursor of preribosome,BP,
19495,GO:1902629,1,0.996309394743907,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
19496,GO:1902630,1,0.976286963918714,0,3,regulation of membrane hyperpolarization,BP,
19497,GO:1902631,1,0.991043108908164,0,1,negative regulation of membrane hyperpolarization,BP,
19498,GO:1902636,1,0.984078909625398,0,3,kinociliary basal body,CC,
19499,GO:1902644,1,0.901007209514356,0,18,tertiary alcohol metabolic process,BP,
19500,GO:1902645,1,0.939937188908263,0,8,tertiary alcohol biosynthetic process,BP,
19501,GO:1902652,1,0.41755277980003,0,136,secondary alcohol metabolic process,BP,
19502,GO:1902653,1,0.660749139419022,0,63,secondary alcohol biosynthetic process,BP,
19503,GO:1902656,1,0.85889567108095,0,21,calcium ion import into cytosol,BP,
19504,GO:1902659,1,0.984275305928257,0,3,regulation of glucose mediated signaling pathway,BP,
19505,GO:1902661,1,0.984275305928257,0,3,positive regulation of glucose mediated signaling pathway,BP,
19506,GO:1902667,1,0.713080598623578,0,43,regulation of axon guidance,BP,
19507,GO:1902668,1,0.810367149287444,0,27,negative regulation of axon guidance,BP,
19508,GO:1902669,1,0.935418179953458,0,8,positive regulation of axon guidance,BP,
19511,GO:1902683,1,0.898625480969697,0,16,regulation of receptor localization to synapse,BP,
19512,GO:1902684,1,0.996352169792451,0,1,negative regulation of receptor localization to synapse,BP,
19513,GO:1902685,1,0.970609800242848,0,4,positive regulation of receptor localization to synapse,BP,
19515,GO:1902688,1,0.986142807120098,0,2,regulation of NAD metabolic process,BP,
19516,GO:1902689,1,0.986142807120098,0,2,negative regulation of NAD metabolic process,BP,
19517,GO:1902691,1,0.99278896603214,0,1,respiratory basal cell differentiation,BP,
19519,GO:1902710,1,0.881437084874576,0,18,GABA receptor complex,CC,
19520,GO:1902711,1,0.888817091457596,0,17,GABA-A receptor complex,CC,
19522,GO:1902723,1,0.971855768537763,0,4,negative regulation of skeletal muscle satellite cell proliferation,BP,
19523,GO:1902724,1,0.984205419638226,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
19524,GO:1902725,1,0.970727818176895,0,4,negative regulation of satellite cell differentiation,BP,
19525,GO:1902728,1,0.984205419638226,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19526,GO:1902729,1,0.992427247822258,0,1,negative regulation of proteoglycan biosynthetic process,BP,
19527,GO:1902730,1,0.971046286171159,0,4,positive regulation of proteoglycan biosynthetic process,BP,
19528,GO:1902731,1,0.973287991940105,0,3,negative regulation of chondrocyte proliferation,BP,
19529,GO:1902732,1,0.971497271996205,0,5,positive regulation of chondrocyte proliferation,BP,
19530,GO:1902737,1,0.970659085155223,0,4,dendritic filopodium,CC,
19531,GO:1902742,1,0.789240160980634,0,34,apoptotic process involved in development,BP,
19533,GO:1902744,1,0.969232643616984,0,4,negative regulation of lamellipodium organization,BP,
19535,GO:1902746,1,0.940721794077856,0,9,regulation of lens fiber cell differentiation,BP,
19536,GO:1902747,1,0.964585194134443,0,6,negative regulation of lens fiber cell differentiation,BP,
19537,GO:1902748,1,0.981104062439345,0,2,positive regulation of lens fiber cell differentiation,BP,
19539,GO:1902750,1,0.594346509150895,0,94,negative regulation of cell cycle G2/M phase transition,BP,
19540,GO:1902751,1,0.829674390855651,0,29,positive regulation of cell cycle G2/M phase transition,BP,
19541,GO:1902761,1,0.992808712385998,0,1,positive regulation of chondrocyte development,BP,
19542,GO:1902766,1,0.99167710871593,0,2,skeletal muscle satellite cell migration,BP,
19543,GO:1902767,1,0.986664364737054,0,2,isoprenoid biosynthetic process via mevalonate,BP,
19544,GO:1902769,1,0.98894460310163,0,1,regulation of choline O-acetyltransferase activity,BP,
19545,GO:1902771,1,0.98894460310163,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19546,GO:1902773,1,0.992858149289181,0,1,GTPase activator complex,CC,
19547,GO:1902774,1,0.953323393694628,0,7,late endosome to lysosome transport,BP,
19548,GO:1902775,1,0.97731822694214,0,3,mitochondrial large ribosomal subunit assembly,BP,
19549,GO:1902803,1,0.964651273076018,0,5,regulation of synaptic vesicle transport,BP,
19550,GO:1902804,1,0.996352169792451,0,1,negative regulation of synaptic vesicle transport,BP,
19551,GO:1902805,1,0.991783411295803,0,1,positive regulation of synaptic vesicle transport,BP,
19555,GO:1902809,1,0.97565912671936,0,4,regulation of skeletal muscle fiber differentiation,BP,
19556,GO:1902811,1,0.982476200891481,0,3,positive regulation of skeletal muscle fiber differentiation,BP,
19557,GO:1902816,1,0.961454470583055,0,5,regulation of protein localization to microtubule,BP,
19558,GO:1902817,1,0.961454470583055,0,5,negative regulation of protein localization to microtubule,BP,
19559,GO:1902822,1,0.974479451031077,0,4,regulation of late endosome to lysosome transport,BP,
19560,GO:1902823,1,0.98252604674027,0,2,negative regulation of late endosome to lysosome transport,BP,
19561,GO:1902824,1,0.991811766152427,0,2,positive regulation of late endosome to lysosome transport,BP,
19562,GO:1902834,1,0.992543896580655,0,1,regulation of proline import across plasma membrane,BP,
19563,GO:1902836,1,0.992543896580655,0,1,positive regulation of proline import across plasma membrane,BP,
19564,GO:1902838,1,0.992064186951491,0,1,regulation of nuclear migration along microtubule,BP,
19565,GO:1902841,1,0.96946482793026,0,4,regulation of netrin-activated signaling pathway,BP,
19566,GO:1902842,1,0.96946482793026,0,4,negative regulation of netrin-activated signaling pathway,BP,
19567,GO:1902846,1,0.990917185225543,0,1,positive regulation of mitotic spindle elongation,BP,
19568,GO:1902847,1,0.993120895894487,0,1,regulation of neuronal signal transduction,BP,
19570,GO:1902855,1,0.934615378599654,0,9,regulation of non-motile cilium assembly,BP,
19571,GO:1902856,1,0.977236726759695,0,3,negative regulation of non-motile cilium assembly,BP,
19572,GO:1902857,1,0.962335273911817,0,5,positive regulation of non-motile cilium assembly,BP,
19573,GO:1902858,1,0.994754663009123,0,1,propionyl-CoA metabolic process,BP,
19574,GO:1902860,1,0.994754663009123,0,1,propionyl-CoA biosynthetic process,BP,
19575,GO:1902866,1,0.954165584311405,0,7,regulation of retina development in camera-type eye,BP,
19576,GO:1902867,1,0.99275919239589,0,1,negative regulation of retina development in camera-type eye,BP,
19577,GO:1902868,1,0.988761406386382,0,2,positive regulation of retina development in camera-type eye,BP,
19578,GO:1902869,1,0.98160115248904,0,3,regulation of amacrine cell differentiation,BP,
19579,GO:1902870,1,0.99275919239589,0,1,negative regulation of amacrine cell differentiation,BP,
19580,GO:1902871,1,0.988761406386382,0,2,positive regulation of amacrine cell differentiation,BP,
19581,GO:1902882,1,0.596768748092938,0,79,regulation of response to oxidative stress,BP,
19582,GO:1902883,1,0.757268576554887,0,43,negative regulation of response to oxidative stress,BP,
19583,GO:1902884,1,0.894349113793662,0,18,positive regulation of response to oxidative stress,BP,
19584,GO:1902889,1,0.991126559871638,0,1,protein localization to spindle microtubule,BP,
19586,GO:1902894,1,0.903321594745993,0,14,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,
19588,GO:1902896,1,0.978697583665371,0,3,terminal web assembly,BP,
19589,GO:1902897,1,0.980147600692492,0,3,regulation of postsynaptic density protein 95 clustering,BP,
19590,GO:1902902,1,0.930616448707799,0,12,negative regulation of autophagosome assembly,BP,
19593,GO:1902905,1,0.279202863025663,0,190,positive regulation of supramolecular fiber organization,BP,
19594,GO:1902908,1,0.9882281558839,0,2,regulation of melanosome transport,BP,
19595,GO:1902910,1,0.992414112316059,0,1,positive regulation of melanosome transport,BP,
19597,GO:1902912,1,0.99325505912211,0,1,pyruvate kinase complex,CC,
19598,GO:1902913,1,0.992737439110689,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19599,GO:1902914,1,0.856431771577942,0,22,regulation of protein polyubiquitination,BP,
19600,GO:1902915,1,0.934318029352752,0,9,negative regulation of protein polyubiquitination,BP,
19601,GO:1902916,1,0.930358833398237,0,11,positive regulation of protein polyubiquitination,BP,
19602,GO:1902930,1,0.62594036655234,0,69,regulation of alcohol biosynthetic process,BP,
19603,GO:1902931,1,0.922799906882941,0,13,negative regulation of alcohol biosynthetic process,BP,
19604,GO:1902932,1,0.877004031295258,0,20,positive regulation of alcohol biosynthetic process,BP,
19606,GO:1902937,1,0.979909265275453,0,3,inward rectifier potassium channel complex,CC,
19607,GO:1902938,1,0.977087894963898,0,3,regulation of intracellular calcium activated chloride channel activity,BP,
19608,GO:1902939,1,0.993047491148901,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19609,GO:1902941,1,0.984016636371865,0,2,regulation of voltage-gated chloride channel activity,BP,
19610,GO:1902943,1,0.984016636371865,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19611,GO:1902945,1,0.992476152744622,0,1,metalloendopeptidase activity involved in amyloid precursor protein catabolic process,MF,
19612,GO:1902946,1,0.922626471930977,0,10,protein localization to early endosome,BP,
19613,GO:1902947,1,0.933604915635886,0,10,regulation of tau-protein kinase activity,BP,
19614,GO:1902948,1,0.98126705710765,0,2,negative regulation of tau-protein kinase activity,BP,
19615,GO:1902949,1,0.961680509704572,0,6,positive regulation of tau-protein kinase activity,BP,
19616,GO:1902950,1,0.937086218790805,0,10,regulation of dendritic spine maintenance,BP,
19617,GO:1902951,1,0.979993542600246,0,3,negative regulation of dendritic spine maintenance,BP,
19618,GO:1902952,1,0.98122982907135,0,3,positive regulation of dendritic spine maintenance,BP,
19619,GO:1902953,1,0.971464404730478,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19620,GO:1902954,1,0.979747842201652,0,2,regulation of early endosome to recycling endosome transport,BP,
19621,GO:1902955,1,0.98894460310163,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19622,GO:1902956,1,0.97299171337878,0,5,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19623,GO:1902957,1,0.986024597750748,0,2,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19624,GO:1902958,1,0.986784281923548,0,3,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19625,GO:1902959,1,0.940905894179909,0,9,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19626,GO:1902960,1,0.983290221032143,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19627,GO:1902961,1,0.956902650380416,0,7,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19628,GO:1902962,1,0.981518203978641,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19629,GO:1902963,1,0.981518203978641,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19630,GO:1902965,1,0.935778924389904,0,8,regulation of protein localization to early endosome,BP,
19631,GO:1902966,1,0.935778924389904,0,8,positive regulation of protein localization to early endosome,BP,
19632,GO:1902969,1,0.89720345183293,0,15,mitotic DNA replication,BP,
19633,GO:1902975,1,0.963583759334407,0,5,mitotic DNA replication initiation,BP,
19634,GO:1902977,1,0.995294923827603,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19635,GO:1902983,1,0.992644466817449,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19636,GO:1902988,1,0.974012439944719,0,3,neurofibrillary tangle assembly,BP,
19637,GO:1902990,1,0.981153701752917,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19638,GO:1902991,1,0.77772483105546,0,36,regulation of amyloid precursor protein catabolic process,BP,
19639,GO:1902992,1,0.897828478653012,0,15,negative regulation of amyloid precursor protein catabolic process,BP,
19640,GO:1902993,1,0.868072268671686,0,21,positive regulation of amyloid precursor protein catabolic process,BP,
19641,GO:1902994,1,0.984413914003229,0,3,regulation of phospholipid efflux,BP,
19642,GO:1902995,1,0.984413914003229,0,3,positive regulation of phospholipid efflux,BP,
19643,GO:1902996,1,0.98214078230165,0,2,regulation of neurofibrillary tangle assembly,BP,
19644,GO:1902997,1,0.98894460310163,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19645,GO:1902998,1,0.993120895894487,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19646,GO:1903000,1,0.996514293846025,0,1,regulation of lipid transport across blood-brain barrier,BP,
19647,GO:1903002,1,0.996514293846025,0,1,positive regulation of lipid transport across blood-brain barrier,BP,
19648,GO:1903003,1,0.960335699745822,0,6,positive regulation of protein deubiquitination,BP,
19649,GO:1903004,1,0.99248346894442,0,1,regulation of protein K63-linked deubiquitination,BP,
19650,GO:1903006,1,0.99248346894442,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19651,GO:1903007,1,0.99248346894442,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19652,GO:1903008,1,0.507698254199122,0,104,organelle disassembly,BP,
19655,GO:1903012,1,0.955656914809904,0,8,positive regulation of bone development,BP,
19656,GO:1903015,1,0.991096081767879,0,2,regulation of exo-alpha-sialidase activity,BP,
19657,GO:1903016,1,0.99526624345881,0,1,negative regulation of exo-alpha-sialidase activity,BP,
19658,GO:1903017,1,0.995810206885099,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19659,GO:1903018,1,0.758171660535312,0,44,regulation of glycoprotein metabolic process,BP,
19660,GO:1903019,1,0.922565312838333,0,14,negative regulation of glycoprotein metabolic process,BP,
19661,GO:1903020,1,0.849669021675989,0,24,positive regulation of glycoprotein metabolic process,BP,
19662,GO:1903025,1,0.921992099229387,0,12,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19663,GO:1903026,1,0.97376952502416,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19664,GO:1903027,1,0.980675633950828,0,3,regulation of opsonization,BP,
19665,GO:1903028,1,0.986109813620722,0,2,positive regulation of opsonization,BP,
19666,GO:1903031,1,0.988995484089735,0,2,regulation of microtubule plus-end binding,BP,
19667,GO:1903033,1,0.988995484089735,0,2,positive regulation of microtubule plus-end binding,BP,
19670,GO:1903036,1,0.675785482002696,0,61,positive regulation of response to wounding,BP,
19673,GO:1903039,1,0.258802486907065,0,216,positive regulation of leukocyte cell-cell adhesion,BP,
19674,GO:1903041,1,0.992808712385998,0,1,regulation of chondrocyte hypertrophy,BP,
19675,GO:1903043,1,0.992808712385998,0,1,positive regulation of chondrocyte hypertrophy,BP,
19676,GO:1903044,1,0.953153539827046,0,8,protein localization to membrane raft,BP,
19677,GO:1903045,1,0.991783981880174,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19678,GO:1903046,1,0.356576917926442,0,156,meiotic cell cycle process,BP,
19681,GO:1903051,1,0.657115663097233,0,65,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19683,GO:1903053,1,0.762175149678242,0,38,regulation of extracellular matrix organization,BP,
19684,GO:1903054,1,0.929905116060888,0,11,negative regulation of extracellular matrix organization,BP,
19685,GO:1903055,1,0.878683184059543,0,18,positive regulation of extracellular matrix organization,BP,
19686,GO:1903056,1,0.985683034082284,0,2,regulation of melanosome organization,BP,
19687,GO:1903059,1,0.958894147011561,0,7,regulation of protein lipidation,BP,
19688,GO:1903060,1,0.992350539024567,0,2,negative regulation of protein lipidation,BP,
19689,GO:1903061,1,0.973609840949017,0,4,positive regulation of protein lipidation,BP,
19690,GO:1903069,1,0.946820461358283,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19691,GO:1903070,1,0.983107431918732,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19692,GO:1903071,1,0.957585263535795,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19693,GO:1903072,1,0.996698971982734,0,1,regulation of death-inducing signaling complex assembly,BP,
19694,GO:1903073,1,0.996698971982734,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19696,GO:1903077,1,0.861249505877821,0,23,negative regulation of protein localization to plasma membrane,BP,
19698,GO:1903080,1,0.996620610494782,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19699,GO:1903082,1,0.996620610494782,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19700,GO:1903093,1,0.984156337503768,0,3,regulation of protein K48-linked deubiquitination,BP,
19701,GO:1903094,1,0.993109126719105,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19702,GO:1903095,1,0.985673813210377,0,2,ribonuclease III complex,CC,
19703,GO:1903096,1,0.992866031482335,0,1,protein localization to meiotic spindle midzone,BP,
19704,GO:1903108,1,0.981513547923394,0,3,regulation of mitochondrial transcription,BP,
19705,GO:1903109,1,0.988922757053375,0,2,positive regulation of mitochondrial transcription,BP,
19706,GO:1903115,1,0.731163758771118,0,41,regulation of actin filament-based movement,BP,
19707,GO:1903116,1,0.970168003902513,0,4,positive regulation of actin filament-based movement,BP,
19708,GO:1903119,1,0.992461695877957,0,1,protein localization to actin cytoskeleton,BP,
19709,GO:1903121,1,0.975643845976308,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19710,GO:1903122,1,0.996698971982734,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19711,GO:1903123,1,0.98980976425874,0,1,regulation of thioredoxin peroxidase activity,BP,
19712,GO:1903124,1,0.98980976425874,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19713,GO:1903125,1,0.98980976425874,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19714,GO:1903126,1,0.994770150841765,0,1,negative regulation of centriole-centriole cohesion,BP,
19715,GO:1903131,1,0.79654495035838,0,34,mononuclear cell differentiation,BP,
19716,GO:1903135,1,0.977524083372569,0,4,cupric ion binding,MF,
19717,GO:1903136,1,0.963451400664447,0,7,cuprous ion binding,MF,
19718,GO:1903140,1,0.903439575062114,0,15,regulation of establishment of endothelial barrier,BP,
19719,GO:1903141,1,0.985034096998901,0,2,negative regulation of establishment of endothelial barrier,BP,
19720,GO:1903142,1,0.961006793804354,0,6,positive regulation of establishment of endothelial barrier,BP,
19721,GO:1903143,1,0.985318186759303,0,3,adrenomedullin receptor complex,CC,
19722,GO:1903146,1,0.753130811908622,0,40,regulation of autophagy of mitochondrion,BP,
19723,GO:1903147,1,0.947239506517165,0,8,negative regulation of autophagy of mitochondrion,BP,
19724,GO:1903165,1,0.993400194006259,0,1,response to polycyclic arene,BP,
19725,GO:1903167,1,0.996698971982734,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19726,GO:1903168,1,0.996698971982734,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19728,GO:1903170,1,0.808383983008249,0,35,negative regulation of calcium ion transmembrane transport,BP,
19729,GO:1903173,1,0.98793239519143,0,2,fatty alcohol metabolic process,BP,
19730,GO:1903176,1,0.996698971982734,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19731,GO:1903178,1,0.996698971982734,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19732,GO:1903179,1,0.989365074154528,0,2,regulation of dopamine biosynthetic process,BP,
19733,GO:1903181,1,0.989365074154528,0,2,positive regulation of dopamine biosynthetic process,BP,
19734,GO:1903182,1,0.996492397595218,0,1,regulation of SUMO transferase activity,BP,
19735,GO:1903184,1,0.996698971982734,0,1,L-dopa metabolic process,BP,
19736,GO:1903185,1,0.996698971982734,0,1,L-dopa biosynthetic process,BP,
19737,GO:1903189,1,0.996698971982734,0,1,glyoxal metabolic process,BP,
19738,GO:1903190,1,0.996698971982734,0,1,glyoxal catabolic process,BP,
19739,GO:1903195,1,0.996698971982734,0,1,regulation of L-dopa biosynthetic process,BP,
19740,GO:1903197,1,0.996698971982734,0,1,positive regulation of L-dopa biosynthetic process,BP,
19741,GO:1903198,1,0.996698971982734,0,1,regulation of L-dopa decarboxylase activity,BP,
19742,GO:1903200,1,0.996698971982734,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19743,GO:1903201,1,0.684154857045769,0,58,regulation of oxidative stress-induced cell death,BP,
19744,GO:1903202,1,0.768020549199604,0,41,negative regulation of oxidative stress-induced cell death,BP,
19745,GO:1903203,1,0.846783801632502,0,23,regulation of oxidative stress-induced neuron death,BP,
19746,GO:1903204,1,0.887529562710173,0,17,negative regulation of oxidative stress-induced neuron death,BP,
19747,GO:1903205,1,0.875311124951925,0,21,regulation of hydrogen peroxide-induced cell death,BP,
19748,GO:1903206,1,0.910459493409003,0,15,negative regulation of hydrogen peroxide-induced cell death,BP,
19749,GO:1903207,1,0.978232090459748,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
19750,GO:1903208,1,0.978232090459748,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
19751,GO:1903209,1,0.913798565596454,0,14,positive regulation of oxidative stress-induced cell death,BP,
19752,GO:1903210,1,0.983596816964942,0,2,glomerular visceral epithelial cell apoptotic process,BP,
19753,GO:1903214,1,0.755464405224133,0,43,regulation of protein targeting to mitochondrion,BP,
19754,GO:1903215,1,0.956770361280084,0,7,negative regulation of protein targeting to mitochondrion,BP,
19755,GO:1903216,1,0.986367473646707,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19756,GO:1903217,1,0.986367473646707,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19757,GO:1903223,1,0.96155029251922,0,5,positive regulation of oxidative stress-induced neuron death,BP,
19758,GO:1903224,1,0.973608164897968,0,4,regulation of endodermal cell differentiation,BP,
19759,GO:1903225,1,0.977942712387953,0,3,negative regulation of endodermal cell differentiation,BP,
19760,GO:1903231,1,0.992814805989691,0,2,mRNA binding involved in posttranscriptional gene silencing,MF,
19761,GO:1903232,1,0.975597341316989,0,5,melanosome assembly,BP,
19762,GO:1903233,1,0.967597509866027,0,4,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19763,GO:1903235,1,0.992227477747027,0,1,positive regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19764,GO:1903236,1,0.921802689672647,0,13,regulation of leukocyte tethering or rolling,BP,
19765,GO:1903237,1,0.985570206963587,0,4,negative regulation of leukocyte tethering or rolling,BP,
19766,GO:1903238,1,0.946617743885489,0,8,positive regulation of leukocyte tethering or rolling,BP,
19767,GO:1903241,1,0.98123013457871,0,3,U2-type prespliceosome assembly,BP,
19768,GO:1903242,1,0.938755592702166,0,8,regulation of cardiac muscle hypertrophy in response to stress,BP,
19769,GO:1903243,1,0.953135530060497,0,6,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19770,GO:1903244,1,0.98492034294557,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19771,GO:1903248,1,0.990038223672271,0,1,regulation of citrulline biosynthetic process,BP,
19772,GO:1903249,1,0.990038223672271,0,1,negative regulation of citrulline biosynthetic process,BP,
19773,GO:1903251,1,0.957583108002581,0,7,multi-ciliated epithelial cell differentiation,BP,
19774,GO:1903265,1,0.941251186284514,0,10,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19775,GO:1903276,1,0.980457049170173,0,4,regulation of sodium ion export across plasma membrane,BP,
19776,GO:1903278,1,0.980457049170173,0,4,positive regulation of sodium ion export across plasma membrane,BP,
19777,GO:1903279,1,0.979746052830703,0,3,regulation of calcium:sodium antiporter activity,BP,
19778,GO:1903280,1,0.991892552361565,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19779,GO:1903281,1,0.987755228840001,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19780,GO:1903282,1,0.99273199371895,0,1,regulation of glutathione peroxidase activity,BP,
19781,GO:1903284,1,0.99273199371895,0,1,positive regulation of glutathione peroxidase activity,BP,
19782,GO:1903285,1,0.985072824135113,0,2,positive regulation of hydrogen peroxide catabolic process,BP,
19783,GO:1903286,1,0.940635351243485,0,8,regulation of potassium ion import,BP,
19784,GO:1903288,1,0.948099392240079,0,7,positive regulation of potassium ion import across plasma membrane,BP,
19785,GO:1903292,1,0.985594237938229,0,2,protein localization to Golgi membrane,BP,
19786,GO:1903293,1,0.734008934859172,0,46,phosphatase complex,CC,
19787,GO:1903294,1,0.97695412517703,0,3,regulation of glutamate secretion, neurotransmission,BP,
19788,GO:1903296,1,0.97695412517703,0,3,positive regulation of glutamate secretion, neurotransmission,BP,
19789,GO:1903297,1,0.970779233734959,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19790,GO:1903298,1,0.970779233734959,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19791,GO:1903299,1,0.948178571093513,0,9,regulation of hexokinase activity,BP,
19792,GO:1903300,1,0.977888469896069,0,4,negative regulation of hexokinase activity,BP,
19793,GO:1903301,1,0.969625145260628,0,5,positive regulation of hexokinase activity,BP,
19794,GO:1903302,1,0.994992460256299,0,1,regulation of pyruvate kinase activity,BP,
19796,GO:1903306,1,0.870988496109165,0,22,negative regulation of regulated secretory pathway,BP,
19797,GO:1903307,1,0.706543287914341,0,53,positive regulation of regulated secretory pathway,BP,
19798,GO:1903311,1,0.128361732147785,0,316,regulation of mRNA metabolic process,BP,
19799,GO:1903312,1,0.599818415481712,0,75,negative regulation of mRNA metabolic process,BP,
19800,GO:1903313,1,0.589200480609805,0,78,positive regulation of mRNA metabolic process,BP,
19801,GO:1903314,1,0.994728818783657,0,1,regulation of nitrogen cycle metabolic process,BP,
19803,GO:1903318,1,0.852450219774092,0,27,negative regulation of protein maturation,BP,
19807,GO:1903322,1,0.431685293634978,0,128,positive regulation of protein modification by small protein conjugation or removal,BP,
19808,GO:1903326,1,0.983803999959223,0,2,regulation of tRNA metabolic process,BP,
19809,GO:1903327,1,0.983803999959223,0,2,negative regulation of tRNA metabolic process,BP,
19810,GO:1903332,1,0.928831207613319,0,12,regulation of protein folding,BP,
19811,GO:1903333,1,0.967395026167723,0,6,negative regulation of protein folding,BP,
19812,GO:1903334,1,0.973561856091509,0,4,positive regulation of protein folding,BP,
19813,GO:1903335,1,0.974479451031077,0,4,regulation of vacuolar transport,BP,
19814,GO:1903336,1,0.98252604674027,0,2,negative regulation of vacuolar transport,BP,
19815,GO:1903337,1,0.991811766152427,0,2,positive regulation of vacuolar transport,BP,
19816,GO:1903341,1,0.991561133730953,0,1,regulation of meiotic DNA double-strand break formation,BP,
19817,GO:1903343,1,0.991561133730953,0,1,positive regulation of meiotic DNA double-strand break formation,BP,
19818,GO:1903347,1,0.971189238656767,0,4,negative regulation of bicellular tight junction assembly,BP,
19819,GO:1903348,1,0.962716349433788,0,6,positive regulation of bicellular tight junction assembly,BP,
19820,GO:1903349,1,0.971380388449142,0,4,omegasome membrane,CC,
19821,GO:1903350,1,0.641990999534535,0,71,response to dopamine,BP,
19822,GO:1903351,1,0.641990999534535,0,71,cellular response to dopamine,BP,
19823,GO:1903352,1,0.959602128023161,0,6,L-ornithine transmembrane transport,BP,
19824,GO:1903353,1,0.992201106598446,0,1,regulation of nucleus organization,BP,
19825,GO:1903358,1,0.902179282346943,0,15,regulation of Golgi organization,BP,
19826,GO:1903361,1,0.959999332087999,0,8,protein localization to basolateral plasma membrane,BP,
19828,GO:1903363,1,0.608289707092598,0,77,negative regulation of cellular protein catabolic process,BP,
19831,GO:1903366,1,0.996568367492993,0,1,negative regulation of fear response,BP,
19833,GO:1903371,1,0.96303938299603,0,5,regulation of endoplasmic reticulum tubular network organization,BP,
19834,GO:1903373,1,0.977594799183329,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
19835,GO:1903375,1,0.977763987395671,0,3,facioacoustic ganglion development,BP,
19836,GO:1903376,1,0.953823670304861,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19837,GO:1903377,1,0.975665988018016,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19838,GO:1903378,1,0.985038384825462,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19839,GO:1903381,1,0.992329368544028,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19840,GO:1903382,1,0.992329368544028,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19841,GO:1903383,1,0.990188024119418,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19842,GO:1903384,1,0.990188024119418,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19843,GO:1903385,1,0.977972761346428,0,3,regulation of homophilic cell adhesion,BP,
19844,GO:1903387,1,0.991996764777601,0,1,positive regulation of homophilic cell adhesion,BP,
19845,GO:1903391,1,0.962710600865044,0,5,regulation of adherens junction organization,BP,
19846,GO:1903392,1,0.977847626679871,0,3,negative regulation of adherens junction organization,BP,
19847,GO:1903393,1,0.98452356393,0,2,positive regulation of adherens junction organization,BP,
19848,GO:1903394,1,0.994203567229265,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19849,GO:1903400,1,0.945364345548393,0,8,L-arginine transmembrane transport,BP,
19850,GO:1903401,1,0.964365533362788,0,5,L-lysine transmembrane transport,BP,
19851,GO:1903402,1,0.992482927498219,0,1,regulation of renal phosphate excretion,BP,
19852,GO:1903403,1,0.992482927498219,0,1,negative regulation of renal phosphate excretion,BP,
19853,GO:1903405,1,0.934283875209495,0,12,protein localization to nuclear body,BP,
19854,GO:1903406,1,0.992514839993871,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19855,GO:1903408,1,0.992514839993871,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19856,GO:1903409,1,0.524703325709223,0,98,reactive oxygen species biosynthetic process,BP,
19857,GO:1903412,1,0.976516019071175,0,5,response to bile acid,BP,
19858,GO:1903413,1,0.976516019071175,0,5,cellular response to bile acid,BP,
19859,GO:1903416,1,0.967263856237593,0,5,response to glycoside,BP,
19860,GO:1903420,1,0.991359486719096,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19861,GO:1903421,1,0.839994231048254,0,24,regulation of synaptic vesicle recycling,BP,
19862,GO:1903422,1,0.984409716903614,0,2,negative regulation of synaptic vesicle recycling,BP,
19863,GO:1903423,1,0.935159082168039,0,9,positive regulation of synaptic vesicle recycling,BP,
19864,GO:1903426,1,0.600104408814291,0,79,regulation of reactive oxygen species biosynthetic process,BP,
19865,GO:1903427,1,0.845097829879069,0,27,negative regulation of reactive oxygen species biosynthetic process,BP,
19866,GO:1903428,1,0.745039896548514,0,45,positive regulation of reactive oxygen species biosynthetic process,BP,
19867,GO:1903429,1,0.859487063171556,0,22,regulation of cell maturation,BP,
19868,GO:1903430,1,0.963280027131784,0,6,negative regulation of cell maturation,BP,
19869,GO:1903431,1,0.92912166055504,0,10,positive regulation of cell maturation,BP,
19870,GO:1903432,1,0.819102808660916,0,31,regulation of TORC1 signaling,BP,
19871,GO:1903433,1,0.985729984208672,0,2,regulation of constitutive secretory pathway,BP,
19872,GO:1903434,1,0.992484773000702,0,1,negative regulation of constitutive secretory pathway,BP,
19873,GO:1903435,1,0.993194584787208,0,1,positive regulation of constitutive secretory pathway,BP,
19874,GO:1903436,1,0.984091883728173,0,2,regulation of mitotic cytokinetic process,BP,
19875,GO:1903438,1,0.984091883728173,0,2,positive regulation of mitotic cytokinetic process,BP,
19876,GO:1903439,1,0.974733267760967,0,5,calcitonin family receptor complex,CC,
19877,GO:1903440,1,0.982456852655947,0,4,amylin receptor complex,CC,
19878,GO:1903441,1,0.922082772668241,0,11,protein localization to ciliary membrane,BP,
19879,GO:1903442,1,0.992488314549241,0,1,response to lipoic acid,BP,
19880,GO:1903444,1,0.986141930598713,0,2,negative regulation of brown fat cell differentiation,BP,
19881,GO:1903445,1,0.986125880941879,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19882,GO:1903450,1,0.990142741323835,0,1,regulation of G1 to G0 transition,BP,
19883,GO:1903452,1,0.990142741323835,0,1,positive regulation of G1 to G0 transition,BP,
19884,GO:1903457,1,0.995013884957315,0,1,lactate catabolic process,BP,
19885,GO:1903461,1,0.992788001996533,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19886,GO:1903463,1,0.97277737666558,0,4,regulation of mitotic cell cycle DNA replication,BP,
19887,GO:1903464,1,0.987997488692986,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19888,GO:1903465,1,0.991797095072954,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19889,GO:1903487,1,0.984673911668286,0,3,regulation of lactation,BP,
19890,GO:1903489,1,0.992078003702125,0,2,positive regulation of lactation,BP,
19891,GO:1903490,1,0.984091883728173,0,2,positive regulation of mitotic cytokinesis,BP,
19892,GO:1903492,1,0.996761692975591,0,1,response to acetylsalicylate,BP,
19893,GO:1903494,1,0.99667126295483,0,1,response to dehydroepiandrosterone,BP,
19894,GO:1903496,1,0.99667126295483,0,1,response to 11-deoxycorticosterone,BP,
19895,GO:1903504,1,0.915595895852634,0,14,regulation of mitotic spindle checkpoint,BP,
19901,GO:1903512,1,0.99501010876105,0,1,phytanic acid metabolic process,BP,
19902,GO:1903513,1,0.845731472312523,0,26,endoplasmic reticulum to cytosol transport,BP,
19903,GO:1903514,1,0.802672206147731,0,31,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
19904,GO:1903515,1,0.982657725864457,0,2,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19905,GO:1903516,1,0.980452166121142,0,3,regulation of single strand break repair,BP,
19906,GO:1903517,1,0.993038571577508,0,1,negative regulation of single strand break repair,BP,
19907,GO:1903518,1,0.987326258474652,0,2,positive regulation of single strand break repair,BP,
19908,GO:1903519,1,0.989055849723549,0,2,regulation of mammary gland involution,BP,
19909,GO:1903521,1,0.989055849723549,0,2,positive regulation of mammary gland involution,BP,
19911,GO:1903523,1,0.813178173276014,0,30,negative regulation of blood circulation,BP,
19913,GO:1903525,1,0.954479173769368,0,6,regulation of membrane tubulation,BP,
19914,GO:1903526,1,0.98494668491579,0,2,negative regulation of membrane tubulation,BP,
19915,GO:1903527,1,0.969071550337567,0,4,positive regulation of membrane tubulation,BP,
19920,GO:1903537,1,0.987338749421328,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
19921,GO:1903538,1,0.987338749421328,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19922,GO:1903539,1,0.755780708106768,0,41,protein localization to postsynaptic membrane,BP,
19923,GO:1903540,1,0.898892141986396,0,16,establishment of protein localization to postsynaptic membrane,BP,
19924,GO:1903541,1,0.917455312248352,0,14,regulation of exosomal secretion,BP,
19925,GO:1903542,1,0.987147067738002,0,2,negative regulation of exosomal secretion,BP,
19926,GO:1903543,1,0.917455312248352,0,14,positive regulation of exosomal secretion,BP,
19927,GO:1903544,1,0.992580181249192,0,1,response to butyrate,BP,
19928,GO:1903545,1,0.992580181249192,0,1,cellular response to butyrate,BP,
19929,GO:1903546,1,0.964004610136691,0,5,protein localization to photoreceptor outer segment,BP,
19930,GO:1903547,1,0.993028375618283,0,2,regulation of growth hormone activity,BP,
19931,GO:1903551,1,0.962338518541049,0,6,regulation of extracellular exosome assembly,BP,
19932,GO:1903553,1,0.97301672104369,0,4,positive regulation of extracellular exosome assembly,BP,
19935,GO:1903557,1,0.746579578858073,0,47,positive regulation of tumor necrosis factor superfamily cytokine production,BP,
19937,GO:1903564,1,0.946771190761034,0,7,regulation of protein localization to cilium,BP,
19938,GO:1903565,1,0.985239209776664,0,2,negative regulation of protein localization to cilium,BP,
19939,GO:1903566,1,0.967964729161866,0,4,positive regulation of protein localization to cilium,BP,
19940,GO:1903567,1,0.986789647185776,0,2,regulation of protein localization to ciliary membrane,BP,
19941,GO:1903568,1,0.99258655662872,0,1,negative regulation of protein localization to ciliary membrane,BP,
19942,GO:1903569,1,0.994160236591153,0,1,positive regulation of protein localization to ciliary membrane,BP,
19943,GO:1903570,1,0.992544043955141,0,1,regulation of protein kinase D signaling,BP,
19944,GO:1903572,1,0.992544043955141,0,1,positive regulation of protein kinase D signaling,BP,
19945,GO:1903573,1,0.743244721101708,0,48,negative regulation of response to endoplasmic reticulum stress,BP,
19946,GO:1903575,1,0.974344254558675,0,5,cornified envelope assembly,BP,
19947,GO:1903576,1,0.994934185789107,0,1,response to L-arginine,BP,
19949,GO:1903579,1,0.848896947043634,0,25,negative regulation of ATP metabolic process,BP,
19951,GO:1903584,1,0.992387446489806,0,1,regulation of histone deubiquitination,BP,
19952,GO:1903586,1,0.992387446489806,0,1,positive regulation of histone deubiquitination,BP,
19955,GO:1903589,1,0.960623770129703,0,6,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19956,GO:1903593,1,0.981080380977994,0,4,regulation of histamine secretion by mast cell,BP,
19957,GO:1903595,1,0.981080380977994,0,4,positive regulation of histamine secretion by mast cell,BP,
19958,GO:1903596,1,0.96876064372675,0,5,regulation of gap junction assembly,BP,
19959,GO:1903597,1,0.988757639217738,0,2,negative regulation of gap junction assembly,BP,
19960,GO:1903598,1,0.979777944969853,0,3,positive regulation of gap junction assembly,BP,
19961,GO:1903599,1,0.865345308735423,0,19,positive regulation of autophagy of mitochondrion,BP,
19962,GO:1903608,1,0.962397241674876,0,6,protein localization to cytoplasmic stress granule,BP,
19963,GO:1903609,1,0.993447727017397,0,1,negative regulation of inward rectifier potassium channel activity,BP,
19964,GO:1903610,1,0.995284192982024,0,1,regulation of calcium-dependent ATPase activity,BP,
19965,GO:1903611,1,0.995284192982024,0,1,negative regulation of calcium-dependent ATPase activity,BP,
19966,GO:1903613,1,0.965895417532795,0,6,regulation of protein tyrosine phosphatase activity,BP,
19967,GO:1903614,1,0.984993244579237,0,3,negative regulation of protein tyrosine phosphatase activity,BP,
19968,GO:1903615,1,0.980614174792593,0,3,positive regulation of protein tyrosine phosphatase activity,BP,
19969,GO:1903618,1,0.992468032218389,0,1,regulation of transdifferentiation,BP,
19970,GO:1903620,1,0.992468032218389,0,1,positive regulation of transdifferentiation,BP,
19971,GO:1903621,1,0.995240981603154,0,1,protein localization to photoreceptor connecting cilium,BP,
19972,GO:1903624,1,0.929012866337394,0,13,regulation of DNA catabolic process,BP,
19973,GO:1903625,1,0.974634258217745,0,4,negative regulation of DNA catabolic process,BP,
19974,GO:1903626,1,0.970498679004868,0,6,positive regulation of DNA catabolic process,BP,
19975,GO:1903627,1,0.995284192982024,0,1,regulation of dUTP diphosphatase activity,BP,
19976,GO:1903629,1,0.995284192982024,0,1,positive regulation of dUTP diphosphatase activity,BP,
19977,GO:1903630,1,0.991777303471985,0,2,regulation of aminoacyl-tRNA ligase activity,BP,
19978,GO:1903631,1,0.995284192982024,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
19979,GO:1903632,1,0.996476664588687,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19980,GO:1903633,1,0.995284192982024,0,1,regulation of leucine-tRNA ligase activity,BP,
19981,GO:1903634,1,0.995284192982024,0,1,negative regulation of leucine-tRNA ligase activity,BP,
19982,GO:1903636,1,0.99684265558581,0,1,regulation of protein insertion into mitochondrial outer membrane,BP,
19983,GO:1903638,1,0.99684265558581,0,1,positive regulation of protein insertion into mitochondrial outer membrane,BP,
19984,GO:1903644,1,0.973605591010922,0,5,regulation of chaperone-mediated protein folding,BP,
19985,GO:1903645,1,0.993454839987184,0,2,negative regulation of chaperone-mediated protein folding,BP,
19986,GO:1903646,1,0.986227810806512,0,2,positive regulation of chaperone-mediated protein folding,BP,
19987,GO:1903649,1,0.848579596516896,0,23,regulation of cytoplasmic transport,BP,
19988,GO:1903650,1,0.986039765191031,0,3,negative regulation of cytoplasmic transport,BP,
19989,GO:1903651,1,0.91711059723195,0,11,positive regulation of cytoplasmic transport,BP,
19990,GO:1903659,1,0.961930106147257,0,6,regulation of complement-dependent cytotoxicity,BP,
19991,GO:1903660,1,0.990160465024912,0,2,negative regulation of complement-dependent cytotoxicity,BP,
19992,GO:1903661,1,0.994503047059694,0,1,positive regulation of complement-dependent cytotoxicity,BP,
19995,GO:1903672,1,0.780910495812621,0,37,positive regulation of sprouting angiogenesis,BP,
19996,GO:1903673,1,0.995304437434514,0,1,mitotic cleavage furrow formation,BP,
19997,GO:1903674,1,0.995321028817568,0,1,regulation of cap-dependent translational initiation,BP,
19998,GO:1903676,1,0.995321028817568,0,1,positive regulation of cap-dependent translational initiation,BP,
19999,GO:1903677,1,0.983767208357999,0,3,regulation of cap-independent translational initiation,BP,
20000,GO:1903679,1,0.983767208357999,0,3,positive regulation of cap-independent translational initiation,BP,
20001,GO:1903689,1,0.946314454934303,0,6,regulation of wound healing, spreading of epidermal cells,BP,
20002,GO:1903690,1,0.965290373862096,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
20003,GO:1903691,1,0.980348752173479,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
20004,GO:1903697,1,0.992610068231064,0,1,negative regulation of microvillus assembly,BP,
20005,GO:1903699,1,0.988537332350495,0,1,tarsal gland development,BP,
20006,GO:1903701,1,0.992042096219856,0,1,substantia propria of cornea development,BP,
20007,GO:1903704,1,0.992468032218389,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
20008,GO:1903706,1,0.0657028007418713,0,428,regulation of hemopoiesis,BP,
20009,GO:1903707,1,0.454171697678834,0,126,negative regulation of hemopoiesis,BP,
20010,GO:1903708,1,0.30236791083894,0,186,positive regulation of hemopoiesis,BP,
20011,GO:1903709,1,0.988537332350495,0,1,uterine gland development,BP,
20012,GO:1903710,1,0.992468160929538,0,1,spermine transmembrane transport,BP,
20013,GO:1903712,1,0.992500590259723,0,1,cysteine transmembrane transport,BP,
20014,GO:1903713,1,0.995107588931649,0,1,asparagine transmembrane transport,BP,
20015,GO:1903714,1,0.991943534146207,0,1,isoleucine transmembrane transport,BP,
20016,GO:1903715,1,0.960643194966254,0,6,regulation of aerobic respiration,BP,
20017,GO:1903719,1,0.958340556998264,0,7,regulation of I-kappaB phosphorylation,BP,
20018,GO:1903720,1,0.992452147626154,0,1,negative regulation of I-kappaB phosphorylation,BP,
20019,GO:1903721,1,0.965631592909927,0,6,positive regulation of I-kappaB phosphorylation,BP,
20020,GO:1903722,1,0.960795500492543,0,6,regulation of centriole elongation,BP,
20021,GO:1903723,1,0.989992465818853,0,2,negative regulation of centriole elongation,BP,
20022,GO:1903724,1,0.970510874592151,0,4,positive regulation of centriole elongation,BP,
20024,GO:1903726,1,0.946204256168212,0,8,negative regulation of phospholipid metabolic process,BP,
20026,GO:1903729,1,0.901522275675445,0,15,regulation of plasma membrane organization,BP,
20027,GO:1903742,1,0.98816524926531,0,2,regulation of anterograde synaptic vesicle transport,BP,
20028,GO:1903743,1,0.996352169792451,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
20029,GO:1903744,1,0.991783411295803,0,1,positive regulation of anterograde synaptic vesicle transport,BP,
20030,GO:1903747,1,0.640430565193361,0,71,regulation of establishment of protein localization to mitochondrion,BP,
20031,GO:1903748,1,0.945108656369874,0,9,negative regulation of establishment of protein localization to mitochondrion,BP,
20032,GO:1903749,1,0.69322196982374,0,58,positive regulation of establishment of protein localization to mitochondrion,BP,
20033,GO:1903750,1,0.984559764151285,0,3,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
20034,GO:1903751,1,0.984559764151285,0,3,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
20035,GO:1903753,1,0.958215789278343,0,6,negative regulation of p38MAPK cascade,BP,
20036,GO:1903755,1,0.996492397595218,0,1,positive regulation of SUMO transferase activity,BP,
20037,GO:1903760,1,0.977139010466955,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
20038,GO:1903762,1,0.984889691687466,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
20040,GO:1903764,1,0.954832630079211,0,7,regulation of potassium ion export across plasma membrane,BP,
20041,GO:1903765,1,0.978943530624355,0,3,negative regulation of potassium ion export across plasma membrane,BP,
20042,GO:1903766,1,0.983112609150568,0,3,positive regulation of potassium ion export across plasma membrane,BP,
20043,GO:1903767,1,0.993696128496363,0,1,sweet taste receptor complex,CC,
20044,GO:1903768,1,0.993696128496363,0,1,taste receptor complex,CC,
20045,GO:1903770,1,0.993038571577508,0,1,negative regulation of beta-galactosidase activity,BP,
20046,GO:1903772,1,0.980632589859204,0,4,regulation of viral budding via host ESCRT complex,BP,
20047,GO:1903774,1,0.984097528920874,0,3,positive regulation of viral budding via host ESCRT complex,BP,
20048,GO:1903775,1,0.98740821765756,0,2,regulation of DNA double-strand break processing,BP,
20049,GO:1903778,1,0.991379226479663,0,1,protein localization to vacuolar membrane,BP,
20050,GO:1903779,1,0.616025694950656,0,67,regulation of cardiac conduction,BP,
20051,GO:1903781,1,0.97744712965719,0,3,positive regulation of cardiac conduction,BP,
20052,GO:1903786,1,0.982989655265638,0,2,regulation of glutathione biosynthetic process,BP,
20053,GO:1903788,1,0.993311805709434,0,1,positive regulation of glutathione biosynthetic process,BP,
20054,GO:1903789,1,0.92141123510936,0,12,regulation of amino acid transmembrane transport,BP,
20055,GO:1903792,1,0.831540689460148,0,27,negative regulation of anion transport,BP,
20056,GO:1903793,1,0.738886533015281,0,48,positive regulation of anion transport,BP,
20057,GO:1903795,1,0.951913542728079,0,6,regulation of inorganic anion transmembrane transport,BP,
20058,GO:1903796,1,0.983183385807556,0,2,negative regulation of inorganic anion transmembrane transport,BP,
20059,GO:1903797,1,0.984016636371865,0,2,positive regulation of inorganic anion transmembrane transport,BP,
20061,GO:1903799,1,0.906749104225696,0,14,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
20063,GO:1903801,1,0.966438227525175,0,5,L-leucine import across plasma membrane,BP,
20064,GO:1903803,1,0.995285386751004,0,1,L-glutamine import across plasma membrane,BP,
20065,GO:1903804,1,0.975029681349235,0,4,glycine import across plasma membrane,BP,
20066,GO:1903806,1,0.991943534146207,0,1,L-isoleucine import across plasma membrane,BP,
20067,GO:1903810,1,0.990836780290473,0,1,L-histidine import across plasma membrane,BP,
20068,GO:1903812,1,0.992409588456598,0,1,L-serine import across plasma membrane,BP,
20069,GO:1903814,1,0.996743521086397,0,1,regulation of collecting lymphatic vessel constriction,BP,
20070,GO:1903815,1,0.996743521086397,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
20072,GO:1903818,1,0.902904500196217,0,15,positive regulation of voltage-gated potassium channel activity,BP,
20073,GO:1903823,1,0.993038571577508,0,1,telomere single strand break repair,BP,
20074,GO:1903824,1,0.993038571577508,0,1,negative regulation of telomere single strand break repair,BP,
20076,GO:1903826,1,0.945364345548393,0,8,arginine transmembrane transport,BP,
20080,GO:1903830,1,0.900875941655157,0,15,magnesium ion transmembrane transport,BP,
20081,GO:1903837,1,0.993898281598366,0,1,regulation of mRNA 3'-UTR binding,BP,
20082,GO:1903839,1,0.993898281598366,0,1,positive regulation of mRNA 3'-UTR binding,BP,
20083,GO:1903840,1,0.992191960627403,0,1,response to arsenite(3-),BP,
20084,GO:1903841,1,0.992191960627403,0,1,cellular response to arsenite(3-),BP,
20085,GO:1903842,1,0.9722024425484,0,4,response to arsenite ion,BP,
20086,GO:1903843,1,0.9722024425484,0,4,cellular response to arsenite ion,BP,
20087,GO:1903844,1,0.44017209277539,0,117,regulation of cellular response to transforming growth factor beta stimulus,BP,
20088,GO:1903845,1,0.575369910198301,0,79,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
20089,GO:1903846,1,0.816274367369567,0,29,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
20090,GO:1903847,1,0.982264202157013,0,2,regulation of aorta morphogenesis,BP,
20091,GO:1903849,1,0.982264202157013,0,2,positive regulation of aorta morphogenesis,BP,
20092,GO:1903850,1,0.980500801418895,0,4,regulation of cristae formation,BP,
20093,GO:1903852,1,0.985110811907635,0,3,positive regulation of cristae formation,BP,
20094,GO:1903859,1,0.853416726265477,0,23,regulation of dendrite extension,BP,
20095,GO:1903860,1,0.989365331488703,0,2,negative regulation of dendrite extension,BP,
20096,GO:1903861,1,0.862604010635015,0,21,positive regulation of dendrite extension,BP,
20097,GO:1903862,1,0.957044846336438,0,9,positive regulation of oxidative phosphorylation,BP,
20098,GO:1903867,1,0.938635737962824,0,9,extraembryonic membrane development,BP,
20099,GO:1903881,1,0.992502700385995,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
20100,GO:1903883,1,0.992502700385995,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
20101,GO:1903884,1,0.992502700385995,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
20102,GO:1903886,1,0.992502700385995,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
20103,GO:1903891,1,0.972662188670859,0,4,regulation of ATF6-mediated unfolded protein response,BP,
20104,GO:1903892,1,0.986115942672785,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
20105,GO:1903893,1,0.993840149791128,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
20106,GO:1903894,1,0.923190648542433,0,13,regulation of IRE1-mediated unfolded protein response,BP,
20107,GO:1903895,1,0.969553642726222,0,5,negative regulation of IRE1-mediated unfolded protein response,BP,
20108,GO:1903896,1,0.95984605950668,0,6,positive regulation of IRE1-mediated unfolded protein response,BP,
20110,GO:1903898,1,0.968808769437266,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
20112,GO:1903900,1,0.421009056827971,0,137,regulation of viral life cycle,BP,
20113,GO:1903901,1,0.644594317232062,0,71,negative regulation of viral life cycle,BP,
20114,GO:1903902,1,0.682347885115479,0,59,positive regulation of viral life cycle,BP,
20115,GO:1903903,1,0.977759910107351,0,3,regulation of establishment of T cell polarity,BP,
20116,GO:1903905,1,0.984337740008209,0,2,positive regulation of establishment of T cell polarity,BP,
20117,GO:1903906,1,0.993318579134512,0,1,regulation of plasma membrane raft polarization,BP,
20118,GO:1903909,1,0.923392387465226,0,11,regulation of receptor clustering,BP,
20119,GO:1903910,1,0.99424195867487,0,1,negative regulation of receptor clustering,BP,
20120,GO:1903911,1,0.969453074554859,0,5,positive regulation of receptor clustering,BP,
20121,GO:1903912,1,0.973743119302183,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
20122,GO:1903916,1,0.99413231174732,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
20123,GO:1903917,1,0.99413231174732,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
20124,GO:1903918,1,0.990732619633034,0,1,regulation of actin filament severing,BP,
20125,GO:1903919,1,0.990732619633034,0,1,negative regulation of actin filament severing,BP,
20126,GO:1903921,1,0.984112491915632,0,2,regulation of protein processing in phagocytic vesicle,BP,
20127,GO:1903923,1,0.984112491915632,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
20128,GO:1903924,1,0.994534223746718,0,1,estradiol binding,MF,
20129,GO:1903925,1,0.995423541794903,0,1,response to bisphenol A,BP,
20130,GO:1903926,1,0.995423541794903,0,1,cellular response to bisphenol A,BP,
20131,GO:1903929,1,0.986946835524219,0,2,primary palate development,BP,
20132,GO:1903935,1,0.972828361286806,0,5,response to sodium arsenite,BP,
20133,GO:1903936,1,0.972828361286806,0,5,cellular response to sodium arsenite,BP,
20134,GO:1903939,1,0.984220525210375,0,2,regulation of TORC2 signaling,BP,
20135,GO:1903943,1,0.995205851745779,0,1,regulation of hepatocyte apoptotic process,BP,
20136,GO:1903944,1,0.995205851745779,0,1,negative regulation of hepatocyte apoptotic process,BP,
20137,GO:1903946,1,0.987151945156203,0,2,negative regulation of ventricular cardiac muscle cell action potential,BP,
20138,GO:1903947,1,0.984889691687466,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
20139,GO:1903949,1,0.984986446864701,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
20140,GO:1903952,1,0.992471757367305,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
20141,GO:1903954,1,0.992471757367305,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
20142,GO:1903955,1,0.8076474292145,0,32,positive regulation of protein targeting to mitochondrion,BP,
20143,GO:1903959,1,0.802757168486216,0,30,regulation of anion transmembrane transport,BP,
20144,GO:1903960,1,0.899990628209955,0,15,negative regulation of anion transmembrane transport,BP,
20145,GO:1903961,1,0.929007372779506,0,10,positive regulation of anion transmembrane transport,BP,
20146,GO:1903963,1,0.88177402133944,0,22,arachidonate transport,BP,
20147,GO:1903964,1,0.981919031415147,0,3,monounsaturated fatty acid metabolic process,BP,
20148,GO:1903965,1,0.99629549147422,0,1,monounsaturated fatty acid catabolic process,BP,
20149,GO:1903966,1,0.985570627762818,0,2,monounsaturated fatty acid biosynthetic process,BP,
20150,GO:1903969,1,0.970605900647847,0,5,regulation of response to macrophage colony-stimulating factor,BP,
20151,GO:1903970,1,0.991888994820189,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
20152,GO:1903971,1,0.978544633410088,0,3,positive regulation of response to macrophage colony-stimulating factor,BP,
20153,GO:1903972,1,0.970605900647847,0,5,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20154,GO:1903973,1,0.991888994820189,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20155,GO:1903974,1,0.978544633410088,0,3,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20156,GO:1903975,1,0.908348145960788,0,15,regulation of glial cell migration,BP,
20157,GO:1903976,1,0.977865933736341,0,4,negative regulation of glial cell migration,BP,
20158,GO:1903977,1,0.933017644011164,0,10,positive regulation of glial cell migration,BP,
20159,GO:1903978,1,0.896965766292199,0,16,regulation of microglial cell activation,BP,
20160,GO:1903979,1,0.953973686965537,0,7,negative regulation of microglial cell activation,BP,
20161,GO:1903980,1,0.958566291560242,0,6,positive regulation of microglial cell activation,BP,
20162,GO:1903981,1,0.991227345361269,0,2,enterobactin binding,MF,
20163,GO:1903984,1,0.978875847304129,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
20164,GO:1903988,1,0.992608555360218,0,1,iron ion export across plasma membrane,BP,
20165,GO:1903995,1,0.948902653229435,0,8,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20166,GO:1903996,1,0.996151306609999,0,1,negative regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20167,GO:1903997,1,0.952570623530635,0,7,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20168,GO:1903998,1,0.964907587854834,0,6,regulation of eating behavior,BP,
20169,GO:1903999,1,0.977719404449173,0,4,negative regulation of eating behavior,BP,
20170,GO:1904000,1,0.98689921731356,0,2,positive regulation of eating behavior,BP,
20171,GO:1904008,1,0.996260416614264,0,1,response to monosodium glutamate,BP,
20172,GO:1904009,1,0.996260416614264,0,1,cellular response to monosodium glutamate,BP,
20173,GO:1904010,1,0.996260416614264,0,1,response to Aroclor 1254,BP,
20174,GO:1904016,1,0.969247334757435,0,4,response to Thyroglobulin triiodothyronine,BP,
20175,GO:1904017,1,0.982649231100463,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
20178,GO:1904020,1,0.981329027583641,0,3,regulation of G protein-coupled receptor internalization,BP,
20179,GO:1904021,1,0.98855442352819,0,2,negative regulation of G protein-coupled receptor internalization,BP,
20180,GO:1904022,1,0.992691803075415,0,1,positive regulation of G protein-coupled receptor internalization,BP,
20181,GO:1904023,1,0.986142807120098,0,2,regulation of glucose catabolic process to lactate via pyruvate,BP,
20182,GO:1904024,1,0.986142807120098,0,2,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
20183,GO:1904026,1,0.964684476297733,0,5,regulation of collagen fibril organization,BP,
20184,GO:1904027,1,0.986280020813645,0,2,negative regulation of collagen fibril organization,BP,
20185,GO:1904028,1,0.985544389064126,0,2,positive regulation of collagen fibril organization,BP,
20187,GO:1904030,1,0.825952594163374,0,30,negative regulation of cyclin-dependent protein kinase activity,BP,
20190,GO:1904036,1,0.777634697575008,0,38,negative regulation of epithelial cell apoptotic process,BP,
20191,GO:1904037,1,0.819072402432941,0,32,positive regulation of epithelial cell apoptotic process,BP,
20192,GO:1904041,1,0.9926432603516,0,1,regulation of cystathionine beta-synthase activity,BP,
20193,GO:1904042,1,0.9926432603516,0,1,negative regulation of cystathionine beta-synthase activity,BP,
20194,GO:1904044,1,0.973380948013704,0,5,response to aldosterone,BP,
20195,GO:1904045,1,0.994568002194877,0,1,cellular response to aldosterone,BP,
20196,GO:1904046,1,0.996725737755439,0,1,negative regulation of vascular endothelial growth factor production,BP,
20197,GO:1904047,1,0.925967368563741,0,13,S-adenosyl-L-methionine binding,MF,
20198,GO:1904048,1,0.981795186435358,0,2,regulation of spontaneous neurotransmitter secretion,BP,
20199,GO:1904049,1,0.989380932583281,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
20200,GO:1904050,1,0.992333666231734,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
20201,GO:1904054,1,0.986241981667807,0,2,regulation of cholangiocyte proliferation,BP,
20202,GO:1904056,1,0.986241981667807,0,2,positive regulation of cholangiocyte proliferation,BP,
20203,GO:1904057,1,0.995912405228962,0,1,negative regulation of sensory perception of pain,BP,
20204,GO:1904058,1,0.965306008091007,0,6,positive regulation of sensory perception of pain,BP,
20205,GO:1904059,1,0.970318593668802,0,3,regulation of locomotor rhythm,BP,
20209,GO:1904071,1,0.955531947271595,0,4,presynaptic active zone assembly,BP,
20210,GO:1904073,1,0.990885480912164,0,1,regulation of trophectodermal cell proliferation,BP,
20211,GO:1904075,1,0.990885480912164,0,1,positive regulation of trophectodermal cell proliferation,BP,
20212,GO:1904090,1,0.983682978615432,0,4,peptidase inhibitor complex,CC,
20213,GO:1904092,1,0.977036109135604,0,4,regulation of autophagic cell death,BP,
20214,GO:1904093,1,0.996620610494782,0,1,negative regulation of autophagic cell death,BP,
20215,GO:1904098,1,0.980874760915254,0,3,regulation of protein O-linked glycosylation,BP,
20216,GO:1904100,1,0.980874760915254,0,3,positive regulation of protein O-linked glycosylation,BP,
20217,GO:1904106,1,0.993272770923987,0,1,protein localization to microvillus,BP,
20218,GO:1904108,1,0.992515802301045,0,1,protein localization to ciliary inversin compartment,BP,
20219,GO:1904109,1,0.987065584560306,0,1,positive regulation of cholesterol import,BP,
20220,GO:1904115,1,0.664139233684656,0,56,axon cytoplasm,CC,
20221,GO:1904116,1,0.977330150073764,0,3,response to vasopressin,BP,
20222,GO:1904117,1,0.977330150073764,0,3,cellular response to vasopressin,BP,
20223,GO:1904118,1,0.992784167791999,0,1,regulation of otic vesicle morphogenesis,BP,
20224,GO:1904120,1,0.992784167791999,0,1,positive regulation of otic vesicle morphogenesis,BP,
20225,GO:1904121,1,0.99582347391602,0,1,phosphatidylethanolamine transfer activity,MF,
20226,GO:1904124,1,0.963841048393383,0,7,microglial cell migration,BP,
20227,GO:1904139,1,0.963841048393383,0,7,regulation of microglial cell migration,BP,
20228,GO:1904140,1,0.996100010277382,0,1,negative regulation of microglial cell migration,BP,
20229,GO:1904141,1,0.967616009471601,0,6,positive regulation of microglial cell migration,BP,
20230,GO:1904149,1,0.985258393005457,0,3,regulation of microglial cell mediated cytotoxicity,BP,
20231,GO:1904151,1,0.985258393005457,0,3,positive regulation of microglial cell mediated cytotoxicity,BP,
20232,GO:1904152,1,0.920416253576388,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
20233,GO:1904153,1,0.943406407062167,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
20234,GO:1904154,1,0.982973685326102,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
20235,GO:1904155,1,0.984793593503164,0,2,DN2 thymocyte differentiation,BP,
20236,GO:1904156,1,0.992614948362936,0,1,DN3 thymocyte differentiation,BP,
20237,GO:1904158,1,0.976097448780708,0,3,axonemal central apparatus assembly,BP,
20238,GO:1904161,1,0.988474674246552,0,2,DNA synthesis involved in UV-damage excision repair,BP,
20241,GO:1904177,1,0.945958981755009,0,8,regulation of adipose tissue development,BP,
20242,GO:1904178,1,0.988684898427906,0,2,negative regulation of adipose tissue development,BP,
20243,GO:1904179,1,0.956790011039473,0,6,positive regulation of adipose tissue development,BP,
20246,GO:1904182,1,0.947478880503397,0,8,regulation of pyruvate dehydrogenase activity,BP,
20247,GO:1904183,1,0.965297962503244,0,5,negative regulation of pyruvate dehydrogenase activity,BP,
20248,GO:1904184,1,0.984972558475477,0,2,positive regulation of pyruvate dehydrogenase activity,BP,
20249,GO:1904192,1,0.990067536892281,0,1,regulation of cholangiocyte apoptotic process,BP,
20250,GO:1904193,1,0.990067536892281,0,1,negative regulation of cholangiocyte apoptotic process,BP,
20251,GO:1904195,1,0.990067536892281,0,1,regulation of granulosa cell proliferation,BP,
20252,GO:1904197,1,0.990067536892281,0,1,positive regulation of granulosa cell proliferation,BP,
20253,GO:1904199,1,0.992458489616274,0,1,positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization,BP,
20254,GO:1904200,1,0.982668037768624,0,2,iodide transmembrane transport,BP,
20255,GO:1904201,1,0.990067536892281,0,1,regulation of iodide transport,BP,
20256,GO:1904202,1,0.990067536892281,0,1,negative regulation of iodide transport,BP,
20257,GO:1904204,1,0.981609330295012,0,2,regulation of skeletal muscle hypertrophy,BP,
20258,GO:1904205,1,0.991457804535671,0,1,negative regulation of skeletal muscle hypertrophy,BP,
20259,GO:1904206,1,0.990067536892281,0,1,positive regulation of skeletal muscle hypertrophy,BP,
20260,GO:1904210,1,0.996283950358076,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20261,GO:1904211,1,0.987796656712877,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
20262,GO:1904212,1,0.990067536892281,0,1,regulation of iodide transmembrane transport,BP,
20263,GO:1904213,1,0.990067536892281,0,1,negative regulation of iodide transmembrane transport,BP,
20264,GO:1904217,1,0.983209273529587,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20265,GO:1904219,1,0.983209273529587,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20266,GO:1904220,1,0.97657644270167,0,4,regulation of serine C-palmitoyltransferase activity,BP,
20267,GO:1904222,1,0.983209273529587,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
20268,GO:1904226,1,0.994635528004373,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20269,GO:1904227,1,0.994635528004373,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20270,GO:1904229,1,0.983748981419627,0,2,regulation of succinate dehydrogenase activity,BP,
20271,GO:1904231,1,0.990937060031253,0,1,positive regulation of succinate dehydrogenase activity,BP,
20272,GO:1904232,1,0.987530769970421,0,2,regulation of aconitate hydratase activity,BP,
20273,GO:1904234,1,0.987530769970421,0,2,positive regulation of aconitate hydratase activity,BP,
20274,GO:1904235,1,0.981755198732696,0,2,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20275,GO:1904237,1,0.981755198732696,0,2,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20276,GO:1904238,1,0.949837361509224,0,8,pericyte cell differentiation,BP,
20277,GO:1904239,1,0.996283950358076,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20278,GO:1904240,1,0.996283950358076,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20279,GO:1904245,1,0.988544472708545,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
20280,GO:1904246,1,0.995697015410691,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
20281,GO:1904247,1,0.992816862330188,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
20282,GO:1904251,1,0.924968026548548,0,12,regulation of bile acid metabolic process,BP,
20283,GO:1904252,1,0.986128120964423,0,2,negative regulation of bile acid metabolic process,BP,
20284,GO:1904253,1,0.981249475862198,0,3,positive regulation of bile acid metabolic process,BP,
20285,GO:1904259,1,0.9573699714141,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20286,GO:1904261,1,0.9573699714141,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20287,GO:1904262,1,0.929343971363967,0,11,negative regulation of TORC1 signaling,BP,
20288,GO:1904263,1,0.911058137779514,0,15,positive regulation of TORC1 signaling,BP,
20289,GO:1904266,1,0.990907255086257,0,1,regulation of Schwann cell chemotaxis,BP,
20290,GO:1904268,1,0.990907255086257,0,1,positive regulation of Schwann cell chemotaxis,BP,
20291,GO:1904270,1,0.996146873357945,0,1,pyroptosome complex assembly,BP,
20292,GO:1904271,1,0.978550531346755,0,3,L-proline import across plasma membrane,BP,
20293,GO:1904273,1,0.979488313246878,0,3,L-alanine import across plasma membrane,BP,
20294,GO:1904274,1,0.994536822080751,0,1,tricellular tight junction assembly,BP,
20295,GO:1904282,1,0.99523977488528,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20296,GO:1904283,1,0.99523977488528,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20297,GO:1904288,1,0.970131861262683,0,4,BAT3 complex binding,MF,
20298,GO:1904289,1,0.985313189673235,0,2,regulation of mitotic DNA damage checkpoint,BP,
20299,GO:1904290,1,0.992339318118405,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
20300,GO:1904292,1,0.821099218431258,0,30,regulation of ERAD pathway,BP,
20301,GO:1904293,1,0.916787668409906,0,14,negative regulation of ERAD pathway,BP,
20302,GO:1904294,1,0.904181659182903,0,15,positive regulation of ERAD pathway,BP,
20303,GO:1904298,1,0.979608861712791,0,2,regulation of transcytosis,BP,
20304,GO:1904300,1,0.979608861712791,0,2,positive regulation of transcytosis,BP,
20305,GO:1904301,1,0.992446562585314,0,1,regulation of maternal process involved in parturition,BP,
20306,GO:1904303,1,0.992446562585314,0,1,positive regulation of maternal process involved in parturition,BP,
20307,GO:1904304,1,0.971624744628401,0,5,regulation of gastro-intestinal system smooth muscle contraction,BP,
20308,GO:1904306,1,0.971624744628401,0,5,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20309,GO:1904313,1,0.992472708438387,0,1,response to methamphetamine hydrochloride,BP,
20310,GO:1904315,1,0.735968402405229,0,44,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20311,GO:1904316,1,0.992446562585314,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20312,GO:1904317,1,0.992446562585314,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20313,GO:1904321,1,0.912152326314658,0,11,response to forskolin,BP,
20314,GO:1904322,1,0.912152326314658,0,11,cellular response to forskolin,BP,
20315,GO:1904323,1,0.993031215140746,0,1,regulation of inhibitory G protein-coupled receptor phosphorylation,BP,
20316,GO:1904325,1,0.993031215140746,0,1,positive regulation of inhibitory G protein-coupled receptor phosphorylation,BP,
20317,GO:1904327,1,0.984502144328206,0,2,protein localization to cytosolic proteasome complex,BP,
20318,GO:1904328,1,0.993348948151922,0,1,regulation of myofibroblast contraction,BP,
20319,GO:1904338,1,0.947263488845261,0,9,regulation of dopaminergic neuron differentiation,BP,
20320,GO:1904339,1,0.987015742575036,0,2,negative regulation of dopaminergic neuron differentiation,BP,
20321,GO:1904340,1,0.980765950925783,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20322,GO:1904341,1,0.992049146936613,0,1,regulation of colon smooth muscle contraction,BP,
20323,GO:1904343,1,0.992049146936613,0,1,positive regulation of colon smooth muscle contraction,BP,
20324,GO:1904344,1,0.990720259016454,0,2,regulation of gastric mucosal blood circulation,BP,
20325,GO:1904346,1,0.990720259016454,0,2,positive regulation of gastric mucosal blood circulation,BP,
20326,GO:1904347,1,0.988874550665806,0,2,regulation of small intestine smooth muscle contraction,BP,
20327,GO:1904349,1,0.988874550665806,0,2,positive regulation of small intestine smooth muscle contraction,BP,
20329,GO:1904351,1,0.972029636259126,0,4,negative regulation of protein catabolic process in the vacuole,BP,
20331,GO:1904353,1,0.834131101343805,0,26,regulation of telomere capping,BP,
20332,GO:1904354,1,0.937740336994926,0,8,negative regulation of telomere capping,BP,
20333,GO:1904355,1,0.896841730870582,0,17,positive regulation of telomere capping,BP,
20334,GO:1904356,1,0.672880766105848,0,58,regulation of telomere maintenance via telomere lengthening,BP,
20335,GO:1904357,1,0.838086705616927,0,24,negative regulation of telomere maintenance via telomere lengthening,BP,
20336,GO:1904358,1,0.78727038174435,0,37,positive regulation of telomere maintenance via telomere lengthening,BP,
20337,GO:1904370,1,0.992461695877957,0,1,regulation of protein localization to actin cortical patch,BP,
20338,GO:1904372,1,0.992461695877957,0,1,positive regulation of protein localization to actin cortical patch,BP,
20339,GO:1904373,1,0.988545545123253,0,2,response to kainic acid,BP,
20341,GO:1904376,1,0.849079835747637,0,25,negative regulation of protein localization to cell periphery,BP,
20343,GO:1904378,1,0.978787260041971,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20344,GO:1904379,1,0.984502144328206,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20345,GO:1904380,1,0.898411117961241,0,15,endoplasmic reticulum mannose trimming,BP,
20346,GO:1904381,1,0.977257577771405,0,3,Golgi apparatus mannose trimming,BP,
20347,GO:1904382,1,0.971644394813235,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20348,GO:1904383,1,0.98781514281067,0,2,response to sodium phosphate,BP,
20349,GO:1904385,1,0.86459613091295,0,22,cellular response to angiotensin,BP,
20350,GO:1904386,1,0.963606962443755,0,5,response to L-phenylalanine derivative,BP,
20351,GO:1904387,1,0.985372081326104,0,2,cellular response to L-phenylalanine derivative,BP,
20352,GO:1904389,1,0.996054408384378,0,1,rod bipolar cell differentiation,BP,
20353,GO:1904391,1,0.996054408384378,0,1,response to ciliary neurotrophic factor,BP,
20354,GO:1904393,1,0.973013336259591,0,4,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20355,GO:1904394,1,0.99424195867487,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20356,GO:1904395,1,0.98656778700477,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20357,GO:1904396,1,0.929876335156478,0,10,regulation of neuromuscular junction development,BP,
20358,GO:1904397,1,0.990318854705174,0,2,negative regulation of neuromuscular junction development,BP,
20359,GO:1904398,1,0.970102934393832,0,4,positive regulation of neuromuscular junction development,BP,
20360,GO:1904399,1,0.983720402500058,0,3,heparan sulfate binding,MF,
20361,GO:1904400,1,0.992799221737581,0,1,response to Thyroid stimulating hormone,BP,
20362,GO:1904404,1,0.990826340024239,0,1,response to formaldehyde,BP,
20363,GO:1904406,1,0.913376029340499,0,14,negative regulation of nitric oxide metabolic process,BP,
20364,GO:1904407,1,0.786825826333742,0,37,positive regulation of nitric oxide metabolic process,BP,
20365,GO:1904408,1,0.996547773841177,0,1,melatonin binding,MF,
20366,GO:1904412,1,0.992518692750008,0,1,regulation of cardiac ventricle development,BP,
20367,GO:1904414,1,0.992518692750008,0,1,positive regulation of cardiac ventricle development,BP,
20368,GO:1904415,1,0.960233496294747,0,6,regulation of xenophagy,BP,
20369,GO:1904417,1,0.960233496294747,0,6,positive regulation of xenophagy,BP,
20370,GO:1904423,1,0.984927839464583,0,2,dehydrodolichyl diphosphate synthase complex,CC,
20371,GO:1904424,1,0.916768647050424,0,12,regulation of GTP binding,BP,
20372,GO:1904425,1,0.986270103167761,0,2,negative regulation of GTP binding,BP,
20373,GO:1904426,1,0.984649287634705,0,2,positive regulation of GTP binding,BP,
20375,GO:1904428,1,0.951652180597454,0,6,negative regulation of tubulin deacetylation,BP,
20376,GO:1904429,1,0.957825129396547,0,6,regulation of t-circle formation,BP,
20377,GO:1904430,1,0.97809159177755,0,3,negative regulation of t-circle formation,BP,
20378,GO:1904431,1,0.979284217871338,0,3,positive regulation of t-circle formation,BP,
20379,GO:1904432,1,0.991922197203273,0,2,regulation of ferrous iron binding,BP,
20380,GO:1904434,1,0.991922197203273,0,2,positive regulation of ferrous iron binding,BP,
20381,GO:1904435,1,0.991922197203273,0,2,regulation of transferrin receptor binding,BP,
20382,GO:1904437,1,0.991922197203273,0,2,positive regulation of transferrin receptor binding,BP,
20383,GO:1904438,1,0.996562875933798,0,1,regulation of iron ion import across plasma membrane,BP,
20384,GO:1904439,1,0.996562875933798,0,1,negative regulation of iron ion import across plasma membrane,BP,
20386,GO:1904448,1,0.983345969428703,0,2,regulation of aspartate secretion,BP,
20387,GO:1904450,1,0.983345969428703,0,2,positive regulation of aspartate secretion,BP,
20388,GO:1904456,1,0.995416654488942,0,1,negative regulation of neuronal action potential,BP,
20389,GO:1904457,1,0.994071727941164,0,1,positive regulation of neuronal action potential,BP,
20390,GO:1904464,1,0.966108797075196,0,5,regulation of matrix metallopeptidase secretion,BP,
20391,GO:1904465,1,0.990196211436779,0,2,negative regulation of matrix metallopeptidase secretion,BP,
20392,GO:1904466,1,0.984443195171952,0,2,positive regulation of matrix metallopeptidase secretion,BP,
20393,GO:1904470,1,0.996340173474856,0,1,regulation of endothelin production,BP,
20394,GO:1904472,1,0.996340173474856,0,1,positive regulation of endothelin production,BP,
20395,GO:1904475,1,0.97550130102972,0,3,regulation of Ras GTPase binding,BP,
20396,GO:1904477,1,0.991388821048341,0,1,positive regulation of Ras GTPase binding,BP,
20397,GO:1904478,1,0.96610872791677,0,6,regulation of intestinal absorption,BP,
20398,GO:1904479,1,0.990332263210332,0,2,negative regulation of intestinal absorption,BP,
20399,GO:1904480,1,0.99432685821291,0,1,positive regulation of intestinal absorption,BP,
20400,GO:1904481,1,0.98845812519745,0,2,response to tetrahydrofolate,BP,
20401,GO:1904482,1,0.98845812519745,0,2,cellular response to tetrahydrofolate,BP,
20402,GO:1904491,1,0.96293748192245,0,7,protein localization to ciliary transition zone,BP,
20405,GO:1904499,1,0.9925769027008,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20406,GO:1904501,1,0.9925769027008,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20407,GO:1904502,1,0.962138262367643,0,5,regulation of lipophagy,BP,
20408,GO:1904504,1,0.962138262367643,0,5,positive regulation of lipophagy,BP,
20409,GO:1904505,1,0.971241576023796,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20410,GO:1904506,1,0.971241576023796,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20411,GO:1904508,1,0.996051199785396,0,1,regulation of protein localization to basolateral plasma membrane,BP,
20412,GO:1904510,1,0.996051199785396,0,1,positive regulation of protein localization to basolateral plasma membrane,BP,
20413,GO:1904515,1,0.984220525210375,0,2,positive regulation of TORC2 signaling,BP,
20414,GO:1904526,1,0.934932536078666,0,10,regulation of microtubule binding,BP,
20415,GO:1904527,1,0.983651179414781,0,2,negative regulation of microtubule binding,BP,
20416,GO:1904528,1,0.964882278988216,0,6,positive regulation of microtubule binding,BP,
20417,GO:1904529,1,0.98465245729073,0,2,regulation of actin filament binding,BP,
20418,GO:1904530,1,0.992794307618735,0,1,negative regulation of actin filament binding,BP,
20419,GO:1904531,1,0.991799658234766,0,1,positive regulation of actin filament binding,BP,
20420,GO:1904533,1,0.978503556203845,0,3,regulation of telomeric loop disassembly,BP,
20421,GO:1904534,1,0.986074718384767,0,2,negative regulation of telomeric loop disassembly,BP,
20422,GO:1904535,1,0.99232301188456,0,1,positive regulation of telomeric loop disassembly,BP,
20423,GO:1904538,1,0.992157738584238,0,1,regulation of glycolytic process through fructose-6-phosphate,BP,
20424,GO:1904539,1,0.992157738584238,0,1,negative regulation of glycolytic process through fructose-6-phosphate,BP,
20425,GO:1904542,1,0.993467708443951,0,1,regulation of free ubiquitin chain polymerization,BP,
20426,GO:1904544,1,0.993467708443951,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20427,GO:1904550,1,0.994936728070176,0,1,response to arachidonic acid,BP,
20428,GO:1904555,1,0.978550531346755,0,3,L-proline transmembrane transport,BP,
20429,GO:1904556,1,0.986291070638035,0,2,L-tryptophan transmembrane transport,BP,
20430,GO:1904557,1,0.97469524199719,0,4,L-alanine transmembrane transport,BP,
20431,GO:1904562,1,0.981673820178008,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20432,GO:1904565,1,0.9927687192972,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20433,GO:1904566,1,0.9927687192972,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20434,GO:1904567,1,0.992890982785859,0,1,response to wortmannin,BP,
20435,GO:1904568,1,0.992890982785859,0,1,cellular response to wortmannin,BP,
20436,GO:1904569,1,0.992567700381144,0,2,regulation of selenocysteine incorporation,BP,
20437,GO:1904570,1,0.995701080102347,0,1,negative regulation of selenocysteine incorporation,BP,
20438,GO:1904571,1,0.996853230751024,0,1,positive regulation of selenocysteine incorporation,BP,
20439,GO:1904572,1,0.995701080102347,0,1,negative regulation of mRNA binding,BP,
20440,GO:1904573,1,0.995701080102347,0,1,regulation of selenocysteine insertion sequence binding,BP,
20441,GO:1904574,1,0.995701080102347,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20442,GO:1904576,1,0.98901807144609,0,2,response to tunicamycin,BP,
20443,GO:1904577,1,0.98901807144609,0,2,cellular response to tunicamycin,BP,
20444,GO:1904578,1,0.982344830492696,0,3,response to thapsigargin,BP,
20445,GO:1904579,1,0.982344830492696,0,3,cellular response to thapsigargin,BP,
20446,GO:1904580,1,0.981213705567866,0,3,regulation of intracellular mRNA localization,BP,
20447,GO:1904582,1,0.981213705567866,0,3,positive regulation of intracellular mRNA localization,BP,
20448,GO:1904585,1,0.994705529194295,0,1,response to putrescine,BP,
20449,GO:1904586,1,0.994705529194295,0,1,cellular response to putrescine,BP,
20450,GO:1904587,1,0.961217186505513,0,6,response to glycoprotein,BP,
20451,GO:1904588,1,0.996447081436245,0,1,cellular response to glycoprotein,BP,
20454,GO:1904591,1,0.751076934516383,0,41,positive regulation of protein import,BP,
20455,GO:1904594,1,0.975613085768278,0,3,regulation of termination of RNA polymerase II transcription,BP,
20456,GO:1904595,1,0.988910336026141,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20457,GO:1904596,1,0.996340173474856,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20458,GO:1904597,1,0.996340173474856,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20459,GO:1904602,1,0.990051120128626,0,2,serotonin-activated cation-selective channel complex,CC,
20460,GO:1904606,1,0.988008183970979,0,2,fat cell apoptotic process,BP,
20461,GO:1904612,1,0.969519848049914,0,4,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20462,GO:1904613,1,0.983946351344217,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20463,GO:1904616,1,0.98465245729073,0,2,regulation of actin binding,BP,
20464,GO:1904617,1,0.992794307618735,0,1,negative regulation of actin binding,BP,
20465,GO:1904618,1,0.991799658234766,0,1,positive regulation of actin binding,BP,
20466,GO:1904627,1,0.975673477684221,0,4,response to phorbol 13-acetate 12-myristate,BP,
20467,GO:1904628,1,0.975673477684221,0,4,cellular response to phorbol 13-acetate 12-myristate,BP,
20468,GO:1904631,1,0.99449135845416,0,1,response to glucoside,BP,
20469,GO:1904633,1,0.983596816964942,0,2,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20470,GO:1904635,1,0.983596816964942,0,2,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20471,GO:1904636,1,0.973222095035583,0,4,response to ionomycin,BP,
20472,GO:1904637,1,0.973222095035583,0,4,cellular response to ionomycin,BP,
20473,GO:1904638,1,0.984267020847092,0,2,response to resveratrol,BP,
20474,GO:1904639,1,0.991408023303973,0,1,cellular response to resveratrol,BP,
20475,GO:1904640,1,0.981661478452113,0,3,response to methionine,BP,
20476,GO:1904643,1,0.991376969569417,0,1,response to curcumin,BP,
20479,GO:1904647,1,0.9898716552933,0,1,response to rotenone,BP,
20480,GO:1904649,1,0.988008183970979,0,2,regulation of fat cell apoptotic process,BP,
20481,GO:1904651,1,0.992577307963612,0,1,positive regulation of fat cell apoptotic process,BP,
20483,GO:1904666,1,0.879253181498523,0,23,regulation of ubiquitin protein ligase activity,BP,
20484,GO:1904667,1,0.962731621568628,0,9,negative regulation of ubiquitin protein ligase activity,BP,
20485,GO:1904668,1,0.920383774632626,0,13,positive regulation of ubiquitin protein ligase activity,BP,
20486,GO:1904672,1,0.945758043289734,0,8,regulation of somatic stem cell population maintenance,BP,
20487,GO:1904673,1,0.97756797674988,0,3,negative regulation of somatic stem cell population maintenance,BP,
20488,GO:1904674,1,0.985339651352379,0,2,positive regulation of somatic stem cell population maintenance,BP,
20489,GO:1904675,1,0.992985757593682,0,1,regulation of somatic stem cell division,BP,
20490,GO:1904677,1,0.992985757593682,0,1,positive regulation of somatic stem cell division,BP,
20491,GO:1904679,1,0.988646428515982,0,1,myo-inositol import across plasma membrane,BP,
20493,GO:1904681,1,0.993400194006259,0,1,response to 3-methylcholanthrene,BP,
20495,GO:1904684,1,0.966126578705213,0,4,negative regulation of metalloendopeptidase activity,BP,
20497,GO:1904688,1,0.970642806976141,0,5,regulation of cytoplasmic translational initiation,BP,
20498,GO:1904689,1,0.996559892621918,0,1,negative regulation of cytoplasmic translational initiation,BP,
20499,GO:1904690,1,0.973994353953695,0,4,positive regulation of cytoplasmic translational initiation,BP,
20500,GO:1904691,1,0.991524170579933,0,2,negative regulation of type B pancreatic cell proliferation,BP,
20501,GO:1904692,1,0.989299490046614,0,2,positive regulation of type B pancreatic cell proliferation,BP,
20502,GO:1904693,1,0.975476966595084,0,3,midbrain morphogenesis,BP,
20503,GO:1904694,1,0.974447751789751,0,3,negative regulation of vascular associated smooth muscle contraction,BP,
20504,GO:1904695,1,0.988639662270108,0,2,positive regulation of vascular associated smooth muscle contraction,BP,
20505,GO:1904697,1,0.996761692975591,0,1,regulation of acinar cell proliferation,BP,
20506,GO:1904699,1,0.996761692975591,0,1,positive regulation of acinar cell proliferation,BP,
20508,GO:1904701,1,0.995568695093763,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20509,GO:1904702,1,0.991933904800663,0,1,regulation of protein localization to adherens junction,BP,
20511,GO:1904706,1,0.903620108984159,0,17,negative regulation of vascular associated smooth muscle cell proliferation,BP,
20514,GO:1904710,1,0.996586890788437,0,1,positive regulation of granulosa cell apoptotic process,BP,
20515,GO:1904711,1,0.995568695093763,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20516,GO:1904713,1,0.983132861402368,0,2,beta-catenin destruction complex binding,MF,
20517,GO:1904714,1,0.952112276357061,0,8,regulation of chaperone-mediated autophagy,BP,
20518,GO:1904715,1,0.982588566126281,0,3,negative regulation of chaperone-mediated autophagy,BP,
20519,GO:1904716,1,0.994165323664128,0,1,positive regulation of chaperone-mediated autophagy,BP,
20520,GO:1904717,1,0.959121795258313,0,5,regulation of AMPA glutamate receptor clustering,BP,
20521,GO:1904719,1,0.986478331103486,0,2,positive regulation of AMPA glutamate receptor clustering,BP,
20522,GO:1904723,1,0.995568695093763,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20523,GO:1904724,1,0.775062288494342,0,52,tertiary granule lumen,CC,
20524,GO:1904729,1,0.977260454610038,0,4,regulation of intestinal lipid absorption,BP,
20525,GO:1904730,1,0.99344668091026,0,1,negative regulation of intestinal lipid absorption,BP,
20526,GO:1904731,1,0.99432685821291,0,1,positive regulation of intestinal lipid absorption,BP,
20527,GO:1904732,1,0.972703016377494,0,5,regulation of electron transfer activity,BP,
20528,GO:1904734,1,0.99686536995809,0,1,positive regulation of electron transfer activity,BP,
20529,GO:1904738,1,0.841830017581293,0,21,vascular associated smooth muscle cell migration,BP,
20530,GO:1904742,1,0.97262528779517,0,4,regulation of telomeric DNA binding,BP,
20531,GO:1904743,1,0.980877647777078,0,2,negative regulation of telomeric DNA binding,BP,
20532,GO:1904744,1,0.991588410411241,0,2,positive regulation of telomeric DNA binding,BP,
20533,GO:1904746,1,0.966254007792223,0,5,negative regulation of apoptotic process involved in development,BP,
20534,GO:1904747,1,0.966340341283448,0,5,positive regulation of apoptotic process involved in development,BP,
20535,GO:1904748,1,0.92628340703993,0,11,regulation of apoptotic process involved in development,BP,
20536,GO:1904749,1,0.950732716496339,0,8,regulation of protein localization to nucleolus,BP,
20537,GO:1904750,1,0.991217346647788,0,1,negative regulation of protein localization to nucleolus,BP,
20538,GO:1904751,1,0.978034496226677,0,4,positive regulation of protein localization to nucleolus,BP,
20539,GO:1904752,1,0.841830017581293,0,21,regulation of vascular associated smooth muscle cell migration,BP,
20540,GO:1904753,1,0.964457574359364,0,5,negative regulation of vascular associated smooth muscle cell migration,BP,
20541,GO:1904754,1,0.872897147754341,0,16,positive regulation of vascular associated smooth muscle cell migration,BP,
20542,GO:1904760,1,0.969382655330575,0,4,regulation of myofibroblast differentiation,BP,
20543,GO:1904761,1,0.976740692132782,0,3,negative regulation of myofibroblast differentiation,BP,
20544,GO:1904762,1,0.992468545037976,0,1,positive regulation of myofibroblast differentiation,BP,
20545,GO:1904764,1,0.99502268818626,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20546,GO:1904766,1,0.991081732532417,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
20547,GO:1904768,1,0.989025300269253,0,2,all-trans-retinol binding,MF,
20548,GO:1904772,1,0.993528819933978,0,1,response to tetrachloromethane,BP,
20549,GO:1904776,1,0.936158960352697,0,9,regulation of protein localization to cell cortex,BP,
20550,GO:1904777,1,0.99325505912211,0,1,negative regulation of protein localization to cell cortex,BP,
20551,GO:1904778,1,0.954016884256965,0,6,positive regulation of protein localization to cell cortex,BP,
20552,GO:1904779,1,0.925342575161676,0,10,regulation of protein localization to centrosome,BP,
20553,GO:1904780,1,0.984700945039735,0,2,negative regulation of protein localization to centrosome,BP,
20554,GO:1904781,1,0.945371769156078,0,7,positive regulation of protein localization to centrosome,BP,
20555,GO:1904782,1,0.984947747220441,0,2,negative regulation of NMDA glutamate receptor activity,BP,
20556,GO:1904783,1,0.970410243214847,0,5,positive regulation of NMDA glutamate receptor activity,BP,
20557,GO:1904784,1,0.991882482568147,0,1,NLRP1 inflammasome complex assembly,BP,
20558,GO:1904790,1,0.99298782644476,0,1,regulation of shelterin complex assembly,BP,
20559,GO:1904792,1,0.99298782644476,0,1,positive regulation of shelterin complex assembly,BP,
20560,GO:1904793,1,0.9925769027008,0,1,regulation of euchromatin binding,BP,
20561,GO:1904796,1,0.953883848152951,0,7,regulation of core promoter binding,BP,
20562,GO:1904797,1,0.987888946884105,0,2,negative regulation of core promoter binding,BP,
20563,GO:1904798,1,0.965582220111642,0,5,positive regulation of core promoter binding,BP,
20564,GO:1904799,1,0.992473991890159,0,1,regulation of neuron remodeling,BP,
20565,GO:1904800,1,0.992473991890159,0,1,negative regulation of neuron remodeling,BP,
20566,GO:1904803,1,0.996837800321798,0,1,regulation of translation involved in cellular response to UV,BP,
20567,GO:1904806,1,0.986555151512788,0,2,regulation of protein oxidation,BP,
20568,GO:1904808,1,0.986555151512788,0,2,positive regulation of protein oxidation,BP,
20569,GO:1904809,1,0.984592711675985,0,2,regulation of dense core granule transport,BP,
20570,GO:1904811,1,0.984592711675985,0,2,positive regulation of dense core granule transport,BP,
20571,GO:1904812,1,0.992474164909478,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20572,GO:1904813,1,0.497080909536251,0,123,ficolin-1-rich granule lumen,CC,
20573,GO:1904814,1,0.926120416227279,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20574,GO:1904815,1,0.99298782644476,0,1,negative regulation of protein localization to chromosome, telomeric region,BP,
20575,GO:1904816,1,0.932665063073987,0,12,positive regulation of protein localization to chromosome, telomeric region,BP,
20576,GO:1904823,1,0.982515637016202,0,3,purine nucleobase transmembrane transport,BP,
20577,GO:1904825,1,0.975677542944963,0,4,protein localization to microtubule plus-end,BP,
20578,GO:1904826,1,0.990686468107618,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20579,GO:1904828,1,0.990686468107618,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20580,GO:1904829,1,0.995691921465553,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20581,GO:1904831,1,0.995691921465553,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20582,GO:1904833,1,0.981106097017209,0,4,positive regulation of removal of superoxide radicals,BP,
20583,GO:1904835,1,0.985865043136723,0,2,dorsal root ganglion morphogenesis,BP,
20584,GO:1904837,1,0.802350974601185,0,30,beta-catenin-TCF complex assembly,BP,
20585,GO:1904841,1,0.990166207469729,0,2,TORC2 complex binding,MF,
20586,GO:1904842,1,0.990505500667703,0,2,response to nitroglycerin,BP,
20587,GO:1904843,1,0.994702939885281,0,1,cellular response to nitroglycerin,BP,
20588,GO:1904844,1,0.983995756161607,0,3,response to L-glutamine,BP,
20589,GO:1904845,1,0.983995756161607,0,3,cellular response to L-glutamine,BP,
20590,GO:1904847,1,0.968428702818818,0,5,regulation of cell chemotaxis to fibroblast growth factor,BP,
20591,GO:1904848,1,0.996492397595218,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20592,GO:1904849,1,0.979194434897092,0,3,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20593,GO:1904850,1,0.99298782644476,0,1,negative regulation of establishment of protein localization to telomere,BP,
20594,GO:1904851,1,0.945774121105229,0,10,positive regulation of establishment of protein localization to telomere,BP,
20595,GO:1904854,1,0.992715375182131,0,1,proteasome core complex binding,MF,
20596,GO:1904855,1,0.996398387260517,0,1,proteasome regulatory particle binding,MF,
20597,GO:1904861,1,0.819220822108879,0,26,excitatory synapse assembly,BP,
20598,GO:1904862,1,0.886973568405909,0,16,inhibitory synapse assembly,BP,
20599,GO:1904863,1,0.99249113358529,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20600,GO:1904864,1,0.99249113358529,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20601,GO:1904867,1,0.934283875209495,0,12,protein localization to Cajal body,BP,
20602,GO:1904868,1,0.979307303121077,0,2,telomerase catalytic core complex assembly,BP,
20603,GO:1904869,1,0.938559408827956,0,11,regulation of protein localization to Cajal body,BP,
20604,GO:1904871,1,0.938559408827956,0,11,positive regulation of protein localization to Cajal body,BP,
20605,GO:1904872,1,0.903732190589383,0,18,regulation of telomerase RNA localization to Cajal body,BP,
20606,GO:1904874,1,0.925758293970592,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20607,GO:1904875,1,0.987894833560367,0,2,regulation of DNA ligase activity,BP,
20608,GO:1904876,1,0.993040051200457,0,1,negative regulation of DNA ligase activity,BP,
20609,GO:1904877,1,0.994819089385882,0,1,positive regulation of DNA ligase activity,BP,
20610,GO:1904878,1,0.983543141960618,0,2,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20611,GO:1904879,1,0.986711683169955,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20612,GO:1904880,1,0.979024804588799,0,3,response to hydrogen sulfide,BP,
20613,GO:1904881,1,0.985069843148974,0,2,cellular response to hydrogen sulfide,BP,
20614,GO:1904882,1,0.979307303121077,0,2,regulation of telomerase catalytic core complex assembly,BP,
20615,GO:1904884,1,0.979307303121077,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20616,GO:1904885,1,0.959268537000712,0,5,beta-catenin destruction complex assembly,BP,
20617,GO:1904886,1,0.882061629147359,0,17,beta-catenin destruction complex disassembly,BP,
20618,GO:1904887,1,0.98980976425874,0,1,Wnt signalosome assembly,BP,
20620,GO:1904889,1,0.897350797552946,0,15,regulation of excitatory synapse assembly,BP,
20621,GO:1904891,1,0.981796146104416,0,3,positive regulation of excitatory synapse assembly,BP,
20623,GO:1904893,1,0.873025126581775,0,20,negative regulation of receptor signaling pathway via STAT,BP,
20625,GO:1904895,1,0.995845031675732,0,1,ESCRT complex assembly,BP,
20626,GO:1904896,1,0.940780546037774,0,10,ESCRT complex disassembly,BP,
20627,GO:1904897,1,0.992627338486534,0,1,regulation of hepatic stellate cell proliferation,BP,
20628,GO:1904899,1,0.992627338486534,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20629,GO:1904902,1,0.995845031675732,0,1,ESCRT III complex assembly,BP,
20630,GO:1904903,1,0.940780546037774,0,10,ESCRT III complex disassembly,BP,
20631,GO:1904904,1,0.975271891285259,0,4,regulation of endothelial cell-matrix adhesion via fibronectin,BP,
20632,GO:1904906,1,0.975271891285259,0,4,positive regulation of endothelial cell-matrix adhesion via fibronectin,BP,
20633,GO:1904907,1,0.978593726492786,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20634,GO:1904908,1,0.978593726492786,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20635,GO:1904910,1,0.99298782644476,0,1,regulation of establishment of RNA localization to telomere,BP,
20636,GO:1904911,1,0.99298782644476,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20637,GO:1904913,1,0.99298782644476,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
20638,GO:1904914,1,0.99298782644476,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
20639,GO:1904923,1,0.90773222099846,0,13,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20640,GO:1904924,1,0.994065446234984,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20641,GO:1904925,1,0.913156406657811,0,12,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20642,GO:1904928,1,0.974049472542795,0,3,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20643,GO:1904929,1,0.95533933187454,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20644,GO:1904933,1,0.991685564322805,0,1,regulation of cell proliferation in midbrain,BP,
20645,GO:1904934,1,0.991685564322805,0,1,negative regulation of cell proliferation in midbrain,BP,
20647,GO:1904938,1,0.958245875462656,0,5,planar cell polarity pathway involved in axon guidance,BP,
20648,GO:1904947,1,0.992873456259171,0,1,folate import into mitochondrion,BP,
20649,GO:1904948,1,0.905604927540731,0,15,midbrain dopaminergic neuron differentiation,BP,
20650,GO:1904949,1,0.5978333283079,0,76,ATPase complex,CC,
20653,GO:1904953,1,0.934775606749723,0,10,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20654,GO:1904954,1,0.981892472360666,0,3,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20655,GO:1904955,1,0.991685564322805,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
20656,GO:1904956,1,0.971798818868322,0,5,regulation of midbrain dopaminergic neuron differentiation,BP,
20657,GO:1904958,1,0.984065879253473,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20658,GO:1904959,1,0.972703016377494,0,5,regulation of cytochrome-c oxidase activity,BP,
20659,GO:1904960,1,0.99686536995809,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20660,GO:1904970,1,0.977040043492706,0,3,brush border assembly,BP,
20661,GO:1904971,1,0.992305235802394,0,1,regulation of viral translation,BP,
20662,GO:1904973,1,0.992305235802394,0,1,positive regulation of viral translation,BP,
20663,GO:1904975,1,0.984595183426944,0,2,response to bleomycin,BP,
20664,GO:1904976,1,0.984595183426944,0,2,cellular response to bleomycin,BP,
20665,GO:1904977,1,0.988799270923416,0,2,lymphatic endothelial cell migration,BP,
20666,GO:1904978,1,0.977902056850851,0,3,regulation of endosome organization,BP,
20667,GO:1904979,1,0.994510840433996,0,1,negative regulation of endosome organization,BP,
20668,GO:1904980,1,0.990977974665183,0,1,positive regulation of endosome organization,BP,
20669,GO:1904983,1,0.994788200524064,0,1,glycine import into mitochondrion,BP,
20670,GO:1904984,1,0.996439731715527,0,1,regulation of quinolinate biosynthetic process,BP,
20671,GO:1904985,1,0.996439731715527,0,1,negative regulation of quinolinate biosynthetic process,BP,
20672,GO:1904990,1,0.993983099777948,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20673,GO:1904992,1,0.993983099777948,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20674,GO:1904994,1,0.847334351929038,0,26,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20675,GO:1904995,1,0.97866297548142,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20676,GO:1904996,1,0.876313452010059,0,20,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20677,GO:1904997,1,0.982632130429277,0,3,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20678,GO:1904998,1,0.992992677245858,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20679,GO:1904999,1,0.989567086220264,0,2,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20680,GO:1905000,1,0.9901929528191,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20681,GO:1905003,1,0.996439731715527,0,1,picolinic acid metabolic process,BP,
20682,GO:1905004,1,0.996439731715527,0,1,picolinic acid biosynthetic process,BP,
20683,GO:1905005,1,0.957567451786254,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20684,GO:1905006,1,0.987455846810857,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20685,GO:1905007,1,0.962016283397036,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20686,GO:1905008,1,0.993650213761529,0,1,regulation of L-lysine import across plasma membrane,BP,
20687,GO:1905010,1,0.993650213761529,0,1,positive regulation of L-lysine import across plasma membrane,BP,
20688,GO:1905012,1,0.996439731715527,0,1,regulation of 'de novo' NAD biosynthetic process from tryptophan,BP,
20689,GO:1905024,1,0.970129622846106,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20690,GO:1905025,1,0.99282830691148,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20691,GO:1905026,1,0.984889691687466,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20692,GO:1905030,1,0.982539327326497,0,2,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20693,GO:1905031,1,0.960612590381012,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20694,GO:1905032,1,0.99282830691148,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20695,GO:1905033,1,0.984889691687466,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20696,GO:1905034,1,0.988394668407911,0,2,regulation of antifungal innate immune response,BP,
20697,GO:1905035,1,0.99299686131453,0,1,negative regulation of antifungal innate immune response,BP,
20698,GO:1905036,1,0.995365681875009,0,1,positive regulation of antifungal innate immune response,BP,
20699,GO:1905037,1,0.543121464367826,0,91,autophagosome organization,BP,
20700,GO:1905038,1,0.907052440607595,0,16,regulation of membrane lipid metabolic process,BP,
20702,GO:1905040,1,0.993871543672424,0,1,otic placode development,BP,
20703,GO:1905041,1,0.994487462707336,0,1,regulation of epithelium regeneration,BP,
20704,GO:1905042,1,0.994487462707336,0,1,negative regulation of epithelium regeneration,BP,
20705,GO:1905044,1,0.99325505912211,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20706,GO:1905045,1,0.99325505912211,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20708,GO:1905049,1,0.943366093405599,0,7,negative regulation of metallopeptidase activity,BP,
20710,GO:1905051,1,0.99240151695163,0,2,regulation of base-excision repair,BP,
20711,GO:1905053,1,0.99240151695163,0,2,positive regulation of base-excision repair,BP,
20712,GO:1905056,1,0.972652390405086,0,3,calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration,MF,
20713,GO:1905059,1,0.989997365981349,0,1,calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
20714,GO:1905060,1,0.97586175744265,0,3,calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
20715,GO:1905062,1,0.993372868562766,0,1,positive regulation of cardioblast proliferation,BP,
20716,GO:1905063,1,0.906695261819307,0,14,regulation of vascular associated smooth muscle cell differentiation,BP,
20717,GO:1905064,1,0.942410797703645,0,8,negative regulation of vascular associated smooth muscle cell differentiation,BP,
20718,GO:1905065,1,0.962124430147496,0,6,positive regulation of vascular associated smooth muscle cell differentiation,BP,
20719,GO:1905066,1,0.989781168305386,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20720,GO:1905067,1,0.995568695093763,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20721,GO:1905068,1,0.994186975883146,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20722,GO:1905069,1,0.987178581646325,0,2,allantois development,BP,
20723,GO:1905071,1,0.984168880772133,0,2,tight junction disassembly,BP,
20724,GO:1905073,1,0.984168880772133,0,2,regulation of tight junction disassembly,BP,
20725,GO:1905075,1,0.984168880772133,0,2,positive regulation of tight junction disassembly,BP,
20726,GO:1905089,1,0.988302318431554,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20727,GO:1905090,1,0.988302318431554,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20728,GO:1905097,1,0.95037979477332,0,7,regulation of guanyl-nucleotide exchange factor activity,BP,
20729,GO:1905098,1,0.97425402155379,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20730,GO:1905099,1,0.991388821048341,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20731,GO:1905103,1,0.978571371900976,0,3,integral component of lysosomal membrane,CC,
20733,GO:1905115,1,0.996454349417187,0,1,regulation of lateral attachment of mitotic spindle microtubules to kinetochore,BP,
20734,GO:1905116,1,0.996454349417187,0,1,positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore,BP,
20735,GO:1905123,1,0.984779233092024,0,2,regulation of glucosylceramidase activity,BP,
20736,GO:1905132,1,0.988259798324501,0,2,regulation of meiotic chromosome separation,BP,
20737,GO:1905133,1,0.992866031482335,0,1,negative regulation of meiotic chromosome separation,BP,
20738,GO:1905134,1,0.99536100842981,0,1,positive regulation of meiotic chromosome separation,BP,
20739,GO:1905135,1,0.985225586303113,0,2,biotin import across plasma membrane,BP,
20740,GO:1905143,1,0.996039904493371,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20741,GO:1905144,1,0.844719225557868,0,27,response to acetylcholine,BP,
20742,GO:1905145,1,0.844719225557868,0,27,cellular response to acetylcholine,BP,
20744,GO:1905150,1,0.955077761938105,0,7,regulation of voltage-gated sodium channel activity,BP,
20745,GO:1905152,1,0.991644959332016,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20746,GO:1905153,1,0.898271703533518,0,16,regulation of membrane invagination,BP,
20747,GO:1905154,1,0.98742702064527,0,2,negative regulation of membrane invagination,BP,
20748,GO:1905155,1,0.915753816156631,0,13,positive regulation of membrane invagination,BP,
20749,GO:1905161,1,0.992015457543922,0,1,protein localization to phagocytic vesicle,BP,
20750,GO:1905162,1,0.982814544671307,0,3,regulation of phagosome maturation,BP,
20751,GO:1905164,1,0.995365681875009,0,1,positive regulation of phagosome maturation,BP,
20753,GO:1905166,1,0.972029636259126,0,4,negative regulation of lysosomal protein catabolic process,BP,
20755,GO:1905168,1,0.929077805138374,0,10,positive regulation of double-strand break repair via homologous recombination,BP,
20756,GO:1905169,1,0.992015457543922,0,1,regulation of protein localization to phagocytic vesicle,BP,
20757,GO:1905171,1,0.992015457543922,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20758,GO:1905172,1,0.976963527726039,0,3,RISC complex binding,MF,
20759,GO:1905174,1,0.988540300431572,0,2,regulation of vascular associated smooth muscle cell dedifferentiation,BP,
20760,GO:1905176,1,0.993069464019609,0,1,positive regulation of vascular associated smooth muscle cell dedifferentiation,BP,
20761,GO:1905178,1,0.988676078829814,0,2,regulation of cardiac muscle tissue regeneration,BP,
20762,GO:1905179,1,0.988676078829814,0,2,negative regulation of cardiac muscle tissue regeneration,BP,
20763,GO:1905184,1,0.992870016751526,0,1,positive regulation of protein serine/threonine phosphatase activity,BP,
20764,GO:1905186,1,0.99536100842981,0,1,regulation of metaphase/anaphase transition of meiosis I,BP,
20765,GO:1905188,1,0.99536100842981,0,1,positive regulation of metaphase/anaphase transition of meiosis I,BP,
20766,GO:1905198,1,0.986638425746034,0,2,manchette assembly,BP,
20767,GO:1905199,1,0.993873967922025,0,1,manchette disassembly,BP,
20768,GO:1905202,1,0.986278191394225,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20769,GO:1905203,1,0.971493724835455,0,4,regulation of connective tissue replacement,BP,
20770,GO:1905204,1,0.996340173474856,0,1,negative regulation of connective tissue replacement,BP,
20771,GO:1905205,1,0.97506320647204,0,3,positive regulation of connective tissue replacement,BP,
20772,GO:1905206,1,0.967962141936464,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20776,GO:1905214,1,0.92824472605819,0,12,regulation of RNA binding,BP,
20777,GO:1905215,1,0.995701080102347,0,1,negative regulation of RNA binding,BP,
20778,GO:1905216,1,0.947108832678757,0,9,positive regulation of RNA binding,BP,
20779,GO:1905217,1,0.992799221737581,0,1,response to astaxanthin,BP,
20780,GO:1905219,1,0.980315554381218,0,2,regulation of platelet formation,BP,
20781,GO:1905221,1,0.980315554381218,0,2,positive regulation of platelet formation,BP,
20782,GO:1905222,1,0.992759640759435,0,1,atrioventricular canal morphogenesis,BP,
20783,GO:1905223,1,0.982327143264121,0,2,epicardium morphogenesis,BP,
20784,GO:1905224,1,0.977015621281112,0,3,clathrin-coated pit assembly,BP,
20785,GO:1905225,1,0.989271626731802,0,2,response to thyrotropin-releasing hormone,BP,
20786,GO:1905226,1,0.996406188665148,0,1,regulation of adhesion of symbiont to host epithelial cell,BP,
20787,GO:1905229,1,0.996447081436245,0,1,cellular response to thyrotropin-releasing hormone,BP,
20788,GO:1905232,1,0.96581546164451,0,5,cellular response to L-glutamate,BP,
20789,GO:1905239,1,0.992131133513588,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20790,GO:1905240,1,0.992131133513588,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20791,GO:1905242,1,0.986067543197545,0,2,response to 3,3',5-triiodo-L-thyronine,BP,
20792,GO:1905243,1,0.993423809071627,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20793,GO:1905244,1,0.91767665341932,0,12,regulation of modification of synaptic structure,BP,
20794,GO:1905245,1,0.935542842194825,0,10,regulation of aspartic-type peptidase activity,BP,
20795,GO:1905246,1,0.983290221032143,0,2,negative regulation of aspartic-type peptidase activity,BP,
20796,GO:1905247,1,0.951449353947697,0,8,positive regulation of aspartic-type peptidase activity,BP,
20797,GO:1905255,1,0.991334697294006,0,1,regulation of RNA binding transcription factor activity,BP,
20798,GO:1905258,1,0.992771053545033,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20799,GO:1905259,1,0.992771053545033,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20800,GO:1905267,1,0.983620465543116,0,3,endonucleolytic cleavage involved in tRNA processing,BP,
20801,GO:1905268,1,0.709885678618013,0,48,negative regulation of chromatin organization,BP,
20802,GO:1905269,1,0.500213420922439,0,98,positive regulation of chromatin organization,BP,
20803,GO:1905271,1,0.99682667456356,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20804,GO:1905273,1,0.99682667456356,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20805,GO:1905274,1,0.962648299182042,0,5,regulation of modification of postsynaptic actin cytoskeleton,BP,
20806,GO:1905276,1,0.877584400266577,0,18,regulation of epithelial tube formation,BP,
20807,GO:1905277,1,0.992826729914151,0,1,negative regulation of epithelial tube formation,BP,
20808,GO:1905278,1,0.974765808368617,0,4,positive regulation of epithelial tube formation,BP,
20809,GO:1905279,1,0.976160325220645,0,3,regulation of retrograde transport, endosome to Golgi,BP,
20810,GO:1905280,1,0.992909064628238,0,1,negative regulation of retrograde transport, endosome to Golgi,BP,
20811,GO:1905285,1,0.992518692750008,0,1,fibrous ring of heart morphogenesis,BP,
20812,GO:1905286,1,0.981185661005874,0,3,serine-type peptidase complex,CC,
20813,GO:1905288,1,0.940609035046292,0,9,vascular associated smooth muscle cell apoptotic process,BP,
20814,GO:1905289,1,0.974342636882656,0,3,regulation of CAMKK-AMPK signaling cascade,BP,
20815,GO:1905291,1,0.996620610494782,0,1,positive regulation of CAMKK-AMPK signaling cascade,BP,
20816,GO:1905292,1,0.980250525926475,0,3,regulation of neural crest cell differentiation,BP,
20817,GO:1905294,1,0.980250525926475,0,3,positive regulation of neural crest cell differentiation,BP,
20818,GO:1905301,1,0.976737398062893,0,3,regulation of macropinocytosis,BP,
20819,GO:1905302,1,0.992333666231734,0,1,negative regulation of macropinocytosis,BP,
20820,GO:1905303,1,0.984284465034843,0,2,positive regulation of macropinocytosis,BP,
20821,GO:1905304,1,0.990068065470808,0,1,regulation of cardiac myofibril assembly,BP,
20822,GO:1905305,1,0.990068065470808,0,1,negative regulation of cardiac myofibril assembly,BP,
20823,GO:1905309,1,0.989352680569835,0,1,positive regulation of cohesin loading,BP,
20824,GO:1905310,1,0.980250525926475,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20825,GO:1905312,1,0.980250525926475,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20826,GO:1905313,1,0.994593981600062,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20827,GO:1905314,1,0.772958441360053,0,36,semi-lunar valve development,BP,
20828,GO:1905317,1,0.992289691663676,0,1,inferior endocardial cushion morphogenesis,BP,
20829,GO:1905319,1,0.983632732287318,0,3,mesenchymal stem cell migration,BP,
20830,GO:1905320,1,0.983632732287318,0,3,regulation of mesenchymal stem cell migration,BP,
20831,GO:1905322,1,0.983632732287318,0,3,positive regulation of mesenchymal stem cell migration,BP,
20832,GO:1905323,1,0.957150302988457,0,6,telomerase holoenzyme complex assembly,BP,
20833,GO:1905327,1,0.996007069956112,0,1,tracheoesophageal septum formation,BP,
20835,GO:1905331,1,0.893650159659476,0,16,negative regulation of morphogenesis of an epithelium,BP,
20837,GO:1905333,1,0.985732463910325,0,4,regulation of gastric motility,BP,
20838,GO:1905335,1,0.976670152966261,0,3,regulation of aggrephagy,BP,
20839,GO:1905337,1,0.976670152966261,0,3,positive regulation of aggrephagy,BP,
20840,GO:1905340,1,0.977238038245905,0,4,regulation of protein localization to kinetochore,BP,
20841,GO:1905341,1,0.99343209438584,0,1,negative regulation of protein localization to kinetochore,BP,
20842,GO:1905342,1,0.977238038245905,0,4,positive regulation of protein localization to kinetochore,BP,
20843,GO:1905344,1,0.982543917336631,0,3,prostaglandin catabolic process,BP,
20844,GO:1905347,1,0.96632906652449,0,6,endodeoxyribonuclease complex,CC,
20845,GO:1905348,1,0.817164932186024,0,35,endonuclease complex,CC,
20846,GO:1905349,1,0.993177150518796,0,1,ciliary transition zone assembly,BP,
20847,GO:1905354,1,0.874074472031648,0,24,exoribonuclease complex,CC,
20848,GO:1905355,1,0.992073703372733,0,1,spine apparatus assembly,BP,
20849,GO:1905359,1,0.992866031482335,0,1,protein localization to meiotic spindle,BP,
20850,GO:1905360,1,0.830939362628802,0,32,GTPase complex,CC,
20851,GO:1905364,1,0.995430413442757,0,1,regulation of endosomal vesicle fusion,BP,
20852,GO:1905365,1,0.994510840433996,0,1,regulation of intralumenal vesicle formation,BP,
20853,GO:1905366,1,0.994510840433996,0,1,negative regulation of intralumenal vesicle formation,BP,
20854,GO:1905368,1,0.648646511271511,0,83,peptidase complex,CC,
20855,GO:1905369,1,0.724930639748846,0,65,endopeptidase complex,CC,
20856,GO:1905370,1,0.994065446234984,0,1,serine-type endopeptidase complex,CC,
20857,GO:1905371,1,0.987661913512702,0,2,ceramide phosphoethanolamine metabolic process,BP,
20858,GO:1905373,1,0.987661913512702,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20859,GO:1905377,1,0.992320624149615,0,1,response to D-galactose,BP,
20860,GO:1905380,1,0.976552382412979,0,4,regulation of snRNA transcription by RNA polymerase II,BP,
20861,GO:1905382,1,0.976552382412979,0,4,positive regulation of snRNA transcription by RNA polymerase II,BP,
20862,GO:1905383,1,0.924584210807545,0,11,protein localization to presynapse,BP,
20863,GO:1905384,1,0.988774404972178,0,2,regulation of protein localization to presynapse,BP,
20864,GO:1905386,1,0.988774404972178,0,2,positive regulation of protein localization to presynapse,BP,
20865,GO:1905394,1,0.961186186880797,0,5,retromer complex binding,MF,
20866,GO:1905395,1,0.985538447964265,0,3,response to flavonoid,BP,
20867,GO:1905396,1,0.996349187462576,0,1,cellular response to flavonoid,BP,
20868,GO:1905397,1,0.991235778702027,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20869,GO:1905402,1,0.991235778702027,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20870,GO:1905403,1,0.995154499671731,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20871,GO:1905404,1,0.99606239377017,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20872,GO:1905405,1,0.989352680569835,0,1,regulation of mitotic cohesin loading,BP,
20873,GO:1905406,1,0.989352680569835,0,1,positive regulation of mitotic cohesin loading,BP,
20874,GO:1905407,1,0.988051555098337,0,2,regulation of creatine transmembrane transporter activity,BP,
20875,GO:1905408,1,0.988051555098337,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20877,GO:1905414,1,0.992455237799069,0,1,negative regulation of dense core granule exocytosis,BP,
20878,GO:1905415,1,0.992455237799069,0,1,positive regulation of dense core granule exocytosis,BP,
20879,GO:1905420,1,0.98102255472986,0,3,vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
20880,GO:1905424,1,0.988446506258258,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20881,GO:1905426,1,0.988446506258258,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20882,GO:1905429,1,0.979994666010966,0,3,response to glycine,BP,
20883,GO:1905430,1,0.987484321897536,0,2,cellular response to glycine,BP,
20884,GO:1905432,1,0.992455237799069,0,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20885,GO:1905433,1,0.992455237799069,0,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20886,GO:1905435,1,0.98581079459984,0,2,regulation of histone H3-K4 trimethylation,BP,
20887,GO:1905437,1,0.98581079459984,0,2,positive regulation of histone H3-K4 trimethylation,BP,
20888,GO:1905438,1,0.987895982590078,0,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20889,GO:1905443,1,0.992350687656838,0,1,regulation of clathrin coat assembly,BP,
20890,GO:1905445,1,0.992350687656838,0,1,positive regulation of clathrin coat assembly,BP,
20891,GO:1905446,1,0.963830153863542,0,7,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20892,GO:1905447,1,0.986024597750748,0,2,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20893,GO:1905448,1,0.977494182711981,0,5,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20894,GO:1905449,1,0.948299899402575,0,7,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20895,GO:1905450,1,0.983594755233552,0,2,negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20896,GO:1905451,1,0.964122406718093,0,5,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20897,GO:1905453,1,0.994046636166459,0,1,regulation of myeloid progenitor cell differentiation,BP,
20898,GO:1905454,1,0.994046636166459,0,1,negative regulation of myeloid progenitor cell differentiation,BP,
20899,GO:1905456,1,0.943540378058272,0,8,regulation of lymphoid progenitor cell differentiation,BP,
20900,GO:1905457,1,0.982449128491833,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20901,GO:1905458,1,0.984908922929953,0,2,positive regulation of lymphoid progenitor cell differentiation,BP,
20902,GO:1905459,1,0.940609035046292,0,9,regulation of vascular associated smooth muscle cell apoptotic process,BP,
20903,GO:1905460,1,0.982885598892982,0,2,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
20904,GO:1905461,1,0.956994706150476,0,7,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
20905,GO:1905462,1,0.965594323363837,0,6,regulation of DNA duplex unwinding,BP,
20906,GO:1905463,1,0.980739112172838,0,3,negative regulation of DNA duplex unwinding,BP,
20907,GO:1905464,1,0.984560823160178,0,3,positive regulation of DNA duplex unwinding,BP,
20908,GO:1905468,1,0.992015457543922,0,1,regulation of clathrin-coated pit assembly,BP,
20909,GO:1905469,1,0.992015457543922,0,1,negative regulation of clathrin-coated pit assembly,BP,
20910,GO:1905474,1,0.996130464954528,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
20912,GO:1905476,1,0.822992500822444,0,30,negative regulation of protein localization to membrane,BP,
20914,GO:1905483,1,0.988620308305733,0,1,regulation of motor neuron migration,BP,
20915,GO:1905485,1,0.988620308305733,0,1,positive regulation of motor neuron migration,BP,
20916,GO:1905492,1,0.992532651688149,0,1,positive regulation of branching morphogenesis of a nerve,BP,
20917,GO:1905502,1,0.986035428773057,0,2,acetyl-CoA binding,MF,
20918,GO:1905503,1,0.995618040134565,0,1,regulation of motile cilium assembly,BP,
20919,GO:1905505,1,0.995618040134565,0,1,positive regulation of motile cilium assembly,BP,
20920,GO:1905508,1,0.775448794288223,0,33,protein localization to microtubule organizing center,BP,
20921,GO:1905512,1,0.993682281764436,0,1,regulation of short-term synaptic potentiation,BP,
20922,GO:1905513,1,0.993682281764436,0,1,negative regulation of short-term synaptic potentiation,BP,
20923,GO:1905515,1,0.704391816079539,0,50,non-motile cilium assembly,BP,
20924,GO:1905516,1,0.926617081976466,0,12,positive regulation of fertilization,BP,
20925,GO:1905517,1,0.762309643157665,0,48,macrophage migration,BP,
20926,GO:1905518,1,0.992179920376533,0,1,regulation of presynaptic active zone assembly,BP,
20927,GO:1905520,1,0.992179920376533,0,1,positive regulation of presynaptic active zone assembly,BP,
20928,GO:1905521,1,0.807991583647416,0,36,regulation of macrophage migration,BP,
20929,GO:1905522,1,0.950612117669871,0,9,negative regulation of macrophage migration,BP,
20930,GO:1905523,1,0.874576844748742,0,22,positive regulation of macrophage migration,BP,
20931,GO:1905524,1,0.990649405434926,0,1,negative regulation of protein autoubiquitination,BP,
20932,GO:1905526,1,0.9869500897403,0,2,regulation of Golgi lumen acidification,BP,
20933,GO:1905528,1,0.992343497629272,0,1,positive regulation of Golgi lumen acidification,BP,
20934,GO:1905532,1,0.986754213609008,0,2,regulation of leucine import across plasma membrane,BP,
20935,GO:1905533,1,0.986754213609008,0,2,negative regulation of leucine import across plasma membrane,BP,
20936,GO:1905535,1,0.992022883027979,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20937,GO:1905537,1,0.992022883027979,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20938,GO:1905538,1,0.963542130274738,0,5,polysome binding,MF,
20939,GO:1905541,1,0.993650213761529,0,1,regulation of L-arginine import across plasma membrane,BP,
20940,GO:1905546,1,0.994383722993668,0,1,cellular response to phenylpropanoid,BP,
20941,GO:1905547,1,0.995896293794625,0,1,regulation of subtelomeric heterochromatin assembly,BP,
20942,GO:1905549,1,0.995896293794625,0,1,positive regulation of subtelomeric heterochromatin assembly,BP,
20943,GO:1905550,1,0.990436447141777,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20944,GO:1905552,1,0.990436447141777,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20945,GO:1905553,1,0.980888882019324,0,4,regulation of blood vessel branching,BP,
20946,GO:1905555,1,0.9844889541747,0,3,positive regulation blood vessel branching,BP,
20947,GO:1905562,1,0.868488942046402,0,20,regulation of vascular endothelial cell proliferation,BP,
20948,GO:1905563,1,0.966924273204218,0,5,negative regulation of vascular endothelial cell proliferation,BP,
20949,GO:1905564,1,0.898230570833686,0,15,positive regulation of vascular endothelial cell proliferation,BP,
20950,GO:1905572,1,0.993137339727904,0,1,ganglioside GM1 transport to membrane,BP,
20951,GO:1905573,1,0.988485451948617,0,2,ganglioside GM1 binding,MF,
20952,GO:1905574,1,0.993137339727904,0,1,ganglioside GM2 binding,MF,
20953,GO:1905575,1,0.993137339727904,0,1,ganglioside GM3 binding,MF,
20955,GO:1905577,1,0.993137339727904,0,1,ganglioside GP1c binding,MF,
20956,GO:1905578,1,0.993974432545152,0,1,regulation of ERBB3 signaling pathway,BP,
20957,GO:1905580,1,0.993974432545152,0,1,positive regulation of ERBB3 signaling pathway,BP,
20958,GO:1905581,1,0.988910066430473,0,2,positive regulation of low-density lipoprotein particle clearance,BP,
20959,GO:1905589,1,0.993650213761529,0,1,positive regulation of L-arginine import across plasma membrane,BP,
20960,GO:1905590,1,0.992765517626142,0,1,fibronectin fibril organization,BP,
20961,GO:1905594,1,0.996547773841177,0,1,resveratrol binding,MF,
20962,GO:1905595,1,0.988442336808347,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
20963,GO:1905596,1,0.992514744707551,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20964,GO:1905597,1,0.995897193514659,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
20965,GO:1905598,1,0.98296208903686,0,2,negative regulation of low-density lipoprotein receptor activity,BP,
20966,GO:1905599,1,0.995897193514659,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20967,GO:1905600,1,0.972059204278254,0,4,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20968,GO:1905601,1,0.98296208903686,0,2,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20969,GO:1905602,1,0.988910066430473,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20970,GO:1905603,1,0.949331818208399,0,7,regulation of blood-brain barrier permeability,BP,
20971,GO:1905604,1,0.985922562940012,0,2,negative regulation of blood-brain barrier permeability,BP,
20972,GO:1905605,1,0.962892061078825,0,5,positive regulation of blood-brain barrier permeability,BP,
20973,GO:1905606,1,0.785014558383698,0,33,regulation of presynapse assembly,BP,
20974,GO:1905607,1,0.995568695093763,0,1,negative regulation of presynapse assembly,BP,
20975,GO:1905608,1,0.992179920376533,0,1,positive regulation of presynapse assembly,BP,
20976,GO:1905610,1,0.992022883027979,0,1,regulation of mRNA cap binding,BP,
20977,GO:1905612,1,0.992022883027979,0,1,positive regulation of mRNA cap binding,BP,
20978,GO:1905616,1,0.977602818328397,0,3,regulation of miRNA mediated inhibition of translation,BP,
20979,GO:1905618,1,0.977602818328397,0,3,positive regulation of miRNA mediated inhibition of translation,BP,
20980,GO:1905634,1,0.961469751876871,0,5,regulation of protein localization to chromatin,BP,
20981,GO:1905636,1,0.979883515496514,0,3,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20982,GO:1905642,1,0.99325505912211,0,1,negative regulation of DNA methylation,BP,
20983,GO:1905643,1,0.978836823494392,0,3,positive regulation of DNA methylation,BP,
20984,GO:1905647,1,0.978550531346755,0,3,proline import across plasma membrane,BP,
20985,GO:1905651,1,0.979041640514118,0,3,regulation of artery morphogenesis,BP,
20986,GO:1905653,1,0.979041640514118,0,3,positive regulation of artery morphogenesis,BP,
20987,GO:1905661,1,0.981504163935276,0,3,regulation of telomerase RNA reverse transcriptase activity,BP,
20988,GO:1905662,1,0.994179328080043,0,1,negative regulation of telomerase RNA reverse transcriptase activity,BP,
20989,GO:1905663,1,0.987251380760868,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20990,GO:1905664,1,0.977289546046955,0,4,regulation of calcium ion import across plasma membrane,BP,
20991,GO:1905665,1,0.988885796112704,0,2,positive regulation of calcium ion import across plasma membrane,BP,
20992,GO:1905666,1,0.905565905891631,0,13,regulation of protein localization to endosome,BP,
20993,GO:1905667,1,0.992478588180237,0,1,negative regulation of protein localization to endosome,BP,
20994,GO:1905668,1,0.912435095885541,0,12,positive regulation of protein localization to endosome,BP,
20995,GO:1905671,1,0.977117662926112,0,4,regulation of lysosome organization,BP,
20996,GO:1905673,1,0.994303650955748,0,1,positive regulation of lysosome organization,BP,
20997,GO:1905674,1,0.987969431978205,0,3,regulation of adaptive immune memory response,BP,
20998,GO:1905675,1,0.991813589705539,0,2,negative regulation of adaptive immune memory response,BP,
20999,GO:1905676,1,0.996124438356641,0,1,positive regulation of adaptive immune memory response,BP,
21000,GO:1905684,1,0.97947211975102,0,3,regulation of plasma membrane repair,BP,
21001,GO:1905687,1,0.991725365074557,0,1,regulation of diacylglycerol kinase activity,BP,
21002,GO:1905689,1,0.991725365074557,0,1,positive regulation of diacylglycerol kinase activity,BP,
21003,GO:1905693,1,0.994728818783657,0,1,regulation of phosphatidic acid biosynthetic process,BP,
21004,GO:1905695,1,0.994728818783657,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
21005,GO:1905696,1,0.984388880118149,0,2,regulation of polysome binding,BP,
21006,GO:1905698,1,0.992305235802394,0,1,positive regulation of polysome binding,BP,
21007,GO:1905702,1,0.972550265771436,0,4,regulation of inhibitory synapse assembly,BP,
21008,GO:1905703,1,0.995050281405622,0,1,negative regulation of inhibitory synapse assembly,BP,
21009,GO:1905704,1,0.985074653500038,0,2,positive regulation of inhibitory synapse assembly,BP,
21010,GO:1905705,1,0.991058938608315,0,1,cellular response to paclitaxel,BP,
21011,GO:1905706,1,0.993763887252838,0,1,regulation of mitochondrial ATP synthesis coupled proton transport,BP,
21012,GO:1905709,1,0.955003292359293,0,7,negative regulation of membrane permeability,BP,
21014,GO:1905711,1,0.992491251317947,0,1,response to phosphatidylethanolamine,BP,
21015,GO:1905719,1,0.986312387811634,0,2,protein localization to perinuclear region of cytoplasm,BP,
21016,GO:1905720,1,0.990917185225543,0,1,cytoplasmic microtubule bundle,CC,
21017,GO:1905721,1,0.982324017059279,0,3,mitotic spindle astral microtubule end,CC,
21018,GO:1905725,1,0.975677542944963,0,4,protein localization to microtubule end,BP,
21019,GO:1905735,1,0.992543896580655,0,1,regulation of L-proline import across plasma membrane,BP,
21020,GO:1905737,1,0.992543896580655,0,1,positive regulation of L-proline import across plasma membrane,BP,
21021,GO:1905747,1,0.989702640527098,0,2,negative regulation of saliva secretion,BP,
21022,GO:1905748,1,0.989702640527098,0,2,hard palate morphogenesis,BP,
21023,GO:1905749,1,0.970120411296364,0,4,regulation of endosome to plasma membrane protein transport,BP,
21024,GO:1905751,1,0.983850003426716,0,2,positive regulation of endosome to plasma membrane protein transport,BP,
21025,GO:1905764,1,0.978757121563233,0,3,regulation of protection from non-homologous end joining at telomere,BP,
21026,GO:1905765,1,0.978757121563233,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
21027,GO:1905767,1,0.991159755703047,0,1,regulation of double-stranded telomeric DNA binding,BP,
21028,GO:1905768,1,0.991159755703047,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
21030,GO:1905771,1,0.987292661375598,0,3,negative regulation of mesodermal cell differentiation,BP,
21032,GO:1905773,1,0.976693189507885,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
21033,GO:1905774,1,0.973629243309205,0,5,regulation of DNA helicase activity,BP,
21034,GO:1905775,1,0.988898753992293,0,2,negative regulation of DNA helicase activity,BP,
21035,GO:1905776,1,0.984560823160178,0,3,positive regulation of DNA helicase activity,BP,
21036,GO:1905777,1,0.979459804531766,0,3,regulation of exonuclease activity,BP,
21037,GO:1905778,1,0.986074718384767,0,2,negative regulation of exonuclease activity,BP,
21038,GO:1905779,1,0.993292626999948,0,1,positive regulation of exonuclease activity,BP,
21039,GO:1905784,1,0.988419339558284,0,2,regulation of anaphase-promoting complex-dependent catabolic process,BP,
21040,GO:1905786,1,0.988419339558284,0,2,positive regulation of anaphase-promoting complex-dependent catabolic process,BP,
21041,GO:1905787,1,0.993376889315338,0,1,regulation of detection of mechanical stimulus involved in sensory perception of touch,BP,
21042,GO:1905788,1,0.993376889315338,0,1,negative regulation of detection of mechanical stimulus involved in sensory perception of touch,BP,
21043,GO:1905793,1,0.981097397780051,0,2,protein localization to pericentriolar material,BP,
21044,GO:1905794,1,0.989377366836931,0,1,response to puromycin,BP,
21045,GO:1905795,1,0.989377366836931,0,1,cellular response to puromycin,BP,
21046,GO:1905799,1,0.992180386555922,0,1,regulation of intraciliary retrograde transport,BP,
21047,GO:1905802,1,0.993111170536567,0,1,regulation of cellular response to manganese ion,BP,
21048,GO:1905809,1,0.842640915225625,0,24,negative regulation of synapse organization,BP,
21049,GO:1905818,1,0.669394506428613,0,62,regulation of chromosome separation,BP,
21050,GO:1905819,1,0.790820291144223,0,37,negative regulation of chromosome separation,BP,
21051,GO:1905820,1,0.904568616737819,0,15,positive regulation of chromosome separation,BP,
21052,GO:1905828,1,0.993273709828807,0,1,regulation of prostaglandin catabolic process,BP,
21053,GO:1905832,1,0.95958034151013,0,5,positive regulation of spindle assembly,BP,
21054,GO:1905834,1,0.995663126925001,0,1,response to pyrimidine ribonucleotide,BP,
21055,GO:1905835,1,0.995663126925001,0,1,cellular response to pyrimidine ribonucleotide,BP,
21056,GO:1905838,1,0.986074718384767,0,2,regulation of telomeric D-loop disassembly,BP,
21057,GO:1905839,1,0.986074718384767,0,2,negative regulation of telomeric D-loop disassembly,BP,
21058,GO:1905843,1,0.98887514585023,0,1,regulation of cellular response to gamma radiation,BP,
21059,GO:1905853,1,0.996514293846025,0,1,regulation of heparan sulfate binding,BP,
21060,GO:1905855,1,0.996514293846025,0,1,positive regulation of heparan sulfate binding,BP,
21061,GO:1905856,1,0.993627520566558,0,1,negative regulation of pentose-phosphate shunt,BP,
21062,GO:1905858,1,0.996514293846025,0,1,regulation of heparan sulfate proteoglycan binding,BP,
21063,GO:1905860,1,0.996514293846025,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
21064,GO:1905863,1,0.982957366898074,0,2,invadopodium organization,BP,
21066,GO:1905868,1,0.982547875614953,0,3,regulation of 3'-UTR-mediated mRNA stabilization,BP,
21067,GO:1905869,1,0.99325505912211,0,1,negative regulation of 3'-UTR-mediated mRNA stabilization,BP,
21068,GO:1905870,1,0.989220847468287,0,2,positive regulation of 3'-UTR-mediated mRNA stabilization,BP,
21069,GO:1905874,1,0.889557566041491,0,16,regulation of postsynaptic density organization,BP,
21070,GO:1905875,1,0.992991982258347,0,1,negative regulation of postsynaptic density organization,BP,
21071,GO:1905878,1,0.989539548682269,0,1,invadopodium disassembly,BP,
21072,GO:1905879,1,0.928467445137521,0,11,regulation of oogenesis,BP,
21073,GO:1905880,1,0.973407808498168,0,4,negative regulation of oogenesis,BP,
21074,GO:1905881,1,0.966080388681436,0,5,positive regulation of oogenesis,BP,
21075,GO:1905883,1,0.99432685821291,0,1,regulation of triglyceride transport,BP,
21076,GO:1905885,1,0.99432685821291,0,1,positive regulation of triglyceride transport,BP,
21077,GO:1905890,1,0.996514293846025,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
21078,GO:1905891,1,0.993120895894487,0,1,regulation of cellular response to thapsigargin,BP,
21079,GO:1905892,1,0.993120895894487,0,1,negative regulation of cellular response to thapsigargin,BP,
21080,GO:1905894,1,0.993120895894487,0,1,regulation of cellular response to tunicamycin,BP,
21081,GO:1905895,1,0.993120895894487,0,1,negative regulation of cellular response to tunicamycin,BP,
21084,GO:1905899,1,0.996007069956112,0,1,regulation of smooth muscle tissue development,BP,
21085,GO:1905900,1,0.996007069956112,0,1,negative regulation of smooth muscle tissue development,BP,
21086,GO:1905901,1,0.996007069956112,0,1,positive regulation of smooth muscle tissue development,BP,
21088,GO:1905903,1,0.987292661375598,0,3,negative regulation of mesoderm formation,BP,
21090,GO:1905906,1,0.957998864832148,0,7,regulation of amyloid fibril formation,BP,
21091,GO:1905907,1,0.978607750865969,0,4,negative regulation of amyloid fibril formation,BP,
21092,GO:1905908,1,0.973982824030948,0,4,positive regulation of amyloid fibril formation,BP,
21093,GO:1905912,1,0.98927915401082,0,2,regulation of calcium ion export across plasma membrane,BP,
21094,GO:1905913,1,0.995480314344197,0,1,negative regulation of calcium ion export across plasma membrane,BP,
21095,GO:1905915,1,0.98102255472986,0,3,regulation of cell differentiation involved in phenotypic switching,BP,
21096,GO:1905916,1,0.984329551230839,0,2,negative regulation of cell differentiation involved in phenotypic switching,BP,
21097,GO:1905917,1,0.996640898098766,0,1,positive regulation of cell differentiation involved in phenotypic switching,BP,
21098,GO:1905918,1,0.991508864907806,0,2,regulation of CoA-transferase activity,BP,
21099,GO:1905920,1,0.991508864907806,0,2,positive regulation of CoA-transferase activity,BP,
21100,GO:1905927,1,0.989539548682269,0,1,regulation of invadopodium disassembly,BP,
21101,GO:1905929,1,0.989539548682269,0,1,positive regulation of invadopodium disassembly,BP,
21102,GO:1905930,1,0.98102255472986,0,3,regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
21103,GO:1905931,1,0.984329551230839,0,2,negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
21104,GO:1905932,1,0.996640898098766,0,1,positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
21105,GO:1905933,1,0.996194664242819,0,1,regulation of cell fate determination,BP,
21106,GO:1905934,1,0.996194664242819,0,1,negative regulation of cell fate determination,BP,
21107,GO:1905936,1,0.982675610846674,0,4,regulation of germ cell proliferation,BP,
21108,GO:1905937,1,0.985958080768987,0,3,negative regulation of germ cell proliferation,BP,
21109,GO:1905938,1,0.99667126295483,0,1,positive regulation of germ cell proliferation,BP,
21110,GO:1905939,1,0.892460165488377,0,19,regulation of gonad development,BP,
21111,GO:1905940,1,0.968448108719561,0,5,negative regulation of gonad development,BP,
21112,GO:1905941,1,0.936194295970491,0,11,positive regulation of gonad development,BP,
21113,GO:1905952,1,0.451110231377409,0,126,regulation of lipid localization,BP,
21114,GO:1905953,1,0.782187053176804,0,36,negative regulation of lipid localization,BP,
21115,GO:1905954,1,0.602117653304158,0,82,positive regulation of lipid localization,BP,
21116,GO:1905956,1,0.986498919978207,0,2,positive regulation of endothelial tube morphogenesis,BP,
21117,GO:1905957,1,0.992395820850584,0,1,regulation of cellular response to alcohol,BP,
21118,GO:1905959,1,0.992395820850584,0,1,positive regulation of cellular response to alcohol,BP,
21119,GO:1905961,1,0.952270390971999,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
21120,GO:1905962,1,0.972402727439449,0,5,glutamatergic neuron differentiation,BP,
21121,GO:1990000,1,0.905107279197196,0,17,amyloid fibril formation,BP,
21122,GO:1990001,1,0.963905107884399,0,6,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
21123,GO:1990005,1,0.98904040206685,0,2,granular vesicle,CC,
21124,GO:1990008,1,0.995757015106155,0,1,neurosecretory vesicle,CC,
21125,GO:1990009,1,0.97046543622974,0,4,retinal cell apoptotic process,BP,
21127,GO:1990023,1,0.904835814988871,0,13,mitotic spindle midzone,CC,
21128,GO:1990026,1,0.984729813944815,0,2,hippocampal mossy fiber expansion,CC,
21129,GO:1990030,1,0.986439537707762,0,2,pericellular basket,CC,
21130,GO:1990031,1,0.992738707941557,0,1,pinceau fiber,CC,
21131,GO:1990032,1,0.992355558859115,0,1,parallel fiber,CC,
21132,GO:1990034,1,0.95009033299137,0,7,calcium ion export across plasma membrane,BP,
21133,GO:1990036,1,0.971688285654222,0,4,calcium ion import into sarcoplasmic reticulum,BP,
21134,GO:1990037,1,0.985682429349751,0,3,Lewy body core,CC,
21135,GO:1990038,1,0.995209498639171,0,1,Lewy body corona,CC,
21136,GO:1990044,1,0.995947578788108,0,1,protein localization to lipid droplet,BP,
21137,GO:1990046,1,0.996412808538561,0,1,stress-induced mitochondrial fusion,BP,
21138,GO:1990047,1,0.994388900781044,0,1,spindle matrix,CC,
21139,GO:1990048,1,0.941357690928803,0,7,anterograde neuronal dense core vesicle transport,BP,
21140,GO:1990049,1,0.955346974913629,0,5,retrograde neuronal dense core vesicle transport,BP,
21141,GO:1990050,1,0.983683795280222,0,4,phosphatidic acid transfer activity,MF,
21142,GO:1990051,1,0.969830387606552,0,5,activation of protein kinase C activity,BP,
21143,GO:1990070,1,0.996780210223161,0,1,TRAPPI protein complex,CC,
21144,GO:1990071,1,0.987847161561023,0,2,TRAPPII protein complex,CC,
21145,GO:1990072,1,0.990056765485928,0,2,TRAPPIII protein complex,CC,
21146,GO:1990074,1,0.992545082782729,0,1,polyuridylation-dependent mRNA catabolic process,BP,
21147,GO:1990075,1,0.966424317658074,0,4,periciliary membrane compartment,CC,
21148,GO:1990079,1,0.979958998624505,0,3,cartilage homeostasis,BP,
21149,GO:1990086,1,0.971809382206971,0,4,lens fiber cell apoptotic process,BP,
21150,GO:1990089,1,0.699261132263163,0,51,response to nerve growth factor,BP,
21151,GO:1990090,1,0.712890564154389,0,48,cellular response to nerve growth factor stimulus,BP,
21153,GO:1990108,1,0.976058419854912,0,3,protein linear deubiquitination,BP,
21154,GO:1990111,1,0.98072009932566,0,4,spermatoproteasome complex,CC,
21155,GO:1990112,1,0.986555151512788,0,2,RQC complex,CC,
21156,GO:1990114,1,0.995881823773946,0,1,RNA polymerase II core complex assembly,BP,
21157,GO:1990116,1,0.986555151512788,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
21158,GO:1990117,1,0.996762136804637,0,1,B cell receptor apoptotic signaling pathway,BP,
21159,GO:1990120,1,0.97632924361779,0,3,messenger ribonucleoprotein complex assembly,BP,
21160,GO:1990124,1,0.931765818339929,0,10,messenger ribonucleoprotein complex,CC,
21161,GO:1990126,1,0.856459702485105,0,22,retrograde transport, endosome to plasma membrane,BP,
21162,GO:1990127,1,0.992435727392954,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
21163,GO:1990130,1,0.968200201321604,0,5,GATOR1 complex,CC,
21164,GO:1990131,1,0.979116990234936,0,4,Gtr1-Gtr2 GTPase complex,CC,
21165,GO:1990134,1,0.992122528912016,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
21166,GO:1990136,1,0.993806601762081,0,1,linoleate 9S-lipoxygenase activity,MF,
21168,GO:1990144,1,0.960799174327863,0,7,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
21169,GO:1990145,1,0.985337515147593,0,2,maintenance of translational fidelity,BP,
21170,GO:1990147,1,0.992634423027795,0,1,talin binding,MF,
21171,GO:1990164,1,0.973186406413334,0,4,histone H2A phosphorylation,BP,
21172,GO:1990165,1,0.995055285925821,0,1,single-strand break-containing DNA binding,MF,
21173,GO:1990166,1,0.994179328080043,0,1,protein localization to site of double-strand break,BP,
21174,GO:1990167,1,0.982821615946968,0,2,protein K27-linked deubiquitination,BP,
21175,GO:1990168,1,0.976174263965542,0,3,protein K33-linked deubiquitination,BP,
21176,GO:1990169,1,0.959409329224664,0,11,stress response to copper ion,BP,
21177,GO:1990170,1,0.995070275787515,0,1,stress response to cadmium ion,BP,
21178,GO:1990172,1,0.991663250672266,0,1,G protein-coupled receptor catabolic process,BP,
21179,GO:1990173,1,0.926892616945711,0,13,protein localization to nucleoplasm,BP,
21180,GO:1990174,1,0.984124550416515,0,2,phosphodiesterase decapping endonuclease activity,MF,
21181,GO:1990175,1,0.99247693412678,0,1,EH domain binding,MF,
21182,GO:1990180,1,0.984420561508463,0,3,mitochondrial tRNA 3'-end processing,BP,
21183,GO:1990182,1,0.902327579808244,0,17,exosomal secretion,BP,
21184,GO:1990183,1,0.996743521086397,0,1,lymphatic vascular process in circulatory system,BP,
21185,GO:1990184,1,0.98680700275936,0,2,amino acid transport complex,CC,
21186,GO:1990186,1,0.996743521086397,0,1,regulation of lymphatic vessel size,BP,
21187,GO:1990188,1,0.993546277708003,0,1,euchromatin binding,MF,
21188,GO:1990189,1,0.985515172177611,0,3,peptide-serine-N-acetyltransferase activity,MF,
21189,GO:1990190,1,0.992844522629793,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
21190,GO:1990192,1,0.996743521086397,0,1,collecting lymphatic vessel constriction,BP,
21192,GO:1990221,1,0.987121430549109,0,2,L-cysteine desulfurase complex,CC,
21193,GO:1990226,1,0.958028253145081,0,7,histone methyltransferase binding,MF,
21195,GO:1990238,1,0.991267238382462,0,1,double-stranded DNA endodeoxyribonuclease activity,MF,
21196,GO:1990239,1,0.958602798269943,0,6,steroid hormone binding,MF,
21197,GO:1990246,1,0.966722662104563,0,5,uniplex complex,CC,
21198,GO:1990247,1,0.947174257667552,0,7,N6-methyladenosine-containing RNA binding,MF,
21199,GO:1990248,1,0.993627520566558,0,1,regulation of transcription from RNA polymerase II promoter in response to DNA damage,BP,
21200,GO:1990253,1,0.943634500294349,0,8,cellular response to leucine starvation,BP,
21201,GO:1990254,1,0.968563749219606,0,5,keratin filament binding,MF,
21202,GO:1990256,1,0.98852277446536,0,1,signal clustering,BP,
21203,GO:1990258,1,0.981713851784614,0,3,histone glutamine methylation,BP,
21204,GO:1990259,1,0.996523552675938,0,1,histone-glutamine methyltransferase activity,MF,
21205,GO:1990261,1,0.99325505912211,0,1,pre-mRNA catabolic process,BP,
21206,GO:1990262,1,0.993296441976419,0,1,anti-Mullerian hormone signaling pathway,BP,
21207,GO:1990264,1,0.934212276650263,0,8,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
21208,GO:1990266,1,0.586728125664075,0,98,neutrophil migration,BP,
21209,GO:1990267,1,0.987506018760861,0,2,response to transition metal nanoparticle,BP,
21210,GO:1990268,1,0.992690345055696,0,1,response to gold nanoparticle,BP,
21211,GO:1990269,1,0.973617603962844,0,4,RNA polymerase II C-terminal domain phosphoserine binding,MF,
21212,GO:1990275,1,0.993058782399663,0,1,preribosome binding,MF,
21213,GO:1990276,1,0.993300267375014,0,1,RNA 5'-methyltransferase activity,MF,
21214,GO:1990280,1,0.991126559871638,0,1,RNA localization to chromatin,BP,
21215,GO:1990298,1,0.99471717727404,0,1,bub1-bub3 complex,CC,
21216,GO:1990314,1,0.947397721751407,0,7,cellular response to insulin-like growth factor stimulus,BP,
21217,GO:1990316,1,0.939631211878469,0,8,Atg1/ULK1 kinase complex,CC,
21218,GO:1990332,1,0.99246592438391,0,1,Ire1 complex,CC,
21221,GO:1990356,1,0.996492397595218,0,1,sumoylated E2 ligase complex,CC,
21222,GO:1990357,1,0.976094920249256,0,4,terminal web,CC,
21223,GO:1990379,1,0.968779000298882,0,6,lipid transport across blood-brain barrier,BP,
21224,GO:1990380,1,0.91775803251941,0,10,Lys48-specific deubiquitinase activity,MF,
21225,GO:1990381,1,0.896965071985949,0,17,ubiquitin-specific protease binding,MF,
21226,GO:1990384,1,0.957324511209234,0,7,hyaloid vascular plexus regression,BP,
21227,GO:1990385,1,0.992444246346376,0,1,meiotic spindle midzone,CC,
21228,GO:1990386,1,0.995161868590964,0,1,mitotic cleavage furrow ingression,BP,
21229,GO:1990390,1,0.992560662383874,0,1,protein K33-linked ubiquitination,BP,
21230,GO:1990391,1,0.789969413437326,0,33,DNA repair complex,CC,
21231,GO:1990393,1,0.963945213349856,0,5,3M complex,CC,
21232,GO:1990399,1,0.994487462707336,0,1,epithelium regeneration,BP,
21233,GO:1990401,1,0.987193415560253,0,2,embryonic lung development,BP,
21234,GO:1990402,1,0.99102707641493,0,2,embryonic liver development,BP,
21235,GO:1990403,1,0.921163801427334,0,12,embryonic brain development,BP,
21236,GO:1990404,1,0.888804315483029,0,16,protein ADP-ribosylase activity,MF,
21237,GO:1990405,1,0.950802130023052,0,7,protein antigen binding,MF,
21238,GO:1990406,1,0.988880399541666,0,2,CGRP receptor complex,CC,
21239,GO:1990407,1,0.996714926336893,0,1,calcitonin gene-related peptide binding,MF,
21240,GO:1990408,1,0.988880399541666,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
21241,GO:1990409,1,0.988939139892398,0,2,adrenomedullin binding,MF,
21242,GO:1990410,1,0.981573719759557,0,4,adrenomedullin receptor signaling pathway,BP,
21243,GO:1990414,1,0.947729621654995,0,8,replication-born double-strand break repair via sister chromatid exchange,BP,
21244,GO:1990415,1,0.981175231860788,0,3,Pex17p-Pex14p docking complex,CC,
21245,GO:1990416,1,0.926398824514838,0,10,cellular response to brain-derived neurotrophic factor stimulus,BP,
21246,GO:1990418,1,0.981832823008465,0,3,response to insulin-like growth factor stimulus,BP,
21247,GO:1990422,1,0.996698971982734,0,1,glyoxalase (glycolic acid-forming) activity,MF,
21248,GO:1990423,1,0.976920950127039,0,3,RZZ complex,CC,
21249,GO:1990425,1,0.974412577140165,0,3,ryanodine receptor complex,CC,
21250,GO:1990426,1,0.983279578681104,0,2,mitotic recombination-dependent replication fork processing,BP,
21251,GO:1990427,1,0.990818650640373,0,1,stereocilia tip-link density,CC,
21252,GO:1990428,1,0.980965450243405,0,3,miRNA transport,BP,
21253,GO:1990429,1,0.981175231860788,0,3,peroxisomal importomer complex,CC,
21254,GO:1990430,1,0.964985930139611,0,5,extracellular matrix protein binding,MF,
21255,GO:1990435,1,0.990818650640373,0,1,upper tip-link density,CC,
21256,GO:1990437,1,0.994521232542148,0,1,snRNA 2'-O-methylation,BP,
21257,GO:1990438,1,0.994521232542148,0,1,U6 2'-O-snRNA methylation,BP,
21258,GO:1990439,1,0.992970095840506,0,1,MAP kinase serine/threonine phosphatase activity,MF,
21259,GO:1990440,1,0.937669487417145,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21260,GO:1990441,1,0.975331044380966,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21261,GO:1990442,1,0.989507833711844,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
21262,GO:1990443,1,0.98865494629708,0,2,peptidyl-threonine autophosphorylation,BP,
21263,GO:1990444,1,0.98649980186657,0,2,F-box domain binding,MF,
21264,GO:1990446,1,0.98143868688257,0,5,U1 snRNP binding,MF,
21265,GO:1990447,1,0.996596859708267,0,1,U2 snRNP binding,MF,
21266,GO:1990448,1,0.991241997302979,0,1,exon-exon junction complex binding,MF,
21267,GO:1990452,1,0.985241514098553,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
21268,GO:1990454,1,0.920486347686148,0,12,L-type voltage-gated calcium channel complex,CC,
21269,GO:1990456,1,0.97836363670654,0,3,mitochondrion-endoplasmic reticulum membrane tethering,BP,
21271,GO:1990460,1,0.971980972703098,0,4,leptin receptor binding,MF,
21272,GO:1990462,1,0.985185748101664,0,2,omegasome,CC,
21273,GO:1990467,1,0.99472623237241,0,1,NuA3a histone acetyltransferase complex,CC,
21274,GO:1990468,1,0.99472623237241,0,1,NuA3b histone acetyltransferase complex,CC,
21275,GO:1990478,1,0.990916738815453,0,2,response to ultrasound,BP,
21276,GO:1990481,1,0.970456798911606,0,5,mRNA pseudouridine synthesis,BP,
21277,GO:1990498,1,0.974752683029862,0,3,mitotic spindle microtubule,CC,
21280,GO:1990505,1,0.983279578681104,0,2,mitotic DNA replication maintenance of fidelity,BP,
21281,GO:1990511,1,0.971546986789972,0,4,piRNA biosynthetic process,BP,
21282,GO:1990513,1,0.984223992220469,0,2,CLOCK-BMAL transcription complex,CC,
21283,GO:1990518,1,0.978045715867839,0,3,single-stranded 3'-5' DNA helicase activity,MF,
21284,GO:1990519,1,0.988501017888923,0,2,pyrimidine nucleotide import into mitochondrion,BP,
21285,GO:1990523,1,0.979673770558127,0,3,bone regeneration,BP,
21286,GO:1990529,1,0.992406010996839,0,1,glycosylphosphatidylinositol-mannosyltransferase I complex,CC,
21287,GO:1990535,1,0.92840492190217,0,9,neuron projection maintenance,BP,
21288,GO:1990539,1,0.994283053758508,0,1,fructose import across plasma membrane,BP,
21289,GO:1990540,1,0.992681400907057,0,1,mitochondrial manganese ion transmembrane transport,BP,
21290,GO:1990542,1,0.645374163339726,0,73,mitochondrial transmembrane transport,BP,
21291,GO:1990546,1,0.995957962710815,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
21292,GO:1990548,1,0.992873456259171,0,1,mitochondrial FAD transmembrane transport,BP,
21293,GO:1990564,1,0.973114494355745,0,5,protein polyufmylation,BP,
21294,GO:1990565,1,0.989584622100923,0,2,HSP90-CDC37 chaperone complex,CC,
21295,GO:1990569,1,0.96770001103981,0,5,UDP-N-acetylglucosamine transmembrane transport,BP,
21296,GO:1990572,1,0.992468032218389,0,1,TERT-RMRP complex,CC,
21298,GO:1990575,1,0.982973989937049,0,3,mitochondrial L-ornithine transmembrane transport,BP,
21299,GO:1990578,1,0.98569558752275,0,2,perinuclear endoplasmic reticulum membrane,CC,
21300,GO:1990579,1,0.99246592438391,0,1,peptidyl-serine trans-autophosphorylation,BP,
21301,GO:1990583,1,0.995161868590964,0,1,phospholipase D activator activity,MF,
21302,GO:1990584,1,0.99013684096547,0,3,cardiac Troponin complex,CC,
21303,GO:1990589,1,0.985345379310167,0,2,ATF4-CREB1 transcription factor complex,CC,
21304,GO:1990590,1,0.989753370777728,0,2,ATF1-ATF4 transcription factor complex,CC,
21305,GO:1990592,1,0.973114494355745,0,5,protein K69-linked ufmylation,BP,
21306,GO:1990597,1,0.984878494364129,0,2,AIP1-IRE1 complex,CC,
21307,GO:1990599,1,0.978757121563233,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
21308,GO:1990604,1,0.979025746669291,0,3,IRE1-TRAF2-ASK1 complex,CC,
21309,GO:1990613,1,0.992543017703786,0,1,mitochondrial membrane fusion,BP,
21310,GO:1990617,1,0.992473271645646,0,2,CHOP-ATF4 complex,CC,
21311,GO:1990619,1,0.988413287390073,0,2,histone H3-K9 deacetylation,BP,
21312,GO:1990622,1,0.991724529438853,0,2,CHOP-ATF3 complex,CC,
21313,GO:1990630,1,0.99246592438391,0,1,IRE1-RACK1-PP2A complex,CC,
21314,GO:1990635,1,0.957630447724026,0,6,proximal dendrite,CC,
21315,GO:1990637,1,0.979577158881209,0,3,response to prolactin,BP,
21316,GO:1990641,1,0.984539574881461,0,3,response to iron ion starvation,BP,
21317,GO:1990646,1,0.992890982785859,0,1,cellular response to prolactin,BP,
21318,GO:1990654,1,0.992180619553696,0,1,sebum secreting cell proliferation,BP,
21319,GO:1990665,1,0.992530785611932,0,2,AnxA2-p11 complex,CC,
21320,GO:1990666,1,0.984575066520203,0,2,PCSK9-LDLR complex,CC,
21321,GO:1990667,1,0.988442336808347,0,2,PCSK9-AnxA2 complex,CC,
21322,GO:1990668,1,0.969921574041315,0,5,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
21323,GO:1990678,1,0.992424437769411,0,1,histone H4-K16 deacetylation,BP,
21324,GO:1990682,1,0.986522006306684,0,2,CSF1-CSF1R complex,CC,
21325,GO:1990696,1,0.983233543786109,0,2,USH2 complex,CC,
21326,GO:1990697,1,0.994539420434272,0,1,protein depalmitoleylation,BP,
21327,GO:1990698,1,0.988112064355427,0,2,palmitoleoyltransferase activity,MF,
21328,GO:1990699,1,0.994539420434272,0,1,palmitoleyl hydrolase activity,MF,
21329,GO:1990700,1,0.992475477155422,0,1,nucleolar chromatin organization,BP,
21330,GO:1990705,1,0.975100974527406,0,3,cholangiocyte proliferation,BP,
21331,GO:1990707,1,0.988852137285306,0,1,nuclear subtelomeric heterochromatin,CC,
21332,GO:1990708,1,0.9926524730805,0,1,conditioned place preference,BP,
21333,GO:1990709,1,0.929590085795065,0,8,presynaptic active zone organization,BP,
21335,GO:1990715,1,0.981635836046851,0,3,mRNA CDS binding,MF,
21336,GO:1990716,1,0.976437101357746,0,3,axonemal central apparatus,CC,
21337,GO:1990718,1,0.989576328643311,0,1,axonemal central pair projection,CC,
21338,GO:1990723,1,0.981514787266847,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
21339,GO:1990726,1,0.981481472274408,0,5,Lsm1-7-Pat1 complex,CC,
21340,GO:1990729,1,0.995205851745779,0,1,primary miRNA modification,BP,
21341,GO:1990730,1,0.985074256176216,0,2,VCP-NSFL1C complex,CC,
21342,GO:1990731,1,0.992519724978507,0,1,UV-damage excision repair, DNA incision,BP,
21343,GO:1990736,1,0.992458489616274,0,1,regulation of vascular associated smooth muscle cell membrane depolarization,BP,
21344,GO:1990737,1,0.980602275351421,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
21345,GO:1990739,1,0.990067536892281,0,1,granulosa cell proliferation,BP,
21346,GO:1990742,1,0.981679773099804,0,3,microvesicle,CC,
21347,GO:1990743,1,0.972516156944214,0,4,protein sialylation,BP,
21348,GO:1990744,1,0.995205851745779,0,1,primary miRNA methylation,BP,
21349,GO:1990745,1,0.977674537684758,0,3,EARP complex,CC,
21350,GO:1990748,1,0.60151127214766,0,98,cellular detoxification,BP,
21351,GO:1990751,1,0.990907255086257,0,1,Schwann cell chemotaxis,BP,
21352,GO:1990752,1,0.77097241388494,0,32,microtubule end,CC,
21353,GO:1990755,1,0.99325505912211,0,1,mitotic spindle microtubule depolymerization,BP,
21354,GO:1990756,1,0.925853942702316,0,14,ubiquitin ligase-substrate adaptor activity,MF,
21355,GO:1990757,1,0.980066246237106,0,3,ubiquitin ligase activator activity,MF,
21356,GO:1990758,1,0.995500471337558,0,1,mitotic sister chromatid biorientation,BP,
21357,GO:1990760,1,0.977149839472681,0,3,osmolarity-sensing cation channel activity,MF,
21358,GO:1990761,1,0.975648629906673,0,3,growth cone lamellipodium,CC,
21360,GO:1990764,1,0.993348948151922,0,1,myofibroblast contraction,BP,
21361,GO:1990765,1,0.992049146936613,0,1,colon smooth muscle contraction,BP,
21362,GO:1990768,1,0.990720259016454,0,2,gastric mucosal blood circulation,BP,
21364,GO:1990770,1,0.988874550665806,0,2,small intestine smooth muscle contraction,BP,
21365,GO:1990771,1,0.991537243903476,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
21366,GO:1990773,1,0.966108797075196,0,5,matrix metallopeptidase secretion,BP,
21367,GO:1990774,1,0.978875585299731,0,3,tumor necrosis factor secretion,BP,
21368,GO:1990775,1,0.996340173474856,0,1,endothelin production,BP,
21369,GO:1990776,1,0.843681716975591,0,25,response to angiotensin,BP,
21370,GO:1990777,1,0.852502128719852,0,30,lipoprotein particle,CC,
21372,GO:1990780,1,0.992461695877957,0,1,cytoplasmic side of dendritic spine plasma membrane,CC,
21373,GO:1990782,1,0.53539247223247,0,93,protein tyrosine kinase binding,MF,
21374,GO:1990784,1,0.985768953079311,0,2,response to dsDNA,BP,
21375,GO:1990785,1,0.971396606284215,0,4,response to water-immersion restraint stress,BP,
21376,GO:1990786,1,0.985768953079311,0,2,cellular response to dsDNA,BP,
21377,GO:1990787,1,0.990776411233436,0,1,negative regulation of hh target transcription factor activity,BP,
21378,GO:1990791,1,0.953079975883414,0,7,dorsal root ganglion development,BP,
21379,GO:1990798,1,0.996761692975591,0,1,pancreas regeneration,BP,
21380,GO:1990809,1,0.975167379288506,0,4,endoplasmic reticulum tubular network membrane organization,BP,
21381,GO:1990811,1,0.99325505912211,0,1,MWP complex,CC,
21382,GO:1990812,1,0.970936203447336,0,4,growth cone filopodium,CC,
21383,GO:1990814,1,0.996256435376408,0,1,DNA/DNA annealing activity,MF,
21384,GO:1990817,1,0.994399259932995,0,1,RNA adenylyltransferase activity,MF,
21385,GO:1990822,1,0.926698482666031,0,11,basic amino acid transmembrane transport,BP,
21386,GO:1990823,1,0.527918397505518,0,93,response to leukemia inhibitory factor,BP,
21387,GO:1990825,1,0.940071147598292,0,10,sequence-specific mRNA binding,MF,
21388,GO:1990828,1,0.994705529194295,0,1,hepatocyte dedifferentiation,BP,
21389,GO:1990829,1,0.987981276169852,0,2,C-rich single-stranded DNA binding,MF,
21390,GO:1990830,1,0.527918397505518,0,93,cellular response to leukemia inhibitory factor,BP,
21391,GO:1990832,1,0.99502268818626,0,1,slow axonal transport,BP,
21392,GO:1990833,1,0.99502268818626,0,1,clathrin-uncoating ATPase activity,MF,
21393,GO:1990834,1,0.973423267165106,0,4,response to odorant,BP,
21394,GO:1990836,1,0.992457854656774,0,1,lysosomal matrix,CC,
21396,GO:1990838,1,0.99325505912211,0,1,poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends,MF,
21397,GO:1990839,1,0.986773834805377,0,2,response to endothelin,BP,
21399,GO:1990843,1,0.991408023303973,0,1,subsarcolemmal mitochondrion,CC,
21400,GO:1990844,1,0.991408023303973,0,1,interfibrillar mitochondrion,CC,
21402,GO:1990851,1,0.974389675373312,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
21403,GO:1990859,1,0.994316539461777,0,1,cellular response to endothelin,BP,
21404,GO:1990863,1,0.996761692975591,0,1,acinar cell proliferation,BP,
21405,GO:1990864,1,0.996761692975591,0,1,response to growth hormone-releasing hormone,BP,
21406,GO:1990867,1,0.996761692975591,0,1,response to gastrin,BP,
21407,GO:1990868,1,0.644276505828849,0,80,response to chemokine,BP,
21408,GO:1990869,1,0.644276505828849,0,80,cellular response to chemokine,BP,
21410,GO:1990876,1,0.991235831904316,0,1,cytoplasmic side of nuclear pore,CC,
21411,GO:1990878,1,0.996761692975591,0,1,cellular response to gastrin,BP,
21412,GO:1990879,1,0.986555151512788,0,2,CST complex,CC,
21413,GO:1990882,1,0.992474164909478,0,1,rRNA acetylation,BP,
21414,GO:1990883,1,0.992474164909478,0,1,rRNA cytidine N-acetyltransferase activity,MF,
21415,GO:1990884,1,0.992474164909478,0,1,RNA acetylation,BP,
21416,GO:1990889,1,0.988074460228626,0,2,H4K20me3 modified histone binding,MF,
21417,GO:1990890,1,0.986753088286824,0,2,netrin receptor binding,MF,
21419,GO:1990907,1,0.917367978312923,0,11,beta-catenin-TCF complex,CC,
21420,GO:1990909,1,0.914266219399714,0,11,Wnt signalosome,CC,
21421,GO:1990910,1,0.977042785111047,0,4,response to hypobaric hypoxia,BP,
21422,GO:1990911,1,0.975463708624035,0,4,response to psychosocial stress,BP,
21423,GO:1990913,1,0.973968117106088,0,4,sperm head plasma membrane,CC,
21424,GO:1990917,1,0.993728670751326,0,1,ooplasm,CC,
21425,GO:1990918,1,0.970458651034003,0,4,double-strand break repair involved in meiotic recombination,BP,
21426,GO:1990922,1,0.992627338486534,0,1,hepatic stellate cell proliferation,BP,
21427,GO:1990923,1,0.981503751690001,0,3,PET complex,CC,
21428,GO:1990926,1,0.979138540281055,0,3,short-term synaptic potentiation,BP,
21429,GO:1990927,1,0.984415324115988,0,2,calcium ion regulated lysosome exocytosis,BP,
21430,GO:1990928,1,0.752540142384583,0,45,response to amino acid starvation,BP,
21431,GO:1990930,1,0.996007069956112,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
21432,GO:1990931,1,0.985043122976977,0,2,RNA N6-methyladenosine dioxygenase activity,MF,
21433,GO:1990935,1,0.986820220547455,0,3,splicing factor binding,MF,
21434,GO:1990936,1,0.988540300431572,0,2,vascular associated smooth muscle cell dedifferentiation,BP,
21435,GO:1990938,1,0.992468160929538,0,1,peptidyl-aspartic acid autophosphorylation,BP,
21437,GO:1990948,1,0.981899606229987,0,5,ubiquitin ligase inhibitor activity,MF,
21438,GO:1990949,1,0.99536100842981,0,1,metaphase/anaphase transition of meiosis I,BP,
21439,GO:1990955,1,0.992454902064336,0,1,G-rich single-stranded DNA binding,MF,
21440,GO:1990959,1,0.992513243047183,0,1,eosinophil homeostasis,BP,
21441,GO:1990960,1,0.992513243047183,0,1,basophil homeostasis,BP,
21442,GO:1990961,1,0.953199239738633,0,8,xenobiotic detoxification by transmembrane export across the plasma membrane,BP,
21443,GO:1990962,1,0.966374339787105,0,5,xenobiotic transport across blood-brain barrier,BP,
21444,GO:1990963,1,0.9950964198591,0,1,establishment of blood-retinal barrier,BP,
21445,GO:1990966,1,0.974114294000513,0,4,ATP generation from poly-ADP-D-ribose,BP,
21446,GO:1990968,1,0.991334697294006,0,1,modulation by host of RNA binding by virus,BP,
21447,GO:1990969,1,0.991334697294006,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
21448,GO:1990971,1,0.992476711570874,0,1,EMILIN complex,CC,
21449,GO:1990983,1,0.993634309567024,0,1,tRNA demethylation,BP,
21450,GO:1990984,1,0.986094183079146,0,2,tRNA demethylase activity,MF,
21451,GO:2000001,1,0.904000972985109,0,16,regulation of DNA damage checkpoint,BP,
21452,GO:2000002,1,0.96982503426542,0,5,negative regulation of DNA damage checkpoint,BP,
21453,GO:2000003,1,0.99325505912211,0,1,positive regulation of DNA damage checkpoint,BP,
21454,GO:2000004,1,0.995611667834955,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
21455,GO:2000005,1,0.995611667834955,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
21456,GO:2000006,1,0.995611667834955,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
21457,GO:2000007,1,0.995611667834955,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
21458,GO:2000008,1,0.772100884244589,0,39,regulation of protein localization to cell surface,BP,
21459,GO:2000009,1,0.920921199662461,0,13,negative regulation of protein localization to cell surface,BP,
21460,GO:2000010,1,0.892962557274059,0,17,positive regulation of protein localization to cell surface,BP,
21461,GO:2000011,1,0.994586188491571,0,1,regulation of adaxial/abaxial pattern formation,BP,
21462,GO:2000015,1,0.977854205880524,0,4,regulation of determination of dorsal identity,BP,
21463,GO:2000016,1,0.99216082177126,0,2,negative regulation of determination of dorsal identity,BP,
21464,GO:2000017,1,0.985581497327644,0,2,positive regulation of determination of dorsal identity,BP,
21465,GO:2000018,1,0.942676394209261,0,9,regulation of male gonad development,BP,
21466,GO:2000019,1,0.992480005246956,0,1,negative regulation of male gonad development,BP,
21467,GO:2000020,1,0.949822793758654,0,8,positive regulation of male gonad development,BP,
21470,GO:2000035,1,0.937056522923324,0,10,regulation of stem cell division,BP,
21471,GO:2000036,1,0.800475410372227,0,31,regulation of stem cell population maintenance,BP,
21472,GO:2000040,1,0.987536341472811,0,2,regulation of planar cell polarity pathway involved in axis elongation,BP,
21473,GO:2000041,1,0.987536341472811,0,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
21474,GO:2000042,1,0.906990286736531,0,13,negative regulation of double-strand break repair via homologous recombination,BP,
21475,GO:2000043,1,0.994218906995635,0,1,regulation of cardiac cell fate specification,BP,
21477,GO:2000047,1,0.881007666046944,0,18,regulation of cell-cell adhesion mediated by cadherin,BP,
21478,GO:2000048,1,0.93967872098338,0,9,negative regulation of cell-cell adhesion mediated by cadherin,BP,
21479,GO:2000049,1,0.937600998157043,0,9,positive regulation of cell-cell adhesion mediated by cadherin,BP,
21480,GO:2000050,1,0.845967915492133,0,23,regulation of non-canonical Wnt signaling pathway,BP,
21481,GO:2000051,1,0.953453198857225,0,6,negative regulation of non-canonical Wnt signaling pathway,BP,
21482,GO:2000052,1,0.915859784916611,0,13,positive regulation of non-canonical Wnt signaling pathway,BP,
21483,GO:2000053,1,0.992362313737938,0,1,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21484,GO:2000054,1,0.992362313737938,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21485,GO:2000056,1,0.995398212808038,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21486,GO:2000057,1,0.995398212808038,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21488,GO:2000059,1,0.750906586772818,0,45,negative regulation of ubiquitin-dependent protein catabolic process,BP,
21490,GO:2000061,1,0.996007069956112,0,1,regulation of ureter smooth muscle cell differentiation,BP,
21491,GO:2000062,1,0.996007069956112,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
21492,GO:2000063,1,0.996007069956112,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
21493,GO:2000064,1,0.949029251900538,0,7,regulation of cortisol biosynthetic process,BP,
21494,GO:2000065,1,0.973495211800611,0,4,negative regulation of cortisol biosynthetic process,BP,
21495,GO:2000066,1,0.992480005246956,0,1,positive regulation of cortisol biosynthetic process,BP,
21496,GO:2000074,1,0.952325618201397,0,8,regulation of type B pancreatic cell development,BP,
21497,GO:2000077,1,0.985656456868494,0,2,negative regulation of type B pancreatic cell development,BP,
21498,GO:2000078,1,0.985986511829411,0,3,positive regulation of type B pancreatic cell development,BP,
21499,GO:2000079,1,0.992362313737938,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21500,GO:2000080,1,0.992362313737938,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21501,GO:2000095,1,0.901993964117921,0,15,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21502,GO:2000096,1,0.941542766335774,0,9,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21505,GO:2000101,1,0.992985757593682,0,1,regulation of mammary stem cell proliferation,BP,
21506,GO:2000103,1,0.992985757593682,0,1,positive regulation of mammary stem cell proliferation,BP,
21507,GO:2000104,1,0.886078452525973,0,18,negative regulation of DNA-dependent DNA replication,BP,
21508,GO:2000105,1,0.914909335819568,0,12,positive regulation of DNA-dependent DNA replication,BP,
21509,GO:2000106,1,0.62707961436488,0,77,regulation of leukocyte apoptotic process,BP,
21510,GO:2000107,1,0.773300008177511,0,43,negative regulation of leukocyte apoptotic process,BP,
21511,GO:2000108,1,0.859767767826138,0,25,positive regulation of leukocyte apoptotic process,BP,
21512,GO:2000109,1,0.955400374693762,0,7,regulation of macrophage apoptotic process,BP,
21513,GO:2000110,1,0.980186228868398,0,3,negative regulation of macrophage apoptotic process,BP,
21514,GO:2000111,1,0.980560698824733,0,3,positive regulation of macrophage apoptotic process,BP,
21517,GO:2000114,1,0.868589806306951,0,18,regulation of establishment of cell polarity,BP,
21520,GO:2000118,1,0.976829870906956,0,4,regulation of sodium-dependent phosphate transport,BP,
21521,GO:2000119,1,0.992936609128296,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21522,GO:2000120,1,0.991267807553053,0,2,positive regulation of sodium-dependent phosphate transport,BP,
21523,GO:2000121,1,0.937945819820529,0,11,regulation of removal of superoxide radicals,BP,
21524,GO:2000124,1,0.978813814690061,0,3,regulation of endocannabinoid signaling pathway,BP,
21526,GO:2000136,1,0.897822195387427,0,15,regulation of cell proliferation involved in heart morphogenesis,BP,
21527,GO:2000137,1,0.974005839198297,0,3,negative regulation of cell proliferation involved in heart morphogenesis,BP,
21528,GO:2000138,1,0.96617121661959,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
21529,GO:2000142,1,0.7379298331027,0,44,regulation of DNA-templated transcription, initiation,BP,
21530,GO:2000143,1,0.958267156200995,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21531,GO:2000144,1,0.782038028866029,0,36,positive regulation of DNA-templated transcription, initiation,BP,
21535,GO:2000152,1,0.974589425589599,0,5,regulation of ubiquitin-specific protease activity,BP,
21536,GO:2000155,1,0.955477132400969,0,9,positive regulation of cilium-dependent cell motility,BP,
21537,GO:2000156,1,0.985597452448854,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21538,GO:2000157,1,0.993109126719105,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21539,GO:2000158,1,0.988801449538242,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21540,GO:2000167,1,0.991937485430931,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21541,GO:2000169,1,0.942616154391386,0,8,regulation of peptidyl-cysteine S-nitrosylation,BP,
21542,GO:2000170,1,0.981920958797113,0,3,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21543,GO:2000171,1,0.818509653886337,0,27,negative regulation of dendrite development,BP,
21544,GO:2000172,1,0.962115391729868,0,5,regulation of branching morphogenesis of a nerve,BP,
21545,GO:2000173,1,0.992473991890159,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21546,GO:2000174,1,0.992471877123297,0,1,regulation of pro-T cell differentiation,BP,
21547,GO:2000176,1,0.992471877123297,0,1,positive regulation of pro-T cell differentiation,BP,
21549,GO:2000178,1,0.859384240013523,0,22,negative regulation of neural precursor cell proliferation,BP,
21551,GO:2000180,1,0.992480005246956,0,1,negative regulation of androgen biosynthetic process,BP,
21553,GO:2000182,1,0.972935589654375,0,4,regulation of progesterone biosynthetic process,BP,
21554,GO:2000184,1,0.987640651060482,0,2,positive regulation of progesterone biosynthetic process,BP,
21555,GO:2000191,1,0.892475203868737,0,18,regulation of fatty acid transport,BP,
21556,GO:2000192,1,0.960581694822806,0,5,negative regulation of fatty acid transport,BP,
21557,GO:2000193,1,0.929123733111605,0,13,positive regulation of fatty acid transport,BP,
21558,GO:2000194,1,0.932845302460071,0,12,regulation of female gonad development,BP,
21559,GO:2000195,1,0.975787856237603,0,4,negative regulation of female gonad development,BP,
21560,GO:2000196,1,0.985659025452136,0,3,positive regulation of female gonad development,BP,
21561,GO:2000197,1,0.94816602339583,0,7,regulation of ribonucleoprotein complex localization,BP,
21562,GO:2000199,1,0.992794796532939,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21563,GO:2000200,1,0.992794796532939,0,1,regulation of ribosomal subunit export from nucleus,BP,
21564,GO:2000202,1,0.992794796532939,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21565,GO:2000206,1,0.992794796532939,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21566,GO:2000208,1,0.992794796532939,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21567,GO:2000209,1,0.862064850687933,0,21,regulation of anoikis,BP,
21568,GO:2000210,1,0.973398977670506,0,5,positive regulation of anoikis,BP,
21569,GO:2000211,1,0.97663511795335,0,3,regulation of glutamate metabolic process,BP,
21570,GO:2000212,1,0.992121294367649,0,1,negative regulation of glutamate metabolic process,BP,
21571,GO:2000213,1,0.994728818783657,0,1,positive regulation of glutamate metabolic process,BP,
21572,GO:2000224,1,0.985647280239526,0,3,regulation of testosterone biosynthetic process,BP,
21573,GO:2000225,1,0.989141682654667,0,2,negative regulation of testosterone biosynthetic process,BP,
21574,GO:2000226,1,0.996194664242819,0,1,regulation of pancreatic A cell differentiation,BP,
21575,GO:2000227,1,0.996194664242819,0,1,negative regulation of pancreatic A cell differentiation,BP,
21576,GO:2000229,1,0.991873208402617,0,2,regulation of pancreatic stellate cell proliferation,BP,
21577,GO:2000230,1,0.995447523178614,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21578,GO:2000231,1,0.996409506317867,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21579,GO:2000232,1,0.915348688767223,0,13,regulation of rRNA processing,BP,
21580,GO:2000233,1,0.977081547928394,0,3,negative regulation of rRNA processing,BP,
21581,GO:2000234,1,0.944377900221162,0,9,positive regulation of rRNA processing,BP,
21584,GO:2000243,1,0.631514850688367,0,72,positive regulation of reproductive process,BP,
21586,GO:2000250,1,0.990994308074824,0,1,negative regulation of actin cytoskeleton reorganization,BP,
21587,GO:2000251,1,0.90160948799153,0,19,positive regulation of actin cytoskeleton reorganization,BP,
21588,GO:2000252,1,0.960639473430298,0,8,negative regulation of feeding behavior,BP,
21589,GO:2000253,1,0.964862652129887,0,5,positive regulation of feeding behavior,BP,
21590,GO:2000254,1,0.982675610846674,0,4,regulation of male germ cell proliferation,BP,
21591,GO:2000255,1,0.985958080768987,0,3,negative regulation of male germ cell proliferation,BP,
21592,GO:2000256,1,0.99667126295483,0,1,positive regulation of male germ cell proliferation,BP,
21593,GO:2000269,1,0.889180206897075,0,17,regulation of fibroblast apoptotic process,BP,
21594,GO:2000270,1,0.951113424457763,0,7,negative regulation of fibroblast apoptotic process,BP,
21595,GO:2000271,1,0.944101197103804,0,8,positive regulation of fibroblast apoptotic process,BP,
21596,GO:2000272,1,0.775121376289118,0,42,negative regulation of signaling receptor activity,BP,
21598,GO:2000275,1,0.981901525014412,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21599,GO:2000276,1,0.990483411229261,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21600,GO:2000277,1,0.996698971982734,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21603,GO:2000282,1,0.982169513892085,0,3,regulation of cellular amino acid biosynthetic process,BP,
21604,GO:2000283,1,0.990038223672271,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21605,GO:2000284,1,0.996698971982734,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21606,GO:2000286,1,0.979843502684825,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21608,GO:2000288,1,0.941682067511874,0,9,positive regulation of myoblast proliferation,BP,
21610,GO:2000291,1,0.912273811039692,0,14,regulation of myoblast proliferation,BP,
21611,GO:2000295,1,0.978357975877089,0,4,regulation of hydrogen peroxide catabolic process,BP,
21612,GO:2000296,1,0.993184443990241,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21613,GO:2000297,1,0.977465159458079,0,3,negative regulation of synapse maturation,BP,
21614,GO:2000298,1,0.969542760209922,0,4,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21615,GO:2000299,1,0.975303991189514,0,3,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21616,GO:2000300,1,0.582622880594783,0,77,regulation of synaptic vesicle exocytosis,BP,
21617,GO:2000301,1,0.975342162632517,0,4,negative regulation of synaptic vesicle exocytosis,BP,
21618,GO:2000302,1,0.913758706457135,0,12,positive regulation of synaptic vesicle exocytosis,BP,
21619,GO:2000303,1,0.91587465015774,0,15,regulation of ceramide biosynthetic process,BP,
21620,GO:2000304,1,0.944233651547082,0,9,positive regulation of ceramide biosynthetic process,BP,
21621,GO:2000307,1,0.986942307565985,0,2,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21622,GO:2000308,1,0.994152611553279,0,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21623,GO:2000309,1,0.99274771897635,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21625,GO:2000311,1,0.837027611031103,0,25,regulation of AMPA receptor activity,BP,
21626,GO:2000312,1,0.977772289291826,0,3,regulation of kainate selective glutamate receptor activity,BP,
21627,GO:2000313,1,0.991246929901444,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21628,GO:2000314,1,0.995850606966582,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21629,GO:2000316,1,0.895765967971135,0,16,regulation of T-helper 17 type immune response,BP,
21630,GO:2000317,1,0.935349301779822,0,9,negative regulation of T-helper 17 type immune response,BP,
21631,GO:2000318,1,0.957708922892449,0,7,positive regulation of T-helper 17 type immune response,BP,
21632,GO:2000319,1,0.909079450540764,0,14,regulation of T-helper 17 cell differentiation,BP,
21633,GO:2000320,1,0.942269626686773,0,8,negative regulation of T-helper 17 cell differentiation,BP,
21634,GO:2000321,1,0.964797334070882,0,6,positive regulation of T-helper 17 cell differentiation,BP,
21635,GO:2000322,1,0.946506475189952,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21636,GO:2000323,1,0.958492177284428,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21637,GO:2000324,1,0.987500626358441,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21638,GO:2000325,1,0.978283601003285,0,3,regulation of nuclear receptor transcription coactivator activity,BP,
21639,GO:2000327,1,0.982183444589344,0,2,positive regulation of nuclear receptor transcription coactivator activity,BP,
21640,GO:2000328,1,0.978370668493347,0,4,regulation of T-helper 17 cell lineage commitment,BP,
21641,GO:2000329,1,0.986474806815379,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21642,GO:2000330,1,0.991785887361782,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
21643,GO:2000331,1,0.985174448565919,0,2,regulation of terminal button organization,BP,
21644,GO:2000332,1,0.990792451539154,0,2,regulation of blood microparticle formation,BP,
21645,GO:2000334,1,0.990792451539154,0,2,positive regulation of blood microparticle formation,BP,
21646,GO:2000338,1,0.981047445726023,0,3,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21647,GO:2000340,1,0.981047445726023,0,3,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21649,GO:2000342,1,0.987204790640637,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21651,GO:2000344,1,0.947431876126525,0,9,positive regulation of acrosome reaction,BP,
21652,GO:2000345,1,0.921482806573905,0,13,regulation of hepatocyte proliferation,BP,
21653,GO:2000346,1,0.979986181065124,0,3,negative regulation of hepatocyte proliferation,BP,
21654,GO:2000347,1,0.954604875444733,0,8,positive regulation of hepatocyte proliferation,BP,
21655,GO:2000348,1,0.964720834149084,0,6,regulation of CD40 signaling pathway,BP,
21656,GO:2000349,1,0.987512458616412,0,2,negative regulation of CD40 signaling pathway,BP,
21657,GO:2000350,1,0.996620610494782,0,1,positive regulation of CD40 signaling pathway,BP,
21658,GO:2000351,1,0.743345597543467,0,46,regulation of endothelial cell apoptotic process,BP,
21659,GO:2000352,1,0.838888996715247,0,26,negative regulation of endothelial cell apoptotic process,BP,
21660,GO:2000353,1,0.890001588282006,0,19,positive regulation of endothelial cell apoptotic process,BP,
21661,GO:2000354,1,0.967349730443358,0,6,regulation of ovarian follicle development,BP,
21662,GO:2000355,1,0.990337816294558,0,2,negative regulation of ovarian follicle development,BP,
21663,GO:2000356,1,0.996007069956112,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21664,GO:2000357,1,0.996007069956112,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21665,GO:2000358,1,0.996007069956112,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21666,GO:2000359,1,0.990772312022399,0,2,regulation of binding of sperm to zona pellucida,BP,
21667,GO:2000360,1,0.990772312022399,0,2,negative regulation of binding of sperm to zona pellucida,BP,
21668,GO:2000361,1,0.977738672388125,0,3,regulation of prostaglandin-E synthase activity,BP,
21669,GO:2000363,1,0.977738672388125,0,3,positive regulation of prostaglandin-E synthase activity,BP,
21670,GO:2000367,1,0.984088047661339,0,3,regulation of acrosomal vesicle exocytosis,BP,
21671,GO:2000368,1,0.991546795540683,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
21672,GO:2000369,1,0.870745014873879,0,18,regulation of clathrin-dependent endocytosis,BP,
21673,GO:2000370,1,0.961715914843255,0,5,positive regulation of clathrin-dependent endocytosis,BP,
21674,GO:2000371,1,0.965532563746415,0,5,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21675,GO:2000373,1,0.965532563746415,0,5,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21676,GO:2000374,1,0.988564542463925,0,3,regulation of oxygen metabolic process,BP,
21677,GO:2000376,1,0.993533764517919,0,2,positive regulation of oxygen metabolic process,BP,
21679,GO:2000378,1,0.732801547418151,0,50,negative regulation of reactive oxygen species metabolic process,BP,
21682,GO:2000381,1,0.962707153315081,0,7,negative regulation of mesoderm development,BP,
21686,GO:2000386,1,0.988766428351571,0,2,positive regulation of ovarian follicle development,BP,
21687,GO:2000387,1,0.996277473795601,0,1,regulation of antral ovarian follicle growth,BP,
21688,GO:2000388,1,0.996277473795601,0,1,positive regulation of antral ovarian follicle growth,BP,
21689,GO:2000389,1,0.968658408534758,0,5,regulation of neutrophil extravasation,BP,
21690,GO:2000391,1,0.974453887392371,0,4,positive regulation of neutrophil extravasation,BP,
21692,GO:2000393,1,0.985370435614136,0,2,negative regulation of lamellipodium morphogenesis,BP,
21694,GO:2000395,1,0.992731858743359,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21695,GO:2000397,1,0.992731858743359,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21698,GO:2000403,1,0.82859274511303,0,33,positive regulation of lymphocyte migration,BP,
21701,GO:2000406,1,0.848478642413725,0,28,positive regulation of T cell migration,BP,
21702,GO:2000407,1,0.970168586359037,0,5,regulation of T cell extravasation,BP,
21703,GO:2000408,1,0.992660119957199,0,1,negative regulation of T cell extravasation,BP,
21704,GO:2000409,1,0.981969623832742,0,3,positive regulation of T cell extravasation,BP,
21705,GO:2000410,1,0.978051914283272,0,4,regulation of thymocyte migration,BP,
21706,GO:2000412,1,0.983147660750802,0,3,positive regulation of thymocyte migration,BP,
21707,GO:2000413,1,0.99274771897635,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21708,GO:2000415,1,0.99274771897635,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21709,GO:2000416,1,0.974476173210248,0,4,regulation of eosinophil migration,BP,
21710,GO:2000417,1,0.987991661426253,0,2,negative regulation of eosinophil migration,BP,
21711,GO:2000418,1,0.986321915320208,0,2,positive regulation of eosinophil migration,BP,
21712,GO:2000419,1,0.992582695342739,0,1,regulation of eosinophil extravasation,BP,
21713,GO:2000420,1,0.992582695342739,0,1,negative regulation of eosinophil extravasation,BP,
21714,GO:2000422,1,0.993527733145221,0,1,regulation of eosinophil chemotaxis,BP,
21715,GO:2000424,1,0.993527733145221,0,1,positive regulation of eosinophil chemotaxis,BP,
21716,GO:2000425,1,0.937338749878355,0,10,regulation of apoptotic cell clearance,BP,
21717,GO:2000426,1,0.988269615028298,0,2,negative regulation of apoptotic cell clearance,BP,
21718,GO:2000427,1,0.950612598147593,0,8,positive regulation of apoptotic cell clearance,BP,
21719,GO:2000431,1,0.992477156159595,0,1,regulation of cytokinesis, actomyosin contractile ring assembly,BP,
21720,GO:2000434,1,0.986266774896841,0,3,regulation of protein neddylation,BP,
21721,GO:2000435,1,0.993475657523002,0,2,negative regulation of protein neddylation,BP,
21722,GO:2000436,1,0.992744259439078,0,1,positive regulation of protein neddylation,BP,
21723,GO:2000437,1,0.974040014043095,0,4,regulation of monocyte extravasation,BP,
21724,GO:2000438,1,0.991147196399667,0,1,negative regulation of monocyte extravasation,BP,
21725,GO:2000439,1,0.982741570113137,0,3,positive regulation of monocyte extravasation,BP,
21726,GO:2000446,1,0.984466959923876,0,3,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21727,GO:2000448,1,0.992007085210157,0,2,positive regulation of macrophage migration inhibitory factor signaling pathway,BP,
21728,GO:2000449,1,0.984667461812062,0,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21729,GO:2000451,1,0.989327547918705,0,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21730,GO:2000452,1,0.990775834167858,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21731,GO:2000454,1,0.995464532119532,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21732,GO:2000458,1,0.989478010183,0,2,regulation of astrocyte chemotaxis,BP,
21733,GO:2000463,1,0.810722715116336,0,28,positive regulation of excitatory postsynaptic potential,BP,
21734,GO:2000464,1,0.993835340362938,0,1,positive regulation of astrocyte chemotaxis,BP,
21735,GO:2000465,1,0.950906057897866,0,7,regulation of glycogen (starch) synthase activity,BP,
21736,GO:2000466,1,0.978452028039483,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21737,GO:2000467,1,0.973473958209054,0,4,positive regulation of glycogen (starch) synthase activity,BP,
21738,GO:2000468,1,0.975880353762925,0,3,regulation of peroxidase activity,BP,
21739,GO:2000469,1,0.98980976425874,0,1,negative regulation of peroxidase activity,BP,
21740,GO:2000470,1,0.985928642457927,0,2,positive regulation of peroxidase activity,BP,
21741,GO:2000471,1,0.986004466800454,0,2,regulation of hematopoietic stem cell migration,BP,
21742,GO:2000473,1,0.986004466800454,0,2,positive regulation of hematopoietic stem cell migration,BP,
21743,GO:2000474,1,0.986500773162381,0,2,regulation of opioid receptor signaling pathway,BP,
21744,GO:2000479,1,0.882841410222629,0,19,regulation of cAMP-dependent protein kinase activity,BP,
21745,GO:2000480,1,0.946076279863844,0,9,negative regulation of cAMP-dependent protein kinase activity,BP,
21746,GO:2000481,1,0.962478480645411,0,5,positive regulation of cAMP-dependent protein kinase activity,BP,
21747,GO:2000485,1,0.9865471145797,0,2,regulation of glutamine transport,BP,
21748,GO:2000486,1,0.992577307963612,0,1,negative regulation of glutamine transport,BP,
21749,GO:2000487,1,0.993925171941381,0,1,positive regulation of glutamine transport,BP,
21750,GO:2000489,1,0.958148769647765,0,6,regulation of hepatic stellate cell activation,BP,
21751,GO:2000490,1,0.987766391669197,0,2,negative regulation of hepatic stellate cell activation,BP,
21752,GO:2000491,1,0.970019268061334,0,4,positive regulation of hepatic stellate cell activation,BP,
21753,GO:2000492,1,0.992920184257471,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21754,GO:2000494,1,0.992920184257471,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21755,GO:2000501,1,0.981349021797183,0,5,regulation of natural killer cell chemotaxis,BP,
21756,GO:2000502,1,0.992802574655102,0,2,negative regulation of natural killer cell chemotaxis,BP,
21757,GO:2000503,1,0.988464262636225,0,3,positive regulation of natural killer cell chemotaxis,BP,
21758,GO:2000504,1,0.994193353797425,0,1,positive regulation of blood vessel remodeling,BP,
21759,GO:2000508,1,0.955266136098196,0,9,regulation of dendritic cell chemotaxis,BP,
21760,GO:2000509,1,0.992639680906928,0,1,negative regulation of dendritic cell chemotaxis,BP,
21761,GO:2000510,1,0.962352120531242,0,8,positive regulation of dendritic cell chemotaxis,BP,
21762,GO:2000511,1,0.996473668370333,0,1,regulation of granzyme A production,BP,
21763,GO:2000513,1,0.996473668370333,0,1,positive regulation of granzyme A production,BP,
21764,GO:2000514,1,0.713075931595216,0,55,regulation of CD4-positive, alpha-beta T cell activation,BP,
21765,GO:2000515,1,0.842490912818366,0,27,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
21766,GO:2000516,1,0.828954697886181,0,32,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
21767,GO:2000517,1,0.996473668370333,0,1,regulation of T-helper 1 cell activation,BP,
21768,GO:2000518,1,0.996473668370333,0,1,negative regulation of T-helper 1 cell activation,BP,
21769,GO:2000520,1,0.985286204732826,0,3,regulation of immunological synapse formation,BP,
21770,GO:2000521,1,0.990559431507809,0,2,negative regulation of immunological synapse formation,BP,
21771,GO:2000522,1,0.994677031264593,0,1,positive regulation of immunological synapse formation,BP,
21772,GO:2000523,1,0.983349965633286,0,3,regulation of T cell costimulation,BP,
21773,GO:2000524,1,0.996030141837984,0,1,negative regulation of T cell costimulation,BP,
21774,GO:2000525,1,0.987269799083208,0,2,positive regulation of T cell costimulation,BP,
21775,GO:2000526,1,0.994677031264593,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21776,GO:2000527,1,0.996730964658139,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21777,GO:2000529,1,0.996730964658139,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21778,GO:2000532,1,0.993818551343362,0,1,regulation of renal albumin absorption,BP,
21779,GO:2000533,1,0.993818551343362,0,1,negative regulation of renal albumin absorption,BP,
21780,GO:2000535,1,0.957959750902092,0,6,regulation of entry of bacterium into host cell,BP,
21781,GO:2000536,1,0.991060049921919,0,1,negative regulation of entry of bacterium into host cell,BP,
21782,GO:2000537,1,0.988897436189445,0,2,regulation of B cell chemotaxis,BP,
21783,GO:2000538,1,0.988897436189445,0,2,positive regulation of B cell chemotaxis,BP,
21784,GO:2000539,1,0.993825738201288,0,1,regulation of protein geranylgeranylation,BP,
21785,GO:2000541,1,0.993825738201288,0,1,positive regulation of protein geranylgeranylation,BP,
21788,GO:2000544,1,0.968428702818818,0,5,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21789,GO:2000545,1,0.996492397595218,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21790,GO:2000546,1,0.979194434897092,0,3,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21791,GO:2000547,1,0.988263035987117,0,3,regulation of dendritic cell dendrite assembly,BP,
21792,GO:2000548,1,0.996730964658139,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21793,GO:2000549,1,0.996810748117585,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21794,GO:2000551,1,0.952563570055919,0,9,regulation of T-helper 2 cell cytokine production,BP,
21795,GO:2000552,1,0.989885255417584,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21796,GO:2000553,1,0.962300800139759,0,7,positive regulation of T-helper 2 cell cytokine production,BP,
21797,GO:2000554,1,0.974127610345114,0,5,regulation of T-helper 1 cell cytokine production,BP,
21798,GO:2000556,1,0.974127610345114,0,5,positive regulation of T-helper 1 cell cytokine production,BP,
21799,GO:2000557,1,0.996473668370333,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21800,GO:2000558,1,0.996473668370333,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21801,GO:2000559,1,0.991147196399667,0,1,regulation of CD24 production,BP,
21802,GO:2000560,1,0.991147196399667,0,1,positive regulation of CD24 production,BP,
21803,GO:2000561,1,0.947822404180687,0,11,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21804,GO:2000562,1,0.965572657299922,0,8,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21805,GO:2000563,1,0.97408508646189,0,5,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21806,GO:2000564,1,0.9593171932062,0,7,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21807,GO:2000566,1,0.981359431257483,0,4,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21808,GO:2000567,1,0.996044757766901,0,1,regulation of memory T cell activation,BP,
21809,GO:2000568,1,0.996044757766901,0,1,positive regulation of memory T cell activation,BP,
21810,GO:2000569,1,0.992655629060049,0,1,regulation of T-helper 2 cell activation,BP,
21811,GO:2000570,1,0.992655629060049,0,1,positive regulation of T-helper 2 cell activation,BP,
21812,GO:2000571,1,0.992553532471137,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21813,GO:2000572,1,0.992553532471137,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21815,GO:2000574,1,0.946164736011876,0,9,regulation of microtubule motor activity,BP,
21816,GO:2000575,1,0.991783411295803,0,1,negative regulation of microtubule motor activity,BP,
21817,GO:2000576,1,0.982401333806674,0,4,positive regulation of microtubule motor activity,BP,
21818,GO:2000580,1,0.989073321949908,0,3,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21819,GO:2000582,1,0.989073321949908,0,3,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21820,GO:2000583,1,0.970748248476794,0,4,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21821,GO:2000584,1,0.992486307883421,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21822,GO:2000586,1,0.936707198018095,0,8,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21823,GO:2000587,1,0.967135513279179,0,4,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21824,GO:2000588,1,0.975889052930792,0,3,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21825,GO:2000589,1,0.978222955236897,0,3,regulation of metanephric mesenchymal cell migration,BP,
21826,GO:2000591,1,0.978222955236897,0,3,positive regulation of metanephric mesenchymal cell migration,BP,
21827,GO:2000592,1,0.984991601333973,0,2,regulation of metanephric DCT cell differentiation,BP,
21828,GO:2000594,1,0.984991601333973,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21829,GO:2000595,1,0.992451971441975,0,1,regulation of optic nerve formation,BP,
21830,GO:2000597,1,0.992451971441975,0,1,positive regulation of optic nerve formation,BP,
21831,GO:2000601,1,0.936368779262087,0,9,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21832,GO:2000606,1,0.992826729914151,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21833,GO:2000607,1,0.992826729914151,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21834,GO:2000609,1,0.968637836767841,0,5,regulation of thyroid hormone generation,BP,
21835,GO:2000611,1,0.973126214947023,0,4,positive regulation of thyroid hormone generation,BP,
21836,GO:2000612,1,0.99248346894442,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21837,GO:2000615,1,0.926555754596829,0,11,regulation of histone H3-K9 acetylation,BP,
21838,GO:2000616,1,0.992052010581334,0,1,negative regulation of histone H3-K9 acetylation,BP,
21839,GO:2000617,1,0.946562809153393,0,8,positive regulation of histone H3-K9 acetylation,BP,
21840,GO:2000618,1,0.9576747350871,0,6,regulation of histone H4-K16 acetylation,BP,
21841,GO:2000619,1,0.981710019581025,0,3,negative regulation of histone H4-K16 acetylation,BP,
21842,GO:2000620,1,0.98265600422146,0,2,positive regulation of histone H4-K16 acetylation,BP,
21843,GO:2000622,1,0.969232023932031,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21844,GO:2000623,1,0.969232023932031,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21845,GO:2000625,1,0.977714277876696,0,3,regulation of miRNA catabolic process,BP,
21846,GO:2000627,1,0.977714277876696,0,3,positive regulation of miRNA catabolic process,BP,
21847,GO:2000628,1,0.929807907031035,0,10,regulation of miRNA metabolic process,BP,
21848,GO:2000630,1,0.960834054216376,0,6,positive regulation of miRNA metabolic process,BP,
21849,GO:2000631,1,0.98460877893061,0,2,regulation of pre-miRNA processing,BP,
21850,GO:2000632,1,0.98460877893061,0,2,negative regulation of pre-miRNA processing,BP,
21851,GO:2000634,1,0.98066203964335,0,3,regulation of primary miRNA processing,BP,
21852,GO:2000635,1,0.98066203964335,0,3,negative regulation of primary miRNA processing,BP,
21854,GO:2000638,1,0.95956167502444,0,6,regulation of SREBP signaling pathway,BP,
21855,GO:2000639,1,0.979639023208168,0,3,negative regulation of SREBP signaling pathway,BP,
21856,GO:2000640,1,0.986889424267904,0,2,positive regulation of SREBP signaling pathway,BP,
21857,GO:2000641,1,0.892836563832743,0,17,regulation of early endosome to late endosome transport,BP,
21858,GO:2000642,1,0.99308214472774,0,2,negative regulation of early endosome to late endosome transport,BP,
21859,GO:2000643,1,0.941891671152992,0,8,positive regulation of early endosome to late endosome transport,BP,
21860,GO:2000644,1,0.930761073478727,0,10,regulation of receptor catabolic process,BP,
21861,GO:2000645,1,0.980714496237124,0,3,negative regulation of receptor catabolic process,BP,
21862,GO:2000646,1,0.955937952658482,0,6,positive regulation of receptor catabolic process,BP,
21863,GO:2000647,1,0.927544130874284,0,11,negative regulation of stem cell proliferation,BP,
21866,GO:2000650,1,0.91504026658799,0,12,negative regulation of sodium ion transmembrane transporter activity,BP,
21868,GO:2000653,1,0.967541477143429,0,4,regulation of genetic imprinting,BP,
21869,GO:2000654,1,0.992486473496815,0,1,regulation of cellular response to testosterone stimulus,BP,
21870,GO:2000655,1,0.992486473496815,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21871,GO:2000656,1,0.995398212808038,0,1,regulation of apolipoprotein binding,BP,
21872,GO:2000657,1,0.995398212808038,0,1,negative regulation of apolipoprotein binding,BP,
21873,GO:2000659,1,0.956737694091959,0,8,regulation of interleukin-1-mediated signaling pathway,BP,
21874,GO:2000660,1,0.974169304472628,0,5,negative regulation of interleukin-1-mediated signaling pathway,BP,
21875,GO:2000661,1,0.992183642931096,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21876,GO:2000668,1,0.937854554410806,0,11,regulation of dendritic cell apoptotic process,BP,
21877,GO:2000669,1,0.963245717430966,0,7,negative regulation of dendritic cell apoptotic process,BP,
21878,GO:2000670,1,0.973649936497701,0,4,positive regulation of dendritic cell apoptotic process,BP,
21881,GO:2000674,1,0.943934970567192,0,9,regulation of type B pancreatic cell apoptotic process,BP,
21882,GO:2000675,1,0.958571728466323,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21883,GO:2000676,1,0.98473720377674,0,3,positive regulation of type B pancreatic cell apoptotic process,BP,
21884,GO:2000677,1,0.737397409687223,0,46,regulation of transcription regulatory region DNA binding,BP,
21885,GO:2000678,1,0.893771696387229,0,19,negative regulation of transcription regulatory region DNA binding,BP,
21886,GO:2000679,1,0.86865872370316,0,21,positive regulation of transcription regulatory region DNA binding,BP,
21887,GO:2000683,1,0.986025236891825,0,2,regulation of cellular response to X-ray,BP,
21888,GO:2000685,1,0.993149866754886,0,1,positive regulation of cellular response to X-ray,BP,
21889,GO:2000690,1,0.992421927553956,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21890,GO:2000691,1,0.992421927553956,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21891,GO:2000696,1,0.89480886147491,0,16,regulation of epithelial cell differentiation involved in kidney development,BP,
21892,GO:2000697,1,0.971728450591285,0,5,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21893,GO:2000698,1,0.967131598983267,0,5,positive regulation of epithelial cell differentiation involved in kidney development,BP,
21894,GO:2000699,1,0.992826729914151,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21895,GO:2000701,1,0.992826729914151,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21896,GO:2000702,1,0.992826729914151,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21897,GO:2000703,1,0.992826729914151,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21898,GO:2000705,1,0.977733392305338,0,3,regulation of dense core granule biogenesis,BP,
21899,GO:2000706,1,0.99251142507962,0,1,negative regulation of dense core granule biogenesis,BP,
21900,GO:2000707,1,0.985111598309513,0,2,positive regulation of dense core granule biogenesis,BP,
21901,GO:2000718,1,0.996725737755439,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21902,GO:2000719,1,0.996725737755439,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21903,GO:2000721,1,0.976287187053415,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21904,GO:2000722,1,0.977997419626896,0,3,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21905,GO:2000723,1,0.993448773682912,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21906,GO:2000724,1,0.984447787438749,0,2,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21910,GO:2000729,1,0.989456870287504,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21911,GO:2000730,1,0.992740832877466,0,1,regulation of termination of RNA polymerase I transcription,BP,
21912,GO:2000733,1,0.992826729914151,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21913,GO:2000734,1,0.992826729914151,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21915,GO:2000737,1,0.868548815720083,0,19,negative regulation of stem cell differentiation,BP,
21916,GO:2000738,1,0.867215497556693,0,21,positive regulation of stem cell differentiation,BP,
21918,GO:2000740,1,0.99251142507962,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21919,GO:2000741,1,0.96757672023385,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21920,GO:2000742,1,0.994890857381385,0,1,regulation of anterior head development,BP,
21921,GO:2000744,1,0.994890857381385,0,1,positive regulation of anterior head development,BP,
21922,GO:2000752,1,0.993215885492504,0,1,regulation of glucosylceramide catabolic process,BP,
21923,GO:2000753,1,0.993215885492504,0,1,positive regulation of glucosylceramide catabolic process,BP,
21924,GO:2000754,1,0.993215885492504,0,1,regulation of sphingomyelin catabolic process,BP,
21925,GO:2000755,1,0.993215885492504,0,1,positive regulation of sphingomyelin catabolic process,BP,
21926,GO:2000756,1,0.67048049119163,0,60,regulation of peptidyl-lysine acetylation,BP,
21927,GO:2000757,1,0.88723211646656,0,19,negative regulation of peptidyl-lysine acetylation,BP,
21928,GO:2000758,1,0.806508092396258,0,32,positive regulation of peptidyl-lysine acetylation,BP,
21929,GO:2000759,1,0.992202015559982,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21930,GO:2000761,1,0.992202015559982,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21931,GO:2000763,1,0.994170413662504,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21932,GO:2000764,1,0.994170413662504,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21933,GO:2000765,1,0.837695904959332,0,26,regulation of cytoplasmic translation,BP,
21934,GO:2000766,1,0.943664788056057,0,8,negative regulation of cytoplasmic translation,BP,
21935,GO:2000767,1,0.93252907264417,0,10,positive regulation of cytoplasmic translation,BP,
21936,GO:2000768,1,0.992477156159595,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
21937,GO:2000772,1,0.767122286691472,0,41,regulation of cellular senescence,BP,
21938,GO:2000773,1,0.873218878698645,0,19,negative regulation of cellular senescence,BP,
21939,GO:2000774,1,0.943018883980504,0,12,positive regulation of cellular senescence,BP,
21940,GO:2000775,1,0.994878076411831,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21941,GO:2000777,1,0.98943019011322,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21942,GO:2000779,1,0.613041743765671,0,70,regulation of double-strand break repair,BP,
21943,GO:2000780,1,0.82929236778299,0,26,negative regulation of double-strand break repair,BP,
21944,GO:2000781,1,0.814273461230655,0,28,positive regulation of double-strand break repair,BP,
21945,GO:2000785,1,0.796198582089528,0,34,regulation of autophagosome assembly,BP,
21946,GO:2000786,1,0.940450749947069,0,8,positive regulation of autophagosome assembly,BP,
21947,GO:2000790,1,0.982953123034923,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21948,GO:2000791,1,0.982953123034923,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21949,GO:2000793,1,0.96456459196386,0,4,cell proliferation involved in heart valve development,BP,
21950,GO:2000794,1,0.942797303298277,0,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21951,GO:2000795,1,0.990395377989719,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21952,GO:2000797,1,0.99251142507962,0,1,regulation of amniotic stem cell differentiation,BP,
21953,GO:2000798,1,0.99251142507962,0,1,negative regulation of amniotic stem cell differentiation,BP,
21954,GO:2000800,1,0.995854312720373,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21955,GO:2000802,1,0.995854312720373,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21956,GO:2000804,1,0.975613085768278,0,3,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21957,GO:2000805,1,0.986555151512788,0,2,negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21958,GO:2000806,1,0.988910336026141,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21959,GO:2000807,1,0.930337638817082,0,9,regulation of synaptic vesicle clustering,BP,
21960,GO:2000808,1,0.991849293856569,0,1,negative regulation of synaptic vesicle clustering,BP,
21961,GO:2000809,1,0.961047359060227,0,5,positive regulation of synaptic vesicle clustering,BP,
21963,GO:2000811,1,0.890114352905143,0,16,negative regulation of anoikis,BP,
21964,GO:2000812,1,0.992482386659034,0,1,regulation of barbed-end actin filament capping,BP,
21965,GO:2000815,1,0.985853643454242,0,2,regulation of mRNA stability involved in response to oxidative stress,BP,
21966,GO:2000816,1,0.790820291144223,0,37,negative regulation of mitotic sister chromatid separation,BP,
21967,GO:2000818,1,0.98876976598731,0,2,negative regulation of myoblast proliferation,BP,
21968,GO:2000819,1,0.979322631129665,0,3,regulation of nucleotide-excision repair,BP,
21969,GO:2000820,1,0.979541010467677,0,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21972,GO:2000825,1,0.980615087903961,0,4,positive regulation of androgen receptor activity,BP,
21973,GO:2000826,1,0.766401010076021,0,38,regulation of heart morphogenesis,BP,
21974,GO:2000827,1,0.993873967922025,0,1,mitochondrial RNA surveillance,BP,
21975,GO:2000828,1,0.987201564072943,0,2,regulation of parathyroid hormone secretion,BP,
21976,GO:2000830,1,0.991797095072954,0,1,positive regulation of parathyroid hormone secretion,BP,
21977,GO:2000831,1,0.916049477026575,0,16,regulation of steroid hormone secretion,BP,
21978,GO:2000832,1,0.984149169969071,0,2,negative regulation of steroid hormone secretion,BP,
21979,GO:2000833,1,0.956283832069927,0,9,positive regulation of steroid hormone secretion,BP,
21980,GO:2000834,1,0.9926531008435,0,1,regulation of androgen secretion,BP,
21981,GO:2000836,1,0.9926531008435,0,1,positive regulation of androgen secretion,BP,
21982,GO:2000843,1,0.983784099721895,0,2,regulation of testosterone secretion,BP,
21983,GO:2000845,1,0.983784099721895,0,2,positive regulation of testosterone secretion,BP,
21984,GO:2000846,1,0.930340648447128,0,13,regulation of corticosteroid hormone secretion,BP,
21985,GO:2000847,1,0.984149169969071,0,2,negative regulation of corticosteroid hormone secretion,BP,
21986,GO:2000848,1,0.966402089892003,0,7,positive regulation of corticosteroid hormone secretion,BP,
21987,GO:2000849,1,0.954875896004428,0,9,regulation of glucocorticoid secretion,BP,
21988,GO:2000850,1,0.984149169969071,0,2,negative regulation of glucocorticoid secretion,BP,
21989,GO:2000851,1,0.979931591585997,0,5,positive regulation of glucocorticoid secretion,BP,
21990,GO:2000852,1,0.983179063647841,0,4,regulation of corticosterone secretion,BP,
21991,GO:2000854,1,0.992978071828239,0,2,positive regulation of corticosterone secretion,BP,
21992,GO:2000855,1,0.974317259021307,0,4,regulation of mineralocorticoid secretion,BP,
21993,GO:2000857,1,0.98619626282492,0,2,positive regulation of mineralocorticoid secretion,BP,
21994,GO:2000858,1,0.974317259021307,0,4,regulation of aldosterone secretion,BP,
21995,GO:2000860,1,0.98619626282492,0,2,positive regulation of aldosterone secretion,BP,
21996,GO:2000864,1,0.979847693725077,0,3,regulation of estradiol secretion,BP,
21997,GO:2000866,1,0.988384959252514,0,2,positive regulation of estradiol secretion,BP,
21998,GO:2000870,1,0.991938287775777,0,2,regulation of progesterone secretion,BP,
21999,GO:2000872,1,0.996857656294296,0,1,positive regulation of progesterone secretion,BP,
22000,GO:2000878,1,0.989349630498951,0,2,positive regulation of oligopeptide transport,BP,
22001,GO:2000880,1,0.989349630498951,0,2,positive regulation of dipeptide transport,BP,
22002,GO:2000896,1,0.992744259439078,0,1,amylopectin metabolic process,BP,
22003,GO:2000909,1,0.98040700558588,0,2,regulation of sterol import,BP,
22004,GO:2000911,1,0.987065584560306,0,1,positive regulation of sterol import,BP,
22005,GO:2000969,1,0.943479344830792,0,8,positive regulation of AMPA receptor activity,BP,
22006,GO:2000970,1,0.994049141089785,0,1,regulation of detection of glucose,BP,
22007,GO:2000971,1,0.994049141089785,0,1,negative regulation of detection of glucose,BP,
22008,GO:2000973,1,0.950701048468306,0,7,regulation of pro-B cell differentiation,BP,
22009,GO:2000974,1,0.982449128491833,0,3,negative regulation of pro-B cell differentiation,BP,
22010,GO:2000975,1,0.992380263846205,0,1,positive regulation of pro-B cell differentiation,BP,
22011,GO:2000977,1,0.974915306681716,0,5,regulation of forebrain neuron differentiation,BP,
22012,GO:2000978,1,0.989284251385353,0,3,negative regulation of forebrain neuron differentiation,BP,
22013,GO:2000979,1,0.992825158104098,0,1,positive regulation of forebrain neuron differentiation,BP,
22014,GO:2000980,1,0.955067004031947,0,7,regulation of inner ear receptor cell differentiation,BP,
22015,GO:2000981,1,0.975208148925855,0,4,negative regulation of inner ear receptor cell differentiation,BP,
22016,GO:2000983,1,0.996473668370333,0,1,regulation of ATP citrate synthase activity,BP,
22017,GO:2000984,1,0.996473668370333,0,1,negative regulation of ATP citrate synthase activity,BP,
22018,GO:2000986,1,0.996568367492993,0,1,negative regulation of behavioral fear response,BP,
22020,GO:2001012,1,0.957216997393143,0,7,mesenchymal cell differentiation involved in renal system development,BP,
22021,GO:2001013,1,0.96898110439372,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
22022,GO:2001014,1,0.875465632851682,0,19,regulation of skeletal muscle cell differentiation,BP,
22023,GO:2001015,1,0.958802234631243,0,6,negative regulation of skeletal muscle cell differentiation,BP,
22024,GO:2001016,1,0.960155387963978,0,6,positive regulation of skeletal muscle cell differentiation,BP,
22026,GO:2001021,1,0.630892773010814,0,72,negative regulation of response to DNA damage stimulus,BP,
22028,GO:2001023,1,0.96023814077361,0,5,regulation of response to drug,BP,
22029,GO:2001025,1,0.99325505912211,0,1,positive regulation of response to drug,BP,
22030,GO:2001026,1,0.881771380278563,0,18,regulation of endothelial cell chemotaxis,BP,
22031,GO:2001027,1,0.978124744835872,0,3,negative regulation of endothelial cell chemotaxis,BP,
22032,GO:2001028,1,0.908341699745603,0,14,positive regulation of endothelial cell chemotaxis,BP,
22033,GO:2001029,1,0.991861136689447,0,1,regulation of cellular glucuronidation,BP,
22034,GO:2001031,1,0.991861136689447,0,1,positive regulation of cellular glucuronidation,BP,
22035,GO:2001032,1,0.866476281362996,0,21,regulation of double-strand break repair via nonhomologous end joining,BP,
22036,GO:2001033,1,0.962137948380808,0,6,negative regulation of double-strand break repair via nonhomologous end joining,BP,
22037,GO:2001034,1,0.924681346732746,0,11,positive regulation of double-strand break repair via nonhomologous end joining,BP,
22038,GO:2001035,1,0.988437693959186,0,2,regulation of tongue muscle cell differentiation,BP,
22039,GO:2001037,1,0.988437693959186,0,2,positive regulation of tongue muscle cell differentiation,BP,
22040,GO:2001038,1,0.977651463944229,0,3,regulation of cellular response to drug,BP,
22041,GO:2001040,1,0.99325505912211,0,1,positive regulation of cellular response to drug,BP,
22042,GO:2001044,1,0.911026956774625,0,15,regulation of integrin-mediated signaling pathway,BP,
22043,GO:2001045,1,0.976578125381985,0,3,negative regulation of integrin-mediated signaling pathway,BP,
22044,GO:2001046,1,0.956584331040393,0,7,positive regulation of integrin-mediated signaling pathway,BP,
22045,GO:2001049,1,0.995129860713951,0,1,regulation of tendon cell differentiation,BP,
22046,GO:2001051,1,0.995129860713951,0,1,positive regulation of tendon cell differentiation,BP,
22047,GO:2001053,1,0.936414471365527,0,11,regulation of mesenchymal cell apoptotic process,BP,
22048,GO:2001054,1,0.945988594037039,0,9,negative regulation of mesenchymal cell apoptotic process,BP,
22049,GO:2001055,1,0.989884949894034,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
22051,GO:2001057,1,0.636284128977315,0,69,reactive nitrogen species metabolic process,BP,
22052,GO:2001065,1,0.996337752721494,0,1,mannan binding,MF,
22053,GO:2001069,1,0.954016920122492,0,7,glycogen binding,MF,
22054,GO:2001070,1,0.985900634668146,0,2,starch binding,MF,
22055,GO:2001074,1,0.988534916645731,0,2,regulation of metanephric ureteric bud development,BP,
22056,GO:2001076,1,0.988534916645731,0,2,positive regulation of metanephric ureteric bud development,BP,
22057,GO:2001106,1,0.97550130102972,0,3,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
22058,GO:2001108,1,0.991388821048341,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
22059,GO:2001109,1,0.985315001263615,0,2,regulation of lens epithelial cell proliferation,BP,
22060,GO:2001111,1,0.985315001263615,0,2,positive regulation of lens epithelial cell proliferation,BP,
22061,GO:2001112,1,0.992154869422285,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
22062,GO:2001113,1,0.992154869422285,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
22064,GO:2001136,1,0.992611594594126,0,1,negative regulation of endocytic recycling,BP,
22065,GO:2001137,1,0.966785174269286,0,4,positive regulation of endocytic recycling,BP,
22066,GO:2001138,1,0.939690707192526,0,11,regulation of phospholipid transport,BP,
22067,GO:2001140,1,0.939690707192526,0,11,positive regulation of phospholipid transport,BP,
22069,GO:2001142,1,0.993682281764436,0,1,nicotinate transport,BP,
22070,GO:2001144,1,0.994643313763242,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
22071,GO:2001145,1,0.994643313763242,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
22072,GO:2001148,1,0.989349630498951,0,2,regulation of dipeptide transmembrane transport,BP,
22073,GO:2001150,1,0.989349630498951,0,2,positive regulation of dipeptide transmembrane transport,BP,
22074,GO:2001151,1,0.992691803075415,0,1,regulation of renal water transport,BP,
22075,GO:2001153,1,0.992691803075415,0,1,positive regulation of renal water transport,BP,
22076,GO:2001160,1,0.988928244876729,0,2,regulation of histone H3-K79 methylation,BP,
22077,GO:2001162,1,0.988928244876729,0,2,positive regulation of histone H3-K79 methylation,BP,
22078,GO:2001163,1,0.994405736711206,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
22079,GO:2001165,1,0.994405736711206,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
22080,GO:2001166,1,0.966423165356448,0,5,regulation of histone H2B ubiquitination,BP,
22081,GO:2001168,1,0.971505488076325,0,4,positive regulation of histone H2B ubiquitination,BP,
22082,GO:2001169,1,0.909543482567518,0,15,regulation of ATP biosynthetic process,BP,
22083,GO:2001170,1,0.979324732516105,0,3,negative regulation of ATP biosynthetic process,BP,
22084,GO:2001171,1,0.941334186431051,0,10,positive regulation of ATP biosynthetic process,BP,
22085,GO:2001173,1,0.994770150841765,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
22086,GO:2001176,1,0.994218906995635,0,1,regulation of mediator complex assembly,BP,
22087,GO:2001178,1,0.994218906995635,0,1,positive regulation of mediator complex assembly,BP,
22088,GO:2001185,1,0.900231660431368,0,17,regulation of CD8-positive, alpha-beta T cell activation,BP,
22089,GO:2001186,1,0.973668025941104,0,5,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
22090,GO:2001187,1,0.951543850368854,0,8,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
22091,GO:2001188,1,0.972227099488952,0,6,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
22092,GO:2001189,1,0.983716020092203,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
22093,GO:2001190,1,0.98832284708986,0,3,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
22094,GO:2001191,1,0.993092034082734,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
22095,GO:2001193,1,0.993092034082734,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
22096,GO:2001197,1,0.9573699714141,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
22097,GO:2001198,1,0.941314380645896,0,12,regulation of dendritic cell differentiation,BP,
22098,GO:2001199,1,0.970800775318833,0,6,negative regulation of dendritic cell differentiation,BP,
22099,GO:2001200,1,0.977328303534865,0,4,positive regulation of dendritic cell differentiation,BP,
22100,GO:2001204,1,0.933282997442542,0,10,regulation of osteoclast development,BP,
22101,GO:2001205,1,0.9686632847562,0,4,negative regulation of osteoclast development,BP,
22102,GO:2001206,1,0.978297655187037,0,4,positive regulation of osteoclast development,BP,
22103,GO:2001207,1,0.992490373839655,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
22104,GO:2001208,1,0.992490373839655,0,1,negative regulation of transcription elongation by RNA polymerase I,BP,
22105,GO:2001212,1,0.904615445360015,0,16,regulation of vasculogenesis,BP,
22106,GO:2001213,1,0.991736530860661,0,1,negative regulation of vasculogenesis,BP,
22107,GO:2001214,1,0.930813305575996,0,12,positive regulation of vasculogenesis,BP,
22108,GO:2001222,1,0.741205871827606,0,38,regulation of neuron migration,BP,
22109,GO:2001223,1,0.934077483238722,0,9,negative regulation of neuron migration,BP,
22110,GO:2001224,1,0.889248833657744,0,14,positive regulation of neuron migration,BP,
22111,GO:2001225,1,0.932297891657316,0,10,regulation of chloride transport,BP,
22112,GO:2001226,1,0.978560580063577,0,3,negative regulation of chloride transport,BP,
22113,GO:2001228,1,0.976721717793234,0,2,regulation of response to gamma radiation,BP,
22114,GO:2001229,1,0.98771123609118,0,1,negative regulation of response to gamma radiation,BP,
22123,GO:2001241,1,0.933662460266863,0,11,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
22125,GO:2001243,1,0.581003009674723,0,91,negative regulation of intrinsic apoptotic signaling pathway,BP,
22127,GO:2001245,1,0.970653597026535,0,5,regulation of phosphatidylcholine biosynthetic process,BP,
22128,GO:2001246,1,0.99247445228052,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
22129,GO:2001247,1,0.981366706395942,0,3,positive regulation of phosphatidylcholine biosynthetic process,BP,
22130,GO:2001248,1,0.994728818783657,0,1,regulation of ammonia assimilation cycle,BP,
22131,GO:2001250,1,0.994728818783657,0,1,positive regulation of ammonia assimilation cycle,BP,
22132,GO:2001251,1,0.422177652933438,0,124,negative regulation of chromosome organization,BP,
22133,GO:2001252,1,0.313026980877615,0,168,positive regulation of chromosome organization,BP,
22134,GO:2001253,1,0.97774038760718,0,3,regulation of histone H3-K36 trimethylation,BP,
22135,GO:2001255,1,0.984740850825031,0,2,positive regulation of histone H3-K36 trimethylation,BP,
22136,GO:2001256,1,0.921195193768398,0,13,regulation of store-operated calcium entry,BP,
22140,GO:2001260,1,0.982697247716472,0,3,regulation of semaphorin-plexin signaling pathway,BP,
22141,GO:2001262,1,0.994170413662504,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
22143,GO:2001268,1,0.970686486763845,0,6,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
22145,GO:2001270,1,0.972143820899312,0,5,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
22146,GO:2001271,1,0.979099630641567,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
22147,GO:2001272,1,0.992897236899484,0,2,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
22148,GO:2001279,1,0.935677151687526,0,11,regulation of unsaturated fatty acid biosynthetic process,BP,
22149,GO:2001280,1,0.952666795380894,0,8,positive regulation of unsaturated fatty acid biosynthetic process,BP,
22150,GO:2001286,1,0.955410763022962,0,7,regulation of caveolin-mediated endocytosis,BP,
22151,GO:2001287,1,0.98861434221091,0,2,negative regulation of caveolin-mediated endocytosis,BP,
22152,GO:2001288,1,0.9737608760418,0,4,positive regulation of caveolin-mediated endocytosis,BP,
22153,GO:2001293,1,0.984465364782561,0,2,malonyl-CoA metabolic process,BP,
22154,GO:2001294,1,0.994614758928299,0,1,malonyl-CoA catabolic process,BP,
22155,GO:2001295,1,0.989796212033453,0,1,malonyl-CoA biosynthetic process,BP,
22156,GO:2001300,1,0.962257098114059,0,7,lipoxin metabolic process,BP,
22157,GO:2001301,1,0.962257098114059,0,7,lipoxin biosynthetic process,BP,
22158,GO:2001302,1,0.981245589191792,0,3,lipoxin A4 metabolic process,BP,
22159,GO:2001303,1,0.981245589191792,0,3,lipoxin A4 biosynthetic process,BP,
22160,GO:2001304,1,0.994167868300104,0,1,lipoxin B4 metabolic process,BP,
22161,GO:2001306,1,0.994167868300104,0,1,lipoxin B4 biosynthetic process,BP,
22162,GO:2001311,1,0.989667316596678,0,2,lysobisphosphatidic acid metabolic process,BP,
4009,GO:0008347,1,0.720985618970812,0,48,glial cell migration,BP,
14621,GO:0060487,1,0.882684035344498,0,20,lung epithelial cell differentiation,BP,
18812,GO:1900273,1,0.843219222750776,0,22,positive regulation of long-term synaptic potentiation,BP,
14226,GO:0055075,1,0.824999048200593,0,27,potassium ion homeostasis,BP,
13276,GO:0050661,1,0.738681953775137,0,50,NADP binding,MF,
5604,GO:0015932,1,0.730144987481979,0,51,nucleobase-containing compound transmembrane transporter activity,MF,
3540,GO:0007035,1.00000000000001,0.868370338846937,0,23,vacuolar acidification,BP,
1860,GO:0004177,1.00000000000001,0.749418401123336,0,43,aminopeptidase activity,MF,
11786,GO:0045143,1.00000000000001,0.745215907326213,0,45,homologous chromosome segregation,BP,
6840,GO:0021692,1.00000000000001,0.89596549271635,0,14,cerebellar Purkinje cell layer morphogenesis,BP,
4527,GO:0009650,1.00000000000001,0.925013806755313,0,13,UV protection,BP,
